PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Booy, EP; Henson, ES; Gibson, SB				Booy, E. P.; Henson, E. S.; Gibson, S. B.			Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer	ONCOGENE			English	Article						Mcl-1; Elk-1; breast cancer; regulation; drug resistance	ACTIVATED PROTEIN-KINASE; BCL-2 FAMILY PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; COLORECTAL-CANCER; MULTIPLE-MYELOMA; MEK INHIBITION; FACTOR COMPLEX; APOPTOSIS; RESISTANCE; GENE	Myeloid cell leukaemia-1 (Mcl-1) is an anti-apoptotic member of the Bcl-2 family that is elevated in a variety of tumour types including breast cancer. In breast tumours, increased Mcl-1 expression correlates with high tumour grade and poor patient survival. We have previously demonstrated that Her-2 levels correspond to increased Mcl-1 expression in breast tumours. Epidermal growth factor (EGF) receptor signalling is frequently deregulated in breast cancer and leads to increased proliferation and survival. Herein, we determined the critical downstream signals responsible for the EGF mediated increase of Mcl-1 and their role in cell survival. We found that both Mcl-1 mRNA and protein levels are rapidly induced upon stimulation with EGF. Promoter analysis revealed that an Elk-1 transcription factor-binding site is critical for EGF activation of the Mcl-1 promoter. Furthermore, we found that knockdown of Elk-1 or inhibition of the Erk signalling pathway was sufficient to block EGF upregulation of Mcl-1 and EGF mediated cell survival. Using chromatin immunoprecipitation and biotin labelled probes of the Mcl-1 promoter, we found that Elk-1 and serum response factor are bound to the promoter after EGF stimulation. To determine whether Mcl-1 confers a survival advantage, we found that knockdown of Mcl-1 expression increased apoptosis whereas overexpression of Mcl-1 inhibited drug induced cell death. In human breast tumours, we found a correlation between phosphorylated Elk-1 and Mcl-1 protein levels. These results indicate that the EGF induced activation of Elk-1 is an important mediator of Mcl-1 expression and cell survival and therefore a potential therapeutic target in breast cancer. Oncogene (2011) 30, 2367-2378; doi: 10.1038/onc.2010.616; published online 24 January 2011	[Booy, E. P.; Henson, E. S.; Gibson, S. B.] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; [Booy, E. P.; Henson, E. S.; Gibson, S. B.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0V9, Canada	University of Manitoba; University of Manitoba	Gibson, SB (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	gibsonsb@cc.umanitoba.ca		Gibson, Spencer/0000-0003-0119-732X	Canadian Breast Cancer Foundation; Prairie chapter; Canadian Institutes for Health Research (CIHR)	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Prairie chapter; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The work is supported by a grant from the Canadian Breast Cancer Foundation, Prairie chapter. Evan Booy is supported by the Canadian Institutes for Health Research (CIHR) CGS Doctoral award. Dr Gibson is a Manitoba Research Chair. The Manitoba Tumour Bank is a member of the Canadian Tumour Repository Network (CTRNet) and is supported by a grant from the CIHR	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; Backus HHJ, 2001, ANN ONCOL, V12, P779, DOI 10.1023/A:1011112227044; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Cetin Z, 2010, MED ONCOL, V27, P853, DOI 10.1007/s12032-009-9296-7; Chen FM, 2006, BIOORG MED CHEM LETT, V16, P6281, DOI 10.1016/j.bmcl.2006.09.038; CHRYSOGELOS SA, 1994, BREAST CANCER RES TR, V29, P29, DOI 10.1007/BF00666179; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Klapper LN, 2000, ADV CANCER RES, V77, P25; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Martin AP, 2009, CANCER BIOL THER, V8, P2084; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Nanda R, 2007, REV RECENT CLIN TRIA, V2, P111, DOI 10.2174/157488707780599375; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Sambade MJ, 2009, RADIOTHER ONCOL, V93, P639, DOI 10.1016/j.radonc.2009.09.006; Schubert KM, 2001, BIOCHEM J, V356, P473, DOI 10.1042/0264-6021:3560473; Schulze-Bergkamen H, 2008, WORLD J GASTROENTERO, V14, P3829, DOI 10.3748/wjg.14.3829; SINGLETON TP, 1992, PATHOL ANNU, V27, P165; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vickers ER, 2004, MOL CELL BIOL, V24, P10340, DOI 10.1128/MCB.24.23.10340-10351.2004; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Watson PH, 1996, CAN MED ASSOC J, V155, P281; Witters LM, 2007, ONCOL REP, V17, P465; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zoppoli G, 2010, CURR CANCER DRUG TAR, V10, P168, DOI 10.2174/156800910791054211	57	92	95	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	20					2367	2378		10.1038/onc.2010.616	http://dx.doi.org/10.1038/onc.2010.616			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21258408	Green Published, hybrid			2022-12-25	WOS:000290789200008
J	Pellissier, LP; Barthet, G; Gaven, F; Cassier, E; Trinquet, E; Pin, JP; Marin, P; Dumuis, A; Bockaert, J; Baneres, JL; Claeysen, S				Pellissier, Lucie P.; Barthet, Gael; Gaven, Florence; Cassier, Elisabeth; Trinquet, Eric; Pin, Jean-Philippe; Marin, Philippe; Dumuis, Aline; Bockaert, Joel; Baneres, Jean-Louis; Claeysen, Sylvie			G Protein Activation by Serotonin Type 4 Receptor Dimers EVIDENCE THAT TURNING ON TWO PROTOMERS IS MORE EFFICIENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; COUPLED RECEPTOR; 5-HT4 RECEPTOR; CONFORMATIONAL-CHANGES; GPCR; OLIGOMERS; RHODOPSIN; AGONIST; BINDING; HETERODIMERIZATION	The discovery that class C G protein-coupled receptors (GPCRs) function as obligatory dimeric entities has generated major interest in GPCR oligomerization. Oligomerization now appears to be a common feature among all GPCR classes. However, the functional significance of this process remains unclear because, in vitro, some monomeric GPCRs, such as rhodopsin and beta(2)-adrenergic receptors, activate G proteins. By using wild type and mutant serotonin type 4 receptors (5-HT(4)Rs) (including a 5-HT4-RASSL) expressed in COS-7 cells as models of class A GPCRs, we show that activation of one protomer in a dimer was sufficient to stimulate G proteins. However, coupling efficiency was 2 times higher when both protomers were activated. Expression of combinations of 5-HT4, in which both protomers were able to bind to agonists but only one could couple to G proteins, suggested that upon agonist occupancy, protomers did not independently couple to G proteins but rather that only one G protein was activated. Coupling of a single heterotrimeric G(s) protein to a receptor dimer was further confirmed in vitro, using the purified recombinant WT RASSL 5-HT4R obligatory heterodimer. These results, together with previous findings, demonstrate that, differently from class C GPCR dimers, class A GPCR dimers have pleiotropic activation mechanisms.	[Pellissier, Lucie P.; Barthet, Gael; Gaven, Florence; Cassier, Elisabeth; Pin, Jean-Philippe; Marin, Philippe; Dumuis, Aline; Bockaert, Joel; Claeysen, Sylvie] Univ Montpellier, CNRS, Inst Genom Fonct, UMR5203, F-34094 Montpellier 5, France; [Pellissier, Lucie P.; Barthet, Gael; Gaven, Florence; Cassier, Elisabeth; Pin, Jean-Philippe; Marin, Philippe; Dumuis, Aline; Bockaert, Joel; Claeysen, Sylvie] CNRS, INSERM, U661, F-34094 Montpellier, France; [Baneres, Jean-Louis] Fac Pharm Montpellier, Inst Biomol Max Mousseron, F-34093 Montpellier, France; [Trinquet, Eric] CisBioInternational, F-30200 Bagnols Sur Ceze, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Claeysen, S (corresponding author), Univ Montpellier, CNRS, Inst Genom Fonct, UMR5203, 141 Rue Cardonille, F-34094 Montpellier 5, France.	sylvie.claeysen@igf.cnrs.fr	Pin, Jean-Philippe/Y-6668-2019; Claeysen, Sylvie/C-8599-2014; Pellissier, Lucie P/L-8239-2014	Pin, Jean-Philippe/0000-0002-1423-345X; Claeysen, Sylvie/0000-0002-0576-5518; Pellissier, Lucie P/0000-0001-7085-3242; Baneres, jean-louis/0000-0001-7078-1285; Barthet, Gael/0000-0003-4025-1616	CNRS; INSERM; Ministere Francais de la Recherche [ANR Blanc-2006-0087-02]; Universite de Montpellier	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Universite de Montpellier	This work was supported by grants from CNRS, INSERM, Ministere Francais de la Recherche (ANR Blanc-2006-0087-02; "GPCR Dimers"), and Universite de Montpellier.	ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Barthet G, 2005, J BIOL CHEM, V280, P27924, DOI 10.1074/jbc.M502272200; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; Chinault SL, 2004, J BIOL CHEM, V279, P16091, DOI 10.1074/jbc.M311099200; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Kuwajima M, 2004, J COMP NEUROL, V474, P589, DOI 10.1002/cne.20158; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Milligan G, 2001, J CELL SCI, V114, P1265; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Park PSH, 2008, ANNU REV PHARMACOL, V48, P107, DOI 10.1146/annurev.pharmtox.48.113006.094630; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	56	63	63	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9985	9997		10.1074/jbc.M110.201939	http://dx.doi.org/10.1074/jbc.M110.201939			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247891	Green Published, hybrid			2022-12-25	WOS:000288547000013
J	Sakthivelu, V; Seidel, RP; Winklhofer, KF; Tatzelt, J				Sakthivelu, Vignesh; Seidel, Ralf P.; Winklhofer, Konstanze F.; Tatzelt, Joerg			Conserved Stress-protective Activity between Prion Protein and Shadoo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; SCRAPIE; PRP; DISEASES; MICE; DOMAIN	Shadoo (Sho) is a neuronally expressed glycoprotein of unknown function. Although there is no overall sequence homology to the cellular prion protein (PrPC), both proteins contain a highly conserved internal hydrophobic domain (HD) and are tethered to the outer leaflet of the plasma membrane via a C-terminal glycosylphosphatidylinositol anchor. A previous study revealed that Sho can reduce toxicity of a PrP mutant devoid of the HD (PrP Delta HD). We have now studied the stress-protective activity of Sho in detail and identified domains involved in this activity. Like PrPC, Sho protects cells against physiological stressors such as the excitotoxin glutamate. Moreover, both PrPC and Sho required the N-terminal domain for this activity; the stress-protective capacity of PrP Delta N as well as Sho Delta N was significantly impaired. In both proteins, the HD promoted homodimer formation; however, deletion of the HD had different effects. Although Sho Delta HD lost its stress-protective activity, PrP Delta HD acquired a neurotoxic potential. Finally, we could show that the N-terminal domain of PrPC could be functionally replaced by that of Sho, suggesting a similar function of the N termini of Sho and PrPC. Our study reveals a conserved physiological activity between PrPC and Sho to protect cells from stress-induced toxicity and suggests that Sho and PrPC might act on similar signaling pathways.	[Sakthivelu, Vignesh; Winklhofer, Konstanze F.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Seidel, Ralf P.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	University of Munich; Max Planck Society	Tatzelt, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de		Winklhofer, Konstanze/0000-0002-7256-8231; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB 596]; Max Planck Society; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) [BioDisc, DIP5.1]; Deutscher Akademischer Austauschdienst (DAAD); DZNE-German Center for Neurodegenerative Diseases	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DZNE-German Center for Neurodegenerative Diseases	The work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) (BioDisc, DIP5.1), by a Ph.D. fellowship from the Deutscher Akademischer Austauschdienst (DAAD) (to V. S.), and by support from the DZNE-German Center for Neurodegenerative Diseases (to J. T.).	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kiachopoulos S, 2005, J BIOL CHEM, V280, P9320, DOI 10.1074/jbc.M412525200; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Tatzelt A, 2004, AMYLOID, V11, P162, DOI 10.1080/1350-612040000723; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Van den Brulle J, 2008, BIOTECHNIQUES, V45, P340, DOI 10.2144/000112953; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	30	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8901	8908		10.1074/jbc.M110.185470	http://dx.doi.org/10.1074/jbc.M110.185470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21257747	hybrid, Green Published			2022-12-25	WOS:000288247700021
J	Garcia-Gonzalez, F; Simmons, LW				Garcia-Gonzalez, Francisco; Simmons, Leigh W.			Good Genes and Sexual Selection in Dung Beetles (Onthophagus taurus): Genetic Variance in Egg-to-Adult and Adult Viability	PLOS ONE			English	Article							SPERM COMPETITION; MATE CHOICE; EVOLUTION; COEVOLUTION; PHENOTYPE; CONFLICT; FITNESS; MALES	Whether species exhibit significant heritable variation in fitness is central for sexual selection. According to good genes models there must be genetic variation in males leading to variation in offspring fitness if females are to obtain genetic benefits from exercising mate preferences, or by mating multiply. However, sexual selection based on genetic benefits is controversial, and there is limited unambiguous support for the notion that choosy or polyandrous females can increase the chances of producing offspring with high viability. Here we examine the levels of additive genetic variance in two fitness components in the dung beetle Onthophagus taurus. We found significant sire effects on egg-to-adult viability and on son, but not daughter, survival to sexual maturity, as well as moderate coefficients of additive variance in these traits. Moreover, we do not find evidence for sexual antagonism influencing genetic variation for fitness. Our results are consistent with good genes sexual selection, and suggest that both pre- and postcopulatory mate choice, and male competition could provide indirect benefits to females.	[Garcia-Gonzalez, Francisco; Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia	University of Western Australia	Garcia-Gonzalez, F (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia.	pgarcia@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011; Garcia-Gonzalez, Francisco/A-3780-2008	Simmons, Leigh W/0000-0003-0562-1474; Garcia-Gonzalez, Francisco/0000-0001-9515-9038	Australian Research Council	Australian Research Council(Australian Research Council)	Funding was provided by Australian Research Council grants to FGG and to LWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bilde T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-295; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; BURT A, 1995, EVOLUTION, V49, P1, DOI 10.1111/j.1558-5646.1995.tb05954.x; Cameron E, 2003, J EVOLUTION BIOL, V16, P1055, DOI 10.1046/j.1420-9101.2003.00584.x; Charlesworth B, 1987, SEXUAL SELECTION TES, P21; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Garcia-Gonzalez F, 2004, AM NAT, V164, P457, DOI 10.1086/423987; Garcia-Gonzalez F, 2007, EVOLUTION, V61, P816, DOI 10.1111/j.1558-5646.2007.00084.x; Hanski I., 1991, DUNG BEETLE ECOLOGY; Hood G.M., 2009, POPTOOLS VERSION 3 1; Houle D, 2002, P ROY SOC B-BIOL SCI, V269, P97, DOI 10.1098/rspb.2001.1823; HOULE D, 1992, GENETICS, V130, P195; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2000, EVOLUTION, V54, P936, DOI 10.1111/j.0014-3820.2000.tb00093.x; Hunt J, 2002, P NATL ACAD SCI USA, V99, P6828, DOI 10.1073/pnas.092676199; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kotiaho JS, 2003, AM NAT, V161, P852, DOI 10.1086/375173; Lynch M., 1998, GENETICS ANAL QUANTI; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Rantala MJ, 2007, HEREDITY, V98, P329, DOI 10.1038/sj.hdy.6800945; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Simmons LW, 2007, P NATL ACAD SCI USA, V104, P16604, DOI 10.1073/pnas.0704871104; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons Leigh W., 2011, P66; Simmons LW, 2009, CURR BIOL, V19, P1442, DOI 10.1016/j.cub.2009.06.056; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; StatSoft I., 2007, STAT DAT AN SOFTW SY; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006	41	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16233	10.1371/journal.pone.0016233	http://dx.doi.org/10.1371/journal.pone.0016233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267411	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500047
J	Dempster, T; Sanchez-Jerez, P; Fernandez-Jover, D; Bayle-Sempere, J; Nilsen, R; Bjorn, PA; Uglem, I				Dempster, Tim; Sanchez-Jerez, Pablo; Fernandez-Jover, Damian; Bayle-Sempere, Just; Nilsen, Rune; Bjorn, Pal-Arne; Uglem, Ingebrigt			Proxy Measures of Fitness Suggest Coastal Fish Farms Can Act as Population Sources and Not Ecological Traps for Wild Gadoid Fish	PLOS ONE			English	Article							SALMON FARMS; ATLANTIC COD; SPATIOTEMPORAL DISTRIBUTION; SEA LICE; AGGREGATION; MOVEMENTS; INFECTION; PATTERNS; ENERGY; SALAR	Background: Ecological traps form when artificial structures are added to natural habitats and induce mismatches between habitat preferences and fitness consequences. Their existence in terrestrial systems has been documented, yet little evidence suggests they occur in marine environments. Coastal fish farms are widespread artificial structures in coastal ecosystems and are highly attractive to wild fish. Methodology/Principal Findings: To investigate if coastal salmon farms act as ecological traps for wild Atlantic cod (Gadus morhua) and saithe (Pollachius virens), we compared proxy measures of fitness between farm-associated fish and control fish caught distant from farms in nine locations throughout coastal Norway, the largest coastal fish farming industry in the world. Farms modified wild fish diets in both quality and quantity, thereby providing farm-associated wild fish with a strong trophic subsidy. This translated to greater somatic (saithe: 1.06-1.12 times; cod: 1.06-1.11 times) and liver condition indices (saithe: 1.4-1.8 times; cod: 2.0-2.8 times) than control fish caught distant from farms. Parasite loads of farm-associated wild fish were modified from control fish, with increased external and decreased internal parasites, however the strong effect of the trophic subsidy overrode any effects of altered loads upon condition. Conclusions and Significance: Proxy measures of fitness provided no evidence that salmon farms function as ecological traps for wild fish. We suggest fish farms may act as population sources for wild fish, provided they are protected from fishing while resident at farms to allow their increased condition to manifest as greater reproductive output.	[Dempster, Tim] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Dempster, Tim] SINTEF Fisheries & Aquaculture, Trondheim, Norway; [Sanchez-Jerez, Pablo; Fernandez-Jover, Damian; Bayle-Sempere, Just] Univ Alicante, Dept Marine Sci & Appl Biol, E-03080 Alicante, Spain; [Bjorn, Pal-Arne; Uglem, Ingebrigt] NOFIMA, Tromso, Norway; [Uglem, Ingebrigt] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	University of Melbourne; SINTEF; Universitat d'Alacant; Nofima; Norwegian Institute Nature Research	Dempster, T (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	tim.dempster@sintef.no	Bayle-Sempere, Just Tomàs/J-1574-2012; Sanchez-Jerez, Pablo/L-4750-2014; Dempster, Tim/E-9630-2011	Bayle-Sempere, Just Tomàs/0000-0001-6841-1824; Sanchez-Jerez, Pablo/0000-0003-4047-238X; Dempster, Tim/0000-0001-8041-426X; Fernandez-Jover, Damian/0000-0002-2553-6472	Norwegian Research Council [173384]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding was provided by the Norwegian Research Council Havet og kysten program to the CoastACE project (no: 173384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol O, 2010, J APPL ICHTHYOL, V26, P11, DOI 10.1111/j.1439-0426.2009.01348.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BERG E, 2008, KYST HAVBRUK, P79; Bjorn PA, 2009, AQUACULTURE, V286, P36, DOI 10.1016/j.aquaculture.2008.08.038; Bricknell IR, 2006, ICES J MAR SCI, V63, P253, DOI 10.1016/j.icesjms.2005.10.009; Bustnes JO, 2010, ENVIRON SCI TECHNOL, V44, P8736, DOI 10.1021/es102195d; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Dempster T, 2002, MAR ECOL PROG SER, V242, P237, DOI 10.3354/meps242237; Dempster T, 2010, ESTUAR COAST SHELF S, V86, P271, DOI 10.1016/j.ecss.2009.11.007; Dempster T, 2009, MAR ECOL PROG SER, V385, P1, DOI 10.3354/meps08050; Diamant A., 2007, CIESM WORKSHOP MONOG, V32, P49; *FAO, 2009, FISHST PLUS AQ PROD; Fernandez-Jover D, 2008, ICES J MAR SCI, V65, P1153, DOI 10.1093/icesjms/fsn091; Fernandez-Jover D, 2007, MAR ENVIRON RES, V63, P1, DOI 10.1016/j.marenvres.2006.05.002; FERNANDEZJOVER D, 2011, EST COAST S IN PRESS; Gjosaeter J., 2008, KYST HAVBRUK, P52; Graham DA, 2006, DIS AQUAT ORGAN, V72, P193, DOI 10.3354/dao072193; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; Hemmingsen W, 2001, ADV MAR BIOL, V40, P1, DOI 10.1016/S0065-2881(01)40002-2; Heuch PA, 2007, DIS AQUAT ORGAN, V77, P149, DOI 10.3354/dao01833; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Jorstad KE, 2008, REV FISH SCI, V16, P285, DOI 10.1080/10641260701678017; KHAN RA, 1993, J PARASITOL, V79, P954, DOI 10.2307/3283738; Klimpel S, 2004, PARASITOL RES, V94, P1, DOI 10.1007/s00436-004-1154-0; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2010, AQUACULT ENV INTERAC, V1, P21, DOI 10.3354/aei0004; Kutti T, 2007, AQUACULTURE, V262, P355, DOI 10.1016/j.aquaculture.2006.10.008; Lambert Y, 1997, CAN J FISH AQUAT SCI, V54, P104, DOI 10.1139/cjfas-54-S1-104; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Maurstad A, 2007, HUM ECOL, V35, P601, DOI 10.1007/s10745-007-9126-5; *NORW DIR FISH, 2009, STAT AQ 2008; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Salze G, 2005, AQUAC RES, V36, P1488, DOI 10.1111/j.1365-2109.2005.01367.x; Skjaeraasen JE, 2006, CAN J FISH AQUAT SCI, V63, P310, DOI 10.1139/F05-218; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thorstad Eva B., 2008, NINA Temahefte, V36, P1; Uglem I, 2008, AQUAC RES, V39, P158, DOI 10.1111/j.1365-2109.2007.01872.x; Uglem I, 2010, AQUACULT ENV INTERAC, V1, P11, DOI 10.3354/aei00003; Uglem I, 2009, MAR ECOL PROG SER, V384, P251, DOI 10.3354/meps08001; Wallace IS, 2008, J FISH DIS, V31, P177, DOI 10.1111/j.1365-2761.2007.00886.x	41	59	59	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15646	10.1371/journal.pone.0015646	http://dx.doi.org/10.1371/journal.pone.0015646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264217	gold, Green Published, Green Submitted			2022-12-25	WOS:000286517600011
J	Hao, P; Zheng, HJ; Yu, Y; Ding, GH; Gu, WY; Chen, ST; Yu, ZH; Ren, SX; Oda, M; Konno, T; Wang, SY; Li, XA; Ji, ZS; Zhao, GP				Hao, Pei; Zheng, Huajun; Yu, Yao; Ding, Guohui; Gu, Wenyi; Chen, Shuting; Yu, Zhonghao; Ren, Shuangxi; Oda, Munehiro; Konno, Tomonobu; Wang, Shengyue; Li, Xuan; Ji, Zai-Si; Zhao, Guoping			Complete Sequencing and Pan-Genomic Analysis of Lactobacillus delbrueckii subsp bulgaricus Reveal Its Genetic Basis for Industrial Yogurt Production	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GRAM-NEGATIVE BACTERIA; STREPTOCOCCUS-THERMOPHILUS; MAXIMUM-LIKELIHOOD; FLAVOR FORMATION; MISMATCH REPAIR; SIGNAL PEPTIDES; IDENTIFICATION; PREDICTION; DATABASE	Lactobacillus delbrueckii subsp. bulgaricus (Lb. bulgaricus) is an important species of Lactic Acid Bacteria (LAB) used for cheese and yogurt fermentation. The genome of Lb. bulgaricus 2038, an industrial strain mainly used for yogurt production, was completely sequenced and compared against the other two ATCC collection strains of the same subspecies. Specific physiological properties of strain 2038, such as lysine biosynthesis, formate production, aspartate-related carbon-skeleton intermediate metabolism, unique EPS synthesis and efficient DNA restriction/modification systems, are all different from those of the collection strains that might benefit the industrial production of yogurt. Other common features shared by Lb. bulgaricus strains, such as efficient protocooperation with Streptococcus thermophilus and lactate production as well as well-equipped stress tolerance mechanisms may account for it being selected originally for yogurt fermentation industry. Multiple lines of evidence suggested that Lb. bulgaricus 2038 was genetically closer to the common ancestor of the subspecies than the other two sequenced collection strains, probably due to a strict industrial maintenance process for strain 2038 that might have halted its genome decay and sustained a gene network suitable for large scale yogurt production.	[Hao, Pei; Yu, Yao; Ding, Guohui; Li, Xuan; Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Key Lab Syst Biol, Shanghai, Peoples R China; [Zheng, Huajun; Gu, Wenyi; Chen, Shuting; Ren, Shuangxi; Wang, Shengyue; Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Oda, Munehiro; Konno, Tomonobu; Ji, Zai-Si] Meiji Dairies Corp, Div Res & Dev, Odawara, Japan; [Hao, Pei; Yu, Zhonghao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Zheng, Huajun; Zhao, Guoping] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Yu, Yao] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Meiji Holdings Co., Ltd.; Chinese Academy of Sciences; Fudan University; Chinese Academy of Sciences; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Hao, P (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Key Lab Syst Biol, Shanghai, Peoples R China.	lixuan@sippe.ac.cn; ZAI-SI_JI@meiji-milk.com; gpzhao@sibs.ac.cn	Zheng, Huajun/AAN-4973-2020; Yu, Zhonghao/F-5459-2011; Yu, Yao/B-5868-2015	Yu, Zhonghao/0000-0001-7144-9356; Yu, Yao/0000-0002-2727-1746; Zhao, Guo-Ping/0000-0002-7621-6620; Hao, Pei/0000-0002-1498-7059	National High Technology Research and Development Program of China [2007AA02Z330, 2007AA02Z331]; National Natural Science Foundation of China [30830002]; Meiji Dairies Corporation	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Meiji Dairies Corporation	This work was partly supported by grants from the National High Technology Research and Development Program of China (Contract No. 2007AA02Z330 and 2007AA02Z331) the National Natural Science Foundation of China (30830002), and by funding from Meiji Dairies Corporation. ZSJ conceived the study. MO and TK performed the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Ardo Y, 2006, BIOTECHNOL ADV, V24, P238, DOI 10.1016/j.biotechadv.2005.11.005; Azcarate-Peril MA, 2004, APPL ENVIRON MICROB, V70, P5315, DOI 10.1128/AEM.70.9.5315-5322.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Broadbent JR, 2003, J DAIRY SCI, V86, P407, DOI 10.3168/jds.S0022-0302(03)73619-4; Burrus V, 2001, APPL ENVIRON MICROB, V67, P1522, DOI 10.1128/AEM.67.4.1522-1528.2001; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DEVEREUX R, 1994, APPL ENVIRON MICROB, V60, P3437, DOI 10.1128/AEM.60.9.3437-3439.1994; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Ding GH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003357; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Klingberg TD, 2005, INT J FOOD MICROBIOL, V105, P419, DOI 10.1016/j.ijfoodmicro.2005.03.020; Kullen MJ, 1999, MOL MICROBIOL, V33, P1152, DOI 10.1046/j.1365-2958.1999.01557.x; Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x; Lim EM, 2000, ELECTROPHORESIS, V21, P2557, DOI 10.1002/1522-2683(20000701)21:12&lt;2557::AID-ELPS2557&gt;3.0.CO;2-B; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marilley L, 2004, INT J FOOD MICROBIOL, V90, P139, DOI 10.1016/S0168-1605(03)00304-0; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Perriere G, 2000, GENOME RES, V10, P379, DOI 10.1101/gr.10.3.379; Razeto A, 2002, J MOL BIOL, V318, P109, DOI 10.1016/S0022-2836(02)00086-4; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Ritz H, 2001, J BIOL CHEM, V276, P22273, DOI 10.1074/jbc.M100752200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; van Kranenburg R, 2002, INT DAIRY J, V12, P111, DOI 10.1016/S0958-6946(01)00132-7; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vaningelgem F, 2004, APPL ENVIRON MICROB, V70, P900, DOI 10.1128/AEM.70.2.900-912.2004; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Yang W, 2000, MUTAT RES-DNA REPAIR, V460, P245, DOI 10.1016/S0921-8777(00)00030-6; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZHENG HJ, 2008, MOL BIOL, V3, P15	48	69	74	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15964	10.1371/journal.pone.0015964	http://dx.doi.org/10.1371/journal.pone.0015964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264216	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600014
J	Niikura, T; Sidahmed, E; Hirata-Fukae, C; Aisen, PS; Matsuoka, Y				Niikura, Takako; Sidahmed, Elkhansa; Hirata-Fukae, Chiho; Aisen, Paul S.; Matsuoka, Yasuji			A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RESCUE FACTOR HUMANIN; NEURONAL CELL-DEATH; A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; NEUROPROTECTIVE FACTOR; BEHAVIORAL DEFICITS; COGNITIVE DEFICITS; PEPTIDE HUMANIN	Humanin (HN), a 24-residue peptide, was identified as a novel neuroprotective factor and shows anti-cell death activity against a wide spectrum of Alzheimer's disease (AD)-related cytotoxicities, including exposure to amyloid beta (Abeta), in vitro. We previously demonstrated that the injection of S14G-HN, a highly potent HN derivative, into brain ameliorated memory loss in an Abeta-injection mouse model. To fully understand HN's functions under AD-associated pathological conditions, we examined the effect of S14G-HN on triple transgenic mice harboring APP(swe), tau(P310L), and PS-1(M146V) that show the age-dependent development of multiple pathologies relating to AD. After 3 months of intranasal treatment, behavioral analyses showed that S14G-HN ameliorated cognitive impairment in male mice. Moreover, ELISA and immunohistochemical analyses showed that Abeta levels in brains were markedly lower in S14G-HN-treated male and female mice than in vehicle control mice. We also found the expression level of neprilysin, an Abeta degrading enzyme, in the outer molecular layer of hippocampal formation was increased in S14G-HN-treated mouse brains. NEP activity was also elevated by S14G-HN treatment in vitro. These findings suggest that decreased Abeta level in these mice is at least partly attributed to S14G-HN-induced increase of neprilysin level. Although HN was identified as an anti-neuronal death factor, these results indicate that HN may also have a therapeutic effect on amyloid accumulation in AD.	[Niikura, Takako] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Niikura, Takako; Sidahmed, Elkhansa; Hirata-Fukae, Chiho; Matsuoka, Yasuji] Georgetown Univ, Dept Neurol, Washington, DC USA; [Aisen, Paul S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Simon Fraser University; Georgetown University; University of California System; University of California San Diego	Niikura, T (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	tniikura@sfu.ca			National Institutes of Health [AG026478, AG022455]; Natural Sciences and Engineering Research Council of Canada [386973-2010]; NATIONAL INSTITUTE ON AGING [R01AG026478, K01AG022455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partly supported by the National Institutes of Health (grants AG026478 and AG022455 to YM) (www.nih.gov) and Natural Sciences and Engineering Research Council of Canada (386973-2010 to TN) (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Craft S, 2006, ALZ DIS ASSOC DIS, V20, P298, DOI 10.1097/01.wad.0000213866.86934.7e; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Gozes I, 2009, CURR ALZHEIMER RES, V6, P455, DOI 10.2174/156720509789207895; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; HOANG PT, 2009, METABOLISM; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2005, J MOL NEUROSCI, V25, P165, DOI 10.1385/JMN:25:2:165; Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Kariya S, 2002, NEUROREPORT, V13, P903, DOI 10.1097/00001756-200205070-00034; Kharebava G, 2008, J NEUROSCI, V28, P11409, DOI 10.1523/JNEUROSCI.2135-08.2008; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Niikura T., 2007, INT J MED BIOL FRONT, V12, P199, DOI [10.2174/157015906776359577, DOI 10.2174/157015906776359577]; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Nitta A, 1997, JPN J PHARMACOL, V73, P51, DOI 10.1254/jjp.73.51; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Schmidt Stephen D., 2004, V299, P267; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang D, 2005, APOPTOSIS, V10, P963, DOI 10.1007/s10495-005-1191-x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; William H, 2002, DRUG DELIV TECHNOL, V2, P46; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; YAMADA M, 2007, NEUROPSYCHOPHARMACOL; Yamada M, 2008, NEUROPSYCHOPHARMACOL, V33, P2020, DOI 10.1038/sj.npp.1301591; Yamaguchi Y, 2002, BRAIN RES, V945, P259, DOI 10.1016/S0006-8993(02)02816-0; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200	75	59	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16259	10.1371/journal.pone.0016259	http://dx.doi.org/10.1371/journal.pone.0016259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264226	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600024
J	Akundi, RS; Huang, ZY; Eason, J; Pandya, JD; Zhi, LT; Cass, WA; Sullivan, PG; Bueler, H				Akundi, Ravi S.; Huang, Zhenyu; Eason, Joshua; Pandya, Jignesh D.; Zhi, Lianteng; Cass, Wayne A.; Sullivan, Patrick G.; Bueeler, Hansruedi			Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice	PLOS ONE			English	Article							NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3-BETA; NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; C-JUN PHOSPHORYLATION; GROWTH-FACTOR-ALPHA; FOS MESSENGER-RNA; PARKINSONS-DISEASE; OXIDATIVE STRESS; MOUSE MODEL	Background: PTEN-induced kinase 1 (PINK1) is linked to recessive Parkinsonism (EOPD). Pink1 deletion results in impaired dopamine (DA) release and decreased mitochondrial respiration in the striatum of mice. To reveal additional mechanisms of Pink1-related dopaminergic dysfunction, we studied Ca2+ vulnerability of purified brain mitochondria, DA levels and metabolism and whether signaling pathways implicated in Parkinson's disease (PD) display altered activity in the nigrostriatal system of Pink1(-/-) mice. Methods and Findings: Purified brain mitochondria of Pink1(-/-) mice showed impaired Ca2+ storage capacity, resulting in increased Ca2+ induced mitochondrial permeability transition (mPT) that was rescued by cyclosporine A. A subpopulation of neurons in the substantia nigra of Pink1(-/-) mice accumulated phospho-c-Jun, showing that Jun N-terminal kinase (JNK) activity is increased. Pink1(-/-) mice 6 months and older displayed reduced DA levels associated with increased DA turnover. Moreover, Pink1(-/-) mice had increased levels of IL-1 beta, IL-12 and IL-10 in the striatum after peripheral challenge with lipopolysaccharide (LPS), and Pink1(-/-) embryonic fibroblasts showed decreased basal and inflammatory cytokine-induced nuclear factor kappa-beta (NF-kappa B) activity. Quantitative transcriptional profiling in the striatum revealed that Pink1(-/-) mice differentially express genes that (i) are upregulated in animals with experimentally induced dopaminergic lesions, (ii) regulate innate immune responses and/or apoptosis and (iii) promote axonal regeneration and sprouting. Conclusions: Increased mitochondrial Ca2+ sensitivity and JNK activity are early defects in Pink1(-/-) mice that precede reduced DA levels and abnormal DA homeostasis and may contribute to neuronal dysfunction in familial PD. Differential gene expression in the nigrostriatal system of Pink1(-/-) mice supports early dopaminergic dysfunction and shows that Pink1 deletion causes aberrant expression of genes that regulate innate immune responses. While some differentially expressed genes may mitigate neurodegeneration, increased LPS-induced brain cytokine expression and impaired cytokine-induced NF-kappa B activation may predispose neurons of Pink1(-/-) mice to inflammation and injury-induced cell death.	[Akundi, Ravi S.; Huang, Zhenyu; Eason, Joshua; Pandya, Jignesh D.; Zhi, Lianteng; Cass, Wayne A.; Sullivan, Patrick G.; Bueeler, Hansruedi] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Sullivan, Patrick G.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Akundi, RS (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA.	hansruedi.bueler@uky.edu	Büeler, Hansruedi/J-6965-2017; Akundi, Ravi Shankar/J-2673-2019	Büeler, Hansruedi/0000-0002-4892-7177; Akundi, Ravi Shankar/0000-0003-3782-5965	National Center for Research Resources (NCRR) [P20 RR15592]; Parkinson Schweiz; American Parkinson's Disease Association (APDA); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Parkinson Schweiz; American Parkinson's Disease Association (APDA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a COBRE grant (P20 RR15592) from the National Center for Research Resources (NCRR), as well as by grants from Parkinson Schweiz and the American Parkinson's Disease Association (APDA) to H.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Badiani A, 1998, J NEUROSCI, V18, P10579; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Cadet P, 2003, INT J MOL MED, V12, P485; Campbell G, 2005, EXP NEUROL, V192, P340, DOI 10.1016/j.expneurol.2004.11.026; Cao JP, 2008, BRAIN RES BULL, V76, P505, DOI 10.1016/j.brainresbull.2008.03.007; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Desteno DA, 2009, NEUROSCIENCE, V162, P118, DOI 10.1016/j.neuroscience.2009.04.052; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; Doucet JP, 1996, EUR J NEUROSCI, V8, P365, DOI 10.1111/j.1460-9568.1996.tb01220.x; DRAGUNOW M, 1995, MOL BRAIN RES, V30, P393, DOI 10.1016/0169-328X(95)00037-S; DRAGUNOW M, 1991, MOL BRAIN RES, V10, P355, DOI 10.1016/0169-328X(91)90096-G; Falk A, 2002, J NEUROSCI RES, V69, P757, DOI 10.1002/jnr.10410; Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Francis JS, 2004, MOL BRAIN RES, V124, P199, DOI 10.1016/j.molbrainres.2003.10.027; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Garcia-Gorostiaga I, 2009, ANN NEUROL, V65, P759, DOI 10.1002/ana.21687; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gayle DA, 2002, DEV BRAIN RES, V133, P27, DOI 10.1016/S0165-3806(01)00315-7; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HARDING AJ, 1994, J NEUROSCI METH, V51, P83, DOI 10.1016/0165-0270(94)90028-0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; JOH TH, 1993, ADV NEUROL, V60, P316; Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Liang YD, 2009, BRAIN RES, V1286, P221, DOI 10.1016/j.brainres.2009.06.049; Lin ST, 2008, MOL CELL BIOCHEM, V315, P41, DOI 10.1007/s11010-008-9787-4; Liu M, 2010, J NEUROCHEM, V112, P773, DOI 10.1111/j.1471-4159.2009.06497.x; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McCoy MK, 2008, MOL THER, V16, P1572, DOI 10.1038/mt.2008.146; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003; Nagao M, 2009, NEUROSCI LETT, V449, P103, DOI 10.1016/j.neulet.2008.10.104; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nilsson A, 2005, NEUROREPORT, V16, P213, DOI 10.1097/00001756-200502280-00002; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067; Pearson AG, 2003, MOL BRAIN RES, V120, P38, DOI 10.1016/j.molbrainres.2003.09.014; POOLE AC, 2008, P NATL ACAD SCI US; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rentzos M, 2009, ACTA NEUROL SCAND, V119, P332, DOI 10.1111/j.1600-0404.2008.01103.x; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Song DY, 2008, EXP NEUROL, V209, P268, DOI 10.1016/j.expneurol.2007.09.033; Sossi V, 2002, J CEREBR BLOOD F MET, V22, P232, DOI 10.1097/00004647-200202000-00011; SPINA MB, 1989, P NATL ACAD SCI USA, V86, P1398, DOI 10.1073/pnas.86.4.1398; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 2000, NEUROSCIENCE, V99, P457, DOI 10.1016/S0306-4522(00)00213-X; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tang WH, 2009, CELL RES, V19, P758, DOI 10.1038/cr.2009.57; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Teismann P, 2001, NEUROREPORT, V12, P1049, DOI 10.1097/00001756-200104170-00037; Timmons S, 2009, NEUROSCI LETT, V467, P30, DOI 10.1016/j.neulet.2009.09.055; Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; VIVESBAUZA C, 2009, P NATL ACAD SCI US; Vlug AS, 2005, EUR J NEUROSCI, V22, P1881, DOI 10.1111/j.1460-9568.2005.04389.x; Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winter C, 1998, BRAIN RES, V801, P198, DOI 10.1016/S0006-8993(98)00601-5; Winter C, 2002, MOL BRAIN RES, V104, P194, DOI 10.1016/S0169-328X(02)00378-9; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	143	127	134	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16038	10.1371/journal.pone.0016038	http://dx.doi.org/10.1371/journal.pone.0016038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249202	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000011
J	Kang, DD; Lin, YY; Moreno, JR; Randall, TD; Khader, SA				Kang, Dongwan D.; Lin, Yinyao; Moreno, Javier-Rangel; Randall, Troy D.; Khader, Shabaana A.			Profiling Early Lung Immune Responses in the Mouse Model of Tuberculosis	PLOS ONE			English	Article							MHC CLASS-II; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; GRANULOMA-FORMATION; INTERFERON-GAMMA; NEUTROPHIL MIGRATION; PEPTIDE ENA-78; INFECTION; RECEPTOR; MACROPHAGES	Tuberculosis (TB) is caused by the intracellular bacteria Mycobacterium tuberculosis, and kills more than 1.5 million people every year worldwide. Immunity to TB is associated with the accumulation of IFN gamma-producing T helper cell type 1 (Th1) in the lungs, activation of M. tuberculosis-infected macrophages and control of bacterial growth. However, very little is known regarding the early immune responses that mediate accumulation of activated Th1 cells in the M. tuberculosis-infected lungs. To define the induction of early immune mediators in the M. tuberculosis-infected lung, we performed mRNA profiling studies and characterized immune cells in M. tuberculosis-infected lungs at early stages of infection in the mouse model. Our data show that induction of mRNAs involved in the recognition of pathogens, expression of inflammatory cytokines, activation of APCs and generation of Th1 responses occurs between day 15 and day 21 post infection. The induction of these mRNAs coincides with cellular accumulation of Th1 cells and activation of myeloid cells in M. tuberculosis-infected lungs. Strikingly, we show the induction of mRNAs associated with Gr1(+) cells, namely neutrophils and inflammatory monocytes, takes place on day 12 and coincides with cellular accumulation of Gr1(+) cells in M. tuberculosis-infected lungs. Interestingly, in vivo depletion of Gr1(+) neutrophils between days 10-15 results in decreased accumulation of Th1 cells on day 21 in M. tuberculosis-infected lungs without impacting overall protective outcomes. These data suggest that the recruitment of Gr1(+) neutrophils is an early event that leads to production of chemokines that regulate the accumulation of Th1 cells in the M. tuberculosis-infected lungs.	[Kang, Dongwan D.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Kang, Dongwan D.; Lin, Yinyao; Khader, Shabaana A.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Infect Dis, Pittsburgh, PA 15261 USA; [Moreno, Javier-Rangel; Randall, Troy D.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester	Kang, DD (corresponding author), Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA.	Shabaana.Khader@chp.edu		A Khader, Shabaana/0000-0002-9545-4982; Rangel-Moreno, Javier/0000-0002-9738-1182	Children's Hospital of Pittsburgh; Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System [HL69409, AI072689];  [1K99/R00AI075106-01];  [R21AI083541]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI075106, R21AI083541, R01AI072689, R00AI075106] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh; Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by 1K99/R00AI075106-01, R21AI083541 and Children's Hospital of Pittsburgh to SAK; HL69409 and AI072689 to TDR and a Research Advisory Committee Grant from Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Aoki N, 2009, J LEUKOCYTE BIOL, V85, P508, DOI 10.1189/jlb.0508329; APPELBERG R, 1994, IMMUNOLOGY, V82, P361; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bjorkman L, 2008, J LEUKOCYTE BIOL, V83, P245, DOI 10.1189/jlb.0607-408; Boles KS, 1999, TISSUE ANTIGENS, V54, P27, DOI 10.1034/j.1399-0039.1999.540103.x; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Casanova JL, 2001, SWISS MED WKLY, V131, P445; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHANG MS, 1994, J BIOL CHEM, V269, P25277; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DEBEER FC, 1984, THORAX, V39, P196, DOI 10.1136/thx.39.3.196; DENIS M, 1991, J INFECT DIS, V163, P919, DOI 10.1093/infdis/163.4.919; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fulton SA, 2004, INFECT IMMUN, V72, P2101, DOI 10.1128/IAI.72.4.2101-2110.2004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Gonzalez-Juarrero M, 2009, AM J RESP CELL MOL, V40, P398, DOI 10.1165/rcmb.2008-0248OC; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Koenig R, 2008, SCIENCE, V319, P894, DOI 10.1126/science.319.5865.894; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; MAY ME, 1987, INFECT IMMUN, V55, P2304, DOI 10.1128/IAI.55.9.2304-2307.1987; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Noss EH, 2000, CELL IMMUNOL, V201, P63, DOI 10.1006/cimm.2000.1633; Olakanmi O, 2004, INFECT IMMUN, V72, P2022, DOI 10.1128/IAI.72.4.2022-2028.2004; Oliveira SHP, 2008, INFLAMMATION, V31, P36, DOI 10.1007/s10753-007-9047-x; Pasquinelli V, 2004, J IMMUNOL, V172, P1177, DOI 10.4049/jimmunol.172.2.1177; Pechkovsky DV, 2000, FEMS IMMUNOL MED MIC, V29, P27, DOI 10.1111/j.1574-695X.2000.tb01501.x; Pflugh DL, 2000, J IMMUNOL, V165, P313, DOI 10.4049/jimmunol.165.1.313; Pompei L, 2007, J IMMUNOL, V178, P5192, DOI 10.4049/jimmunol.178.8.5192; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Riedel DD, 1997, INFECT IMMUN, V65, P4620, DOI 10.1128/IAI.65.11.4620-4623.1997; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Roberts AD, 2002, METHOD MICROBIOL, V32, P433; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Singh PP, 2006, MICROBES INFECT, V8, P541, DOI 10.1016/j.micinf.2005.08.007; Sommer G, 2008, J CELL BIOCHEM, V104, P2241, DOI 10.1002/jcb.21782; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zenaro E, 2009, J LEUKOCYTE BIOL, V86, P1393, DOI 10.1189/jlb.0409242	79	85	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16161	10.1371/journal.pone.0016161	http://dx.doi.org/10.1371/journal.pone.0016161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249199	Green Published, gold, Green Accepted			2022-12-25	WOS:000286515000023
J	Skelton, MR; Schaefer, TL; Graham, DL; Degrauw, TJ; Clark, JF; Williams, MT; Vorhees, CV				Skelton, Matthew R.; Schaefer, Tori L.; Graham, Devon L.; degrauw, Ton J.; Clark, Joseph F.; Williams, Michael T.; Vorhees, Charles V.			Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency	PLOS ONE			English	Article							MORRIS WATER MAZE; MENTAL-RETARDATION; LOCOMOTOR-ACTIVITY; GENE SLC6A8; BRAIN; DEFECT; LOCALIZATION; EXPRESSION; MONOAMINES; CLONING	Mutations in the creatine (Cr) transporter (CrT; Slc6a8) gene lead to absence of brain Cr and intellectual disabilities, loss of speech, and behavioral abnormalities. To date, no mouse model of CrT deficiency exists in which to understand and develop treatments for this condition. The purpose of this study was to generate a mouse model of human CrT deficiency. We created mice with exons 2-4 of Slc6a8 flanked by loxP sites and crossed these to Cre:CMV mice to create a line of ubiquitous CrT knockout expressing mice. Mice were tested for learning and memory deficits and assayed for Cr and neurotransmitter levels. Male CrT-/y (affected) mice lack Cr in the brain and muscle with significant reductions of Cr in other tissues including heart and testes. CrT-/y mice showed increased path length during acquisition and reversal learning in the Morris water maze. During probe trials, CrT-/y mice showed increased average distance from the platform site. CrT-/y mice showed reduced novel object recognition and conditioned fear memory compared to CrT+/y. CrT-/y mice had increased serotonin and 5-hydroxyindole acetic acid in the hippocampus and prefrontal cortex. Ubiquitous CrT knockout mice have learning and memory deficits resembling human CrT deficiency and this model should be useful in understanding this disorder.	[Skelton, Matthew R.; Schaefer, Tori L.; Graham, Devon L.; degrauw, Ton J.; Williams, Michael T.; Vorhees, Charles V.] Univ Cincinnati, Coll Med, Div Neurol, Cincinnati Childrens Res Fdn, Cincinnati, OH 45221 USA; [Skelton, Matthew R.; Schaefer, Tori L.; Graham, Devon L.; degrauw, Ton J.; Williams, Michael T.; Vorhees, Charles V.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Skelton, MR (corresponding author), Univ Cincinnati, Coll Med, Div Neurol, Cincinnati Childrens Res Fdn, Cincinnati, OH 45221 USA.	Matthew.skelton@cchmc.org		Vorhees, Charles/0000-0003-3558-8812; Graham, Devon/0000-0003-0318-4602; Skelton, Matthew/0000-0003-4941-3546; Williams, Michael/0000-0001-9841-9683	National Institutes of Health (NIH) [DA021394, ES015689, T32 ES007051, NS049172]; Division of Neurology at CCHMC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015689, T32ES007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021394] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Neurology at CCHMC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants DA021394 (CVV), ES015689 (MTW), T32 ES007051 (TLS & DLG), and NS049172 (JFC) and the Division of Neurology at CCHMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta ML, 2005, AM J PHYSIOL-CELL PH, V289, pC1015, DOI 10.1152/ajpcell.00137.2005; Agostinho FR, 2009, BRAIN RES BULL, V80, P337, DOI 10.1016/j.brainresbull.2009.09.002; Alvarez C, 2002, NEUROSCIENCE, V115, P753, DOI 10.1016/S0306-4522(02)00484-0; Anselm IM, 2006, J INHERIT METAB DIS, V29, P214, DOI 10.1007/s10545-006-0123-4; BARNWELL LFS, 1995, GENE, V159, P287, DOI 10.1016/0378-1119(95)00104-E; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Braissant O, 2001, MOL BRAIN RES, V86, P193, DOI 10.1016/S0169-328X(00)00269-2; BRAISSANT O, 2008, J INHERIT METAB DIS; Braissant Olivier, 2007, V46, P67; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Cecil KM, 2001, ANN NEUROL, V49, P401, DOI 10.1002/ana.79; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Clark AJ, 2006, HUM GENET, V119, P604, DOI 10.1007/s00439-006-0162-9; Clark RE, 2000, J NEUROSCI, V20, P8853; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; deGrauw TJ, 2003, MOL CELL BIOCHEM, V244, P45, DOI 10.1023/A:1022487218904; DeGrauw TJ, 2002, NEUROPEDIATRICS, V33, P232, DOI 10.1055/s-2002-36743; Ehrman LA, 2006, GENES BRAIN BEHAV, V5, P540, DOI 10.1111/j.1601-183X.2006.00209.x; Fons C, 2008, J INHERIT METAB DIS, V31, P724, DOI 10.1007/s10545-008-0902-1; Garcia-Miranda P, 2009, J PHYSIOL PHARMACOL, V60, P127; Grace CE, 2010, NEUROTOXICOL TERATOL, V32, P346, DOI 10.1016/j.ntt.2010.01.006; GREGOR P, 1995, GENOMICS, V25, P332, DOI 10.1016/0888-7543(95)80155-F; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Lion-Francois L, 2006, NEUROLOGY, V67, P1713, DOI 10.1212/01.wnl.0000239153.39710.81; Mak CSW, 2009, NEUROSCIENCE, V163, P571, DOI 10.1016/j.neuroscience.2009.06.065; Mancardi MM, 2007, EPILEPSIA, V48, P1211, DOI 10.1111/j.1528-1167.2007.01148.x; Martinez-Munoz C, 2008, GENE, V418, P53, DOI 10.1016/j.gene.2008.04.003; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Pimenta AF, 2005, MENT RETARD DEV D R, V11, P295, DOI 10.1002/mrdd.20084; Poo-Arguelles P, 2006, J INHERIT METAB DIS, V29, P220, DOI 10.1007/s10545-006-0212-4; PUUSEPP H, 2009, J INHERIT METAB DIS; Pyne-Geithman GJ, 2004, MOL CELL BIOCHEM, V262, P35, DOI 10.1023/B:MCBI.0000038213.15646.4a; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; Rosenberg EH, 2006, J INHERIT METAB DIS, V29, P345, DOI 10.1007/s10545-006-0271-6; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Santos PM, 2009, BRAIN RES BULL, V80, P327, DOI 10.1016/j.brainresbull.2009.09.007; Schaefer TL, 2009, NEUROSCIENCE, V164, P1431, DOI 10.1016/j.neuroscience.2009.09.059; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; SEMPERE A, 2009, J INHERIT METAB DIS; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Tachikawa Masanori, 2007, V46, P83; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	45	75	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16187	10.1371/journal.pone.0016187	http://dx.doi.org/10.1371/journal.pone.0016187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249153	Green Submitted, Green Published, gold			2022-12-25	WOS:000286515000029
J	Deng, YQ; Dai, JX; Ji, GH; Jiang, T; Wang, HJ; Yang, HO; Tan, WL; Liu, R; Yu, M; Ge, BX; Zhu, QY; Qin, ED; Guo, YJ; Qin, CF				Deng, Yong-Qiang; Dai, Jian-Xin; Ji, Guang-Hui; Jiang, Tao; Wang, Hua-Jing; Yang, Hai-ou; Tan, Weng-Long; Liu, Ran; Yu, Man; Ge, Bao-Xue; Zhu, Qing-Yu; Qin, E-De; Guo, Ya-Jun; Qin, Cheng-Feng			A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein	PLOS ONE			English	Article							VIRUS ENVELOPE PROTEIN; DENGUE VIRUS; WEST-NILE; DOMAIN-III; JAPANESE ENCEPHALITIS; STRUCTURAL BASIS; E-GLYCOPROTEIN; INFECTION; TYPE-2; IDENTIFICATION	Flaviviruses are a group of human pathogenic, enveloped RNA viruses that includes dengue (DENV), yellow fever (YFV), West Nile (WNV), and Japanese encephalitis (JEV) viruses. Cross-reactive antibodies against Flavivirus have been described, but most of them are generally weakly neutralizing. In this study, a novel monoclonal antibody, designated mAb 2A10G6, was determined to have broad cross-reactivity with DENV 1-4, YFV, WNV, JEV, and TBEV. Phage-display biopanning and structure modeling mapped 2A10G6 to a new epitope within the highly conserved flavivirus fusion loop peptide, the (DRXW101)-D-98 motif. Moreover, in vitro and in vivo experiments demonstrated that 2A10G6 potently neutralizes DENV 1-4, YFV, and WNV and confers protection from lethal challenge with DENV 1-4 and WNV in murine model. Furthermore, functional studies revealed that 2A10G6 blocks infection at a step after viral attachment. These results define a novel broadly flavivirus cross-reactive mAb with highly neutralizing activity that can be further developed as a therapeutic agent against severe flavivirus infections in humans.	[Deng, Yong-Qiang; Jiang, Tao; Liu, Ran; Yu, Man; Zhu, Qing-Yu; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Dai, Jian-Xin; Ji, Guang-Hui; Wang, Hua-Jing; Guo, Ya-Jun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Dai, Jian-Xin; Wang, Hua-Jing; Yang, Hai-ou; Tan, Weng-Long; Guo, Ya-Jun] State Key Lab Antibody Med & Targeted Therapy, Shanghai, Peoples R China; [Ge, Bao-Xue] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci, Shanghai 200030, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Deng, YQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	yjguo@smmu.edu.cn; cfqin@hotmail.com	Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926; Ji, Guanghui/0000-0003-3763-2311	National Natural Science Foundation of China [30972613]; Major Special Program of National Science and Technology of China [2008ZX10004-014, 2009ZX10004-015]; International Foundation for Science [F/4622-1]; 973 projects of the National Science and Technology of China; 863 projects of the National Science and Technology of China [2010CB833605, 2006aa02A244]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Special Program of National Science and Technology of China; International Foundation for Science(International Foundation for Science); 973 projects of the National Science and Technology of China(National Basic Research Program of China); 863 projects of the National Science and Technology of China(National High Technology Research and Development Program of China)	This work was supported by, in part, by the National Natural Science Foundation of China (No. 30972613), the Major Special Program of National Science and Technology of China (2008ZX10004-014 and 2009ZX10004-015), International Foundation for Science (F/4622-1), and 973 and 863 projects of the National Science and Technology of China (2010CB833605 and 2006aa02A244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Goncalvez AP, 2004, J VIROL, V78, P12910, DOI 10.1128/JVI.78.23.12910-12918.2004; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gould LH, 2005, J VIROL, V79, P14606, DOI 10.1128/JVI.79.23.14606-14613.2005; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MARASCO WA, 2007, NAT BIOTECHNOL, V23, P1421; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, EXPERT OPIN BIOL TH, V7, P885, DOI 10.1517/14712598.7.6.885; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036; Ray D, 2006, DRUG DISCOV, V1, P45; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Volkova TD, 1999, ARCH VIROL, V144, P1035, DOI 10.1007/s007050050566; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0	40	109	118	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16059	10.1371/journal.pone.0016059	http://dx.doi.org/10.1371/journal.pone.0016059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264311	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000018
J	Inclan, YF; Huseby, MJ; Engel, JN				Inclan, Yuki F.; Huseby, Medora J.; Engel, Joanne N.			FimL Regulates cAMP Synthesis in Pseudomonas aeruginosa	PLOS ONE			English	Article							CHP CHEMOSENSORY SYSTEM; ADENYLATE-CYCLASE; CYCLIC-AMP; TWITCHING MOTILITY; ESCHERICHIA-COLI; GENETIC-ANALYSIS; MOUSE MODEL; IN-VITRO; VIRULENCE; EXPRESSION	Pseudomonas aeruginosa, a ubiquitous bacteria found in diverse ecological niches, is an important cause of acute infections in immunocompromised individuals and chronic infections in patients with Cystic Fibrosis. One signaling molecule required for the coordinate regulation of virulence factors associated with acute infections is 3', 5'-cyclic adenosine monophosphate, (cAMP), which binds to and activates a catabolite repressor homolog, Vfr. Vfr controls the transcription of many virulence factors, including those associated with Type IV pili (TFP), the Type III secretion system (T3SS), the Type II secretion system, flagellar-mediated motility, and quorum sensing systems. We previously identified FimL, a protein with histidine phosphotransfer-like domains, as a regulator of Vfr-dependent processes, including TFP-dependent motility and T3SS function. In this study, we carried out genetic and physiologic studies to further define the mechanism of action of FimL. Through a genetic screen designed to identify suppressors of FimL, we found a putative cAMP-specific phosphodiesterase (CpdA), suggesting that FimL regulates cAMP levels. Inactivation of CpdA increases cAMP levels and restores TFP-dependent motility and T3SS function to fimL mutants, consistent with in vivo phosphodiesterase activity. By constructing combinations of double and triple mutants in the two adenylate cyclase genes (cyaA and cyaB), fimL, and cpdA, we show that Delta fimL mutants resemble Delta cyaB mutants in TM defects, decreased T3SS transcription, and decreased cAMP levels. Similar to some of the virulence factors that they regulate, we demonstrate that CyaB and FimL are polarly localized. These results reveal new complexities in the regulation of diverse virulence pathways associated with acute P. aeruginosa infections.	[Inclan, Yuki F.; Huseby, Medora J.; Engel, Joanne N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Engel, Joanne N.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Inclan, Yuki F.; Huseby, Medora J.; Engel, Joanne N.] Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Inclan, YF (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Jengel@medicine.ucsf.edu			NIH [R01 AI42806]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 AI42806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Buddelmeijer N, 2006, J BACTERIOL, V188, P2928, DOI 10.1128/JB.188.8.2928-2935.2006; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; Ellefson DD, 1997, J BACTERIOL, V179, P825, DOI 10.1128/jb.179.3.825-830.1997; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fuchs EL, 2010, J BACTERIOL, V192, P3553, DOI 10.1128/JB.00363-10; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Gorke B, 2008, NAT REV MICROBIOL, V6, DOI 10.1038/nrmicro1932-c2; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Kanack KJ, 2006, MICROBIOL-SGM, V152, P3485, DOI 10.1099/mic.0.29008-0; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Leech AJ, 2006, J BACTERIOL, V188, P8479, DOI 10.1128/JB.00157-06; LIU PV, 1966, J INFECT DIS, V116, P481, DOI 10.1093/infdis/116.4.481; Macfadyen LP, 1998, J BACTERIOL, V180, P4401, DOI 10.1128/JB.180.17.4401-4405.1998; Mandell GL, 2010, MANDELL DOUGLAS BENN; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Monod J., 1942, ACTUALITES SCI IND; NICAS TI, 1984, INFECT IMMUN, V45, P470, DOI 10.1128/IAI.45.2.470-474.1984; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; SAIER MH, 1975, J BIOL CHEM, V250, P7593; SIEGEL LS, 1977, J BACTERIOL, V129, P87, DOI 10.1128/JB.129.1.87-96.1977; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TSUDA M, 1983, J BACTERIOL, V153, P1018, DOI 10.1128/JB.153.2.1018-1026.1983; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; WEST SEH, 1994, J BACTERIOL, V176, P7532, DOI 10.1128/JB.176.24.7532-7542.1994; Whitchurch CB, 2004, MOL MICROBIOL, V52, P873, DOI 10.1111/j.1365-2958.2004.04026.x; Whitchurch CB, 2005, MOL MICROBIOL, V55, P1357, DOI 10.1111/j.1365-2958.2005.04479.x; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4	46	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15867	10.1371/journal.pone.0015867	http://dx.doi.org/10.1371/journal.pone.0015867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264306	Green Published, gold, Green Submitted			2022-12-25	WOS:000286514000008
J	Mendizabal, I; Valente, C; Gusmao, A; Alves, C; Gomes, V; Goios, A; Parson, W; Calafell, F; Alvarez, L; Amorim, A; Gusmao, L; Comas, D; Prata, MJ				Mendizabal, Isabel; Valente, Cristina; Gusmao, Alfredo; Alves, Cintia; Gomes, Veronica; Goios, Ana; Parson, Walther; Calafell, Francesc; Alvarez, Luis; Amorim, Antonio; Gusmao, Leonor; Comas, David; Joao Prata, Maria			Reconstructing the Indian Origin and Dispersal of the European Roma: A Maternal Genetic Perspective	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; MACROHAPLOGROUP-M; Y-CHROMOSOME; MTDNA; LINEAGES; GYPSIES; DIVERSITY; HISTORY; EASTERN; POPULATIONS	Previous genetic, anthropological and linguistic studies have shown that Roma (Gypsies) constitute a founder population dispersed throughout Europe whose origins might be traced to the Indian subcontinent. Linguistic and anthropological evidence point to Indo-Aryan ethnic groups from North-western India as the ancestral parental population of Roma. Recently, a strong genetic hint supporting this theory came from a study of a private mutation causing primary congenital glaucoma. In the present study, complete mitochondrial control sequences of Iberian Roma and previously published maternal lineages of other European Roma were analyzed in order to establish the genetic affinities among Roma groups, determine the degree of admixture with neighbouring populations, infer the migration routes followed since the first arrival to Europe, and survey the origin of Roma within the Indian subcontinent. Our results show that the maternal lineage composition in the Roma groups follows a pattern of different migration routes, with several founder effects, and low effective population sizes along their dispersal. Our data allowed the confirmation of a North/West migration route shared by Polish, Lithuanian and Iberian Roma. Additionally, eleven Roma founder lineages were identified and degrees of admixture with host populations were estimated. Finally, the comparison with an extensive database of Indian sequences allowed us to identify the Punjab state, in North-western India, as the putative ancestral homeland of the European Roma, in agreement with previous linguistic and anthropological studies.	[Mendizabal, Isabel; Calafell, Francesc; Comas, David] CEXS UPF PRBB, CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain; [Valente, Cristina; Gusmao, Alfredo; Alves, Cintia; Gomes, Veronica; Goios, Ana; Alvarez, Luis; Amorim, Antonio; Gusmao, Leonor; Joao Prata, Maria] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Valente, Cristina; Amorim, Antonio; Joao Prata, Maria] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria; [Calafell, Francesc; Comas, David] CIBERESP, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universidade do Porto; Universidade do Porto; Medical University of Innsbruck; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Mendizabal, I (corresponding author), CEXS UPF PRBB, CSIC UPF, Inst Evolutionary Biol, Barcelona, Spain.	david.comas@upf.edu	Comas, David/D-5382-2014; Parson, Walther/AAD-6845-2020; Gusmao, Leonor/B-3122-2013; Alvarez, Luis/J-6022-2013; Gomes, Verónica/J-6041-2013; ALVES, CINTIA/C-7208-2013; Prata, Maria João/A-6945-2010; Gusmão, Leonor/L-8931-2019; Amorim, Antonio/A-7938-2008; Goios, Ana/J-6012-2013; Calafell, Francesc/C-8595-2014; Mendizabal, Isabel/AAD-7249-2021; Mendizabal, Isabel/L-8750-2014	Comas, David/0000-0002-5075-0956; Gusmao, Leonor/0000-0003-0432-6481; Alvarez, Luis/0000-0003-1311-4536; ALVES, CINTIA/0000-0002-9492-5922; Prata, Maria João/0000-0002-0583-1028; Gusmão, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Goios, Ana/0000-0002-3297-8420; Calafell, Francesc/0000-0002-1083-9438; Gomes, Veronica/0000-0003-2815-6376; Parson, Walther/0000-0002-5692-2392; Valente, Cristina/0000-0002-4721-9718; Mendizabal, Isabel/0000-0002-9018-3474	Basque Government (Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza) [BFI107.4]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/63343/2009, SFRH/BD/36045/2007, SFRH/BPD/43646/2008, SFRH/BPD/65000/2009, PTDC/ANT/70413/2006, POCI 2010]; Programa Operacional Ciencia e Inovacao; Direccion General de Investigacion, Ministerio de Educacion y Ciencia, Spain [CGL2009-14944/BOS]; Direccio General de Recerca, Generalitat de Catalunya [2009SGR1101]; Austrian Science Fund (FWF) [TR397]	Basque Government (Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza)(Basque Government); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Ciencia e Inovacao; Direccion General de Investigacion, Ministerio de Educacion y Ciencia, Spain(Spanish Government); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	IM was supported by a fellowship by the Basque Government (Hezkuntza, Unibertsitate eta Ikerketa Saila, Eusko Jaurlaritza, BFI107.4). Fundacao para a Ciencia e Tecnologia (FCT) supported CV, VG, AG and LA through grants SFRH/BD/63343/2009, SFRH/BD/36045/2007, SFRH/BPD/43646/2008 and SFRH/BPD/65000/2009, respectively. This work was partially financed by FCT through project PTDC/ANT/70413/2006 and POCI 2010, Programa Operacional Ciencia e Inovacao; Direccion General de Investigacion, Ministerio de Educacion y Ciencia, Spain (CGL2009-14944/BOS); Direccio General de Recerca, Generalitat de Catalunya (2009SGR1101) and the Austrian Science Fund (FWF): TR397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Alvarez J. Carlos, 2007, Legal Medicine, V9, P293, DOI 10.1016/j.legalmed.2007.05.005; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ARIAS DL, 2001, GAZETA ANTROPOLOGI, V17, P13; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; COLOCCI A, 1889, GLI ZINGARA STORIA P; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Dubut V, 2009, ANN HUM GENET, V73, P314, DOI 10.1111/j.1469-1809.2009.00519.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez O, 2008, TISSUE ANTIGENS, V71, P426, DOI 10.1111/j.1399-0039.2008.01016.x; Fraser A., 1992, GYPSIES; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Gusmao A, 2010, AM J PHYS ANTHROPOL, V141, P507, DOI 10.1002/ajpa.21166; Hancock I, 1987, SCHOLARSHIP GYPSY ST, P1; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Hurles ME, 2002, GENETICS, V160, P289; IOVITA R, 2004, AM ANTHROPOL, V106, P15; Irwin J, 2007, INT J LEGAL MED, V121, P377, DOI 10.1007/s00414-006-0128-4; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Malyarchuk BA, 2006, ANN HUM GENET, V70, P195, DOI 10.1111/j.1529-8817.2005.00222.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Nei M., 1987, MOL EVOLUTIONARY GEN; Parson W, 2007, FORENSIC SCI INT-GEN, V1, P88, DOI 10.1016/j.fsigen.2007.01.018; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; REYNIERS A, 1995, INT MIGRATION LABOUR, V1; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; TAJIMA F, 1983, GENETICS, V105, P437; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Weyrauch W.O., 2001, GYPSY LAW ROMANI LEG	43	55	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15988	10.1371/journal.pone.0015988	http://dx.doi.org/10.1371/journal.pone.0015988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264345	Green Published, gold			2022-12-25	WOS:000286513100023
J	Deshmane, SL; Mukerjee, R; Fan, SS; Sawaya, BE				Deshmane, Satish L.; Mukerjee, Ruma; Fan, Shongshan; Sawaya, Bassel E.			High-Performance Capillary Electrophoresis for Determining HIV-1 Tat Protein in Neurons	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MICROTUBULE-ASSOCIATED PROTEIN-2; CELLS; APOPTOSIS; TRANSCRIPTION; MECHANISM; DEATH; EXPRESSION; NEUROAIDS; INFECTION	The HIV-1 protein, Tat has been implicated in AIDS pathogenesis however, the amount of circulating Tat is believed to be very low and its quantification has been difficult. We performed the quantification of Tat released from infected cells and taken up by neurons using high performance capillary electrophoresis. This is the first report to successfully measure the amount of Tat in neurons and places Tat as a key player involved in HIV-associated neurocognitive disorders.	[Deshmane, Satish L.] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Deshmane, Satish L.] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Mukerjee, Ruma; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurol, Lab Mol Studies Neurodegenerat Dis, Philadelphia, PA 19122 USA; [Fan, Shongshan] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Deshmane, SL (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	sawaya@temple.edu			NIH [R01NS059327]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH R01NS059327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini S, 2005, MOL CELL BIOL, V25, P8126, DOI 10.1128/MCB.25.18.8126-8138.2005; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Baba M, 2004, CURR TOP MED CHEM, V4, P871, DOI 10.2174/1568026043388466; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; Gendelman HE, 1997, AIDS, V11, pS35; Kaul M, 2008, FRONT BIOSCI-LANDMRK, V13, P2484, DOI 10.2741/2860; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lim RWL, 2000, J BIOL CHEM, V275, P20578, DOI 10.1074/jbc.M001887200; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Mukerjee R, 2008, CELL CYCLE, V7, P2682, DOI 10.4161/cc.7.17.6450; New DR, 1997, J NEUROVIROL, V3, P168, DOI 10.3109/13550289709015806; Noorbakhsh F, 2005, J IMMUNOL, V174, P7320, DOI 10.4049/jimmunol.174.11.7320; Ramirez SH, 2001, J NEUROCHEM, V78, P874, DOI 10.1046/j.1471-4159.2001.00467.x; Rom I, 2009, BRAIN RES, V1275, P81, DOI 10.1016/j.brainres.2009.03.024; Sawaya BE, 2000, J BIOL CHEM, V275, P35209, DOI 10.1074/jbc.M005197200; Shivji M, 2005, J BIOL CHEM, V280, P15219, DOI 10.1074/jbc.M413946200; Skinner S, 2009, HIV MED, V10, P246, DOI 10.1111/j.1468-1293.2008.00679.x; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466	27	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16148	10.1371/journal.pone.0016148	http://dx.doi.org/10.1371/journal.pone.0016148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249135	Green Published, Green Submitted, gold			2022-12-25	WOS:000286512900024
J	Fan, LC; Chiang, WF; Liang, CH; Tsai, YT; Wong, TY; Chen, KC; Hong, TM; Chen, YL				Fan, L-C; Chiang, W-F; Liang, C-H; Tsai, Y-T; Wong, T-Y; Chen, K-C; Hong, T-M; Chen, Y-L			alpha-Catulin knockdown induces senescence in cancer cells	ONCOGENE			English	Article						alpha-catulin; senescence; p53; DNA damage; cDNA microarray; cancer	ONCOGENE-INDUCED SENESCENCE; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; NUCLEOTIDE EXCISION-REPAIR; CELLULAR SENESCENCE; IN-VIVO; CHROMOSOMAL INSTABILITY; TUMORIGENESIS; CATENIN; ACTIVATION	Cellular senescence functions as a tumor suppressor that protects against cancer progression. alpha-Catulin, an alpha-catenin-related protein, is reported to have tumorigenic potential because it regulates the nuclear factor-kappa B (NF-kappa B) pathway, but little is known about its clinical relevance and the mechanism through which it regulates cancer progression. Here, we found that alpha-catulin mRNA levels were significantly upregulated in cancer cell lines and clinical oral squamous cell carcinomas, which positively correlated with tumor size (P = 0.001) and American Joint Committee on Cancer (AJCC) stage (P = 0.004). alpha-Catulin knockdown in the OC2 and A549 cancer cell lines dramatically decreased cell proliferation and contributed to cellular senescence, and inhibited OC2 xenograft growth. Mechanistic dissection showed that alpha-catulin depletion strongly induced the DNA-damage response (DDR) in both cell lines, via a p53/p21-dependent pathway in A549 cells, but a p53/p21-independent pathway in OC2 cells carrying mutant p53. Global gene expression analysis revealed that alpha-catulin knockdown altered cell-cycle regulation and DDR pathways at the presenescent stage as well as significantly downregulate several crucial genes related to mitotic chromosome condensation, DDR and DNA repair systems, which suggests that its depletion-induced cellular senescence might be caused by chromosome condensation failures, severe DNA damage and impaired DNA repair ability. Our study provides evidence that alpha-catulin promotes tumor growth by preventing cellular senescence and suggests that downregulating alpha-catulin may be a promising therapeutic approach for cancer treatment. Oncogene (2011) 30, 2610-2621; doi:10.1038/onc.2010.637; published online 31 January 2011	[Tsai, Y-T; Wong, T-Y; Chen, K-C; Chen, Y-L] Natl Cheng Kung Univ, Inst Oral Med, Coll Med, Tainan 70101, Taiwan; [Fan, L-C; Liang, C-H; Hong, T-M; Chen, Y-L] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chiang, W-F] Chi Mei Med Ctr, Dept Dent, Liouying, Taiwan; [Chiang, W-F] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; [Hong, T-M] Natl Cheng Kung Hosp, Dept Clin Med Res, Tainan, Taiwan; [Hong, T-M] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University	Chen, YL (corresponding author), Natl Cheng Kung Univ, Inst Oral Med, Coll Med, 1 Univ Rd, Tainan 70101, Taiwan.	tmhong@mail.ncku.edu.tw; yuhling@mail.ncku.edu.tw	Chiang, Wei-Fan/L-6537-2019; Chen, Yuh-Ling/AAS-7957-2021	Chiang, Wei-Fan/0000-0002-9240-1404; 	National Science Council [NSC 96-2311-B-006-005-MY3, NSC 97-2314-B-384-003-MY3, NSC 99-3112-B-006-011, NSC 99-2627-B-006-003]; Department of Health, Taiwan [DOH99-TD-C-111-003]; National Science Council, Taiwan [NSC 97-3112-B-001-016]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants NSC 96-2311-B-006-005-MY3, NSC 97-2314-B-384-003-MY3, NSC 99-3112-B-006-011 and NSC 99-2627-B-006-003 from the National Science Council, and DOH99-TD-C-111-003 from the Department of Health, Taiwan. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of National Science Council, Taiwan (NSC 97-3112-B-001-016).	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Coelho PA, 2003, J CELL SCI, V116, P4763, DOI 10.1242/jcs.00799; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Li YF, 2009, J GENE MED, V11, P3, DOI 10.1002/jgm.1270; LLeonart ME, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-3; Merdek KD, 2004, MOL CELL BIOL, V24, P2410, DOI 10.1128/MCB.24.6.2410-2422.2004; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Miura K, 1996, CANCER RES, V56, P1629; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; SCHULTZ DC, 1995, CANCER RES, V55, P2150; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suzuki T, 2002, EXP GERONTOL, V37, P1005, DOI 10.1016/S0531-5565(02)00061-X; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Walen KH, 2007, CELL BIOL INT, V31, P1447, DOI 10.1016/j.cellbi.2007.06.015; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Yang HL, 2006, CANCER RES, V66, P3096, DOI 10.1158/0008-5472.CAN-05-3620; Zhang JS, 1998, GENOMICS, V54, P149, DOI 10.1006/geno.1998.5458; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	41	15	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	23					2610	2621		10.1038/onc.2010.637	http://dx.doi.org/10.1038/onc.2010.637			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21278790				2022-12-25	WOS:000291677800002
J	Tsushima, K; Osawa, T; Yanai, H; Nakajima, A; Takaoka, A; Manabe, I; Ohba, Y; Imai, Y; Taniguchi, T; Nagai, R				Tsushima, Kensuke; Osawa, Tomoko; Yanai, Hideyuki; Nakajima, Akira; Takaoka, Akinori; Manabe, Ichiro; Ohba, Yusuke; Imai, Yasushi; Taniguchi, Tadatsugu; Nagai, Ryozo			IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension	FASEB JOURNAL			English	Article						cardiac remodeling; inflammation; heart failure	CONGESTIVE-HEART-FAILURE; SMOOTH-MUSCLE-CELLS; TOLL-LIKE RECEPTORS; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; GENE INDUCTION; DIASTOLIC DYSFUNCTION; MECHANICAL STRETCH; ANTIVIRAL RESPONSE; VIRAL-INFECTION	Hypertension is a typical modern lifestyle-related disease that is closely associated with the development of cardiovascular disorders. Elevation of angiotensin II (ANG II) is one of several critical factors for hypertension and heart failure; however, the mechanisms underlying the ANG II-mediated pathogenesis are still poorly understood. Here, we show that ANG II-mediated cardiac fibrosis, but not hypertrophy, is regulated by interferon regulatory factor 3 (IRF3), which until now has been exclusively studied in the innate immune system. In a ANG II-infusion mouse model (3.0 mg/kg/d), we compared IRF3-deficient mice (Irf3(-/-)/Bcl2l12(-/-)) with matched wild-type (WT) controls. The development of cardiac fibrosis [3.95 +/- 0.62% (WT) vs. 1.41 +/- 0.46% (Irf3(-/-)/Bcl2l12(-/-)); P < 0.01] and accompanied reduction in left ventricle end-diastolic dimension [2.89 +/- 0.10 mm (WT) vs. 3.51 +/- 0.15 mm (Irf3(-/-)/Bcl2l12(-/-)); P=0.012] are strongly suppressed in Irf3(-/-)/Bcl2l12(-/-) mice, whereas hypertrophy still develops. Further, we provide evidence for the activation of IRF3 by ANG II signaling in mouse cardiac fibroblasts. Unlike the activation of IRF3 by innate immune receptors, IRF3 activation by ANG II is unique in that it is activated through the canonical ERK signaling pathway. Thus, our present study reveals a hitherto unrecognized function of IRF3 in cardiac remodeling, providing new insight into the progression of hypertension-induced cardiac pathogenesis.-Tsushima, K., Osawa, T., Yanai, H., Nakajima, A., Takaoka, A., Manabe, I., Ohba, Y., Imai, Y., Taniguchi, T., Nagai, R. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension. FASEB J. 25, 1531-1543 (2011). www.fasebj.org	[Taniguchi, Tadatsugu] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido, Japan; [Yanai, Hideyuki; Taniguchi, Tadatsugu] Japan Sci & Technol Agcy, Tokyo, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Japan Science & Technology Agency (JST)	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp; nagai-tky@umin.ac.jp	Manabe, Ichiro/AAE-5105-2021; Yanai, Hideyuki/AGK-5933-2022; Manabe, Ichiro/E-1529-2014; Ohba, Yusuke/E-7944-2011	Yanai, Hideyuki/0000-0002-0115-9000; Tsushima, Kensuke/0000-0001-7338-7849	KAKENHI [17012005, 19041021, 19500492, 21790710]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23659196] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank A. Fukamizu (Tsukuba University, Tsukuba, Japan) for murine AT1a receptor expression vector and AT1a-293T cell line; S. Yamaoka (Tokyo Medical and Dental University, Tokyo, Japan) for Pin1 expression vector; M. Matsuda (Kyoto University, Kyoto, Japan) for RasV12 expression vector; D. Savitsky, T. Fujita, K. Maemura, K. Honda, T. Tamura, T. Suzuki, S. Kano, and H. Negishi for invaluable advice; and N. Yamanaka and M. Shishido for technical assistance. This work was supported in part by grants KAKENHI 17012005, 19041021, 19500492, and 21790710 and by the Global Center of Excellence Program Integrative Life Science Based on the Study of Biosignaling Mechanisms from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Borgland SL, 2000, J VIROL, V74, P3941, DOI 10.1128/JVI.74.9.3941-3947.2000; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Deguchi J, 1999, CIRC RES, V85, P565, DOI 10.1161/01.RES.85.7.565; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hitomi H, 2007, CURR OPIN CARDIOL, V22, P311, DOI 10.1097/HCO.0b013e3281532b53; HOIT BD, 1995, J CLIN INVEST, V95, P1519, DOI 10.1172/JCI117824; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ishida JJ, 1999, INT J MOL MED, V3, P263; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin M, 1995, Hypertens Res, V18, P151, DOI 10.1291/hypres.18.151; Liu JJ, 2011, APOPTOSIS, V16, P94, DOI 10.1007/s10495-010-0549-x; Malhotra R, 1999, CIRC RES, V85, P137, DOI 10.1161/01.RES.85.2.137; Matsumoto T, 2003, CIRCULATION, V107, P2555, DOI 10.1161/01.CIR.0000074041.81728.79; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Nakajima A, 2009, P NATL ACAD SCI USA, V106, P12448, DOI 10.1073/pnas.0905702106; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Sadoshima J, 1996, EMBO J, V15, P775, DOI 10.1002/j.1460-2075.1996.tb00413.x; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sano M, 2000, J BIOL CHEM, V275, P29717, DOI 10.1074/jbc.M003128200; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Touyz RM, 2000, PHARMACOL REV, V52, P639; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; WEBER KT, 1989, J MOL CELL CARDIOL, V21, P121, DOI 10.1016/0022-2828(89)90778-5; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamazaki T, 1998, CIRC RES, V82, P430, DOI 10.1161/01.RES.82.4.430; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	53	34	35	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1531	1543		10.1096/fj.10-174615	http://dx.doi.org/10.1096/fj.10-174615			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21266535				2022-12-25	WOS:000290023800011
J	Habtemichael, EN; Brewer, PD; Romenskaia, I; Mastick, CC				Habtemichael, Estifanos N.; Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley			Kinetic Evidence That Glut4 Follows Different Endocytic Pathways than the Receptors for Transferrin and alpha(2)-Macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; GLUCOSE-TRANSPORTER GLUT4; 3T3-L1 ADIPOCYTES; CELL-SURFACE; RATE-CONSTANT; SUBCELLULAR TRAFFICKING; STORAGE COMPARTMENTS; INSULIN INCREASES; RAT ADIPOCYTES; VESICLES	Insulin regulates glucose uptake through effects on the trafficking of the glucose transporter Glut4. To investigate the degree of overlap between Glut4 and the general endocytic pathways, the kinetics of trafficking of Glut4 and the receptors for transferrin (Tf) and alpha 2-macroglobulin (alpha-2-M; LRP-1) were compared using quantitative flow cytometric assays. Insulin increased the exocytic rate constant (k(ex)) for both Glut4 and Tf. However, the k(ex) of Glut4 was 5-15 times slower than Tf in both basal and insulin-stimulated cells. The endocytic rate constant (k(en)) of Glut4 was also five times slower than Tf. Insulin did not affect the k(en) of either protein. In basal cells, the k(en) for alpha-2-M/LRP-1 was similar to Glut4 but 5-fold slower than Tf. Insulin increased k(en) for alpha-2-M/LRP-1 by 30%. In contrast, the k(ex) for LRP-1 was five times faster than Glut4 in basal cells, and insulin did not increase this rate constant. Thus, although there is overlap in the protein machineries/compartments utilized, the differences in trafficking kinetics indicate that Glut4, the Tf receptor, and LRP-1 are differentially processed both within the cell and at the plasma membrane. It has been reported that insulin decreases the k(en) of Glut4 in adipocytes. However, the effect of exocytosis on the "internalization" assays was not considered. Because it is counterintuitive, the effect of exocytosis on these assays is often overlooked in endocytosis studies. Using mathematical modeling and simulation, we show that the reported decrease in Glut4 k(en) can be entirely accounted for by the well established increase in Glut4 k(ex).	[Habtemichael, Estifanos N.; Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	National Institutes of Health [DK56197]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56197. This work was also supported by grants from the American Diabetes Association.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Antonescu CN, 2009, BIOSCIENCE REP, V29, P1, DOI 10.1042/BSR20080105; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; CHAKRABARTI R, 1993, J CELL BIOL, V123, P79, DOI 10.1083/jcb.123.1.79; Cormont M, 1996, ENDOCRINOLOGY, V137, P3408, DOI 10.1210/en.137.8.3408; CORVERA S, 1989, J BIOL CHEM, V264, P10133; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; Ko KWS, 2001, BIOCHEMISTRY-US, V40, P752, DOI 10.1021/bi001797+; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Martin S, 2000, J CELL SCI, V113, P3427; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MAXFIELD FR, 1982, J CELL BIOL, V95, pA271; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Ramm G, 2000, MOL BIOL CELL, V11, P4079, DOI 10.1091/mbc.11.12.4079; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; SATOH S, 1993, J BIOL CHEM, V268, P17820; SHEPHERD PR, 1995, BIOCHEM BIOPH RES CO, V211, P535, DOI 10.1006/bbrc.1995.1846; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TYCKO B, 1982, CELL, V28, P643, DOI 10.1016/0092-8674(82)90219-7; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wei ML, 1998, J CELL BIOL, V140, P565, DOI 10.1083/jcb.140.3.565; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	53	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10115	10125		10.1074/jbc.M111.217935	http://dx.doi.org/10.1074/jbc.M111.217935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252237	Green Published, hybrid			2022-12-25	WOS:000288547000026
J	Bridier, A; Le Coq, D; Dubois-Brissonnet, F; Thomas, V; Aymerich, S; Briandet, R				Bridier, Arnaud; Le Coq, Dominique; Dubois-Brissonnet, Florence; Thomas, Vincent; Aymerich, Stephane; Briandet, Romain			The Spatial Architecture of Bacillus subtilis Biofilms Deciphered Using a Surface-Associated Model and In Situ Imaging	PLOS ONE			English	Article							RESPONSE REGULATOR DEGU; LASER-SCANNING MICROSCOPY; MASTER REGULATOR; GENES; MOTILITY; TRANSCRIPTION; IDENTIFICATION; EXPRESSION; FLAGELLA; SPO0A	The formation of multicellular communities known as biofilms is the part of bacterial life cycle in which bacteria display cooperative behaviour and differentiated phenotypes leading to specific functions. Bacillus subtilis is a Gram-positive bacterium that has served for a decade as a model to study the molecular pathways that control biofilm formation. Most of the data on B. subtilis biofilms have come from studies on the formation of pellicles at the air-liquid interface, or on the complex macrocolonies that develop on semi-solid nutritive agar. Here, using confocal laser scanning microcopy, we show that B. subtilis strains of different origins are capable of forming biofilms on immersed surfaces with dramatically protruding "beanstalk-like'' structures with certain strains. Indeed, these structures can reach a height of more than 300 mu m with one undomesticated strain from a medical environment. Using 14 GFP-labeled mutants previously described as affecting pellicle or complex colony formation, we have identified four genes whose inactivation significantly impeded immersed biofilm development, and one mutation triggering hyperbiofilm formation. We also identified mutations causing the three-dimensional architecture of the biofilm to be altered. Taken together, our results reveal that B. subtilis is able to form specific biofilm features on immersed surfaces, and that the development of these multicellular surface-associated communities involves regulation pathways that are common to those governing the formation of pellicle and/or complex colonies, and also some specific mechanisms. Finally, we propose the submerged surface-associated biofilm as another relevant model for the study of B. subtilis multicellular communities.	[Bridier, Arnaud; Le Coq, Dominique; Aymerich, Stephane; Briandet, Romain] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Bridier, Arnaud; Dubois-Brissonnet, Florence] AgroParisTech, UMR MICALIS 1319, Jouy En Josas, France; [Thomas, Vincent] Steris, Fontenay Aux Roses, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Bridier, A (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	romain.briandet@jouy.inra.fr	Thomas, Vincent/A-8941-2012; Thomas, Vincent/AAB-6394-2022; bridier, arnaud/D-7183-2013; Thomas, Vincent/AAB-8982-2019; Briandet, Romain/AAD-2102-2020	Thomas, Vincent/0000-0003-4034-9525; Thomas, Vincent/0000-0003-4034-9525; bridier, arnaud/0000-0003-4812-3301; Briandet, Romain/0000-0002-8123-3492; Le Coq, Dominique/0000-0001-5756-2280; Bridier, Arnaud/0000-0002-7221-8944; Dubois-Brissonnet, Florence/0000-0003-2998-7518	Essonne Departement [A02137]	Essonne Departement	This study received support from a public grant "MEDICEN-Region Paris, Ile-de-France'' in the framework of the "Global deconta'' program (http://www.medicen.org/). This national scientific program was coordinated by V. Thomas, employed by Steris SA. V. Thomas participated in the design of the study, but not in data collection and analysis, decision to publish, or preparation of the manuscript. The "Essonne Departement'' is also acknowledged for its financial support of the confocal microscopy facility (public grant ASTRE n<SUP>o</SUP>A02137). The "Essonnes Departement'' had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati G, 2004, J BACTERIOL, V186, P6003, DOI 10.1128/jb.186.18.6003-6014.2004; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chai YR, 2009, MOL MICROBIOL, V74, P876, DOI 10.1111/j.1365-2958.2009.06900.x; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Costerton J. William, 2007, V1, P1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; CRUTZ AM, 1992, J BACTERIOL, V174, P6087, DOI 10.1128/JB.174.19.6087-6095.1992; DAHL MK, 1992, J BIOL CHEM, V267, P14509; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hamon MA, 2004, MOL MICROBIOL, V52, P847, DOI 10.1111/j.1365-2958.2004.04023.x; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hamze K, 2009, MICROBIOL-SGM, V155, P398, DOI 10.1099/mic.0.021477-0; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; Jules M, 2009, J BACTERIOL, V191, P3168, DOI 10.1128/JB.01783-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KIEL JAKW, 1995, APPL ENVIRON MICROB, V61, P4244, DOI 10.1128/AEM.61.12.4244-4250.1995; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kobayashi K, 2008, MOL MICROBIOL, V69, P1399, DOI 10.1111/j.1365-2958.2008.06369.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kobayashi K, 2007, J BACTERIOL, V189, P4920, DOI 10.1128/JB.00157-07; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kuehn M, 1998, APPL ENVIRON MICROB, V64, P4115; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; Martin DJH, 2008, J HOSP INFECT, V69, P377, DOI 10.1016/j.jhin.2008.04.010; Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0; Nagorska K, 2008, J BACTERIOL, V190, P3546, DOI 10.1128/JB.01665-07; Ohsawa T, 2009, BIOSCI BIOTECH BIOCH, V73, P2096, DOI 10.1271/bbb.90341; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ryu JH, 2005, APPL ENVIRON MICROB, V71, P247, DOI 10.1128/AEM.71.1.247-254.2005; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Stover AG, 1999, J BACTERIOL, V181, P7065; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Verhamme DT, 2009, J BACTERIOL, V191, P100, DOI 10.1128/JB.01236-08; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Xavier JB, 2003, WATER SCI TECHNOL, V47, P31, DOI 10.2166/wst.2003.0273; YANG M, 1987, J BACTERIOL, V169, P434, DOI 10.1128/jb.169.1.434-437.1987	56	46	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16177	10.1371/journal.pone.0016177	http://dx.doi.org/10.1371/journal.pone.0016177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267464	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500044
J	Furuya, EY; Dick, A; Perencevich, EN; Pogorzelska, M; Goldmann, D; Stone, PW				Furuya, E. Yoko; Dick, Andrew; Perencevich, Eli N.; Pogorzelska, Monika; Goldmann, Donald; Stone, Patricia W.			Central Line Bundle Implementation in US Intensive Care Units and Impact on Bloodstream Infections	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CHLORHEXIDINE; SURVEILLANCE; SAFETY	Background: Central line-associated bloodstream infections (CLABSI) represent a serious patient safety issue. To prevent these infections, bundled interventions are increasingly recommended. We examine the extent of adoption of Central Line (CL) Bundle elements throughout US intensive care units (ICU) and determine their effectiveness in preventing CLABSIs. Methodology/Principal Findings: In this cross-sectional study, National Healthcare Safety Network (NHSN) hospitals provided the following: ICU-specific NHSN-reported rates of CLABSI/1,000 central line days; policies and compliance rates regarding bundle components; and other setting characteristics. In 250 hospitals the mean CLABSI rate was 2.1 per 1000 central line days and 49% reported having a written CL Bundle policy. However, of those that monitored compliance, only 38% reported very high compliance with the CL Bundle. Only when an ICU had a policy, monitored compliance, and had >= 95% compliance did CLABSI rates decrease. Complying with any one of three CL Bundle elements resulted in decreased CLABSI rates (beta = -1.029, p = 0.015). If an ICU without good bundle compliance achieved high compliance with any one bundle element, we estimated that its CLABSI rate would decrease by 38%. Conclusions/Significance: In NHSN hospitals across the US, the CL Bundle is associated with lower infection rates only when compliance is high. Hospitals must target improving bundle implementation and compliance as opposed to simply instituting policies.	[Furuya, E. Yoko] Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA; [Dick, Andrew] RAND Corp, Boston, MA USA; [Perencevich, Eli N.] Iowa City VA, Dept Internal Med, Iowa City, IA USA; [Perencevich, Eli N.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Pogorzelska, Monika] Columbia Univ, Sch Nursing, New York, NY USA; [Goldmann, Donald] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Donald] Childrens Hosp, Boston, MA 02115 USA; [Stone, Patricia W.] Columbia Univ, Sch Nursing, New York, NY USA	Columbia University; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Columbia University; Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Columbia University	Furuya, EY (corresponding author), Columbia Univ Coll Phys & Surg, Div Infect Dis, 630 W 168th St, New York, NY 10032 USA.	ps2024@columbia.edu		Pogorzelska-Maziarz, Monika/0000-0002-3449-9722; Perencevich, Eli/0000-0002-3721-3355	National Institutes of Health [R01NR010107]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was funded by National Institutes of Health (R01NR010107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; *CDCP, 2008, NHSN MAN PAT SAF COM; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Emori TG, 1998, INFECT CONT HOSP EP, V19, P308; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; *HLTH RES ED TRUST, HRET HOSP ASS ANN PA; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; Horan TC, 1997, AM J INFECT CONTROL, V25, P73, DOI 10.1016/S0196-6553(97)90031-6; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Irizarry L, 1996, CHEMOTHERAPY, V42, P248, DOI 10.1159/000239451; Kaissi A, 2006, HEALTH CARE MANAG, V25, P292, DOI 10.1097/00126450-200610000-00002; Kampf G, 1998, J HOSP INFECT, V38, P297, DOI 10.1016/S0195-6701(98)90078-0; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; *MILL LIV CAMP, 2006, GETT START KIT HOW T; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Perencevich EN, 2007, INFECT CONT HOSP EP, V28, P1121, DOI 10.1086/521852; Pronovost Peter, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Sticca G, 2004, Ann Ig, V16, P187; Stone PW, 2009, AM J INFECT CONTROL, V37, P351, DOI 10.1016/j.ajic.2008.11.001; Stone PW, 2006, CRIT CARE MED, V34, P1907, DOI 10.1097/01.CCM.0000218411.53557.29; Thongpiyapoom Somchit, 2004, Journal of the Medical Association of Thailand, V87, P819; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Wootton M, 2009, INFECT CONT HOSP EP, V30, P226, DOI 10.1086/595691; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060; 2005, MMWR MORBIDITY MORTA, V54, P1013	29	147	153	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15452	10.1371/journal.pone.0015452	http://dx.doi.org/10.1371/journal.pone.0015452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267440	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500023
J	Kosuge, H; Sherlock, SP; Kitagawa, T; Terashima, M; Barral, JK; Nishimura, DG; Dai, HJ; McConnell, MV				Kosuge, Hisanori; Sherlock, Sarah P.; Kitagawa, Toshiro; Terashima, Masahiro; Barral, Joelle K.; Nishimura, Dwight G.; Dai, Hongjie; McConnell, Michael V.			FeCo/Graphite Nanocrystals for Multi-Modality Imaging of Experimental Vascular Inflammation	PLOS ONE			English	Article							MACROPHAGES IN-VIVO; PLAQUE DESTABILIZATION; CONTRAST AGENT; ATHEROSCLEROSIS; MRI; VISUALIZATION; EXPRESSION; CELLS; MICE	Background: FeCo/graphitic-carbon nanocrystals (FeCo/GC) are biocompatible, high-relaxivity, multi-functional nanoparticles. Macrophages represent important cellular imaging targets for assessing vascular inflammation. We evaluated FeCo/GC for vascular macrophage uptake and imaging in vivo using fluorescence and MRI. Methods and Results: Hyperlipidemic and diabetic mice underwent carotid ligation to produce a macrophage-rich vascular lesion. In situ and ex vivo fluorescence imaging were performed at 48 hours after intravenous injection of FeCo/GC conjugated to Cy5.5 (n = 8, 8 nmol of Cy5.5/mouse). Significant fluorescence signal from FeCo/GC-Cy5.5 was present in the ligated left carotid arteries, but not in the control (non-ligated) right carotid arteries or sham-operated carotid arteries (p = 0.03 for ligated vs. non-ligated). Serial in vivo 3T MRI was performed at 48 and 72 hours after intravenous FeCo/GC (n = 6, 270 mu g Fe/mouse). Significant T2* signal loss from FeCo/GC was seen in ligated left carotid arteries, not in non-ligated controls (p = 0.03). Immunofluorescence staining showed colocalization of FeCo/GC and macrophages in ligated carotid arteries. Conclusions: FeCo/GC accumulates in vascular macrophages in vivo, allowing fluorescence and MR imaging. This multifunctional high-relaxivity nanoparticle platform provides a promising approach for cellular imaging of vascular inflammation.	[Kosuge, Hisanori; Kitagawa, Toshiro; Terashima, Masahiro; McConnell, Michael V.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Sherlock, Sarah P.; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Stanford University	Kosuge, H (corresponding author), Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA.	mcconnell@stanford.edu	Dai, Hongjie/ABC-4574-2021	McConnell, Michael/0000-0001-8743-0932	National Institutes of Health [R01-HL078678]; American Heart Association [0825272-F]; Stanford Bio-X Interdisciplinary Initiative; GE Healthcare; NATIONAL CANCER INSTITUTE [R01CA135109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stanford Bio-X Interdisciplinary Initiative; GE Healthcare(General ElectricGE Healthcare); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (R01-HL078678, nih.gov), the American Heart Association (0825272-F, heart.org), and Stanford Bio-X Interdisciplinary Initiatives Program (biox.stanford.edu), as well as MRI research support from GE Healthcare (gehealthcare.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Cormode DP, 2008, SMALL, V4, P1437, DOI 10.1002/smll.200701285; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Fortin JP, 2008, EUR BIOPHYS J BIOPHY, V37, P223, DOI 10.1007/s00249-007-0197-4; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harmon KJ, 2000, AM J PATHOL, V156, P1741, DOI 10.1016/S0002-9440(10)65045-6; Howarth SPS, 2009, EUR J RADIOL, V70, P555, DOI 10.1016/j.ejrad.2008.01.047; Hyafil F, 2006, ARTERIOSCL THROM VAS, V26, P176, DOI 10.1161/01.ATV.0000194098.82677.57; Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Kolodgie FD, 2003, CIRCULATION, V108, P3134, DOI 10.1161/01.CIR.0000105761.00573.50; Lee JH, 2009, MAGN RESON MED, V62, P1497, DOI 10.1002/mrm.22132; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Seo WS, 2006, NAT MATER, V5, P971, DOI 10.1038/nmat1775; TERASHIMA M, 2010, MOL IMAGING BIO 1106; Terashima M, 2011, BIOMATERIALS, V32, P1430, DOI 10.1016/j.biomaterials.2010.09.029; Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Yu ZG, 2004, AM J PHYSIOL-RENAL, V286, pF720, DOI 10.1152/ajprenal.00165.2003	29	25	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14523	10.1371/journal.pone.0014523	http://dx.doi.org/10.1371/journal.pone.0014523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264237	gold, Green Published			2022-12-25	WOS:000286516500005
J	Brackman, G; Celen, S; Hillaert, U; Van Calenbergh, S; Cos, P; Maes, L; Nelis, HJ; Coenye, T				Brackman, Gilles; Celen, Shari; Hillaert, Ulrik; Van Calenbergh, Serge; Cos, Paul; Maes, Louis; Nelis, Hans J.; Coenye, Tom			Structure-Activity Relationship of Cinnamaldehyde Analogs as Inhibitors of AI-2 Based Quorum Sensing and Their Effect on Virulence of Vibrio spp	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; HARVEYI; EXPRESSION; REGULATOR; SEQUENCE; PROTEIN; LUMINESCENCE; AUTOINDUCER; VULNIFICUS; SMCR	Background: Many bacteria, including Vibrio spp., regulate virulence gene expression in a cell-density dependent way through a communication process termed quorum sensing (QS). Hence, interfering with QS could be a valuable novel antipathogenic strategy. Cinnamaldehyde has previously been shown to inhibit QS-regulated virulence by decreasing the DNA-binding ability of the QS response regulator LuxR. However, little is known about the structure-activity relationship of cinnamaldehyde analogs. Methodology/Principal Findings: By evaluating the QS inhibitory activity of a series of cinnamaldehyde analogs, structural elements critical for autoinducer-2 QS inhibition were identified. These include an alpha, beta unsaturated acyl group capable of reacting as Michael acceptor connected to a hydrophobic moiety and a partially negative charge. The most active cinnamaldehyde analogs were found to affect the starvation response, biofilm formation, pigment production and protease production in Vibrio spp in vitro, while exhibiting low cytotoxicity. In addition, these compounds significantly increased the survival of the nematode Caenorhabditis elegans infected with Vibrio anguillarum, Vibrio harveyi and Vibrio vulnificus. Conclusions/Significance: Several new and more active cinnamaldehyde analogs were discovered and they were shown to affect Vibrio spp. virulence factor production in vitro and in vivo. Although ligands for LuxR have not been identified so far, the nature of different cinnamaldehyde analogs and their effect on the DNA binding ability of LuxR suggest that these compounds act as LuxR-ligands.	[Brackman, Gilles; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Celen, Shari; Hillaert, Ulrik; Van Calenbergh, Serge] Univ Ghent, Med Chem Lab, B-9000 Ghent, Belgium; [Cos, Paul; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium	Ghent University; Ghent University; University of Antwerp	Brackman, G (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	tom.coenye@UGent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Van Calenbergh, Serge/A-3167-2008; Maes, Louis JRM/A-2384-2017; cos, paul/AAU-3896-2020; Cos, Paul/L-9717-2015	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Van Calenbergh, Serge/0000-0002-4201-1264; Maes, Louis JRM/0000-0002-2324-9509; cos, paul/0000-0003-4361-8911; Cos, Paul/0000-0003-4361-8911	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Fund for Scientific research - Flanders (FWO-Vlaanderen); Ghent University	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific research - Flanders (FWO-Vlaanderen)(FWO); Ghent University(Ghent University)	This work was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen, www.iwt.be), Fund for Scientific research - Flanders (FWO-Vlaanderen, www.fwo.be) and by the Special Research Fund (BOF) of Ghent University (www.ugent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Battistuzzi G, 2003, ORG LETT, V5, P777, DOI 10.1021/ol034071p; Brackman G, 2009, RES MICROBIOL, V160, P144, DOI 10.1016/j.resmic.2008.12.003; Brackman G, 2009, MICROBIOL-SGM, V155, P4114, DOI 10.1099/mic.0.032474-0; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Defoirdt T, 2006, APPL ENVIRON MICROB, V72, P6419, DOI 10.1128/AEM.00753-06; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Lautens M, 2004, J ORG CHEM, V69, P3478, DOI 10.1021/jo049874k; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Niu C, 2006, LETT APPL MICROBIOL, V43, P489, DOI 10.1111/j.1472-765X.2006.02001.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Stiernagle Theresa, 2006, WormBook, P1; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; TOPLISS JG, 1972, J MED CHEM, V15, P1066, DOI 10.1021/jm00280a017; TOPLISS JG, 1977, J MED CHEM, V20, P463, DOI 10.1021/jm00214a001; Wu ZX, 2004, J MED CHEM, V47, P3282, DOI 10.1021/jm0499615; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	31	89	95	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16084	10.1371/journal.pone.0016084	http://dx.doi.org/10.1371/journal.pone.0016084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249192	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000017
J	Ng, CA; Hunter, MJ; Perry, MD; Mobli, M; Ke, Y; Kuchel, PW; King, GF; Stock, D; Vandenberg, JI				Ng, Chai Ann; Hunter, Mark J.; Perry, Matthew D.; Mobli, Mehdi; Ke, Ying; Kuchel, Philip W.; King, Glenn F.; Stock, Daniela; Vandenberg, Jamie I.			The N-Terminal Tail of hERG Contains an Amphipathic alpha-Helix That Regulates Channel Deactivation	PLOS ONE			English	Article							K+ CHANNELS; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; MOLECULAR-BASIS; PAS DOMAIN; MUTATIONS; FAMILY	The cytoplasmic N-terminal domain of the human ether-a-go-go related gene (hERG) K+ channel is critical for the slow deactivation kinetics of the channel. However, the mechanism(s) by which the N-terminal domain regulates deactivation remains to be determined. Here we show that the solution NMR structure of the N-terminal 135 residues of hERG contains a previously described Per-Arnt-Sim (PAS) domain (residues 26-135) as well as an amphipathic alpha-helix (residues 13-23) and an initial unstructured segment (residues 2-9). Deletion of residues 2-25, only the unstructured segment (residues 2-9) or replacement of the alpha-helix with a flexible linker all result in enhanced rates of deactivation. Thus, both the initial flexible segment and the alpha-helix are required but neither is sufficient to confer slow deactivation kinetics. Alanine scanning mutagenesis identified R5 and G6 in the initial flexible segment as critical for slow deactivation. Alanine mutants in the helical region had less dramatic phenotypes. We propose that the PAS domain is bound close to the central core of the channel and that the N-terminal alpha-helix ensures that the flexible tail is correctly orientated for interaction with the activation gating machinery to stabilize the open state of the channel.	[Ng, Chai Ann; Hunter, Mark J.; Perry, Matthew D.; Ke, Ying; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Ng, Chai Ann; Kuchel, Philip W.; Vandenberg, Jamie I.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Mobli, Mehdi; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Stock, Daniela] Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Darlinghurst, NSW, Australia; [Stock, Daniela; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; University of Sydney; University of Queensland; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Ng, CA (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Mobli, Mehdi/O-7244-2014; Vandenberg, Jamie I/B-6608-2013; King, Glenn F/J-5059-2012	Mobli, Mehdi/0000-0003-2420-4262; Vandenberg, Jamie I/0000-0002-3859-3716; King, Glenn F/0000-0002-2308-2200; Kuchel, Philip/0000-0003-4100-7332; Ng, Chai Ann/0000-0002-3120-5450	Australian Research Council [DP0986316]; National Health & Medical Research Council [459401]; National Heart Foundation of Australia [G09S-450]	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was funded by grants from the Australian Research Council (DP0986316; http://www.arc.gov.au/), the National Health & Medical Research Council (459401; http://www.nhmrc.gov.au/), National Heart Foundation of Australia (G09S-450; www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; [Anonymous], 2008, AMBER 10; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Guntert Peter, 2004, Methods Mol Biol, V278, P353; GUSTINA A, 2009, P NATL ACAD SCI US; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; LI Q, 2010, BIOCH BIOPHYS RES CO; Mobli M, 2008, CONCEPT MAGN RESON A, V32A, P436, DOI 10.1002/cmr.a.20126; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Muskett F.W., 2010, J BIOL CHEM; Pandini A, 2005, PROTEIN ENG DES SEL, V18, P127, DOI 10.1093/protein/gzi017; Perrin MJ, 2008, PROG BIOPHYS MOL BIO, V98, P137, DOI 10.1016/j.pbiomolbio.2008.10.006; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHONHERR R, 1996, J PHYSL; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749	30	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16191	10.1371/journal.pone.0016191	http://dx.doi.org/10.1371/journal.pone.0016191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249148	Green Submitted, gold, Green Published			2022-12-25	WOS:000286515000031
J	Mengatto, CM; Mussano, F; Honda, Y; Colwell, CS; Nishimura, I				Mengatto, Cristiane Machado; Mussano, Federico; Honda, Yoshitomo; Colwell, Christopher S.; Nishimura, Ichiro			Circadian Rhythm and Cartilage Extracellular Matrix Genes in Osseointegration: A Genome-Wide Screening of Implant Failure by Vitamin D Deficiency	PLOS ONE			English	Article							BONE; CLOCK; CALCIUM; MOUSE; TRANSCRIPTION; CHONDROCYTE; PHYSIOLOGY; GENETICS; COLLAGEN; SURFACE	Background: Successful dental and orthopedic implants require the establishment of an intimate association with bone tissue; however, the mechanistic explanation of how biological systems accomplish osseointegration is still incomplete. We sought to identify critical gene networks involved in osseointegration by exploring the implant failure model under vitamin D deficiency. Methodology: Adult male Sprague-Dawley rats were exposed to control or vitamin D-deficient diet prior to the osteotomy surgery in the femur bone and the placement of T-shaped Ti4Al6V implant. Two weeks after the osteotomy and implant placement, tissue formed at the osteotomy site or in the hollow chamber of T-shaped implant was harvested and total RNA was evaluated by whole genome microarray analyses. Principal Findings: Two-way ANOVA of microarray data identified 103 genes that were significantly (. 2 fold) modulated by the implant placement and vitamin D deficiency. Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses assigned the highest z-score to the circadian rhythm pathway including neuronal PAS domain 2 (NPAS2), and period homolog 2 (Per2). NPAS2 and Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/Bmal 1) were upregulated around implant and diminished by vitamin D deficiency, whereas the expression pattern of Per2 was complementary. Hierarchical cluster analysis further revealed that NPAS2 was in a group predominantly composed of cartilage extracellular matrix (ECM) genes. Whereas the expression of bone ECM genes around implant was not significantly affected by vitamin D deficiency, cartilage ECM genes were modulated by the presence of the implant and vitamin D status. In a proof-of-concept in vitro study, the expression of cartilage type II and X collagens was found upregulated when mouse mesenchymal stem cells were cultured on implant disk with 1,25D supplementation. Conclusions: This study suggests that the circadian rhythm system and cartilage extracellular matrix may be involved in the establishment of osseointegration under vitamin D regulation.	[Mengatto, Cristiane Machado; Mussano, Federico; Honda, Yoshitomo; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA; [Mengatto, Cristiane Machado] Univ Estadual Campinas, Piracicaba Sch Dent, Dept Prosthodont & Periodontol, Sao Paulo, Brazil; [Mussano, Federico] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Colwell, Christopher S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Universidade Estadual de Campinas; University of Turin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mengatto, CM (corresponding author), Univ Calif Los Angeles, Sch Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90024 USA.	inishimura@dentistry.ucla.edu	Honda, Yoshitomo/AAC-3994-2020; Mengatto, Cristiane Machado/E-7285-2016; Colwell, Chris/AAM-6111-2020	Honda, Yoshitomo/0000-0002-4392-2318; Mengatto, Cristiane Machado/0000-0002-1059-8419; Colwell, Christopher/0000-0002-1059-184X; Mussano, Federico/0000-0001-5800-0749	Coordination for the Improvement of Higher Education Personnel (CAPES), Sao Paulo, Brazil; Biomet3I, Palm Beach Garden, FL; National Center for Research Resources, National Institutes of Health (NCRR/NIH) [C06 RR014529]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER	Coordination for the Improvement of Higher Education Personnel (CAPES), Sao Paulo, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Biomet3I, Palm Beach Garden, FL; National Center for Research Resources, National Institutes of Health (NCRR/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported, in part by the Doctoral Program Scholarship from Coordination for the Improvement of Higher Education Personnel (CAPES), Sao Paulo, Brazil (for CMM) and Biomet3I, Palm Beach Garden, FL (for IN). This investigation was conducted in part in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR014529 from the National Center for Research Resources, National Institutes of Health (NCRR/NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. S., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P344; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; ALBREKTSSON T, 1987, ACTA ORTHOP SCAND, V58, P567, DOI 10.3109/17453678709146401; Alvim-Pereira F, 2008, INT J ORAL MAX IMPL, V23, P409; BARSHAVIT Z, 1983, J CLIN INVEST, V72, P526, DOI 10.1172/JCI111000; Borgs L, 2009, CELL CYCLE, V8, P832, DOI 10.4161/cc.8.6.7869; Carinci F, 2004, CLIN ORAL IMPLAN RES, V15, P180, DOI 10.1111/j.1600-0501.2004.00997.x; Carinci Francesco, 2003, J Oral Implantol, V29, P215, DOI 10.1563/1548-1336(2003)029<0215:AOOMCR>2.3.CO;2; Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163; Davies John E, 2003, J Dent Educ, V67, P932; Devlin B, 2003, HEREDITY, V91, P537, DOI 10.1038/sj.hdy.6800370; ECONS MJ, 1992, J CLIN ENDOCR METAB, V75, P408, DOI 10.1210/jc.75.2.408; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernes de Abreu DA., 2009, PSYCHONEUROENDOCR S1, V34, pS265, DOI DOI 10.1016/J.PSYNEUEN.2009.05.023; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Heaney RP, 2003, AM J CLIN NUTR, V78, P912, DOI 10.1093/ajcn/78.5.912; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; HOKUGO A, 2010, J BONE MINER RES; Holahan CM, 2008, INT J ORAL MAX IMPL, V23, P905; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; IWASA F, 2009, BIOMATERIALS; Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x; KHAN WS, 2010, J ORTHOP RES; Kim CS, 2006, J ORAL REHABIL, V33, P368, DOI 10.1111/j.1365-2842.2005.01553.x; Kojima N, 2008, CLIN ORAL IMPLAN RES, V19, P173, DOI 10.1111/j.1600-0501.2007.01432.x; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002; Lekholm U, 2003, PERIODONTOL 2000, V33, P194, DOI 10.1046/j.0906-6713.2003.03316.x; Lin A, 2009, INT J ORAL MAX IMPL, V24, P808; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008; MARKWAY BD, 2009, CELL TRANSPLANT; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020; Mendes VC, 2009, J BIOMED MATER RES A, V90A, P577, DOI 10.1002/jbm.a.32126; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Nishimura I, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/24/245101; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Reginster JY, 2005, CURR MED RES OPIN, V21, P579, DOI 10.1185/030079905X41435; Saintonge S, 2009, PEDIATRICS, V123, P797, DOI 10.1542/peds.2008-1195; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Schwartz Zvi, 2005, Alpha Omegan, V98, P9; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tull KI, 2009, AGE AGEING, V38, P609, DOI [10.1093/ageing/afp102, 10.1093/ageing/afp195]; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	58	39	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15848	10.1371/journal.pone.0015848	http://dx.doi.org/10.1371/journal.pone.0015848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264318	gold, Green Submitted, Green Published			2022-12-25	WOS:000286514000007
J	Zinocker, S; Wang, MY; Gaustad, P; Kvalheim, G; Rolstad, B; Vaage, JT				Zinocker, Severin; Wang, Meng-Yu; Gaustad, Peter; Kvalheim, Gunnar; Rolstad, Bent; Vaage, John T.			Mycoplasma Contamination Revisited: Mesenchymal Stromal Cells Harboring Mycoplasma hyorhinis Potently Inhibit Lymphocyte Proliferation In Vitro	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; ADIPOSE-TISSUE; IMMUNOSUPPRESSIVE PROPERTIES; INTERNATIONAL-SOCIETY; FAIL; SUPPRESSION; RESISTANT; CULTURES	Background: Mesenchymal stromal cells (MSC) have important immunomodulatory effects that can be exploited in the clinical setting, e. g. in patients suffering from graft-versus-host disease after allogeneic stem cell transplantation. In an experimental animal model, cultures of rat T lymphocytes were stimulated in vitro either with the mitogen Concanavalin A or with irradiated allogeneic cells in mixed lymphocyte reactions, the latter to simulate allo-immunogenic activation of transplanted T cells in vivo. This study investigated the inhibitory effects of rat bone marrow-derived MSC subsequently found to be infected with a common mycoplasma species (Mycoplasma hyorhinis) on T cell activation in vitro and experimental graft-versus-host disease in vivo. Principal Findings: We found that M. hyorhinis infection increased the anti-proliferative effect of MSC dramatically, as measured by both radiometric and fluorimetric methods. Inhibition could not be explained solely by the well-known ability of mycoplasmas to degrade tritiated thymidine, but likely was the result of rapid dissemination of M. hyorhinis in the lymphocyte culture. Conclusions: This study demonstrates the potent inhibitory effect exerted by M. hyorhinis in standard lymphocyte proliferation assays in vitro. MSC are efficient vectors of mycoplasma infection, emphasizing the importance of monitoring cell cultures for contamination.	[Zinocker, Severin; Vaage, John T.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Zinocker, Severin; Rolstad, Bent] Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0027 Oslo, Norway; [Wang, Meng-Yu] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Tumor Biol, Oslo, Norway; [Gaustad, Peter] Univ Oslo, Rikshosp, Inst Microbiol, N-0027 Oslo, Norway; [Kvalheim, Gunnar] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Cellular Therapy, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Zinocker, S (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway.	j.t.vaage@medisin.uio.no	Zinöcker, Severin/G-9026-2011	Zinöcker, Severin/0000-0003-1730-0125; Vaage, John T./0000-0003-0988-5768	European Commission [MRTN-CT-2004-512253]; Research Council of Norway and the Norwegian Cancer Society	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway and the Norwegian Cancer Society	This work was supported by the Marie Curie Research Training Network grant MRTN-CT-2004-512253 ('TRANS-NET') under the European Commission's Sixth Framework Programme (Ph.D. grant to SZ), and by the Research Council of Norway and the Norwegian Cancer Society (grants to BR and JTV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Badillo AT, 2008, BRIT J HAEMATOL, V141, P224, DOI 10.1111/j.1365-2141.2008.07040.x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jarvinen L, 2008, J IMMUNOL, V181, P4389, DOI 10.4049/jimmunol.181.6.4389; Kagemann G, 2005, BIOL CHEM, V386, P1055, DOI 10.1515/BC.2005.121; KOSTYAL DA, 1995, INFECT IMMUN, V63, P3858, DOI 10.1128/IAI.63.10.3858-3863.1995; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; MERKENSCHLAGER M, 1988, IMMUNOLOGY, V63, P125; Mielcarek M, 2011, BIOL BLOOD MARROW TR, V17, P214, DOI 10.1016/j.bbmt.2010.08.015; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nestvold JM, 2008, TRANSPLANTATION, V85, P102, DOI 10.1097/01.tp.0000296856.53493.1f; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POLLACK JD, 1983, YALE J BIOL MED, V56, P709; Prigozhina TB, 2008, EXP HEMATOL, V36, P1370, DOI 10.1016/j.exphem.2008.04.022; RAJ N, 2002, J COMP PATHOL, V140, P85, DOI DOI 10.1016/J.JCPA.2008.08.004; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rosner C, 2010, IMMUNOGENETICS, V62, P149, DOI 10.1007/s00251-010-0424-5; Shahzad W, 2010, VET IMMUNOL IMMUNOP, V136, P116, DOI 10.1016/j.vetimm.2010.02.001; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; SINIGAGLIA F, 1985, EUR J IMMUNOL, V15, P692, DOI 10.1002/eji.1830150710; SINIGAGLIA F, 1985, J IMMUNOL METHODS, V76, P85, DOI 10.1016/0022-1759(85)90483-1; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tisato V, 2007, LEUKEMIA, V21, P1992, DOI 10.1038/sj.leu.2404847; Totte P, 2008, VET RES, V39, DOI 10.1051/vetres:2007046; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Vanden Bush TJ, 2004, BIOCHEM BIOPH RES CO, V315, P336, DOI 10.1016/j.bbrc.2004.01.063; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	14	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16005	10.1371/journal.pone.0016005	http://dx.doi.org/10.1371/journal.pone.0016005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264307	Green Published, gold, Green Submitted			2022-12-25	WOS:000286514000015
J	Lele, UN; Baig, UI; Watve, MG				Lele, Uttara N.; Baig, Ulfat I.; Watve, Milind G.			Phenotypic Plasticity and Effects of Selection on Cell Division Symmetry in Escherichia coli	PLOS ONE			English	Article							STEM-CELLS; LIFE-SPAN; EVOLUTION; PROTEINS; YEAST; RESTRICTION; SENESCENCE; BACTERIA; SIR2	Aging has been demonstrated in unicellular organisms and is presumably due to asymmetric distribution of damaged proteins and other components during cell division. Whether the asymmetry-induced aging is inevitable or an adaptive and adaptable response is debated. Although asymmetric division leads to aging and death of some cells, it increases the effective growth rate of the population as shown by theoretical and empirical studies. Mathematical models predict on the other hand, that if the cells divide symmetrically, cellular aging may be delayed or absent, growth rate will be reduced but growth yield will increase at optimum repair rates. Therefore in nutritionally dilute (oligotrophic) environments, where growth yield may be more critical for survival, symmetric division may get selected. These predictions have not been empirically tested so far. We report here that Escherichia coli grown in oligotrophic environments had greater morphological and functional symmetry in cell division. Both phenotypic plasticity and genetic selection appeared to shape cell division time asymmetry but plasticity was lost on prolonged selection. Lineages selected on high nutrient concentration showed greater frequency of presumably old or dead cells. Further, there was a negative correlation between cell division time asymmetry and growth yield but there was no significant correlation between asymmetry and growth rate. The results suggest that cellular aging driven by asymmetric division may not be hardwired but shows substantial plasticity as well as evolvability in response to the nutritional environment.	[Lele, Uttara N.; Baig, Ulfat I.] Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India; [Watve, Milind G.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Lele, UN (corresponding author), Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India.	milind@iiserpune.ac.in			Council for Scientific and Industrial Research, India	Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	UL was supported by a junior research fellowship by the Council for Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Johnson LR, 2006, MECH AGEING DEV, V127, P786, DOI 10.1016/j.mad.2006.07.004; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P1011, DOI 10.1016/j.mad.2005.03.021; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lin HF, 1997, DEVELOPMENT, V124, P2463; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; NYSTROM T, 1995, J BACTERIOL, V177, P5707, DOI 10.1128/jb.177.19.5707-5710.1995; Pfeiffer T, 2002, Z PHYS CHEM, V216, P51, DOI 10.1524/zpch.2002.216.1.051; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009; Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Turke PW, 2008, Q REV BIOL, V83, P243, DOI 10.1086/590509; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Watve M, 2000, CURR SCI INDIA, V78, P1535; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150	28	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e14516	10.1371/journal.pone.0014516	http://dx.doi.org/10.1371/journal.pone.0014516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249222	gold, Green Published, Green Submitted			2022-12-25	WOS:000286513100002
J	Phang, BH; Chua, HW; Li, HH; Linn, YC; Sabapathy, K				Phang, Beng Hooi; Chua, Hui Wan; Li, Huihua; Linn, Yeh Ching; Sabapathy, Kanaga			Characterization of Novel and Uncharacterized p53 SNPs in the Chinese Population - Intron 2 SNP Co-Segregates with the Common Codon 72 Polymorphism	PLOS ONE			English	Article							LUNG-CANCER SUSCEPTIBILITY; COLORECTAL-CANCER; INCREASED RISK; BREAST-CANCER; ONSET AGE; ASSOCIATION; GENE; VARIANTS; PROMOTES; LEUKEMIA	Multiple single nucleotide polymorphisms (SNPs) have been identified in the tumor suppressor gene p53, though the relevance of many of them is unclear. Some of them are also differentially distributed in various ethnic populations, suggesting selective functionality. We have therefore sequenced all exons and flanking regions of p53 from the Singaporean Chinese population and report here the characterization of some novel and uncharacterized SNPs - four in intron 1 (nucleotide positions 8759/10361/10506/11130), three in intron 3 (11968/11969/11974) and two in the 3'UTR (19168/19514). Allelic frequencies were determined for all these and some known SNPs, and were compared in a limited scale to leukemia and lung cancer patient samples. Intron 2 (11827) and 7 (14181/14201) SNPs were found to have a high minor allele frequency of between 26-47%, in contrast to the lower frequencies found in the US population, but similar in trend to the codon 72 polymorphism (SNP12139) that shows a distribution pattern correlative with latitude. Several of the SNPs were linked, such as those in introns 1, 3 and 7. Most interestingly, we noticed the co-segregation of the intron 2 and the codon 72 SNPs, the latter which has been shown to be expressed in an allele-specific manner, suggesting possible regulatory crosstalk. Association analysis indicated that the T/G alleles in both the co-segregating intron 7 SNPs and a 4tagSNP haplotype was strongly associated increased susceptibility to lung cancer in non-smoker females [ OR: 1.97 (1.32, 3.394)]. These data together demonstrate high SNP diversity in p53 gene between different populations, highlighting ethnicity-based differences, and their association with cancer risk.	[Phang, Beng Hooi; Chua, Hui Wan; Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore; [Li, Huihua] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Linn, Yeh Ching] Singapore Gen Hosp, Dept Hematol, Singapore 0316, Singapore; [Sabapathy, Kanaga] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Sabapathy, Kanaga] Duke Natl Univ Singapore, Canc & Stem Cell Biol Program, Grad Sch Med, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National University of Singapore	Phang, BH (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore, Singapore.	cmrksb@nccs.com.sg			National Medical Research Council; Singhealth Research Foundation	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singhealth Research Foundation(SingHealth)	The authors acknowledge the grant support from the National Medical Research Council and the Singhealth Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Biros E, 2001, LUNG CANCER, V31, P157, DOI 10.1016/S0169-5002(00)00188-4; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Buyru N, 2003, ONCOL REP, V10, P711; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chua HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-88; Damin APS, 2006, CANCER DETECT PREV, V30, P523, DOI 10.1016/j.cdp.2006.09.007; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Gu Qi-hua, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P319; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Khadang B, 2007, CANCER GENET CYTOGEN, V173, P38, DOI 10.1016/j.cancergencyto.2006.09.010; Kupper M, 2001, BRIT J HAEMATOL, V112, P768, DOI 10.1046/j.1365-2141.2001.02566.x; Lavin LF, 1999, INT J RADIAT BIOL, V75, P1201; Lehman TA, 2000, CANCER RES, V60, P1062; Li Ye-qing, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P386; Lum SS, 2008, CARCINOGENESIS, V29, P754, DOI 10.1093/carcin/bgn024; Mabrouk I, 2003, ANN NY ACAD SCI, V1010, P764, DOI 10.1196/annals.1299.137; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Papadakis E. N., 2000, Molecular Cell Biology Research Communications, V3, P389, DOI 10.1006/mcbr.2000.0241; PETITJEAN A, 2002, REV ONCOGENE, V26, P2157; Phang BH, 2008, EUR J CANCER, V44, P760, DOI 10.1016/j.ejca.2008.02.007; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; PROSSER J, 1991, NUCLEIC ACIDS RES, V19, P4799, DOI 10.1093/nar/19.17.4799-a; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Siddique MM, 2005, CANCER EPIDEM BIOMAR, V14, P2245, DOI 10.1158/1055-9965.EPI-05-0153; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Toyama T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1682; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang YC, 1999, CLIN CANCER RES, V5, P129; Wang-Gohrke S, 1999, BRIT J CANCER, V81, P179, DOI 10.1038/sj.bjc.6690669; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681	40	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15320	10.1371/journal.pone.0015320	http://dx.doi.org/10.1371/journal.pone.0015320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249215	Green Submitted, Green Published, gold			2022-12-25	WOS:000286513100005
J	Palacios-Chaves, L; Conde-Alvarez, R; Gil-Ramirez, Y; Zuniga-Ripa, A; Barquero-Calvo, E; Chacon-Diaz, C; Chaves-Olarte, E; Arce-Gorvel, V; Gorvel, JP; Moreno, E; de Miguel, MJ; Grillo, MJ; Moriyon, I; Iriarte, M				Palacios-Chaves, Leyre; Conde-Alvarez, Raquel; Gil-Ramirez, Yolanda; Zuniga-Ripa, Amaia; Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Arce-Gorvel, Vilma; Gorvel, Jean-Pierre; Moreno, Edgardo; de Miguel, Maria-Jesus; Grillo, Maria-Jesus; Moriyon, Ignacio; Iriarte, Maite			Brucella abortus Ornithine Lipids Are Dispensable Outer Membrane Components Devoid of a Marked Pathogen-Associated Molecular Pattern	PLOS ONE			English	Article							BACTERICIDAL CATIONIC PEPTIDES; PSEUDOMONAS-FLUORESCENS; LIPOPOLYSACCHARIDE; RESISTANCE; MUTANTS; CELLS; MICE; PHOSPHATIDYLCHOLINE; FLAVOBACTERIUM; IDENTIFICATION	The brucellae are alpha-Proteobacteria facultative intracellular parasites that cause an important zoonosis. These bacteria escape early detection by innate immunity, an ability associated to the absence of marked pathogen-associated molecular patterns in the cell envelope lipopolysaccharide, lipoproteins and flagellin. We show here that, in contrast to the outer membrane ornithine lipids (OL) of other Gram negative bacteria, Brucella abortus OL lack a marked pathogen-associated molecular pattern activity. We identified two OL genes (olsB and olsA) and by generating the corresponding mutants found that olsB deficient B. abortus did not synthesize OL or their lyso-OL precursors. Liposomes constructed with B. abortus OL did not trigger IL-6 or TNF-alpha release by macrophages whereas those constructed with Bordetella pertussis OL and the olsB mutant lipids as carriers were highly active. The OL deficiency in the olsB mutant did not promote proinflammatory responses or generated attenuation in mice. In addition, OL deficiency did not increase sensitivity to polymyxins, normal serum or complement consumption, or alter the permeability to antibiotics and dyes. Taken together, these observations indicate that OL have become dispensable in the extant brucellae and are consistent within the trend observed in alpha-Proteobacteria animal pathogens to reduce and eventually eliminate the envelope components susceptible of recognition by innate immunity.	[Palacios-Chaves, Leyre; Conde-Alvarez, Raquel; Gil-Ramirez, Yolanda; Zuniga-Ripa, Amaia; Moriyon, Ignacio; Iriarte, Maite] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Conde-Alvarez, Raquel] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Trop, Heredia, Costa Rica; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Fac Sci Luminy, INSERM,CNRS,U631,UMR6102, Marseille, France; [Moreno, Edgardo] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Pedro, Costa Rica; [de Miguel, Maria-Jesus] CITA, Unidad Sanidad Anim, Zaragoza, Spain; [Grillo, Maria-Jesus] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Pamplona, Spain	University of Navarra; University of Basel; Universidad Costa Rica; Universidad Nacional Costa Rica; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Costa Rica; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra	Palacios-Chaves, L (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.	miriart@unav.es	BARQUERO-CALVO, ELIAS/GLU-1867-2022; Conde-Álvarez, Raquel/K-5854-2014; Moriyon, Ignacio/N-4764-2016; Grilló, María-Jesús/F-9621-2011; Zúñiga-Ripa, Amaia/ABB-4859-2020; ZÃÃiga, Amaia/GXF-9866-2022; De Miguel, María Jesús/K-5860-2014; ZUÑIGA-RIPA, AMAIA/F-5117-2017; IRIARTE, MAITE/L-9460-2014; Gorvel, Jean-Pierre/O-1332-2018	BARQUERO-CALVO, ELIAS/0000-0003-4428-3340; Conde-Álvarez, Raquel/0000-0003-0046-3577; Moriyon, Ignacio/0000-0002-4288-0195; Grilló, María-Jesús/0000-0002-1819-0186; Zúñiga-Ripa, Amaia/0000-0001-7865-8994; De Miguel, María Jesús/0000-0002-5037-3687; ZUÑIGA-RIPA, AMAIA/0000-0001-7865-8994; IRIARTE, MAITE/0000-0002-6726-8920; Gorvel, Jean-Pierre/0000-0002-2829-9804; Arce-Gorvel, Vilma/0000-0003-0090-837X	Ministerio de Ciencia y Tecnologia of Spain [AGL2008-04514-C03]; Universidad Nacional de Costa Rica; S-Conare UNA/UCR, Costa Rica [IFEG29]; NeTropica [P00059, F00013-02]; MICIT/CONICIT [IFDG12]; Fundacion CRUSA-CSIC [CR2008-0006]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale and the Ministry of Education in France; Ministerio de Ciencia y Tecnologia of Spain; University of Navarra	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad Nacional de Costa Rica; S-Conare UNA/UCR, Costa Rica; NeTropica; MICIT/CONICIT; Fundacion CRUSA-CSIC; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale and the Ministry of Education in France; Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Navarra	Research at the laboratories of the authors is supported by the Ministerio de Ciencia y Tecnologia of Spain (AGL2008-04514-C03); FIDA, Universidad Nacional de Costa Rica; FS-Conare UNA/UCR IFEG29 Costa Rica; NeTropica P00059 and F00013-02; MICIT/CONICIT IFDG12; Fundacion CRUSA-CSIC (CR2008-0006); Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale and the Ministry of Education in France. Fellowship support for L.P.-C., Y.G.-R. and A.Z.-R from the Ministerio de Ciencia y Tecnologia of Spain, Gobierno de Navarra and Friends of the University of Navarra is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993; DETEJADA GM, 1995, INFECT IMMUN, V63, P3054; DETEJADA GM, 1993, J BACTERIOL, V175, P5273; DORRER E, 1977, ARCH MICROBIOL, V114, P87, DOI 10.1007/BF00429636; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Freer E, 1996, J BACTERIOL, V178, P5867, DOI 10.1128/jb.178.20.5867-5876.1996; GAMAZO C, 1987, INFECT IMMUN, V55, P609, DOI 10.1128/IAI.55.3.609-615.1987; Gao JL, 2004, MOL MICROBIOL, V53, P1757, DOI 10.1111/j.1365-2958.2004.04240.x; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Grillo MJ, 2006, VACCINE, V24, P2910, DOI 10.1016/j.vaccine.2005.12.038; Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; IRIARTE M, 2004, MOL CELL BIOL, P159; Kato H, 1997, MICROBIOL IMMUNOL, V41, P101, DOI 10.1111/j.1348-0421.1997.tb01175.x; KAWAI Y, 1985, EUR J BIOCHEM, V147, P367, DOI 10.1111/j.1432-1033.1985.tb08759.x; Kawai Y, 1985, Dev Biol Stand, V61, P249; Kawai Y, 1999, FEMS IMMUNOL MED MIC, V23, P67, DOI 10.1016/S0928-8244(98)00122-9; KAWAI Y, 1991, INFECT IMMUN, V59, P2560, DOI 10.1128/IAI.59.8.2560-2566.1991; KAWAI Y, 1991, FEMS MICROBIOL LETT, V83, P127; Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P205; KAWAI Y, 1989, INFECT IMMUN, V57, P2086, DOI 10.1128/IAI.57.7.2086-2091.1989; Kawai Y, 2000, FEMS IMMUNOL MED MIC, V28, P197, DOI 10.1016/S0928-8244(00)00156-5; Kong WM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-12; KUPFER D, 1984, J BACTERIOL, V159, P776, DOI 10.1128/JB.159.2.776-779.1984; Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005; Lin MQ, 2003, CELL MICROBIOL, V5, P809, DOI 10.1046/j.1462-5822.2003.00322.x; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; MORIYON I, 1982, J BACTERIOL, V152, P822; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Rikihisa Y, 2006, CURR OPIN MICROBIOL, V9, P95, DOI 10.1016/j.mib.2005.12.003; Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; THIELE O W, 1973, European Journal of Biochemistry, V34, P333, DOI 10.1111/j.1432-1033.1973.tb02764.x; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Weissenmayer B, 2002, MOL MICROBIOL, V45, P721, DOI 10.1046/j.1365-2958.2002.03043.x; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200	55	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16030	10.1371/journal.pone.0016030	http://dx.doi.org/10.1371/journal.pone.0016030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249206	Green Published, gold, Green Submitted			2022-12-25	WOS:000286512900019
J	Batista-Nascimento, L; Neef, DW; Liu, PCC; Rodrigues-Pousada, C; Thiele, DJ				Batista-Nascimento, Liliana; Neef, Daniel W.; Liu, Phillip C. C.; Rodrigues-Pousada, Claudina; Thiele, Dennis J.			Deciphering Human Heat Shock Transcription Factor 1 Regulation via Post-Translational Modification in Yeast	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; FACTOR-I; POLYGLUTAMINE TOXICITY; MOLECULAR CHAPERONES; NUCLEAR-LOCALIZATION; FACTOR TRIMERIZATION; HUNTINGTONS-DISEASE; GENE-TRANSCRIPTION	Heat shock transcription factor 1 (HSF1) plays an important role in the cellular response to proteotoxic stresses. Under normal growth conditions HSF1 is repressed as an inactive monomer in part through post-translation modifications that include protein acetylation, sumoylation and phosphorylation. Upon exposure to stress HSF1 homotrimerizes, accumulates in nucleus, binds DNA, becomes hyper-phosphorylated and activates the expression of stress response genes. While HSF1 and the mechanisms that regulate its activity have been studied for over two decades, our understanding of HSF1 regulation remains incomplete. As previous studies have shown that HSF1 and the heat shock response promoter element (HSE) are generally structurally conserved from yeast to metazoans, we have made use of the genetically tractable budding yeast as a facile assay system to further understand the mechanisms that regulate human HSF1 through phosphorylation of serine 303. We show that when human HSF1 is expressed in yeast its phosphorylation at S303 is promoted by the MAP-kinase Slt2 independent of a priming event at S307 previously believed to be a prerequisite. Furthermore, we show that phosphorylation at S303 in yeast and mammalian cells occurs independent of GSK3, the kinase primarily thought to be responsible for S303 phosphorylation. Lastly, while previous studies have suggested that S303 phosphorylation represses HSF1-dependent transactivation, we now show that S303 phosphorylation also represses HSF1 multimerization in both yeast and mammalian cells. Taken together, these studies suggest that yeast cells will be a powerful experimental tool for deciphering aspects of human HSF1 regulation by post-translational modifications.	[Batista-Nascimento, Liliana; Rodrigues-Pousada, Claudina] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Genom & Stress Lab, Oeiras, Portugal; [Neef, Daniel W.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Liu, Phillip C. C.] Incyte Corp, Appl Technol Grp, Wilmington, DE USA	Universidade Nova de Lisboa; Duke University; Incyte	Batista-Nascimento, L (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Genom & Stress Lab, Oeiras, Portugal.	dennis.thiele@duke.edu		Rodrigues-Pousada, Claudina/0000-0002-5075-3639	National Institutes of Health [GM076954, R01-NS065890]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/39389/2007, PTDC/BIAMIC/108747/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health National Research Service Award (NRSA) Postdoctoral Fellowship GM076954 (to DWN), grant R01-NS065890 (to DJT), and grants from the Fundacao para a Ciencia e Tecnologia (No. SFRH/BD/39389/2007 to LB-N and No. PTDC/BIAMIC/108747/2008 to CR-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PCCL contributed to this manuscript before employment at Incyte Corporation, which had no involvement in this study.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ahn SG, 2001, GENE DEV, V15, P2134, DOI 10.1101/gad.894801; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; Liu PCC, 1999, J BIOL CHEM, V274, P17219, DOI 10.1074/jbc.274.24.17219; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; MAZZONI C, 1993, J CELL BIOL, V123, P1821, DOI 10.1083/jcb.123.6.1821; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Orosz A, 1996, MOL CELL BIOL, V16, P7018; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rimoldi M, 2001, BRAIN RES BULL, V56, P353, DOI 10.1016/S0361-9230(01)00602-5; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Xia WL, 1998, J BIOL CHEM, V273, P8749, DOI 10.1074/jbc.273.15.8749; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	49	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15976	10.1371/journal.pone.0015976	http://dx.doi.org/10.1371/journal.pone.0015976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253609	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900033
J	Kenney, J; Aravantinou, M; Singer, R; Hsu, M; Rodriguez, A; Kizima, L; Abraham, CJ; Menon, R; Seidor, S; Chudolij, A; Gettie, A; Blanchard, J; Lifson, JD; Piatak, M; Fernandez-Romero, JA; Zydowsky, TM; Robbiani, M				Kenney, Jessica; Aravantinou, Meropi; Singer, Rachel; Hsu, Mayla; Rodriguez, Aixa; Kizima, Larisa; Abraham, Ciby J.; Menon, Radhika; Seidor, Samantha; Chudolij, Anne; Gettie, Agegnehu; Blanchard, James; Lifson, Jeffrey D.; Piatak, Michael, Jr.; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa			An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE INHIBITORS; PLACEBO-CONTROLLED TRIAL; RHESUS MACAQUES; INTRAVAGINAL INOCULATION; DENDRITIC CELLS; VIRAL LOAD; TRANSIENT VIREMIA; SIV; TRANSMISSION	Background: Repeated use, coitus-independent microbicide gels that do not contain antiretroviral agents also used as first line HIV therapy are urgently needed to curb HIV spread. Current formulations require high doses (millimolar range) of antiretroviral drugs and typically only provide short-term protection in macaques. We used the macaque model to test the efficacy of a novel combination microbicide gel containing zinc acetate and micromolar doses of the novel non-nucleoside reverse transcriptase inhibitor MIV-150 for up to 24 h after repeated gel application. Methods and Findings: Rhesus macaques were vaginally challenged with SHIV-RT up to 24 h after repeated administration of microbicide versus placebo gels. Infection status was determined by measuring virologic and immunologic parameters. Combination microbicide gels containing 14 mM zinc acetate dihydrate and 50 mM MIV-150 afforded full protection (21 of 21 animals) for up to 24 h after 2 weeks of daily application. Partial protection was achieved with the MIV-150 gel (56% of control at 8 h after last application, 11% at 24 h), while the zinc acetate gel afforded more pronounced protection (67% at 8-24 h). Marked protection persisted when the zinc acetate or MIV-150/zinc acetate gels were applied every other day for 4 weeks prior to challenge 24 h after the last gel was administered (11 of 14 protected). More MIV-150 was associated with cervical tissue 8 h after daily dosing of MIV-150/zinc acetate versus MIV-150, while comparable MIV-150 levels were associated with vaginal tissues and at 24 h. Conclusions: A combination MIV-150/zinc acetate gel and a zinc acetate gel provide significant protection against SHIV-RT infection for up to 24 h. This represents a novel advancement, identifying microbicides that do not contain anti-viral agents used to treat HIV infection and which can be used repeatedly and independently of coitus, and underscores the need for future clinical testing of their safety and ability to prevent HIV transmission in humans.	[Kenney, Jessica; Aravantinou, Meropi; Singer, Rachel; Hsu, Mayla; Rodriguez, Aixa; Kizima, Larisa; Abraham, Ciby J.; Menon, Radhika; Seidor, Samantha; Chudolij, Anne; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa] Populat Council, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Lifson, Jeffrey D.; Piatak, Michael, Jr.] NCI, AIDS & Canc Virus Program, SAIC Frederick, Frederick, MD 21701 USA	Population Council; Rockefeller University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Kenney, J (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org			National Institutes of Health (NIH) [U19 AI065412, RR00164]; United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; Swedish Ministry of Foreign Affairs; Swedish International Development Cooperation Agency; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065412] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Swedish Ministry of Foreign Affairs; Swedish International Development Cooperation Agency; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) grant U19 AI065412, the United States Agency for International Development (USAID) Cooperative Agreement GPO-A-00-04-00019-00, the Swedish Ministry of Foreign Affairs, the Swedish International Development Cooperation Agency, the NIH base grant RR00164, and in part, with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. This research is made possible by the generous support of the American people through the USAID. The contents of this manuscript are the sole responsibility of the Population Council and do not necessarily reflect the views of USAID or the United States government. MR is a 2002 Elizabeth Glaser Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Bacci A, 2002, J IMMUNOL, V168, P2904, DOI 10.4049/jimmunol.168.6.2904; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Ford N, 2010, CURR OPIN HIV AIDS, V5, P38, DOI 10.1097/COH.0b013e3283339b41; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; Frank I, 2008, J VIROL, V82, P5329, DOI 10.1128/JVI.01987-07; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; HAASE AT, NATURE, V464, P217; Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Haraguchi Y, 1999, ANTIVIR RES, V43, P123, DOI 10.1016/S0166-3542(99)00040-6; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hoare A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010981; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Karim QA, 2010, SCI EXPRESS; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Kilmarx PH, 2006, JAIDS-J ACQ IMM DEF, V43, P327, DOI 10.1097/01.qai.0000243056.59860.c1; Kim EY, 2005, J VIROL, V79, P4886, DOI 10.1128/JVI.79.8.4886-4895.2005; KUMAR N, 1990, J STEROID BIOCHEM, V37, P587, DOI 10.1016/0960-0760(90)90405-A; KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Llibre JM, 2010, CLIN INFECT DIS, V50, P872, DOI 10.1086/650732; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Martin S, 2010, J WOMENS HEALTH, V19, P1; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; McChesney MB, 1998, J VIROL, V72, P10029, DOI 10.1128/JVI.72.12.10029-10035.1998; McLean CA, 2010, AIDS, V24, P717, DOI 10.1097/QAD.0b013e328333bf89; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Nuttall JP, 2008, ANTIMICROB AGENTS CH, V52, P909, DOI 10.1128/AAC.00330-07; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Veazey RS, 2008, P NATL ACAD SCI USA, V105, P10531, DOI 10.1073/pnas.0802666105; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9; Wilkin Timothy J, 2010, Top HIV Med, V18, P66; Zhu TF, 2004, VIROLOGY, V323, P208, DOI 10.1016/j.virol.2004.03.004	57	74	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15835	10.1371/journal.pone.0015835	http://dx.doi.org/10.1371/journal.pone.0015835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246052	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511200018
J	Tse, JR; Engler, AJ				Tse, Justin R.; Engler, Adam J.			Stiffness Gradients Mimicking In Vivo Tissue Variation Regulate Mesenchymal Stem Cell Fate	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; RIGIDITY; MIGRATION; ADHESION; FIBRONECTIN; FIBROBLASTS; MECHANICS; DUROTAXIS; MOVEMENT; FORCES	Mesenchymal stem cell (MSC) differentiation is regulated in part by tissue stiffness, yet MSCs can often encounter stiffness gradients within tissues caused by pathological, e.g., myocardial infarction similar to 8.7 +/- 1.5 kPa/mm, or normal tissue variation, e.g., myocardium similar to 0.6 +/- 0.9 kPa/mm; since migration predominantly occurs through physiological rather than pathological gradients, it is not clear whether MSC differentiate or migrate first. MSCs cultured up to 21 days on a hydrogel containing a physiological gradient of 1.0 +/- 0.1 kPa/mm undergo directed migration, or durotaxis, up stiffness gradients rather than remain stationary. Temporal assessment of morphology and differentiation markers indicates that MSCs migrate to stiffer matrix and then differentiate into a more contractile myogenic phenotype. In those cells migrating from soft to stiff regions however, phenotype is not completely determined by the stiff hydrogel as some cells retain expression of a neural marker. These data may indicate that stiffness variation, not just stiffness alone, can be an important regulator of MSC behavior.	[Tse, Justin R.; Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Tse, JR (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	aengler@ucsd.edu		Tse, Justin/0000-0003-2408-3763	National Institutes of Health [1DP02OD006460]; American Heart Association [0865150F]; National Science Foundation [0754718]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (1DP02OD006460), American Heart Association (0865150F), and National Science Foundation (0754718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, J CELL SCI, V122, P1647, DOI 10.1242/jcs.040824; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Guilak F, 2000, BIORHEOLOGY, V37, P27; Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Jacot JG, 2008, BIOPHYS J, V95, P3479, DOI 10.1529/biophysj.107.124545; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102; Lazopoulos KA, 2008, J BIOMECH, V41, P1289, DOI 10.1016/j.jbiomech.2008.01.008; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	44	335	347	0	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15978	10.1371/journal.pone.0015978	http://dx.doi.org/10.1371/journal.pone.0015978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246050	Green Published, gold			2022-12-25	WOS:000286511200030
J	Strub, T; Giuliano, S; Ye, T; Bonet, C; Keime, C; Kobi, D; Le Gras, S; Cormont, M; Ballotti, R; Bertolotto, C; Davidson, I				Strub, T.; Giuliano, S.; Ye, T.; Bonet, C.; Keime, C.; Kobi, D.; Le Gras, S.; Cormont, M.; Ballotti, R.; Bertolotto, C.; Davidson, I.			Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma	ONCOGENE			English	Article						senescence; DNA repair; cancer; metastasis	CELL-DIVISION; MALIGNANT-MELANOMA; LINEAGE SURVIVAL; GENE-EXPRESSION; DAMAGE RESPONSE; GROWTH-FACTOR; NEURAL CREST; HUMAN CANCER; MITF; APOPTOSIS	Malignant melanoma is an aggressive cancer known for its notorious resistance to most current therapies. The basic helix-loop-helix microphthalmia transcription factor (MITF) is the master regulator determining the identity and properties of the melanocyte lineage, and is regarded as a lineage-specific 'oncogene' that has a critical role in the pathogenesis of melanoma. MITF promotes melanoma cell proliferation, whereas sustained supression of MITF expression leads to senescence. By combining chromatin immunoprecipitation coupled to high throughput sequencing (ChIP-seq) and RNA sequencing analyses, we show that MITF directly regulates a set of genes required for DNA replication, repair and mitosis. Our results reveal how loss of MITF regulates mitotic fidelity, and through defective replication and repair induces DNA damage, ultimately ending in cellular senescence. These findings reveal a lineage-specific control of DNA replication and mitosis by MITF, providing new avenues for therapeutic intervention in melanoma. The identification of MITF-binding sites and gene-regulatory networks establish a framework for understanding oncogenic basic helix-loop-helix factors such as N-myc or TFE3 in other cancers. Oncogene (2011) 30, 2319-2332; doi: 10.1038/onc.2010.612; published online 24 January 2011	[Giuliano, S.; Bonet, C.; Ballotti, R.; Bertolotto, C.] CHU Nice, INSERM, U895, Team 1, Nice, France; [Giuliano, S.; Bonet, C.; Ballotti, R.; Bertolotto, C.] CHU Nice, Dept Dermatol, Nice, France; [Strub, T.; Ye, T.; Keime, C.; Kobi, D.; Le Gras, S.; Davidson, I.] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Cormont, M.] Fac Med Nice, INSERM, U895, Team 7, F-06034 Nice, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Bertolotto, C (corresponding author), CHU Nice, INSERM, U895, Team 1, Nice, France.	corine.bertolotto@unice.fr; irwin@igbmc.fr	Strub, Thomas/AAH-3573-2019; BALLOTTI, Robert/F-8825-2013; Bertolotto-Ballotti, Corine/O-2155-2016; Giuliano, Sandy/U-2498-2019; Bertolotto, Corine/AAF-6634-2021; Ye, Tao/D-8026-2011	Bertolotto, Corine/0000-0001-6971-7753; BALLOTTI, Robert/0000-0002-7322-4908; Strub, Thomas/0000-0001-6252-0181; CORMONT, Mireille/0000-0001-6918-2410; Davidson, Irwin/0000-0001-5533-1171; KEIME, Celine/0000-0001-7604-3814; Le Gras, Stephanie/0000-0001-6293-6507	CNRS; INSERM; Association pour la Recherche contre le Cancer [4985, 7823]; Ligue Nationale contre le Cancer; Institut national du Cancer [R08009AP]; ANR; Conseil Regional de la Region Provence-Alpes-Cote d'Azur; Nice University Hospital; Conseil General des Alpes Maritimes	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut national du Cancer(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); Conseil Regional de la Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Nice University Hospital; Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur)	We thank B Jost for Illumina sequencing, A Hamiche and E Soutoglou for antibodies. This work was supported by grants from the CNRS, the INSERM, the Association pour la Recherche contre le Cancer grant 4985 and 7823, the Ligue Nationale contre le Cancer, the Institut national du Cancer grant R08009AP and the ANR Regulome project grant. We thank the Conseil Regional de la Region Provence-Alpes-Cote d'Azur, the Nice University Hospital and the Conseil General des Alpes Maritimes for funding of the C3M MiCa Cell Imaging Facility. ID and CB are 'equipes labellisees' of the Ligue Nationale contre le Cancer.	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bentley DJ, 2002, J CELL SCI, V115, P1551; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Garraway LA, 2005, COLD SH Q B, V70, P25, DOI 10.1101/sqb.2005.70.016; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Goding C R, 2000, Forum (Genova), V10, P176; Goding CR, 2000, GENE DEV, V14, P1712; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Kim DS, 2004, INT J BIOCHEM CELL B, V36, P1482, DOI 10.1016/j.biocel.2003.10.023; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Koyanagi K, 2006, CLIN CANCER RES, V12, P1137, DOI 10.1158/1078-0432.CCR-05-1847; Krebs A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-533; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Levy C, 2010, CELL, V141, P994, DOI 10.1016/j.cell.2010.05.004; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Moore R, 2004, ONCOGENE, V23, P6726, DOI 10.1038/sj.onc.1207675; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Rothhammer T, 2005, CANCER RES, V65, P448; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schmit TL, 2009, J INVEST DERMATOL, V129, P2843, DOI 10.1038/jid.2009.172; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Steingrimsson E, 2008, PIGM CELL MELANOMA R, V21, P412, DOI 10.1111/j.1755-148X.2008.00473.x; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	166	172	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	20					2319	2332		10.1038/onc.2010.612	http://dx.doi.org/10.1038/onc.2010.612			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21258399				2022-12-25	WOS:000290789200004
J	Heldsinger, A; Grabauskas, G; Song, I; Owyang, C				Heldsinger, Andrea; Grabauskas, Gintautas; Song, Il; Owyang, Chung			Synergistic Interaction between Leptin and Cholecystokinin in the Rat Nodose Ganglia Is Mediated by PI3K and STAT3 Signaling Pathways IMPLICATIONS FOR LEPTIN AS A REGULATOR OF SHORT TERM SATIETY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAGAL AFFERENT NEURONS; FOOD-INTAKE; CCK RECEPTORS; OB-R; MICE; ACTIVATION; SECRETION; INVOLVEMENT; AFFINITY; STOMACH	Research has shown that the synergistic interaction between vagal cholecystokinin-A receptors (CCKARs) and leptin receptors (LRbs) mediates short term satiety. We hypothesize that this synergistic interaction is mediated by cross-talk between signaling cascades used by CCKARs and LRbs, which, in turn, activates closure of K+ channels, leading to membrane depolarization and neuronal firing. Whole cell patch clamp recordings were performed on isolated rat nodose ganglia neurons. Western immunoblots elucidated the intracellular signaling pathways that modulate leptin/CCK synergism. In addition, STAT3, PI3K, Src, and MAPK genes were silenced by lentiviral infection and transient Lipofectamine transfection of cultured rat nodose ganglia to determine the effect of these molecules on leptin/CCK synergism. Patch clamp studies showed that a combination of leptin and CCK-8 caused a significant increase in membrane input resistance compared with leptin or CCK-8 alone. Silencing the STAT3 gene abolished the synergistic action of leptin/CCK-8 on neuronal firing. Leptin/CCK-8 synergistically stimulated a 7.7-fold increase in phosphorylated STAT3 (pSTAT3), which was inhibited by AG490, C3 transferase, PP2, LY294002, and wortmannin, but not PD98059. Silencing the Src and PI3K genes resulted in a loss of leptin/CCK-stimulated pSTAT3. We conclude that the synergistic interaction between vagal CCKARs and LRbs is mediated by the phosphorylation of STAT3, which, in turn, activates closure of K+ channels, leading to membrane depolarization and neuronal firing. This involves the interaction between CCK/Src/PI3K cascades and leptin/JAK2/PI3K/STAT3 signaling pathways. Malfunctioning of these signaling molecules may result in eating disorders.	[Heldsinger, Andrea; Grabauskas, Gintautas; Song, Il; Owyang, Chung] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Owyang, C (corresponding author), Univ Michigan Hlth Syst, Taubman Ctr 3912L, 1150 E Med Ctr Dr,SPC 5362, Ann Arbor, MI 48109 USA.	cowyang@med.umich.edu	Grabauskas, Gintautas/CAG-1799-2022		National Institutes of Health, NIDDK [R01 DK 48419, P30 DK 39433]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048419] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 48419 and P30 DK 39433 from NIDDK.	Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Baldwin BA, 1998, PROG NEUROBIOL, V55, P477, DOI 10.1016/S0301-0082(98)00005-7; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; Burdyga G, 2002, NEUROSCIENCE, V109, P339, DOI 10.1016/S0306-4522(01)00474-2; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; de Lartigue G, 2010, ENDOCRINOLOGY, V151, P3589, DOI 10.1210/en.2010-0106; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frontini A, 2008, BRAIN RES, V1215, P105, DOI 10.1016/j.brainres.2008.03.078; Grill HJ, 2010, FRONT NEUROENDOCRIN, V31, P61, DOI 10.1016/j.yfrne.2009.10.005; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Loftus TM, 1999, SEMIN CELL DEV BIOL, V10, P11, DOI 10.1006/scdb.1998.0274; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Nozu F, 2000, EUR J CELL BIOL, V79, P803, DOI 10.1078/0171-9335-00108; Owyang C, 2008, GASTROENTEROLOGY, V134, pA96; Pan WH, 2001, LIFE SCI, V68, P2705, DOI 10.1016/S0024-3205(01)01085-2; PASSARO E, 1982, BRAIN RES, V241, P338, DOI 10.1016/0006-8993(82)91073-3; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; Ritter RC, 1999, NEUROPEPTIDES, V33, P387, DOI 10.1054/npep.1999.0051; Ruiter M, 2010, ENDOCRINOLOGY, V151, P1509, DOI 10.1210/en.2009-0854; Sobhani I, 2000, GUT, V47, P178, DOI 10.1136/gut.47.2.178; Sutton GM, 2004, J NEUROSCI, V24, P10240, DOI 10.1523/JNEUROSCI.2764-04.2004; Tsunoda Y, 1996, BIOCHEM BIOPH RES CO, V227, P876, DOI 10.1006/bbrc.1996.1599; Wang YH, 1997, AM J PHYSIOL-REG I, V273, pR833, DOI 10.1152/ajpregu.1997.273.2.R833; WEATHERFORD SC, 1993, AM J PHYSIOL, V264, pR244, DOI 10.1152/ajpregu.1993.264.2.R244; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065; Williams DL, 2009, AM J PHYSIOL-REG I, V297, pR1238, DOI 10.1152/ajpregu.00182.2009; ZARBIN MA, 1981, LIFE SCI, V29, P697, DOI 10.1016/0024-3205(81)90022-9; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	35	32	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11707	11715		10.1074/jbc.M110.198945	http://dx.doi.org/10.1074/jbc.M110.198945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270124	Green Published, hybrid			2022-12-25	WOS:000288797100078
J	Pathak, N; Austin, CA; Drummond, IA				Pathak, Narendra; Austin, Christina A.; Drummond, Iain A.			Tubulin Tyrosine Ligase-like Genes ttll3 and ttll6 Maintain Zebrafish Cilia Structure and Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; INTRAFLAGELLAR TRANSPORT; ALPHA-TUBULIN; POLYGLYCYLATION; MICROTUBULES; GLUTAMYLATION; GLYCYLATION; AXONEME; DOMAIN	Tubulin post-translational modifications generate microtubule heterogeneity and modulate microtubule function, and are catalyzed by tubulin tyrosine ligase-like (TTLL) proteins. Using antibodies specific to monoglycylated, polyglycylated, and glutamylated tubulin in whole mount immunostaining of zebrafish embryos, we observed distinct, tissue-specific patterns of tubulin modifications. Tubulin modification patterns in cilia correlated with the expression of ttll3 and ttll6 in ciliated cells. Expression screening of all zebrafish tubulin tyrosine ligase-like genes revealed additional tissue-specific expression of ttll1 in brain neurons, ttll4 in muscle, and ttll7 in otic placodes. Knockdown of ttll3 eliminated cilia tubulin glycylation but had surprisingly mild effects on cilia structure and motility. Similarly, knockdown of ttll6 strongly reduced cilia tubulin glutamylation but only partially affected cilia structure and motility. Combined loss of function of ttll3 and ttll6 caused near complete loss of cilia motility and induced a variety of axonemal ultrastructural defects similar to defects previously observed in zebrafish fleer mutants, which were shown to lack tubulin glutamylation. Consistently, we find that fleer mutants also lack tubulin glycylation. These results indicate that tubulin glycylation and glutamylation have overlapping functions in maintaining cilia structure and motility and that the fleer/dyf-1 TPR protein is required for both types of tubulin post-translational modification.	[Pathak, Narendra; Drummond, Iain A.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Austin, Christina A.; Drummond, Iain A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Drummond, IA (corresponding author), 149 13th St, Charlestown, MA 02129 USA.	idrummon@receptor.mgh.harvard.edu			National Institutes of Health [K01DK078741, RO1DK053093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078741, R01DK070263, R01DK053093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK078741 (to N. P.) and RO1DK053093 (to I. A. D.).	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; ADOUTTE A, 1991, BIOL CELL, V71, P227, DOI 10.1016/0248-4900(91)90069-Y; BLOOMFIELD P, 1987, TOXICOLOGY, V46, P237, DOI 10.1016/0300-483X(87)90130-2; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; Bulinski JC, 2009, DEV CELL, V16, P773, DOI 10.1016/j.devcel.2009.06.003; Dave D, 2009, EUKARYOT CELL, V8, P1397, DOI 10.1128/EC.00378-08; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dossou SJY, 2007, CELL MOTIL CYTOSKEL, V64, P847, DOI 10.1002/cm.20229; Drummond IA, 1998, DEVELOPMENT, V125, P4655; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; FACKENTHAL JD, 1993, DEV BIOL, V158, P213, DOI 10.1006/dbio.1993.1180; Fennell BJ, 2008, INT J PARASITOL, V38, P527, DOI 10.1016/j.ijpara.2007.09.005; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hoyle HD, 2008, CELL MOTIL CYTOSKEL, V65, P295, DOI 10.1002/cm.20261; Iftode F, 2000, BIOL CELL, V92, P615, DOI 10.1016/S0248-4900(00)01107-2; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Popodi EM, 2005, CELL MOTIL CYTOSKEL, V62, P48, DOI 10.1002/cm.20085; Redeker V, 2005, J BIOL CHEM, V280, P596, DOI 10.1074/jbc.M408324200; REDEKER V, 1994, SCIENCE, V266, P1688, DOI 10.1126/science.7992051; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; RUDIGER M, 1995, FEBS LETT, V364, P147, DOI 10.1016/0014-5793(95)00373-H; Schneider A, 1997, J CELL SCI, V110, P431; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Thazhath R, 2004, MOL BIOL CELL, V15, P4136, DOI 10.1091/mbc.E04-03-0247; Thazhath R, 2002, NAT CELL BIOL, V4, P256, DOI 10.1038/ncb764; Thisse C., 1998, ZEBRAFISH SCI MON, V5, P8; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vinh J, 1999, BIOCHEMISTRY-US, V38, P3133, DOI 10.1021/bi982304s; Vladar EK, 2008, TRENDS CELL BIOL, V18, P517, DOI 10.1016/j.tcb.2008.08.004; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Xia L, 2000, J CELL BIOL, V149, P1097, DOI 10.1083/jcb.149.5.1097	52	61	63	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11685	11695		10.1074/jbc.M110.209817	http://dx.doi.org/10.1074/jbc.M110.209817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262966	Green Published, hybrid			2022-12-25	WOS:000288797100076
J	Sun, QA; Ju, TZ; Cummings, RD				Sun, Qian; Ju, Tongzhong; Cummings, Richard D.			The Transmembrane Domain of the Molecular Chaperone Cosmc Directs Its Localization to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TRANSFERRIN RECEPTOR; PROTEIN O-GLYCOSYLATION; MEMBRANE-PROTEINS; GOLGI-APPARATUS; CYTOPLASMIC DOMAIN; SECRETORY PATHWAY; RETENTION SIGNAL; ANCHORED PROTEIN; CYTOCHROME B(5); INVARIANT CHAIN	The molecular basis for retention of integral membrane proteins in the endoplasmic reticulum (ER) is not well understood. We recently discovered a novel ER molecular chaperone termed Cosmc, which is essential for folding and normal activity of the Golgi enzyme T-synthase. Cosmc, a type II single-pass transmembrane protein, lacks any known ER retrieval/retention motifs. To explore specific ER localization determinants in Cosmc we generated a series of Cosmc mutants along with chimeras of Cosmc with a non-ER resident type II protein, the human transferrin receptor. Here we show that the 18 amino acid transmembrane domain (TMD) of Cosmc is essential for ER localization and confers ER retention to select chimeras. Moreover, mutations of a single Cys residue within the TMD of Cosmc prevent formation of disulfide-bonded dimers of Cosmc and eliminate ER retention. These studies reveal that Cosmc has a unique ER-retention motif within its TMD and provide new insights into the molecular mechanisms by which TMDs of resident ER proteins contribute to ER localization.	[Cummings, Richard D.] Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976	National Institutes of Health [R01 GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068559 (to R. D. C.).	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Boulaflous A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-144; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Contreras I, 2004, PLANT J, V38, P685, DOI 10.1111/j.1365-313X.2004.02075.x; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; DO SI, 1992, GLYCOBIOLOGY, V2, P345, DOI 10.1093/glycob/2.4.345; DO SI, 1990, J BIOL CHEM, V265, P114; Fang G., 2002, PCR MEDIATED RECOMBI; Fu J, 2000, J BIOL CHEM, V275, P3984, DOI 10.1074/jbc.275.6.3984; Fu J, 2000, EUR J CELL BIOL, V79, P219, DOI 10.1078/S0171-9335(04)70025-4; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Gomord V, 1999, BIOCHIMIE, V81, P607, DOI 10.1016/S0300-9084(99)80118-7; Hardt B, 2003, GLYCOBIOLOGY, V13, P159, DOI 10.1093/glycob/cwg013; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Harter C, 1996, BBA-REV BIOMEMBRANES, V1286, P75, DOI 10.1016/0304-4157(96)00003-2; HAYES GR, 1992, GLYCOBIOLOGY, V2, P355, DOI 10.1093/glycob/2.4.355; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Ju T., 2011, GLYCOBIOLOG IN PRESS; Ju T., 2011, ANGEW CHEM, V50, P2; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; Rutledge EA, 1998, J BIOL CHEM, V273, P12169, DOI 10.1074/jbc.273.20.12169; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; SCHNEIDER C, 1982, J BIOL CHEM, V257, P8516; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P211; TROWBRIDGE IS, 1986, BIOCHEM SOC SYMP, P117; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	63	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11529	11542		10.1074/jbc.M110.173591	http://dx.doi.org/10.1074/jbc.M110.173591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262965	Green Published, hybrid			2022-12-25	WOS:000288797100063
J	Han, XH; Jin, YR; Seto, M; Yoon, JK				Han, Xiang Hua; Jin, Yong-Ri; Seto, Marianne; Yoon, Jeong Kyo			A WNT/beta-Catenin Signaling Activator, R-spondin, Plays Positive Regulatory Roles during Skeletal Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERMINATION GENE MYF5; STEM-CELLS; MULTIPLE PHASES; MUSCLE; MYOD; EXPRESSION; FAMILY; R-SPONDIN1; PROTEINS; PATHWAY	R-spondins (RSPOs) are a recently characterized family of secreted proteins that activate WNT/beta-catenin signaling. In this study, we investigated the potential roles of the RSPO proteins during myogenic differentiation. Overexpression of the Rspo1 gene or administration of recombinant RSPO2 protein enhanced mRNA and protein expression of a basic helix-loop-helix (bHLH) class myogenic determination factor, MYF5, in both C2C12 myoblasts and primary satellite cells, whereas MYOD or PAX7 expression was not affected. RSPOs also promoted myogenic differentiation and induced hypertrophic myotube formation in C2C12 cells. In addition, Rspo2 and Rspo3 gene knockdown by RNA interference significantly compromised MYF5 expression, myogenic differentiation, and myotube formation. Furthermore, Myf5 expression was reduced in the developing limbs of mouse embryos lacking the Rspo2 gene. Finally, we demonstrated that blocking of WNT/beta-catenin signaling by DKK1 or a dominant-negative form of TCF4 reversed MYF5 expression, myogenic differentiation, and hypertrophic myotube formation induced by RSPO2, indicating that RSPO2 exerts its activity through the WNT/beta-catenin signaling pathway. Our results provide strong evidence that RSPOs are key positive regulators of skeletal myogenesis acting through the WNT/beta-catenin signaling pathway.	[Han, Xiang Hua; Jin, Yong-Ri; Seto, Marianne; Yoon, Jeong Kyo] Maine Med Ctr, Ctr Mol Med, Ctr Biomed Res Excellence Stem Cell Biol & Regene, Res Inst, Scarborough, ME 04074 USA; [Seto, Marianne] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA	Maine Medical Center; University of Maine System; University of Maine Orono	Yoon, JK (corresponding author), Maine Med Ctr, Ctr Mol Med, Ctr Biomed Res Excellence Stem Cell Biol & Regene, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	yoonje@mmc.org	jin, yongri/D-8392-2012		National Institutes of Health [P20 RR015555, R01 AR055278, P20 RR018789]; Maine Medical Center Research Institute [P20 RR018789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Medical Center Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. Lucy Liaw and Doug Spicer for comments and suggestions and Norma Albrecht for proofreading the manuscript. We are grateful to Drs. Masanobu Kawai and Doug Spicer for providing reagents. We also thank Nancy Chandler-Conrey in Recombinant Viral Vector Core (supported by National Institutes of Health Grant P20 RR015555 to R. Friesel, Program Director) for producing Rspo1 and Delta NTCF4 retroviruses, and Bioinformatics core for qRT-PCR analyses (supported by P20 RR018789) at Maine Medical Center Research Institute.; This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR018789 (to D.M. Wojchowski, Program Director and J.K.Y., Project Principal Investigator) and R01 AR055278 (to J.K.Y., Principal Investigator).	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1994, DEVELOPMENT, V120, P3083; Brunelli S, 2007, DEV BIOL, V304, P604, DOI 10.1016/j.ydbio.2007.01.006; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dedieu S, 2002, INT J DEV BIOL, V46, P235; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Hadchouel J, 2003, DEVELOPMENT, V130, P3415, DOI 10.1242/dev.00552; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nam JS, 2007, GENE EXPR PATTERNS, V7, P306, DOI 10.1016/j.modgep.2006.08.006; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teboul L, 2002, DEVELOPMENT, V129, P4571; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Xu QH, 1998, DEVELOPMENT, V125, P4767; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	48	71	76	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10649	10659		10.1074/jbc.M110.169391	http://dx.doi.org/10.1074/jbc.M110.169391			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252233	hybrid, Green Published			2022-12-25	WOS:000288547000079
J	Ping, Y; Waro, G; Licursi, A; Smith, S; Vo-Ba, DA; Tsunoda, S				Ping, Yong; Waro, Girma; Licursi, Ashley; Smith, Sarah; Vo-Ba, Dai-An; Tsunoda, Susan			Shal/K(v)4 Channels Are Required for Maintaining Excitability during Repetitive Firing and Normal Locomotion in Drosophila	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; RHYTHMICALLY ACTIVE NEURONS; CA1 PYRAMIDAL NEURONS; OUTWARD K+ CURRENT; POTASSIUM CHANNELS; I-A; SYNAPTIC-TRANSMISSION; FLIGHT MUSCLES; NERVOUS-SYSTEM; SHAKER MUTANTS	Background: Rhythmic behaviors, such as walking and breathing, involve the coordinated activity of central pattern generators in the CNS, sensory feedback from the PNS, to motoneuron output to muscles. Unraveling the intrinsic electrical properties of these cellular components is essential to understanding this coordinated activity. Here, we examine the significance of the transient A-type K+ current (I-A), encoded by the highly conserved Shal/K(v)4 gene, in neuronal firing patterns and repetitive behaviors. While I-A is present in nearly all neurons across species, elimination of I-A has been complicated in mammals because of multiple genes underlying I-A, and/or electrical remodeling that occurs in response to affecting one gene. Methodology/Principal Findings: In Drosophila, the single Shal/K(v)4 gene encodes the predominant I-A current in many neuronal cell bodies. Using a transgenically expressed dominant-negative subunit (DNK(v)4), we show that I-A is completely eliminated from cell bodies, with no effect on other currents. Most notably, DNK(v)4 neurons display multiple defects during prolonged stimuli. DNK(v)4 neurons display shortened latency to firing, a lower threshold for repetitive firing, and a progressive decrement in AP amplitude to an adapted state. We record from identified motoneurons and show that Shal/K(v)4 channels are similarly required for maintaining excitability during repetitive firing. We then examine larval crawling, and adult climbing and grooming, all behaviors that rely on repetitive firing. We show that all are defective in the absence of Shal/K(v)4 function. Further, knock-out of Shal/K(v)4 function specifically in motoneurons significantly affects the locomotion behaviors tested. Conclusions/Significance: Based on our results, Shal/K(v)4 channels regulate the initiation of firing, enable neurons to continuously fire throughout a prolonged stimulus, and also influence firing frequency. This study shows that Shal/K(v)4 channels play a key role in repetitively firing neurons during prolonged input/output, and suggests that their function and regulation are important for rhythmic behaviors.	[Ping, Yong; Waro, Girma; Licursi, Ashley; Smith, Sarah; Vo-Ba, Dai-An; Tsunoda, Susan] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Ping, Y (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	susan.tsunoda@colostate.edu		Ping, Yong/0000-0003-1066-5471	National Institutes of Health [R01 GM083335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the National Institutes of Health (R01 GM083335 to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bergquist S, 2010, NEURON, V66, P220, DOI 10.1016/j.neuron.2010.03.023; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; BROADIE KS, 1993, J NEUROSCI, V13, P167; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Choi JC, 2004, J NEUROPHYSIOL, V91, P2353, DOI 10.1152/jn.01115.2003; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Diao FQ, 2010, MOL CELL NEUROSCI, V45, P75, DOI 10.1016/j.mcn.2010.06.001; Diao FQ, 2009, MOL CELL NEUROSCI, V42, P33, DOI 10.1016/j.mcn.2009.05.003; Fawcett GL, 2006, J BIOL CHEM, V281, P30725, DOI 10.1074/jbc.M605814200; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gasque G, 2005, J NEUROSCI, V25, P2348, DOI 10.1523/JNEUROSCI.4384-04.2005; Hess D, 2001, P NATL ACAD SCI USA, V98, P5276, DOI 10.1073/pnas.091096198; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lee D, 2003, J NEUROSCI, V23, P4625; Lee D, 2000, J NEUROSCI, V20, P2104; Lee D, 1999, J NEUROSCI, V19, P5311; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lim A, 2009, J NEUROSCI, V29, P951, DOI 10.1523/JNEUROSCI.2582-08.2009; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Malin SA, 2001, J NEUROSCI, V21, P8004, DOI 10.1523/JNEUROSCI.21-20-08004.2001; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PHILLIS RW, 1993, GENETICS, V133, P581; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rogero O, 1997, J NEUROSCI, V17, P5108; Ryglewski S, 2009, J NEUROPHYSIOL, V102, P3673, DOI 10.1152/jn.00693.2009; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; SALKOFF L, 1985, J PHYSIOL-PARIS, V80, P275; SALKOFF LB, 1983, J PHYSIOL-LONDON, V337, P687, DOI 10.1113/jphysiol.1983.sp014649; Schaefer JE, 2010, J NEUROPHYSIOL, V104, P1257, DOI 10.1152/jn.00298.2010; Shibata R, 2000, J NEUROSCI, V20, P4145; SOLC CK, 1987, SCIENCE, V236, P1094, DOI 10.1126/science.2437657; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Su HL, 2003, J NEUROSCI, V23, P9246; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Ueda A, 2006, J NEUROSCI, V26, P6238, DOI 10.1523/JNEUROSCI.0862-06.2006; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WU CF, 1985, J NEUROSCI, V5, P2626; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; ZAGOTTA WN, 1988, J NEUROSCI, V8, P4765	61	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16043	10.1371/journal.pone.0016043	http://dx.doi.org/10.1371/journal.pone.0016043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264215	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600017
J	Gannavaram, S; Sharma, P; Duncan, RC; Salotra, P; Nakhasi, HL				Gannavaram, Sreenivas; Sharma, Paresh; Duncan, Robert C.; Salotra, Poonam; Nakhasi, Hira L.			Mitochondrial Associated Ubiquitin Fold Modifier-1 Mediated Protein Conjugation in Leishmania donovani	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; PARASITIC PROTOZOA; LIGASE; IDENTIFICATION; SYSTEM; PROTEASOME; EXPRESSION; GENES; TARENTOLAE	In this report, we demonstrate the existence of the ubiquitin fold modifier-1 (Ufm1) and its conjugation pathway in trypanosomatid parasite Leishmania donovani. LdUfm1 is activated by E1-like enzyme LdUba5. LdUfc1 (E2) specifically interacted with LdUfm1 and LdUba5 to conjugate LdUfm1 to proteinaceous targets. Mass spectrometry analysis revealed that LdUfm1 is conjugated to Leishmania protein targets that are associated with mitochondria. Immunofluorescence experiments showed that Leishmania Ufm1, Uba5 and Ufc1 are associated with the mitochondria. The demonstration that all the components of this system as well as the substrates are associated with mitochondrion suggests it may have physiological roles not yet described in any other organism. Overexpression of a non-conjugatable form of LdUfm1 and an active site mutant of LdUba5 resulted in reduced survival of Leishmania in the macrophage. Since mitochondrial activities are developmentally regulated in the life cycle of trypanosomatids, Ufm1 mediated modifications of mitochondrial proteins may be important in such regulation. Thus, Ufm1 conjugation pathway in Leishmania could be explored as a potential drug target in the control of Leishmaniasis.	[Gannavaram, Sreenivas; Duncan, Robert C.; Nakhasi, Hira L.] US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Sharma, Paresh; Salotra, Poonam] Inst Pathol ICMR, New Delhi, India	US Food & Drug Administration (FDA)	Gannavaram, S (corresponding author), US FDA, Lab Emerging Pathogens, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	salotra@vsnl.com; hira.nakhasi@fda.hhs.gov	Duncan, Robert/I-8168-2015	Duncan, Robert/0000-0001-8409-2501; Gannavaram, Sreenivas/0000-0002-6557-8220; Salotra, Poonam/0000-0002-4057-4872				Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; FLEISCHMANN J, 1994, GENE, V144, P45, DOI 10.1016/0378-1119(94)90201-1; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Goldenberg SJ, 2010, BIOCHEM SOC T, V38, P132, DOI 10.1042/BST0380132; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hashimoto M, 2010, CELL MICROBIOL, V12, P19, DOI 10.1111/j.1462-5822.2009.01375.x; Henriquez Diana A., 1993, Biological Research, V26, P151; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Horrocks P, 2000, MOL BIOCHEM PARASIT, V105, P115, DOI 10.1016/S0166-6851(99)00174-7; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KIRCHHOFF LV, 1988, J BIOL CHEM, V263, P12698; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; LIAO S, 2010, EXP CELL RES; Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018; LOWRIE DJ, 1993, AM J TROP MED HYG, V49, P545, DOI 10.4269/ajtmh.1993.49.545; MAGNANI M, 1991, J BIOL CHEM, V266, P21018; Manning-Cela R, 2006, ARCH MED RES, V37, P593, DOI 10.1016/j.arcmed.2005.11.013; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Maslov DA, 2006, MOL BIOCHEM PARASIT, V148, P69, DOI 10.1016/j.molbiopara.2006.02.021; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; Srividya G, 2007, PARASITOLOGY, V134, P1527, DOI 10.1017/S003118200700296X; TATSUMI K, 2009, J BIOL CHEM; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	44	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16156	10.1371/journal.pone.0016156	http://dx.doi.org/10.1371/journal.pone.0016156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264253	gold, Green Published, Green Submitted			2022-12-25	WOS:000286516500032
J	Mohn, D; Zehnder, M; Stark, WJ; Imfeld, T				Mohn, Dirk; Zehnder, Matthias; Stark, Wendelin J.; Imfeld, Thomas			Electrochemical Disinfection of Dental Implants - a Proof of Concept	PLOS ONE			English	Article							ESCHERICHIA-COLI; PERI-IMPLANTITIS; ELECTRIC-CURRENT; DRINKING-WATER; INACTIVATION	Background: Peri-implantitis has gained significant clinical attention in recent years. This disease is an inflammatory reaction to microorganisms around dental implants. Due to the limited accessibility, non-invasive antimicrobial strategies are of high interest. An unexpected approach to implant disinfection may evolve from electrolysis. Given the electrical conductivity of titanium implants, alkalinity or active oxidants can be generated in body fluids. We investigated the use of dental titanium implants as electrodes for the local generation of disinfectants. Our hypothesis was that electrolysis can reduce viable counts of adhering bacteria, and that this reduction should be greater if active oxidative species are generated. Methodology/Principal Findings: As model systems, dental implants, covered with a mono-species biofilm of Escherichia coli C43, were placed in photographic gelatin prepared with physiological saline. Implants were treated by a continuous current of 0 - 10 mA for 15 minutes. The reduction of viable counts was investigated on cathodes and anodes. In separate experiments, the local change in pH was visualized using color indicators embedded in the gelatin. Oxidative species were qualitatively detected by potassium iodide-starch paper. The in situ generated alkaline environment around cathodic implants caused a reduction of up to 2 orders of magnitude in viable E. coli counts. On anodic implants, in contrast to cathodic counterparts, oxidative species were detected. Here, a current of merely 7.5 mA caused complete kill of the bacteria. Conclusions/Significance: This laboratory study shows that electrochemical treatment may provide access to a new way to decontaminate dental implants in situ.	[Mohn, Dirk; Stark, Wendelin J.] ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland; [Zehnder, Matthias; Imfeld, Thomas] Univ Zurich, Ctr Dent Med, Dept Prevent Dent Periodontol & Cariol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mohn, D (corresponding author), ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland.	thomas.imfeld@zzmk.uzh.ch	Stark, Wendelin J./A-8680-2008; Mohn, Dirk/N-3035-2019; Mohn, Dirk/K-8574-2012	Mohn, Dirk/0000-0003-0907-7074; Zehnder, Matthias/0000-0001-9545-7828	Department of Preventive Dentistry and Oral Epidemiology, University of Zurich, Center for Dental Medicine	Department of Preventive Dentistry and Oral Epidemiology, University of Zurich, Center for Dental Medicine	This work was financially supported by the Department of Preventive Dentistry and Oral Epidemiology, University of Zurich, Center for Dental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 1993, P 1 EUR WORKSH PER, P365; Bergmann H, 2005, ELECTROCHIM ACTA, V50, P5218, DOI 10.1016/j.electacta.2005.01.061; Brandle N, 2008, J ENDODONT, V34, P579, DOI 10.1016/j.joen.2008.02.027; CLESCERL L, 1999, STANDARD METHODS EXA, pCH4; CZARNETZKI LR, 1992, J APPL ELECTROCHEM, V22, P315, DOI 10.1007/BF01092683; DAVIS CP, 1982, J CLIN MICROBIOL, V15, P891, DOI 10.1128/JCM.15.5.891-894.1982; DAVIS CP, 1994, ANTIMICROB AGENTS CH, V38, P2768, DOI 10.1128/AAC.38.12.2768; Drees KP, 2003, WATER RES, V37, P2291, DOI 10.1016/S0043-1354(03)00009-5; Dychdala G.R., 1991, CHLORINE CHLORINE CO, V4th ed., P131; German Institute for Standardization, 2005, EFF CURR HUM BEING 1; GROSSMAN LI, 1931, DENT COSMOS, V73, P147; Hong SH, 2008, BIOTECHNOL BIOENG, V100, P379, DOI 10.1002/bit.21760; Jeong J, 2009, WATER RES, V43, P895, DOI 10.1016/j.watres.2008.11.033; Kakisis I, 2008, COCHRANE DATABASE SY, V2; Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Martinez-Huitle CA, 2008, ANGEW CHEM INT EDIT, V47, P1998, DOI 10.1002/anie.200703621; Mombelli A, 1994, Periodontol 2000, V4, P74, DOI 10.1111/j.1600-0757.1994.tb00007.x; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x; PAREILLEUX A, 1970, APPL MICROBIOL, V19, P421, DOI 10.1128/AEM.19.3.421-424.1970; PATERMARAKIS G, 1990, WATER RES, V24, P1491, DOI 10.1016/0043-1354(90)90083-I; RAJESHWAR K, 1994, J APPL ELECTROCHEM, V24, P1077; SCHONE E, 1879, LIEBIGS ANN, V195, P228; Siren EK, 1997, INT ENDOD J, V30, P91, DOI 10.1046/j.1365-2591.1997.00057.x; SOMMER RF, 1961, CLIN ENDODONTICS MAN, P199; SUNADA I, 1962, J DENT RES, V41, P375, DOI 10.1177/00220345620410020801; Urano H, 2006, J BIOSCI BIOENG, V102, P457, DOI 10.1263/jbb.102.457	29	32	32	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16157	10.1371/journal.pone.0016157	http://dx.doi.org/10.1371/journal.pone.0016157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264247	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500033
J	Pasquevich, KA; Ibanez, AE; Coria, LM; Samartino, CG; Estein, SM; Zwerdling, A; Barrionuevo, P; Oliveira, FS; Seither, C; Warzecha, H; Oliveira, SC; Giambartolomei, GH; Cassataro, J				Pasquevich, Karina A.; Ibanez, Andres E.; Coria, Lorena M.; Garcia Samartino, Clara; Estein, Silvia M.; Zwerdling, Astrid; Barrionuevo, Paula; Oliveira, Fernanda S.; Seither, Christine; Warzecha, Heribert; Oliveira, Sergio C.; Giambartolomei, Guillermo H.; Cassataro, Juliana			An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; OUTER-MEMBRANE PROTEIN-31; BRUCELLA-ABORTUS; HOST-DEFENSE; T-CELLS; KLEBSIELLA-PNEUMONIAE; BALB/C MICE; TH17 CELLS; INFECTION; IMMUNIZATION	As Brucella infections occur mainly through mucosal surfaces, the development of mucosal administered vaccines could be radical for the control of brucellosis. In this work we evaluated the potential of Brucella abortus 19 kDa outer membrane protein (U-Omp19) as an edible subunit vaccine against brucellosis. We investigated the protective immune response elicited against oral B. abortus infection after vaccination of mice with leaves from transgenic plants expressing U-Omp19; or with plant-made or E. coli-made purified U-Omp19. All tested U-Omp19 formulations induced protection against Brucella when orally administered without the need of adjuvants. U-Omp19 also induced protection against a systemic challenge when parenterally administered. This built-in adjuvant ability of U-Omp19 was independent of TLR4 and could be explained at least in part by its capability to activate dendritic cells in vivo. While unadjuvanted U-Omp19 intraperitoneally administered induced a specific Th1 response, following U-Omp19 oral delivery a mixed specific Th1-Th17 response was induced. Depletion of CD4(+) T cells in mice orally vaccinated with U-Omp19 resulted in a loss of the elicited protection, indicating that this cell type mediates immune protection. The role of IL-17 against Brucella infection has never been explored. In this study, we determined that if IL-17A was neutralized in vivo during the challenge period, the mucosal U-Omp19 vaccine did not confer mucosal protection. On the contrary, IL-17A neutralization during the infection did not influence at all the subsistence and growth of this bacterium in PBS-immunized mice. All together, our results indicate that an oral unadjuvanted vaccine based on U-Omp19 induces protection against a mucosal challenge with Brucella abortus by inducing an adaptive IL-17 immune response. They also indicate different and important new aspects i) IL-17 does not contribute to reduce the bacterial burden in non vaccinated mice and ii) IL-17 plays a central role in vaccine mediated anti-Brucella mucosal immunity.	[Pasquevich, Karina A.; Ibanez, Andres E.; Coria, Lorena M.; Garcia Samartino, Clara; Zwerdling, Astrid; Barrionuevo, Paula; Giambartolomei, Guillermo H.; Cassataro, Juliana] Univ Buenos Aires, Fac Med, Lab Inmunogenet, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina; [Pasquevich, Karina A.; Ibanez, Andres E.; Coria, Lorena M.; Garcia Samartino, Clara; Zwerdling, Astrid; Barrionuevo, Paula; Giambartolomei, Guillermo H.; Cassataro, Juliana] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral IDEHU CONICET, Buenos Aires, DF, Argentina; [Estein, Silvia M.] Univ Nacl, Ctr Prov Buenos Aires, Lab Inmunol, Dept Sanidad Anim & Med Prevent,Fac Ciencias Vet, Tandil, Argentina; [Oliveira, Fernanda S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Seither, Christine; Warzecha, Heribert] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade Federal de Minas Gerais; Technical University of Darmstadt	Pasquevich, KA (corresponding author), Univ Buenos Aires, Fac Med, Lab Inmunogenet, Hosp Clin Jose de San Martin, Buenos Aires, DF, Argentina.	jucassat@ffyb.uba.ar	Oliveira, Sergio Costa/AAG-5408-2021	Oliveira, Sergio Costa/0000-0003-4062-5577; Pasquevich, Karina Alejandra/0000-0003-4448-0977; ESTEIN, SILVIA/0000-0002-9533-0680; Cassataro, Juliana/0000-0002-7122-869X	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina) [PICT 2006 Nu 1670]; ANPCyT/CNPq PICT [2008 Nu 18, CONICET: PIP 5239]; Universidad de Buenos Aires [M408]; CNPq/Prosul [490485/2007-3]; CNPq/ANPCyT [490528/2008-2]; INCT/Vacinas	Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina)(ANPCyT); ANPCyT/CNPq PICT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); CNPq/Prosul(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/ANPCyT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); INCT/Vacinas	This work was supported by grants from the Bill and Melinda Gates Foundation through the Grand Challenges Explorations Initiative; from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina): PICT 2006 Nu 1670, ANPCyT/CNPq PICT 2008 Nu 18, CONICET: PIP 5239; and from the Universidad de Buenos Aires: M408 (to JC). This work was also supported by grants from CNPq/Prosul #490485/2007-3, CNPq/ANPCyT # 490528/2008-2, and INCT/Vacinas (to SCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2002, INFECT IMMUN, V70, P1915, DOI 10.1128/IAI.70.4.1915-1923.2002; Ashford DA, 2004, VACCINE, V22, P3435, DOI 10.1016/j.vaccine.2004.02.041; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Bowden RA, 2000, MICROBES INFECT, V2, P481, DOI 10.1016/S1286-4579(00)00317-8; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Cabrera A, 2009, IMMUNOBIOLOGY, V214, P467, DOI 10.1016/j.imbio.2008.11.016; Cassataro J, 2005, INFECT IMMUN, V73, P8079, DOI 10.1128/IAI.73.12.8079-8088.2005; Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005; Cassataro J, 2007, VACCINE, V25, P5958, DOI 10.1016/j.vaccine.2007.05.049; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P632; Delpino MV, 2007, INFECT IMMUN, V75, P299, DOI 10.1128/IAI.00952-06; Florentino MA, 2008, VET MICROBIOL, V132, P302, DOI 10.1016/j.vetmic.2008.05.003; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Golding B, 2001, MICROBES INFECT, V3, P43, DOI 10.1016/S1286-4579(00)01350-2; Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Izadjoo MJ, 2004, INFECT IMMUN, V72, P4031, DOI 10.1128/IAI.72.7.4031-4039.2004; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Liljeqvist S, 1999, J BIOTECHNOL, V73, P1, DOI 10.1016/S0168-1656(99)00107-8; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Magnani DM, 2009, INFECT IMMUN, V77, P5181, DOI 10.1128/IAI.00231-09; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Mason HS, 2002, TRENDS MOL MED, V8, P324, DOI 10.1016/S1471-4914(02)02360-2; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nicoletti P, 1990, Adv Biotechnol Processes, V13, P147; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pasquali P, 2003, INFECT IMMUN, V71, P2326, DOI 10.1128/IAI.71.5.2326-2330.2003; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; PERKINS SD, 2010, FEMS MICROBIOL REV; Pontes DS, 2004, J DRUG TARGET, V11, P489, DOI 10.1080/10611860410001670035; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rice J., 2005, Animal Health Research Reviews, V6, P199, DOI 10.1079/AHR2005110; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Sala F, 2003, VACCINE, V21, P803, DOI 10.1016/S0264-410X(02)00603-5; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Shewen PE, 2009, VET IMMUNOL IMMUNOP, V128, P192, DOI 10.1016/j.vetimm.2008.10.297; Sieve AN, 2009, EUR J IMMUNOL, V39, P426, DOI 10.1002/eji.200838726; STABEL TJ, 1990, INFECT IMMUN, V58, P2048, DOI 10.1128/IAI.58.7.2048-2055.1990; STEVENS MG, 1995, INFECT IMMUN, V63, P264, DOI 10.1128/IAI.63.1.264-270.1995; Streatfield SJ, 2006, METHODS, V38, P150, DOI 10.1016/j.ymeth.2005.09.013; Tibor A, 1999, INFECT IMMUN, V67, P4960, DOI 10.1128/IAI.67.9.4960-4962.1999; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Velikovsky CA, 2003, INFECT IMMUN, V71, P5750, DOI 10.1128/IAI.71.10.5750-5755.2003; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	66	78	82	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16203	10.1371/journal.pone.0016203	http://dx.doi.org/10.1371/journal.pone.0016203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264260	gold, Green Submitted, Green Published			2022-12-25	WOS:000286516500038
J	Poole, KES; Treece, GM; Ridgway, GR; Mayhew, PM; Borggrefe, J; Gee, AH				Poole, Kenneth E. S.; Treece, Graham M.; Ridgway, Gerard R.; Mayhew, Paul M.; Borggrefe, Jan; Gee, Andrew H.			Targeted Regeneration of Bone in the Osteoporotic Human Femur	PLOS ONE			English	Article							DENSITY	We have recently developed image processing techniques for measuring the cortical thicknesses of skeletal structures in vivo, with resolution surpassing that of the underlying computed tomography system. The resulting thickness maps can be analysed across cohorts by statistical parametric mapping. Applying these methods to the proximal femurs of osteoporotic women, we discover targeted and apparently synergistic effects of pharmaceutical osteoporosis therapy and habitual mechanical load in enhancing bone thickness.	[Poole, Kenneth E. S.; Mayhew, Paul M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Treece, Graham M.; Gee, Andrew H.] Univ Cambridge, Dept Engn, Cambridge CB2 2QQ, England; [Ridgway, Gerard R.] UCL, Inst Neurol, London, England; [Borggrefe, Jan] Univ Schleswig Holstein, Dept Diagnost Radiol, Kiel, Germany	University of Cambridge; University of Cambridge; University of London; University College London; University of Kiel; Schleswig Holstein University Hospital	Poole, KES (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	kp254@nhs.net	Borggrefe, Jan/N-6549-2018; Ridgway, Gerard/F-5145-2010	Borggrefe, Jan/0000-0003-2908-7560; Ridgway, Gerard/0000-0002-7676-7860	Arthritis Research UK; Cambridge Biomedical Research Centre (National Institute for Health Research)	Arthritis Research UK(Versus Arthritis); Cambridge Biomedical Research Centre (National Institute for Health Research)(National Institute for Health Research (NIHR))	This work was supported by an Arthritis Research UK Clinician Scientist Fellowship award to KESP (The FEMCO study, ARC17822, http://www.arthritisresearchuk.org/) and by the Cambridge Biomedical Research Centre (National Institute for Health Research), an institutional award that supports PMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Borggrefe J, 2010, J BONE MINER RES, V25, P472, DOI 10.1359/jbmr.090820; Burr DB, 2010, LANCET, V375, P1672, DOI 10.1016/S0140-6736(10)60444-8; Eastell R, 2009, J BONE MINER RES, V24, P726, DOI 10.1359/JBMR.081215; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; Misof BM, 2003, J CLIN ENDOCR METAB, V88, P1150, DOI 10.1210/jc.2002-021988; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Roberts MD, 2009, J BIOMECH, V42, P2431, DOI 10.1016/j.jbiomech.2009.08.030; Roux W., 1885, ARCH ANAT PHYSL ANAT, V9, P120; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Treece GM, 2010, MED IMAGE ANAL, V14, P276, DOI 10.1016/j.media.2010.01.003; Worsley K., 2009, NEUROIMAGE, V47, pS102, DOI [10.1016/s1053-8119(09)70882-1, DOI 10.1016/S1053-8119(09)70882-1, 10.1016/S1053-8119(09)70882-1]	17	42	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16190	10.1371/journal.pone.0016190	http://dx.doi.org/10.1371/journal.pone.0016190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264263	Green Published, gold			2022-12-25	WOS:000286516500037
J	Thalhammer, A; Bencokova, Z; Poole, R; Loenarz, C; Adam, J; O'Flaherty, L; Schodel, J; Mole, D; Giaslakiotis, K; Schofield, CJ; Hammond, EM; Ratcliffe, PJ; Pollard, PJ				Thalhammer, Armin; Bencokova, Zuzana; Poole, Rachel; Loenarz, Christoph; Adam, Julie; O'Flaherty, Linda; Schoedel, Johannes; Mole, David; Giaslakiotis, Konstantinos; Schofield, Christopher J.; Hammond, Ester M.; Ratcliffe, Peter J.; Pollard, Patrick J.			Human AlkB Homologue 5 Is a Nuclear 2-Oxoglutarate Dependent Oxygenase and a Direct Target of Hypoxia-Inducible Factor 1 alpha ( HIF-1 alpha)	PLOS ONE			English	Article							DNA-DAMAGE; HISTONE DEMETHYLASES; FACTOR HIF; EXPRESSION; HYDROXYLASE; FAMILY; GENE; IDENTIFICATION; ACTIVATION; INDUCTION	Human 2-oxoglutarate oxygenases catalyse a range of biological oxidations including the demethylation of histone and nucleic acid substrates and the hydroxylation of proteins and small molecules. Some of these processes are centrally involved in regulation of cellular responses to hypoxia. The ALKBH proteins are a sub-family of 2OG oxygenases that are defined by homology to the Escherichia coli DNA-methylation repair enzyme AlkB. Here we report evidence that ALKBH5 is probably unique amongst the ALKBH genes in being a direct transcriptional target of hypoxia inducible factor-1 (HIF-1) and is induced by hypoxia in a range of cell types. We show that purified recombinant ALKBH5 is a bona fide 2OG oxygenase that catalyses the decarboxylation of 2OG but appears to have different prime substrate requirements from those so far defined for other ALKBH family members. Our findings define a new class of HIF-transcriptional target gene and suggest that ALKBH5 may have a role in the regulation of cellular responses to hypoxia.	[Thalhammer, Armin; Loenarz, Christoph; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England; [Thalhammer, Armin; Loenarz, Christoph; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford Ctr Integrat Syst Biol, Oxford, England; [Bencokova, Zuzana; Poole, Rachel; Hammond, Ester M.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Giaslakiotis, Konstantinos] John Radcliffe Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Thalhammer, A (corresponding author), Univ Oxford, Chem Res Lab, Oxford, England.	patrick.pollard@well.ox.ac.uk	Pollard, Patrick/F-7516-2012	Pollard, Patrick/0000-0002-4459-4993; Ratcliffe, Peter/0000-0002-2853-806X; Schodel, Johannes/0000-0002-3587-8839; Loenarz, Christoph/0000-0002-8843-2531; Mole, David/0000-0002-0984-300X; Schofield, Christopher/0000-0002-0290-6565; Adam, Julie/0000-0002-7980-7151; Hammond, Ester/0000-0002-2335-3146	Beit Memorial Fellowship; Rhodes Scholarship; Wellcome Trust [WT91112]; Cancer Research UK [C6079/A9485, C6515/A9321]; Biological and Biotechnological Research Council; BBSRC [BB/D011523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; Cancer Research UK [6947] Funding Source: researchfish	Beit Memorial Fellowship; Rhodes Scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biological and Biotechnological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	PJP is in receipt of a Beit Memorial Fellowship. CL is in receipt of a Rhodes Scholarship. AT is in receipt of a Cancer Research UK Studentship. This work was supported by the Wellcome Trust [WT91112], Cancer Research UK [C6079/A9485] and [C6515/A9321], and the Biological and Biotechnological Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; MULLER TA, 2009, DNA REPAIR AMST; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; PIRES IM, 2010, CANC RES; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; SABOURIN PJ, 1982, J BIOL CHEM, V257, P7460; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Sowter HM, 2003, CANCER RES, V63, P6130; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Wykoff CC, 2000, CANCER RES, V60, P7075; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106	39	95	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16210	10.1371/journal.pone.0016210	http://dx.doi.org/10.1371/journal.pone.0016210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264265	Green Published, Green Submitted, gold			2022-12-25	WOS:000286516500039
J	Orru, M; Bakesova, J; Brugarolas, M; Quiroz, C; Beaumont, V; Goldberg, SR; Lluis, C; Cortes, A; Franco, R; Casado, V; Canela, EI; Ferre, S				Orru, Marco; Bakesova, Jana; Brugarolas, Marc; Quiroz, Cesar; Beaumont, Vahri; Goldberg, Steven R.; Lluis, Carme; Cortes, Antoni; Franco, Rafael; Casado, Vicent; Canela, Enric I.; Ferre, Sergi			Striatal Pre- and Postsynaptic Profile of Adenosine A(2A) Receptor Antagonists	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINE-D-2 RECEPTORS; BASAL GANGLIA; D2 DOPAMINE; HETEROMERS; NEUROTRANSMISSION; PHOSPHORYLATION; DISORDERS	Striatal adenosine A(2A) receptors (A(2A)Rs) are highly expressed in medium spiny neurons (MSNs) of the indirect efferent pathway, where they heteromerize with dopamine D-2 receptors (D(2)Rs). A(2A)Rs are also localized presynaptically in corticostriatal glutamatergic terminals contacting MSNs of the direct efferent pathway, where they heteromerize with adenosine A(1) receptors (A(1)Rs). It has been hypothesized that postsynaptic A(2A)R antagonists should be useful in Parkinson's disease, while presynaptic A(2A)R antagonists could be beneficial in dyskinetic disorders, such as Huntington's disease, obsessive-compulsive disorders and drug addiction. The aim or this work was to determine whether selective A(2A)R antagonists may be subdivided according to a preferential pre-versus postsynaptic mechanism of action. The potency at blocking the motor output and striatal glutamate release induced by cortical electrical stimulation and the potency at inducing locomotor activation were used as in vivo measures of pre- and postsynaptic activities, respectively. SCH-442416 and KW-6002 showed a significant preferential pre-and postsynaptic profile, respectively, while the other tested compounds (MSX-2, SCH-420814, ZM-241385 and SCH-58261) showed no clear preference. Radioligand-binding experiments were performed in cells expressing A(2A)R-D2R and A(1)R-A(2A)R heteromers to determine possible differences in the affinity of these compounds for different A(2A)R heteromers. Heteromerization played a key role in the presynaptic profile of SCH-442416, since it bound with much less affinity to A(2A)R when co-expressed with D2R than with A(1)R. KW-6002 showed the best relative affinity for A(2A)R coexpressed with D2R than co-expressed with A(1)R, which can at least partially explain the postsynaptic profile of this compound. Also, the in vitro pharmacological profile of MSX-2, SCH-420814, ZM-241385 and SCH-58261 was is in accordance with their mixed pre-and postsynaptic profile. On the basis of their preferential pre-versus postsynaptic actions, SCH-442416 and KW-6002 may be used as lead compounds to obtain more effective antidyskinetic and antiparkinsonian compounds, respectively.	[Orru, Marco; Quiroz, Cesar; Goldberg, Steven R.; Ferre, Sergi] NIDA, IRP, NIH, DHHS, Baltimore, MD USA; [Bakesova, Jana; Brugarolas, Marc; Lluis, Carme; Cortes, Antoni; Franco, Rafael; Casado, Vicent; Canela, Enric I.] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Beaumont, Vahri] CHDI Fdn, CHDI Management, Los Angeles, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); CIBERNED; University of Barcelona	Orru, M (corresponding author), NIDA, IRP, NIH, DHHS, Baltimore, MD USA.	sferre@intra.nida.nih.gov	Ferre, Sergi/K-6115-2014; Canela, Enric I./M-8726-2013; Orrù, Marco/ABE-4316-2021; Franco, Rafael/C-3694-2015; Casadó, Vicent/K-1660-2014	Ferre, Sergi/0000-0002-1747-1779; Canela, Enric I./0000-0003-4992-7440; Franco, Rafael/0000-0003-2549-4919; Casadó, Vicent/0000-0002-1764-3825; Beaumont, Vahri/0000-0002-6488-2175; Brugarolas, Marc/0000-0002-2277-1266	National Institute on Drug Abuse; CHDI Foundation; Spanish Ministerio de Ciencia y Tecnologia [SAF2008-00146, SAF2008-03229-E]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); CHDI Foundation; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Work supported by the National Institute on Drug Abuse, Intramural Research Program, CHDI Foundation and by the Spanish Ministerio de Ciencia y Tecnologia (grant numbers SAF2008-00146 and SAF2008-03229-E). The co-author Vahri Baumont, scientific manager from CHDI Foundation, participated in the design of the experiments. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azdad K, 2009, NEUROPSYCHOPHARMACOL, V34, P972, DOI 10.1038/npp.2008.144; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Casad V, 2007, PHARMACOL THERAPEUT, V116, P343, DOI 10.1016/j.pharmthera.2007.05.010; CASADO V, 1990, ANAL BIOCHEM, V184, P117, DOI 10.1016/0003-2697(90)90022-2; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Chen JF, 2001, P NATL ACAD SCI USA, V98, P1970, DOI 10.1073/pnas.98.4.1970; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; Ciruela F, 1995, J NEUROSCI RES, V42, P818, DOI 10.1002/jnr.490420610; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; FRANCO R, 2005, TRENDS BIOCHEM SCI, V26, P221; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Jenner P, 2003, NEUROLOGY, V61, pS4, DOI 10.1212/WNL.61.6_suppl_3.S4; Kaasinen V, 2000, J NUCL MED, V41, P65; Navarro G, 2009, J BIOL CHEM, V284, P28058, DOI 10.1074/jbc.M109.034231; Obeso JA, 2002, NEWS PHYSIOL SCI, V17, P51, DOI 10.1152/rips.01363.2001; Pinna A, 2002, EUR J PHARMACOL, V446, P75, DOI 10.1016/S0014-2999(02)01818-6; Quarta D, 2004, J NEUROCHEM, V91, P873, DOI 10.1111/j.1471-4159.2004.02761.x; Quiroz C, 2010, EXP NEUROL, V224, P292, DOI 10.1016/j.expneurol.2010.04.004; Quiroz C, 2009, THESCIENTIFICWORLDJO, V9, P1321, DOI 10.1100/tsw.2009.143; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Varani K, 2010, FASEB J, V24, P587, DOI 10.1096/fj.09-141044	31	89	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16088	10.1371/journal.pone.0016088	http://dx.doi.org/10.1371/journal.pone.0016088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264319	Green Published, gold, Green Submitted			2022-12-25	WOS:000286514000020
J	Graham, M; Liang, BH; Van Domselaar, G; Bastien, N; Beaudoin, C; Tyler, S; Kaplen, B; Landry, E; Li, Y				Graham, Morag; Liang, Binhua; Van Domselaar, Gary; Bastien, Nathalie; Beaudoin, Carole; Tyler, Shaun; Kaplen, Brynn; Landry, Erika; Li, Yan		Natl Influenza A H1N1pdm Genomics	Nationwide Molecular Surveillance of Pandemic H1N1 Influenza A Virus Genomes: Canada, 2009	PLOS ONE			English	Article							HEMAGGLUTININ; REPLICATION; ASSOCIATION; EMERGENCE; INFECTION; PROTEINS; PROGRESS	Background: In April 2009, a novel triple-reassortant swine influenza A H1N1 virus ("A/H1N1pdm"; also known as SOIV) was detected and spread globally as the first influenza pandemic of the 21(st) century. Sequencing has since been conducted at an unprecedented rate globally in order to monitor the diversification of this emergent virus and to track mutations that may affect virus behavior. Methodology/Principal Findings: By Sanger sequencing, we determined consensus whole-genome sequences for A/H1N1pdm viruses sampled nationwide in Canada over 33 weeks during the 2009 first and second pandemic waves. A total of 235 virus genomes sampled from unique subjects were analyzed, providing insight into the temporal and spatial trajectory of A/H1N1pdm lineages within Canada. Three clades (2, 3, and 7) were identifiable within the first two weeks of A/H1N1pdm appearance, with clades 5 and 6 appearing thereafter; further diversification was not apparent. Only two viral sites displayed evidence of adaptive evolution, located in hemagglutinin (HA) corresponding to D222 in the HA receptor-binding site, and to E374 at HA2-subunit position 47. Among the Canadian sampled viruses, we observed notable genetic diversity (1.47x10(-3) amino acid substitutions per site) in the gene encoding PBI, particularly within the viral genomic RNA (vRNA)-binding domain (residues 493-757). This genome data set supports the conclusion that A/H1N1pdm is evolving but not excessively relative to other H1N1 influenza A viruses. Entropy analysis was used to investigate whether any mutated A/H1N1pdm protein residues were associated with infection severity; however no virus genotypes were observed to trend with infection severity. One virus that harboured heterozygote coding mutations, including PB2 D567D/G, was attributed to a severe and potentially mixed infection; yet the functional significance of this PB2 mutation remains unknown. Conclusions/Significance: These findings contribute to enhanced understanding of Influenza A/H1N1pdm viral dynamics.	[Graham, Morag; Liang, Binhua; Van Domselaar, Gary; Bastien, Nathalie; Beaudoin, Carole; Tyler, Shaun; Kaplen, Brynn; Landry, Erika; Li, Yan] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Graham, Morag; Van Domselaar, Gary; Li, Yan] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB, Canada; [Beaudoin, Carole] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba	Graham, M (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	morag.graham@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407	Public Health Agency of Canada (PHAC)	Public Health Agency of Canada (PHAC)	This work was supported by federal funds from the Public Health Agency of Canada (PHAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H., 2006, Virologie (Montrouge), V10, P301, DOI [10.1684/vir.2006.0006, 10.1684/vir.2011.7062]; Barman S, 2000, J VIROL, V74, P6538, DOI 10.1128/JVI.74.14.6538-6545.2000; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Domingo E, 2010, VET RES, V41, DOI 10.1051/vetres/2010010; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Embree J, 2010, BIOCHEM CELL BIOL, V88, P589, DOI 10.1139/O10-025; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Furuse Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-67; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jombart T, 2011, HEREDITY, V106, P383, DOI 10.1038/hdy.2010.78; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Lin DZ, 2007, ACTA BIOCH BIOPH SIN, V39, P155, DOI 10.1111/j.1745-7270.2007.00263.x; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; MAURERSTROH S, 2010, PLOS CURR INFLUENZA, pN1162; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nelson M, 2009, PLOS CURR INFLUENZA, P1; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; *STAT CAN, 2010, CAN COMMUN HLTH SURV, P2; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2010, TRANSCR OP STAT VIRT; *WHO, 2010, PAND HINI 2009 UPD 1; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Yang H, 2010, PLOS CURR INFLUENZA, pRRN1152; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zwickl D., 2006, GARLI GENETIC ALGORI; 2009, FLUWATCH        0823; 2010, FLUWATCH        0117	64	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16087	10.1371/journal.pone.0016087	http://dx.doi.org/10.1371/journal.pone.0016087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249207	Green Submitted, gold, Green Published			2022-12-25	WOS:000286512900021
J	Huang, T; Wan, SB; Xu, ZP; Zheng, YF; Feng, KY; Li, HP; Kong, XY; Cai, YD				Huang, Tao; Wan, Sibao; Xu, Zhongping; Zheng, Yufang; Feng, Kai-Yan; Li, Hai-Peng; Kong, Xiangyin; Cai, Yu-Dong			Analysis and Prediction of Translation Rate Based on Sequence and Functional Features of the mRNA	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN EXPRESSION; GENE-EXPRESSION; CODON USAGE; FEATURE-SELECTION; ABUNDANCE; MODEL	Protein concentrations depend not only on the mRNA level, but also on the translation rate and the degradation rate. Prediction of mRNA's translation rate would provide valuable information for in-depth understanding of the translation mechanism and dynamic proteome. In this study, we developed a new computational model to predict the translation rate, featured by (1) integrating various sequence-derived and functional features, (2) applying the maximum relevance & minimum redundancy method and incremental feature selection to select features to optimize the prediction model, and (3) being able to predict the translation rate of RNA into high or low translation rate category. The prediction accuracies under rich and starvation condition were 68.8% and 70.0%, respectively, evaluated by jackknife cross-validation. It was found that the following features were correlated with translation rate: codon usage frequency, some gene ontology enrichment scores, number of RNA binding proteins known to bind its mRNA product, coding sequence length, protein abundance and 5'UTR free energy. These findings might provide useful information for understanding the mechanisms of translation and dynamic proteome. Our translation rate prediction model might become a high throughput tool for annotating the translation rate of mRNAs in large-scale.	[Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao; Feng, Kai-Yan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Wan, Sibao] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China; [Xu, Zhongping; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xu, Zhongping; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Yufang] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Li, Hai-Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai University; Fudan University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	lihaipeng@picb.ac.cn; xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624; cai, yudong/0000-0001-5664-7979	Chinese Academy of Sciences [KSCX1-YW-R-74]; Systems Biology Research Foundation of Shanghai University; Shanghai Science and Technology Committee [09DZ227180]; National Basic Research Program of China [2011CB510102, 2011CB510101]	Chinese Academy of Sciences(Chinese Academy of Sciences); Systems Biology Research Foundation of Shanghai University(Shanghai University); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX1-YW-R-74), Systems Biology Research Foundation of Shanghai University, Shanghai Science and Technology Committee (09DZ227180), Shanghai Science and Technology Committee (09DZ227180), the National Basic Research Program of China (2011CB510102, 2011CB510101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN JE, 1979, J BIOL CHEM, V254, P1927; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Charif D, 2005, BIOINFORMATICS, V21, P545, DOI 10.1093/bioinformatics/bti037; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V44, P60, DOI 10.1002/prot.1072.abs; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Glass GV, 1995, STAT METHODS ED PSYC, V3rd; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; LILJENSTROM H, 1987, J THEOR BIOL, V124, P43, DOI 10.1016/S0022-5193(87)80251-5; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Osada Y, 1999, BIOINFORMATICS, V15, P578, DOI 10.1093/bioinformatics/15.7.578; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Ringner M, 2005, PLOS COMPUT BIOL, V1, P585, DOI 10.1371/journal.pcbi.0010072; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tuller T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-391; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100	47	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16036	10.1371/journal.pone.0016036	http://dx.doi.org/10.1371/journal.pone.0016036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253596	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900037
J	Stefflova, K; Dulik, MC; Barnholtz-Sloan, JS; Pai, AA; Walker, AH; Rebbeck, TR				Stefflova, Klara; Dulik, Matthew C.; Barnholtz-Sloan, Jill S.; Pai, Athma A.; Walker, Amy H.; Rebbeck, Timothy R.			Dissecting the Within-Africa Ancestry of Populations of African Descent in the Americas	PLOS ONE			English	Article							CASE-CONTROL ASSOCIATION; Y-CHROMOSOME; MITOCHONDRIAL-DNA; ADMIXTURE PROPORTIONS; GENETIC-STRUCTURE; UNITED-STATES; MTDNA; STRATIFICATION; DIVERSITY; HISTORY	Background: The ancestry of African-descended Americans is known to be drawn from three distinct populations: African, European, and Native American. While many studies consider this continental admixture, few account for the genetically distinct sources of ancestry within Africa - the continent with the highest genetic variation. Here, we dissect the within-Africa genetic ancestry of various populations of the Americas self-identified as having primarily African ancestry using uniparentally inherited mitochondrial DNA. Methods and Principal Findings: We first confirmed that our results obtained using uniparentally-derived group admixture estimates are correlated with the average autosomal-derived individual admixture estimates (hence are relevant to genomic ancestry) by assessing continental admixture using both types of markers (mtDNA and Y-chromosome vs. ancestry informative markers). We then focused on the within-Africa maternal ancestry, mining our comprehensive database of published mtDNA variation (similar to 5800 individuals from 143 African populations) that helped us thoroughly dissect the African mtDNA pool. Using this well-defined African mtDNA variation, we quantified the relative contributions of maternal genetic ancestry from multiple W/WC/SW/SE (West to South East) African populations to the different pools of today's African-descended Americans of North and South America and the Caribbean. Conclusions: Our analysis revealed that both continental admixture and within-Africa admixture may be critical to achieving an adequate understanding of the ancestry of African-descended Americans. While continental ancestry reflects gender-specific admixture processes influenced by different socio-historical practices in the Americas, the within-Africa maternal ancestry reflects the diverse colonial histories of the slave trade. We have confirmed that there is a genetic thread connecting Africa and the Americas, where each colonial system supplied their colonies in the Americas with slaves from African colonies they controlled or that were available for them at the time. This historical connection is reflected in different relative contributions from populations of W/WC/SW/SE Africa to geographically distinct Africa-derived populations of the Americas, adding to the complexity of genomic ancestry in groups ostensibly united by the same demographic label.	[Stefflova, Klara; Walker, Amy H.; Rebbeck, Timothy R.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Dulik, Matthew C.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Pai, Athma A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Case Western Reserve University; University of Chicago; University of Pennsylvania; Pennsylvania Medicine	Stefflova, K (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	Klara.Stefflova@cancer.org.uk	Rebbeck, Timothy/GLU-8348-2022; Barnholtz-Sloan, Jill/A-4817-2011	Rebbeck, Timothy/0000-0002-4799-1900; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Pai, Athma/0000-0002-7995-9948; Barsi, Klara/0000-0001-9338-0468	Public Health Service [R29-ES08031, R01-CA85074, P50-CA105641]; NATIONAL CANCER INSTITUTE [P50CA105641, R01CA085074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008031] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants to TRR from the Public Health Service (R29-ES08031, R01-CA85074, and P50-CA105641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Benn-Torres J, 2008, ANN HUM GENET, V72, P90, DOI 10.1111/j.1469-1809.2007.00398.x; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Bonilla C, 2004, AM J HUM BIOL, V16, P289, DOI 10.1002/ajhb.20025; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Ribeiro-dos-Santos AKC, 2007, FORENSIC SCI INT, V167, P77, DOI 10.1016/j.forsciint.2005.12.033; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Goncalves VF, 2007, GENET MOL RES, V6, P256; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Guerreiro V, 2009, GENET MOL BIOL, V32, P1, DOI 10.1590/S1415-47572009005000001; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hammer MF, 2006, FORENSIC SCI INT, V164, P45, DOI 10.1016/j.forsciint.2005.11.013; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; McLean DC, 2005, AM J PHYS ANTHROPOL, V127, P427, DOI 10.1002/ajpa.20047; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Miljkovic-Gacic I, 2005, HUM HERED, V60, P129, DOI 10.1159/000089553; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Rawley J, 2005, TRANSATLANTIC SLAVE; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Silva DA, 2006, AM J HUM BIOL, V18, P829, DOI 10.1002/ajhb.20567; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; SLATKIN M, 1995, GENETICS, V139, P457; Stefflova K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007842; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torres JB, 2007, ANN HUM GENET, V71, P782, DOI 10.1111/j.1469-1809.2007.00380.x; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wang YT, 2004, GENET EPIDEMIOL, V27, P14, DOI 10.1002/gepi.20003; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141	60	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14495	10.1371/journal.pone.0014495	http://dx.doi.org/10.1371/journal.pone.0014495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710KZ	21253579	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511900004
J	Song, NN; Xiu, JB; Huang, Y; Chen, JY; Zhang, L; Gutknecht, L; Lesch, KP; Li, H; Ding, YQ				Song, Ning-Ning; Xiu, Jian-Bo; Huang, Ying; Chen, Jia-Yin; Zhang, Lei; Gutknecht, Lise; Lesch, Klaus Peter; Li, He; Ding, Yu-Qiang			Adult Raphe-Specific Deletion of Lmx1b Leads to Central Serotonin Deficiency	PLOS ONE			English	Article							MOLECULAR-GENETICS; SONIC HEDGEHOG; NEURONS; MICE; BRAIN; EXPRESSION; SYSTEM; PET-1; TRANSPORTER; DISORDERS	The transcription factor Lmx1b is essential for the differentiation and survival of central serotonergic (5-HTergic) neurons during embryonic development. However, the role of Lmx1b in adult 5-HTergic neurons is unknown. We used an inducible Cre-LoxP system to selectively inactivate Lmx1b expression in the raphe nuclei of adult mice. Pet1-CreER(T2) mice were generated and crossed with Lmx1b(flox/flox) mice to obtain Pet1-CreER(T2); Lmx1b(flox/flox) mice (which termed as Lmx1b iCKO). After administration of tamoxifen, the level of 5-HT in the brain of Lmx1b iCKO mice was reduced to 60% of that in control mice, and the expression of tryptophan hydroxylase 2 (Tph2), serotonin transporter (Sert) and vesicular monoamine transporter 2 (Vmat2) was greatly down-regulated. On the other hand, the expression of dopamine and norepinephrine as well as aromatic L-amino acid decarboxylase (Aadc) and Pet1 was unchanged. Our results reveal that Lmx1b is required for the biosynthesis of 5-HT in adult mouse brain, and it may be involved in maintaining normal functions of central 5-HTergic neurons by regulating the expression of Tph2, Sert and Vmat2.	[Song, Ning-Ning; Xiu, Jian-Bo; Huang, Ying; Chen, Jia-Yin; Zhang, Lei; Ding, Yu-Qiang] Tongji Univ, Dept Anat & Neurobiol, Sch Med, Shanghai 200092, Peoples R China; [Gutknecht, Lise; Lesch, Klaus Peter] Univ Wurzburg, Dept Psychiat & Psychotherapy, Wurzburg, Germany; [Li, He] Huazhong Univ Sci & Technol, Key Lab Nervous Syst Dis, Minist Educ China, Div Histol & Embryol,Dept Anat,Tongji Med Coll, Wuhan 430074, Peoples R China	Tongji University; University of Wurzburg; Huazhong University of Science & Technology; Ministry of Education, China	Song, NN (corresponding author), Tongji Univ, Dept Anat & Neurobiol, Sch Med, Shanghai 200092, Peoples R China.	songnn1982@gmail.com; dingyuqiang@gmail.com	Lesch, Klaus-Peter/J-4906-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Ding, Yu-Qiang/0000-0003-1202-4635; Song, Ning-Ning/0000-0001-5206-1911; Zhang, Lei/0000-0001-7242-5292	National Natural Science Foundation of China [30430260]; Ministry of Science and Technology of China [2006CB943903, 2007CB512303, 2009ZX09501-030]; Deutsche Forschungsgemeinschaft [KFO 125, SFB 581, SFB TRR 58]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the National Natural Science Foundation of China (30430260), the Ministry of Science and Technology of China (2006CB943903, 2007CB512303, 2009ZX09501-030) and the Deutsche Forschungsgemeinschaft (KFO 125, SFB 581, SFB TRR 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DM, 1982, J COMP NEUROL, V212, P173, DOI 10.1002/cne.902120207; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cheng LP, 2003, J NEUROSCI, V23, P9961; COPPEN ALEC, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Koed K, 2000, EUR NEUROPSYCHOPHARM, V10, P501, DOI 10.1016/S0924-977X(00)00121-8; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Middlemiss DN, 2002, CURR OPIN PHARMACOL, V2, P18, DOI 10.1016/S1471-4892(01)00116-3; Naughton M, 2000, HUM PSYCHOPHARM CLIN, V15, P397, DOI 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.3.CO;2-C; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van Doorninck J H, 1999, J Neurosci, V19, pRC12; Yan W, 1997, DEV BRAIN RES, V98, P185, DOI 10.1016/S0165-3806(96)00175-7; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	34	58	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15998	10.1371/journal.pone.0015998	http://dx.doi.org/10.1371/journal.pone.0015998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246047	Green Published, gold			2022-12-25	WOS:000286511200031
J	Woltman, AM; den Brouw, MLO; Biesta, PJ; Shi, CC; Janssen, HLA				Woltman, Andrea M.; den Brouw, Marjoleine L. Op; Biesta, Paula J.; Shi, Cui C.; Janssen, Harry L. A.			Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function	PLOS ONE			English	Article							IFN-ALPHA PRODUCTION; NONPARENCHYMAL LIVER-CELLS; C VIRUS; VIRAL-INFECTION; GENE-EXPRESSION; NATURAL-KILLER; I INTERFERON; RECEPTOR; HBV; IMMUNOLOGY	Chronic hepatitis B virus (HBV) infection is caused by inadequate anti-viral immunity. Activation of plasmacytoid dendritic cells (pDC) leading to IFN alpha production is important for effective anti-viral immunity. Hepatitis B virus (HBV) infection lacks IFN alpha induction in animal models and patients and chronic HBV patients display impaired IFN alpha production by pDC. Therefore, HBV and HBV-derived proteins were examined for their effect on human pDC in vitro. In addition, the in vitro findings were compared to the function of pDC derived from chronic HBV patients ex vivo. In contrast to other viruses, HBV did not activate pDC. Moreover, HBV and HBsAg abrogated CpG-A/TLR9-induced, but not Loxoribine/TLR7-induced, mTOR-mediated S6 phosphorylation, subsequent IRF7 phosphorylation and IFN alpha gene transcription. HBV/HBsAg also diminished upregulation of co-stimulatory molecules, production of TNF alpha, IP-10 and IL-6 and pDC-induced NK cell function, whereas TLR7-induced pDC function was hardly affected. In line, HBsAg preferentially bound to TLR9-triggered pDC demonstrating that once pDC are able to bind HBV/HBsAg, the virus exerts its immune regulatory effect. HBV not only directly interfered with pDC function, but also indirectly by interfering with monocyte-pDC interaction. Also HBeAg diminished pDC function to a certain extent, but via another unknown mechanism. Interestingly, patients with HBeAg-positive chronic hepatitis B displayed impaired CpG-induced IFN alpha production by pDC without significant alterations in Loxoribine-induced pDC function compared to HBeAg-negative patients and healthy controls. The lack of activation and the active inhibition of pDC by HBV may both contribute to HBV persistence. The finding that the interaction between pDC and HBV may change upon activation may aid in the identification of a scavenging receptor supporting immunosuppressive effects of HBV and also in the design of novel treatment strategies for chronic HBV.	[Woltman, Andrea M.; den Brouw, Marjoleine L. Op; Biesta, Paula J.; Shi, Cui C.; Janssen, Harry L. A.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Shi, Cui C.] Rujin Hosp, Dept Infect Dis, Shanghai, Peoples R China	Erasmus University Rotterdam; Erasmus MC	Woltman, AM (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	a.woltman@erasmusmc.nl	Woltman, Andrea/GYV-2656-2022	Woltman, Andrea/0000-0001-9904-6751	Netherlands Organisation for Scientific Research (NWO) [Veni 916.66.015, Vidi 917.59.329]; China Scholarship Council	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); China Scholarship Council(China Scholarship Council)	This study was supported by grants from the Netherlands Organisation for Scientific Research (NWO) to AW (Veni 916.66.015) and HJ (Vidi 917.59.329) and China Scholarship Council to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Della Chiesa M, 2005, TRENDS MICROBIOL, V13, P128, DOI 10.1016/j.tim.2005.01.006; Della Chiesa M, 2006, BLOOD, V108, P3851, DOI 10.1182/blood-2006-02-004028; den Brouw MLO, 2008, J VIRAL HEPATITIS, V15, P675, DOI 10.1111/j.1365-2893.2008.00993.x; den Brouw MLO, 2009, VIROLOGY, V393, P84, DOI 10.1016/j.virol.2009.07.015; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fanning SL, 2006, J IMMUNOL, V177, P5829, DOI 10.4049/jimmunol.177.9.5829; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Liu BS, 2009, J LEUKOCYTE BIOL, V85, P205, DOI 10.1189/jlb.0408241; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tavakoli S, 2008, CLIN EXP IMMUNOL, V151, P61, DOI 10.1111/j.1365-2249.2007.03547.x; TJWA ETT, J HEPATOL IN PRESS; van der Molen RG, 2006, HEPATOLOGY, V44, P907, DOI 10.1002/hep.21340; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; Vanlandschoot P, 2002, J GEN VIROL, V83, P1281, DOI 10.1099/0022-1317-83-6-1281; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Woltman AM, 2010, GUT, V59, P115, DOI 10.1136/gut.2009.181040; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xie Q, 2009, MICROBES INFECT, V11, P515, DOI 10.1016/j.micinf.2009.02.008; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	39	109	141	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15324	10.1371/journal.pone.0015324	http://dx.doi.org/10.1371/journal.pone.0015324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246041	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200007
J	MacTavish, H; Diallo, JS; Huang, BC; Stanford, M; Le Boeuf, F; De Silva, N; Cox, J; Simmons, JG; Guimond, T; Falls, T; McCart, AJ; Atkins, H; Breitbach, C; Kirn, D; Thorne, S; Bell, JC				MacTavish, Heather; Diallo, Jean-Simon; Huang, Baocheng; Stanford, Marianne; Le Boeuf, Fabrice; De Silva, Naomi; Cox, Julie; Simmons, John Graydon; Guimond, Tanya; Falls, Theresa; McCart, Andrea J.; Atkins, Harry; Breitbach, Caroline; Kirn, David; Thorne, Stephen; Bell, John C.			Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors	PLOS ONE			English	Article							INNATE ANTIVIRAL RESPONSE; TUMOR-SPECIFIC DEFECTS; T-CELL LYMPHOMA; TRICHOSTATIN-A; GENE-EXPRESSION; IN-VITRO; CANCER; PROTEIN; AGENTS; POXVIRUS	Histone deacetylase inhibitors (HDI) dampen cellular innate immune response by decreasing interferon production and have been shown to increase the growth of vesicular stomatitis virus and HSV. As attenuated tumour-selective oncolytic vaccinia viruses (VV) are already undergoing clinical evaluation, the goal of this study is to determine whether HDI can also enhance the potency of these poxviruses in infection-resistant cancer cell lines. Multiple HDIs were tested and Trichostatin A (TSA) was found to potently enhance the spread and replication of a tumour selective vaccinia virus in several infection-resistant cancer cell lines. TSA significantly decreased the number of lung metastases in a syngeneic B16F10LacZ lung metastasis model yet did not increase the replication of vaccinia in normal tissues. The combination of TSA and VV increased survival of mice harbouring human HCT116 colon tumour xenografts as compared to mice treated with either agent alone. We conclude that TSA can selectively and effectively enhance the replication and spread of oncolytic vaccinia virus in cancer cells.	[MacTavish, Heather; Diallo, Jean-Simon; Stanford, Marianne; Le Boeuf, Fabrice; De Silva, Naomi; Cox, Julie; Simmons, John Graydon; Guimond, Tanya; Falls, Theresa; Atkins, Harry; Bell, John C.] Ottawa Hosp, Ctr Canc Therapeut, Res Inst, Ottawa, ON, Canada; [MacTavish, Heather; Diallo, Jean-Simon; Stanford, Marianne; Le Boeuf, Fabrice; De Silva, Naomi; Cox, Julie; Simmons, John Graydon; Atkins, Harry; Bell, John C.] Univ Ottawa, Ottawa, ON, Canada; [Huang, Baocheng; Thorne, Stephen] Univ Pittsburgh, Dept Surg, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Huang, Baocheng; Thorne, Stephen] Univ Pittsburgh, Dept Immunol, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Breitbach, Caroline; Kirn, David; Thorne, Stephen; Bell, John C.] Jennerex Biotherapeut Ltd, San Francisco, CA USA; [McCart, Andrea J.] Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	MacTavish, H (corresponding author), Ottawa Hosp, Ctr Canc Therapeut, Res Inst, Ottawa, ON, Canada.	jbell@ohri.ca	Falls, Theresa/GWZ-9829-2022; Diallo, Jean-Simon/G-4465-2017	Falls, Theresa/0000-0001-5995-9118; Diallo, Jean-Simon/0000-0002-4862-2795; Stanford, Marianne/0000-0003-0432-3707	Terry Fox Foundation; Ottawa Regional Cancer Foundation; FRSQ; CIHR; OGSST; Ontario Institute for Cancer Research; Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ)	Terry Fox Foundation; Ottawa Regional Cancer Foundation; FRSQ(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR)); OGSST; Ontario Institute for Cancer Research; Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This study was supported by grants to JB and HA from the Terry Fox Foundation and the Ottawa Regional Cancer Foundation; JSD is a recipient of an FRSQ post-doctoral fellowship. FB is a recipient of a CIHR post-doctoral fellowship. HM is supported by an OGSST studentship. JB is supported by the Ontario Institute for Cancer Research. JB, DK, ST, and CB are affiliated with or employed by Jennerex Biotherapeutics. With the exception of JB and ST who are affiliated with Jennerex Biotherapeutics, the funders had no role in study design, data collection and analysis, or decision to publish.; We would like to thank Dr. Anne-Marie Mes-Masson for kindly providing the normal ovarian cell lines. To this end, tumor banking was supported by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec (FRSQ), affiliated to the Canadian Tumor Repository Network (CTRNet). We would also like to thank Dominique Vaillant and Stefanie Reid for their technical assistance.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Arsenio J, 2008, VIROLOGY, V377, P124, DOI 10.1016/j.virol.2008.04.014; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; CHOU TC, 1977, J BIOL CHEM, V252, P6438; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Diallo JS, 2010, MOL THER, V18, P1123, DOI 10.1038/mt.2010.67; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Genin P, 2003, J VIROL, V77, P7113, DOI 10.1128/JVI.77.12.7113-7119.2003; Kirn DH, 2007, PLOS MED, V4, P2001, DOI 10.1371/journal.pmed.0040353; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Kirstein JM, 2009, CLIN EXP METASTAS, V26, P121, DOI 10.1007/s10585-008-9221-z; Liu TC, 2008, MOL THER, V16, P1637, DOI 10.1038/mt.2008.143; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; McCart JA, 2001, CANCER RES, V61, P8751; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moreira JMA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-30; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015; Stanford MM, 2008, MOL THER, V16, P52, DOI 10.1038/sj.mt.6300348; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vlasakova J, 2007, BLOOD, V109, P1373, DOI 10.1182/blood-2006-02-003418; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; XU B, 1994, BLOOD, V84, P1942; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang ZN, 2005, ANN NY ACAD SCI, V1056, P69, DOI 10.1196/annals.1352.005	43	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e14462	10.1371/journal.pone.0014462	http://dx.doi.org/10.1371/journal.pone.0014462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21283510	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000285793600005
J	Crescenzi, E; Pacifico, F; Lavorgna, A; De Palma, R; D'Aiuto, E; Palumbo, G; Formisano, S; Leonardi, A				Crescenzi, E.; Pacifico, F.; Lavorgna, A.; De Palma, R.; D'Aiuto, E.; Palumbo, G.; Formisano, S.; Leonardi, A.			NF-kappa B-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells	ONCOGENE			English	Article						premature senescence; NF-kappa B; apoptosis; Fas; senescence-associated secretory phenotype	ONCOGENE-INDUCED SENESCENCE; IMMUNE-SYSTEM; DNA-DAMAGE; IN-VIVO; CELLULAR SENESCENCE; MEDIATED APOPTOSIS; CANCER-THERAPY; P53; PHENOTYPE; DEATH	Induction of a senescent phenotype in tumor cells has been linked to anticancer immune response, however, the molecular mechanisms mediating these phenomenon have not yet been determined. In this study, we present evidence that induction of premature senescence in human cancer cell lines induces Fas expression, and loss of resistance to Fas-induced apoptosis. Triggering of Fas by using the agonistic antibody CH11 or the recombinant ligand APO010, activates an apoptotic pathway responsible for cell death. Secretion of pro-inflammatory cytokines by the senescent cells, particularly TNF-alpha and IFN-gamma, mediates Fas upregulation. Indeed, treatment of proliferating cancer cell lines with TNF-alpha and IFN-gamma, upregulates Fas expression, while blocking TNF-alpha and IFN-gamma by using neutralizing antibodies, decreases Fas expression in senescent cells. We also demonstrate that NF-kappa B has a central role in controlling the senescence-associated secretory phenotype (SASP) by the premature senescent cells, and that TNF-alpha and IFN-gamma, transcriptionally controlled by NF-kappa B, are the main mediators of Fas upregulation. Our data suggest the existence of an NF-kappa B- dependent autocrine loop, mediated by TNF-alpha and IFN-gamma, responsible for expression of Fas on the surface of senescent cells, and for their killing. Oncogene (2011) 30, 2707-2717; doi: 10.1038/onc.2011.1; published online 31 January 2011	[Lavorgna, A.; Palumbo, G.; Formisano, S.; Leonardi, A.] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Crescenzi, E.; Pacifico, F.] Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [De Palma, R.; D'Aiuto, E.] Univ Naples 2, Dipartimento Internist Clin & Sperimentale, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Universita della Campania Vanvitelli	Leonardi, A (corresponding author), Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.	leonardi@unina.it	Pacifico, Francesco/AAX-3958-2020; leonardi, antonio/A-2887-2009; Lavorgna, Alfonso/A-5357-2012; Palumbo, Giuseppe/N-3136-2016	Pacifico, Francesco/0000-0001-9563-3596; leonardi, antonio/0000-0001-8636-9623; Palumbo, Giuseppe/0000-0001-9380-8436; CRESCENZI, ELVIRA/0000-0002-9258-8053; De Palma, Raffaele/0000-0001-9070-8878	MIUR [2008CCPKRP, 2007WJZZR2]	MIUR(Ministry of Education, Universities and Research (MIUR))	MIUR # 2008CCPKRP to AL; MIUR # 2007WJZZR2 to GP	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Chang BD, 1999, CANCER RES, V59, P3761; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fluhr H, 2007, J CELL SCI, V120, P4126, DOI 10.1242/jcs.009761; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gasser S, 2006, CANCER RES, V66, P3959, DOI 10.1158/0008-5472.CAN-05-4603; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Houston A, 2004, CURR OPIN PHARMACOL, V4, P321, DOI 10.1016/j.coph.2004.03.008; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kimura M, 2003, CELL DEATH DIFFER, V10, P718, DOI 10.1038/sj.cdd.4401219; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Mirzayans R, 2005, RADIAT RES, V163, P53, DOI 10.1667/RR3280; NAUMANN M, 1993, ONCOGENE, V8, P2275; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Ouaaz F, 1999, J EXP MED, V189, P999, DOI 10.1084/jem.189.6.999; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; te Poele RH, 2002, CANCER RES, V62, P1876; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verbrugge I, 2009, CLIN CANCER RES, V15, P2031, DOI 10.1158/1078-0432.CCR-08-2125; WAJAPEYEE N, 2008, CELL, V133, P1006; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	39	49	51	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	24					2707	2717		10.1038/onc.2011.1	http://dx.doi.org/10.1038/onc.2011.1			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21278794				2022-12-25	WOS:000291678500002
J	Yim, PD; Gallos, G; Xu, DB; Zhang, Y; Emala, CW				Yim, Peter D.; Gallos, George; Xu, Dingbang; Zhang, Yi; Emala, Charles W.			Novel expression of a functional glycine receptor chloride channel that attenuates contraction in airway smooth muscle	FASEB JOURNAL			English	Article						membrane potential; isoproterenol; organ bath; guinea pig; FLIPR	PHYSIOLOGICAL ROLES; RELAXATION; ACTIVATION; MECHANISMS; RELEASE	Airway smooth muscle (ASM) contraction is an important component of the pathophysiology of asthma. Taurine, an agonist of glycine receptor chloride (GlyR Cl(-)) channels, was found to relax contracted ASM, which led us to question whether functional GlyR Cl(-) channels are expressed in ASM. Messenger RNA for beta (GLRB), alpha 1 (GLRA1), alpha 2 (GLRA2), and alpha 4 (GLRA4) subunits were found in human (Homo sapiens) and guinea pig (Cavia porcellus) tracheal smooth muscle. Immunoblotting confirmed the protein expression of GLRA1 and GLRB subunits in ASM. Electrical activity of cultured human ASM cells was assessed using a fluorescent potentiometric dye and electrophysiological recordings. Glycine increased current and significantly increased fluorescence in a dose-dependent manner. The GlyR Cl(-) channel antagonist strychnine significantly blocked the effects of glycine on potentiometric fluorescence in ASM cells. Guinea pig airway ring relaxation of ACh-induced contractions by isoproterenol was significantly left-shifted in the presence of glycine. This effect of glycine was blocked by pretreatment with the GlyR Cl(-) channel antagonist strychnine. Glycine treatment during tachykinin- and acetylcholine-induced contractions significantly decreased the maintenance of muscle force compared to control. GlyR Cl(-) channels are expressed on ASM and regulate smooth muscle force and offer a novel target for therapeutic relaxation of ASM.-Yim, P. D., Gallos, G., Xu, D., Zhang, Y., Emala, C. W. Novel expression of a functional glycine receptor chloride channel that attenuates contraction in airway smooth muscle. FASEB J. 25, 1706-1717 (2011). www.fasebj.org	[Yim, Peter D.; Gallos, George; Xu, Dingbang; Zhang, Yi; Emala, Charles W.] Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Yim, PD (corresponding author), Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, 650 168th St,Rm 713, New York, NY 10032 USA.	pdy1@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008464] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMED T, 1988, J ALLERGY CLIN IMMUN, V81, P133, DOI 10.1016/0091-6749(88)90232-1; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; DENEYNDEN JV, 2009, FRONT MOL NEUROSCI, V2, P9; Elster L, 1998, NEUROSCIENCE, V84, P519, DOI 10.1016/S0306-4522(97)00535-6; Froh M, 2002, AM J PHYSIOL-GASTR L, V283, pG856, DOI 10.1152/ajpgi.00503.2001; Gallos G, 2008, AM J PHYSIOL-LUNG C, V295, pL1040, DOI 10.1152/ajplung.90330.2008; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Imtiaz MS, 2010, FEBS J, V277, P278, DOI 10.1111/j.1742-4658.2009.07437.x; Janssen LJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1757, DOI 10.1152/ajpcell.1997.272.6.C1757; Janssen LJ, 2004, AM J PHYSIOL-LUNG C, V287, pL852, DOI 10.1152/ajplung.00130.2004; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; Jensen AA, 2005, EUR J PHARMACOL, V521, P39, DOI 10.1016/j.ejphar.2005.08.002; Jooste E, 2005, ANESTHESIOLOGY, V102, P117, DOI 10.1097/00000542-200501000-00020; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; Liu QH, 2009, P NATL ACAD SCI USA, V106, P11418, DOI 10.1073/pnas.0813307106; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Michoud MC, 2009, AM J RESP CELL MOL, V40, P217, DOI 10.1165/rcmb.2006-0444OC; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Sahan-Firat S, 2005, EUR J PHARMACOL, V528, P169, DOI 10.1016/j.ejphar.2005.10.055; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Wang YX, 1997, AM J PHYSIOL-CELL PH, V273, pC509, DOI 10.1152/ajpcell.1997.273.2.C509; Wijesinghe M, 2009, EUR RESPIR J, V34, P803, DOI 10.1183/09031936.00159708	27	23	24	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1706	1717		10.1096/fj.10-170530	http://dx.doi.org/10.1096/fj.10-170530			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21282206	Green Published			2022-12-25	WOS:000290023800026
J	Hoeppner, LH; Secreto, FJ; Razidlo, DF; Whitney, TJ; Westendorf, JJ				Hoeppner, Luke H.; Secreto, Frank J.; Razidlo, David F.; Whitney, Tiffany J.; Westendorf, Jennifer J.			Lef1 Delta N Binds beta-Catenin and Increases Osteoblast Activity and Trabecular Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER FACTOR-I; MESENCHYMAL STEM-CELLS; COLON-CANCER; DIFFERENTIATED OSTEOBLASTS; OSTEOGENIC DIFFERENTIATION; EXPRESSION; LEF1; PROMOTER; TRANSCRIPTION; ACTIVATION	Lymphoid enhancer-binding factor (Lef) 1 is a high mobility group protein best known as a Wnt-responsive transcription factor that associates with beta-catenin. Lef1 Delta N is a short isoform of Lef1 that lacks the first 113 amino acids and a well characterized high affinity beta-catenin binding domain present in the full-length protein. Both Lef1 isoforms bind DNA and regulate gene expression. We previously reported that Lef1 is expressed in proliferating osteoblasts and blocks osteocalcin expression. In contrast, Lef1 Delta N is only detectable in the later stages of osteoblast differentiation and promotes osteogenesis in vitro. Here, we show that Lef1 Delta N retains the ability to interact physically and functionally with beta-catenin. Unlike what has been reported in T cells and colon cancer cell lines, Lef1 Delta N activated gene transcription in the absence of exogenous beta-catenin and cooperated with constitutively active beta-catenin to stimulate gene transcription in mesenchymal and osteoblastic cells. Residues at the N terminus of Lef1 Delta N were required for beta-catenin binding and the expression of osteoblast differentiation genes. To determine the role of Lef1 Delta N on bone formation in vivo, a Lef1 Delta N transgene was expressed in committed osteoblasts using the 2.3-kb fragment of the type 1 collagen promoter. The Lef1 Delta N transgenic mice had higher trabecular bone volume in the proximal tibias and L5 vertebrae. Histological analyses of tibial sections revealed no differences in osteoblast, osteoid, or osteoclast surface areas. However, bone formation and mineral apposition rates as well as osteocalcin levels were increased in Lef1 Delta N transgenic mice. Together, our data indicate that Lef1 Delta N binds beta-catenin, stimulates Lef/Tcf reporter activity, and promotes terminal osteoblast differentiation.	[Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		Hoeppner, Luke/0000-0003-3948-4244	National Institutes of Health [AR050074, AR048147-S1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050074, R01AR048147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050074 and AR048147-S1.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Atcha FA, 2003, J BIOL CHEM, V278, P16169, DOI 10.1074/jbc.M213218200; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeppner LH, 2009, J CELL PHYSIOL, V221, P480, DOI 10.1002/jcp.21879; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Mariadason JM, 2001, CANCER RES, V61, P3465; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Niemann C, 2002, DEVELOPMENT, V129, P95; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; OOSTERWEGEL M, 1993, THYMUS, V22, P67; Secreto Frank J, 2009, Curr Osteoporos Rep, V7, P64; Shibamoto S, 2004, EXP CELL RES, V292, P11, DOI 10.1016/j.yexcr.2003.08.009; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Smith E, 2005, J BIOL CHEM, V280, P2388, DOI 10.1074/jbc.M406294200; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang WB, 2005, ACTA BIOCH BIOPH SIN, V37, P173, DOI 10.1111/j.1745-7270.2005.00023.x; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	46	24	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10950	10959		10.1074/jbc.M110.165100	http://dx.doi.org/10.1074/jbc.M110.165100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270130	Green Published, hybrid			2022-12-25	WOS:000288797100007
J	Hu, X; Kim, JA; Castillo, A; Huang, M; Liu, JX; Wang, B				Hu, Xin; Kim, Jin Ah; Castillo, Andy; Huang, Michael; Liu, Jianxin; Wang, Bin			NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; BRCA1; CANCER; BRCC36; UBIQUITINATION; SUSCEPTIBILITY; RECOGNITION; DEGRADATION; PARTNERS; DOMAIN	BRCC36-deubiquitinating enzyme (DUB) forms two different complexes through interactions with two different adaptor proteins Abraxas and ABRO1 in cells. Abraxas mainly localizes in the nucleus, mediating the interaction of BRCC36 with BRCA1. ABRO1 is mainly localized in the cytoplasm. Because it lacks the BRCA1-interacting motif, the ABRO1 complex does not interact with BRCA1. Both BRCC36-containing complexes contain common components including BRE and NBA1/MERIT40. Here, we found that the two complexes are assembled in a similar manner and NBA1 and BRE interaction is critical for maintaining the integrity of both of the complexes. Knockdown of NBA1 or BRE leads to decreased levels of components of the two BRCC36-containing complexes. We provided evidence that NBA1 interacts with BRE through a C-terminal conserved motif of the NBA1 protein and a C-terminal UEV domain of the BRE protein. Furthermore, the NBA1-BRE interaction is required for cellular resistance to ionizing irradiation and NBA1's role in recruiting BRCA1 to DNA damage sites. Together, these studies reveal critical interactions required for the formation and function of BRCC36-containing DUB complexes.	[Hu, Xin; Kim, Jin Ah; Castillo, Andy; Liu, Jianxin; Wang, Bin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Bin] Univ Texas Grad Sch Biomed Sci, Genes & Dev Program, Houston, TX 77030 USA; [Huang, Michael] Rice Univ, Houston, TX 77005 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University	Wang, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bwang3@mdanderson.org			National Institutes of Health; NCI [1K01CA116275-01]; Sidney Kimmel Foundation; M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [K01CA116275, R01CA155025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Foundation; M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health, NCI Howard Temin Award (1K01CA116275-01) and a Sidney Kimmel Foundation Scholar Award (to B. W.) and an M.D. Anderson Cancer Center IRG fund.	Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Weger S, 2007, VIROLOGY, V362, P192, DOI 10.1016/j.virol.2006.12.010; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	38	57	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11734	11745		10.1074/jbc.M110.200857	http://dx.doi.org/10.1074/jbc.M110.200857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282113	Green Published, hybrid			2022-12-25	WOS:000288797100081
J	Rickert, KW; Patel, SB; Allison, TJ; Byrne, NJ; Darke, PL; Ford, RE; Guerin, DJ; Hall, DL; Kornienko, M; Lu, J; Munshi, SK; Reid, JC; Shipman, JM; Stanton, EF; Wilson, KJ; Young, JR; Soisson, SM; Lumb, KJ				Rickert, Keith W.; Patel, Sangita B.; Allison, Timothy J.; Byrne, Noel J.; Darke, Paul L.; Ford, Rachael E.; Guerin, David J.; Hall, Dawn L.; Kornienko, Maria; Lu, Jun; Munshi, Sanjeev K.; Reid, John C.; Shipman, Jennifer M.; Stanton, Elizabeth F.; Wilson, Kevin J.; Young, Jonathon R.; Soisson, Stephen M.; Lumb, Kevin J.			Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; CRYSTAL-STRUCTURE; DISCOVERY; MUTATIONS; ALIGNMENT; DESIGN; POTENT	The receptor tyrosine kinase c-Met is implicated in oncogenesis and is the target for several small molecule and biologic agents in clinical trials for the treatment of cancer. Binding of the hepatocyte growth factor to the cell surface receptor of c-Met induces activation via autophosphorylation of the kinase domain. Here we describe the structural basis of c-Met activation upon autophosphorylation and the selective small molecule inhibiton of autophosphorylated c-Met. MK-2461 is a potent c-Met inhibitor that is selective for the phosphorylated state of the enzyme. Compound 1 is an MK-2461 analog with a 20-fold enthalpy-driven preference for the autophosphorylated over unphosphorylated c-Met kinase domain. The crystal structure of the unbound kinase domain phosphorylated at Tyr-1234 and Tyr-1235 shows that activation loop phosphorylation leads to the ejection and disorder of the activation loop and rearrangement of helix alpha C and the G loop to generate a viable active site. Helix alpha C adopts a orientation different from that seen in activation loop mutants. The crystal structure of the complex formed by the autophosphorylated c-Met kinase domain and compound 1 reveals a significant induced fit conformational change of the G loop and ordering of the activation loop, explaining the selectivity of compound 1 for the autophosphorylated state. The results highlight the role of structural plasticity within the kinase domain in imparting the specificity of ligand binding and provide the framework for structure-guided design of activated c-Met inhibitors.	[Rickert, Keith W.; Patel, Sangita B.; Allison, Timothy J.; Byrne, Noel J.; Darke, Paul L.; Ford, Rachael E.; Hall, Dawn L.; Kornienko, Maria; Lu, Jun; Munshi, Sanjeev K.; Reid, John C.; Shipman, Jennifer M.; Soisson, Stephen M.; Lumb, Kevin J.] Merck Res Labs, West Point, PA 19486 USA; [Guerin, David J.; Stanton, Elizabeth F.; Wilson, Kevin J.; Young, Jonathon R.] Merck Res Labs, Dept Chem, Boston, MA 02115 USA	Merck & Company; Merck & Company	Lumb, KJ (corresponding author), Merck Res Labs, 770 Sumneytown Pike, West Point, PA 19486 USA.	kevin.lumb@merck.com		Lumb, Kevin/0000-0003-2778-9956				Albrecht BK, 2008, J MED CHEM, V51, P2879, DOI 10.1021/jm800043g; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boezio AA, 2009, BIOORG MED CHEM LETT, V19, P6307, DOI 10.1016/j.bmcl.2009.09.096; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; D'Angelo ND, 2008, J MED CHEM, V51, P5766, DOI 10.1021/jm8006189; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; Kornienko M, 2005, ASSAY DRUG DEV TECHN, V3, P661, DOI 10.1089/adt.2005.3.661; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishii H, 2010, BIOORG MED CHEM LETT, V20, P1405, DOI 10.1016/j.bmcl.2009.12.109; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Porter J, 2009, BIOORG MED CHEM LETT, V19, P397, DOI 10.1016/j.bmcl.2008.11.062; Porter J, 2009, BIOORG MED CHEM LETT, V19, P2780, DOI 10.1016/j.bmcl.2009.03.110; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	30	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11218	11225		10.1074/jbc.M110.204404	http://dx.doi.org/10.1074/jbc.M110.204404			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21247903	Green Published, hybrid			2022-12-25	WOS:000288797100033
J	Lu, M; Zheng, LL; Han, B; Wang, LL; Wang, P; Liu, H; Sun, XL				Lu, Mei; Zheng, Lanlan; Han, Bo; Wang, Luanluan; Wang, Pin; Liu, Heng; Sun, Xiulian			REST Regulates DYRK1A Transcription in a Negative Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; CELL LUNG-CANCER; DOWN-SYNDROME; TARGET GENES; ALZHEIMER-DISEASE; FUNCTIONAL-LINK; KINASE DYRK1A; EXPRESSION; PROTEIN; REPRESSOR	DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) has been shown to be involved in learning and memory impairments in Alzheimer disease and Down syndrome. As a homolog of Drosophila minibrain gene, DYRK1A also plays important roles in neurodevelopment; however, the function and regulatory mechanism of DYRK1A in neurodevelopment remain elusive. REST (RE1 silencing transcription factor) plays vital roles in neuronal differentiation. Here, we found that REST can activate DYRK1A transcription via a neuron-restrictive silencer element at bp -833 to -815 of human DYRK1A promoter. The coordinated expression of DYRK1A and REST in mouse brain further supports the cross-interaction of DYRK1A and REST during neurodevelopment. Moreover, we showed that DYRK1A dosage imbalance reduced REST protein stability and transcriptional activity through facilitating ubiquitination and subsequent degradation of REST protein. Therefore, the regulation of DYRK1A by REST in a negative feedback loop suggests that DYRK1A and REST are closely related in neurodevelopment.	[Lu, Mei; Zheng, Lanlan; Han, Bo; Wang, Luanluan; Wang, Pin; Liu, Heng; Sun, Xiulian] Shandong Univ, Qilu Hosp, Otolaryngol Lab, Jinan 250012, Shandong, Peoples R China; [Lu, Mei] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Shandong, Peoples R China; [Han, Bo] Chinese Acad Sci, Qingdao Inst Bioenegry & Bioproc Technol, Qingdao 266101, Peoples R China; [Liu, Heng] Shandong Univ Tradit Chinese Med, Inst Tradit Chinese Med Theory, Jinan 250014, Peoples R China	Shandong University; Shandong University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Shandong University of Traditional Chinese Medicine	Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Otolaryngol Lab, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	xiulians@gmail.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coulson JM, 2000, CANCER RES, V60, P1840; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hara D, 2009, BIOCHEM BIOPH RES CO, V384, P506, DOI 10.1016/j.bbrc.2009.05.007; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lepagnol-Bestel AM, 2009, HUM MOL GENET, V18, P1405, DOI 10.1093/hmg/ddp047; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Maenz B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-30; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Okui M, 1999, GENOMICS, V62, P165, DOI 10.1006/geno.1999.5998; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780	38	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10755	10763		10.1074/jbc.M110.174540	http://dx.doi.org/10.1074/jbc.M110.174540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252229	Green Published, hybrid			2022-12-25	WOS:000288547000089
J	Lyukmanova, EN; Shenkarev, ZO; Shulepko, MA; Mineev, KS; D'Hoedt, D; Kasheverov, IE; Filkin, SY; Krivolapova, AP; Janickova, H; Dolezal, V; Dolgikh, DA; Arseniev, AS; Bertrand, D; Tsetlin, VI; Kirpichnikov, MP				Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Mineev, Konstantin S.; D'Hoedt, Dieter; Kasheverov, Igor E.; Filkin, Sergey Yu.; Krivolapova, Alexandra P.; Janickova, Helena; Dolezal, Vladimir; Dolgikh, Dmitry A.; Arseniev, Alexander S.; Bertrand, Daniel; Tsetlin, Victor I.; Kirpichnikov, Mikhail P.			NMR Structure and Action on Nicotinic Acetylcholine Receptors of Water-soluble Domain of Human LYNX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-NEUROTOXINS; CRYSTAL-STRUCTURE; WEAK TOXIN; FUNCTIONAL-PROPERTIES; PROTOTOXIN LYNX1; VENOM INTERACTS; NAJA-KAOUTHIA; IN-VIVO; SNAKE; BINDING	Discovery of proteins expressed in the central nervous system sharing the three-finger structure with snake alpha-neurotoxins provoked much interest to their role in brain functions. Prototoxin LYNX1, having homology both to Ly6 proteins and three-finger neurotoxins, is the first identified member of this family membrane-tethered by a GPI anchor, which considerably complicates in vitro studies. We report for the first time the NMR spatial structure for the water-soluble domain of human LYNX1 lacking a GPI anchor (ws-LYNX1) and its concentration-dependent activity on nicotinic acetylcholine receptors (nAChRs). At 5-30 mu M, ws-LYNX1 competed with I-125-alpha-bungarotoxin for binding to the acetylcholine-binding proteins (AChBPs) and to Torpedo nAChR. Exposure of Xenopus oocytes expressing alpha 7 nAChRs to 1 mu M ws-LYNX1 enhanced the response to acetylcholine, but no effect was detected on alpha 4 beta 2 and alpha 3 beta 2 nAChRs. Increasing ws-LYNX1 concentration to 10 mu M caused a modest inhibition of these three nAChR subtypes. A common feature for ws-LYNX1 and LYNX1 is a decrease of nAChR sensitivity to high concentrations of acetylcholine. NMR and functional analysis both demonstrate that ws-LYNX1 is an appropriate model to shed light on the mechanism of LYNX1 action. Computer modeling, based on ws-LYNX1 NMR structure and AChBP x-ray structure, revealed a possible mode of ws-LYNX1 binding.	[Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Mineev, Konstantin S.; Kasheverov, Igor E.; Filkin, Sergey Yu.; Krivolapova, Alexandra P.; Dolgikh, Dmitry A.; Arseniev, Alexander S.; Tsetlin, Victor I.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [D'Hoedt, Dieter; Bertrand, Daniel] Ctr Med Univ Geneva, Dept Neurosci, CH-1211 Geneva 4, Switzerland; [Janickova, Helena; Dolezal, Vladimir] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Geneva; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Lomonosov Moscow State University	Tsetlin, VI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya Str, Moscow 117997, Russia.	vits@mx.ibch.ru	Lyukmanova, Ekaterina/F-2340-2014; Shulepko, Mikhail/N-9124-2016; Dolezal, Vladimir/A-8732-2008; Tsetlin, Victor/X-2491-2018; Dolgikh, Dmitry A/F-2369-2014; Luginina, Aleksandra/AAO-3695-2020; Janickova, Helena/Q-7211-2017; Janickova, Helena/G-7748-2014; Mineev, Konstantin/E-4151-2010; Mineev, Konstantin/AAC-6662-2019; Mineev, Konstantin S/Q-3948-2018; Shenkarev, Zakhar O./P-1808-2015; Kasheverov, Igor E/F-6024-2014; Filkin, Sergey/B-9991-2016	Lyukmanova, Ekaterina/0000-0002-9728-9407; Dolezal, Vladimir/0000-0003-3412-256X; Luginina, Aleksandra/0000-0003-2697-456X; Janickova, Helena/0000-0003-0310-7893; Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin S/0000-0002-2418-9421; Shenkarev, Zakhar O./0000-0003-1383-3522; Shulepko, Mikhail/0000-0002-0436-2127; Kirpichnikov, Mikhail/0000-0001-8170-1607; Dolgikh, Dmitry/0000-0002-9880-7202; Filkin, Sergey/0000-0002-4710-6051	Russian Academy of Sciences; Russian Foundation for Basic Research (RFBR) [08-04-01603, 09-04-01567]; RFBR-NWO (Netherlands Organization for Scientific Research) [06-04-89400]; FP7 Grant; Institute of Physiology [AV0Z50110509]; Agency of the Czech Republic [305/09/0681]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); RFBR-NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); FP7 Grant; Institute of Physiology; Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by grants from the Russian Academy of Sciences "Molecular and Cellular Biology," Russian Foundation for Basic Research (RFBR) Grants 08-04-01603 and 09-04-01567, RFBR-NWO (Netherlands Organization for Scientific Research) Grant 06-04-89400, and FP7 Grant "Neurocypres."; Supported by Project AV0Z50110509 of the Institute of Physiology and Agency of the Czech Republic Grant 305/09/0681.	Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; ARSENIEV AS, 1984, FEBS LETT, V165, P57, DOI 10.1016/0014-5793(84)80014-9; BAX A, 1994, METHOD ENZYMOL, V239, P79; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Leath KJ, 2007, ACTA CRYSTALLOGR F, V63, P648, DOI 10.1107/S1744309107033477; Liu ZW, 2009, J NEUROCHEM, V110, P1707, DOI 10.1111/j.1471-4159.2009.06274.x; Lomholt AF, 2009, BRIT J CANCER, V101, P992, DOI 10.1038/sj.bjc.6605228; Lyukmanova EN, 2010, RUSS J BIOORG CHEM+, V36, P137, DOI 10.1134/S1068162010020019; Lyukmanova EN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1142, DOI 10.1134/S0006297909100101; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2004, RUSS J BIOORG CHEM+, V30, P25, DOI 10.1023/B:RUBI.0000015770.38602.e3; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Mordvitsev DY, 2007, COMPUT BIOL CHEM, V31, P72, DOI 10.1016/j.compbiolchem.2007.02.011; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Nastopoulos V, 1998, ACTA CRYSTALLOGR D, V54, P964, DOI 10.1107/S0907444998005125; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; PILLET L, 1993, J BIOL CHEM, V268, P909; Rasch MG, 2008, FRONT BIOSCI-LANDMRK, V13, P6752, DOI 10.2741/3186; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Wuthrich K, 1986, NMR PROTEINS NUCL AC	48	67	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10618	10627		10.1074/jbc.M110.189100	http://dx.doi.org/10.1074/jbc.M110.189100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252236	Green Published, hybrid			2022-12-25	WOS:000288547000076
J	Torres, J; Funk, HM; Zegers, MMP; ter Beest, MBA				Torres, Jacqueline; Funk, Holly M.; Zegers, Mirjam M. P.; ter Beest, Martin B. A.			The Syntaxin 4 N Terminus Regulates Its Basolateral Targeting by Munc18c-dependent and -independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; CANINE KIDNEY-CELLS; PLASMA-MEMBRANE; MDCK CELLS; SURFACE POLARITY; ADAPTER COMPLEX; EXCHANGE FACTOR; TIGHT JUNCTION; PROTEINS; SNARE	To generate and maintain epithelial cell polarity, specific sorting of proteins into vesicles destined for the apical and basolateral domain is required. Syntaxin 3 and 4 are apical and basolateral SNARE proteins important for the specificity of vesicle fusion at the apical and basolateral plasma membrane domains, respectively, but how these proteins are specifically targeted to these domains themselves is unclear. Munc18/SM proteins are potential regulators of this process. Like syntaxins, they are crucial for exocytosis and vesicle fusion. However, how munc18c and syntaxin 4 regulate the function of each other is unclear. Here, we investigated the requirement of syntaxin 4 in the delivery of basolateral membrane and secretory proteins, the basolateral targeting of syntaxin 4, and the role of munc18c in this targeting. Depletion of syntaxin 4 resulted in significant reduction of basolateral targeting, suggesting no compensation by other syntaxin forms. Mutational analysis identified amino acids Leu-25 and to a lesser extent Val-26 as essential for correct localization of syntaxin 4. Recently, it was shown that the N-terminal peptide of syntaxin 4 is involved in binding to munc18c. A mutation in this region that affects munc18c binding shows that munc18c binding is required for stabilization of syntaxin 4 at the plasma membrane but not for its correct targeting. We conclude that the N terminus serves two functions in membrane targeting. First, it harbors the sorting motif, which targets syntaxin 4 basolaterally in a munc18c-independent manner and second, it allows for munc18c binding, which stabilizes the protein in a munc18c-dependent manner.	[Torres, Jacqueline; Funk, Holly M.; Zegers, Mirjam M. P.; ter Beest, Martin B. A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago	ter Beest, MBA (corresponding author), 5841 S Maryland Ave,AB532-MC5032, Chicago, IL 60637 USA.	mterbe@surgery.bsd.uchicago	Zegers, Mirjam M P/B-6818-2012; Zegers, Mirjam/L-3160-2019	Zegers, Mirjam M P/0000-0002-1190-4094; Zegers, Mirjam/0000-0002-1190-4094	American Cancer Society, Ohio Division; National Institutes of Health [GM076363]; Ohio Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076363] Funding Source: NIH RePORTER	American Cancer Society, Ohio Division(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the American Cancer Society, Ohio Division (to M. B. A. t. B.) and by National Institutes of Health Grant GM076363 (to M. M. P. Z.).	ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; Cosen-Binker LI, 2008, WORLD J GASTROENTERO, V14, P2314, DOI 10.3748/wjg.14.2314; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Deora AA, 2004, MOL BIOL CELL, V15, P4148, DOI 10.1091/mbc.E04-01-0058; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Fuellekrug Joachim, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-8; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; HERZLINGER DA, 1984, J CELL BIOL, V98, P1777, DOI 10.1083/jcb.98.5.1777; Hinners I, 2003, EMBO REP, V4, P1182, DOI 10.1038/sj.embor.7400018; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Luton F, 2005, METHOD ENZYMOL, V404, P332, DOI 10.1016/S0076-6879(05)04029-2; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; NABI IR, 1991, J CELL BIOL, V115, P1573, DOI 10.1083/jcb.115.6.1573; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Steegmaier M, 2000, TRAFFIC, V1, P553, DOI 10.1034/j.1600-0854.2000.010705.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Toomre D, 1999, J CELL SCI, V112, P21; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Torkko JM, 2008, J CELL SCI, V121, P1193, DOI 10.1242/jcs.015495; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wakabayashi Y, 2007, HISTOCHEM CELL BIOL, V127, P463, DOI 10.1007/s00418-007-0274-x; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	56	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10834	10846		10.1074/jbc.M110.186668	http://dx.doi.org/10.1074/jbc.M110.186668			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278252	hybrid, Green Published			2022-12-25	WOS:000288547000097
J	Welch, AK; Bostwick, CJ; Cain, BD				Welch, Amanda K.; Bostwick, Caleb J.; Cain, Brian D.			Manipulations in the Peripheral Stalk of the Saccharomyces cerevisiae F1F0-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; ELASTIC POWER TRANSMISSION; ESCHERICHIA-COLI; B-SUBUNITS; 2ND STALK; YEAST; F-1-ATPASE; CATALYSIS; ABSENCE; REGION	The Saccharomyces cerevisiae F1F0-ATP synthase peripheral stalk is composed of the OSCP, h, d, and b subunits. The b subunit has two membrane-spanning domains and a large hydrophilic domain that extends along one side of the enzyme to the top of F-1. In contrast, the Escherichia coli peripheral stalk has two identical b subunits, and subunits with substantially altered lengths can be incorporated into a functional F1F0-ATP synthase. The differences in subunit structure between the eukaryotic and prokaryotic peripheral stalks raised a question about whether the two stalks have similar physical and functional properties. In the present work, the length of the S. cerevisiae b subunit has been manipulated to determine whether the F1F0-ATP synthase exhibited the same tolerances as in the bacterial enzyme. Plasmid shuffling was used for ectopic expression of altered b subunits in a strain carrying a chromosomal disruption of the ATP4 gene. Wild type growth phenotypes were observed for insertions of up to 11 and a deletion of four amino acids on a nonfermentable carbon source. In mitochondria-enriched fractions, abundant ATP hydrolysis activity was seen for the insertion mutants. ATPase activity was largely oligomycin-insensitive in these mitochondrial fractions. In addition, very poor complementation was seen in a mutant with an insertion of 14 amino acids. Lengthier deletions yielded a defective enzyme. The results suggest that although the eukaryotic peripheral stalk is near its minimum length, the b subunit can be extended a considerable distance.	[Welch, Amanda K.; Bostwick, Caleb J.; Cain, Brian D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Cain, BD (corresponding author), POB 100245,1600 SW Archer Rd, Gainesville, FL 32610 USA.	bcain@ufl.edu			USPHS [ROIGM070978]	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service)	This work supported by National Institutes of Health Service Grant ROIGM070978 from USPHS.	Ackerman Sharon H, 2007, Methods Mol Biol, V372, P363, DOI 10.1007/978-1-59745-365-3_26; Amberg DC, 2005, METHODS YEAST GENETI, P161; Bi YM, 2008, BBA-BIOENERGETICS, V1777, P583, DOI 10.1016/j.bbabio.2008.03.004; Boyer PD, 2002, FEBS LETT, V512, P29, DOI 10.1016/S0014-5793(02)02293-7; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Claggett SB, 2009, J BIOL CHEM, V284, P16531, DOI 10.1074/jbc.M109.002980; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Gavin PD, 2003, BBA-BIOENERGETICS, V1607, P167, DOI 10.1016/j.bbabio.2003.09.013; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grabar TB, 2003, J BIOL CHEM, V278, P34751, DOI 10.1074/jbc.M303361200; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; McLachlin DT, 2000, BIOCHEMISTRY-US, V39, P3486, DOI 10.1021/bi992586b; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MOORE D, 1996, CURRENT PROTOCOLS MO, V2; NAGLEY P, 1986, FEBS LETT, V195, P159, DOI 10.1016/0014-5793(86)80152-1; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; PAUL MF, 1992, EUR J BIOCHEM, V205, P163, DOI 10.1111/j.1432-1033.1992.tb16764.x; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorgen PL, 1999, J BIOL CHEM, V274, P36261, DOI 10.1074/jbc.274.51.36261; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; VELOURS J, 1988, EUR J BIOCHEM, V170, P637, DOI 10.1111/j.1432-1033.1988.tb13745.x; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; WAECHTER ABY, 2011, P NATL ACAD IN PRESS; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Weimann T, 2008, BIOCHEMISTRY-US, V47, P3556, DOI 10.1021/bi702000g; Welch AK, 2008, J BIOENERG BIOMEMBR, V40, P1, DOI 10.1007/s10863-008-9124-3; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200	35	5	6	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10155	10162		10.1074/jbc.M110.213447	http://dx.doi.org/10.1074/jbc.M110.213447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257750	hybrid, Green Published			2022-12-25	WOS:000288547000030
J	Mosch, K; Franz, H; Soeroes, S; Singh, PB; Fischle, W				Mosch, Kerstin; Franz, Henriette; Soeroes, Szabolcs; Singh, Prim B.; Fischle, Wolfgang			HP1 Recruits Activity-Dependent Neuroprotective Protein to H3K9me3 Marked Pericentromeric Heterochromatin for Silencing of Major Satellite Repeats	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; HISTONE H3; TRANSCRIPTIONAL REPRESSION; MAMMALIAN HETEROCHROMATIN; CHROMOSOME SEGREGATION; BINDING MODULES; SHADOW DOMAIN; FISSION YEAST; LYSINE 9; CHROMATIN	H3 lysine 9 trimethylation (H3K9me3) is a histone posttranslational modification (PTM) that has emerged as hallmark of pericentromeric heterochromatin. This constitutive chromatin domain is composed of repetitive DNA elements, whose transcription is differentially regulated. Mammalian cells contain three HP1 proteins, HP1 alpha, HP1 beta and HP1 gamma These have been shown to bind to H3K9me3 and are thought to mediate the effects of this histone PTM. However, the mechanisms of HP1 chromatin regulation and the exact functional role at pericentromeric heterochromatin are still unclear. Here, we identify activity-dependent neuroprotective protein (ADNP) as an H3K9me3 associated factor. We show that ADNP does not bind H3K9me3 directly, but that interaction is mediated by all three HP1 isoforms in vitro. However, in cells ADNP localization to areas of pericentromeric heterochromatin is only dependent on HP1 alpha and HP1 beta. Besides a PGVLL sequence patch we uncovered an ARKS motif within the ADNP homeodomain involved in HP1 dependent H3K9me3 association and localization to pericentromeric heterochromatin. While knockdown of ADNP had no effect on HP1 distribution and heterochromatic histone and DNA modifications, we found ADNP silencing major satellite repeats. Our results identify a novel factor in the translation of H3K9me3 at pericentromeric heterochromatin that regulates transcription.	[Mosch, Kerstin; Franz, Henriette; Soeroes, Szabolcs; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, Gottingen, Germany; [Singh, Prim B.] Res Ctr Borstel, Div Immunoepigenet, Borstel, Germany	Max Planck Society; Forschungszentrum Borstel	Mosch, K (corresponding author), Max Planck Inst Biophys Chem, Lab Chromatin Biochem, Gottingen, Germany.	wfischl@gwdg.de	Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; Franz, Henriette/0000-0001-9358-7442	Max Planck Society via Network of Excellence "The Epigenome'' of the European Union	Max Planck Society via Network of Excellence "The Epigenome'' of the European Union	This work was funded by the Max Planck Society via intramural funds as well as by the Network of Excellence "The Epigenome'' of the European Union FP6 (NET program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brown JP, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-9; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Delattre M, 2000, J CELL SCI, V113, P4253; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Eymery A, 2009, INT J DEV BIOL, V53, P259, DOI 10.1387/ijdb.082673ae; Falandry C, 2010, J BIOL CHEM, V285, P20234, DOI 10.1074/jbc.M109.052399; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; FRANZ H, 2009, J BIOL CHEM, V5, P5; Furman S, 2004, NEURON GLIA BIOL, V1, P193, DOI 10.1017/S1740925X05000013; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gozes I, 1999, ANN NY ACAD SCI, V897, P125, DOI 10.1111/j.1749-6632.1999.tb07884.x; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Horakova AH, 2010, J STRUCT BIOL, V169, P124, DOI 10.1016/j.jsb.2009.09.007; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon SH, 2008, MOL CELLS, V26, P217; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Linder B, 2001, EMBO REP, V2, P211, DOI 10.1093/embo-reports/kve039; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Qu Jian-hui, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P520; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Steingart RA, 2006, MOL CELL ENDOCRINOL, V252, P148, DOI 10.1016/j.mce.2006.03.029; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Zamir I, 1997, P NATL ACAD SCI USA, V94, P14400, DOI 10.1073/pnas.94.26.14400; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1; Zemlyak I, 2007, PEPTIDES, V28, P2004, DOI 10.1016/j.peptides.2007.08.004	73	43	43	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15894	10.1371/journal.pone.0015894	http://dx.doi.org/10.1371/journal.pone.0015894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267468	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500031
J	Bakanda, C; Birungi, J; Mwesigwa, R; Zhang, W; Hagopian, A; Ford, N; Mills, EJ				Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert; Zhang, Wendy; Hagopian, Amy; Ford, Nathan; Mills, Edward J.			Density of Healthcare Providers and Patient Outcomes: Evidence from a Nationally Representative Multi-Site HIV Treatment Program in Uganda	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-RESOURCES; DRUG-RESISTANCE; SCALING-UP; ADHERENCE; AFRICA; POPULATION; HIV/AIDS	Objective: We examined the association between density of healthcare providers and patient outcomes using a large nationally representative cohort of patients receiving combination antiretroviral therapy (cART) in Uganda. Design: We obtained data from The AIDS Support Organization (TASO) in Uganda. Patients 18 years of age and older who initiated cART at TASO between 2004 and 2008 contributed to this analysis. The number of healthcare providers per 100 patients, the number of patients lost to follow-up per 100 person years and number of deaths per 100 person years were calculated. Spearman correlation was used to identify associations between patient loss to follow-up and mortality with the healthcare provider-patient ratios. Results: We found no significant associations between the number of patients lost to follow-up and physicians (p = 0.45), nurses (p = 0.93), clinical officers (p = 0.80), field officers (p = 0.56), and healthcare providers overall (p = 0.83). Similarly, no significant associations were observed between mortality and physicians (p = 0.65), nurses (p = 0.49), clinical officers (p = 0.73), field officers (p = 0.78), and healthcare providers overall (p = 0.73). Conclusions: Patient outcomes, as measured by loss to follow-up and mortality, were not significantly associated with the number of doctors, nurses, clinical officers, field officers, or healthcare providers overall. This may suggest that that other factors, such as the presence of volunteer patient supporters or broader political or socioeconomic influences, may be more closely associated with outcomes of care among patients on cART in Uganda.	[Bakanda, Celestin; Birungi, Josephine; Mwesigwa, Robert] AIDS Support Org, Kampala, Uganda; [Zhang, Wendy] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hagopian, Amy] Univ Cape Town, Div Infect Dis, ZA-7925 Cape Town, South Africa; [Ford, Nathan] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	B.C. Centre for Excellence in HIV/AIDS; University of Cape Town; University of Washington; University of Washington Seattle; University of Ottawa	Bakanda, C (corresponding author), AIDS Support Org, Kampala, Uganda.	edward.mills@uottawa.ca						Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; BOYARINOVA G, 2007, J NURSING ALLIED HLT, V1, P1; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Knodel J, 2010, RES AGING, V32, P19, DOI 10.1177/0164027509348130; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; LAMBDIN B, 2010, PATIENT VOLUME HUMAN; Marino P, 2007, SOC WORK HEALTH CARE, V45, P67, DOI 10.1300/J010v45n01_05; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills Edward J, 2009, Curr HIV/AIDS Rep, V6, P201, DOI 10.1007/s11904-009-0027-7; O'Brien Daniel P, 2010, Confl Health, V4, P12, DOI 10.1186/1752-1505-4-12; Parkhurst JO, 2004, SOC SCI MED, V59, P1913, DOI 10.1016/j.socscimed.2004.02.026; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Robinson JJA, 2001, J ADV NURS, V34, P445, DOI 10.1046/j.1365-2648.2001.01773.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *UNAIDS, 2009, AIDS EP UPD; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16279	10.1371/journal.pone.0016279	http://dx.doi.org/10.1371/journal.pone.0016279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710ND	21264224	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600025
J	Baron, T; Vulin, J; Biacabe, AG; Lakhdar, L; Verchere, J; Torres, JM; Bencsik, A				Baron, Thierry; Vulin, Johann; Biacabe, Anne-Gaelle; Lakhdar, Latefa; Verchere, Jeremy; Torres, Juan-Maria; Bencsik, Anna			Emergence of Classical BSE Strain Properties during Serial Passages of H-BSE in Wild-Type Mice	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; MOLECULAR ANALYSIS; PRION DISEASES; TRANSGENIC MICE; SCRAPIE AGENT; VARIANT CJD; IDENTIFICATION; SIMILARITIES	Background: Two distinct forms of atypical spongiform encephalopathies (H-BSE and L-BSE) have recently been identified in cattle. Transmission studies in several wild-type or transgenic mouse models showed that these forms were associated with two distinct major strains of infectious agents, which also differed from the unique strain that had been isolated from cases of classical BSE during the food-borne epizootic disease. Methodology/Principal Findings: H-BSE was monitored during three serial passages in C57BL/6 mice. On second passage, most of the inoculated mice showed molecular features of the abnormal prion protein (PrP(d)) and brain lesions similar to those observed at first passage, but clearly distinct from those of classical BSE in this mouse model. These features were similarly maintained during a third passage. However, on second passage, some of the mice exhibited distinctly different molecular and lesion characteristics, reminiscent of classical BSE in C57Bl/6 mice. These similarities were confirmed on third passage from such mice, for which the same survival time was also observed as with classical BSE adapted to C57Bl/6 mice. Lymphotropism was rarely detected in mice with H-BSE features. In contrast, PrP(d) was detectable, on third passage, in the spleens of most mice exhibiting classical BSE features, the pattern being indistinguishable from that found in C57Bl/6 mice infected with classical BSE. Conclusion/Significance: Our data demonstrate the emergence of a prion strain with features similar to classical BSE during serial passages of H-BSE in wild-type mice. Such findings might help to explain the origin of the classical BSE epizootic disease, which could have originated from a putatively sporadic form of BSE.	[Baron, Thierry; Vulin, Johann; Biacabe, Anne-Gaelle; Lakhdar, Latefa; Verchere, Jeremy; Bencsik, Anna] Agence Francaise Secur Sanit Aliments Lyon, Lyon, France; [Torres, Juan-Maria] Ist Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain		Baron, T (corresponding author), Agence Francaise Secur Sanit Aliments Lyon, Lyon, France.	thierry.baron@anses.fr	BENCSIK, Anna A/HGC-4260-2022; Torres, Juan Maria/L-8768-2013	BENCSIK, Anna A/0000-0002-8671-6290; Torres, Juan Maria/0000-0003-0443-9232				Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Baron T, 2006, LANCET, V367, P297, DOI 10.1016/S0140-6736(06)68060-4; Baron TGM, 2001, J VIROL, V75, P107, DOI 10.1128/JVI.75.1.107-114.2001; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Baron T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010310; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Bencsik A, 2005, J VIROL METHODS, V124, P197, DOI 10.1016/j.jviromet.2004.11.027; Bencsik A, 2007, HISTOCHEM CELL BIOL, V127, P531, DOI 10.1007/s00418-007-0276-8; Bencsik AA, 2006, J HISTOCHEM CYTOCHEM, V54, P849, DOI 10.1369/jhc.5C6895.2006; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Brown DA, 2003, NEUROPATH APPL NEURO, V29, P262, DOI 10.1046/j.1365-2990.2003.00462.x; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRUCE ME, 1996, PRION DIS, P223; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Green R, 2005, J COMP PATHOL, V132, P117, DOI 10.1016/j.jcpa.2004.08.002; Hagiwara K, 2007, JPN J INFECT DIS, V60, P305; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Kuczius T, 1998, J INFECT DIS, V178, P693, DOI 10.1086/515337; Lasmezas CI, 1996, J GEN VIROL, V77, P1601, DOI 10.1099/0022-1317-77-7-1601; Lezmi S, 2006, J HISTOCHEM CYTOCHEM, V54, P1087, DOI 10.1369/jhc.5A6892.2006; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Nicot S, 2010, J GEN VIROL, V91, P570, DOI 10.1099/vir.0.014464-0; Okada H, 2011, VET PATHOL, V48, P942, DOI 10.1177/0300985810382672; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; WILESMITH JW, 1988, VET REC, V123, P638	42	48	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15839	10.1371/journal.pone.0015839	http://dx.doi.org/10.1371/journal.pone.0015839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264286	Green Published, Green Submitted, gold			2022-12-25	WOS:000286516500012
J	Hachiya, A; Kodama, EN; Schuckmann, MM; Kirby, KA; Michailidis, E; Sakagami, Y; Oka, S; Singh, K; Sarafianos, SG				Hachiya, Atsuko; Kodama, Eiichi N.; Schuckmann, Matthew M.; Kirby, Karen A.; Michailidis, Eleftherios; Sakagami, Yasuko; Oka, Shinichi; Singh, Kamalendra; Sarafianos, Stefan G.			K70Q Adds High-Level Tenofovir Resistance to "Q151M Complex" HIV Reverse Transcriptase through the Enhanced Discrimination Mechanism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOSIDE ANALOG RESISTANCE; BETA-3-BETA-4 HAIRPIN LOOP; SITE-DIRECTED MUTAGENESIS; INHIBITORS IN-VITRO; POL GENE-MUTATIONS; FINGERS SUBDOMAIN; DRUG SUSCEPTIBILITY; NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING	HIV-1 carrying the "Q151M complex" reverse transcriptase (RT) mutations (A62V/V75I/F77L/F116Y/Q151M, or Q151Mc) is resistant to many FDA-approved nucleoside RT inhibitors (NRTIs), but has been considered susceptible to tenofovir disoproxil fumarate (TFV-DF or TDF). We have isolated from a TFV-DF-treated HIV patient a Q151Mc-containing clinical isolate with high phenotypic resistance to TFV-DF. Analysis of the genotypic and phenotypic testing over the course of this patient's therapy lead us to hypothesize that TFV-DF resistance emerged upon appearance of the previously unreported K70Q mutation in the Q151Mc background. Virological analysis showed that HIV with only K70Q was not significantly resistant to TFV-DF. However, addition of K70Q to the Q151Mc background significantly enhanced resistance to several approved NRTIs, and also resulted in high-level (10-fold) resistance to TFV-DF. Biochemical experiments established that the increased resistance to tenofovir is not the result of enhanced excision, as K70Q/Q151Mc RT exhibited diminished, rather than enhanced ATP-based primer unblocking activity. Pre-steady state kinetic analysis of the recombinant enzymes demonstrated that addition of the K70Q mutation selectively decreases the binding of tenofovir-diphosphate (TFV-DP), resulting in reduced incorporation of TFV into the nascent DNA chain. Molecular dynamics simulations suggest that changes in the hydrogen bonding pattern in the polymerase active site of K70Q/Q151Mc RT may contribute to the observed changes in binding and incorporation of TFV-DP. The novel pattern of TFV-resistance may help adjust therapeutic strategies for NRTI-experienced patients with multi-drug resistant (MDR) mutations.	[Hachiya, Atsuko; Schuckmann, Matthew M.; Kirby, Karen A.; Michailidis, Eleftherios; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Hachiya, Atsuko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Sendai, Miyagi 980, Japan; [Sakagami, Yasuko] Kyoto Univ, Inst Virus Res, Kyoto 606, Japan	University of Missouri System; University of Missouri Columbia; National Center for Global Health & Medicine - Japan; Tohoku University; Kyoto University	Hachiya, A (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.	kodama515@m.tains.tohoku.ac.jp; sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Michailidis, Eleftherios/0000-0002-9907-4346; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X; Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor and Welfare; Korea Food & Drug Administration; Ministry of Knowledge and Economy, Republic of Korea; National Institutes of Health (NIH) [AI094715, AI076119, AI079801, AI074389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI079801, R21AI079801, R01AI076119, R01AI074389, R21AI094715] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant for the promotion of AIDS Research from the Ministry of Health, Labor and Welfare (AH and EK, http://www.mhlw.go.jp/english/index.html), by grants from the Korea Food & Drug Administration and the Ministry of Knowledge and Economy, Bilateral International Collaborative R&D Program, Republic of Korea (SGS) and by National Institutes of Health (NIH, http://nih.gov/) research grants AI094715, AI076119, AI079801, and AI074389 to SGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Boyer PL, 2002, J VIROL, V76, P9143, DOI 10.1128/JVI.76.18.9143-9151.2002; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Chappell BJ, 2007, AIDS, V21, P761, DOI 10.1097/QAD.0b013e3280187533; CLARK S, 2006, HIV SEQUENCE COMPEND, V2005, P58; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; Delaugerre C, 2008, J MED VIROL, V80, P762, DOI 10.1002/jmv.21158; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Feng JY, 2006, NUCLEOS NUCLEOT NUCL, V25, P89, DOI 10.1080/15257770500379157; Feng JY, 2005, ANTIVIR RES, V66, P153, DOI 10.1016/j.antiviral.2005.03.001; Frangeul A, 2008, ANTIVIR THER, V13, P115; Frangeul A, 2007, ANTIMICROB AGENTS CH, V51, P3162, DOI 10.1128/AAC.00145-07; Frankel FA, 2005, ANTIMICROB AGENTS CH, V49, P2657, DOI 10.1128/AAC.49.7.2657-2664.2005; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Garforth SJ, 2007, J MOL BIOL, V365, P38, DOI 10.1016/j.jmb.2006.09.057; GU ZX, 1994, J BIOL CHEM, V269, P28118; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kagan RM, 2007, ANTIVIR RES, V75, P210, DOI 10.1016/j.antiviral.2007.03.006; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kew Y, 1998, J BIOL CHEM, V273, P7529, DOI 10.1074/jbc.273.13.7529; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; Lerma JGG, 1999, ANTIMICROB AGENTS CH, V43, P264, DOI 10.1128/AAC.43.2.264; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Margot NA, 2002, AIDS, V16, P1227, DOI 10.1097/00002030-200206140-00004; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Matamoros T, 2004, J BIOL CHEM, V279, P24569, DOI 10.1074/jbc.M312658200; Matsumi S, 2003, AIDS, V17, P1127, DOI 10.1097/00002030-200305230-00003; McColl DJ, 2003, J ANTIMICROB CHEMOTH, V51, P219, DOI 10.1093/jac/dkg109; Menendez-Arias L, 2008, VIRUS RES, V134, P1, DOI 10.1016/j.virusres.2008.01.009; Meyer PR, 2003, J VIROL, V77, P3871, DOI 10.1128/JVI.77.6.3871-3877.2003; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; Ren J, 2004, J MOL BIOL, V336, P569, DOI 10.1016/j.jmb.2003.12.055; Rigourd M, 2002, J BIOL CHEM, V277, P18611, DOI 10.1074/jbc.M110836200; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; SCHUCKMANN MM, J BIOL CHEM; SHAFER RW, 1994, J INFECT DIS, V169, P722, DOI 10.1093/infdis/169.4.722; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Singh K, 2007, J BIOL CHEM, V282, P10594, DOI 10.1074/jbc.M611242200; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Smith RA, 2008, ANTIMICROB AGENTS CH, V52, P329, DOI 10.1128/AAC.01004-07; TU X, 2001, NAT STRUCT MOL BIOL, V17, P1202; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; Van Houtte M, 2009, J MED VIROL, V81, P1702, DOI 10.1002/jmv.21585; Van Laethem K, 2007, INFECT GENET EVOL, V7, P600, DOI 10.1016/j.meegid.2007.05.006; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4; Winters MA, 1997, ANTIMICROB AGENTS CH, V41, P757, DOI 10.1128/AAC.41.4.757	64	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16242	10.1371/journal.pone.0016242	http://dx.doi.org/10.1371/journal.pone.0016242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249155	Green Submitted, Green Published, gold			2022-12-25	WOS:000286515000035
J	Trimble, MJ; van Aarde, RJ				Trimble, Morgan J.; van Aarde, Rudi J.			Decline of Birds in a Human Modified Coastal Dune Forest Landscape in South Africa	PLOS ONE			English	Article							POPULATION DECLINES; CONSERVATION; ABUNDANCE; COMMUNITIES; HABITATS; BIODIVERSITY; RANGE	Previous studies demonstrate that old-growth forest remnants and vegetation regenerating after anthropogenic disturbance provide habitat for birds in a human modified coastal dune forest landscape in northern KwaZulu-Natal, South Africa. However, occurrence does not ensure persistence. Based on a 13-year monitoring database we calculated population trends for 37 bird species and general trends in overall bird density in different vegetation types. We evaluated species' characteristics as covariates of population trend and assessed changes in rainfall and proportional area and survey coverage per vegetation type. 76% of species assessed have declined, 57% significantly so at an average rate of 13.9% per year. Overall, bird density has fallen at 12.2% per year across old-growth forest and woody regenerating vegetation types. Changes in proportional area and coverage per vegetation type may partly explain trends for a few species but are unlikely to account for most. Below average rainfall may have contributed to bird declines. However, other possibilities warrant further investigation. Species with larger range extents tended to decline more sharply than did others, and these species may be responding to environmental changes on a broader geographical scale. Our results cast doubt on the future persistence of birds in this human modified landscape. More research is needed to elucidate the mechanisms driving population decline in the study area and to investigate whether the declines identified here are more widespread across the region and perhaps the continent.	[Trimble, Morgan J.; van Aarde, Rudi J.] Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa	University of Pretoria	Trimble, MJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa.	rjvaarde@zoology.up.ac.za	Trimble, Morgan J/B-1161-2010	Trimble, Morgan J/0000-0002-9914-0788	Richards Bay Minerals; National Research Foundation	Richards Bay Minerals; National Research Foundation	Richards Bay Minerals and the National Research Foundation provided support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKINS RA, 1987, WILSON BULL, V99, P7; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BirdLife International, 2004, STAT WORLDS BIRDS 20; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Camphysen CJ, 2001, ENVIRON POLLUT, V112, P443, DOI 10.1016/S0269-7491(00)00138-X; Daily GC, 2001, NATURE, V411, P245, DOI 10.1038/35077178; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Dunn EH, 2002, CONSERV BIOL, V16, P1632, DOI 10.1046/j.1523-1739.2002.01250.x; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; FAABORG J, 1982, Wilson Bulletin, V94, P20; FRY DM, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432528; Grainger MJ, 2011, RESTOR ECOL, V19, P111, DOI 10.1111/j.1526-100X.2009.00630.x; GRAINGER MJ, 2011, RESTOR ECOL IN PRESS; Green RE, 2008, BIOL LETTERS, V4, P599, DOI 10.1098/rsbl.2008.0052; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Haskell DG, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000063; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Komar O, 2006, BIRD CONSERV INT, V16, P1, DOI 10.1017/S0959270906000074; Kritzinger JJ, 1998, S AFR J SCI, V94, P71; Kuper W, 2004, ANN MO BOT GARD, V91, P525; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Leuteritz T., 2008, IUCN RED LIST THREAT; Low A. B., 1998, VEGETATION S AFRICA; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Mehlman DW, 1997, ECOL APPL, V7, P614; Nel DC, 2002, POLAR BIOL, V25, P81, DOI 10.1007/s003000100315; OLSEN P, 2008, STAT AUSTR BIRDS 200; Peakall DB, 2000, ECOTOXICOLOGY, V9, P239, DOI 10.1023/A:1026541210511; Petit LJ, 1999, ECOGRAPHY, V22, P292, DOI 10.1111/j.1600-0587.1999.tb00505.x; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sekercioglu CH, 2002, BIOL CONSERV, V107, P229, DOI 10.1016/S0006-3207(02)00097-6; Sigel BJ, 2006, CONSERV BIOL, V20, P111, DOI 10.1111/j.1523-1739.2005.00293.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; STEENKAMP Y, 2004, HOTSPOTS REVISITED E; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Thomas L., 2009, DISTANCE 6 0 RELEASE; Underhill LG, 2005, ICES J MAR SCI, V62, P360, DOI 10.1016/j.icesjms.2005.01.005; *US COMM, 2009, STAT BIRDS US AM 200; vanAarde RJ, 1996, LANDSCAPE URBAN PLAN, V34, P277, DOI 10.1016/0169-2046(95)00237-5; VANAARDE RJ, 1980, S AFR J WILDL RES, V10, P123; vanAarde RJ, 1996, RESTOR ECOL, V4, P334, DOI 10.1111/j.1526-100X.1996.tb00186.x; VanWyk AE, 1996, BIODIVERSITY OF AFRICAN PLANTS, P198; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Wassenaar TD, 2005, ECOLOGY, V86, P655, DOI 10.1890/03-0836; Wikelski M, 2004, ECOL SOC, V9; Zuur Alain F., 2009, P1; [No title captured]	60	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16176	10.1371/journal.pone.0016176	http://dx.doi.org/10.1371/journal.pone.0016176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249203	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000026
J	Pantaleo, A; Ferru, E; Carta, F; Mannu, F; Simula, LF; Khadjavi, A; Pippia, P; Turrini, F				Pantaleo, Antonella; Ferru, Emanuela; Carta, Franco; Mannu, Franca; Simula, Luigi F.; Khadjavi, Amina; Pippia, Proto; Turrini, Francesco			Irreversible AE1 Tyrosine Phosphorylation Leads to Membrane Vesiculation in G6PD Deficient Red Cells	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; ERYTHROCYTE-MEMBRANE; BAND-3; PROTEIN; PHAGOCYTOSIS; ANTIBODIES; SYK; G6PD-DEFICIENT; PHOSPHATASE	Background: While G6PD deficiency is one of the major causes of acute hemolytic anemia, the membrane changes leading to red cell lysis have not been extensively studied. New findings concerning the mechanisms of G6PD deficient red cell destruction may facilitate our understanding of the large individual variations in susceptibility to pro-oxidant compounds and aid the prediction of the hemolytic activity of new drugs. Methodology/Principal Findings: Our results show that treatment of G6PD deficient red cells with diamide (0.25 mM) or divicine (0.5 mM) causes: (1) an increase in the oxidation and tyrosine phosphorylation of AE1; (2) progressive recruitment of phosphorylated AE1 in large membrane complexes which also contain hemichromes; (3) parallel red cell lysis and a massive release of vesicles containing hemichromes. We have observed that inhibition of AE1 phosphorylation by Syk kinase inhibitors prevented its clustering and the membrane vesiculation while increases in AE1 phosphorylation by tyrosine phosphatase inhibitors increased both red cell lysis and vesiculation rates. In control RBCs we observed only transient AE1 phosphorylation. Conclusions/Significance: Collectively, our findings indicate that persistent tyrosine phosphorylation produces extensive membrane destabilization leading to the loss of vesicles which contain hemichromes. The proposed mechanism of hemolysis may be applied to other hemolytic diseases characterized by the accumulation of hemoglobin denaturation products.	[Pantaleo, Antonella; Khadjavi, Amina; Turrini, Francesco] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Ferru, Emanuela] Univ Verona, Sect Internal Med, Dept Clin & Expt Med, I-37100 Verona, Italy; [Carta, Franco; Mannu, Franca] Nurex Srl, Sassari, Italy; [Simula, Luigi F.] Hosp Alghero, Sassari, Italy; [Pippia, Proto] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy	University of Turin; University of Verona; University of Sassari	Pantaleo, A (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	francesco.turrini@unito.it	Pantaleo, Antonella/ABA-5190-2020	carta, franco/0000-0001-7776-8243				Arese P, 1989, Folia Haematol Int Mag Klin Morphol Blutforsch, V116, P745; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Baker M A, 1984, Toxicol Pathol, V12, P331; Barbero G, 2006, ANAL BIOCHEM, V349, P62, DOI 10.1016/j.ab.2005.10.020; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Bordin L, 2005, MOL MEMBR BIOL, V22, P411, DOI 10.1080/09687860500233679; Bordin L, 2005, BBA-MOL CELL RES, V1745, P20, DOI 10.1016/j.bbamcr.2004.12.010; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CAPRARI P, 1991, BIOCHEM MED METAB B, V45, P16, DOI 10.1016/0885-4505(91)90004-5; CHEVION M, 1982, EUR J BIOCHEM, V127, P405, DOI 10.1111/j.1432-1033.1982.tb06886.x; COUPER KN, PLOS PATHOGENS, V6; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; GUTMANN C, AIDS LONDON ENGLAND, V24, P2347; HARRISON ML, 1994, J BIOL CHEM, V269, P955; JOHNSON RM, 1994, BLOOD, V83, P1117; KANNAN R, 1988, J BIOL CHEM, V263, P13766; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; Luzzatto L, 2006, HAEMATOLOGICA, V91, P1303; MANNU F, 1995, BLOOD, V86, P2014, DOI 10.1182/blood.V86.5.2014.bloodjournal8652014; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nantakomol Duangdao, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P146; PANTALEO A, PROTEOMICS, V19, P3469; Pantaleo A, 2008, AUTOIMMUN REV, V7, P457, DOI 10.1016/j.autrev.2008.03.017; Pantaleo A, 2009, BIOCHEM J, V418, P359, DOI 10.1042/BJ20081557; Tavazzi D, 1998, HEMOGLOBIN, V22, P483, DOI 10.3109/03630269809071545; Terra HTMB, 1998, AM J HEMATOL, V58, P224, DOI 10.1002/(SICI)1096-8652(199807)58:3<224::AID-AJH11>3.0.CO;2-9; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; Tokumasu F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005828; TURRINI F, 1994, BBA-BIOMEMBRANES, V1190, P297, DOI 10.1016/0005-2736(94)90087-6; TURRINI F, 1985, BLOOD, V66, P302; Turrini F, 2003, REDOX REP, V8, P300, DOI 10.1179/135100003225002943; WAGNER GM, 1986, J LAB CLIN MED, V108, P315; Westerman M, 2008, BRIT J HAEMATOL, V142, P126, DOI 10.1111/j.1365-2141.2008.07155.x; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X; Winograd E, 2005, MOL BIOCHEM PARASIT, V142, P98, DOI 10.1016/j.molbiopara.2005.03.013; Zipser Y, 1996, BIOCHEM J, V314, P881, DOI 10.1042/bj3140881; Zipser Y, 1997, FEBS LETT, V406, P126, DOI 10.1016/S0014-5793(97)00263-9	44	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15847	10.1371/journal.pone.0015847	http://dx.doi.org/10.1371/journal.pone.0015847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246053	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200020
J	Andorfer, P; Rotheneder, H				Andorfer, P.; Rotheneder, H.			EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest	ONCOGENE			English	Article						EAPP; p21; apoptosis; DNA damage; cell-cycle arrest	DEPENDENT KINASE INHIBITOR; S-PHASE ENTRY; DNA-REPLICATION; P53-MEDIATED APOPTOSIS; HISTONE DEACETYLASE-1; TRANSCRIPTION FACTORS; MULTIDRUG-RESISTANCE; TUMOR SUPPRESSION; P21; P53	We previously identified and characterized E2F-associated phospho-protein (EAPP), a nuclear phosphoprotein that interacts with the activating members of the E2F transcription factor family. EAPP levels are frequently elevated in transformed human cells. To examine the biological relevance of EAPP, we studied its properties in stressed and unstressed cells. Overexpression of EAPP in U2OS cells increased the fraction of G1 cells and lead to heightened resistance against DNA damage-or E2F1-induced apoptosis in a p21-dependent manner. EAPP itself becomes upregulated in confluent cells and after DNA damage and stimulates the expression of p21 independently of p53. It binds to the p21 promoter and seems to be required for the assembly of the transcription initiation complex. RNAi-mediated knockdown of EAPP expression brought about increased sensitivity towards DNA damage and resulted in apoptosis even in the absence of stress. Our results indicate that the level of EAPP is critical for cellular homeostasis. Too much of it results in G1 arrest and resistance to apoptosis, which, paradoxically, might favor cellular transformation. Too little EAPP seems to retard the expression not only of the p21 gene, but also of a number of other genes and ultimately results in apoptosis. Oncogene (2011) 30, 2679-2690; doi:10.1038/onc.2010.639; published online 24 January 2011	[Andorfer, P.; Rotheneder, H.] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Rotheneder, H (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	Johann.Rotheneder@meduniwien.ac.at			Austrian FWF [P18417]; Herzfelder'sche Familienstiftung	Austrian FWF(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung	We are grateful to H Nomura, BH Park, A Ashworth, and N Heintz for expression vectors. We thank Christian Seiser for helpful discussions and the histone antibodies, Erhard Wintersberger and Christian Seiser for critically reading this manuscript, Ingrid Mudrak and Egon Ogris for help with the generation of the monoclonal EAPP antibody, and Thomas Sauer for assistance with the FACS analysis. This work was supported by the Austrian FWF (Grant P18417) and by the Herzfelder'sche Familienstiftung.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Baptiste-Okoh N, 2008, CELL CYCLE, V7, P1133, DOI 10.4161/cc.7.9.5805; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; CHEN K, 2010, MOL PHARM; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; GOUBIN F, 1995, ONCOGENE, V10, P2281; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Janicke RU, 2007, CELL CYCLE, V6, P407; Karakas B, 2007, CANCER BIOL THER, V6, P1025, DOI 10.4161/cbt.6.7.4202; Kawasaki T, 1996, INT J CANCER, V68, P501, DOI 10.1002/(SICI)1097-0215(19961115)68:4<501::AID-IJC16>3.0.CO;2-7; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Novy M, 2005, MOL BIOL CELL, V16, P2181, DOI 10.1091/mbc.E04-11-0975; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Schwarzmayr L, 2008, INT J BIOCHEM CELL B, V40, P2845, DOI 10.1016/j.biocel.2008.06.001; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zhu HM, 2002, CELL CYCLE, V1, P59, DOI 10.4161/cc.1.1.101	51	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	23					2679	2690		10.1038/onc.2010.639	http://dx.doi.org/10.1038/onc.2010.639			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21258403	Green Published, hybrid			2022-12-25	WOS:000291677800008
J	Normant, E; Paez, G; West, KA; Lim, AR; Slocum, KL; Tunkey, C; McDougall, J; Wylie, AA; Robison, K; Caliri, K; Palombella, VJ; Fritz, CC				Normant, E.; Paez, G.; West, K. A.; Lim, A. R.; Slocum, K. L.; Tunkey, C.; McDougall, J.; Wylie, A. A.; Robison, K.; Caliri, K.; Palombella, V. J.; Fritz, C. C.			The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models	ONCOGENE			English	Article						Hsp90; EML4-ALK; IPI-504; NSCLC; ALK inhibitor	PROTEIN 90 INHIBITOR; GASTROINTESTINAL STROMAL TUMOR; CELL LUNG-CANCER; KINASE INHIBITOR; BREAST-CANCER; HEAT-SHOCK-PROTEIN-90 INHIBITION; FUSION GENE; CHAPERONE; SURVIVAL; IDENTIFICATION	Heat shock protein 90 (Hsp90) is an emerging target for cancer therapy due to its important role in maintaining the activity and stability of key oncogenic signaling proteins. We show here that the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion protein, presumed to be the oncogenic driver in about 5% of patients with non-small cell lung cancer (NSCLC), is associated with Hsp90 in cells and is rapidly degraded upon exposure of cells to IPI-504. We find EML4-ALK to be more sensitive to Hsp90 inhibition than either HER2 or mutant epidermal growth factor receptor (EGFR) with an inhibitory concentration (IC)(50) for protein degradation in the low nanomolar range. This degradation leads to a potent inhibition of downstream signaling pathways and to the induction of growth arrest and apoptosis in cells carrying the EML4-ALK fusion. To generate a causative link between the expression of EML4-ALK and sensitivity to IPI-504, we introduced an EML4-ALK cDNA into HEK293 cells and show that the expression of the fusion protein sensitizes cells to IPI-504 both in vitro and in vivo. In a xenograft model of a human NSCLC cell line containing the ALK rearrangement, we observe tumor regression at clinically relevant doses of IPI-504. Finally, cells that have been selected for resistance to ALK kinase inhibitors retain their sensitivity to IPI-504. We have recently observed partial responses to administration of IPI-504 as a single agent in a phase 2 clinical trial in patients with NSCLC, specifically in patients that carry an ALK rearrangement. This study provides a molecular explanation for these clinical observations. Oncogene (2011) 30, 2581-2586; doi:10.1038/onc.2010.625; published online 24 January 2011	[Normant, E.; Paez, G.; West, K. A.; Lim, A. R.; Slocum, K. L.; Tunkey, C.; McDougall, J.; Wylie, A. A.; Robison, K.; Caliri, K.; Palombella, V. J.; Fritz, C. C.] Infin Pharmaceut, Cambridge, MA 02139 USA		Normant, E (corresponding author), Infin Pharmaceut, 780 Mem Dr, Cambridge, MA 02139 USA.	emmanuel.normant@infi.com						An WG, 2000, CELL GROWTH DIFFER, V11, P355; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dewaele B, 2008, CLIN CANCER RES, V14, P5749, DOI 10.1158/1078-0432.CCR-08-0533; Fumo G, 2004, BLOOD, V103, P1078, DOI 10.1182/blood-2003-07-2477; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Leow CC, 2009, MOL CANCER THER, V8, P2131, DOI 10.1158/1535-7163.MCT-08-1038; Li CF, 2008, CLIN CANCER RES, V14, P7822, DOI 10.1158/1078-0432.CCR-08-1369; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Munster PN, 2001, CANCER RES, V61, P2945; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; PARK J, 2008, AACR M; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Ruiz MIG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001722; Sequist LV, 2010, J CLIN ONCOL, V28, P4953, DOI 10.1200/JCO.2010.30.8338; Sequist LV, 2010, J CLIN ONCOL, V28; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Shimamura T, 2008, J THORAC ONCOL, V3, pS152, DOI 10.1097/JTO.0b013e318174ea3a; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	31	114	122	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	22					2581	2586		10.1038/onc.2010.625	http://dx.doi.org/10.1038/onc.2010.625			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21258415				2022-12-25	WOS:000291198400009
J	Wani, AA; Jafarnejad, SM; Zhou, J; Li, G				Wani, A. A.; Jafarnejad, S. M.; Zhou, J.; Li, G.			Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappa B/interleukin-6 signaling pathway	ONCOGENE			English	Article						ILK; angiogenesis; melanoma; NF-kappa B; IL-6; VEGF	ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE; PROSTATE-CANCER CELLS; PROTEIN-KINASE; DEPENDENT ANGIOGENESIS; EXPRESSION INCREASES; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; TUMOR ANGIOGENESIS	Integrin-linked kinase (ILK) is a highly conserved serine-threonine protein kinase involved in cell-extracellular matrix interactions, cytoskeletal organization and cell signaling. Overexpression of ILK in epithelial cells leads to anchorage-independent growth with increased cell cycle progression. Previously, we have shown that ILK upregulation strongly correlates with melanoma progression, invasion and inversely correlates with 5-year survival of melanoma patients. However, the molecular mechanism by which ILK enhances melanoma progression is currently unknown. In the present study, we found that proangiogenic molecule interleukin-6 (IL-6) is the downstream target of ILK in melanoma cells. ILK overexpression increased IL-6, whereas silencing of ILK suppressed IL-6 expression at both messenger RNA and protein levels. ILK also altered the activity and subcellular localization of nuclear factor-kappaB (NF-kappa B) subunit p65. We further found that ILK enhanced the IL-6 gene transcription by promoting the binding of NF-kB p65 to IL-6 promoter. Moreover, ILK overexpression in melanoma cells enhanced the tube-forming ability of endothelial cells in vitro and microvessel formation in vivo. ILK-induced tube and blood vessel formation of endothelial cells was significantly reduced upon IL-6 inhibition in ILK-overexpressing melanoma cells. To delineate the mechanism by which ILK-induced IL-6 production can enhance angiogenesis, further analysis of the downstream targets of IL-6 signaling showed an increased activity of the signal transducer and activator of transcription 3 (STAT3) in ILK-overexpressing cells. As STAT3 binds to vascular endothelial growth factor (VEGF) promoter, we found that VEGF levels were elevated in ILK-overexpressing cells and declined upon transfection of IL-6 small interfering RNA, suggesting that ILK may regulate VEGF expression through IL-6 pathway by activating STAT3. Oncogene (2011) 30, 2778-2788; doi: 10.1038/onc.2010.644; published online 31 January 2011	[Wani, A. A.; Jafarnejad, S. M.; Li, G.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V6H 3Z6, Canada; [Zhou, J.] Nanjing Med Univ, Sch Publ Hlth, Ctr Canc, Dept Mol Cell Biol & Toxicol, Nanjing, Peoples R China	University of British Columbia; Vancouver Coastal Health Research Institute; Nanjing Medical University	Li, G (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	gangli@interchange.ubc.ca	Li, Gang/A-8257-2011	Jafarnejad, Seyed Mehdi/0000-0002-5129-7081	Canadian Institutes of Health Research [MOP-84559, MOP-93810]; Cancer Research Society; Canadian Dermatology Foundation; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Canadian Dermatology Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	We thank Drs R Byers and AP Albinos for providing melanoma cell lines, Dr M Garate and Mr K Assi for valuable suggestions, and Dr S Hendy for technical assistance. This study was supported by the Canadian Institutes of Health Research (MOP-84559 and MOP-93810), the Cancer Research Society and the Canadian Dermatology Foundation to GL. AAW is supported by the Postdoctoral Fellowship from Michael Smith Foundation for Health Research.	Adachi Y, 2006, INT J CANCER, V119, P1303, DOI 10.1002/ijc.22006; Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Bravou V, 2003, BRIT J CANCER, V89, P2340, DOI 10.1038/sj.bjc.6601482; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Delrieu I, 1999, BIOCHEM J, V340, P201, DOI 10.1042/0264-6021:3400201; Dutcher J P, 2001, Curr Oncol Rep, V3, P353, DOI 10.1007/s11912-001-0089-1; Gao K, 2006, CANCER RES, V66, P8382, DOI 10.1158/0008-5472.CAN-05-4402; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Ito R, 2003, VIRCHOWS ARCH, V442, P118, DOI 10.1007/s00428-002-0718-6; Jee SH, 2004, J INVEST DERMATOL, V123, P1169, DOI 10.1111/j.0022-202X.2004.23497.x; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Karst AM, 2009, INT J CANCER, V124, P494, DOI 10.1002/ijc.23973; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Mahnke JL, 2000, FERTIL STERIL, V73, P166, DOI 10.1016/S0015-0282(99)00466-5; Matsui H, 1999, CARDIOVASC RES, V42, P104, DOI 10.1016/S0008-6363(98)00285-5; Mouawad R, 2002, CYTOKINES CELL MOL T, V7, P151, DOI 10.1080/13684730210002328; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Saidi A, 2009, INT J CANCER, V125, P1054, DOI 10.1002/ijc.24380; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Tan C, 2002, J BIOL CHEM, V277, P3109, DOI 10.1074/jbc.M108673200; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Watanabe M, 2005, BIOL PROCED ONLINE, V7, P41, DOI 10.1251/bpo104; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wong RPC, 2007, MOL CANCER THER, V6, P1692, DOI 10.1158/1535-7163.MCT-07-0134; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113	48	62	69	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	24					2778	2788		10.1038/onc.2010.644	http://dx.doi.org/10.1038/onc.2010.644			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21278793				2022-12-25	WOS:000291678500008
J	Hwang-Verslues, WW; Chang, PH; Wei, PC; Yang, CY; Huang, CK; Kuo, WH; Shew, JY; Chang, KJ; Lee, EYHP; Lee, WH				Hwang-Verslues, W. W.; Chang, P-H; Wei, P-C; Yang, C-Y; Huang, C-K; Kuo, W-H; Shew, J-Y; Chang, K-J; Lee, E. Y-H P.; Lee, W-H			miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1	ONCOGENE			English	Article						miR-495; breast cancer stem cell; REDD1; E-cadherin; E12/E47; hypoxia resistance	INDUCIBLE FACTORS; SELF-RENEWAL; EXPRESSION; MICRORNA; METASTASIS; GROWTH; GENES; MTOR; PROLIFERATION; ACTIVATION	MicroRNAs (miRNAs) are involved in tumorigenecity by regulating specific oncogenes and tumor suppressor genes, and their roles in breast cancer stem cells (BCSCs) are becoming apparent. Distinct from the CD44(+)/CD24(-/low) sub-population, we have isolated a novel PROCR(+)/ESA(+) BCSC sub-population. To explore miRNA-regulatory mechanisms in this sub-population, we performed miRNA expression profiling and found miR-495 as the most highly upegulated miRNA in PROCR(+)/ESA(+) cells. Coincidently, high upregulation of miR-495 was also found in CD44(+)/CD24(-/low) BCSCs, reflecting its potential importance in maintaining common BCSC properties. Ectopic expression of miR-495 in breast cancer cells promoted their colony formation in vitro and tumorigenesis in mice. miR-495 directly suppressed E-cadherin expression to promote cell invasion and inhibited REDD1 expression to enhance cell proliferation in hypoxia through post-transcriptional mechanism. miR-495 expression was directly modulated by transcription factor E12/E47, which itself is highly expressed in BCSCs. These findings reveal a novel regulatory pathway centered on miR-495 that contributes to BCSC properties and hypoxia resistance. Oncogene (2011) 30, 2463-2474; doi:10.1038/onc.2010.618; published online 24 January 2011	[Lee, W-H] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Hwang-Verslues, W. W.; Chang, P-H; Wei, P-C; Yang, C-Y; Huang, C-K; Shew, J-Y; Lee, E. Y-H P.; Lee, W-H] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, W-H; Chang, K-J] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chang, K-J] Cheng Ching Gen Hosp, Taichung, Taiwan; [Lee, E. Y-H P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu		KUO, WEN-HUNG/0000-0002-9881-4605; Wei, Pei-Chi/0000-0002-3309-0511; Chang, King jen/0000-0001-9811-3422; Hwang-Verslues, Wendy/0000-0002-0383-1710	Academia Sinica [2371, 4012]; Postdocotral Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); Postdocotral Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Academia Sinica Peak Project (grant number 2371, 4012); and an Academia Sinica Distinguished Postdocotral Fellowship and a Postdocotral Research Fellowship to WWHV. We thank Dr Paul E Verslues (Institute of Plant and Microbial Biology, Academia Sinica) for critical proofreading of the manuscript and Ms Meng-Han Wang for her kind assistance through this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Yang XM, 2009, BREAST CANCER RES TR, V117, P423, DOI 10.1007/s10549-008-0133-z; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	44	157	164	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	21					2463	2474		10.1038/onc.2010.618	http://dx.doi.org/10.1038/onc.2010.618			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21258409				2022-12-25	WOS:000291008000008
J	Shechtman, CF; Henneberry, AL; Seimon, TA; Tinkelenberg, AH; Wilcox, LJ; Lee, E; Fazlollahi, M; Munkacsi, AB; Bussemaker, HJ; Tabas, I; Sturley, SL				Shechtman, Caryn F.; Henneberry, Annette L.; Seimon, Tracie A.; Tinkelenberg, Arthur H.; Wilcox, Lisa J.; Lee, Eunjee; Fazlollahi, Mina; Munkacsi, Andrew B.; Bussemaker, Harmen J.; Tabas, Ira; Sturley, Stephen L.			Loss of Subcellular Lipid Transport Due to ARV1 Deficiency Disrupts Organelle Homeostasis and Activates the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; FUNCTIONAL-ANALYSIS; MEMBRANE-PROTEINS; GENE-EXPRESSION; QUALITY-CONTROL; MESSENGER-RNA; YEAST ARV1; CHOLESTEROL	The ARV1-encoded protein mediates sterol transport from the endoplasmic reticulum (ER) to the plasma membrane. Yeast ARV1 mutants accumulate multiple lipids in the ER and are sensitive to pharmacological modulators of both sterol and sphingolipid metabolism. Using fluorescent and electron microscopy, we demonstrate sterol accumulation, subcellular membrane expansion, elevated lipid droplet formation, and vacuolar fragmentation in ARV1 mutants. Motif-based regression analysis of ARV1 deletion transcription profiles indicates activation of Hac1p, an integral component of the unfolded protein response (UPR). Accordingly, we show constitutive splicing of HAC1 transcripts, induction of a UPR reporter, and elevated expression of UPR targets in ARV1 mutants. IRE1, encoding the unfolded protein sensor in the ER lumen, exhibits a lethal genetic interaction with ARV1, indicating a viability requirement for the UPR in cells lacking ARV1. Surprisingly, ARV1 mutants expressing a variant of Ire1p defective in sensing unfolded proteins are viable. Moreover, these strains also exhibit constitutive HAC1 splicing that interacts with DTT-mediated perturbation of protein folding. These data suggest that a component of UPR induction in arv1 Delta strains is distinct from protein misfolding. Decreased ARV1 expression in murine macrophages also results in UPR induction, particularly up-regulation of activating transcription factor-4, CHOP (C/EBP homologous protein), and apoptosis. Cholesterol loading or inhibition of cholesterol esterification further elevated CHOP expression in ARV1 knockdown cells. Thus, loss or down-regulation of ARV1 disturbs membrane and lipid homeostasis, resulting in a disruption of ER integrity, one consequence of which is induction of the UPR.	[Shechtman, Caryn F.; Henneberry, Annette L.; Tinkelenberg, Arthur H.; Wilcox, Lisa J.; Tabas, Ira; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Munkacsi, Andrew B.; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Seimon, Tracie A.; Tabas, Ira] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Med Ctr, Dept Anat & Cell Biol, New York, NY 10032 USA; [Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Lee, Eunjee; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Fazlollahi, Mina] Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu		Munkacsi, Andrew/0000-0003-3033-395X	National Institutes of Health [DK54320, 5TL1RR02415803, T32GM008798, T32GM082797, R01HG003008, U54CA121852, HL075662, HL057560]; American Heart Association [0735594T]; American Diabetes Association; Ara Parseghian Medical Research Foundation; Canadian Institutes of Health Research; National Institutes of Health, NHLBI [T32HL07343]; Charles H. Revson Foundation; Irving Institute for Clinical and Translational Research (National Institutes of Health) [UL1 RR024156]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL075662, R01HL057560] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, T32GM082797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); Ara Parseghian Medical Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Charles H. Revson Foundation; Irving Institute for Clinical and Translational Research (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54320 (to S. L. S.). This work was also supported by the American Heart Association, the American Diabetes Association, and the Ara Parseghian Medical Research Foundation.; Supported by National Institutes of Health, Clinical and Translational Science Award Training Grant 5TL1RR02415803.; Supported by a fellowship from the Canadian Institutes of Health Research.; Supported by American Heart Association Grant 0735594T.; Supported by a National Institutes of Health, NHLBI, postdoctoral training fellowship in atherosclerosis (Grant T32HL07343).; Supported by National Institutes of Health Training Grant T32GM008798.; Supported by National Institutes of Health Training Grant T32GM082797.; Supported by the Charles H. Revson Foundation and the Irving Institute for Clinical and Translational Research (National Institutes of Health Grant UL1 RR024156).; Supported by National Institutes of Health Grants R01HG003008 and U54CA121852.; Supported by National Institutes of Health Grants HL075662 and HL057560.	Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gulati S, 2010, PROG LIPID RES, V49, P353, DOI 10.1016/j.plipres.2010.03.003; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Lee E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.64; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; NISHIMURA H, 1992, FEBS LETT, V297, P155, DOI 10.1016/0014-5793(92)80349-L; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; REINHART MP, 1990, EXPERIENTIA, V46, P599, DOI 10.1007/BF01939699; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong FM, 2010, J BIOL CHEM, V285, P33632, DOI 10.1074/jbc.M110.165761; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	49	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.215038	http://dx.doi.org/10.1074/jbc.M110.215038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21266578	hybrid, Green Published			2022-12-25	WOS:000289077500008
J	Gambus, A; Khoudoli, GA; Jones, RC; Blow, JJ				Gambus, Agnieszka; Khoudoli, Guennadi A.; Jones, Richard C.; Blow, J. Julian			MCM2-7 Form Double Hexamers at Licensed Origins in Xenopus Egg Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; MINICHROMOSOME MAINTENANCE PROTEIN; DORMANT ORIGINS; HUMAN-CELLS; HELICASE ACTIVITY; EXCESS MCM2-7; GINS COMPLEX; S-PHASE; CDC45; INITIATION	In late mitosis and G1, Mcm2-7 are assembled onto replication origins to license them for initiation in the upcoming S phase. After initiation, Mcm2-7 provide helicase activity to unwind DNA at the replication fork. Here we examine the structure of Mcm2-7 on chromatin in Xenopus egg extracts. We show that prior to replication initiation, Mcm2-7 is present at licensed replication origins in a complex with a molecular mass close to double that of the Mcm2-7 hexamer. This complex has approximately stoichiometric quantities of the 6 Mcm2-7 proteins and we conclude that it consists of a double heterohexamer. This provides a configuration potentially capable of initiating a pair of bidirectional replication forks in S phase. We also show that after initiation, Mcm2-7 associate with Cdc45 and GINS to form a relatively stable CMG (Cdc45-MCM-GINS) complex. The CMG proteins also associate less strongly with other replication proteins, consistent with the idea that a single CMG complex forms the core of the replisome.	[Gambus, Agnieszka; Khoudoli, Guennadi A.; Blow, J. Julian] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Jones, Richard C.] NextGen Sci Inc, Ann Arbor, MI 48108 USA	University of Dundee	Blow, JJ (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland.	j.j.blow@dundee.ac.uk	Gambus, Aga/AAK-4687-2021; Blow, J. Julian/B-3977-2009	Gambus, Aga/0000-0002-4648-0332; Blow, J. Julian/0000-0002-9524-5849	CRUK [C303/A3135, C303/A8102, C303/A7399, C303/A5434]; BBSRC [BB/H013024/1]; Wellcome Trust [08136/Z/06/Z, 083524/Z/07/Z]; Biotechnology and Biological Sciences Research Council [BB/H013024/1] Funding Source: researchfish	CRUK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by CRUK (Grants C303/A3135, C303/A8102, C303/A7399, and C303/A5434, BBSRC (Grant BB/H013024/1), and the Wellcome Trust (Grants 08136/Z/06/Z and 083524/Z/07/Z).	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; DINGMAN CW, 1974, J THEOR BIOL, V43, P187, DOI 10.1016/S0022-5193(74)80052-4; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Falaschi A, 2000, TRENDS GENET, V16, P88, DOI 10.1016/S0168-9525(99)01917-4; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Frolova NS, 2002, MOL BIOL CELL, V13, P1298, DOI 10.1091/mbc.01-08-0382; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Khoudoli GA, 2008, CURR BIOL, V18, P838, DOI 10.1016/j.cub.2008.04.075; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2001, CURR OPIN GENET DEV, V11, P64, DOI 10.1016/S0959-437X(00)00158-1; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Wigley DB, 2009, CURR OPIN STRUC BIOL, V19, P72, DOI 10.1016/j.sbi.2008.12.010; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	48	95	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11855	11864		10.1074/jbc.M110.199521	http://dx.doi.org/10.1074/jbc.M110.199521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282109	hybrid, Green Published			2022-12-25	WOS:000288797100092
J	Marquer, C; Devauges, V; Cossec, JC; Liot, G; Lecart, S; Saudou, F; Duyckaerts, C; Leveque-Fort, S; Potier, MC				Marquer, Catherine; Devauges, Viviane; Cossec, Jack-Christophe; Liot, Geraldine; Lecart, Sandrine; Saudou, Frederic; Duyckaerts, Charles; Leveque-Fort, Sandrine; Potier, Marie-Claude			Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid peptide; fluorescence microscopy	FLUORESCENCE CORRELATION SPECTROSCOPY; CLATHRIN-DEPENDENT MECHANISM; ALZHEIMERS-DISEASE; BETA-SECRETASE; MEMBRANE CHOLESTEROL; HIPPOCAMPAL-NEURONS; BACE; MICROSCOPY; RECEPTOR; PATHWAY	Amyloid peptide (A beta) is generated by sequential cleavage of the amyloid precursor protein (APP) by beta-secretase (Bace1) and gamma-secretase. A beta production increases after plasma membrane cholesterol loading through unknown mechanisms. To determine how APP-Bace1 proximity affects this phenomenon, we developed a fluorescence lifetime imaging microscopy-Forster resonance energy transfer (FLIM-FRET) technique for visualization of these molecules either by epifluorescence or at the plasma membrane only using total internal reflection fluorescence. Further, we used fluorescence correlation spectroscopy to determine the lipid rafts partition of APP-yellow fluorescent protein (YFP) and Bace1-green fluorescent protein (GFP) molecules at the plasma membrane of neurons. We show that less than 10 min after cholesterol exposure, Bace1-GFP/APP-mCherry proximity increases selectively at the membrane and APP relocalizes to raft domains, preceded by rapid endocytosis. After longer cholesterol exposures, APP and Bace1 are found in proximity intracellularly. We demonstrate that cholesterol loading does not increase A beta production by having a direct impact on Bace1 catalytic activity but rather by altering the accessibility of Bace1 to its substrate, APP. This change in accessibility is mediated by clustering in lipid rafts, followed by rapid endocytosis.-Marquer, C., Devauges, V., Cossec, J.-C., Liot, G., Lecart, S., Saudou, F., Duyckaerts, C., Leveque-Fort, S., Potier, M.-C. Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J. 25, 1295-1305 (2011). www.fasebj.org	[Marquer, Catherine; Cossec, Jack-Christophe; Duyckaerts, Charles; Potier, Marie-Claude] UPMC, Hop La Pitie Salpetriere, CRICM, INSERM UMR S975,CNRS UMR7225, F-75013 Paris, France; [Devauges, Viviane; Lecart, Sandrine; Leveque-Fort, Sandrine] Univ Paris 11, Ctr Laser, Ctr Photon Biomed, FR2764, Orsay, France; [Devauges, Viviane; Leveque-Fort, Sandrine] Univ Paris 11, CNRS UMR8214, Inst Sci Mol Orsay, Orsay, France; [Liot, Geraldine; Saudou, Frederic] CNRS, INSERM, Inst Curie, Unite Signalisat Neurobiol & Canc,UMR3306,U1005, F-91405 Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Potier, MC (corresponding author), UPMC, Hop La Pitie Salpetriere, CRICM, INSERM UMR S975,CNRS UMR7225, F-75013 Paris, France.	marie-claude.potier@upmc.fr	SAUDOU, Frédéric/L-3454-2014	SAUDOU, Frédéric/0000-0001-6107-1046; Potier, Marie-Claude/0000-0003-2462-7150; Cossec, Jack-Christophe/0000-0002-0836-1009; Leveque-Fort, Sandrine/0000-0002-9218-3363; Liot, Geraldine/0000-0002-4784-7693	Ministere de la Recherche; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche; Fondation Institut du Cerveau et de la Moelle	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Institut du Cerveau et de la Moelle	The authors gratefully acknowledge Ghislaine Grange and Emilie Jaumain for expert technical help. The authors thank Diana Zala and Adina Lazar for fruitful discussions, and Dr. Bradley Hyman (Massachusetts General Hospital, Charlestown, MA, USA), Dr. Frederic Checler (Institut de Pharmacologie Moleculaire et Cellulaire, Valbonne, France), and Dr. Christoph Kaether (Fritz Lipmann Institute, Leibniz, Germany) for their kind gifts of plasmid. V. D. had a fellowship from Ministere de la Recherche. J.C.C. had a fellowship from Ministere de la Recherche and Fondation pour la Recherche Medicale. This work was supported by a grant from Agence Nationale de la Recherche. The authors are also grateful to the Fondation Institut du Cerveau et de la Moelle for their financial support. The authors declare no conflict of interest.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ALLINQUANT B, 1994, J NEUROSCI, V14, P6842; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Blandin P, 2009, APPL OPTICS, V48, P553, DOI 10.1364/AO.48.000553; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P839, DOI 10.1016/j.bbalip.2010.03.010; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu WW, 2009, J NEUROCHEM, V108, P341, DOI 10.1111/j.1471-4159.2008.05753.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Panchal M, 2010, J LIPID RES, V51, P598, DOI 10.1194/jlr.M001859; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Requejo-Isidro J, 2004, OPT LETT, V29, P2249, DOI 10.1364/OL.29.002249; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; von Arnim CAF, 2008, BIOCHEM BIOPH RES CO, V370, P207, DOI 10.1016/j.bbrc.2008.03.047; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com	51	124	131	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1295	1305		10.1096/fj.10-168633	http://dx.doi.org/10.1096/fj.10-168633			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21257714				2022-12-25	WOS:000288982800018
J	Szeto, GL; Pomerantz, JL; Graham, DRM; Clements, JE				Szeto, Gregory L.; Pomerantz, Joel L.; Graham, David R. M.; Clements, Janice E.			Minocycline Suppresses Activation of Nuclear Factor of Activated T Cells 1 (NFAT1) in Human CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; LYMPHOCYTE-ACTIVATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CALCIUM; FAMILY; LUPUS; CA2+	Minocycline is a tetracycline family antibiotic that has anti-inflammatory and immunomodulatory properties. These properties have shown promise in the treatment of conditions such as rheumatoid arthritis, Huntington disease, and multiple sclerosis. As lymphocyte activation is involved in the pathogenesis of many of these diseases, T cells are postulated to be a primary target in minocycline therapy. Previous studies have demonstrated attenuation of CD4(+) T cell activation by minocycline, but a specific mechanism has not been elucidated. In this study, we investigated the effect of minocycline on the activity of three key transcription factors regulating CD4(+) T cell activation: NF-kappa B, AP-1 (activator protein 1), and NFAT (nuclear factor of activated T) cells. Our data demonstrate that minocycline selectively impairs NFAT-mediated transcriptional activation, a result of increased phosphorylation and reduced nuclear translocation of the isoform NFAT1. Minocycline increased the activity of the NFAT kinase GSK3 and decreased intracellular Ca2+ flux, both of which facilitate NFAT1 phosphorylation. These findings provide a novel mechanism for minocycline induced suppression of CD4(+) T cell activation and may better inform the application of minocycline as an immunomodulatory agent.	[Szeto, Gregory L.; Graham, David R. M.; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Pomerantz, Joel L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Graham, David R. M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Clements, JE (corresponding author), 733 N Broadway,BRB 839, Baltimore, MD 21205 USA.	jclement@jhmi.edu	Szeto, Gregory/N-9648-2019; Szeto, Gregory/A-6932-2013	Szeto, Gregory/0000-0001-7604-1333; Szeto, Gregory/0000-0001-7604-1333; Pomerantz, Joel L./0000-0002-5030-1018	National Institutes of Health [NS055648, MH087233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055648 and MH087233.	ALBERT PR, 1984, J BIOL CHEM, V259, P5350; Antonenko YN, 2010, J BIOENERG BIOMEMBR, V42, P151, DOI 10.1007/s10863-010-9271-1; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; BRION M, 1981, INORG CHIM A-BIOINOR, V55, P47, DOI 10.1016/S0020-1693(00)90781-3; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cron RQ, 2001, DNA CELL BIOL, V20, P761, DOI 10.1089/104454901753438570; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Fernandez-Gomez FJ, 2005, NEUROSCIENCE, V133, P959, DOI 10.1016/j.neuroscience.2005.03.019; Fujii Y, 2006, CLIN IMMUNOL, V119, P297, DOI 10.1016/j.clim.2006.01.001; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Giuliani F, 2005, J LEUKOCYTE BIOL, V78, P135, DOI 10.1189/jlb.0804477; GOMEZ DA, 2000, J BIOL CHEM, V275, P13872; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Kloppenburg M, 1995, CLIN EXP IMMUNOL, V102, P635; Kyttaris VC, 2007, J IMMUNOL, V178, P1960, DOI 10.4049/jimmunol.178.3.1960; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lori F, 2008, CURR OPIN HIV AIDS, V3, P99, DOI 10.1097/COH.0b013e3282f525cf; Luo C, 1996, MOL CELL BIOL, V16, P3955; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mehta J, 2010, ARTHRITIS RHEUM-US, V62, P2499, DOI 10.1002/art.27554; Midtvedt K., 2004, TRANSPL P, V36, p430S; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Nikodemova M, 2010, J NEUROIMMUNOL, V219, P33, DOI 10.1016/j.jneuroim.2009.11.009; O'Dell JR, 1999, ARTHRITIS RHEUM, V42, P1691, DOI 10.1002/1529-0131(199908)42:8<1691::AID-ANR18>3.0.CO;2-S; ODell JR, 1997, ARTHRITIS RHEUM, V40, P842, DOI 10.1002/art.1780400510; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Pessler F, 2004, GENES IMMUN, V5, P158, DOI 10.1038/sj.gene.6364047; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Robichaud GA, 2002, J BIOL CHEM, V277, P23733, DOI 10.1074/jbc.M201563200; Schlienger RG, 2000, DERMATOLOGY, V200, P223, DOI 10.1159/000018387; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; SIMMONDS P, 1991, LANCET, V338, P1159, DOI 10.1016/0140-6736(91)92029-2; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; TILLEY BC, 1995, ANN INTERN MED, V122, P81, DOI 10.7326/0003-4819-122-2-199501150-00001; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	59	37	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11275	11282		10.1074/jbc.M110.210518	http://dx.doi.org/10.1074/jbc.M110.210518			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282105	Green Published, hybrid			2022-12-25	WOS:000288797100039
J	Bekes, M; Prudden, J; Srikumar, T; Raught, B; Boddy, MN; Salvesen, GS				Bekes, Miklos; Prudden, John; Srikumar, Tharan; Raught, Brian; Boddy, Michael N.; Salvesen, Guy S.			The Dynamics and Mechanism of SUMO Chain Deconjugation by SUMO-specific Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CONJUGATION SITES; MASS-SPECTROMETRY; POLYUBIQUITIN CHAINS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CELL-DIVISION; ACTIVE-SITE; UBIQUITIN; COMPLEX; SUMOYLATION	SUMOylation of proteins is a cyclic process that requires both conjugation and deconjugation of SUMO moieties. Besides modification by a single SUMO, SUMO chains have also been observed, yet the dynamics of SUMO conjugation/deconjugation remain poorly understood. Using a non-deconjugatable form of SUMO we demonstrate the underappreciated existence of SUMO chains in vivo, we highlight the importance of SUMO deconjugation, and we demonstrate the highly dynamic nature of the SUMO system. We show that SUMO-specific proteases (SENPs) play a crucial role in the dynamics of SUMO chains in vivo by constant deconjugation. Preventing deSUMOylation in Schizosaccharomyces pombe results in slow growth and a sensitivity to replication stress, highlighting the biological requirement for deSUMOylation dynamics. Furthermore, we present the mechanism of SUMO chain deconjugation by SENPs, which occurs via a stochastic mechanism, resulting in cleavage anywhere within a chain. Our results offer mechanistic insights into the workings of deSUMOylating proteases and highlight their importance in the homeostasis of (poly)SUMO-modified substrates.	[Bekes, Miklos; Salvesen, Guy S.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Bekes, Miklos; Salvesen, Guy S.] Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92037 USA; [Prudden, John; Boddy, Michael N.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Srikumar, Tharan; Raught, Brian] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Srikumar, Tharan; Raught, Brian] MaRS Ctr, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Scripps Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Salvesen, GS (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@sanfordburnham.org	Srikumar, Tharan/Q-5642-2016		National Institutes of Health (NIH) [GM068608, GM081840, AI061139, NS061758, RR020843]; Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068608, R01GM081840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061758] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants GM068608 and GM081840, a Scholar Award from the Leukemia and Lymphoma Society, and NIH Grants AI061139, NS061758, and RR020843 (to M. N. B. and G. S. S.).	Bekes M, 2010, BIOCHEM RES TRENDS, P5; Borges HL, 2005, P NATL ACAD SCI USA, V102, P15587, DOI 10.1073/pnas.0503925102; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; DAHLBACK B, 1995, THROMB HAEMOSTASIS, V74, P139; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2010, NAT PROTOC, V5, P873, DOI 10.1038/nprot.2010.40; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jeram SM, 2010, PROTEOMICS, V10, P254, DOI 10.1002/pmic.200900648; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; KOLLI N, 2010, BIOCH J; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Srikumar T, 2010, PROTEOMICS, V10, P337, DOI 10.1002/pmic.200900627; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; SYDORSKYY Y, 2010, MOL CELL BIOL; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	60	59	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10238	10247		10.1074/jbc.M110.205153	http://dx.doi.org/10.1074/jbc.M110.205153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247896	hybrid, Green Published			2022-12-25	WOS:000288547000041
J	Hatakeyama, T; Kamiya, T; Kusunoki, M; Nakamura-Tsuruta, S; Hirabayashi, J; Goda, S; Unno, H				Hatakeyama, Tomomitsu; Kamiya, Takuro; Kusunoki, Masami; Nakamura-Tsuruta, Sachiko; Hirabayashi, Jun; Goda, Shuichiro; Unno, Hideaki			Galactose Recognition by a Tetrameric C-type Lectin, CEL-IV, Containing the EPN Carbohydrate Recognition Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVERTEBRATE CUCUMARIA-ECHINATA; MANNOSE-BINDING PROTEINS; AMINO-ACID-SEQUENCE; POLYANDROCARPA-MISAKIENSIS; N-ACETYLGALACTOSAMINE; ANIMAL LECTINS; DOMAIN; RICIN; EXPRESSION; APOPTOSIS	CEL-IV is a C-type lectin isolated from a sea cucumber, Cucumaria echinata. This lectin is composed of four identical C-type carbohydrate- recognition domains (CRDs). X-ray crystallographic analysis of CEL-IV revealed that its tetrameric structure was stabilized by multiple interchain disulfide bonds among the subunits. Although CEL-IV has the EPN motif in its carbohydrate- binding sites, which is known to be characteristic of mannose binding C-type CRDs, it showed preferential binding of galactose and N-acetylgalactosamine. Structural analyses of CEL-IV-melibiose and CEL-IV-raffinose complexes revealed that their galactose residues were recognized in an inverted orientation compared with mannose binding C-type CRDs containing the EPN motif, by the aid of a stacking interaction with the side chain of Trp-79. Changes in the environment of Trp-79 induced by binding to galactose were detected by changes in the intrinsic fluorescence and UV absorption spectra of WT CEL-IV and its site-directed mutants. The binding specificity of CEL-IV toward complex oligosaccharides was analyzed by frontal affinity chromatography using various pyridylamino sugars, and the results indicate preferential binding to oligosaccharides containing Gal beta 1-3/4(Fuc alpha 1-3/4) GlcNAc structures. These findings suggest that the specificity for oligosaccharides may be largely affected by interactions with amino acid residues in the binding site other than those determining the monosaccharide specificity.	[Hatakeyama, Tomomitsu; Kamiya, Takuro; Goda, Shuichiro; Unno, Hideaki] Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528521, Japan; [Kusunoki, Masami] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan; [Nakamura-Tsuruta, Sachiko; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Nagasaki University; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Hatakeyama, T (corresponding author), Nagasaki Univ, Fac Engn, Dept Appl Chem, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp	Hirabayashi, Jun/M-3998-2018; Hideaki, UNNO/ABG-9471-2020; Goda, Shuichiro/E-7177-2013	Hirabayashi, Jun/0000-0002-8571-359X; Hideaki, UNNO/0000-0001-5917-269X; Goda, Shuichiro/0000-0002-0525-6887; Hatakeyama, Tomomitsu/0000-0002-9505-1980	Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science [20580100]	Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was conducted under the Cooperative Research Program of Institute for Protein Research, Osaka University and was supported by Grant-in-aid for Scientific Research 20580100 from the Japan Society for the Promotion of Science.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; COWGILL RW, 1967, BIOCHIM BIOPHYS ACTA, V133, P6, DOI 10.1016/0005-2795(67)90034-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Gourdine JP, 2008, J BIOL CHEM, V283, P30112, DOI 10.1074/jbc.M804353200; HATAKEYAMA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1314, DOI 10.1271/bbb.59.1314; Hatakeyama T, 2006, BBA-GEN SUBJECTS, V1760, P318, DOI 10.1016/j.bbagen.2006.01.011; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatakeyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P157, DOI 10.1271/bbb.66.157; Hatakeyama T, 2007, J BIOL CHEM, V282, P37826, DOI 10.1074/jbc.M705604200; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Hirabayashi J, 2004, GLYCOCONJUGATE J, V21, P35, DOI 10.1023/B:GLYC.0000043745.18988.a1; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; Hosono M, 2005, BBA-GEN SUBJECTS, V1725, P160, DOI 10.1016/j.bbagen.2005.07.009; IOBST ST, 1994, J BIOL CHEM, V269, P15512; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kuramoto T, 2005, J BIOCHEM, V137, P41, DOI 10.1093/jb/mvi005; Kuroda J, 2010, MOL CANCER RES, V8, P994, DOI 10.1158/1541-7786.MCR-10-0040; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Liu B, 2008, BMB REP, V41, P369, DOI 10.5483/BMBRep.2008.41.5.369; Liu YC, 2007, MOL IMMUNOL, V44, P598, DOI 10.1016/j.molimm.2006.01.015; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura S, 2005, FEBS J, V272, P2784, DOI 10.1111/j.1742-4658.2005.04698.x; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; SundarRaj S, 2009, MOL IMMUNOL, V46, P3411, DOI 10.1016/j.molimm.2009.07.013; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; Tasumi S, 2002, J BIOL CHEM, V277, P27305, DOI 10.1074/jbc.M202648200; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; Yamanishi T, 2007, J BIOCHEM, V142, P587, DOI 10.1093/jb/mvm164; YAMASAKI N, 1985, J BIOCHEM-TOKYO, V98, P1555, DOI 10.1093/oxfordjournals.jbchem.a135424; YANARI S, 1960, J BIOL CHEM, V235, P2818; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	43	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10305	10315		10.1074/jbc.M110.200576	http://dx.doi.org/10.1074/jbc.M110.200576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247895	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000288547000048
J	Zimmer, SL; McEvoy, SM; Li, J; Qu, J; Read, LK				Zimmer, Sara L.; McEvoy, Sarah M.; Li, Jun; Qu, Jun; Read, Laurie K.			A Novel Member of the RNase D Exoribonuclease Family Functions in Mitochondrial Guide RNA Metabolism in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-CYCLE STAGES; INDUCIBLE EXPRESSION SYSTEM; MESSENGER-RNA; ESCHERICHIA-COLI; RIBOSOMAL-RNA; DEVELOPMENTAL REGULATION; NADH DEHYDROGENASE; APOCYTOCHROME-B; BINDING COMPLEX; ZINC-FINGER	RNA turnover and RNA editing are essential for regulation of mitochondrial gene expression in Trypanosoma brucei. RNA turnover is controlled in part by RNA 3' adenylation and uridylation status, with trans-acting factors also impacting RNA homeostasis. However, little is known about the mitochondrial degradation machinery or its regulation in T. brucei. We have identified a mitochondrial exoribonuclease, TbRND, whose expression is highly up-regulated in the insect proliferative stage of the parasite. TbRND shares sequence similarity with RNase D family enzymes but differs from all reported members of this family in possessing a CCHC zinc finger domain. In vitro, TbRND exhibits 3' to 5' exoribonuclease activity, with specificity toward uridine homopolymers, including the 3' oligo(U) tails of guide RNAs (gRNAs) that provide the sequence information for RNA editing. Several lines of evidence generated from RNAi-mediated knockdown and overexpression cell lines indicate that TbRND functions in gRNA metabolism in vivo. First, TbRND depletion results in gRNA tails extended by 2-3 nucleotides on average. Second, overexpression of wild type but not catalytically inactive TbRND results in a substantial decrease in the total gRNA population and a consequent inhibition of RNA editing. The observed effects on the gRNA population are specific as rRNAs, which are also 3'-uridylated, are unaffected by TbRND depletion or overexpression. Finally, we show that gRNA binding proteins co-purify with TbRND. In summary, TbRND is a novel 3' to 5' exoribonuclease that appears to have evolved a function highly specific to the mitochondrion of trypanosomes.	[Zimmer, Sara L.; McEvoy, Sarah M.; Read, Laurie K.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Amherst, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Read, LK (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA.	lread@buffalo.edu	Li, Jun/N-3806-2014	Li, Jun/0000-0001-9940-3421; Zimmer, Sara/0000-0002-1707-1839	National Institutes of Health [RO1 AI077520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI077520 (to L. K. R.).	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; ADLER BK, 1991, MOL CELL BIOL, V11, P5878, DOI 10.1128/MCB.11.12.5878; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Aphasizheva I, 2010, MOL CELL BIOL, V30, P1555, DOI 10.1128/MCB.01281-09; Aphasizheva I, 2009, RNA, V15, P1322, DOI 10.1261/rna.1538809; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; BHAT GJ, 1992, MOL BIOCHEM PARASIT, V52, P231, DOI 10.1016/0166-6851(92)90055-O; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Clay NK, 2005, PLANT CELL, V17, P1994, DOI 10.1105/tpc.105.032771; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; CUDNY H, 1981, J BIOL CHEM, V256, P5633; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; FEAGIN JE, 1985, NUCLEIC ACIDS RES, V13, P4577, DOI 10.1093/nar/13.12.4577; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; Grams J, 2000, EMBO J, V19, P5525, DOI 10.1093/emboj/19.20.5525; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Henriksson N, 2010, J BIOL CHEM, V285, P163, DOI 10.1074/jbc.M109.043893; Hernandez A, 2010, J BIOL CHEM, V285, P1220, DOI 10.1074/jbc.M109.051862; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Jensen BC, 2007, MOL BIOCHEM PARASIT, V151, P28, DOI 10.1016/j.molbiopara.2006.10.002; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Kao CY, 2007, MOL BIOCHEM PARASIT, V154, P158, DOI 10.1016/j.molbiopara.2007.04.014; Kao CY, 2005, MOL CELL BIOL, V25, P1634, DOI 10.1128/MCB.25.5.1634-1644.2005; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Koslowsky DJ, 1997, MOL BIOCHEM PARASIT, V90, P81, DOI 10.1016/S0166-6851(97)00133-3; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; Leung SS, 2001, NUCLEIC ACIDS RES, V29, P703, DOI 10.1093/nar/29.3.703; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Lin-Chao S, 2007, J BIOMED SCI, V14, P523, DOI 10.1007/s11373-007-9178-y; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Malecki M, 2007, J MOL BIOL, V372, P23, DOI 10.1016/j.jmb.2007.06.074; Mattiacio JL, 2008, NUCLEIC ACIDS RES, V36, P319, DOI 10.1093/nar/gkm690; Mattiacio JL, 2009, FEBS LETT, V583, P2333, DOI 10.1016/j.febslet.2009.06.024; Militello KT, 1999, NUCLEIC ACIDS RES, V27, P1377, DOI 10.1093/nar/27.5.1377; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Narayanan N, 2006, BIOCHEMISTRY-US, V45, P12617, DOI 10.1021/bi060925c; Niemann M, 2009, NUCLEIC ACIDS RES, V37, P1897, DOI 10.1093/nar/gkp049; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Penschow JL, 2004, EUKARYOT CELL, V3, P1206, DOI 10.1128/EC.3.5.1206-1216.2004; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; POLLARD VW, 1991, MOL CELL BIOL, V11, P1668, DOI 10.1128/MCB.11.3.1668; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; READ LK, 1994, MOL BIOCHEM PARASIT, V68, P297, DOI 10.1016/0166-6851(94)90174-0; READ LK, 1992, J BIOL CHEM, V267, P1123; READ LK, 1994, MOL CELL BIOL, V14, P2629, DOI 10.1128/MCB.14.4.2629; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; RILEY GR, 1994, J BIOL CHEM, V269, P6101; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; ROUSSELL DL, 1993, P NATL ACAD SCI USA, V90, P9300, DOI 10.1073/pnas.90.20.9300; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Ryan CM, 2006, MOL BIOCHEM PARASIT, V146, P68, DOI 10.1016/j.molbiopara.2005.10.019; Ryan CM, 2003, J BIOL CHEM, V278, P32753, DOI 10.1074/jbc.M303552200; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SOUZA AE, 1993, MOL CELL BIOL, V13, P6832, DOI 10.1128/MCB.13.11.6832; SOUZA AE, 1992, MOL CELL BIOL, V12, P2100, DOI 10.1128/MCB.12.5.2100; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taghbalout A, 2008, MOL MICROBIOL, V70, P780, DOI 10.1111/j.1365-2958.2008.06457.x; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; WEBB JR, 1993, J BIOL CHEM, V268, P13994; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yu LE, 2006, RNA, V12, P1050, DOI 10.1261/rna.3406; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	106	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10329	10340		10.1074/jbc.M110.152439	http://dx.doi.org/10.1074/jbc.M110.152439			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252235	Green Published, hybrid			2022-12-25	WOS:000288547000050
J	Barbagallo, APM; Wang, ZL; Zheng, H; D'Adamio, L				Barbagallo, Alessia P. M.; Wang, Zilai; Zheng, Hui; D'Adamio, Luciano			A Single Tyrosine Residue in the Amyloid Precursor Protein Intracellular Domain Is Essential for Developmental Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK-INTERACTING PROTEIN-1; NEURAL STEM-CELLS; FAMILY-MEMBERS; DEFICIENT MICE; APP; PHOSPHORYLATION; GENE; FE65; PROLIFERATION; GENERATION	The A beta-precursor protein (APP) intracellular domain is highly conserved and contains many potentially important residues, in particular the (YENPTY687)-Y-682 motif. To dissect the functions of this sequence in vivo, we created an APP knock-in allele mutating Tyr(682) to Gly (Y682G). Crossing this allele to APP-like protein 2 (APLP2) knock-out background showed that mutation of Tyr(682) results in postnatal lethality and neuromuscular synapse defects similar to doubly deficient APP/APLP2 mice. Our results demonstrate that a single residue in the APP intracellular region, Tyr(682), is indispensable for the essential function of APP in developmental regulation.	[Barbagallo, Alessia P. M.; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Wang, Zilai; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [D'Adamio, Luciano] Inst Cellular Biol & Neurobiol, Natl Res Council Italy, I-00143 Rome, Italy	Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; Consiglio Nazionale delle Ricerche (CNR)	D'Adamio, L (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	National Institutes of Health [AG033007, AG020670, AG032051]; Alzheimer Disease Research Grant [A2003-076, NIRG-10-173876]; NATIONAL INSTITUTE ON AGING [R01AG020670, R01AG032051, R01AG033007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Disease Research Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG033007 (to L. D.) and AG020670 and AG032051 (to H.Z.). This work was also supported in part by Alzheimer Disease Research Grants A2003-076 (to L. D.) and NIRG-10-173876 (to A. P. M. B.).	Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hata Y, 1996, J NEUROSCI, V16, P2488; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heber S, 2000, J NEUROSCI, V20, P7951; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Swistowski A, 2009, J NEUROSCI, V29, P15703, DOI 10.1523/JNEUROSCI.4351-09.2009; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tremml P, 1998, BEHAV BRAIN RES, V95, P65, DOI 10.1016/S0166-4328(97)00211-8; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	38	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8717	8721		10.1074/jbc.C111.219873	http://dx.doi.org/10.1074/jbc.C111.219873			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21266574	Green Published, hybrid			2022-12-25	WOS:000288247700002
J	Caccamo, A; Maldonado, MA; Majumder, S; Medina, DX; Holbein, W; Magri, A; Oddo, S				Caccamo, Antonella; Maldonado, Monica A.; Majumder, Smita; Medina, David X.; Holbein, Walter; Magri, Andrea; Oddo, Salvatore			Naturally Secreted Amyloid-beta Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; LONG-TERM-MEMORY; PROTEIN-TAU TAU; P70 S6 KINASE; ALZHEIMERS-DISEASE; A-BETA; LIFE-SPAN; SIGNALING PATHWAY; TRANSGENIC MICE; IN-VIVO	Reducing the mammalian target of rapamycin (mTOR) activity increases lifespan and health span in a variety of organisms. Alterations in protein homeostasis and mTOR activity and signaling have been reported in several neurodegenerative disorders, including Alzheimer disease (AD); however, the causes of such deregulations remain elusive. Here, we show that mTOR activity and signaling are increased in cell lines stably transfected with mutant amyloid precursor protein (APP) and in brains of 3xTg-AD mice, an animal model of AD. In addition, we show that in the 3xTg-AD mice, mTOR activity can be reduced to wild type levels by genetically preventing A beta accumulation. Similarly, intrahippocampal injections of an anti-A beta antibody reduced A beta levels and normalized mTOR activity, indicating that high A beta levels are necessary for mTOR hyperactivity in 3xTg-AD mice. We also show that the intrahippocampal injection of naturally secreted A beta is sufficient to increase mTOR signaling in the brains of wild type mice. The mechanism behind the A beta-induced mTOR hyperactivity is mediated by the proline- rich Akt substrate 40 (PRAS40) as we show that the activation of PRAS40 plays a key role in the A beta-induced mTOR hyperactivity. Taken together, our data show that A beta accumulation, which has been suggested to be the culprit of AD pathogenesis, causes mTOR hyperactivity by regulating PRAS40 phosphorylation. These data further indicate that the mTOR pathway is one of the pathways by which A beta exerts its toxicity and further support the idea that reducing mTOR signaling in AD may be a valid therapeutic approach.	[Caccamo, Antonella; Maldonado, Monica A.; Majumder, Smita; Medina, David X.; Holbein, Walter; Magri, Andrea; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Caccamo, Antonella; Maldonado, Monica A.; Majumder, Smita; Medina, David X.; Magri, Andrea; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Oddo, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	oddo@uthscsa.edu	Magrì, Andrea/K-4580-2016	Magrì, Andrea/0000-0002-3080-2667; Oddo, Salvatore/0000-0001-7304-7430	National Institutes of Health [K99/R00 AG29729-4]; NIA [RC2AG036613]; NATIONAL INSTITUTE ON AGING [R00AG029729, R01AG037637, RC2AG036613, K99AG029729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K99/R00 AG29729-4 (to S. O.) and RC2AG036613 (to S. O., Sub-Principal Investigator) from the NIA.	An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Cao RF, 2009, J NEUROSCI, V29, P12372, DOI 10.1523/JNEUROSCI.3486-09.2009; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Ito S, 2007, EXP GERONTOL, V42, P532, DOI 10.1016/j.exger.2006.11.012; Ito S, 2006, NEUROSCI RES, V56, P294, DOI 10.1016/j.neures.2006.07.009; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Martin D, 2001, J NEUROCHEM, V78, P1000, DOI 10.1046/j.1471-4159.2001.00472.x; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nascimento EBM, 2010, CELL SIGNAL, V22, P961, DOI 10.1016/j.cellsig.2010.02.002; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; Oddo S, 2009, BRAIN PATHOL, V19, P421, DOI 10.1111/j.1750-3639.2008.00194.x; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P33, DOI 10.1073/pnas.0710424105; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang F, 2009, CANCER BIOL THER, V8, P846, DOI 10.4161/cbt.8.9.8210; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	84	119	125	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8924	8932		10.1074/jbc.M110.180638	http://dx.doi.org/10.1074/jbc.M110.180638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21266573	hybrid, Green Published			2022-12-25	WOS:000288247700024
J	Kim, SH; Serezani, CH; Okunishi, K; Zaslona, Z; Aronoff, DM; Peters-Golden, M				Kim, Sang-Hoon; Serezani, Carlos Henrique; Okunishi, Katsuhide; Zaslona, Zbigniew; Aronoff, David M.; Peters-Golden, Marc			Distinct Protein Kinase A Anchoring Proteins Direct Prostaglandin E-2 Modulation of Toll-like Receptor Signaling in Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; CYCLIC-AMP; PERITONEAL-MACROPHAGES; ARACHIDONIC-ACID; HOST-DEFENSE; EXPRESSION; CAMP; INHIBITION; CYCLOOXYGENASE-2	Toll-like receptors (TLRs) direct a proinflammatory program in macrophages. One mediator whose generation is induced by TLR ligation is prostaglandin E-2 (PGE(2)), which is well known to increase intracellular cAMP upon G protein-coupled receptor ligation. How PGE(2)/cAMP shapes the nascent TLR response and the mechanisms by which it acts remain poorly understood. Here we explored PGE(2)/cAMP regulation of NO production in primary rat alveolar macrophages stimulated with the TLR4 ligand LPS. Endogenous PGE(2) synthesis accounted for nearly half of the increment in NO production in response to LPS. The enhancing effect of PGE(2) on LPS-stimulated NO was mediated via cAMP, generated mainly upon ligation of the E prostanoid 2 receptor and acting via protein kinase A (PKA) rather than via the exchange protein activated by cAMP. Isoenzyme-selective cAMP agonists and peptide disruptors of protein kinase A anchoring proteins (AKAPs) implicated PKA regulatory subunit type I (RI) interacting with an AKAP in this process. Gene knockdown of potential RI-interacting AKAPs expressed in alveolar macrophages revealed that AKAP10 was required for PGE(2) potentiation of LPS-induced NO synthesis. AKAP10 also mediated PGE(2) potentiation of the expression of cytokines IL-10 and IL-6, whereas PGE(2) suppression of TNF-alpha was mediated by AKAP8-anchored PKA-RII. Our data illustrate the pleiotropic manner in which G protein-coupled receptor-derived cAMP signaling can influence TLR responses in primary macrophages and suggest that AKAP10 may coordinate increases in gene expression.	[Kim, Sang-Hoon; Serezani, Carlos Henrique; Okunishi, Katsuhide; Zaslona, Zbigniew; Peters-Golden, Marc] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Univ Michigan Hlth Syst, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Kim, Sang-Hoon] Eulji Univ, Sch Med, Div Allergy & Resp Med, Dept Internal Med, Seoul 139711, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eulji University	Peters-Golden, M (corresponding author), Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, 6301 MSRB 3,Box 5642,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	; serezani, C. Henrique/H-1675-2013	Aronoff, David/0000-0003-4587-6121; Zaslona, Zbigniew/0000-0003-3361-4140; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health [HL58897, HD057176]; American Lung Association; Uehara Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057176] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103777, R01HL058897, R56HL058897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Uehara Memorial Foundation(Uehara Memorial Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58897 (to M. P.-G.) and HD057176 (to D. M. A.). This work was also supported by American Lung Association Senior Postdoctoral Research Fellowships (to C. H. S. and K. O.) and a Uehara Memorial Foundation research fellowship (to K. O.).	ADEREM AA, 1986, J EXP MED, V164, P165, DOI 10.1084/jem.164.1.165; Aronoff DM, 2007, J IMMUNOL, V178, P1628, DOI 10.4049/jimmunol.178.3.1628; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Aronoff DM, 2009, J IMMUNOL, V183, P2642, DOI 10.4049/jimmunol.0900129; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; FERNANDEZREPOLLET E, 1982, J HISTOCHEM CYTOCHEM, V30, P466, DOI 10.1177/30.5.6804558; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Harbrecht BG, 1997, J LEUKOCYTE BIOL, V61, P712, DOI 10.1002/jlb.61.6.712; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Khanduja KL, 2006, LIFE SCI, V78, P1662, DOI 10.1016/j.lfs.2005.07.033; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; KONOPSKI Z, 1993, SCAND J IMMUNOL, V37, P587, DOI 10.1111/j.1365-3083.1993.tb02576.x; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moon EY, 2005, J NEUROSCI RES, V81, P38, DOI 10.1002/jnr.20535; OGREID D, 1989, EUR J BIOCHEM, V181, P19; Pang LH, 1997, BIOCHEM PHARMACOL, V53, P493, DOI 10.1016/S0006-2952(96)00737-X; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; PETERSGOLDEN M, 1987, AM REV RESPIR DIS, V135, P1020; RADDASSI K, 1993, CELL IMMUNOL, V149, P50, DOI 10.1006/cimm.1993.1135; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Stokka AJ, 2006, BIOCHEM J, V400, P493, DOI 10.1042/BJ20060962; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Welsh DA, 2001, MED CLIN N AM, V85, P1329, DOI 10.1016/S0025-7125(05)70383-7; WILBORN J, 1995, AM J PHYSIOL-LUNG C, V268, pL294, DOI 10.1152/ajplung.1995.268.2.L294; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	42	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8875	8883		10.1074/jbc.M110.187815	http://dx.doi.org/10.1074/jbc.M110.187815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21247892	Green Published, hybrid			2022-12-25	WOS:000288247700018
J	Kotian, S; Liyanarachchi, S; Zelent, A; Parvin, JD				Kotian, Shweta; Liyanarachchi, Sandhya; Zelent, Arthur; Parvin, Jeffrey D.			Histone Deacetylases 9 and 10 Are Required for Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; HDAC INHIBITORS; IN-VIVO; MAMMALIAN-CELLS; DIRECTED REPAIR; CANCER; EXPRESSION; DOMAIN; BRCA1; TRANSCRIPTION	We tested the role of histone deacetylases (HDACs) in the homologous recombination process. A tissue-culture based homology-directed repair assay was used in which repair of a double-stranded break by homologous recombination results in gene conversion of an inactive GFP allele to an active GFP gene. Our rationale was that hyperacetylation caused by HDAC inhibitor treatment would increase chromatin accessibility to repair factors, thereby increasing homologous recombination. Contrary to expectation, treatment of cells with the inhibitors significantly reduced homologous recombination activity. Using RNA interference to deplete each HDAC, we found that depletion of either HDAC9 or HDAC10 specifically inhibited homologous recombination. By assaying for sensitivity of cells to the interstrand cross-linker mitomycin C, we found that treatment of cells with HDAC inhibitors or depletion of HDAC9 or HDAC10 resulted in increased sensitivity to mitomycin C. Our data reveal an unanticipated function of HDAC9 and HDAC10 in the homologous recombination process.	[Kotian, Shweta; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Zelent, Arthur] Inst Canc Res, Sect Haemato Oncol, Sutton SM2 5NG, Surrey, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of London; Institute of Cancer Research - UK	Parvin, JD (corresponding author), Ohio State Univ, Dept Biomed Informat, Ctr Comprehens Canc, Columbus, OH 43210 USA.	jeffrey.parvin@osumc.edu	Zelent, Arthur/B-3532-2009; Kotian, Shweta/GMX-3418-2022; Parvin, Jeffrey D/C-8955-2009	Zelent, Arthur/0000-0002-7968-9888	NCI [R01 CA141090]; NATIONAL CANCER INSTITUTE [R01CA141090] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA141090 from the NCI (to J. D. P.).	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Garber K, 2007, NAT BIOTECHNOL, V25, P17, DOI 10.1038/nbt0107-17; GINSBURG E, 1973, P NATL ACAD SCI USA, V70, P2457, DOI 10.1073/pnas.70.8.2457; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Guidez F, 2001, CURR TOP MICROBIOL, V254, P165; Han JW, 2000, CANCER RES, V60, P6068; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kwon SH, 2002, J BIOL CHEM, V277, P2073, DOI 10.1074/jbc.M106699200; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Moynahan ME, 2001, CANCER RES, V61, P4842; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pan LN, 2007, CELL MOL IMMUNOL, V4, P337; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Uhl M, 2010, DNA REPAIR, V9, P383, DOI 10.1016/j.dnarep.2009.12.020; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yuan Z, 2007, CELL CYCLE, V6, P2869, DOI 10.4161/cc.6.23.5026; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	42	66	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7722	7726		10.1074/jbc.C110.194233	http://dx.doi.org/10.1074/jbc.C110.194233			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21247901	Green Published, hybrid			2022-12-25	WOS:000288013300002
J	Brenet, F; Moh, M; Funk, P; Feierstein, E; Viale, AJ; Socci, ND; Scandura, JM				Brenet, Fabienne; Moh, Michelle; Funk, Patricia; Feierstein, Erika; Viale, Agnes J.; Socci, Nicholas D.; Scandura, Joseph M.			DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CYTOSINE-METHYLATION; GENE-EXPRESSION; X-CHROMOSOME; CPG ISLANDS; HUMAN-CELLS; CANCER; METHYLOME; REPRESSION; RESOLUTION	Tissue specific patterns of methylated cytosine residues vary with age, can be altered by environmental factors, and are often abnormal in human disease yet the cellular consequences of DNA methylation are incompletely understood. Although the bodies of highly expressed genes are often extensively methylated in plants, the relationship between intragenic methylation and expression is less clear in mammalian cells. We performed genome-wide analyses of DNA methylation and gene expression to determine how the pattern of intragenic methylation correlates with transcription and to assess the relationship between methylation of exonic and intronic portions of the gene body. We found that dense exonic methylation is far more common than previously recognized or expected statistically, yet first exons are relatively spared compared to more downstream exons and introns. Dense methylation surrounding the transcription start site (TSS) is uncoupled from methylation within more downstream regions suggesting that there are at least two classes of intragenic methylation. Whereas methylation surrounding the TSS is tightly linked to transcriptional silencing, methylation of more downstream regions is unassociated with the magnitude of gene expression. Notably, we found that DNA methylation downstream of the TSS, in the region of the first exon, is much more tightly linked to transcriptional silencing than is methylation in the upstream promoter region. These data provide direct evidence that DNA methylation is interpreted dissimilarly in different regions of the gene body and suggest that first exon methylation blocks transcript initiation, or vice versa. Our data also show that once initiated, downstream methylation is not a significant impediment to polymerase extension. Thus, the consequences of most intragenic DNA methylation must extend beyond the modulation of transcription magnitude. Sequencing data and gene expression microarray data have been submitted to the GEO online database (accession number SRA012081.1). Supporting information including expanded methods and ten additional figures in support of the manuscript is provided.	[Brenet, Fabienne; Moh, Michelle; Funk, Patricia; Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, Lab Mol Hematopoiesis, New York, NY USA; [Scandura, Joseph M.] Weill Cornell Med Coll, Leukemia Program, New York, NY USA; [Feierstein, Erika; Viale, Agnes J.] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center	Brenet, F (corresponding author), Weill Cornell Med Coll, Dept Med, Lab Mol Hematopoiesis, New York, NY USA.	jms2003@med.cornell.edu	Brenet, Fabienne/R-1881-2016	Brenet, Fabienne/0000-0003-4098-1096; Scandura, Joseph/0000-0002-9525-143X	Clinical and Translation Science Center at Weill Cornell Medical College [UL1RR024996]; Cornell Belfer Family Hematology-Oncology Division; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	Clinical and Translation Science Center at Weill Cornell Medical College; Cornell Belfer Family Hematology-Oncology Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant UL1RR024996 of the Clinical and Translation Science Center at Weill Cornell Medical College (JMS) and by Cornell Belfer Family Hematology-Oncology Division startup funds (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin SB, 1998, ADV CANCER RES, V72, P141; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1978, J MOL BIOL, V118, P49, DOI 10.1016/0022-2836(78)90243-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korshunova Y, 2008, GENOME RES, V18, P19, DOI 10.1101/gr.6883307; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Singal R, 1999, BLOOD, V93, P4059, DOI 10.1182/blood.V93.12.4059; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; [No title captured]	60	402	410	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14524	10.1371/journal.pone.0014524	http://dx.doi.org/10.1371/journal.pone.0014524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267076	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500006
J	Garcia, MN; Farias, MSD; Avila, MM; Rabinovich, RD				Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Mercedes Avila, Maria; Daniel Rabinovich, Roberto			Presence of p24-Antigen Associated to Erythrocyte in HIV-Positive Individuals Even in Patients with Undetectable Plasma Viral Load	PLOS ONE			English	Article							RED-BLOOD-CELLS; IMMUNE-COMPLEXES; IN-VIVO; P24 ANTIGEN; T-CELLS; COMPLEMENT; RECEPTOR; INFECTION; EXPRESSION; BINDING	Background: HIV adherence to erythrocytes has been demonstrated in vitro, and it has been suggested that erythrocytes may be carriers of the virus. However, the association between HIV particles or viral proteins and erythrocytes in HIV-infected individuals is still to be elucidated. Methodology/Principal Findings: HIV-positive participants (n = 112) were classified into two groups according to values of three plasma viral loads (pVL) determined during the 12-month period prior to the study. The first group included 71 individuals with detectable pVL, whereas the second group included 41 individuals with undetectable pVL. Plasma viral load, erythrocyte-associated p24-antigen and p24-antigen in plasma were determined at the moment of the study. A total of 51 out of the 71 patients with detectable pVL showed erythrocyte-associated p24-antigen whereas 13 showed p24-antigen in plasma. Twenty-two out of the 51 patients with erythrocyte-associated p24-antigen showed pVL<10,000 copies/ml and undetectable p24-antigen in plasma. The data indicates that the amount of erythrocyte-associated p24-antigen was not related to p24-antigen in plasma or pVL levels in this group. Among the 41 patients with prior undetectable pVL, eight presented detectable pVL and erythrocyte-associated p24-antigen at the moment of the study. The other 33 showed undetectable pVL and five of these presented erythrocyte-associated p24-antigen. A positive relationship was found between the presence of erythrocyte-associated p24-antigen and the detectable pVL at the moment of the study (p<0.00001). Even more, in another series of assays, a detectable viral load associated to erythrocytes was determined and it was always accompanied by erythrocyte-associated p24-antigen detection. Conclusions/Significance: This study demonstrates the presence of erythrocyte-associated p24-antigen in HIV-infected individuals. Since erythrocyte-associated p24-antigen is not always related to pVL or p24-antigen in plasma, erythrocyte-associated p24-antigen showed viral expression not represented in plasma. Therefore, the determination of erythrocyte-associated p24-antigen may contribute to better understand the kinetics and/or evolution of HIV infection.	[Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Mercedes Avila, Maria; Daniel Rabinovich, Roberto] Univ Buenos Aires, Natl Reference Ctr AIDS, Sch Med, Dept Microbiol, Buenos Aires, DF, Argentina	University of Buenos Aires	Garcia, MN (corresponding author), Univ Buenos Aires, Natl Reference Ctr AIDS, Sch Med, Dept Microbiol, Buenos Aires, DF, Argentina.	mgarcia@fmed.uba.ar		Garcia, Maria Noe/0000-0002-2167-1298	Argentina's National Agency for Promotion of Science and Technology [PICT 2067]; National Council for Technology and Scientific Research [PIP 6118]	Argentina's National Agency for Promotion of Science and Technology(ANPCyT); National Council for Technology and Scientific Research	This work was partly supported by grants from Argentina's National Agency for Promotion of Science and Technology (www.agencia.gov.ar) (PICT 2067 to Maria Mercedes Avila) and the National Council for Technology and Scientific Research (www.conicet.gov.ar) (PIP 6118 to Maria Mercedes Avila). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Banki Z, 2006, J IMMUNOL, V177, P3469, DOI 10.4049/jimmunol.177.5.3469; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; COHEN JHM, 1988, PRESSE MED, V17, P727; Farias MSD, 2009, J VIROL METHODS, V158, P6, DOI 10.1016/j.jviromet.2009.01.010; Fierer DS, 2007, J INFECT DIS, V196, P587, DOI 10.1086/519741; Gulzar N, 2008, CURR HIV RES, V6, P585, DOI 10.2174/157016208786501544; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; Prado JG, 2004, J CLIN MICROBIOL, V42, P1620, DOI 10.1128/JCM.42.4.1620-1625.2004; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHIFFERLI JA, 1988, J IMMUNOL, V140, P899; Schupbach J, 2003, INT ARCH ALLERGY IMM, V132, P196, DOI 10.1159/000074552; Schupbach J, 2005, JAIDS-J ACQ IMM DEF, V40, P250, DOI 10.1097/01.qai.0000181281.75670.56; Schupbach Jorg, 2002, AIDS Reviews, V4, P83; TAUSK FA, 1986, J CLIN INVEST, V78, P977, DOI 10.1172/JCI112688; Terpos E, 2008, MED SCI MONITOR, V14, pCR276	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14544	10.1371/journal.pone.0014544	http://dx.doi.org/10.1371/journal.pone.0014544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267446	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500014
J	Stuhrmann, B; Huber, F; Kas, J				Stuhrmann, Bjoern; Huber, Florian; Kaes, Josef			Robust Organizational Principles of Protrusive Biopolymer Networks in Migrating Living Cells	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; FLUORESCENT SPECKLE MICROSCOPY; ARP2/3 COMPLEX; QUANTITATIVE-ANALYSIS; FILAMENT TURNOVER; DEPOLYMERIZING FACTOR; LEADING-EDGE; CELLULAR MOTILITY; RETROGRADE FLOW; NONMUSCLE CELLS	Cell migration is associated with the dynamic protrusion of a thin actin-based cytoskeletal extension at the cell front, which has been shown to consist of two different substructures, the leading lamellipodium and the subsequent lamellum. While the formation of the lamellipodium is increasingly well understood, organizational principles underlying the emergence of the lamellum are just beginning to be unraveled. We report here on a 1D mathematical model which describes the reaction-diffusion processes of a polarized actin network in steady state, and reproduces essential characteristics of the lamellipodium-lamellum system. We observe a steep gradient in filament lengths at the protruding edge, a local depolymerization maximum a few microns behind the edge, as well as a differential dominance of the network destabilizer ADF/cofilin and the stabilizer tropomyosin. We identify simple and robust organizational principles giving rise to the derived network characteristics, uncoupled from the specifics of any molecular implementation, and thus plausibly valid across cell types. An analysis of network length dependence on physico-chemical system parameters implies that to limit array treadmilling to cellular dimensions, network growth has to be truncated by mechanisms other than aging-induced depolymerization, e. g., by myosin-associated network dissociation at the transition to the cell body. Our work contributes to the analytical understanding of the cytoskeletal extension's bisection into lamellipodium and lamellum and sheds light on how cells organize their molecular machinery to achieve motility.	[Stuhrmann, Bjoern; Huber, Florian; Kaes, Josef] Univ Leipzig, Inst Soft Matter Phys, Leipzig, Germany	Leipzig University	Stuhrmann, B (corresponding author), FOM Inst AMOLF, Biol Soft Matter Grp, Amsterdam, Netherlands.	stuhrmann@amolf.nl	Huber, Florian/F-6191-2011	Huber, Florian/0000-0002-3535-9406; Kas, Josef A./0000-0003-3158-2480	Leipzig Graduate College [GK 1097]; Graduate School "Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)"	Leipzig Graduate College; Graduate School "Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)"	This work has been supported by the Leipzig Graduate College "GK 1097 InterNeuro -Interdisciplinary Approaches in Cellular Neuroscience" (http://www.uni-leipzig.de/ineuro/) and the Graduate School "Leipzig School of Natural Sciences - Building with Molecules and Nano-objects (BuildMoNa)" (http://www.buildmona.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Adachi T, 2009, J BIOMECH, V42, P297, DOI 10.1016/j.jbiomech.2008.11.012; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; ALT W, 2009, CELL MECH, P89; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROSCHAT KO, 1990, J BIOL CHEM, V265, P21323; Brunner CA, 2006, EUR BIOPHYS J BIOPHY, V35, P713, DOI 10.1007/s00249-006-0079-1; Bugyi B, 2008, FEBS LETT, V582, P2086, DOI 10.1016/j.febslet.2008.02.065; CARLIER MF, 1991, J BIOL CHEM, V266, P1; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carlsson AE, 2006, BIOPHYS J, V90, P413, DOI 10.1529/biophysj.105.069765; Carlsson AE, 2003, BIOPHYS J, V84, P2907, DOI 10.1016/S0006-3495(03)70018-6; Carlsson AE, 2008, METHOD CELL BIOL, V84, P911, DOI 10.1016/S0091-679X(07)84029-5; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Edelstein-Keshet L, 2001, J MATH BIOL, V43, P325, DOI 10.1007/s002850100102; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fleischer F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/420; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gopinathan A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058103; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huber F, 2008, BIOPHYS J, V95, P5508, DOI 10.1529/biophysj.108.134817; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kueh HY, 2010, BIOPHYS J, V99, P2153, DOI 10.1016/j.bpj.2010.07.038; Kuusela E, 2009, J MATH BIOL, V58, P135, DOI 10.1007/s00285-008-0179-x; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Novak IL, 2008, BIOPHYS J, V95, P1627, DOI 10.1529/biophysj.108.130096; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Plastino J, 2005, CURR OPIN CELL BIOL, V17, P62, DOI 10.1016/j.ceb.2004.12.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Rubinstein B, 2005, MULTISCALE MODEL SIM, V3, P413, DOI 10.1137/04060370X; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; Schreiber CH, 2010, P NATL ACAD SCI USA, V107, P9141, DOI 10.1073/pnas.1002538107; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Small JV, 2010, TRENDS CELL BIOL, V20, P628, DOI 10.1016/j.tcb.2010.08.006; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Weichsel J, 2010, P NATL ACAD SCI USA, V107, P6304, DOI 10.1073/pnas.0913730107; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	87	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14471	10.1371/journal.pone.0014471	http://dx.doi.org/10.1371/journal.pone.0014471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267070	gold, Green Published			2022-12-25	WOS:000286519500002
J	Gonzalez-Bosquet, J; Calcei, J; Wei, JS; Garcia-Closas, M; Sherman, ME; Hewitt, S; Vockley, J; Lissowska, J; Yang, HP; Khan, J; Chanock, S				Gonzalez-Bosquet, Jesus; Calcei, Jacob; Wei, Jun S.; Garcia-Closas, Montserrat; Sherman, Mark E.; Hewitt, Stephen; Vockley, Joseph; Lissowska, Jolanta; Yang, Hannah P.; Khan, Javed; Chanock, Stephen			Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers	PLOS ONE			English	Article							CELL LUNG-CANCER; PARAFFIN-EMBEDDED TISSUES; BREAST-CANCER; ACTIVATING MUTATIONS; AMPLICON ANALYSIS; GENE-MUTATIONS; SINGLE CELLS; RISK-FACTORS; GENOME; AMPLIFICATION	Identification of somatic mutations in cancer is a major goal for understanding and monitoring the events related to cancer initiation and progression. High resolution melting (HRM) curve analysis represents a fast, post-PCR high-throughput method for scanning somatic sequence alterations in target genes. The aim of this study was to assess the sensitivity and specificity of HRM analysis for tumor mutation screening in a range of tumor samples, which included 216 frozen pediatric small rounded blue-cell tumors as well as 180 paraffin-embedded tumors from breast, endometrial and ovarian cancers (60 of each). HRM analysis was performed in exons of the following candidate genes known to harbor established commonly observed mutations: PIK3CA, ERBB2, KRAS, TP53, EGFR, BRAF, GATA3, and FGFR3. Bi-directional sequencing analysis was used to determine the accuracy of the HRM analysis. For the 39 mutations observed in frozen samples, the sensitivity and specificity of HRM analysis were 97% and 87%, respectively. There were 67 mutation/variants in the paraffin-embedded samples, and the sensitivity and specificity for the HRM analysis were 88% and 80%, respectively. Paraffin-embedded samples require higher quantity of purified DNA for high performance. In summary, HRM analysis is a promising moderate-throughput screening test for mutations among known candidate genomic regions. Although the overall accuracy appears to be better in frozen specimens, somatic alterations were detected in DNA extracted from paraffin-embedded samples.	[Gonzalez-Bosquet, Jesus; Calcei, Jacob; Chanock, Stephen] NCI, Lab Translat Genom, DHHS, NIH, Bethesda, MD 20892 USA; [Wei, Jun S.; Khan, Javed] NCI, Adv Technol Ctr, Pediat Oncol Branch, Ctr Canc Res,DHHS,NIH, Bethesda, MD 20892 USA; [Garcia-Closas, Montserrat; Sherman, Mark E.; Yang, Hannah P.] NCI, Hormonal & Reprod Epidemiol Branch, Div Canc Epidemiol & Genet, DHHS,NIH, Bethesda, MD 20892 USA; [Hewitt, Stephen] NCI, Tissue Array Res Program, DHHS, NIH, Bethesda, MD 20892 USA; [Vockley, Joseph] NCI, Off Canc Genom, DHHS, NIH, Bethesda, MD 20892 USA; [Lissowska, Jolanta] M Sklodowska Curie Inst Oncol & Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Maria Sklodowska-Curie National Research Institute of Oncology	Gonzalez-Bosquet, J (corresponding author), NCI, Lab Translat Genom, DHHS, NIH, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Calcei, Jacob/AAY-1260-2020; Khan, Javed/P-9157-2014; Garcia-Closas, Montserrat/F-3871-2015; Garcia-Closas, Montserrat/AAZ-6930-2021; Lissowska, Jolanta/AAH-3252-2020	Calcei, Jacob/0000-0002-4895-1046; Garcia-Closas, Montserrat/0000-0003-1033-2650; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lissowska, Jolanta/0000-0003-2695-5799; Gonzalez Bosquet, Jesus/0000-0002-2079-4528; Hewitt, Stephen/0000-0001-8283-1788	NATIONAL CANCER INSTITUTE [ZIACP010201, ZIASC010366, ZIABC010591, ZICBC011257, ZIABC010998] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brinton LA, 2007, BRIT J CANCER, V96, P1450, DOI 10.1038/sj.bjc.6603731; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Chanock SJ, 2007, NAT GENET, V39, P283, DOI 10.1038/ng0307-283; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dedhia P, 2007, ASIAN PAC J CANCER P, V8, P55; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Dobrowolski SE, 2005, HUM MUTAT, V25, P306, DOI 10.1002/humu.20137; Fadhil W, 2010, J CLIN PATHOL, V63, P134, DOI 10.1136/jcp.2009.070508; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Closas M, 2006, BRIT J CANCER, V95, P123, DOI 10.1038/sj.bjc.6603207; Garcia-Closas M, 2006, HUM GENET, V119, P376, DOI 10.1007/s00439-006-0135-z; Garcia-Closas M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-60; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Geigl JB, 2007, NAT PROTOC, V2, P3173, DOI 10.1038/nprot.2007.476; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haque KA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-20; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Krypuy M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-168; Lax SF, 2000, CANCER-AM CANCER SOC, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.3.CO;2-L; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lonie Lorne, 2006, Hum Mutat, V27, P1160, DOI 10.1002/humu.9467; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rivero ERC, 2006, PATHOL RES PRACT, V202, P523, DOI 10.1016/j.prp.2006.02.007; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith GD, 2008, J CLIN PATHOL, V61, P487, DOI 10.1136/jcp.2007.051425; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Staats B, 2005, NAT GENET, V37, P109, DOI 10.1038/ng0205-109; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Takano EA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-59; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wen L, 2001, MOL BIOTECHNOL, V17, P135, DOI 10.1385/MB:17:2:135; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Willmore C, 2004, AM J CLIN PATHOL, V122, P206, DOI 10.1309/4E6UYBY62N2FCA6N; Willmore-Payne C, 2006, MODERN PATHOL, V19, p319A; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	50	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14522	10.1371/journal.pone.0014522	http://dx.doi.org/10.1371/journal.pone.0014522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264207	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600006
J	Miyamoto, Y; Kitamura, N; Nakamura, Y; Futamura, M; Miyamoto, T; Yoshida, M; Ono, M; Ichinose, S; Arakawa, H				Miyamoto, Yuji; Kitamura, Noriaki; Nakamura, Yasuyuki; Futamura, Manabu; Miyamoto, Takafumi; Yoshida, Masaki; Ono, Masaya; Ichinose, Shizuko; Arakawa, Hirofumi			Possible Existence of Lysosome-Like Organella within Mitochondria and Its Role in Mitochondrial Quality Control	PLOS ONE			English	Article							PROTEIN-DEGRADATION; SOMATIC MUTATIONS; AAA PROTEASES; LON PROTEASE; AUTOPHAGY; CANCER; CELLS; DNA; MITOPHAGY; MAINTENANCE	The accumulation of unhealthy mitochondria results in mitochondrial dysfunction, which has been implicated in aging, cancer, and a variety of degenerative diseases. However, the mechanism by which mitochondrial quality is regulated remains unclear. Here, we show that Mieap, a novel p53-inducible protein, induces intramitochondrial lysosome-like organella that plays a critical role in mitochondrial quality control. Mieap expression is directly regulated by p53 and is frequently lost in human cancer as result of DNA methylation. Mieap dramatically induces the accumulation of lysosomal proteins within mitochondria and mitochondrial acidic condition without destroying the mitochondrial structure (designated MALM, for Mieap-induced accumulation of lysosome-like organelles within mitochondria) in response to mitochondrial damage. MALM was not related to canonical autophagy. MALM is involved in the degradation of oxidized mitochondrial proteins, leading to increased ATP synthesis and decreased reactive oxygen species generation. These results suggest that Mieap induces intramitochondrial lysosome-like organella that plays a critical role in mitochondrial quality control by eliminating oxidized mitochondrial proteins. Cancer cells might accumulate unhealthy mitochondria due to p53 mutations and/or Mieap methylation, representing a potential cause of the Warburg effect.	[Miyamoto, Yuji; Kitamura, Noriaki; Nakamura, Yasuyuki; Futamura, Manabu; Miyamoto, Takafumi; Yoshida, Masaki; Arakawa, Hirofumi] Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan; [Ono, Masaya] Natl Canc Ctr, Res Inst, Div Chemotherapy, Tokyo 104, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan.	harakawa@ncc.go.jp	Arakawa, Hirofumi/L-3459-2013; Miyamoto, Takafumi/T-6950-2019	Arakawa, Hirofumi/0000-0001-6077-0638; Miyamoto, Takafumi/0000-0001-9363-2864; Miyamoto, Yuji/0000-0003-3948-5044	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [23591966] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant support: a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Ministry of Health, Labor and Welfare for the 3rd-Term Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Assaily W, 2006, CANCER CELL, V10, P4, DOI 10.1016/j.ccr.2006.06.014; Baines CP, 2009, J MOL CELL CARDIOL, V46, P850, DOI 10.1016/j.yjmcc.2009.02.007; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Holtzman E., 1989, LYSOSOMES, P1, DOI [10.1007/978-1-4899-2540-4_1, DOI 10.1007/978-1-4899-2540-4_1]; Iida H, 2004, MOL REPROD DEV, V68, P385, DOI 10.1002/mrd.20101; Iiizumi M, 2002, CANCER RES, V62, P1246; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Luellmann-Rauch Renate, 2005, P1; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Masuda Yoshiko, 2006, J Hum Genet, V51, P652, DOI 10.1007/s10038-006-0004-6; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	48	54	62	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16054	10.1371/journal.pone.0016054	http://dx.doi.org/10.1371/journal.pone.0016054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264221	Green Submitted, Green Published, gold			2022-12-25	WOS:000286517600019
J	Ohmine, S; Sakuma, R; Sakuma, T; Thatava, T; Takeuchi, H; Ikeda, Y				Ohmine, Seiga; Sakuma, Ryuta; Sakuma, Toshie; Thatava, Tayaramma; Takeuchi, Hiroaki; Ikeda, Yasuhiro			The Antiviral Spectra of TRIM5 alpha Orthologues and Human TRIM Family Proteins against Lentiviral Production	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; INFECTIOUS MOLECULAR CLONE; RETROVIRUS RESTRICTION; ENVELOPE SEQUENCE; HIV-1 ISOLATE; FULL-LENGTH; OLD-WORLD; GAG; TYPE-2; DOMAIN	Background: Rhesus monkey TRIM5 alpha (TRIM5 alpha rh) recognizes the incoming HIV-1 core through its C-terminal B30.2(PRYSPRY) domain and promotes its premature disassembly or degradation before reverse transcription. Previously, we have shown that TRIM5 alpha rh blocks HIV-1 production through the N-terminal RBCC domain by the recognition of Gag polyproteins. Although all TRIM family proteins have RBCC domains, it remains elusive whether they possess similar late-restriction activities. Methodology/Principal Findings: We examined the antiviral spectra of TRIM5 alpha orthologues and human TRIM family members which have a genetic locus proximal to human TRIM5 alpha (TRIM5 alpha hu), against primate lentiviral production. When HIV-1 virus-like particles (VLPs) were generated in the presence of TRIM5 alpha proteins, rhesus, African green and cynomolgus monkey TRIM5 alpha (TRIM5 alpha ag and TRIM5 alpha cy), but not TRIM5 alpha hu, were efficiently incorporated into VLPs, suggesting an interaction between HIV-1 Gag and TRIM5 alpha proteins. TRIM5 alpha rh potently restricted the viral production of HIV-1 groups M and O and HIV-2, but not simian lentiviruses including SIV(MAC)1A11, SIV(AGM)Tan-1 or SIV(AGM)SAB-1. TRIM5 alpha hu did not show notable late restriction activities against these lentiviruses. TRIM5 alpha ag and TRIM5 alpha cy showed intermediate restriction phenotypes against HIV-1 and HIV-2, but showed no restriction activity against SIV production. A series of chimeric TRIM5 alpha constructs indicated that the N-terminal region of TRIM5 alpha ag and TRIM5 alpha cy are essential for the late restriction activity, while the C-terminal region of TRIM5 alpha cy negatively regulates the late restriction activity against HIV-1. When select human TRIM family proteins were examined, TRIM21 and 22 were efficiently incorporated into HIV-1 VLPs, while only TRIM22 reduced HIV-1 titers up to 5-fold. The antiviral activities and encapsidation efficiencies did not correlate with their relative expression levels in the producer cells. Conclusions/Significance: Our results demonstrated the variations in the late restriction activities among closely related TRIM5 alpha orthologues and a subset of human TRIM family proteins, providing further insights into the late restriction activities of TRIM proteins.	[Ohmine, Seiga; Sakuma, Ryuta; Sakuma, Toshie; Thatava, Tayaramma; Ikeda, Yasuhiro] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Takeuchi, Hiroaki] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan	Mayo Clinic; University of Tokyo	Ohmine, S (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu	Takeuchi, Hiroaki/F-9728-2012	Takeuchi, Hiroaki/0000-0002-5689-9858	National Institutes of Health; Mayo Foundation; Siebens Ph.D. Training Fellowship;  [1R56AI074363-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Siebens Ph.D. Training Fellowship; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health, 1R56AI074363-01A1 (YI), the Mayo Foundation (YI), and the Siebens Ph.D. Training Fellowship (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; CHARNEAU P, 1994, VIROLOGY, V205, P247, DOI 10.1006/viro.1994.1640; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Dittmar MT, 1999, AIDS RES HUM RETROV, V15, P707, DOI 10.1089/088922299310791; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; Ikeda Y, 2004, J VIROL, V78, P11816, DOI 10.1128/JVI.78.21.11816-11822.2004; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; JIN MJ, 1994, EMBO J, V13, P2935, DOI 10.1002/j.1460-2075.1994.tb06588.x; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; KIM FM, 1995, J VIROL, V69, P1755, DOI 10.1128/JVI.69.3.1755-1761.1995; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li X, 2007, VIROLOGY, V360, P419, DOI 10.1016/j.virol.2006.10.035; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; LUCIW PA, 1992, AIDS RES HUM RETROV, V8, P395, DOI 10.1089/aid.1992.8.395; Maillard PV, 2010, J VIROL, V84, P5790, DOI 10.1128/JVI.02413-09; Morner A, 1999, J VIROL, V73, P2343; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Pacheco B, 2010, VIROLOGY, V408, P204, DOI 10.1016/j.virol.2010.09.019; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sakuma R, 2007, GENE THER, V14, P185, DOI 10.1038/sj.gt.3302852; SAKUMA R, 2009, J BIOL CHEM; Sakuma R, 2008, NAT MED, V14, P236, DOI 10.1038/nm0308-236; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tebit DM, 2004, VIROLOGY, V326, P329, DOI 10.1016/j.virol.2004.05.027; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035	51	15	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16121	10.1371/journal.pone.0016121	http://dx.doi.org/10.1371/journal.pone.0016121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264255	Green Published, Green Submitted, gold			2022-12-25	WOS:000286516500030
J	Balagam, R; Singh, V; Sagi, AR; Dixit, NM				Balagam, Rajesh; Singh, Vasantika; Sagi, Aparna Raju; Dixit, Narendra M.			Taking Multiple Infections of Cells and Recombination into Account Leads to Small Within-Host Effective-Population-Size Estimates of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VIVO; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION; DRUG-RESISTANCE; GENETIC DRIFT; GENERATION TIME; LYMPHOID-TISSUE; TARGET-CELLS; T-CELLS	Whether HIV-1 evolution in infected individuals is dominated by deterministic or stochastic effects remains unclear because current estimates of the effective population size of HIV-1 in vivo, N(e), are widely varying. Models assuming HIV-1 evolution to be neutral estimate N(e)similar to 10(2)-10(4), smaller than the inverse mutation rate of HIV-1 (similar to 10(5)), implying the predominance of stochastic forces. In contrast, a model that includes selection estimates N(e)>10(5), suggesting that deterministic forces would hold sway. The consequent uncertainty in the nature of HIV-1 evolution compromises our ability to describe disease progression and outcomes of therapy. We perform detailed bit-string simulations of viral evolution that consider large genome lengths and incorporate the key evolutionary processes underlying the genomic diversification of HIV-1 in infected individuals, namely, mutation, multiple infections of cells, recombination, selection, and epistatic interactions between multiple loci. Our simulations describe quantitatively the evolution of HIV-1 diversity and divergence in patients. From comparisons of our simulations with patient data, we estimate N(e)similar to 10(3)-10(4), implying predominantly stochastic evolution. Interestingly, we find that N(e) and the viral generation time are correlated with the disease progression time, presenting a route to a priori prediction of disease progression in patients. Further, we show that the previous estimate of N(e)>10(5) reduces as the frequencies of multiple infections of cells and recombination assumed increase. Our simulations with N(e)similar to 10(3)-10(4) may be employed to estimate markers of disease progression and outcomes of therapy that depend on the evolution of viral diversity and divergence.	[Balagam, Rajesh; Singh, Vasantika; Sagi, Aparna Raju; Dixit, Narendra M.] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India; [Dixit, Narendra M.] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Balagam, R (corresponding author), Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.	narendra@chemeng.iisc.ernet.in	Suryawanshi, Vasantika/ABA-8637-2020	Suryawanshi, Vasantika/0000-0003-1497-7480	National Institutes of Health [AI065334]; Jawaharlal Nehru Centre for Advanced Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant AI065334. ARS acknowledges the Jawaharlal Nehru Centre for Advanced Scientific Research for a fellowship under JNCASR-SRFP-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; Arora P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000305; Bocharov G, 2005, J GEN VIROL, V86, P3109, DOI 10.1099/vir.0.81138-0; Boerlijst MC, 1996, P ROY SOC B-BIOL SCI, V263, P1577, DOI 10.1098/rspb.1996.0231; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bretscher MT, 2004, BIOESSAYS, V26, P180, DOI 10.1002/bies.10386; Brown AJL, 1997, P NATL ACAD SCI USA, V94, P1862, DOI 10.1073/pnas.94.5.1862; Carvajal-Rodriguez A, 2007, INFECT GENET EVOL, V7, P476, DOI 10.1016/j.meegid.2007.02.001; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Chen JB, 2005, J VIROL, V79, P4140, DOI 10.1128/JVI.79.7.4140-4149.2005; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Dang Q, 2004, P NATL ACAD SCI USA, V101, P632, DOI 10.1073/pnas.0307636100; DIMITROV DS, 1995, NATURE, V375, P194, DOI 10.1038/375194b0; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dixit N. M., 2008, FUTURE HIV THER, V2, P375; Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102; Dixit NM, 2004, ANTIVIR THER, V9, P237; Dixit NM, 2004, J VIROL, V78, P8942, DOI 10.1128/JVI.78.16.8942-8945.2004; ESHEL I, 1970, Theoretical Population Biology, V1, P88, DOI 10.1016/0040-5809(70)90043-2; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fraser C, 2005, J ROY SOC INTERFACE, V2, P489, DOI 10.1098/rsif.2005.0064; Frost SDW, 2001, P NATL ACAD SCI USA, V98, P6975, DOI 10.1073/pnas.131056998; Gadhamsetty S, 2010, J VIROL, V84, P10230, DOI 10.1128/JVI.01010-10; Gheorghiu-Svirschevski S, 2007, MOL BIOL EVOL, V24, P574, DOI 10.1093/molbev/msl189; Gillespie JH, 2000, GENETICS, V155, P909; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Hartl D., 2007, PRINCIPLES POPULATIO; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; JOSEFSSON L, 2010, 17 C RETR OPP INF; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Kouyos RD, 2006, TRENDS MICROBIOL, V14, P507, DOI 10.1016/j.tim.2006.10.001; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu Y, 2006, VIROLOGY, V347, P140, DOI 10.1016/j.virol.2005.11.036; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Nijhuis M, 1998, P NATL ACAD SCI USA, V95, P14441, DOI 10.1073/pnas.95.24.14441; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Rouzine IM, 2010, THEOR POPUL BIOL, V77, P189, DOI 10.1016/j.tpb.2010.02.001; Rouzine IM, 1999, P NATL ACAD SCI USA, V96, P10758, DOI 10.1073/pnas.96.19.10758; Rouzine IM, 2005, GENETICS, V170, P7, DOI 10.1534/genetics.104.029926; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Seo TK, 2002, GENETICS, V160, P1283; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155; Suryavanshi GW, 2007, PLOS COMPUT BIOL, V3, P2003, DOI 10.1371/journal.pcbi.0030205; Telenti A, 2006, NAT REV MICROBIOL, V4, P865, DOI 10.1038/nrmicro1532; Telenti A, 2008, CURR OPIN HIV AIDS, V3, P28, DOI 10.1097/COH.0b013e3282f18ac0; Vijay NNV, 2008, J GEN VIROL, V89, P1467, DOI 10.1099/vir.0.83668-0; Voronin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000431; Williamson S, 2005, MOL BIOL EVOL, V22, P456, DOI 10.1093/molbev/msi029; Wright S, 1931, GENETICS, V16, P0097	69	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e14531	10.1371/journal.pone.0014531	http://dx.doi.org/10.1371/journal.pone.0014531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249189	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000286515000002
J	Chua, YS; Boh, BK; Ponyeam, W; Hagen, T				Chua, Yee Shin; Boh, Boon Kim; Ponyeam, Wanpen; Hagen, Thilo			Regulation of Cullin RING E3 Ubiquitin Ligases by CAND1 In Vivo	PLOS ONE			English	Article							COP9 SIGNALOSOME; PROTEIN; COMPLEX; CUL1; NEDD8; ARABIDOPSIS; SUBSTRATE; DENEDDYLATION; NEDDYLATION; CLEAVAGE	Cullin RING ligases are multi-subunit complexes consisting of a cullin protein which forms a scaffold onto which the RING protein Rbx1/2 and substrate receptor subunits assemble. CAND1, which binds to cullins that are not conjugated with Nedd8 and not associated with substrate receptors, has been shown to function as a positive regulator of Cullin ligases in vivo. Two models have been proposed to explain this requirement: (i) CAND1 sequesters cullin proteins and thus prevents autoubiquitination of substrate receptors, and (ii) CAND1 is required to promote the exchange of bound substrate receptors. Using mammalian cells, we show that CAND1 is predominantly cytoplasmically localized and that cullins are the major CAND1 interacting proteins. However, only small amounts of CAND1 bind to Cul1 in cells, despite low basal levels of Cul1 neddylation and approximately equal cytoplasmic endogenous protein concentrations of CAND1 and Cul1. Compared to F-box protein substrate receptors, binding of CAND1 to Cul1 in vivo is weak. Furthermore, preventing binding of F-box substrate receptors to Cul1 does not increase CAND1 binding. In conclusion, our study suggests that CAND1 does not function by sequestering cullins in vivo to prevent substrate receptor autoubiquitination and is likely to regulate cullin RING ligase activity via alternative mechanisms.	[Chua, Yee Shin; Boh, Boon Kim; Ponyeam, Wanpen; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Boh, Boon Kim; Hagen, Thilo] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	National University of Singapore; National University of Singapore	Chua, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchth@nus.edu.sg			Singapore Biomedical Research Council [07/1/21/19/500]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by a grant from the Singapore Biomedical Research Council (grant number 07/1/21/19/500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bosu DR, 2010, DEV BIOL, V346, P113, DOI 10.1016/j.ydbio.2010.07.020; Cheng YF, 2004, PLANT PHYSIOL, V135, P1020, DOI 10.1104/pp.104.044495; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Feng SH, 2004, PLANT CELL, V16, P1870, DOI 10.1105/tpc.021949; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Min KW, 2005, BIOCHEM BIOPH RES CO, V334, P867, DOI 10.1016/j.bbrc.2005.06.188; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	25	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16071	10.1371/journal.pone.0016071	http://dx.doi.org/10.1371/journal.pone.0016071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249194	Green Submitted, Green Published, gold			2022-12-25	WOS:000286515000013
J	Lee, SJ; Lee, MH; Kim, DW; Lee, S; Huang, SM; Ryu, MJ; Kim, YK; Kim, SJ; Kim, SJ; Hwang, JH; Oh, S; Cho, H; Kim, JM; Lim, DS; Jo, YS; Shong, M				Lee, Seong Jin; Lee, Min Hee; Kim, Dong Wook; Lee, SeongEun; Huang, Songmei; Ryu, Min Jeong; Kim, Yong Kyung; Kim, Sung Jin; Kim, Soung Jung; Hwang, Jung Hwan; Oh, Sangphil; Cho, Heeyeong; Kim, Jin Man; Lim, Dae-Sik; Jo, Young Suk; Shong, Minho			Cross-Regulation between Oncogenic BRAF(V600E) Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma	PLOS ONE			English	Article							PROMOTER METHYLATION PROFILE; TUMOR-SUPPRESSOR RASSF1A; PROTEIN-KINASE; BRAF MUTATION; SIGNALING PATHWAY; GROWTH-FACTOR; CLINICOPATHOLOGICAL FEATURES; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; HIGH PREVALENCE	Background: The BRAF(V600E) mutation leading to constitutive signaling of MEK-ERK pathways causes papillary thyroid cancer (PTC). Ras association domain family 1A (RASSF1A), which is an important regulator of MST1 tumor suppressor pathways, is inactivated by hypermethylation of its promoter region in 20 to 32% of PTC. However, in PTC without RASSF1A methylation, the regulatory mechanisms of RASSF1A-MST1 pathways remain to be elucidated, and the functional cooperation or cross regulation between BRAF(V600E) and MST1, which activates Foxo3, has not been investigated. Methodology/Principal Findings: The negative regulators of the cell cycle, p21 and p27, are strongly induced by transcriptional activation of FoxO3 in BRAF(V600E) positive thyroid cancer cells. The FoxO3 transactivation is augmented by RASSF1A and the MST1 signaling pathway. Interestingly, introduction of BRAF(V600E) markedly abolished FoxO3 transactivation and resulted in the suppression of p21 and p27 expression. The suppression of FoxO3 transactivation by BRAF(V600E) is strongly increased by coexpression of MST1 but it is not observed in the cells in which MST1, but not MST2, is silenced. Mechanistically, BRAF(V600E) was able to bind to the C-terminal region of MST1 and resulted in the suppression of MST1 kinase activities. The induction of the G1-checkpoint CDK inhibitors, p21 and p27, by the RASSF1A-MST1-FoxO3 pathway facilitates cellular apoptosis, whereasaddition of BRAF(V600E) inhibits the apoptotic processes through the inactivation of MST1. Transgenic induction of BRAF(V600E) in the thyroid gland results in cancers resembling human papillary thyroid cancers. The development of BRAF(V600E) transgenic mice with the MST1 knockout background showed that these mice had abundant foci of poorly differentiated carcinomas and large areas without follicular architecture or colloid formation. Conclusions/Significance: The results of this study revealed that the oncogenic effect of BRAF(V600E) is associated with the inhibition of MST1 tumor suppressor pathways, and that the activity of RASSF1A-MST1-FoxO3 pathways determines the phenotypes of BRAF(V600E) tumors.	[Lee, Seong Jin; Lee, Min Hee; Kim, Dong Wook; Lee, SeongEun; Ryu, Min Jeong; Kim, Yong Kyung; Kim, Sung Jin; Kim, Soung Jung; Hwang, Jung Hwan; Shong, Minho] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea; [Huang, Songmei; Kim, Jin Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Lee, Seong Jin; Cho, Heeyeong] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Taejon 305606, South Korea; [Hwang, Jung Hwan] Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon, South Korea; [Oh, Sangphil; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jo, Young Suk] Chungnam Natl Univ Hosp, Res Ctr Endocrine & Metab Dis, Taejon, South Korea	Chungnam National University; Chungnam National University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Chungnam National University Hospital	Lee, SJ (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea.	ysmrj@cnuh.ac.kr; minhos@cnu.ac.kr	/H-7803-2012; Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Min Hee/0000-0002-7403-7274; Cho, Heeyeong/0000-0003-0755-915X; KIM, JIN MAN/0000-0003-0905-9730; shong, minho/0000-0002-0247-7115	Ministry of Education; Ministry of Science Technology [M10748000319-07N4800-31910]; Korea Healthcare Technology, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100588]; Ministry of Science & Technology, Republic of Korea [M10748000319-07N4800-31910]	Ministry of Education; Ministry of Science Technology; Korea Healthcare Technology, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Ministry of Science & Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Science & Technology (MOST), Republic of Korea)	This work was supported in part by the second phase of the BK 21 Program of the Ministry of Education, by the Research Program for New Drug Target Discovery (M10748000319-07N4800-31910) grant from the Ministry of Science & Technology and by a grant of the Korea Healthcare Technology R&D Project (A100588), Ministry for Health, Welfare & Family Affairs, Republic of Korea. MHL, SEL, SH, MJR, SJK, JMK and MS were supported in part by the second phase of the Brain Korea 21 program of the Ministry of Education. JMK, YSJ and MS were supported by the Research Program for New Drug Target Discovery (M10748000319-07N4800-31910) grant from the Ministry of Science & Technology, Republic of Korea. MHL, SEL, MJR, YKK, SJK, SJK, YSJ and MS were supported in part by a grant of the Korea Healthcare Technology R&D Project (A100588), Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Hoque MO, 2005, J CLIN ENDOCR METAB, V90, P4011, DOI 10.1210/jc.2005-0313; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Jung HS, 2005, MOL ENDOCRINOL, V19, P2748, DOI 10.1210/me.2005-0122; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Maruyama R, 2001, CANCER RES, V61, P8659; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Nakamura N, 2005, LAB INVEST, V85, p93A; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; O'Neill E, 2005, CELL CYCLE, V4, P365, DOI 10.4161/cc.4.3.1531; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schagdarsurengin U, 2002, CANCER RES, V62, P3698; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Uribe P, 2006, J INVEST DERMATOL, V126, P161, DOI 10.1038/sj.jid.5700011; van der Heide LP, 2005, TRENDS BIOCHEM SCI, V30, P81, DOI 10.1016/j.tibs.2004.12.002; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2004, CANCER RES, V64, P1664, DOI 10.1158/0008-5472.CAN-03-3242; Xu XL, 2003, CANCER RES, V63, P4561; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518	51	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16180	10.1371/journal.pone.0016180	http://dx.doi.org/10.1371/journal.pone.0016180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249150	Green Published, Green Submitted, gold			2022-12-25	WOS:000286515000027
J	Yewhalaw, D; Wassie, F; Steurbaut, W; Spanoghe, P; Van Bortel, W; Denis, L; Tessema, DA; Getachew, Y; Coosemans, M; Duchateau, L; Speybroeck, N				Yewhalaw, Delenasaw; Wassie, Fantahun; Steurbaut, Walter; Spanoghe, Pieter; Van Bortel, Wim; Denis, Leen; Tessema, Dejene A.; Getachew, Yehenew; Coosemans, Marc; Duchateau, Luc; Speybroeck, Niko			Multiple Insecticide Resistance: An Impediment to Insecticide-Based Malaria Vector Control Program	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; KNOCKDOWN RESISTANCE; KDR MUTATION; CULEX-QUINQUEFASCIATUS; NATURAL-POPULATIONS; BURKINA-FASO; ARABIENSIS; DDT; SUSCEPTIBILITY; ACE-1(R)	Background: Indoor Residual Spraying (IRS), insecticide-treated nets (ITNs) and long-lasting insecticidal nets (LLINs) are key components in malaria prevention and control strategy. However, the development of resistance by mosquitoes to insecticides recommended for IRS and/or ITNs/LLINs would affect insecticide-based malaria vector control. We assessed the susceptibility levels of Anopheles arabiensis to insecticides used in malaria control, characterized basic mechanisms underlying resistance, and evaluated the role of public health use of insecticides in resistance selection. Methodology/Principal findings: Susceptibility status of An. arabiensis was assessed using WHO bioassay tests to DDT, permethrin, deltamethrin, malathion and propoxur in Ethiopia from August to September 2009. Mosquito specimens were screened for knockdown resistance (kdr) and insensitive acetylcholinesterase (ace-1(R)) mutations using AS-PCR and PCR-RFLP, respectively. DDT residues level in soil from human dwellings and the surrounding environment were determined by Gas Chromatography with Electron Capture Detector. An. arabiensis was resistant to DDT, permethrin, deltamethrin and malathion, but susceptible to propoxur. The West African kdr allele was found in 280 specimens out of 284 with a frequency ranged from 95% to 100%. Ace-1(R) mutation was not detected in all specimens scored for the allele. Moreover, DDT residues were found in soil samples from human dwellings but not in the surrounding environment. Conclusion: The observed multiple-resistance coupled with the occurrence of high kdr frequency in populations of An. arabiensis could profoundly affect the malaria vector control programme in Ethiopia. This needs an urgent call for implementing rational resistance management strategies and integrated vector control intervention.	[Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Jimma, Ethiopia; [Wassie, Fantahun] Jimma Univ, Dept Environm Hlth, Jimma, Ethiopia; [Tessema, Dejene A.] Jimma Univ, Dept Chem, Jimma, Ethiopia; [Getachew, Yehenew] Jimma Univ, Dept Plant Sci, Jimma, Ethiopia; [Steurbaut, Walter; Spanoghe, Pieter] Univ Ghent, Dept Crop Protect Chem, B-9000 Ghent, Belgium; [Van Bortel, Wim; Denis, Leen; Coosemans, Marc] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Duchateau, Luc] Univ Ghent, Dept Physiol & Biometr, B-9000 Ghent, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Sch Publ Hlth, Inst Hlth & Soc, B-1200 Brussels, Belgium	Jimma University; Jimma University; Jimma University; Jimma University; Ghent University; Institute of Tropical Medicine (ITM); Ghent University; Universite Catholique Louvain	Yewhalaw, D (corresponding author), Jimma Univ, Dept Biol, Jimma, Ethiopia.	delenasaw.yewhalaw@ju.edu.et	Spanoghe, Pieter/B-9440-2015; Van Bortel, Wim/AFV-4687-2022; Van Bortel, Wim/AAU-5948-2021	Spanoghe, Pieter/0000-0002-8158-4401; Van Bortel, Wim/0000-0002-6644-518X; Speybroeck, Niko/0000-0003-3322-3502	Flemish Interuniversity Council (Council of Flemish Universities, VLIR-IUC)	Flemish Interuniversity Council (Council of Flemish Universities, VLIR-IUC)	This work received financial support from the Flemish Interuniversity Council (Programme of Institutional University Cooperation of the Council of Flemish Universities, VLIR-IUC). The funders had no role in study design, data collection, decision to publish and preparation of the manuscript.	Abdalla H, 2008, T ROY SOC TROP MED H, V102, P263, DOI 10.1016/j.trstmh.2007.10.008; ABOSE Y, 1998, WHOMAL1998, P19; AHMED A, 2004, B MED J, V328, P1378; Akogbeto MC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-204; Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2001, ETH DEM HLTH SURV 20; [Anonymous], 2007, INS TREAT MOSQ NETS; [Anonymous], 2006, IND RES SPRAYING US; Balkew M., 2003, Parassitologia (Rome), V45, P1; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Biscoe ML., 2004, CURRENT POLICY STATU; BROGDON WG, 1988, J AM MOSQUITO CONTR, V4, P152; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Daddi Jima, 2005, Ethiopian Journal of Health Development, V19, P16; Dalton JP, 2009, TRENDS PARASITOL, V25, P59, DOI 10.1016/j.pt.2008.11.002; DAVIDSON G, 1982, P INT WORK RES INS U, P137; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; ELGADDAL AA, 1985, J TROP MED HYG, V88, P153; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Fanello C, 2003, MED VET ENTOMOL, V17, P333, DOI 10.1046/j.1365-2915.2003.00450.x; Fettene M, 2004, AFR ENTOMOL, V12, P83; Gilles MT, 1987, ANOPHELINAE AFRICA S, P55; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; HEMINGWAY J, 1983, T ROY SOC TROP MED H, V77, P477, DOI 10.1016/0035-9203(83)90118-9; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; *INS RES ACT COMM, 2006, PREV MAN INS RES VEC; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Mandavilli A, 2006, NATURE, V443, P250, DOI 10.1038/443250b; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; *ROLL BACK MAL, 2004, ETH ROLL BACK MAL CO; Sadasivaiah S, 2007, AM J TROP MED HYG, V77, P249, DOI 10.4269/ajtmh.2007.77.249; Schapira A, 2006, LANCET, V368, P2111, DOI 10.1016/S0140-6736(06)69812-7; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tripet F, 2007, AM J TROP MED HYG, V76, P81; Tulu NA, 1993, ECOLOGY HLTH DIS ETH, P341; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; VERHAEGHEN K, 2009, THESIS ANTWERP U ANT, P127; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weissmann G, 2006, FASEB J, V20, P2427, DOI 10.1096/fj.06-1201ufm; WHO, 1998, WHOCDSCPCMAL9812; *WHO, 2002, MAN IND RES SPRAYING; World Health Organization, 2004, WHOCDSCPEPVC200410; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	65	102	106	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16066	10.1371/journal.pone.0016066	http://dx.doi.org/10.1371/journal.pone.0016066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264325	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514300006
J	Ansari, MA; Pope, EC; Carpenter, S; Scholte, EJ; Butt, TM				Ansari, Minshad Ali; Pope, Edward C.; Carpenter, Simon; Scholte, Ernst-Jan; Butt, Tariq M.			Entomopathogenic Fungus as a Biological Control for an Important Vector of Livestock Disease: The Culicoides Biting Midge	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; CULEX-QUINQUEFASCIATUS; MOSQUITOS; EFFICACY; NUBECULOSUS; INFECTION; DIPTERA; CATTLE	Background: The recent outbreak of bluetongue virus in northern Europe has led to an urgent need to identify control measures for the Culicoides (Diptera: Ceratopogonidae) biting midges that transmit it. Following successful use of the entomopathogenic fungus Metarhizium anisopliae against larval stages of biting midge Culicoides nubeculosus Meigen, we investigated the efficacy of this strain and other fungi (Beauveria bassiana, Isaria fumosorosea and Lecanicillium longisporum) as biocontrol agents against adult C. nubeculosus in laboratory and greenhouse studies. Methodology/Findings: Exposure of midges to 'dry' conidia of all fungal isolates caused significant reductions in survival compared to untreated controls. Metarhizium anisopliae strain V275 was the most virulent, causing a significantly decrease in midge survival compared to all other fungal strains tested. The LT(50) value for strain V275 was 1.42 days compared to 2.21-3.22 days for the other isolates. The virulence of this strain was then further evaluated by exposing C. nubeculosus to varying doses (10(8)-10(11) conidia m(-2)) using different substrates (horse manure, damp peat, leaf litter) as a resting site. All exposed adults were found to be infected with the strain V275 four days after exposure. A further study exposed C. nubeculosus adults to 'dry' conidia and 'wet' conidia (conidia suspended in 0.03% aq. Tween 80) of strain V275 applied to damp peat and leaf litter in cages within a greenhouse. 'Dry' conidia were more effective than 'wet' conidia, causing 100% mortality after 5 days. Conclusion/Significance: This is the first study to demonstrate that entomopathogenic fungi are potential biocontrol agents against adult Culicoides, through the application of 'dry' conidia on surfaces (e. g., manure, leaf litter, livestock) where the midges tend to rest. Subsequent conidial transmission between males and females may cause an increased level of fungi-induced mortality in midges thus reducing the incidence of disease.	[Ansari, Minshad Ali; Pope, Edward C.; Butt, Tariq M.] Swansea Univ, Swansea, W Glam, Wales; [Carpenter, Simon] Inst Anim Hlth, Vector Borne Dis Programme, Pirbright, England; [Scholte, Ernst-Jan] Natl Ctr Monitoring Vectors, Minist Agr Nat & Food Qual, Wageningen, Netherlands	Swansea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Ansari, MA (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	m.a.ansari@swansea.ac.uk	Pope, Edward/G-5665-2011; Carpenter, Simon T/C-2718-2013	Pope, Edward/0000-0001-5781-5575; Carpenter, Simon T/0000-0001-5775-045X; Butt, Tariq/0000-0002-8789-9543	European Regional Development Fund (ERDF) through the Ireland-Wales Programme (INTERREG 4A); BBSRC [BBS/E/I/00001445] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001445] Funding Source: researchfish	European Regional Development Fund (ERDF) through the Ireland-Wales Programme (INTERREG 4A)(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the IMPACT project, which is partly funded by the European Regional Development Fund (ERDF) through the Ireland-Wales Programme (INTERREG 4A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2008, ENTOMOL EXP APPL, V127, P80, DOI 10.1111/j.1570-7458.2008.00674.x; Ansari MA, 2010, ACTA TROP, V113, P1, DOI 10.1016/j.actatropica.2009.08.022; Ansari MA, 2009, CROP PROT, V28, P269, DOI 10.1016/j.cropro.2008.11.003; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Bukhari T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-22; Butt TM, 1998, BIOCONTROL SCI TECHN, V8, P533, DOI 10.1080/09583159830045; Carpenter S, 2008, MED VET ENTOMOL, V22, P175, DOI 10.1111/j.1365-2915.2008.00743.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Darbro JM, 2009, AM J TROP MED HYG, V80, P992, DOI 10.4269/ajtmh.2009.80.992; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Howard AFV, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-87; JENKINS NE, 1998, BIOCONTROL NEWS INFO, V19, P21; Kannan SK, 2008, AFR J BIOTECHNOL, V7, P838; LACEY CM, 1988, J INVERTEBR PATHOL, V52, P108, DOI 10.1016/0022-2011(88)90109-7; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mnyone LL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-309; Papadopoulos E, 2009, VET PARASITOL, V163, P110, DOI 10.1016/j.vetpar.2009.03.041; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; Scholte Ernst-Jan, 2004, Malar J, V3, P45, DOI 10.1186/1475-2875-3-45; Skrobek A, 2008, BIOCONTROL, V53, P361, DOI 10.1007/s10526-007-9077-1; SPSS, 2007, SPSS STAT SOFTW VERS; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; SWEENEY W, 1985, INTEGRATED MOSQUITO, V2, P269; Unkles SE, 2004, BIOCONTROL SCI TECHN, V14, P397, DOI 10.1080/09583150310001639178; Webb L, 2010, B ENTOMOL RES, V100, P175, DOI 10.1017/S0007485309006981; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963	33	54	57	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16108	10.1371/journal.pone.0016108	http://dx.doi.org/10.1371/journal.pone.0016108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264343	gold, Green Submitted, Green Published			2022-12-25	WOS:000286513100026
J	Evans, JA; Leise, TL; Castanon-Cervantes, O; Davidson, AJ				Evans, Jennifer A.; Leise, Tanya L.; Castanon-Cervantes, Oscar; Davidson, Alec J.			Intrinsic Regulation of Spatiotemporal Organization within the Suprachiasmatic Nucleus	PLOS ONE			English	Article							CIRCADIAN OSCILLATIONS; PROTEIN EXPRESSION; NEURONS; CLOCK; MOUSE; PHASE; INDUCTION; GENES; MPER1; PER1	The mammalian pacemaker in the suprachiasmatic nucleus (SCN) contains a population of neural oscillators capable of sustaining cell-autonomous rhythms in gene expression and electrical firing. A critical question for understanding pacemaker function is how SCN oscillators are organized into a coherent tissue capable of coordinating circadian rhythms in behavior and physiology. Here we undertake a comprehensive analysis of oscillatory function across the SCN of the adult PER2::LUC mouse by developing a novel approach involving multi-position bioluminescence imaging and unbiased computational analyses. We demonstrate that there is phase heterogeneity across all three dimensions of the SCN that is intrinsically regulated and extrinsically modulated by light in a region-specific manner. By investigating the mechanistic bases of SCN phase heterogeneity, we show for the first time that phase differences are not systematically related to regional differences in period, waveform, amplitude, or brightness. Furthermore, phase differences are not related to regional differences in the expression of arginine vasopressin and vasoactive intestinal polypeptide, two key neuropeptides characterizing functionally distinct subdivisions of the SCN. The consistency of SCN spatiotemporal organization across individuals and across planes of section suggests that the precise phasing of oscillators is a robust feature of the pacemaker important for its function.	[Evans, Jennifer A.; Castanon-Cervantes, Oscar; Davidson, Alec J.] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Leise, Tanya L.] Amherst Coll, Dept Math, Amherst, MA 01002 USA	Morehouse School of Medicine; Amherst College	Evans, JA (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	adavidson@msm.edu		Leise, Tanya/0000-0002-7458-7604	NINDS/NIH [U54NS060659]; NCI/NIH [P20CA132389]; NCMHD/NIH [S21MD000101]; NCRR/NIH [G12-RR03034]; Georgia Research Alliance; NSF Center for Behavioral Neuroscience; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCMHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Georgia Research Alliance; NSF Center for Behavioral Neuroscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NINDS/NIH grant U54NS060659, NCI/NIH grant P20CA132389, NCMHD/NIH grant S21MD000101, NCRR/NIH grant G12-RR03034, the Georgia Research Alliance, and the NSF Center for Behavioral Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Butler MP, 2009, J BIOL RHYTHM, V24, P340, DOI 10.1177/0748730409344800; Dardente H, 2002, BRAIN RES, V958, P261, DOI 10.1016/S0006-8993(02)03563-1; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Drouyer E, 2010, J COMP NEUROL, V518, P1249, DOI 10.1002/cne.22272; Fisher NI, 1995, STAT ANAL CIRCULAR D; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jobst EE, 2004, NEUROSCIENCE, V123, P87, DOI 10.1016/j.neuroscience.2003.08.059; Jobst EE, 2002, EUR J NEUROSCI, V16, P2469, DOI 10.1046/j.1460-9568.2002.02309.x; Kalsbeek A, 2006, CHRONOBIOL INT, V23, P521, DOI 10.1080/07420520600651073; Karatsoreos IN, 2004, J NEUROSCI, V24, P68, DOI 10.1523/JNEUROSCI.1666-03.2004; Klein DC, SUPRACHIASMATIC NUCL; Kriegsfeld LJ, 2004, J COMP NEUROL, V468, P361, DOI 10.1002/cne.10995; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; LEVINE JD, 2002, BMC NEUROSCI, V3; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Nagano M, 2003, J NEUROSCI, V23, P6141; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Romijn HJ, 1997, EUR J NEUROSCI, V9, P2613, DOI 10.1111/j.1460-9568.1997.tb01691.x; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan L, 2007, COLD SPRING HARB SYM, V72, P527, DOI 10.1101/sqb.2007.72.037; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; YAN L, 2009, REV ENDOCR METAB DIS; Yan L, 2008, EUR J NEUROSCI, V28, P2108, DOI 10.1111/j.1460-9568.2008.06493.x; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yan LL, 2002, EUR J NEUROSCI, V15, P1153, DOI 10.1046/j.1460-9568.2002.01955.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	48	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15869	10.1371/journal.pone.0015869	http://dx.doi.org/10.1371/journal.pone.0015869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249213	gold, Green Published, Green Submitted			2022-12-25	WOS:000286512900010
J	Petitbarat, M; Rahmati, M; Serazin, V; Dubanchet, S; Morvan, C; Wainer, R; de Mazancourt, P; Chaouat, G; Foidart, JM; Munaut, C; Ledee, N				Petitbarat, Marie; Rahmati, Mona; Serazin, Valerie; Dubanchet, Sylvie; Morvan, Corinne; Wainer, Robert; de Mazancourt, Philippe; Chaouat, Gerard; Foidart, Jean-Michel; Munaut, Carine; Ledee, Nathalie			TWEAK Appears as a Modulator of Endometrial IL-18 Related Cytotoxic Activity of Uterine Natural Killers	PLOS ONE			English	Article							IN-VITRO; MULTIFUNCTIONAL CYTOKINE; TNF SUPERFAMILY; NK CELLS; EXPRESSION; RECEPTOR; BIOLOGY; MODEL; PROLIFERATION; IMPLANTATION	Background: TWEAK (Tumor necrosis factor like WEAK inducer of apoptosis) is highly expressed by different immune cells and triggers multiple cellular responses, including control of angiogenesis. Our objective was to investigate its role in the human endometrium during the implantation window, using an ex-vivo endometrial microhistoculture model. Indeed, previous results suggested that basic TWEAK expression influences the IL-18 related uNK recruitment and local cytotoxicity. Methodology/Principal Findings: Endometrial biopsies were performed 7 to 9 days after the ovulation surge of women in monitored natural cycles. Biopsies were cut in micro-pieces and cultured on collagen sponge with appropriate medium. Morphology, functionality and cell death were analysed at different time of the culture. We used this ex vivo model to study mRNA expressions of NKp46 (a uNK cytotoxic receptor) and TGF-beta1 (protein which regulates uNK cytokine production) after adjunction of excess of recombinant IL-18 and either recombinant TWEAK or its antibody. NKp46 protein expression was also detailed by immunohistochemistry in selected patients with high basic mRNA level of IL-18 and either low or high mRNA level of TWEAK. The NKp46 immunostaining was stronger in patients with an IL-18 over-expression and a low TWEAK expression, when compared with patients with both IL-18 and TWEAK high expressions. We did not observe any difference for TWEAK expression when recombinant protein IL-18 or its antibody was added, or conversely, for IL-18 expression when TWEAK or its antibody was added in the culture medium. In a pro-inflammatory environment (obtained by an excess of IL-18), inhibition of TWEAK was able to increase significantly NKp46 and TGF-beta1 mRNA expressions. Conclusions/Significance: TWEAK doesn't act on IL-18 expression but seems to control IL-18 related cytotoxicity on uNK cells when IL-18 is over-expressed. Thus, TWEAK appears as a crucial physiological modulator to prevent endometrial uNK cytotoxicity in human.	[Petitbarat, Marie; Rahmati, Mona; Dubanchet, Sylvie; Chaouat, Gerard; Ledee, Nathalie] Univ Paris 11, Hop Antoine Beclere, INSERM, UMR S0782,U782, Clamart, France; [Serazin, Valerie; Morvan, Corinne; Wainer, Robert; de Mazancourt, Philippe] Univ Versailles St Quentin Yvelines, CHI Poissy St Germain Laye, Dept Reprod Med & Mol Biol, EA 2493, Poissy, France; [Foidart, Jean-Michel; Munaut, Carine] Univ Liege, CHU Sart Tilman, Lab Tumor & Dev Biol, Liege, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Universite Paris Saclay; University of Liege	Ledee, N (corresponding author), Univ Paris 11, Hop Antoine Beclere, INSERM, UMR S0782,U782, Clamart, France.	nathalie-ledee@orange.fr	LEDEE, nathalie/AAE-8303-2019; Munaut, Carine/K-8138-2019	LEDEE, nathalie/0000-0002-3166-2643	University Paris XI; Inserm Research Institute	University Paris XI; Inserm Research Institute	This work was supported by University Paris XI and Inserm Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Bell E, 2006, NAT REV IMMUNOL, V6, P91, DOI 10.1038/nri1790; BENTINLEY U, 1994, J REPROD FERTIL, V101, P327; BERGH PA, 1992, FERTIL STERIL, V58, P537; Blauer M, 2005, HUM REPROD, V20, P864, DOI 10.1093/humrep/deh722; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Croy BA, 2003, REPRODUCTION, V126, P149, DOI 10.1530/rep.0.1260149; Croy BA, 1997, AM J REPROD IMMUNOL, V37, P463; DUDLEY DJ, 1992, AM J OBSTET GYNECOL, V167, P1774, DOI 10.1016/0002-9378(92)91774-5; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; Faye A, 2005, PLACENTA, V26, P262, DOI 10.1016/j.placenta.2004.08.005; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Krussel JS, 1999, MOL HUM REPROD, V5, P452, DOI 10.1093/molehr/5.5.452; Laird SM, 2005, PLACENTA, V26, pA26; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Ledee N, 2008, J REPROD IMMUNOL, V77, P57, DOI 10.1016/j.jri.2007.07.006; Ledee-Bataille N, 2005, FERTIL STERIL, V83, P598, DOI 10.1016/j.fertnstert.2004.11.021; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Loke YW, 1996, AM J REPROD IMMUNOL, V35, P256; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Manaster I, 2008, J IMMUNOL, V181, P1869, DOI 10.4049/jimmunol.181.3.1869; OSTEEN KG, 1994, P NATL ACAD SCI USA, V91, P10129, DOI 10.1073/pnas.91.21.10129; PETITBARAT M, 2009, FERTIL STERIL; Petitbarat M, 2010, FERTIL STERIL, V94, P1141, DOI 10.1016/j.fertnstert.2009.10.049; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Pierro E, 2001, BIOL REPROD, V64, P831, DOI 10.1095/biolreprod64.3.831; Raine-Fenning NJ, 2004, HUM REPROD, V19, P330, DOI 10.1093/humrep/deh056; Raine-Fenning NJ, 2004, HUM REPROD, V19, P2605, DOI 10.1093/humrep/deh459; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488	33	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14497	10.1371/journal.pone.0014497	http://dx.doi.org/10.1371/journal.pone.0014497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249128	Green Published, Green Submitted, gold			2022-12-25	WOS:000286512900003
J	Golovina, TN; Mikheeva, T; Brusko, TM; Blazar, BR; Bluestone, JA; Riley, JL				Golovina, Tatiana N.; Mikheeva, Tatiana; Brusko, Todd M.; Blazar, Bruce R.; Bluestone, Jeffrey A.; Riley, James L.			Retinoic Acid and Rapamycin Differentially Affect and Synergistically Promote the Ex Vivo Expansion of Natural Human T Regulatory Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; DE-NOVO GENERATION; TGF-BETA; TRANSPLANTATION TOLERANCE; INFECTIOUS TOLERANCE; PERIPHERAL-BLOOD; FOXP3 EXPRESSION; CUTTING EDGE; IN-VIVO	Natural T regulatory cells (Tregs) are challenging to expand ex vivo, and this has severely hindered in vivo evaluation of their therapeutic potential. All trans retinoic acid (ATRA) plays an important role in mediating immune homeostasis in vivo, and we investigated whether ATRA could be used to promote the ex vivo expansion of Tregs purified from adult human peripheral blood. We found that ATRA helped maintain FOXP3 expression during the expansion process, but this effect was transient and serum-dependent. Furthermore, natural Tregs treated with rapamycin, but not with ATRA, suppressed cytokine production in co-cultured effector T cells. This suppressive activity correlated with the ability of expanded Tregs to induce FOXP3 expression in non-Treg cell populations. Examination of CD45RA+ and CD45RA- Treg subsets revealed that ATRA failed to maintain suppressive activity in either population, but interestingly, Tregs expanded in the presence of both rapamycin and ATRA displayed more suppressive activity and had a more favorable epigenetic status of the FOXP3 gene than Tregs expanded in the presence of rapamycin only. We conclude that while the use of ATRA as a single agent to expand Tregs for human therapy is not warranted, its use in combination with rapamycin may have benefit.	[Golovina, Tatiana N.; Mikheeva, Tatiana; Riley, James L.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Golovina, Tatiana N.; Mikheeva, Tatiana; Riley, James L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Brusko, Todd M.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Blazar, Bruce R.; Bluestone, Jeffrey A.] Univ Minnesota, Ctr Canc, Minneapolis, MN USA; [Blazar, Bruce R.; Bluestone, Jeffrey A.] Univ Minnesota, Dept Pediat, Div Bone Marrow Transplant, Minneapolis, MN 55455 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Golovina, TN (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	rileyj@exchange.upenn.edu		Brusko, Todd/0000-0003-2878-9296; Riley, James/0000-0002-1057-576X	Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy; JDRF Center on Cord Blood Therapies for Type 1 Diabetes, Leukemia and Lymphoma Translational Research [R6029-07];  [P01 CA067493]; NATIONAL CANCER INSTITUTE [F32CA067493, P01CA142106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy; JDRF Center on Cord Blood Therapies for Type 1 Diabetes, Leukemia and Lymphoma Translational Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Juvenile Diabetes Research Foundation Collaborative Centers for Cell Therapy and the JDRF Center on Cord Blood Therapies for Type 1 Diabetes, Leukemia and Lymphoma Translational Research (grant R6029-07) and P01 CA067493. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2008, IMMUNOL REV, V223, P391, DOI 10.1111/j.1600-065X.2008.00634.x; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bonewald LF, 1997, ENDOCRINOLOGY, V138, P657, DOI 10.1210/en.138.2.657; Chai JG, 2005, TRANSPLANTATION, V79, P1310, DOI 10.1097/01.TP.0000159147.56408.9C; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2006, BLOOD, V108, p903A, DOI 10.1182/blood.V108.11.3163.3163; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim CH, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/416910; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moore C, 2009, TRANSPL P, V41, P2670, DOI 10.1016/j.transproceed.2009.06.130; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; RACKE MK, 1995, J IMMUNOL, V154, P450; Reifen R, 2002, J NUTR, V132, P2743, DOI 10.1093/jn/132.9.2743; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Taylor P, 2004, BLOOD, V104, p16A; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002; Zunino SJ, 2007, J NUTR, V137, P1216, DOI 10.1093/jn/137.5.1216	55	106	113	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15868	10.1371/journal.pone.0015868	http://dx.doi.org/10.1371/journal.pone.0015868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253593	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511900018
J	Patel, S; Macaulay, K; Woodgett, JR				Patel, Satish; Macaulay, Katrina; Woodgett, James R.			Tissue-Specific Analysis of Glycogen Synthase Kinase-3 alpha (GSK-3 alpha) in Glucose Metabolism: Effect of Strain Variation	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-2; BETA-CELLS; HOMEOSTASIS; INHIBITION; LIVER; ACTIVATION; EXPRESSION; GSK-3-BETA; PLAYS; MICE	Background: Over-activity and elevated expression of glycogen synthase kinase-3 (GSK-3) has been implicated in the etiology of insulin resistance and Type 2 diabetes. Administration of specific GSK-3 inhibitors to diabetic or obese rodent models improves glycaemic control and insulin sensitivity. However, due to the indiscriminatory nature of these inhibitors, the relative contribution of the two isoforms of GSK-3 (GSK-3 alpha and GSK-3 beta) is not known. Recently, we demonstrated that an out-bred strain of mice (ICR) lacking expression of GSK-3 alpha in all tissues displayed improved insulin sensitivity and enhanced hepatic glucose metabolism. We also found that muscle (but not liver) inactivation of GSK-3 beta conferred insulin and glucose sensitization in an in-bred strain of mice (C57BL/6). Methodology/Principal Findings: Here, we have employed tissue-specific deletion of GSK-3 alpha, to examine the relative contribution of two insulin-sensitive tissues, muscle and liver, towards the insulin sensitization phenotype originally observed in the global GSK-3 alpha KO animals. We found that mice in which GSK-3 alpha has been inactivated in either skeletal-muscle or liver displayed no differences in glucose tolerance or insulin sensitivity compared to wild type littermates. Given the strain differences in our original analyses, we examined the insulin and glucose sensitivity of global GSK-3 alpha KO animals bred onto a C57BL/6 background. These animals also revealed no significant differences in glucose metabolism/insulin sensitivity compared to their wild type littermates. Furthermore, deletion of hepatic GSK-3 alpha on the out-bred, ICR background failed to reproduce the insulin sensitivity manifested by the global deletion of this isoform. Conclusions/Significance: From these data we conclude that the improved insulin sensitivity and hepatic glucose homeostasis phenotype observed upon global inactivation of GSK-3 alpha is strain-specific. We surmise that the insulin-sensitization observed in the out-bred strain of mice lacking GSK-3 alpha is mediated by indirect means that do not require intrinsic function of GSK-3 alpha in skeletal muscle and liver tissues.	[Patel, Satish; Macaulay, Katrina; Woodgett, James R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Patel, S (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	woodgett@lunenfeld.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797	Canadian Institutes of Health Research [MOP 74711]; Canadian Diabetes Association [OG-3-07-2425-JW]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	Canadian Institutes of Health Research - http://www.cihr-irsc.gc.ca MOP 74711. Canadian Diabetes Association OG-3-07-2425-JW - http://www.diabetes.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cline GW, 2002, DIABETES, V51, pA314; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dokken BB, 2006, AM J PHYSIOL-ENDOC M, V291, pE207, DOI 10.1152/ajpendo.00628.2005; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; MacAulay K, 2008, EXPERT OPIN THER TAR, V12, P1265, DOI 10.1517/14728222.12.10.1265 ; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	27	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15845	10.1371/journal.pone.0015845	http://dx.doi.org/10.1371/journal.pone.0015845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253590	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900013
J	Serra, V; Scaltriti, M; Prudkin, L; Eichhorn, PJA; Ibrahim, YH; Chandarlapaty, S; Markman, B; Rodriguez, O; Guzman, M; Rodriguez, S; Gili, M; Russillo, M; Parra, JL; Singh, S; Arribas, J; Rosen, N; Baselga, J				Serra, V.; Scaltriti, M.; Prudkin, L.; Eichhorn, P. J. A.; Ibrahim, Y. H.; Chandarlapaty, S.; Markman, B.; Rodriguez, O.; Guzman, M.; Rodriguez, S.; Gili, M.; Russillo, M.; Parra, J. L.; Singh, S.; Arribas, J.; Rosen, N.; Baselga, J.			PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer	ONCOGENE			English	Article						PI3K/mTOR; HER2; feedback; ERK; BEZ235	PHASE-II; TRASTUZUMAB RESISTANCE; PATHWAY ACTIVATION; ANTITUMOR-ACTIVITY; PTEN; RECEPTOR; PIK3CA; MUTATIONS; GENE; MEK	There is a strong rationale to therapeutically target the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway in breast cancer since it is highly deregulated in this disease and it also mediates resistance to anti-HER2 therapies. However, initial studies with rapalogs, allosteric inhibitors of mTORC1, have resulted in limited clinical efficacy probably due to the release of a negative regulatory feedback loop that triggers AKT and ERK signaling. Since activation of AKT occurs via PI3K, we decided to explore whether PI3K inhibitors prevent the activation of these compensatory pathways. Using HER2-overexpressing breast cancer cells as a model, we observed that PI3K inhibitors abolished AKT activation. However, PI3K inhibition resulted in a compensatory activation of the ERK signaling pathway. This enhanced ERK signaling occurred as a result of activation of HER family receptors as evidenced by induction of HER receptors dimerization and phosphorylation, increased expression of HER3 and binding of adaptor molecules to HER2 and HER3. The activation of ERK was prevented with either MEK inhibitors or anti-HER2 monoclonal antibodies and tyrosine kinase inhibitors. Combined administration of PI3K inhibitors with either HER2 or MEK inhibitors resulted in decreased proliferation, enhanced cell death and superior anti-tumor activity compared with single agent PI3K inhibitors. Our findings indicate that PI3K inhibition in HER2-overexpressing breast cancer activates a new compensatory pathway that results in ERK dependency. Combined anti-MEK or anti-HER2 therapy with PI3K inhibitors may be required in order to achieve optimal efficacy in HER2-overexpressing breast cancer. This approach warrants clinical evaluation. Oncogene (2011) 30, 2547-2557; doi:10.1038/onc.2010.626; published online 31 January 2011	[Baselga, J.] Vall Hebron Univ Hosp, VHIO, Expt Therapeut Program, E-08035 Barcelona, Spain; [Scaltriti, M.; Baselga, J.] Massachusetts Gen Hosp, Ctr Canc, Ctr Canc Res, Boston, MA USA; [Prudkin, L.; Rodriguez, S.] Vall Hebron Inst Oncol, Mol Pathol Program, Barcelona, Spain; [Chandarlapaty, S.; Rosen, N.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Chandarlapaty, S.; Rosen, N.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Markman, B.; Baselga, J.] Vall Hebron Univ Hosp, Dept Med Oncol, E-08035 Barcelona, Spain; [Parra, J. L.; Arribas, J.] Vall Hebron Inst Oncol, Growth Factors Lab, Barcelona, Spain; [Singh, S.] Prometheus Therapeut & Diagnost, San Diego, CA USA; [Arribas, J.; Baselga, J.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Arribas, J.] Inst Catalana Recerca & Estudis Acancats, Barcelona, Spain; [Baselga, J.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Harvard University; Massachusetts General Hospital; Vall d'Hebron Institut d'Oncologia (VHIO); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; ICREA; Harvard University; Massachusetts General Hospital	Baselga, J (corresponding author), Vall Hebron Univ Hosp, VHIO, Expt Therapeut Program, Passeig Vall Hebron 119-129, E-08035 Barcelona, Spain.	jbaselga@vhio.net	Serra, Violeta/AAG-8328-2019; Arribas, Joaquin/M-4482-2014; Rosen, Neal/ABF-2677-2020	Arribas, Joaquin/0000-0002-0504-0664; Serra, Violeta/0000-0001-6620-1065; Eichhorn, Pieter/0000-0001-5840-943X	Instituto de Salud Carlos III [PSO9/00623]; Breast Cancer Research Foundation; ERC [AdG09 250244]; NATIONAL CANCER INSTITUTE [K08CA134833] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Breast Cancer Research Foundation; ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	This research was supported by grants from the Instituto de Salud Carlos III (Intrasalud PSO9/00623), from the Breast Cancer Research Foundation and from the ERC (AdG09 250244). BEZ235 and NVP-AEW541 were kindly provided by C Garcia-Echeverria from Novartis, Basel, Switzerland. The AKT1/2/3 inhibitor was provided by Pradip Majumder at Merck Research Laboratories, Boston. Lapatinib was kindly provided by GlaxoSmithKline, Research Triangle Park, NJ. Torin1 was obtained from Whitehead/DFCI. Trastuzumab was kindly provided by F Hoffmann-La Roche, Basel, Switzerland.	Andre F, 2008, J CLIN ONCOL S, V26; Banerji U, 2010, CLIN CANCER RES, V16, P1613, DOI 10.1158/1078-0432.CCR-09-2483; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chaturvedi D, 2009, ONCOGENE, V28, P1187, DOI 10.1038/onc.2008.490; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clark AS, 2002, MOL CANCER THER, V1, P707; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Crowder RJ, 2009, CANCER RES, V69, P3955, DOI 10.1158/0008-5472.CAN-08-4450; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Ellard SL, 2009, J CLIN ONCOL, V27, P4536, DOI 10.1200/JCO.2008.21.3033; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Flaherty K, 2009, J CLIN ONCOL, V27; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; GARRETT J, 2009, CANC RES S, V69; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Makhija S, 2010, J CLIN ONCOL, V28, P1215, DOI 10.1200/JCO.2009.22.3354; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shapiro G, 2009, J CLIN ONCOL S, V27, p15s; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	54	395	411	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	22					2547	2557		10.1038/onc.2010.626	http://dx.doi.org/10.1038/onc.2010.626			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21278786	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000291198400006
J	Mansfield, RE; Musselman, CA; Kwan, AH; Oliver, SS; Garske, AL; Davrazou, F; Denu, JM; Kutateladze, TG; Mackay, JP				Mansfield, Robyn E.; Musselman, Catherine A.; Kwan, Ann H.; Oliver, Samuel S.; Garske, Adam L.; Davrazou, Foteini; Denu, John M.; Kutateladze, Tatiana G.; Mackay, Joel P.			Plant Homeodomain (PHD) Fingers of CHD4 Are Histone H3-binding Modules with Preference for Unmodified H3K4 and Methylated H3K9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING FACTOR; NURD REPRESSOR COMPLEX; BINDING MODULES; DNA-DAMAGE; LYSINE-4 METHYLATION; AUTOIMMUNE REGULATOR; HETEROCHROMATIN FORMATION; TUMOR-SUPPRESSOR; GENE REPRESSION; MOLECULAR-BASIS	A major challenge in chromatin biology is to understand the mechanisms by which chromatin is remodeled into active or inactive states as required during development and cell differentiation. One complex implicated in these processes is the nucleosome remodeling and histone deacetylase (NuRD) complex, which contains both histone deacetylase and nucleosome remodeling activities and has been implicated in the silencing of subsets of genes involved in various stages of cellular development. Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a core component of the NuRD complex and contains a nucleosome remodeling ATPase domain along with two chromodomains and two plant homeodomain (PHD) fingers. We have previously demonstrated that the second PHD finger of CHD4 binds peptides corresponding to the N terminus of histone H3 methylated at Lys(9). Here, we determine the solution structure of PHD2 in complex with H3K9me3, revealing the molecular basis of histone recognition, including a cation-pi recognition mechanism for methylated Lys(9). Additionally, we demonstrate that the first PHD finger also exhibits binding to the N terminus of H3, and we establish the histone-binding surface of this domain. This is the first instance where histone binding ability has been demonstrated for two separate PHD modules within the one protein. These findings suggest that CHD4 could bind to two H3 N-terminal tails on the same nucleosome or on two separate nucleosomes simultaneously, presenting exciting implications for the mechanism by which CHD4 and the NuRD complex could direct chromatin remodeling.	[Mansfield, Robyn E.; Kwan, Ann H.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Musselman, Catherine A.; Davrazou, Foteini; Kutateladze, Tatiana G.] Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Oliver, Samuel S.; Garske, Adam L.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Sydney; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Wisconsin System; University of Wisconsin Madison	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	; Mackay, Joel/D-6834-2011	Kwan, Ann/0000-0002-1506-2226; Musselman, Catherine/0000-0002-8356-7971; Mackay, Joel/0000-0001-7508-8033; Kutateladze, Tatiana/0000-0001-7375-6990	National Institutes of Health [R01 CA113472]; National Health and Medical Research Council of Australia; Australian Research Council; Australian postgraduate award; Australian postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA113472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059785, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian postgraduate award(Australian Government); Australian postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA113472 Grant (to T. G. K.). This work was also supported in part by a Program Grant from the National Health and Medical Research Council of Australia (to J. P. M.) and a Discovery Project Grant from the Australian Research Council (to A. H. K.).; Supported by an Australian postgraduate award.; Supported by an Australian postdoctoral fellowship.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bardiaux B, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-30; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; Garske AL, 2010, NAT CHEM BIOL, V6, P283, DOI [10.1038/NCHEMBIO.319, 10.1038/nchembio.319]; GODDARD T, 2005, SPARKY VERSION 3 113; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hughes RM, 2007, CHEM-EUR J, V13, P5753, DOI 10.1002/chem.200601753; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pacifico F, 2007, J CLIN ENDOCR METAB, V92, P1458, DOI 10.1210/jc.2006-2199; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; ROBERTS GCK, 1993, NMR MACROMOLECULES, P315; Scanlon MJ, 1997, STRUCTURE, V5, P1585, DOI 10.1016/S0969-2126(97)00307-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	76	115	116	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11779	11791		10.1074/jbc.M110.208207	http://dx.doi.org/10.1074/jbc.M110.208207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278251	Green Published, hybrid			2022-12-25	WOS:000288797100085
J	Richard, D; Bartfai, R; Volz, J; Ralph, SA; Muller, S; Stunnenberg, HG; Cowman, AF				Richard, Dave; Bartfai, Richard; Volz, Jennifer; Ralph, Stuart A.; Muller, Sylke; Stunnenberg, Hendrik G.; Cowman, Alan F.			A Genome-wide Chromatin-associated Nuclear Peroxiredoxin from the Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN PEROXIDASES; ANTIOXIDANT SYSTEMS; OXIDATIVE STRESS; HISTONE H1; PROTEIN; REDOX; ERYTHROCYTE; INVASION; DOMAIN; GLUTAREDOXIN	Malaria parasites are subjected to high levels of oxidative stress during their development inside erythrocytes and the ability of the parasite to defend itself against this assault is critical to its survival. Therefore, Plasmodium possesses an effective antioxidant defense system that could potentially be used as a target for the development of inhibitor-based therapy. We have identified an unusual peroxiredoxin protein that localizes to the nucleus of Plasmodium falciparum and have renamed it Pfn Prx (PF10_0268, earlier called MCP1). Our work reveals that Pfn Prx has a broad specificity of substrate being able to utilize thioredoxin and glutaredoxin as reductants and having the ability to reduce simple and complex peroxides. Intriguingly, chromatin immunoprecipitation followed by deep sequencing reveals that the enzyme associates with chromatin in a genome-wide manner with a slight enrichment in coding regions. Our results represent the first description of a dedicated chromatin-associated peroxiredoxin and potentially represent an ingenious way by which the parasite can survive the highly oxidative environment within its human host.	[Richard, Dave; Volz, Jennifer; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Bartfai, Richard; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3052, Australia; [Muller, Sylke] Univ Glasgow, Fac Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; [Muller, Sylke] Univ Glasgow, Fac Biomed & Life Sci, Wellcome Ctr Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia	Walter & Eliza Hall Institute; Radboud University Nijmegen; University of Melbourne; University of Glasgow; University of Glasgow; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3052, Australia.	cowman@wehi.edu.au	Stunnenberg, Hendrik G./D-6875-2012; Bartfai, Richard/E-2083-2012; Cowman, Alan F/C-7642-2013; Ralph, Stuart/C-8590-2014	Stunnenberg, Hendrik G./0000-0002-0066-1576; Bartfai, Richard/0000-0002-8460-6477; Cowman, Alan F/0000-0001-5145-9004; Ralph, Stuart/0000-0003-0114-7808	National Health and Medical Research Council of Australia (NHMRC); Canadian Institutes of Health Research; Netherlands Organization for Scientific Research	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the National Health and Medical Research Council of Australia (NHMRC).; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.; Supported by the Netherlands Organization for Scientific Research.	Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Akerman SE, 2003, MOL BIOCHEM PARASIT, V130, P75, DOI 10.1016/S0166-6851(03)00161-0; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; HAYASHI T, 1987, J BIOCHEM-TOKYO, V102, P369, DOI 10.1093/oxfordjournals.jbchem.a122063; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; HUDSONTAYLOR DE, 1995, MOL MICROBIOL, V15, P463, DOI 10.1111/j.1365-2958.1995.tb02260.x; HUNT NH, 1990, BLOOD CELLS, V16, P499; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Kawazu S, 2000, MOL BIOCHEM PARASIT, V109, P165, DOI 10.1016/S0166-6851(00)00243-7; KIM KW, 1988, J BIOL CHEM, V263, P4704; KLOTZ FW, 1989, MOL BIOCHEM PARASIT, V36, P177, DOI 10.1016/0166-6851(89)90190-4; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V112, P219, DOI 10.1016/S0166-6851(00)00372-8; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V113, P303, DOI 10.1016/S0166-6851(01)00219-5; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rahlfs S, 2001, EUR J BIOCHEM, V268, P1404, DOI 10.1046/j.1432-1327.2001.02005.x; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Rouhier N, 2008, BBA-GEN SUBJECTS, V1780, P1249, DOI 10.1016/j.bbagen.2007.12.007; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SUBIRANA JA, 1990, BIOPOLYMERS, V29, P1351, DOI 10.1002/bip.360291003; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Sztajer H, 2001, J BIOL CHEM, V276, P7397, DOI 10.1074/jbc.M008631200; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VERNET G, 1990, BIOCHIM BIOPHYS ACTA, V1048, P281, DOI 10.1016/0167-4781(90)90068-D; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; ZYKOVA TA, 2010, J BIOL CHEM	54	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11746	11755		10.1074/jbc.M110.198499	http://dx.doi.org/10.1074/jbc.M110.198499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282103	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000288797100082
J	Cross, PJ; Dobson, RCJ; Patchett, ML; Parker, EJ				Cross, Penelope J.; Dobson, Renwick C. J.; Patchett, Mark L.; Parker, Emily J.			Tyrosine Latching of a Regulatory Gate Affords Allosteric Control of Aromatic Amino Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CONFORMATIONAL SELECTION; CHORISMATE MUTASE; SHIKIMATE PATHWAY; DAHP SYNTHASE; ACT DOMAIN; PURIFICATION; ENZYMES	The first step of the shikimate pathway for aromatic amino acid biosynthesis is catalyzed by 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS). Thermotoga maritima DAH7PS (TmaDAH7PS) is tetrameric, with monomer units comprised of a core catalytic (beta/alpha)(8) barrel and an N-terminal domain. This enzyme is inhibited strongly by tyrosine and to a lesser extent by the presence of phenylalanine. A truncated mutant of TmaDAH7PS lacking the N-terminal domain was catalytically more active and completely insensitive to tyrosine and phenylalanine, consistent with a role for this domain in allosteric inhibition. The structure of this protein was determined to 2.0 angstrom. In contrast to the wild-type enzyme, this enzyme is dimeric. Wild-type TmaDAH7PS was co-crystallized with tyrosine, and the structure of this complex was determined to a resolution of 2.35 angstrom. Tyrosine was found to bind at the interface between two regulatory N-terminal domains, formed from diagonally located monomers of the tetramer, revealing a major reorganization of the regulatory domain with respect to the barrel relative to unliganded enzyme. This significant conformational rearrangement observed in the crystal structures was also clearly evident from small angle X-ray scattering measurements recorded in the presence and absence of tyrosine. The closed conformation adopted by the protein on tyrosine binding impedes substrate entry into the neighboring barrel, revealing an unusual tyrosine-controlled gating mechanism for allosteric control of this enzyme.	[Parker, Emily J.] Univ Canterbury, Dept Chem, Biomol Interact Ctr, Christchurch 8040, New Zealand; [Cross, Penelope J.; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8140, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Patchett, Mark L.] Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand	University of Canterbury; University of Canterbury; University of Canterbury; University of Melbourne; Massey University	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Biomol Interact Ctr, Private Bag 4800, Christchurch 8040, New Zealand.	emily.parker@canterbury.ac.nz	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Parker, Emily/0000-0002-9571-9987	University of Canterbury; New Zealand Marsden Fund [UOC0710]; C.R. Roper Bequest for Fellowship	University of Canterbury; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); C.R. Roper Bequest for Fellowship	This work was supported by a doctoral scholarship from the University of Canterbury (for P.J.C.), Grant UOC0710 from the New Zealand Marsden Fund, and the C.R. Roper Bequest for Fellowship (to R.C.J.D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho Y, 2003, J BIOL CHEM, V278, P8333, DOI 10.1074/jbc.M212124200; Curien G, 2008, PLANT PHYSIOL BIOCH, V46, P325, DOI 10.1016/j.plaphy.2007.12.006; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gosset G, 2001, J BACTERIOL, V183, P4061, DOI 10.1128/JB.183.13.4061-4070.2001; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HERRMANN KM, 1991, CURR TOP PLANT PHYSL, V7, P12; HOFFMANN PJ, 1972, BIOCHIM BIOPHYS ACTA, V268, P550, DOI 10.1016/0005-2744(72)90352-X; Jensen RA, 2002, J MOL EVOL, V54, P416, DOI 10.1007/s00239-001-0031-z; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; OGINO T, 1982, P NATL ACAD SCI-BIOL, V79, P5828, DOI 10.1073/pnas.79.19.5828; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; TRIBE DE, 1976, J BACTERIOL, V127, P1085, DOI 10.1128/JB.127.3.1085-1097.1976; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2003, J BIOL CHEM, V278, P27525, DOI 10.1074/jbc.M304631200; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248	48	45	45	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10216	10224		10.1074/jbc.M110.209924	http://dx.doi.org/10.1074/jbc.M110.209924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282100	hybrid, Green Published			2022-12-25	WOS:000288547000038
J	Tang, ZZ; Sharma, S; Zheng, SK; Chawla, G; Nikolic, J; Black, DL				Tang, Zhen Zhi; Sharma, Shalini; Zheng, Sika; Chawla, Geetanjali; Nikolic, Julia; Black, Douglas L.			Regulation of the Mutually Exclusive Exons 8a and 8 in the CaV1.2 Calcium Channel Transcript by Polypyrimidine Tract-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; CA2+ CHANNELS; ANTISENSE OLIGONUCLEOTIDES; FUNCTIONAL DIVERSITY; SPLICING REPRESSION; RNA; EXPRESSION; DISEASE; MOUSE; COMPLEX	CaV1.2 calcium channels play roles in diverse cellular processes such as gene regulation, muscle contraction, and membrane excitation and are diversified in their activity through extensive alternative splicing of the CaV1.2 mRNA. The mutually exclusive exons 8a and 8 encode alternate forms of transmembrane segment 6 (IS6) in channel domain 1. The human genetic disorder Timothy syndrome is caused by mutations in either of these two CaV1.2 exons, resulting in disrupted Ca2+ homeostasis and severe pleiotropic disease phenotypes. The tissue-specific pattern of exon 8/8a splicing leads to differences in symptoms between patients with exon 8 or 8a mutations. Elucidating the mechanisms controlling the exon 8/8a splicing choice will be important in understanding the spectrum of defects associated with the disease. We found that the polypyrimidine tract-binding protein (PTB) mediates a switch from exon 8 to 8a splicing. PTB and its neuronal homolog, nPTB, are widely studied splicing regulators controlling large sets of alternative exons. During neuronal development, PTB expression is down-regulated with a concurrent increase in nPTB expression. Exon 8a is largely repressed in embryonic mouse brain but is progressively induced during neuronal differentiation as PTB is depleted. This splicing repression is mediated by the direct binding of PTB to sequence elements upstream of exon 8a. The nPTB protein is a weaker repressor of exon 8a, resulting in a shift in exon choice when nPTB replaces PTB in cells. These results provide mechanistic understanding of how these two exons, important for human disease, are controlled.	[Tang, Zhen Zhi; Sharma, Shalini; Zheng, Sika; Chawla, Geetanjali; Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Nikolic, Julia; Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	dougb@microbio.ucla.edu	Zheng, Sika/ABB-9203-2020; Chawla, Geetanjali/AAH-9493-2021	Zheng, Sika/0000-0002-0573-4981; Chawla, Geetanjali/0000-0003-0354-3716	National Institutes of Health Grant [RO1 GM49662]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049662] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM49662 (to D. L. B.).	Aartsma-Rus A, 2006, ANN NY ACAD SCI, V1082, P74, DOI 10.1196/annals.1348.058; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Carafoli E, 1999, CALCIUM CELLULAR REG; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheng XY, 2009, AM J PHYSIOL-HEART C, V297, pH680, DOI 10.1152/ajpheart.00109.2009; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fairbrother W, 2008, BIOESSAYS, V30, P1, DOI 10.1002/bies.20696; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Jones RB, 2001, J BIOL CHEM, V276, P4158, DOI 10.1074/jbc.M006151200; Jurkat-Rott K, 2004, J PHYSIOL-LONDON, V554, P609, DOI 10.1113/jphysiol.2003.052712; Khoo B, 2009, CURR OPIN MOL THER, V11, P108; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liao P, 2005, CARDIOVASC RES, V68, P197, DOI 10.1016/j.cardiores.2005.06.024; Liao P, 2010, PFLUG ARCH EUR J PHY, V460, P353, DOI 10.1007/s00424-009-0753-0; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Modafferi EF, 1999, RNA, V5, P687, DOI 10.1017/S1355838299990155; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Rubin BY, 2008, NEUROMOL MED, V10, P148, DOI 10.1007/s12017-007-8019-5; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Smith CWJ, 2005, CELL, V123, P1, DOI 10.1016/j.cell.2005.09.010; SMITH CWJ, 1989, CELL, V56, P749, DOI 10.1016/0092-8674(89)90678-8; SOLDATOV NM, 1992, P NATL ACAD SCI USA, V89, P4628, DOI 10.1073/pnas.89.10.4628; SOLDATOV NM, 1994, GENOMICS, V22, P77, DOI 10.1006/geno.1994.1347; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; STEA A, 1995, HDB RECEPTORS CHANNE, P113; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; Tang ZZ, 2008, BBA-MOL CELL RES, V1783, P118, DOI 10.1016/j.bbamcr.2007.11.003; Tang ZZ, 2007, CELL CALCIUM, V41, P417, DOI 10.1016/j.ceca.2006.08.002; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Tsien RW, 1999, CALCIUM AS A CELLULAR REGULATOR, P171; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	72	46	47	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10007	10016		10.1074/jbc.M110.208116	http://dx.doi.org/10.1074/jbc.M110.208116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282112	Green Published, hybrid			2022-12-25	WOS:000288547000015
J	Wang, JY; Yeh, CL; Chou, HC; Yang, CH; Fu, YN; Chen, YT; Cheng, HW; Huang, CYF; Liu, HP; Huang, SF; Chen, YR				Wang, Jiz-Yuh; Yeh, Chi-Ling; Chou, Hsiao-Chin; Yang, Chi-Hwa; Fu, Yu-Ning; Chen, Ya-Ting; Cheng, Hui-Wen; Huang, Chi-Ying F.; Liu, Hui-Ping; Huang, Shiu-Feng; Chen, Yi-Rong			Vaccinia H1-related Phosphatase Is a Phosphatase of ErbB Receptors and Is Down-regulated in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; DUAL-SPECIFICITY PHOSPHATASE; N-TERMINAL KINASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VHR; ACTIVATION; PATHWAY; GENE	Vaccinia H1-related phosphatase (VHR) is classified as a dual specificity phosphatase. Unlike typical dual specificity phosphatases, VHR lacks the MAPK-binding domain and shows poor activity against MAPKs. We found that EGF receptor (EGFR) was a direct substrate of VHR and that overexpression of VHR down-regulated EGFR phosphorylation, particularly at Tyr-992 residue. Expression ofVHRinhibited the activation of phospholipase C gamma and protein kinase C, both downstream effectors of Tyr-992 phosphorylation of EGFR. Decreasing VHR expression by RNA interference caused higher EGFR phosphorylation at Tyr-992. In addition to EGFR, VHR also directly dephosphorylated ErbB2. Consistent with these results, suppression of VHR augmented the foci formation ability of H1299 non-small cell lung cancer (NSCLC) cells, whereas overexpression of VHR suppressed cell growth in both two- and three-dimensional cultures. Expression of VHR also suppressed tumor formation in a mouse xenograft model. Furthermore, VHR expression was significantly lower in NSCLC tissues in comparison to that in normal lung tissues. Collectively, this study shows that down- regulation of VHR expression enhances the signaling of ErbB receptors and may be involved in NSCLC pathogenesis.	[Wang, Jiz-Yuh; Yeh, Chi-Ling; Chou, Hsiao-Chin; Yang, Chi-Hwa; Fu, Yu-Ning; Chen, Ya-Ting; Cheng, Hui-Wen; Huang, Shiu-Feng; Chen, Yi-Rong] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan 35053, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan; [Liu, Hui-Ping] BenQ Med Ctr, Dept Thorac Surg, Nanjing 210019, Peoples R China; [Liu, Hui-Ping] Chang Gung Mem Hosp, Dept Cardiovasc & Thorac Surg, Tao Yuan 33302, Taiwan; [Huang, Shiu-Feng] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan 33302, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, YR (corresponding author), 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	yrchen@nhri.org.tw	Huang, Chi-Ying/AFL-7729-2022; Chen, Yi-Rong/E-3991-2010; Chen, Yi-Rong/CAF-2186-2022; Huang, Shiu-Feng Kathy/E-3977-2010; Huang, Chi-Ying/AAG-7672-2022; Chen, Yi-Rong/CAH-7991-2022	Huang, Chi-Ying/0000-0003-4898-4937; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002; Huang, Chi-Ying/0000-0003-4898-4937; Chen, Yi-Rong/0000-0002-4307-3002	National Health Research Institutes [MG-098-PP-03, MG-099-PP-03]; Department of Health [DOH98-TD-G-111-026]; Taiwan National Science Council [97-2320-B-400-008-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); Department of Health; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes Grants MG-098-PP-03 and MG-099-PP-03, Department of Health Grant DOH98-TD-G-111-026, and Taiwan National Science Council Grant 97-2320-B-400-008-MY3 (to Y.-R.C.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Chen YR, 2002, J BIOL CHEM, V277, P39334, DOI 10.1074/jbc.M202070200; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Hood KL, 2002, BIOCHEM BIOPH RES CO, V298, P545, DOI 10.1016/S0006-291X(02)02488-9; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Marti F, 2001, J IMMUNOL, V166, P197, DOI 10.4049/jimmunol.166.1.197; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Schumacher MA, 2002, BIOCHEMISTRY-US, V41, P3009, DOI 10.1021/bi015799l; SIERKE SL, 1993, BIOCHEM BIOPH RES CO, V191, P45, DOI 10.1006/bbrc.1993.1182; Smith A, 1997, CURR BIOL, V7, P893, DOI 10.1016/S0960-9822(06)00380-0; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Tanoue T, 2001, J BIOL CHEM, V276, P26629, DOI 10.1074/jbc.M101981200; Todd JL, 2002, ONCOGENE, V21, P2573, DOI 10.1038/sj.onc.1205344; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	32	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10177	10184		10.1074/jbc.M110.163295	http://dx.doi.org/10.1074/jbc.M110.163295			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262974	Green Published, hybrid			2022-12-25	WOS:000288547000033
J	Watanabe, A; Tatematsu, M; Saeki, K; Shibata, S; Shime, H; Yoshimura, A; Obuse, C; Seya, T; Matsumoto, M				Watanabe, Ayako; Tatematsu, Megumi; Saeki, Kazuko; Shibata, Sachiko; Shime, Hiroaki; Yoshimura, Akihiko; Obuse, Chikashi; Seya, Tsukasa; Matsumoto, Misako			Raftlin Is Involved in the Nucleocapture Complex to Induce Poly(I:C)-mediated TLR3 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; TRIF-DEPENDENT PATHWAYS; HEPATITIS-C VIRUS; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; DENDRITIC CELLS; INTERFERON INDUCTION; LIPID RAFT	The double-stranded RNA analog, poly(I: C), extracellularly activates both the endosomal Toll-like receptor (TLR) 3 and the cytoplasmic RNA helicase, melanoma differentiation-associated gene 5, leading to the production of type I interferons (IFNs) and inflammatory cytokines. The mechanism by which extracellular poly(I: C) is delivered to TLR3-positive organelles and the cytoplasm remains to be elucidated. Here, we show that the cytoplasmic lipid raft protein, Raftlin, is essential for poly(I: C) cellular uptake in human myeloid dendritic cells and epithelial cells. When Raftlin was silenced, poly(I: C) failed to enter cells and induction of IFN-beta production was inhibited. In addition, cellular uptake of B-type oligodeoxynucleotide that shares its uptake receptor with poly(I: C) was suppressed in Raftlin knockdown cells. Upon poly(I: C) stimulation, Raftlin was translocated from the cytoplasm to the plasma membrane where it colocalized with poly(I: C), and thereafter moved to TLR3-positive endosomes. Thus, Raftlin cooperates with the uptake receptor to mediate cell entry of poly(I: C), which is critical for activation of TLR3.	[Watanabe, Ayako; Tatematsu, Megumi; Shime, Hiroaki; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Saeki, Kazuko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 8128582, Japan; [Shibata, Sachiko; Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan	Hokkaido University; Kyushu University; Hokkaido University; Keio University	Matsumoto, M (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	matumoto@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Obuse, Chikashi/F-5273-2011; Shime, Hiroaki/D-8721-2012; Seya, Tsukasa/A-4336-2012; Yoshimura, Akihiko/K-5515-2013; Shime, Hiroaki/P-6454-2019	Shime, Hiroaki/0000-0003-0209-5034	Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Akiyama Foundation; NorthTec Foundation; Yakult Foundation; MEXT; Grants-in-Aid for Scientific Research [22114008] Funding Source: KAKEN	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Akiyama Foundation; NorthTec Foundation; Yakult Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture, the Ministry of Health, Labor, and Welfare of Japan, and the Akiyama Foundation, NorthTec Foundation, Yakult Foundation, and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ding CL, 2006, EUR J IMMUNOL, V36, P2013, DOI 10.1002/eji.200635850; Ebihara T, 2008, HEPATOLOGY, V48, P48, DOI 10.1002/hep.22337; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; LINDENMANN J, 1957, BRIT J EXP PATHOL, V38, P551; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; NAGANO Y, 1954, CR SOC BIOL, V148, P1700; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ohno H, 2006, J CELL SCI, V119, P3719, DOI 10.1242/jcs.03085; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	35	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10702	10711		10.1074/jbc.M110.185793	http://dx.doi.org/10.1074/jbc.M110.185793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266579	Green Published, hybrid			2022-12-25	WOS:000288547000084
J	Watts, T; Khalimonchuk, O; Wolf, RZ; Turk, EM; Mohr, G; Winge, DR				Watts, Talina; Khalimonchuk, Oleh; Wolf, Rachel Z.; Turk, Edward M.; Mohr, Georg; Winge, Dennis R.			Mne1 Is a Novel Component of the Mitochondrial Splicing Apparatus Responsible for Processing of a COX1 Group I Intron in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DEAD-BOX PROTEIN; SACCHAROMYCES-CEREVISIAE; RNA CHAPERONE; GENE; REQUIRES; LOCALIZATION; DEGRADOSOME; BIOGENESIS; EXPRESSION	Saccharomyces cerevisiae cells lacking Mne1 are deficient in intron splicing in the gene encoding the Cox1 subunit of cytochrome oxidase but contain wild-type levels of the bc(1) complex. Thus, Mne1 has no role in splicing of COB introns or expression of the COB gene. Northern experiments suggest that splicing of the COX1 aI5 beta intron is dependent on Mne1 in addition to the previously known Mrs1, Mss116, Pet54, and Suv3 factors. Processing of the aI5 beta intron is similarly impaired in mne1 Delta and mrs1 Delta cells and overexpression of Mrs1 partially restores the respiratory function of mne1 Delta cells. Mrs1 is known to function in the initial transesterification reaction of splicing. Mne1 is a mitochondrial matrix protein loosely associated with the inner membrane and is found in a high mass ribonucleoprotein complex specifically associated with the COX1 mRNA even within an intronless strain. Mne1 does not appear to have a secondary function in COX1 processing or translation, because disruption of MNE1 in cells containing intronless mtDNA does not lead to a respiratory growth defect. Thus, the primary defect in mne1 Delta cells is splicing of the aI5 beta intron in COX1.	[Watts, Talina; Khalimonchuk, Oleh; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Watts, Talina; Khalimonchuk, Oleh; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Wolf, Rachel Z.; Mohr, Georg] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Turk, Edward M.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Austin; Case Western Reserve University	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678; Mohr, Georg/0000-0002-6411-0685	National Institutes of Health [GM083292, GM037951]; American Heart Association [10POST4300044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037951, R01GM083292, R37GM037951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083292 (to D. R. W.) and GM037951 (to Alan M. Lambowitz, University of Texas at Austin), and American Heart Association Grant 10POST4300044 (to O. K.).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Barros MH, 2006, J BIOL CHEM, V281, P3743, DOI 10.1074/jbc.M510778200; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; BONITZ SG, 1980, J BIOL CHEM, V255, P1927; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chou JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000432; COSTANZO MC, 1989, GENETICS, V122, P297; DAUM G, 1982, J BIOL CHEM, V257, P3028; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Duncan CDS, 2010, BIOCHEMISTRY-US, V49, P5418, DOI 10.1021/bi100267g; Duncan CDS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008983; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; Herbert Christopher J., 1992, Gene Expression, V2, P203; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Karunatilaka KS, 2010, NATURE, V467, P935, DOI 10.1038/nature09422; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; Khalimonchuk O, 2006, EUKARYOT CELL, V5, P997, DOI 10.1128/EC.00092-06; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; LAMBOWITZ AM, 1999, RNA WORLD, V2, P451; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luban C, 2005, GENE, V354, P72, DOI 10.1016/j.gene.2005.03.023; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Moreno JI, 2009, CURR GENET, V55, P475, DOI 10.1007/s00294-009-0260-z; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; NYBERG TM, 2006, IN VIVO STUDIES YEAS, P190; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sambrook J, 1989, MOL CLONING LABORATO; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SERAPHIN B, 1988, EMBO J, V7, P1455, DOI 10.1002/j.1460-2075.1988.tb02963.x; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; SHIN J, 2010, FASEB J, V24; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; Woodson SA, 2005, CURR OPIN STRUC BIOL, V15, P324, DOI 10.1016/j.sbi.2005.05.007; Yoshikawa S, 2000, J INORG BIOCHEM, V82, P1, DOI 10.1016/S0162-0134(00)00137-9	55	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10137	10146		10.1074/jbc.M110.205625	http://dx.doi.org/10.1074/jbc.M110.205625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257754	hybrid, Green Published			2022-12-25	WOS:000288547000028
J	Zhang, CL; Li, AM; Zhang, XC; Xiao, H				Zhang, Chengliang; Li, Aimin; Zhang, Xinchun; Xiao, Hua			A Novel TIP30 Protein Complex Regulates EGF Receptor Signaling and Endocytic Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-METASTASIS; EARLY ENDOSOMES; RAB5; EXPRESSION; INHIBITION; INTERACTS; FUSION	Activated epidermal growth factor receptor (EGFR) continues to signal in the early endosome, but how this signaling process is regulated is less well understood. Here we describe a protein complex consisting of TIP30, endophilin B1, and acyl-CoA synthetase long chain family member 4 (ACSL4) that interacts with Rab5a and regulates EGFR endocytosis and signaling. These proteins are required for the proper endocytic trafficking of EGF-EGFR. Knockdown of TIP30, ACSL4, endophilin B1, or Rab5a in human liver cancer cells or genetic knock-out of Tip30 in mouse primary hepatocytes results in the trapping of EGF-EGFR complexes in early endosomes, leading to delayed EGFR degradation and prolonged EGFR signaling. Furthermore, we show that Rab5a colocalizes with vacuolar (H+)-ATPases (V-ATPases) on transport vesicles. The TIP30 complex facilitates trafficking of Rab5a and V-ATPases to EEA1-positve endosomes in response to EGF. Together, these results suggest that this TIP30 complex regulates EGFR endocytosis by facilitating the transport of V-ATPases from trans-Golgi network to early endosomes.	[Zhang, Chengliang; Li, Aimin; Xiao, Hua] Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA; [Zhang, Chengliang; Zhang, Xinchun] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Li, Aimin] So Med Univ, Dept Oncol, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China	Michigan State University; Michigan State University; Southern Medical University - China	Xiao, H (corresponding author), 3193 Biomed & Phys Sci Bldg, E Lansing, MI 48824 USA.	xiaoh@msu.edu	Zhang, Chengliang/E-6943-2016	Zhang, Chengliang/0000-0003-3798-4157; Zhang, Chengliang/0000-0001-6999-4670	National Institutes of Health [RO1 DK066110-01]; NIDDK [W81XWH-08-1-0377]; Department of Defense; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK066110-01 and W81XWH-08-1-0377 from the NIDDK (to H.X.). This work was also supported by a grant from the Department of Defense.	Authier F, 1999, FEBS LETT, V461, P25, DOI 10.1016/S0014-5793(99)01413-1; BACKER JM, 1990, J BIOL CHEM, V265, P14828; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HU CD, 2005, CURRENT PROTOCOLS PR; Ito M, 2003, CANCER RES, V63, P8763; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; King FW, 2004, MOL CELL BIOL, V24, P7091, DOI 10.1128/MCB.24.16.7091-7101.2004; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Lee L W, 2004, Ann Acad Med Singap, V33, pS30; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2008, AUTOPHAGY, V4, P121, DOI 10.4161/auto.5265; Tong X, 2009, AM J PATHOL, V174, P1931, DOI 10.2353/ajpath.2009.080846; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Xiao H, 1998, P NATL ACAD SCI USA, V95, P2146, DOI 10.1073/pnas.95.5.2146; YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang CL, 2010, CANCER RES, V70, P10224, DOI 10.1158/0008-5472.CAN-10-3057; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280; Zhao J, 2007, HUM PATHOL, V38, P293, DOI 10.1016/j.humpath.2006.08.005	47	42	48	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9373	9381		10.1074/jbc.M110.207720	http://dx.doi.org/10.1074/jbc.M110.207720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252234	Green Published, hybrid			2022-12-25	WOS:000288247700066
J	Colon, M; Hernandez, F; Lopez, K; Quezada, H; Gonzalez, J; Lopez, G; Aranda, C; Gonzalez, A				Colon, Maritrini; Hernandez, Fabiola; Lopez, Karla; Quezada, Hector; Gonzalez, James; Lopez, Geovani; Aranda, Cristina; Gonzalez, Alicia			Saccharomyces cerevisiae Bat1 and Bat2 Aminotransferases Have Functionally Diverged from the Ancestral-Like Kluyveromyces lactis Orthologous Enzyme	PLOS ONE			English	Article							AMINO-ACID TRANSAMINASES; FUSEL ALCOHOL PRODUCTION; GLUTAMATE SYNTHASE; ESCHERICHIA-COLI; GENE DUPLICATION; SHUTTLE VECTORS; YEAST GENOME; MITOCHONDRIAL; METABOLISM; EXPRESSION	Background: Gene duplication is a key evolutionary mechanism providing material for the generation of genes with new or modified functions. The fate of duplicated gene copies has been amply discussed and several models have been put forward to account for duplicate conservation. The specialization model considers that duplication of a bifunctional ancestral gene could result in the preservation of both copies through subfunctionalization, resulting in the distribution of the two ancestral functions between the gene duplicates. Here we investigate whether the presumed bifunctional character displayed by the single branched chain amino acid aminotransferase present in K. lactis has been distributed in the two paralogous genes present in S. cerevisiae, and whether this conservation has impacted S. cerevisiae metabolism. Principal Findings: Our results show that the KlBat1 orthologous BCAT is a bifunctional enzyme, which participates in the biosynthesis and catabolism of branched chain aminoacids (BCAAs). This dual role has been distributed in S. cerevisiae Bat1 and Bat2 paralogous proteins, supporting the specialization model posed to explain the evolution of gene duplications. BAT1 is highly expressed under biosynthetic conditions, while BAT2 expression is highest under catabolic conditions. Bat1 and Bat2 differential relocalization has favored their physiological function, since biosynthetic precursors are generated in the mitochondria (Bat1), while catabolic substrates are accumulated in the cytosol (Bat2). Under respiratory conditions, in the presence of ammonium and BCAAs the bat1 Delta bat2 Delta double mutant shows impaired growth, indicating that Bat1 and Bat2 could play redundant roles. In K. lactis wild type growth is independent of BCAA degradation, since a Klbat1 Delta mutant grows under this condition. Conclusions: Our study shows that BAT1 and BAT2 differential expression and subcellular relocalization has resulted in the distribution of the biosynthetic and catabolic roles of the ancestral BCAT in two isozymes improving BCAAs metabolism and constituting an adaptation to facultative metabolism.	[Colon, Maritrini; Hernandez, Fabiola; Lopez, Karla; Gonzalez, James; Lopez, Geovani; Aranda, Cristina; Gonzalez, Alicia] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Quezada, Hector] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Colon, M (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	amanjarr@ifc.unam.mx	López-Ortiz, Geovani/AAV-4009-2021; Lopez-Ortiz, Geovani/AAX-8420-2021; Quezada, Hector/AAJ-8486-2021	Lopez-Ortiz, Geovani/0000-0003-0280-0012; Quezada, Hector/0000-0003-2663-4696; Gonzalez, Alicia/0000-0002-1276-5719; Gonzalez, James/0000-0002-7329-4025; Colon-Gonzalez, Maritrini/0000-0001-6821-1726	Direccion General de Asuntos del Personal Academico, UNAM [IN210706-3, N2042093]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [49970]; Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico [PIFUTP08-1654]; Macroproyecto de Tecnologias de la Informacion y La Computacion, UNAM	Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico; Macroproyecto de Tecnologias de la Informacion y La Computacion, UNAM(Universidad Nacional Autonoma de Mexico)	This study was funded by Direccion General de Asuntos del Personal Academico, UNAM, grant IN210706-3 and N2042093 (http://dgapa.unam.mx); Consejo Nacional de Ciencia y Tecnologia (CONACYT), grant 49970 (http://www.conacyt.gob.mx/Paginas/default.aspx); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico, grant PIFUTP08-1654 (http://www.icyt.df.gob.mx) and Macroproyecto de Tecnologias de la Informacion y La Computacion, UNAM (http://www.mtuic.unam.mx). MC was recipient of a PhD Fellowship from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano A, 2005, MOL MICROBIOL, V57, P291, DOI 10.1111/j.1365-2958.2005.04689.x; BELTZER JP, 1988, J BIOL CHEM, V263, P368; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COGONI C, 1995, J BACTERIOL, V177, P792, DOI 10.1128/jb.177.3.792-798.1995; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Eden A, 2001, APPL MICROBIOL BIOT, V55, P296, DOI 10.1007/s002530000506; Force A, 1999, GENETICS, V151, P1531; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kispal G, 1996, J BIOL CHEM, V271, P24458, DOI 10.1074/jbc.271.40.24458; LEEPENG FC, 1979, J BACTERIOL, V139, P339, DOI 10.1128/JB.139.2.339-345.1979; Lilly M, 2006, FEMS YEAST RES, V6, P726, DOI 10.1111/j.1567-1364.2006.00057.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch M, 2000, GENETICS, V154, P459; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Navarro-Olmos R, 2010, MOL BIOL CELL, V21, P489, DOI 10.1091/mbc.E09-06-0472; Okada K, 2001, BIOCHEMISTRY-US, V40, P7453, DOI 10.1021/bi010384l; Prohl C, 2000, METHOD ENZYMOL, V324, P365; Quezada H, 2008, MICROBIOL-SGM, V154, P1656, DOI 10.1099/mic.0.2008/017103-0; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RYAN ED, 1973, J BACTERIOL, V116, P222, DOI 10.1128/JB.116.1.222-225.1973; Sambrook J., 2002, MOL CLONING LAB MANU; Schoondermark-Stolk SA, 2005, FEMS YEAST RES, V5, P757, DOI 10.1016/j.femsyr.2005.02.005; SIKORSKI RS, 1989, GENETICS, V122, P19; STRUHL K, 1981, J MOL BIOL, V152, P535, DOI 10.1016/0022-2836(81)90267-9; TAYLOR EJ, MOL BIOL CELL, V21, P2202; Valenzuela L, 2001, J BACTERIOL, V183, P2331, DOI 10.1128/JB.183.7.2331-2334.2001; Valenzuela L, 1998, J BACTERIOL, V180, P3533, DOI 10.1128/JB.180.14.3533-3540.1998; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yennawar N, 2001, ACTA CRYSTALLOGR D, V57, P506, DOI 10.1107/S0907444901001925	37	45	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16099	10.1371/journal.pone.0016099	http://dx.doi.org/10.1371/journal.pone.0016099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267457	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500038
J	Wan, QH; Zhang, P; Ni, XW; Wu, HL; Chen, YY; Kuang, YY; Ge, YF; Fang, SG				Wan, Qiu-Hong; Zhang, Pei; Ni, Xiao-Wei; Wu, Hai-Long; Chen, Yi-Yan; Kuang, Ye-Ye; Ge, Yun-Fa; Fang, Sheng-Guo			A Novel HURRAH Protocol Reveals High Numbers of Monomorphic MHC Class II Loci and Two Asymmetric Multi-Locus Haplotypes in the Pere David's Deer	PLOS ONE			English	Article							DRB GENES; MATE CHOICE; IDENTIFICATION; SEQUENCE; DNA; ORGANIZATION; POLYMORPHISM; EXPRESSION; DIVERSITY; SOFTWARE	The Pere David's deer is a highly inbred, but recovered, species, making it interesting to consider their adaptive molecular evolution from an immunological perspective. Prior to this study, genomic sequencing was the only method for isolating all functional MHC genes within a certain species. Here, we report a novel protocol for isolating MHC class II loci from a species, and its use to investigate the adaptive evolution of this endangered deer at the level of multi-locus haplotypes. This protocol was designated "HURRAH" based on its various steps and used to estimate the total number of MHC class II loci. We confirmed the validity of this novel protocol in the giant panda and then used it to examine the Pere David's deer. Our results revealed that the Pere David's deer possesses nine MHC class II loci and therefore has more functional MHC class II loci than the eight genome-sequenced mammals for which full MHC data are currently available. This could potentially account at least in part for the strong survival ability of this species in the face of severe bottlenecking. The results from the HURRAH protocol also revealed that: (1) All of the identified MHC class II loci were monomorphic at their antigen-binding regions, although DRA was dimorphic at its cytoplasmic tail; and (2) these genes constituted two asymmetric functional MHC class II multi-locus haplotypes: DRA1*01, DRB1 similar to DRB3 similar to DQA1 similar to DQB2 (H1) and DRA1*02 similar to DRB2 similar to DRB4 similar to DQA2 similar to DQB1 (H2). The latter finding indicates that the current members of the deer species have lost the powerful ancestral MHC class II haplotypes of nine or more loci, and have instead fixed two relatively weak haplotypes containing five genes. As a result, the Pere David's deer are currently at risk for increased susceptibility to infectious pathogens.	[Wan, Qiu-Hong; Zhang, Pei; Ni, Xiao-Wei; Wu, Hai-Long; Chen, Yi-Yan; Kuang, Ye-Ye; Ge, Yun-Fa; Fang, Sheng-Guo] Zhejiang Univ, State Conservat Ctr Gene Resources Endangered Wil, Key Lab Conservat Biol Endangered Wildlife, Minist Educ,Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Hai-Long] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China	Zhejiang University; Anhui Normal University	Wan, QH (corresponding author), Zhejiang Univ, State Conservat Ctr Gene Resources Endangered Wil, Key Lab Conservat Biol Endangered Wildlife, Minist Educ,Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	sgfanglab@zju.edu.cn			National Basic Research Program of China (973 program) [2007CB411600]; State Forestry Administration; Fundamental Research Funds for the Central Universities of P. R. China	National Basic Research Program of China (973 program)(National Basic Research Program of China); State Forestry Administration; Fundamental Research Funds for the Central Universities of P. R. China	This work was supported by a grant from the National Basic Research Program of China (the 973 program; grant no. 2007CB411600), a special grant from the State Forestry Administration, and the Fundamental Research Funds for the Central Universities of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 2006, ANIM SCI J, V77, P127, DOI 10.1111/j.1740-0929.2006.00331.x; Babik W, 2005, MOL ECOL, V14, P4249, DOI 10.1111/j.1365-294X.2005.02751.x; Ballingall KT, 1997, IMMUNOGENETICS, V46, P237, DOI 10.1007/s002510050268; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BEIDLER JL, 1982, ANAL BIOCHEM, V126, P374, DOI 10.1016/0003-2697(82)90530-9; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Bowen L, 2002, IMMUNOGENETICS, V54, P332, DOI 10.1007/s00251-002-0472-6; Childers CP, 2006, ANIM GENET, V37, P121, DOI 10.1111/j.1365-2052.2005.01395.x; Croisetiere S, 2008, MOL IMMUNOL, V45, P3107, DOI 10.1016/j.molimm.2008.03.007; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Ding Y-H, 2004, CHINESE MILU RES; Ellis SA, 1999, IMMUNOL REV, V167, P159, DOI 10.1111/j.1600-065X.1999.tb01389.x; Fernandes CA, 2008, CONSERV GENET, V9, P681, DOI 10.1007/s10592-007-9364-5; Gutierrez-Espeleta GA, 2001, HEREDITY, V86, P439, DOI 10.1046/j.1365-2540.2001.00853.x; Heimeier D, 2009, MAR MAMMAL SCI, V25, P68, DOI 10.1111/j.1748-7692.2008.00244.x; Heinzelmann L, 2009, J MAR BIOL ASSOC UK, V89, P1009, DOI 10.1017/S0025315409003245; Herrmann-Hoesing LM, 2008, IMMUNOGENETICS, V60, P167, DOI 10.1007/s00251-008-0275-5; Jager I, 2007, J EVOLUTION BIOL, V20, P2005, DOI 10.1111/j.1420-9101.2007.01366.x; Jiang ZG, 2000, WILDLIFE SOC B, V28, P681; Jiao Y, 2008, CONSERV GENET, V9, P771, DOI 10.1007/s10592-007-9388-x; JONES ML, 1983, BIOL MANAGEMENT EXTI; KLEIN J, 1986, NATURAL HIST MAJOR H; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lancaster Alex, 2003, Pac Symp Biocomput, P514; Loiseau C, 2008, ECOL LETT, V11, P258, DOI 10.1111/j.1461-0248.2007.01141.x; Marsh S. G. E., 2000, HLA FACTSBOOK; Meyer-Lucht Y, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-39; Mikko S, 1999, IMMUNOL REV, V167, P169, DOI 10.1111/j.1600-065X.1999.tb01390.x; Niranjan SK, 2009, VET IMMUNOL IMMUNOP, V130, P268, DOI 10.1016/j.vetimm.2009.02.006; OHTAISHI N, 1990, MAMMAL REV, V20, P125, DOI 10.1111/j.1365-2907.1990.tb00108.x; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWEN L, 1998, SEQUENCE MOUSE MAJOR; Sambrook J, 2001, MOL CLONING LAB MANU; Schaschl H, 2004, DEV COMP IMMUNOL, V28, P265, DOI 10.1016/j.dci.2003.08.003; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Swarbrick PA, 1997, ANIM GENET, V28, P49, DOI 10.1111/j.1365-2052.1997.00063.x; SWARBRICK PA, 1995, IMMUNOGENETICS, V42, P1, DOI 10.1007/BF00164981; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Takada T, 1998, IMMUNOGENETICS, V48, P408, DOI 10.1007/s002510050452; Vage D. I., 1994, Animal Biotechnology, V5, P65, DOI 10.1080/10495399409525804; WALLACE AJ, 2002, METHODS MOL BIOL, V187; Wan QH, 2003, ANIM REPROD SCI, V77, P1, DOI 10.1016/S0378-4320(02)00249-X; Wan QH, 2003, FORENSIC SCI INT, V131, P75, DOI 10.1016/S0379-0738(02)00398-5; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Wan QH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004147; Wu HL, 2008, CONSERV GENET, V9, P1679, DOI 10.1007/s10592-008-9523-3; Yang WC, 2007, ZOOL STUD, V46, P664; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zhang Lin-yuan, 2010, Sichuan Journal of Zoology, V29, P505	55	25	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14518	10.1371/journal.pone.0014518	http://dx.doi.org/10.1371/journal.pone.0014518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267075	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500005
J	Aziz, A; Harrop, SP; Bishop, NE				Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.			DIA1R Is an X-Linked Gene Related to Deleted In Autism-1	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; MENTAL-RETARDATION; INTERSTITIAL DELETION; MICRODELETION SYNDROMES; LONG ARM; INTELLECTUAL DISABILITY; FUNCTIONAL ANNOTATION; ENDOPLASMIC-RETICULUM; ASPERGER-SYNDROME; CHILDHOOD AUTISM	Background: Autism spectrum disorders (ASDs) are frequently occurring disorders diagnosed by deficits in three core functional areas: social skills, communication, and behaviours and/or interests. Mental retardation frequently accompanies the most severe forms of ASDs, while overall ASDs are more commonly diagnosed in males. Most ASDs have a genetic origin and one gene recently implicated in the etiology of autism is the Deleted-In-Autism-1 (DIA1) gene. Methodology/Principal Findings: Using a bioinformatics-based approach, we have identified a human gene closely related to DIA1, we term DIA1R (DIA1-Related). While DIA1 is autosomal (chromosome 3, position 3q24), DIA1R localizes to the X chromosome at position Xp11.3 and is known to escape X-inactivation. The gene products are of similar size, with DIA1 encoding 430, and DIA1R 433, residues. At the amino acid level, DIA1 and DIA1R are 62% similar overall (28% identical), and both encode signal peptides for targeting to the secretory pathway. Both genes are ubiquitously expressed, including in fetal and adult brain tissue. Conclusions/Significance: Examination of published literature revealed point mutations in DIA1R are associated with X-linked mental retardation (XLMR) and DIA1R deletion is associated with syndromes with ASD-like traits and/or XLMR. Together, these results support a model where the DIA1 and DIA1R gene products regulate molecular traffic through the cellular secretory pathway or affect the function of secreted factors, and functional deficits cause disorders with ASD-like symptoms and/or mental retardation.	[Aziz, Azhari; Harrop, Sean P.; Bishop, Naomi E.] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia	La Trobe University	Aziz, A (corresponding author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3083, Australia.	N.Bishop@latrobe.edu.au			La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	La Trobe University; Malaysian Ministry of Higher Education; Islamic Science University of Malaysia	NEB and SPH were supported by La Trobe University and AA by La Trobe University, the Malaysian Ministry of Higher Education, and the Islamic Science University of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; *ADDMNSYPI, 2009, MMWR-MORBID MORTAL W, V58, P1; ALBERCH P, 1991, GENETICA, V84, P5, DOI 10.1007/BF00123979; ALMATEEN M, 1986, AM J DIS CHILD, V140, P761, DOI 10.1001/archpedi.1986.02140220043029; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALVARADO M, 1987, AM J MED GENET, V27, P781, DOI 10.1002/ajmg.1320270406; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; AZIZ A, 2010, PLOS ONE IN PRESS; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bishop L, 1998, GASTROENTEROLOGY, V115, P1154, DOI 10.1016/S0016-5085(98)70086-1; Bonaglia MC, 2010, EUR J HUM GENET, V18, P1302, DOI 10.1038/ejhg.2010.115; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brito AR, 2009, J NEUROIMAGING, V19, P337, DOI 10.1111/j.1552-6569.2009.00366.x; Bryson SE, 2008, CAN J PSYCHIAT, V53, P449, DOI 10.1177/070674370805300710; Castagnola M, 2008, J PROTEOME RES, V7, P5327, DOI 10.1021/pr8004088; Castellani ML, 2009, INT J IMMUNOPATH PH, V22, P15, DOI 10.1177/039463200902200103; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Cederlund M, 2008, J AUTISM DEV DISORD, V38, P72, DOI 10.1007/s10803-007-0364-6; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chiorino G, 2008, J BIOL REG HOMEOS AG, V22, P7; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Coury D, 2009, CURR OPIN PEDIATR, V21, P828, DOI 10.1097/MOP.0b013e328331eaaa; Creswell CS, 1999, NEUROCASE, V5, P511, DOI 10.1080/13554799908402746; Emanuele E, 2010, CLIN BIOCHEM, V43, P317, DOI 10.1016/j.clinbiochem.2009.10.005; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engstrom I, 2003, AUTISM, V7, P99, DOI 10.1177/1362361303007001008; Feenstra I, 2007, AM J MED GENET A, V143A, P1858, DOI 10.1002/ajmg.a.31850; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; FOMBONNE E, 1992, SOC PSYCH PSYCH EPID, V27, P203, DOI 10.1007/BF00789007; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; GILLBERG C, 1991, BRIT J PSYCHIAT, V158, P403, DOI 10.1192/bjp.158.3.403; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Grafodatskaya D, 2010, J AM ACAD CHILD PSY, V49, P794, DOI 10.1016/j.jaac.2010.05.005; Groen W, 2010, J AM ACAD CHILD PSY, V49, P552, DOI 10.1016/j.jaac.2009.12.023; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Hayashi S, 2008, AM J MED GENET A, V146A, P2145, DOI 10.1002/ajmg.a.32433; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hoekstra RA, 2009, BRIT J PSYCHIAT, V195, P531, DOI 10.1192/bjp.bp.108.060889; Hoekstra RA, 2010, AM J MED GENET B, V153B, P994, DOI 10.1002/ajmg.b.31066; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Honda H, 2005, DEV MED CHILD NEUROL, V47, P10, DOI 10.1017/S0012162205000034; Hong D, 2009, DEV DISABIL RES REV, V15, P270, DOI 10.1002/ddrr.79; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2000, J ROY SOC MED, V93, P351, DOI 10.1177/014107680009300704; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Jensen LR, 2007, EUR J HUM GENET, V15, P68, DOI 10.1038/sj.ejhg.5201714; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kates WR, 2004, AM J PSYCHIAT, V161, P539, DOI 10.1176/appi.ajp.161.3.539; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Ko WT, 2003, AM J MED GENET A, V120A, P413, DOI 10.1002/ajmg.a.20149; KONSTANTAREAS MM, 1987, J AUTISM DEV DISORD, V17, P585, DOI 10.1007/BF01486973; Kooy R Frank, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-11; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Lee SN, 2006, J BIOL CHEM, V281, P3312, DOI 10.1074/jbc.M506635200; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lim DJ, 2000, VACCINE, V19, pS17, DOI 10.1016/S0264-410X(00)00273-5; Losh M, 2008, J NEUROPATH EXP NEUR, V67, P829, DOI 10.1097/NEN.0b013e318184482d; Lotter V., 1966, SOC PSYCHIATR, V1, P124, DOI [10.1007/BF00584048, https://doi.org/10.1007/BF00584048]; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mayes SD, 2004, J DEV PHYS DISABIL, V16, P257, DOI 10.1023/B:JODD.0000032301.07550.0e; McDougle CJ, 2005, J CLIN PSYCHIAT, V66, P9; McMahon HE, 2008, ENDOCRINOLOGY, V149, P812, DOI 10.1210/en.2007-1439; Meacock SL, 2000, ESSAYS BIOCHEM, V36, P1; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; National Center for Health Statistics, 2007, NAT SURV CHILDR HLTH; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Nishiyama T, 2009, J HUM GENET, V54, P56, DOI 10.1038/jhg.2008.3; Nordin V, 1996, DEV MED CHILD NEUROL, V38, P314; Nordin V, 1998, ACTA PSYCHIAT SCAND, V97, P99, DOI 10.1111/j.1600-0447.1998.tb09970.x; O'Hare A, 2009, ARCH DIS CHILDHOOD-E, V94, P161, DOI 10.1136/adc.2008.150490; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ortiz-Mantilla S, 2010, NEUROIMAGE, V49, P2791, DOI 10.1016/j.neuroimage.2009.10.029; Passmore M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-72; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PIVEN J, 1991, J AUTISM DEV DISORD, V21, P51, DOI 10.1007/BF02206997; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptak Carolyn, 2010, Dialogues Clin Neurosci, V12, P25; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Renty J, 2006, AUTISM, V10, P511, DOI 10.1177/1362361306066604; Reyniers E, 1999, AM J HUM GENET, V65, pA340; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; ROBIN NH, 1993, CLIN GENET, V44, P335; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Rosenhall U, 1999, J AUTISM DEV DISORD, V29, P349, DOI 10.1023/A:1023022709710; Rutter M, 2000, J ABNORM CHILD PSYCH, V28, P3, DOI 10.1023/A:1005113900068; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2010, NEUROSCI RES, V67, P197, DOI 10.1016/j.neures.2010.03.006; Sadakata T, 2009, CEREBELLUM, V8, P312, DOI 10.1007/s12311-009-0097-5; SANDEN MWN, 2003, NEUROSCI BIOBEHAV R, V27, P329; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Santos M, 2009, J CHILD NEUROL, V24, P49, DOI 10.1177/0883073808321043; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Sbacchi S, 2010, CURR GENOMICS, V11, P136, DOI 10.2174/138920210790886880; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Shaffer LG, 2007, AM J MED GENET C, V145C, P335, DOI 10.1002/ajmg.c.30152; Shaffer LG, 2007, GENET MED, V9, P607, DOI 10.1097/GIM.0b013e3181484b49; Shapira Stuart K., 1998, Current Opinion in Pediatrics, V10, P622; Shi LM, 2004, EXPERT REV MOL DIAGN, V4, P761, DOI 10.1586/14737159.4.6.761; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Sivaswamy L, 2010, J CHILD NEUROL, V25, P1223, DOI 10.1177/0883073809358765; Skrzypski M, 2008, LUNG CANCER, V59, P147, DOI 10.1016/j.lungcan.2007.11.008; Slavotinek AM, 1997, J MED GENET, V34, P430, DOI 10.1136/jmg.34.5.430; Slavotinek AM, 2008, HUM GENET, V124, P1, DOI 10.1007/s00439-008-0513-9; SMITH DEP, 1988, J AUTISM DEV DISORD, V18, P53, DOI 10.1007/BF02211818; Stahlberg A, 2005, EXPERT REV MOL DIAGN, V5, P221, DOI 10.1586/14737159.5.2.221; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takatalo M, 2008, DEV DYNAM, V237, P2243, DOI 10.1002/dvdy.21646; Takatalo MS, 2006, PROTEOMICS, V6, P3502, DOI 10.1002/pmic.200500516; Tang BL, 2008, BBA-MOL CELL RES, V1783, P169, DOI 10.1016/j.bbamcr.2007.11.011; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuchiya KJ, 2007, BIOL PSYCHIAT, V62, P1056, DOI 10.1016/j.biopsych.2006.12.018; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Verhoeven JS, 2010, NEURORADIOLOGY, V52, P3, DOI 10.1007/s00234-009-0583-y; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VORSTMAN JA, 2010, MOL PSYCHIA IN PRESS; WARING R, 2001, SULPHATION AUTISM WH; WARING R, 2001, Patent No. 2001077681; Wilkes T, 2007, OMICS, V11, P1, DOI 10.1089/omi.2006.0001; Wilkins MR, 1999, METH MOL B, V112, P531; World Health Organisation, 2007, INT STAT CLASS DIS R; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yen KH, 2009, BIOINFORMATICS, V25, P845, DOI 10.1093/bioinformatics/btn649; Zhang XY, 2004, AM J MED GENET A, V129A, P286, DOI 10.1002/ajmg.a.30121; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zweier C, 2005, EUR J MED GENET, V48, P360, DOI 10.1016/j.ejmg.2005.04.016	172	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14534	10.1371/journal.pone.0014534	http://dx.doi.org/10.1371/journal.pone.0014534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264219	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600009
J	Fucile, G; Di Biase, D; Nahal, H; La, G; Khodabandeh, S; Chen, YN; Easley, K; Christendat, D; Kelley, L; Provart, NJ				Fucile, Geoffrey; Di Biase, David; Nahal, Hardeep; La, Garon; Khodabandeh, Shokoufeh; Chen, Yani; Easley, Kante; Christendat, Dinesh; Kelley, Lawrence; Provart, Nicholas J.			ePlant and the 3D Data Display Initiative: Integrative Systems Biology on the World Wide Web	PLOS ONE			English	Article							GENE-EXPRESSION MAP; MULTIPLE SEQUENCE ALIGNMENT; MODEL DATA-ANALYSIS; DATA SETS; E-CELL; ARABIDOPSIS; VISUALIZATION; NETWORK; KNOWLEDGEBASE; ANNOTATION	Visualization tools for biological data are often limited in their ability to interactively integrate data at multiple scales. These computational tools are also typically limited by two-dimensional displays and programmatic implementations that require separate configurations for each of the user's computing devices and recompilation for functional expansion. Towards overcoming these limitations we have developed "ePlant" (http://bar.utoronto.ca/eplant) - a suite of open-source world wide web-based tools for the visualization of large-scale data sets from the model organism Arabidopsis thaliana. These tools display data spanning multiple biological scales on interactive three-dimensional models. Currently, ePlant consists of the following modules: a sequence conservation explorer that includes homology relationships and single nucleotide polymorphism data, a protein structure model explorer, a molecular interaction network explorer, a gene product subcellular localization explorer, and a gene expression pattern explorer. The ePlant's protein structure explorer module represents experimentally determined and theoretical structures covering >70% of the Arabidopsis proteome. The ePlant framework is accessed entirely through a web browser, and is therefore platform-independent. It can be applied to any model organism. To facilitate the development of three-dimensional displays of biological data on the world wide web we have established the "3D Data Display Initiative" (http://3ddi.org).	[Fucile, Geoffrey; Di Biase, David; Nahal, Hardeep; La, Garon; Khodabandeh, Shokoufeh; Chen, Yani; Christendat, Dinesh; Provart, Nicholas J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Nahal, Hardeep; Christendat, Dinesh; Provart, Nicholas J.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Easley, Kante] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Kelley, Lawrence] Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, Div Mol Biosci, Dept Life Sci, London, England	University of Toronto; University of Toronto; University of Toronto; Imperial College London	Fucile, G (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	nicholas.provart@utoronto.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an NSERC Discovery Grant to NJP. Open access publication costs were defrayed by the Ontario Genomics Institute Genomics Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2009, ECONOMIST, V392, P32; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Behr J., 2009, P 14 INT C 3D WEB TE, P127, DOI DOI 10.1145/1559764.1559784; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2009, PLANT CELL, V21, P1034, DOI 10.1105/tpc.109.066050; Card S. K., 1999, READINGS INFORM VISU; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coruzzi G, 2006, DEV BIOL, V295, P327, DOI 10.1016/j.ydbio.2006.04.025; de Tayrac M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-32; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Fucile G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000292; Garcia Castro Alexander, 2005, Appl Bioinformatics, V4, P157; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gehlenborg N, 2009, BIOINFORMATICS, V25, P682, DOI 10.1093/bioinformatics/btp005; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; *JMOL PROJ, JMOL OP SOURC JAV VI; Kahlem P, 2007, ANN NY ACAD SCI, V1115, P23, DOI 10.1196/annals.1407.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McDermott J, 2003, NUCLEIC ACIDS RES, V31, P3736, DOI 10.1093/nar/gkg550; Mendes Pedro, 2009, V500, P17, DOI 10.1007/978-1-59745-525-1_2; Merico D, 2009, NAT BIOTECHNOL, V27, P921, DOI 10.1038/nbt.1567; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Neerincx PBT, 2005, BRIEF BIOINFORM, V6, P178, DOI 10.1093/bib/6.2.178; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; O'Donoghue SI, 2010, NAT METHODS, V7, pS2, DOI 10.1038/nmeth.f.301; Paananen J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-26; Pavlopoulos GA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-104; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Sagotsky JA, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.39; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stephens SM, 2006, CURR OPIN DRUG DISC, V9, P240; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Swanson R, 2005, SEX PLANT REPROD, V18, P163, DOI 10.1007/s00497-005-0009-x; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tsesmetzis N, 2008, PLANT CELL, V20, P1426, DOI 10.1105/tpc.108.057976; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Wolfram Research Inc., 2008, MATH VERS 7 0; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Zhong W, 2007, DEVELOPMENT, V134, P3227, DOI 10.1242/dev.001073	72	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15237	10.1371/journal.pone.0015237	http://dx.doi.org/10.1371/journal.pone.0015237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249219	Green Submitted, Green Published, gold			2022-12-25	WOS:000286513100003
J	Hinchey, J; Jeon, BY; Alley, H; Chen, B; Goldberg, M; Derrick, S; Morris, S; Jacobs, WR; Porcelli, SA; Lee, S				Hinchey, Joseph; Jeon, Bo Y.; Alley, Holly; Chen, Bing; Goldberg, Michael; Derrick, Steven; Morris, Sheldon; Jacobs, William R., Jr.; Porcelli, Steven A.; Lee, Sunhee			Lysine Auxotrophy Combined with Deletion of the SecA2 Gene Results in a Safe and Highly Immunogenic Candidate Live Attenuated Vaccine for Tuberculosis	PLOS ONE			English	Article							CD8(+) T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; FUNCTIONAL IMPAIRMENT; IMMUNE-RESPONSE; VIRAL-INFECTION; BCG; SMEGMATIS; DIAMINOPIMELATE; GENERATION; EFFECTOR	Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a major global health problem, despite the widespread use of the M. bovis Bacille Calmette-Guerin (BCG) vaccine and the availability of drug therapies. In recent years, the high incidence of coinfection of M. tuberculosis and HIV, as well as escalating problems associated with drug resistance, has raised ominous concerns with regard to TB control. Vaccination with BCG has not proven highly effective in controlling TB, and also has been associated with increasing concerns about the potential for the vaccine to cause disseminated mycobacterial infection in HIV infected hosts. Thus, the development of an efficacious and safe TB vaccine is generally viewed as a critical to achieving control of the ongoing global TB pandemic. In the current study, we have analyzed the vaccine efficacy of an attenuated M. tuberculosis strain that combines a mutation that enhances T cell priming (Delta secA2) with a strongly attenuating lysine auxotrophy mutation (Delta lysA). The Delta secA2 mutant was previously shown to be defective in the inhibition of apoptosis and markedly increased priming of antigen-specific CD8(+) T cells in vivo. Similarly, the Delta secA2 Delta lysA strain retained enhanced apoptosis and augmented CD8+ T cell stimulatory effects, but with a noticeably improved safety profile in immunosuppressed mice. Thus, the M. tuberculosis Delta secA2 Delta lysA mutant represents a live attenuated TB vaccine strain with the potential to deliver increased protection and safety compared to standard BCG vaccination.	[Hinchey, Joseph; Chen, Bing; Goldberg, Michael; Jacobs, William R., Jr.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Jeon, Bo Y.] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Alley, Holly; Lee, Sunhee] Duke Human Vaccine Inst, Durham, NC USA; [Derrick, Steven; Morris, Sheldon] US FDA, Ctr Biol Evaluat, Bethesda, MD 20014 USA; [Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA; [Porcelli, Steven A.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yonsei University; Yonsei University Health System; US Food & Drug Administration (FDA); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Hinchey, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	sunhee.lee@duke.edu		Jacobs, William/0000-0003-3321-3080	NIH [U54 AI057157, AI063537]; Einstein Cancer Center (NIH/NCI) [NIH/NCI CA013330]; Einstein Center for AIDS Research (NIH) [NIH AI-51519]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063537, R21AI090434, R37AI026170, U54AI057157, P30AI051519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Center (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Center for AIDS Research (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SL was supported by NIH grant U54 AI057157. SAP and WRJ were supported by NIH Program Project Grant AI063537. Flow cytometry studies were carried out using core facilities supported by the Einstein Cancer Center (NIH/NCI CA013330) and the Einstein Center for AIDS Research (NIH AI-51519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Behar SM, 2007, EXPERT REV VACCINES, V6, P441, DOI 10.1586/14760584.6.3.441; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Consaul SA, 2003, FEMS MICROBIOL LETT, V225, P131, DOI 10.1016/S0378-1097(03)00502-0; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Ha SJ, 2008, IMMUNOL REV, V223, P317, DOI 10.1111/j.1600-065X.2008.00638.x; Hesseling AC, 2003, CLIN INFECT DIS, V37, P1226, DOI 10.1086/378298; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; KAUFMANN SH, LANCET, V375, P2110; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Serbina NV, 2001, INFECT IMMUN, V69, P4320, DOI 10.1128/IAI.69.7.4320-4328.2001; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Villarreal-Ramos B, 2009, EXPERT REV VACCINES, V8, P1531, DOI 10.1586/ERV.09.109; Vogel TU, 2001, J VIROL, V75, P2458, DOI 10.1128/JVI.75.5.2458-2461.2001; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Winau F, 2005, APOPTOSIS, V10, P707, DOI 10.1007/s10495-005-2940-6	32	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15857	10.1371/journal.pone.0015857	http://dx.doi.org/10.1371/journal.pone.0015857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264335	Green Published, gold, Green Submitted			2022-12-25	WOS:000286513100014
J	Efimova, O; Szankasi, P; Kelley, TW				Efimova, Olga; Szankasi, Philippe; Kelley, Todd W.			Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+Effector T Cells	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; REDUCED OXIDATIVE BURST; TGF-BETA; NADPH OXIDASE; RECEPTOR STIMULATION; AUTOIMMUNE-DISEASE; HYDROGEN-PEROXIDE; ARTHRITIS; MICE; PROLIFERATION	Background: Multiple mechanisms have been advanced to account for CD4+FOXP3+ regulatory T cell (Treg)-mediated suppression of CD4+ effector T cells (Teffs) but none appear to completely explain suppression. Previous data indicates that Tregs may affect the microenvironment redox state. Given the inherent redox sensitivity of T cells, we tested the hypothesis that oxidants may mediate the direct suppression of Teffs by Tregs. Methodology/Principal Findings: Tregs and Teffs were isolated from the spleens of wild type (WT) C57BL/6 mice or Ncf1(p47phox)-deficient C57BL/6 mice which lack NADPH oxidase function. Teffs were labeled with CFSE and co-cultured with unlabeled Tregs at varying Treg:Teff ratios in the presence of anti-CD3/CD28 coated beads for 3 days in suppression assays. Treg-mediated suppression was quantified by flow cytometric analysis of CFSE dilution in Teffs. The presence of the antioxidants n-acetylcysteine (NAC) or 2-mercaptoethanol or inhibitors of NADPH oxidase (diphenyleneiodonium and VAS-2870) resulted in reduced WT Treg-mediated suppression. The observed suppression was in part dependent upon TGF beta as it was partially blocked with neutralizing antibodies. The suppression of Teff proliferation induced by exogenous TGF beta treatment could be overcome with NAC. Ncf1-deficient Teff were slightly but significantly less sensitive than WT Teff to suppression by exogenous TGF beta. Ncf1-deficient Tregs suppressed Ncf1-deficient Teff very poorly compared to wild type controls. There was partial but incomplete reconstitution of suppression in assays with WT Tregs and Ncf1-deficient Teff. Conclusions/Significance: We present evidence that NADPH oxidase derived ROS plays a role in the direct Treg mediated suppression of CD4+ effector T cells in a process that is blocked by thiol-containing antioxidants, NADPH oxidase inhibitors or a lack of Ncf1 expression in Tregs and Teffs. Oxidants may represent a potential new target for therapeutic modulation of Treg function.	[Efimova, Olga; Kelley, Todd W.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Szankasi, Philippe; Kelley, Todd W.] ARUP Labs, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories	Efimova, O (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	todd.kelley@path.utah.edu			University of Utah	University of Utah	This work was supported by funds provided to the principle investigator by the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; CHRIST M, 1994, J IMMUNOL, V153, P1936; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Edinger AL, 2002, P NATL ACAD SCI USA, V99, P1107, DOI 10.1073/pnas.042707999; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hagenow K, 2009, J IMMUNOL, V183, P874, DOI 10.4049/jimmunol.0900966; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Huang A, 2006, COLORECTAL DIS, V8, P637, DOI 10.1111/j.1463-1318.2006.01030.x; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Itoh M, 1999, J IMMUNOL, V162, P5317; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kwon J, 2003, FREE RADICAL BIO MED, V35, P406, DOI 10.1016/S0891-5849(03)00318-6; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Meurer SK, 2005, BIOCHEM PHARMACOL, V70, P1026, DOI 10.1016/j.bcp.2005.07.001; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; van de Loo FAJ, 2003, AM J PATHOL, V163, P1525, DOI 10.1016/S0002-9440(10)63509-2; YAN Z, 2010, J BIOL CHEM     1030; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	46	76	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16013	10.1371/journal.pone.0016013	http://dx.doi.org/10.1371/journal.pone.0016013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253614	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511900035
J	Efroni, S; Ben-Hamo, R; Edmonson, M; Greenblum, S; Schaefer, CF; Buetow, KH				Efroni, Sol; Ben-Hamo, Rotem; Edmonson, Michael; Greenblum, Sharon; Schaefer, Carl F.; Buetow, Kenneth H.			Detecting Cancer Gene Networks Characterized by Recurrent Genomic Alterations in a Population	PLOS ONE			English	Article							DNA COPY-NUMBER; UBIQUITIN-PROTEASOME PATHWAY; HIGH-RESOLUTION ANALYSIS; HUMAN BREAST-TUMORS; PATIENT SURVIVAL; P53 STATUS; HYBRIDIZATION; EXPRESSION; MICROARRAYS; REVEALS	High resolution, system-wide characterizations have demonstrated the capacity to identify genomic regions that undergo genomic aberrations. Such research efforts often aim at associating these regions with disease etiology and outcome. Identifying the corresponding biologic processes that are responsible for disease and its outcome remains challenging. Using novel analytic methods that utilize the structure of biologic networks, we are able to identify the specific networks that are highly significantly, nonrandomly altered by regions of copy number amplification observed in a systems-wide analysis. We demonstrate this method in breast cancer, where the state of a subset of the pathways identified through these regions is shown to be highly associated with disease survival and recurrence.	[Efroni, Sol; Ben-Hamo, Rotem] Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel; [Schaefer, Carl F.; Buetow, Kenneth H.] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Edmonson, Michael; Greenblum, Sharon; Buetow, Kenneth H.] NIH, Lab Populat Genet, Bethesda, MD 20892 USA	Bar Ilan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Efroni, S (corresponding author), Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel.	buetowk@nih.gov	Efroni, Sol/I-6752-2012	Efroni, Sol/0000-0001-7927-6349	European Union; NATIONAL CANCER INSTITUTE [ZIHCO020005, ZIHBC010470] Funding Source: NIH RePORTER	European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SE is funded by the European Union through its International Reintegration Grants (IRG) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barlund M, 2000, CANCER RES, V60, P5340; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Buetow KH, 2002, CANCER CELL, V1, P315, DOI 10.1016/S1535-6108(02)00065-X; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cowell JK, 2003, ADV CANCER RES, V90, P91, DOI 10.1016/S0065-230X(03)90003-0; Edelman E, 2006, BIOINFORMATICS, V22, pE108, DOI 10.1093/bioinformatics/btl231; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fisher RA, 1932, STAT METHODS RES WOR, p[xiii, 11]; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Isaacs JS, 2004, J BIOL CHEM, V279, P16128, DOI 10.1074/jbc.M313342200; ISOLA JJ, 1995, AM J PATHOL, V147, P905; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Jeffrey SS, 2003, BREAST CANCER RES, V5, P320, DOI 10.1186/bcr655; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Schaefer C. F., 2007, PATHWAY INTERACTION; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Strausberg RL, 2002, CANCER INVEST, V20, P1038, DOI 10.1081/CNV-120005922; TANNER MM, 1994, CANCER RES, V54, P4257; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011	48	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14437	10.1371/journal.pone.0014437	http://dx.doi.org/10.1371/journal.pone.0014437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21283511	Green Submitted, Green Published, gold			2022-12-25	WOS:000286510500003
J	Chatterjee, S; Feinstein, SI; Dodia, C; Sorokina, E; Lien, YC; Nguyen, S; Debolt, K; Speicher, D; Fisher, AB				Chatterjee, Shampa; Feinstein, Sheldon I.; Dodia, Chandra; Sorokina, Elena; Lien, Yu-Chin; Su Nguyen; Debolt, Kris; Speicher, David; Fisher, Aron B.			Peroxiredoxin 6 Phosphorylation and Subsequent Phospholipase A(2) Activity Are Required for Agonist-mediated Activation of NADPH Oxidase in Mouse Pulmonary Microvascular Endothelium and Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMOXIC LUNG ISCHEMIA; 1-CYS PEROXIREDOXIN; HUMAN NEUTROPHILS; PROTEIN-KINASE; GLUTATHIONE-PEROXIDASE; RESPIRATORY BURST; SHEAR-STRESS; MAP KINASES; CELLS; P67(PHOX)	Peroxiredoxin 6 (Prdx6), a bifunctional enzyme with glutathione peroxidase and phospholipase A2 (PLA(2)) activities, participates in the activation of NADPH oxidase 2 (NOX2) in neutrophils, but the mechanism for this effect is not known. We now demonstrate that Prdx6 is required for agonist-induced NOX2 activation in pulmonary microvascular endothelial cells (PMVEC) and that the effect requires the PLA(2) activity of Prdx6. Generation of reactive oxygen species (ROS) in response to angiotensin II (Ang II) or phorbol 12-myristate 13-acetate was markedly reduced in perfused lungs and isolated PMVEC from Prdx6 null mice. Rac1 and p47(phox), cytosolic components of NOX2, translocated to the endothelial cell membrane after Ang II treatment in wild-type but not Prdx6 null PMVEC. MJ33, an inhibitor of Prdx6 PLA(2) activity, blocked agonist-induced PLA(2) activity and ROS generation in PMVEC by > 80%, whereas inhibitors of other PLA(2)s were ineffective. Transfection of Prx6 null cells with wild-type and C47S mutant Prdx6, but not with mutants of the PLA(2) active site (S32A, H26A, and D140A), "rescued" Ang II-induced PLA(2) activity and ROS generation. Ang II treatment of wild-type cells resulted in phosphorylation of Prdx6 and its subsequent translocation from the cytosol to the cell membrane. Phosphorylation as well as PLA(2) activity and ROS generation were markedly reduced by the MAPK inhibitor, U0126. Thus, agonist-induced MAPK activation leads to Prdx6 phosphorylation and translocation to the cell membrane, where its PLA(2) activity facilitates assembly of the NOX2 complex and activation of the oxidase.	[Fisher, Aron B.] Univ Penn, Sch Med, Inst Environm Med, Med Ctr, Philadelphia, PA 19104 USA; [Speicher, David] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute	Fisher, AB (corresponding author), Univ Penn, Sch Med, Inst Environm Med, Med Ctr, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	abf@mail.med.upenn.edu	NGUYEN, SU/S-5377-2016	Lien, Yu-Chin/0000-0002-2764-1794	National Institutes of Health [HL105509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL105509. This work was presented in part at the 2010 Experimental Biology meeting in Anaheim, CA.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 1998, COMP BIOCHEM PHYS B, V120, P393, DOI 10.1016/S0305-0491(98)10046-9; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Bostan M, 2003, J CELL MOL MED, V7, P57, DOI 10.1111/j.1582-4934.2003.tb00203.x; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; DANA R, 1994, BIOCHEM J, V297, P217, DOI 10.1042/bj2970217; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; DUSI S, 1994, BIOCHEM J, V304, P243, DOI 10.1042/bj3040243; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 1996, J LIPID RES, V37, P1057; FISHER AB, 2011, ANTIOXID RE IN PRESS; FORMAN HJ, 1980, J BIOL CHEM, V255, P9879; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Hazan I, 1997, BIOCHEM J, V326, P867, DOI 10.1042/bj3260867; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Leavey PJ, 2002, J BIOL CHEM, V277, P45181, DOI 10.1074/jbc.M202869200; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; LU DJ, 1993, BLOOD CELLS, V19, P343; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Manevich Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P139, DOI 10.1016/j.abb.2009.02.008; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Mo YQ, 2003, FEBS LETT, V555, P192, DOI 10.1016/S0014-5793(03)01199-2; O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Silliman CC, 2003, J LEUKOCYTE BIOL, V73, P511, DOI 10.1189/jlb.0402179; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Torres M, 1999, ARCH BIOCHEM BIOPHYS, V366, P231, DOI 10.1006/abbi.1999.1225; Wu Y, 2009, BIOCHEM J, V419, P669, DOI 10.1042/BJ20082061; Yu G, 2007, MICROCIRCULATION, V14, P125, DOI 10.1080/10739680601131218; Zhang QW, 2008, ANTIOXID REDOX SIGN, V10, P679, DOI 10.1089/ars.2007.1521; Zhang QW, 2005, AM J PHYSIOL-LUNG C, V289, pL954, DOI 10.1152/ajplung.00210.2005; Zhao XX, 2002, J BIOL CHEM, V277, P25385, DOI 10.1074/jbc.M203630200	41	98	105	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11696	11706		10.1074/jbc.M110.206623	http://dx.doi.org/10.1074/jbc.M110.206623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262967	hybrid, Green Published			2022-12-25	WOS:000288797100077
J	Pifer, PM; Yates, EA; Legleiter, J				Pifer, Phillip M.; Yates, Elizabeth A.; Legleiter, Justin			Point Mutations in A beta Result in the Formation of Distinct Polymorphic Aggregates in the Presence of Lipid Bilayers	PLOS ONE			English	Article							AMYLOID ION CHANNELS; ALZHEIMERS-DISEASE; IN-VITRO; SECONDARY STRUCTURE; PRECURSOR PROTEIN; WILD-TYPE; PEPTIDE; FIBRILLOGENESIS; OLIGOMERIZATION; TOXICITY	A hallmark of Alzheimer's disease (AD) is the rearrangement of the beta-amyloid (A beta) peptide to a non-native conformation that promotes the formation of toxic, nanoscale aggregates. Recent studies have pointed to the role of sample preparation in creating polymorphic fibrillar species. One of many potential pathways for A beta toxicity may be modulation of lipid membrane function on cellular surfaces. There are several mutations clustered around the central hydrophobic core of A beta near the alpha-secretase cleavage site (E22G Arctic mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish mutation). These point mutations are associated with hereditary diseases ranging from almost pure cerebral amyloid angiopathy (CAA) to typical Alzheimer's disease pathology with plaques and tangles. We investigated how these point mutations alter A beta aggregation in the presence of supported lipid membranes comprised of total brain lipid extract. Brain lipid extract bilayers were used as a physiologically relevant model of a neuronal cell surface. Intact lipid bilayers were exposed to predominantly monomeric preparations of Wild Type or different mutant forms of A beta, and atomic force microscopy was used to monitor aggregate formation and morphology as well as bilayer integrity over a 12 hour period. The goal of this study was to determine how point mutations in A beta, which alter peptide charge and hydrophobic character, influence interactions between A beta and the lipid surface. While fibril morphology did not appear to be significantly altered when mutants were prepped similarly and incubated under free solution conditions, aggregation in the lipid membranes resulted in a variety of polymorphic aggregates in a mutation dependent manner. The mutant peptides also had a variable ability to disrupt bilayer integrity.	[Pifer, Phillip M.; Yates, Elizabeth A.; Legleiter, Justin] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Legleiter, Justin] W Virginia Univ, WVnano Initiat, Morgantown, WV 26506 USA; [Legleiter, Justin] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Pifer, PM (corresponding author), W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.	justin.legleiter@mail.wvu.edu		Yates, Elizabeth A./0000-0002-7141-306X	West Virginia University	West Virginia University	The research was funded by a start-up fund provided by West Virginia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Clements A, 1996, J NEUROCHEM, V66, P740; CLEMENTS A, 1993, NEUROSCI LETT, V161, P17, DOI 10.1016/0304-3940(93)90129-9; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; Demeester N, 2001, EUR J NEUROSCI, V13, P2015, DOI 10.1046/j.0953-816x.2001.01579.x; Fernandes F, 2003, BIOPHYS J, V85, P2430, DOI 10.1016/S0006-3495(03)74666-9; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han X, 2000, J MOL BIOL, V304, P953, DOI 10.1006/jmbi.2000.4251; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jass J, 2000, BIOPHYS J, V79, P3153, DOI 10.1016/S0006-3495(00)76549-0; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2004, J MOL BIOL, V335, P997, DOI 10.1016/j.jmb.2003.11.019; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lindstrom F, 2002, PHYS CHEM CHEM PHYS, V4, P5524, DOI 10.1039/b206351d; Lins L, 2002, PROTEIN ENG, V15, P513, DOI 10.1093/protein/15.6.513; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Pastor MT, 2008, J MOL BIOL, V375, P695, DOI 10.1016/j.jmb.2007.08.012; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; ROTH GS, 1995, TRENDS NEUROSCI, V18, P203, DOI 10.1016/0166-2236(95)93902-A; Sennvik K, 2002, NEUROSCI LETT, V326, P51, DOI 10.1016/S0304-3940(02)00305-1; Sian AK, 2000, BIOCHEM J, V349, P299, DOI 10.1042/0264-6021:3490299; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; STATHOPULOS PB, 2003, P NAT ACAD SCI US, V100; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; VANNOSTRAND WE, 2001, J BIOL CHEM, V376, P32680; Verbeek MM, 1997, J NEUROPATH EXP NEUR, V56, P751; WALLIN A, 1989, ACTA NEUROL SCAND, V80, P319, DOI 10.1111/j.1600-0404.1989.tb03886.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zameer A, 2006, BIOCHEMISTRY-US, V45, P11532, DOI 10.1021/bi060601o; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	67	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16248	10.1371/journal.pone.0016248	http://dx.doi.org/10.1371/journal.pone.0016248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267410	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500048
J	Yoon, MY; Lee, KM; Park, Y; Yoon, SS				Yoon, Mi Young; Lee, Kang-Mu; Park, Yongjin; Yoon, Sang Sun			Contribution of Cell Elongation to the Biofilm Formation of Pseudomonas aeruginosa during Anaerobic Respiration	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; CYSTIC-FIBROSIS; NITRIC-OXIDE; ESCHERICHIA-COLI; RESISTANCE; NITRATE; METABOLISM; DIVISION; CARBENICILLIN; INFECTIONS	Pseudomonas aeruginosa, a gram-negative bacterium of clinical importance, forms more robust biofilm during anaerobic respiration, a mode of growth presumed to occur in abnormally thickened mucus layer lining the cystic fibrosis (CF) patient airway. However, molecular basis behind this anaerobiosis-triggered robust biofilm formation is not clearly defined yet. Here, we identified a morphological change naturally accompanied by anaerobic respiration in P. aeruginosa and investigated its effect on the biofilm formation in vitro. A standard laboratory strain, PAO1 was highly elongated during anaerobic respiration compared with bacteria grown aerobically. Microscopic analysis demonstrated that cell elongation likely occurred as a consequence of defective cell division. Cell elongation was dependent on the presence of nitrite reductase (NIR) that reduces nitrite (NO2-) to nitric oxide (NO) and was repressed in PAO1 in the presence of carboxy-PTIO, a NO antagonist, demonstrating that cell elongation involves a process to respond to NO, a spontaneous byproduct of the anaerobic respiration. Importantly, the non-elongated NIR-deficient mutant failed to form biofilm, while a mutant of nitrate reductase (NAR) and wild type PAO1, both of which were highly elongated, formed robust biofilm. Taken together, our data reveal a role of previously undescribed cell biological event in P. aeruginosa biofilm formation and suggest NIR as a key player involved in such process.	[Yoon, Mi Young; Lee, Kang-Mu; Park, Yongjin; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, MY (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea.	sangsun_yoon@yuhs.ac		Yoon, Sang Sun/0000-0003-2979-365X	Ministry for Health, Welfare and Family Affairs, Republic of Korea [A090951]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea, A090951 to SSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.202001; Acosta D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.131801; Benkert B, 2008, MICROBIOL-SGM, V154, P3053, DOI 10.1099/mic.0.2008/018929-0; BHATTI AR, 1976, J BACTERIOL, V126, P400, DOI 10.1128/JB.126.1.400-409.1976; BURTON P, 1983, MOL GEN GENET, V190, P128, DOI 10.1007/BF00330334; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Filiatrault MJ, 2005, INFECT IMMUN, V73, P3764, DOI 10.1128/IAI.73.6.3764-3772.2005; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; GORETSKI J, 1990, J BIOL CHEM, V265, P11535; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; HASSETT DJ, 1995, J BACTERIOL, V177, P6330, DOI 10.1128/jb.177.22.6330-6337.1995; Hassett DJ, 1999, METHOD ENZYMOL, V310, P599; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; JAGGER KN, 1983, J CLIN MICROBIOL, V17, P55, DOI 10.1128/JCM.17.1.55-59.1983; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; O'May CY, 2006, FEMS IMMUNOL MED MIC, V48, P373, DOI 10.1111/j.1574-695X.2006.00157.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ojoo JC, 2005, THORAX, V60, P22, DOI 10.1136/thx.2003.017327; PHAIR JP, 1969, APPL MICROBIOL, V18, P303, DOI 10.1128/AEM.18.3.303-306.1969; RELLA M, 1982, ANTIMICROB AGENTS CH, V22, P242, DOI 10.1128/AAC.22.2.242; RICO AI, 2010, MOL MICROBIOL; ROLINSON GN, 1980, J GEN MICROBIOL, V120, P317; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; SHEARER BG, 1983, EUR J CLIN MICROBIOL, V2, P148, DOI 10.1007/BF02001581; Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Teitzel GM, 2003, APPL ENVIRON MICROB, V69, P2313, DOI 10.1128/AEM.69.4.2313-2320.2003; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Wong KKY, 1997, ANTIMICROB AGENTS CH, V41, P2009, DOI 10.1128/AAC.41.9.2009; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	49	81	82	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16105	10.1371/journal.pone.0016105	http://dx.doi.org/10.1371/journal.pone.0016105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267455	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500039
J	Meadows, E; Flynn, JM; Klein, WH				Meadows, Eric; Flynn, Jesse M.; Klein, William H.			Myogenin Regulates Exercise Capacity but Is Dispensable for Skeletal Muscle Regeneration in Adult mdx Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NITRIC-OXIDE SYNTHASE; MUTANT MICE; MOUSE; EXPRESSION; GENE; MYOD; METABOLISM; ADAPTATION; GLYCOLYSIS	Duchenne muscular dystrophy (DMD) is the most prevalent inherited childhood muscle disorder in humans. mdx mice exhibit a similar pathophysiology to the human disorder allowing for an in-depth investigation of DMD. Myogenin, a myogenic regulatory factor, is best known for its role in embryonic myogenesis, but its role in adult muscle maintenance and regeneration is still poorly understood. Here, we generated an mdx:Myog(flox/flox) mouse harboring a tamoxifen-inducible Cre recombinase transgene, which was used to conditionally delete Myog during adult life. After tamoxifen treatment, three groups of mice were created to study the effects of Myog deletion: mdx:Myog(flox/flox) mice (mdx), Myog(flox/flox) mice (wildtype), and mdx:Myog(flox Delta/flox Delta):Cre-ER mice (mdx:Myog-deleted). mdx: Myog-deleted mice exhibited no adverse phenotype and behaved normally. When run to exhaustion, mdx:Myog-deleted mice demonstrated an enhanced capacity for exercise compared to mdx mice, running nearly as far as wild-type mice. Moreover, these mice showed the same signature characteristics of muscle regeneration as mdx mice. Unexpectedly, we found that myogenin was dispensable for muscle regeneration. Factors associated with muscle fatigue, metabolism, and proteolysis were significantly altered in mdx: Myogdeleted mice, and this might contribute to their increased exercise capacity. Our results reveal novel functions for myogenin in adult muscle and suggest that reducing Myog expression in other muscle disease models may partially restore muscle function.	[Meadows, Eric; Flynn, Jesse M.; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meadows, Eric; Flynn, Jesse M.] Univ Texas Houston, Sch Biomed Sci Houston, Grad Training Program Genes & Dev, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Meadows, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	whklein@mdanderson.org			Muscular Dystrophy Association [MDA4289]; Robert A. Welch Foundation [G-0010]	Muscular Dystrophy Association(Muscular Dystrophy Association); Robert A. Welch Foundation(The Welch Foundation)	The work was supported by grants to W.H.K. from the Muscular Dystrophy Association (MDA4289) and from the Robert A. Welch Foundation (G-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2004, SCIENCE, V305, P1112, DOI 10.1126/science.1103078; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BULFIELD G, 1978, GENETICS, V89, P551; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; Ciafaloni E, 2008, CURR TREAT OPTION N, V10, P86, DOI 10.1007/s11940-008-0010-4; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; De la Porte S, 1999, INT REV CYTOL, V191, P99, DOI 10.1016/S0074-7696(08)60158-8; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; ENGEL A, 2004, MED PUB DIVISION, P2; Flynn JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013535; Gladden LB, 2008, MED SCI SPORT EXER, V40, P477, DOI [10.1249/mss.0b013e31815fa580, 10.1249/MSS.0b013e31815fa580]; GLESBY MJ, 1988, MUSCLE NERVE, V11, P852, DOI 10.1002/mus.880110809; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hamilton MT, 2000, J APPL PHYSIOL, V88, P327, DOI 10.1152/jappl.2000.88.1.327; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jin Y, 2000, ACTA NEUROPATHOL, V99, P619, DOI 10.1007/s004010051172; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Muir LA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001100; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Wehling-Henricks M, 2009, HUM MOL GENET, V18, P3439, DOI 10.1093/hmg/ddp288; Zhu XP, 2006, MUSCLE NERVE, V33, P104, DOI 10.1002/mus.20445	48	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16184	10.1371/journal.pone.0016184	http://dx.doi.org/10.1371/journal.pone.0016184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264243	Green Submitted, Green Published, gold			2022-12-25	WOS:000286516500034
J	Zhang, J; Wu, ZQ; Zhou, LL; Li, HL; Teng, HJ; Dai, W; Wang, YQ; Sun, ZS				Zhang, Jing; Wu, Zhouqiao; Zhou, Linglin; Li, Huili; Teng, Huajing; Dai, Wei; Wang, Yongqing; Sun, Zhong Sheng			Deficiency of Antinociception and Excessive Grooming Induced by Acute Immobilization Stress in Per1 Mutant Mice	PLOS ONE			English	Article							INDUCED ANALGESIA; ANALYSIS ALGORITHM; HPA AXIS; BEHAVIOR; MPER2; VASOPRESSIN; OXYTOCIN; NEUROENDOCRINE; STIMULATION; RELEASE	Acute stressors induce changes in numerous behavioral parameters through activation of the hypothalamic-pituitary-adrenal (HPA) axis. Several important hormones in paraventricular nucleus of the hypothalamus (PVN) play the roles in these stress-induced reactions. Corticotropin-releasing hormone (CRH), arginine-vasopressin (AVP) and corticosterone are considered as molecular markers for stress-induced grooming behavior. Oxytocin in PVN is an essential modulator for stress-induced antinociception. The clock gene, Per1, has been identified as an effecter response to the acute stresses, but its function in neuroendocrine stress systems remains unclear. In the present study we observed the alterations in grooming and nociceptive behaviors induced by acute immobilization stress in Per1 mutant mice and other genotypes (wild types and Per2 mutant). The results displayed that stress elicited a more robust effect on grooming behavior in Per1 mutant mice than in other genotypes. Subsequently, the obvious stress-induced antinociception was observed in the wild-type and Per2 mutant mice, however, in Per1 mutant, this antinociceptive effects were partially-reversed (mechanical sensitivity), or over-reversed to hyperalgesia (thermal sensitivity). The real-time qPCR results showed that in PVN, there were stress-induced up-regulations of Crh, Avp and c-fos in all of genotypes; moreover, the expression change of Crh in Per1 mutant mice was much larger than in others. Another hormonal gene, Oxt, was up-regulated induced by stress in wild-type and Per2 mutant but not in Per1 mutant. In addition, the stress significantly elevated the serum corticosterone levels without genotype-dependent differences, and accordingly the glucocorticoid receptor gene, Nr3c1, expressed with a similar pattern in PVN of all strains. Taken together, the present study indicated that in acute stress treated Per1 mutant mice, there are abnormal hormonal responses in PVN, correlating with the aberrant performance of stress-induced behaviors. Therefore, our findings suggest a novel functional role of Per1 in neuroendocrine stress system, which further participates in analgesic regulation.	[Zhang, Jing; Teng, Huajing; Dai, Wei; Wang, Yongqing; Sun, Zhong Sheng] Chinese Acad Sci, Behav Genet Ctr, Beijing, Peoples R China; [Zhang, Jing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wu, Zhouqiao] Peking Univ, Hosp 3, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zhou, Linglin] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Li, Huili] Capital Inst Pediat, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Wenzhou Medical University; Capital Institute of Pediatrics (CIP)	Zhang, J (corresponding author), Chinese Acad Sci, Behav Genet Ctr, Beijing, Peoples R China.	zsunusa@yahoo.com	Li, Huili/AAP-9120-2020; Huajing, Teng/AAF-4040-2020; Sun, Zhongsheng/AAS-4883-2020	Huajing, Teng/0000-0001-9952-3618; Sun, Zhongsheng/0000-0002-7640-5026; Li, Huili/0000-0002-9248-0720	National Natural Science Foundation of China [31071133]; Major State Basic Research Development Program of China [2007CB512302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31071133) and Major State Basic Research Development Program of China (2007CB512302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Antonijevic I, 2008, STRESS, V11, P15, DOI 10.1080/10253890701378967; BARROS HMT, 1994, PHARMACOL TOXICOL, V74, P339, DOI 10.1111/j.1600-0773.1994.tb01370.x; BUWALDA B, 1993, PHYSIOL BEHAV, V54, P947, DOI 10.1016/0031-9384(93)90307-2; CALDWELL JD, 1986, REGUL PEPTIDES, V14, P261, DOI 10.1016/0167-0115(86)90009-1; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Condes-Lara M, 2008, NEUROSCI LETT, V444, P199, DOI 10.1016/j.neulet.2008.08.027; Condes-Lara M, 2009, EUR J NEUROSCI, V30, P1056, DOI 10.1111/j.1460-9568.2009.06899.x; DAMORE A, 1992, J PHARMACOL TOXICOL, V27, P197, DOI 10.1016/1056-8719(92)90041-X; DeLaTorre S, 2009, PAIN, V144, P320, DOI 10.1016/j.pain.2009.05.002; Eguibar JR, 2003, PHARMACOL BIOCHEM BE, V74, P827, DOI 10.1016/S0091-3057(02)01082-1; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Fediuc S, 2006, J APPL PHYSIOL, V100, P1867, DOI 10.1152/japplphysiol.01416.2005; Ford GK, 2008, PAIN, V140, P3, DOI 10.1016/j.pain.2008.09.023; Jezova D, 1995, ANN NY ACAD SCI, V771, P192, DOI 10.1111/j.1749-6632.1995.tb44681.x; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Korzeniewska Iwona, 1995, Polish Journal of Pharmacology, V47, P381; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; LaBuda CJ, 2000, BRAIN RES, V869, P1, DOI 10.1016/S0006-8993(00)02196-X; Lumley LA, 2001, PHYSIOL BEHAV, V73, P451, DOI 10.1016/S0031-9384(01)00501-7; Ma S, 2005, J NEUROENDOCRINOL, V17, P22, DOI 10.1111/j.1365-2826.2005.01279.x; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; MOODY TW, 1988, ANN NY ACAD SCI, V525, P281, DOI 10.1111/j.1749-6632.1988.tb38613.x; Nishioka T, 1998, BRAIN RES, V781, P57, DOI 10.1016/S0006-8993(97)01159-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Robinson DA, 2002, J PHYSIOL-LONDON, V540, P593, DOI 10.1113/jphysiol.2001.013492; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Seo YJ, 2006, BRAIN RES BULL, V71, P279, DOI 10.1016/j.brainresbull.2006.09.012; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Tavakoli-Nezhad M, 2007, J BIOL RHYTHM, V22, P81, DOI 10.1177/0748730406296717; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	36	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16212	10.1371/journal.pone.0016212	http://dx.doi.org/10.1371/journal.pone.0016212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264262	Green Submitted, Green Published, gold			2022-12-25	WOS:000286516500040
J	Ngamskulrungroj, P; Price, J; Sorrell, T; Perfect, JR; Meyer, W				Ngamskulrungroj, Popchai; Price, Jennifer; Sorrell, Tania; Perfect, John R.; Meyer, Wieland			Cryptococcus gattii Virulence Composite: Candidate Genes Revealed by Microarray Analysis of High and Less Virulent Vancouver Island Outbreak Strains	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; CELL-WALL INTEGRITY; BRITISH-COLUMBIA; MOLECULAR ANALYSIS; FUNGAL PATHOGEN; USTILAGO-MAYDIS; DISTINCT ROLES; CAPSULE; YEAST; GROWTH	Human and animal cryptococcosis due to an unusual molecular type of Cryptococcus gattii (VGII) emerged recently on Vancouver Island, Canada. Unlike C. neoformans, C. gattii causes disease mainly in immunocompetent hosts, despite producing a similar suite of virulence determinants. To investigate a potential relationship between the regulation of expression of a virulence gene composite and virulence, we took advantage of two subtypes of VGII (a and b), one highly virulent (R265) and one less virulent (R272), that were identified from the Vancouver outbreak. By expression microarray analysis, 202 genes showed at least a 2-fold difference in expression with 108 being up-and 94 being down-regulated in strain R265 compared with strain R272. Specifically, expression levels of genes encoding putative virulence factors (e. g. LAC1, LAC2, CAS3 and MPK1) and genes encoding proteins involved in cell wall assembly, carbohydrate and lipid metabolism were increased in strain R265, whereas genes involved in the regulation of mitosis and ergosterol biosynthesis were suppressed. In vitro phenotypic studies and transcription analysis confirmed the microarray results. Gene disruption of LAC1 and MPK1 revealed defects in melanin synthesis and cell wall integrity, respectively, where CAS3 was not essential for capsule production. Moreover, MPK1 also controls melanin and capsule production and causes a severe attenuation of the virulence in a murine inhalational model. Overall, this study provides the basis for further genetic studies to characterize the differences in the virulence composite of strains with minor evolutionary divergences in gene expression in the primary pathogen C. gattii, that have led to a major invasive fungal infection outbreak.	[Ngamskulrungroj, Popchai; Sorrell, Tania; Meyer, Wieland] Univ Sydney, Westmead Hosp,Mol Mycol Res Lab, Westmead Millennium Inst,Sydney Emerging Infect &, Ctr Infect Dis & Microbiol,Sydney Med Sch Westmed, Westmead, NSW 2145, Australia; [Ngamskulrungroj, Popchai; Price, Jennifer] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ngamskulrungroj, Popchai; Perfect, John R.] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand	University of Sydney; Westmead Institute for Medical Research; Duke University; Mahidol University	Ngamskulrungroj, P (corresponding author), Univ Sydney, Westmead Hosp,Mol Mycol Res Lab, Westmead Millennium Inst,Sydney Emerging Infect &, Ctr Infect Dis & Microbiol,Sydney Med Sch Westmed, Westmead, NSW 2145, Australia.	w.meyer@usyd.edu.au	Meyer, Wieland/G-1204-2015; Sorrell, Tania/AAZ-5286-2020; Ngamskulrungroj, Popchai/ABE-7699-2021; Ngamskulrungroj, Popchai/N-8545-2019	Meyer, Wieland/0000-0001-9933-8340; Ngamskulrungroj, Popchai/0000-0001-5162-5498; Sorrell, Tania/0000-0001-9460-0960	Endeavour International Postgraduate Research Scholarship (EIPRS); University of Sydney; National Institute of Allergy and Infectious Diseases (NIAID) Public Heath Service [AI28388, AI73896]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028388, R01AI073896, R56AI028388] Funding Source: NIH RePORTER	Endeavour International Postgraduate Research Scholarship (EIPRS)(Australian Government); University of Sydney(University of Sydney); National Institute of Allergy and Infectious Diseases (NIAID) Public Heath Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Endeavour International Postgraduate Research Scholarship (EIPRS) and International Postgraduate Award (IPA) of the University of Sydney scholarship to PN and a bridging grant of University of Sydney to WM. Also National Institute of Allergy and Infectious Diseases (NIAID) Public Heath Service AI28388 and AI73896 for JRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Alspaugh JA, 1998, FUNGAL GENET BIOL, V25, P1, DOI 10.1006/fgbi.1998.1079; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Banuett F, 1995, ANNU REV GENET, V29, P179, DOI 10.1146/annurev.ge.29.120195.001143; Boekhout T, 1997, INT J SYST BACTERIOL, V47, P432, DOI 10.1099/00207713-47-2-432; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Carrillo-Munoz A J, 2006, Rev Esp Quimioter, V19, P130; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chayakulkeeree M, 2007, ANTIMICROB AGENTS CH, V51, P3537, DOI 10.1128/AAC.00442-07; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Chung SY, 2002, EUKARYOT CELL, V1, P432, DOI 10.1128/EC.1.3.432-439.2002; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; Datta K, 2009, INTERDISCIP PERSPECT, DOI DOI 10.1155/2009/176532; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Garcia-Muse T, 2004, J CELL SCI, V117, P487, DOI 10.1242/jcs.00877; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Hicks JK, 2007, EUKARYOT CELL, V6, P413, DOI 10.1128/EC.00213-06; Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; KWONCHUNG JK, 1992, MED MYCOL, P397; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Latouche GN, 2002, FEMS YEAST RES, V2, P551, DOI 10.1016/S1567-1356(02)00130-7; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; NCCLS, 2002, REF METH BROTH DIL A, V22; NGAMSKULRUNGROJ P, 2010, CLIN MICROBIOL INFEC, DOI DOI 10.1111/J.1469-0691.2010.03222.X; Ngamskulrungroj P, 2008, MED MYCOL, V46, P665, DOI 10.1080/13693780802210734; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Ngamskulrungroj Popchai, 2009, Australasian Mycologist, V28, P9; Nosanchuk JD, 1999, ANTIMICROB AGENTS CH, V43, P233, DOI 10.1093/jac/43.2.233; Pardini G, 2006, J BIOL CHEM, V281, P40399, DOI 10.1074/jbc.M606361200; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; PLEMPEL M, 1984, DERMATOLOGICA, V169, P11, DOI 10.1159/000249635; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Shea JM, 2006, FEMS YEAST RES, V6, P469, DOI 10.1111/j.1567-1364.2006.00080.x; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Stephen C, 2002, CAN VET J, V43, P792; Takeo K, 2004, FEMS YEAST RES, V4, P737, DOI 10.1016/j.femsyr.2004.01.005; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Velegraki A, 2001, MED MYCOL, V39, P419, DOI 10.1080/mmy.39.5.419.422; Viviani MA, 2006, FEMS YEAST RES, V6, P614, DOI 10.1111/j.1567-1364.2006.00081.x; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wright LC, 2004, BIOCHEM J, V384, P377, DOI 10.1042/BJ20041079; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	74	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16076	10.1371/journal.pone.0016076	http://dx.doi.org/10.1371/journal.pone.0016076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249145	Green Submitted, gold, Green Published			2022-12-25	WOS:000286515000015
J	Ramshini, H; Parrini, C; Relini, A; Zampagni, M; Mannini, B; Pesce, A; Saboury, AA; Nemat-Gorgani, M; Chiti, F				Ramshini, Hassan; Parrini, Claudia; Relini, Annalisa; Zampagni, Mariagioia; Mannini, Benedetta; Pesce, Alessandra; Saboury, Ali Akbar; Nemat-Gorgani, Mohsen; Chiti, Fabrizio			Large Proteins Have a Great Tendency to Aggregate but a Low Propensity to Form Amyloid Fibrils	PLOS ONE			English	Article							FORMATION IN-VITRO; HYPF-N; DOMAIN; FIBRILLATION; LYSOZYME; BETA(2)-MICROGLOBULIN; TOXICITY; DISEASE; STATE; PH	The assembly of soluble proteins into ordered fibrillar aggregates with cross-beta structure is an essential event of many human diseases. The polypeptides undergoing aggregation are generally small in size. To explore if the small size is a primary determinant for the formation of amyloids under pathological conditions we have created two databases of proteins, forming amyloid-related and non-amyloid deposits in human diseases, respectively. The size distributions of the two protein populations are well separated, with the systems forming non-amyloid deposits appearing significantly larger. We have then investigated the propensity of the 486-residue hexokinase-B from Saccharomyces cerevisiae (YHKB) to form amyloid-like fibrils in vitro. This size is intermediate between the size distributions of amyloid and non-amyloid forming proteins. Aggregation was induced under conditions known to be most effective for amyloid formation by normally globular proteins: (i) low pH with salts, (ii) pH 5.5 with trifluoroethanol. In both situations YHKB aggregated very rapidly into species with significant beta-sheet structure, as detected using circular dichroism and X-ray diffraction, but a weak Thioflavin T and Congo red binding. Moreover, atomic force microscopy indicated a morphology distinct from typical amyloid fibrils. Both types of aggregates were cytotoxic to human neuroblastoma cells, as indicated by the MTT assay. This analysis indicates that large proteins have a high tendency to form toxic aggregates, but low propensity to form regular amyloid in vivo and that such a behavior is intrinsically determined by the size of the protein, as suggested by the in vitro analysis of our sample protein.	[Ramshini, Hassan; Zampagni, Mariagioia; Mannini, Benedetta; Chiti, Fabrizio] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Ramshini, Hassan; Saboury, Ali Akbar; Nemat-Gorgani, Mohsen] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Parrini, Claudia; Relini, Annalisa; Pesce, Alessandra] Univ Genoa, Dipartimento Fis, Genoa, Italy	University of Florence; University of Tehran; University of Genoa	Ramshini, H (corresponding author), Sabzevar Payam Noor Univ, Dept Biol, Sabzevar, Iran.	fabrizio.chiti@unifi.it	Ramshini(fazelinejad), hassan/GQQ-9129-2022; Pesce, Alessandra/A-3660-2015; Mannini, Benedetta/GLV-6007-2022; Relini, Annalisa/AHC-3105-2022; Saboury, Ali Akbar/L-6136-2019; Mannini, Benedetta/ABC-4854-2020	Mannini, Benedetta/0000-0001-6812-7348; RELINI, ANNALISA/0000-0002-4040-9279	Research Council of the University of Tehran; Iranian National Science Foundation (INSF); Italian Ministry of University, Research and Instruction (MIUR); European Community (EC)	Research Council of the University of Tehran(University of Tehran); Iranian National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Italian Ministry of University, Research and Instruction (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Community (EC)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Research Council of the University of Tehran, the Iranian National Science Foundation (INSF), the Italian Ministry of University, Research and Instruction (MIUR) and the European Community (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; Campioni S, 2008, J MOL BIOL, V379, P554, DOI 10.1016/j.jmb.2008.04.002; Castiglioni E, 2007, CHIRALITY, V19, P642, DOI 10.1002/chir.20436; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Desai A, 2006, BIOCHIMIE, V88, P1435, DOI 10.1016/j.biochi.2006.05.008; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Gast K, 2003, EUR BIOPHYS J BIOPHY, V32, P710, DOI 10.1007/s00249-003-0336-5; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; KARUPPIAH N, 1995, BIOCHEM BIOPH RES CO, V211, P60, DOI 10.1006/bbrc.1995.1778; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; McGowan DP, 2000, NEUROSCIENCE, V100, P677, DOI 10.1016/S0306-4522(00)00391-2; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; SCHMIDT JJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P458, DOI 10.1016/0003-9861(73)90537-7; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zerovnik E, 2002, BIOCHEM SOC T, V30, P543	37	45	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16075	10.1371/journal.pone.0016075	http://dx.doi.org/10.1371/journal.pone.0016075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249193	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000014
J	Shih, DQ; Barrett, R; Zhang, XL; Yeager, N; Koon, HW; Phaosawasdi, P; Song, YH; Ko, B; Wong, MH; Michelsen, KS; Martins, G; Pothoulakis, C; Targan, SR				Shih, David Q.; Barrett, Robert; Zhang, Xiaolan; Yeager, Nicole; Koon, Hon Wai; Phaosawasdi, Piangwarin; Song, Yahui; Ko, Brian; Wong, Michelle H.; Michelsen, Kathrin S.; Martins, Gislaine; Pothoulakis, Charalabos; Targan, Stephan R.			Constitutive TL1A (TNFSF15) Expression on Lymphoid or Myeloid Cells Leads to Mild Intestinal Inflammation and Fibrosis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR 9; IFN-GAMMA PRODUCTION; T-CELL; CROHNS-DISEASE; DENDRITIC CELLS; BOWEL-DISEASE; COLITIS; MICE; LYMPHOCYTES; ILEITIS	TL1A is a member of the TNF superfamily and its expression is increased in the mucosa of inflammatory bowel disease patients. Moreover, a subset of Crohn's disease (CD) patients with the risk TL1A haplotype is associated with elevated TL1A expression and a more severe disease course. To investigate the in vivo role of elevated TL1A expression, we generated two transgenic (Tg) murine models with constitutive Tl1a expression in either lymphoid or myeloid cells. Compared to wildtype (WT) mice, constitutive expression of Tl1a in either lymphoid or myeloid cells showed mild patchy inflammation in the small intestine, which was more prominent in the ileum. In addition, mice with constitutive Tl1a expression exhibited enhanced intestinal and colonic fibrosis compared to WT littermates. The percentage of T cells expressing the gut homing chemokine receptors CCR9 and CCR10 was higher in the Tl1a Tg mice compared to WT littermates. Sustained expression of Tl1A in T cells also lead to increased Foxp3+ Treg cells. T cells or antigen presenting cells (APC) with constitutive expression of Tl1a were found to have a more activated phenotype and mucosal mononuclear cells exhibit enhanced Th1 cytokine activity. These results indicated an important role of TL1A in mucosal T cells and APC function and showed that up-regulation of TL1A expression can promote mucosal inflammation and gut fibrosis.	[Shih, David Q.; Barrett, Robert; Zhang, Xiaolan; Yeager, Nicole; Phaosawasdi, Piangwarin; Ko, Brian; Wong, Michelle H.; Michelsen, Kathrin S.; Martins, Gislaine; Targan, Stephan R.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Zhang, Xiaolan] Hebei Med Univ, Hosp 2, Dept Gastroenterol, Shijianzuang, Peoples R China; [Koon, Hon Wai; Song, Yahui; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Hebei Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shih, DQ (corresponding author), Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	targans@cshs.org	Barrett, Robert/AAG-1941-2021		USPHS [DK056328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, R01DK056328] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	USPHS grant DK056328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Biener-Ramanujan E, 2010, FEBS LETT, V584, P2376, DOI 10.1016/j.febslet.2010.04.030; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Di Sabatino A, 2009, GUT, V58, P777, DOI 10.1136/gut.2008.149096; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Hieshima K, 2004, J IMMUNOL, V173, P3668, DOI 10.4049/jimmunol.173.6.3668; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kang YJ, 2005, CYTOKINE, V29, P229, DOI 10.1016/j.cyto.2004.12.001; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Koon HW, 2010, AM J PATHOL, V177, P2300, DOI 10.2353/ajpath.2010.100314; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Marsal J, 2002, EUR J IMMUNOL, V32, P3488, DOI 10.1002/1521-4141(200212)32:12<3488::AID-IMMU3488>3.0.CO;2-E; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; MEYLAN F, 2010, MUCOSAL IMMUNOL; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Papadakis KA, 2004, FASEB J, V18, pA465; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; Prehn JL, 2004, CLIN IMMUNOL, V112, P66, DOI 10.1016/j.clim.2004.02.007; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rachmilewitz D, 2006, INFLAMM BOWEL DIS, V12, P339, DOI 10.1097/01.MIB.0000217335.30689.77; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Shih David Q, 2009, Curr Gastroenterol Rep, V11, P473; Shih DQ, 2009, EUR J IMMUNOL, V39, P3239, DOI 10.1002/eji.200839087; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Shinoda M, 2010, J GASTROENTEROL, V45, P608, DOI 10.1007/s00535-010-0210-z; Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; STAPPENBACK TS, 2010, AUTOPHAGY, V7; Svensson M, 2002, J CLIN INVEST, V110, P1113, DOI 10.1172/JCI200215988; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; TARABAN VY, 2010, MUCOSAL IMMUNOL; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	52	132	143	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16090	10.1371/journal.pone.0016090	http://dx.doi.org/10.1371/journal.pone.0016090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264313	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000021
J	Kulathila, R; Kulathila, R; Indic, M; van den Berg, B				Kulathila, Rithika; Kulathila, Ragini; Indic, Mridhu; van den Berg, Bert			Crystal Structure of Escherichia coli CusC, the Outer Membrane Component of a Heavy Metal Efflux Pump	PLOS ONE			English	Article							PROTEIN; MECHANISMS; EXPRESSION; RESISTANCE	Background: While copper has essential functions as an enzymatic co-factor, excess copper ions are toxic for cells, necessitating mechanisms for regulating its levels. The cusCBFA operon of E. coli encodes a four-component efflux pump dedicated to the extrusion of Cu(I) and Ag(I) ions. Methodology/Principal Findings: We have solved the X-ray crystal structure of CusC, the outer membrane component of the Cus heavy metal efflux pump, to 2.3 A resolution. The structure has the largest extracellular opening of any outer membrane factor (OMF) protein and suggests, for the first time, the presence of a tri-acylated N-terminal lipid anchor. Conclusions/Significance: The CusC protein does not have any obvious features that would make it specific for metal ions, suggesting that the narrow substrate specificity of the pump is provided by other components of the pump, most likely by the inner membrane component CusA.	[Kulathila, Rithika; Kulathila, Ragini; Indic, Mridhu; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Kulathila, R (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Institutes of Health (NIGMS) [R01 GM085785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research in the lab is supported by the National Institutes of Health (NIGMS grant R01 GM085785 to BvdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; [Anonymous], PYMOL MOL GRAPH SYST; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Conroy O, 2010, FEMS MICROBIOL LETT, V308, P115, DOI 10.1111/j.1574-6968.2010.02006.x; Deniaud A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006214; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAUN RS, 1992, GENE, V112, P37, DOI 10.1016/0378-1119(92)90300-E; Kittleson JT, 2006, BIOCHEMISTRY-US, V45, P11096, DOI 10.1021/bi0612622; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Neilsen PO, 2001, J IMMUNOL, V167, P5231, DOI 10.4049/jimmunol.167.9.5231; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; SU CC, 2010, PROTEIN SCI     1027; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	29	72	75	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15610	10.1371/journal.pone.0015610	http://dx.doi.org/10.1371/journal.pone.0015610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249122	Green Submitted, gold, Green Published			2022-12-25	WOS:000286512900008
J	Sullivan, MJ; Curson, ARJ; Shearer, N; Todd, JD; Green, RT; Johnston, AWB				Sullivan, Matthew J.; Curson, Andrew R. J.; Shearer, Neil; Todd, Jonathan D.; Green, Robert T.; Johnston, Andrew W. B.			Unusual Regulation of a Leaderless Operon Involved in the Catabolism of Dimethylsulfoniopropionate in Rhodobacter sphaeroides	PLOS ONE			English	Article							DIMETHYL SULFIDE; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; CLONING VECTORS; HIGHER-PLANTS; DDDP GENE; BACTERIA; DMSP; OCEAN; SULFUR	Rhodobacter sphaeroides strain 2.4.1 is a widely studied bacterium that has recently been shown to cleave the abundant marine anti-stress molecule dimethylsulfoniopropionate (DMSP) into acrylate plus gaseous dimethyl sulfide. It does so by using a lyase encoded by dddL, the promoter-distal gene of a three-gene operon, acuR-acuI-dddL. Transcription of the operon was enhanced when cells were pre-grown with the substrate DMSP, but this induction is indirect, and requires the conversion of DMSP to the product acrylate, the bona fide co-inducer. This regulation is mediated by the product of the promoter-proximal gene acuR, a transcriptional regulator in the TetR family. AcuR represses the operon in the absence of acrylate, but this is relieved by the presence of the co-inducer. Another unusual regulatory feature is that the acuR-acuI-dddL mRNA transcript is leaderless, such that acuR lacks a Shine-Dalgarno ribosomal binding site and 59-UTR, and is translated at a lower level compared to the downstream genes. This regulatory unit may be quite widespread in bacteria, since several other taxonomically diverse lineages have adjacent acuR-like and acuI-like genes; these operons also have no 59 leader sequences or ribosomal binding sites and their predicted cis-acting regulatory sequences resemble those of R. sphaeroides acuR-acuI-dddL.	[Sullivan, Matthew J.; Curson, Andrew R. J.; Todd, Jonathan D.; Green, Robert T.; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Shearer, Neil; Green, Robert T.] Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Sullivan, MJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Johnston, Andrew W B/D-1859-2009; Todd, Jonathan/B-8967-2009; Sullivan, Matthew J/C-3857-2009; Curson, Andrew RJ/B-8964-2009	Todd, Jonathan/0000-0003-0777-9312; Sullivan, Matthew J/0000-0003-2276-3132; 	NERC [BBE01688X1, NE/E018033/1]; BBSRC [BBE01688X1, NE/E018033/1]; Natural Environment Research Council [NE/E018033/1, NE/F001339/1, NE/F001312/1] Funding Source: researchfish; NERC [NE/F001339/1, NE/F001312/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a PhD studentship to MJS from the NERC (http://www.nerc.ac.uk/) and by grants BBE01688X1 and NE/E018033/1 to AWBJ from the NERC and BBSRC (http://www.bbsrc.ac.uk/) respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaway D, 2001, ENVIRON MICROBIOL, V3, P397, DOI 10.1046/j.1462-2920.2001.00205.x; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bensing BA, 1996, P NATL ACAD SCI USA, V93, P7794, DOI 10.1073/pnas.93.15.7794; CANTONI GL, 1956, J BIOL CHEM, V222, P171; Choudhary M, 2007, J BACTERIOL, V189, P1914, DOI 10.1128/JB.01498-06; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kirkwood M, 2010, MICROBIOL-SGM, V156, P1900, DOI 10.1099/mic.0.038927-0; KLOCK G, 1986, J MOL BIOL, V189, P633, DOI 10.1016/0022-2836(86)90493-6; Kowalewsky S, 2006, BIOL LETT-UK, V2, P106, DOI 10.1098/rsbl.2005.0380; Kurata A, 2005, J BIOL CHEM, V280, P20286, DOI 10.1074/jbc.M414605200; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Messing J, 1979, RECOMBINANT DNA TECH, V2, P43; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; O'Donnell SM, 2001, J BACTERIOL, V183, P1277, DOI 10.1128/JB.183.4.1277-1283.2001; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; TODD JD, 2010, ENV MICROBIOL; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; van Niel CB, 1944, BACTERIOL REV, V8, P1; WALZ A, 1976, NATURE, V262, P665, DOI 10.1038/262665a0; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	48	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15972	10.1371/journal.pone.0015972	http://dx.doi.org/10.1371/journal.pone.0015972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249136	Green Published, gold			2022-12-25	WOS:000286512900016
J	Orozovic, G; Orozovic, K; Lennerstrand, J; Olsen, B				Orozovic, Goran; Orozovic, Kanita; Lennerstrand, Johan; Olsen, Bjorn			Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds	PLOS ONE			English	Article							NEURAMINIDASE ACTIVE-SITE; COMBINATION CHEMOTHERAPY; GENETIC-CHARACTERIZATION; REDUCED SENSITIVITY; DRUG-RESISTANCE; IN-VITRO; INHIBITORS; H5N1; SUSCEPTIBILITY; EVOLUTION	The neuraminidase (NA) inhibitors oseltamivir and zanamivir are the first-line of defense against potentially fatal variants of influenza A pandemic strains. However, if resistant virus strains start to arise easily or at a high frequency, a new anti-influenza strategy will be necessary. This study aimed to investigate if and to what extent NA inhibitor-resistant mutants exist in the wild population of influenza A viruses that inhabit wild birds. NA sequences of all NA subtypes available from 5490 avian, 379 swine and 122 environmental isolates were extracted from NCBI databases. In addition, a dataset containing 230 virus isolates from mallard collected at Ottenby Bird Observatory (Oland, Sweden) was analyzed. Isolated NA RNA fragments from Ottenby were transformed to cDNA by RT-PCR, which was followed by sequencing. The analysis of genotypic profiles for NAs from both data sets in regard to antiviral resistance mutations was performed using bioinformatics tools. All 6221 sequences were scanned for oseltamivir- (I117V, E119V, D198N, I222V, H274Y, R292K, N294S and I314V) and zanamivir-related mutations (V116A, R118K, E119G/A/D, Q136K, D151E, R152K, R224K, E276D, R292K and R371K). Of the sequences from the avian NCBI dataset, 132 (2.4%) carried at least one, or in two cases even two and three, NA inhibitor resistance mutations. Swine and environmental isolates from the same data set had 18 (4.75%) and one (0.82%) mutant, respectively, with at least one mutation. The Ottenby sequences carried at least one mutation in 15 cases (6.52%). Therefore, resistant strains were more frequently found in Ottenby samples than in NCBI data sets. However, it is still uncertain if these mutations are the result of natural variations in the viruses or if they are induced by the selective pressure of xenobiotics (e.g., oseltamivir, zanamivir).	[Orozovic, Goran] Linneaus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Orozovic, Goran; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Sect Zoonot Ecol & Epidemiol, Uppsala, Sweden; [Orozovic, Kanita] Linneaus Univ, Sect Bioorgan & Biophys Chem Lab, Kalmar, Sweden; [Lennerstrand, Johan] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden	Linnaeus University; Uppsala University; Linnaeus University; Uppsala University	Orozovic, G (corresponding author), Linneaus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden.	goran.orozovic@lnu.se		Olsen, Bjorn/0000-0002-4646-691X; Tripp, Ralph/0000-0002-2924-9956	Swedish Research Council; Swedish Research Council Formas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was financially supported by the Swedish Research Council and the Swedish Research Council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, ANTIVIR RES, V77, P163, DOI 10.1016/j.antiviral.2007.08.008; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baigent SJ, 1999, VIROLOGY, V263, P323, DOI 10.1006/viro.1999.9931; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Deshpande J. D., 2009, Pravara Medical Review, V4, P4; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferraris O, 2005, ANTIVIR RES, V68, P43, DOI 10.1016/j.antiviral.2005.07.004; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Govorkova EA, 2010, VIRUSES-BASEL, V2, P1510, DOI 10.3390/v2081510; Gubareva LV, 2004, INT CONGR SER, V1263, P126, DOI 10.1016/j.ics.2004.01.048; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Harvala H, 2010, EUROSURVEILLANCE, V15, P2; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006; Ho HT, 2007, ANTIVIR RES, V76, P263, DOI 10.1016/j.antiviral.2007.08.002; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ilyushina N, 2006, ANTIVIR RES, V70, pA29; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Jhee SS, 2008, ANTIMICROB AGENTS CH, V52, P3687, DOI 10.1128/AAC.00327-08; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li JL, 2010, VIRUS RES, V147, P40, DOI 10.1016/j.virusres.2009.10.002; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Musiychuk K, 2007, INFLUENZA OTHER RESP, V1, P19, DOI 10.1111/j.1750-2659.2006.00005.x; Okomo-Adhiambo M, 2010, ANTIVIR RES, V85, P381, DOI 10.1016/j.antiviral.2009.11.005; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2010, J VIROL METHODS, V170, P94, DOI 10.1016/j.jviromet.2010.09.006; Oshitani Hitoshi, 2006, Journal of Infection and Chemotherapy, V12, P167, DOI 10.1007/s10156-006-0453-z; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Richard M, 2008, J CLIN VIROL, V41, P20, DOI 10.1016/j.jcv.2007.10.021; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024	62	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16028	10.1371/journal.pone.0016028	http://dx.doi.org/10.1371/journal.pone.0016028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253602	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900036
J	Del Giudice, M				Del Giudice, Marco			Reduced Fertility in Patients' Families Is Consistent with the Sexual Selection Model of Schizophrenia and Schizotypy	PLOS ONE			English	Article							EPIDEMIOLOGY; PREVALENCE; CREATIVITY; RELATIVES; SIBLINGS; FITNESS; SUCCESS; COHORT; BIRTH	Background: Schizophrenia is a mental disorder marked by an evolutionarily puzzling combination of high heritability, reduced reproductive success, and a remarkably stable prevalence. Recently, it has been proposed that sexual selection may be crucially involved in the evolution of schizophrenia. In the sexual selection model (SSM) of schizophrenia and schizotypy, schizophrenia represents the negative extreme of a sexually selected indicator of genetic fitness and condition. Schizotypal personality traits are hypothesized to increase the sensitivity of the fitness indicator, thus conferring mating advantages on high-fitness individuals but increasing the risk of schizophrenia in low-fitness individuals; the advantages of successful schzotypy would be mediated by enhanced courtship-related traits such as verbal creativity. Thus, schizotypy-increasing alleles would be maintained by sexual selection, and could be selectively neutral or even beneficial, at least in some populations. However, most empirical studies find that the reduction in fertility experienced by schizophrenic patients is not compensated for by increased fertility in their unaffected relatives. This finding has been interpreted as indicating strong negative selection on schizotypy-increasing alleles, and providing evidence against sexual selection on schizotypy. Methodology: A simple mathematical model is presented, showing that reduced fertility in the families of schizophrenic patients can coexist with selective neutrality of schizotypy-increasing alleles, or even with positive selection on schizotypy in the general population. If the SSM is correct, studies of patients' families can be expected to underestimate the true fertility associated with schizotypy. Significance: This paper formally demonstrates that reduced fertility in the families of schizophrenic patients does not constitute evidence against sexual selection on schizotypy-increasing alleles. Futhermore, it suggests that the fertility estimates derived from extant studies may be biased to an unknown extent. These results have important implications for the evolutionary genetics of psychosis.	Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy	University of Turin	Del Giudice, M (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.	marco.delgiudice@unito.it	Del Giudice, Marco/F-7007-2010	Del Giudice, Marco/0000-0001-8526-1573	Regione Piemonte (Piedmont regional administration, Italy); bando Scienze Umane e Sociali [4/2006]	Regione Piemonte (Piedmont regional administration, Italy)(Regione Piemonte); bando Scienze Umane e Sociali	The study was supported by a grant from the Regione Piemonte (Piedmont regional administration, Italy). The grant title is: "bando Scienze Umane e Sociali 2008, L.R. n. 4/2006". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila M, 2001, SCHIZOPHR RES, V47, P233, DOI 10.1016/S0920-9964(00)00062-1; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; Brune M, 2004, NEUROSCI BIOBEHAV R, V28, P41, DOI 10.1016/j.neubiorev.2003.10.002; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Del Giudice M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00041; Doi N, 2009, PLOS ONE, V4, pA208, DOI 10.1371/journal.pone.0007799; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Haukka J, 2003, AM J PSYCHIAT, V160, P460, DOI 10.1176/appi.ajp.160.3.460; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; Kinney DK, 2000, CREATIVITY RES J, V13, P17; MacCabe JH, 2009, PSYCHOL MED, V39, P1667, DOI 10.1017/S0033291709005431; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 1999, ACTA PSYCHIAT SCAND, V99, P441, DOI 10.1111/j.1600-0447.1999.tb00990.x; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; NANKO S, 1993, ACTA PSYCHIAT SCAND, V87, P400, DOI 10.1111/j.1600-0447.1993.tb03395.x; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D., 2001, STRONG IMAGINATION M; Nettle D, 2006, BEHAV BRAIN SCI, V29, P418, DOI 10.1017/S0140525X06359092; Nettle D, 2006, J RES PERS, V40, P876, DOI 10.1016/j.jrp.2005.09.004; Nimgaonkar VL, 1998, ACTA PSYCHIAT SCAND, V98, P348, DOI 10.1111/j.1600-0447.1998.tb10097.x; PERUSSE D, 1993, BEHAV BRAIN SCI, V16, P267, DOI 10.1017/S0140525X00029939; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schretlen DJ, 2010, SCHIZOPHR RES, V118, P224, DOI 10.1016/j.schres.2010.01.008; Shaner A, 2004, SCHIZOPHR RES, V70, P101, DOI 10.1016/j.schres.2003.09.014; Srinivasan TN, 1997, ACTA PSYCHIAT SCAND, V96, P260, DOI 10.1111/j.1600-0447.1997.tb10161.x; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011	28	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e16040	10.1371/journal.pone.0016040	http://dx.doi.org/10.1371/journal.pone.0016040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CZ	21253008	gold, Green Published			2022-12-25	WOS:000285793200079
J	Sangster-Guity, N; Conrad, BH; Papadopoulos, N; Bunz, F				Sangster-Guity, N.; Conrad, B. H.; Papadopoulos, N.; Bunz, F.			ATR mediates cisplatin resistance in a p53 genotype-specific manner	ONCOGENE			English	Article						p53; ATR; cisplatin; synthetic lethality; gene targeting	HUMAN CANCER-CELLS; DNA-DAMAGE RESPONSE; REPLICATION CHECKPOINT; ATAXIA-TELANGIECTASIA; CYCLE CHECKPOINTS; SECKEL-SYNDROME; ACTIVATION; SURVIVAL; PATHWAY; PHOSPHORYLATION	The protein kinase encoded by the ataxia telangiectasia and Rad3-related (ATR) gene is activated by DNA-damaging agents that are frequently used as anticancer therapeutics. Inhibition of ATR expression in cultured cancer cells has been demonstrated to increase sensitivity to chemotherapeutic drugs, including the DNA-cross-linking agent cisplatin. Cisplatin is a widely used and effective drug, but its use is associated with significant toxicity. Here, we demonstrate that genetic inhibition of ATR expression selectively enhanced cisplatin sensitivity in human colorectal cancer cells with inactivated p53. A knock-in strategy was used to restore wild-type p53 in cells harboring wild-type or mutant ATR alleles. Knock-in of functional p53 in ATR-deficient cells restored checkpoint function, suppressed apoptotic pathways and markedly increased clonogenic survival after cisplatin treatment. These results suggest that a strategy that combines specific inhibitors of ATR and conventional therapies might promote synthetic lethality in p53-deficient tumors, and thus minimize toxicity to normal tissues. Oncogene (2011) 30, 2526-2533; doi:10.1038/onc.2010.624; published online 24 January 2011	[Sangster-Guity, N.; Conrad, B. H.; Bunz, F.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA; [Sangster-Guity, N.; Papadopoulos, N.; Bunz, F.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Bunz, F (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, David H Koch Canc Res Bldg,1550 Orleans St,Room 4, Baltimore, MD 21231 USA.	fbunz@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012	Conrad, Bogdan/0000-0002-2984-099X	Flight Attendant Medical Research Institute; NCI [T32CA121937]; NATIONAL CANCER INSTITUTE [T32CA121937, R01CA104253] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Flight Attendant Medical Research Institute and the NCI (T32CA121937).	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Chung JH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000863; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Collis SJ, 2003, CANCER RES, V63, P1550; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Hurley PJ, 2007, ONCOGENE, V26, P2535, DOI 10.1038/sj.onc.1210049; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jirmanova L, 2005, CELL CYCLE, V4, P1428, DOI 10.4161/cc.4.10.2055; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Pirollo KF, 2000, ANTI-CANCER DRUG, V11, P419, DOI 10.1097/00001813-200007000-00002; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Robinson HMR, 2006, ONCOGENE, V25, P5359, DOI 10.1038/sj.onc.1209532; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Ruzankina Y, 2009, NAT GENET, V41, P1144, DOI 10.1038/ng.441; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner JM, 2010, PHARMACEUTICALS, V3, P1311, DOI 10.3390/ph3051311; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; WALDMAN T, 1995, CANCER RES, V55, P5187; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Zenvirt S, 2010, ONCOGENE, V29, P6149, DOI 10.1038/onc.2010.343; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	49	52	54	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	22					2526	2533		10.1038/onc.2010.624	http://dx.doi.org/10.1038/onc.2010.624			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21258400	Green Accepted			2022-12-25	WOS:000291198400004
J	Angiolini, E; Coan, PM; Sandovici, I; Iwajomo, OH; Peck, G; Burton, GJ; Sibley, CP; Reik, W; Fowden, AL; Constancia, M				Angiolini, Emily; Coan, Phillip M.; Sandovici, Ionel; Iwajomo, O. H.; Peck, Gerrard; Burton, Graham J.; Sibley, Colin P.; Reik, Wolf; Fowden, Abigail L.; Constancia, Miguel			Developmental adaptations to increased fetal nutrient demand in mouse genetic models of Igf2-mediated overgrowth	FASEB JOURNAL			English	Article						genomic imprinting; insulin-like growth factor; H19; placenta	BECKWITH-WIEDEMANN; PLACENTAL EFFICIENCY; IGF-II; TRANSPORT; INSULIN; GROWTH; DELETION; OBESITY; REGION; MICE	The healthy development of the fetus depends on an optimal balance between fetal genetic drive for growth and the maternal ability to provide nutrients through the placenta. Nothing is known about fetal-placental signaling in response to increased fetal demand in the situation of overgrowth. Here, we examined this question using the H19(Delta 13) mouse model, shown previously to result in elevated levels of Igf2. Fetal and placental weights in H19(Delta 13) were increased by 23% and 45%, respectively, at E19, when compared with wild-type mice. Unexpectedly, we found that disproportionately large H19(Delta 13) placentas transport 20-35% less (per gram placenta) glucose and system A amino acids and have similar reductions in passive permeability, despite a significantly greater surface area for nutrient exchange and theoretical diffusion capacity compared with wild-type mice. Expression of key transporter genes Slc2a3 and Slc38a4 was reduced by similar to 20%. Decreasing the overgrowth of the H19(Delta 13) placenta by genetically reducing levels of Igf2P0 resulted in up-regulation of system A activity and maintenance of fetal overgrowth. Our results provide direct evidence that large placentas can modify their nutrient transfer capacity to regulate fetal nutrient acquisition. Our findings are indicative of fetal-placental signaling mechanisms that limit total demand for maternal nutrients.-Angiolini, E., Coan, P.M., Sandovici, I., Iwajomo, O.H., Peck, G., Burton, G.J., Sibley, C.P., Reik, W., Fowden, A.L., Constancia, M. Developmental adaptations to increased fetal nutrient demand in mouse genetic models of Igf2-mediated overgrowth. FASEB J. 25, 1737-1745 (2011). www.fasebj.org	[Angiolini, Emily; Sandovici, Ionel; Peck, Gerrard; Constancia, Miguel] Univ Cambridge, Dept Obstet & Gynaecol, Metab Res Labs, Cambridge CB2 0SW, England; [Coan, Phillip M.; Sandovici, Ionel; Burton, Graham J.; Reik, Wolf; Fowden, Abigail L.; Constancia, Miguel] Univ Cambridge, Dept Physiol Dev & Neurosci, Ctr Trophoblast Res, Cambridge CB2 0SW, England; [Angiolini, Emily; Iwajomo, O. H.; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge, England; [Angiolini, Emily; Sandovici, Ionel; Peck, Gerrard; Constancia, Miguel] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Sibley, Colin P.] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr,Sch Biomed, Manchester M13 0JH, Lancs, England	University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Manchester	Constancia, M (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Metab Res Labs, Rosie Hosp, Robinson Way, Cambridge CB2 0SW, England.	jmasmc2@cam.ac.uk	Coan, P. M./ABA-1971-2020; Constancia, Miguel/F-6654-2013; Coan, P. M./AFQ-3665-2022; Reik, Wolf/I-6794-2012; sandovici, Ionel/H-3505-2019	Coan, P. M./0000-0001-6158-380X; Coan, P. M./0000-0001-6158-380X; sandovici, Ionel/0000-0001-5674-4269; Reik, Wolf/0000-0003-0216-9881; Constancia, Miguel/0000-0002-8976-1679	Biotechnology and Biological Sciences Research Council; FP6 Epigenome Network of Excellence; Medical Research Council Center for Obesity and Related Metabolic Disorders; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S119, BB/B50118X/2, S18929, BB/B50118X/1, BB/C513626/1] Funding Source: researchfish; Medical Research Council [G0700760, G0600717B] Funding Source: researchfish; MRC [G0700760] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FP6 Epigenome Network of Excellence; Medical Research Council Center for Obesity and Related Metabolic Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Paul Smith for technical help with the placental transfer assays, E. Walters and Anne Segonds-Pichon for help with the statistical analyses, and Prof. Anne Ferguson-Smith for advice and discussions. This work was supported by grants from the Biotechnology and Biological Sciences Research Council, FP6 Epigenome Network of Excellence, and the Medical Research Council Center for Obesity and Related Metabolic Disorders.	Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Atkinson DE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2787; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Cramer S, 2002, AM J PHYSIOL-CELL PH, V282, pC153, DOI 10.1152/ajpcell.2002.282.1.C153; Dilworth MR, 2010, P NATL ACAD SCI USA, V107, P3894, DOI 10.1073/pnas.0911710107; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Esquiliano DR, 2009, PLACENTA, V30, P693, DOI 10.1016/j.placenta.2009.05.004; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Gicquel C, 2006, HORM RES, V65, P28, DOI 10.1159/000091503; Jansson T, 2006, PLACENTA, V27, pS109, DOI 10.1016/j.placenta.2006.01.017; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jansson T, 2002, DIABETES, V51, P2214, DOI 10.2337/diabetes.51.7.2214; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kawahara M, 2010, J REPROD DEVELOP, V56, P79, DOI 10.1262/jrd.09-140A; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; SCHRODER HJ, 1995, EUR J OBSTET GYN R B, V63, P81, DOI 10.1016/0301-2115(95)02206-M; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; Stotland NE, 2004, INT J GYNECOL OBSTET, V87, P220, DOI 10.1016/j.ijgo.2004.08.010; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; WENG EY, 1995, AM J MED GENET, V56, P366, DOI 10.1002/ajmg.1320560405; Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161	34	49	49	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1737	1745		10.1096/fj.10-175273	http://dx.doi.org/10.1096/fj.10-175273			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21282203				2022-12-25	WOS:000290023800029
J	Bahney, CS; Hsu, CW; Yoo, JU; West, JL; Johnstone, B				Bahney, Chelsea S.; Hsu, Chih-Wei; Yoo, Jung U.; West, Jennifer L.; Johnstone, Brian			A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells	FASEB JOURNAL			English	Article						biodegradable scaffold; cartilage tissue engineering; matrix metalloproteinase; poly(ethylene glycol) diacrylate; matrilysin	HYALURONIC-ACID HYDROGELS; IN-VITRO CHONDROGENESIS; POLY(ETHYLENE GLYCOL); EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; CONTROLLED DIFFERENTIATION; TISSUE REGENERATION; AMINO PROPEPTIDE; DEGRADATION; MATRILYSIN	Cartilage tissue engineering aims to replace damaged or diseased tissue with a functional regenerate that restores joint function. Scaffolds are used to deliver cells and facilitate tissue development, but they can also interfere with the structural assembly of the cartilage matrix. Biodegradable scaffolds have been proposed as a means to improve matrix deposition and the biomechanical properties of neocartilage. The challenge is designing scaffolds with appropriate degradation rates, ideally such that scaffold degradation is proportional to matrix deposition. In this study, we developed a bioresponsive hydrogel with cell-mediated degradation aligned to the chondrogenic differentiation of human mesenchymal stem cells (hMSCs). We identified matrix metalloproteinase 7 (MMP7) as an enzyme with a temporal expression pattern that corresponded with cartilage development. By embedding MMP7 peptide substrates within a poly(ethylene glycol) diacrylate backbone, we built MMP7-sensitive hydrogels with distinct degradation rates. When MMP7-sensitive scaffolds were compared with nondegradable scaffolds in vitro, photoencapsulated hMSCs produced neocartilage constructs with more extensive collagenous matrices, as demonstrated through immunohistochemistry and biochemical quantification of matrix molecules. Furthermore, these changes translated into an increased dynamic compressive modulus. This work presents a practical strategy for designing biomaterials uniquely tuned to individual biological processes.-Bahney, C. S., Hsu, C.-W., Yoo, J. U., West, J. L., Johnstone, B. A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB J. 25, 1486-1496 (2011). www.fasebj.org	[Bahney, Chelsea S.; Yoo, Jung U.; Johnstone, Brian] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97239 USA; [Bahney, Chelsea S.; Johnstone, Brian] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Hsu, Chih-Wei; West, Jennifer L.] Rice Univ, Dept Bioengn, Houston, TX USA	Oregon Health & Science University; Oregon Health & Science University; Rice University	Johnstone, B (corresponding author), Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, 3181 SW Sam Jackson Rd,OP31, Portland, OR 97239 USA.	johnstob@ohsu.edu	Hsu, Chih-Wei/ABI-1472-2020; West, Jennifer L/A-4582-2008	Hsu, Chih-Wei/0000-0002-9591-9567; West, Jennifer L/0000-0001-8550-2875	Gerlinger Endowment (Oregon Health and Science University); National Football League Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	Gerlinger Endowment (Oregon Health and Science University); National Football League Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Hans Peter Bachinger and Jessica Hacker (Shriners Hospital, Portland, OR, USA) for synthesizing the peptides used to build the bioresponsive hydrogels; Drs. Trevor Lujan and Michael Bottlang (Legacy Biomechanics Laboratory, Portland, OR, USA) for assistance with mechanical testing; Dr. Ronen Schweitzer (Oregon Health and Science University) for providing embryonic mouse limbs for immunohistochemical staining; and Drs. Bob Hart and Alex Ching (Oregon Health and Science University) for providing bone marrow aspirates following patient consent. Research was supported in part by grants from the Gerlinger Endowment (Oregon Health and Science University) and the National Football League Charities. The authors declare the following conflict of interest: the process for in vitro chondrogenesis of MSCs was patented by B.J. and J.U.Y and licensed to Osiris Therapeutics, Inc. (Columbia, MD, USA).	Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Bryant S J, 1999, Biomed Sci Instrum, V35, P309; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319; Burns JW, 2009, NAT MATER, V8, P441, DOI 10.1038/nmat2462; Buxton AN, 2007, TISSUE ENG, V13, P2549, DOI 10.1089/ten.2007.0075; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fingleton B, 2007, HYBRIDOMA, V26, P22, DOI 10.1089/hyb.2006.028; Fingleton BM, 1999, APMIS, V107, P102, DOI 10.1111/j.1699-0463.1999.tb01532.x; Flannery CR, 2006, FRONT BIOSCI-LANDMRK, V11, P544, DOI 10.2741/1818; Fukui N, 2002, J BIOL CHEM, V277, P2193, DOI 10.1074/jbc.M105485200; Graham N B, 1998, Med Device Technol, V9, P22; Graham N B, 1998, Med Device Technol, V9, P18; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695; Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093; Ii M, 2006, EXP BIOL MED, V231, P20; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Johnstone B., 2006, CELL SOURCES CARTILA; Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Lujan TJ, 2009, J APPL PHYSIOL, V106, P423, DOI 10.1152/japplphysiol.90748.2008; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1702, DOI 10.2741/1916; Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4; Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V333, P1011, DOI 10.1016/j.bbrc.2005.06.010; Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Park S, 2006, J BIOMECH ENG-T ASME, V128, P623, DOI 10.1115/1.2206201; Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rice MA, 2004, J BIOMED MATER RES A, V70A, P560, DOI 10.1002/jbm.a.30106; Rice MA, 2007, TISSUE ENG, V13, P683, DOI 10.1089/ten.2006.0142; Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m; Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035; Salinas CN, 2009, J BIOMED MATER RES A, V90A, P456, DOI 10.1002/jbm.a.32112; Scherer RL, 2008, MOL IMAGING, V7, P118, DOI 10.2310/7290.2008.00010; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Wang FQ, 2005, INT J CANCER, V114, P19, DOI 10.1002/ijc.20697; Wang WS, 2006, CELL MOL LIFE SCI, V63, P663, DOI 10.1007/s00018-005-5425-4; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024; Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027; Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	70	91	98	5	56	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1486	1496		10.1096/fj.10-165514	http://dx.doi.org/10.1096/fj.10-165514			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21282205	Green Published			2022-12-25	WOS:000290023800007
J	Zhang, LP; Rajan, V; Lin, E; Hu, ZY; Han, HQ; Zhou, XL; Song, YP; Min, HS; Wang, XN; Du, J; Mitch, WE				Zhang, Liping; Rajan, Vik; Lin, Eugene; Hu, Zhaoyong; Han, H. Q.; Zhou, Xiaolan; Song, Yanping; Min, Hosung; Wang, Xiaonan; Du, Jie; Mitch, William E.			Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease	FASEB JOURNAL			English	Article						inflammatory cytokines; muscle protein synthesis; muscle protein degradation; muscle wasting	UBIQUITIN-PROTEASOME PATHWAY; FOXO TRANSCRIPTION FACTORS; KAPPA-B KINASE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PROTEIN-DEGRADATION; MUSCULAR-DYSTROPHY; EXPRESSION; GENE; ACTIVATION	Chronic kidney disease (CKD) and several other catabolic conditions are characterized by increased circulating inflammatory cytokines, defects in IGF-1 signaling, abnormal muscle protein metabolism, and progressive muscle atrophy. In these conditions, no reliable treatments successfully block the development of muscle atrophy. In mice with CKD, we found a 2- to 3-fold increase in myostatin expression in muscle. Its pharmacological inhibition by subcutaneous injections of an anti-myostatin peptibody into CKD mice (IC(50) similar to 1.2 nM) reversed the loss of body weight (approximate to 5-7% increase in body mass) and muscle mass (similar to 10% increase in muscle mass) and suppressed circulating inflammatory cytokines vs. results from CKD mice injected with PBS. Pharmacological myostatin inhibition also decreased the rate of protein degradation (16.38 +/- 1.29%; P < 0.05), increased protein synthesis in extensor digitorum longus muscles (13.21 +/- 1.09%; P < 0.05), markedly enhanced satellite cell function, and improved IGF-1 intracellular signaling. In cultured muscle cells, TNF-alpha increased myostatin expression via a NF-kappa B-dependent pathway, whereas muscle cells exposed to myostatin stimulated IL-6 production via p38 MAPK and MEK1 pathways. Because IL-6 stimulates muscle protein breakdown, we conclude that CKD increases myostatin through cytokine-activated pathways, leading to muscle atrophy. Myostatin antagonism might become a therapeutic strategy for improving muscle growth in CKD and other conditions with similar characteristics.-Zhang, L., Rajan, V., Lin, E., Hu, Z., Han, H. Q., Zhou, X., Song, Y., Min, H., Wang, X., Du, J., Mitch, W. E. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 25, 1653-1663 (2011). www.fasebj.org	[Zhang, Liping; Rajan, Vik; Lin, Eugene; Hu, Zhaoyong; Du, Jie; Mitch, William E.] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Han, H. Q.; Zhou, Xiaolan; Song, Yanping; Min, Hosung] Amgen Inc, Metab Disorders Dept, Thousand Oaks, CA USA; [Wang, Xiaonan] Emory Univ, Div Renal, Atlanta, GA 30322 USA	Baylor College of Medicine; Amgen; Emory University	Mitch, WE (corresponding author), Baylor Coll Med, Div Nephrol, M-S BCM 395,1 Baylor Plaza,ABBR R705, Houston, TX 77030 USA.	mitch@bcm.edu		Lin, Eugene/0000-0002-3559-5134	Satellite Healthcare; American Diabetes Association [1-11-BS-194]; National Institutes of Health [R37-DK37175, R01-DK62828, P50-DK64233]; Amgen Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037175, P50DK064233, R01DK062828] Funding Source: NIH RePORTER	Satellite Healthcare; American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Inc.(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Huiling Wang and Limei Ran for their assistance with care of mice with CKD. This study was sponsored by Satellite Healthcare (L.Z.), the American Diabetes Association (1-11-BS-194; L.Z.), the National Institutes of Health (grants R37-DK37175, R01-DK62828, and P50-DK64233), and a grant from Dr. and Mrs. Harold Selzman. Portions of these experiments were supported by a grant from Amgen Inc. L.Z., V. R., E. L., Z.H., X. W., J.D., and W. E. M declare no conflicts of interest. H. Q. H., X.Z., Y.S., and H. M. are current or former employees of Amgen Inc.	Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bartoli M, 2007, GENE THER, V14, P733, DOI 10.1038/sj.gt.3302928; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; HASSELGREN PO, 1987, ARCH SURG-CHICAGO, V122, P228; Hu Zhaoyong, 2009, J Clin Invest, V119, P3059, DOI 10.1172/JCI38770; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Philip B, 2005, CELL SIGNAL, V17, P365, DOI 10.1016/j.cellsig.2004.08.003; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SHORTREED K, 2008, SKELETAL MUSCLE DAMA, P77; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sumner CJ, 2009, HUM MOL GENET, V18, P3145, DOI 10.1093/hmg/ddp253; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Wang XH, 2010, J BIOL CHEM, V285, P3527; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Zachwieja J J, 1999, J Gravit Physiol, V6, P11; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Zhang LP, 2005, CANCER RES, V65, P457; Zhang LP, 2005, CIRC RES, V97, P975, DOI 10.1161/01.RES.0000190589.52286.41; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	46	200	210	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1653	1663		10.1096/fj.10-176917	http://dx.doi.org/10.1096/fj.10-176917			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21282204	Green Published			2022-12-25	WOS:000290023800022
J	Chen, CXJ; Soto, I; Guo, YL; Liu, YA				Chen, Celia X. -J.; Soto, Ileana; Guo, Ya-Lan; Liu, Yuan			Control of Secondary Granule Release in Neutrophils by Ral GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIVO PROTEIN TRANSDUCTION; PHOSPHOINOSITIDE 3-KINASE; TYROSINE KINASES; RAP2 PROTEINS; SIRP-ALPHA; ACTIVATION; TRANSMIGRATION; RECEPTOR; ADHESION; MIGRATION	Neutrophil (polymorphonuclear leukocyte; PMN) inflammatory functions, including cell adhesion, diapedesis, and phagocytosis, are dependent on the mobilization and release of various intracellular granules/vesicles. In this study, we found that treating PMN with damnacanthal, a Ras family GTPase inhibitor, resulted in a specific release of secondary granules but not primary or tertiary granules and caused dysregulation of PMN chemotactic transmigration and cell surface protein interactions. Analysis of the activities of Ras members identified Ral GTPase as a key regulator during PMN activation and degranulation. In particular, Ral was active in freshly isolated PMN, whereas chemoattractant stimulation induced a quick deactivation of Ral that correlated with PMN degranulation. Overexpression of a constitutively active Ral (Ral23V) in PMN inhibited chemoattractant-induced secondary granule release. By subcellular fractionation, we found that Ral, which was associated with the plasma membrane under the resting condition, was redistributed to secondary granules after chemoattractant stimulation. Blockage of cell endocytosis appeared to inhibit Ral translocation intracellularly. In conclusion, these results demonstrate that Ral is a critical regulator in PMN that specifically controls secondary granule release during PMN response to chemoattractant stimulation.	[Chen, Celia X. -J.; Soto, Ileana; Guo, Ya-Lan; Liu, Yuan] Georgia State Univ, Dept Biol, Program Cell & Mol Biol & Physiol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Liu, YA (corresponding author), Georgia State Univ, Dept Biol, Program Cell & Mol Biol & Physiol, POB 4010, Atlanta, GA 30303 USA.	yliu@gsu.edu		Mauldin, Ileana/0000-0002-9318-8342	National Institutes of Health [AI073622]; American Heart Association [0565251B]; American Cancer Society [RSG-09-193-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health R21 Grant AI073622. This study was also supported in part by Beginning Grant-in-aid 0565251B from the American Heart Association and Research Scholar Grant RSG-09-193-01-LIB from the American Cancer Society.	Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Brumelll JH, 1996, J BIOL CHEM, V271, P1455, DOI 10.1074/jbc.271.3.1455; Bruyninckx WJ, 2001, BLOOD, V97, P3251, DOI 10.1182/blood.V97.10.3251; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Choi M, 2003, BLOOD, V102, P2259, DOI 10.1182/blood-2002-09-2960; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; FALTYNEK CR, 1995, BIOCHEMISTRY-US, V34, P12404, DOI 10.1021/bi00038a038; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Gao XP, 2007, J BIOL CHEM, V282, P6116, DOI 10.1074/jbc.M610248200; Hinoi T, 1996, J BIOL CHEM, V271, P19710, DOI 10.1074/jbc.271.33.19710; HIRAMATSU T, 1993, CANCER LETT, V73, P161, DOI 10.1016/0304-3835(93)90259-C; Hiwasa T, 1997, NEUROSCI LETT, V238, P115, DOI 10.1016/S0304-3940(97)00861-6; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kawai M, 2003, HYPERTENSION, V41, P956, DOI 10.1161/01.HYP.0000063884.36641.63; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kobayashi SD, 2003, MICROBES INFECT, V5, P1337, DOI 10.1016/j.micinf.2003.09.013; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Liu Y, 2000, J CELL SCI, V113, P2363; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; M'Rabet L, 1999, J BIOL CHEM, V274, P21847, DOI 10.1074/jbc.274.31.21847; Macaluso M, 2002, J CELL PHYSIOL, V192, P125, DOI 10.1002/jcp.10109; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Makino A, 2005, AM J PHYSIOL-CELL PH, V288, pC863, DOI 10.1152/ajpcell.00358.2004; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOLLINEDO F, 1993, FEBS LETT, V326, P209, DOI 10.1016/0014-5793(93)81792-X; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Parkos CA, 1997, AM J PHYSIOL-GASTR L, V273, pG763, DOI 10.1152/ajpgi.1997.273.4.G763; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SANDVIG K, 1988, J CELL BIOCHEM, V36, P73, DOI 10.1002/jcb.240360108; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; van Bergen En Henegouwen P. M., 2009, CELL COMMUN SIGNAL, V7, P24; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014; Zen K, 2008, IMMUNOBIOLOGY, V213, P13, DOI 10.1016/j.imbio.2007.07.001	59	9	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11724	11733		10.1074/jbc.M110.154203	http://dx.doi.org/10.1074/jbc.M110.154203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282111	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000288797100080
J	Garland, RC; Sun, DW; Zandi, S; Xie, F; Faez, S; Tayyari, F; Frimmel, SAF; Schering, A; Nakao, S; Hafezi-Moghadam, A				Garland, Rebecca C.; Sun, Dawei; Zandi, Souska; Xie, Fang; Faez, Sepideh; Tayyari, Faryan; Frimmel, Sonja A. F.; Schering, Alexander; Nakao, Shintaro; Hafezi-Moghadam, Ali			Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury	FASEB JOURNAL			English	Article						platelet-activating factor; leukocyte recruitment; endotoxin-induced uveitis; P-selectin glycoprotein ligand-1; ginkgolide B; WEB 2086	PLATELET-ACTIVATING-FACTOR; ENDOTOXIN-INDUCED UVEITIS; SELECTIN GLYCOPROTEIN LIGAND-1; ROLLING IN-VIVO; P-SELECTIN; FACTOR-ACETYLHYDROLASE; HUMAN NEUTROPHILS; FACTOR RECEPTOR; UP-REGULATION; PLASMA	Uveitis is a systemic immune disease and a common cause of blindness. The eye is an ideal organ for light-based imaging of molecular events underlying vascular and immune diseases. The phospholipid platelet-activating factor (PAF) is an important mediator of inflammation, the action of which in endothelial and immune cells in vivo is not well understood. The purpose of this study was to investigate the role of PAF in endothelial injury in uveitis. Here, we use our recently introduced in vivo molecular imaging approach in combination with the PAF inhibitors WEB 2086 (WEB) and ginkgolide B (GB). The differential inhibitory effects of WEB and GB in reducing LPS-induced endothelial injury in the choroid indicate an important role for PAF-like lipids, which might not require the PAF receptor for their signaling. P-selectin glycoprotein ligand-1-mediated rolling of mouse leukocytes on immobilized P-selectin in our autoperfused microflow chamber assay revealed a significant reduction in rolling velocity on the cells' contact with PAF. Rolling cells that came in contact with PAF rapidly assumed morphological signs of cell activation, indicating that activation during rolling does not require integrins. Our results show a key role for PAF in mediating endothelial and leukocyte activation in acute ocular inflammation. Our in vivo molecular imaging provides a detailed view of cellular and molecular events in the complex physiological setting.-Garland, R. C., Sun, D., Zandi, S., Xie, F., Faez, S., Tayyari, F., Frimmel, S. A. F., Schering, A., Nakao, S., Hafezi-Moghadam, A. Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. FASEB J. 25, 1284-1294 (2011). www.fasebj.org	[Garland, Rebecca C.; Sun, Dawei; Zandi, Souska; Xie, Fang; Schering, Alexander; Hafezi-Moghadam, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Funct & Mol Imaging, Boston, MA 02115 USA; [Garland, Rebecca C.; Sun, Dawei; Zandi, Souska; Xie, Fang; Schering, Alexander; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Garland, Rebecca C.; Sun, Dawei; Zandi, Souska; Xie, Fang; Faez, Sepideh; Tayyari, Faryan; Frimmel, Sonja A. F.; Schering, Alexander; Nakao, Shintaro; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Garland, Rebecca C.; Sun, Dawei; Zandi, Souska; Xie, Fang; Faez, Sepideh; Tayyari, Faryan; Frimmel, Sonja A. F.; Schering, Alexander; Nakao, Shintaro; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Sun, Dawei] Harbin Med Coll, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harbin Medical University	Hafezi-Moghadam, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Excellence Funct & Mol Imaging, 221 Longwood Ave,3rd Floor, Boston, MA 02115 USA.	ahm@bwh.harvard.edu	Tayyari, Faryan/AAS-9020-2020	Zandi, Souska/0000-0001-9351-4278; Hafezi-Moghadam, Ali/0000-0002-5336-0697	U.S. National Institutes of Health [AI-050775]; American Health Assistance Foundation; Malaysian Palm Oil Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Malaysian Palm Oil Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research-grade YSPSL (recombinant soluble P-selectin glycoprotein ligand IgG fusion protein rPSGL-Ig) was a kind gift of Y's Therapeutics (San Bruno, CA, USA). This work was supported by U.S. National Institutes of Health grant AI-050775, the American Health Assistance Foundation, and the Malaysian Palm Oil Board.	Almulki L, 2009, FASEB J, V23, P929, DOI 10.1096/fj.08-118760; Davenpeck KL, 2000, J IMMUNOL, V165, P2764, DOI 10.4049/jimmunol.165.5.2764; Devine L, 1996, IMMUNOLOGY, V88, P456, DOI 10.1046/j.1365-2567.1996.d01-666.x; Gardner AA, 2008, J BIOL CHEM, V283, P17099, DOI 10.1074/jbc.M802394200; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Hafezi-Moghadam A, 2004, AM J PHYSIOL-CELL PH, V286, pC876, DOI 10.1152/ajpcell.00500.2003; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; Howard KM, 2000, J BIOL CHEM, V275, P19891, DOI 10.1074/jbc.M001462200; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Maliba R, 2008, J LEUKOCYTE BIOL, V83, P352, DOI 10.1189/jlb.0107056; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; Miyahara S, 2008, FASEB J, V22, P1973, DOI 10.1096/fj.07-096891; Miyamoto K, 1996, INVEST OPHTH VIS SCI, V37, P2708; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; NUNEZ D, 1986, EUR J PHARMACOL, V123, P197, DOI 10.1016/0014-2999(86)90660-6; ODONNELL SR, 1988, BRIT J PHARMACOL, V94, P437, DOI 10.1111/j.1476-5381.1988.tb11545.x; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Rollin S, 2004, BLOOD, V103, P3789, DOI 10.1182/blood-2003-07-2272; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Schmidt H, 1996, J SURG RES, V60, P29, DOI 10.1006/jsre.1996.0006; Seo HS, 2006, CLIN VACCINE IMMUNOL, V13, P452, DOI 10.1128/CVI.13.4.452-458.2006; SMILEY PL, 1991, J BIOL CHEM, V266, P11104; STEWART AG, 1988, BRIT J PHARMACOL, V94, P1225, DOI 10.1111/j.1476-5381.1988.tb11642.x; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Sun DW, 2010, FASEB J, V24, P1532, DOI 10.1096/fj.09-148981; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Suzuma K, 1997, INVEST OPHTH VIS SCI, V38, P1610; Tellis CC, 2009, BBA-MOL CELL BIOL L, V1791, P327, DOI 10.1016/j.bbalip.2009.02.015; Xie F, 2010, AM J PATHOL, V177, P39, DOI 10.2353/ajpath.2010.100007; YUE TL, 1991, J LIPID MEDIATOR, V3, P13	36	19	21	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1284	1294		10.1096/fj.10-160051	http://dx.doi.org/10.1096/fj.10-160051			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21257713	Green Published			2022-12-25	WOS:000288982800017
J	Lemke, CT; Goudreau, N; Zhao, SP; Hucke, O; Thibeault, D; Llinas-Brunet, M; White, PW				Lemke, Christopher T.; Goudreau, Nathalie; Zhao, Songping; Hucke, Oliver; Thibeault, Diane; Llinas-Brunet, Montse; White, Peter W.			Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS3 PROTEASE; SERINE-PROTEASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; HCV INFECTION; HYDROGEN-BOND; COFACTOR; PEPTIDE; POTENT; DOMAIN	Hepatitis C virus infection, a major cause of liver disease worldwide, is curable, but currently approved therapies have suboptimal efficacy. Supplementing these therapies with direct-acting antiviral agents has the potential to considerably improve treatment prospects for hepatitis C virus-infected patients. The critical role played by the viral NS3 protease makes it an attractive target, and despite its shallow, solvent-exposed active site, several potent NS3 protease inhibitors are currently in the clinic. BI 201335, which is progressing through Phase IIb trials, contains a unique C-terminal carboxylic acid that binds noncovalently to the active site and a bromo-quinoline substitution on its proline residue that provides significant potency. In this work we have used stopped flow kinetics, x-ray crystallography, and NMR to characterize these distinctive features. Key findings include: slow association and dissociation rates within a single-step binding mechanism; the critical involvement of water molecules in acid binding; and protein side chain rearrangements, a bromine-oxygen halogen bond, and profound pK(a) changes within the catalytic triad associated with binding of the bromoquinoline moiety.	[Lemke, Christopher T.; Goudreau, Nathalie; Zhao, Songping; Hucke, Oliver; Thibeault, Diane; Llinas-Brunet, Montse; White, Peter W.] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada	Boehringer Ingelheim	Lemke, CT (corresponding author), Boehringer Ingelheim Canada Ltd, Res & Dev, 2100 Cunard St, Laval, PQ H7S 2G5, Canada.	christopher.lemke@boehringer-ingelheim.com						Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Butkiewicz N, 2000, J VIROL, V74, P4291, DOI 10.1128/JVI.74.9.4291-4301.2000; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; Dahl G, 2009, BIOCHEMISTRY-US, V48, P11592, DOI 10.1021/bi9016928; DeSantis G, 1998, J AM CHEM SOC, V120, P8582, DOI 10.1021/ja980072e; Di Marco S, 2000, J BIOL CHEM, V275, P7152, DOI 10.1074/jbc.275.10.7152; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Gallo M, 2009, J MOL BIOL, V385, P1142, DOI 10.1016/j.jmb.2008.11.017; Gentile I, 2009, CURR MED CHEM, V16, P1115, DOI 10.2174/092986709787581789; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goudreau N, 2005, EXPERT OPIN INV DRUG, V14, P1129, DOI 10.1517/13543784.14.9.1129; Goudreau N, 2004, J MED CHEM, V47, P123, DOI 10.1021/jm0303002; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hinrichsen H, 2004, GASTROENTEROLOGY, V127, P1347, DOI 10.1053/j.gastro.2004.08.002; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kronenberger B, 2009, ANN HEPATOL, V8, P103, DOI 10.1016/S1665-2681(19)31786-7; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Llinas-Brunet M, 2000, BIOORG MED CHEM LETT, V10, P2267, DOI 10.1016/S0960-894X(00)00465-0; Llinas-Brunet M, 1998, BIOORG MED CHEM LETT, V8, P2719, DOI 10.1016/S0960-894X(98)00480-6; Llinas-Brunet M, 2004, J MED CHEM, V47, P6584, DOI 10.1021/jm0494523; Llinas-Brunet M, 2010, J MED CHEM, V53, P6466, DOI 10.1021/jm100690x; Lu YX, 2009, J MED CHEM, V52, P2854, DOI 10.1021/jm9000133; Markley JL, 1996, BIOCHEMISTRY-US, V35, P11092, DOI 10.1021/bi961366k; Mederacke I, 2009, CURR OPIN INVEST DR, V10, P181; PELTON JG, 1993, PROTEIN SCI, V2, P543; Rajagopalan R, 2009, BIOCHEMISTRY-US, V48, P2559, DOI 10.1021/bi900038p; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Stranzl GR, 2004, J BIOL CHEM, V279, P3699, DOI 10.1074/jbc.M306814200; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Tsantrizos Y. S., 2003, ANGEW CHEM INT EDIT, V42, P1356; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Voth AR, 2007, CURR TOP MED CHEM, V7, P1336; WALTER J, 1983, H-S Z PHYSIOL CHEM, V364, P949, DOI 10.1515/bchm2.1983.364.2.949; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10	43	40	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11434	11443		10.1074/jbc.M110.211417	http://dx.doi.org/10.1074/jbc.M110.211417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270126	Green Published, hybrid			2022-12-25	WOS:000288797100055
J	Smith, M; Mallin, DR; Simon, JA; Courey, AJ				Smith, Matthew; Mallin, Daniel R.; Simon, Jeffrey A.; Courey, Albert J.			Small Ubiquitin-like Modifier (SUMO) Conjugation Impedes Transcriptional Silencing by the Polycomb Group Repressor Sex Comb on Midleg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-LYSINE-BINDING; GROUP PROTEIN COMPLEX; HOX GENE; METHYLTRANSFERASE ACTIVITY; FINGER PROTEIN; PCG PROTEINS; RING FINGER; DNA-BINDING; DROSOPHILA; SUMOYLATION	The Drosophila protein Sex Comb on Midleg (Scm) is a member of the Polycomb group (PcG), a set of transcriptional repressors that maintain silencing of homeotic genes during development. Recent findings have identified PcG proteins both as targets for modification by the small ubiquitin-like modifier (SUMO) protein and as catalytic components of the SUMO conjugation pathway. We have found that the SUMO-conjugating enzyme Ubc9 binds to Scm and that this interaction, which requires the Scm C-terminal sterile alpha motif (SAM) domain, is crucial for the efficient sumoylation of Scm. Scm is associated with the major Polycomb response element (PRE) of the homeotic gene Ultrabithorax (Ubx), and efficient PRE recruitment requires an intact Scm SAM domain. Global reduction of sumoylation augments binding of Scm to the PRE. This is likely to be a direct effect of Scm sumoylation because mutations in the SUMO acceptor sites in Scm enhance its recruitment to the PRE, whereas translational fusion of SUMO to the Scm N terminus interferes with this recruitment. In the metathorax, Ubx expression promotes haltere formation and suppresses wing development. When SUMO levels are reduced, we observe decreased expression of Ubx and partial haltere-to-wing transformation phenotypes. These observations suggest that SUMO negatively regulates Scm function by impeding its recruitment to the Ubx major PRE.	[Smith, Matthew; Courey, Albert J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Mallin, Daniel R.; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities	Courey, AJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, POB 951569,607 Charles E Young,Dr E, Los Angeles, CA 90095 USA.	courey@chem.ucla.edu			National Institutes of Health [GM63596, GM49850]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049850, R01GM063596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63596 (to A. J. C.) and GM49850 (to J. A. S.).	Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Bornemann D, 1998, GENETICS, V150, P675; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kim CA, 2005, J BIOL CHEM, V280, P27769, DOI 10.1074/jbc.M503055200; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; MCKEON J, 1994, MOL GEN GENET, V244, P474, DOI 10.1007/BF00583898; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; PELEGRI F, 1994, GENETICS, V136, P1341; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Ratnaparkhi GS, 2008, DEV COMP IMMUNOL, V32, P1290, DOI 10.1016/j.dci.2008.04.006; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Roseman RR, 2001, GENETICS, V158, P291; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Smith M, 2004, J BIOL CHEM, V279, P43805, DOI 10.1074/jbc.M404942200; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang LJ, 2010, MOL CELL BIOL, V30, P2584, DOI 10.1128/MCB.01451-09; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zhang H, 2004, NAT GENET, V36, P507, DOI 10.1038/ng1336; Zhang J, 2008, J BIOL CHEM, V283, P7464, DOI 10.1074/jbc.M707122200	45	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11391	11400		10.1074/jbc.M110.214569	http://dx.doi.org/10.1074/jbc.M110.214569			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278366	hybrid, Green Published			2022-12-25	WOS:000288797100051
J	Mayer, SI; Muller, I; Mannebach, S; Endo, T; Thiel, G				Mayer, Sabine I.; Mueller, Isabelle; Mannebach, Stefanie; Endo, Takeshi; Thiel, Gerald			Signal Transduction of Pregnenolone Sulfate in Insulinoma Cells ACTIVATION OF EGR-1 EXPRESSION INVOLVING TRPM3, VOLTAGE-GATED CALCIUM CHANNELS, ERK, AND TERNARY COMPLEX FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; EPIDERMAL-GROWTH-FACTOR; FINGER TRANSCRIPTION FACTOR; ACTIVATED PROTEIN-KINASES; TETRADECANOYLPHORBOL ACETATE; BIOLOGICAL-ACTIVITY; GENE-TRANSCRIPTION; SYNAPSIN-I; SYNAPTIC-TRANSMISSION; INDUCED PROLIFERATION	The neurosteroid pregnenolone sulfate acts on the nervous system by modifying neurotransmission and receptor functions, thus influencing synaptic strength, neuronal survival, and neurogenesis. Here we show that pregnenolone sulfate induces a signaling cascade in insulinoma cells leading to enhanced expression of the zinc finger transcription factor Egr-1 and Egr-1-responsive target genes. Pharmacological and genetic experiments revealed that influx of Ca2+ ions via transient receptor potential M3 and voltage-gated Ca2+ channels, elevation of the cytosolic Ca2+ level, and activation of ERK are essential for connecting pregnenolone sulfate stimulation with enhanced Egr-1 biosynthesis. Expression of a dominant-negative mutant of Elk-1, a key regulator of gene transcription driven by a serum response element, attenuated Egr-1 expression following stimulation, indicating that Elk-1 or related ternary complex factors connect the transcription of the Egr-1 gene with the pregnenolone sulfate-induced intracellular signaling cascade elicited by the initial influx of Ca2+. The newly synthesized Egr-1 was biologically active and bound under physiological conditions to the regulatory regions of the Pdx-1, Synapsin I, and Chromogranin B genes. Pdx-1 is a major regulator of insulin gene transcription. Accordingly, elevated insulin promoter activity and increased mRNA levels of insulin could be detected in pregnenolone sulfate-stimulated insulinoma cells. Likewise, the biosynthesis of synapsin I, a synaptic vesicle protein that is found at secretory granules in insulinoma cells, was stimulated in pregnenolone sulfate-treated INS-1 cells. Together, these data show that pregnenolone sulfate induces a signaling cascade in insulinoma cells that is very similar to the signaling cascade induced by glucose in beta-cells.	[Mayer, Sabine I.; Mueller, Isabelle; Thiel, Gerald] Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Mannebach, Stefanie] Univ Saarland, Med Ctr, Dept Expt & Clin Pharmacol & Toxicol, D-66421 Homburg, Germany; [Endo, Takeshi] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba 2638522, Japan	Saarland University; Saarland University; Chiba University	Thiel, G (corresponding author), Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, Bldg 44, D-66421 Homburg, Germany.	gerald.thiel@uks.eu	Mayer, Sabine/GXH-4352-2022; Tuluc, Petronel/C-2527-2011		Deutsche Forschungsgemeinschaft [SFB 530/C14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 530/C14.	Akk G, 2001, J PHYSIOL-LONDON, V532, P673, DOI 10.1111/j.1469-7793.2001.0673e.x; Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bauer I, 2005, ARCH BIOCHEM BIOPHYS, V438, P36, DOI 10.1016/j.abb.2005.03.016; Bauer I, 2007, J CELL BIOCHEM, V100, P242, DOI 10.1002/jcb.21075; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bernal-Mizrachi E, 2001, AM J PHYSIOL-ENDOC M, V281, pE1286, DOI 10.1152/ajpendo.2001.281.6.E1286; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Charalampopoulos I, 2008, TRENDS ENDOCRIN MET, V19, P300, DOI 10.1016/j.tem.2008.07.004; Chen L, 2005, J NEUROPHYSIOL, V94, P4131, DOI 10.1152/jn.00755.2004; Chen L, 2010, HIPPOCAMPUS, V20, P499, DOI 10.1002/hipo.20649; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ekici M, 2008, NEUROCHEM INT, V53, P165, DOI 10.1016/j.neuint.2008.07.006; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gibbs TT, 2006, PHARMACOL BIOCHEM BE, V84, P555, DOI 10.1016/j.pbb.2006.07.031; Giordano T, 2008, DIABETOLOGIA, V51, P997, DOI 10.1007/s00125-008-0980-5; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Groot M, 2000, EUR J CELL BIOL, V79, P924, DOI 10.1078/0171-9335-00126; Hige T, 2006, EUR J NEUROSCI, V24, P1955, DOI 10.1111/j.1460-9568.2006.05080.x; Hohl M, 2005, EUR J NEUROSCI, V22, P2216, DOI 10.1111/j.1460-9568.2005.04404.x; Horak M, 2006, NEUROSCIENCE, V137, P93, DOI 10.1016/j.neuroscience.2005.08.058; Josefsen K, 1999, DIABETOLOGIA, V42, P195, DOI 10.1007/s001250051139; Kaufmann K, 2001, J NEUROL SCI, V189, P83, DOI 10.1016/S0022-510X(01)00562-7; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Kaufmann K, 2002, J CELL BIOCHEM, V85, P381, DOI 10.1002/jcb.10145; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006311; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matsumoto K, 1999, J BIOL CHEM, V274, P2053, DOI 10.1074/jbc.274.4.2053; Mayer SI, 2009, J CELL SCI, V122, P3340, DOI 10.1242/jcs.048272; Mayer SI, 2009, EUR J CELL BIOL, V88, P19, DOI 10.1016/j.ejcb.2008.07.002; Mayer SI, 2008, J CELL BIOCHEM, V105, P1267, DOI 10.1002/jcb.21927; Mayer SI, 2008, ENDOCRINOLOGY, V149, P6311, DOI 10.1210/en.2008-0251; Mayo W, 2001, HORM BEHAV, V40, P215, DOI 10.1006/hbeh.2001.1677; Nakajima-Nagata N, 2004, BIOCHEM BIOPH RES CO, V318, P631, DOI 10.1016/j.bbrc.2004.04.071; Rossler OG, 2008, ARCH BIOCHEM BIOPHYS, V470, P93, DOI 10.1016/j.abb.2007.11.008; Rossler OG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-40; Rossler O.G., 2006, TRANSCRIPTION FACTOR, P379; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Spohn D, 2010, MOL PHARMACOL, V78, P865, DOI 10.1124/mol.110.067637; Stefano L, 2006, J NEUROCHEM, V97, P92, DOI 10.1111/j.1471-4159.2006.03749.x; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; THIEL G, 1994, J BIOL CHEM, V269, P15294; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; Tian JM, 1999, J BIOL CHEM, V274, P15173, DOI 10.1074/jbc.274.21.15173; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Yang M, 2010, MOL CELL ENDOCRINOL, V315, P308, DOI 10.1016/j.mce.2009.09.033; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	56	57	58	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10084	10096		10.1074/jbc.M110.202697	http://dx.doi.org/10.1074/jbc.M110.202697			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21257751	Green Published, hybrid			2022-12-25	WOS:000288547000023
J	Recchia, AG; De Francesco, EM; Vivacqua, A; Sisci, D; Panno, ML; Ando, S; Maggiolini, M				Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Vivacqua, Adele; Sisci, Diego; Panno, Maria Luisa; Ando, Sebastiano; Maggiolini, Marcello			The G Protein-coupled Receptor 30 Is Up-regulated by Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) in Breast Cancer Cells and Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; MITOCHONDRIAL COMPLEX-III; ESTROGEN-RECEPTOR; INDUCED APOPTOSIS; TRANSCRIPTIONAL RESPONSE; FACTOR CTGF/CCN2; FACTOR 1-ALPHA; FREE-RADICALS; TUMOR-GROWTH; FACTOR-I	GPR30, also known as GPER, has been suggested to mediate rapid effects induced by estrogens in diverse normal and cancer tissues. Hypoxia is a common feature of solid tumors involved in apoptosis, cell survival, and proliferation. The response to low oxygen environment is mainly mediated by the hypoxia-inducible factor named HIF-1 alpha, which activates signaling pathways leading to adaptive mechanisms in tumor cells. Here, we demonstrate that the hypoxia induces HIF-1 alpha expression, which in turn mediates the up-regulation of GPER and its downstream target CTGF in estrogen receptor-negative SkBr3 breast cancer cells and in HL-1 cardiomyocytes. Moreover, we show that HIF-1 alpha-responsive elements located within the promoter region of GPER are involved in hypoxia-dependent transcription of GPER, which requires the ROS-induced activation of EGFR/ERK signaling in both SkBr3 and HL-1 and cells. Interestingly, the apoptotic response to hypoxia was prevented by estrogens through GPER in SkBr3 cells. Taken together, our data suggest that the hypoxia-induced expression of GPER may be included among the mechanisms involved in the anti-apoptotic effects elicited by estrogens, particularly in a low oxygen microenvironment.	[Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Vivacqua, Adele; Sisci, Diego; Maggiolini, Marcello] Univ Calabria, Dept Pharmacobiol, I-87030 Cosenza, Italy; [Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Cell Biol, I-87030 Cosenza, Italy	University of Calabria; University of Calabria	Maggiolini, M (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87030 Cosenza, Italy.	marcellomaggiolini@yahoo.it	vivacqua, adele/I-2771-2015; /AAD-9701-2019; Maggiolini, Marcello/Z-4729-2019; Recchia, Anna Grazia/ABA-5228-2020	vivacqua, adele/0000-0001-5333-8396; /0000-0001-6577-1541; Recchia, Anna Grazia/0000-0001-5748-2002; Maggiolini, Marcello/0000-0002-7485-854X	Associazione Italiana per la Ricerca sul Cancro [8925/2009]; Ministero dell'Universita e Ricerca Scientifica e Tecnologica [2008PK2WCW/2008]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Project 8925/2009 and Ministero dell'Universita e Ricerca Scientifica e Tecnologica Cofin Project Prot. 2008PK2WCW/2008.	Albanito L, 2008, ENDOCRINOLOGY, V149, P3799, DOI 10.1210/en.2008-0117; Arias-Pulido H, 2010, BREAST CANCER RES TR, V123, P51, DOI 10.1007/s10549-009-0631-7; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Calzada MJ, 2007, CLIN TRANSL ONCOL, V9, P278, DOI 10.1007/s12094-007-0055-y; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Davoli A, 2010, CANCER CHEMOTH PHARM, V65, P611, DOI 10.1007/s00280-009-1208-1; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Galanis A, 2008, CANCER LETT, V266, P12, DOI 10.1016/j.canlet.2008.02.028; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Generali D, 2009, J CLIN ONCOL, V27, P227, DOI 10.1200/JCO.2007.13.7083; Gerstner B, 2009, J NEUROSCI RES, V87, P2078, DOI 10.1002/jnr.22023; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Goonewardene TI, 2002, MICROSC RES TECHNIQ, V59, P41, DOI 10.1002/jemt.10175; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hong KH, 2006, CLIN EXP IMMUNOL, V146, P362, DOI 10.1111/j.1365-2249.2006.03199.x; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Koledova Vera V, 2007, Expert Rev Cardiovasc Ther, V5, P777; Krick S, 2005, AM J RESP CELL MOL, V32, P395, DOI 10.1165/rcmb.2004-0314OC; Kurebayashi J, 2001, JPN J CANCER RES, V92, P1093, DOI 10.1111/j.1349-7006.2001.tb01064.x; Kurokawa H, 2003, CLIN CANCER RES, V9, p511S; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lee M, 2009, ADV DRUG DELIVER REV, V61, P842, DOI 10.1016/j.addr.2009.04.017; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Malhotra R, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-9; Nicholson RI, 2002, ANN NY ACAD SCI, V963, P104, DOI 10.1111/j.1749-6632.2002.tb04101.x; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P1, DOI 10.1016/j.mce.2009.04.005; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; SEMENZA GL, 2009, SYST BIOL MED, V2, P336; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Stice JP, 2009, FUTUR CARDIOL, V5, P93, DOI 10.2217/14796678.5.1.93; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Yi JM, 2009, BIOCHEM BIOPH RES CO, V378, P842, DOI 10.1016/j.bbrc.2008.11.142; Zhao LQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-24; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010; Zhong H, 1999, CANCER RES, V59, P5830	71	85	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10773	10782		10.1074/jbc.M110.172247	http://dx.doi.org/10.1074/jbc.M110.172247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266576	Green Published, hybrid			2022-12-25	WOS:000288547000091
J	Verhalen, B; Wilkens, S				Verhalen, Brandy; Wilkens, Stephan			P-glycoprotein Retains Drug-stimulated ATPase Activity upon Covalent Linkage of the Two Nucleotide Binding Domains at Their C-terminal Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; ABC TRANSPORTER; MULTIDRUG-RESISTANCE; MALTOSE TRANSPORTER; ELECTRON-MICROSCOPY; ALTERNATING ACCESS; CATALYTIC CYCLE; MOLECULAR-BASIS; SITE; INTERMEDIATE	P-glycoprotein (Pgp), a member of the ABC transporter family, functions as an ATP hydrolysis-driven efflux pump to rid the cell of toxic organic compounds, including a variety of drugs used in anti-cancer chemotherapy. We have recently obtained EM projection images of lipid-bound Pgp without nucleotide and transport substrate that showed the two halves of the transporter separated by a central cavity (Lee, J. Y., Urbatsch, I. L., Senior, A. E., and Wilkens, S. (2002) J. Biol. Chem. 277, 4012540131). Addition of nucleotide and/or substrate lead to a close association of the two halves of the transporter, thereby closing the central cavity (Lee, J. Y., Urbatsch, I. L., Senior, A. E., and Wilkens, S. (2008) J. Biol. Chem. 283, 5769-5779). Here, we used cysteine-mediated disulfide cross-linking to further delineate the structural rearrangements of the two nucleotide binding domains (NBD1 and NBD2) that take place during catalysis. Cysteines introduced at or near the C-terminal ends of NBD1 and NBD2 allowed for spontaneous disulfide cross-linking under nonreducing conditions. For mutant A627C/S1276C, disulfide formation was with high efficiency and cross-linked Pgp retained 30-68% drug-stimulated ATPase activity compared with reduced or cysteine-less Pgp. Two other cysteine pairs (K615C/S1276C and A627C/K1260C) also formed a disulfide but to a lesser extent, and the cross-linked form of these two mutants had lower drug-stimulated ATPase activity. The data suggest that the C-terminal ends of the two NBDs of Pgp are not required to undergo significant motion with respect to one another during the catalytic cycle.	[Verhalen, Brandy; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [CA100246, GM058600]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100246 and GM058600 (to S. W.).	Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J LIPID RES, V42, P1007; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104	33	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10476	10482		10.1074/jbc.M110.193151	http://dx.doi.org/10.1074/jbc.M110.193151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278250	hybrid, Green Published			2022-12-25	WOS:000288547000064
J	Resnik-Docampo, M; de Celis, JF				Resnik-Docampo, Martin; de Celis, Jose F.			MAP4K3 Is a Component of the TORC1 Signalling Complex that Modulates Cell Growth and Viability in Drosophila melanogaster	PLOS ONE			English	Article							AMINO-ACIDS; PATTERN-FORMATION; GENE-EXPRESSION; RAG GTPASES; S6 KINASE; TARGET; SIZE; MTOR; REGULATOR; PATHWAY	Background: MAP4K3 is a conserved Ser/Thr kinase that has being found in connection with several signalling pathways, including the Imd, EGFR, TORC1 and JNK modules, in different organisms and experimental assays. We have analyzed the consequences of changing the levels of MAP4K3 expression in the development of the Drosophila wing, a convenient model system to characterize gene function during epithelial development. Methodology and Principal Findings: Using loss-of-function mutants and over-expression conditions we find that MAP4K3 activity affects cell growth and viability in the Drosophila wing. These requirements are related to the modulation of the TORC1 and JNK signalling pathways, and are best detected when the larvae grow in a medium with low protein concentration (TORC1) or are exposed to irradiation (JNK). We also show that MAP4K3 display strong genetic interactions with different components of the InR/Tor signalling pathway, and can interact directly with the GTPases RagA and RagC and with the multi-domain kinase Tor. Conclusions and Significance: We suggest that MAP4K3 has two independent functions during wing development, one related to the activation of the JNK pathway in response to stress and other in the assembling or activation of the TORC1 complex, being critical to modulate cellular responses to changes in nutrient availability.	[Resnik-Docampo, Martin] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Resnik-Docampo, M (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jfdecelis@cbm.uam.es	resnik-docampo, martin/B-7671-2019; de+Celis, Jose/AAE-8142-2019	resnik-docampo, martin/0000-0001-7016-9061; de Celis, Jose F./0000-0003-4808-9844	Fundacin Ramn Areces;  [BFU2009-09403];  [CSD2007-00008]	Fundacin Ramn Areces; ; 	Grants BFU2009-09403 and CSD2007-00008 were given to J.F.dC., and an institutional grant from Fundacin Ramn Areces to the Centro de Biologia Molecular Severo Ochoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bryk B, 2010, DEV BIOL, V344, P150, DOI 10.1016/j.ydbio.2010.04.027; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Cohen S. M., 1993, IMAGINAL DISC DEV; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cook Simon J, 2007, Biochem J, V403, pe1; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gelbart WM, 1997, NUCLEIC ACIDS RES, V25, P63, DOI 10.1093/nar/25.1.63; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito K, 1997, DEVELOPMENT, V124, P761; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lam D, 2009, CELL CYCLE, V8, P3248, DOI 10.4161/cc.8.20.9572; Lam D, 2009, P NATL ACAD SCI USA, V106, P11978, DOI 10.1073/pnas.0900608106; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Molnar C, 2006, GENETICS, V174, P1635, DOI 10.1534/genetics.106.061283; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Stewart MJ, 1996, P NATL ACAD SCI USA, V93, P10791, DOI 10.1073/pnas.93.20.10791; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zinke I, 1999, DEVELOPMENT, V126, P5275	56	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14528	10.1371/journal.pone.0014528	http://dx.doi.org/10.1371/journal.pone.0014528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267071	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500007
J	Rubins, KH; Hensley, LE; Relman, DA; Brown, PO				Rubins, Kathleen H.; Hensley, Lisa E.; Relman, David A.; Brown, Patrick O.			Stunned Silence: Gene Expression Programs in Human Cells Infected with Monkeypox or Vaccinia Virus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BROAD SPECIES-SPECIFICITY; DEPENDENT PROTEIN-KINASE; HUMAN HELA-CELLS; E3L GENE; OLIGONUCLEOTIDE ARRAYS; INTERFERON-ALPHA; BINDING-PROTEINS; ANKARA INFECTION; IMMUNE EVASION	Poxviruses use an arsenal of molecular weapons to evade detection and disarm host immune responses. We used DNA microarrays to investigate the gene expression responses to infection by monkeypox virus (MPV), an emerging human pathogen, and Vaccinia virus (VAC), a widely used model and vaccine organism, in primary human macrophages, primary human fibroblasts and HeLa cells. Even as the overwhelmingly infected cells approached their demise, with extensive cytopathic changes, their gene expression programs appeared almost oblivious to poxvirus infection. Although killed (gamma-irradiated) MPV potently induced a transcriptional program characteristic of the interferon response, no such response was observed during infection with either live MPV or VAC. Moreover, while the gene expression response of infected cells to stimulation with ionomycin plus phorbol 12-myristate 13-acetate (PMA), or poly (I-C) was largely unimpaired by infection with MPV, a cluster of pro-inflammatory genes were a notable exception. Poly(I-C) induction of genes involved in alerting the innate immune system to the infectious threat, including TNF-alpha, IL-1 alpha and beta, CCL5 and IL-6, were suppressed by infection with live MPV. Thus, MPV selectively inhibits expression of genes with critical roles in cell-signaling pathways that activate innate immune responses, as part of its strategy for stealthy infection.	[Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; [Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; [Rubins, Kathleen H.; Brown, Patrick O.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Hensley, Lisa E.] USA, Med Res Inst Infect Dis, Frederick, MD USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Brown, Patrick O.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Howard Hughes Medical Institute; Stanford University	Rubins, KH (corresponding author), Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA.	pbrown@stanford.edu		Relman, David A./0000-0001-8331-1354; Hensley, Lisa/0000-0003-1188-4342	Howard Hughes Medical Institute; National Institutes of Health [CA77097, AI54922]; Thomas C. and Joan M. Merigan Endowment at Stanford University; NATIONAL CANCER INSTITUTE [R01CA077097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054922] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas C. and Joan M. Merigan Endowment at Stanford University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was supported by the Howard Hughes Medical Institute (POB), National Institutes of Health Grants CA77097 (POB) and AI54922 (DAR); and the Thomas C. and Joan M. Merigan Endowment at Stanford University (DAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 1996, COMP IMMUNOL MICROB, V19, P305, DOI 10.1016/0147-9571(96)00013-6; ALCAMI A, 1995, J VIROL, V69, P4633; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alkhalil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-173; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; CARROLL K, 1993, J BIOL CHEM, V268, P12837; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Cunnion KM, 1999, MOL GENET METAB, V67, P278, DOI 10.1006/mgme.1999.2878; DAVIES MV, 1992, J VIROL, V66, P1943, DOI 10.1128/JVI.66.4.1943-1950.1992; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; ESPOSITO JJ, 2001, VIROLOGY, P2885; Guerra S, 2004, J VIROL, V78, P5820, DOI 10.1128/JVI.78.11.5820-5834.2004; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Jahrling PB, 1996, ARCH VIROL, P135; JEZEK Z, 1988, HUMAN MONKEYPOX, P1; Jezek Z, 1988, HUMAN MONKEYPOX; Kim YG, 2004, P NATL ACAD SCI USA, V101, P1514, DOI 10.1073/pnas.0308260100; Liu Y, 2001, VIROLOGY, V289, P378, DOI 10.1006/viro.2001.1154; Ludwig H, 2005, J VIROL, V79, P2584, DOI 10.1128/JVI.79.4.2584-2596.2005; MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288; MOSSMAN K, 1995, VIROLOGY, V208, P762, DOI 10.1006/viro.1995.1208; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rasschaert J, 2003, DIABETOLOGIA, V46, pA48; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072; Rubins KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002628; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Shchelkunov SN, 2002, VIROLOGY, V297, P172, DOI 10.1006/viro.2002.1446; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Weaver JR, 2008, IMMUNOL REV, V225, P96, DOI 10.1111/j.1600-065X.2008.00691.x; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	60	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15615	10.1371/journal.pone.0015615	http://dx.doi.org/10.1371/journal.pone.0015615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267444	Green Submitted, Green Published, gold			2022-12-25	WOS:000286519500024
J	Strauss, R; Li, ZY; Liu, Y; Beyer, I; Persson, J; Sova, P; Moller, T; Pesonen, S; Hemminki, A; Hamerlik, P; Drescher, C; Urban, N; Bartek, J; Lieber, A				Strauss, Robert; Li, Zong-Yi; Liu, Ying; Beyer, Ines; Persson, Jonas; Sova, Pavel; Moeller, Thomas; Pesonen, Sari; Hemminki, Akseli; Hamerlik, Petra; Drescher, Charles; Urban, Nicole; Bartek, Jiri; Lieber, Andre			Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity	PLOS ONE			English	Article							STEM-CELL PROPERTIES; E-CADHERIN; PROSPECTIVE IDENTIFICATION; TUMOR PROGRESSION; EXPRESSION; TRANSITION; CARCINOMA; CD133; SUBPOPULATION; GLIOBLASTOMA	In our studies of ovarian cancer cells we have identified subpopulations of cells that are in a transitory E/M hybrid stage, i.e. cells that simultaneously express epithelial and mesenchymal markers. E/M cells are not homogenous but, in vitro and in vivo, contain subsets that can be distinguished based on a number of phenotypic features, including the subcellular localization of E-cadherin, and the expression levels of Tie2, CD133, and CD44. A cellular subset (E/M-MP) (membrane E-cadherin(low)/cytoplasmic E-cadherin(high)/CD133(high), CD44(high), Tie2(low)) is highly enriched for tumor-forming cells and displays features which are generally associated with cancer stem cells. Our data suggest that E/M-MP cells are able to differentiate into different lineages under certain conditions, and have the capacity for self-renewal, i.e. to maintain a subset of undifferentiated E/M-MP cells during differentiation. Trans-differentiation of E/M-MP cells into mesenchymal or epithelial cells is associated with a loss of stem cell markers and tumorigenicity. In vivo xenograft tumor growth is driven by E/M-MP cells, which give rise to epithelial ovarian cancer cells. In contrast, in vitro, we found that E/M-MP cells differentiate into mesenchymal cells, in a process that involves pathways associated with an epithelial-to-mesenchymal transition. We also detected phenotypic plasticity that was dependent on external factors such as stress created by starvation or contact with either epithelial or mesenchymal cells in co-cultures. Our study provides a better understanding of the phenotypic complexity of ovarian cancer and has implications for ovarian cancer therapy.	[Strauss, Robert; Li, Zong-Yi; Liu, Ying; Beyer, Ines; Persson, Jonas; Lieber, Andre] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Sova, Pavel; Lieber, Andre] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Pesonen, Sari; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Helsinki, Finland; [Pesonen, Sari; Hemminki, Akseli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Drescher, Charles; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Strauss, Robert; Hamerlik, Petra; Bartek, Jiri] Ctr Genotox Stress Res, Danish Canc Soc, Dept Cell Cycle & Canc, Copenhagen, Denmark; [Hamerlik, Petra; Bartek, Jiri] Palacky Univ, Lab Genom Integr, CR-77147 Olomouc, Czech Republic; [Hamerlik, Petra; Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Fred Hutchinson Cancer Center; Danish Cancer Society; Palacky University Olomouc; Palacky University Olomouc	Strauss, R (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	lieber00@u.washington.edu	Bartek, Jiri/G-5870-2014; , Petra/U-2260-2019; Beyer, Ines/Q-3236-2017	, Petra/0000-0002-5856-0161; Beyer, Ines/0000-0001-7468-4466; Lieber, Andre/0000-0001-6742-6266	NIH [R01 CA080192, R01 HLA078836]; Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer [P50 CA83636]; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA136487, R01CA144057, R01CA080192] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported by NIH grants R01 CA080192, R01 HLA078836, and Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer Grant P50 CA83636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnoux V, 2005, MOL B INT U, P111; Auersperg N, 2002, INT J GYNECOL CANCER, V12, P691, DOI 10.1046/j.1525-1438.2002.01152.x; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fong MY, 2010, HISTOL HISTOPATHOL, V25, P113, DOI 10.14670/HH-25.113; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Imai T, 2004, HUM PATHOL, V35, P1469, DOI 10.1016/j.humpath.2004.09.014; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li ZY, 2004, MOL THER, V9, P650, DOI 10.1016/j.ymthe.2004.01.021; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; Martin V, 2009, ONCOGENE, V28, P2358, DOI 10.1038/onc.2009.103; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Thiery JP, 2005, DEV CELL, V8, P456, DOI 10.1016/j.devcel.2005.03.002; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; TURLEY EA, 2008, NAT CLIN PRACT ONCOL; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wong Alice S T, 2002, Cancer Treat Res, V107, P161; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	47	148	154	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16186	10.1371/journal.pone.0016186	http://dx.doi.org/10.1371/journal.pone.0016186			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264259	gold, Green Submitted, Green Published			2022-12-25	WOS:000286516500035
J	Zhang, J; Alcaide, P; Liu, L; Sun, JS; He, AN; Luscinskas, FW; Shi, GP				Zhang, Jie; Alcaide, Pilar; Liu, Li; Sun, Jiusong; He, Aina; Luscinskas, Francis W.; Shi, Guo-Ping			Regulation of Endothelial Cell Adhesion Molecule Expression by Mast Cells, Macrophages, and Neutrophils	PLOS ONE			English	Article							E-DEFICIENT MICE; P-SELECTIN; ATHEROSCLEROTIC LESIONS; UNSTABLE ANGINA; UP-REGULATION; VCAM-1; ICAM-1; ATHEROGENESIS; INFILTRATION; CYTOKINES	Background: Leukocyte adhesion to the vascular endothelium and subsequent transendothelial migration play essential roles in the pathogenesis of cardiovascular diseases such as atherosclerosis. The leukocyte adhesion is mediated by localized activation of the endothelium through the action of inflammatory cytokines. The exact proinflammatory factors, however, that activate the endothelium and their cellular sources remain incompletely defined. Methods and Results: Using bone marrow-derived mast cells from wild-type, Tnf(-/-), Ifng(-/-), Il6(-/-) mice, we demonstrated that all three of these pro-inflammatory cytokines from mast cells induced the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), P-selectin, and E-selectin in murine heart endothelial cells (MHEC) at both mRNA and protein levels. Compared with TNF-alpha and IL6, IFN-gamma appeared weaker in the induction of the mRNA levels, but at protein levels, both IL6 and IFN-gamma were weaker inducers than TNF-alpha. Under physiological shear flow conditions, mast cell-derived TNF-alpha and IL6 were more potent than IFN-gamma in activating MHEC and in promoting neutrophil adhesion. Similar observations were made when neutrophils or macrophages were used. Neutrophils and macrophages produced the same sets of pro-inflammatory cytokines as did mast cells to induce MHEC adhesion molecule expression, with the exception that macrophage-derived IFN-gamma showed negligible effect in inducing VCAM-1 expression in MHEC. Conclusion: Mast cells, neutrophils, and macrophages release pro-inflammatory cytokines such as TNF-alpha, IFN-gamma, and IL6 that induce expression of adhesion molecules in endothelium and recruit of leukocytes, which is essential to the pathogenesis of vascular inflammatory diseases.	[Zhang, Jie; Liu, Li; Sun, Jiusong; He, Aina; Shi, Guo-Ping] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Alcaide, Pilar; Luscinskas, Francis W.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol,Med Sch, Boston, MA 02115 USA; [Liu, Li] Huzhou Teachers Coll, Sch Life Sci, Huzhou, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Huzhou University	Zhang, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	gshi@rics.bwh.harvard.edu		Luscinskas, Francis/0000-0001-7100-4103	National Institutes of Health (NIH) [HL60942, HL81090, HL88547, HL094706, HL36028, HL53993]; American Heart Association [0840118N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036028, R01HL060942, K99HL094706, R01HL088547, R01HL081090, R00HL094706, R01HL053993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institutes of Health (NIH) grants HL60942, HL81090, HL88547 (GPS); HL094706 (PA), HL36028 and HL53993 (FWL) and American Heart Association EIA award 0840118N (GPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JB, 1985, HUM PATHOL, V16, P562, DOI 10.1016/S0046-8177(85)80105-2; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; de Vries IJM, 1998, J ALLERGY CLIN IMMUN, V102, P461, DOI 10.1016/S0091-6749(98)70136-8; Dong ZM, 2000, CIRCULATION, V101, P2290, DOI 10.1161/01.CIR.101.19.2290; DUSTIN ML, 1986, J IMMUNOL, V137, P245; EBISAWA M, 1992, J IMMUNOL, V149, P4021; Gerszten RE, 1998, CIRC RES, V82, P871; Grabie N, 2003, AM J PATHOL, V163, P2413, DOI 10.1016/S0002-9440(10)63596-1; JOHNSONTIDEY RR, 1994, AM J PATHOL, V144, P952; Kneilling M, 2009, BLOOD, V114, P1696, DOI 10.1182/blood-2008-11-187682; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; MENG H, 1995, J CELL PHYSIOL, V165, P40, DOI 10.1002/jcp.1041650106; Miyamoto S, 2008, HEART, V94, P1002, DOI 10.1136/hrt.2007.121640; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Piqueras L, 2000, CIRCULATION, V102, P2118, DOI 10.1161/01.CIR.102.17.2118; POSTON RN, 1992, AM J PATHOL, V140, P665; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Rotzius P, 2009, ATHEROSCLEROSIS, V202, P111, DOI 10.1016/j.atherosclerosis.2008.04.009; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Tenaglia AN, 1997, AM J CARDIOL, V79, P742, DOI 10.1016/S0002-9149(96)00861-2; Torres R, 2002, IMMUNOL CELL BIOL, V80, P170, DOI 10.1046/j.1440-1711.2002.01069.x; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	37	202	211	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14525	10.1371/journal.pone.0014525	http://dx.doi.org/10.1371/journal.pone.0014525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264293	gold, Green Published, Green Submitted			2022-12-25	WOS:000286516500006
J	Kang, HJ; Coulibaly, F; Proft, T; Baker, EN				Kang, Hae Joo; Coulibaly, Fasseli; Proft, Thomas; Baker, Edward N.			Crystal Structure of Spy0129, a Streptococcus pyogenes Class B Sortase Involved in Pilus Assembly	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; GRAM-POSITIVE BACTERIA; SORTING SIGNAL BINDING; CELL-WALL; SURFACE-PROTEINS; ACTIVE-SITE; GROUP-A; CORYNEBACTERIUM-DIPHTHERIAE; BACILLUS-ANTHRACIS; IN-VITRO	Sortase enzymes are cysteine transpeptidases that mediate the covalent attachment of substrate proteins to the cell walls of Gram-positive bacteria, and thereby play a crucial role in virulence, infection and colonisation by pathogens. Many cell-surface proteins are anchored by the housekeeping sortase SrtA but other more specialised sortases exist that attach subsets of proteins or function in pilus assembly. The sortase Spy0129, or SrtC1, from the M1 SF370 strain of Streptococcus pyogenes is responsible for generating the covalent linkages between the pilin subunits in the pili of this organism. The crystal structure of Spy0129 has been determined at 2.3 angstrom resolution (R = 20.4%, Rfree = 26.0%). The structure shows that Spy0129 is a class B sortase, in contrast to other characterised pilin polymerases, which belong to class C. Spy0129 lacks a flap believed to function in substrate recognition in class C enzymes and instead has an elaborated beta 6/beta 7 loop. The two independent Spy0129 molecules in the crystal show differences in the positions and orientations of the catalytic Cys and His residues, Cys221 and His126, correlated with movements of the beta 7/beta 8 and beta 4/beta 5 loops that respectively follow these residues. Bound zinc ions stabilise these alternative conformations in the crystal. This conformational variability is likely to be important for function although there is no evidence that zinc is involved in vivo.	[Kang, Hae Joo; Coulibaly, Fasseli; Proft, Thomas; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Kang, Hae Joo; Coulibaly, Fasseli; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Proft, Thomas] Univ Auckland, Sch Med Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Kang, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosceinces, London, England.	ted.baker@auckland.ac.nz	Proft, Thomas/H-4686-2019	Proft, Thomas/0000-0002-9275-5042; Baker, Edward/0000-0003-2456-7661; Coulibaly, Fasseli/0000-0003-3380-2117	Health Research Council of New Zealand; Foundation for Research, Science and Technology of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery	Health Research Council of New Zealand(Health Research Council of New Zealand); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Maurice Wilkins Centre for Molecular Biodiscovery	This work was supported by the Health Research Council of New Zealand, the Foundation for Research, Science and Technology of New Zealand, and the Maurice Wilkins Centre for Molecular Biodiscovery. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Holm SE, 1996, NEW ENGL J MED, V335, P590, DOI 10.1056/NEJM199608223350811; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	61	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15969	10.1371/journal.pone.0015969	http://dx.doi.org/10.1371/journal.pone.0015969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264317	gold, Green Published, Green Submitted			2022-12-25	WOS:000286514000013
J	Murthy, S; Hayward, GS; Wheelan, S; Forman, MS; Ahn, JH; Pass, RF; Arav-Boger, R				Murthy, Suchetha; Hayward, Gary S.; Wheelan, Sarah; Forman, Michael S.; Ahn, Jin-Hyun; Pass, Robert F.; Arav-Boger, Ravit			Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; POLYMORPHISMS; RECEPTOR; ALPHA; BLOOD	Background: Infection with multiple CMV strains is common in immunocompromised hosts, but its occurrence in normal hosts has not been well-studied. Methods: We analyzed CMV strains longitudinally in women who acquired CMV while enrolled in a CMV glycoprotein B (gB) vaccine trial. Sequencing of four variable genes was performed in samples collected from seroconversion and up to 34 months thereafter. Results: 199 cultured isolates from 53 women and 65 original fluids from a subset of 19 women were sequenced. 51 women were infected with one strain each without evidence for genetic drift; only two women shed multiple strains. Genetic variability among strains increased with the number of sequenced genetic loci. Nevertheless, 13 of 53 women proved to be infected with an identical CMV strain based on sequencing at all four variable genes. CMV vaccine did not alter the degree of genetic diversity amongst strains. Conclusions: Primary CMV infection in healthy women nearly always involves shedding of one strain that remains stable over time. Immunization with CMVgB-1 vaccine strain is not selective against specific strains. Although 75% of women harbored their unique strain, or a strain shared with only one other woman, 25% shared a single common strain, suggesting that this predominant strain with a particular combination of genetic loci is advantageous in this large urban area.	[Murthy, Suchetha; Arav-Boger, Ravit] Johns Hopkins Med Inst, Dept Pediat, Div Infect Dis, Baltimore, MD 21205 USA; [Hayward, Gary S.] Johns Hopkins Med Inst, Sidney Kimmel Canc Res Ctr, Baltimore, MD 21205 USA; [Wheelan, Sarah] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Forman, Michael S.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ahn, Jin-Hyun] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon, South Korea; [Pass, Robert F.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); University of Alabama System; University of Alabama Birmingham	Murthy, S (corresponding author), Johns Hopkins Med Inst, Dept Pediat, Div Infect Dis, Baltimore, MD 21205 USA.	boger@jhmi.edu		Pass, Robert/0000-0003-2029-0247	NIH KO8 [1K08AI074907-01A1]; Sanofi-Pasteur [CMEO1, U01-AI063565]; NIH Center for Research Resources [5UL1 RR025777]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI063565, K08AI074907] Funding Source: NIH RePORTER	NIH KO8(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi-Pasteur; NIH Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH KO8 (1K08AI074907-01A1), Sanofi-Pasteur CMEO1 to RAB, and U01-AI063565 to RFP. This project was also supported by 5UL1 RR025777 to the University of Alabama at Birmingham from the NIH Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Arav-Boger R, 2006, J INFECT DIS, V193, P788, DOI 10.1086/500508; Arav-Boger R, 2005, VIRUS GENES, V31, P65, DOI 10.1007/s11262-005-2201-3; Arav-Boger R, 2006, J INFECT DIS, V194, P464, DOI 10.1086/505427; Baldanti F, 1998, ARCH VIROL, V143, P1701, DOI 10.1007/s007050050410; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; BALE JF, 1993, J CLIN MICROBIOL, V31, P2433, DOI 10.1128/JCM.31.9.2433-2438.1993; Benedict CA, 1999, J IMMUNOL, V162, P6967; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; CHANDLER SH, 1987, J INFECT DIS, V155, P655, DOI 10.1093/infdis/155.4.655; CHOU SW, 1986, NEW ENGL J MED, V314, P1418, DOI 10.1056/NEJM198605293142205; CHOU SW, 1989, J INFECT DIS, V160, P11, DOI 10.1093/infdis/160.1.11; DAL MP, 2001, J HUMAN VIROL, V4, P26; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Lurain NS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-4; Novak Z, 2008, J CLIN MICROBIOL, V46, P882, DOI 10.1128/JCM.01079-07; Novak Z, 2009, CLIN VACCINE IMMUNOL, V16, P288, DOI 10.1128/CVI.00281-08; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pignatelli S, 2004, REV MED VIROL, V14, P383, DOI 10.1002/rmv.438; Pignatelli S, 2010, CLIN INFECT DIS, V51, P33, DOI 10.1086/653423; Puchhammer-Stockl E, 2006, TRANSPLANTATION, V81, P187, DOI 10.1097/01.tp.0000194858.50812.cb; Rasmussen L, 2003, J INFECT DIS, V187, P809, DOI 10.1086/367900; Revello MG, 2008, J MED VIROL, V80, P1415, DOI 10.1002/jmv.21243; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Stanton R, 2005, J MED VIROL, V75, P42, DOI 10.1002/jmv.20235; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrago D, 2003, J CLIN MICROBIOL, V41, P2872, DOI 10.1128/JCM.41.7.2872-2877.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trincado DE, 2000, J MED VIROL, V61, P481, DOI 10.1002/1096-9071(200008)61:4&lt;481::AID-JMV11&gt;3.0.CO;2-H; Verbraak FD, 1998, AIDS, V12, P713, DOI 10.1097/00002030-199807000-00007	32	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15949	10.1371/journal.pone.0015949	http://dx.doi.org/10.1371/journal.pone.0015949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264339	Green Published, gold, Green Submitted			2022-12-25	WOS:000286513100020
J	Sytnikova, YA; Kubarenko, AV; Schafer, A; Weber, ANR; Niehrs, C				Sytnikova, Yuliya A.; Kubarenko, Andriy V.; Schaefer, Andrea; Weber, Alexander N. R.; Niehrs, Christof			Gadd45a Is an RNA Binding Protein and Is Localized in Nuclear Speckles	PLOS ONE			English	Article							NEGATIVE GROWTH-CONTROL; CELL-CYCLE CHECKPOINTS; DNA DEMETHYLATION; RIBOSOMAL-PROTEINS; CRYSTAL-STRUCTURE; CHICKEN-EMBRYO; U4 SNRNA; COMPLEX; GLYCOSYLASE; DOMAINS	Background: The Gadd45 proteins play important roles in growth control, maintenance of genomic stability, DNA repair, and apoptosis. Recently, Gadd45 proteins have also been implicated in epigenetic gene regulation by promoting active DNA demethylation. Gadd45 proteins have sequence homology with the L7Ae/L30e/S12e RNA binding superfamily of ribosomal proteins, which raises the question if they may interact directly with nucleic acids. Principal Findings: Here we show that Gadd45a binds RNA but not single-or double stranded DNA or methylated DNA in vitro. Sucrose density gradient centrifugation experiments demonstrate that Gadd45a is present in high molecular weight particles, which are RNase sensitive. Gadd45a displays RNase-sensitive colocalization in nuclear speckles with the RNA helicase p68 and the RNA binding protein SC35. A K45A point mutation defective in RNA binding was still active in DNA demethylation. This suggests that RNA binding is not absolutely essential for demethylation of an artificial substrate. A point mutation at G39 impared RNA binding, nuclear speckle localization and DNA demethylation, emphasizing its relevance for Gadd45a function. Significance: The results implicate RNA in Gadd45a function and suggest that Gadd45a is associated with a ribonucleoprotein particle.	[Sytnikova, Yuliya A.; Schaefer, Andrea; Niehrs, Christof] Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Heidelberg, Germany; [Kubarenko, Andriy V.; Weber, Alexander N. R.] Deutsch Krebsforschungszentrum, Div Toll Like Receptors & Canc, D-6900 Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Sytnikova, YA (corresponding author), Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.de	Sytnikova, Yuliya/J-6118-2017	Weber, Alexander/0000-0002-8627-7056; Sytnikova, Yuliya/0000-0002-8468-5101	Deutsche Forschungsgemeinschaft [NI 286/12-1, WE-4295/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Grant NI 286/12-1 to Christof Niehrs, and WE-4295/1-1 to Alexander Weber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chao JA, 2004, STRUCTURE, V12, P1165, DOI 10.1016/j.str.2004.04.023; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DREYFUSS G, 1988, J CELL BIOL, V106, P1419, DOI 10.1083/jcb.106.5.1419; Fayolle C, 2006, CELL CYCLE, V5, P1859, DOI 10.4161/cc.5.16.3119; Fremont M, 1997, NUCLEIC ACIDS RES, V25, P2375, DOI 10.1093/nar/25.12.2375; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Jost JP, 1999, FEBS LETT, V449, P251, DOI 10.1016/S0014-5793(99)00454-8; Jost JP, 1997, NUCLEIC ACIDS RES, V25, P4545, DOI 10.1093/nar/25.22.4545; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; KEARSEY JM, 1995, ONCOGENE, V11, P1675; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; KOONIN EV, 1994, NUCLEIC ACIDS RES, V22, P2166, DOI 10.1093/nar/22.11.2166; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Lin IG, 2001, EMBO REP, V2, P108, DOI 10.1093/embo-reports/kve023; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; MELO F, 1997, P INT C INTELL SYST, V5, P187; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Oruganti SV, 2005, BIOCHEM BIOPH RES CO, V333, P550, DOI 10.1016/j.bbrc.2005.05.141; Peretz G, 2007, GENETICS, V177, P1691, DOI 10.1534/genetics.107.079517; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Sambrook J, 1989, MOL CLONING LABORATO; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schrag JD, 2008, P NATL ACAD SCI USA, V105, P6566, DOI 10.1073/pnas.0800086105; Schwarz S, 2000, EUR J CELL BIOL, V79, P488, DOI 10.1078/0171-9335-00070; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; STEPANOV AS, 1971, FEBS LETT, V18, P13, DOI 10.1016/0014-5793(71)80395-2; Swisher JFA, 1998, NUCLEIC ACIDS RES, V26, P5573, DOI 10.1093/nar/26.24.5573; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tornatore L, 2008, J MOL BIOL, V378, P97, DOI 10.1016/j.jmb.2008.01.074; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Vairapandi M, 2000, J CELL BIOCHEM, V79, P249, DOI 10.1002/1097-4644(20001101)79:2<249::AID-JCB80>3.0.CO;2-Z; VAKSER IA, 1994, PROTEINS, V20, P320, DOI 10.1002/prot.340200405; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	68	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14500	10.1371/journal.pone.0014500	http://dx.doi.org/10.1371/journal.pone.0014500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249130	gold, Green Published, Green Submitted			2022-12-25	WOS:000286512900005
J	Coskun, AF; Sencan, I; Su, TW; Ozcan, A				Coskun, Ahmet F.; Sencan, Ikbal; Su, Ting-Wei; Ozcan, Aydogan			Lensfree Fluorescent On-Chip Imaging of Transgenic Caenorhabditis elegans Over an Ultra-Wide Field-of-View	PLOS ONE			English	Article							SIGNAL RECOVERY; C. ELEGANS	We demonstrate lensfree on-chip fluorescent imaging of transgenic Caenorhabditis elegans (C. elegans) over an ultra-wide field-of-view (FOV) of e. g., >2-8 cm(2) with a spatial resolution of similar to 10 mu m. This is the first time that a lensfree on-chip platform has successfully imaged fluorescent C. elegans samples. In our wide-field lensfree imaging platform, the transgenic samples are excited using a prism interface from the side, where the pump light is rejected through total internal reflection occurring at the bottom facet of the substrate. The emitted fluorescent signal from C. elegans samples is then recorded on a large area opto-electronic sensor-array over an FOV of e. g., >2-8 cm(2), without the use of any lenses, thin-film interference filters or mechanical scanners. Because fluorescent emission rapidly diverges, such lensfree fluorescent images recorded on a chip look blurred due to broad point-spread-function of our platform. To combat this resolution challenge, we use a compressive sampling algorithm to uniquely decode the recorded lensfree fluorescent patterns into higher resolution images, demonstrating similar to 10 mm resolution. We tested the efficacy of this compressive decoding approach with different types of opto-electronic sensors to achieve a similar resolution level, independent of the imaging chip. We further demonstrate that this wide FOV lensfree fluorescent imaging platform can also perform sequential bright-field imaging of the same samples using partially-coherent lensfree digital in-line holography that is coupled from the top facet of the same prism used in fluorescent excitation. This unique combination permits ultra-wide field dual-mode imaging of C. elegans on a chip which could especially provide a useful tool for high-throughput screening applications in biomedical research.	[Coskun, Ahmet F.; Sencan, Ikbal; Su, Ting-Wei; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Calif NanoSyst Inst CNSI, Los Angeles, CA USA	University of California System; University of California Los Angeles	Coskun, AF (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	ozcan@ucla.edu	Ozcan, Aydogan/I-2608-2013; Sencan-Egilmez, Ikbal/GCE-9253-2022; Coskun, Ahmet F./K-2084-2013	Ozcan, Aydogan/0000-0002-0717-683X; Sencan-Egilmez, Ikbal/0000-0002-2903-041X; Coskun, Ahmet F./0000-0002-5797-1524	NSF [0754880, 0930501]; Office of Naval Research (ONR); Office of the Director, National Institutes of Health [DP2OD006427]; Okawa Foundation; Vodafone Americas Foundation; DARPA DSO [56556-MS-DRP]; NIH [1R21EB009222-01]; AFOSR [08NE255]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009222] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006427] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0954482, 0930501, 0754880] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Okawa Foundation; Vodafone Americas Foundation; DARPA DSO(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	A. Ozcan gratefully acknowledges the support of NSF (CAREER Award on BioPhotonics), the Office of Naval Research (ONR) under the Young Investigator Award 2009 and the NIH Director's New Innovator Award - Award Number DP2OD006427 from the Office of the Director, National Institutes of Health. The authors also acknowledge the support of the Okawa Foundation, Vodafone Americas Foundation, DARPA DSO (under 56556-MS-DRP), NSF BISH program (under Awards # 0754880 and 0930501), NIH (under 1R21EB009222-01), and AFOSR (under Project #08NE255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs DSC, 1997, APPL OPTICS, V36, P1766, DOI 10.1364/AO.36.001766; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; CHOKSHI TV, 2010, AUTOMATED MICROFLUID; Coskun AF, 2010, OPT EXPRESS, V18, P10510, DOI 10.1364/OE.18.010510; Coskun AF, 2010, LAB CHIP, V10, P824, DOI 10.1039/b926561a; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Isikman SO, 2010, LAB CHIP, V10, P1109, DOI 10.1039/c001200a; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kural C, 2009, BIOCHEMISTRY-US, V48, P4663, DOI 10.1021/bi8023477; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Pulak Rock, 2006, V351, P275; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Richard C, 2009, LAB CHIP, V9, P1371, DOI 10.1039/b819080a; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Semple JI, 2010, NAT METHODS, V7, P725, DOI 10.1038/nmeth.1495; Seo S, 2010, ANAL CHEM, V82, P4621, DOI 10.1021/ac1007915; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Su TW, 2010, OPT EXPRESS, V18, P9690, DOI 10.1364/OE.18.009690; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	33	61	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15955	10.1371/journal.pone.0015955	http://dx.doi.org/10.1371/journal.pone.0015955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253611	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900031
J	Gu, TL; Deng, XX; Huang, FZ; Tucker, M; Crosby, K; Rimkunas, V; Wang, Y; Deng, G; Zhu, L; Tan, ZP; Hu, YR; Wu, CL; Nardone, J; MacNeill, J; Ren, JM; Reeves, C; Innocenti, G; Norris, B; Yuan, J; Yu, JA; Haack, H; Shen, BY; Peng, CH; Li, HW; Zhou, XM; Liu, XY; Rush, J; Comb, MJ				Gu, Ting-Lei; Deng, Xiaxing; Huang, Feizhou; Tucker, Meghan; Crosby, Katherine; Rimkunas, Victoria; Wang, Yi; Deng, Gang; Zhu, Lei; Tan, Zhiping; Hu, Yerong; Wu, Chunlin; Nardone, Julie; MacNeill, Joan; Ren, Jianmin; Reeves, Cynthia; Innocenti, Gregory; Norris, Brett; Yuan, Jin; Yu, Jian; Haack, Herbert; Shen, Baiyong; Peng, Chenghong; Li, Hongwei; Zhou, Xinmin; Liu, Xunyang; Rush, John; Comb, Michael J.			Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma	PLOS ONE			English	Article							LIVER-REGENERATION; CANCER; GLIOBLASTOMA; EXPRESSION; PHOSPHORYLATION; PATHOGENESIS; PATHWAY; PROTEIN; GENES	Cholangiocarcinoma, also known as bile duct cancer, is the second most common primary hepatic carcinoma with a median survival of less than 2 years. The molecular mechanisms underlying the development of this disease are not clear. To survey activated tyrosine kinases signaling in cholangiocarcinoma, we employed immunoaffinity profiling coupled to mass spectrometry and identified DDR1, EPHA2, EGFR, and ROS tyrosine kinases, along with over 1,000 tyrosine phosphorylation sites from about 750 different proteins in primary cholangiocarcinoma patients. Furthermore, we confirmed the presence of ROS kinase fusions in 8.7% (2 out of 23) of cholangiocarcinoma patients. Expression of the ROS fusions in 3T3 cells confers transforming ability both in vitro and in vivo, and is responsive to its kinase inhibitor. Our data demonstrate that ROS kinase is a promising candidate for a therapeutic target and for a diagnostic molecular marker in cholangiocarcinoma. The identification of ROS tyrosine kinase fusions in cholangiocarcinoma, along with the presence of other ROS kinase fusions in lung cancer and glioblastoma, suggests that a more broadly based screen for activated ROS kinase in cancer is warranted.	[Gu, Ting-Lei; Tucker, Meghan; Crosby, Katherine; Rimkunas, Victoria; Wang, Yi; Nardone, Julie; MacNeill, Joan; Ren, Jianmin; Reeves, Cynthia; Innocenti, Gregory; Norris, Brett; Yuan, Jin; Yu, Jian; Haack, Herbert; Rush, John; Comb, Michael J.] Cell Signaling Technol, Danvers, MA USA; [Deng, Xiaxing; Shen, Baiyong; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Ctr Organ Transplantat, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Huang, Feizhou; Deng, Gang; Zhu, Lei; Liu, Xunyang] Cent S Univ, Xiangya Hosp 3, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Tan, Zhiping; Hu, Yerong; Wu, Chunlin; Zhou, Xinmin] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Shanghai Jiao Tong University; Central South University; Central South University	Gu, TL (corresponding author), Cell Signaling Technol, Danvers, MA USA.	tgu@cellsignal.com; mcomb@cellsignal.com		Peng, Chenghong/0000-0002-5573-7873				Acquaviva J, 2009, BBA-REV CANCER, V1795, P37, DOI 10.1016/j.bbcan.2008.07.006; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Eom M, 2008, PATHOL INT, V58, P226, DOI 10.1111/j.1440-1827.2008.02215.x; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Hertl M, 2005, ONCOLOGIST, V10, P269, DOI 10.1634/theoncologist.10-4-269; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Seki E, 2008, J HEPATOL, V48, P237, DOI 10.1016/j.jhep.2007.08.020	23	230	259	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15640	10.1371/journal.pone.0015640	http://dx.doi.org/10.1371/journal.pone.0015640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253578	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900007
J	Lu, H; Zhu, ZY; Dong, LL; Jia, XM; Sun, XR; Yan, L; Chai, YF; Jiang, YY; Cao, YY				Lu, Hui; Zhu, ZhenYu; Dong, LingLing; Jia, XinMing; Sun, XuanRong; Yan, Lan; Chai, YiFeng; Jiang, YuanYing; Cao, YingYing			Lack of Trehalose Accelerates H2O2-Induced Candida albicans Apoptosis through Regulating Ca2+ Signaling Pathway and Caspase Activity	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; GENE; CALCINEURIN; STRESS; DISRUPTION; RESISTANCE; TOLERANCE; MORPHOGENESIS; EPIDEMIOLOGY; MITOCHONDRIA	Trehalose is a non-reducing disaccharide and can be accumulated in response to heat or oxidative stresses in Candida albicans. Here we showed that a C. albicans tps1 Delta mutant, which is deficient in trehalose synthesis, exhibited increased apoptosis rate upon H2O2 treatment together with an increase of intracellular Ca2+ level and caspase activity. When the intracellular Ca2+ level was stimulated by adding CaCl2 or A23187, both the apoptosis rate and caspase activity were increased. In contrast, the presence of two calcium chelators, EGTA and BAPTA, could attenuate these effects. Moreover, we investigated the role of Ca2+ pathway in C. albicans apoptosis and found that both calcineurin and the calcineurin-dependent transcription factor, Crz1p, mutants showed decreased apoptosis and caspase activity upon H2O2 treatment compared to the wild-type cells. Expression of CaMCA1, the only gene found encoding a C. albicans metacaspase, in calcineurin-deleted or Crz1p-deleted cells restored the cell sensitivity to H2O2. Our results suggest that Ca2+ and its downstream calcineurin/Crz1p/CaMCA1 pathway are involved in H2O2 -induced C. albicans apoptosis. Inhibition of this pathway might be the mechanism for the protective role of trehalose in C. albicans.	[Lu, Hui; Zhu, ZhenYu; Dong, LingLing; Jia, XinMing; Sun, XuanRong; Yan, Lan; Chai, YiFeng; Jiang, YuanYing; Cao, YingYing] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Naval Medical University	Lu, H (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	caoyingying608@yahoo.com.cn	jiang, anyi/GPT-0379-2022	Lu, Hui/0000-0002-8422-0427	National Natural Science Foundation of China [30630071, 30870105]; Shanghai Rising-Star Program [08QA14001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by the National Natural Science Foundation of China (No. 30630071, 30870105) and Shanghai Rising-Star Program (08QA14001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dhaheri RS, 2010, J MED MICROBIOL, V59, P149, DOI 10.1099/jmm.0.015784-0; ALVAREZ P, 2002, MICROBIOLOGY, V148, P2599; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bader T, 2006, INFECT IMMUN, V74, P4366, DOI 10.1128/IAI.00142-06; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Cao YY, 2009, FUNGAL GENET BIOL, V46, P183, DOI 10.1016/j.fgb.2008.11.001; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Liu Q, 2009, TRANSFUSION, V49, P2158, DOI 10.1111/j.1537-2995.2009.02254.x; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martinez-Esparza M, 2007, CLIN MICROBIOL INFEC, V13, P384, DOI 10.1111/j.1469-0691.2007.01663.x; Onyewu Chiatogu, 2004, Infection and Immunity, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Redding SW, 1999, J CLIN MICROBIOL, V37, P3896, DOI 10.1128/JCM.37.12.3896-3900.1999; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; STEINBACH WJ, 2000, PHYSIOL REV, V80, P1483; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Wadskog I, 2004, MOL BIOL CELL, V15, P1436, DOI 10.1091/mbc.E03-02-0114; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281	42	42	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15808	10.1371/journal.pone.0015808	http://dx.doi.org/10.1371/journal.pone.0015808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246042	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511200015
J	Drake, LL; Boudko, DY; Marinotti, O; Carpenter, VK; Dawe, AL; Hansen, IA				Drake, Lisa L.; Boudko, Dmitri Y.; Marinotti, Osvaldo; Carpenter, Victoria K.; Dawe, Angus L.; Hansen, Immo A.			The Aquaporin Gene Family of the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							GENOME SEQUENCE; WATER CHANNEL; BEETLEBASE; GLYCEROL; BRAIN	Background: The mosquito, Aedes aegypti, is the principal vector of the Dengue and yellow fever viruses. During feeding, an adult female can take up more than its own body weight in vertebrate blood. After a blood meal females excrete large amounts of urine through their excretion system, the Malpighian tubules (MT). Diuresis starts within seconds after the mosquito starts feeding. Aquaporins (AQPs) are a family of membrane transporters that regulate the flow of water, glycerol and other small molecules across cellular membranes in both prokaryotic and eukaryotic cells. Our aim was to identify aquaporins that function as water channels, mediating transcellular water transport in MTs of adult female Ae. aegypti. Methodology/Principal Findings: Using a bioinformatics approach we screened genome databases and identified six putative AQPs in the genome of Ae. aegypti. Phylogenetic analysis showed that five of the six Ae. aegypti AQPs have high similarity to classical water-transporting AQPs of vertebrates. Using microarray, reverse transcription and real time PCR analysis we found that all six AQPs are expressed in distinct patterns in mosquito tissues/body parts. AaAQP1, 4, and 5 are strongly expressed in the adult female MT. RNAi-mediated knockdown of the MT-expressed mosquito AQPs resulted in significantly reduced diuresis. Conclusions/Significance: Our results support the notion that AQP1, 4, and 5 function as water transporters in the MTs of adult female Ae. aegypti mosquitoes. Our results demonstrate the importance of these AQPs for mosquito diuresis after blood ingestion and highlight their potential as targets for the development of novel vector control strategies.	[Drake, Lisa L.; Carpenter, Victoria K.; Dawe, Angus L.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hansen, Immo A.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA; [Dawe, Angus L.; Hansen, Immo A.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; [Boudko, Dmitri Y.] Rosalind Franklin Univ, Chicago Med Sch, N Chicago, IL USA; [Marinotti, Osvaldo] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	New Mexico State University; New Mexico State University; New Mexico State University; Chicago Medical School; Rosalind Franklin University Medical & Science; University of California System; University of California Irvine	Drake, LL (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu		Marinotti, Osvaldo/0000-0002-7173-7160; Boudko, Dmitri/0000-0002-1899-044X	Howard Hughes Medical Institute [52005881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI030464] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project had two funding sources. First, start-up money given to Immo Hansen by the vice president for research of New Mexico State University. Secondly, this project was supported in part by grant #52005881 to NMSU from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; BOORMAN J. P. T., 1960, ANN TROP MED ANDPARASITOL, V54, P8; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Clements A.N., 1992, BIOL MOSQUITOES, V1; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; EMBL-EBI, 2010, ENS AED AEG; Furukawa K, 2009, MOL MICROBIOL, V74, P1272, DOI 10.1111/j.1365-2958.2009.06933.x; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Ikeguchi M, 2009, FRONT BIOSCI-LANDMRK, V14, P1283, DOI 10.2741/3308; Jagge CL, 2008, INSECT MOL BIOL, V17, P413, DOI 10.1111/j.1365-2583.2008.00817.x; Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kaufmann N, 2005, AM J PHYSIOL-CELL PH, V289, pC397, DOI 10.1152/ajpcell.00612.2004; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu KCTH, 2010, CLON CHAR AN GAMB AQ; NCBI, 2009, PRIMERBLAST; NCBI, 2010, GENB; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; NIAID, 2010, VECT; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Pietrantonio PV, 2000, INSECT MOL BIOL, V9, P407, DOI 10.1046/j.1365-2583.2000.00201.x; Pittendrigh BR, 2006, J MED ENTOMOL, V43, P1103, DOI 10.1603/0022-2585(2006)43[1103:SOANTG]2.0.CO;2; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Rambaut A., FIGTREE; REDINGTON BC, 1976, J INSECT PHYSIOL, V22, P961, DOI 10.1016/0022-1910(76)90079-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schepel SA, 2010, AM J PHYSL REGUL INT; Shepard AR, 2005, ANAL BIOCHEM, V344, P287, DOI 10.1016/j.ab.2005.06.005; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Spring JH, 2009, J EXP BIOL, V212, P358, DOI 10.1242/jeb.024794; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatsumi K, 2009, FEBS LETT, V583, P2077, DOI 10.1016/j.febslet.2009.05.035; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Wang LJ, 2007, NUCLEIC ACIDS RES, V35, pD476, DOI 10.1093/nar/gkl776; Wang S, 1996, J EXP BIOL, V199, P2537; Yoder JA, 2006, J INSECT PHYSIOL, V52, P202, DOI 10.1016/j.jinsphys.2005.10.005; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	46	71	74	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15578	10.1371/journal.pone.0015578	http://dx.doi.org/10.1371/journal.pone.0015578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21249121	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200028
J	Chen, R; Liliental, JE; Kowalski, PE; Lu, Q; Cohen, SN				Chen, R.; Liliental, J. E.; Kowalski, P. E.; Lu, Q.; Cohen, S. N.			Regulation of transcription of hypoxia-inducible factor-1 alpha (HIF-1 alpha) by heat shock factors HSF2 and HSF4	ONCOGENE			English	Article						heat shock factor; heat shock element; angiogenesis; HSE; VEGF; HIF-1 alpha	ENDOTHELIAL GROWTH-FACTOR; PROTEOTOXIC STRESS; FACTOR FAMILY; RESPONSE ELEMENT; LENS DEVELOPMENT; EXPRESSION; CELLS; GENE; INDUCTION; PROMOTER	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a principal regulator of angiogenesis and other cellular responses to hypoxic stress in both normal and tumor cells. To identify novel mechanisms that regulate expression of HIF-1 alpha, we designed a genome-wide screen for expressed sequence tags (ESTs) that when transcribed in the antisense direction increase production of the HIF-1 alpha target, vascular endothelial growth factor (VEGF), in human breast cancer cells. We discovered that heat shock factor (HSF) proteins 2 and 4-which previously have been implicated in the control of multiple genes that modulate cell growth and differentiation and protect against effects of environmental and cellular stresses-function together to maintain a steady state level of HIF-1 alpha transcription and VEGF production in these cells. We show both HSFs bind to discontinuous heat shock element (HSE) sequences we identified in the HIF-1 alpha promoter region and that downregulation of either HSF activates transcription of HIF-1 alpha. We further demonstrate that HSF2 and HSF4 displace each other from HSF/HSE complexes in the HIF-1 alpha promoter so that HIF-1 alpha transcription is also activated by overexpression of either HSFs. These results argue that HSF2 and HSF4 regulate transcription of HIF-1 alpha and that a critical balance between these HSF is required to maintain HIF-alpha expression in a repressed state. Our findings reveal a previously unsuspected role for HSFs in control of VEGF and other genes activated by canonical HIF-1 alpha-mediated signaling. Oncogene (2011) 30, 2570-2580; doi:10.1038/onc.2010.623; published online 24 January 2011	[Chen, R.; Liliental, J. E.; Kowalski, P. E.; Lu, Q.; Cohen, S. N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Cohen, S. N.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Cohen, SN (corresponding author), Stanford Univ, Dept Genet, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	sncohen@stanford.edu			Kwoh-Ting Li Professorship; National Foundation for Cancer Research (NFCR)	Kwoh-Ting Li Professorship; National Foundation for Cancer Research (NFCR)	The study was supported by funds from the Kwoh-Ting Li Professorship to SNC, and by a grant from the National Foundation for Cancer Research (NFCR) to SNC.	Akerfelt M, 2008, P NATL ACAD SCI USA, V105, P11224, DOI 10.1073/pnas.0800620105; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2008, J BIOL CHEM, V283, P29961, DOI 10.1074/jbc.M804629200; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jiang BH, 1997, CANCER RES, V57, P5328; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Mazure NM, 1996, CANCER RES, V56, P3436; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Murphy LA, 2008, EXP CELL RES, V314, P2224, DOI 10.1016/j.yexcr.2008.04.015; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Ng YS, 2006, EXP CELL RES, V312, P527, DOI 10.1016/j.yexcr.2005.11.008; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pipinikas C, 2008, BIOMARKERS, V13, P680, DOI 10.1080/13547500802591992 ; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Schafer C, 1999, AM J PHYSIOL-CELL PH, V277, pC1032; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Somasundaram T, 2004, J BIOL CHEM, V279, P44497, DOI 10.1074/jbc.M405813200; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yamamoto N, 2009, FEBS J, V276, P1962, DOI 10.1111/j.1742-4658.2009.06923.x; Zhang J, 2008, J BIOL CHEM, V283, P7464, DOI 10.1074/jbc.M707122200; Zhang Y, 2001, J CELL BIOCHEM, V82, P692, DOI 10.1002/jcb.1191	43	31	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	22					2570	2580		10.1038/onc.2010.623	http://dx.doi.org/10.1038/onc.2010.623			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21258402				2022-12-25	WOS:000291198400008
J	Perier, A; Fregni, G; Wittnebel, S; Gad, S; Allard, M; Gervois, N; Escudier, B; Azzarone, B; Caignard, A				Perier, A.; Fregni, G.; Wittnebel, S.; Gad, S.; Allard, M.; Gervois, N.; Escudier, B.; Azzarone, B.; Caignard, A.			Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma	ONCOGENE			English	Article						von Hippel-Lindau mutation; NK cells; renal cell carcinoma; immunotherapy	TUMOR-SUPPRESSOR GENE; NK CELLS; IFN-GAMMA; HLA-G; DOWN-REGULATION; POOR SURVIVAL; EXPRESSION; CANCER; RECEPTORS; HYPOXIA	The tumor suppressor gene von Hippel-Lindau (VHL) is involved in the development of sporadic clear-cell renal cell carcinoma (RCC). VHL interferes with angiogenesis and also controls cell adhesion and invasion. Therapies that target VHL-controlled genes are currently being evaluated in RCC patients. RCC is a immunogenic tumor and treatment with interleukin-2 (IL2) or interferon (IFN)-alpha results in regression in some patients. We used two renal tumor cell lines (RCC6 and RCC4) carrying VHL loss-of-function mutations to investigate the role of mutant VHL in susceptibility to natural killer (NK) cell-mediated lysis. The RCC6 and RCC4 cell lines were transfected with the wild-type gene to restore the function of VHL. The presence of the gene in RCC cells downregulated hypoxia-inducible factor (HIF)-1 alpha and subsequently decreased vascular endothelial growth factor (VEGF) production. Relative to control transfectants and parental cells, pVHL-transfected cell lines activated resting and IL2-activated NK cells less strongly, as assessed by IFN gamma secretion, NK degranulation and cell lysis. NKG2A, a human leukocyte antigen (HLA)-I-specific inhibitory NK receptor, controls the lysis of tumor targets. We show that HLA-I expression in RCC-pVHL cells is stronger than that in parental and controls cells, although the expression of activating receptor NK ligands remains unchanged. Blocking NKG2A/HLA-I interactions substantially increased lysis of RCC-pVHL, but had little effect on the lysis of VHL-mutated RCC cell lines. In addition, in response to IFN alpha, the exponential growth of RCC-pVHL was inhibited more than that of RCC-pE cells, indicating that VHL mutations may be involved in IFN alpha resistance. These results indicate that a decreased expression of HLA-I molecules in mutated VHL renal tumor cells sensitizes them to NK-mediated lysis. These results suggest that combined immunotherapy with anti-angiogenic drugs may be beneficial for patients with mutated VHL. Oncogene (2011) 30, 2622-2632; doi:10.1038/onc.2010.638; published online 24 January 2011	[Perier, A.; Fregni, G.; Caignard, A.] Univ Paris 05, CNRS, INSERM, Inst Cochin,UMR 8104,U1016, F-75014 Paris, France; [Fregni, G.] Inst Gustave Roussy, INSERM, U753, F-94805 Villejuif, France; [Gad, S.] Inst Gustave Roussy, INSERM, U753, Lab Genet Oncol EPHE, F-94805 Villejuif, France; [Allard, M.; Gervois, N.] INSERM, U892, Nantes, France; [Escudier, B.] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; [Azzarone, B.] Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Caignard, A (corresponding author), Univ Paris 05, CNRS, INSERM, Inst Cochin,UMR 8104,U1016, Batiment Gustave Roussy,27 Rue Faubourg St Jacque, F-75014 Paris, France.	anne.caignard@inserm.fr	Azzarone, Bruno/AAH-9251-2019; Caignard, Anne/F-8159-2013; Gervois, Nadine/K-6658-2015; allard, mathilde/C-9577-2018	Azzarone, Bruno/0000-0002-5962-3849; Caignard, Anne/0000-0001-9923-6045; Gervois, Nadine/0000-0002-0092-3919; allard, mathilde/0000-0002-2217-1295; GAD (LAPITEAU), Sophie/0000-0002-3158-6791	INSERM; INCa; la Fondation pour la Recherche Medicale (FRM); la Ligue Nationale contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INCa(Institut National du Cancer (INCA) France); la Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from INSERM, INCa, la Fondation pour la Recherche Medicale (FRM) and la Ligue Nationale contre le Cancer. AP had a grant from FRM. We thank Dr Nadege Bercovici for helpful discussion and reading of manuscript.	Aggelis V, 2009, PROTEOMICS, V9, P2118, DOI 10.1002/pmic.200800756; Alberti L, 2004, INT J CANCER, V111, P653, DOI 10.1002/ijc.20287; Atkins D, 2004, J UROLOGY, V171, P885, DOI 10.1097/01.ju.0000094807.95420.fe; Atkins MB, 2009, CANCER-AM CANCER SOC, V115, P2327, DOI 10.1002/cncr.24231; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Cozar J, 2005, CANCER IMMUNOL IMMUN, V54, P858, DOI 10.1007/s00262-004-0646-1; Donskov F, 2002, BRIT J CANCER, V87, P194, DOI 10.1038/sj.bjc.6600437; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gad S, 2007, BRIT J CANCER, V96, P336, DOI 10.1038/sj.bjc.6603492; Gati A, 2004, INT J CANCER, V109, P393, DOI 10.1002/ijc.11730; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gobin SJP, 2000, HUM IMMUNOL, V61, P1102, DOI 10.1016/S0198-8859(00)00198-1; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Ibrahim EC, 2001, CANCER RES, V61, P6838; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Kilburn BA, 2000, BIOL REPROD, V62, P739, DOI 10.1095/biolreprod62.3.739; Kopper L, 2006, PATHOL ONCOL RES, V12, P5, DOI 10.1007/BF02893425; Lahn M, 1999, EUR UROL, V35, P70, DOI 10.1159/000019821; Lanier LL, 2000, J EXP MED, V191, P1259, DOI 10.1084/jem.191.8.1259; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Linehan WM, 2009, CANCER-AM CANCER SOC, V115, P2252, DOI 10.1002/cncr.24230; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Mouillot G, 2007, HUM IMMUNOL, V68, P277, DOI 10.1016/j.humimm.2006.10.016; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Osborne A, 1997, NUCLEIC ACIDS RES, V25, P5095, DOI 10.1093/nar/25.24.5095; Parker AS, 2005, UROLOGY, V65, P1090, DOI 10.1016/j.urology.2004.12.040; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2008, INT J CANCER, V123, P395, DOI 10.1002/ijc.23496; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Schleypen JS, 2003, INT J CANCER, V106, P905, DOI 10.1002/ijc.11321; Segerer S, 2006, KIDNEY INT, V69, P1765, DOI 10.1038/sj.ki.5000337; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Smits KM, 2008, CLIN CANCER RES, V14, P782, DOI 10.1158/1078-0432.CCR-07-1753; Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; WHALEY JM, 1994, AM J HUM GENET, V55, P1092; Wittnebel S, 2007, CANCER RES, V67, P5594, DOI 10.1158/0008-5472.CAN-06-4406; Wysocki PJ, 2010, CANCER GENE THER, V17, P465, DOI 10.1038/cgt.2010.2; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Zagzag D, 2005, LAB INVEST, V85, P328, DOI 10.1038/labinvest.3700233; Zhu J, 2006, J IMMUNOL METHODS, V309, P25, DOI 10.1016/j.jim.2005.10.018	54	21	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	23					2622	2632		10.1038/onc.2010.638	http://dx.doi.org/10.1038/onc.2010.638			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21258414				2022-12-25	WOS:000291677800003
J	Chen, H; Liu, LH; Ma, BY; Ma, TM; Hou, JJ; Xie, GM; Wu, W; Yang, FQ; Chen, YG				Chen, Hua; Liu, Linhua; Ma, Benyu; Ma, Ting Martin; Hou, Jun-Jie; Xie, Guo-Ming; Wu, Wei; Yang, Fu-Quan; Chen, Ye-Guang			Protein Kinase A-mediated 14-3-3 Association Impedes Human Dapper1 to Promote Dishevelled Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; COLORECTAL-CANCER; WNT PATHWAY; PHOSPHORYLATION; ACTIVATION; GENE; CYCLOOXYGENASE-2; BINDING; MICE; OVEREXPRESSION	Wnt signaling regulates embryo development and tissue homeostasis, and its deregulation leads to an array of diseases, including cancer. Dapper1 has been shown to be a key negative regulator of Wnt signaling. However, its function and regulation remain poorly understood. In this study, we report that 14-3-3 beta interacts with human Dapper1 (hDpr1). The interaction is dependent on protein kinase A (PKA)-mediated phosphorylation of hDpr1 at Ser-237 and Ser-827. 14-3-3 beta binding attenuates the ability of hDpr1 to promote Dishevelled (Dvl) degradation, thus enhancing Wnt signaling. We further provide evidence that PKA-mediated Dpr1 phosphorylation may contribute to growth and tumor formation of colon cancer Caco2 cells. Finally, we show that cyclooxygenase-2 expression and PKA activation are positively correlated with Dvl protein levels in colon cancer samples. Together, our findings establish a novel layer of regulation of Wnt signaling by PKA via the 14-3-3-Dpr1-Dvl axis.	[Chen, Hua; Liu, Linhua; Ma, Benyu; Ma, Ting Martin; Xie, Guo-Ming; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Chen, Hua; Liu, Linhua; Ma, Benyu; Ma, Ting Martin; Xie, Guo-Ming; Wu, Wei; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hou, Jun-Jie; Yang, Fu-Quan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019		National Natural Science Foundation of China [30930050, 30921004]; 973 Program [2006CB943401, 2010CB833706, 2010CB833703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30930050 and 30921004 and the 973 Program Grants 2006CB943401 and 2010CB833706 (to Y.-G.C.) and 2010CB833703 (to F.-Q.Y.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Itoh K, 2005, J BIOL, V4; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Teran E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005522; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	59	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14870	14880		10.1074/jbc.M110.211607	http://dx.doi.org/10.1074/jbc.M110.211607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21262972	hybrid, Green Published			2022-12-25	WOS:000289788300017
J	Mohan, SK; Yu, C				Mohan, Sepuru K.; Yu, Chin			The IL1 alpha-S100A13 Heterotetrameric Complex Structure A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR INTERLEUKIN 1 alpha SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; RHEUMATOID-ARTHRITIS; MAMMALIAN-CELLS; PLASMA-MEMBRANE; FUNCTIONAL-ROLE; CHEMICAL-SHIFT; EXPORT ROUTES; HEAT-SHOCK; PROTEIN; S100A13	Interleukin 1 alpha (IL1 alpha) plays an important role in several key biological functions, such as angiogenesis, cell proliferation, and tumor growth in several types of cancer. IL1 alpha is a potent cytokine that induces a wide spectrum of immunological and inflammatory activities. The biological effects of IL1 alpha are mediated through the activation of transmembrane receptors (IL1Rs) and therefore require the release of the protein into the extracellular space. IL1 alpha is exported through a non-classical release pathway involving the formation of a specific multiprotein complex, which includes IL1 alpha and S100A13. Because IL1 alpha plays an important role in cell proliferation and angiogenesis, inhibiting the formation of the IL1 alpha-S100A13 complex would be an effective strategy to inhibit a wide range of cancers. To understand the molecular events in the IL1 alpha release pathway, we studied the structure of the IL1 alpha-S100A13 tetrameric complex, which is the key complex formed during the non-classical pathway of IL1 alpha release.	[Mohan, Sepuru K.; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan	National Tsing Hua University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cyu.nthu@gmail.com	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	National Science Council of Taiwan [98-2113-M-007-018-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grant 98-2113-M-007-018-MY2.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bhattacharya S, 2003, STRUCTURE, V11, P738, DOI 10.1016/S0969-2126(03)00132-1; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Carreira CM, 2001, CANCER RES, V61, P8079; Chang HK, 2010, BIOMOL NMR ASSIGN, V4, P59, DOI 10.1007/s12104-010-9207-z; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Combarros O, 2007, J NEUROL, V254, P115, DOI 10.1007/s00415-006-0291-z; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Goddard T. D., 2008, SPARKY 3; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; GRZESIEK S, 1993, J MAGN RESON SER B, V102, P103, DOI 10.1006/jmrb.1993.1069; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hayrabedyan S, 2005, J REPROD IMMUNOL, V67, P87, DOI 10.1016/j.jri.2005.07.001; Hubbard S. J., 1993, NACCESS; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; KATHIR KM, 2007, BIOCHIM BIOPHYS ACTA, V12, P3080; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Landriscina M, 2001, J BIOL CHEM, V276, P25549, DOI 10.1074/jbc.M102925200; Landriscina M, 2006, J NEURO-ONCOL, V80, P251, DOI 10.1007/s11060-006-9189-y; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; Mandinova A, 2003, J CELL SCI, V116, P2687, DOI 10.1242/jcs.00471; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pierce A, 2008, EUR J CANCER, V44, P151, DOI 10.1016/j.ejca.2007.10.017; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rani SG, 2010, BIOCHEMISTRY-US, V49, P2585, DOI 10.1021/bi9019077; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shin JT, 1996, BBA-MOL CELL RES, V1312, P27, DOI 10.1016/0167-4889(96)00013-4; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sivaraja V, 2006, BIOPHYS J, V91, P1832, DOI [10.1529/biophysj.105.079988, 10.1529/biophysj.106.079988]; Soldi R, 2007, EXP CELL RES, V313, P3308, DOI 10.1016/j.yexcr.2007.05.031; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Tarantini F, 2001, J BIOL CHEM, V276, P5147, DOI 10.1074/jbc.C000714200; Wang AJ, 1996, CURR OPIN BIOTECH, V7, P403, DOI 10.1016/S0958-1669(96)80115-7; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	60	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14608	14617		10.1074/jbc.M110.201954	http://dx.doi.org/10.1074/jbc.M110.201954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21270123	hybrid, Green Published			2022-12-25	WOS:000289556200080
J	Azoulay-Alfaguter, I; Yaffe, Y; Licht-Murava, A; Urbanska, M; Jaworski, J; Pietrokovski, S; Hirschberg, K; Eldar-Finkelman, H				Azoulay-Alfaguter, Inbar; Yaffe, Yakey; Licht-Murava, Avital; Urbanska, Malgorzata; Jaworski, Jacek; Pietrokovski, Shmuel; Hirschberg, Koret; Eldar-Finkelman, Hagit			Distinct Molecular Regulation of Glycogen Synthase Kinase-3 alpha Isozyme Controlled by Its N-terminal Region FUNCTIONAL ROLE IN CALCIUM/CALPAIN SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MAP KINASE; CYCLIN D1; SUBSTRATE-SPECIFICITY; ALZHEIMERS-DISEASE; BINDING-PROTEIN; CALPAIN; PHOSPHORYLATION; GSK-3; TARGET	Glycogen synthase kinase-3 (GSK-3) is expressed as two isozymes alpha and beta. They share high similarity in their catalytic domains but differ in their N- and C-terminal regions, with GSK-3 alpha having an extended glycine-rich N terminus. Here, we undertook live cell imaging combined with molecular and bioinformatic studies to understand the distinct functions of the GSK-3 isozymes focusing on GSK-3 alpha N-terminal region. We found that unlike GSK-3 beta, which shuttles between the nucleus and cytoplasm, GSK-3 alpha was excluded from the nucleus. Deletion of the N-terminal region of GSK-3 alpha resulted in nuclear localization, and treatment with leptomycin B resulted in GSK-3 alpha accumulation in the nucleus. GSK-3 alpha rapidly accumulated in the nucleus in response to calcium or serum deprivation, and accumulation was strongly inhibited by the calpain inhibitor calpeptin. This nuclear accumulation was not mediated by cleavage of the N-terminal region or phosphorylation of GSK-3 alpha. Rather, we show that calcium-induced GSK-3 alpha nuclear accumulation was governed by GSK-3 alpha binding with as yet unknown calpain-sensitive protein or proteins; this binding was mediated by the N-terminal region. Bioinformatic and experimental analyses indicated that nuclear exclusion of GSK-3 alpha was likely an exclusive characteristic of mammalian GSK-3 alpha. Finally, we show that nuclear localization of GSK-3 alpha reduced the nuclear pool of beta-catenin and its target cyclin D1. Taken together, these data suggest that the N-terminal region of GSK-3 alpha is responsible for its nuclear exclusion and that binding with a calcium/calpain-sensitive product enables GSK-3 alpha nuclear retention. We further uncovered a novel link between calcium and nuclear GSK-3 alpha-mediated inhibition of the canonical Wnt/beta-catenin pathway.	[Eldar-Finkelman, Hagit] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Yaffe, Yakey; Hirschberg, Koret] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Urbanska, Malgorzata; Jaworski, Jacek] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Pietrokovski, Shmuel] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Weizmann Institute of Science	Eldar-Finkelman, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	heldar@post.tau.ac.il		Pietrokovski, Shmuel/0000-0001-8573-5863; Urbanska, Malgorzata/0000-0001-9521-0366; Yaffe, Yakey/0000-0003-4518-191X; Eldar-Finkelman, Hagit/0000-0002-8460-9686	European Union [223276]; Israeli Academy of Sciences [341/10]	European Union(European Commission); Israeli Academy of Sciences	This work was supported by Seventh Framework Program (FP7) European Union Grant 223276 "NeuroGSK3" and Israeli Academy of Sciences Grant 341/10.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bendetz-Nezer S, 2007, J BIOL CHEM, V282, P25114, DOI 10.1074/jbc.M703120200; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Bertipaglia I., 2007, V45, P29; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Bijur GN, 2000, J BIOL CHEM, V275, P7583, DOI 10.1074/jbc.275.11.7583; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dukhovny A, 2008, J CELL SCI, V121, P865, DOI 10.1242/jcs.019463; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franca-Koh J, 2002, J BIOL CHEM, V277, P43844, DOI 10.1074/jbc.M207265200; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Goni-Oliver P, 2009, J ALZHEIMERS DIS, V18, P843, DOI 10.3233/JAD-2009-1190; Goslin K., 1991, CULTURING NERVE CELL, P251; Gould TD, 2004, J CLIN PSYCHIAT, V65, P10; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang HC, 2006, CURR DRUG TARGETS, V7, P1389, DOI 10.2174/1389450110607011389; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Johnson GVW, 2006, J ALZHEIMERS DIS, V9, P243; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kindler S, 2009, J BIOL CHEM, V284, P25431, DOI 10.1074/jbc.M109.022137; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li G, 2002, P NATL ACAD SCI USA, V99, P13254, DOI 10.1073/pnas.202355799; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Schloesser RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P110, DOI 10.1038/sj.npp.1301575; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	72	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13470	13480		10.1074/jbc.M110.127969	http://dx.doi.org/10.1074/jbc.M110.127969			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21266584	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000289282200067
J	Boeda, B; Knowles, PP; Briggs, DC; Murray-Rust, J; Soriano, E; Garvalov, BK; McDonald, NQ; Way, M				Boeda, Batiste; Knowles, Phillip P.; Briggs, David C.; Murray-Rust, Judith; Soriano, Erika; Garvalov, Boyan K.; McDonald, Neil Q.; Way, Michael			Molecular Recognition of the Tes LIM2-3 Domains by the Actin-related Protein Arp7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR ACTIN; ACROSOME; ACROPLAXOME; EVOLUTION; REGION; GENES; PLATE	Actin-related proteins (Arps) are a highly conserved family of proteins that have extensive sequence and structural similarity to actin. All characterized Arps are components of large multimeric complexes associated with chromatin or the cytoskeleton. In addition, the human genome encodes five conserved but largely uncharacterized "orphan" Arps, which appear to be mostly testis-specific. Here we show that Arp7A, which has 43% sequence identity with beta-actin, forms a complex with the cytoskeletal proteins Tes and Mena in the subacrosomal layer of round spermatids. The N-terminal 65-residue extension to the actin-like fold of Arp7A interacts directly with Tes. The crystal structure of the 1-65(Arp7A).LIM2-3(Tes).EVH1(Mena) complex reveals that residues 28-49 of Arp7A contact the LIM2-3 domains of Tes. Two alanine residues from Arp7A that occupy equivalent apolar pockets in both LIM domains as well as an intervening GPAK linker that binds the LIM2-3 junction are critical for the Arp7A-Tes interaction. Equivalent occupied apolar pockets are also seen in the tandem LIM domain structures of LMO4 and Lhx3 bound to unrelated ligands. Our results indicate that apolar pocket interactions are a common feature of tandem LIM domain interactions, but ligand specificity is principally determined by the linker sequence.	[Knowles, Phillip P.; Briggs, David C.; Murray-Rust, Judith; Soriano, Erika; McDonald, Neil Q.] London Res Inst, Canc Res UK, Struct Biol Lab, London WC2A 3LY, England; [Boeda, Batiste; Way, Michael] London Res Inst, Cell Motil Lab, London WC2A 3LY, England; [Briggs, David C.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Garvalov, Boyan K.] Univ Giessen, Inst Neuropathol, D-35392 Giessen, Germany; [Boeda, Batiste] Inst Pasteur, CNRS 2582, Cell Polar & Migrat Grp, F-75724 Paris, France; [McDonald, Neil Q.] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [McDonald, Neil Q.] Birkbeck Coll, London WC1E 7HX, England	Cancer Research UK; University of Manchester; Justus Liebig University Giessen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; Birkbeck University London; University College London; University of London; Birkbeck University London	McDonald, NQ (corresponding author), London Res Inst, Canc Res UK, Struct Biol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	neil.mcdonald@cancer.org.uk; michael.way@cancer.org.uk	Garvalov, Boyan K./AAF-6414-2020; BOEDA, Batiste/L-7217-2018	Garvalov, Boyan K./0000-0003-0013-9064; Soriano, Erika V./0000-0002-2972-9386; Boeda, Batiste/0000-0002-0806-8582; Way, Michael/0000-0001-7207-2722; Briggs, David/0000-0002-9793-7339	Cancer Research UK [10747] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Behnen M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-34; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Chadwick BP, 1999, GENOMICS, V58, P302, DOI 10.1006/geno.1999.5848; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goodson HV, 2002, J CELL SCI, V115, P2619; Hara Y, 2008, FEBS LETT, V582, P2998, DOI 10.1016/j.febslet.2008.07.058; Heid HW, 2002, EXP CELL RES, V279, P177, DOI 10.1006/excr.2002.5603; Hisano M, 2003, MOL REPROD DEV, V65, P148, DOI 10.1002/mrd.10276; Hyenne V, 2007, REPRODUCTION, V133, P563, DOI 10.1530/REP-06-0271; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Meagher RB, 2009, INT REV CEL MOL BIO, V277, P157, DOI 10.1016/S1937-6448(09)77005-4; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Tanaka H, 2003, BIOL REPROD, V69, P475, DOI 10.1095/biolreprod.103.015867; Tatarelli C, 2000, GENOMICS, V68, P1, DOI 10.1006/geno.2000.6272; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	42	27	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11543	11554		10.1074/jbc.M110.171264	http://dx.doi.org/10.1074/jbc.M110.171264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278383	hybrid, Green Published			2022-12-25	WOS:000288797100064
J	Pylypenko, O; Song, L; Squires, G; Liu, XY; Zong, AB; Houdusse, A; Sweeney, HL				Pylypenko, Olena; Song, Lin; Squires, Gaelle; Liu, Xiaoyan; Zong, Alan B.; Houdusse, Anne; Sweeney, H. Lee			Role of Insert-1 of Myosin VI in Modulating Nucleotide Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CARDIOMYOPATHY; KINETIC MECHANISM; ACTIN-FILAMENTS; BINDING; MOTOR; SUBFRAGMENT-1; PROCESSIVITY; STROKE; ATPASE; SITES	Myosin VI is unique in its directionality among myosin superfamily members and also displays a slow and strain-dependent rate of ATP binding that allows for gating between its heads. In this study we demonstrate that leucine 310 is positioned by a class VI-specific insert, insert-1, so as to account for the selective hindrance of ATP versus ADP binding. Mutation of leucine 310 to glycine removes all influence of insert-1 on ATP binding. Furthermore, by analyzing myosin VI structures with either leucine 310 substituted to a glycine or complete removal of insert-1, we conclude that nucleotides may initially bind to myosin by their purine rings before docking their phosphate moieties. Otherwise, insert-1 could not exert a differential influence on ATP versus ADP binding.	[Pylypenko, Olena; Squires, Gaelle; Houdusse, Anne] CNRS, Inst Curie, UMR144, F-75248 Paris 05, France; [Song, Lin; Liu, Xiaoyan; Zong, Alan B.; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Pennsylvania	Houdusse, A (corresponding author), CNRS, Inst Curie, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	Anne.Houdusse@curie.fr	Sweeney, H Lee/F-1862-2010	Pylypenko, Olena/0000-0001-7073-5238	National Institutes of Health [DC009100]; CNRS; ANR Blanche [BLAN07-3_193368]; ACI BCMS; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR Blanche(French National Research Agency (ANR)); ACI BCMS; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC009100 (to H. L. S.). This work was also supported by CNRS (to A. H.), ANR Blanche BLAN07-3_193368 (to A. H.), and ACI BCMS (to A. H.).	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; Havndrup O, 2003, CARDIOVASC RES, V57, P347, DOI 10.1016/S0008-6363(02)00711-3; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Reifenberger JG, 2009, P NATL ACAD SCI USA, V106, P18255, DOI 10.1073/pnas.0900005106; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	31	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11716	11723		10.1074/jbc.M110.200626	http://dx.doi.org/10.1074/jbc.M110.200626			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278381	Green Published, hybrid			2022-12-25	WOS:000288797100079
J	Chen, CH; Huang, PH; Chu, PC; Chen, MC; Chou, CC; Wang, DS; Kulp, SK; Teng, CM; Wang, QB; Chen, CS				Chen, Chun-Han; Huang, Po-Hsien; Chu, Po-Chen; Chen, Mei-Chuan; Chou, Chih-Chien; Wang, Dasheng; Kulp, Samuel K.; Teng, Che-Ming; Wang, Qianben; Chen, Ching-Shih			Energy Restriction-mimetic Agents Induce Apoptosis in Prostate Cancer Cells in Part through Epigenetic Activation of KLF6 Tumor Suppressor Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-6; TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; UP-REGULATION; TARGET; SP1; THIAZOLIDINEDIONES; METABOLISM; CARCINOMA; PROMOTER	Although energy restriction has been recognized as an important target for cancer prevention, the mechanism by which energy restriction-mimetic agents (ERMAs) mediate apoptosis remains unclear. By using a novel thiazolidinedione-derived ERMA, CG-12 (Wei, S., Kulp, S. K., and Chen, C. S. (2010) J. Biol. Chem. 285, 9780-9791), vis-a-vis 2-deoxyglucose and glucose deprivation, we obtain evidence that epigenetic activation of the tumor suppressor gene Kruppel-like factor 6 (KLF6) plays a role in ERMA-induced apoptosis in LNCaP prostate cancer cells. KLF6 regulates the expression of many proapoptotic genes, and shRNA-mediated KLF6 knockdown abrogated the ability of ERMAs to induce apoptosis. Chromatin immunoprecipitation analysis indicates that this KLF6 transcriptional activation was associated with increased histone H3 acetylation and histone H3 lysine 4 trimethylation occupancy at the promoter region. Several lines of evidence demonstrate that the enhancing effect of ERMAs on these active histone marks was mediated through transcriptional repression of histone deacetylases and H3 lysine 4 demethylases by down-regulating Sp1 expression. First, putative Sp1-binding elements are present in the promoters of the affected histone-modifying enzymes, and luciferase reporter assays indicate that site-directed mutagenesis of these Sp1 binding sites significantly diminished the promoter activities. Second, shRNA-mediated knockdown of Sp1 mimicked the repressive effect of energy restriction on these histone-modifying enzymes. Third, ectopic Sp1 expression protected cells from the repressive effect of CG-12 on these histone-modifying enzymes, thereby abolishing the activation of KLF6 expression. Together, these findings underscore the intricate relationship between energy restriction and epigenetic regulation of tumor suppressor gene expression, which has therapeutic relevance to foster novel strategies for prostate cancer therapy.	[Chen, Chun-Han; Huang, Po-Hsien; Chu, Po-Chen; Chen, Mei-Chuan; Chou, Chih-Chien; Wang, Dasheng; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Wang, Qianben] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Chen, Chun-Han; Chen, Mei-Chuan; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10051, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Taiwan University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 336 Parks Hall,500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Wang, Qianben/E-4267-2011	TENG, CHE-MING/0000-0002-9719-7334	National Institutes of Health [CA112250]; Department of Defense [W81XWH-09-0198]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in whole or in part, by National Institutes of Health Grant CA112250 and Department of Defense Prostate Cancer Research Program Grant W81XWH-09-0198.	Bott SRJ, 2005, PROSTATE CANCER P D, V8, P321, DOI 10.1038/sj.pcan.4500822; Britschgi A, 2008, ONCOGENE, V27, P5706, DOI 10.1038/onc.2008.179; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Catteau A, 2004, INT J ONCOL, V25, P5; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sangodkar J, 2009, EUR J CANCER, V45, P666, DOI 10.1016/j.ejca.2008.11.009; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Teixeira MS, 2007, INT J CANCER, V121, P1976, DOI 10.1002/ijc.22926; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wei SO, 2010, J BIOL CHEM, V285, P9780, DOI 10.1074/jbc.M109.065466; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yang J, 2008, J MED CHEM, V51, P2100, DOI 10.1021/jm701212m	38	16	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9968	9976		10.1074/jbc.M110.203240	http://dx.doi.org/10.1074/jbc.M110.203240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282102	hybrid, Green Published			2022-12-25	WOS:000288547000011
J	Telford, JC; Yeung, JHF; Xu, GG; Kiefel, MJ; Watts, AG; Hader, S; Chan, J; Bennet, AJ; Moore, MM; Taylor, GL				Telford, Judith C.; Yeung, Juliana H. F.; Xu, Guogang; Kiefel, Milton J.; Watts, Andrew G.; Hader, Stefan; Chan, Jefferson; Bennet, Andrew J.; Moore, Margo M.; Taylor, Garry L.			The Aspergillus fumigatus Sialidase Is a 3-Deoxy-D-glycero-D-galacto-2-nonulosonic Acid Hydrolase (KDNase) STRUCTURAL AND MECHANISTIC INSIGHTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAMINATED NEURAMINIC ACID; POLY(ALPHA 2,8-DEAMINONEURAMINIC ACID); VIBRIO-CHOLERAE NEURAMINIDASE; EXTRACELLULAR-MATRIX PROTEINS; CRYSTAL-STRUCTURE; TRANS-SIALIDASE; STREPTOCOCCUS-PNEUMONIAE; DEAMINONEURAMINIC ACID; BACTERIAL SIALIDASE; VIRUS NEURAMINIDASE	Aspergillus fumigatus is a filamentous fungus that can cause severe respiratory disease in immunocompromised individuals. A putative sialidase from A. fumigatus was recently cloned and shown to be relatively poor in cleaving N-acetylneuraminic acid (Neu5Ac) in comparison with bacterial sialidases. Here we present the first crystal structure of a fungal sialidase. When the apo structure was compared with bacterial sialidase structures, the active site of the Aspergillus enzyme suggested that Neu5Ac would be a poor substrate because of a smaller pocket that normally accommodates the acetamido group of Neu5Ac in sialidases. A sialic acid with a hydroxyl in place of an acetamido group is 2-keto-3-deoxynononic acid (KDN). We show that KDN is the preferred substrate for the A. fumigatus sialidase and that A. fumigatus can utilize KDN as a sole carbon source. A 1.45-angstrom resolution crystal structure of the enzyme in complex with KDN reveals KDN in the active site in a boat conformation and nearby a second binding site occupied by KDN in a chair conformation, suggesting that polyKDN may be a natural substrate. The enzyme is not inhibited by the sialidase transition state analog 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (Neu5Ac2en) but is inhibited by the related 2,3-didehydro-2,3dideoxy-D-glycero-D-galacto-nonulosonic acid that we show bound to the enzyme in a 1.84-angstrom resolution crystal structure. Using a fluorinated KDN substrate, we present a 1.5-angstrom resolution structure of a covalently bound catalytic intermediate. The A. fumigatus sialidase is therefore a KDNase with a similar catalytic mechanism to Neu5Ac exosialidases, and this study represents the first structure of a KDNase.	[Telford, Judith C.; Xu, Guogang; Taylor, Garry L.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Yeung, Juliana H. F.; Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Chan, Jefferson; Bennet, Andrew J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Kiefel, Milton J.] Griffith Univ, Inst Glyc, Griffith, Qld 9726, Australia; [Watts, Andrew G.; Hader, Stefan] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of St Andrews; Simon Fraser University; Simon Fraser University; Griffith University; University of Bath	Taylor, GL (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	glt2@st-andrews.ac.uk	Taylor, Garry/G-3017-2014; Kiefel, Milton/O-4740-2019; Xu, Guogang/AAN-9289-2020; Kiefel, Milton/A-6509-2015; Watts, Andrew/D-2802-2014	Kiefel, Milton/0000-0003-1030-1440; Xu, Guogang/0000-0002-6380-3500; Watts, Andrew/0000-0003-4299-2717; Chan, Jefferson/0000-0003-4139-4379	Scottish Structural Proteomics Facility at St. Andrews; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Scottish Funding Council; Queensland International Fellowship; Natural Sciences and Engineering Research Council of Canada	Scottish Structural Proteomics Facility at St. Andrews; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Funding Council; Queensland International Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by the Scottish Structural Proteomics Facility at St. Andrews and funds from the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and the Scottish Funding Council (to G. L. T.).; Supported by the Biotechnology and Biological Sciences Research Council.; Recipient of a Queensland International Fellowship.; Supported by the Natural Sciences and Engineering Research Council of Canada.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Inoue S, 1996, J BIOL CHEM, V271, P24341, DOI 10.1074/jbc.271.40.24341; Inoue S, 1998, J BIOL CHEM, V273, P27199, DOI 10.1074/jbc.273.42.27199; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; KANAMORI A, 1994, HISTOCHEMISTRY, V101, P333, DOI 10.1007/BF00268994; KITAJIMA K, 1994, J BIOL CHEM, V269, P21415; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luo Y, 1998, STRUCTURE, V6, P521, DOI 10.1016/S0969-2126(98)00053-7; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NADANO D, 1986, J BIOL CHEM, V261, P1550; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Nishino S, 1996, J BIOL CHEM, V271, P2909, DOI 10.1074/jbc.271.6.2909; Qu BX, 1996, P NATL ACAD SCI USA, V93, P8995, DOI 10.1073/pnas.93.17.8995; Schulz EC, 2010, J MOL BIOL, V397, P341, DOI 10.1016/j.jmb.2010.01.028; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SONG Y, 1993, GLYCOBIOLOGY, V3, P31, DOI 10.1093/glycob/3.1.31; Sun XL, 2000, CARBOHYD RES, V323, P1; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Terada T, 1997, J BIOL CHEM, V272, P5452, DOI 10.1074/jbc.272.9.5452; Terada T, 1996, EUR J BIOCHEM, V236, P852, DOI 10.1111/j.1432-1033.1996.00852.x; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Tiralongo J, 2009, MICROBIOL-SGM, V155, P3100, DOI 10.1099/mic.0.026997-0; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Varki A., 2009, ESSENTIALS GLYCOBIOL; Warwas ML, 2010, GLYCOCONJUGATE J, V27, P533, DOI 10.1007/s10719-010-9299-9; Wasylnka JA, 2001, MICROBIOL-UK, V147, P869, DOI 10.1099/00221287-147-4-869; Wasylnka JA, 2000, INFECT IMMUN, V68, P3377, DOI 10.1128/IAI.68.6.3377-3384.2000; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Xu GG, 2008, ACTA CRYSTALLOGR F, V64, P772, DOI 10.1107/S1744309108024044; Xu GG, 2009, J MOL BIOL, V386, P828, DOI 10.1016/j.jmb.2008.12.084; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032; Ziak M, 1996, P NATL ACAD SCI USA, V93, P2759, DOI 10.1073/pnas.93.7.2759	50	22	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10783	10792		10.1074/jbc.M110.207043	http://dx.doi.org/10.1074/jbc.M110.207043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247893	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000288547000092
J	Erez, Y; Tischler, H; Belelovsky, K; Bar-Gad, I				Erez, Yaara; Tischler, Hadass; Belelovsky, Katya; Bar-Gad, Izhar			Dispersed Activity during Passive Movement in the Globus Pallidus of the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Primate	PLOS ONE			English	Article							BASAL GANGLIA; SUBTHALAMIC NUCLEUS; PARKINSONIAN MONKEYS; NEURONAL-ACTIVITY; LIMB MOVEMENT; DISCHARGE; ORGANIZATION; CIRCUITS; DISEASE; MODEL	Parkinson's disease is a neurodegenerative disorder manifesting in debilitating motor symptoms. This disorder is characterized by abnormal activity throughout the cortico-basal ganglia loop at both the single neuron and network levels. Previous neurophysiological studies have suggested that the encoding of movement in the parkinsonian state involves correlated activity and synchronized firing patterns. In this study, we used multi-electrode recordings to directly explore the activity of neurons from the globus pallidus of parkinsonian primates during passive limb movements and to determine the extent to which they interact and synchronize. The vast majority (80/103) of the recorded pallidal neurons responded to periodic flexion-extension movements of the elbow. The response pattern was sinusoidal-like and the timing of the peak response of the neurons was uniformly distributed around the movement cycle. The interaction between the neuronal activities was analyzed for 123 simultaneously recorded pairs of neurons. Movement-based signal correlation values were diverse and their mean was not significantly different from zero, demonstrating that the neurons were not activated synchronously in response to movement. Additionally, the difference in the peak responses phase of pairs of neurons was uniformly distributed, showing their independent firing relative to the movement cycle. Our results indicate that despite the widely distributed activity in the globus pallidus of the parkinsonian primate, movement encoding is dispersed and independent rather than correlated and synchronized, thus contradicting current views that posit synchronous activation during Parkinson's disease.	[Erez, Yaara; Tischler, Hadass; Belelovsky, Katya; Bar-Gad, Izhar] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel; [Bar-Gad, Izhar] Bar Ilan Univ, Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Erez, Y (corresponding author), Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel.	bargadi@mail.biu.ac.il		Bar-Gad, Izhar/0000-0002-2999-4083; Erez, Yaara/0000-0001-9563-816X	Israel Science Foundation (ISF) [1000/05, 327/09]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported in part by Israel Science Foundation (ISF, http://www.isf.org.il/english/default.asp) grants 1000/05 and 327/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BAKER KB, 2010, EXP NEUROL; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Boraud T, 2000, J NEUROPHYSIOL, V83, P1760, DOI 10.1152/jn.2000.83.3.1760; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; DELONG MR, 1985, J NEUROPHYSIOL, V53, P530, DOI 10.1152/jn.1985.53.2.530; Erez Y, 2009, J NEUROSCI, V29, P7797, DOI 10.1523/JNEUROSCI.0401-09.2009; FILION M, 1988, BRAIN RES, V444, P165, DOI 10.1016/0006-8993(88)90924-9; Gdowski MJ, 2001, J NEUROPHYSIOL, V85, P998, DOI 10.1152/jn.2001.85.2.998; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; HAMADA I, 1990, J NEUROPHYSIOL, V64, P1892, DOI 10.1152/jn.1990.64.6.1892; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Heimer G, 2002, J NEUROSCI, V22, P7850; IANSEK R, 1980, J PHYSIOL-LONDON, V301, P439, DOI 10.1113/jphysiol.1980.sp013216; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Leblois A, 2006, EUR J NEUROSCI, V24, P1201, DOI 10.1111/j.1460-9568.2006.04984.x; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Levy R, 2000, J NEUROSCI, V20, P7766; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Schneider JS, 2003, BRAIN RES, V990, P38, DOI 10.1016/S0006-8993(03)03382-1; STERIO D, 1994, ANN NEUROL, V35, P586, DOI 10.1002/ana.410350512; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Taha JM, 1996, J NEUROSURG, V85, P1005, DOI 10.3171/jns.1996.85.6.1005; Turner RS, 1997, J NEUROPHYSIOL, V77, P1051, DOI 10.1152/jn.1997.77.3.1051; Vitek JL, 1998, J NEUROSURG, V88, P1027, DOI 10.3171/jns.1998.88.6.1027	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16293	10.1371/journal.pone.0016293	http://dx.doi.org/10.1371/journal.pone.0016293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267415	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500050
J	Xu, ZP; Zheng, YF; Zhu, YF; Kong, XY; Hu, LD				Xu, Zhongping; Zheng, Yufang; Zhu, Yufei; Kong, Xiangyin; Hu, Landian			Evidence for OTUD-6B Participation in B Lymphocytes Cell Cycle after Cytokine Stimulation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA; DEUBIQUITINATING ENZYME; GENE-EXPRESSION; D2 EXPRESSION; REGULATOR; IDENTIFICATION; TRANSITION; FAMILY; MEMBER	Deubiquitinating enzymes (DUBs) are important regulators of cell proliferation. Here we identified a functional deubiquitinating enzyme, ovarian tumor domain-containing 6B (OTUD-6B). Mutation of the conserved Cys residue abolished its deubiquitinating activity in vitro. Otud-6b expression was induced with cytokine stimulation in both mouse Ba/F3 cells and primary B lymphocytes followed a rapid decrease. This rapid decrease was partially facilitated by tristetraprolin (TTP) destabilization of Otud-6b mRNA through AU-rich motifs. Enforced expression of OTUD-6B in Ba/F3 cells could block cell proliferation by arresting cells in G1 phase. In addition, cyclin D2 level was down-regulated when OTUD-6B WT was overexpressed. Therefore, down-regulation of Otud-6b expression after prolonged cytokine stimulation may be required for cell proliferation in B lymphocytes.	[Xu, Zhongping; Zhu, Yufei; Kong, Xiangyin; Hu, Landian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Zhongping; Zhu, Yufei; Kong, Xiangyin; Hu, Landian] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Yufang] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Kong, Xiangyin; Hu, Landian] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Xu, Zhongping; Zhu, Yufei; Kong, Xiangyin; Hu, Landian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, ZP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xiangyinster@gmail.com; ldhu2005@gmail.com	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624	National High Technology Research and Development Program of China [2006AA02Z330, 2006AA02A301]; Chinese Academy of Sciences [KSCX1-YW-R-74, KSCX1-YW-22]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National High Technology Research and Development Program of China (2006AA02Z330, 2006AA02A301), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-74, KSCX1-YW-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, CYTOKINE GROWTH F R, V18, P73, DOI 10.1016/j.cytogfr.2007.01.007; Almeida S, 2008, J INVEST DERMATOL, V128, P587, DOI 10.1038/sj.jid.5701045; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Buzzeo MP, 2007, EXP HEMATOL, V35, P1456, DOI 10.1016/j.exphem.2007.06.001; CaligarisCappio F, 1996, IMMUNOL TODAY, V17, P206, DOI 10.1016/0167-5699(96)30008-X; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; DeSalle LM, 2001, FEBS LETT, V490, P179, DOI 10.1016/S0014-5793(01)02121-4; Dey A, 2000, MOL BIOL CELL, V11, P3835, DOI 10.1091/mbc.11.11.3835; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KLUG G, 1993, MOL MICROBIOL, V9, P1, DOI 10.1111/j.1365-2958.1993.tb01663.x; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu Yong-Yu, 2004, Methods Mol Biol, V249, P177; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Vicari L, 2006, LEUKEMIA, V20, P2208, DOI 10.1038/sj.leu.2404447; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275; Zhu Y, 1996, MOL CELL BIOL, V16, P4808; Zhu YA, 1997, J BIOL CHEM, V272, P51	45	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14514	10.1371/journal.pone.0014514	http://dx.doi.org/10.1371/journal.pone.0014514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267069	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500004
J	Ringvall, M; Thulin, AA; Zhang, L; Cedervall, J; Tsuchida-Straeten, N; Jahnen-Dechent, W; Siegbahn, A; Olsson, AK				Ringvall, Maria; Thulin, Asa; Zhang, Lei; Cedervall, Jessica; Tsuchida-Straeten, Nobuko; Jahnen-Dechent, Willi; Siegbahn, Agneta; Olsson, Anna-Karin			Enhanced Platelet Activation Mediates the Accelerated Angiogenic Switch in Mice Lacking Histidine-Rich Glycoprotein	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TUMOR-GROWTH; COAGULATION; INHIBITORS; FRAGMENT; ADHESION	Background: The heparin-binding plasma protein histidine-rich glycoprotein (HRG; alternatively, HRGP/HPRG) can suppress tumor angiogenesis and growth in vitro and in vivo. Mice lacking the HRG gene are viable and fertile, but have an enhanced coagulation resulting in decreased bleeding times. In addition, the angiogenic switch is significantly enhanced in HRG-deficient mice. Methodology/Principal Findings: To address whether HRG deficiency affects tumor development, we have crossed HRG knockout mice with the RIP1-Tag2 mouse, a well established orthotopic model of multistage carcinogenesis. RIP1-Tag2 HRG(-/-) mice display significantly larger tumor volume compared to their RIP1-Tag2 HRG(+/+) littermates, supporting a role for HRG as an endogenous regulator of tumor growth. In the present study we also demonstrate that platelet activation is increased in mice lacking HRG. To address whether this elevated platelet activation contributes to the increased pathological angiogenesis in HRG-deficient mice, they were rendered thrombocytopenic before the onset of the angiogenic switch by injection of the anti-platelet antibody GP1b alpha. Interestingly, this treatment suppressed the increase in angiogenic neoplasias seen in HRG knockout mice. However, if GP1b alpha treatment was initiated at a later stage, after the onset of the angiogenic switch, no suppression of tumor growth was detected in HRG-deficient mice. Conclusions: Our data show that increased platelet activation mediates the accelerated angiogenic switch in HRG-deficient mice. Moreover, we conclude that platelets play a crucial role in the early stages of tumor development but are of less significance for tumor growth once angiogenesis has been initiated.	[Ringvall, Maria; Thulin, Asa; Zhang, Lei; Cedervall, Jessica; Olsson, Anna-Karin] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Tsuchida-Straeten, Nobuko; Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Dept Biomed Engn, Biointerface Lab, Aachen, Germany; [Siegbahn, Agneta] Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Uppsala University; RWTH Aachen University; Uppsala University; Uppsala University Hospital	Ringvall, M (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	zhang, lei/AAI-7464-2021; Zhang, Lei/N-7913-2016; Jahnen-Dechent, Willi/A-7608-2011	zhang, lei/0000-0001-7438-0489; Zhang, Lei/0000-0001-7438-0489; Jahnen-Dechent, Willi/0000-0003-1315-4407	Swedish Research Council [K2007-64X-20571-01-4, K2007-64P-20570-01-4]; Swedish Cancer Society [08 0375]; Swedish Society of Medicine [SLS-101361]; Jeanssons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Society of Medicine; Jeanssons Foundation; Ake Wiberg Foundation	Financial support was provided by the Swedish Research Council (www.vr.se) grant nr: K2007-64X-20571-01-4, K2007-64P-20570-01-4, the Swedish Cancer Society (www.cancerfonden.se) grant nr: 08 0375, the Swedish Society of Medicine (www.sls.se) grant nr: SLS-101361, Jeanssons Foundation (www.jeanssonsstiftelser.se) and Ake Wiberg Foundation (www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, LAB ANIM-UK, V22, P195; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Chiodoni C, 2006, J EXP MED, V203, P2441, DOI 10.1084/jem.20060844; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hulett MD, 2000, IMMUNOL CELL BIOL, V78, P280, DOI 10.1046/j.1440-1711.2000.00940.x; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Juarez JC, 2002, CANCER RES, V62, P5344; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; Jurk K, 2005, SEMIN THROMB HEMOST, V31, P381, DOI 10.1055/s-2005-916671; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LEUNG LLK, 1983, BLOOD, V62, P1016; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Olsson AK, 2004, CANCER RES, V64, P599, DOI 10.1158/0008-5472.CAN-03-1941; Pipili-Synetos E, 1998, BRIT J PHARMACOL, V125, P1252, DOI 10.1038/sj.bjp.0702191; POON IK, 2010, BLOOD; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Staton CA, 2005, J CELL MOL MED, V9, P286, DOI 10.1111/j.1582-4934.2005.tb00356.x; Thulin A, 2009, MOL CANCER RES, V7, P1792, DOI 10.1158/1541-7786.MCR-09-0094; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; Verheul HMW, 2000, BLOOD, V96, P4216, DOI 10.1182/blood.V96.13.4216	28	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14526	10.1371/journal.pone.0014526	http://dx.doi.org/10.1371/journal.pone.0014526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264222	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600007
J	Anderson, JL; Shearer, CA				Anderson, Jennifer L.; Shearer, Carol A.			Population Genetics of the Aquatic Fungus Tetracladium marchalianum over Space and Time	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; LEAF-LITTER; HYPHOMYCETE CONIDIA; TAPESIA-YALLUNDAE; LEAVES; STREAM; BREAKDOWN; DYNAMICS; COLONIZATION; DIVERSITY	Aquatic hyphomycete fungi are fundamental mediators of energy flow and nutrient spiraling in rivers. These microscopic fungi are primarily dispersed in river currents, undergo substantial annual fluctuations in abundance, and reproduce either predominantly or exclusively asexually. These aspects of aquatic hyphomycete biology are expected to influence levels and distributions of genetic diversity over both spatial and temporal scales. In this study, we investigated the spatiotemporal distribution of genotypic diversity in the representative aquatic hyphomycete Tetracladium marchalianum. We sampled populations of this fungus from seven sites, three sites each in two rivers in Illinois, USA, and one site in a Wisconsin river, USA, and repeatedly sampled one population over two years to track population genetic parameters through two seasonal cycles. The resulting fungal isolates (N = 391) were genotyped at eight polymorphic microsatellite loci. In spite of seasonal reductions in the abundance of this species, genotypic diversity was consistently very high and allele frequencies remarkably stable over time. Likewise, genotypic diversity was very high at all sites. Genetic differentiation was only observed between the most distant rivers (similar to 450 km). Clear evidence that T. marchalianum reproduces sexually in nature was not observed. Additionally, we used phylogenetic analysis of partial beta-tubulin gene sequences to confirm that the fungal isolates studied here represent a single species. These results suggest that populations of T. marchalianum may be very large and highly connected at local scales. We speculate that large population sizes and colonization of alternate substrates in both terrestrial and aquatic environments may effectively buffer the aquatic populations from in-stream population fluctuations and facilitate stability in allele frequencies over time. These data also suggest that overland dispersal is more important for structuring populations of T. marchalianum over geographic scales than expected.	[Anderson, Jennifer L.; Shearer, Carol A.] Univ Illinois, Dept Plant Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Anderson, JL (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	jennia@uoregon.edu	Anderson, Jennifer L/I-5435-2012	Anderson, Jennifer L/0000-0002-0713-6897	Research Board at the University of Illinois at Urbana-Champaign	Research Board at the University of Illinois at Urbana-Champaign	The Research Board at the University of Illinois at Urbana-Champaign funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raheem AM, 1997, MYCOPATHOLOGIA, V138, P163, DOI 10.1023/A:1006860011208; Abelho M, 1998, HYDROBIOLOGIA, V386, P147, DOI 10.1023/A:1003532921432; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; AIMER RD, 1985, BOT J LINN SOC, V91, P61, DOI 10.1111/j.1095-8339.1985.tb01135.x; Anderson JL, 2006, MOL ECOL NOTES, V6, P703, DOI 10.1111/j.1471-8286.2006.01316.x; ANDERSON JL, 2004, PLANT BIOL; ARSUFFI TL, 1984, OIKOS, V42, P144, DOI 10.2307/3544786; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; BALDY V, 1995, OIKOS, V74, P93, DOI 10.2307/3545678; BANDONI RJ, 1972, CAN J BOTANY, V50, P2283, DOI 10.1139/b72-297; BARLOCHER F, 1983, ECOLOGY, V64, P1266, DOI 10.2307/1937834; BARLOCHER F, 1981, T BRIT MYCOL SOC, V76, P160; BARLOCHER F, 1992, FRESHWATER BIOL, V28, P1, DOI 10.1111/j.1365-2427.1992.tb00556.x; BARLOCHER F, 1982, OECOLOGIA, V52, P1, DOI 10.1007/BF00349003; BARLOCHER F, 1974, J ECOL, V62, P761, DOI 10.2307/2258954; Baschien C, 2006, NOVA HEDWIGIA, V83, P311, DOI 10.1127/0029-5035/2006/0083-0311; Berbee ML, 2003, MYCOL RES, V107, P169, DOI 10.1017/S0953756203007263; Bergemann SE, 2002, NEW PHYTOL, V156, P313, DOI 10.1046/j.1469-8137.2002.00507.x; BURNETT J, 2003, FUNGAL POPULATIONS S; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Carbone I, 1999, EVOLUTION, V53, P11, DOI [10.1111/j.1558-5646.1999.tb05329.x, 10.2307/2640916]; CHAMIER AC, 1985, BOT J LINN SOC, V91, P67, DOI 10.1111/j.1095-8339.1985.tb01136.x; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; CHAUVET E, 1992, NOVA HEDWIGIA, V54, P379; CHAUVET E, 1988, Revue des Sciences de l'Eau, V1, P203; CHERGUI H, 1990, ARCH HYDROBIOL, V118, P341; CHERGUI H, 1991, FRESHWATER BIOL, V26, P97, DOI 10.1111/j.1365-2427.1991.tb00512.x; DESCALS E, 1995, NOVA HEDWIGIA, V60, P551; Douhan GW, 2002, MOL ECOL, V11, P2229, DOI 10.1046/j.1365-294X.2002.01607.x; Douhan GW, 2002, PHYTOPATHOLOGY, V92, P703, DOI 10.1094/PHYTO.2002.92.7.703; England PR, 2003, CONSERV GENET, V4, P595, DOI 10.1023/A:1025639811865; Fabre E, 1997, MYCOL RES, V101, P908, DOI 10.1017/S0953756297003948; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FIRDAUSEBAREEN, 1994, CAN J BOT, V72, P1316, DOI 10.1139/b94-161; FISHER PJ, 1989, MYCOL RES, V92, P367, DOI 10.1016/S0953-7562(89)80081-4; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Garnett H, 2000, MYCOLOGIA, V92, P29, DOI 10.2307/3761447; GESSNER MO, 1993, MYCOL RES, V97, P163, DOI 10.1016/S0953-7562(09)80238-4; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Gessner MO, 1998, J N AM BENTHOL SOC, V17, P403, DOI 10.2307/1468362; Gonczol J, 1999, ARCH HYDROBIOL, V144, P495; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulis V, 2004, MYCOLOGIA, V96, P57, DOI 10.2307/3761988; Gulis V, 2008, APPL ENVIRON MICROB, V74, P1094, DOI 10.1128/AEM.01903-07; Hurst LD, 1996, TRENDS ECOL EVOL, V11, pA46; INGOLD CT, 1979, AM J BOT, V66, P218, DOI 10.2307/2442527; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Laitung B, 2004, MOL ECOL, V13, P1679, DOI 10.1111/j.1365-294X.2004.02135.x; Letourneau A, 2010, FUNGAL DIVERS, V40, P51, DOI 10.1007/s13225-009-0006-8; Linde CC, 2003, FUNGAL GENET BIOL, V40, P115, DOI 10.1016/S1087-1845(03)00110-5; McGlashan DJ, 2001, CAN J FISH AQUAT SCI, V58, P1842, DOI 10.1139/cjfas-58-9-1842; Meffe G. K., 1994, PRINCIPLES CONSERVAT; MICHOD RE, 1987, EVOLUTION SEX EXAMIN; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Miller AN, 2005, MOL PHYLOGENET EVOL, V35, P60, DOI 10.1016/j.ympev.2005.01.007; MINSHALL GW, 1967, ECOLOGY, V48, P139; MotheJeanLouis AM, 1997, CAN J BOT, V75, P155, DOI 10.1139/b97-018; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; NILSSON SVEN, 1964, SYMBOLAE BOT UPSALIENSIS, V18, P1; Pelaez F, 1996, MYCOL RES, V100, P831, DOI 10.1016/S0953-7562(96)80030-X; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; RANZONI FV, 1979, MYCOLOGIA, V71, P786, DOI 10.2307/3759189; ROLDAN A, 1989, MYCOL RES, V93, P452, DOI 10.1016/S0953-7562(89)80039-5; SANDERS PF, 1978, T BRIT MYCOL SOC, V71, P231, DOI 10.1016/S0007-1536(78)80103-X; SANDERS PF, 1979, T BRIT MYCOL SOC, V73, P103, DOI 10.1016/S0007-1536(79)80079-0; Sati SC, 2005, MYCOLOGIA, V97, P45, DOI 10.3852/mycologia.97.1.45; Seena S, 2010, FUNGAL DIVERS, V44, P77, DOI 10.1007/s13225-010-0056-y; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; Shearer C.A., 1992, ECOLOGY AQUATIC HYPH, P77, DOI DOI 10.1007/978-3-642-76855-2_4; Sivichai S, 2003, FUNG DIVERS RES SER, V10, P259; SRIDHAR KR, 1993, MYCOL RES, V97, P1530, DOI 10.1016/S0953-7562(09)80229-3; SRIDHAR KR, 1992, MYCOL RES, V96, P305, DOI 10.1016/S0953-7562(09)80942-8; SUBERKROPP K, 1980, CAN J BOT, V58, P1025, DOI 10.1139/b80-126; Suberkropp K, 1997, FRESHWATER BIOL, V38, P169, DOI 10.1046/j.1365-2427.1997.00203.x; SUBERKROPP K, 1991, MYCOL RES, V95, P843, DOI 10.1016/S0953-7562(09)80048-8; Suberkropp K, 2001, APPL ENVIRON MICROB, V67, P5063, DOI 10.1128/AEM.67.11.5063-5068.2001; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THAKUR SB, 1977, MYCOLOGIA, V69, P843, DOI 10.2307/3758877; Vandenkoornhuyse P, 2001, HEREDITY, V87, P243, DOI 10.1046/j.1365-2540.2001.00941.x; Viji G, 2002, PLANT DIS, V86, P827, DOI 10.1094/PDIS.2002.86.8.827; WEBSTER J, 1981, BIOL CONIDIAL FUNGI, P295; Webster JR, 1999, FRESHWATER BIOL, V41, P687, DOI 10.1046/j.1365-2427.1999.00409.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weyers HS, 1996, J N AM BENTHOL SOC, V15, P408, DOI 10.2307/1467795; Wright S., 1978, EVOLUTION GENETICS P, V4; YUN T, 1996, PLANT BIOL; Zeigler RS, 1998, ANNU REV PHYTOPATHOL, V36, P249, DOI 10.1146/annurev.phyto.36.1.249	93	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15908	10.1371/journal.pone.0015908	http://dx.doi.org/10.1371/journal.pone.0015908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264239	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500015
J	Mutnal, MB; Cheeran, MCJ; Hu, SX; Lokensgard, JR				Mutnal, Manohar B.; Cheeran, Maxim C-J.; Hu, Shuxian; Lokensgard, James R.			Murine Cytomegalovirus Infection of Neural Stem Cells Alters Neurogenesis in the Developing Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FLOW-CYTOMETRIC ANALYSIS; PROGENITOR CELLS; MOUSE-BRAIN; CEREBELLAR DEVELOPMENT; ADULT NEUROGENESIS; SIGNALING PROTEIN; EXPRESSION; DIFFERENTIATION; PRECURSORS	Background: Congenital cytomegalovirus (CMV) brain infection causes serious neuro-developmental sequelae including: mental retardation, cerebral palsy, and sensorineural hearing loss. But, the mechanisms of injury and pathogenesis to the fetal brain are not completely understood. The present study addresses potential pathogenic mechanisms by which this virus injures the CNS using a neonatal mouse model that mirrors congenital brain infection. This investigation focused on, analysis of cell types infected with mouse cytomegalovirus (MCMV) and the pattern of injury to the developing brain. Methodology/Principal Findings: We used our MCMV infection model and a multi-color flow cytometry approach to quantify the effect of viral infection on the developing brain, identifying specific target cells and the consequent effect on neurogenesis. In this study, we show that neural stem cells (NSCs) and neuronal precursor cells are the principal target cells for MCMV in the developing brain. In addition, viral infection was demonstrated to cause a loss of NSCs expressing CD133 and nestin. We also showed that infection of neonates leads to subsequent abnormal brain development as indicated by loss of CD24(hi) cells that incorporated BrdU. This neonatal brain infection was also associated with altered expression of Oct4, a multipotency marker; as well as down regulation of the neurotrophins BDNF and NT3, which are essential to regulate the birth and differentiation of neurons during normal brain development. Finally, we report decreased expression of doublecortin, a marker to identify young neurons, following viral brain infection. Conclusions: MCMV brain infection of newborn mice causes significant loss of NSCs, decreased proliferation of neuronal precursor cells, and marked loss of young neurons.	[Mutnal, Manohar B.; Hu, Shuxian; Lokensgard, James R.] Univ Minnesota, Dept Med, Neuroimmunol Lab, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA; [Cheeran, Maxim C-J.] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mutnal, MB (corresponding author), Univ Minnesota, Dept Med, Neuroimmunol Lab, Ctr Infect Dis & Microbiol Translat Res, Box 736 UMHC, Minneapolis, MN 55455 USA.	loken006@umn.edu	Mutnal, Manohar B/K-4744-2012; Cheeran, Maxim C-J/C-2135-2009	Cheeran, Maxim C-J/0000-0002-5331-4746	National Institute of Neurological Disorders and Stroke [R01 NS-038836]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038836] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Award Number R01 NS-038836 from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; BALE JF, 1984, ARCH NEUROL-CHICAGO, V41, P310, DOI 10.1001/archneur.1984.04050150092023; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Becroft D M, 1981, Perspect Pediatr Pathol, V6, P203; Belvindrah R, 2002, J NEUROSCI, V22, P3594; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Breau MA, 2006, DEVELOPMENT, V133, P1725, DOI 10.1242/dev.02346; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carson CT, 2006, NAT MED, V12, P1237, DOI 10.1038/nm1106-1237; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Cheeran MCJ, 2008, J NEUROVIROL, V14, P437, DOI 10.1080/13550280802356845; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; HORAN PK, 1986, P NATL ACAD SCI USA, V83, P8361, DOI 10.1073/pnas.83.21.8361; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Koontz T, 2008, J EXP MED, V205, P423, DOI 10.1084/jem.20071489; Kosugi I, 2000, LAB INVEST, V80, P1373, DOI 10.1038/labinvest.3780145; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LUO MH, J VIROL, V84, P3528; Maric D, 2004, MOL NEUROBIOL, V30, P49, DOI 10.1385/MN:30:1:049; Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Reuter JD, 2005, J VIROL, V79, P9527, DOI 10.1128/JVI.79.15.9527-9539.2005; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shinmura Y, 1997, ACTA NEUROPATHOL, V93, P551, DOI 10.1007/s004010050651; Sossey-Alaoui K, 1998, HUM MOL GENET, V7, P1327, DOI 10.1093/hmg/7.8.1327; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; TSUTSUI Y, 1995, PATHOL INT, V45, P91, DOI 10.1111/j.1440-1827.1995.tb03428.x; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; van den Pol AN, 2002, J VIROL, V76, P8842, DOI 10.1128/JVI.76.17.8842-8854.2002; Wiesner SM, 2009, CANCER RES, V69, P431, DOI 10.1158/0008-5472.CAN-08-1800	53	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16211	10.1371/journal.pone.0016211	http://dx.doi.org/10.1371/journal.pone.0016211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249143	Green Submitted, gold, Green Published			2022-12-25	WOS:000286515000032
J	Tyan, SW; Kuo, WH; Huang, CK; Pan, CC; Shew, JY; Chang, KJ; Lee, EYHP; Lee, WH				Tyan, Shiaw-Wei; Kuo, Wen-Hung; Huang, Chun-Kai; Pan, Chi-Chun; Shew, Jin-Yuh; Chang, King-Jen; Lee, Eva Y. -H. P.; Lee, Wen-Hwa			Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis	PLOS ONE			English	Article							TUMOR-STROMAL INTERACTIONS; MICROENVIRONMENT; HETEROGENEITY; METASTASIS; CARCINOMAS; BETA; MET	It has been well documented that microenvironment consisting of stroma affects breast cancer progression. However, the mechanisms by which cancer cells and fibroblasts, the major cell type in stroma, interact with each other during tumor development remains to be elucidated. Here, we show that the human cancer-associated fibroblasts (CAFs) had higher activity in enhancing breast tumorigenecity compared to the normal tissue-associated fibroblasts (NAFs) isolated from the same patients. The expression level of hepatocyte growth factor (HGF) in these fibroblasts was positively correlated with their ability to enhance breast tumorigenesis in mice. Deprivation of HGF using a neutralizing antibody reduced CAF-mediated colony formation of human breast cancer cells, indicating that CAFs enhanced cancer cell colony formation mainly through HGF secretion. Co-culture with human breast cancer MDA-MB-468 cells in a transwell system enhanced NAFs to secret HGF as well as promote tumorigenecity. The newly gained ability of these "educated'' NAFs became irreversible after continuing this process till fourth passage. These results suggested that breast cancer cells could alter the nature of its surrounding fibroblasts to secrete HGF to support its own progression through paracrine signaling.	[Tyan, Shiaw-Wei; Huang, Chun-Kai; Pan, Chi-Chun; Shew, Jin-Yuh; Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Irvine; University of California System; University of California Irvine	Tyan, SW (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	kingjen@ntu.edu.tw; elee@uci.edu; whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014	KUO, WEN-HUNG/0000-0002-9881-4605; Chang, King jen/0000-0001-9811-3422	Academia Sinica [2371, 4012]; biotech company; GeneTex; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); biotech company; GeneTex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Academia Sinica Peak Project (grant number 2371, 4012, http://www.sinica.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Based on University of California Irvine policy, WHL and EL declare that they have financial interests of a biotech company, GeneTex, which distributes research reagents globally and owns stock from Schering-Plough, a publicly traded pharmaceutical company, like any stockholder. WHL is on the board of directors, and EL is a consultant. GeneTex did not support this work in any way. These data and material will be distributed freely following the policies of PLoS ONE. It is the authors' recognition that these financial interests could not generate any bias toward this work, and do not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakamura T, 1997, CANCER RES, V57, P3305; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Wurtz SO, 2005, ENDOCR-RELAT CANCER, V12, P215, DOI 10.1677/erc.1.00719	24	130	136	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15313	10.1371/journal.pone.0015313	http://dx.doi.org/10.1371/journal.pone.0015313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249190	Green Published, gold			2022-12-25	WOS:000286515000004
J	Lukoye, D; Cobelens, FGJ; Ezati, N; Kirimunda, S; Adatu, FE; Lule, JK; Nuwaha, F; Joloba, ML				Lukoye, Deus; Cobelens, Frank G. J.; Ezati, Nicholas; Kirimunda, Samuel; Adatu, Francis E.; Lule, Joseph K.; Nuwaha, Fred; Joloba, Moses L.			Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection	PLOS ONE			English	Article							TUBERCULOSIS	Background: Drug resistance among tuberculosis patients in sub-Saharan Africa is increasing, possibly due to association with HIV infection. We studied drug resistance and HIV infection in a representative sample of 533 smear-positive tuberculosis patients diagnosed in Kampala, Uganda. Methods/Principal Findings: Among 473 new patients, multidrug resistance was found in 5 (1.1%, 95% CI 0.3-2.5) and resistance to any drug in 57 (12.1%, 9.3-15.3). Among 60 previously treated patients this was 7 (11.7%, 4.8-22.6) and 17 (28.3%; 17.5-41.4), respectively. Of 517 patients with HIV results, 165 (31.9%, 27.9-36.1) tested positive. Neither multidrug (adjusted odds ratio (ORadj) 0.7; 95% CI 0.19-2.6) nor any resistance (ORadj 0.7; 0.43-1.3) was associated with HIV status. Primary resistance to any drug was more common among patients who had worked in health care (ORadj 3.5; 1.0-12.0). Conclusion/Significance: Anti-tuberculosis drug resistance rates in Kampala are low and not associated with HIV infection, but may be associated with exposure during health care.	[Lukoye, Deus] Kampala City Council, Dept Publ Hlth, Kampala, Uganda; [Cobelens, Frank G. J.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Lukoye, Deus; Ezati, Nicholas; Adatu, Francis E.; Joloba, Moses L.] Natl TB & Leprosy Programme, Kampala, Uganda; [Kirimunda, Samuel; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Lule, Joseph K.; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	University of Amsterdam; Academic Medical Center Amsterdam; Makerere University; Makerere University	Lukoye, D (corresponding author), Kampala City Council, Dept Publ Hlth, Kampala, Uganda.	moses.joloba@case.edu		Lukoye, Deus/0000-0002-5362-9924; Joloba, Moses/0000-0002-0334-9983; Cobelens, Frank/0000-0002-4367-1133; kirimunda, Samuel/0000-0002-8769-5516	Netherlands Government (NACCAP) European Union (Europe AID) through CPCD Uganda [SANTE/2006/105-316]; INTERACT program	Netherlands Government (NACCAP) European Union (Europe AID) through CPCD Uganda(European Commission); INTERACT program	This study was funded by the Netherlands Government (NACCAP) European Union (Europe AID) grant SANTE/2006/105-316 through CPCD Uganda and the INTERACT program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretzel G, 1999, INT J TUBERC LUNG D, V3, P810; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P189; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; *WHO, 2003, GLOB PROJ ANT DRUG R; *WHO, 2001, GUID SUSC TEST 2 LIN; *WHO IUATLD WIT, 2004, GLOB PROJ ANT DRUG R; World Health Organization, 2008, 4 WHOHTMTB, P394; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	14	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16130	10.1371/journal.pone.0016130	http://dx.doi.org/10.1371/journal.pone.0016130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249225	Green Submitted, Green Published, gold			2022-12-25	WOS:000286513100028
J	Mitchell, MD; McCormick, MI; Ferrari, MCO; Chivers, DP				Mitchell, Matthew D.; McCormick, Mark I.; Ferrari, Maud C. O.; Chivers, Douglas P.			Coral Reef Fish Rapidly Learn to Identify Multiple Unknown Predators upon Recruitment to the Reef	PLOS ONE			English	Article							CHEMICAL ALARM CUES; FATHEAD MINNOWS; PIMEPHALES-PROMELAS; ANTIPREDATOR BEHAVIOR; ACQUIRED RECOGNITION; PREY ANIMALS; RISK; PROSPECTUS; AVOIDANCE; SUBSTANCE	Organisms often undergo shifts in habitats as their requirements change with ontogeny. Upon entering a new environment, it is vitally important to be able to rapidly assess predation risk. Predation pressure should selectively promote mechanisms that enable the rapid identification of novel predators. Here we tested the ability of a juvenile marine fish to simultaneously learn the identity of multiple previously unknown predators. Individuals were conditioned with a 'cocktail' of novel odours (from two predators and two non-predators) paired with either a conspecific alarm cue or a saltwater control and then tested for recognition of the four odours individually and two novel odours (one predator and one non-predator) the following day. Individuals conditioned with the 'cocktail' and alarm cue responded to the individual 'cocktail' odours with an antipredator response compared to controls. These results demonstrate that individuals acquire recognition of novel odours and that the responses were not due to innate recognition of predators or due to a generalised response to novel odours. Upon entering an unfamiliar environment prey species are able to rapidly assess the risk of predation, enhancing their chances of survival, through the assessment of chemical stimuli.	[Mitchell, Matthew D.; McCormick, Mark I.] James Cook Univ, Australia Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Mitchell, Matthew D.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Ferrari, Maud C. O.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	James Cook University; James Cook University; University of California System; University of California Davis; University of Saskatchewan	Mitchell, MD (corresponding author), James Cook Univ, Australia Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	matthew.mitchell1@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645; Chivers, Douglas/0000-0002-9497-4329	Australian Research Council; ARC Centre of Excellence for Coral Reef Studies [CE0561432]; Natural Sciences and Engineering Council of Canada	Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was supplied by the Australian Research Council (www.arc.gov.au), ARC Centre of Excellence for Coral Reef Studies (Grant No. CE0561432, www.coralcoe.org.au) and the Natural Sciences and Engineering Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquistapace P, 2003, J CRUSTACEAN BIOL, V23, P364, DOI 10.1651/0278-0372(2003)023[0364:UPALOP]2.0.CO;2; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); Booth DJ, 2004, OECOLOGIA, V140, P289, DOI 10.1007/s00442-004-1608-1; BROWN GE, 1995, BEHAV ECOL SOCIOBIOL, V36, P105, DOI 10.1007/s002650050130; Brown GE, 2001, ETHOLOGY, V107, P401, DOI 10.1046/j.1439-0310.2001.00671.x; Brown Grant E., 2005, P34; CHIVERS DP, 1994, J FISH BIOL, V44, P273, DOI 10.1006/jfbi.1994.1026; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Darwish TL, 2005, ANIM BEHAV, V70, P83, DOI 10.1016/j.anbehav.2004.09.017; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2006, ANIM BEHAV, V71, P19, DOI 10.1016/j.anbehav.2005.02.016; Ferrari MCO, 2006, CAN J ZOOL, V84, P505, DOI 10.1139/Z06-027; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Fievet V, 2008, OIKOS, V117, P1380, DOI 10.1111/j.0030-1299.2008.16629.x; Goldman B, 1976, P125; Golub JL, 2005, J FISH BIOL, V66, P1073, DOI 10.1111/j.0022-1112.2005.00658.x; Griffen BD, 2006, OECOLOGIA, V146, P608, DOI 10.1007/s00442-005-0211-4; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hazlett BA, 2003, ETHOLOGY, V109, P765, DOI 10.1046/j.1439-0310.2003.00916.x; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Holmes TH, 2010, BEHAV PROCESS, V83, P299, DOI 10.1016/j.beproc.2010.01.013; Jachner A, 1999, ENVIRON BIOL FISH, V54, P433, DOI 10.1023/A:1007523732293; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kristensen EA, 2004, J FISH BIOL, V64, P643, DOI 10.1111/j.1095-8649.2004.00328.x; Larson JK, 2005, ANIM BEHAV, V69, P51, DOI 10.1016/j.anbehav.2004.04.005; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGURRAN AE, 1989, ETHOLOGY, V82, P216, DOI 10.1111/j.1439-0310.1989.tb00501.x; Mathis A, 1996, ANIM BEHAV, V51, P185, DOI 10.1006/anbe.1996.0016; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; McCormick MI, 2008, CORAL REEFS, V27, P105, DOI 10.1007/s00338-007-0296-9; Meekan MG, 2001, MAR BIOL, V139, P373; Mirza RS, 2001, BEHAVIOUR, V138, P1249, DOI 10.1163/15685390152822201; Mirza RS, 2003, CAN J ZOOL, V81, P88, DOI 10.1139/Z02-216; Montgomery John C., 2008, P3; Randall JE, 1997, FISHES GREAT BARRIER; SANO M, 1984, FOOD HABITS TELEOSTE; SAVINO JF, 1989, ENVIRON BIOL FISH, V24, P287, DOI 10.1007/BF00001402; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SMITH RJF, 1989, ETHOLOGY, V83, P19; SWIHART RK, 1991, J CHEM ECOL, V17, P767, DOI 10.1007/BF00994199; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065; VAIL A, 2009, THESIS J COOK U TOWN; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; Wisenden Brian D., 2006, P259; Wisenden Brian D., 2003, P236, DOI 10.1007/978-0-387-22628-6_12	51	59	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15764	10.1371/journal.pone.0015764	http://dx.doi.org/10.1371/journal.pone.0015764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249216	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000286513100011
J	Clark, MS; Thorne, MAS; Toullec, JY; Meng, Y; Guan, LL; Peck, LS; Moore, S				Clark, Melody S.; Thorne, Michael A. S.; Toullec, Jean-Yves; Meng, Yan; Guan, Le Luo; Peck, Lloyd S.; Moore, Stephen			Antarctic Krill 454 Pyrosequencing Reveals Chaperone and Stress Transcriptome	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GLUCAN BINDING-PROTEIN; SUPEROXIDE-DISMUTASE; EUPHAUSIA-SUPERBA; MOLECULAR-CLONING; SOUTHERN-OCEAN; BETA-GLUCAN; CLIMATE-CHANGE; RIMICARIS-EXOCULATA; AMINO-ACID	Background: The Antarctic krill Euphausia superba is a keystone species in the Antarctic food chain. Not only is it a significant grazer of phytoplankton, but it is also a major food item for charismatic megafauna such as whales and seals and an important Southern Ocean fisheries crop. Ecological data suggest that this species is being affected by climate change and this will have considerable consequences for the balance of the Southern Ocean ecosystem. Hence, understanding how this organism functions is a priority area and will provide fundamental data for life history studies, energy budget calculations and food web models. Methodology/Principal Findings: The assembly of the 454 transcriptome of E. superba resulted in 22,177 contigs with an average size of 492bp (ranging between 137 and 8515bp). In depth analysis of the data revealed an extensive catalogue of the cellular chaperone systems and the major antioxidant proteins. Full length sequences were characterised for the chaperones HSP70, HSP90 and the super-oxide dismutase antioxidants, with the discovery of potentially novel duplications of these genes. The sequence data contained 41,470 microsatellites and 17,776 Single Nucleotide Polymorphisms (SNPs/INDELS), providing a resource for population and also gene function studies. Conclusions: This paper details the first 454 generated data for a pelagic Antarctic species or any pelagic crustacean globally. The classical "stress proteins'', such as HSP70, HSP90, ferritin and GST were all highly expressed. These genes were shown to be over expressed in the transcriptomes of Antarctic notothenioid fish and hypothesized as adaptations to living in the cold, with the associated problems of decreased protein folding efficiency and increased vulnerability to damage by reactive oxygen species. Hence, these data will provide a major resource for future physiological work on krill, but in particular a suite of "stress'' genes for studies understanding marine ectotherms' capacities to cope with environmental change.	[Clark, Melody S.; Thorne, Michael A. S.; Peck, Lloyd S.] British Antarctic Survey, NERC, Cambridge, England; [Toullec, Jean-Yves] Univ Paris 06, UPMC, CNRS, UMR 7144,Stn Biol Roscoff, Roscoff, France; [Meng, Yan; Guan, Le Luo; Moore, Stephen] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of Alberta	Clark, MS (corresponding author), British Antarctic Survey, NERC, Cambridge, England.	mscl@bas.ac.uk	Clark, Melody S/D-7371-2014	Clark, Melody S/0000-0002-3442-3824; Moore, Stephen/0000-0002-9758-166X; Thorne, Michael/0000-0001-7759-612X	Livestock Gentech: an Alberta Ingenuity Centre at the University of Alberta; la Region Bretagne (France); l'Institut Paul-Emile Victor (IPEV); Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Livestock Gentech: an Alberta Ingenuity Centre at the University of Alberta; la Region Bretagne (France)(Region Bretagne); l'Institut Paul-Emile Victor (IPEV); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for the 454 run provided by Livestock Gentech: an Alberta Ingenuity Centre at the University of Alberta. JYT benefits from funding provided by la Region Bretagne (France) and also l'Institut Paul-Emile Victor (IPEV). The analyses were completed by the team from the British Antarctic Survey within the Ecosystems Adaptations and Physiology Work Package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Agianian B, 2003, J MOL BIOL, V326, P151, DOI 10.1016/S0022-2836(02)01327-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Batlle M, 2011, BBA-GENE REGUL MECH, V1809, P46, DOI 10.1016/j.bbagrm.2010.10.005; Beck G, 2002, DEV COMP IMMUNOL, V26, P11, DOI 10.1016/S0145-305X(01)00051-9; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Buchholz F, 2003, MAR FRESHW BEHAV PHY, V36, P229, DOI 10.1080/10236240310001623376; BUCHHOLZ F, 1991, MAR ECOL PROG SER, V69, P217, DOI 10.3354/meps069217; *CBS, CBS PRED SERV PRED N; *CBS, CBS PRED SERV ON LIN; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Cheng WT, 2006, FISH SHELLFISH IMMUN, V21, P453, DOI 10.1016/j.fsi.2006.02.005; Cheng WT, 2006, FISH SHELLFISH IMMUN, V21, P102, DOI 10.1016/j.fsi.2005.10.009; Cheng WT, 2006, FISH SHELLFISH IMMUN, V20, P438, DOI 10.1016/j.fsi.2005.05.016; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark MS, 2008, CELL STRESS CHAPERON, V13, P39, DOI 10.1007/s12192-008-0014-8; Clark MS, 2008, CELL STRESS CHAPERON, V13, P51, DOI 10.1007/s12192-008-0015-7; Clark MS, 2008, POLAR BIOL, V31, P171, DOI 10.1007/s00300-007-0344-5; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Clark MS, 2009, CELL STRESS CHAPERON, V14, P649, DOI 10.1007/s12192-009-0117-x; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Clarke A., 1976, Bulletin Br Antarct Surv, VNo. 43, P111; *CLC, CLC MAINWORKBENCH SO; Costantino E, 2009, CANCER LETT, V279, P39, DOI 10.1016/j.canlet.2009.01.018; Cottin D, 2010, J EXP MAR BIOL ECOL, V393, P9, DOI 10.1016/j.jembe.2010.06.008; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; De Pitta C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-45; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dodson RE, 1997, J BIOL CHEM, V272, P12249, DOI 10.1074/jbc.272.19.12249; ENGMAN DM, 1990, J IMMUNOL, V144, P3987; Everson I, 2000, KRILL BIOL ECOLOGY F; Falk-Petersen S, 2000, CAN J FISH AQUAT SCI, V57, P178, DOI 10.1139/cjfas-57-S3-178; FAO, 2005, 457 FAO; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Fraser KPP, 2007, J EXP BIOL, V210, P2691, DOI 10.1242/jeb.003715; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Gross M, 2004, CURR PROTEIN PEPT SC, V5, P213, DOI 10.2174/1389203043379684; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; Hagen W, 2001, MAR BIOL, V139, P95, DOI 10.1007/s002270000527; Hagen W, 1999, INVERTEBR REPROD DEV, V36, P25, DOI 10.1080/07924259.1999.9652674; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hofmann GE, 2000, J EXP BIOL, V203, P2331; Huang TS, 1996, EUR J BIOCHEM, V236, P450, DOI 10.1111/j.1432-1033.1996.00450.x; Jarman SN, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-S3-51; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jiang SG, 2009, MOL BIOL REP, V36, P127, DOI 10.1007/s11033-007-9160-9; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Korcsmaros T, 2007, J BIOSCIENCES, V32, P441, DOI 10.1007/s12038-007-0043-y; Larade K, 2004, J EXP BIOL, V207, P1353, DOI 10.1242/jeb.00872; Lin YC, 2008, MOL IMMUNOL, V45, P1346, DOI 10.1016/j.molimm.2007.09.005; Liu J, 2004, CELL STRESS CHAPERON, V9, P313, DOI 10.1379/CSC-40R.1; Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1; MACAULAY MC, 1984, J CRUSTACEAN BIOL, V4, P16, DOI 10.1163/1937240X84X00480; Machida RJ, 2004, MAR BIOTECHNOL, V6, P238, DOI 10.1007/s10126-003-0016-6; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; MAYER C, PHOBOS 3 3 10 2006 2; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; MURPHY EJ, 2010, SO OC FOOD WEB MOD W; Nebert Daniel W., 2004, Human Genomics, V1, P460; NICOL S, 1994, ANTARCTIC SCI GLOBAL, V33, P144; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Obermuller BE, 2010, MAR ECOL PROG SER, V415, P109, DOI 10.3354/meps08735; PACHAURI RK, 2007, IPCC CLIMATE CHANGE; Pantzartzi CN, 2009, GENE, V431, P47, DOI 10.1016/j.gene.2008.10.028; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Peck LS, 2010, GLOBAL CHANGE BIOL, V16, P2614, DOI 10.1111/j.1365-2486.2009.02071.x; Peck LS, 2006, BIOL REV, V81, P75, DOI 10.1017/S1464793105006871; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Place S, 2005, POLAR BIOL, V28, P261, DOI 10.1007/s00300-004-0697-y; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quetin LB, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P285, DOI 10.5479/si.097884601X.21; QUETIN LB, 1991, AM ZOOL, V31, P49; Ravaux J, 2007, GENE, V386, P162, DOI 10.1016/j.gene.2006.09.001; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ritz DA, 2003, J MAR BIOL ASSOC UK, V83, P329, DOI 10.1017/S002531540300715Xh; Romo-Figueroa MG, 2004, DEV COMP IMMUNOL, V28, P713, DOI 10.1016/j.dci.2003.11.008; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; SCHININA ME, 1989, ARCH BIOCHEM BIOPHYS, V272, P507, DOI 10.1016/0003-9861(89)90246-4; Schram FR, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P233; Seear P, 2009, J EXP MAR BIOL ECOL, V381, P57, DOI 10.1016/j.jembe.2009.09.010; Shen X, 2010, MOL BIOL REP, V37, P771, DOI 10.1007/s11033-009-9602-7; Siegel V, 2005, POLAR BIOL, V29, P1, DOI 10.1007/s00300-005-0058-5; Sorensen JG, 2007, J BIOSCIENCES, V32, P447, DOI 10.1007/s12038-007-0044-x; Tarling GA, 2009, DEEP-SEA RES PT I, V56, P1994, DOI 10.1016/j.dsr.2009.07.004; Teschke M, 2008, MAR BIOL, V154, P315, DOI 10.1007/s00227-008-0925-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorne MAS, 2010, MAR GENOM, V3, P35, DOI 10.1016/j.margen.2010.02.002; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Trathan PN, 2010, ANTARCT SCI, V22, P387, DOI 10.1017/S0954102010000222; Truebano M, 2010, J EXP MAR BIOL ECOL, V391, P65, DOI 10.1016/j.jembe.2010.06.011; Vargas-Albores F, 2000, AQUACULTURE, V191, P13, DOI 10.1016/S0044-8486(00)00416-6; Vayssier M, 1999, PARASITOLOGY, V119, P81, DOI 10.1017/S0031182099004461; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; Wu LT, 2008, MOL REPROD DEV, V75, P952, DOI 10.1002/mrd.20817; Yamaguchi H, 2005, EXP CELL RES, V303, P415, DOI 10.1016/j.yexcr.2004.10.005; Yepiz-Plascencia G, 1998, COMP BIOCHEM PHYS B, V121, P309, DOI 10.1016/S0305-0491(98)10104-9; Zhang JQ, 2006, J BIOTECHNOL, V125, P173, DOI 10.1016/j.jbiotec.2006.03.010; Zhang XY, 2009, COMP BIOCHEM PHYS C, V150, P465, DOI 10.1016/j.cbpc.2009.07.002; Zhao DX, 2010, FISH SHELLFISH IMMUN, V29, P698, DOI 10.1016/j.fsi.2010.06.002; NEWBLER ASSEMBLY SOF	127	64	69	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15919	10.1371/journal.pone.0015919	http://dx.doi.org/10.1371/journal.pone.0015919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253607	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900023
J	Costa, TP; Brown, JD; Howerth, EW; Stallknecht, DE; Swayne, DE				Costa, Taiana P.; Brown, Justin D.; Howerth, Elizabeth W.; Stallknecht, David E.; Swayne, David E.			Homo- and Heterosubtypic Low Pathogenic Avian Influenza Exposure on H5N1 Highly Pathogenic Avian Influenza Virus Infection in Wood Ducks (Aix sponsa)	PLOS ONE			English	Article							A-VIRUSES; WILD BIRDS; HONG-KONG; ASIAN LINEAGE; CHICKENS; SUSCEPTIBILITY; PROTECTION; WATERFOWL; OUTBREAKS; IMMUNITY	Wild birds in the Orders Anseriformes and Charadriiformes are the natural reservoirs for avian influenza (AI) viruses. Although they are often infected with multiple AI viruses, the significance and extent of acquired immunity in these populations is not understood. Pre-existing immunity to AI virus has been shown to modulate the outcome of a highly pathogenic avian influenza (HPAI) virus infection in multiple domestic avian species, but few studies have addressed this effect in wild birds. In this study, the effect of pre-exposure to homosubtypic (homologous hemagglutinin) and heterosubtypic (heterologous hemagglutinin) low pathogenic avian influenza (LPAI) viruses on the outcome of a H5N1 HPAI virus infection in wood ducks (Aix sponsa) was evaluated. Pre- exposure of wood ducks to different LPAI viruses did not prevent infection with H5N1 HPAI virus, but did increase survival associated with H5N1 HPAI virus infection. The magnitude of this effect on the outcome of the H5N1 HPAI virus infection varied between different LPAI viruses, and was associated both with efficiency of LPAI viral replication in wood ducks and the development of a detectable humoral immune response. These observations suggest that in naturally occurring outbreaks of H5N1 HPAI, birds with pre-existing immunity to homologous hemagglutinin or neuraminidase subtypes of AI virus may either survive H5N1 HPAI virus infection or live longer than naive birds and, consequently, could pose a greater risk for contributing to viral transmission and dissemination. The mechanisms responsible for this protection and/or the duration of this immunity remain unknown. The results of this study are important for surveillance efforts and help clarify epidemiological data from outbreaks of H5N1 HPAI virus in wild bird populations.	[Costa, Taiana P.; Howerth, Elizabeth W.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Costa, Taiana P.; Brown, Justin D.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA 30602 USA; [Swayne, David E.] ARS, SE Poultry Res Lab, USDA, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Costa, TP (corresponding author), Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA.	dstall@uga.edu	Costa, Taiana/O-9469-2019; Costa, Taiana/HHS-5800-2022; Swayne, David/AAP-7166-2020	Costa, Taiana/0000-0002-5010-4188; Costa, Taiana/0000-0002-5010-4188; Swayne, David/0000-0001-7472-1992	Southeast Poultry Research Laboratory [58-6612-2-0220]; Southeastern Cooperative Wildlife Disease Study (SCWDS) [58-6612-2-0220]; Current Research Information System project [6612-32000-048-00D]	Southeast Poultry Research Laboratory; Southeastern Cooperative Wildlife Disease Study (SCWDS); Current Research Information System project	Funding for this work was provided through specific Cooperative Agreement #58-6612-2-0220 between the Southeast Poultry Research Laboratory (http://www.ars.usda.gov/main/site_main.htm?modecode = 66-12-07-00) and the Southeastern Cooperative Wildlife Disease Study (SCWDS) (http://scwds.org/), through the continued sponsorship of SCWDS member state and federal agencies, and Current Research Information System project 6612-32000-048-00D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; BROWN DW, 1992, AVIAN DIS, V36, P515, DOI 10.2307/1591743; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; CHAMBERS TM, 1988, VIROLOGY, V167, P414, DOI 10.1016/0042-6822(88)90103-1; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; HINSHAW VS, 1980, VIROLOGY, V102, P412, DOI 10.1016/0042-6822(80)90108-7; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pantin-Jackwood Mary J., 2008, V436, P77, DOI 10.1007/978-1-59745-279-3_10; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6	39	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15987	10.1371/journal.pone.0015987	http://dx.doi.org/10.1371/journal.pone.0015987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253608	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511900034
J	Singhal, R; Deng, XT; Chenchik, AA; Kandel, ES				Singhal, Ruchi; Deng, Xiaotao; Chenchik, Alex A.; Kandel, Eugene S.			Long-Distance Effects of Insertional Mutagenesis	PLOS ONE			English	Article							NF-KAPPA-B; RNA-POLYMERASE-II; GENE-THERAPY; HUMAN-CELLS; C-MYC; ACTIVATION; SYSTEM; VECTORS; SCID-X1; PROTEIN	Background: Most common systems of genetic engineering of mammalian cells are associated with insertional mutagenesis of the modified cells. Insertional mutagenesis is also a popular approach to generate random alterations for gene discovery projects. A better understanding of the interaction of the structural elements within an insertional mutagen and the ability of such elements to influence host genes at various distances away from the insertion site is a matter of considerable practical importance. Methodology/Principal Findings: We observed that, in the context of a lentiviral construct, a transcript, which is initiated at an internal CMV promoter/enhancer region and incorporates a splice donor site, is able to extend past a collinear viral LTR and trap exons of host genes, while the polyadenylation signal, which is naturally present in the LTR, is spliced out. Unexpectedly, when a vector, which utilizes this phenomenon, was used to produce mutants with elevated activity of NF-kappa B, we found mutants, which owed their phenotype to the effect of the insert on a gene located tens or even hundreds of kilobases away from the insertion site. This effect did not result from a CMV-driven transcript, but was sensitive to functional suppression of the insert. Interestingly, despite the long-distance effect, expression of loci most closely positioned to the insert appeared unaffected. Conclusions/Significance: We concluded that a polyadenylation signal in a retroviral LTR, when occurring within an intron, is an inefficient barrier against the formation of a hybrid transcript, and that a vector containing a strong enhancer may selectively affect the function of genes far away from its insertion site. These phenomena have to be considered when experimental or therapeutic transduction is performed. In particular, the long-distance effects of insertional mutagenesis bring into question the relevance of the lists of disease-associated retroviral integration targets, which did not undergo functional validation.	[Singhal, Ruchi; Kandel, Eugene S.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Deng, Xiaotao; Chenchik, Alex A.] Cellecta Inc, Mountain View, CA USA	Roswell Park Cancer Institute	Singhal, R (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	eugenekandel@yahoo.com			National Cancer Institute [CA098176, CA137708, CA116060, CA132841]; NATIONAL CANCER INSTITUTE [R21CA116060, R21CA137708, K01CA098176, R43CA132841] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following grants from the National Cancer Institute: CA098176, CA137708, CA116060 and CA132841. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. XD and AAC are employees of Cellecta, Inc. and as such Cellecta, Inc. played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Dasgupta M, 2008, CELL CYCLE, V7, P2249, DOI 10.4161/cc.7.14.6310; Dong BH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003144; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kandel ES, 2005, P NATL ACAD SCI USA, V102, P6425, DOI 10.1073/pnas.0502463102; Kandel ES, 2002, MOL CELL, V10, P1495, DOI 10.1016/S1097-2765(02)00777-3; KANDEL ES, 2003, SIGNAL TRANSDUCERS A; Kichina JV, 2008, CELL CYCLE, V7, P2081, DOI 10.4161/cc.7.14.6598; Lengler J, 2005, ANAL BIOCHEM, V343, P116, DOI 10.1016/j.ab.2005.05.004; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Matz Mikhail V, 2003, Methods Mol Biol, V221, P41; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neugebauer KM, 2006, NAT STRUCT MOL BIOL, V13, P385, DOI 10.1038/nsmb0506-385; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Sathe SS, 2004, P NATL ACAD SCI USA, V101, P192, DOI 10.1073/pnas.0306812101; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; SWAIN A, 1993, J VIROL, V67, P6265, DOI 10.1128/JVI.67.10.6265-6269.1993; SWAIN A, 1992, SCIENCE, V255, P841, DOI 10.1126/science.1371365; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15832	10.1371/journal.pone.0015832	http://dx.doi.org/10.1371/journal.pone.0015832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246045	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511200017
J	Wallace, BP; DiMatteo, AD; Hurley, BJ; Finkbeiner, EM; Bolten, AB; Chaloupka, MY; Hutchinson, BJ; Abreu-Grobois, FA; Amorocho, D; Bjorndal, KA; Bourjea, J; Bowen, BW; Duenas, RB; Casale, P; Choudhury, BC; Costa, A; Dutton, PH; Fallabrino, A; Girard, A; Girondot, M; Godfrey, MH; Hamann, M; Lopez-Mendilaharsu, M; Marcovaldi, MA; Mortimer, JA; Musick, JA; Nel, R; Pilcher, NJ; Seminoff, JA; Troeng, S; Witherington, B; Mast, RB				Wallace, Bryan P.; DiMatteo, Andrew D.; Hurley, Brendan J.; Finkbeiner, Elena M.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Alberto Abreu-Grobois, F.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Girard, Alexandre; Girondot, Marc; Godfrey, Matthew H.; Hamann, Mark; Lopez-Mendilaharsu, Milagros; Marcovaldi, Maria Angela; Mortimer, Jeanne A.; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Seminoff, Jeffrey A.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.			Regional Management Units for Marine Turtles: A Novel Framework for Prioritizing Conservation and Research across Multiple Scales	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; EVOLUTIONARILY-SIGNIFICANT-UNITS; CHELONIA-MYDAS; MITOCHONDRIAL-DNA; CARETTA-CARETTA; POPULATION-STRUCTURE; GENETIC-STRUCTURE; SATELLITE TRACKING; PROTECTED AREAS; PACIFIC	Background: Resolving threats to widely distributed marine megafauna requires definition of the geographic distributions of both the threats as well as the population unit(s) of interest. In turn, because individual threats can operate on varying spatial scales, their impacts can affect different segments of a population of the same species. Therefore, integration of multiple tools and techniques - including site-based monitoring, genetic analyses, mark-recapture studies and telemetry - can facilitate robust definitions of population segments at multiple biological and spatial scales to address different management and research challenges. Methodology/Principal Findings: To address these issues for marine turtles, we collated all available studies on marine turtle biogeography, including nesting sites, population abundances and trends, population genetics, and satellite telemetry. We georeferenced this information to generate separate layers for nesting sites, genetic stocks, and core distributions of population segments of all marine turtle species. We then spatially integrated this information from fine-to coarse-spatial scales to develop nested envelope models, or Regional Management Units (RMUs), for marine turtles globally. Conclusions/Significance: The RMU framework is a solution to the challenge of how to organize marine turtles into units of protection above the level of nesting populations, but below the level of species, within regional entities that might be on independent evolutionary trajectories. Among many potential applications, RMUs provide a framework for identifying data gaps, assessing high diversity areas for multiple species and genetic stocks, and evaluating conservation status of marine turtles. Furthermore, RMUs allow for identification of geographic barriers to gene flow, and can provide valuable guidance to marine spatial planning initiatives that integrate spatial distributions of protected species and human activities. In addition, the RMU framework - including maps and supporting metadata - will be an iterative, user-driven tool made publicly available in an online application for comments, improvements, download and analysis.	[Wallace, Bryan P.; DiMatteo, Andrew D.; Hurley, Brendan J.; Finkbeiner, Elena M.; Bolten, Alan B.; Chaloupka, Milani Y.; Hutchinson, Brian J.; Alberto Abreu-Grobois, F.; Amorocho, Diego; Bjorndal, Karen A.; Bourjea, Jerome; Bowen, Brian W.; Briseno Duenas, Raquel; Casale, Paolo; Choudhury, B. C.; Costa, Alice; Dutton, Peter H.; Fallabrino, Alejandro; Girard, Alexandre; Girondot, Marc; Godfrey, Matthew H.; Hamann, Mark; Lopez-Mendilaharsu, Milagros; Marcovaldi, Maria Angela; Mortimer, Jeanne A.; Musick, John A.; Nel, Ronel; Pilcher, Nicolas J.; Seminoff, Jeffrey A.; Troeng, Sebastian; Witherington, Blair; Mast, Roderic B.] IUCN, SSC Marine Turtle Specialist Grp, Burning Issues Working Grp, Arlington, VA USA; [Wallace, Bryan P.; Hurley, Brendan J.; Hutchinson, Brian J.; Troeng, Sebastian; Mast, Roderic B.] Conservat Int, Global Marine Div, Arlington, VA USA; [Wallace, Bryan P.; Finkbeiner, Elena M.] Duke Univ, Ctr Marine Conservat, Beaufort, NC USA; [DiMatteo, Andrew D.] Duke Univ, Marine Geospatial Ecol Lab, Durham, NC USA; [Bolten, Alan B.; Bjorndal, Karen A.] Univ Florida, Dept Biol, Archie Carr Ctr Sea Turtle Res, Gainesville, FL USA; [Chaloupka, Milani Y.] Univ Queensland, Ecol Modelling Serv Pty Ltd, Brisbane, Qld, Australia; [Alberto Abreu-Grobois, F.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Sinaloa, Mexico; [Amorocho, Diego] Ctr Invest Medio Ambiente & Desarrollo, Cali, Colombia; [Bourjea, Jerome] IFREMER, Lab Ressources Halieut, Le Port, Reunion, France; [Bowen, Brian W.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Briseno Duenas, Raquel] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Mazatlan, Banco Informac Tortugas Marinas BITMAR, Mazatlan, Sinaloa, Mexico; [Casale, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Casale, Paolo] World Wildlife Fund Italy, World Wildlife Fund Mediterranean Turtle Programm, Rome, Italy; [Choudhury, B. C.] Wildlife Inst India, Dept Endangered Species Management, Dehra Dun, Uttarakhand, India; [Costa, Alice] World Wildlife Fund Mozambique, Maputo, Mozambique; [Fallabrino, Alejandro] Karumbe, Montevideo, Uruguay; [Girard, Alexandre] Assoc RENATURA, Albens, France; [Girondot, Marc] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France; [Godfrey, Matthew H.] N Carolina Wildlife Resources Commiss, Beaufort, NC USA; [Hamann, Mark] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Lopez-Mendilaharsu, Milagros; Marcovaldi, Maria Angela] Fundacao Pro Tamar, Projeto Tamar ICMBio, Salvador, BA, Brazil; [Lopez-Mendilaharsu, Milagros] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Musick, John A.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Sch Environm Sci, Port Elizabeth, South Africa; [Pilcher, Nicolas J.] Marine Res Fdn, Sabah, Malaysia; [Seminoff, Jeffrey A.] NOAA, Marine Turtle Ecol & Assessment Program, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Troeng, Sebastian] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Troeng, Sebastian] Sea Turtle Conservancy, Sci Advisory Comm, Gainesville, FL USA; [Witherington, Blair] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL USA	Conservation International; Duke University; Duke University; State University System of Florida; University of Florida; University of Queensland; Universidad Nacional Autonoma de Mexico; Ifremer; Universidad Nacional Autonoma de Mexico; Sapienza University Rome; Wildlife Institute of India; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; James Cook University; Universidade do Estado do Rio de Janeiro; William & Mary; Virginia Institute of Marine Science; Nelson Mandela University; National Oceanic Atmospheric Admin (NOAA) - USA; Lund University; Florida Fish & Wildlife Conservation Commission	Wallace, BP (corresponding author), IUCN, SSC Marine Turtle Specialist Grp, Burning Issues Working Grp, Arlington, VA USA.	b.wallace@conservation.org	Grobois, Alberto Abreu/A-3560-2017; Girondot, Marc/A-7663-2010	Grobois, Alberto Abreu/0000-0002-7350-757X; CASALE, PAOLO/0000-0003-2534-6158; Bourjea, Jerome/0000-0001-7149-3648; Hamann, Mark/0000-0003-4588-7955; Girard, Alexandre/0000-0002-2973-5137; Bolten, Alan/0000-0002-4834-2742; Bjorndal, Karen/0000-0002-6286-1901; Girondot, Marc/0000-0001-6645-8530; Mortimer, Jeanne A./0000-0001-6318-2890	National Fish and Wildlife Foundation; Offield Family Foundation; National Fish and Wildlife Foundation; Offield Family Foundation	National Fish and Wildlife Foundation; Offield Family Foundation; National Fish and Wildlife Foundation; Offield Family Foundation	This study was funded by the National Fish and Wildlife Foundation and the Offield Family Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MYC is employed by a commercial company that provides ecological modelling services, and his involvement in this study was partially supported by this company. However, this support in no way biased his contributions to all aspects of this study, the overall process or resulting products generated by this study.	ABREUGROBOIS FA, 2007, IUCN RED LIST STATUS, P39; Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Bass AL, 2004, CONSERV GENET, V5, P783, DOI 10.1007/s10592-004-1979-1; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Bjorndal KA, 2005, MAR BIOL, V147, P1449, DOI 10.1007/s00227-005-0045-y; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal KA, 2008, MOL ECOL, V17, P2185, DOI 10.1111/j.1365-294X.2008.03752.x; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 1998, ECOL APPL, V8, P1; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 1999, MOL ECOL, V8, pS5, DOI 10.1046/j.1365-294X.1999.00798.x; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Bowen BW, 2004, MOL ECOL, V13, P3797, DOI 10.1111/j.1365-294X.2004.02356.x; BOWEN BW, 1995, P NAT ACAD SCI, V92, P3371; Boyle MC, 2009, P R SOC B, V276, P1993, DOI 10.1098/rspb.2008.1931; C?lix M., 2018, EUROPEAN RED LIST SA; Carreras C, 2007, CONSERV GENET, V8, P761, DOI 10.1007/s10592-006-9224-8; Carreras C, 2006, MAR BIOL, V149, P1269, DOI 10.1007/s00227-006-0282-8; Conant TA., 2009, LOGGERHEAD SEA TURTL; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dow W., 2007, 6 WIDECAST, P267; Dryden J, 2008, WILDLIFE RES, V35, P477, DOI 10.1071/WR07087; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; FitzSimmons NN, 1997, GENETICS, V147, P1843; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Formia Angela, 2007, Endangered Species Research, V3, P145, DOI 10.3354/esr003145; FRAZIER J, 1985, J HERPETOL, V19, P1, DOI 10.2307/1564414; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; KARL SA, 1992, GENETICS, V131, P163; LAHANAS PN, 1994, GENETICA, V94, P57, DOI 10.1007/BF01429220; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; LIMPUS CJ, 2008, BIOL REV AUSTR MARIN, P96; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Martien Karen K., 2003, Journal of Cetacean Research and Management, V5, P213; MEYLAN AB, 1990, SCIENCE, V248, P724, DOI 10.1126/science.2333522; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mrosovsky N, 2003, PREDICTING EXTINCTIO; Musick John A., 1997, P137; Seminoff JA, 2008, J EXP MAR BIOL ECOL, V356, P52, DOI 10.1016/j.jembe.2007.12.007; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Suryan RM, 2009, PROG OCEANOGR, V81, P214, DOI 10.1016/j.pocean.2009.04.012; Taylor BL, 1999, MOL ECOL, V8, pS11, DOI 10.1046/j.1365-294X.1999.00797.x; Wallace Bryan P., 2009, Endangered Species Research, V7, P11, DOI 10.3354/esr00177; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 1995, AM FISH S S, V17, P8; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Yorio P, 2009, CONSERV LETT, V2, P171, DOI 10.1111/j.1755-263X.2009.00062.x; 1996, FED RED, V61, P4722	59	378	407	1	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15465	10.1371/journal.pone.0015465	http://dx.doi.org/10.1371/journal.pone.0015465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21253007	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000285572900021
J	Ip, CKM; Cheung, ANY; Ngan, HYS; Wong, AST				Ip, C. K. M.; Cheung, A. N. Y.; Ngan, H. Y. S.; Wong, A. S. T.			p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells	ONCOGENE			English	Article						p70 S6 kinase; ovarian cancer; actin; Rac1; Cdc42	GROWTH-FACTOR; MESSENGER-RNA; RHO-GTPASES; G-PROTEINS; LOCALIZATION; ACTIVATION; EXPRESSION; ONCOGENE; PHOSPHORYLATION; INHIBITION	Ovarian cancer is highly metastatic with a poor prognosis. The serine/threonine kinase, p70 S6 kinase (p70(S6K)), which is a downstream effector of phosphatidylinositol 3-kinase/Akt pathway, is frequently activated in ovarian cancer. Here, we show that p70(S6K) is a critical regulator of the actin cytoskeleton in the acquisition of the metastatic phenotype. This regulation is through two important activities: p70(S6K) acts as an actin filament cross-linking protein and as a Rho family GTPase-activating protein. Ectopic expression of constitutively active p70(S6K) in ovarian cancer cells induced a marked reorganization of the actin cytoskeleton and promoted directional cell migration. Using cosedimentation and differential sedimentation assays, p70(S6K) was found to directly bind to and cross-link actin filaments. Immunofluorescence studies showed p70(S6K) colocalized with cytochalasin D-sensitive actin at the leading edge of motile cells. The p70(S6K) did not affect the kinetics of spontaneous actin polymerization, but could stabilize actin filaments by the inhibition of cofilin-induced actin depolymerization. In addition, we showed that p70(S6K) stimulated the rapid activation of both Rac1 and Cdc42, and their downstream effector p21-activated kinase (PAK1), but not RhoA. Depletion of p70(S6K) expression or inhibition of its activity resulted in significant inhibition of actin cytoskeleton reorganization and reduced migration, with a concomitant reduction in Rac1, Cdc42 and PAK1 activation, confirming that the effect was p70(S6K) specific. Similarly, the actin cytoskeleton reorganization/migratory phenotype could be reversed by expression of dominant negative Rac1 and Cdc42, or inhibition of PAK1. These results reveal a new direction for understanding the oncogenic roles of p70(S6K) in tumor progression. Oncogene (2011) 30, 2420-2432; doi:10.1038/onc.2010.615; published online 24 January 2011	[Ip, C. K. M.; Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Cheung, A. N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ngan, H. Y. S.] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, AST (corresponding author), Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biol Sci Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	awong1@hku.hk	Wong, Alice/AFJ-4595-2022; Cheung, Annie Nga Yin/C-4231-2009	Wong, Alice/0000-0002-0676-6475; Ip, Carman K.M./0000-0002-6672-5982; Ngan, Hextan Y S/0000-0003-3945-159X; Cheung, Annie Nga Yin/0000-0002-1584-7568	Research Grant Council [HKU 7599/05M]; HKU	Research Grant Council(Hong Kong Research Grants Council); HKU(University of Hong Kong)	We thank Dr N Auersperg, G Thomas and A Hall for providing cell lines and cDNA constructs. This work was supported by the Research Grant Council grant HKU 7599/05M and the HKU Outstanding Young Research Award (AST Wong).	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; BUICK RN, 1985, CANCER RES, V45, P3668; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Corps AN, 1997, INT J CANCER, V73, P151, DOI 10.1002/(SICI)1097-0215(19970926)73:1<151::AID-IJC23>3.0.CO;2-I; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Filonenko VV, 2004, EXP ONCOL, V26, P294; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; HOLMES GR, 1976, BIOCHIM BIOPHYS ACTA, V446, P445, DOI 10.1016/0005-2795(76)90010-6; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Philp AJ, 2001, CANCER RES, V61, P7426; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schraml P, 2003, AM J PATHOL, V163, P985, DOI 10.1016/S0002-9440(10)63458-X; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Sowter HM, 1999, INT J CANCER, V83, P476, DOI 10.1002/(SICI)1097-0215(19991112)83:4<476::AID-IJC7>3.0.CO;2-V; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Wong AST, 2004, EXP CELL RES, V299, P248, DOI 10.1016/j.yexcr.2004.06.002; Zhou HY, 2006, ENDOCRINOLOGY, V147, P2557, DOI 10.1210/en.2005-1404	38	72	76	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	21					2420	2432		10.1038/onc.2010.615	http://dx.doi.org/10.1038/onc.2010.615			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21258406	Bronze, Green Submitted			2022-12-25	WOS:000291008000004
J	Kwak, HJ; Kim, YJ; Chun, KR; Woo, YM; Park, SJ; Jeong, JA; Jo, SH; Kim, TH; Min, HS; Chae, JS; Choi, EJ; Kim, G; Shin, SH; Gwak, HS; Kim, SK; Hong, EK; Lee, GK; Choi, KH; Kim, JH; Yoo, H; Park, JB; Lee, SH				Kwak, H-J; Kim, Y-J; Chun, K-R; Woo, Y. M.; Park, S-J; Jeong, J-A; Jo, S. H.; Kim, T. H.; Min, H. S.; Chae, J. S.; Choi, E-J; Kim, G.; Shin, S-H; Gwak, H-S; Kim, S-K; Hong, E-K; Lee, G-K; Choi, K-H; Kim, J. H.; Yoo, H.; Park, J. B.; Lee, S-H			Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas	ONCOGENE			English	Article						glioma; invasion; hyaluronan; miR-21; spry2; PTEN	INVASION; GLIOBLASTOMA; MICRORNA-21; HYALURONAN; ADHESION; TARGETS; SPROUTY	Gliomas are associated with high mortality because of their exceedingly invasive character. As these tumors acquire their invasiveness from low-grade tumors, it is very important to understand the detailed molecular mechanisms of invasion onset. Recent evidences suggest the significant role of microRNAs in tumor invasion. Thus, we hypothesized that deregulation of microRNAs may be important for the malignant progression of gliomas. We found that the aberrant expression of miR-21 is responsible for glioma invasion by disrupting the negative feedback circuit of Ras/MAPK signaling, which is mediated by Spry2. Upregulation of miR-21 was triggered by tumor microenvironmental factors such as hyaluronan and growth factors in glioma cells lacking functional phosphatase and tensin homolog (PTEN), but not harboring wild-type PTEN. Consistently with these in vitro results, Spry2 protein levels were significantly decreased in 79.7% of invasive WHO grade II-IV human glioma tissues, but not in non-invasive grade I and normal tissues. The Spry2 protein levels were not correlated with their mRNA levels, but inversely correlated with miR-21 levels. Taken together, these results suggest that the post-transcriptional regulation of Spry2 by miR-21 has an essential role on the malignant progression of human gliomas. Thus, Spry2 may be a novel therapeutic target for treating gliomas. Oncogene (2011) 30, 2433-2442; doi:10.1038/onc.2010.620; published online 31 January 2011	[Kwak, H-J; Kim, Y-J; Chun, K-R; Woo, Y. M.; Park, S-J; Jeong, J-A; Jo, S. H.; Kim, T. H.; Kim, G.; Choi, K-H; Park, J. B.] Natl Canc Ctr, Res Inst Hosp, Specif Organs Canc Branch, Goyang 411769, Gyeonggi, South Korea; [Kim, Y-J] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Min, H. S.; Hong, E-K; Lee, G-K] Natl Canc Ctr, Res Inst Hosp, Dept Pathol, Goyang 411769, Gyeonggi, South Korea; [Chae, J. S.; Choi, E-J] Korea Univ, Sch Life Sci & Biotechnol, Lab Cell Death & Human Dis, Seoul, South Korea; [Shin, S-H; Gwak, H-S; Yoo, H.; Lee, S-H] Natl Canc Ctr, Res Inst Hosp, Neurooncol Clin, Goyang 411769, Gyeonggi, South Korea; [Kim, S-K] Seoul Natl Univ, Coll Med, Seoul Natl Univ Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea; [Kim, J. H.] Natl Canc Ctr, Res Inst Hosp, Carcinogenesis Branch, Goyang 411769, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); Korea University; National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital; National Cancer Center - Korea (NCC)	Park, JB (corresponding author), Natl Canc Ctr, Res Inst Hosp, Specif Organs Canc Branch, 323 Ilsan Ro, Goyang 411769, Gyeonggi, South Korea.	jbp@ncc.re.kr; nslsh@ncc.re.kr	Choi, Kyungho/J-5685-2012; Kim, Seung-Ki/J-2742-2012	Choi, Kyungho/0000-0003-1635-173X	National Cancer Center [1010171, 1010172, 1110120, 1110110]; National Research Foundation [2010-0016811, 2010-0016704]	National Cancer Center; National Research Foundation	This work was supported by the National Cancer Center Grants (1010171, 1010172, and 1110120) and the National Research Foundation Grant (2010-0016811). JHK was supported by the National Cancer Center Grant (1110110) and the National Research Foundation Grant (2010-0016704).	Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kim MS, 2008, MOL CANCER RES, V6, P1657, DOI 10.1158/1541-7786.MCR-08-0034; Kim MS, 2005, INT J ONCOL, V27, P839; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; MERZAK A, 1994, CANCER RES, V54, P3988; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Park MJ, 2002, CANCER RES, V62, P6318; Roversi G, 2006, ONCOGENE, V25, P1571, DOI 10.1038/sj.onc.1209177; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391	24	113	118	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	21					2433	2442		10.1038/onc.2010.620	http://dx.doi.org/10.1038/onc.2010.620			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21278789				2022-12-25	WOS:000291008000005
J	Shan, S; Chen, XH; Liu, T; Zhao, HC; Rao, ZH; Lou, ZY				Shan, Shan; Chen, Xuehui; Liu, Ting; Zhao, Hanchao; Rao, Zihe; Lou, Zhiyong			Crystal structure of 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis	FASEB JOURNAL			English	Article						mechanism; drug discovery	NON-MEVALONATE PATHWAY; ISOPRENOID BIOSYNTHESIS; MECHANISM; ENZYMES; TARGET	Isoprenoid precursors, which are a large group of natural products and play key roles in many biological pathways, can only be biosynthesized by the 2-C-methyl-D-erythritol 4-phosphate pathway in Mycobacterium tuberculosis. The 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE), which is an essential enzyme in the isoprenoid precursor biosynthesis pathway, catalyzes ATP-dependent phosphorylation of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) to 4-diphosphocytidyl-2C-methyl-D-erythritol-2-phosphate and plays a crucial role in M. tuberculosis survival. Therefore, IspE is characterized as an attractive and potential target for antimicrobial drug discovery. However, no experimental structure of M. tuberculosis IspE has been reported, which has hindered our understanding of its structural details and mechanism of action. Here, we report the expression and purification of fully active full-length M. tuberculosis IspE and solve the high-resolution crystal structures of IspE alone and in complex with either the substrate CDP-ME or nonhydrolyzable ATP analog or ADP. The structures present a characteristic galactose/homoserine/mevalonate/phosphomevalonate kinase superfamily alpha/beta-fold with a catalytic center located in a cleft between 2 domains and display clear substrate and ATP binding pockets. Our results also indicate distinct differences in ligand binding of M. tuberculosis IspE with other reported IspEs. Combined with the results of mutagenesis and enzymatic studies, our results provide useful information on the structural basis of IspE for future anti-M. tuberculosis drug discovery targeting this kinase.-Shan, S. Chen, X., Liu, T., Zhao, H., Rao, Z., Lou, Z. Crystal structure of 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis. FASEB J. 25, 1577-1584 (2011). www.fasebj.org	[Shan, Shan; Zhao, Hanchao; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Shan, Shan; Zhao, Hanchao; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, MOE Lab Prot Sci, Beijing 100084, Peoples R China; [Chen, Xuehui; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100080, Peoples R China; [Liu, Ting; Rao, Zihe; Lou, Zhiyong] Tianjin Joint Acad Biotechnol & Med, High Throughput Mol Drug Discovery Ctr, Tianjin, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lou, ZY (corresponding author), Tsinghua Univ, Struct Biol Lab, New Life Sci Bldg, Beijing 100084, Peoples R China.	louzy@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022	Zhao, Hanchao/0000-0002-4121-2435	National Natural Science Foundation of China [30870486, 30770516, 30730022]; 973 Project [2007CB914304, 2010CB530100]; National Major Projects [2009ZX09311-001, 2009ZX10004-304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); National Major Projects	This work was supported by the National Natural Science Foundation of China (grants 30870486, 30770516, and 30730022), the 973 Project (grants 2007CB914304 and 2010CB530100), and the National Major Projects (grants 2009ZX09311-001 and 2009ZX10004-304).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernal C, 2005, ANAL BIOCHEM, V340, P245, DOI 10.1016/j.ab.2005.01.055; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; de Ruyck J, 2008, CURR PROTEIN PEPT SC, V9, P117; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoh H, 2009, CHEM BIOL, V16, P1230, DOI 10.1016/j.chembiol.2009.10.014; Eoh H, 2009, TUBERCULOSIS, V89, P1, DOI 10.1016/j.tube.2008.07.004; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Holm L, 1996, METHOD ENZYMOL, V266, P653; Jirage Dayadevi, 2010, Infectious Disorders - Drug Targets, V10, P134; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; [李爱华 Li Aihua], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P680; Lou ZY, 2010, PROTEIN CELL, V1, P435, DOI 10.1007/s13238-010-0057-3; [马万顺 Ma Wanshun], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P638; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Rohmer M, 1998, PROG DRUG RES, V50, P135; Sgraja T, 2008, FEBS J, V275, P2779, DOI 10.1111/j.1742-4658.2008.06418.x; Testa C. A., 2003, Current Pharmaceutical Biotechnology, V4, P248, DOI 10.2174/1389201033489784; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Wada T, 2003, J BIOL CHEM, V278, P30022, DOI 10.1074/jbc.M304339200; [张淑妍 ZHANG Shuyan], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P97; Zhou T, 2000, STRUCTURE, V8, P1247, DOI 10.1016/S0969-2126(00)00533-5	39	16	16	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1577	1584		10.1096/fj.10-175786	http://dx.doi.org/10.1096/fj.10-175786			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21282208				2022-12-25	WOS:000290023800015
J	Lambert, S; Drews, A; Rizun, O; Wagner, TFJ; Lis, A; Mannebach, S; Plant, S; Portz, M; Meissner, M; Philipp, SE; Oberwinkler, J				Lambert, Sachar; Drews, Anna; Rizun, Oleksandr; Wagner, Thomas F. J.; Lis, Annette; Mannebach, Stefanie; Plant, Sandra; Portz, Melanie; Meissner, Marcel; Philipp, Stephan E.; Oberwinkler, Johannes			Transient Receptor Potential Melastatin 1 (TRPM1) Is an Ion-conducting Plasma Membrane Channel Inhibited by Zinc Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; PANCREATIC BETA-CELLS; RETINAL BIPOLAR CELLS; GENE-EXPRESSION; MGLUR6; TRANSMISSION; SELECTIVITY; MELANOMA; DISRUPTION; PERMEATION	TRPM1 is the founding member of the melastatin subgroup of transient receptor potential (TRP) proteins, but it has not yet been firmly established that TRPM1 proteins form ion channels. Consequently, the biophysical and pharmacological properties of these proteins are largely unknown. Here we show that heterologous expression of TRPM1 proteins induces ionic conductances that can be activated by extracellular steroid application. However the current amplitudes observed were too small to enable a reliable biophysical characterization. We overcame this limitation by modifying TRPM1 channels in several independent ways that increased the similarity to the closely related TRPM3 channels. The resulting constructs produced considerably larger currents after overexpression. We also demonstrate that unmodified TRPM1 and TRPM3 proteins form functional heteromultimeric channels. With these approaches, we measured the divalent permeability profile and found that channels containing the pore of TRPM1 are inhibited by extracellular zinc ions at physiological concentrations, in contrast to channels containing only the pore of TRPM3. Applying these findings to pancreatic beta cells, we found that TRPM1 proteins do not play a major role in steroid-activated currents of these cells. The inhibition of TRPM1 by zinc ions is primarily due to a short stretch of seven amino acids present only in the pore region of TRPM1 but not of TRPM3. Combined, our data demonstrate that TRPM1 proteins are bona fide ion-conducting plasma membrane channels. Their distinct biophysical properties allow a reliable identification of endogenous TRPM1-mediated currents.	[Lambert, Sachar; Drews, Anna; Rizun, Oleksandr; Wagner, Thomas F. J.; Lis, Annette; Mannebach, Stefanie; Plant, Sandra; Portz, Melanie; Meissner, Marcel; Philipp, Stephan E.; Oberwinkler, Johannes] Univ Saarland, D-66421 Homburg, Germany	Saarland University	Oberwinkler, J (corresponding author), Univ Klinikum Saarlandes, Gebaude 46, D-66421 Homburg, Germany.	johannes.oberwinkler@uniklinikum-saarland.de	Philipp, Stephan/AAR-7519-2020	Oberwinkler, Johannes/0000-0002-8541-3626; Philipp, Stephan/0000-0003-1959-9167	Deutsche Forschungsgemeinschaft [GK 1326, SFB 530, SFB 894]; HOMFOR; Forschungskommission der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HOMFOR; Forschungskommission der Universitat des Saarlandes	This work was supported by Deutsche Forschungsgemeinschaft (GK 1326, SFB 530, SFB 894 and Emmy Noether-program), HOMFOR, and Forschungskommission der Universitat des Saarlandes.	Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Braman J, 1996, Methods Mol Biol, V57, P31; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Duncan LM, 1998, CANCER RES, V58, P1515; Duncan LM, 2001, J CLIN ONCOL, V19, P568, DOI 10.1200/JCO.2001.19.2.568; Erickson LA, 2009, MODERN PATHOL, V22, P969, DOI 10.1038/modpathol.2009.56; Frederickson CJ, 2006, J NEUROSCI METH, V154, P19, DOI 10.1016/j.jneumeth.2005.11.014; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Georgiev P, 2010, CELL METAB, V12, P386, DOI 10.1016/j.cmet.2010.08.012; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jeong SW, 2003, NEUROREPORT, V14, P1537, DOI 10.1097/00001756-200308060-00028; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Komatsu K, 2005, J AM CHEM SOC, V127, P10197, DOI 10.1021/ja050301e; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lis A, 2005, N-S ARCH PHARMACOL, V371, P315, DOI 10.1007/s00210-005-1050-x; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nakajima Y, 2009, J BIOCHEM, V145, P811, DOI 10.1093/jb/mvp038; Nakamura M, 2010, MOL VIS, V16, P425; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Okawa H, 2010, J GEN PHYSIOL, V136, P443, DOI 10.1085/jgp.201010477; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Paoletti P, 1997, J NEUROSCI, V17, P5711; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Redenti S, 2005, VISION RES, V45, P3520, DOI 10.1016/j.visres.2005.07.039; Redenti S, 2007, EXP EYE RES, V85, P580, DOI 10.1016/j.exer.2007.07.017; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Snellman J, 2008, PROG RETIN EYE RES, V27, P450, DOI 10.1016/j.preteyeres.2008.03.003; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2003, CELL CALCIUM, V33, P299, DOI 10.1016/S0143-4160(03)00044-7; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Warnat J, 1999, J PHYSIOL-LONDON, V518, P631, DOI 10.1111/j.1469-7793.1999.0631p.x; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	57	54	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.202945	http://dx.doi.org/10.1074/jbc.M110.202945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21278253	Green Published, hybrid			2022-12-25	WOS:000289077500037
J	Finigan, JH; Faress, JA; Wilkinson, E; Mishra, RS; Nethery, DE; Wyler, D; Shatat, M; Ware, LB; Matthay, MA; Mason, R; Silver, RF; Kern, JA				Finigan, James H.; Faress, Jihane A.; Wilkinson, Emily; Mishra, Rangnath S.; Nethery, David E.; Wyler, David; Shatat, Mohammad; Ware, Lorraine B.; Matthay, Michael A.; Mason, Robert; Silver, Richard F.; Kern, Jeffrey A.			Neuregulin-1-Human Epidermal Receptor-2 Signaling Is a Central Regulator of Pulmonary Epithelial Permeability and Acute Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; GROWTH-FACTOR RECEPTOR; CANCER CELL-LINES; EGF RECEPTOR; IN-VITRO; ALVEOLAR EPITHELIUM; CYSTIC-FIBROSIS; MICE LACKING; FACTOR-ALPHA; INTERLEUKIN-1	The mechanisms behind the loss of epithelial barrier function leading to alveolar flooding in acute lung injury (ALI) are incompletely understood. We hypothesized that the tyrosine kinase receptor human epidermal growth factor receptor-2 (HER2) would be activated in an inflammatory setting and participate in ALI. Interleukin-1 beta (IL-1 beta) exposure resulted in HER2 activation in human epithelial cells and markedly increased conductance across a monolayer of airway epithelial cells. Upon HER2 blockade, conductance changes were significantly decreased. Mechanistic studies revealed that HER2 trans-activation by IL-1 beta required a disintegrin and metalloprotease 17 (ADAM17)-dependent shedding of the ligand neuregulin-1 (NRG-1). In murine models of ALI, NRG-1-HER2 signaling was activated, and ADAM17 blockade resulted in decreased NRG-1 shedding, HER2 activation, and lung injury in vivo. Finally, NRG-1 was detectable and elevated in pulmonary edema fluid from patients with ALI. These results suggest that the ADAM17-NRG-1-HER2 axis modulates the alveolar epithelial barrier and contributes to the pathophysiology of ALI.	[Finigan, James H.; Mason, Robert; Kern, Jeffrey A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Finigan, James H.; Faress, Jihane A.; Wilkinson, Emily; Mishra, Rangnath S.; Nethery, David E.; Wyler, David; Shatat, Mohammad; Silver, Richard F.] Case Western Reserve Univ, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Finigan, James H.; Faress, Jihane A.; Wilkinson, Emily; Mishra, Rangnath S.; Nethery, David E.; Wyler, David; Shatat, Mohammad; Silver, Richard F.] Case Western Reserve Univ, Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Ware, Lorraine B.] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Dept Med, Sch Med, Nashville, TN 37232 USA; [Matthay, Michael A.] Univ Calif San Francisco, Res Inst, Dept Med, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Res Inst, Dept Anesthesia, San Francisco, CA 94143 USA	National Jewish Health; Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finigan, JH (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St,K736A, Denver, CO 80206 USA.	FiniganJ@NJHealth.org	Ware, Lorraine/AAJ-9307-2021	Ware, Lorraine/0000-0002-9429-4702; Kern, Jeffrey/0000-0001-9709-9622; Shatat, Mohammad/0000-0002-8715-6889	National Institutes of Health [HL075422, K08 HL086668, HL029891, HL51856, HL51854, HL081332, HL103836]; Veterans Affairs merit award; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103836, R01HL051854, K08HL086668, R37HL051856, R01HL029891, R01HL051856, R01HL075422, U01HL081332, R37HL029891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL075422 (to J.A.K.), K08 HL086668 (to J.H.F.), HL029891 (to R.S.M.), HL51856 (to M.A.M.), HL51854 (to M.A.M.), HL081332 (to L.B.W.), and HL103836 (to L.B.W.). This work was also supported by Veterans Affairs merit awards (to J.A.K. and R.F.S.) and an American Heart Association established investigator award (to L.B.W.).	Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Faress JA, 2007, J APPL PHYSIOL, V103, P2077, DOI 10.1152/japplphysiol.00239.2007; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gollamudi M, 2004, LUNG CANCER, V43, P135, DOI 10.1016/j.lungcan.2003.08.027; GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315; Goto Y, 2000, AM J RESP CELL MOL, V23, P712, DOI 10.1165/ajrcmb.23.6.4031; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; INOUE S, 1976, J ULTRA MOL STRUCT R, V56, P215, DOI 10.1016/S0022-5320(76)80167-0; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; KERN JA, 1992, AM J RESP CELL MOL, V6, P359, DOI 10.1165/ajrcmb/6.4.359; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; LUETTEKE NC, 1993, CELL GROWTH DIFFER, V4, P203; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Mato N, 2009, EUR RESPIR J, V33, P1415, DOI 10.1183/09031936.00084307; MATTHAY MA, 1994, CHEST, V105, pS67, DOI 10.1378/chest.105.3_Supplement.67S; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Modelska K, 1999, AM J RESP CRIT CARE, V160, P1450, DOI 10.1164/ajrccm.160.5.9901096; Nethery DE, 2005, J APPL PHYSIOL, V99, P298, DOI 10.1152/japplphysiol.01360.2004; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Patel NV, 2000, AM J RESP CELL MOL, V22, P432, DOI 10.1165/ajrcmb.22.4.3854; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PITTET JF, 1995, AM J RESP CRIT CARE, V151, P1093; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shimabukuro DW, 2003, CRIT CARE MED, V31, pS524, DOI 10.1097/01.CCM.0000081437.06466.B3; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SILER TM, 1989, EXP LUNG RES, V15, P881, DOI 10.3109/01902148909069633; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	59	36	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10660	10670		10.1074/jbc.M110.208041	http://dx.doi.org/10.1074/jbc.M110.208041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247898	Green Published, hybrid			2022-12-25	WOS:000288547000080
J	Liebminger, E; Veit, C; Pabst, M; Batoux, M; Zipfel, C; Altmann, F; Mach, L; Strasser, R				Liebminger, Eva; Veit, Christiane; Pabst, Martin; Batoux, Martine; Zipfel, Cyril; Altmann, Friedrich; Mach, Lukas; Strasser, Richard			beta-N-Acetylhexosaminidases HEXO1 and HEXO3 Are Responsible for the Formation of Paucimannosidic N-Glycans in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE ALPHA-1,3-LINKED FUCOSE; LC-ESI-MS; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; PLANT IMMUNITY; RECEPTOR EFR; GLYCOSYLATION; CELLS; EXPRESSION; XYLOSE	Most plant glycoproteins contain substantial amounts of paucimannosidic N-glycans instead of their direct biosynthetic precursors, complex N-glycans with terminal N-acetylglucosamine residues. We now demonstrate that two beta-N-acetylhexosaminidases (HEXO1 and HEXO3) residing in different subcellular compartments jointly account for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. Total N-glycan analysis of hexo knock-out plants revealed that HEXO1 and HEXO3 contribute equally to the production of paucimannosidic N-glycans in roots, whereas N-glycan processing in leaves depends more heavily on HEXO3 than on HEXO1. Because hexo1 hexo3 double mutants do not display any obvious phenotype even upon exposure to different forms of abiotic or biotic stress, it should be feasible to improve the quality of glycoprotein therapeutics produced in plants by down-regulation of endogenous beta-N-acetylhexosaminidase activities.	[Liebminger, Eva; Veit, Christiane; Mach, Lukas; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Pabst, Martin; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Batoux, Martine; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020; ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011; Pabst, Martin/GOH-1766-2022	ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583; Pabst, Martin/0000-0001-9897-0723; Strasser, Richard/0000-0001-8764-6530; Altmann, Friedrich/0000-0002-0112-7877; Mach, Lukas/0000-0001-9013-5408	Austrian Science Fund [P19092, P20817]; Gatsby Charitable Foundation; BBSRC [BB/E024874/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 20817] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E024874/1] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Austrian Science Fund Grants P19092 and P20817. Research in the Zipfel laboratory is supported by the Gatsby Charitable Foundation.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Butaye KMJ, 2004, PLANT J, V39, P440, DOI 10.1111/j.1365-313X.2004.02144.x; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dirnberger D, 2001, EUR J BIOCHEM, V268, P4570, DOI 10.1046/j.1432-1327.2001.02384.x; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Frey AD, 2009, PLANT BIOTECHNOL J, V7, P33, DOI 10.1111/j.1467-7652.2008.00370.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hartweck LM, 2002, GENETICS, V161, P1279; Jin CS, 2006, GLYCOBIOLOGY, V16, P349, DOI 10.1093/glycob/cwj071; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Karg SR, 2010, J BIOTECHNOL, V146, P54, DOI 10.1016/j.jbiotec.2010.01.005; Kobae Y, 2006, BIOSCI BIOTECH BIOCH, V70, P980, DOI 10.1271/bbb.70.980; Koprivova A, 2004, PLANT BIOTECHNOL J, V2, P517, DOI 10.1111/j.1467-7652.2004.00100.x; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Palacpac NQ, 1999, P NATL ACAD SCI USA, V96, P4692, DOI 10.1073/pnas.96.8.4692; Rouwendal GJA, 2007, GLYCOBIOLOGY, V17, P334, DOI 10.1093/glycob/cwl078; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 1999, GLYCOCONJUGATE J, V16, P787, DOI 10.1023/A:1007127815012; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; STURM A, 1991, EUR J BIOCHEM, V199, P169, DOI 10.1111/j.1432-1033.1991.tb16106.x; Suga S, 2001, PLANTA, V212, P294, DOI 10.1007/s004250000396; TAKAHASHI N, 1986, BIOCHEMISTRY-US, V25, P388, DOI 10.1021/bi00350a018; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zhu KY, 1996, PLANT PHYSIOL, V110, P195, DOI 10.1104/pp.110.1.195; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	42	57	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10793	10802		10.1074/jbc.M110.178020	http://dx.doi.org/10.1074/jbc.M110.178020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252225	Green Published, hybrid			2022-12-25	WOS:000288547000093
J	Chen, XP; Zhao, YF; Guo, ZM; Zhou, LC; Okoro, EU; Yang, H				Chen, Xinping; Zhao, Yanfeng; Guo, Zhongmao; Zhou, Lichun; Okoro, Emmanuel U.; Yang, Hong			Transcriptional Regulation of ATP-binding Cassette Transporter A1 Expression by a Novel Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-ZETA; CHOLESTEROL EFFLUX; X-RECEPTOR; TANGIER-DISEASE; IN-VITRO; GENE; INHIBITOR; 3-KINASE; ABCA1; ATHEROSCLEROSIS	ATP-binding cassette transporter A1 (ABCA1) is a membrane- bound protein that regulates the efflux of cholesterol derived from internalized lipoproteins. Using a mouse macrophage cell line, this report studied the impact of low-density lipoproteins (LDL) on ABCA1 expression and the signaling pathway responsible for lipoprotein-induced ABCA1 expression. Our data demonstrated that treatment of macrophages with LDL increased ABCA1 mRNA and protein levels 4.3- and 3.5-fold, respectively. LDL also induced an similar to 2-fold increase in macrophage surface expression of ABCA1 and a 14-fold-increase in apolipoprotein AI-mediated cholesterol efflux. In addition, LDL significantly increased the level of phosphorylated specificity protein 1 (Sp1) and the amount of Sp1 bound to the ABCA1 promoter without alteration in total Sp1 protein level. Mutation of the Sp1 binding site in the ABCA1 promoter and inhibition of Sp1 DNA binding with mithramycin A suppressed the ABCA1 promoter activity and reduced the ABCA1 expression level induced by LDL. LDL treatment also elevated protein kinase C-zeta (PKC-zeta) phosphorylation and induced PKC-zeta binding with Sp1. Inhibition of PKC-zeta with kinase inhibitors or overexpression of kinase-dead PKC-zeta attenuated Sp1 phosphorylation and ABCA1 expression induced by LDL. These results demonstrate for the first time that activation of the PKC zeta-Sp1 signaling cascade is a mechanism for regulation of LDL-induced ABCA1 expression.	[Chen, Xinping; Guo, Zhongmao; Zhou, Lichun; Okoro, Emmanuel U.; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Zhao, Yanfeng] Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Peoples R China	Meharry Medical College; Wuhan University	Yang, H (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			National Institutes of Health [R01ES014471, R01HL089382, SC1HL101431, U54RR026140]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL101431, R01HL089382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by National Institutes of Health Grants R01ES014471 and R01HL089382 (to Z. G.) and SC1HL101431 and U54RR026140 (to H. Y.).	BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; CHISOLM GM, 1996, ATHEROSCLEROSIS CORO, P129; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Costet P, 2000, J BIOL CHEM, V275, P28240; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Shenoy NG, 2003, J IMMUNOL, V171, P3734, DOI 10.4049/jimmunol.171.7.3734; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Tang TA, 2010, FREE RADICAL BIO MED, V49, P487, DOI 10.1016/j.freeradbiomed.2010.05.007; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yang H, 2003, FREE RADICAL BIO MED, V35, P266, DOI 10.1016/S0891-5849(03)00277-6; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	29	27	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8917	8923		10.1074/jbc.M110.214429	http://dx.doi.org/10.1074/jbc.M110.214429			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21257755	Green Published, hybrid			2022-12-25	WOS:000288247700023
J	McMaster, A; Jangani, M; Sommer, P; Han, N; Brass, A; Beesley, S; Lu, WQ; Berry, A; Loudon, A; Donn, R; Ray, DW				McMaster, Andrew; Jangani, Maryam; Sommer, Paula; Han, Namshik; Brass, Andy; Beesley, Stephen; Lu, Weiqun; Berry, Andrew; Loudon, Andrew; Donn, Rachelle; Ray, David W.			Ultradian Cortisol Pulsatility Encodes a Distinct, Biologically Important Signal	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; PROMOTER; STRESS; GENE; TRANSCRIPTION; MODULATION; RELEASE; RHYTHM; ADRENOCORTICOTROPIN; CORTICOTROPIN	Context: Cortisol is released in ultradian pulses. The biological relevance of the resulting fluctuating cortisol concentration has not been explored. Objective: Determination of the biological consequences of ultradian cortisol pulsatility. Design: A novel flow through cell culture system was developed to deliver ultradian pulsed or continuous cortisol to cells. The effects of cortisol dynamics on cell proliferation and survival, and on gene expression were determined. In addition, effects on glucocorticoid receptor (GR) expression levels and phosphorylation, as a potential mediator, were measured. Results: Pulsatile cortisol caused a significant reduction in cell survival compared to continuous exposure of the same cumulative dose, due to increased apoptosis. Comprehensive analysis of the transcriptome response by microarray identified genes with a differential response to pulsatile versus continuous glucocorticoid delivery. These were confirmed with qRT-PCR. Several transcription factor binding sites were enriched in these differentially regulated target genes, including CCAAT-displacement protein (CDP). A CDP regulated reporter gene (MMTV-luc) was, as predicted, also differentially regulated by pulsatile compared to continuous cortisol delivery. Importantly there was no effect of cortisol delivery kinetics on either GR expression, or activation (GR phosphoSer(211)). Conclusions: Cortisol oscillations exert important effects on target cell gene expression, and phenotype. This is not due to differences in cumulative cortisol exposure, or either expression, or activation of the GR. This suggests a novel means to regulate GR function.	[McMaster, Andrew; Jangani, Maryam; Sommer, Paula; Lu, Weiqun; Berry, Andrew; Ray, David W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Endocrine Sci Res Grp, Manchester, Lancs, England; [McMaster, Andrew; Jangani, Maryam; Berry, Andrew; Donn, Rachelle] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Han, Namshik; Brass, Andy; Beesley, Stephen; Lu, Weiqun; Loudon, Andrew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Life Sci, Manchester, Lancs, England; [Han, Namshik; Brass, Andy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Comp Sci, Manchester, Lancs, England; [Sommer, Paula] Univ Kwa Zulu, Sch Biol Sci, Durban, South Africa	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Kwazulu Natal	McMaster, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Endocrine Sci Res Grp, Manchester, Lancs, England.	Rachelle.donn@manchester.ac.uk; David.w.ray@manchester.ac.uk	Sommer, Paula/E-9454-2010; beesley, stephen/B-4841-2017	Sommer, Paula/0000-0001-6810-5587; Loudon, Andrew/0000-0003-3648-445X; Donn, Rachelle/0000-0001-6976-9828; Han, Namshik/0000-0002-7741-6384; Ray, David/0000-0002-4739-6773; Brass, Andrew/0000-0002-0389-7058; beesley, stephen/0000-0001-6010-124X	Arthritis Research UK; NIHR Manchester Biomedical Research Centre	Arthritis Research UK(Versus Arthritis); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	The authors are grateful to Arthritis Research UK for support (RD, AB, AMcM), BBSRC (WL, AL), and Wellcome Trust (PS, DWR). The authors acknowledge support from the NIHR Manchester Biomedical Research Centre (MJ, DWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergendahl M, 2000, J CLIN ENDOCR METAB, V85, P2203, DOI 10.1210/jc.85.6.2203; Bijlsma JWJ, 2005, RHEUM DIS CLIN N AM, V31, pXIII, DOI 10.1016/j.rdc.2004.11.001; Chrousos GP, 1998, ENDOCRINOLOGY, V139, P437, DOI 10.1210/endo.139.2.5857; Cutolo M, 2005, RHEUM DIS CLIN N AM, V31, P115, DOI 10.1016/j.rdc.2004.09.005; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Invitti C, 1998, METABOLISM, V47, P143, DOI 10.1016/S0026-0495(98)90210-4; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KERRIGAN JR, 1993, J CLIN ENDOCR METAB, V76, P1505, DOI 10.1210/jc.76.6.1505; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Lightman S L, 2000, Novartis Found Symp, V227, P244; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Muglia LJ, 1997, J CLIN INVEST, V99, P2923, DOI 10.1172/JCI119487; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; SARNYAI Z, 1995, J CLIN ENDOCR METAB, V80, P54, DOI 10.1210/jc.80.1.54; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sommer P, 2007, ONCOGENE, V26, P7111, DOI 10.1038/sj.onc.1210524; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; VELDHUIS JD, 1990, J CLIN ENDOCR METAB, V71, P452, DOI 10.1210/jcem-71-2-452; VELDHUIS JD, 1989, AM J PHYSIOL, V257, pE5, DOI 10.1152/ajpendo.1989.257.1.E6; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Windle RJ, 2001, J NEUROENDOCRINOL, V13, P905, DOI 10.1046/j.1365-2826.2001.00715.x; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001; Zhu Q, 2002, J VIROL, V76, P2168, DOI 10.1128/JVI.76.5.2168-2179.2002	38	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15766	10.1371/journal.pone.0015766	http://dx.doi.org/10.1371/journal.pone.0015766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267416	Green Submitted, gold, Green Published			2022-12-25	WOS:000286519500027
J	Francis, J; Lin, WC; Rozenblatt-Rosen, O; Meyerson, M				Francis, Joshua; Lin, Wenchu; Rozenblatt-Rosen, Orit; Meyerson, Matthew			The Menin Tumor Suppressor Protein Is Phosphorylated in Response to DNA Damage	PLOS ONE			English	Article							ENDOCRINE NEOPLASIA TYPE-1; HISTONE METHYLTRANSFERASE COMPLEX; EXPRESSION ANALYSIS; TARGET GENES; CELL-LINES; CHROMATIN; IDENTIFICATION; MUTATIONS; REPAIR; FANCD2	Background: Multiple endocrine neoplasia type 1 (MEN1) is a heritable cancer syndrome characterized by tumors of the pituitary, pancreas and parathyroid. Menin, the product of the MEN1 gene, is a tumor suppressor protein that functions in part through the regulation of transcription mediated by interactions with chromatin modifying enzymes. Principal Findings: Here we show menin association with the 5' regions of DNA damage response genes increases after DNA damage and is correlated with RNA polymerase II association but not with changes in histone methylation. Furthermore, we were able to detect significant levels of menin at the 3' regions of CDKN1A and GADD45A under conditions of enhanced transcription following DNA damage. We also demonstrate that menin is specifically phosphorylated at Ser394 in response to several forms of DNA damage, Ser487 is dynamically phosphorylated and Ser543 is constitutively phosphorylated. Phosphorylation at these sites however does not influence the ability to interact with histone methyltransferase activity. In contrast, the interaction between menin and RNA polymerase II is influenced by phosphorylation, whereby a phospho-deficient mutant had a higher affinity for the elongating form of RNA polymerase compared to wild type. Additionally, a subset of MEN1-associated missense point mutants, fail to undergo DNA damage dependent phosphorylation. Conclusion: Together, our findings suggest that the menin tumor suppressor protein undergoes DNA damage induced phosphorylation and participates in the DNA damage transcriptional response.	[Francis, Joshua; Lin, Wenchu; Rozenblatt-Rosen, Orit; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Francis, Joshua; Lin, Wenchu; Rozenblatt-Rosen, Orit; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Francis, J (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Rozenblatt-Rosen, Orit/HDN-4182-2022	Meyerson, Matthew/0000-0002-9133-8108	Caring for Carcinoid Foundation; Ruth L. Kirschstein National Research Service [F32DK77424]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077424] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Caring for Carcinoid Foundation (M.M.) and a Ruth L. Kirschstein National Research Service Award Post-Doctoral fellowship F32DK77424 (J.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2004, ANN NY ACAD SCI, V1014, P189, DOI 10.1196/annals.1294.020; Agarwal SK, 2007, NEOPLASIA, V9, P101, DOI 10.1593/neo.06706; Bazzi W, 2008, GASTROENTEROLOGY, V135, P1698, DOI 10.1053/j.gastro.2008.07.031; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dreijerink KMA, 2009, J INTERN MED, V266, P53, DOI 10.1111/j.1365-2796.2009.02115.x; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Farley SM, 2006, J SURG RES, V133, P29, DOI 10.1016/j.jss.2006.02.021; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; Guru SC, 1999, MAMM GENOME, V10, P592, DOI 10.1007/s003359901051; Guru SC, 2001, GENE, V263, P31, DOI 10.1016/S0378-1119(00)00562-X; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heppner C, 1997, NAT GENET, V16, P375, DOI 10.1038/ng0897-375; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kottemann MC, 2009, DNA REPAIR, V8, P944, DOI 10.1016/j.dnarep.2009.06.001; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; MacConaill LE, 2006, MOL CANCER RES, V4, P793, DOI 10.1158/1541-7786.MCR-06-0123; Marek LR, 2008, DNA REPAIR, V7, P476, DOI 10.1016/j.dnarep.2007.12.009; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wautot V, 2000, INT J CANCER, V85, P877, DOI 10.1002/(SICI)1097-0215(20000315)85:6<877::AID-IJC23>3.0.CO;2-F; Wu Xinjiang, 2008, Curr Mol Med, V8, P805, DOI 10.2174/156652408786733702; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zhuang ZP, 1997, CANCER RES, V57, P4682	39	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16119	10.1371/journal.pone.0016119	http://dx.doi.org/10.1371/journal.pone.0016119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264250	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500029
J	Mateo, R; Baos, AR; Vidal, D; Camarero, PR; Martinez-Haro, M; Taggart, MA				Mateo, Rafael; Baos, Ana R.; Vidal, Dolors; Camarero, Pablo R.; Martinez-Haro, Monica; Taggart, Mark A.			Bioaccessibility of Pb from Ammunition in Game Meat Is Affected by Cooking Treatment	PLOS ONE			English	Article							VITRO DIGESTION MODELS; LEAD-EXPOSURE; NORTHERN ONTARIO; HUMAN DIET; SHOT; BIOAVAILABILITY; GREENLAND; CADMIUM; MERCURY; HEALTH	Background: The presence of lead (Pb) ammunition residues in game meat has been widely documented, yet little information exists regarding the bioaccessibility of this Pb contamination. We study how cooking treatment (recipe) can affect Pb bioaccessibility in meat of animals hunted with Pb ammunition. Methodology/Principal Findings: We used an in vitro gastrointestinal simulation to study bioaccessibility. The simulation was applied to meat from red-legged partridge (Alectoris rufa) hunted with Pb shot pellets and cooked using various traditional Spanish game recipes involving wine or vinegar. Total Pb concentrations in the meat were higher in samples with visible Pb ammunition by X-ray (mean +/- SE: 3.29 +/- 1.12 mu g/g w.w.) than in samples without this evidence (1.28 +/- 0.61 mu g/g). The percentage of Pb that was bioaccessible within the simulated intestine phase was far higher in meat cooked with vinegar (6.75%) and wine (4.51%) than in uncooked meat (0.7%). Risk assessment simulations using our results transformed to bioavailability and the Integrated Exposure Uptake Biokinetic model (IEUBK; US EPA) show that the use of wine instead of vinegar in cooking recipes may reduce the percentage of children that would be expected to have >10 mu g/dl of Pb in blood from 2.08% to 0.26% when game meat represents 50% of the meat in diet. Conclusions/Significance: Lead from ammunition in game meat is more bioaccessible after cooking, especially when using highly acidic recipes. These results are important because existing theoretical models regarding Pb uptake and subsequent risk in humans should take such factors into account.	[Mateo, Rafael; Baos, Ana R.; Vidal, Dolors; Camarero, Pablo R.; Martinez-Haro, Monica; Taggart, Mark A.] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Mateo, R (corresponding author), CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain.	rafael.mateo@uclm.es	Vidal, Dolo/AAF-2431-2020; Vidal, M Dolors/K-2192-2012; Mateo, Rafael/AAU-1480-2020; Mateo, Rafael/A-3117-2011; Martinez-Haro, Mónica/B-8363-2015	Vidal, Dolo/0000-0002-8671-6960; Vidal, M Dolors/0000-0002-8671-6960; Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Martinez-Haro, Mónica/0000-0002-4326-5805; Camarero Abella, Pablo R/0000-0002-2047-6554; Taggart, Mark/0000-0002-0649-8490	Spanish Ministry of Science and Innovation (MICINN) [CGL2007-62797]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by the Spanish Ministry of Science and Innovation (MICINN) under CGL2007-62797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLTROP D, 1975, POSTGRAD MED J, V51, P805, DOI 10.1136/pgmj.51.601.805; Bjerregaard P, 2004, ENVIRON HEALTH PERSP, V112, P1496, DOI 10.1289/ehp.7083; Burger J, 1997, ENVIRON RES, V75, P173, DOI 10.1006/enrs.1997.3789; Carlisle JC, 2009, J ENVIRON SCI HEAL A, V44, P1200, DOI 10.1080/10934520903139829; CUADRADO C, 1995, FOOD ADDIT CONTAM, V12, P107, DOI 10.1080/02652039509374285; *EUR COMM, 2001, OFF J EUR COMM; Falco G, 2005, FOOD CHEM TOXICOL, V43, P1713, DOI 10.1016/j.fct.2005.05.014; *FAO WHO, 2000, TECHN REP SER WHO, V896; Ferrandis P, 2008, ENVIRON SCI TECHNOL, V42, P6271, DOI 10.1021/es800215y; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hanning RM, 2003, J ENVIRON MONITOR, V5, P241, DOI 10.1039/b208220a; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Johansen P, 2001, ENVIRON POLLUT, V112, P501, DOI 10.1016/S0269-7491(00)00130-5; Juhasz AL, 2009, ENVIRON SCI TECHNOL, V43, P4503, DOI 10.1021/es803238u; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693; Llobett JM, 2003, J AGR FOOD CHEM, V51, P838, DOI 10.1021/jf020734q; Martinez-Haro M, 2009, ENVIRON SCI TECHNOL, V43, P9480, DOI 10.1021/es901960e; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; MOREIRAS O, 1993, NUTR RES, V13, P851, DOI 10.1016/S0271-5317(05)80588-3; Mushak P, 1998, ENVIRON HEALTH PERSP, V106, P1467, DOI 10.1289/ehp.98106s61467; Oomen AG, 2002, ENVIRON SCI TECHNOL, V36, P3326, DOI 10.1021/es010204v; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P116, DOI 10.1007/s00244-002-1226-z; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; RUBIO C, 2004, REV TOXICOL, V21, P72, DOI DOI 10.1590/S0036-36342010000200010; Ruby MV, 1996, ENVIRON SCI TECHNOL, V30, P422, DOI 10.1021/es950057z; Ryan JA, 2004, ENVIRON SCI TECHNOL, V38, p18A, DOI 10.1021/es040337r; Scheuhammer AM, 1998, ENVIRON POLLUT, V102, P251, DOI 10.1016/S0269-7491(98)00083-9; Schroder JL, 2004, J ENVIRON QUAL, V33, P513, DOI 10.2134/jeq2004.0513; Taggart MA, 2011, ENVIRON INT, V37, P18, DOI 10.1016/j.envint.2010.06.007; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; Tsuji LJS, 2001, J ENVIRON MONITOR, V3, P702, DOI 10.1039/b106163c; U.S. EPA, 2007, US GUID INT EXP UPT; *US EPA, 1994, GUID MAN INT EXP UPT; Van de Wiele TR, 2007, J ENVIRON SCI HEAL A, V42, P1203, DOI 10.1080/10934520701434919	37	41	42	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15892	10.1371/journal.pone.0015892	http://dx.doi.org/10.1371/journal.pone.0015892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264290	gold, Green Published			2022-12-25	WOS:000286516500014
J	Trognitz, B; Scheldeman, X; Hansel-Hohl, K; Kuant, A; Grebe, H; Hermann, M				Trognitz, Bodo; Scheldeman, Xavier; Hansel-Hohl, Karin; Kuant, Aldo; Grebe, Hans; Hermann, Michael			Genetic Population Structure of Cacao Plantings within a Young Production Area in Nicaragua	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; THEOBROMA-CACAO; GERMPLASM; DIVERSITY; INFERENCE; L.	Significant cocoa production in the municipality of Waslala, Nicaragua, began in 1961. Since the 1980s, its economic importance to rural smallholders increased, and the region now contributes more than 50% of national cocoa bean production. This research aimed to assist local farmers to develop production of high-value cocoa based on optimal use of cacao biodiversity. Using microsatellite markers, the allelic composition and genetic structure of cacao was assessed from 44 representative plantings and two unmanaged trees. The population at Waslala consists of only three putative founder genotype spectra (lineages). Two (B and R) were introduced during the past 50 years and occur in >95% of all trees sampled, indicating high rates of outcrossing. Based on intermediate allelic diversity, there was large farm-to-farm multilocus genotypic variation. GIS analysis revealed unequal distribution of the genotype spectra, with R being frequent within a 2 km corridor along roads, and B at more remote sites with lower precipitation. The third lineage, Y, was detected in the two forest trees. For explaining the spatial stratification of the genotype spectra, both human intervention and a combination of management and selection driven by environmental conditions, appear responsible. Genotypes of individual trees were highly diverse across plantings, thus enabling selection for farm-specific qualities. On-farm populations can currently be most clearly recognized by the degree of the contribution of the three genotype spectra. Of two possible strategies for future development of cacao in Waslala, i.e. introducing more unrelated germplasm, or working with existing on-site diversity, the latter seems most appropriate. Superior genotypes could be selected by their specific composite genotype spectra as soon as associations with desired quality traits are established, and clonally multiplied. The two Y trees from the forest share a single multilocus genotype, possibly representing the Mayan, 'ancient Criollo' cacao.	[Trognitz, Bodo; Hansel-Hohl, Karin] Austrian Inst Technol, Seibersdorf, Austria; [Scheldeman, Xavier] Biovers Int, Cali, Colombia; [Kuant, Aldo; Grebe, Hans] Pro Mundo Humano, Managua, Nicaragua; [Hermann, Michael] Crops Future, Serdang, Selangor, Malaysia	Austrian Institute of Technology (AIT); Alliance; Bioversity International	Trognitz, B (corresponding author), Austrian Inst Technol, Seibersdorf, Austria.	bodo.trognitz@ait.ac.at	Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361	Austrian Development Agency, ADA; Austrian Institute of Technology, AIT [1.U4.00077]	Austrian Development Agency, ADA; Austrian Institute of Technology, AIT	Funded by the Austrian Development Agency, ADA (NICACAO Project), (http://www.entwicklung.at/en/) and the Austrian Institute of Technology, AIT (1.U4.00077) (http://www.ait.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication content is solely the responsibility of the authors and does not necessarily represent the official views of ADA nor AIT.	Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Irish BM, 2010, CROP SCI, V50, P656, DOI 10.2135/cropsci2009.06.0299; Johnson ES, 2009, CROP SCI, V49, P564, DOI 10.2135/cropsci2008.03.0128; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; LANAUD C, 1987, CAFE CACAO THE, V31, P267; Li YC, 2002, HEREDITY, V89, P127, DOI 10.1038/sj.hdy.6800115; *MARENA, 2005, ATL RES BIOSF BOS; Merrill T., 1994, NICARAGUA COUNTRY ST; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; MOTILAL LA, 2008, TROPICAL PLANT BIOL, V2; Motilal LA, 2010, PLANT GENET RESOUR-C, V8, P106, DOI 10.1017/S1479262109990232; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT, P15; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Saunders JA, 2004, THEOR APPL GENET, V110, P41, DOI 10.1007/s00122-004-1762-1; Wood G.A.R., 1985, COCOA, V4th; Zhang D, 2008, CONSERV GENET, V9, P327, DOI 10.1007/s10592-007-9345-8; Zhang DP, 2006, ANN BOT-LONDON, V98, P647, DOI 10.1093/aob/mcl146; Zhang DP, 2006, CROP SCI, V46, P2084, DOI 10.2135/cropsci2006.01.0004; Zhang DP, 2009, TREE GENET GENOMES, V5, P1, DOI 10.1007/s11295-008-0163-z	27	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16056	10.1371/journal.pone.0016056	http://dx.doi.org/10.1371/journal.pone.0016056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264251	gold, Green Published			2022-12-25	WOS:000286516500025
J	Lee, YJ; Wang, SX; Slone, SR; Yacoubian, TA; Witt, SN				Lee, Yong Joo; Wang, Shaoxiao; Slone, Sunny R.; Yacoubian, Talene A.; Witt, Stephan N.			Defects in Very Long Chain Fatty Acid Synthesis Enhance Alpha-Synuclein Toxicity in a Yeast Model of Parkinson's Disease	PLOS ONE			English	Article							PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; GENE; NEURODEGENERATION; PATHWAYS; MUTATION; CLONING; SPHINGOLIPIDS; BIOSYNTHESIS; ELONGATION	We identified three S. cerevisiae lipid elongase null mutants (elo1D, elo2D, and elo3D) that enhance the toxicity of alpha-synuclein (alpha-syn). These elongases function in the endoplasmic reticulum (ER) to catalyze the elongation of medium chain fatty acids to very long chain fatty acids, which is a component of sphingolipids. Without alpha-syn expression, the various elo mutants showed no growth defects, no reactive oxygen species (ROS) accumulation, and a modest decrease in survival of aged cells compared to wild-type cells. With (WT, A53T or E46K) alpha-syn expression, the various elo mutants exhibited severe growth defects (although A30P had a negligible effect on growth), ROS accumulation, aberrant protein trafficking, and a dramatic decrease in survival of aged cells compared to wild-type cells. Inhibitors of ceramide synthesis, myriocin and FB1, were extremely toxic to wild-type yeast cells expressing (WT, A53T, or E46K) alpha-syn but much less toxic to cells expressing A30P. The elongase mutants and ceramide synthesis inhibitors enhance the toxicity of WT alpha-syn, A53T and E46K, which transit through the ER, but have a negligible effect on A30P, which does not transit through the ER. Disruption of ceramide-sphingolipid homeostasis in the ER dramatically enhances the toxicity of alpha-syn (WT, A53T, and E46K).	[Lee, Yong Joo; Wang, Shaoxiao; Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Slone, Sunny R.; Yacoubian, Talene A.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Alabama System; University of Alabama Birmingham	Lee, YJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.	switt1@lsuhsc.edu	wang, shaoxiao/N-7126-2013; Witt, Stephan N/M-7922-2013	wang, shaoxiao/0000-0002-0195-6210; Witt, Stephan N/0000-0002-6462-2840	National Institutes of Health [NS057656]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant NS057656 (S.N.W.) from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2004, CELL TISSUE RES, V318, P185, DOI 10.1007/s00441-004-0922-6; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021; Bras JM, 2009, BBA-MOL BASIS DIS, V1792, P597, DOI 10.1016/j.bbadis.2008.11.008; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Carratu MR, 2003, TOXICOL LETT, V140, P459, DOI 10.1016/S0378-4274(03)00042-0; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Flower TR, 2007, J CELL BIOL, V177, P1091, DOI 10.1083/jcb.200610071; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jump DB, 2009, METHODS MOL BIOL, V579, P375, DOI 10.1007/978-1-60761-322-0_19; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mielke MM, 2010, NEUROBIOL AGING, V31, P17, DOI 10.1016/j.neurobiolaging.2008.03.011; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponnusamy S, 2008, J BIOL CHEM, V283, P27514, DOI 10.1074/jbc.M802980200; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stevens VL, 1997, J BIOL CHEM, V272, P18020, DOI 10.1074/jbc.272.29.18020; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	61	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15946	10.1371/journal.pone.0015946	http://dx.doi.org/10.1371/journal.pone.0015946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264320	Green Published, gold, Green Submitted			2022-12-25	WOS:000286514000011
J	Baratchi, S; Kanwar, RK; Kanwar, JR				Baratchi, Sara; Kanwar, Rupinder K.; Kanwar, Jagat R.			Survivin Mutant Protects Differentiated Dopaminergic SK-N-SH Cells Against Oxidative Stress	PLOS ONE			English	Article							PARKINSONS-DISEASE; GLUTATHIONE-PEROXIDASE; EXPRESSION; APOPTOSIS; PROTEINS; ANTAGONISTS; CHECKPOINT; BRAIN; IAP	Oxidative stress is due to an imbalance of antioxidant/pro-oxidant homeostasis and is associated with the progression of several neurological diseases, including Parkinson's and Alzheimer's disease and amyotrophic lateral sclerosis. Furthermore, oxidative stress is responsible for the neuronal loss and dysfunction associated with disease pathogenesis. Survivin is a member of the inhibitors of the apoptosis (IAP) family of proteins, but its neuroprotective effects have not been studied. Here, we demonstrate that SurR9-C84A, a survivin mutant, has neuroprotective effects against H2O2-induced neurotoxicity. Our results show that H2O2 toxicity is associated with an increase in cell death, mitochondrial membrane depolarisation, and the expression of cyclin D1 and caspases 9 and 3. In addition, pre-treatment with SurR9-C84A reduces cell death by decreasing both the level of mitochondrial depolarisation and the expression of cyclin D1 and caspases 9 and 3. We further show that SurR9-C84A increases the antioxidant activity of GSH-peroxidase and catalase, and effectively counteracts oxidant activity following exposure to H2O2. These results suggest for the first time that SurR9-C84A is a promising treatment to protect neuronal cells against H2O2-induced neurotoxicity.	[Baratchi, Sara; Kanwar, Rupinder K.; Kanwar, Jagat R.] Deakin Univ, Lab Immunol & Mol Biomed Res, Ctr Biotechnol & Interdisciplinary Biosci, Inst Technol Res & Innovat, Waurn Ponds, Vic, Australia	Deakin University	Baratchi, S (corresponding author), Deakin Univ, Lab Immunol & Mol Biomed Res, Ctr Biotechnol & Interdisciplinary Biosci, Inst Technol Res & Innovat, Waurn Ponds, Vic, Australia.	jagat.kanwar@deakin.edu.au	Baratchi, Sara/V-2683-2019	Baratchi, Sara/0000-0003-3588-7951	Deakin University	Deakin University	The study was supported by postgraduate fellowship from Deakin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATCHI S, 2010, J NEUROIMMUNOLOGY; Baratchi S, 2010, CRIT REV BIOCHEM MOL, V45, P535, DOI 10.3109/10409238.2010.516740; Baratchi S, 2010, J NEUROIMMUNOL, V227, P120, DOI 10.1016/j.jneuroim.2010.06.024; Baratchi S, 2009, CURR NANOSCI, V5, P15, DOI 10.2174/157341309787314665; Barone P, 2010, EUR J NEUROL, V17, P364, DOI 10.1111/j.1468-1331.2009.02900.x; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Chang PA, 2005, MOL BRAIN RES, V141, P30, DOI 10.1016/j.molbrainres.2005.07.012; Cheung CHA, 2006, EJC SUPPL, V4, P149, DOI 10.1016/S1359-6349(06)70493-1; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; del Rio M. Jimenez, 2004, Current Medicinal Chemistry - Central Nervous System Agents, V4, P279; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Donnini S, 2009, CELL CYCLE, V8, P1271, DOI 10.4161/cc.8.8.8301; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JOHANNSEN P, 1991, J NEUROL NEUROSUR PS, V54, P679, DOI 10.1136/jnnp.54.8.679; Jordan-Sciutto KL, 2002, J NEUROSCI, V22, P2185, DOI 10.1523/JNEUROSCI.22-06-02185.2002; Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155; Kanwar JR, 2004, CANCER GENE THER, V11, P853; Kanwar JR, 2001, J NATL CANCER I, V93, P1541, DOI 10.1093/jnci/93.20.1541; Kanwar RK, 2010, CURR MED CHEM, V17, P1509, DOI 10.2174/092986710790979935; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Morris MC, 2000, CURR OPIN BIOTECH, V11, P461, DOI 10.1016/S0958-1669(00)00128-2; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; West AB, 2005, TRENDS NEUROSCI, V28, P348, DOI 10.1016/j.tins.2005.05.002; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005	33	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15865	10.1371/journal.pone.0015865	http://dx.doi.org/10.1371/journal.pone.0015865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249229	gold, Green Published, Green Submitted			2022-12-25	WOS:000286513100016
J	Krall, JA; Beyer, EM; MacBeath, G				Krall, Jordan A.; Beyer, Elsa M.; MacBeath, Gavin			High- and Low-Affinity Epidermal Growth Factor Receptor-Ligand Interactions Activate Distinct Signaling Pathways	PLOS ONE			English	Article							BREAST-CANCER CELLS; EGF-RECEPTOR; NEGATIVE COOPERATIVITY; FACTOR BINDING; APOPTOSIS; SURFACE; TRANSDUCTION; EXPRESSION; INTEGRIN; SYSTEM	Signaling mediated by the Epidermal Growth Factor Receptor (EGFR) is crucial in normal development, and aberrant EGFR signaling has been implicated in a wide variety of cancers. Here we find that the high- and low-affinity interactions between EGFR and its ligands activate different signaling pathways. While high-affinity ligand binding is sufficient for activation of most canonical signaling pathways, low-affinity binding is required for the activation of the Signal transducers and activators of transcription (Stats) and Phospholipase C-gamma 1 (PLC gamma 1). As the Stat proteins are involved in many cellular responses including proliferation, migration and apoptosis, these results assign a function to low-affinity interactions that has been omitted from computational models of EGFR signaling. The existence of receptors with distinct signaling properties provides a way for EGFR to respond to different concentrations of the same ligand in qualitatively different ways.	[Krall, Jordan A.; MacBeath, Gavin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Beyer, Elsa M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Krall, JA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	gavin_macbeath@harvard.edu		MacBeath, Gavin/0000-0003-2585-6772	WM Keck Foundation; Camille and Henry Dreyfus Foundation; National Institutes of Health [R33 CA128726, R21 CA126720, P50 GM068762]; NATIONAL CANCER INSTITUTE [R21CA126720, R33CA128726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); Camille and Henry Dreyfus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by awards from the WM Keck Foundation and the Camille and Henry Dreyfus Foundation, and by grants from the National Institutes of Health (R33 CA128726, R21 CA126720, and P50 GM068762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Colomiere M, 2009, INT J BIOCHEM CELL B, V41, P1034, DOI 10.1016/j.biocel.2008.09.018; Danielsen AJ, 2002, GROWTH FACTORS, V20, P1, DOI 10.1080/08977190290022185; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Garcia R, 2006, CELL CYCLE, V5, P1840; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Hendriks BS, 2003, CANCER RES, V63, P1130; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kottke TJ, 1999, J BIOL CHEM, V274, P15927, DOI 10.1074/jbc.274.22.15927; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mayawala K, 2005, FEBS LETT, V579, P3043, DOI 10.1016/j.febslet.2005.04.059; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Rezgui SS, 2000, INT J CANCER, V87, P360, DOI 10.1002/1097-0215(20000801)87:3<360::AID-IJC8>3.0.CO;2-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43	30	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15945	10.1371/journal.pone.0015945	http://dx.doi.org/10.1371/journal.pone.0015945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264347	Green Published, Green Submitted, gold			2022-12-25	WOS:000286513100019
J	Cox, RL; Underwood, EC				Cox, Robin L.; Underwood, Emma C.			The Importance of Conserving Biodiversity Outside of Protected Areas in Mediterranean Ecosystems	PLOS ONE			English	Article							CAPE FLORISTIC REGION; TERRESTRIAL VERTEBRATES; PLANT DIVERSITY; CLIMATE-CHANGE; CONSERVATION; CALIFORNIA; PATTERNS; ECOREGIONS; MANAGEMENT	Mediterranean-type ecosystems constitute one of the rarest terrestrial biomes and yet they are extraordinarily biodiverse. Home to over 250 million people, the five regions where these ecosystems are found have climate and coastal conditions that make them highly desirable human habitats. The current conservation landscape does not reflect the mediterranean biome's rarity and its importance for plant endemism. Habitat conversion will clearly outpace expansion of formal protected-area networks, and conservationists must augment this traditional strategy with new approaches to sustain the mediterranean biota. Using regional scale datasets, we determine the area of land in each of the five regions that is protected, converted (e. g., to urban or industrial), impacted (e. g., intensive, cultivated agriculture), or lands that we consider to have conservation potential. The latter are natural and semi-natural lands that are unprotected (e. g., private range lands) but sustain numerous native species and associated habitats. Chile has the greatest proportion of its land (75%) in this category and California-Mexico the least (48%). To illustrate the potential for achieving mediterranean biodiversity conservation on these lands, we use species-area curves generated from ecoregion scale data on native plant species richness and vertebrate species richness. For example, if biodiversity could be sustained on even 25% of existing unprotected, natural and semi-natural lands, we estimate that the habitat of more than 6,000 species could be represented. This analysis suggests that if unprotected natural and semi-natural lands are managed in a manner that allows for persistence of native species, we can realize significant additional biodiversity gains. Lasting biodiversity protection at the scale needed requires unprecedented collaboration among stakeholders to promote conservation both inside and outside of traditional protected areas, including on lands where people live and work.	[Cox, Robin L.] Nature Conservancy, San Francisco, CA USA; [Underwood, Emma C.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	Nature Conservancy; University of California System; University of California Davis	Cox, RL (corresponding author), Nature Conservancy, San Francisco, CA USA.	rcox@tnc.org			Nature Conservancy of California; Rodney Johnson/Katherine Ordway	Nature Conservancy of California; Rodney Johnson/Katherine Ordway	This research was funded by The Nature Conservancy of California and the Rodney Johnson/Katherine Ordway Stewardship Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Center for International Earth Science Information Network (CIESIN) Columbia University Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD GPW; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; COWLING RM, 1999, PARKS, V9, P17; COX N, 2006, STATUS DISTRIBUTION; GREUTER W, 1994, PHILOS T ROY SOC B, V344, P41, DOI 10.1098/rstb.1994.0049; HARRIS W, 2008, EXT NAT FARM BILL TR; HOBBS RJ, 1991, CONSERV BIOL, V15, P1522; Huntsinger Lynn, 2004, V37, P309; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Kemper J, 1999, BIOL CONSERV, V90, P103, DOI 10.1016/S0006-3207(99)00021-X; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Low A.B., 1996, VEGETATION S AFRICA; LUMBRERAS EL, 2001, CONV CONS EUR WILDL; LUNT ID, 1990, AUST J ECOL, V15, P155, DOI 10.1111/j.1442-9993.1990.tb01524.x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; MCCREARY D, 2004, OAK WOODLAND CONSERV; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Merenlender A. M., 2000, California Agriculture, V54, P7, DOI 10.3733/ca.v054n03p7; Merenlender AM, 2008, CALIF AGR, V62, P148, DOI 10.3733/ca.v062n04p148; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; *NRCS, 2008, NEW FARM BILL CONS R; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Onate JJ, 1998, J ENVIRON MANAGE, V52, P227, DOI 10.1006/jema.1997.0173; Pauchard A, 2002, NAT AREA J, V22, P318; RIELY SP, 2003, CONSERV BIOL, V17, P566; Rouget M, 2003, BIOL CONSERV, V112, P129, DOI 10.1016/S0006-3207(02)00396-8; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Simonetti JA, 1999, REV CHIL HIST NAT, V72, P493; Sirami C, 2010, LANDSCAPE URBAN PLAN, V96, P214, DOI 10.1016/j.landurbplan.2010.03.007; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Thorne JH, 2006, NAT AREA J, V26, P137, DOI 10.3375/0885-8608(2006)26[137:ACDFTC]2.0.CO;2; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; United Nations Environment Programme, 2002, 6 M C PART CONV BIOL; Watson JEM, 2009, DIVERS DISTRIB, V15, P1028, DOI 10.1111/j.1472-4642.2009.00601.x; WESTMAN WE, 1983, VEGETATIO, V52, P3; White C, 2008, CONSERV BIOL, V22, P1380, DOI 10.1111/j.1523-1739.2008.01103.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; *WORLD WILDL FUND, 2006, WILDFINDER ONL DAT S; Zavaleta ES, 2007, DIVERS DISTRIB, V13, P735, DOI 10.1111/j.1472-4642.2007.00384.x	50	99	102	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14508	10.1371/journal.pone.0014508	http://dx.doi.org/10.1371/journal.pone.0014508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249126	Green Submitted, Green Published, gold			2022-12-25	WOS:000286512900006
J	de la Garza-Rodea, AS; Verweij, MC; Boersma, H; van der Velde-van Dijke, I; de Vries, AAF; Hoeben, RC; van Bekkum, DW; Wiertz, EJHJ; Knaan-Shanzer, S				de la Garza-Rodea, Anabel S.; Verweij, Marieke C.; Boersma, Hester; van der Velde-van Dijke, Ietje; de Vries, Antoine A. F.; Hoeben, Rob C.; van Bekkum, Dirk W.; Wiertz, Emmanuel J. H. J.; Knaan-Shanzer, Shoshan			Exploitation of Herpesvirus Immune Evasion Strategies to Modify the Immunogenicity of Human Mesenchymal Stem Cell Transplants	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; MARROW STROMAL CELLS; I HEAVY-CHAINS; CYTOMEGALOVIRUS-ENCODED US2; VERSUS-HOST-DISEASE; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; MEMBRANE-PROTEIN; DENDRITIC CELLS	Background: Mesenchymal stem cells (MSCs) are multipotent cells residing in the connective tissue of many organs and holding great potential for tissue repair. In culture, human MSCs (hMSCs) are capable of extensive proliferation without showing chromosomal aberrations. Large numbers of hMSCs can thus be acquired from small samples of easily obtainable tissues like fat and bone marrow. MSCs can contribute to regeneration indirectly by secretion of cytokines or directly by differentiation into specialized cell types. The latter mechanism requires their long-term acceptance by the recipient. Although MSCs do not elicit immune responses in vitro, animal studies have revealed that allogeneic and xenogeneic MSCs are rejected. Methodology/Principal Findings: We aim to overcome MSC immune rejection through permanent down-regulation of major histocompatibility complex (MHC) class I proteins on the surface of these MHC class II-negative cells through the use of viral immune evasion proteins. Transduction of hMSCs with a retroviral vector encoding the human cytomegalovirus US11 protein resulted in strong inhibition of MHC class I surface expression. When transplanted into immunocompetent mice, persistence of the US11-expressing and HLA-ABC-negative hMSCs at levels resembling those found in immunodeficient (i.e., NOD/SCID) mice could be attained provided that recipients' natural killer (NK) cells were depleted prior to cell transplantation. Conclusions/Significance: Our findings demonstrate the potential utility of herpesviral immunoevasins to prevent rejection of xenogeneic MSCs. The observation that down-regulation of MHC class I surface expression renders hMSCs vulnerable to NK cell recognition and cytolysis implies that multiple viral immune evasion proteins are likely required to make hMSCs non-immunogenic and thereby universally transplantable.	[de la Garza-Rodea, Anabel S.; Boersma, Hester; van der Velde-van Dijke, Ietje; de Vries, Antoine A. F.; Hoeben, Rob C.; van Bekkum, Dirk W.; Knaan-Shanzer, Shoshan] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Verweij, Marieke C.; Wiertz, Emmanuel J. H. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	de la Garza-Rodea, AS (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	s.knaan@lumc.nl	de Vries, Antoine/ABG-5787-2021; Hoeben, Rob C./A-5771-2008	Hoeben, Rob C./0000-0001-9443-8377	Universidad Autonoma de Nuevo Leon, Monterrey, Mexico; Diabetes Research Foundation [DFN 2005.00.0212, DFN 2007.00.015]; Association Francaise contre les Myopathies (AFM) [12259-SR-GROUPE E]; Leiden University [7207/5-3-06\Kk]	Universidad Autonoma de Nuevo Leon, Monterrey, Mexico; Diabetes Research Foundation; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Leiden University	This study was supported by a Scholarship to ASdlGR from the Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, and by research grants from the Diabetes Research Foundation (DFN 2005.00.0212 and DFN 2007.00.015), the Association Francaise contre les Myopathies (AFM; 12259-SR-GROUPE E) and the Leiden University Fund (LUF pilot study 7207/5-3-06\Kk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barel MT, 2006, MOL IMMUNOL, V43, P1258, DOI 10.1016/j.molimm.2005.07.005; Barel MT, 2006, INT IMMUNOL, V18, P173, DOI 10.1093/intimm/dxh362; Barel MT, 2003, J IMMUNOL, V171, P6757, DOI 10.4049/jimmunol.171.12.6757; Barel MT, 2003, EUR J IMMUNOL, V33, P1707, DOI 10.1002/eji.200323912; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Chen GY, 2010, ANN THORAC SURG, V90, P190, DOI 10.1016/j.athoracsur.2010.02.074; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Daga A, 2002, GENE THER, V9, P915, DOI 10.1038/sj.gt.3301727; DELAGARZARODEA AS, 2010, CELL TRANSP IN PRESS; Dewan MZ, 2005, BIOMED PHARMACOTHER, V59, pS375, DOI 10.1016/S0753-3322(05)80082-4; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duan WM, 2001, EXP NEUROL, V167, P108, DOI 10.1006/exnr.2000.7537; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Eliopoulos N, 2003, GENE THER, V10, P478, DOI 10.1038/sj.gt.3301919; Eppens EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; FAUSTMAN D, 1991, SCIENCE, V252, P1700, DOI 10.1126/science.1710828; Gasser S, 2006, IMMUNOL REV, V214, P130, DOI 10.1111/j.1600-065X.2006.00460.x; Goncalves MAFV, 2001, VIROLOGY, V288, P236, DOI 10.1006/viro.2001.1073; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Horst D, 2009, J IMMUNOL, V182, P2313, DOI 10.4049/jimmunol.0803218; Hsieh CL, 2002, TRANSPL IMMUNOL, V9, P111, DOI 10.1016/S0966-3274(02)00033-3; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Knaan-Shanzer S, 2005, STEM CELLS, V23, P1598, DOI 10.1634/stemcells.2005-0016; Knaan-Shanzer S, 2008, STEM CELLS, V26, P3210, DOI 10.1634/stemcells.2007-0117; Kojaoghlanian T, 2009, GENE THER, V16, P340, DOI 10.1038/gt.2008.172; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Leong CC, 1998, J EXP MED, V187, P1681, DOI 10.1084/jem.187.10.1681; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Lipinska AD, 2006, J VIROL, V80, P5822, DOI 10.1128/JVI.02707-05; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Machold RP, 1997, J EXP MED, V185, P363, DOI 10.1084/jem.185.2.363; MONTOLIU L, 1995, P NATL ACAD SCI USA, V92, P4244, DOI 10.1073/pnas.92.10.4244; Morandi F, 2008, STEM CELLS, V26, P1275, DOI 10.1634/stemcells.2007-0878; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; PAKZABAN P, 1995, NEUROSCIENCE, V65, P983, DOI 10.1016/0306-4522(94)00626-G; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prigozhina TB, 2008, EXP HEMATOL, V36, P1370, DOI 10.1016/j.exphem.2008.04.022; Radosevich TJ, 2003, HUM GENE THER, V14, P1765, DOI 10.1089/104303403322611773; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rasmusson I, 2007, SCAND J IMMUNOL, V65, P336, DOI 10.1111/j.1365-3083.2007.01905.x; Rehm A, 2002, J VIROL, V76, P5043, DOI 10.1128/JVI.76.10.5043-5050.2002; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; SWIFT S, 1999, CURR PROTOC IMMUNOL, V10; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; van Tuyn J, 2007, FASEB J, V21, P3369, DOI 10.1096/fj.07-8211com; Viswanathan K, 2005, P NATL ACAD SCI USA, V102, P5808, DOI 10.1073/pnas.0501650102; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Wang Y, 2007, J ORTHOP RES, V25, P926, DOI 10.1002/jor.20385; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wiertz EJ, 2007, J VIROL, V81, P4389, DOI 10.1128/JVI.01525-06; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Xia Z, 2006, J CELL BIOCHEM, V98, P966, DOI 10.1002/jcb.20730; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zdoroveac A, 2008, J SURG RES, V145, P161, DOI 10.1016/j.jss.2007.08.031; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018	78	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14493	10.1371/journal.pone.0014493	http://dx.doi.org/10.1371/journal.pone.0014493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253016	gold, Green Submitted, Green Published			2022-12-25	WOS:000286511900002
J	Cheong, JK; Nguyen, TH; Wang, H; Tan, P; Voorhoeve, PM; Lee, SH; Virshup, DM				Cheong, J. K.; Nguyen, T. H.; Wang, H.; Tan, P.; Voorhoeve, P. M.; Lee, S. H.; Virshup, D. M.			IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1 delta/epsilon and Wnt/beta-catenin independent inhibition of mitotic spindle formation	ONCOGENE			English	Article						casein kinase 1; Wnt; IC261; mitotic spindle; cancer; synthetic lethal	CASEIN KINASE-I; DROSOPHILA CLOCK GENE; DOUBLE-TIME; EPSILON; PHOSPHORYLATION; WNT; CK1-EPSILON; PATHWAY; FAMILY; GROWTH	Casein kinase 1 delta and epsilon (CK1 delta/epsilon) are key regulators of diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. Recent studies suggest that they have an important role in oncogenesis. RNA interference screens identified CK1 epsilon as a pro-survival factor in cancer cells in vitro and the CK1 delta/epsilon-specific inhibitor IC261 is remarkably effective at selective, synthetic lethal killing of cancer cells. The recent development of the nanomolar CK1 delta/epsilon-selective inhibitor, PF670462 (PF670) and the CK1 epsilon-selective inhibitor PF4800567 (PF480) offers an opportunity to further test the role of CK1 delta/epsilon in cancer. Unexpectedly, and unlike IC261, PF670 and PF480 were unable to induce cancer cell death. PF670 is a potent inhibitor of CK1 delta/epsilon in cells; nanomolar concentrations are sufficient to inhibit CK1 delta/epsilon activity as measured by repression of intramolecular autophosphorylation, phosphorylation of disheveled2 proteins and Wnt/beta-catenin signaling. Likewise, small interfering RNA knockdown of CK1 delta and CK1 epsilon reduced Wnt/beta-catenin signaling without affecting cell viability, further suggesting that CK1 delta/epsilon inhibition may not be relevant to the IC261-induced cell death. Thus, while PF670 is a potent inhibitor of Wnt signaling, it only modestly inhibits cell proliferation. In contrast, while sub-micromolar concentrations of IC261 neither inhibited CK1 delta/epsilon kinase activity nor blocked Wnt/beta-catenin signaling in cancer cells, it caused a rapid induction of prometaphase arrest and subsequent apoptosis in multiple cancer cell lines. In a stepwise transformation model, IC261-induced killing required both overactive Ras and inactive p53. IC261 binds to tubulin with an affinity similar to colchicine and is a potent inhibitor of microtubule polymerization. This activity accounts for many of the diverse biological effects of IC261 and, most importantly, for its selective cancer cell killing. Oncogene (2011) 30, 2558-2569; doi:10.1038/onc.2010.627; published online 24 January 2011	[Cheong, J. K.; Nguyen, T. H.; Wang, H.; Tan, P.; Voorhoeve, P. M.; Lee, S. H.; Virshup, D. M.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Voorhoeve, P. M.; Virshup, D. M.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Virshup, DM (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Nguyen, Hung/M-8118-2014; Virshup, David M/C-1449-2009	Nguyen, Hung/0000-0001-8378-555X; Virshup, David M/0000-0001-6976-850X; Wang, Hannah/0000-0002-0600-2555	Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; National Research Foundation; National Medical Research Council; Singapore Millennium Foundation (SMF)	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation)	We thank Velani Utomo, Ha Yin Lee, Simran Kaur and Qin Luo (Duke-NUS) for their excellent technical and computational support. We are also grateful to our Duke and Duke-NUS colleagues Tim Haystead, Sin Tiong Ong, Shirish Shenolikar, Patrick Casey and members of the Virshup laboratory for their helpful discussions. This work was supported by the Duke-NUS Signature Research Program funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore, and a Singapore Translational Research Investigator Award to DMV funded by the National Research Foundation and the National Medical Research Council. JKC was supported by a Singapore Millennium Foundation (SMF) Postdoctoral Fellowship.	Agapova LS, 1999, ONCOGENE, V18, P3135, DOI 10.1038/sj.onc.1202386; Arora S, 2009, CANCER RES, V69, P1910, DOI 10.1158/0008-5472.CAN-08-0877; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Bryant CD, 2009, PSYCHOPHARMACOLOGY, V203, P703, DOI 10.1007/s00213-008-1417-z; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Clokie S, 2009, FEBS J, V276, P6971, DOI 10.1111/j.1742-4658.2009.07405.x; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gigant B, 2009, TOP CURR CHEM, V286, P259, DOI 10.1007/128_2008_11; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Hampton T, 2004, JAMA-J AM MED ASSOC, V292, P419, DOI 10.1001/jama.292.4.419; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Sprouse J, 2009, PSYCHOPHARMACOLOGY, V204, P735, DOI 10.1007/s00213-009-1503-x; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vielhaber E, 2001, IUBMB LIFE, V51, P73, DOI 10.1080/15216540152122049; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08	47	89	95	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	22					2558	2569		10.1038/onc.2010.627	http://dx.doi.org/10.1038/onc.2010.627			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21258417	Green Published, hybrid			2022-12-25	WOS:000291198400007
J	Meotti, FC; Jameson, GNL; Turner, R; Harwood, T; Stockwell, S; Rees, MD; Thomas, SR; Kettle, AJ				Meotti, Flavia C.; Jameson, Guy N. L.; Turner, Rufus; Harwood, Tim; Stockwell, Samantha; Rees, Martin D.; Thomas, Shane R.; Kettle, Anthony J.			Urate as a Physiological Substrate for Myeloperoxidase IMPLICATIONS FOR HYPERURICEMIA AND INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; URIC-ACID OXIDATION; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; HYPOCHLOROUS ACID; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; CATALYZED OXIDATION; ANTIOXIDANT DEFENSE; LIPID-PEROXIDATION	Urate and myeloperoxidase (MPO) are associated with adverse outcomes in cardiovascular disease. In this study, we assessed whether urate is a likely physiological substrate for MPO and if the products of their interaction have the potential to exacerbate inflammation. Urate was readily oxidized by MPO and hydrogen peroxide to 5-hydroxyisourate, which decayed to predominantly allantoin. The redox intermediates of MPO were reduced by urate with rate constants of 4.6 x 10(5) M-1 s(-1) for compound land 1.7 x 10(4) M-1 s(-1) for compound II. Urate competed with chloride for oxidation by MPO and at hyperuricemic levels is expected to be a substantive substrate for the enzyme. Oxidation of urate promoted super-stoichiometric consumption of glutathione, which indicates that it is converted to a free radical intermediate. In combination with superoxide and hydrogen peroxide, MPO oxidized mate to a reactive hydroperoxide. This would form by addition of superoxide to the urate radical. Urate also enhanced MPO-dependent consumption of nitric oxide. In human plasma, stimulated neutrophils produced allantoin in a reaction dependent on the NADPH oxidase, MPO and superoxide. We propose that urate is a physiological substrate for MPO that is oxidized to the urate radical. The reactions of this radical with superoxide and nitric oxide provide a plausible link between urate and MPO in cardiovascular disease.	[Meotti, Flavia C.; Turner, Rufus; Harwood, Tim; Stockwell, Samantha; Kettle, Anthony J.] Univ Otago, Dept Pathol, Free Rad Res Grp, Christchurch, New Zealand; [Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Rees, Martin D.; Thomas, Shane R.] Univ New S Wales, Ctr Vasc Res, Sch Med Sci, Sydney, NSW, Australia	University of Otago; University of Otago; University of New South Wales Sydney	Kettle, AJ (corresponding author), Univ Otago, Dept Pathol, Free Rad Res Grp, POB 4345, Christchurch, New Zealand.	tony.kettle@otago.ac.nz	Jameson, Guy N. L./J-3258-2015; Meotti, Flavia/H-1621-2015; Meotti, Flavia/AAS-8804-2021; Harwood, Tim/H-3636-2012; Kettle, Anthony J/A-8520-2008	Jameson, Guy N. L./0000-0001-9416-699X; Meotti, Flavia/0000-0002-7217-3352; Kettle, Anthony J/0000-0002-8218-7766; Rees, Martin/0000-0002-3564-5736	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil); Health Research Council of New Zealand; New Zealand Centre of Excellence for Growth and Development; National Health and Medical Research Council [568721]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Centre of Excellence for Growth and Development; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil), the Health Research Council of New Zealand, and the New Zealand Centre of Excellence for Growth and Development and in part by National Health and Medical Research Council Project Grant 568721 (to S. R. T. and A. J. K.).	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Agner K., 1941, ACTA PHYSIOL SCAND, V2, P1; Alderman MH, 2007, CIRCULATION, V116, P880, DOI 10.1161/CIRCULATIONAHA.107.728600; Allegra M, 2001, BIOCHEM BIOPH RES CO, V282, P380, DOI 10.1006/bbrc.2001.4582; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARUOMA OI, 1989, FEBS LETT, V244, P76, DOI 10.1016/0014-5793(89)81166-4; Baldus S, 2006, CIRCULATION, V113, P1871, DOI 10.1161/CIRCULATIONAHA.105.590083; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BEERS RF, 1952, J BIOL CHEM, V195, P133; Benzie IFF, 1996, REDOX REP, V2, P231, DOI 10.1080/13510002.1996.11747055; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; CANELLAKIS ES, 1955, J BIOL CHEM, V213, P397; CHAPMAN AL, 2001, BIOCHEM J, V417, P773; Das AB, 2010, FREE RADICAL BIO MED, V48, P1540, DOI 10.1016/j.freeradbiomed.2010.02.039; DORNER RW, 1981, ANN RHEUM DIS, V40, P70, DOI 10.1136/ard.40.1.70; Dunford HB, 1999, BIOCHEM CELL BIOL, V77, P449, DOI 10.1139/bcb-77-5-449; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Filipe P, 2002, EUR J BIOCHEM, V269, P5474, DOI 10.1046/j.1432-1033.2002.03245.x; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Fridovich I., 1985, HDB METHODS OXYGEN R, P51; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gaffo AL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2761; GROOTVELD M, 1987, BIOCHEM J, V243, P803, DOI 10.1042/bj2430803; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; HOOGLAND H, 1987, BIOCHIM BIOPHYS ACTA, V916, P76, DOI 10.1016/0167-4838(87)90212-3; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; KETTLE AJ, 1989, BIOCHEM J, V263, P823, DOI 10.1042/bj2630823; Kettle AJ, 2000, REDOX REP, V5, P179, DOI 10.1179/135100000101535726; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1990, METHOD ENZYMOL, V300, P111; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; KITTRIDGE KJ, 1984, FEBS LETT, V170, P162, DOI 10.1016/0014-5793(84)81391-5; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; MARQUEZ LA, 1994, J BIOL CHEM, V269, P7950; MARQUEZ LA, 1990, J BIOL CHEM, V265, P5666; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MARQUEZ LA, 1990, J BIOL CHEM, V265, P6074; Marshall CJ, 2010, AM J CARDIOL, V106, P316, DOI 10.1016/j.amjcard.2010.03.028; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; Meotti FC, 2008, FREE RADICAL BIO MED, V44, P109, DOI 10.1016/j.freeradbiomed.2007.09.017; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; MUNDAY R, 1989, BIOCHEM PHARMACOL, V38, P4349, DOI 10.1016/0006-2952(89)90641-2; Nagy P, 2009, J BIOL CHEM, V284, P14723, DOI 10.1074/jbc.M809396200; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Santus R, 2001, FREE RADICAL RES, V35, P129, DOI 10.1080/10715760100300671; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; SHI Y, 2010, CLIN INVESTIGATOR, V120, P1809; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Viazzi F, 2005, HYPERTENSION, V45, P991, DOI 10.1161/01.HYP.0000161184.10873.ea; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; VOLK KJ, 1990, J PHARMACEUT BIOMED, V8, P205, DOI 10.1016/0731-7085(90)80028-N; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Ximenes VF, 2010, BIOCHEM J, V425, P285, DOI 10.1042/BJ20090776; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; Zhang CX, 2001, AM J PHYSIOL-HEART C, V281, pH1469, DOI 10.1152/ajpheart.2001.281.4.H1469; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	80	96	101	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12901	12911		10.1074/jbc.M110.172460	http://dx.doi.org/10.1074/jbc.M110.172460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21266577	hybrid, Green Published			2022-12-25	WOS:000289282200010
J	Cortesio, CL; Boateng, LR; Piazza, TM; Bennin, DA; Huttenlocher, A				Cortesio, Christa L.; Boateng, Lindsy R.; Piazza, Timothy M.; Bennin, David A.; Huttenlocher, Anna			Calpain-mediated Proteolysis of Paxillin Negatively Regulates Focal Adhesion Dynamics and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MEMBRANE PROTRUSION; CYTOPLASMIC DOMAIN; ALPHA-PARVIN; LD MOTIFS; CLEAVAGE; INVASION; TRANSFORMATION; LOCALIZATION; ACTOPAXIN	The dynamic turnover of integrin-mediated adhesions is important for cell migration. Paxillin is an adaptor protein that localizes to focal adhesions and has been implicated in cell motility. We previously reported that calpain-mediated proteolysis of talin1 and focal adhesion kinase mediates adhesion disassembly in motile cells. To determine whether calpain-mediated paxillin proteolysis regulates focal adhesion dynamics and cell motility, we mapped the preferred calpain proteolytic site in paxillin. The cleavage site is between the paxillin LD1 and LD2 motifs and generates a C-terminal fragment that is similar in size to the alternative product paxillin delta. The calpain-generated proteolytic fragment, like paxillin delta, functions as a paxillin antagonist and impairs focal adhesion disassembly and migration. We generated mutant paxillin with a point mutation (S95G) that renders it partially resistant to calpain proteolysis. Paxillin-deficient cells that express paxillin S95G display increased turnover of zyxin-containing adhesions using time-lapse microscopy and also show increased migration. Moreover, cancer-associated somatic mutations in paxillin are common in the N-terminal region between the LD1 and LD2 motifs and confer partial calpain resistance. Taken together, these findings suggest a novel role for calpain-mediated proteolysis of paxillin as a negative regulator of focal adhesion dynamics and migration that may function to limit cancer cell invasion.	[Cortesio, Christa L.; Piazza, Timothy M.; Bennin, David A.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Cortesio, Christa L.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Boateng, Lindsy R.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 1550 Linden Dr,4225 Microbial Sci Bldg, Madison, WI 53706 USA.	huttenlocher@wisc.edu			National Institutes of Health [R01 CA085862-08]; Department of Defense [BC073295]; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA085862-08 (to A. H.). This work was also supported by Department of Defense Pre-Doctoral Fellowship BC073295 (to C. L. C.).	Bhatt A, 2002, J CELL SCI, V115, P3415; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cortesio CL, 2010, MOL BIOL CELL, V21, P186, DOI 10.1091/mbc.E09-02-0106; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Mamoune A, 2003, CANCER RES, V63, P4632; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Sprague CR, 2008, J BIOL CHEM, V283, P9217, DOI 10.1074/jbc.M707436200; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120	32	78	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9998	10006		10.1074/jbc.M110.187294	http://dx.doi.org/10.1074/jbc.M110.187294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21270128	hybrid, Green Published			2022-12-25	WOS:000288547000014
J	Capilla, A; Pazo-Alvarez, P; Darriba, A; Campo, P; Gross, J				Capilla, Almudena; Pazo-Alvarez, Paula; Darriba, Alvaro; Campo, Pablo; Gross, Joachim			Steady-State Visual Evoked Potentials Can Be Explained by Temporal Superposition of Transient Event-Related Responses	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; RESONANCE PHENOMENA; BRAIN DYNAMICS; EEG RESPONSES; STIMULI; GENERATION; FREQUENCY; FLICKER; OSCILLATIONS; HABITUATION	Background: One common criterion for classifying electrophysiological brain responses is based on the distinction between transient (i.e. event-related potentials, ERPs) and steady-state responses (SSRs). The generation of SSRs is usually attributed to the entrainment of a neural rhythm driven by the stimulus train. However, a more parsimonious account suggests that SSRs might result from the linear addition of the transient responses elicited by each stimulus. This study aimed to investigate this possibility. Methodology/Principal Findings: We recorded brain potentials elicited by a checkerboard stimulus reversing at different rates. We modeled SSRs by sequentially shifting and linearly adding rate-specific ERPs. Our results show a strong resemblance between recorded and synthetic SSRs, supporting the superposition hypothesis. Furthermore, we did not find evidence of entrainment of a neural oscillation at the stimulation frequency. Conclusions/Significance: This study provides evidence that visual SSRs can be explained as a superposition of transient ERPs. These findings have critical implications in our current understanding of brain oscillations. Contrary to the idea that neural networks can be tuned to a wide range of frequencies, our findings rather suggest that the oscillatory response of a given neural network is constrained within its natural frequency range.	[Capilla, Almudena; Gross, Joachim] Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging CCNi, Glasgow, Lanark, Scotland; [Capilla, Almudena] Univ Autonoma Madrid, Dept Biol & Hlth Psychol, Madrid, Spain; [Pazo-Alvarez, Paula; Darriba, Alvaro] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain; [Campo, Pablo] Univ Complutense Madrid, Ctr Magnetoencephalog Dr Perez Modrego, Madrid, Spain; [Campo, Pablo] Univ Politecn Madrid, Univ Complutense Madrid, Ctr Biomed Technol, Lab Cognit & Computat Neurosci, Madrid, Spain; [Campo, Pablo] Univ Autonoma Madrid, Dept Basic Psychol, Madrid, Spain; [Gross, Joachim] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Glasgow; Autonomous University of Madrid; Universidade de Santiago de Compostela; Complutense University of Madrid; Complutense University of Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Autonomous University of Madrid; University of Glasgow	Capilla, A (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Ctr Cognit Neuroimaging CCNi, Glasgow, Lanark, Scotland.	almudena.capilla@uam.es	Capilla, Almudena/B-9387-2011; Darriba, Álvaro/M-5417-2015; Gross, Joachim/C-5886-2009; Darriba, Alvaro/E-6641-2013; Campo, Pablo/M-3317-2019; Pazo-Alvarez, Paula/K-6537-2014; Campo, Pablo/I-8156-2012	Capilla, Almudena/0000-0002-4181-4284; Darriba, Álvaro/0000-0001-5425-5752; Gross, Joachim/0000-0002-3994-1006; Campo, Pablo/0000-0003-4539-6857; Pazo-Alvarez, Paula/0000-0001-8144-9536; Campo, Pablo/0000-0003-4539-6857	Spanish Ministry of Science and Innovation [2008-0168]; Spanish Ministry of Science and Innovation (Ramon y Cajal) [RYC-2010-05748]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation (Ramon y Cajal)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation (2008-0168 Postdoctoral Fellowship to A. Capilla; and RYC-2010-05748 Ramon y Cajal Fellowship to P. Campo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P138; AZZENA GB, 1995, HEARING RES, V83, P1, DOI 10.1016/0378-5955(94)00184-R; BACAR E, 1980, EEG BRAIN DYNAMICS R; BASAR E, 1987, INT J NEUROSCI, V33, P103; Bohorquez J, 2007, P ANN INT IEEE EMBS, P2444, DOI 10.1109/IEMBS.2007.4352822; Bohorquez J, 2008, CLIN NEUROPHYSIOL, V119, P2598, DOI 10.1016/j.clinph.2008.08.002; Boutros NN, 1999, PSYCHIAT RES, V88, P119, DOI 10.1016/S0165-1781(99)00074-8; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; CELESIA GG, 1982, ANN NY ACAD SCI, V388, P290, DOI 10.1111/j.1749-6632.1982.tb50797.x; Conti G, 1999, CLIN NEUROPHYSIOL, V110, P62, DOI 10.1016/S0168-5597(98)00045-8; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; ERWIN RJ, 1986, ELECTROEN CLIN NEURO, V64, P417, DOI 10.1016/0013-4694(86)90075-1; Fuentemilla LI, 2006, NEUROIMAGE, V30, P909, DOI 10.1016/j.neuroimage.2005.10.036; GALAMBOS R, 1982, ANN NY ACAD SCI, V388, P722, DOI 10.1111/j.1749-6632.1982.tb50841.x; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Heinrich S P, 2001, Doc Ophthalmol, V102, P141, DOI 10.1023/A:1017509717071; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; HILLYARD SA, 1985, TRENDS NEUROSCI, V8, P400, DOI 10.1016/0166-2236(85)90142-0; JERVIS BW, 1983, IEEE T BIO-MED ENG, V30, P43, DOI 10.1109/TBME.1983.325165; Kerr CC, 2008, BIOL CYBERN, V98, P171, DOI 10.1007/s00422-007-0201-1; Klimesch W, 2006, NEUROIMAGE, V29, P808, DOI 10.1016/j.neuroimage.2005.08.041; KLIMESCH W, 2009, NEUROIMAGE; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Martinez-Montes E, 2008, STAT MED, V27, P2922, DOI 10.1002/sim.3132; McEvoy L, 1997, PSYCHOPHYSIOLOGY, V34, P308, DOI 10.1111/j.1469-8986.1997.tb02401.x; Moratti S, 2007, HUM BRAIN MAPP, V28, P1318, DOI 10.1002/hbm.20342; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; PICTON TW, 1992, ELECTROEN CLIN NEURO, V84, P90, DOI 10.1016/0168-5597(92)90071-I; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; REGAN D, 1982, ANN NY ACAD SCI, V388, P45, DOI 10.1111/j.1749-6632.1982.tb50784.x; Regan D, 2009, VISION RES, V49, pV, DOI 10.1016/S0042-6989(09)00142-4; Regan D., 1989, HUMAN BRAIN ELECTROP; Rennie CJ, 2002, BIOL CYBERN, V86, P457, DOI 10.1007/s00422-002-0310-9; Risner ML, 2009, NEUROIMAGE, V45, P463, DOI 10.1016/j.neuroimage.2008.12.031; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Ross B, 2005, J NEUROPHYSIOL, V94, P4082, DOI 10.1152/jn.00469.2005; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Sable JJ, 2004, PSYCHOPHYSIOLOGY, V41, P636, DOI 10.1111/j.1469-8986.2004.00192.x; SANTARELLI R, 1995, HEARING RES, V83, P9, DOI 10.1016/0378-5955(94)00185-S; Santarelli R, 1999, SCAND AUDIOL, V28, P23; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; SPEKREIJSE H, 1977, VISUAL EVOKED POTENT; Srinivasan R, 2006, BRAIN TOPOGR, V18, P167, DOI 10.1007/s10548-006-0267-4; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; STAPELLS DR, 1988, ELECTROEN CLIN NEURO, V71, P289, DOI 10.1016/0168-5597(88)90029-9; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wilcox RR, 2003, PSYCHOL METHODS, V8, P254, DOI 10.1037/1082-989X.8.3.254; Zaehle T, 2010, EXP BRAIN RES, V203, P629, DOI 10.1007/s00221-010-2265-8	58	128	130	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14543	10.1371/journal.pone.0014543	http://dx.doi.org/10.1371/journal.pone.0014543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267081	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000286519500013
J	Feikin, DR; Olack, B; Bigogo, GM; Audi, A; Cosmas, L; Aura, B; Burke, H; Njenga, MK; Williamson, J; Breiman, RF				Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Williamson, John; Breiman, Robert F.			The Burden of Common Infectious Disease Syndromes at the Clinic and Household Level from Population-Based Surveillance in Rural and Urban Kenya	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PERIPHERAL HEALTH FACILITIES; WESTERN KENYA; COTRIMOXAZOLE PROPHYLAXIS; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; RISK-FACTORS; MORBIDITY SURVEILLANCE; INTEGRATED MANAGEMENT; PNEUMOCOCCAL DISEASE	Background: Characterizing infectious disease burden in Africa is important for prioritizing and targeting limited resources for curative and preventive services and monitoring the impact of interventions. Methods: From June 1, 2006 to May 31, 2008, we estimated rates of acute lower respiratory tract illness (ALRI), diarrhea and acute febrile illness (AFI) among >50,000 persons participating in population-based surveillance in impoverished, rural western Kenya (Asembo) and an informal settlement in Nairobi, Kenya (Kibera). Field workers visited households every two weeks, collecting recent illness information and performing limited exams. Participants could access free high-quality care in a designated referral clinic in each site. Incidence and longitudinal prevalence were calculated and compared using Poisson regression. Results: Incidence rates resulting in clinic visitation were the following: ALRI - 0.36 and 0.51 episodes per year for children <5 years and 0.067 and 0.026 for persons >= 5 years in Asembo and Kibera, respectively; diarrhea - 0.40 and 0.71 episodes per year for children <5 years and 0.09 and 0.062 for persons >= 5 years in Asembo and Kibera, respectively; AFI - 0.17 and 0.09 episodes per year for children <5 years and 0.03 and 0.015 for persons >= 5 years in Asembo and Kibera, respectively. Annually, based on household visits, children <5 years in Asembo and Kibera had 60 and 27 cough days, 10 and 8 diarrhea days, and 37 and 11 fever days, respectively. Household-based rates were higher than clinic rates for diarrhea and AFI, this difference being several-fold greater in the rural than urban site. Conclusions: Individuals in poor Kenyan communities still suffer from a high burden of infectious diseases, which likely hampers their development. Urban slum and rural disease incidence and clinic utilization are sufficiently disparate in Africa to warrant data from both settings for estimating burden and focusing interventions.	[Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Breiman, Robert F.] Ctr Dis Control & Prevent Nairobi, Int Emerging Infect Program Kenya, Nairobi, Kenya; [Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Breiman, Robert F.] Ctr Dis Control & Prevent Kisumu, Int Emerging Infect Program Kenya, Kisumu, Kenya; [Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Williamson, John; Breiman, Robert F.] CDC Publ Hlth & Res Collaborat, Kenya Med Res Inst, Kisumu, Kenya; [Feikin, Daniel R.; Olack, Beatrice; Bigogo, Godfrey M.; Audi, Allan; Cosmas, Leonard; Aura, Barrack; Burke, Heather; Njenga, M. Kariuki; Williamson, John; Breiman, Robert F.] CDC Publ Hlth & Res Collaborat, Kenya Med Res Inst, Nairobi, Kenya	Kenya Medical Research Institute; Kenya Medical Research Institute	Feikin, DR (corresponding author), Ctr Dis Control & Prevent Nairobi, Int Emerging Infect Program Kenya, Nairobi, Kenya.	dfeikin@ke.cdc.gov	Bigogo, Godfrey/W-3591-2019	Audi, Allan/0000-0003-1683-554X	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded through core funding of CDC's International Emerging Infections Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bickel P.J., 2001, MATH STAT BASIC IDEA; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BREIMAN RF, J HLTH POPU IN PRESS; Breman JG, 2001, AM J TROP MED HYG, V64, pI; BURTON DC, J HLTH POPU IN PRESS; CAMPBELL H, 1989, LANCET, V1, P297, DOI 10.1016/S0140-6736(89)91308-1; *CENTR BUR STAT, 2001, POP DISTR ADM AR URB, P2; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; FAGBULE D, 1994, J TROP PEDIATRICS, V40, P279, DOI 10.1093/tropej/40.5.279; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Hayes J A, 1990, Health Care Strateg Manage, V8, P12; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; MANUNEBO MN, 1994, J TROP MED HYG, V97, P31; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; McElroy PD, 2001, AM J TROP MED HYG, V64, P18, DOI 10.4269/ajtmh.2001.64.18; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; *MIN HLTH KEN CBS, 2004, KEN DEM HLTH SURV 20; Mirza NM, 1997, AM J EPIDEMIOL, V146, P776, DOI 10.1093/oxfordjournals.aje.a009354; Molbak K, 1997, AM J EPIDEMIOL, V146, P273, DOI 10.1093/oxfordjournals.aje.a009263; Morris SS, 1998, AM J EPIDEMIOL, V147, P1087, DOI 10.1093/oxfordjournals.aje.a009403; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; MURRAY CJL, 1996, GLOBAL HLTH STAT, P286; Ngongo CJ, 2008, INT Q COMMUNITY HEAL, V28, P33, DOI 10.2190/IQ.28.1.d; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; OYEJIDE CO, 1990, REV INFECT DIS, V12, pS1042; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P38; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Schmidt WP, 2007, EPIDEMIOLOGY, V18, P537, DOI 10.1097/EDE.0b013e318093f3ce; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Syagga P. M., 2001, SLUM UPGRADING LESSO; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; Van Hemelrijck MJJ, 2009, TROP MED INT HEALTH, V14, P62, DOI 10.1111/j.1365-3156.2008.02184.x; WAFULA EM, 1990, REV INFECT DIS, V12, pS1035; WHO, 2010, WORLD HLTH STAT; WHO, 2008, INT MAN CHILDH ILLN; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; World Health Organization, 2010, WHO STAT INF SYST; Wright JA, 2006, J HEALTH POPUL NUTR, V24, P8	65	124	125	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16085	10.1371/journal.pone.0016085	http://dx.doi.org/10.1371/journal.pone.0016085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267459	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500037
J	Tanner, MJ; Welliver, RC; Chen, MQ; Shtutman, M; Godoy, A; Smith, G; Mian, BM; Buttyan, R				Tanner, Matthew J.; Welliver, R. Charles, Jr.; Chen, Mengqian; Shtutman, Michael; Godoy, Alejandro; Smith, Gary; Mian, Badar M.; Buttyan, Ralph			Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells	PLOS ONE			English	Article							REGULATED GENES; MOLECULAR REGULATION; LNCAP CELLS; IN-VIVO; IDENTIFICATION; PROGRESSION; MICROENVIRONMENT; CARCINOGENESIS	The androgen receptor (AR) is expressed in a subset of prostate stromal cells and functional stromal cell AR is required for normal prostate developmental and influences the growth of prostate tumors. Although we are broadly aware of the specifics of the genomic actions of AR in prostate cancer cells, relatively little is known regarding the gene targets of functional AR in prostate stromal cells. Here, we describe a novel human prostate stromal cell model that enabled us to study the effects of AR on gene expression in these cells. The model involves a genetically manipulated variant of immortalized human WPMY-1 prostate stromal cells that overexpresses wildtype AR (WPMY-AR) at a level comparable to LNCaP cells and is responsive to dihydrotestosterone (DHT) stimulation. Use of WPMY-AR cells for gene expression profiling showed that the presence of AR, even in the absence of DHT, significantly altered the gene expression pattern of the cells compared to control (WPMY-Vec) cells. Treatment of WPMY-AR cells, but not WPMY-Vec control cells, with DHT resulted in further changes that affected the expression of 141 genes by 2-fold or greater compared to vehicle treated WPMY-AR cells. Remarkably, DHT significantly downregulated more genes than were upregulated but many of these changes reversed the initial effects of AR overexpression alone on individual genes. The genes most highly effected by DHT treatment were categorized based upon their role in cancer pathways or in cell signaling pathways (transforming growth factor-beta, Wnt, Hedgehog and MAP Kinase) thought to be involved in stromal-epithelial crosstalk during prostate or prostate cancer development. DHT treatment of WPMY-AR cells was also sufficient to alter their paracrine potential for prostate cancer cells as conditioned medium from DHT-treated WPMY-AR significantly increased growth of LNCaP cells compared to DHT-treated WPMY-Vec cell conditioned medium.	[Tanner, Matthew J.; Chen, Mengqian; Shtutman, Michael; Buttyan, Ralph] Ordway Res Inst, Albany, NY USA; [Welliver, R. Charles, Jr.; Mian, Badar M.; Buttyan, Ralph] Albany Med Coll, Dept Surg, Div Urol, Albany, NY 12208 USA; [Welliver, R. Charles, Jr.; Mian, Badar M.] Stratton Vet Affairs Med Ctr, Albany, NY USA; [Godoy, Alejandro; Smith, Gary] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA	Ordway Research Institute; Albany Medical College; Roswell Park Cancer Institute	Tanner, MJ (corresponding author), Ordway Res Inst, Albany, NY USA.	rbuttyan@ordwayresearch.org	Godoy, Alejandro/GPS-4942-2022; Shtutman, Michael/AAB-8391-2020; Mian, Badar M/GYJ-4637-2022	Shtutman, Michael/0000-0002-2458-3226; Mian, Badar M/0000-0002-1698-9525; Tanner, Matthew/0000-0002-4392-5535; Giannakakou, Paraskevi/0000-0001-7378-262X; Chen, Mengqian/0000-0003-1706-9509; Welliver, Charles/0000-0001-8520-3218	Equinox Foundation; Medical Research Foundation of Albany, New York; Department of Defense (DoD) [W81XWH-10-100125, W81XWH-09-1-0330]	Equinox Foundation; Medical Research Foundation of Albany, New York; Department of Defense (DoD)(United States Department of Defense)	This work was funded by the Equinox Foundation and the Medical Research Foundation of Albany, New York. MT was an American Urological Association (URA) Foundation Research Fellow. MC and AG are recipients of Department of Defense (DoD) Prostate Cancer Research Program (PCRP) Postdoctoral Research Fellowships (W81XWH-10-100125 [to MC] and W81XWH-09-1-0330 [to AG]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basanta D, 2009, CANCER RES, V69, P7111, DOI 10.1158/0008-5472.CAN-08-3957; Cano P, 2007, CANCER RES, V67, P511, DOI 10.1158/0008-5472.CAN-06-1478; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; GLEAVE M, 1991, CANCER RES, V51, P3753; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Hu P, 2006, CANCER INFORM, V2, P289; Imperato-McGinley J, 2002, MOL CELL ENDOCRINOL, V198, P51, DOI 10.1016/S0303-7207(02)00368-4; IWAMURA M, 1994, J HISTOCHEM CYTOCHEM, V42, P783, DOI 10.1177/42.6.8189040; Jariwala U, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-39; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Liu AY, 1997, PROSTATE, V30, P145, DOI 10.1002/(SICI)1097-0045(19970215)30:3<145::AID-PROS1>3.0.CO;2-L; Mechlin CW, 2010, J UROLOGY, V184, P344, DOI 10.1016/j.juro.2010.03.007; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mohler JL, 1996, CLIN CANCER RES, V2, P889; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Price DT, 2000, J UROLOGY, V164, P2145, DOI 10.1016/S0022-5347(05)66987-X; Rostad K, 2007, INT J ONCOL, V30, P19; SAR M, 1990, ENDOCRINOLOGY, V127, P3180, DOI 10.1210/endo-127-6-3180; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; SULTAN C, 1993, J STEROID BIOCHEM, V46, P519, DOI 10.1016/0960-0760(93)90178-Y; Thompson IM, 2009, J UROLOGY, V182, P499, DOI 10.1016/j.juro.2009.04.015; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Velasco AM, 2004, ENDOCRINOLOGY, V145, P3913, DOI 10.1210/en.2004-0311; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Xu LL, 2001, INT J CANCER, V92, P322, DOI 10.1002/ijc.1196	35	44	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16027	10.1371/journal.pone.0016027	http://dx.doi.org/10.1371/journal.pone.0016027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267466	Green Submitted, Green Published, gold			2022-12-25	WOS:000286519500036
J	Jankowska, EA; Filippatos, GS; von Haehling, S; Papassotiriou, J; Morgenthaler, NG; Cicoira, M; Schefold, JC; Rozentryt, P; Ponikowska, B; Doehner, W; Banasiak, W; Hartmann, O; Struck, J; Bergmann, A; Anker, SD; Ponikowski, P				Jankowska, Ewa A.; Filippatos, Gerasimos S.; von Haehling, Stephan; Papassotiriou, Jana; Morgenthaler, Nils G.; Cicoira, Mariantonietta; Schefold, Joerg C.; Rozentryt, Piotr; Ponikowska, Beata; Doehner, Wolfram; Banasiak, Waldemar; Hartmann, Oliver; Struck, Joachim; Bergmann, Andreas; Anker, Stefan D.; Ponikowski, Piotr			Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; MIDREGIONAL PRO-ADRENOMEDULLIN; PROGNOSTIC VALUE; BIG ENDOTHELIN-1; PREDICTING SURVIVAL; MARKERS; VASOCONSTRICTION; DIAGNOSIS	Objectives: We hypothesised that assessment of plasma C-terminal pro-endothelin-1 (CT-proET-1), a stable endothelin-1 precursor fragment, is of prognostic value in patients with chronic heart failure (CHF), beyond other prognosticators, including N-terminal pro-B-type natriuretic peptide (NT-proBNP). Methods: We examined 491 patients with systolic CHF (age: 63 +/- 11 years, 91% men, New York Heart Association [NYHA] class [I/II/III/IV]: 9%/45%/38%/8%, 69% ischemic etiology). Plasma CT-proET-1 was detected using a chemiluminescence immunoassay. Results: Increasing CT-proET-1 was a predictor of increased cardiovascular mortality at 12-months of follow-up (standardized hazard ratio 1.42, 95% confidence interval [CI] 1.04-1.95, p = 0.03) after adjusting for NT-proBNP, left ventricular ejection fraction (LVEF), age, creatinine, NYHA class. In receiver operating characteristic curve analysis, areas under curve for 12-month follow-up were similar for CT-proET-1 and NT-proBNP (p = 0.40). Both NT-proBNP and CT-proET-1 added prognostic value to a base model that included LVEF, age, creatinine, and NYHA class. Adding CT-proET-1 to the base model had stronger prognostic power (p<0.01) than adding NT-proBNP (p<0.01). Adding CT-proET-1 to NT-proBNP in this model yielded further prognostic information (p = 0.02). Conclusions: Plasma CT-proET-1 constitutes a novel predictor of increased 12-month cardiovascular mortality in patients with CHF. High CT-proET-1 together with high NT-proBNP enable to identify patients with CHF and particularly unfavourable outcomes.	[Jankowska, Ewa A.; Ponikowski, Piotr] Wroclaw Mil Hosp, Dept Heart Dis, Wroclaw, Poland; [Jankowska, Ewa A.; Banasiak, Waldemar; Ponikowski, Piotr] Mil Hosp, Dept Cardiol, Wroclaw, Poland; [Filippatos, Gerasimos S.] Atticon Univ Hosp, Dept Cardiol, Athens, Greece; [von Haehling, Stephan; Doehner, Wolfram; Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany; [von Haehling, Stephan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Clin Cardiol, London, England; [Papassotiriou, Jana; Morgenthaler, Nils G.; Hartmann, Oliver; Struck, Joachim; Bergmann, Andreas] Biotechnol Ctr Hennigsdorf Berlin, BRAHMS AG, Res Dept, Hennigsdorf, Germany; [Cicoira, Mariantonietta] Univ Verona, Dept Biomed & Surg Sci, Cardiol Sect, I-37100 Verona, Italy; [Schefold, Joerg C.] Charite, Dept Nephrol & Intens Care Med, Berlin, Germany; [Rozentryt, Piotr] Silesian Ctr Heart Dis, Dept Cardiol 3, Zabrze, Poland; [Ponikowska, Beata] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland; [Doehner, Wolfram] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Anker, Stefan D.] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy	University Hospital Attikon; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; Thermo Fisher Scientific; Brahms AG; University of Verona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Silesian Center for Heart Diseases; Wroclaw Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Jankowska, EA (corresponding author), Wroclaw Mil Hosp, Dept Heart Dis, Wroclaw, Poland.	Ewa.Jankowska@antro.pan.wroc.pl	Jankowska, Ewa A/AAY-3040-2020; Ponikowski, Piotr/O-6454-2015; Filippatos, Gerasimos/ABA-4656-2021; Jankowska, Ewa A/O-6358-2015; Jankowska, Ewa A/G-7960-2011; Jankowska, Ewa/ABD-4073-2021	Jankowska, Ewa A/0000-0002-9202-432X; Ponikowski, Piotr/0000-0002-3391-7064; Jankowska, Ewa A/0000-0002-9202-432X; Doehner, Wolfram/0000-0001-7598-708X; Ponikowska, Beata/0000-0002-6044-5322; Rozentryt, Piotr/0000-0002-8979-2205; Schefold, Joerg C./0000-0001-9162-5724	B.R.A.H.M.S AG	B.R.A.H.M.S AG	Stephan von Haehling has received speaker's fees from B.R.A.H.M.S AG for giving presentations on biomarkers produced and marketed by B.R.A.H.M.S. AG. Nils G. Morgenthaler, Jana Papassotiriou, Joachim Struck, Oliver Hartmann, and Andreas Bergmann are employed by B.R.A.H.M.S. AG, which is a biotech company that developed the CT-proET-1 assay. The funder B.R.A.H.M.S. AG was involved in data collection and analysis and reviewed the manuscript before submission. Andreas Bergmann is a member of the board of directors and shareholder of B.R.A.H.M.S. AG. Stefan D. Anker has received consultant honoraria from B.R.A.H.M.S. AG.	Adlbrecht C, 2009, EUR J HEART FAIL, V11, P361, DOI 10.1093/eurjhf/hfp004; Behnes M, 2008, CLIN CHEM LAB MED, V46, P204, DOI 10.1515/CCLM.2008.040; Berger R, 2003, J HEART LUNG TRANSPL, V22, P1037, DOI 10.1016/S1053-2498(02)00560-0; Brunner F, 2006, PHARMACOL THERAPEUT, V111, P508, DOI 10.1016/j.pharmthera.2005.11.001; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Dieplinger B, 2010, CLIN BIOCHEM, V43, P714, DOI 10.1016/j.clinbiochem.2010.02.002; Ferro CJ, 1998, CIRCULATION, V97, P2323, DOI 10.1161/01.CIR.97.23.2323; Gardner RS, 2005, EUR J HEART FAIL, V7, P253, DOI 10.1016/j.ejheart.2004.06.002; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Harrell FE, 2001, REGRESSION MODELING; Hulsmann M, 1998, J AM COLL CARDIOL, V32, P1695, DOI 10.1016/S0735-1097(98)00437-9; Isnard R, 2000, AM J CARDIOL, V86, P417, DOI 10.1016/S0002-9149(00)00957-7; Khan SQ, 2007, AM HEART J, V154, P736, DOI 10.1016/j.ahj.2007.06.016; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Marasciulo FL, 2006, CURR MED CHEM, V13, P1655, DOI 10.2174/092986706777441968; Masson S, 2006, J CARD FAIL, V12, P375, DOI 10.1016/j.cardfail.2006.02.013; Masson S, 2010, EUR J HEART FAIL, V12, P338, DOI 10.1093/eurjhf/hfp206; Pacher R, 1996, J AM COLL CARDIOL, V27, P633, DOI 10.1016/0735-1097(95)00520-X; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Pousset F, 1997, EUR HEART J, V18, P254; Rossi GP, 2000, ANN CLIN BIOCHEM, V37, P608, DOI 10.1258/0004563001899906; Selvais PL, 2000, J CARD FAIL, V6, P201, DOI 10.1054/jcaf.2000.8833; Stanek B, 1997, TRANSPL P, V29, P595, DOI 10.1016/S0041-1345(96)00097-8; Stanek B, 2001, J AM COLL CARDIOL, V38, P436, DOI 10.1016/S0735-1097(01)01383-3; Struck J, 2005, PEPTIDES, V26, P2482, DOI 10.1016/j.peptides.2005.05.010; Sugden Peter H., 2005, Current Vascular Pharmacology, V3, P343, DOI 10.2174/157016105774329390; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tsutamoto T, 1999, EUR HEART J, V20, P1799, DOI 10.1053/euhj.1999.1746; TSUTAMOTO T, 1995, AM J CARDIOL, V76, P803, DOI 10.1016/S0002-9149(99)80231-8; van Beneden R, 2004, J CARD FAIL, V10, P490, DOI 10.1016/j.cardfail.2004.04.001; von Haehling S, 2007, J AM COLL CARDIOL, V50, P1973, DOI 10.1016/j.jacc.2007.08.012; von Haehling S, 2010, EUR J HEART FAIL, V12, P484, DOI 10.1093/eurjhf/hfq031; WEITZBERG E, 1991, BIOCHEM BIOPH RES CO, V180, P1298, DOI 10.1016/S0006-291X(05)81336-1	33	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14506	10.1371/journal.pone.0014506	http://dx.doi.org/10.1371/journal.pone.0014506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264211	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600002
J	Marsolier-Kergoat, MC				Marsolier-Kergoat, Marie-Claude			A Simple Model for the Influence of Meiotic Conversion Tracts on GC Content	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; RECOMBINATION HOT-SPOTS; SACCHAROMYCES-CEREVISIAE; HUMAN GENOME; GENE CONVERSION; DNA REVEALS; HOTSPOTS; YEAST; EVOLUTION; SITES	A strong correlation between GC content and recombination rate is observed in many eukaryotes, which is thought to be due to conversion events linked to the repair of meiotic double-strand breaks. In several organisms, the length of conversion tracts has been shown to decrease exponentially with increasing distance from the sites of meiotic doublestrand breaks. I show here that this behavior leads to a simple analytical model for the evolution and the equilibrium state of the GC content of sequences devoid of meiotic double-strand break sites. In the yeast Saccharomyces cerevisiae, meiotic double-strand breaks are practically excluded from protein-coding sequences. A good fit was observed between the predictions of the model and the variations of the average GC content of the third codon position (GC3) of S. cerevisiae genes. Moreover, recombination parameters that can be extracted by fitting the data to the model coincide with experimentally determined values. These results thus indicate that meiotic recombination plays an important part in determining the fluctuations of GC content in yeast coding sequences. The model also accounted for the different patterns of GC variations observed in the genes of Candida species that exhibit a variety of sexual lifestyles, and hence a wide range of meiotic recombination rates. Finally, the variations of the average GC3 content of human and chicken coding sequences could also be fitted by the model. These results suggest the existence of a widespread pattern of GC variation in eukaryotic genes due to meiotic recombination, which would imply the generality of two features of meiotic recombination: its association with GC-biased gene conversion and the quasi-exclusion of meiotic double-strand breaks from coding sequences. Moreover, the model points out to specific constraints on protein fragments encoded by exon terminal sequences, which are the most affected by the GC bias.	CEA Saclay, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Marsolier-Kergoat, MC (corresponding author), CEA Saclay, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France.	mcmk@cea.fr			ARC (Association pour la Recherche sur le Cancer) [4917, ANR-07-BLAN-0091 - CSD 8]	ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from the ARC (Association pour la Recherche sur le Cancer, fixed subvention # 4917; http://www.arc-cancer.net/) and from the ANR (Agence Nationale de la Recherche, ANR-07-BLAN-0091 - CSD 8; http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; HILLIKER AJ, 1994, GENETICS, V137, P1019; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Noor MAF, 2008, MOL BIOL EVOL, V25, P2439, DOI 10.1093/molbev/msn186; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; R Development Core Team, 2009, R FDN STAT COMP; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P582, DOI 10.1073/pnas.48.4.582; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107; Webster MT, 2006, MOL BIOL EVOL, V23, P1203, DOI 10.1093/molbev/msk008; Wu ZK, 2010, NUCLEIC ACIDS RES, V38, P2346, DOI 10.1093/nar/gkp1251	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16109	10.1371/journal.pone.0016109	http://dx.doi.org/10.1371/journal.pone.0016109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249197	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000019
J	Rea, G; Lambreva, M; Polticelli, F; Bertalan, I; Antonacci, A; Pastorelli, S; Damasso, M; Johanningmeier, U; Giardi, MT				Rea, Giuseppina; Lambreva, Maya; Polticelli, Fabio; Bertalan, Ivo; Antonacci, Amina; Pastorelli, Sandro; Damasso, Mario; Johanningmeier, Udo; Giardi, Maria Teresa			Directed Evolution and In Silico Analysis of Reaction Centre Proteins Reveal Molecular Signatures of Photosynthesis Adaptation to Radiation Pressure	PLOS ONE			English	Article							PHOTOSYSTEM-II; CHLAMYDOMONAS-REINHARDTII; D1 PROTEIN; RHODOBACTER-SPHAEROIDES; SINGLET OXYGEN; HIGH LIGHT; MUTANTS; WATER; CYANOBACTERIA; DEGRADATION	Evolutionary mechanisms adopted by the photosynthetic apparatus to modifications in the Earth's atmosphere on a geological time-scale remain a focus of intense research. The photosynthetic machinery has had to cope with continuously changing environmental conditions and particularly with the complex ionizing radiation emitted by solar flares. The photosynthetic D1 protein, being the site of electron tunneling-mediated charge separation and solar energy transduction, is a hot spot for the generation of radiation-induced radical injuries. We explored the possibility to produce D1 variants tolerant to ionizing radiation in Chlamydomonas reinhardtii and clarified the effect of radiation-induced oxidative damage on the photosynthetic proteins evolution. In vitro directed evolution strategies targeted at the D1 protein were adopted to create libraries of chlamydomonas random mutants, subsequently selected by exposures to radical-generating proton or neutron sources. The common trend observed in the D1 aminoacidic substitutions was the replacement of less polar by more polar amino acids. The applied selection pressure forced replacement of residues more sensitive to oxidative damage with less sensitive ones, suggesting that ionizing radiation may have been one of the driving forces in the evolution of the eukaryotic photosynthetic apparatus. A set of the identified aminoacidic substitutions, close to the secondary plastoquinone binding niche and oxygen evolving complex, were introduced by site-directed mutagenesis in untransformed strains, and their sensitivity to free radicals attack analyzed. Mutants displayed reduced electron transport efficiency in physiological conditions, and increased photosynthetic performance stability and oxygen evolution capacity in stressful high-light conditions. Finally, comparative in silico analyses of D1 aminoacidic sequences of organisms differently located in the evolution chain, revealed a higher ratio of residues more sensitive to oxidative damage in the eukaryotic/cyanobacterial proteins compared to their bacterial orthologs. These results led us to hypothesize an archaean atmosphere less challenging in terms of ionizing radiation than the present one.	[Rea, Giuseppina; Lambreva, Maya; Antonacci, Amina; Pastorelli, Sandro; Damasso, Mario; Giardi, Maria Teresa] CNR, Inst Crystallog, Monterotondo, Italy; [Polticelli, Fabio] Univ Roma Tre, Dept Biol, Rome, Italy; [Bertalan, Ivo] Univ Halle Wittenberg, Inst Plant Physiol, Halle, Saale, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Roma Tre University; Martin Luther University Halle Wittenberg	Rea, G (corresponding author), CNR, Inst Crystallog, Monterotondo, Italy.	giuseppina.rea@mlib.ic.cnr.it	Polticelli, Fabio/A-4573-2009; Lambreva, Maya Dimova/D-6917-2017; Antonacci, Amina/I-4374-2012; REA, GIUSEPPINA/B-9479-2015	Polticelli, Fabio/0000-0002-7657-2019; Lambreva, Maya Dimova/0000-0001-5750-0899; Antonacci, Amina/0000-0002-3245-3739; REA, GIUSEPPINA/0000-0001-7353-727X; Giardi, Maria Teresa/0000-0002-7401-5905; Damasso, Mario/0000-0001-9984-4278	Italian Space Agency; European Space Agency [ESA-RA-LS-01-Flight/BN-004, ILSRA-2009-1001, ASI N I/021/10/0]	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Space Agency(European Space AgencyEuropean Commission)	This work was supported from 2005 to 2010 by the Italian Space Agency (http://www.asi.it/en) and the European Space Agency (http://www.esa.int/esaCP/index.html) (call_ideas_nov2004-2006 mod, HME-GA/2005-037 registration code ESA-RA-LS-01-Flight/BN-004, ILSRA-2009-1001, ASI N I/021/10/0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; Benton ER, 2001, NUCL INSTRUM METH B, V184, P255, DOI 10.1016/S0168-583X(01)00748-0; Berger T, 2008, Z MED PHYS, V18, P265, DOI 10.1016/j.zemedi.2008.06.014; COCKELL CS, 2001, LECT NOTES ASTROBIOL, P219; Damasso M, 2009, RADIAT MEAS, V44, P263, DOI 10.1016/j.radmeas.2009.03.007; Dauvillee D, 2004, PHOTOSYNTH RES, V79, P219, DOI 10.1023/B:PRES.0000015384.24958.a9; Dillon JG, 2003, ENVIRON MICROBIOL, V5, P473, DOI 10.1046/j.1462-2920.2003.00435.x; Draganic IG, 2005, RADIAT PHYS CHEM, V72, P181, DOI 10.1016/j.radphyschem.2004.09.012; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Eriksson KM, 2009, APPL ENVIRON MICROB, V75, P897, DOI 10.1128/AEM.01830-08; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FINER JJ, 1992, MOL GEN GENET, V251, P373; Forster B, 2001, PHOTOSYNTH RES, V67, P5, DOI 10.1023/A:1010611509209; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Giardi MT, 2005, TRENDS BIOTECHNOL, V23, P257, DOI 10.1016/j.tibtech.2005.03.003; GM Cooper, 2004, CELL MOL APPROACH; Gupta RS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-167; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hall D. O., 1999, PHOTOSYNTHESIS; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Heathcote P, 2002, TRENDS BIOCHEM SCI, V27, P79, DOI 10.1016/S0968-0004(01)02034-5; Hideg E, 2000, METHOD ENZYMOL, V319, P77; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; JOHANNINGMEIER U, 1993, PLANT MOL BIOL, V22, P91, DOI 10.1007/BF00038998; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; Kiang NY, 2007, ASTROBIOLOGY, V7, P252, DOI 10.1089/ast.2006.0108; Koepke J, 2007, J MOL BIOL, V371, P396, DOI 10.1016/j.jmb.2007.04.082; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakatos M, 2001, EUR J PHYCOL, V36, P367, DOI 10.1080/09670260110001735518; Lardans A, 1998, J BIOL CHEM, V273, P11082, DOI 10.1074/jbc.273.18.11082; Ledford HK, 2005, PLANT CELL ENVIRON, V28, P1037, DOI 10.1111/j.1365-3040.2005.01374.x; Leslie M, 2009, SCIENCE, V323, P1286, DOI 10.1126/science.323.5919.1286; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; NEWMAN SM, 1990, GENETICS, V126, P875; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Olsson LC, 2000, J EXP BOT, V51, P265, DOI 10.1093/jexbot/51.343.265; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Potter JA, 2005, J BIOL CHEM, V280, P27155, DOI 10.1074/jbc.M501961200; Preiss S, 2001, EUR J BIOCHEM, V268, P4562, DOI 10.1046/j.1432-1327.2001.02383.x; Rea G, 2008, INT J RADIAT BIOL, V84, P867, DOI 10.1080/09553000802460149; Scognamiglio V, 2009, ANAL BIOANAL CHEM, V394, P1081, DOI 10.1007/s00216-009-2668-1; Sicora CI, 2008, BBA-BIOENERGETICS, V1777, P130, DOI 10.1016/j.bbabio.2007.09.001; Singh SP, 2010, AGEING RES REV, V9, P79, DOI 10.1016/j.arr.2009.05.004; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Wilski S, 2006, PESTIC BIOCHEM PHYS, V84, P157, DOI 10.1016/j.pestbp.2005.07.001; Xiong J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-245; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zeng XQ, 2010, PHYSIOL PLANTARUM, V138, P215, DOI 10.1111/j.1399-3054.2009.01316.x; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	57	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16216	10.1371/journal.pone.0016216	http://dx.doi.org/10.1371/journal.pone.0016216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249156	Green Submitted, Green Published, gold			2022-12-25	WOS:000286515000034
J	Secondini, C; Wetterwald, A; Schwaninger, R; Thalmann, GN; Cecchini, MG				Secondini, Chiara; Wetterwald, Antoinette; Schwaninger, Ruth; Thalmann, George N.; Cecchini, Marco G.			The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-6; OSTEOBLAST DIFFERENTIATION; TGF-BETA; EXPRESSION; WNT; CELLS; MECHANISMS; RESORPTION; DISEASE; DKK1	Members of the BMP and Wnt protein families play a relevant role in physiologic and pathologic bone turnover. Extracellular antagonists are crucial for the modulation of their activity. Lack of expression of the BMP antagonist noggin by osteoinductive, carcinoma-derived cell lines is a determinant of the osteoblast response induced by their bone metastases. In contrast, osteolytic, carcinoma-derived cell lines express noggin constitutively. We hypothesized that cancer cell-derived noggin may contribute to the pathogenesis of osteolytic bone metastasis of solid cancers by repressing bone formation. Intra-osseous xenografts of PC-3 prostate cancer cells induced osteolytic lesions characterized not only by enhanced osteoclast-mediated bone resorption, but also by decreased osteoblast-mediated bone formation. Therefore, in this model, uncoupling of the bone remodeling process contributes to osteolysis. Bone formation was preserved in the osteolytic lesions induced by noggin-silenced PC-3 cells, suggesting that cancer cell-derived noggin interferes with physiologic bone coupling. Furthermore, intra-osseous tumor growth of noggin-silenced PC-3 cells was limited, most probably as a result of the persisting osteoblast activity. This investigation provides new evidence for a model of osteolytic bone metastasis where constitutive secretion of noggin by cancer cells mediates inhibition of bone formation, thereby preventing repair of osteolytic lesions generated by an excess of osteoclast-mediated bone resorption. Therefore, noggin suppression may be a novel strategy for the treatment of osteolytic bone metastases.	[Secondini, Chiara] Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland; Univ Bern, Dept Clin Res, Bern, Switzerland	University of Bern; University of Bern	Secondini, C (corresponding author), Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland.	marco.cecchini@dkf.unibe.ch			European Commission [CANCURE-2006-020970, PRIMA-504587]; Swiss National Foundation [3200-068409.02]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by grants from the European Commission (CANCURE-2006-020970 and PRIMA-504587) and from the Swiss National Foundation (3200-068409.02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 1995, WORLD J UROL, V13, P337; BATAILLE R, 1986, BRIT J CANCER, V53, P805, DOI 10.1038/bjc.1986.136; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; BUCKLE CH, 2010, CURR PHARM DES; Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Chanda D, 2009, CLIN CANCER RES, V15, P7175, DOI 10.1158/1078-0432.CCR-09-1938; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Gazzerro E, 2003, BONE, V32, P111, DOI 10.1016/S8756-3282(02)00948-1; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Hamdy FC, 1997, CANCER RES, V57, P4427; HARRIS SE, 1994, PROSTATE, V24, P204, DOI 10.1002/pros.2990240406; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Haudenschild DR, 2004, CANCER RES, V64, P8276, DOI 10.1158/0008-5472.CAN-04-2251; Heath DJ, 2008, CALCIFIED TISSUE INT, V83, P6; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; KULENKAMPFF HA, 1986, VIRCHOWS ARCH A, V409, P817, DOI 10.1007/BF00710766; Lage MJ, 2008, AM J MANAG CARE, V14, P317; Lintern KB, 2009, J BIOL CHEM, V284, P23159, DOI 10.1074/jbc.M109.025478; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mastro AM, 2004, J CELL BIOCHEM, V91, P265, DOI 10.1002/jcb.10746; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Morrissey C, 2010, PROSTATE, V70, P412, DOI 10.1002/pros.21075; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; MUNDY GR, 2008, PRIMER NETABOLIC BON, P374; NERI B, 1989, CANCER INVEST, V7, P551, DOI 10.3109/07357908909017529; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Parfitt A M, 1995, Can J Oncol, V5 Suppl 1, P1; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; ROODMAN GD, 2010, J BONE MINER METAB; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; SASAKI A, 1995, CANCER RES, V55, P3551; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; SUNDQUIST KT, 1995, BONE, V16, P39, DOI 10.1016/S8756-3282(94)00005-0; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; TAUBE T, 1992, EUR J HAEMATOL, V49, P192; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Vukmirovic-Popovic S, 2002, BONE, V31, P529, DOI 10.1016/S8756-3282(02)00847-5; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yaccoby S, 2006, HAEMATOL-HEMATOL J, V91, P192; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	66	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16078	10.1371/journal.pone.0016078	http://dx.doi.org/10.1371/journal.pone.0016078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249149	Green Published, Green Submitted, gold			2022-12-25	WOS:000286515000016
J	Baumgartner, A; Coleman, S; Swanson, B				Baumgartner, Alex; Coleman, Seth; Swanson, Brook			The Cost of the Sword: Escape Performance in Male Swordtails	PLOS ONE			English	Article							XIPHOPHORUS; PREFERENCE; PREDATORS; SELECTION; SIGNALS; BIAS	The handicap theory of sexual selection posits that male display traits that are favored in mate choice come at a significant cost to performance. We tested one facet of this hypothesis in the green swordtail (Xiphophorus helleri). In this species, the lower ray of male caudal fin is extended into a 'sword', which serves to attract potential mates. However, bearing a long sword may increase drag and thus compromise a male's ability to swim effectively. We tested escape performance in this species by eliciting C-start escape responses, an instinctive escape behavior, in males with various sword lengths. We then removed males' swords and retested escape performance. We found no relationship between escape performance and sword length and no effect of sword removal on escape performance. While having a large sword may attract a predator's attention, our results suggest that sword size does not compromise a male's escape performance.	[Baumgartner, Alex; Coleman, Seth; Swanson, Brook] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA	Gonzaga University	Baumgartner, A (corresponding author), Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA.	swansonb@gonzaga.edu		Baumgartner, Alexander/0000-0002-0009-2756	Howard Hughes Medical Institute; Gonzaga University; MJ Murdock Charitable Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gonzaga University; MJ Murdock Charitable Trust	This study was funded by grants from the Howard Hughes Medical Institute (www.hhmi.org), Gonzaga University (www.gonzaga.edu), and the MJ Murdock Charitable Trust (www.murdock-trust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; BASOLO AL, 1995, ANIM BEHAV, V50, P365, DOI 10.1006/anbe.1995.0252; Basolo AL, 2003, P ROY SOC B-BIOL SCI, V270, P1631, DOI 10.1098/rspb.2003.2388; Domenici P, 1997, J EXP BIOL, V200, P1165; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; GARCIA CM, 1994, BEHAV ECOL SOCIOBIOL, V35, P253, DOI 10.1007/s002650050096; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Houde A.E., 1997, SEX COLOR MATE CHOIC; KATZIR G, 1993, COPEIA, P549; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Marcus JM, 1999, SYST BIOL, V48, P491, DOI 10.1080/106351599260111; MOLLER AP, 1994, EVOLUTION, V48, P1676, DOI 10.1111/j.1558-5646.1994.tb02204.x; Morris MR, 2001, COPEIA, P65, DOI 10.1643/0045-8511(2001)001[0065:PRAPON]2.0.CO;2; NISSANOV J, 1989, AM ZOOL, V29, P103; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rosenthal GG, 2001, AM NAT, V158, P146, DOI 10.1086/321309; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Royle NJ, 2006, FUNCT ECOL, V20, P662, DOI 10.1111/j.1365-2435.2006.01147.x; Wakeling JM, 2006, FISH PHYSIOL, V23, P333, DOI 10.1016/S1546-5098(05)23009-1; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WEIHS D, 1989, AM ZOOL, V29, P151; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi Amotz, 1997, HANDICAP PRINCIPLE M; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	26	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15837	10.1371/journal.pone.0015837	http://dx.doi.org/10.1371/journal.pone.0015837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253013	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900011
J	Goldstein-Daruech, N; Cope, EK; Zhao, KQ; Vukovic, K; Kofonow, JM; Doghramji, L; Gonzalez, B; Chiu, AG; Kennedy, DW; Palmer, JN; Leid, JG; Kreindler, JL; Cohen, NA				Goldstein-Daruech, Natalia; Cope, Emily K.; Zhao, Ke-Qing; Vukovic, Katarina; Kofonow, Jennifer M.; Doghramji, Laurel; Gonzalez, Bernardo; Chiu, Alexander G.; Kennedy, David W.; Palmer, James N.; Leid, Jeffery G.; Kreindler, James L.; Cohen, Noam A.			Tobacco Smoke Mediated Induction of Sinonasal Microbial Biofilms	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS; BACTERIAL BIOFILMS; EPITHELIAL-CELLS; STAPHYLOCOCCUS-EPIDERMIDIS; COTININE LEVELS; AIRWAY; LIPOPOLYSACCHARIDE; ACTIVATION; EXPRESSION	Cigarette smokers and those exposed to second hand smoke are more susceptible to life threatening infection than nonsmokers. While much is known about the devastating effect tobacco exposure has on the human body, less is known about the effect of tobacco smoke on the commensal and commonly found pathogenic bacteria of the human respiratory tract, or human respiratory tract microbiome. Chronic rhinosinusitis (CRS) is a common medical complaint, affecting 16% of the US population with an estimated aggregated cost of $6 billion annually. Epidemiologic studies demonstrate a correlation between tobacco smoke exposure and rhinosinusitis. Although a common cause of CRS has not been defined, bacterial presence within the nasal and paranasal sinuses is assumed to be contributory. Here we demonstrate that repetitive tobacco smoke exposure induces biofilm formation in a diverse set of bacteria isolated from the sinonasal cavities of patients with CRS. Additionally, bacteria isolated from patients with tobacco smoke exposure demonstrate robust in vitro biofilm formation when challenged with tobacco smoke compared to those isolated from smoke naive patients. Lastly, bacteria from smoke exposed patients can revert to a non-biofilm phenotype when grown in the absence of tobacco smoke. These observations support the hypothesis that tobacco exposure induces sinonasal biofilm formation, thereby contributing to the conversion of a transient and medically treatable infection to a persistent and therapeutically recalcitrant condition.	[Goldstein-Daruech, Natalia; Zhao, Ke-Qing; Kofonow, Jennifer M.; Doghramji, Laurel; Chiu, Alexander G.; Kennedy, David W.; Palmer, James N.; Cohen, Noam A.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Goldstein-Daruech, Natalia] Pontificia Univ Catolica Chile, PhD Program Med Sci, Santiago, Chile; [Goldstein-Daruech, Natalia; Gonzalez, Bernardo] Univ Adolfo Ibanez, Fac Ingn & Ciencia, Santiago, Chile; [Cope, Emily K.; Leid, Jeffery G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Zhao, Ke-Qing] Fudan Univ, Dept Otorhinolaryngol Head & Neck Surg, Eye & ENT Hosp, Sch Shanghai Med, Shanghai 200433, Peoples R China; [Vukovic, Katarina] Univ Hosp Ctr, Dept Otorhonolaryngol Head & Neck Surg, Zagreb, Croatia; [Kreindler, James L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kreindler, James L.] Univ Penn, Sch Med, Dept Pediat, Div Pulm Med, Philadelphia, PA 19104 USA; [Cohen, Noam A.] Philadelphia Vet Affairs Med Ctr, Surg Serv, Philadelphia, PA USA	University of Pennsylvania; Pontificia Universidad Catolica de Chile; Universidad Adolfo Ibanez; Northern Arizona University; Fudan University; University of Zagreb; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Goldstein-Daruech, N (corresponding author), Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA.	cohenn@uphs.upenn.edu	Chiu, Alexander G/J-1230-2014; González, Bernardo/AAW-9578-2021	Chiu, Alexander G/0000-0002-7592-6575; Cohen, Noam/0000-0002-9462-3932	Flight Attendants Medical Research Institute; Comision Nacional de investigacion cientifica y tecnologica de Chile (CONICYT); Cotutela/Codireccion 2009-2010 Pontificia Universidad Catolica de Chile	Flight Attendants Medical Research Institute; Comision Nacional de investigacion cientifica y tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Cotutela/Codireccion 2009-2010 Pontificia Universidad Catolica de Chile	This work was funded by the Flight Attendants Medical Research Institute as well as training fellowship grants from Comision Nacional de investigacion cientifica y tecnologica de Chile (CONICYT), and Cotutela/Codireccion 2009-2010 Pontificia Universidad Catolica de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MB, 2007, CURR OPIN ALLERGY CL, V7, P5, DOI 10.1097/ACI.0b013e3280114eef; APSELOFF G, 1994, CLIN PHARMACOL THER, V56, P460, DOI 10.1038/clpt.1994.161; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bagaitkar J, 2009, ENVIRON MICROBIOL, V11, P1242, DOI 10.1111/j.1462-2920.2008.01852.x; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Bertrand B., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P227; Bhattacharyya N, 1999, ARCH OTOLARYNGOL, V125, P1117; Briggs RD, 2004, LARYNGOSCOPE, V114, P126, DOI 10.1097/00005537-200401000-00022; Brook I, 2008, ANN OTO RHINOL LARYN, V117, P727, DOI 10.1177/000348940811701003; Brook I, 2010, INT J PEDIATR OTORHI, V74, P447, DOI 10.1016/j.ijporl.2010.01.006; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Cherry Donald K, 2002, Adv Data, P1; CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982; COHEN NA, 2009, LARYNGOSCOPE; Cohen NA, 2006, ANN OTO RHINOL LARYN, V115, P20; Colman G, 1976, Aust Dent J, V21, P111; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Daines SM, 2010, CURR OPIN OTOLARYNGO, V18, P187, DOI 10.1097/MOO.0b013e328338206a; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Ebbert JO, 2007, ENVIRON HEALTH-GLOB, V6, P1, DOI 10.1186/1476-069X-6-28; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Fullmer SC, 2009, J DENT RES, V88, P524, DOI 10.1177/0022034509338676; GLIKLICH RE, 1995, OTOLARYNG HEAD NECK, V113, P104, DOI 10.1016/S0194-5998(95)70152-4; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamilos Daniel L, 2010, Proc Am Thorac Soc, V7, P245, DOI 10.1513/pats.200909-098AL; Heyder J, 1975, Inhaled Part, V4 Pt 1, P107; Jorissen M., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P219; Kennedy D W, 1992, Laryngoscope, V102, P1; Kennedy DW, 2004, ANN OTO RHINOL LARYN, V113, P6, DOI 10.1177/00034894041130S503; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Lan MY, 2007, AM J RHINOL, V21, P218, DOI 10.2500/ajr.2007.21.2966; Lane AP, 2009, CURR ALLERGY ASTHM R, V9, P205, DOI 10.1007/s11882-009-0030-5; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Lee WK, 2007, AM J RHINOL, V21, P658, DOI 10.2500/ajr.2007.21.3094; Lewis SJ, 2003, BIOMARKERS, V8, P218, DOI 10.1080/1354750031000120125; Lieu JEC, 2000, ARCH OTOLARYNGOL, V126, P940, DOI 10.1001/archotol.126.8.940; Ly Nghi, 2002, Adv Data, P1; Mackay J, 2002, TOBACCO ATLAS; McMaster SK, 2008, BRIT J PHARMACOL, V153, P536, DOI 10.1038/sj.bjp.0707595; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Mirza N, 1999, OTOLARYNG CLIN N AM, V32, P243, DOI 10.1016/S0030-6665(05)70128-6; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Palmer J, 2006, ANN OTO RHINOL LARYN, V115, P35; Palmer JN, 2005, OTOLARYNG CLIN N AM, V38, P1193, DOI 10.1016/j.otc.2005.07.004; Perloff JR, 2004, AM J RHINOL, V18, P377, DOI 10.1177/194589240401800607; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Ramadan HH, 2005, OTOLARYNG HEAD NECK, V132, P414, DOI 10.1016/j.otohns.2004.11.011; Ramadan HH, 2002, OTOLARYNG HEAD NECK, V127, P546, DOI 10.1067/mhn.2002.129816; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; Savitski AN, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-120; Smith TL, 2005, LARYNGOSCOPE, V115, P2199, DOI 10.1097/01.mlg.0000182825.82910.80; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Trevino RJ, 1996, OTOLARYNG HEAD NECK, V114, P239, DOI 10.1016/S0194-5998(96)70174-2; Zurak K, 2009, J MED MICROBIOL, V58, P1231, DOI 10.1099/jmm.0.010579-0	59	64	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15700	10.1371/journal.pone.0015700	http://dx.doi.org/10.1371/journal.pone.0015700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253587	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900008
J	Li, MY; Shen, QA; Xu, HY; Wong, FM; Cui, JZ; Li, ZD; Hong, N; Wang, L; Zhao, HB; Ma, B; Hong, YH				Li, Mingyou; Shen, Qian; Xu, Hongyan; Wong, Foong Mei; Cui, Jianzhou; Li, Zhendong; Hong, Ni; Wang, Li; Zhao, Haobin; Ma, Bo; Hong, Yunhan			Differential Conservation and Divergence of Fertility Genes boule and dazl in the Rainbow Trout	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; VASA-LIKE GENE; CAENORHABDITIS-ELEGANS HOMOLOG; GREEN FLUORESCENT PROTEIN; MALE-STERILITY GENE; RNA LOCALIZATION; EXPRESSION; SPERMATOGENESIS; PLASM; GAMETOGENESIS	Background: The genes boule and dazl are members of the DAZ (Deleted in Azoospermia) family encoding RNA binding proteins essential for germ cell development. Although dazl exhibits bisexual expression in mitotic and meiotic germ cells in diverse animals, boule shows unisexual meiotic expression in invertebrates and mammals but a bisexual mitotic and meiotic expression in medaka. How boule and dazl have evolved different expression patterns in diverse organisms has remained unknown. Methodology and Principal Findings: Here we chose the fish rainbow trout (Oncorhynchus mykiss) as a second lower vertebrate model to investigate the expression of boule and dazl. By molecular cloning and sequence comparison, we identified cDNAs encoding the trout Boule and Dazl proteins, which have a conserved RNA-recognition motif and a maximal similarity to their homologs. By RT-PCR analysis, adult RNA expression of trout boule and dazl is restricted to the gonads of both sexes. By chromogenic and two-color fluorescence in situ hybridization, we revealed bisexual and germline-specific expression of boule and dazl. We found that dazl displays conserved expression throughout gametogenesis and concentrates in the Balbinani's body of early oocytes and the chromatoid body of sperm. Surprisingly, boule exhibits mitotic and meiotic expression in the male but meiosis-specific expression in the female. Conclusions: Our data underscores differential conservation and divergence of DAZ family genes during vertebrate evolution. We propose a model in which the diversity of boule expression in sex and stage specificity might have resulted from selective loss or gain of its expression in one sex and mitotic germ cells.	[Li, Mingyou; Shen, Qian; Xu, Hongyan; Wong, Foong Mei; Cui, Jianzhou; Li, Zhendong; Hong, Ni; Wang, Li; Zhao, Haobin; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ma, Bo] Heilongjiang Fisheries Res Inst, Haerbin City, Peoples R China; [Hong, Yunhan] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Jinzhou, Peoples R China	National University of Singapore; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS	Li, MY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009; Hong, Ni/Y-6114-2018; Cui, Jianzhou/AAU-7765-2020	Hong, Ni/0000-0002-9404-3110; Cui, Jianzhou/0000-0003-1666-4082; Li, Mingyou/0000-0002-8729-7964	Biomedical Research Council of Singapore [R-08-1-21-19-585, SBIC-SSCC C-002-2007]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of Singapore (R-08-1-21-19-585 & SBIC-SSCC C-002-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng MH, 1998, DEV BIOL, V204, P567, DOI 10.1006/dbio.1998.9098; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Elis S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-110; Houston DW, 1998, DEVELOPMENT, V125, P171; IWAMATSU T, 1988, ZOOL SCI, V5, P20; Johnson AD, 2001, DEV BIOL, V234, P402, DOI 10.1006/dbio.2001.0264; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; KITO G, J REPROD DEV, V56, P341; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Liu WS, 2007, CYTOGENET GENOME RES, V116, P65, DOI 10.1159/000097419; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Okutsu T, 2007, SCIENCE, V317, P1517, DOI 10.1126/science.1145626; Otori M, 2006, MOL BIOL CELL, V17, P3147, DOI 10.1091/mbc.E05-11-1067; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; TIMMERMANS LPM, 1985, CELL BIOL INT REP, V9, P518, DOI 10.1016/0309-1651(85)90005-0; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Xu HY, 2007, GENE EXPR PATTERNS, V7, P332, DOI 10.1016/j.modgep.2006.08.001; Xu HY, 2010, SCI CHINA LIFE SCI, V53, P435, DOI 10.1007/s11427-010-0058-8; Xu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006097; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323; Yoshizaki G, 2000, MOL REPROD DEV, V55, P364, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;364::AID-MRD2&gt;3.0.CO;2-8	37	42	52	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15910	10.1371/journal.pone.0015910	http://dx.doi.org/10.1371/journal.pone.0015910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253610	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900022
J	Hwang, J; Kim, Y; Kang, HB; Jaroszewski, L; Deacon, AM; Lee, H; Choi, WC; Kim, KJ; Kim, CH; Kang, BS; Lee, JO; Oh, TK; Kim, JW; Wilson, IA; Kim, MH				Hwang, Jungwon; Kim, Yoonjeong; Kang, Ho Bum; Jaroszewski, Lukasz; Deacon, Ashley M.; Lee, Hwiseop; Choi, Won-Chan; Kim, Kyung-Jin; Kim, Cheol-Hee; Kang, Beom Sik; Lee, Jie-Oh; Oh, Tae-Kwang; Kim, Jae Wha; Wilson, Ian A.; Kim, Myung Hee			Crystal Structure of the Human N-Myc Downstream-regulated Gene 2 Protein Provides Insight into Its Role as a Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; BETA-CATENIN; METASTASIS SUPPRESSOR; COLORECTAL-CANCER; PROSTATE-CANCER; DOWN-REGULATION; C-MYC; NDRG2; EXPRESSION; DIFFERENTIATION	Considerable attention has recently been paid to the N-Myc downstream-regulated gene (NDRG) family because of its potential as a tumor suppressor in many human cancers. Primary amino acid sequence information suggests that the NDRG family proteins may belong to the alpha/beta-hydrolase (ABH) superfamily; however, their functional role has not yet been determined. Here, we present the crystal structures of the human and mouse NDRG2 proteins determined at 2.0 and 1.7 angstrom resolution, respectively. Both NDRG2 proteins show remarkable structural similarity to the ABH superfamily, despite limited sequence similarity. Structural analysis suggests that NDRG2 is a nonenzymatic member of the ABH superfamily, because it lacks the catalytic signature residues and has an occluded substrate-binding site. Several conserved structural features suggest NDRG may be involved in molecular interactions. Mutagenesis data based on the structural analysis support a crucial role for helix alpha 6 in the suppression of TCF/beta-catenin signaling in the tumorigenesis of human colorectal cancer, via a molecular interaction.	[Kang, Ho Bum; Kim, Jae Wha] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea; [Hwang, Jungwon; Kim, Yoonjeong; Lee, Hwiseop; Choi, Won-Chan; Oh, Tae-Kwang; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Div Biosyst Res, Taejon 305806, South Korea; [Hwang, Jungwon; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Yoonjeong; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Jaroszewski, Lukasz] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Kim, Kyung-Jin] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Kim, Cheol-Hee] Chungnam Natl Univ, GRAST, Taejon 305764, South Korea; [Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Kim, Myung Hee] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon 305333, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Kyungpook National University; Sanford Burnham Prebys Medical Discovery Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Pohang University of Science & Technology (POSTECH); Chungnam National University; Chungnam National University; Scripps Research Institute	Kim, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea.	wjkim@kribb.re.kr; wilson@scripps.edu; mhk8n@kribb.re.kr	Kim, Cheol-Hee/F-6278-2013; Lee, Jie-Oh/AAG-4302-2020; Lee, Jie-Oh/C-1581-2011	Lee, Jie-Oh/0000-0001-6519-6049; Kim, Cheol-Hee/0000-0002-3019-0699; Kim, Jae Wha/0000-0002-1507-2731	Ministry of Education, Science, and Technology; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A090509]; National Institutes of Health, NIGMS Protein Structure Initiative [U54 GM074898]; National Science Foundation; University of California and Henry Wheeler; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health (NCRR Biomedical Technology Program and NIGMS); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898] Funding Source: NIH RePORTER	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Institutes of Health, NIGMS Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); University of California and Henry Wheeler(University of California System); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health (NCRR Biomedical Technology Program and NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)NIH National Center for Research Resources (NCRR)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the 21C Frontier Microbial Genomics and Applications Center Program (to M. H. K.) funded by the Ministry of Education, Science, and Technology and in part by Korea Healthcare Technology R&D Project Grant A090509 (to J. W. K.) funded by the Ministry for Health, Welfare and Family Affairs, Republic of Korea.; We thank Drs. Kyung-Jin Kim and Ghyung-Hwa Kim at Pohang Accelerator Laboratory for help with human NDRG2 data collection. We also thank all the members of the Joint Center for Structural Genomics for their general contributions to the mouse NDRG2 protein production and structure determination. The Joint Center for Structural Genomics is supported by the National Institutes of Health, NIGMS Protein Structure Initiative Grant U54 GM074898. Beamline 8.3.1 was funded by the National Science Foundation, University of California and Henry Wheeler. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and the National Institutes of Health (NCRR Biomedical Technology Program and NIGMS). Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. Portions of this work were carried out at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Assamaki R, 2007, GENE CHROMOSOME CANC, V46, P564, DOI 10.1002/gcc.20439; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Chakrabarty S, 2003, CANCER RES, V63, P67; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Elmi F, 2005, J BACTERIOL, V187, P8470, DOI 10.1128/JB.187.24.8470-8476.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Furuta H, 2010, BIOCHEM BIOPH RES CO, V391, P1785, DOI 10.1016/j.bbrc.2009.12.156; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Guang RJ, 2000, CANCER RES, V60, P749; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hummerich L, 2006, ONCOGENE, V25, P111, DOI 10.1038/sj.onc.1209016; Kaneko T, 2005, PROTEIN SCI, V14, P558, DOI 10.1110/ps.041170005; Kim MH, 2008, PROTEINS, V70, P578, DOI 10.1002/prot.21680; Kim YJ, 2009, INT J CANCER, V124, P7, DOI 10.1002/ijc.23945; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kwon SY, 2005, PLASMID, V53, P274, DOI 10.1016/j.plasmid.2004.11.006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu JJ, 2006, J CELL PHYSIOL, V207, P287, DOI 10.1002/jcp.20589; Mariadason JM, 2001, CANCER RES, V61, P3465; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schilling SH, 2009, J BIOL CHEM, V284, P25160, DOI 10.1074/jbc.M109.012484; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Shelton DN, 2006, CANCER RES, V66, P7571, DOI 10.1158/0008-5472.CAN-06-1067; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Todd AE, 2002, STRUCTURE, V10, P1435, DOI 10.1016/S0969-2126(02)00861-4; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303	60	57	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14					12450	12460		10.1074/jbc.M110.170803	http://dx.doi.org/10.1074/jbc.M110.170803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21247902	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000289077500059
J	Klein, RR; Bourdon, DM; Costales, CL; Wagner, CD; White, WL; Williams, JD; Hicks, SN; Sondek, J; Thakker, DR				Klein, Ryan R.; Bourdon, David M.; Costales, Chester L.; Wagner, Craig D.; White, Wendy L.; Williams, Jon D.; Hicks, Stephanie N.; Sondek, John; Thakker, Dhiren R.			Direct Activation of Human Phospholipase C by Its Well Known Inhibitor U73122	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PERMEABILITY; PROTEIN-KINASE-C; S-NITROSATION; PANCREATIC LIPASE; CRYSTAL-STRUCTURE; PHOSPHOINOSITIDE HYDROLYSIS; COVALENT MODIFICATION; GASTRIC LIPASE; IN-VIVO; CELLS	Phospholipase C (PLC) enzymes are an important family of regulatory proteins involved in numerous cellular functions, primarily through hydrolysis of the polar head group from inositol- containing membrane phospholipids. U73122 (1-(6-((17 beta-3- methoxyestra-1,3,5(10)-trien-17-yl) amino)hexyl)-1H-pyrrole- 2,5-dione), one of only a few small molecules reported to inhibit the activity of these enzymes, has been broadly applied as a pharmacological tool to implicate PLCs in diverse experimental phenotypes. The purpose of this study was to develop a better understanding of molecular interactions between U73122 and PLCs. Hence, the effects of U73122 on human PLC beta 3 (hPLC beta 3) were evaluated in a cell-free micellar system. Surprisingly, U73122 increased the activity of hPLC beta 3 in a concentration- and time-dependent manner; up to an 8-fold increase in enzyme activity was observed with an EC50 = 13.6 +/- 5 mu M. Activation of hPLC beta 3 by U73122 required covalent modification of cysteines as evidenced by the observation that enzyme activation was attenuated by thiol-containing nucleophiles, L-cysteine and glutathione. Mass spectrometric analysis confirmed covalent reaction with U73122 at eight cysteines, although maximum activation was achieved without complete alkylation; the modified residues were identified by LC/MS/MS peptide sequencing. Interestingly, U73122 (10 mu M) also activated hPLC gamma 1 (> 10-fold) and hPLC beta 2 (similar to 2-fold); PLC delta 1 was neither activated nor inhibited. Therefore, in contrast to its reported inhibitory potential, U73122 failed to inhibit several purified PLCs. Most of these PLCs were directly activated by U73122, and a simple mechanism for the activation is proposed. These results strongly suggest a need to re-evaluate the use of U73122 as a general inhibitor of PLC isozymes.	[Klein, Ryan R.; Costales, Chester L.; Thakker, Dhiren R.] Univ N Carolina, UNC Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27599 USA; [Bourdon, David M.; Hicks, Stephanie N.; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Klein, Ryan R.] GlaxoSmithKline Inc, Drug Metab & Pharmacokinet, Metab Pathways Ctr Excellence Drug Discovery, Res Triangle Pk, NC 27709 USA; [Wagner, Craig D.; White, Wendy L.; Williams, Jon D.] GlaxoSmithKline Inc, Mol Discovery Res, Computat & Struct Chem, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline; GlaxoSmithKline	Thakker, DR (corresponding author), Univ N Carolina, UNC Eshelman Sch Pharm, Div Mol Pharmaceut, CB 7355,Beard Hall, Chapel Hill, NC 27599 USA.	dhiren_thakker@unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [R01-GM057391]; GlaxoSmithKline for dissertation research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062299, R01GM057391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline for dissertation research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM057391 (to J. S.).; Supported by GlaxoSmithKline for dissertation research.	Aloulou A, 2006, BBA-MOL CELL BIOL L, V1761, P995, DOI 10.1016/j.bbalip.2006.06.009; BALDA MS, 1991, J MEMBRANE BIOL, V122, P193, DOI 10.1007/BF01871420; Berg OG, 1998, BIOCHEMISTRY-US, V37, P6615, DOI 10.1021/bi972998p; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Burgdorf C, 2010, J CARDIOVASC PHARM, V55, P555, DOI 10.1097/FJC.0b013e3181d8bec5; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carvou N, 2007, CELL SIGNAL, V19, P42, DOI 10.1016/j.cellsig.2006.05.023; CEREIJIDO M, 1993, J CELL SCI, P127; Chen YJ, 2006, J BIOMED SCI, V13, P667, DOI 10.1007/s11373-006-9100-z; EGLOFF MP, 1995, PROTEIN SCI, V4, P44; Enyeart JJ, 2005, J BIOL CHEM, V280, P30814, DOI 10.1074/jbc.M504283200; Feisst C, 2005, MOL PHARMACOL, V67, P1751, DOI 10.1124/mol.105.011007; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Gloyna W, 2005, REGUL PEPTIDES, V125, P179, DOI 10.1016/j.regpep.2004.08.023; GOLDSMITH EJ, 1989, SCIENCE, V245, P528, DOI 10.1126/science.2756432; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Han S, 2005, J BIOL CHEM, V280, P38228, DOI 10.1074/jbc.M508130200; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Handy DE, 2006, ARTERIOSCL THROM VAS, V26, P1207, DOI 10.1161/01.ATV.0000217632.98717.a0; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong JH, 2006, J BIOL CHEM, V281, P13057, DOI 10.1074/jbc.M601726200; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hou CF, 2004, J PHARMACOL EXP THER, V309, P697, DOI 10.1124/jpet.103.060574; Hughes SACF, 2000, N-S ARCH PHARMACOL, V362, P555; JAMES SR, 1995, J BIOL CHEM, V270, P11872, DOI 10.1074/jbc.270.20.11872; James SR, 1996, BIOCHEM J, V314, P917, DOI 10.1042/bj3140917; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Klose A, 2008, MOL PHARMACOL, V74, P1203, DOI 10.1124/mol.108.047837; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Miersch S, 2005, CLIN BIOCHEM, V38, P777, DOI 10.1016/j.clinbiochem.2005.05.014; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; Ohki SY, 2003, J MOL BIOL, V326, P1539, DOI 10.1016/S0022-2836(03)00048-2; Ohki SY, 2001, J MOL BIOL, V314, P839, DOI 10.1006/jmbi.2001.5200; Pulcinelli FM, 1998, BIOCHEM PHARMACOL, V56, P1481, DOI 10.1016/S0006-2952(98)00146-4; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Tannenbaum SR, 2005, NAT CHEM BIOL, V1, P126, DOI 10.1038/nchembio0805-126; Thomas A, 2005, J BIOL CHEM, V280, P40074, DOI 10.1074/jbc.M502123200; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Wagner CD, 2007, J MASS SPECTROM, V42, P139, DOI 10.1002/jms.1174; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Ward PD, 2003, J PHARMACOL EXP THER, V304, P689, DOI 10.1124/jpet.102.043638; Ward PD, 2002, J BIOL CHEM, V277, P35760, DOI 10.1074/jbc.M203134200; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yang YQ, 2000, J LIPID RES, V41, P48; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504	66	41	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191783	http://dx.doi.org/10.1074/jbc.M110.191783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21266572	Green Published, hybrid			2022-12-25	WOS:000289077500055
J	Yamamoto, K; Taketomi, Y; Isogai, Y; Miki, Y; Sato, H; Masuda, S; Nishito, Y; Morioka, K; Ishimoto, Y; Suzuki, N; Yokota, Y; Hanasaki, K; Ishikawa, Y; Ishii, T; Kobayashi, T; Fukami, K; Ikeda, K; Nakanishi, H; Taguchi, R; Murakamia, M				Yamamoto, Kei; Taketomi, Yoshitaka; Isogai, Yuki; Miki, Yoshimi; Sato, Hiroyasu; Masuda, Seiko; Nishito, Yasumasa; Morioka, Kiyokazu; Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji; Ishikawa, Yukio; Ishii, Toshiharu; Kobayashi, Tetsuyuki; Fukami, Kiyoko; Ikeda, Kazutaka; Nakanishi, Hiroki; Taguchi, Ryo; Murakamia, Makoto			Hair Follicular Expression and Function of Group X Secreted Phospholipase A(2) in Mouse Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-DEPENDENT REGULATION; PROSTAGLANDIN E-2 PRODUCTION; CYCLOOXYGENASE-2 OVEREXPRESSION; HUMAN KERATINOCYTES; ARACHIDONIC-ACID; STRATUM-CORNEUM; DEFICIENT MICE; EPIDERMAL DIFFERENTIATION; REGRESSION CATAGEN; MASS-SPECTROMETRY	Although perturbed lipid metabolism can often lead to skin abnormality, the role of phospholipase A(2) (PLA(2)) in skin homeostasis is poorly understood. In the present study we found that group X-secreted PLA(2) (sPLA(2)-X) was expressed in the outermost epithelium of hair follicles in synchrony with the anagen phase of hair cycling. Transgenic mice overexpressing sPLA(2)-X (PLA2G10-Tg) displayed alopecia, which was accompanied by hair follicle distortion with reduced expression of genes related to hair development, during a postnatal hair cycle. Additionally, the epidermis and sebaceous glands of PLA2G10-Tg skin were hyperplasic. Proteolytic activation of sPLA(2)-X in PLA2G10-Tg skin was accompanied by preferential hydrolysis of phosphatidylethanolamine species with polyunsaturated fatty acids as well as elevated production of some if not all eicosanoids. Importantly, the skin of Pla2g10-deficient mice had abnormal hair follicles with noticeable reduction in a subset of hair genes, a hypoplasic outer root sheath, a reduced number of melanin granules, and unexpected up-regulation of prostanoid synthesis. Collectively, our study highlights the spatiotemporal expression of sPLA(2)-X in hair follicles, the presence of skin-specific machinery leading to sPLA(2)-X activation, a functional link of sPLA(2)-X with hair follicle homeostasis, and compartmentalization of the prostanoid pathway in hair follicles and epidermis.	[Yamamoto, Kei; Taketomi, Yoshitaka; Isogai, Yuki; Miki, Yoshimi; Sato, Hiroyasu; Masuda, Seiko; Murakamia, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Setagaya Ku, Tokyo 1568506, Japan; [Morioka, Kiyokazu] Tokyo Metropolitan Inst Med Sci, Electron Microscope Lab, Setagaya Ku, Tokyo 1568506, Japan; [Taketomi, Yoshitaka; Miki, Yoshimi; Sato, Hiroyasu; Masuda, Seiko] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Isogai, Yuki; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji] Shionogi & Co Ltd, Shionogi Res Labs, Osaka 5610825, Japan; [Ishikawa, Yukio; Ishii, Toshiharu] Toho Univ, Sch Med, Dept Pathol, Ohta Ku, Tokyo 1438540, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Hachioji, Tokyo 1920392, Japan; [Ikeda, Kazutaka; Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Nakanishi, Hiroki; Taguchi, Ryo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Murakamia, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Showa University; Ochanomizu University; Shionogi & Company Limited; Tokyo University of Pharmacy & Life Sciences; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakamia, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859; Nakanishi, Hiroki/0000-0002-5108-1598	Ministry of Education, Science, Culture, Sports, and Technology of Japan; Japan Science and Technology Agency; Cosmetology Research; Nakatomi; Uehara Toray Foundation; Mitsubishi Science Foundation; Grants-in-Aid for Scientific Research [22116005] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Cosmetology Research; Nakatomi; Uehara Toray Foundation; Mitsubishi Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid for Scientific Research (to M. M.) and for Young Investigators (to K. Y., Y. T., and H. S.) from the Ministry of Education, Science, Culture, Sports, and Technology of Japan, SHISEIDO Grants for Scientific Research (to K. Y.), PRESTO (to M. M.), and CREST (to R. T.) from the Japan Science and Technology Agency, and the Cosmetology Research, Nakatomi, Uehara Toray and Mitsubishi Science Foundations (to M. M.).	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bol DK, 2002, CANCER RES, V62, P2516; Botchkarev VA, 1998, AM J PATHOL, V153, P785, DOI 10.1016/S0002-9440(10)65621-0; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cho YM, 2003, J INVEST DERMATOL, V120, P715, DOI 10.1046/j.1523-1747.2003.12147.x; Colombe L, 2007, EXP DERMATOL, V16, P762, DOI 10.1111/j.1600-0625.2007.00586.x; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Eckl KM, 2005, HUM MUTAT, V26, P351, DOI 10.1002/humu.20236; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fluhr JW, 2004, J INVEST DERMATOL, V122, P320, DOI 10.1046/j.0022-202X.2003.00204.x; Fluhr JW, 2001, J INVEST DERMATOL, V117, P44, DOI 10.1046/j.0022-202x.2001.01399.x; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Glotzer DJ, 2008, DEV BIOL, V315, P459, DOI 10.1016/j.ydbio.2008.01.005; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Gurrieri S, 2003, J INVEST DERMATOL, V121, P156, DOI 10.1046/j.1523-1747.2003.12315.x; Haas U, 2005, J INVEST DERMATOL, V124, P204, DOI 10.1111/j.0022-202X.2004.23513.x; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kang HY, 2004, BRIT J DERMATOL, V150, P462, DOI 10.1111/j.1365-2133.2004.05844.x; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kishibe M, 2007, J BIOL CHEM, V282, P5834, DOI 10.1074/jbc.M607998200; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lee JS, 2007, EXP DERMATOL, V16, P118, DOI 10.1111/j.1600-0625.2006.00521.x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li N, 2010, P NATL ACAD SCI USA, V107, P3734, DOI 10.1073/pnas.0911377107; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MaoQiang M, 1996, J INVEST DERMATOL, V106, P57, DOI 10.1111/1523-1747.ep12327246; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Muller-Decker K, 2003, J INVEST DERMATOL, V121, P661, DOI 10.1046/j.1523-1747.2003.12473.x; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Ninomiya Y, 2007, J STEROID BIOCHEM, V103, P44, DOI 10.1016/j.jsbmb.2006.07.009; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pena JC, 1999, EMBO J, V18, P3596, DOI 10.1093/emboj/18.13.3596; Rys-Sikora KE, 2003, J INVEST DERMATOL, V120, P86, DOI 10.1046/j.1523-1747.2003.12001.x; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Scott GA, 2006, J INVEST DERMATOL, V126, P855, DOI 10.1038/sj.jid.5700180; Shridas P, 2010, ARTERIOSCL THROM VAS, V30, P2014, DOI 10.1161/ATVBAHA.110.210237; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Sung YM, 2006, ONCOGENE, V25, P5507, DOI 10.1038/sj.onc.1209538; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Torii E, 2002, BIOCHEM BIOPH RES CO, V290, P696, DOI 10.1006/bbrc.2001.6256; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Yu ZY, 2005, BBA-MOL CELL BIOL L, V1686, P238, DOI 10.1016/j.bbalip.2004.10.007; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079; Zack M, 2011, ATHEROSCLEROSIS, V214, P58, DOI 10.1016/j.atherosclerosis.2010.08.054; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446	81	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11616	11631		10.1074/jbc.M110.206714	http://dx.doi.org/10.1074/jbc.M110.206714			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21266583	hybrid, Green Published			2022-12-25	WOS:000288797100071
J	Lin, MT; Shubin, AA; Samoilova, RI; Narasimhulu, KV; Baldansuren, A; Gennis, RB; Dikanov, SA				Lin, Myat T.; Shubin, Alexander A.; Samoilova, Rimma I.; Narasimhulu, Kuppala V.; Baldansuren, Amgalanbaatar; Gennis, Robert B.; Dikanov, Sergei A.			Exploring by Pulsed EPR the Electronic Structure of Ubisemiquinone Bound at the Q(H) Site of Cytochrome bo(3) from Escherichia coli with in Vivo C-13-Labeled Methyl and Methoxy Substituents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13-ENRICHED UBIQUINONE RADICALS; QUINONE-BINDING-SITES; CHROMOSOMAL GENES; REACTION CENTERS; FUNCTIONAL-ROLE; SPIN-RESONANCE; ESEEM SPECTRA; VITAMIN-K; SEMIQUINONE; OXIDASE	The cytochrome bo(3) ubiquinol oxidase from Escherichia coli resides in the bacterial cytoplasmic membrane and catalyzes the two-electron oxidation of ubiquinol-8 and four-electron reduction of O-2 to water. The one-electron reduced semiquinone forms transiently during the reaction, and the enzyme has been demonstrated to stabilize the semiquinone. The semiquinone is also formed in the D75E mutant, where the mutation has little influence on the catalytic activity, and in the D75H mutant, which is virtually inactive. In this work, wild-type cytochrome bo3 as well as the D75E and D75H mutant proteins were prepared with ubiquinone-8 C-13-labeled selectively at the methyl and two methoxy groups. This was accomplished by expressing the proteins in a methionine auxotroph in the presence of L-methionine with the side chain methyl group C-13-labeled. The C-13-labeled quinone isolated from cytochrome bo(3) was also used for the generation of model anion radicals in alcohol. Two-dimensional pulsed EPR and ENDOR were used for the study of the C-13 methyl and methoxy hyperfine couplings in the semiquinone generated in the three proteins indicated above and in the model system. The data were used to characterize the transferred unpaired spin densities on the methyl and methoxy substituents and the conformations of the methoxy groups. In the wild type and D75E mutant, the constraints on the configurations of the methoxy side chains are similar, but the D75H mutant appears to have altered methoxy configurations, which could be related to the perturbed electron distribution in the semiquinone and the loss of enzymatic activity.	[Lin, Myat T.; Baldansuren, Amgalanbaatar; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Narasimhulu, Kuppala V.; Dikanov, Sergei A.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Shubin, Alexander A.] Russian Acad Sci, Boreskov Inst Catalysis, Novosibirsk 630090, Russia; [Samoilova, Rimma I.] Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Boreskov Institute of Catalysis, Siberian Branch, Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Voevodsky Institute of Chemical Kinetics & Combustion SB RAS	Gennis, RB (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	r-gennis@illinois.edu; dikanov@illinois.edu	Baldansuren, Amgalanbaatar/B-5555-2015; Shubin, Aleksandr A/E-9275-2012; Samoilova, Rimma Ivanovna/T-7956-2017	Baldansuren, Amgalanbaatar/0000-0001-8767-3731; Shubin, Aleksandr A/0000-0001-7920-3350; Samoilova, Rimma Ivanovna/0000-0002-1649-1487	National Institutes of Health [GM062954]; National Institutes of Health, NCRR [S10-RR15878]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy [DE-FG02-08ER15960, DE-FG02-87ER13716]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062954 (to S. A. D.) and National Institutes of Health, NCRR, Grant S10-RR15878 for instrumentation. This work was also supported by Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy Grants DE-FG02-08ER15960 (to S. A. D.) and DE-FG02-87ER13716 (to R. B. G.).	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Asher JR, 2008, THEOR CHEM ACC, V119, P477, DOI 10.1007/s00214-007-0408-1; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Boesch SE, 2009, CHEMPHYSCHEM, V10, P3187, DOI 10.1002/cphc.200900503; Burie JR, 1997, J PHYS CHEM B, V101, P6607, DOI 10.1021/jp970640x; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; DAS MR, 1970, J AM CHEM SOC, V92, P2258, DOI 10.1021/ja00711a011; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; DIKANOV SA, 1995, J MAGN RESON SER A, V116, P125, DOI 10.1006/jmra.1995.1199; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Frisch M. J., 2001, GAUSSIAN 98 REVISION; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Gunner MR, 2008, J BIOENERG BIOMEMBR, V40, P509, DOI 10.1007/s10863-008-9179-1; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P10675, DOI 10.1021/bi012146w; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; JACKMAN LM, 1967, BIOCHIM BIOPHYS ACTA, V141, P1, DOI 10.1016/0304-4165(67)90239-5; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; KIRSTE B, 1987, MAGN RESON CHEM, V25, P166, DOI 10.1002/mrc.1260250216; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P15620, DOI 10.1021/bi0014094; Krivankova L, 1980, Methods Enzymol, V67, P111; Lin MT, 2008, J AM CHEM SOC, V130, P15768, DOI 10.1021/ja805906a; Lubitz W, 1999, APPL MAGN RESON, V17, P1, DOI 10.1007/BF03162067; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; MacMillan F, 2011, FARADAY DISCUSS, V148, P315, DOI 10.1039/c005149g; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; MORTON JR, 1978, J MAGN RESON, V30, P577, DOI 10.1016/0022-2364(78)90284-6; O'Malley PJ, 1998, J PHYS CHEM A, V102, P248, DOI 10.1021/jp972467a; Ohnishi T, 2008, BIOFACTORS, V32, P13, DOI 10.1002/biof.5520320103; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; PRINCE RC, 1983, FEBS LETT, V160, P273, DOI 10.1016/0014-5793(83)80981-8; Puustinen A, 1996, P NATL ACAD SCI USA, V93, P1545, DOI 10.1073/pnas.93.4.1545; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; ROBINSON HH, 1990, J AM CHEM SOC, V112, P4728, DOI 10.1021/ja00168a017; SAMOILOVA RI, 1995, J CHEM SOC PERK T 2, P2063, DOI 10.1039/p29950002063; SAMOILOVA RI, 1994, J CHEM SOC PERK T 2, P609, DOI 10.1039/p29940000609; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; SATOWATANABE M, 1995, FEBS LETT, V374, P265, DOI 10.1016/0014-5793(95)01125-X; Schweiger A., 2001, PRINCIPLES PULSE ELE, P359; Srinivasan N, 2009, BBA-BIOENERGETICS, V1787, P1057, DOI 10.1016/j.bbabio.2009.04.010; Stoll S, 2005, J MAGN RESON, V177, P93, DOI 10.1016/j.jmr.2005.07.012; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; vanLenthe E, 1996, J CHEM PHYS, V105, P6505, DOI 10.1063/1.472460; VANLENTHE E, 1993, J CHEM PHYS, V99, P4597, DOI 10.1063/1.466059; VANLENTHE E, 1994, J CHEM PHYS, V101, P9783, DOI 10.1063/1.467943; VANLIEMT WBS, 1994, RECL TRAV CHIM PAY B, V113, P153; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wraight CA, 2008, BBA-BIOENERGETICS, V1777, P631, DOI 10.1016/j.bbabio.2008.04.025; Yap LL, 2007, J BIOL CHEM, V282, P8777, DOI 10.1074/jbc.M611595200; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200; Yap LL, 2010, BBA-BIOENERGETICS, V1797, P1924, DOI 10.1016/j.bbabio.2010.04.011; YOUNG IG, 1971, J BACTERIOL, V105, P769, DOI 10.1128/JB.105.3.769-778.1971	56	19	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10105	10114		10.1074/jbc.M110.206821	http://dx.doi.org/10.1074/jbc.M110.206821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247900	hybrid, Green Published			2022-12-25	WOS:000288547000025
J	Song, JM; Wang, BZ; Park, KM; Van Rooijen, N; Quan, FS; Kim, MC; Jin, HT; Pekosz, A; Compans, RW; Kang, SM				Song, Jae-Min; Wang, Bao-Zhong; Park, Kyoung-Mi; Van Rooijen, Nico; Quan, Fu-Shi; Kim, Min-Chul; Jin, Hyun-Tak; Pekosz, Andrew; Compans, Richard W.; Kang, Sang-Moo			Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; A VIRUS; EXTRACELLULAR DOMAIN; CONJUGATE VACCINES; RESPONSES; ANTIBODY; IMMUNOGENICITY; ECTODOMAIN; MICE; MACROPHAGES	Background: Current influenza vaccines based on the hemagglutinin protein are strain specific and do not provide good protection against drifted viruses or emergence of new pandemic strains. An influenza vaccine that can confer cross-protection against antigenically different influenza A strains is highly desirable for improving public health. Methodology/Principal Findings: To develop a cross protective vaccine, we generated influenza virus-like particles containing the highly conserved M2 protein in a membrane-anchored form (M2 VLPs), and investigated their immunogenicity and breadth of cross protection. Immunization of mice with M2 VLPs induced anti-M2 antibodies binding to virions of various strains, M2 specific T cell responses, and conferred long-lasting cross protection against heterologous and heterosubtypic influenza viruses. M2 immune sera were found to play an important role in providing cross protection against heterosubtypic virus and an antigenically distinct 2009 pandemic H1N1 virus, and depletion of dendritic and macrophage cells abolished this cross protection, providing new insight into cross-protective immune mechanisms. Conclusions/Significance: These results suggest that presenting M2 on VLPs in a membrane-anchored form is a promising approach for developing broadly cross protective influenza vaccines.	[Song, Jae-Min; Wang, Bao-Zhong; Park, Kyoung-Mi; Quan, Fu-Shi; Kim, Min-Chul; Jin, Hyun-Tak; Compans, Richard W.; Kang, Sang-Moo] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Song, Jae-Min; Wang, Bao-Zhong; Park, Kyoung-Mi; Quan, Fu-Shi; Kim, Min-Chul; Jin, Hyun-Tak; Compans, Richard W.; Kang, Sang-Moo] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Van Rooijen, Nico] Vrije Univ Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Pekosz, Andrew] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Emory University; Emory University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University	Song, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu; skang2@emory.edu	Quan, Fu-Shi/V-1826-2019; Van Rooijen, Nico/Z-1578-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X; Park, Kyoung-Mi/0000-0001-7548-8432; Wang, Bao-Zhong/0000-0002-1561-4318; Pekosz, Andrew/0000-0003-3248-1761	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [AI0680003]; Georgia Research Alliance; Korea Research Foundation [KRF-2007-357-C00088]	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance; Korea Research Foundation(National Research Foundation of Korea)	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant AI0680003 (R.W.C.) and partially by funds from the Georgia Research Alliance (S.M.K.) and the Korea Research Foundation Grant KRF-2007-357-C00088 (J.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Grantham ML, 2010, J VIROL, V84, P8765, DOI 10.1128/JVI.00853-10; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HEUSSER CH, 1977, J EXP MED, V145, P1316, DOI 10.1084/jem.145.5.1316; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Misplon JA, 2010, VACCINE, V28, P5817, DOI 10.1016/j.vaccine.2010.06.069; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009161; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Skountzou I, 2007, J VIROL, V81, P1083, DOI 10.1128/JVI.01692-06; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; THEPEN T, 1991, EUR J IMMUNOL, V21, P2845, DOI 10.1002/eji.1830211128; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yao QZ, 2004, J IMMUNOL, V173, P1951, DOI 10.4049/jimmunol.173.3.1951; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	53	89	97	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14538	10.1371/journal.pone.0014538	http://dx.doi.org/10.1371/journal.pone.0014538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267073	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500011
J	Yu, H; Li, Q				Yu, Hong; Li, Qi			Mutation and Selection on the Wobble Nucleotide in tRNA Anticodons in Marine Bivalve Mitochondrial Genomes	PLOS ONE			English	Article							GENETIC-CODE; EVOLUTION; POSITION; CODONS; 7-METHYLGUANOSINE; METAZOA; BIAS; DNA	Background: Animal mitochondrial genomes typically encode one tRNA for each synonymous codon family, so that each tRNA anticodon essentially has to wobble to recognize two or four synonymous codons. Several factors have been hypothesized to determine the nucleotide at the wobble site of a tRNA anticodon in mitochondrial genomes, such as the codon-anticodon adaptation hypothesis, the wobble versatility hypothesis, the translation initiation and elongation conflict hypothesis, and the wobble cost hypothesis. Principal Findings: In this study, we analyzed codon usage and tRNA anticodon wobble sites of 29 marine bivalve mitochondrial genomes to evaluate features of the wobble nucleotides in tRNA anticodons. The strand-specific mutation bias favors G and T on the H strand in all the 29 marine bivalve mitochondrial genomes. A bias favoring G and T is also visible in the third codon positions of protein-coding genes and the wobble sites of anticodons, rejecting that codon usage bias drives the wobble sites of tRNA anticodons or tRNA anticodon bias drives the evolution of codon usage. Almost all codon families (98.9%) from marine bivalve mitogenomes support the wobble versatility hypothesis. There are a few interesting exceptions involving tRNA(Trp) with an anticodon CCA fixed in Pectinoida species, tRNA(Ser) with a GCU anticodon fixed in Mytiloida mitogenomes, and the uniform anticodon CAU of tRNA(Met) translating the AUR codon family. Conclusions/Significance: These results demonstrate that most of the nucleotides at the wobble sites of tRNA anticodons in marine bivalve mitogenomes are determined by wobble versatility. Other factors such as the translation initiation and elongation conflict, and the cost of wobble translation may contribute to the determination of the wobble nucleotide in tRNA anticodons. The finding presented here provides valuable insights into the previous hypotheses of the wobble nucleotide in tRNA anticodons by adding some new evidence.	[Yu, Hong; Li, Qi] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China	Ocean University of China	Yu, H (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	qili66@ouc.edu.cn			973 Program [2010CB126406]; National Marine Public Welfare Research Program [200905020]	973 Program(National Basic Research Program of China); National Marine Public Welfare Research Program	This study was supported by research grants from 973 Program (2010CB126406), and National Marine Public Welfare Research Program (200905020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; BONITZ SG, 1980, P NATL ACAD SCI-BIOL, V77, P3167, DOI 10.1073/pnas.77.6.3167; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BULMER M, 1991, GENETICS, V129, P897; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Kondow A, 1999, NUCLEIC ACIDS RES, V27, P2554, DOI 10.1093/nar/27.12.2554; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; Min XJ, 2007, DNA RES, V14, P201, DOI 10.1093/dnares/dsm019; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Scouras A, 2006, MOL PHYLOGENET EVOL, V39, P323, DOI 10.1016/j.ympev.2005.11.004; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; TOMITA K, 1999, CODON READING PATTER; Tomita Kozo, 1997, Nucleic Acids Symposium Series, V37, P197; Tong KL, 2004, GENE, V333, P169, DOI 10.1016/j.gene.2004.02.028; Wang XZ, 2007, GENE, V399, P11, DOI 10.1016/j.gene.2007.04.019; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2007, PLOS ONE, V2, pNIL82; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Yokobori S, 2001, J MOL EVOL, V53, P314, DOI 10.1007/s002390010221; Yokoyama Shigeyuki, 1995, P207	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16147	10.1371/journal.pone.0016147	http://dx.doi.org/10.1371/journal.pone.0016147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267462	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500042
J	Lu, Y; Bedard, N; Chevalier, S; Wing, SS				Lu, Yu; Bedard, Nathalie; Chevalier, Simone; Wing, Simon S.			Identification of Distinctive Patterns of USP19-Mediated Growth Regulation in Normal and Malignant Cells	PLOS ONE			English	Article							CDK INHIBITOR P27; UBIQUITIN LIGASE; DEUBIQUITINATING ENZYMES; PROSTATE-CANCER; MICE LACKING; G(1) PHASE; P27(KIP1); DEGRADATION; HYPERPLASIA; PROTEOLYSIS	We previously reported that the USP19 deubiquitinating enzyme positively regulates proliferation in fibroblasts by stabilizing KPC1, a ubiquitin ligase for p27(Kip1). To explore whether this role of USP19 extends to other cellular systems, we tested the effects of silencing of USP19 in several human prostate and breast models, including carcinoma cell lines. Depletion of USP19 inhibited proliferation in prostate cancer DU145, PC-3 and 22RV1 cells, which was similar to the pattern established in fibroblasts in that it was due to decreased progression from G1 to S phase and associated with a stabilization of the cyclin-dependent kinase inhibitor p27(Kip1). However, in contrast to previous findings in fibroblasts, the stabilization of p27(Kip1) upon USP19 depletion was not associated with changes in the levels of the KPC1 ligase. USP19 could also regulate the growth of immortalized MCF10A breast epithelial cells through a similar mechanism. This regulatory pattern was lost, though, in breast cancer MCF7 and MDA-MB-231 cells and in prostate carcinoma LNCaP cells. Of interest, the transformation of fibroblasts through overexpression of an oncogenic form of Ras disrupted the USP19-mediated regulation of cell growth and of levels of p27(Kip1) and KPC1. Thus, the cell context appears determinant for the ability of USP19 to regulate cell proliferation and p27(Kip1) levels. This may occur through both KPC1 dependent and independent mechanisms. Moreover, a complete loss of USP19 function on cell growth may arise as a result of oncogenic transformation of cells.	[Lu, Yu; Bedard, Nathalie; Wing, Simon S.] McGill Univ, Ctr Hlth, Res Inst, Polypeptide Lab,Dept Med, Montreal, PQ, Canada; [Chevalier, Simone] McGill Univ, Ctr Hlth, Res Inst, Div Urol,Dept Surg, Montreal, PQ, Canada	McGill University; McGill University	Lu, Y (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Polypeptide Lab,Dept Med, Montreal, PQ, Canada.	simon.wing@mcgill.ca	Wing, Simon/D-2589-2012	Wing, Simon/0000-0001-8394-7563	National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Fonds de la recherche en sante du Quebec	National Cancer Institute of Canada/Canadian Cancer Society Research Institute; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the National Cancer Institute of Canada/Canadian Cancer Society Research Institute to SSW. SSW was the recipient of a Chercheur National salary award from the Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GUAN X, 2009, J CELL MOL MED; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MCFARLANE C, 2001, CANCER RES, V70, P3329; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimada M, 2009, CANCER SCI, V100, P866, DOI 10.1111/j.1349-7006.2009.01122.x; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5	26	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15936	10.1371/journal.pone.0015936	http://dx.doi.org/10.1371/journal.pone.0015936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264218	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600013
J	Fisher, DO; Blomberg, SP				Fisher, Diana O.; Blomberg, Simon P.			Costs of Reproduction and Terminal Investment by Females in a Semelparous Marsupial	PLOS ONE			English	Article							ANTECHINUS-STUARTII MARSUPIALIA; NATURAL-SELECTION; SENESCENCE; ALLOCATION; SUCCESS; FITNESS; POPULATIONS; SURVIVAL	Evolutionary explanations for life history diversity are based on the idea of costs of reproduction, particularly on the concept of a trade-off between age-specific reproduction and parental survival, and between expenditure on current and future offspring. Such trade-offs are often difficult to detect in population studies of wild mammals. Terminal investment theory predicts that reproductive effort by older parents should increase, because individual offspring become more valuable to parents as the conflict between current versus potential future offspring declines with age. In order to demonstrate this phenomenon in females, there must be an increase in maternal expenditure on offspring with age, imposing a fitness cost on the mother. Clear evidence of both the expenditure and fitness cost components has rarely been found. In this study, we quantify costs of reproduction throughout the lifespan of female antechinuses. Antechinuses are nocturnal, insectivorous, forest-dwelling small (20-40 g) marsupials, which nest in tree hollows. They have a single synchronized mating season of around three weeks, which occurs on predictable dates each year in a population. Females produce only one litter per year. Unlike almost all other mammals, all males, and in the smaller species, most females are semelparous. We show that increased allocation to current reproduction reduces maternal survival, and that offspring growth and survival in the first breeding season is traded-off with performance of the second litter in iteroparous females. In iteroparous females, increased allocation to second litters is associated with severe weight loss in late lactation and post-lactation death of mothers, but increased offspring growth in late lactation and survival to weaning. These findings are consistent with terminal investment. Iteroparity did not increase lifetime reproductive success, indicating that terminal investment in the first breeding season at the expense of maternal survival (i.e. semelparity) is likely to be advantageous for females.	[Fisher, Diana O.; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Fisher, Diana O.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of Queensland; Australian National University	Fisher, DO (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	d.fisher@uq.edu.au	Blomberg, Simone P/B-7613-2008; Fisher, Diana O/C-1324-2010	Blomberg, Simone P/0000-0003-1062-0839; Fisher, Diana O/0000-0002-4017-3710	Australian Research Council	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council (an Australian Postdoctoral Fellowship and an ARF fellowship to DOF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Bates D., 2010, IME4 LINEAR MIXED EF; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; BRAITHWAITE RW, 1979, AM NAT, V113, P151, DOI 10.1086/283372; Broussard DR, 2003, J ANIM ECOL, V72, P212, DOI 10.1046/j.1365-2656.2003.00691.x; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; CHARNOV EL, 1973, AM NAT, V107, P791, DOI 10.1086/282877; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; COCKBURN A, 1994, BEHAV ECOL SOCIOBIOL, V35, P53, DOI 10.1007/BF00167060; COCKBURN A, 1992, AUST J ZOOL, V40, P195, DOI 10.1071/ZO9920195; DICKMAN CR, 1989, AUST J ECOL, V14, P387, DOI 10.1111/j.1442-9993.1989.tb01449.x; Fisher DO, 2009, AUSTRAL ECOL, V34, P858, DOI 10.1111/j.1442-9993.2009.01991.x; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Fisher DO, 2011, BEHAV ECOL SOCIOBIOL, V65, P593, DOI 10.1007/s00265-010-1060-7; Fisher DO, 2005, AUST J ZOOL, V53, P103, DOI 10.1071/ZO04068; Fisher DO, 2001, ECOLOGY, V82, P3531, DOI 10.1890/0012-9658(2001)082[3531:TEBOLH]2.0.CO;2; Gendreau Y, 2005, BEHAV ECOL SOCIOBIOL, V58, P237, DOI 10.1007/s00265-005-0938-2; GREEN B, 1991, AUST J ZOOL, V39, P539, DOI 10.1071/ZO9910539; Hamel S, 2010, ECOL LETT, V13, P915, DOI 10.1111/j.1461-0248.2010.01478.x; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Holleley CE, 2006, MOL ECOL, V15, P3439, DOI 10.1111/j.1365-294X.2006.03001.x; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Le Galliard JF, 2004, NATURE, V432, P502, DOI 10.1038/nature03057; McAdam AG, 2003, J EVOLUTION BIOL, V16, P1249, DOI 10.1046/j.1420-9101.2003.00630.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Parrott ML, 2007, WILDLIFE RES, V34, P437, DOI 10.1071/WR07071; Pianka, 1988, EVOL ECOL; Pinheiro J, 2001, MIXED EFFECTS MODELS; PROMISLOW DEL, 1991, ACTA OECOL, V12, P119; R Development Core Team, 2009, R FDN STAT COMP; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Seamons TR, 2010, BEHAV ECOL SOCIOBIOL, V64, P505, DOI 10.1007/s00265-009-0866-7; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Statham H.L., 1982, P165; Stearns S.C., 1992, pi; Tavecchia G, 2005, J ANIM ECOL, V74, P201, DOI 10.1111/j.1365-2656.2005.00916.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; Westman W, 2002, J MAMMAL, V83, P81, DOI 10.1644/1545-1542(2002)083<0081:DTOTDM>2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; [No title captured]	46	36	36	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15226	10.1371/journal.pone.0015226	http://dx.doi.org/10.1371/journal.pone.0015226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249185	Green Published, gold			2022-12-25	WOS:000286515000003
J	Sugawara, M; Ohye, H; Tomoda, C; Kogai, T; Kamata, Y; Pezeshkpour, GH; Moatamed, F				Sugawara, Masahiro; Ohye, Hidemi; Tomoda, Chisato; Kogai, Takahiko; Kamata, Yoshimasa; Pezeshkpour, Gholam H.; Moatamed, Farhad			A Novel Role for Niemann-Pick Disease Type 2C Protein in Papillae Formation	PLOS ONE			English	Article							APOPTOSIS; NPC2	Background: Despite the presence of papillary structures and papillary tumors in humans, the mechanism of papillae formation is unknown. We describe herein a novel role for Niemann-Pick disease type 2C (NPC2) protein, a cholesterol binding protein in the lysosome, in papillae formation. Methodology/Principal Finding: We examined NPC2 protein expression in surgical samples of papillary tissues by immunohistochemical stain, and all papillary tissues expressed NPC2 protein in the epithelium. To examine our hypothesis of NPC2 protein-mediated papillae formation, we carried out xenograft experiments using wild H460 cells (large cell lung carcinoma cell line) that constitutively expressed abundant NPC2 protein and NPC2 protein-depleted H460 cells by NPC2 shRNA. The xenografts of wild H460 cells and empty shRNA vector cells showed distinct papillae formation, whereas NPC2 protein-depleted H460 cells displayed markedly reduced or no papillae. Since all papillary tissues have open spaces we examined whether NPC2 protein might also contribute to the creation of open spaces. The TUNEL assay in the xenografts of wild and empty shRNA vector H460 cells showed massive cell death, and NPC2 protein-depleted cells displayed minimal cell death. Measurement of caspase 3/7 activities in cultured H460 cells supported NPC2 protein-mediated apoptotic cell death. The presence of excess NPC2 protein, however, did not always produce papillae as seen in the xenografts of CHO cells that were stably transfected with NPC2. Conclusions/Significance: The NPC2 protein of certain cells forms papillae coupled with apoptosis that creates open space. This protein may have future applications to modulate papillae formation and papillary growth in tumor tissues.	[Sugawara, Masahiro; Ohye, Hidemi; Tomoda, Chisato; Kogai, Takahiko] Univ Calif Los Angeles, David Geffen Sch Med, Endocrinol & Diabet Div, Dept Med,Vet Affairs Greater Los Angeles Hlth Car, Los Angeles, CA 90095 USA; [Sugawara, Masahiro] Univ Calif Los Angeles, David Geffen Sch Med, Primary Care Serv, Dept Med,Vet Affairs Greater Los Angeles Hlth Car, Los Angeles, CA 90095 USA; [Kamata, Yoshimasa] Hirosaki Univ, Sch Med, Dept Pathol, Hirosaki, Aomori 036, Japan; [Pezeshkpour, Gholam H.; Moatamed, Farhad] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hirosaki University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Sugawara, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Endocrinol & Diabet Div, Dept Med,Vet Affairs Greater Los Angeles Hlth Car, Los Angeles, CA 90095 USA.	msugawar@ucla.edu			Veterans Affairs	Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Veterans Affairs Merit Review grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asakawa JI, 2002, ENDOCRINOLOGY, V143, P4422, DOI 10.1210/en.2002-220550; Kurz T, 2010, ANTIOXID REDOX SIGN, V13, P511, DOI 10.1089/ars.2009.3005; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Willenborg M, 2005, J LIPID RES, V46, P2559, DOI 10.1194/jlr.M500131-JLR200	8	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15777	10.1371/journal.pone.0015777	http://dx.doi.org/10.1371/journal.pone.0015777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253586	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900010
J	Cerf, E; Gustot, A; Goormaghtigh, E; Ruysschaert, JM; Raussens, V				Cerf, Emilie; Gustot, Adelin; Goormaghtigh, Erik; Ruysschaert, Jean-Marie; Raussens, Vincent			High ability of apolipoprotein E4 to stabilize amyloid-beta peptide oligomers, the pathological entities responsible for Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid cascade; infrared spectroscopy; mechanism of apoE pathogenicity	TRANSFORM INFRARED-SPECTROSCOPY; IMPAIR SYNAPTIC PLASTICITY; GENOME-WIDE ASSOCIATION; CHAIN PLEATED SHEET; AMIDE-ONE VIBRATION; RESONANCE INTERACTION; IDENTIFIES VARIANTS; TRANSGENIC MICE; THIOFLAVIN-T; PROTEIN	Nowadays, the emerging role of amyloid-beta peptide (A beta) oligomers in Alzheimer's disease (AD) is widely accepted, putting aside the old idea that fibrils are the primary entities responsible for the onset of the disease. Besides, carrying the E4 isoform of apolipoprotein E (apoE) represents the highest risk of developing AD. Nevertheless, the involvement of apoE4 in AD remains confusing. The goal of this study was to bring new insights into the role of apoE4 in A beta aggregation. We used infrared spectroscopy, thioflavin T fluorescence, and Western blots to evaluate the influence of apoE isoforms on A beta aggregation in vitro. Comparing A beta controls with A beta incubated either with the apoE3 or apoE4 isoform, we report a 30% reduction of the A beta fibrillar content, whereas the oligomeric content is 2 times higher on incubation with the pathological isoform apoE4. ApoE4 would bind and block A beta in its oligomeric conformation, inhibiting further formation of less toxic fibrillar forms of A beta. While previous studies mostly correlated E4 with fibrils, our report underlines a link between apoE4 and A beta oligomers and therefore reconciles apoE4 with the new amyloid cascade hypothesis. Our observations suggest that apoE4 strongly stabilizes A beta oligomers, the pathological species responsible for Alzheimer's disease.-Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J.-M., Raussens, V. High ability of apolipoprotein E4 to stabilize amyloid-beta peptide oligomers, the pathological entities responsible for Alzheimer's disease. FASEB J. 25, 1585-1595 (2011). www.fasebj.org	[Cerf, Emilie; Gustot, Adelin; Goormaghtigh, Erik; Ruysschaert, Jean-Marie; Raussens, Vincent] Univ Libre Brussels, Ctr Struct Biol & Bioinformat, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Raussens, V (corresponding author), Univ Libre Brussels, Ctr Struct Biol & Bioinformat, Blvd Triomphe CP206-2, B-1050 Brussels, Belgium.	vrauss@ulb.ac.be		Goormaghtigh, Erik/0000-0002-2071-2262				Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Baumann MH, 2000, BIOCHEM J, V349, P77, DOI 10.1042/0264-6021:3490077; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; Cerf E, 2010, SPECTROSC-INT J, V24, P245, DOI 10.1155/2010/916373; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; Goormaghtigh E., 2009, ADV BIOMED SPECTROSC, V2, P104; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Luo JH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000663; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sarroukh R, 2011, CELL MOL LIFE SCI, V68, P1429, DOI 10.1007/s00018-010-0529-x; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wellnitz S, 2005, J NEUROCHEM, V94, P1351, DOI 10.1111/j.1471-4159.2005.03295.x; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200	55	71	74	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1585	1595		10.1096/fj.10-175976	http://dx.doi.org/10.1096/fj.10-175976			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21266538				2022-12-25	WOS:000290023800016
J	Kobrinsky, E; Duong, SQ; Sheydina, A; Soldatov, NM				Kobrinsky, Evgeny; Duong, Son Q.; Sheydina, Anna; Soldatov, Nikolai M.			Microdomain organization and frequency-dependence of CREB-dependent transcriptional signaling in heart cells	FASEB JOURNAL			English	Article						cardiac myocytes; wavelet transform analysis; Ca(v)1.2 calcium channel; FRET microscopy; patch clamp	ELEMENT-BINDING PROTEIN; TARGET GENE ACTIVATION; CARDIAC MEMORY; CALCIUM OSCILLATIONS; PHOSPHORYLATION; EXPRESSION; CHANNEL; CAMP; SPECIFICITY; HYPERTROPHY	Voltage-gated Ca(v)1.2 calcium channels couple membrane depolarization to cAMP response-element-binding protein (CREB)-dependent transcriptional activation. To investigate the spatial and temporal organization of CREB-dependent transcriptional nuclear microdomains, we combined perforated patch-clamp technique and FRET microscopy for monitoring CREB and CREB-binding protein interaction in the nuclei of live cells. The experimental approach to the quantitative assessment of CREB-dependent transcriptional signaling evoked by cAMP-and Ca(v)1.2-dependent mechanisms was devised in COS1 cells expressing recombinant Ca(v)1.2 calcium channels. Using continuous 2-dimensional wavelet transform and time series analyses, we found that nuclear CREB-dependent transcriptional signaling is organized differentially in spatially and temporally separated microdomains of 4 distinct types. In rat neonatal cardiomyocytes, CREB-dependent transcription is mediated by the cAMP-initiated CaMKII-sensitive and Ca(v)1.2-initiated CaMKII-insensitive mechanisms. The latter microdomains show a tendency to exhibit periodic behavior correlated with spontaneous contraction of myocytes suggestive of frequency-dependent CREB-dependent transcriptional regulation in the heart.-Kobrinsky, E., Duong, S. Q., Sheydina, A., Soldatov, N. M. Microdomain organization and frequency-dependence of CREB-dependent transcriptional signaling in heart cells. FASEB J. 25, 1544-1555 (2011). www.fasebj.org	[Kobrinsky, Evgeny; Duong, Son Q.; Sheydina, Anna; Soldatov, Nikolai M.] NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Soldatov, NM (corresponding author), Humgenex Inc, 3105 Starner Ct, Kensington, MD 20895 USA.	soldatovn.humgenex@verizon.net			National Institute on Aging [Z01 AG000294-08]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging Intramural Research Program (Z01 AG000294-08 to NMS). The authors thank Dr. Mark R. Montminy (The Salk Institute for Biological Studies, La Jolla, CA, USA) for providing KID and KIX constructs and Dr. Kenneth R. Boheler (National Institute on Aging, U.S. National Institutes of Health, Baltimore, MD, USA) for providing rat cardiac myocytes.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Colella M, 2008, P NATL ACAD SCI USA, V105, P2859, DOI 10.1073/pnas.0712316105; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FAY FS, 1973, P NATL ACAD SCI USA, V70, P641, DOI 10.1073/pnas.70.3.641; Feng J, 2008, CARDIOVASC RES, V78, P98, DOI 10.1093/cvr/cvn016; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; GRINSTED A, 2009, CROSSWAVELET COHEREN; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; JACQUES L, 2007, YET ANOTHER WAVELET; Klevecz RR, 2007, COLD SPRING HARB SYM, V72, P421, DOI 10.1101/sqb.2007.72.040; Kobayashi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe47; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kobrinsky E, 2005, BIOPHYS J, V88, P3625, DOI 10.1529/biophysj.104.054056; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Kobrinsky E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005587; Koch M, 2003, J NEUROCHEM, V85, P170, DOI 10.1046/j.1471-4159.2003.01651.x; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Li GW, 2009, FEBS LETT, V583, P3979, DOI 10.1016/j.febslet.2009.11.035; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; Mager DE, 2007, BIOPHYS J, V93, P2900, DOI 10.1529/biophysj.106.102582; Maltsev VA, 1998, CIRCULATION, V98, P2545, DOI 10.1161/01.CIR.98.23.2545; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marais E, 2008, CARDIOVASC DRUG THER, V22, P3, DOI 10.1007/s10557-007-6078-3; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ozgen N, 2009, HEART RHYTHM, V6, P564, DOI 10.1016/j.hrthm.2009.01.008; Parker D, 1996, MOL CELL BIOL, V16, P694; Patberg KW, 2003, CIRC RES, V93, pE87, DOI 10.1161/01.RES.0000099505.81736.E7; Plotnikov AN, 2003, CIRCULATION, V107, P2844, DOI 10.1161/01.CIR.0000068376.88600.41; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Rosen MR, 2006, J PHYSIOL-LONDON, V570, P209, DOI 10.1113/jphysiol.2005.097873; Salazar C, 2008, BIOPHYS J, V94, P1203, DOI 10.1529/biophysj.107.113084; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Sviridov AP, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2400248; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Trinkle-Mulcahy L, 2008, FEBS LETT, V582, P1960, DOI 10.1016/j.febslet.2008.04.029; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; YONEMOCHI H, 1990, CIRCULATION, V81, P1401, DOI 10.1161/01.CIR.81.4.1401; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; ZHENG JS, 1994, CIRC RES, V74, P1034, DOI 10.1161/01.RES.74.6.1034	60	13	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1544	1555		10.1096/fj.10-176198	http://dx.doi.org/10.1096/fj.10-176198			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21248242	Green Published			2022-12-25	WOS:000290023800012
J	Pakala, SB; Singh, K; Reddy, SD; Ohshiro, K; Li, DQ; Mishra, L; Kumar, R				Pakala, S. B.; Singh, K.; Reddy, S. D. N.; Ohshiro, K.; Li, D-Q; Mishra, L.; Kumar, R.			TGF-beta 1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells	ONCOGENE			English	Article						TGF-beta 1 signaling; MTA1; FosB; target gene transcription; epithelial-to-mesenchymal transition	BREAST-CANCER; MESENCHYMAL TRANSITIONS; TGF-BETA; TRANSCRIPTIONAL REPRESSION; ESTROGEN-RECEPTOR; MTA1; GENE; PROGRESSION; EXPRESSION; ALPHA	In spite of a large number of transforming growth factor beta 1 (TGF-beta 1)-regulated genes, the nature of its targets with roles in transformation continues to be poorly understood. Here, we discovered that TGF-beta 1 stimulates transcription of metastasis-associated protein 1 (MTA1), a dual master coregulator, in epithelial cells, and that MTA1 status is a determinant of TGF-beta 1-induced epithelial-to-mesenchymal transition (EMT) phenotypes. In addition, we found that MTA1/polymerase II/activator protein-1 (AP-1) co-activator complex interacts with the FosB-gene chromatin and stimulates its transcription, and FosB in turn, utilizes FosB/histone deacetylase 2 complex to repress E-cadherin expression in TGF-beta 1-stimulated mammary epithelial cells. These findings suggest that TGF-beta 1 regulates the components of EMT via stimulating the expression of MTA1, which in turn, induces FosB to repress E-cadherin expression and thus, revealed an inherent function of MTA1 as a target and effector of TGF-beta 1 signaling in epithelial cells. Oncogene (2011) 30, 2230-2241; doi:10.1038/onc.2010.608; published online 24 January 2011	[Pakala, S. B.; Singh, K.; Reddy, S. D. N.; Ohshiro, K.; Li, D-Q; Kumar, R.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Pakala, S. B.; Singh, K.; Reddy, S. D. N.; Ohshiro, K.; Li, D-Q; Kumar, R.] George Washington Univ, Med Ctr, Inst Coregulator Biol, Washington, DC 20037 USA; [Mishra, L.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA	George Washington University; George Washington University; University of Texas System; UTMD Anderson Cancer Center	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837	NIH [CA98823]; NATIONAL CANCER INSTITUTE [R01CA098823, P30CA016672, R01CA106614, P01CA130821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr Toshio Matsumoto for FosB-promoter constructs and Dr Eric R. Fearon for E-cadherin promoter construct. The work was supported by NIH Grant CA98823 (RK).	Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hofer MD, 2004, BRIT J CANCER, V90, P455, DOI 10.1038/sj.bjc.6601535; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; LEE TC, 1994, ONCOGENE, V9, P1047; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; Mahoney MG, 2002, ONCOGENE, V21, P2161, DOI 10.1038/sj.onc.1205277; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Michl P, 2006, CELL CYCLE, V5, P132, DOI 10.4161/cc.5.2.2311; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Ohnishi YN, 2008, MOL BIOL CELL, V19, P4717, DOI 10.1091/mbc.E07-08-0768; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tong D, 2007, ONCOL RES, V16, P465, DOI 10.3727/096504007783338322; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang H, 2006, CLIN CANCER RES, V12, P1479, DOI 10.1158/1078-0432.CCR-05-1519	30	68	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	19					2230	2241		10.1038/onc.2010.608	http://dx.doi.org/10.1038/onc.2010.608			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21258411	Green Accepted			2022-12-25	WOS:000290514600006
J	Norenberg, W; Hempel, C; Urban, N; Sobottka, H; Illes, P; Schaefer, M				Noerenberg, Wolfgang; Hempel, Christoph; Urban, Nicole; Sobottka, Helga; Illes, Peter; Schaefer, Michael			Clemastine Potentiates the Human P2X7 Receptor by Sensitizing It to Lower ATP Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; P2X(7) RECEPTORS; SINGLE-CHANNEL; DIVALENT-CATIONS; PATCH-CLAMP; PORE; MACROPHAGES; MODULATION; RELEASE; PERMEABILITY	P2X7 receptors have emerged as potential drug targets for the treatment of medical conditions such as e. g. rheumatoid arthritis and neuropathic pain. To assess the impact of pharmaceuticals on P2X7, we screened a compound library comprising approved or clinically tested drugs and identified several compounds that augment the ATP-triggered P2X7 activity in a stably transfected HEK293 cell line. Of these, clemastine markedly sensitized Ca2+ entry through P2X7 to lower ATP concentrations. Extracellularly but not intracellularly applied clemastine rapidly and reversibly augmented P2X7-mediated whole-cell currents evoked by non-saturating ATP concentrations. Clemastine also accelerated the ATP-induced pore formation and Yo-Pro-1 uptake, increased the fractional NMDG(+) permeability, and stabilized the open channel conformation of P2X7. Thus, clemastine is an extracellularly binding allosteric modulator of P2X7 that sensitizes P2X7 to lower ATP concentrations and facilitates its pore dilation. The activity of clemastine on native P2X7 receptors, Ca2+ entry, and whole-cell currents was confirmed in human monocyte-derived macrophages. Similar effects were observed in murine bone marrow-derived macrophages. Consistent with the data on recombinant P2X7, clemastine augmented the ATP-induced cation entry and Yo-Pro-1 uptake. In accordance with the observation that P2X7 controls the cytokine release from LPS-primed macrophages, we found that clemastine augmented the IL-1 beta release from LPS-primed human macrophages. Collectively, these data point to a sensitization of the recombinantly or natively expressed human P2X7 receptor toward its physiological activator, ATP, possibly leading to a modulation of macrophage-dependent immune responses.	[Noerenberg, Wolfgang; Hempel, Christoph; Urban, Nicole; Sobottka, Helga; Illes, Peter; Schaefer, Michael] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany	Leipzig University	Schaefer, M (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Hartelstr 16-18, D-04107 Leipzig, Germany.	michael.schaefer@medizin.uni-leipzig.de	Norenberg, Wolfgang/A-1999-2008	Norenberg, Wolfgang/0000-0002-0086-3717	Deutsche Forschungsgemeinschaft [Forschergruppe 748]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funding from the Deutsche Forschungsgemeinschaft within the framework of the Forschergruppe 748.	Acuna-Castillo C, 2007, J NEUROCHEM, V101, P17, DOI 10.1111/j.1471-4159.2006.04343.x; Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Alloisio S, 2006, MOL PHARMACOL, V69, P1975, DOI 10.1124/mol.105.020164; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Chessell IP, 1997, BRIT J PHARMACOL, V121, P1429, DOI 10.1038/sj.bjp.0701278; Coutinho-Silva R, 1997, AM J PHYSIOL-CELL PH, V273, pC1793, DOI 10.1152/ajpcell.1997.273.6.C1793; Davies John Q, 2005, Methods Mol Biol, V290, P105; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Ferrari D, 2007, BRIT J PHARMACOL, V150, P445, DOI 10.1038/sj.bjp.0706994; Ferrari D, 1997, J IMMUNOL, V159, P1451; GALLIN EK, 1988, J MEMBRANE BIOL, V103, P55, DOI 10.1007/BF01871932; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; GomezHernandez JM, 1997, PFLUG ARCH EUR J PHY, V434, P661, DOI 10.1007/s004240050449; Grinius L, 2002, DRUG DEV IND PHARM, V28, P193, DOI 10.1081/DDC-120002452; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Guile SD, 2009, J MED CHEM, V52, P3123, DOI 10.1021/jm801528x; Hong SY, 2009, J IMMUNOL, V183, P578, DOI 10.4049/jimmunol.0900120; Honore P, 2009, BEHAV BRAIN RES, V204, P77, DOI 10.1016/j.bbr.2009.05.018; Izumi Norimasa, 2008, Allergol Int, V57, P257, DOI 10.2332/allergolint.O-07-525; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; PARVEZ M, 1991, ACTA CRYSTALLOGR C, V47, P613, DOI 10.1107/S010827019000796X; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Schwarz N, 2009, PURINERG SIGNAL, V5, P139, DOI 10.1007/s11302-009-9135-5; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Takenouchi T, 2009, CRIT REV IMMUNOL, V29, P335, DOI 10.1615/CritRevImmunol.v29.i4.40; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1998, J PHYSIOL-LONDON, V510, P27, DOI 10.1111/j.1469-7793.1998.027bz.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Wareham K, 2009, BRIT J PHARMACOL, V157, P1215, DOI 10.1111/j.1476-5381.2009.00287.x; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010	57	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11067	11081		10.1074/jbc.M110.198879	http://dx.doi.org/10.1074/jbc.M110.198879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262970	Green Published, hybrid			2022-12-25	WOS:000288797100018
J	Matsumura, F; Yamakita, Y; Yamashiro, S				Matsumura, Fumio; Yamakita, Yoshihiko; Yamashiro, Shigeko			Myosin Phosphatase-targeting Subunit 1 Controls Chromatid Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASES; PROTEIN PHOSPHATASE-1; MAMMALIAN-CELLS; MITOSIS; CDC20; POLO-LIKE-KINASE-1; CENTROSOME; DYNAMICS; DIVISION; COHESION	Myosin phosphatase is a heterotrimeric holoenzyme consisting of myosin phosphatase-targeting subunit 1 (MYPT1), a catalytic subunit of PP1C beta, and a 20-kDa subunit of an unknown function. We have previously reported that myosin phosphatase also controls mitosis, apparently by antagonizing polo-like kinase 1 (PLK1). Here we found that depletion of MYPT1 by siRNA led to precocious chromatid segregation when HeLa cells were arrested at metaphase by a proteasome inhibitor, MG132, or by Cdc20 depletion. Consistently, cyclin B1 and securin were not degraded, indicating that the chromatid segregation is independent of the anaphase-promoting complex/cyclosome. Precocious segregation induced by MYPT1 depletion requires PLK1 activity because a PLK1 inhibitor, BI-2536, blocked precocious segregation. Furthermore, the expression of an unphosphorylatable mutant of SA2 (SCC3 homologue 2), a subunit of the cohesin complex, prevented precocious chromatid segregation induced by MYPT1 depletion. It has been shown that SA2 at centromeres is protected from phosphorylation by PP2A phosphatase recruited by Shugoshin (Sgo1), whereas SA2 along chromosome arms is phosphorylated by PLK1, leading to SA2 dissociation at chromosome arms. Taken together, our results suggest that hyperactivation of PLK1 caused by MYPT1 reduction could override the counteracting PP2A phosphatase, resulting in precocious chromatid segregation. We propose that SA2 at the centromeres is protected by two phosphatases. One is PP2A directly dephosphorylating SA2, and the other is myosin phosphatase counteracting PLK1.	[Matsumura, Fumio; Yamakita, Yoshihiko; Yamashiro, Shigeko] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Matsumura, F (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	Matsumura@biology.rutgers.edu	Yamakita, Yoshihiko/A-3003-2016	Yamashiro, Shigeko/0000-0001-7207-9406; Matsumura, Fumio/0000-0002-8204-153X	National Institutes of Health throughout the NCI [CA42742]; NATIONAL CANCER INSTITUTE [R01CA042742, R37CA042742] Funding Source: NIH RePORTER	National Institutes of Health throughout the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA42742 throughout the NCI (to F. M.).	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chevrier V, 2002, J CELL BIOL, V157, P807, DOI 10.1083/jcb.200203034; Cohen PTW, 2002, J CELL SCI, V115, P241; Dai Wei, 2003, Prog Cell Cycle Res, V5, P327; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	32	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10825	10833		10.1074/jbc.M110.169722	http://dx.doi.org/10.1074/jbc.M110.169722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252232	Green Published, hybrid			2022-12-25	WOS:000288547000096
J	Pinz, I; Tian, R; Belke, D; Swanson, E; Dillmann, W; Ingwall, JS				Pinz, Ilka; Tian, Rong; Belke, Darrell; Swanson, Eric; Dillmann, Wolfgang; Ingwall, Joanne S.			Compromised Myocardial Energetics in Hypertrophied Mouse Hearts Diminish the Beneficial Effect of Overexpressing SERCA2a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADENOVIRAL GENE-TRANSFER; RAT HEARTS; CONTRACTILE RESERVE; CARDIAC CONTRACTILITY; PRESSURE-OVERLOAD; FAILURE; ENERGY; MODEL; ARRHYTHMIAS	The sarcoplasmic reticulum calcium ATPase (SERCA) plays a central role in regulating intracellular Ca2+ homeostasis and myocardial contractility. Several studies show that improving Ca2+ handling in hypertrophied rodent hearts by increasing SERCA activity results in enhanced contractile function. This suggests that SERCA is a potential target for gene therapy in cardiac hypertrophy and failure. However, it raises the issue of increased energy cost resulting from a higher ATPase activity. In this study, we determined whether SERCA overexpression alters the energy cost of increasing myocardial contraction in mouse hearts with pressure-overload hypertrophy using P-31 NMR spectroscopy. We isolated and perfused mouse hearts from wild-type (WT) and transgenic (TG) mice overexpressing the cardiac isoform of SERCA (SERCA2a) 8 weeks after ascending aortic constriction (left ventricular hypertrophy (LVH)) or sham operation. We found that overexpressing SERCA2a enhances myocardial contraction and relaxation in normal mouse hearts during inotropic stimulation with isoproterenol. Energy consumption was proportionate to the increase in contractile function. Thus, increasing SERCA2a expression in the normal heart allows an enhanced inotropic response with no compromise in energy supply and demand. However, this advantage was not sustained in LVH hearts in which the energetic status was compromised. Although the overexpression of SERCA2a prevented the down-regulation of SERCA protein in LVH hearts, TG-LVH hearts showed no increase in inotropic response when compared with WT-LVH hearts. Our results suggest that energy supply may be a limiting factor for the benefit of SERCA overexpression in hypertrophied hearts. Thus, strategies combining energetic support with increasing SERCA activity may improve the therapeutic effectiveness for heart failure.	[Pinz, Ilka; Tian, Rong; Ingwall, Joanne S.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, NMR Lab Physiol Chem, Boston, MA 02115 USA; [Belke, Darrell; Swanson, Eric; Dillmann, Wolfgang] Univ Calif San Diego, Dept Med, Div Endocrine & Metab, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego	Pinz, I (corresponding author), Maine Med Ctr, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	pinzi@mmc.org	Tian, Rui/E-5637-2011; Tian, Rong/ABH-1383-2020	Tian, Rong/0000-0002-3676-3830				Baker DL, 1998, CIRC RES, V83, P1205, DOI 10.1161/01.RES.83.12.1205; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Chen Y, 2004, CIRCULATION, V109, P1898, DOI 10.1161/01.CIR.0000124230.60028.42; Chu GX, 1996, CIRC RES, V79, P1064, DOI 10.1161/01.RES.79.6.1064; del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Dorn GW, 2004, CIRCULATION, V109, P150, DOI 10.1161/01.CIR.0000111581.15521.F5; EBERLI FR, 1992, CIRC RES, V70, P931, DOI 10.1161/01.RES.70.5.931; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; Houser SR, 2003, CIRC RES, V92, P350, DOI 10.1161/01.RES.0000060027.40275.A6; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Ito K, 2000, CIRC RES, V87, P588, DOI 10.1161/01.RES.87.7.588; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; KAMMERMEIER H, 1987, BASIC RES CARDIOL, V82, P31; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Muller OJ, 2003, CARDIOVASC RES, V59, P380, DOI 10.1016/S0008-6363(03)00429-2; O'Donnell JM, 2008, AM J PHYSIOL-HEART C, V295, pH2483, DOI 10.1152/ajpheart.01023.2008; Pinz I, 2008, AM J PHYSIOL-HEART C, V294, pH1459, DOI 10.1152/ajpheart.00911.2007; Tian R, 1997, CIRCULATION, V96, P1313, DOI 10.1161/01.CIR.96.4.1313; Tian R, 1996, AM J PHYSIOL-HEART C, V270, pH1207, DOI 10.1152/ajpheart.1996.270.4.H1207; Tian R, 1998, AM J PHYSIOL-HEART C, V275, pH2064, DOI 10.1152/ajpheart.1998.275.6.H2064	23	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10163	10168		10.1074/jbc.M110.210757	http://dx.doi.org/10.1074/jbc.M110.210757			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278384	hybrid, Green Published			2022-12-25	WOS:000288547000031
J	Tacke, RS; Tosello-Trampont, A; Nguyen, V; Mullins, DW; Hahn, YS				Tacke, Robert S.; Tosello-Trampont, Annie; Nguyen, Virginia; Mullins, David W.; Hahn, Young S.			Extracellular Hepatitis C Virus Core Protein Activates STAT3 in Human Monocytes/Macrophages/Dendritic Cells via an IL-6 Autocrine Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR-CELLS; DENDRITIC CELLS; IMMUNE-SYSTEM; T-CELLS; INFECTION; DIFFERENTIATION; INTERLEUKIN-6; CANCER; INFLAMMATION; MACROPHAGES	Hepatitis C virus (HCV) infection is highly efficient in the establishment of persistent infection, which leads to the development of chronic liver disease and hepatocellular carcinoma. Impaired T cell responses with reduced IFN-gamma production have been reported to be associated with persistent HCV infection. Extracellular HCV core is a viral factor known to cause HCV-induced T cell impairment via its suppressive effect on the activation and induction of pro-inflammatory responses by antigen-presenting cells (APCs). The activation of STAT proteins has been reported to regulate the inflammatory responses and differentiation of APCs. To further characterize the molecular basis for the regulation of APC function by extracellular HCV core, we examined the ability of extracellular HCV core to activate STAT family members(STAT1, -2, -3, -5, and -6). In this study, we report the activation of STAT3 on human monocytes, macrophages, and dendritic cells following treatment with extracellular HCV core as well as treatment with a gC1qR agonistic monoclonal antibody. Importantly, HCV core-induced STAT3 activation is dependent on the activation of the PI3K/Akt pathway. In addition, the production of multifunctional cytokine IL-6 is essential for HCV core-induced STAT3 activation. These results suggest that HCV core-induced STAT3 activation plays a critical role in the alteration of inflammatory responses by APCs, leading to impaired anti-viral T cell responses during HCV infection.	[Tacke, Robert S.; Tosello-Trampont, Annie; Nguyen, Virginia; Mullins, David W.; Hahn, Young S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Tacke, Robert S.; Mullins, David W.; Hahn, Young S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Hahn, Young S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Hahn, YS (corresponding author), UVA, Carter Immunol Ctr, POB 801386, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu	Mullins, David/J-1085-2019	Mullins, David/0000-0002-2644-350X	National Institutes of Health [AI057591, U19AI066328, RO1 CA134799]; Training Fellowship [5T32AI00749611]; NATIONAL CANCER INSTITUTE [R01CA134799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057591, U19AI066328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057591 and U19AI066328 (to Y. S. H.) and RO1 CA134799 (to D. W. M.), and by Training Fellowship 5T32AI00749611 (to R. S. T.).	Barrett S, 2003, J MED VIROL, V71, P212, DOI 10.1002/jmv.10472; Baruah P, 2009, BLOOD, V113, P3485, DOI 10.1182/blood-2008-06-164392; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cussigh A, 2011, IMMUNOGENETICS, V63, P33, DOI 10.1007/s00251-010-0491-7; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Faruqi TR, 2001, P NATL ACAD SCI USA, V98, P9014, DOI 10.1073/pnas.161281298; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; HAHN YS, 2003, NATURE, V15, P946; Hirano T, 1998, Int Rev Immunol, V16, P249; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; KANTO T, 1995, J HEPATOL, V22, P440, DOI 10.1016/0168-8278(95)80107-3; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kortylewski M, 2008, CURR OPIN IMMUNOL, V20, P228, DOI 10.1016/j.coi.2008.03.010; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pickering M C, 2000, Adv Immunol, V76, P227; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Ratta M, 2002, BLOOD, V100, P230, DOI 10.1182/blood.V100.1.230; Rehermann B, 1996, J CLIN INVEST, V98, P1432, DOI 10.1172/JCI118931; Sabile A, 1999, HEPATOLOGY, V30, P1064, DOI 10.1002/hep.510300429; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sundstrom S, 2005, J VIROL, V79, P2230, DOI 10.1128/JVI.79.4.2230-2239.2005; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Waggoner SN, 2005, J IMMUNOL, V175, P4706, DOI 10.4049/jimmunol.175.7.4706; Waggoner SN, 2007, J LEUKOCYTE BIOL, V82, P1407, DOI 10.1189/jlb.0507268; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	41	70	71	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10847	10855		10.1074/jbc.M110.217653	http://dx.doi.org/10.1074/jbc.M110.217653			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21282107	hybrid, Green Published			2022-12-25	WOS:000288547000098
J	Yashin, DV; Dukhanina, EA; Kabanova, OD; Romanova, EA; Lukyanova, TI; Tonevitskii, AG; Raynes, DA; Gnuchev, NV; Guerriero, V; Georgiev, GP; Sashchenko, LP				Yashin, Denis V.; Dukhanina, Elena A.; Kabanova, Olga D.; Romanova, Elena A.; Lukyanova, Tamara I.; Tonevitskii, Alexsander G.; Raynes, Deborah A.; Gnuchev, Nikolai V.; Guerriero, Vince; Georgiev, Georgii P.; Sashchenko, Lidia P.			The Heat Shock-binding Protein (HspBP1) Protects Cells against the Cytotoxic Action of the Tag7-Hsp70 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; APOPTOSIS-INDUCING FACTOR; GRAM-POSITIVE BACTERIA; COCHAPERONE HSPBP1; HSP70 COCHAPERONE; INNATE IMMUNITY; HEAT-SHOCK-PROTEIN-70; TAG7; MECHANISM; LYMPHOCYTES	Heat shock-binding protein HspBP1 is a member of the Hsp70 co-chaperone family. The interaction between HspBP1 and the ATPase domain of the major heat shock protein Hsp70 up-regulates nucleotide exchange and reduces the affinity between Hsp70 and the peptide in its peptide-binding site. Previously we have shown that Tag7 (also known as peptidoglycan recognition protein PGRP-S), an innate immunity protein, interacts with Hsp70 to form a stable Tag7-Hsp70 complex with cytotoxic activity against some tumor cell lines. This complex can be produced in cytotoxic lymphocytes and released during interaction with tumor cells. Here the effect of HspBP1 on the cytotoxic activity of the Tag7-Hsp70 complex was examined. HspBP1 could bind not only to Hsp70, but also to Tag7. This interaction eliminated the cytotoxic activity of Tag7-Hsp70 complex and decreased the ATP concentration required to dissociate Tag7 from the peptide-binding site of Hsp70. Moreover, HspBP1 inhibited the cytotoxic activity of the Tag7-Hsp70 complex secreted by lymphocytes. HspBP1 was detected in cytotoxic CD8+ lymphocytes. This protein was released simultaneously with Tag7-Hsp70 during interaction of these lymphocytes with tumor cells. The simultaneous secretion of the cytotoxic complex with its inhibitor could be a mechanism protecting normal cells from the cytotoxic effect of this complex.	[Yashin, Denis V.; Dukhanina, Elena A.; Kabanova, Olga D.; Romanova, Elena A.; Lukyanova, Tamara I.; Gnuchev, Nikolai V.; Georgiev, Georgii P.; Sashchenko, Lidia P.] Russian Acad Sci, Inst Gene Biol, Moscow 119344, Russia; [Dukhanina, Elena A.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119344, Russia; [Yashin, Denis V.] Univ Oslo, Ctr Med Studies, Moscow 119344, Russia; [Raynes, Deborah A.; Guerriero, Vince] Univ Arizona, Dept Anim Sci, Tucson, AZ 85721 USA; [Guerriero, Vince] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Tonevitskii, Alexsander G.] Moscow MV Lomonosov State Univ, GSP 1, Moscow 119991, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Arizona; University of Arizona; Lomonosov Moscow State University	Sashchenko, LP (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow 119344, Russia.	sashchenko@genebiology.ru		Lukyanova, Tamara/0000-0003-4193-2843	Russian Foundation for Basic Research; RAS; International Centre for Genetic Engineering and Biotechnology (ICGEB)	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna); International Centre for Genetic Engineering and Biotechnology (ICGEB)	This work was supported by the Russian Foundation for Basic Research, RAS program for Molecular and Cellular Biology, and International Centre for Genetic Engineering and Biotechnology (ICGEB).	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CHERTOV OY, 1994, IMMUNOL LETT, V42, P97, DOI 10.1016/0165-2478(94)90042-6; Cho JH, 2005, BLOOD, V106, P2551, DOI 10.1182/blood-2005-02-0530; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; Dukhanina E A, 2007, Dokl Biol Sci, V414, P246, DOI 10.1134/S0012496607030222; Dukhanina EA, 2009, P NATL ACAD SCI USA, V106, P13963, DOI 10.1073/pnas.0900116106; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Evdonin A, 2009, BIOL CELL, V101, P351, DOI 10.1042/BC20080069; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Graner MW, 2009, CANCER SCI, V100, P1870, DOI 10.1111/j.1349-7006.2009.01269.x; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; HERBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651, DOI 10.1146/annurev.iy.04.040186.003251; JIANG SB, 1989, J IMMUNOL, V143, P1453; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; KARELIN AA, 1994, BIOCHEM MOL BIOL INT, V33, P73; Kiselev SL, 1998, J BIOL CHEM, V273, P18633, DOI 10.1074/jbc.273.29.18633; Kustikova OS, 1996, GENETIKA+, V32, P621; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McLellan CA, 2003, J BIOL CHEM, V278, P19017, DOI 10.1074/jbc.M301109200; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Raynes DA, 2006, J IMMUNOASS IMMUNOCH, V27, P251, DOI 10.1080/15321810600734935; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	37	15	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10258	10264		10.1074/jbc.M110.163436	http://dx.doi.org/10.1074/jbc.M110.163436			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247889	hybrid, Green Published			2022-12-25	WOS:000288547000043
J	Joo, HS; Cheung, GYC; Otto, M				Joo, Hwang-Soo; Cheung, Gordon Y. C.; Otto, Michael			Antimicrobial Activity of Community-associated Methicillin-resistant Staphylococcus aureus Is Caused by Phenol-soluble Modulin Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE DETERMINANTS; GENOME SEQUENCE; EPIDERMIDIS; EVOLUTION; PEPTIDES; AGR; IDENTIFICATION; BIOSYNTHESIS; REPLACEMENT; EXPRESSION	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are causing an ongoing pandemic of mostly skin and soft tissue infections. The success of CA-MRSA as pathogens is due to a combination of antibiotic resistance with high virulence. In addition, it has been speculated that CA-MRSA strains such as the epidemic U. S. clone USA300 have increased capacity to colonize human epithelia, owing to bacteriocin-based bacterial interference. We here analyzed the molecular basis of antimicrobial activity detected in S. aureus strains, including those of the USA300 lineage. In contrast to a previous hypothesis, we found that this activity is not due to expression of a lantibiotic-type bacteriocin, but proteolytically processed derivatives of the phenol-soluble modulin (PSM) peptides PSM alpha 1 and PSM alpha 2. Notably, processed PSM alpha 1 and PSM alpha 2 exhibited considerable activity against Streptococcus pyogenes, indicating a role of PSMs in the interference of S. aureus strains with the competing colonizing pathogen. Furthermore, by offering a competitive advantage during colonization of the human body, the characteristically high production of PSMs in USA300 and other CA-MRSA strains may thus contribute not only to virulence but also the exceptional capacity of those strains to sustainably spread in the population, which so far has remained poorly understood.	[Joo, Hwang-Soo; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), 9000 Rockville Pike,Bldg 331W10, Bethesda, MD 20892 USA.	motto@niaid.nih.gov	Cheung, Yiu Chong/K-3565-2012	Otto, Michael/0000-0002-2222-4115; JOO, HWANG-SOO/0000-0003-4668-3225	NIAID, National Institutes of Health [ZIA AI000904-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the NIAID, National Institutes of Health (Grant ZIA AI000904-08).	[Anonymous], 1999, JAMA, V282, P1123; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BEAUDET R, 1982, ANTIMICROB AGENTS CH, V22, P277, DOI 10.1128/AAC.22.2.277; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P88; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Donvito B, 1997, INFECT IMMUN, V65, P95, DOI 10.1128/IAI.65.1.95-100.1997; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Fitzgerald JR, 2000, J APPL MICROBIOL, V88, P1028, DOI 10.1046/j.1365-2672.2000.01071.x; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kocianova S, 2005, J CLIN INVEST, V115, P688, DOI 10.1172/JCI200523523; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; OTTENWALDER B, 1995, APPL ENVIRON MICROB, V61, P3894; Otto M, 1998, FEMS MICROBIOL LETT, V166, P203, DOI 10.1016/S0378-1097(98)00333-4; Otto M, 2001, RES MICROBIOL, V152, P351, DOI 10.1016/S0923-2508(01)01206-2; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peschel A, 1996, J BACTERIOL, V178, P531, DOI 10.1128/jb.178.2.531-536.1996; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Saris PEJ, 1996, ANTON LEEUW INT J G, V69, P151, DOI 10.1007/BF00399420; SCHNELL N, 1992, EUR J BIOCHEM, V204, P57, DOI 10.1111/j.1432-1033.1992.tb16605.x; SCHNELL N, 1989, FEMS MICROBIOL LETT, V58, P263, DOI 10.1016/0378-1097(89)90050-5; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945	42	109	112	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8933	8940		10.1074/jbc.M111.221382	http://dx.doi.org/10.1074/jbc.M111.221382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21278255	Green Published, hybrid			2022-12-25	WOS:000288247700025
J	Kantomaa, MT; Purtsi, J; Taanila, AM; Remes, J; Viholainen, H; Rintala, P; Ahonen, T; Tammelin, TH				Kantomaa, Marko T.; Purtsi, Jarno; Taanila, Anja M.; Remes, Jouko; Viholainen, Helena; Rintala, Pauli; Ahonen, Timo; Tammelin, Tuija H.			Suspected Motor Problems and Low Preference for Active Play in Childhood Are Associated with Physical Inactivity and Low Fitness in Adolescence	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; DEVELOPMENTAL COORDINATION DISORDER; SEDENTARY BEHAVIORS; PRESCHOOL-CHILDREN; PROFICIENCY; COMPETENCE; EVOLUTION; YOUTH	Background: This prospective longitudinal study investigates whether suspected motor problems and low preference for active play in childhood are associated with physical inactivity and low cardiorespiratory fitness in adolescence. Methodology/Principal Findings: The study sample consisted of the Northern Finland Birth Cohort 1986 (NFBC 1986) composed of 5,767 children whose parents responded to a postal inquiry concerning their children's motor skills at age 8 years and who themselves reported their physical activity at age 16 years. Cardiorespiratory fitness was measured with a cycle ergometer test at age 16 years. Odds ratios (OR) and their 95% confidence intervals (95% CI) for the level of physical activity and fitness were obtained from multinomial logistic regression and adjusted for socio-economic position and body mass index. Low preference for active play in childhood was associated with physical inactivity (boys: OR 3.31, 95% CI 2.42-4.53; girls: OR 1.79, 95% CI 1.36-2.36) and low cardiorespiratory fitness (boys: OR 1.87, 95% CI 1.27-2.74; girls: OR 1.52, 95% CI 1.09-2.11) in adolescence. Suspected gross (OR 2.16, 95% CI 1.33-3.49) and fine (OR 1.88, 95% CI 1.35-2.60) motor problems were associated with physical inactivity among boys. Children with suspected motor problems and low preference for active play tended to have an even higher risk of physical inactivity in adolescence. Conclusions/Significance: Low preference for active play in childhood was associated with physical inactivity and low cardiorespiratory fitness in adolescence. Furthermore, children with suspected motor problems and low preference for active play tended to have an even higher risk of physical inactivity in adolescence. Identification of children who do not prefer active play and who have motor problems may allow targeted interventions to support their motor learning and participation in active play and thereby promote their physical activity and fitness in later life.	[Kantomaa, Marko T.; Purtsi, Jarno; Tammelin, Tuija H.] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Kantomaa, Marko T.; Purtsi, Jarno; Viholainen, Helena] Finnish CP Assoc, Helsinki, Finland; [Taanila, Anja M.] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Taanila, Anja M.] Univ Hosp Oulu, Unit Gen Practice, Oulu, Finland; [Remes, Jouko] Finnish Inst Occupat Hlth, Oulu, Finland; [Viholainen, Helena] Univ Jyvaskyla, Dept Educ, Jyvaskyla, Finland; [Rintala, Pauli] Univ Jyvaskyla, Dept Sport Sci, Jyvaskyla, Finland; [Ahonen, Timo] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Oulu; Finnish Institute of Occupational Health; University of Jyvaskyla; University of Jyvaskyla; University of Jyvaskyla	Kantomaa, MT (corresponding author), LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland.	marko.kantomaa@likes.fi	Rintala, Pauli/O-2507-2017	Rintala, Pauli/0000-0002-3405-8169; Kantomaa, Marko/0000-0002-5937-3456; Viholainen, Helena/0000-0002-8164-9180	Academy of Finland; European Union; National Institutes of Health (US); Wellcome Trust (UK); Nordic Academy for Advanced Study (NorFA); Ministry of Education and Culture, Finland	Academy of Finland(Academy of Finland); European Union(European Commission); National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust (UK)(Wellcome Trust); Nordic Academy for Advanced Study (NorFA); Ministry of Education and Culture, Finland	This study was funded by the Academy of Finland, the European Union, the National Institutes of Health (US), the Wellcome Trust (UK), the Nordic Academy for Advanced Study (NorFA) and the Ministry of Education and Culture, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barnett LM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-48; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Barnett LM, 2008, MED SCI SPORT EXER, V40, P2137, DOI 10.1249/MSS.0b013e31818160d3; Bateson Patrick, 2005, P13; Bjorklund D. F., 2005, ORIGINS SOCIAL MIND, P76; Bjorklund DF, 2006, DEV REV, V26, P213, DOI 10.1016/j.dr.2006.02.007; Cairney J, 2007, PEDIATR EXERC SCI, V19, P20, DOI 10.1123/pes.19.1.20; Cantell M, 2008, HUM MOVEMENT SCI, V27, P344, DOI 10.1016/j.humov.2008.02.007; Cliff DP, 2009, PEDIATR EXERC SCI, V21, P436, DOI 10.1123/pes.21.4.436; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Faught BE, 2008, HUM MOVEMENT SCI, V27, P177, DOI 10.1016/j.humov.2008.02.001; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; FOGELHOLM M, 2007, PHYS ACTIVITY POSSIB; Geuze RH, 2001, HUM MOVEMENT SCI, V20, P7, DOI 10.1016/S0167-9457(01)00027-6; Gottlieb G, 2003, HUM DEV, V46, P337, DOI 10.1159/000073306; Graf C, 2004, INT J OBESITY, V28, P22, DOI 10.1038/sj.ijo.0802428; Haga M, 2008, CHILD CARE HLTH DEV, V34, P329, DOI 10.1111/j.1365-2214.2008.00814.x; Haga M, 2009, PHYS THER, V89, P1089, DOI 10.2522/ptj.20090052; Hands B., 2002, DEV COORDINATION DIS, P172; Hands B, 2008, J SCI MED SPORT, V11, P155, DOI 10.1016/j.jsams.2007.02.012; Hay JA, 2004, J ADOLESCENT HEALTH, V34, P308, DOI 10.1016/j.jadohealth.2003.07.004; Jaakkola T, 2009, PERCEPT MOTOR SKILL, V108, P97, DOI 10.2466/PMS.108.1.97-111; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Pellegrini AD, 1998, CHILD DEV, V69, P577, DOI 10.1111/j.1467-8624.1998.tb06226.x; Pellegrini AD, 2007, DEV REV, V27, P261, DOI 10.1016/j.dr.2006.09.001; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Saakslahti A, 1999, PEDIATR EXERC SCI, V11, P327, DOI 10.1123/pes.11.4.327; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Santtila M, 2006, MED SCI SPORT EXER, V38, P1990, DOI 10.1249/01.mss.0000232023.28984.78; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Statistics Finland, 1989, STAT FINL HANDB, V17; Tammelin T, 2007, MED SCI SPORT EXER, V39, P1067, DOI 10.1249/mss.0b13e318058a603; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Whitt-Glover MC, 2009, J PUBLIC HEALTH POL, V30, pS309, DOI 10.1057/jphp.2008.46; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214; Wilson BN, 2000, AM J OCCUP THER, V54, P484, DOI 10.5014/ajot.54.5.484; World Health Organization, 2010, OB OV; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742	42	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14554	10.1371/journal.pone.0014554	http://dx.doi.org/10.1371/journal.pone.0014554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267447	Green Submitted, Green Published, gold			2022-12-25	WOS:000286519500021
J	Kumar, S; Kumar, S; Rajendran, M; Alam, SM; Lin, FF; Cheng, PW; Lin, MF				Kumar, Santosh; Kumar, Satyendra; Rajendran, Mythilypriya; Alam, Syed Mahfuzul; Lin, Fen-Fen; Cheng, Pi-Wan; Lin, Ming-Fong			Steroids Up-Regulate p66Shc Longevity Protein in Growth Regulation by Inhibiting Its Ubiquitination	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; MOLECULAR-WEIGHT PROTEASES; SIGNALING PATHWAY; OXIDATIVE STRESS; BREAST-CANCER; ANDROGEN RECEPTOR; ADAPTER PROTEINS; ACID-PHOSPHATASE; P66(SHC) ISOFORM; SHC	Background: p66Shc, an isoform of Shc adaptor proteins, mediates diverse signals, including cellular stress and mouse longevity. p66Shc protein level is elevated in several carcinomas and steroid-treated human cancer cells. Several lines of evidence indicate that p66Shc plays a critical role in steroid-related carcinogenesis, and steroids play a role in its elevated levels in those cells without known mechanism. Methods and Findings: In this study, we investigated the molecular mechanism by which steroid hormones up-regulate p66Shc protein level. In steroid-treated human prostate and ovarian cancer cells, p66Shc protein levels were elevated, correlating with increased cell proliferation. These steroid effects on p66Shc protein and cell growth were competed out by the respective antagonist. Further, actinomycin D and cyclohexamide could only partially block the elevated p66Shc protein level by steroids. Treatment with proteasomal inhibitors, but not lysosomal protease inhibitor, resulted in elevated p66Shc protein levels, even higher than that by steroids. Using prostate cancer cells as a model, immunoprecipitation revealed that androgens and proteasomal inhibitors reduce the ubiquitinated p66Shc proteins. Conclusions: The data collectively indicate that functional steroid receptors are required in steroid up-regulation of p66Shc protein levels in prostate and ovarian cancer cells, correlating with cell proliferation. In these steroid-treated cells, elevated p66Shc protein level is apparently in part due to inhibiting its ubiquitination. The results may lead to an impact on advanced cancer therapy via the regulation of p66Shc protein by up-regulating its ubiquitination pathway.	[Kumar, Santosh; Kumar, Satyendra; Rajendran, Mythilypriya; Alam, Syed Mahfuzul; Lin, Fen-Fen; Cheng, Pi-Wan; Lin, Ming-Fong] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE USA; [Cheng, Pi-Wan; Lin, Ming-Fong] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kumar, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE USA.	mlin@unmc.edu			National Institutes of Health [R01 CA88184]; Department of Defense [PC074289, PC050769]; Nebraska Research Initiative;  [NE LB506]; NATIONAL CANCER INSTITUTE [R01CA088184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Nebraska Research Initiative; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported in part by National Institutes of Health Grant (R01 CA88184), Department of Defense (PC074289 and PC050769), Nebraska Research Initiative (Cancer Glycobiology Program) and NE LB506 (#2010-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, BIOCHEM BIOPH RES CO, V307, P188, DOI 10.1016/S0006-291X(03)01140-9; Alam SM, 2009, ENDOCR-RELAT CANCER, V16, P1, DOI 10.1677/ERC-08-0179; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Davol PA, 2003, CANCER RES, V63, P6772; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; Eissa NT, 1998, P NATL ACAD SCI USA, V95, P7625, DOI 10.1073/pnas.95.13.7625; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Grossman SR, 2007, CLIN CANCER RES, V13, P5798, DOI 10.1158/1078-0432.CCR-07-0073; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Lee MS, 2004, INT J CANCER, V108, P672, DOI 10.1002/ijc.11621; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2004, J BIOL CHEM, V279, P43900, DOI 10.1074/jbc.M403936200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Park YJ, 2005, ENDOCRINOLOGY, V146, P2473, DOI 10.1210/en.2004-1588; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Stevenson LE, 1998, BREAST CANCER RES TR, V49, P119, DOI 10.1023/A:1006007227747; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; Ventura A, 2002, J BIOL CHEM, V277, P22370, DOI 10.1074/jbc.M200280200; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; Xie YM, 1996, BIOCHEM BIOPH RES CO, V221, P140, DOI 10.1006/bbrc.1996.0559	44	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15942	10.1371/journal.pone.0015942	http://dx.doi.org/10.1371/journal.pone.0015942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264241	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500019
J	Morton, CO; Varga, JJ; Hornbach, A; Mezger, M; Sennefelder, H; Kneitz, S; Kurzai, O; Krappmann, S; Einsele, H; Nierman, WC; Rogers, TR; Loeffler, J				Morton, Charles O.; Varga, John J.; Hornbach, Anke; Mezger, Markus; Sennefelder, Helga; Kneitz, Susanne; Kurzai, Oliver; Krappmann, Sven; Einsele, Hermann; Nierman, William C.; Rogers, Thomas R.; Loeffler, Juergen			The Temporal Dynamics of Differential Gene Expression in Aspergillus fumigatus Interacting with Human Immature Dendritic Cells In Vitro	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TRANSCRIPTIONAL ACTIVATOR CPCA; HUMAN MONOCYTES; INVASIVE ASPERGILLOSIS; HOST-DEFENSE; PROTEINS; VIRULENCE; FUNGI; INFECTION; APOPTOSIS	Dendritic cells (DC) are the most important antigen presenting cells and play a pivotal role in host immunity to infectious agents by acting as a bridge between the innate and adaptive immune systems. Monocyte-derived immature DCs (iDC) were infected with viable resting conidia of Aspergillus fumigatus (Af293) for 12 hours at an MOI of 5; cells were sampled every three hours. RNA was extracted from both organisms at each time point and hybridised to microarrays. iDC cell death increased at 6 h in the presence of A. fumigatus which coincided with fungal germ tube emergence; >80% of conidia were associated with iDC. Over the time course A. fumigatus differentially regulated 210 genes, FunCat analysis indicated significant up-regulation of genes involved in fermentation, drug transport, pathogenesis and response to oxidative stress. Genes related to cytotoxicity were differentially regulated but the gliotoxin biosynthesis genes were down regulated over the time course, while Aspf1 was up-regulated at 9 h and 12 h. There was an up-regulation of genes in the subtelomeric regions of the genome as the interaction progressed. The genes up-regulated by iDC in the presence of A. fumigatus indicated that they were producing a pro-inflammatory response which was consistent with previous transcriptome studies of iDC interacting with A. fumigatus germ tubes. This study shows that A. fumigatus adapts to phagocytosis by iDCs by utilising genes that allow it to survive the interaction rather than just up-regulation of specific virulence genes.	[Morton, Charles O.; Rogers, Thomas R.] Trinity Coll Dublin, Dept Clin Microbiol, Dublin, Ireland; [Varga, John J.; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Hornbach, Anke; Mezger, Markus; Sennefelder, Helga; Einsele, Hermann; Loeffler, Juergen] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany; [Kneitz, Susanne] Interdisziplinares Zentrum Klin Forsch, Labor Microarray Anwendungen, Wurzburg, Germany; [Kurzai, Oliver] Univ Jena, Sept Res Ctr, Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Jena, Germany; [Krappmann, Sven] Univ Wurzburg, Zentrum Infekt Forsch, Wurzburg, Germany	Trinity College Dublin; J. Craig Venter Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); University of Wurzburg	Morton, CO (corresponding author), Trinity Coll Dublin, Dept Clin Microbiol, Dublin, Ireland.	Loeffler_J@medizin.uni-wuerzburg.de	Varga, John J/I-8130-2012; Morton, Charles O/H-4000-2012; Krappmann, Sven/K-2615-2012	Varga, John J/0000-0002-4868-1971; Rogers, Thomas/0000-0003-4336-7729; Mezger, Markus/0000-0002-0211-2343; Kurzai, Oliver/0000-0002-7277-2646; Morton, Charles Oliver/0000-0003-1702-0545; Krappmann, Sven/0000-0002-8299-7777	European Union; US Institutes of Health [1R21AI052236]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052236] Funding Source: NIH RePORTER	European Union(European Commission); US Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a European Union Framework 6 grant as part of a project entitled Development of Novel Management Strategies for Invasive Aspergillosis "MANASP''. Support for the Aspergillus fumigatus microarray work was funded by the US Institutes of Health grant 1R21AI052236 to WCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Braus GH, 2006, MED MYCOL, V44, pS91, DOI 10.1080/13693780600898029; Brown JS, 2000, MOL MICROBIOL, V36, P1371, DOI 10.1046/j.1365-2958.2000.01953.x; Burns S, 2004, CURR BIOL, V14, pR965, DOI 10.1016/j.cub.2004.10.044; Chignard M, 2007, CLIN IMMUNOL, V124, P238, DOI 10.1016/j.clim.2007.05.004; Cortez KJ, 2006, INFECT IMMUN, V74, P2353, DOI 10.1128/IAI.74.4.2353-2365.2006; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; de Gouvea PF, 2008, FUNGAL GENET BIOL, V45, P1135, DOI 10.1016/j.fgb.2008.04.001; Gafa V, 2006, INFECT IMMUN, V74, P1480, DOI 10.1128/IAI.74.3.1480-1489.2006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAHL N, 2009, MED MYCOL, P1; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Hope WW, 2009, MED MYCOL, V47, pS291, DOI 10.1080/13693780802510232; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Kamei K, 2005, MED MYCOL, V43, pS95, DOI 10.1080/13693780500051547; Kang MW, 2008, CELL PHYSIOL BIOCHEM, V21, P215, DOI 10.1159/000113763; Krappmann S, 2004, MOL MICROBIOL, V52, P785, DOI 10.1111/j.1365-2958.2004.04015.x; Kwon-Chung KJ, 2009, MED MYCOL, V47, pS97, DOI 10.1080/13693780802056012; Lacadena J, 2007, FEMS MICROBIOL REV, V31, P212, DOI 10.1111/j.1574-6976.2006.00063.x; Lamarre C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-417; LAMBOU K, MOL MICROBIOL; Langfelder K, 2001, INFECT IMMUN, V69, P6411, DOI 10.1128/IAI.69.10.6411-6418.2001; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Li SM, 2006, PLANTA MED, V72, P1117, DOI 10.1055/s-2006-947195; Loeffler J, 2009, J MED MICROBIOL, V58, P49, DOI 10.1099/jmm.0.003293-0; Luther K, 2006, MED MYCOL, V44, pS219, DOI 10.1080/13693780600892972; Malicev E, 2007, MED MYCOL, V45, P123, DOI 10.1080/13693780601039615; Martinez-Ruiz A, 1999, TOXICON, V37, P1549, DOI 10.1016/S0041-0101(99)00103-8; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Mezger M, 2008, BLOOD, V111, P534, DOI 10.1182/blood-2007-05-090928; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ok M, 2009, CLIN VACCINE IMMUNOL, V16, P1485, DOI 10.1128/CVI.00175-08; Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Phadke AP, 2005, MED MYCOL, V43, pS173, DOI 10.1080/13693780500052099; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Romani L, 2002, TRENDS MICROBIOL, V10, P508, DOI 10.1016/S0966-842X(02)02460-5; Romani L, 2009, MED MYCOL, V47, pS154, DOI 10.1080/13693780802139867; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasse C, 2008, FUNGAL GENET BIOL, V45, P693, DOI 10.1016/j.fgb.2007.12.008; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Serrano-Gomez D, 2005, IMMUNOBIOLOGY, V210, P175, DOI 10.1016/j.imbio.2005.05.011; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Shibuya Kazutoshi, 2006, Nihon Ishinkin Gakkai Zasshi, V47, P249, DOI 10.3314/jjmm.47.249; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Watts C, 2006, CELL, V126, P17, DOI 10.1016/j.cell.2006.06.031; Willger S, 2009, MED MYCOL, V47, pS72, DOI 10.1080/13693780802455313; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xie DX, 2009, INT IMMUNOL, V21, P1251, DOI 10.1093/intimm/dxp087	80	50	146	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16016	10.1371/journal.pone.0016016	http://dx.doi.org/10.1371/journal.pone.0016016			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264256	Green Submitted, Green Published, gold			2022-12-25	WOS:000286516500022
J	Lee, CH; Wang, JD; Chen, PC				Lee, Chang-Hsing; Wang, Jung-Der; Chen, Pau-Chung			Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639,779 Patients with Hepatitis B Virus Infection	PLOS ONE			English	Article							AUTOIMMUNE HEPATITIS; MEDICINE; TAIWAN	Background: Chinese herbal products (CHPs) containing Radix bupleuri are often prescribed for chronic hepatitis. There have been no epidemiological studies in populations with hepatitis B virus (HBV) infection. Our study was conducted to determine the association between the use of CHPs containing Radix bupleuri and the risk of hospitalisation related to liver injury among HBV-infected patients in Taiwan. Methods: From a total of 639,779 patients with diagnoses related to HBV infection, we included hospitalised adult cases with a primary diagnosis of liver injury in the database of Taiwan's national health insurance during the period 1997-2004. Case-control and case-crossover designs were used to assess the risk of hospitalisation with conditional logistic regression models constructed and adjusted for 270 conventionally hepatotoxic drugs. Cumulative doses of these CHPs and Radix bupleuri were assessed for any dose-response relationship. Findings: In total, we collected 1,080 cases fulfilled the inclusion criteria. In the case-control design, the adjusted odds ratio was 1.90 (95% confidence interval [CI]: 1.30 to 2.77). The risks from prescribing the CHPs Xiao-Chai-Hu-Tang and Long-Dan-Xie-Gan-Tang were significantly high, and dose-response relationships were found. The risk of adding each 19 gm dose of Radix bupleuri was 2.19 (95% CI: 1.66 to 2.89). The results using the case-crossover design remained similar. Conclusions: Prescribing Xiao-Chai-Hu-Tang, Long-Dan-Xie-Gan-Tang, or CHPs containing more than 19 gram of Radix bupleuri in HBV-infected patients might increase their risks of liver injury. Further studies are indicated to corroborate the above findings.	[Lee, Chang-Hsing; Wang, Jung-Der; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan; [Lee, Chang-Hsing] Ton Yen Gen Hosp, Dept Occupat Med, Hsinchu, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan	National Taiwan University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital	Lee, CH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan.	pchen@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974	National Science Council, Taiwan [NSC98-2314-B-002-129]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by the National Science Council (NSC98-2314-B-002-129), Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN BR, 1990, LANCET, V336, P177, DOI 10.1016/0140-6736(90)91696-8; Borum ML, 2001, AM J GASTROENTEROL, V96, P1654, DOI 10.1111/j.1572-0241.2001.03827.x; *CDCP, 2008, GUID COMM DIS SURV; Centers for Disease Control and Prevention, 1979, INT CLASS DIS 9 REV; Chen CJ, 2004, HEPATOLOGY, V39, P1196, DOI 10.1002/hep.20222; Chen FP, 2008, J ETHNOPHARMACOL, V117, P84, DOI 10.1016/j.jep.2008.01.018; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Haller CA, 2002, WESTERN J MED, V176, P39, DOI 10.1136/ewjm.176.1.39; Hsu Li-Ming, 2006, J Chin Med Assoc, V69, P86, DOI 10.1016/S1726-4901(09)70119-4; Ikegami F, 2006, HUM EXP TOXICOL, V25, P481, DOI 10.1191/0960327106het654oa; ITOH S, 1995, DIGEST DIS SCI, V40, P1845, DOI 10.1007/BF02212712; Kamiyama T, 1997, AM J GASTROENTEROL, V92, P703; KANE JA, 1995, GUT, V36, P146, DOI 10.1136/gut.36.1.146; Larrey D, 2002, SEMIN LIVER DIS, V22, P145, DOI 10.1055/s-2002-30101; Lee CH, 2006, J ALTERN COMPLEM MED, V12, P233, DOI 10.1089/acm.2006.12.233; Mantani N, 2002, PHYTOMEDICINE, V9, P280, DOI 10.1078/0944-7113-00141; Melchart D, 1999, JAMA-J AM MED ASSOC, V282, P28, DOI 10.1001/jama.282.1.28; Modi AA, 2007, ANTIVIR THER, V12, P285; National Health Research Institutes, 2003, NAT HLTH INS RES DAT; OKA H, 1995, CANCER-AM CANCER SOC, V76, P743, DOI 10.1002/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V; Park GJH, 2001, J GASTROEN HEPATOL, V16, P115, DOI 10.1046/j.1440-1746.2001.02309.x; *THOMS HEALTHC, 2006, MICROMEDEX HEALTHC S, V127; *WHO, 1999, WHO MON MED PLANTS R; Wong VWS, 2005, COMPLEMENT THER MED, V13, P175, DOI 10.1016/j.ctim.2005.04.006; Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x; 2000, J FOOD DRUG ANAL, V8, P270	26	36	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16064	10.1371/journal.pone.0016064	http://dx.doi.org/10.1371/journal.pone.0016064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264326	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514300005
J	Keatley, BE; Bennett, EM; MacDonald, GK; Taranu, ZE; Gregory-Eaves, I				Keatley, Bronwyn E.; Bennett, Elena M.; MacDonald, Graham K.; Taranu, Zofia E.; Gregory-Eaves, Irene			Land-Use Legacies Are Important Determinants of Lake Eutrophication in the Anthropocene	PLOS ONE			English	Article							GLOBAL POPULATION; SURFACE WATERS; PHOSPHORUS; PALEOLIMNOLOGY; AGRICULTURE; CROPLANDS; SOILS	Background: A hallmark of the latter half of the 20(th) century is the widespread, rapid intensification of a variety of anthropogenically-driven environmental changes-a "Great Acceleration." While there is evidence of a Great Acceleration in a variety of factors known to be linked to water quality degradation, such as conversion of land to agriculture and intensification of fertilizer use, it is not known whether there has been a similar acceleration of freshwater eutrophication. Methodology/Principal Findings: Using quantitative reconstructions of diatom-inferred total phosphorus (DI-TP) as a proxy for lake trophic state, we synthesized results from 67 paleolimnological studies from across Europe and North America to evaluate whether most lakes showed a pattern of eutrophication with time and whether this trend was accelerated after 1945 CE, indicative of a Great Acceleration. We found that European lakes have experienced widespread increases in DI-TP over the 20(th) century and that 33% of these lakes show patterns consistent with a post-1945 CE Great Acceleration. In North America, the proportion of lakes that increased in DI-TP over time is much lower and only 9% exhibited a Great Acceleration of eutrophication. Conclusions/Significance: The longer and more widespread history of anthropogenic influence in Europe, the leading cause for the relatively pervasive freshwater eutrophication, provides an important cautionary tale; our current path of intensive agriculture around the world may lead to an acceleration of eutrophication in downstream lakes that could take centuries from which to recover.	[Keatley, Bronwyn E.; Bennett, Elena M.; MacDonald, Graham K.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Keatley, Bronwyn E.; Bennett, Elena M.; MacDonald, Graham K.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Keatley, Bronwyn E.; Taranu, Zofia E.; Gregory-Eaves, Irene] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University; McGill University	Keatley, BE (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.	irene.gregory-eaves@mcgill.ca	MacDonald, Graham/L-5648-2019; Bennett, Elena/A-9553-2008; Gregory-Eaves, Irene/U-9325-2019	MacDonald, Graham/0000-0002-7120-1366; Gregory-Eaves, Irene/0000-0002-0380-5061; Bennett, Elena/0000-0003-3944-2925	Natural Sciences and Engineering Research Council (NSERC) Discovery; Canadian Foundation for Innovation; McGill School of Environment Interdisciplinary Research Seed Fund; Tomlinson Fellowshi; Le Fonds Quebecois de la Recherche sur la Nature et les Technologies	Natural Sciences and Engineering Research Council (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); McGill School of Environment Interdisciplinary Research Seed Fund; Tomlinson Fellowshi; Le Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	The authors acknowledge funding from Natural Sciences and Engineering Research Council (NSERC) Discovery, Canadian Foundation for Innovation, and McGill School of Environment Interdisciplinary Research Seed Fund grants awarded to IG-E and EMB; a Tomlinson Fellowship awarded to BEK; and NSERC and Le Fonds Quebecois de la Recherche sur la Nature et les Technologies Scholarships awarded to GKM and ZET, respectively. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; [Anonymous], 1995, PHOSPHORUS GLOBAL EN; Assessment M.E., 2005, ECOSYSTEMS HUMAN WEL; BATTARBEE R, 2010, J PALEOLIMNOLOGY; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; D'Arcy P, 1997, CAN J FISH AQUAT SCI, V54, P2215, DOI 10.1139/cjfas-54-10-2215; DILLON PJ, 1975, WATER RES, V9, P135, DOI 10.1016/0043-1354(75)90002-0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Hall R.I., 2010, DIATOMS APPL ENV EAR; Hall RI, 1999, LIMNOL OCEANOGR, V44, P739, DOI 10.4319/lo.1999.44.3_part_2.0739; HECKRATH G, 1995, J ENVIRON QUAL, V24, P904, DOI 10.2134/jeq1995.00472425002400050018x; Hesketh N, 2000, J ENVIRON QUAL, V29, P105, DOI 10.2134/jeq2000.00472425002900010013x; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Lotter AF, 2001, J PALEOLIMNOL, V25, P65, DOI 10.1023/A:1008140122230; McDowell RW, 2001, J ENVIRON QUAL, V30, P508, DOI 10.2134/jeq2001.302508x; Miettinen J, 2002, J PALEOLIMNOL, V27, P29, DOI 10.1023/A:1013550811858; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ramankutty N, 2002, AMBIO, V31, P251, DOI 10.1639/0044-7447(2002)031[0251:POTLCI]2.0.CO;2; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Smol J.P., 2009, POLLUTION LAKES RIVE; Steffen W., 2004, IGBP BOOK SERIES; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Taranu ZE, 2008, ECOSYSTEMS, V11, P715, DOI 10.1007/s10021-008-9153-0; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261	30	38	38	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15913	10.1371/journal.pone.0015913	http://dx.doi.org/10.1371/journal.pone.0015913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264341	Green Published, Green Submitted, gold			2022-12-25	WOS:000286513100017
J	Venticinque, L; Jamieson, KV; Meruelo, D				Venticinque, Lisa; Jamieson, Kelly V.; Meruelo, Daniel			Interactions Between Laminin Receptor and the Cytoskeleton During Translation and Cell Motility	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; BINDING PROTEIN; INTERMEDIATE-FILAMENTS; MESSENGER-RNA; HELA-CELLS; MICROFILAMENT BUNDLES; EMBRYO FIBROBLASTS; SURFACE RECEPTOR; MAMMALIAN-CELLS; ACTIN	Human laminin receptor acts as both a component of the 40S ribosomal subunit to mediate cellular translation and as a cell surface receptor that interacts with components of the extracellular matrix. Due to its role as the cell surface receptor for several viruses and its overexpression in several types of cancer, laminin receptor is a pathologically significant protein. Previous studies have determined that ribosomes are associated with components of the cytoskeleton, however the specific ribosomal component(s) responsible has not been determined. Our studies show that laminin receptor binds directly to tubulin. Through the use of siRNA and cytoskeletal inhibitors we demonstrate that laminin receptor acts as a tethering protein, holding the ribosome to tubulin, which is integral to cellular translation. Our studies also show that laminin receptor is capable of binding directly to actin. Through the use of siRNA and cytoskeletal inhibitors we have shown that this laminin receptor-actin interaction is critical for cell migration. These data indicate that interactions between laminin receptor and the cytoskeleton are vital in mediating two processes that are intimately linked to cancer, cellular translation and migration.	[Venticinque, Lisa] NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10003 USA; NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; New York University	Venticinque, L (corresponding author), NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10003 USA.	DM01@mac.com			Litwin foundation; National Cancer Institute, National Institutes of Health [CA100687]; Department of Health and Human Services; NATIONAL CANCER INSTITUTE [R01CA100687] Funding Source: NIH RePORTER	Litwin foundation; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a generous donation from the Litwin foundation and the U.S. Public Health grant CA100687 from the National Cancer Institute, National Institutes of Health, and Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; Basolo F, 1996, CLIN CANCER RES, V2, P1777; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; BROWN S, 1976, J SUPRAMOL STR CELL, V5, P119, DOI 10.1002/jss.400050203; BROWN SS, 1983, P NATL ACAD SCI-BIOL, V80, P5927, DOI 10.1073/pnas.80.19.5927; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2; Chuong SDX, 2004, MOL CELL PROTEOMICS, V3, P970, DOI 10.1074/mcp.M400053-MCP200; CODY RL, 1986, EXP CELL RES, V165, P107, DOI 10.1016/0014-4827(86)90536-7; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; FERRARI S, 1990, CANCER RES, V50, P5825; Ford CL, 1999, CANCER RES, V59, P704; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GOLDMAN RD, 1975, EXP CELL RES, V90, P333, DOI 10.1016/0014-4827(75)90323-7; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; HAMILL D, 1994, J CELL BIOL, V127, P973, DOI 10.1083/jcb.127.4.973; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; HESKETH JE, 1991, CELL BIOL INT REP, V15, P141, DOI 10.1016/0309-1651(91)90105-R; HUGLE B, 1985, J CELL BIOL, V100, P873, DOI 10.1083/jcb.100.3.873; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jamieson KV, 2008, J BIOL CHEM, V283, P3002, DOI 10.1074/jbc.C700206200; JAMIESON KV, 2010, J MOL BIOL; Kaneda Y, 1998, CELL DEATH DIFFER, V5, P20, DOI 10.1038/sj.cdd.4400315; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kondoh N, 2001, ANTICANCER RES, V21, P2429; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Loging WT, 1999, CANCER EPIDEM BIOMAR, V8, P1011; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MAFUNE K, 1992, J SURG RES, V52, P340, DOI 10.1016/0022-4804(92)90113-E; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; MITCHISON TJ, 1995, PHILOS T ROY SOC B, V349, P299, DOI 10.1098/rstb.1995.0117; ORNELLES DA, 1986, MOL CELL BIOL, V6, P1650, DOI 10.1128/MCB.6.5.1650; OSBORN M, 1977, EXP CELL RES, V106, P339, DOI 10.1016/0014-4827(77)90179-3; Pelosi G, 1997, J PATHOL, V183, P62, DOI 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A; PINEIRO D, 2010, MOL CELL BIOCH; Pineiro D, 2007, EXP CELL RES, V313, P3694, DOI 10.1016/j.yexcr.2007.07.025; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; SCHEIMAN J, MOL THER, V18, P63; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25; TOH BH, 1980, CELL TISSUE RES, V211, P163; Traub P, 1998, BIOL CELL, V90, P319, DOI 10.1016/S0248-4900(98)80013-0; vandenBrule FA, 1996, EUR J CANCER, V32A, P1598, DOI 10.1016/0959-8049(96)00119-0; VANVENROOIJ WJ, 1981, EXP CELL RES, V135, P79, DOI 10.1016/0014-4827(81)90301-3; VEDELER A, 1991, MOL CELL BIOCHEM, V100, P183; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; WEWER UM, 1987, CANCER RES, V47, P5691; WOLOSEWICK JJ, 1976, AM J ANAT, V147, P303, DOI 10.1002/aja.1001470305; YANNARIELLOBROWN J, 1988, J CELL BIOL, V106, P1773, DOI 10.1083/jcb.106.5.1773	63	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15895	10.1371/journal.pone.0015895	http://dx.doi.org/10.1371/journal.pone.0015895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249134	Green Published, gold, Green Submitted			2022-12-25	WOS:000286512900011
J	Peiris, PM; Schmidt, E; Calabrese, M; Karathanasis, E				Peiris, Pubudu M.; Schmidt, Erik; Calabrese, Michael; Karathanasis, Efstathios			Assembly of Linear Nano-Chains from Iron Oxide Nanospheres with Asymmetric Surface Chemistry	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; GOLD NANOPARTICLES; FUNCTIONALIZATION; NANOTECHNOLOGY; PARTICLES; NANOWORMS; TRANSPORT; MOTION	Besides the multifunctionality, another equally important aspect of nanoparticles is their engineerability to control the geometrical and chemical properties during fabrication. In this work, we exploited this aspect to define asymmetric surface chemistry of an iron oxide nanosphere by controlling the topology of ligand expression on its surface resulting in a particle with two faces, one displaying only amines and the other only thiols. Specifically, amine-functionalized iron oxide nanospheres were attached on a solid support via a crosslinker containing a disulfide bridge. Liberation of the nanosphere using thiolytic cleavage created thiols on the portion of the particle's surface that interacted with the solid support. Employing a solid-phase strategy and a step-by-step addition of particles, the two unique faces on the same nanosphere served as fittings to assemble them into linear nano-chains. Assembly of chains with various lengths and aspect ratios was controlled by the size and number of the added nanospheres. The characteristics of those chains showed a high degree of uniformity indicating the exceptional control of the synthetic process. Notably, one of the unique properties of the iron oxide nano-chains was an increased magnetic relaxivity, indicating their potential use as contrast agents for magnetic resonance imaging.	[Peiris, Pubudu M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Radiol, Case Ctr Imaging Res, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Peiris, PM (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	stathis@case.edu		Karathanasis, Efstathios/0000-0001-7484-7552	Case Western Reserve University	Case Western Reserve University	This study was supported by a discretionary fund provided by Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2005, ADV MATER, V17, P1949, DOI 10.1002/adma.200401904; Dai Q, 2005, J AM CHEM SOC, V127, P8008, DOI 10.1021/ja042610v; Decuzzi P, 2006, BIOMATERIALS, V27, P5307, DOI 10.1016/j.biomaterials.2006.05.024; Decuzzi P, 2006, ANN BIOMED ENG, V34, P633, DOI 10.1007/s10439-005-9072-6; Decuzzi P, 2008, BIOMATERIALS, V29, P377, DOI 10.1016/j.biomaterials.2007.09.025; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gavze E, 1998, J FLUID MECH, V371, P59, DOI 10.1017/S0022112098002109; Gentile F, 2008, ANN BIOMED ENG, V36, P254, DOI 10.1007/s10439-007-9423-6; Ghaghada KB, 2005, J CONTROL RELEASE, V104, P113, DOI 10.1016/j.jconrel.2005.01.012; GHAGHADA KB, 2006, THESIS U HOUSTON HOU; Gossuin Y, 2010, CONTRAST MEDIA MOL I, V5, P318, DOI 10.1002/cmmi.387; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jeppesen C, 2001, SCIENCE, V293, P465, DOI 10.1126/science.293.5529.465; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Lasic DD, 1996, NATURE, V380, P561, DOI 10.1038/380561a0; LI B, 2007, J AM CHEM SOC, V129; Liu X, 2006, SMALL, V2, P1126, DOI 10.1002/smll.200600162; Lu J, 2009, BIOMATERIALS, V30, P2919, DOI 10.1016/j.biomaterials.2009.02.001; LUDWIG FR, 1985, EUR J BIOCHEM, V151, P83, DOI 10.1111/j.1432-1033.1985.tb09071.x; Maus L, 2009, LANGMUIR, V25, P7910, DOI 10.1021/la900545t; Park JH, 2008, ADV MATER, V20, P1630, DOI 10.1002/adma.200800004; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Pegg EC, 2009, J BIOMED MATER RES A, V90A, P947, DOI 10.1002/jbm.a.32155; Sardar R, 2008, NANO LETT, V8, P731, DOI 10.1021/nl073154m; Sardar R, 2007, J AM CHEM SOC, V129, P5356, DOI 10.1021/ja070933w; Service RF, 2005, SCIENCE, V310, P1132, DOI 10.1126/science.310.5751.1132; Simard J, 2000, CHEM COMMUN, P1943, DOI 10.1039/b004162i; Socrates G, 1994, INFRARED CHARACTERIS; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Sung KM, 2004, J AM CHEM SOC, V126, P5064, DOI 10.1021/ja049578p; Worden JG, 2004, CHEM COMMUN, P518, DOI 10.1039/b312819a; YANG L, 2008, SMALL, V133, P154; Yang LL, 2009, CLIN CANCER RES, V15, P4722, DOI 10.1158/1078-0432.CCR-08-3289; Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8; Yuet KP, 2010, LANGMUIR, V26, P4281, DOI 10.1021/la903348s	38	36	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15927	10.1371/journal.pone.0015927	http://dx.doi.org/10.1371/journal.pone.0015927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253600	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900026
J	Slove, J; Janz, N				Slove, Jessica; Janz, Niklas			The Relationship between Diet Breadth and Geographic Range Size in the Butterfly Subfamily Nymphalinae - A Study of Global Scale	PLOS ONE			English	Article							HOST-PLANT SPECIALIZATION; PHYLOGENETIC-RELATIONSHIPS; LEPIDOPTERA; DIVERSIFICATION; HERITABILITY; EVOLUTION; COLONIZATION; EXPANSIONS; SPECIATION; RESOLUTION	The "oscillation hypothesis" has been proposed as a general explanation for the exceptional diversification of herbivorous insect species. The hypothesis states that speciation rates are elevated through repeated correlated changes - oscillations - in degree of host plant specificity and geographic range. The aim of this study is to test one of the predictions from the oscillation hypothesis: a positive correlation between diet breadth (number of host plants used) and geographic range size, using the globally distributed butterfly subfamily Nymphalinae. Data on diet breadth and global geographic range were collected for 182 Nymphalinae butterflies species and the size of the geographic range was measured using a GIS. We tested both diet breadth and geographic range size for phylogenetic signal to see if species are independent of each other with respect to these characters. As this test gave inconclusive results, data was analysed both using cross-species comparisons and taking phylogeny into account using generalised estimating equations as applied in the APE package in R. Irrespective of which method was used, we found a significant positive correlation between diet breadth and geographic range size. These results are consistent for two different measures of diet breadth and removal of outliers. We conclude that the global range sizes of Nymphalinae butterflies are correlated to diet breadth. That is, butterflies that feed on a large number of host plants tend to have larger geographic ranges than do butterflies that feed on fewer plants. These results lend support for an important step in the oscillation hypothesis of plant-driven diversification, in that it can provide the necessary fuel for future population fragmentation and speciation.	[Slove, Jessica; Janz, Niklas] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Slove, J (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	jessica.slove@zoologi.su.se	Janz, Niklas/B-1756-2010	Janz, Niklas/0000-0002-6379-7905	Swedish National Science Research Council	Swedish National Science Research Council	This work was supported by a grant from the Swedish National Science Research Council to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Beck J, 2006, GLOBAL ECOL BIOGEOGR, V15, P339, DOI 10.1111/j.1466-822x.2006.00230.x; Benkman CW, 1999, AM NAT, V153, pS75, DOI 10.1086/303213; Blackburn TM, 2004, J BIOGEOGR, V31, P285, DOI 10.1046/j.0305-0270.2003.01018.x; Braby MF, 2000, BUTTERFLIES AUSTR TH; Brandle M, 2002, EVOL ECOL RES, V4, P993; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Corbet A.S., 1992, BUTTERFLIES MALAY PE; Dennis RLH, 2000, BIODIVERS CONSERV, V9, P343, DOI 10.1023/A:1008924329854; DeVries PJ, 1987, BUTTERFLIES COSTA RI; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Erwin T.L., 1979, P539; Erwin T.L., 1981, P159; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; IGARASHI S, 1997, LIFE HIST ASIAN BUTT; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Kodandaramaiah U, 2007, J EVOLUTION BIOL, V20, P2181, DOI 10.1111/j.1420-9101.2007.01425.x; LARSEN TB, 1992, BUTTERFLIES KENYA TH; Larsen TB, 2005, BUTTERFLIES W AFRICA; Leneveu J, 2009, BIOL J LINN SOC, V97, P346, DOI 10.1111/j.1095-8312.2009.01208.x; Miller M. A., 2010, CIPRES PORTALS; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Mouillot D, 2007, GLOBAL ECOL BIOGEOGR, V16, P367, DOI 10.1111/j.1466-8238.2007.00292.x; Nosil P, 2002, EVOLUTION, V56, P1701, DOI 10.1111/j.0014-3820.2002.tb01482.x; Nylin S, 2009, EVOL ECOL, V23, P137, DOI 10.1007/s10682-007-9205-5; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Paivinen J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-5; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARSONS M, 1992, WAU ECOLOGY I HDB, V12; Parsons MJ., 1998, BUTTERFLIES PAPUA NE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Quinn RM, 1998, ECOGRAPHY, V21, P279, DOI 10.1111/j.1600-0587.1998.tb00565.x; R Development Core Team, 2009, R FDN STAT COMP; SAVELA M, 2007, LEPIDOPTERA SOME OTH; Scott JA., 1986, BUTTERFLIES N AM NAT; Smith D. S., 1994, BUTTERFLIES W INDIES; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Stireman JO, 2005, J EVOLUTION BIOL, V18, P325, DOI 10.1111/j.1420-9101.2004.00850.x; Strong D.R., 1984, INSECTS PLANTS COMMU; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tennent W.J., 2002, BUTTERFLIES SOLOMON; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 1994, COEVOLUTIONARY PROCE; Wahlberg N, 2005, BIOL J LINN SOC, V86, P227, DOI 10.1111/j.1095-8312.2005.00531.x; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wahlberg N, 2007, MOL PHYLOGENET EVOL, V44, P1257, DOI 10.1016/j.ympev.2007.04.012; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wahlberg N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-92; Webb TJ, 2003, AM NAT, V161, P553, DOI 10.1086/368296; Weingartner E, 2006, J EVOLUTION BIOL, V19, P483, DOI 10.1111/j.1420-9101.2005.01009.x; West-Eberhard Mary Jane, 2003, pi; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zimmermann M, 2000, ANN ENTOMOL SOC AM, V93, P347, DOI 10.1603/0013-8746(2000)093[0347:POECBL]2.0.CO;2	69	37	37	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e16057	10.1371/journal.pone.0016057	http://dx.doi.org/10.1371/journal.pone.0016057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246054	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200032
J	Chou, CS; Nie, Q; Yi, TM				Chou, Ching-Shan; Nie, Qing; Yi, Tau-Mu			Modeling Robustness Tradeoffs in Yeast Cell Polarization Induced by Spatial Gradients	PLOS ONE			English	Article							EXCHANGE FACTOR CDC24; PROTEINS; DIFFUSION; CHEMOTAXIS; GROWTH; MOVEMENT; POLARITY	Cells localize (polarize) internal components to specific locations in response to external signals such as spatial gradients. For example, yeast cells form a mating projection toward the source of mating pheromone. There are specific challenges associated with cell polarization including amplification of shallow external gradients of ligand to produce steep internal gradients of protein components (e. g. localized distribution), response over a broad range of ligand concentrations, and tracking of moving signal sources. In this work, we investigated the tradeoffs among these performance objectives using a generic model that captures the basic spatial dynamics of polarization in yeast cells, which are small. We varied the positive feedback, cooperativity, and diffusion coefficients in the model to explore the nature of this tradeoff. Increasing the positive feedback gain resulted in better amplification, but also produced multiple steady-states and hysteresis that prevented the tracking of directional changes of the gradient. Feedforward/ feedback coincidence detection in the positive feedback loop and multi-stage amplification both improved tracking with only a modest loss of amplification. Surprisingly, we found that introducing lateral surface diffusion increased the robustness of polarization and collapsed the multiple steady-states to a single steady-state at the cost of a reduction in polarization. Finally, in a more mechanistic model of yeast cell polarization, a surface diffusion coefficient between 0.01 and 0.001 mu m(2)/s produced the best polarization performance, and this range is close to the measured value. The model also showed good gradient-sensitivity and dynamic range. This research is significant because it provides an in-depth analysis of the performance tradeoffs that confront biological systems that sense and respond to chemical spatial gradients, proposes strategies for balancing this tradeoff, highlights the critical role of lateral diffusion of proteins in the membrane on the robustness of polarization, and furnishes a framework for future spatial models of yeast cell polarization.	[Chou, Ching-Shan; Nie, Qing] Univ Calif Irvine, Dept Math, Ctr Math & Computat Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA; [Yi, Tau-Mu] Univ Calif Irvine, Ctr Complex Biol Syst, Dept Dev & Cell Biol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Chou, CS (corresponding author), Univ Calif Irvine, Dept Math, Ctr Math & Computat Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	tmy@uci.edu			NIH [R01GM75309, P50GM76516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM075309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH grants R01GM75309 (through the joint NSF/NIGMS initiative to support research in the area of mathematical biology) to QN and TMY, and P50GM76516 to QN and TMY.	ANDREWS BW, 2006, PLOS COMP BIOL, V2; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; [Anonymous], 2004, SYSTEMS BIOL, V1, P54, DOI 10.1049/sb:20045001; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Briggs WL, 2000, MULTIGRID TUTORIAL; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Haugh JM, 2004, BIOPHYS J, V86, P589, DOI 10.1016/S0006-3495(04)74137-5; Horowitz P., 2015, ART ELECT; Iglesias Pablo A, 2002, Sci STKE, V2002, pre12, DOI 10.1126/stke.2002.148.re12; JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; MALY VI, 2004, BIOPHYS J, V86; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Meinhardt H, 1999, J CELL SCI, V112, P2867; Meinhardt H., 1982, MODELS BIOL PATTERN; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Onsum M, 2007, PLOS COMPUT BIOL, V3, P436, DOI 10.1371/journal.pcbi.0030036; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Pruyne D, 2000, J CELL SCI, V113, P365; Skupsky R, 2005, BIOPHYS J, V89, P2806, DOI 10.1529/biophysj.105.061564; Thompson D.W., 1961, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Yi TM, 2007, J STAT PHYS, V128, P193, DOI 10.1007/s10955-007-9285-1; Yi TM, 2007, METHOD ENZYMOL, V422, P123, DOI 10.1016/S0076-6879(06)22006-8	34	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3103	10.1371/journal.pone.0003103	http://dx.doi.org/10.1371/journal.pone.0003103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	21267054	Green Published, Green Submitted, gold			2022-12-25	WOS:000264416600003
J	Barroso-delJesus, A; Lucena-Aguilar, G; Sanchez, L; Ligero, G; Gutierrez-Aranda, I; Menendez, P				Barroso-delJesus, Alicia; Lucena-Aguilar, Gema; Sanchez, Laura; Ligero, Gertrudis; Gutierrez-Aranda, Ivan; Menendez, Pablo			The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells	FASEB JOURNAL			English	Article						hESC; TGF beta/Nodal pathway; self-renewal	CD34(+); QUALITY; TRANSPLANTATION; MAINTENANCE; DERIVATION; DISCOVERY; REVEALS; DICER; IGF; P53	MicroRNAs (miRNAs) have been shown to be important in early development and maintenance of human embryonic stem cells (hESCs). The miRNA miR-302-367 is specifically expressed in hESCs, and its expression decays on differentiation. We previously identified the structure of the gene coding for the human miR-302-367 cluster and characterized its promoter. The promoter activity was functionally validated in hESCs, opening up new avenues to further investigate how these miRNA molecules fit in the complex molecular network conferring "stemness" properties to hESCs. The physiological roles of specific miRNA-mRNA interactions remain largely unknown. Here, we investigated putative miR-302-367 mRNA targets in hESCs, potentially relevant for ESC biology. We found that the Nodal inhibitors Lefty1 and Lefty2 are post-transcriptionally targeted by miR-302s in hESCs. Functional analyses indicate that miR-302s negatively modulate the level of lefties, and become upstream regulators of the TGF beta/Nodal pathway, functioning via Smad-2/3 signaling. Overexpression of the miR-302-367 cluster in hESCs causes a delay in early hESC differentiation, as measured by enhanced levels of ESC-specific transcription factors, coupled to a faster teratoma formation in mice transplanted with miR-302-367-expressing hESCs and a concomitant impairment of germ layer specification, displaying robust decreased levels of early mesodermal, endodermal, and ectodermal specific markers. These findings suggest that Lefty is negatively modulated by miR-302s in hESCs, which plays an important role in maintaining the balance between pluripotency and germ layer specification.-Barroso-delJesus, A., Lucena-Aguilar, G., Sanchez, L., Ligero, G., Gutierrez-Aranda, I., Menendez, P. The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J. 25, 1497-1508 (2011). www.fasebj.org	[Barroso-delJesus, Alicia] CSIC, Genom Facil, Inst Parasitol & Biomed Lopez Neyra, Armilla 18100, Granada, Spain; [Barroso-delJesus, Alicia; Lucena-Aguilar, Gema; Sanchez, Laura; Ligero, Gertrudis; Gutierrez-Aranda, Ivan; Menendez, Pablo] Univ Granada, Consejeria Salud, Ctr Invest Biomed, Andalusian Stem Cell Bank, Armilla, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada	Barroso-delJesus, A (corresponding author), CSIC, Genom Facil, Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento, Armilla 18100, Granada, Spain.	abarroso@ipb.csic.es; pablo.menendez@juntadeandalucia.es	Bujan, Pablo Menendez/W-3736-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; SANCHEZ CONTRERAS, LAURA/0000-0003-2243-6166; Barroso-delJesus, Alicia/0000-0001-8558-0056; Ligero Martin, Gertrudis/0000-0002-5559-0664	Consejeria de Salud [0004/2005, 0030/2006]; Consejeria de Innovacion de la Junta de Andalucia [P08-CTS-3678]; Spanish Ministry of Health (FIS/FEDER) [PI070026, PI100449]; Ministerio de Ciencia e Innovacion [PLE-2009-0111]	Consejeria de Salud; Consejeria de Innovacion de la Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Health (FIS/FEDER)(Instituto de Salud Carlos IIISpanish GovernmentEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by the Consejeria de Salud (grants 0004/2005 to A.B.-D. and 0030/2006 to P. M.) and Consejeria de Innovacion de la Junta de Andalucia (grant P08-CTS-3678 to P. M.), the Spanish Ministry of Health (FIS/FEDER PI070026 and PI100449 to P. M.) and the Ministerio de Ciencia e Innovacion (PLE-2009-0111 to P. M.). The authors thank members of the BACM for their technical support and critical insights. The authors especially thank Dr. Cristina Romero-Lopez for her help in the construction of plvx-302-367 vector and for scientific discussions. The authors are also indebted to Prof. Outi Hovatta (Karolinska Institute, Stockholm, Sweden), Profs. A. Rosa and A. H. Brivanlou (Rockefeller University, New York, NY, USA), and Dr. Alfredo Berzal Herranz (Instituto de Parasitologia y Biomedicina Lopez-Neyra, Granada, Spain) for providing key reagents. The authors declare no conflicts of interest. A.B.-D. designed and performed the experiments, analyzed and interpreted the data, and wrote the paper. G.L.-A., L. S., G. L., and I.G.-A. performed experiments and analyzed the data. P. M. analyzed and interpreted the data and wrote the paper.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; Bueno C, 2010, CYTOTHERAPY, V12, P45, DOI 10.3109/14653240903377052; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Catalina P, 2009, LEUKEMIA RES, V33, P980, DOI 10.1016/j.leukres.2008.08.028; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Cobo F, 2008, CLONING STEM CELLS, V10, P65, DOI 10.1089/clo.2007.0020; Cortes JL, 2008, STEM CELLS DEV, V17, P255, DOI 10.1089/scd.2007.0157; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Gratama JW, 2000, J IMMUNOL METHODS, V239, P13, DOI 10.1016/S0022-1759(00)00154-X; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jesus ABD, 2009, CELL CYCLE, V8, P394; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Laurent LC, 2008, J CELL MOL MED, V12, P2181, DOI 10.1111/j.1582-4934.2008.00513.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Menendez P, 2004, MOL THER, V10, P1109, DOI 10.1016/j.ymthe.2004.08.016; Menendez P, 1998, CYTOMETRY, V34, P264, DOI 10.1002/(SICI)1097-0320(19981215)34:6<264::AID-CYTO4>3.0.CO;2-P; Menendez P, 2002, BRIT J HAEMATOL, V119, P135, DOI 10.1046/j.1365-2141.2002.03794.x; Menendez P, 2005, STEM CELL REV, V1, P151, DOI 10.1385/SCR:1:2:151; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Ramos-Mejia V, 2010, MOL THER, V18, P2173, DOI 10.1038/mt.2010.179; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shojaei F, 2008, EXP HEMATOL, V36, P1436, DOI 10.1016/j.exphem.2008.06.001; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553	52	74	78	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1497	1508		10.1096/fj.10-172221	http://dx.doi.org/10.1096/fj.10-172221			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21266536				2022-12-25	WOS:000290023800008
J	Holscher, M; Silter, M; Krull, S; von Ahlen, M; Hesse, A; Schwartz, P; Wielockx, B; Breier, G; Katschinski, DM; Zieseniss, A				Hoelscher, Marion; Silter, Monique; Krull, Sabine; von Ahlen, Melanie; Hesse, Amke; Schwartz, Peter; Wielockx, Ben; Breier, Georg; Katschinski, Doerthe M.; Zieseniss, Anke			Cardiomyocyte-specific Prolyl-4-hydroxylase Domain 2 Knock Out Protects from Acute Myocardial Ischemic Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; PROLYL 4-HYDROXYLASES; REPERFUSION INJURY; HIF-ALPHA; FACTOR-I; HEART; HYDROXYLATION; PHD2; HYDROXYPROLINE; HYPERTROPHY	Prolylhydroxylase domain proteins (PHD) are cellular oxygen- sensing molecules that regulate the stability of the alpha-subunit of the transcription factor hypoxia inducible factor (HIF)-1. HIF-1 affects cardiac development as well as adaptation of the heart toward increased pressure overload or myocardial infarction. We have disrupted PHD2 in cardiomyocytes (cPhd(-/-)) using Phd2(flox/flox) mice in combination with MLCvCre mice, which resulted in HIF-1 alpha stabilization and activation of HIF target genes in the heart. Although cPhd2(-/-) mice showed no gross abnormalities in cardiac filament structure or function, we observed a significant increased cardiac capillary area in those mice. cPhd2(-/-) mice did not respond differently to increased mechanical load by transverse aortic constriction compared with their wild-type (wt) littermates. After ligation of the left anterior descending artery, however, the area at risk and area of necrosis were significantly smaller in the cPhd2(-/-) mice compared with Phd2 wt mice in line with the described pivotal role of HIF-1 alpha for tissue protection in case of myocardial infarction. This correlated with a decreased number of apoptotic cells in the infarcted myocardium in the cPhd2(-/-) mice and significantly improved cardiac function 3 weeks after myocardial infarction.	[Hoelscher, Marion; Silter, Monique; Krull, Sabine; von Ahlen, Melanie; Hesse, Amke; Katschinski, Doerthe M.; Zieseniss, Anke] Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, D-37073 Gottingen, Germany; [Schwartz, Peter] Univ Gottingen, Dept Anat & Embryol, Univ Med Gottingen, D-37073 Gottingen, Germany; [Wielockx, Ben; Breier, Georg] Tech Univ Dresden, Dept Pathol, D-01307 Dresden, Germany	University of Gottingen; University of Gottingen; Technische Universitat Dresden	Katschinski, DM (corresponding author), Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, Humboldtallee 23, D-37073 Gottingen, Germany.	katschinski@physiol.med.uni-goettingen.de	Wielockx, Ben/AAC-6854-2020; Breier, Georg/E-3580-2016	Wielockx, Ben/0000-0002-4923-2596; Breier, Georg/0000-0002-9467-780X	Kroner Fresenius Stiftung [P25/10//A12/10]; Deutsche Forschungsgemeinschaft [Ka1269/11-1, Br 1336/2-3, SFB 655 A8, Wi 3291/1-1]	Kroner Fresenius Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Kroner Fresenius Stiftung Grant P25/10//A12/10 (to A.Z.) and Deutsche Forschungsgemeinschaft Grants Ka1269/11-1 (to D.M.K.), Br 1336/2-3 and SFB 655 A8 (to G.B.), and Wi 3291/1-1 (to B.W.). The work was performed as collaborative project within the COST Action TD0901 "HypoxiaNet."	Adluri R. S., 2010, ANTIOXID RE IN PRESS; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bekeredjian R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011693; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bohl S, 2009, AM J PHYSIOL-HEART C, V297, pH2054, DOI 10.1152/ajpheart.00836.2009; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Katschinski DM, 2009, ACTA PHYSIOL, V195, P407, DOI 10.1111/j.1748-1716.2008.01952.x; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamisawa S, 1999, J BIOL CHEM, V274, P10066, DOI 10.1074/jbc.274.15.10066; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moslehi J, 2010, CIRCULATION, V122, P1004, DOI 10.1161/CIRCULATIONAHA.109.922427; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Palazzuoli A, 2010, VASC HEALTH RISK MAN, V6, P411; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Silter M, 2010, PFLUG ARCH EUR J PHY, V459, P569, DOI 10.1007/s00424-009-0748-x; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zieseniss A, 2007, CELL TISSUE RES, V327, P583, DOI 10.1007/s00441-006-0322-1	41	63	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11185	11194		10.1074/jbc.M110.186809	http://dx.doi.org/10.1074/jbc.M110.186809			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270129	Green Published, hybrid			2022-12-25	WOS:000288797100029
J	Pullen, L; Bolon, DN				Pullen, Lester; Bolon, Daniel N.			Enforced N-domain Proximity Stimulates Hsp90 ATPase Activity and Is Compatible with Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP90; HEAT-SHOCK-PROTEIN; CRYSTAL-STRUCTURE; STEROID-RECEPTOR; MOLECULAR CLAMP; CHAPERONE; HYDROLYSIS; CYCLE; NUCLEOTIDE; BINDING	Hsp90 populates distinct open and closed conformations mediated by transient N-terminal dimerization. To investigate the mechanistic role of these large conformational changes, we designed Hsp90 with an N-terminal coiled-coil to clamp the termini together and enforce N-domain proximity. Biophysical analyses demonstrate that the coiled-coil effectively maintains N-domain proximity in the absence of ATP, a condition that favors the open state of Hsp90. Enforcing N-domain proximity results in increased ATPase activity, indicating that N-terminal dimerization is a rate-limiting step that is sped-up with the coiled-coil due to increased effective N-domain concentration. The relative difference in ATPase activity between coil-Hsp90 and wt was reduced in the presence of both an ATPase activating (Aha1) and an inhibiting (Sba1) co-chaperone. As both of these co-chaperones bind preferentially to N-terminally dimerized Hsp90, the buffering effect of these co-chaperones demonstrates the biochemical relevance of Hsp90 conformational properties in addition to N-terminal dimerization. Enforcing N-domain proximity is compatible with viability in yeast, underlining the mechanistic relevance of Hsp90 conformational changes that are less dramatic than the transition between fully open and closed.	[Pullen, Lester; Bolon, Daniel N.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Bolon, DN (corresponding author), 364 Plantat St,UMMS LRB 922, Worcester, MA 01605 USA.	Dan.Bolon@umassmed.edu		Bolon, Daniel/0000-0001-5857-6676	National Institutes of Health [R01-GM083038-01A]; American Cancer Society [RSG-08-17301-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM083038-01A and by American Cancer Society Grant RSG-08-17301-GMC.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Wayne N, 2010, J BIOL CHEM, V285, P234, DOI 10.1074/jbc.M109.060129; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	33	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11091	11098		10.1074/jbc.M111.223131	http://dx.doi.org/10.1074/jbc.M111.223131			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278257	Green Published, hybrid			2022-12-25	WOS:000288797100020
J	Chen, TJ; Wang, JQ; Yang, R; Li, JC; Lin, M; Lin, ZL				Chen, Tingjian; Wang, Jianqing; Yang, Rong; Li, Jicong; Lin, Min; Lin, Zhanglin			Laboratory-Evolved Mutants of an Exogenous Global Regulator, IrrE from Deinococcus radiodurans, Enhance Stress Tolerances of Escherichia coli	PLOS ONE			English	Article							ETHANOL-PRODUCTION; TRANSCRIPTION MACHINERY; OXIDATIVE STRESS; GAF DOMAINS; IMPROVEMENT; GENE; RADIORESISTANCE; EXPRESSION; MICROBES; PROTEOME	Background: The tolerance of cells toward different stresses is very important for industrial strains of microbes, but difficult to improve by the manipulation of single genes. Traditional methods for enhancing cellular tolerances are inefficient and time-consuming. Recently, approaches employing global transcriptional or translational engineering methods have been increasingly explored. We found that an exogenous global regulator, irrE from an extremely radiation-resistant bacterium, Deinococcus radiodurans, has the potential to act as a global regulator in Escherichia coli, and that laboratory-evolution might be applied to alter this regulator to elicit different phenotypes for E. coli. Methodology/Principal Findings: To extend the methodology for strain improvement and to obtain higher tolerances toward different stresses, we here describe an approach of engineering irrE gene in E. coli. An irrE library was constructed by randomly mutating the gene, and this library was then selected for tolerance to ethanol, butanol and acetate stresses. Several mutants showing significant tolerances were obtained and characterized. The tolerances of E. coli cells containing these mutants were enhanced 2 to 50-fold, based on cell growth tests using different concentrations of alcohols or acetate, and enhanced 10 to 100-fold based on ethanol or butanol shock experiments. Intracellular reactive oxygen species (ROS) assays showed that intracellular ROS levels were sharply reduced for cells containing the irrE mutants. Sequence analysis of the mutants revealed that the mutations distribute cross all three domains of the protein. Conclusions: To our knowledge, this is the first time that an exogenous global regulator has been artificially evolved to suit its new host. The successes suggest the possibility of improving tolerances of industrial strains by introducing and engineering exogenous global regulators, such as those from extremophiles. This new approach can be applied alone or in combination with other global methods, such as global transcriptional machinery engineering (gTME) for strain improvements.	[Chen, Tingjian; Wang, Jianqing; Yang, Rong; Li, Jicong; Lin, Zhanglin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China; [Lin, Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Minist Agr, Key Lab Crop Biotechnol, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, TJ (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.	linmin57@vip.163.com; zhanglinlin@mail.tsinghua.edu.cn	min, lin/AAJ-7325-2020; Chen, Tingjian/L-2659-2013; Lin, Zhanglin/A-7232-2011; Yang, Rong/J-3718-2014	Chen, Tingjian/0000-0002-4458-4269; Yang, Rong/0000-0001-6427-026X	National Basic Research (973) Program of China [2007CB707804, 2009CB724704]	National Basic Research (973) Program of China(National Basic Research Program of China)	This work was supported by grants from the National Basic Research (973) Program of China (No. 2007CB707804 and No. 2009CB724704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Atsumi S, 2008, CURR OPIN BIOTECH, V19, P414, DOI 10.1016/j.copbio.2008.08.008; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bauermeister A, 2009, ARCH MICROBIOL, V191, P913, DOI 10.1007/s00203-009-0522-7; Bore E, 2007, MICROBIOL-SGM, V153, P935, DOI 10.1099/mic.0.29288-0; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Ghim CM, 2010, BIOTECHNOL BIOPROC E, V15, P11, DOI 10.1007/s12257-009-3065-5; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Jarboe LR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/761042; Jin Y, 2005, P NATL ACAD SCI USA, V102, P18992, DOI 10.1073/pnas.0509653102; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Klein-Marcuschamer D, 2009, APPL ENVIRON MICROB, V75, P2705, DOI 10.1128/AEM.01888-08; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Liu SQ, 2009, NEW BIOTECHNOL, V26, P117, DOI 10.1016/j.nbt.2009.06.984; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; Ochi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1373, DOI 10.1271/bbb.70007; OHTA K, 1991, APPL ENVIRON MICROB, V57, P893, DOI 10.1128/AEM.57.4.893-900.1991; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Patnaik R, 2002, NAT BIOTECHNOL, V20, P707, DOI 10.1038/nbt0702-707; Patnaik R, 2008, BIOTECHNOL PROGR, V24, P38, DOI 10.1021/bp0701214; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Van Duy N, 2007, PROTEOMICS, V7, P698, DOI 10.1002/pmic.200600706; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang ZC, 2008, BIOTECHNOL LETT, V30, P657, DOI 10.1007/s10529-007-9597-x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yan Y, 2009, J IND MICROBIOL BIOT, V36, P471, DOI 10.1007/s10295-009-0532-0; Yeh CH, 1997, P NATL ACAD SCI USA, V94, P10967, DOI 10.1073/pnas.94.20.10967; Yomano LP, 2008, BIOTECHNOL LETT, V30, P2097, DOI 10.1007/s10529-008-9821-3; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhang Y, 2010, J MICROBIOL BIOTECHN, V20, P1156, DOI 10.4014/jmb.0912.12036; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a; Zheng YN, 2009, J IND MICROBIOL BIOT, V36, P1127, DOI 10.1007/s10295-009-0609-9; Zhou S, 2008, BIOTECHNOL LETT, V30, P335, DOI 10.1007/s10529-007-9544-x	44	51	61	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16228	10.1371/journal.pone.0016228	http://dx.doi.org/10.1371/journal.pone.0016228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267412	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500046
J	Nihonmatsu-Kikuchi, N; Hashimoto, R; Hattori, S; Matsuzaki, S; Shinozaki, T; Miura, H; Ohota, S; Tohyama, M; Takeda, M; Tatebayashi, Y				Nihonmatsu-Kikuchi, Naomi; Hashimoto, Ryota; Hattori, Satoko; Matsuzaki, Shinsuke; Shinozaki, Takiko; Miura, Haruka; Ohota, Shigeru; Tohyama, Masaya; Takeda, Masatoshi; Tatebayashi, Yoshitaka			Reduced Rate of Neural Differentiation in the Dentate Gyrus of Adult Dysbindin Null (Sandy) Mouse	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; DTNBP1; SCHIZOPHRENIA; BRAIN; NEUROGENESIS; MUTANT; 6P22.3; ABNORMALITIES	Genetic variations in the gene encoding dysbindin has consistently been associated with schizophrenia and bipolar disorder, although little is known about the neural functions carried out by dysbindin. To gain some insight into this area, we took advantage of the readily available dysbindin-null mouse sandy (sdy-/-) and studied hippocampal neurogenesis using thymidine analogue bromodeoxuridine (BrdU). No significant differences were found in the proliferation (4 hours) or survival (1, 4 and 8 weeks after the last BrdU injection) of progenitors in the subgranular regions of the dentate gyrus between sdy-/- and sdy+/+ (control) mice. However, 4 weeks after the last BrdU injection, a significant reduction was observed in the ratio of neuronal differentiation in sdy-/- when compared to that of sdy+/+ (sdy+/+ = 87.0+/-5.3% vs. sdy-/- = 71.3+/-8.3%, p = 0.01). These findings suggest that dysbindin plays a role during differentiation process in the adult hippocampal neurogenesis and that its deficit may negatively affect neurogenesis-related functions such as cognition and mood.	[Nihonmatsu-Kikuchi, Naomi; Shinozaki, Takiko; Miura, Haruka; Tatebayashi, Yoshitaka] Tokyo Inst Psychiat, Mood Disorders Res Team, Tokyo, Japan; [Nihonmatsu-Kikuchi, Naomi; Ohota, Shigeru] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Hashimoto, Ryota; Matsuzaki, Shinsuke; Tohyama, Masaya; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota; Hattori, Satoko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Matsuzaki, Shinsuke; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Matsuzaki, Shinsuke; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Osaka, Japan; [Matsuzaki, Shinsuke; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan	Tokyo Institute of Psychiatry; Hiroshima University; Osaka University; Osaka University; National Center for Neurology & Psychiatry - Japan; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Nihonmatsu-Kikuchi, N (corresponding author), Tokyo Inst Psychiat, Mood Disorders Res Team, Tokyo, Japan.	tatebayashi-ys@igakuken.or.jp	Hashimoto, Ryota/P-8572-2014; Hashimoto, Ryota/AAE-3200-2019; Hattori, Satoko/AAE-6873-2022	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Hattori, Satoko/0000-0002-1047-6454	Japanese Society for the Promotion of Science [KAKENHI 20390317]; Japanese Ministry of Education, Culture, Sports, Science and Technology; CREST of JST; MEXT [18023045]; Japanese Society for the Promotion of Science; Health and Labour Sciences Research Grants, Japan	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST of JST(Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grants, Japan	Y.T. was supported by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science (KAKENHI 20390317). http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm. R.H. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, CREST of JST, and by a Grant-in-Aid for Scientific Research on Priority Areas (Research on the Pathomechanisms of Brain Disorders) from the MEXT (18023045). http://www.jst.go.jp/kisoken/crest/. http://www.mext.go.jp/english/. S. M. was supported by a Grant-in-Aid for Young Scientists (B) from the Japanese Society for the Promotion of Science. http://www.jsps.go.jp/j-grantsinaid/index.html. M. T. was supported by Health and Labour Sciences Research Grants, Japan. http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Breen G, 2006, AM J PSYCHIAT, V163, P1636, DOI 10.1176/appi.ajp.163.9.1636; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fallgatter AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2002, DOI 10.1038/sj.npp.1301003; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; Guo AY, 2009, MOL PSYCHIATR, V14, P18, DOI 10.1038/mp.2008.88; Hashimoto R, 2010, WORLD J BIOL PSYCHIA, V11, P431, DOI [10.3109/15622970902736503, 10.1080/15622970902736503]; Hashimoto R, 2009, PSYCHIAT CLIN NEUROS, V63, P550, DOI 10.1111/j.1440-1819.2009.01985.x; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Murotani T, 2007, NEUROSCI LETT, V421, P47, DOI 10.1016/j.neulet.2007.05.019; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Straub RE, 2003, BIOL PSYCHIAT, V53, p167S; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15886	10.1371/journal.pone.0015886	http://dx.doi.org/10.1371/journal.pone.0015886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267465	Green Submitted, gold, Green Published			2022-12-25	WOS:000286519500030
J	Smale, DA; Wernberg, T; Peck, LS; Barnes, DKA				Smale, Dan A.; Wernberg, Thomas; Peck, Lloyd S.; Barnes, David K. A.			Turning on the Heat: Ecological Response to Simulated Warming in the Sea	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROCOSM EXPERIMENTS; TEMPERATURE; RECRUITMENT; COMMUNITIES; DISTURBANCE; IMPACTS; GROWTH	Significant warming has been observed in every ocean, yet our ability to predict the consequences of oceanic warming on marine biodiversity remains poor. Experiments have been severely limited because, until now, it has not been possible to manipulate seawater temperature in a consistent manner across a range of marine habitats. We constructed a "hot-plate'' system to directly examine ecological responses to elevated seawater temperature in a subtidal marine system. The substratum available for colonisation and overlying seawater boundary layer were warmed for 36 days, which resulted in greater biomass of marine organisms and a doubling of space coverage by a dominant colonial ascidian. The "hot-plate'' system will facilitate complex manipulations of temperature and multiple stressors in the field to provide valuable information on the response of individuals, populations and communities to environmental change in any aquatic habitat.	[Smale, Dan A.; Wernberg, Thomas] Univ Western Australia, Sch Plant Biol, Oceans Inst, Perth, WA 6009, Australia; [Wernberg, Thomas] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Perth, WA 6009, Australia; [Peck, Lloyd S.; Barnes, David K. A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Western Australia; Australian Institute of Marine Science; University of Western Australia; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Smale, DA (corresponding author), Univ Western Australia, Sch Plant Biol, Oceans Inst, Perth, WA 6009, Australia.	daniel.smale@uwa.edu.au	Wernberg, Thomas/B-4172-2010; Smale, Daniel/Y-2909-2019	Wernberg, Thomas/0000-0003-1185-9745; Smale, Daniel/0000-0003-4157-541X	University of Western Australia [AUD 30K]; NERC [dml011000, bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish	University of Western Australia; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was sourced from the University of Western Australia's postdoctoral development award to DS (AUD 30K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius BP, 2007, J EXP MAR BIOL ECOL, V342, P30, DOI 10.1016/j.jembe.2006.10.012; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Convey P, 2002, ECOLOGY, V83, P3130, DOI 10.1890/0012-9658(2002)083[3130:ROATMT]2.0.CO;2; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Keser M, 2005, J SEA RES, V54, P211, DOI 10.1016/j.seares.2005.05.001; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Maughan BC, 2001, J EXP MAR BIOL ECOL, V256, P59, DOI 10.1016/S0022-0981(00)00304-X; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; POLOCZANSKA ES, 2010, BIOFOULING; Rao TS, 2010, AQUAT ECOL, V44, P463, DOI 10.1007/s10452-009-9304-1; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; RUSS GR, 1980, J EXP MAR BIOL ECOL, V42, P55, DOI 10.1016/0022-0981(80)90166-5; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sugden H, 2008, J ANIM ECOL, V77, P24, DOI 10.1111/j.1365-2656.2007.01323.x; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; UNDERWOOD AJ, EXPT ECOLOGY THEIR L; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Wilson SK, 2010, J EXP BIOL, V213, P894, DOI 10.1242/jeb.037895; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	27	30	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16050	10.1371/journal.pone.0016050	http://dx.doi.org/10.1371/journal.pone.0016050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264244	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000286516500024
J	Rizkallah, R; Alexander, KE; Kassardjian, A; Luscher, B; Hurt, MM				Rizkallah, Raed; Alexander, Karen E.; Kassardjian, Ari; Luescher, Bernhard; Hurt, Myra M.			The Transcription Factor YY1 Is a Substrate for Polo-Like Kinase 1 at the G2/M Transition of the Cell Cycle	PLOS ONE			English	Article							FACTOR YIN-YANG-1; GENE-EXPRESSION; REGULATOR YIN-YANG-1; PROTEIN-KINASE; MESSENGER-RNA; BOX DOMAIN; IN-VIVO; PLK1; CANCER; PHOSPHORYLATION	Yin-Yang 1 (YY1) is an essential multifunctional zinc-finger protein. It has been shown over the past two decades to be a critical regulator of a vast array of biological processes, including development, cell proliferation and differentiation, DNA repair, and apoptosis. YY1 exerts its functions primarily as a transcription factor that can activate or repress gene expression, dependent on its spatial and temporal context. YY1 regulates a large number of genes involved in cell cycle transitions, many of which are oncogenes and tumor-suppressor genes. YY1 itself has been classified as an oncogene and was found to be upregulated in many cancer types. Unfortunately, our knowledge of what regulates YY1 is very minimal. Although YY1 has been shown to be a phosphoprotein, no kinase has ever been identified for the phosphorylation of YY1. Polo-like kinase 1 (Plk1) has emerged in the past few years as a major cell cycle regulator, particularly for cell division. Plk1 has been shown to play important roles in the G/M transition into mitosis and for the proper execution of cytokinesis, processes that YY1 has been shown to regulate also. Here, we present evidence that Plk1 directly phosphorylates YY1 in vitro and in vivo at threonine 39 in the activation domain. We show that this phosphorylation is cell cycle regulated and peaks at G2/M. This is the first report identifying a kinase for which YY1 is a substrate.	[Rizkallah, Raed; Alexander, Karen E.; Kassardjian, Ari; Hurt, Myra M.] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Kassardjian, Ari] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Luescher, Bernhard] Rheinisch Westfalische Tech Hsch Aachen Univ, Inst Biochem & Mol Biol, Aachen, Germany	State University System of Florida; Florida State University; State University System of Florida; Florida State University; RWTH Aachen University	Rizkallah, R (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.	myra.hurt@med.fsu.edu	; Luscher, Bernhard/A-7330-2011	Rizkallah, Raed/0000-0001-8114-4935; Luscher, Bernhard/0000-0002-9622-8709	Florida State University, College of Medicine	Florida State University, College of Medicine	This work was supported by Florida State University, College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 1998, J CELL SCI, V111, P1751; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Arai T, 2008, CELL CYCLE, V7, P3556, DOI 10.4161/cc.7.22.7072; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Baritaki S, 2007, INT J ONCOL, V31, P69; Baritaki S, 2009, CANCER INVEST, V27, P184, DOI 10.1080/07357900802210760; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chinnappan D, 2009, INT J ONCOL, V34, P1417, DOI 10.3892/ijo_00000270; Dalle S, 2009, CLIN CANCER RES, V15, P851, DOI 10.1158/1078-0432.CCR-08-1685; de Nigris F, 2006, EUR J CANCER, V42, P2420, DOI 10.1016/j.ejca.2006.06.008; Delehouzee S, 2005, GENES CELLS, V10, P717, DOI 10.1111/j.1365-2443.2005.00873.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Furlong EEM, 1996, MOL CELL BIOL, V16, P5933; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Grubach L, 2008, EUR J HAEMATOL, V81, P112, DOI 10.1111/j.1600-0609.2008.01083.x; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Libra M, 2008, J HEPATOL, V49, P170, DOI 10.1016/j.jhep.2008.03.031; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Lowery DM, 2004, CELL CYCLE, V3, P128; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Reagan-Shaw S, 2005, IUBMB LIFE, V57, P677, DOI 10.1080/15216540500305910; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Schmit TL, 2009, CELL CYCLE, V8, P2697, DOI 10.4161/cc.8.17.9413; Seligson D, 2005, INT J ONCOL, V27, P131; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Uchiumi T, 1997, J BIOL CHEM, V272, P9166; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; WANG C, 2010, EUR J CELL BIOL; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yakovleva T, 2004, BIOCHEM BIOPH RES CO, V318, P615, DOI 10.1016/j.bbrc.2004.04.065; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308	71	27	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15928	10.1371/journal.pone.0015928	http://dx.doi.org/10.1371/journal.pone.0015928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253604	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900027
J	Koparde, VN; Scarsdale, JN; Kellogg, GE				Koparde, Vishal N.; Scarsdale, J. Neel; Kellogg, Glen E.			Applying an Empirical Hydropathic Forcefield in Refinement May Improve Low-Resolution Protein X-Ray Crystal Structures	PLOS ONE			English	Article							FREE-ENERGY; CRYSTALLOGRAPHY; BINDING; DOMAIN; WATER; SITE; PARAMETERS; COLCHICINE; COMPLEXES; TUBULIN	Background: The quality of X-ray crystallographic models for biomacromolecules refined from data obtained at high-resolution is assured by the data itself. However, at low-resolution, >3.0 angstrom, additional information is supplied by a forcefield coupled with an associated refinement protocol. These resulting structures are often of lower quality and thus unsuitable for downstream activities like structure-based drug discovery. Methodology: An X-ray crystallography refinement protocol that enhances standard methodology by incorporating energy terms from the HINT (Hydropathic INTeractions) empirical forcefield is described. This protocol was tested by refining synthetic low-resolution structural data derived from 25 diverse high-resolution structures, and referencing the resulting models to these structures. The models were also evaluated with global structural quality metrics, e. g., Ramachandran score and MolProbity clashscore. Three additional structures, for which only low-resolution data are available, were also re-refined with this methodology. Results: The enhanced refinement protocol is most beneficial for reflection data at resolutions of 3.0 angstrom or worse. At the low-resolution limit, >= 4.0 angstrom, the new protocol generated models with C alpha positions that have RMSDs that are 0.18 angstrom more similar to the reference high-resolution structure, Ramachandran scores improved by 13%, and clashscores improved by 51%, all in comparison to models generated with the standard refinement protocol. The hydropathic forcefield terms are at least as effective as Coulombic electrostatic terms in maintaining polar interaction networks, and significantly more effective in maintaining hydrophobic networks, as synthetic resolution is decremented. Even at resolutions >= 4.0 angstrom, these latter networks are generally native-like, as measured with a hydropathic interactions scoring tool.	[Koparde, Vishal N.; Scarsdale, J. Neel; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23284 USA; [Koparde, Vishal N.; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Scarsdale, J. Neel] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Koparde, VN (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23284 USA.	jscarsda@vcu.edu; glen.kellogg@vcu.edu		Koparde, Vishal/0000-0001-8978-8495; Kellogg, Glen/0000-0002-6282-6794	United States National Institutes of Health (NIH) [R01 GM071894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071894] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the United States National Institutes of Health (NIH, www.nih.gov) grant R01 GM071894 to G. E. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 1997, J MOL BIOL, V272, P613, DOI 10.1006/jmbi.1997.1249; Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, ANNOUNCING CNS VERSI; Carugo O, 1999, ACTA CRYSTALLOGR D, V55, P479, DOI 10.1107/S0907444998012086; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DePristo MA, 2004, STRUCTURE, V12, P831, DOI 10.1016/j.str.2004.02.031; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fermani S, 2005, J STRUCT BIOL, V149, P204, DOI 10.1016/j.jsb.2004.11.007; HANSCH C, 1968, J ORG CHEM, V33, P347, DOI 10.1021/jo01265a071; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Karmali AM, 2009, ACTA CRYSTALLOGR D, V65, P121, DOI 10.1107/S0907444908040006; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Montelione GT, 2000, NAT STRUCT BIOL, V7, P982, DOI 10.1038/80768; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TL, 2005, J MED CHEM, V48, P6107, DOI 10.1021/jm050502t; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Spyrakis F, 2004, J AM CHEM SOC, V126, P11764, DOI 10.1021/ja0465754; TAKAHASHI H, CRYSTAL STR IN PRESS; Tripathi A, 2008, BIOORGAN MED CHEM, V16, P2235, DOI 10.1016/j.bmc.2007.11.076; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15920	10.1371/journal.pone.0015920	http://dx.doi.org/10.1371/journal.pone.0015920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246043	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511200024
J	Wang, RW; Zhong, XW; Meng, X; Koop, A; Tian, XX; Jones, PP; Fruen, BR; Wagenknecht, T; Liu, Z; Chen, SRW				Wang, Ruiwu; Zhong, Xiaowei; Meng, Xing; Koop, Andrea; Tian, Xixi; Jones, Peter P.; Fruen, Bradley R.; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne			Localization of the Dantrolene-binding Sequence near the FK506-binding Protein-binding Site in the Three-dimensional Structure of the Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CA2+ RELEASE CHANNELS; SKELETAL-MUSCLE; CRYOELECTRON MICROSCOPY; MALIGNANT HYPERTHERMIA; CALCIUM-RELEASE; PHOSPHORYLATION SITE; FKBP12.6 BINDING; DISEASE; MUTATIONS	Dantrolene is believed to stabilize interdomain interactions between the NH2-terminal and central regions of ryanodine receptors by binding to the NH2-terminal residues 590-609 in skeletal ryanodine receptor (RyR1) and residues 601-620 in cardiac ryanodine receptor (RyR2). To gain further insight into the structural basis of dantrolene action, we have attempted to localize the dantrolene-binding sequence in RyR1/RyR2 by using GFP as a structural marker and three-dimensional cryoEM. We inserted GFP into RyR2 after residues Arg-626 and Tyr-846 to generate GFP-RyR2 fusion proteins, RyR2(Arg-626-GFP) and RyR2(Tyr-846-GFP). Insertion of GFP after residue Arg-626 abolished the binding of a bulky GST-or cyan fluorescent protein-tagged FKBP12.6 but not the binding of a smaller, nontagged FKBP12.6, suggesting that residue Arg-626 and the dantrolene-binding sequence are located near the FKBP12.6-binding site. Using cryo-EM, we have mapped the three-dimensional location of Tyr-846-GFP to domain 9, which is also adjacent to the FKBP12.6-binding site. To further map the three-dimensional location of the dantrolene-binding sequence, we generated 10 FRET pairs based on four known three-dimensional locations (FKBP12.6, Ser-437-GFP, Tyr-846-GFP, and Ser-2367-GFP). Based on the FRET efficiencies of these FRET pairs and the corresponding distance relationships, we mapped the three-dimensional location of Arg-626-GFP or -cyan fluorescent protein, hence the dantrolene-binding sequence, to domain 9 near the FKBP12.6-binding site but distant to the central region around residue Ser-2367. An allosteric mechanism by which dantrolene stabilizes interdomain interactions between the NH2-terminal and central regions is proposed.	[Meng, Xing; Wagenknecht, Terence; Liu, Zheng; Chen, S. R. Wayne] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Wang, Ruiwu; Zhong, Xiaowei; Koop, Andrea; Tian, Xixi; Jones, Peter P.; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Wang, Ruiwu; Zhong, Xiaowei; Koop, Andrea; Tian, Xixi; Jones, Peter P.; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Fruen, Bradley R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Wagenknecht, Terence] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org	Jones, Peter P/G-2618-2013	Liu, Zheng/0000-0001-6952-3406; Jones, Pete/0000-0001-7977-1737	National Institutes of Health [R01 HL075210, R01HL095541, R01AR040615, R01HL076433, P41RR01219]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Achievers in Medical Science Scholarship; Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Alberta; Alberta Innovates [201001238] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076433, R01HL075210, R01HL095541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Achievers in Medical Science Scholarship; Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Alberta; Alberta Innovates; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL075210 (to S. R. W. C.), R01HL095541 (to Z. L.), R01AR040615 (to T. W.), and R01HL076433 (to B. R. F.). This work was also supported by research grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada (to S. R. W. C.) and by National Institutes of Health Biotechnological Resource Grant P41RR01219.; Recipient of the Achievers in Medical Science Scholarship.; Recipient of the Alberta Innovates-Health Solutions Studentship Award.; Recipient of Alberta Innovates-Health Solutions and Heart and Stroke Foundation of Alberta Fellowship Awards. Present address: Dept. of Physiology, University of Otago, Dunedin 9054, New Zealand.	Benacquista BL, 2000, BIOPHYS J, V78, P1349, DOI 10.1016/S0006-3495(00)76689-6; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Frank J, 2006, 3 DIMENSIONAL ELECT, P71; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Inan S, 2010, ANESTH ANALG, V111, P1400, DOI 10.1213/ANE.0b013e3181f7181c; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V410, P261, DOI 10.1042/BJ20071257; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Liu Z, 2002, J BIOL CHEM, V277, P46712, DOI 10.1074/jbc.M208124200; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Murayama T, 1999, J BIOL CHEM, V274, P17297, DOI 10.1074/jbc.274.24.17297; Palnitkar SS, 1999, J MED CHEM, V42, P1872, DOI 10.1021/jm9805079; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Paul-Pletzer K, 2005, BIOCHEM J, V387, P905, DOI 10.1042/BJ20041336; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Paul-Pletzer K, 2001, BIOCHEMISTRY-US, V40, P531, DOI 10.1021/bi001502s; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Priori SG, 2005, J CLIN INVEST, V115, P2033, DOI 10.1172/JCI25664; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Sharma MR, 1998, J BIOL CHEM, V273, P18429, DOI 10.1074/jbc.273.29.18429; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200	47	37	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.194316	http://dx.doi.org/10.1074/jbc.M110.194316			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21262961	Green Published, hybrid			2022-12-25	WOS:000289077500035
J	Arcipowski, KM; Stunz, LL; Graham, JP; Kraus, ZJ; Vanden Bush, TJ; Bishop, GA				Arcipowski, Kelly M.; Stunz, Laura L.; Graham, John P.; Kraus, Zachary J.; Vanden Bush, Tony J.; Bishop, Gail A.			Molecular Mechanisms of TNFR-associated Factor 6 (TRAF6) Utilization by the Oncogenic Viral Mimic of CD40, Latent Membrane Protein 1 (LMP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HEART-TRANSPLANT PATIENTS; TERMINAL KINASE PATHWAY; BINDING-SITE; SIGNAL-TRANSDUCTION; CRITICAL MEDIATOR; RING DOMAIN; LYMPHOCYTES	Latent membrane protein 1 (LMP1), encoded by Epstein-Barr virus, is required for EBV-mediated B cell transformation and plays a significant role in the development of posttransplant B cell lymphomas. LMP1 has also been implicated in exacerbation of autoimmune diseases such as systemic lupus erythematosus. LMP1 is a constitutively active functional mimic of the tumor necrosis factor receptor superfamily member CD40, utilizing tumor necrosis factor receptor-associated factor (TRAF) adaptor proteins to induce signaling. However, LMP1-mediated B cell activation is amplified and sustained compared with CD40. We have previously shown that LMP1 and CD40 use TRAFs 1, 2, 3, and 5 differently. TRAF6 is important for CD40 signaling, but the role of TRAF6 in LMP1 signaling in B cells is not clear. Although TRAF6 binds directly to CD40, TRAF6 interaction with LMP1 in B cells has not been characterized. Here we tested the hypothesis that TRAF6 is a critical regulator of LMP1 signaling in B cells, either as part of a receptor-associated complex and/or as a cytoplasmic adaptor protein. Using TRAF6-deficient B cells, we determined that TRAF6 was critical for LMP1-mediated B cell activation. Although CD40-mediated TRAF6-dependent signaling does not require the TRAF6 receptor-binding domain, we found that LMP1 signaling required the presence of this domain. Furthermore, TRAF6 was recruited to the LMP1 signaling complex via the TRAF1/2/3/5 binding site within the cytoplasmic domain of LMP1.	[Arcipowski, Kelly M.; Bishop, Gail A.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Graham, John P.; Kraus, Zachary J.; Bishop, Gail A.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Stunz, Laura L.; Vanden Bush, Tony J.; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, 2193B MERF,375 Newton Rd, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Institutes of Health [CA099997, T32AI007533-12]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Awards CA099997 (to G. A. B.) and T32AI007533-12 (to K. M. A.). K. M. A. was also supported by the American Heart Association.	Abou-Raya A, 2006, AUTOIMMUN REV, V5, P331, DOI 10.1016/j.autrev.2005.12.006; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Fries KL, 1999, VIROLOGY, V264, P159, DOI 10.1006/viro.1999.9980; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Graham JP, 2009, J IMMUNOL, V183, P2966, DOI 10.4049/jimmunol.0900442; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hostager BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011380; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; HU HM, 1994, J BIOL CHEM, V269, P30069; Ikeda O, 2009, FEBS LETT, V583, P1567, DOI 10.1016/j.febslet.2009.04.022; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; KIM KJ, 1979, J IMMUNOL, V122, P549; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Kraus ZJ, 2009, P NATL ACAD SCI USA, V106, P17140, DOI 10.1073/pnas.0903786106; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Luftig M, 2003, P NATL ACAD SCI USA, V100, P15595, DOI 10.1073/pnas.2136756100; Mainou BA, 2007, J VIROL, V81, P9680, DOI 10.1128/JVI.01001-07; Markin CJ, 2008, BIOCHEMISTRY-US, V47, P10010, DOI 10.1021/bi800252x; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Pai S, 2001, SEMIN CANCER BIOL, V11, P455, DOI 10.1006/scbi.2001.0412; Peters AL, 2010, J IMMUNOL, V185, P4053, DOI 10.4049/jimmunol.0904065; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Scheinfeld AG, 1997, AM J PATHOL, V151, P805; Schubert S, 2009, PEDIATR TRANSPLANT, V13, P54, DOI 10.1111/j.1399-3046.2008.00969.x; Schubert S, 2008, J HEART LUNG TRANSPL, V27, P100, DOI 10.1016/j.healun.2007.09.027; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Seliger B, 2008, TRENDS MOL MED, V14, P550, DOI 10.1016/j.molmed.2008.09.010; Stunz LL, 2004, IMMUNITY, V21, P255, DOI 10.1016/j.immuni.2004.07.008; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wan J, 2006, MOL CELL BIOL, V26, P448, DOI 10.1128/MCB.26.2.448-456.2006; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; Wu LM, 2006, J BIOL CHEM, V281, P2162, DOI 10.1074/jbc.M505903200; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Xie P, 2004, J IMMUNOL, V173, P5546, DOI 10.4049/jimmunol.173.9.5546; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	62	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					9948	9955		10.1074/jbc.M110.185983	http://dx.doi.org/10.1074/jbc.M110.185983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262968	Green Published, hybrid			2022-12-25	WOS:000288547000009
J	Dammer, EB; Na, CH; Xu, P; Seyfried, NT; Duong, DM; Cheng, DM; Gearing, M; Rees, H; Lah, JJ; Levey, AI; Rush, J; Peng, JM				Dammer, Eric B.; Na, Chan Hyun; Xu, Ping; Seyfried, Nicholas T.; Duong, Duc M.; Cheng, Dongmei; Gearing, Marla; Rees, Howard; Lah, James J.; Levey, Allan I.; Rush, John; Peng, Junmin			Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; QUANTITATIVE PROTEOMICS; UBIQUITIN CHAINS; NEURODEGENERATIVE DISEASES; PROTEIN UBIQUITINATION; MASS-SPECTROMETRY; CELL-DEATH; AUTOPHAGY; DEGRADATION; REVEALS	Polyubiquitin chains on substrates are assembled through any of seven lysine residues or the N terminus of ubiquitin (Ub), generating diverse linkages in the chain structure. PolyUb linkages regulate the fate of modified substrates, but their abundance and function in mammalian cells are not well studied. We present a mass spectrometry-based method to measure polyUb linkages directly from total lysate of mammalian cells. In HEK293 cells, the level of polyUb linkages was found to be 52% (Lys(48)), 38% (Lys(63)), 8% (Lys(29)), 2% (Lys(11)), and 0.5% or less for linear, Lys(6), Lys(27), and Lys(33) linkages. Tissue specificity of these linkages was examined in mice fully labeled by heavy stable isotopes (i.e. SILAC mice). Moreover, we profiled the Ub linkages in brain tissues from patients of Alzheimer disease with or without concurrent Lewy body disease as well as three cellular models of proteolytic stress: proteasome deficiency, lysosome deficiency, and heat shock. The data support that polyUb chains linked through Lys(6), Lys(11), Lys(27), Lys(29), and Lys(48) mediate proteasomal degradation, whereas Lys(63) chains are preferentially involved in the lysosomal pathway. Mixed linkages, including Lys(48), may also contribute to lysosomal targeting, as both Lys(63) and Lys(48) linkages are colocalized in LC3-labeled autophagosomes. Interestingly, heat shock treatment augments Lys(11), Lys(48), and Lys(63) but not Lys(29) linkages, and this unique pattern is similar to that in the profiled neurodegenerative cases. We conclude that different polyUb linkages play distinct roles under the three proteolytic stress conditions, and protein folding capacity in the heat shock responsive pathway might be more affected in Alzheimer disease.	[Dammer, Eric B.; Na, Chan Hyun; Xu, Ping; Seyfried, Nicholas T.; Duong, Duc M.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Duong, Duc M.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Sch Med, Emory Prote Serv Ctr, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Rees, Howard; Lah, James J.; Levey, Allan I.] Emory Univ, Sch Med, Dept Neurol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Rush, John] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Emory University; Emory University; Emory University; Emory University	Peng, JM (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jpeng@emory.edu	Peng, Junmin/N-2614-2018; Levey, Allan/F-2104-2011; Dammer, Eric B/V-8652-2019	Peng, Junmin/0000-0003-0472-7648; Levey, Allan/0000-0002-3153-502X; Dammer, Eric B/0000-0003-2947-7606; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [AG025688, NS055077, RR025822, NS007480]; American Cancer Society [RSG-09-181]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, T32NS007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025688, NS055077, and RR025822 and Training Grant NS007480 (to E. B. D. and N. T. S.). This work was also supported by Research Scholar Grant RSG-09-181 from the American Cancer Society.	Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hammond TG, 1998, J MEMBRANE BIOL, V162, P157, DOI 10.1007/s002329900353; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paine S, 2009, NEUROSCI LETT, V460, P205, DOI 10.1016/j.neulet.2009.05.074; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pivtoraiko VN, 2010, J NEUROCHEM, V114, P1193, DOI 10.1111/j.1471-4159.2010.06838.x; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Seyfried NT, 2010, MOL CELL PROTEOMICS, V9, P705, DOI 10.1074/mcp.M800390-MCP200; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002864; Zhao SK, 2010, P NATL ACAD SCI USA, V107, P7704, DOI 10.1073/pnas.0908764107	51	127	131	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10457	10465		10.1074/jbc.M110.149633	http://dx.doi.org/10.1074/jbc.M110.149633			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278249	hybrid, Green Published			2022-12-25	WOS:000288547000062
J	Han, SI; Yasuda, K; Kataoka, K				Han, Song-iee; Yasuda, Kunio; Kataoka, Kohsuke			ATF2 Interacts with beta-Cell-enriched Transcription Factors, MafA, Pdx1, and Beta2, and Activates Insulin Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; KEY REGULATOR; GLUCOSE; PROMOTER; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; PROTEINS; GLUCAGON; INHIBIT	Pancreatic beta-cell-restricted expression of insulin is established through several critical cis-regulatory elements located in the insulin gene promoter region. The principal cis elements are A-boxes, E1, and C1/RIPE3b. The beta-cell-enriched transcription factors Pdx1 and Beta2 bind to the A-boxes and E1 element, respectively. A beta-cell-specific trans-acting factor binding to C1/RIPE3b (termed RIPE3b1 activator) was detected by electrophoretic mobility shift assay and has been identified as MafA, a member of the Maf family of basic leucine zipper (bZip) proteins. Here, ATF2, a member of the ATF/CREB family of basic leucine zipper proteins, was identified as a component of the RIPE3b1 activator. ATF2 alone was unable to bind to the C1/RIPE3b element but acquired binding capacity upon complex formation with MafA. ATF2 also interacted with Pdx1 and Beta2, and co-expression of ATF2, MafA, Pdx1, and Beta2 resulted in a synergistic activation of the insulin promoter. Immunohistochemical analysis of mouse pancreas tissue sections showed that ATF2 is enriched in islet endocrine cells, including beta-cells. RNAi-mediated knockdown of MafA or ATF2 in the MIN6 beta-cell line resulted in a significant decrease in endogenous levels of insulin mRNA. These data indicate that ATF2 is an essential component of the positive regulators of the insulin gene expression.	[Han, Song-iee; Yasuda, Kunio; Kataoka, Kohsuke] Nara Inst Sci & Technol, Mol & Dev Biol Lab, Grad Sch Biol Sci, Ikoma 6300192, Japan	Nara Institute of Science & Technology	Kataoka, K (corresponding author), Nara Inst Sci & Technol, Mol & Dev Biol Lab, Grad Sch Biol Sci, 8916-5 Takayama Cho, Ikoma 6300192, Japan.	kkataoka@bs.naist.jp			MEXT, Japan; Mitsubishi Foundation; Takeda Science Foundation; Japan Society for the Promotion of Science	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (DECODE), for Scientific Research (C), and for the Global COE Program in NAIST from MEXT, Japan, a grant from the Mitsubishi Foundation, and a grant from Takeda Science Foundation (to K. K.). This work was also supported by the Postdoctoral Fellowship for Foreign Researchers from the Japan Society for the Promotion of Science (to S. H.).	Abdelli S, 2007, DIABETOLOGIA, V50, P1660, DOI 10.1007/s00125-007-0704-2; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ban N, 2000, DIABETES, V49, P1142, DOI 10.2337/diabetes.49.7.1142; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hay CW, 2007, BBA-GENE STRUCT EXPR, V1769, P79, DOI 10.1016/j.bbaexp.2007.01.005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1468, DOI 10.1210/me.9.11.1468; SHIEH SY, 1991, J BIOL CHEM, V266, P16708; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	33	29	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10449	10456		10.1074/jbc.M110.209510	http://dx.doi.org/10.1074/jbc.M110.209510			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21278380	Green Published, hybrid			2022-12-25	WOS:000288547000061
J	Sharma, V; Freeze, HH				Sharma, Vandana; Freeze, Hudson H.			Mannose Efflux from the Cells A POTENTIAL SOURCE OF MANNOSE IN BLOOD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE POLYMANNOSE OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; GLUCOSE-TRANSPORT; GLYCOPROTEIN-BIOSYNTHESIS; HEXOKINASE; METABOLISM; MEMBRANE; GLYCOGEN; CYTOSOL; PERMEABILITY	All mammals have 50-100 mu M mannose in their blood. However, the source of the dynamic pool of mannose in blood is unknown. Most of it is thought to be derived from glucose in the cells. We studied mannose uptake and release by various cell types. Interestingly, our results show that mannose taken up by the cells through transporters is handled differently from the mannose released within the cells due to glycan processing of protein-bound oligosaccharides. Although more than 95% of incoming mannose is catabolized, most of the mannose released by intracellular processing is expelled from the cells as free mannose predominantly via a nocodazole-sensitive sugar transporter. Under physiological conditions, incoming mannose is more accessible to hexokinase, whereas mannose released within the cells is protected from HK and therefore has a different fate. Our data also suggest that generation of free mannose due to the processing of glycoconjugates composed of glucose-derived mannose and its efflux from the cells can account for most of the mannose found in blood and its steady state maintenance.	[Sharma, Vandana; Freeze, Hudson H.] Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Freeze, Hudson/0000-0001-6316-0501	National Institutes of Health [R01GM55695, R01DK55615, R21HD062914]; Sanford Professorship; Rocket Williams Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Professorship; Rocket Williams Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM55695, R01DK55615, and R21HD062914. This work was also supported by a Sanford Professorship (to H. H. F.) and by the Rocket Williams Fund.	Alton G, 1998, GLYCOBIOLOGY, V8, P285, DOI 10.1093/glycob/8.3.285; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Davis JA, 2001, BBA-GEN SUBJECTS, V1528, P116, DOI 10.1016/S0304-4165(01)00183-0; DEERY WJ, 1981, BIOCHEMISTRY-US, V20, P2316, DOI 10.1021/bi00511a038; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; FREEZE HH, 2010, CURRENT PROTOCOLS IM, pCH8; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; Hardin CD, 1998, AM J PHYSIOL-CELL PH, V274, pC88, DOI 10.1152/ajpcell.1998.274.1.C88; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; HUBBARD SC, 1980, J BIOL CHEM, V255, P1782; Karaivanova VK, 2000, GLYCOBIOLOGY, V10, P727, DOI 10.1093/glycob/10.7.727; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LYNCH RM, 1991, J CELL BIOL, V112, P385, DOI 10.1083/jcb.112.3.385; MALAISSE WJ, 1991, INT J BIOCHEM, V23, P1471, DOI 10.1016/0020-711X(91)90290-4; MANCINI GMS, 1990, J BIOL CHEM, V265, P12380; Marcolongo P, 1996, BIOCHEM BIOPH RES CO, V219, P916, DOI 10.1006/bbrc.1996.0333; Marieb E, 2007, HUMAN ANATOMY PHYSL, P317; MENDES P, 1995, ADV MOL CELL BIOL, V11, P1; Molero JC, 2001, J BIOL CHEM, V276, P43829, DOI 10.1074/jbc.M105452200; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; Ovadi J, 2000, INT REV CYTOL, V192, P255; Panneerselvam K, 1997, BIOCHEM MOL MED, V61, P161, DOI 10.1006/bmme.1997.2599; Panneerselvam K, 1996, J BIOL CHEM, V271, P9417, DOI 10.1074/jbc.271.16.9417; PEDLEY KC, 1993, BIOCHEM J, V291, P515, DOI 10.1042/bj2910515; Rauch MC, 2006, J CELL PHYSIOL, V207, P397, DOI 10.1002/jcp.20582; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Stanley P, 2008, ESSENTIALS GLYCOBIOL, P101; Suzuki T, 2002, GLYCOBIOLOGY, V12, P803, DOI 10.1093/glycob/cwf095; Taguchi T, 2005, AM J PHYSIOL-ENDOC M, V288, pE534, DOI 10.1152/ajpendo.00451.2004; WOOD FC, 1963, J CLIN INVEST, V42, P1300, DOI 10.1172/JCI104814; WOOD RE, 1968, BIOCHIM BIOPHYS ACTA, V163, P171, DOI 10.1016/0005-2736(68)90095-3	38	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10193	10200		10.1074/jbc.M110.194241	http://dx.doi.org/10.1074/jbc.M110.194241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21273394	Green Published, hybrid			2022-12-25	WOS:000288547000035
J	Oelze, M; Knorr, M; Schell, R; Kamuf, J; Pautz, A; Art, J; Wenzel, P; Munzel, T; Kleinert, H; Daiber, A				Oelze, Matthias; Knorr, Maike; Schell, Richard; Kamuf, Jens; Pautz, Andrea; Art, Julia; Wenzel, Philip; Muenzel, Thomas; Kleinert, Hartmut; Daiber, Andreas			Regulation of Human Mitochondrial Aldehyde Dehydrogenase (ALDH-2) Activity by Electrophiles in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ORGANIC NITRATES; MODEL SYSTEMS; NITROGLYCERIN; INHIBITION; BIOACTIVATION; DEFICIENCY; PEROXYNITRITE; TETRANITRATE	Recently, mitochondrial aldehyde dehydrogenase (ALDH-2) was reported to reduce ischemic damage in an experimental myocardial infarction model. ALDH-2 activity is redox-sensitive. Therefore, we here compared effects of various electrophiles (organic nitrates, reactive fatty acid metabolites, or oxidants) on the activity of ALDH-2 with special emphasis on organic nitrate-induced inactivation of the enzyme, the biochemical correlate of nitrate tolerance. Recombinant human ALDH-2 was overexpressed in Escherichia coli; activity was determined with an HPLC-based assay, and reactive oxygen and nitrogen species formation was determined by chemiluminescence, fluorescence, protein tyrosine nitration, and diaminonaphthalene nitrosation. The organic nitrate glyceryl trinitrate caused a severe concentration-dependent decrease in enzyme activity, whereas incubation with pentaerythritol tetranitrate had only minor effects. 4-Hydroxynonenal, an oxidized prostaglandin J(2), and 9- or 10-nitrooleate caused a significant inhibition of ALDH-2 activity, which was improved in the presence of Mg2+ and Ca2+. Hydrogen peroxide and NO generation caused only minor inhibition of ALDH-2 activity, whereas peroxynitrite generation or bolus additions lead to severe impairment of the enzymatic activity, which was prevented by the thioredoxin/ thioredoxin reductase (Trx/TrxR) system. In the presence of glyceryl trinitrate and to a lesser extent pentaerythritol tetranitrate, ALDH-2 may be switched to a peroxynitrite synthase. Electrophiles of different nature potently regulate the enzymatic activity of ALDH-2 and thereby may influence the resistance to ischemic damage in response to myocardial infarction. The Trx/TrxR system may play an important role in this process because it not only prevents inhibition of ALDH-2 but is also inhibited by the ALDH-2 substrate 4-hydroxynonenal.	[Daiber, Andreas] Johannes Gutenberg Univ Mainz, Univ Med, Med Klin 2, Lab Mol Kardiol, D-55101 Mainz, Germany; [Pautz, Andrea; Art, Julia; Kleinert, Hartmut] Johannes Gutenberg Univ Mainz, Inst Pharmakol, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Daiber, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med, Med Klin 2, Lab Mol Kardiol, Obere Zahlbacher Str 63, D-55101 Mainz, Germany.	andreas.daiber@bioredox.com	Wenzel, Philip/Z-1503-2019; Wenzel, Philip/HIA-0033-2022; Kleinert, Hartmut/M-2988-2018; Munzel, Thomas/A-2912-2014	Wenzel, Philip/0000-0002-5397-2781; Wenzel, Philip/0000-0002-5397-2781; Kleinert, Hartmut/0000-0003-2202-3548; Munzel, Thomas/0000-0001-5503-4150	Johannes Gutenberg University; Actavis Deutschland GmbH, Langenfeld, Germany; University Medical Center Mainz (MAIFOR)	Johannes Gutenberg University; Actavis Deutschland GmbH, Langenfeld, Germany; University Medical Center Mainz (MAIFOR)	This work was supported by generous financial support by the Johannes Gutenberg University and University Medical Center Mainz (MAIFOR and Forschungsfonds grants to A. D.). This paper contains results that are part of the doctoral thesis of R. S.; A. D. received honoraries and research support from Actavis Deutschland GmbH, Langenfeld, Germany (manufacturer of PETN).	Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Daiber A, 2005, MOL PHARMACOL, V68, P579, DOI 10.1124/mol.105.011585; Daiber A, 2004, MOL PHARMACOL, V66, P1372, DOI 10.1124/mol.104.002600; Daiber A, 2004, FREE RADICAL RES, V38, P259, DOI 10.1080/10715760410001659773; Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.10.012; Daiber A, 2003, NITRIC OXIDE-BIOL CH, V9, P44, DOI 10.1016/j.niox.2003.08.002; Daiber A, 2009, FREE RADICAL BIO MED, V47, P458, DOI 10.1016/j.freeradbiomed.2009.05.019; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Florang VR, 2007, NEUROTOXICOLOGY, V28, P76, DOI 10.1016/j.neuro.2006.07.018; GOEDDE HW, 1992, HUM GENET, V88, P344; Gori T, 2009, AM J CARDIOVASC DRUG, V9, P7, DOI 10.2165/00129784-200909010-00002; Hink U, 2003, J AM COLL CARDIOL, V42, P1826, DOI 10.1016/j.jacc.2003.07.009; HJELLE JJ, 1982, TOXICOL LETT, V14, P35, DOI 10.1016/0378-4274(82)90007-8; HJELLE JJ, 1983, TOXICOL APPL PHARM, V70, P57, DOI 10.1016/0041-008X(83)90179-5; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Mackenzie IS, 2005, ARTERIOSCL THROM VAS, V25, P1891, DOI 10.1161/01.ATV.0000179599.71086.89; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nakamura Y, 1999, AM HEART J, V138, P577, DOI 10.1016/S0002-8703(99)70163-8; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Pautz A, 2009, PHYSIOL GENOMICS, V38, P176, DOI 10.1152/physiolgenomics.00035.2009; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Wenzel P, 2008, BIOCHEM BIOPH RES CO, V367, P137, DOI 10.1016/j.bbrc.2007.12.089; Wenzel P, 2007, ARTERIOSCL THROM VAS, V27, P1729, DOI 10.1161/ATVBAHA.107.143909; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272	35	33	33	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8893	8900		10.1074/jbc.M110.190017	http://dx.doi.org/10.1074/jbc.M110.190017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252222	hybrid, Green Published			2022-12-25	WOS:000288247700020
J	Jimenez, RM; Delwart, E; Luptak, A				Jimenez, Randi M.; Delwart, Eric; Luptak, Andrej			Structure-based Search Reveals Hammerhead Ribozymes in the Human Microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-CLEAVING RIBOZYMES; HEPATITIS-DELTA-VIRUS; CATALYTIC DIVERSITY; MESSENGER-RNA; ACTIVE-SITE; CLEAVAGE; SEQUENCE; TRANSCRIPTS; SAMPLES; MOTIFS	Deep sequencing of viral or bacterial nucleic acids monitors the presence and diversity of microbes in select populations and locations. Metagenomic study of mammalian viromes can help trace paths of viral transmissions within or between species. High throughput sequencing of patient and untreated sewage microbiomes showed many sequences with no similarity to genomic sequences of known function or origin. To estimate the distribution of functional RNAs in these microbiomes, we used the hammerhead ribozyme (HHR) motif to search for sequences capable of assuming its three-way junction fold. Although only two of the three possible natural HHR topologies had been known, our analysis revealed highly active ribozymes that terminated in any of the three stems. The most abundant of these are type II HHRs, one of which is the fastest natural cis-acting HHR yet discovered. Altogether, 13 ribozymes were confirmed in vitro, but only one showed sequence similarity to previously described HHRs. Sequences surrounding the ribozymes do not generally show similarity to known genes, except in one case, where a ribozyme is immediately preceded by a bacterial RadC gene. We demonstrate that a structure-based search for a known functional RNA is a powerful tool for analysis of metagenomic datasets, complementing sequence alignments.	[Jimenez, Randi M.; Luptak, Andrej] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Luptak, Andrej] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Luptak, Andrej] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Delwart, Eric] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94118 USA; [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94118 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Luptak, A (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA.	aluptak@uci.edu		Delwart, Eric/0000-0002-6296-4484	National Institutes of Health [R01 GM094929, R01 HL083254]; University of California, Irvine; Pew Charitable Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Irvine(University of California System); Pew Charitable Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM094929 (to A. L.) and R01 HL083254 (to E. D.). This work was also supported by the University of California, Irvine, startup funds and the Pew Charitable Funds (to A. L.).	Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Bourdeau V, 1999, NUCLEIC ACIDS RES, V27, P4457, DOI 10.1093/nar/27.22.4457; Canny MD, 2007, BIOCHEMISTRY-US, V46, P3826, DOI 10.1021/bi062077r; Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; De la Pena M, 2001, J BIOL CHEM, V276, P34586, DOI 10.1074/jbc.M103867200; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; de la Pena M, 2010, EMBO REP, V11, P711, DOI 10.1038/embor.2010.100; Dufour D, 2009, NUCLEIC ACIDS RES, V37, P368, DOI 10.1093/nar/gkn918; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; EPSTEIN LM, 1987, COLD SPRING HARB SYM, V52, P261, DOI 10.1101/SQB.1987.052.01.031; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferbeyre G, 2000, GENOME RES, V10, P1011, DOI 10.1101/gr.10.7.1011; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kore AR, 1998, NUCLEIC ACIDS RES, V26, P4116, DOI 10.1093/nar/26.18.4116; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Menger M, 2000, NUCLEIC ACIDS RES, V28, P4428, DOI 10.1093/nar/28.22.4428; Nelson JA, 2006, MOL CELL, V23, P447, DOI 10.1016/j.molcel.2006.08.001; Nielsen H, 2005, SCIENCE, V309, P1584, DOI 10.1126/science.1113645; Nielsen H, 2009, RNA BIOL, V6, P375, DOI 10.4161/rna.6.4.9334; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Riccitelli NJ, 2010, METHODS, V52, P133, DOI 10.1016/j.ymeth.2010.06.005; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Roychowdhury-Saha M, 2006, RNA, V12, P1846, DOI 10.1261/rna.128906; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Scott WG, 2009, BBA-GENE REGUL MECH, V1789, P634, DOI 10.1016/j.bbagrm.2009.09.006; Seehafer C, 2011, RNA, V17, P21, DOI 10.1261/rna.2429911; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Shepotitiovskaya IV, 2008, BIOCHEMISTRY-US, V47, P7034, DOI 10.1021/bi7025358; Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021; Symonds EM, 2009, APPL ENVIRON MICROB, V75, P1402, DOI 10.1128/AEM.01899-08; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; TUSCHL T, 1994, SCIENCE, V266, P785, DOI 10.1126/science.7973630; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; WU HN, 1989, P NATL ACAD SCI USA, V86, P1831, DOI 10.1073/pnas.86.6.1831	48	38	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7737	7743		10.1074/jbc.C110.209288	http://dx.doi.org/10.1074/jbc.C110.209288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21257745	Green Published, hybrid			2022-12-25	WOS:000288013300005
J	Jeong, JH; Bhatia, A; Toth, Z; Oh, S; Inn, KS; Liao, CP; Roy-Burman, P; Melamed, J; Coetzee, GA; Jung, JU				Jeong, Joseph H.; Bhatia, Ayesha; Toth, Zsolt; Oh, Soohwan; Inn, Kyung-Soo; Liao, Chun-Peng; Roy-Burman, Pradip; Melamed, Jonathan; Coetzee, Gerhard A.; Jung, Jae U.			TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; MOUSE MODEL; TYROSINE PHOSPHORYLATION; RECEPTOR PHOSPHORYLATION; TUMOR PROGRESSION; NF-KAPPA-B1 P105; BREAST-CANCER; EXPRESSION; CELLS	Background: Despite its initial positive response to hormone ablation therapy, prostate cancers invariably recur in more aggressive, treatment resistant forms. The lack of our understanding of underlying genetic alterations for the transition from androgen-dependent (AD) to ADI prostate cancer growth hampers our ability to develop target-driven therapeutic strategies for the efficient treatment of ADI prostate cancer. Methodology/Principal Findings: By screening a library of activated human kinases, we have identified TPL2, encoding a serine/threonine kinase, as driving ADI prostate cancer growth. TPL2 activation by over-expressing either wild-type or a constitutively activated form of TPL2 induced ADI growth, whereas the suppression of TPL2 expression and its kinase activity in ADI prostate cancer cells inhibited cell proliferation under androgen-depleted conditions. Most importantly, TPL2 is upregulated in ADI prostate cancers of both the Pten deletion mouse model and the clinical prostate cancer specimens. Conclusions/Significance: Together these data suggest that TPL2 kinase plays a critical role in the promotion of ADI prostate cancer progression. Furthermore, the suppression of TPL2 diminishes ADI prostate cancer growth and a high frequency of TPL2 overexpression in human ADI prostate cancer samples validates TPL2 as a target for the treatment of this deadly disease.	[Jeong, Joseph H.; Bhatia, Ayesha; Toth, Zsolt; Oh, Soohwan; Inn, Kyung-Soo; Jung, Jae U.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Liao, Chun-Peng; Roy-Burman, Pradip] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Melamed, Jonathan] NYU, Dept Pathol, NYU Prostate Canc Tissue Resource, New York, NY 10016 USA; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Urol & Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; New York University; University of Southern California	Jeong, JH (corresponding author), Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	hyeongnj@usc.edu; jaeujung@usc.edu	Melamed, Jonathan/AAV-3769-2020; Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020; Inn, Kyung-Soo/AAJ-4118-2020	Melamed, Jonathan/0000-0003-2844-7990; Coetzee, Gerhard/0000-0001-8820-8364; Liao, Chun-Peng/0000-0001-8920-4322	DoD [060868]; ACS [IRG-58-007-48]; NIH [CA 109147, R01 CA 136924, CA 59705, CA 113392, CA082057, CA31363, CA115284, AI083025, DE019085, CA148616]; Hastings Foundation; Fletcher Jones Foundation; NATIONAL CANCER INSTITUTE [R01CA109147, R01CA082057, RC2CA148616, R01CA115284, R01CA059705, R01CA031363, R01CA113392, R01CA136924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019085] Funding Source: NIH RePORTER	DoD(United States Department of Defense); ACS(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; Fletcher Jones Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded and supported by DoD 060868 and ACS grant IRG-58-007-48 to JHJ, NIH grants CA 109147 and R01 CA 136924 to GAC, NIH grants CA 59705 and CA 113392 to PRB, and CA082057, CA31363, CA115284, AI083025, DE019085, CA148616, Hastings Foundation, and Fletcher Jones Foundation to JUJ. (http://cdmrp.army.mil/, http://www.cancer.org/, http://www.nih.gov/, http://www.fletcherjonesfdn.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Balistreri CR, 2009, J CLIN IMMUNOL, V29, P406, DOI 10.1007/s10875-009-9297-5; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; COFFEY DS, 1993, CANCER, V71, P880, DOI 10.1002/1097-0142(19930201)71:3+<880::AID-CNCR2820711403>3.0.CO;2-6; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gatti G, 2009, PROSTATE, V69, P1387, DOI 10.1002/pros.20984; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gioeli D, 1999, CANCER RES, V59, P279; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Jeong JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003949; Jia L, 2003, MOL CANCER RES, V1, P385; Koivisto P, 1997, CANCER RES, V57, P314; Lee KM, 2009, CANCER RES, V69, P8043, DOI 10.1158/0008-5472.CAN-09-2316; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Liao Chun-Peng, 2010, Hormones & Cancer, V1, P44, DOI 10.1007/s12672-009-0005-y; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; THALMANN GN, 1994, CANCER RES, V54, P2577; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yeung F, 2000, J BIOL CHEM, V275, P40846, DOI 10.1074/jbc.M002755200; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhao XY, 2000, NAT MED, V6, P703, DOI 10.1038/76287; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	51	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16205	10.1371/journal.pone.0016205	http://dx.doi.org/10.1371/journal.pone.0016205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267413	gold, Green Submitted, Green Published			2022-12-25	WOS:000286519500045
J	Xu, X; Jackson, PL; Tanner, S; Hardison, MT; Roda, MA; Blalock, JE; Gaggar, A				Xu, Xin; Jackson, Patricia L.; Tanner, Scott; Hardison, Matthew T.; Roda, Mojtaba Abdul; Blalock, James Edwin; Gaggar, Amit			A Self-Propagating Matrix Metalloprotease-9 (MMP-9) Dependent Cycle of Chronic Neutrophilic Inflammation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CYSTIC-FIBROSIS; GELATINASE-B; SIGNALING PATHWAYS; PROTEIN-KINASES; TNF-ALPHA; P38 MAPK; KAPPA-B; MATRIX-METALLOPROTEINASE-9; CHEMOATTRACTANT	Background: Chronic neutrophilic inflammation is a poorly understood feature in a variety of diseases with notable worldwide morbidity and mortality. We have recently characterized N-acetyl Pro-Gly-Pro (Ac-PGP) as an important neutrophil (PMN) chemoattractant in chronic inflammation generated from the breakdown of collagen by the actions of MMP-9. MMP-9 is present in the granules of PMNs and is differentially released during inflammation but whether Ac-PGP contributes to this ongoing proteolytic activity in chronic neutrophilic inflammation is currently unknown. Methodology/Principal Findings: Utilizing isolated primary blood PMNs from human donors, we found that Ac-PGP induces significant release of MMP-9 and concurrently activates the ERK1/2 MAPK pathway. This MMP-9 release is attenuated by an inhibitor of ERK1/2 MAPK and upstream blockade of CXCR1 and CXCR2 receptors with repertaxin leads to decreased MMP-9 release and ERK 1/2 MAPK activation. Supernatants obtained from PMNs stimulated by Ac-PGP generate more Ac-PGP when incubated with intact collagen ex vivo; this effect is inhibited by an ERK1/2 pathway inhibitor. Finally, clinical samples from individuals with CF demonstrate a notable correlation between Ac-PGP (as measured by liquid chromatography-tandem mass spectrometry) and MMP-9 levels even when accounting for total PMN burden. Conclusions/Significance: These data indicate that ECM-derived Ac-PGP could result in a feed-forward cycle by releasing MMP-9 from activated PMNs through the ligation of CXCR1 and CXCR2 and subsequent activation of the ERK1/2 MAPK, highlighting for the first time a matrix-derived chemokine (matrikine) augmenting its generation through a discrete receptor/intracellular signaling pathway. These findings have notable implications to the development unrelenting chronic PMN inflammation in human disease.	[Xu, Xin; Jackson, Patricia L.; Hardison, Matthew T.; Blalock, James Edwin; Gaggar, Amit] Univ Alabama, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Xu, Xin; Jackson, Patricia L.; Blalock, James Edwin; Gaggar, Amit] Univ Alabama, Gregory Fleming James CF Ctr, Birmingham, AL 35294 USA; [Tanner, Scott] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Roda, Mojtaba Abdul] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol & Pathophysiol, Utrecht, Netherlands; [Gaggar, Amit] Birmingham VA Med Ctr, Pulm Serv, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Utrecht University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Xu, X (corresponding author), Univ Alabama, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	agaggar@uab.edu		Blalock, J. Edwin/0000-0001-5303-8123; Tanner, Scott/0000-0002-7717-5293	University of Alabama; Cystic Fibrosis Foundation [GAGGAR07A0]; NIH/NHLBI [HL07783, HL090999, HL087824, HL102371-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090999, R01HL087824, R01HL102371] Funding Source: NIH RePORTER	University of Alabama; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Alabama Clinical Investigator Fellowship Award, the Cystic Fibrosis Foundation (Grant GAGGAR07A0 to AG) and NIH/NHLBI (HL07783, HL090999, and HL087824 (to JEB) and HL102371-01A1 (to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagoe K, 1998, J IMMUNOL, V160, P4518; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Boyd D, 1996, CANCER METAST REV, V15, P77, DOI 10.1007/BF00049488; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; DEKRUIJF P, EUR J PHARM, V643, P29; Finlay GA, 1997, THORAX, V52, P502, DOI 10.1136/thx.52.6.502; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; GERNEZ Y, EUR RESP J, V35, P467; GREENE CM, AM J RESP CRIT CARE, V181, P31; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Haddox JL, 1999, INVEST OPHTH VIS SCI, V40, pS687; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hii CST, 1999, INFECT IMMUN, V67, P1297, DOI 10.1128/IAI.67.3.1297-1302.1999; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; LU DJ, 1993, BLOOD CELLS, V19, P343; Ludwig A, 1997, BLOOD, V90, P4588; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; McCawley LJ, 1998, J CELL PHYSIOL, V176, P255, DOI 10.1002/(SICI)1097-4652(199808)176:2<255::AID-JCP4>3.0.CO;2-N; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Petrich BG, 2004, TRENDS CARDIOVAS MED, V14, P50, DOI 10.1016/j.tcm.2003.11.002; PFISTER RR, 1995, INVEST OPHTH VIS SCI, V36, pS701; Pugin J, 1999, AM J RESP CELL MOL, V20, P458, DOI 10.1165/ajrcmb.20.3.3311; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2008, AM J RESP CRIT CARE, V178, P822, DOI 10.1164/rccm.200712-1894OC; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Strniskova M, 2002, GEN PHYSIOL BIOPHYS, V21, P231; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; VANDAMME J, 1988, J EXP MED, V167, P1364, DOI 10.1084/jem.167.4.1364; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WEATHINGTON NM, 2005, BIOL CXC CHEMOKINES, P49	46	135	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15781	10.1371/journal.pone.0015781	http://dx.doi.org/10.1371/journal.pone.0015781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249198	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000008
J	Zhang, DD; Qian, YD; Akula, N; Alliey-Rodriguez, N; Tang, JS; Gershon, ES; Liu, CY				Zhang, Dandan; Qian, Yudong; Akula, Nirmala; Alliey-Rodriguez, Ney; Tang, Jinsong; Gershon, Elliot S.; Liu, Chunyu		Bipolar Genome Study	Accuracy of CNV Detection from GWAS Data	PLOS ONE			English	Article							COPY-NUMBER VARIATION; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; HUMAN GENOME; BIPOLAR DISORDER; INCREASE RISK; SCHIZOPHRENIA; POLYMORPHISM; ASSOCIATION; ABERRATIONS	Several computer programs are available for detecting copy number variants (CNVs) using genome-wide SNP arrays. We evaluated the performance of four CNV detection software suites-Birdsuite, Partek, HelixTree, and PennCNV-Affy-in the identification of both rare and common CNVs. Each program's performance was assessed in two ways. The first was its recovery rate, i.e., its ability to call 893 CNVs previously identified in eight HapMap samples by paired-end sequencing of whole-genome fosmid clones, and 51,440 CNVs identified by array Comparative Genome Hybridization (aCGH) followed by validation procedures, in 90 HapMap CEU samples. The second evaluation was program performance calling rare and common CNVs in the Bipolar Genome Study (BiGS) data set (1001 bipolar cases and 1033 controls, all of European ancestry) as measured by the Affymetrix SNP 6.0 array. Accuracy in calling rare CNVs was assessed by positive predictive value, based on the proportion of rare CNVs validated by quantitative real-time PCR (qPCR), while accuracy in calling common CNVs was assessed by false positive/false negative rates based on qPCR validation results from a subset of common CNVs. Birdsuite recovered the highest percentages of known HapMap CNVs containing >20 markers in two reference CNV datasets. The recovery rate increased with decreased CNV frequency. In the tested rare CNV data, Birdsuite and Partek had higher positive predictive values than the other software suites. In a test of three common CNVs in the BiGS dataset, Birdsuite's call was 98.8% consistent with qPCR quantification in one CNV region, but the other two regions showed an unacceptable degree of accuracy. We found relatively poor consistency between the two "gold standards,'' the sequence data of Kidd et al., and aCGH data of Conrad et al. Algorithms for calling CNVs especially common ones need substantial improvement, and a "gold standard'' for detection of CNVs remains to be established.	[Zhang, Dandan] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Dandan; Qian, Yudong; Alliey-Rodriguez, Ney; Gershon, Elliot S.; Liu, Chunyu] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Akula, Nirmala] NIMH, Intramural Res Programs, Bethesda, MD 20892 USA; [Tang, Jinsong] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China	Zhejiang University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central South University	Zhang, DD (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	egershon@yoda.bsd.uchicago.edu; cliu@yoda.bsd.uchicago.edu	Liu, chunyu/Q-3901-2017; Greenwood, Tiffany/F-6356-2012; Liu, Chunyu/G-7561-2012; Smith, Erin/E-5933-2011; Zhang, Dandan/ABA-9747-2020; Mahon, Pamela Belmonte/O-9806-2018; McMahon, Francis J/A-7290-2009	Greenwood, Tiffany/0000-0002-6080-6503; Liu, Chunyu/0000-0002-5986-4415; Mahon, Pamela Belmonte/0000-0002-3947-441X; McMahon, Francis J/0000-0002-9469-305X; Alliey-Rodriguez, Ney/0000-0001-8594-5676; zhang, dandan/0000-0001-5305-9856	National Institute of Mental Health [R01MH080425, 1R01MH081804]; National Alliance for Research on Schizophrenia and Depression [R01MH081804]; Eklund family; Geraldi Norton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081804, R01MH080425, ZIAMH002843] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Eklund family; Geraldi Norton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from The National Institute of Mental Health, R01MH080425 and 1R01MH081804, The National Alliance for Research on Schizophrenia and Depression, R01MH081804, the Eklund family, and the Geraldi Norton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Huang Jing, 2004, Human Genomics, V1, P287; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; MARENNE G, 2010, HUM MUTAT IN PRESS; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mei TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-147; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	33	47	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e14511	10.1371/journal.pone.0014511	http://dx.doi.org/10.1371/journal.pone.0014511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249187	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000001
J	Zschenderlein, C; Gebhardt, C; Halbach, OVU; Kulisch, C; Albrecht, D				Zschenderlein, Carsten; Gebhardt, Christine; Halbach, Oliver von Bohlen und; Kulisch, Christoph; Albrecht, Doris			Capsaicin-Induced Changes in LTP in the Lateral Amygdala Are Mediated by TRPV1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; THALAMIC INPUT SYNAPSES; SYNAPTIC PLASTICITY; BASOLATERAL AMYGDALA; VANILLOID RECEPTORS; MEMORY CONSOLIDATION; NMDA RECEPTOR; ION-CHANNEL; RAT; NEURONS	The transient receptor potential vanilloid type 1 (TRPV1) channel is a well recognized polymodal signal detector that is activated by painful stimuli such as capsaicin. Here, we show that TRPV1 is expressed in the lateral nucleus of the amygdala (LA). Despite the fact that the central amygdala displays the highest neuronal density, the highest density of TRPV1 labeled neurons was found within the nuclei of the basolateral complex of the amygdala. Capsaicin specifically changed the magnitude of long-term potentiation (LTP) in the LA in brain slices of mice depending on the anesthetic (ether, isoflurane) used before euthanasia. After ether anesthesia, capsaicin had a suppressive effect on LA-LTP both in patch clamp and in extracellular recordings. The capsaicin-induced reduction of LTP was completely blocked by the nitric oxide synthase (NOS) inhibitor L-NAME and was absent in neuronal NOS as well as in TRPV1 deficient mice. The specific antagonist of cannabinoid receptor type 1 (CB1), AM 251, was also able to reduce the inhibitory effect of capsaicin on LA-LTP, suggesting that stimulation of TRPV1 provokes the generation of anandamide in the brain which seems to inhibit NO synthesis. After isoflurane anesthesia before euthanasia capsaicin caused a TRPV1-mediated increase in the magnitude of LA-LTP. Therefore, our results also indicate that the appropriate choice of the anesthetics used is an important consideration when brain plasticity and the action of endovanilloids will be evaluated. In summary, our results demonstrate that TRPV1 may be involved in the amygdala control of learning mechanisms.	[Zschenderlein, Carsten; Gebhardt, Christine; Kulisch, Christoph; Albrecht, Doris] Charite, Inst Neurophysiol, CVK, D-13353 Berlin, Germany; [Halbach, Oliver von Bohlen und] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Greifswald, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ernst Moritz Arndt Universitat Greifswald	Zschenderlein, C (corresponding author), Charite, Inst Neurophysiol, CVK, D-13353 Berlin, Germany.	doris.albrecht@charite.de	von Bohlen und Halbach, Oliver/R-3464-2019; von Bohlen und Halbach, Oliver/A-1060-2008	von Bohlen und Halbach, Oliver/0000-0002-6265-9156; von Bohlen und Halbach, Oliver/0000-0002-2613-2517; Kulisch, Christoph/0000-0001-6689-1107	Deutsche Forschungsgemeinschaft (DFG) [AI 342/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (DFG) (AI 342/12-1). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hayani A, 2001, NEUROPHARMACOLOGY, V41, P1000, DOI 10.1016/S0028-3908(01)00145-9; Alter BJ, 2008, NEURON, V57, P629, DOI 10.1016/j.neuron.2008.02.023; Alvares LD, 2006, BRAIN RES, V1075, P60, DOI 10.1016/j.brainres.2005.11.101; Aroniadou-Anderjaska V, 2001, NEUROREPORT, V12, P635, DOI 10.1097/00001756-200103050-00041; Azad SC, 2003, LEARN MEMORY, V10, P116, DOI 10.1101/lm.53303; Baryshnikova LM, 2006, MICROSC RES TECHNIQ, V69, P738, DOI 10.1002/jemt.20345; Benko R, 2005, LIFE SCI, V76, P2773, DOI 10.1016/j.lfs.2004.07.033; Bieda MC, 2009, ANESTH ANALG, V108, P484, DOI 10.1213/ane.0b013e3181904571; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; CHAPMAN PF, 1992, SYNAPSE, V11, P310, DOI 10.1002/syn.890110406; CHAVES AE, 2008, SOC NEUR ABSTR; Chen A, 2003, NEUROSCIENCE, V119, P53, DOI 10.1016/S0306-4522(03)00076-9; Chen Y, 2008, NEUROPEPTIDES, V42, P551, DOI 10.1016/j.npep.2008.08.001; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; de Olmos J.S., 1985, RAT NERVOUS SYSTEM, VI, P223; Derbenev AV, 2006, J NEUROSCI, V26, P9666, DOI 10.1523/JNEUROSCI.1591-06.2006; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Drephal C, 2006, NEUROBIOL LEARN MEM, V85, P272, DOI 10.1016/j.nlm.2005.11.004; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Fendt M, 2002, EUR J NEUROSCI, V15, P1535, DOI 10.1046/j.1460-9568.2002.01988.x; Ferrini F, 2007, PAIN, V129, P195, DOI 10.1016/j.pain.2007.01.009; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; Harrison N, 2008, MOL PHARMACOL, V74, P1180, DOI 10.1124/mol.108.051615; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Immke DC, 2006, SEMIN CELL DEV BIOL, V17, P582, DOI 10.1016/j.semcdb.2006.09.004; Johnson LR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.003.2008; Johnston D., 1995, FDN CELLULAR NEUROPH; Kofalvi A, 2006, NEUROSCI LETT, V403, P151, DOI 10.1016/j.neulet.2006.04.030; Kotaria N, 2005, CELL TISSUE RES, V322, P503, DOI 10.1007/s00441-005-0023-1; Lamprecht R, 2006, NEUROSCIENCE, V139, P821, DOI 10.1016/j.neuroscience.2005.12.055; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Li H, 1998, J NEUROSCI, V18, P1662; Li HB, 2008, ACTA CRYSTALLOGR E, V64, pO465, DOI 10.1107/S1600536808001293; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Marinelli S, 2003, J NEUROSCI, V23, P3136; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; MCDONALD AJ, 1984, J COMP NEUROL, V222, P589, DOI 10.1002/cne.902220410; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Muller T, 2009, LEARN MEMORY, V16, P395, DOI 10.1101/lm.1398709; MULLER W, 1988, EXP BRAIN RES, V72, P287; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Okere CO, 2000, J COMP NEUROL, V423, P670, DOI 10.1002/1096-9861(20000807)423:4<670::AID-CNE11>3.0.CO;2-S; Pan BX, 2009, NEURON, V61, P917, DOI 10.1016/j.neuron.2009.01.029; Pitkanen A, 2003, ANN NY ACAD SCI, V985, P34; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Pollandt S, 2003, NEUROREPORT, V14, P895, DOI 10.1097/00001756-200305060-00025; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Roberts Louise A, 2006, Recent Pat CNS Drug Discov, V1, P65, DOI 10.2174/157488906775245309; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rossi S, 2008, J NEUROSCI, V28, P7284, DOI 10.1523/JNEUROSCI.5346-07.2008; Samson RD, 2003, J NEUROSCI, V23, P1966; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schubert M, 2008, NEUROPSYCHOPHARMACOL, V33, P2524, DOI 10.1038/sj.npp.1301633; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; Trevisani M, 2004, J PHARMACOL EXP THER, V309, P1167, DOI 10.1124/jpet.103.064162; von Bohlen und Halbach O, 2005, CELL TISSUE RES, V322, P201, DOI 10.1007/s00441-005-0004-4; von Bohlen und Halbach O, 1998, PEPTIDES, V19, P1031, DOI 10.1016/S0196-9781(98)00044-8; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5; WATANABE Y, 1995, NEUROSCI RES, V21, P317, DOI 10.1016/0168-0102(94)00867-F; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Westphalen RI, 2006, J PHARMACOL EXP THER, V316, P208, DOI 10.1124/jpet.105.090647; Zechel S, 2007, CELL TISSUE RES, V328, P651, DOI 10.1007/s00441-007-0388-4; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	82	63	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16116	10.1371/journal.pone.0016116	http://dx.doi.org/10.1371/journal.pone.0016116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249195	Green Submitted, Green Published, gold			2022-12-25	WOS:000286515000020
J	Ouwe-Missi-Oukem-Boyer, O; Ndouo, FST; Ollomo, B; Mezui-Me-Ndong, J; Noulin, F; Lachard, I; Ndong-Atome, GR; Makuwa, M; Roques, P; Branger, M; Preux, PM; Mazier, D; Bisser, S				Ouwe-Missi-Oukem-Boyer, Odile; Ndouo, Fousseyni S. Toure; Ollomo, Benjamin; Mezui-Me-Ndong, Jerome; Noulin, Florian; Lachard, Isabelle; Ndong-Atome, Guy-Roger; Makuwa, Maria; Roques, Pierre; Branger, Michel; Preux, Pierre-Marie; Mazier, Dominique; Bisser, Sylvie			Hepatitis C Virus Infection May Lead to Slower Emergence of P. falciparum in Blood	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; B-VIRUS; MALARIA INFECTION; RURAL GABON; PREVALENCE; TRANSMISSION; RESISTANCE; POPULATION; PROTECTION	Background: Areas endemic for Plasmodium falciparum, hepatitis B virus (HBV) and hepatitis C virus (HCV) overlap in many parts of sub-Saharan Africa. HBV and HCV infections develop in the liver, where takes place the first development stage of P. falciparum before its further spread in blood. The complex mechanisms involved in the development of hepatitis may potentially influence the development of the liver stage of malaria parasites. Understanding the molecular mechanisms of these interactions could provide new pathophysiological insights for treatment strategies in Malaria. Methodology: We studied a cohort of 319 individuals living in a village where the three infections are prevalent. The patients were initially given a curative antimalarial treatment and were then monitored for the emergence of asexual P. falciparum forms in blood, fortnightly for one year, by microscopy and polymerase chain reaction. Principal Findings: At inclusion, 65 (20.4%) subjects had detectable malaria parasites in blood, 36 (11.3%) were HBV chronic carriers, and 61 (18.9%) were HCV chronic carriers. During follow-up, asexual P. falciparum forms were detected in the blood of 203 patients. The median time to P. falciparum emergence in blood was respectively 140 and 120 days in HBV- and HBV+ individuals, and 135 and 224 days in HCV- and HCV+ individuals. HCV carriage was associated with delayed emergence of asexual P. falciparum forms in blood relative to patients without HCV infection. Conclusions: This pilot study represents first tentative evidence of a potential epidemiological interaction between HBV, HCV and P. falciparum infections. Age is an important confounding factor in this setting however multivariate analysis points to an interaction between P. falciparum and HCV at the hepatic level with a slower emergence of P. falciparum in HCV chronic carriers. More in depth analysis are necessary to unravel the basis of hepatic interactions between these two pathogens, which could help in identifying new therapeutic approaches against malaria.	[Ouwe-Missi-Oukem-Boyer, Odile; Ndouo, Fousseyni S. Toure; Ollomo, Benjamin; Mezui-Me-Ndong, Jerome; Noulin, Florian; Lachard, Isabelle; Ndong-Atome, Guy-Roger; Makuwa, Maria; Roques, Pierre; Bisser, Sylvie] Ctr Int Rech Med Franceville, Franceville, Gabon; [Branger, Michel] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Preux, Pierre-Marie; Bisser, Sylvie] Univ Limoges, IFR GEIST 145, Inst Neurol Trop, EA NeuroEpidemiol Trop & Comparee 3174, Limoges, France; [Mazier, Dominique] INSERM, U945, Paris, France; [Mazier, Dominique] Univ Paris 06, UMR S945, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Roques, Pierre] CEA, Div ImmunoVirol SIV, Inst Emerging Dis & Innovat Therapies IMETI, Fontenay Aux Roses, France; [Roques, Pierre] Univ Paris 11, UMR E1, Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ouwe-Missi-Oukem-Boyer, O (corresponding author), Chantal Biya Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.	ooukem@yahoo.fr	PREUX, Pierre-Marie/B-8393-2014; noulin, florian/J-3809-2013; Roques, Pierre/M-2212-2013; Preux, Pierre-Marie/N-3538-2019	PREUX, Pierre-Marie/0000-0002-2171-2977; noulin, florian/0000-0001-7430-8073; Roques, Pierre/0000-0003-1825-1054; Preux, Pierre-Marie/0000-0002-2171-2977	Total Gabon; Gabonese government; French Foreign Ministry	Total Gabon(Total SA); Gabonese government; French Foreign Ministry	This study was supported by Centre International de Recherche Medicale de Franceville (CIRMF), which is jointly funded by Total Gabon, the Gabonese government, and the French Foreign Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; BRABIN L, 1989, ANN TROP MED PARASIT, V83, P365, DOI 10.1080/00034983.1989.11812359; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; Daubersies P, 1996, AM J TROP MED HYG, V54, P18, DOI 10.4269/ajtmh.1996.54.18; DAZZA MC, 1993, T ROY SOC TROP MED H, V87, P539, DOI 10.1016/0035-9203(93)90078-5; DELAPORTE E, 1993, T ROY SOC TROP MED H, V87, P636, DOI 10.1016/0035-9203(93)90269-V; Deloron P, 1999, AM J TROP MED HYG, V61, P99, DOI 10.4269/ajtmh.1999.61.99; Dieye A, 1997, PARASITOL TODAY, V13, P48, DOI 10.1016/S0169-4758(96)20062-6; Domarle O, 1999, AM J TROP MED HYG, V61, P926, DOI 10.4269/ajtmh.1999.61.926; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; DUPONT A, 1988, ANN SOC BELG MED TR, V68, P157; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Guidotti LG, 1996, P NATL ACAD SCI USA, V93, P4589, DOI 10.1073/pnas.93.10.4589; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Mayengue PI, 2004, TROP MED INT HEALTH, V9, P949, DOI 10.1111/j.1365-3156.2004.01294.x; Mazier D, 1993, Parassitologia, V35 Suppl, P59; Migot-Nabias F, 1999, TISSUE ANTIGENS, V53, P580, DOI 10.1034/j.1399-0039.1999.530610.x; Migot-Nabias F, 1999, AM J TROP MED HYG, V61, P488; Morel CM, 2002, SCIENCE, V298, P79, DOI 10.1126/science.1078047; MOUNT DL, 1989, B WORLD HEALTH ORGAN, V67, P295; Ndong-Atome GR, 2008, J MED VIROL, V80, P1581, DOI 10.1002/jmv.21252; Njouom R, 2003, J MED VIROL, V71, P219, DOI 10.1002/jmv.10473; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Ouwe-Missi-Oukem-Boyer O N, 2005, Bull Soc Pathol Exot, V98, P343; Oyedeji SI, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-112; Pasquetto V, 2000, J EXP MED, V192, P529, DOI 10.1084/jem.192.4.529; Perraut R, 2003, J INFECT DIS, V188, P1940, DOI 10.1086/379838; Pied S, 2000, J IMMUNOL, V164, P1463, DOI 10.4049/jimmunol.164.3.1463; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; RICHARDLENOBLE D, 1995, AM J TROP MED HYG, V53, P338, DOI 10.4269/ajtmh.1995.53.338; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna CS, 2001, AM J TROP MED HYG, V65, P167, DOI 10.4269/ajtmh.2001.65.167; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Taylor-Robinson, 2000, Parasitol Today, V16, P509, DOI 10.1016/S0169-4758(00)01833-0; TAYLORROBINSON A, 2000, J EXP MED, V192, P529; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Toure FS, 2006, CLIN MED RES, V4, P175, DOI [10.3121/cmr.4.3.175, 10.3121/cmr.4.1.1]; WHO, 2006, GUID TREATM MAL; World Health Organization, 2002, WKLY EPIDEMIOL REC, V77, P45; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013	48	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16034	10.1371/journal.pone.0016034	http://dx.doi.org/10.1371/journal.pone.0016034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249226	gold, Green Submitted, Green Published			2022-12-25	WOS:000286513100024
J	Sukenik, S; Politi, R; Ziserman, L; Danino, D; Friedler, A; Harries, D				Sukenik, Shahar; Politi, Regina; Ziserman, Lior; Danino, Dganit; Friedler, Assaf; Harries, Daniel			Crowding Alone Cannot Account for Cosolute Effect on Amyloid Aggregation	PLOS ONE			English	Article							RAMAN OPTICAL-ACTIVITY; EXCLUDED SURFACE-AREA; PROTEIN AGGREGATION; FIBRIL FORMATION; II CONFORMATION; HEAT-CAPACITIES; BETA-PEPTIDE; WATER; STABILITY; DISEASE	Amyloid fiber formation is a specific form of protein aggregation, often resulting from the misfolding of native proteins. Aimed at modeling the crowded environment of the cell, recent experiments showed a reduction in fibrillation halftimes for amyloid-forming peptides in the presence of cosolutes that are preferentially excluded from proteins and peptides. The effect of excluded cosolutes has previously been attributed to the large volume excluded by such inert cellular solutes, sometimes termed "macromolecular crowding". Here, we studied a model peptide that can fold to a stable monomeric beta-hairpin conformation, but under certain solution conditions aggregates in the form of amyloid fibrils. Using Circular Dichroism spectroscopy (CD), we found that, in the presence of polyols and polyethylene glycols acting as excluded cosolutes, the monomeric beta-hairpin conformation was stabilized with respect to the unfolded state. Stabilization free energy was linear with cosolute concentration, and grew with molecular volume, as would also be predicted by crowding models. After initiating the aggregation process with a pH jump, fibrillation in the presence and absence of cosolutes was followed by ThT fluorescence, transmission electron microscopy, and CD spectroscopy. Polyols (glycerol and sorbitol) increased the lag time for fibril formation and elevated the amount of aggregated peptide at equilibrium, in a cosolute size and concentration dependent manner. However, fibrillation rates remained almost unaffected by a wide range of molecular weights of soluble polyethylene glycols. Our results highlight the importance of other forces beyond the excluded volume interactions responsible for crowding that may contribute to the cosolute effects acting on amyloid formation.	[Sukenik, Shahar; Politi, Regina; Friedler, Assaf; Harries, Daniel] Hebrew Univ Jerusalem, Fritz Haber Res Ctr, Inst Chem, IL-91904 Jerusalem, Israel; [Ziserman, Lior; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Russell Berrie Nanotechnol Inst, Haifa, Israel	Hebrew University of Jerusalem; Technion Israel Institute of Technology	Sukenik, S (corresponding author), Hebrew Univ Jerusalem, Fritz Haber Res Ctr, Inst Chem, Edmund J Safra Campus, IL-91904 Jerusalem, Israel.	daniel@fh.huji.ac.il	Danino, Dganit/D-6832-2016; Sukenik, Shahar/J-4438-2013; Harries, Daniel/F-7016-2012	Danino, Dganit/0000-0002-9782-4940; Sukenik, Shahar/0000-0003-3855-9574; Harries, Daniel/0000-0002-3057-9485	Israel Science Foundation (ISF) [1011/07]; European Research Council under the European Community [203413]; Minerva Foundation, Munich, Germany	Israel Science Foundation (ISF)(Israel Science Foundation); European Research Council under the European Community(European Research Council (ERC)); Minerva Foundation, Munich, Germany	DH has received financial support from the Israel Science Foundation (ISF grant No. 1011/07). AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 203413. The Fritz Haber Research Center is supported by the Minerva Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Athawale MV, 2005, BIOPHYS J, V89, P858, DOI 10.1529/biophysj.104.056671; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Blodgett MB, 2007, J CHEM THERMODYN, V39, P627, DOI 10.1016/j.jct.2006.08.009; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Capp MW, 2009, BIOCHEMISTRY-US, V48, P10372, DOI 10.1021/bi901273r; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; DIPAOLA G, 1977, CAN J CHEM, V55, P3825, DOI 10.1139/v77-540; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eker F, 2004, BIOCHEMISTRY-US, V43, P6893, DOI 10.1021/bi049542+; Eliassi A, 1998, J CHEM ENG DATA, V43, P719, DOI 10.1021/je970228a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gee MB, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253299; GIBBS JW, 1993, EQUILIBRIUM HETEROGE; GLENNER GG, 1980, NEW ENGL J MED, V302, P1333, DOI 10.1056/NEJM198006123022403; Griffiths-Jones SR, 1999, J MOL BIOL, V292, P1051, DOI 10.1006/jmbi.1999.3119; Guo F, 2009, J PHYS CHEM B, V113, P16632, DOI 10.1021/jp9072284; Gurnev PA, 2009, CHEMPHYSCHEM, V10, P1445, DOI 10.1002/cphc.200900312; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamley IW, 2010, MACROMOL BIOSCI, V10, P40, DOI 10.1002/mabi.200900217; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harries D, 2008, METHOD CELL BIOL, V84, P679, DOI 10.1016/S0091-679X(07)84022-2; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; IZHACK C, 2008, ANGEW CHEM, V47, P4062; Kuffel A, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3464768; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu FF, 2009, J PHYS CHEM B, V113, P11320, DOI 10.1021/jp905580j; Maynard AJ, 1998, J AM CHEM SOC, V120, P1996, DOI 10.1021/ja9726769; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Minton AP, 2000, BIOPHYS CHEM, V86, P239, DOI 10.1016/S0301-4622(00)00151-4; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Minton AP, 2001, BIOPHYS J, V80, P1641, DOI 10.1016/S0006-3495(01)76136-X; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; PARSEGIAN VA, 2002, INT REV CYTOLOGY SUR, P1; PARSEGIAN VA, 1995, MACROMOLECULES WATER, P43; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; PERCZEL A, 1991, PROTEIN ENG, V4, P669, DOI 10.1093/protein/4.6.669; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Politi R, 2010, CHEM COMMUN, V46, P6449, DOI 10.1039/c0cc01763a; Politi R, 2009, J PHYS CHEM A, V113, P7548, DOI 10.1021/jp9010026; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Rosgen J, 2007, PROTEIN SCI, V16, P733, DOI 10.1110/ps.062671607; Rudan-Tasic D, 2003, J MOL LIQ, V103, P187, DOI 10.1016/S0167-7322(02)00139-3; SHI Z, 2002, IS POLYPROLINE 2 MAJ, P163; Sidorova NY, 2000, BIOPOLYMERS, V53, P363, DOI 10.1002/(SICI)1097-0282(20000415)53:5<363::AID-BIP1>3.0.CO;2-Q; SILIGARDI G, 1995, BIOPOLYMERS, V37, P281, DOI 10.1002/bip.360370406; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Stanley CB, 2008, BIOPHYS J, V94, P4427, DOI 10.1529/biophysj.107.122705; Sun J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789434; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; White DA, 2010, J AM CHEM SOC, V132, P5170, DOI 10.1021/ja909997e; WYMAN J, 1964, LINKED FUNCTIONS REC, P223; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	71	46	46	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15608	10.1371/journal.pone.0015608	http://dx.doi.org/10.1371/journal.pone.0015608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249221	gold, Green Published			2022-12-25	WOS:000286513100007
J	Cheli, Y; Guiliano, S; Botton, T; Rocchi, S; Hofman, V; Hofman, P; Bahadoran, P; Bertolotto, C; Ballotti, R				Cheli, Y.; Guiliano, S.; Botton, T.; Rocchi, S.; Hofman, V.; Hofman, P.; Bahadoran, P.; Bertolotto, C.; Ballotti, R.			Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny	ONCOGENE			English	Article						Mitf; p27; melanoma; cancer-initiating-cells; tumorigenicity	CANCER STEM-CELLS; TRANSCRIPTION FACTOR; DISTINCT SUBPOPULATION; GROWTH; POPULATIONS; MELANOCYTES; PHENOTYPE; APOPTOSIS; DILUTION; PATHWAY	In melanoma, as well as in other solid tumors, the cells within a given tumor exhibit strong morphological, functional and molecular heterogeneity that might reflect the existence of different cancer cell populations, among which are melanoma-initiating cells (MICs) with 'stemness' properties and their differentiated, fast-growing progeny. The existence of a slow-growing population might explain the resistance of melanoma to classical chemotherapies that target fast growing cells. Therefore, elucidating the biologic properties of MICs and, more importantly, the molecular mechanisms that drive the transition between MICs and their proliferating progeny needs to be addressed to develop an efficient melanoma therapy. Using B16 mouse melanoma cells and syngeneic mice, we show that the inhibition of microphthalmia-associated transcription factor (Mitf), the master regulator of melanocyte differentiation, increases the tumorigenic potential of melanoma cells and upregulates the stem cell markers Oct4 and Nanog. Notably, p27, the CDK inhibitor, is increased in Mitf-depleted cells and is required for exacerbation of the tumorigenic properties of melanoma cells. Further, a slow-growing population with low-Mitf level and high tumorigenic potential exists spontaneously in melanoma. Ablation of this population dramatically decreases tumor formation. Importantly, these data were confirmed using human melanoma cell lines and freshly isolated human melanoma cell from lymph node and skin melanoma metastasis. Taken together our data, identified Mitf and p27 as the key molecular switches that control the transition between MICs and their differentiated progeny. Eradication of low-Mitf cells might be an appealing strategy to cure melanoma. Oncogene (2011) 30, 2307-2318; doi: 10.1038/onc.2010.598; published online 31 January 2011	[Cheli, Y.; Guiliano, S.; Botton, T.; Rocchi, S.; Bahadoran, P.; Bertolotto, C.; Ballotti, R.] Ctr Mediterraneen Med Mol C3M, INSERM, U895, Equipe Biol Pathol Melanocytes 1,Equipe Labellise, F-06204 Nice 3, France; [Cheli, Y.; Guiliano, S.; Botton, T.; Rocchi, S.; Hofman, P.; Bahadoran, P.; Bertolotto, C.; Ballotti, R.] Univ Nice Sophia Antipolis, UFR Med, Nice, France; [Hofman, V.; Hofman, P.] ERI21 EA 4319 & Human Biobank, Nice, France; [Bahadoran, P.; Bertolotto, C.; Ballotti, R.] CHU Nice, Dept Dermatol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Ballotti, R (corresponding author), Ctr Mediterraneen Med Mol C3M, INSERM, U895, Equipe Biol Pathol Melanocytes 1,Equipe Labellise, 151 Route St Antoine Ginestiere, F-06204 Nice 3, France.	ballotti@unice.fr	Bertolotto, Corine/AAF-6634-2021; Rocchi, Stephane/O-4152-2016; Hofman, Paul/P-7654-2018; BALLOTTI, Robert/F-8825-2013; Botton, Thomas/AAA-9258-2020; Cheli, Yann/O-5783-2016	Bertolotto, Corine/0000-0001-6971-7753; Rocchi, Stephane/0000-0002-0943-1304; Hofman, Paul/0000-0003-0431-9353; Botton, Thomas/0000-0001-9079-7014; Cheli, Yann/0000-0001-9839-4332; Bahadoran, Philippe/0000-0002-2481-0556; veronique, HOFMAN/0000-0003-0943-1627; BALLOTTI, Robert/0000-0002-7322-4908	Association pour la Recherche contre le Cancer [ARC 4985]; ARC	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ARC(Australian Research Council)	We wish to thank Genevieve Gozzerino, Agnes Loubat and Karine Bille for their help. This work was supported by the 'Association pour la Recherche contre le Cancer' (grant ARC 4985) and YC and TB have been supported by ARC's fellowships.	Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Botton T, 2009, J INVEST DERMATOL, V129, P1208, DOI 10.1038/jid.2008.346; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Larribere L, 2004, CELL DEATH DIFFER, V11, P1084, DOI 10.1038/sj.cdd.4401475; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schouwey K, 2008, HISTOL HISTOPATHOL, V23, P609, DOI 10.14670/HH-23.609; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Strizzi L, 2008, CELL CYCLE, V7, P1931, DOI 10.4161/cc.7.13.6236; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002	28	161	165	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	20					2307	2318		10.1038/onc.2010.598	http://dx.doi.org/10.1038/onc.2010.598			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21278797				2022-12-25	WOS:000290789200003
J	Henry, J; Hsu, CY; Haftek, M; Nachat, R; de Koning, HD; Gardinal-Galera, I; Hitomi, K; Balica, S; Jean-Decoster, C; Schmitt, AM; Paul, C; Serre, G; Simon, M				Henry, Julie; Hsu, Chiung-Yueh; Haftek, Marek; Nachat, Rachida; de Koning, Heleen D.; Gardinal-Galera, Isabelle; Hitomi, Kiyotaka; Balica, Stefana; Jean-Decoster, Catherine; Schmitt, Anne-Marie; Paul, Carle; Serre, Guy; Simon, Michel			Hornerin is a component of the epidermal cornified cell envelopes	FASEB JOURNAL			English	Article						atopic dermatitis; skin; keratinocytes; transglutaminase; terminal differentiation; corneocytes	BARRIER DYSFUNCTION; ATOPIC-DERMATITIS; FILAGGRIN; EXPRESSION; PROTEIN; IDENTIFICATION; PROFILAGGRIN; INVOLUCRIN; EPITHELIA; MOUSE	A single-nucleotide polymorphism within the gene encoding hornerin (HRNR) has recently been linked with atopic dermatitis (AD) susceptibility. HRNR shares features with filaggrin, a key protein for keratinocyte differentiation, but conflicting reports have been published concerning its expression in the epidermis, and its role is still unknown. To analyze HRNR expression and function in the epidermis, anti-HRNR antibodies were produced and used in Western blot analysis and immunohistochemical, confocal, and immunoelectron microscopy analyses of human skin and of cornified cell envelopes purified from plantar stratum corneum. We also tested whether HRNR was a substrate of transglutaminases. In the epidermis, HRNR was detected at the periphery of keratohyalin granules in the upper granular layer and at the corneocyte periphery in the whole cornified layer. Detected in Western blot analysis as numerous bands, HRNR was relatively insoluble and only extracted from epidermis with urea and/or reducing agents. The presence of HRNR in the purified envelopes was confirmed by immunoelectron microscopy and by Western blot analysis after V8-protease digestion. HRNR was shown to be a substrate of transglutaminase 3. These data demonstrate that HRNR is a component of cornified cell envelopes of human epidermis. Its reduced expression in AD may contribute to the epidermal barrier defect observed in the disease.-Henry, J., Hsu, C.-Y., Haftek, M., Nachat, R., de Koning, H. D., Gardinal-Galera, I., Hitomi, K., Balica, S., Jean-Decoster, C., Schmitt, A.-M., Paul, C., Serre, G., Simon, M. Hornerin is a component of the epidermal cornified cell envelopes. FASEB J. 25, 1567-1576 (2011). www.fasebj.org	[Henry, Julie; Hsu, Chiung-Yueh; Nachat, Rachida; Gardinal-Galera, Isabelle; Paul, Carle; Serre, Guy; Simon, Michel] Univ Toulouse 3, Inst Federatif Rech 150, INSERM, Ctr Hosp Univ,CNRS,UMR5165, F-31062 Toulouse, France; [Haftek, Marek] Univ Lyon 1, EA4169, F-69365 Lyon, France; [de Koning, Heleen D.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Gardinal-Galera, Isabelle; Balica, Stefana; Paul, Carle] Toulouse Univ Hosp, Dept Dermatol, Toulouse, France; [Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Bioagr Sci, Naboya, Japan; [Jean-Decoster, Catherine; Schmitt, Anne-Marie] Pierre Fabre Dermo Cosmet, Ctr Europeen Rech Peau & Epitheliums Revetement, Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Radboud University Nijmegen; CHU de Toulouse; Nagoya University	Simon, M (corresponding author), CHU Purpan, CNRS, UPS UMR5165, Pl Dr Baylac TSA40031, F-31059 Toulouse 9, France.	michel.simon@udear.cnrs.fr	Simon, Michel/B-7308-2011; de Koning, Heleen/A-5374-2011	Simon, Michel/0000-0003-3655-6329; Paul, Carle/0000-0003-0165-5263; Nachat Kappes, Rachida/0000-0001-7523-3560; HSU, Chiung-Yueh/0000-0002-4671-0919	Centre National de la Recherche Scientifique (CNRS), Toulouse III University, Pierre-Fabre Research Institute; French Society for Dermatological Research (SRD); Toulouse University Hospital [action BM0903]; INSERM; Fondation pour la Dermatite Atopique	Centre National de la Recherche Scientifique (CNRS), Toulouse III University, Pierre-Fabre Research Institute(Centre National de la Recherche Scientifique (CNRS)); French Society for Dermatological Research (SRD); Toulouse University Hospital; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Dermatite Atopique(Fondation pour la Recherche Medicale)	The authors thank Prof. Jean-Pierre Chavoin (Plastic Surgery Department, Hospital of Toulouse, Toulouse, France) and Prof. Nam-ho Huh (Okayama University Medical School, Okayama, Japan) for the human skin samples, Renan Destrade for his technical assistance, and Sophie Allard from the confocal microscopy facility [Institut National de la Sante et de la Recherche Medicale (INSERM), IFR150, Toulouse]. Electron microscopy specimens were observed at Centre de Microscopie Electronique Appliquee a la Biologie et la Geologie (CMEABG; University of Lyon, Lyon, France). This work was supported by grants from Centre National de la Recherche Scientifique (CNRS), Toulouse III University, Pierre-Fabre Research Institute, and the French Society for Dermatological Research (SRD), and by the European COST program SKINBAD (action BM0903), Toulouse University Hospital, and INSERM. I. G.-G. was supported by the Fondation pour la Dermatite Atopique. The authors are indebted to all the patients who participated in this study.	Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; DALE BA, 1979, J INVEST DERMATOL, V72, P257, DOI 10.1111/1523-1747.ep12531715; de Koning HD, 2010, J INVEST DERMATOL, V130, P2611, DOI 10.1038/jid.2010.196; Ekanayake-Mudiyanselage S, 1998, J INVEST DERMATOL, V111, P517, DOI 10.1046/j.1523-1747.1998.00318.x; Elias P M, 1999, Am J Contact Dermat, V10, P119, DOI 10.1016/S1046-199X(99)90054-4; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Guerrin M, 2003, BIOCHEM J, V370, P167, DOI 10.1042/BJ20020870; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Hitomi K, 2000, BIOSCI BIOTECH BIOCH, V64, P2128, DOI 10.1271/bbb.64.2128; LYNLEY AM, 1983, BIOCHIM BIOPHYS ACTA, V744, P28, DOI 10.1016/0167-4838(83)90336-9; Makino T, 2003, J HISTOCHEM CYTOCHEM, V51, P485, DOI 10.1177/002215540305100410; Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland R. B., 2006, SKIN BARRIER, P111; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; RICHARDS S, 1988, BIOCHEM J, V253, P153, DOI 10.1042/bj2530153; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; SIMON M, 1995, J INVEST DERMATOL, V105, P432, DOI 10.1111/1523-1747.ep12321148; Simon M, 1996, BIOCHEM J, V317, P173, DOI 10.1042/bj3170173; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SMITH SA, 1986, J INVEST DERMATOL, V86, P168, DOI 10.1111/1523-1747.ep12284213; Sugiura H, 2005, BRIT J DERMATOL, V152, P146, DOI 10.1111/J.1365-2133.2005.06352.X; Taieb A, 1999, CONTACT DERMATITIS, V41, P177, DOI 10.1111/j.1600-0536.1999.tb06125.x; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Torma H, 2008, J INVEST DERMATOL, V128, P1212, DOI 10.1038/sj.jid.5701170; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227	36	64	65	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1567	1576		10.1096/fj.10-168658	http://dx.doi.org/10.1096/fj.10-168658			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21282207				2022-12-25	WOS:000290023800014
J	Chen, D; Vollmar, M; Rossi, MN; Phillips, C; Kraehenbuehl, R; Slade, D; Mehrotra, PV; von Delft, F; Crosthwaite, SK; Gileadi, O; Denu, JM; Ahel, I				Chen, Dawei; Vollmar, Melanie; Rossi, Marianna N.; Phillips, Claire; Kraehenbuehl, Rolf; Slade, Dea; Mehrotra, Pawan V.; von Delft, Frank; Crosthwaite, Susan K.; Gileadi, Opher; Denu, John M.; Ahel, Ivan			Identification of Macrodomain Proteins as Novel O-Acetyl-ADP-ribose Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACRO DOMAIN; CHROMATIN; BINDING; GENE; MECHANISM; PRODUCT; FAMILY	Sirtuins are a family of protein lysine deacetylases, which regulate gene silencing, metabolism, life span, and chromatin structure. Sirtuins utilize NAD(+) to deacetylate proteins, yielding O-acetyl-ADP-ribose (OAADPr) as a reaction product. The macrodomain is a ubiquitous protein module known to bind ADP-ribose derivatives, which diverged through evolution to support many different protein functions and pathways. The observation that some sirtuins and macrodomains are physically linked as fusion proteins or genetically coupled through the same operon, provided a clue that their functions might be connected. Indeed, here we demonstrate that the product of the sirtuin reaction OAADPr is a substrate for several related macrodomain proteins: human MacroD1, human MacroD2, Escherichia colt YmdB, and the sirtuin-linked MacroD-like protein from Staphylococcus aureus. In addition, we show that the cell extracts derived from MacroD-deficient Neurospora crassa strain exhibit a major reduction in the ability to hydrolyze OAADPr. Our data support a novel function of macrodomains as OAADPr deacetylases and potential in vivo regulators of cellular OAADPr produced by NAD(+)-dependent deacetylation.	[Chen, Dawei; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Chen, Dawei; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA; [Vollmar, Melanie; Phillips, Claire; von Delft, Frank; Gileadi, Opher] Univ Oxford, ORCRB, Struct Genom Consortium, Oxford OX3 7DQ, England; [Rossi, Marianna N.; Kraehenbuehl, Rolf; Slade, Dea; Mehrotra, Pawan V.; Ahel, Ivan] Univ Manchester, Paterson Inst Canc Res, DNA Damage Response Grp, Manchester M20 4BX, Lancs, England; [Slade, Dea] Univ Paris 05, INSERM, Fac Med, U1001, F-75015 Paris, France; [Crosthwaite, Susan K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Paterson Institute for Cancer Research; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Manchester	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu; IAhel@picr.man.ac.uk	Gileadi, Opher/F-1105-2013; Rossi, Marianna Nicoletta/S-5083-2019	Gileadi, Opher/0000-0001-6886-898X; Rossi, Marianna Nicoletta/0000-0003-4485-7738; Vollmar, Melanie/0000-0002-9162-9159; Kraehenbuehl, Rolf/0000-0003-2578-5601; von Delft, Frank/0000-0003-0378-0017; Slade, Dea/0000-0002-0052-5910; Ahel, Ivan/0000-0002-9446-3756	Canadian Institutes fin. Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; National Institutes of Health [GM065386]; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, R37GM059785] Funding Source: NIH RePORTER	Canadian Institutes fin. Health Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Structural Genomics Consortium (SGC) is a registered charity (number 1097737) that receives funds from the Canadian Institutes fin. Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; This work was supported, in whole or in part by National Institutes of Health Grant GM065386 to J. M. D.) and by Cancer Research UK (to I. A.).	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Egloff MP, 2006, J VIROL, V80, P8493, DOI 10.1128/JVI.00713-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Hallows WC, 2009, CELL, V137, P404, DOI 10.1016/j.cell.2009.04.036; Han WD, 2003, ENDOCR-RELAT CANCER, V10, P217, DOI 10.1677/erc.0.0100217; Hoff KG, 2005, NAT STRUCT MOL BIOL, V12, P560, DOI 10.1038/nsmb0705-560; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Kumaran D, 2005, PROTEIN SCI, V14, P719, DOI 10.1110/ps.041132005; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lee S, 2008, ANAL BIOCHEM, V383, P174, DOI 10.1016/j.ab.2008.08.033; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Maas NMC, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049510; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuvonen M, 2009, J MOL BIOL, V385, P212, DOI 10.1016/j.jmb.2008.10.045; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Tada M, 2010, CANCER SCI, V101, P1261, DOI 10.1111/j.1349-7006.2010.01500.x; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200	40	122	128	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13261	13271		10.1074/jbc.M110.206771	http://dx.doi.org/10.1074/jbc.M110.206771			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21257746	Green Published, hybrid			2022-12-25	WOS:000289282200047
J	Bergeron, MJ; Burzle, M; Kovacs, G; Simonin, A; Hediger, MA				Bergeron, Marc J.; Buerzle, Marc; Kovacs, Gergely; Simonin, Alexandre; Hediger, Matthias A.			Synthesis, Maturation, and Trafficking of Human Na+-Dicarboxylate Cotransporter NaDC1 Requires the Chaperone Activity of Cyclophilin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS ISOMERASE ACTIVITY; ENDOPLASMIC-RETICULUM STRESS; RENAL TUBULAR-ACIDOSIS; CYCLOSPORINE-A; KIDNEY-TRANSPLANTATION; SURFACE EXPRESSION; PHENOTYPIC CHANGES; SECRETORY PATHWAY; HOMOLOG NINAA; PROTEIN	Renal excretion of citrate, an inhibitor of calcium stone formation, is controlled mainly by reabsorption via the apical Na+-dicarboxylate cotransporter NaDC1 (SLC13A2) in the proximal tubule. Recently, it has been shown that the protein phosphatase calcineurin inhibitors cyclosporin A (CsA) and FK-506 induce hypocitraturia, a risk factor for nephrolithiasis in kidney transplant patients, but apparently through urine acidification. This suggests that these agents up-regulate NaDC1 activity. Using the Xenopus laevis oocyte and HEK293 cell expression systems, we examined first the effect of both anti-calcineurins on NaDC1 activity and expression. While FK-506 had no effect, CsA reduced NaDC1-mediated citrate transport by lowering heterologous carrier expression (as well as endogenous carrier expression in HEK293 cells), indicating that calcineurin is not involved. Given that CsA also binds specifically to cyclophilins, we determined next whether such proteins could account for the observed changes by examining the effect of selected cyclophilin wild types and mutants on NaDC1 activity and cyclophilin-specific siRNA. Interestingly, our data show that the cyclophilin isoform B is likely responsible for down-regulation of carrier expression by CsA and that it does so via its chaperone activity on NaDC1 (by direct interaction) rather than its rotamase activity. We have thus identified for the first time a regulatory partner for NaDC1, and have gained novel mechanistic insight into the effect of CsA on renal citrate transport and kidney stone disease, as well as into the regulation of membrane transporters in general.	[Bergeron, Marc J.] Univ Laval Robert Giffard, Ctr Rech, Unite Neurobiol Cellulaire, Quebec City, PQ G1J 2G3, Canada; [Bergeron, Marc J.; Buerzle, Marc; Kovacs, Gergely; Simonin, Alexandre; Hediger, Matthias A.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Bergeron, Marc J.; Buerzle, Marc; Kovacs, Gergely; Simonin, Alexandre; Hediger, Matthias A.] Univ Bern, Swiss Natl Ctr Competence Res, NCCR TransCure, CH-3012 Bern, Switzerland	Laval University; University of Bern; University of Bern	Bergeron, MJ (corresponding author), Univ Laval Robert Giffard, Ctr Rech, Unite Neurobiol Cellulaire, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada.	marc.bergeron.2@ulaval.ca		Hediger, Matthias/0000-0003-1946-027X	Swiss National Foundation (SNF)	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by a grant from The Swiss National Foundation (SNF) entitled "Calcium and Citrate Transporters in Renal Stone Disease."	Aruga S, 2000, KIDNEY INT, V58, P206, DOI 10.1046/j.1523-1755.2000.00155.x; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Bouvier N, 2009, AM J PHYSIOL-RENAL, V296, pF160, DOI 10.1152/ajprenal.90567.2008; Chen H, 1998, FEBS LETT, V422, P307, DOI 10.1016/S0014-5793(98)00028-3; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Elbaz B, 2008, MOL PHARMACOL, V73, P1254, DOI 10.1124/mol.107.041582; Fujiwara T, 2003, TRANSPL INT, V16, P108, DOI 10.1111/j.1432-2277.2003.tb00271.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Hamm LL, 2002, ENDOCRIN METAB CLIN, V31, P885, DOI 10.1016/S0889-8529(02)00031-2; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; He Y, 2004, J NEPHROL, V17, P34; Heering P, 1996, NEPHRON, V74, P501, DOI 10.1159/000189443; Helekar SA, 1997, P NATL ACAD SCI USA, V94, P5432, DOI 10.1073/pnas.94.10.5432; Ho HTB, 2007, KIDNEY INT, V72, P63, DOI 10.1038/sj.ki.5002258; Hong F, 2004, BIOCHEM BIOPH RES CO, V316, P1073, DOI 10.1016/j.bbrc.2004.02.160; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590, DOI 10.1152/ajprenal.1985.249.4.F590; Keven K, 2007, NEPHROL DIAL TRANSPL, V22, P906, DOI 10.1093/ndt/gfl714; Kimchi-Sarfaty C, 2002, J BIOL CHEM, V277, P2505, DOI 10.1074/jbc.M109154200; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Long K, 2005, BIOORG MED CHEM LETT, V15, P3849, DOI 10.1016/j.bmcl.2005.05.120; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Okamoto N, 2007, INT J UROL, V14, P344, DOI 10.1111/j.1442-2042.2007.01554.x; Pajor A. M., 1996, AM J PHYSIOL, V270, pF642; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Romero MF, 1998, METHOD ENZYMOL, V296, P17; Rosado JA, 2010, ARTERIOSCL THROM VAS, V30, P419, DOI 10.1161/ATVBAHA.109.194530; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; SHAW LM, 1990, CLIN CHEM, V36, P1841; Shiraishi S, 2000, NEUROSCI LETT, V293, P211, DOI 10.1016/S0304-3940(00)01513-5; Stapenhorst L, 2005, PEDIATR NEPHROL, V20, P652, DOI 10.1007/s00467-005-1831-y; Stumpf T, 2008, J BIOL CHEM, V283, P18086, DOI 10.1074/jbc.M801821200; Sune G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013930; TEGZESS AM, 1988, TRANSPLANT P, V20, P530; Tran TT, 2009, ADV EXP MED BIOL, V643, P503, DOI 10.1007/978-0-387-75681-3_52; Tran TT, 2000, J BIOL CHEM, V275, P35708, DOI 10.1074/jbc.M005636200; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341; Wan L., 2009, ASN 42 ANN M SCI EXP; Watanabe S, 2005, AM J PHYSIOL-RENAL, V288, pF40, DOI 10.1152/ajprenal.00218.2004; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764	42	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11242	11253		10.1074/jbc.M110.171728	http://dx.doi.org/10.1074/jbc.M110.171728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21257749	hybrid, Green Published			2022-12-25	WOS:000288797100036
J	Tang, CH; Chen, CF; Chen, WM; Fong, YC				Tang, Chih-Hsin; Chen, Cheng-Fong; Chen, Wei-Ming; Fong, Yi-Chin			IL-6 Increases MMP-13 Expression and Motility in Human Chondrosarcoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCRINE GROWTH-FACTOR; NF-KAPPA-B; IN-VITRO; MATRIX METALLOPROTEINASE-13; ALPHA-V-BETA-3 INTEGRIN; UP-REGULATION; CANCER CELLS; INTERLEUKIN-6; CARCINOMA; MIGRATION	Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. IL-6 is a multifunctional cytokine that is associated with the disease status and outcomes of cancers. However, the effect of IL-6 on the migration activity of human chondrosarcoma cells is mostly unknown. Here, we found that IL-6 increased the migration and expression of MMP-13 in human chondrosarcoma cells. We also found that human chondrosarcoma tissues had significant expression of IL-6, which was higher than that in normal cartilage. IL-6-mediated migration and MMP-13 up-regulation were attenuated by anti-IL-6 receptor antibody, Ras, Raf-1, and a MEK inhibitor. Activation of the Ras, Raf-1, MEK, ERK, and NF-kappa B signaling pathways after IL-6 treatment was demonstrated, and IL-6-induced MMP-13 expression and migration activity were inhibited by the specific inhibitor and mutant Ras, Raf-1, MEK, ERK, and NF-kappa B cascades. In addition, migration-prone sublines demonstrated that cells with increasing migration ability had greater expression of IL-6 and MMP-13. Taken together, these results indicate that IL-6 and IL-6 receptor interaction enhances migration of chondrosarcoma through an increase in MMP-13 production.	[Tang, Chih-Hsin] China Med Univ & Hosp, Sch Med, Dept Pharmacol, Taichung 404, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Chen, Cheng-Fong] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Chen, Wei-Ming] Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei 112, Taiwan; [Fong, Yi-Chin] China Med Univ, Sch Chinese Med, Taichung 404, Taiwan; [Fong, Yi-Chin] China Med Univ Hosp, Dept Orthoped Surg, Taichung 40447, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	chtang@mail.cmu.edu.tw; yichin.fong@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352; Chen, Cheng-Fong/0000-0002-2485-6159	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3]; China Medical University Hospital [DMR-100-086]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by National Science Council of Taiwan Grant NSC99-2320-B-039-003-MY3 and China Medical University Hospital Grant DMR-100-086.	Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; BEREK JS, 1991, AM J OBSTET GYNECOL, V164, P1038, DOI 10.1016/0002-9378(91)90582-C; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHEN L, 1988, P NATL ACAD SCI USA, V85, P8037, DOI 10.1073/pnas.85.21.8037; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EUSTACE D, 1993, GYNECOL ONCOL, V50, P15, DOI 10.1006/gyno.1993.1156; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Fong YC, 2007, J ORTHOP RES, V25, P1106, DOI 10.1002/jor.20364; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Hov H, 2009, EUR J HAEMATOL, V82, P277, DOI 10.1111/j.1600-0609.2009.01212.x; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Li Y, 2008, CYTOKINE, V43, P165, DOI 10.1016/j.cyto.2008.05.007; LU C, 1993, J CELL BIOL, V120, P1281, DOI 10.1083/jcb.120.5.1281; Lu KW, 2008, ANTICANCER RES, V28, P1093; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MIKI S, 1989, FEBS LETT, V250, P607, DOI 10.1016/0014-5793(89)80805-1; Okamoto M, 1997, CANCER RES, V57, P141; Okamoto M, 1997, ENDOCRINOLOGY, V138, P5071, DOI 10.1210/en.138.11.5071; Okamoto M, 1997, INT J CANCER, V72, P149, DOI 10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; SATOH T, 1992, J BIOL CHEM, V267, P24149; Scully SP, 1999, BRAZ J MED BIOL RES, V32, P885, DOI 10.1590/S0100-879X1999000700013; Shi J, 2004, INFLAMM RES, V53, P377, DOI 10.1007/s00011-004-1271-3; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Tan TW, 2009, CARCINOGENESIS, V30, P258, DOI 10.1093/carcin/bgn284; Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	41	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11056	11066		10.1074/jbc.M110.204081	http://dx.doi.org/10.1074/jbc.M110.204081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21278254	Green Published, hybrid			2022-12-25	WOS:000288797100017
J	Choubey, V; Safiulina, D; Vaarmann, A; Cagalinec, M; Wareski, P; Kuum, M; Zharkovsky, A; Kaasik, A				Choubey, Vinay; Safiulina, Dzhamilja; Vaarmann, Annika; Cagalinec, Michal; Wareski, Przemyslaw; Kuum, Malle; Zharkovsky, Alexander; Kaasik, Allen			Mutant A53T alpha-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; MOUSE MODEL; PARKINSONS; DEGRADATION; MITOPHAGY; INDUCTION; PROTEIN; FUSION; NEURODEGENERATION; DYSFUNCTION	Parkinson disease is characterized by the accumulation of aggregated alpha-synuclein as the major component of the Lewy bodies. alpha-Synuclein accumulation in turn leads to compensatory effects that may include the up-regulation of autophagy. Another common feature of Parkinson disease (PD) is mitochondrial dysfunction. Here, we provide evidence that the overactivation of autophagy may be a link that connects the intracellular accumulation of alpha-synuclein with mitochondrial dysfunction. We found that the activation of macroautophagy in primary cortical neurons that overexpress mutant A53T alpha-synuclein leads to massive mitochondrial destruction and loss, which is associated with a bioenergetic deficit and neuronal degeneration. No mitochondrial removal or net loss was observed when we suppressed the targeting of mitochondria to autophagosomes by silencing Parkin, overexpressing wild-type Mitofusin 2 and dominant negative Dynamin-related protein 1 or blocking autophagy by silencing autophagy-related genes. The inhibition of targeting mitochondria to autophagosomes or autophagy was also partially protective against mutant A53T alpha-synuclein-induced neuronal cell death. These data suggest that overactivated mitochondrial removal could be one of the contributing factors that leads to the mitochondrial loss observed in PD models.	[Choubey, Vinay; Safiulina, Dzhamilja; Vaarmann, Annika; Cagalinec, Michal; Wareski, Przemyslaw; Kuum, Malle; Zharkovsky, Alexander; Kaasik, Allen] Univ Tartu, Dept Pharmacol, EE-51014 Tartu, Estonia	University of Tartu	Kaasik, A (corresponding author), Ravila 19, EE-51014 Tartu, Estonia.	allen.kaasik@ut.ee	Kaasik, Allen/I-2738-2015; Safiulina, Dzamilja/I-7336-2015; Cagalinec, Michal/AAC-5087-2022; Choubey, Vinay/H-3170-2015; Vaarmann, Annika/AAH-7289-2021	Cagalinec, Michal/0000-0001-8044-8419; Choubey, Vinay/0000-0002-1953-5692; Vaarmann, Annika/0000-0003-0296-8325; Safiulina, Dzhamilja/0000-0002-4188-4207; Kaasik, Allen/0000-0002-4850-3198	Estonian Science Foundation [7991, 7175, 8125]; European Community; European Regional Development Fund	Estonian Science Foundation; European Community(European Commission); European Regional Development Fund(European Commission)	This work was supported by Grants 7991, 7175, and 8125 from the Estonian Science Foundation, the European Community (Projects BRAIN BIOENERGETICS and ESTBIOREG), and by the European Regional Development Fund.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Ayala A, 2007, FRONT BIOSCI-LANDMRK, V12, P986, DOI 10.2741/2119; Batulan Z, 2006, NEUROBIOL DIS, V24, P213, DOI 10.1016/j.nbd.2006.06.017; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Cheung ZH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-29; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fournier M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006629; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Honda S, 2003, BIOCHEM BIOPH RES CO, V311, P424, DOI 10.1016/j.bbrc.2003.10.008; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kaasik A, 2005, EUR J NEUROSCI, V22, P1023, DOI 10.1111/j.1460-9568.2005.04279.x; Kaasik A, 2007, EPILEPSIA, V48, P752, DOI 10.1111/j.1528-1167.2007.00985.x; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kim I, 2004, HEPATOLOGY, V40, p291A; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Coelln R, 2006, J NEUROSCI, V26, P3685, DOI 10.1523/JNEUROSCI.0414-06.2006; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; YANG DS, 2008, ALZHEIMERS DEMENT, V4, pT223; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhu JH, 2003, BRAIN PATHOL, V13, P473	55	192	195	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10814	10824		10.1074/jbc.M110.132514	http://dx.doi.org/10.1074/jbc.M110.132514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252228	Green Published, hybrid			2022-12-25	WOS:000288547000095
J	de Torres, JP; Casanova, C; Pinto-Plata, V; Varo, N; Restituto, P; Cordoba-Lanus, E; Baz-Davila, R; Aguirre-Jaime, A; Celli, BR				de Torres, Juan P.; Casanova, Ciro; Pinto-Plata, Victor; Varo, Nerea; Restituto, Patricia; Cordoba-Lanus, Elizabeth; Baz-Davila, Rebeca; Aguirre-Jaime, Armando; Celli, Bartolome R.			Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC INFLAMMATION; SERUM BIOMARKERS; SEX-DIFFERENCES; LUNG-CANCER; DIAGNOSIS; MASS	Rationale: Little is known about gender differences in plasma biomarker levels in patients with chronic obstructive pulmonary disease (COPD). Hypothesis: There are differences in serum biomarker levels between women and men with COPD. Objective: Explore gender differences in plasma biomarker levels in patients with COPD and smokers without COPD. Methods: We measured plasma levels of IL-6, IL-8, IL-16, MCP-1, MMP-9, PARC and VEGF in 80 smokers without COPD (40 males, 40 females) and 152 stable COPD patients (76 males, 76 females) with similar airflow obstruction. We determined anthropometrics, smoking history, lung function, exercise tolerance, body composition, BODE index, co-morbidities and quality of life. We then explored associations between plasma biomarkers levels and the clinical characteristics of the patients and also with the clinical and physiological variables known to predict outcome in COPD. Results: The plasma biomarkers level explored were similar in men and women without COPD. In contrast, in patients with COPD the median value in pg/mL of IL-6 (6.26 vs 8.0, p = 0.03), IL-16 (390 vs 321, p = 0.009) and VEGF (50 vs 87, p = 0.02) differed between women and men. Adjusted for smoking history, gender was independently associated with IL-16, PARC and VEGF levels. There were also gender differences in the associations between IL-6, IL-16 and VEGF and physiologic variables that predict outcomes. Conclusions: In stable COPD patients with similar airflow obstruction, there are gender differences in plasma biomarker levels and in the association between biomarker levels and important clinical or physiological variables. Further studies should confirm our findings.	[de Torres, Juan P.] Univ Navarra Clin, Dept Pulm, Pamplona, Spain; [Casanova, Ciro] Hosp Univ Nuestra Senora de Candelaria, Dept Pulm, Santa Cruz De Tenerife, Spain; [Pinto-Plata, Victor] St Elizabeths Med Ctr, Pulm & Crit Care Dept, Boston, MA USA; [Varo, Nerea; Restituto, Patricia] Univ Navarra Clin, Biochem Anal Dept, Pamplona, Spain; [Casanova, Ciro; Cordoba-Lanus, Elizabeth; Baz-Davila, Rebeca; Aguirre-Jaime, Armando] Hosp Univ Nuestra Senora de Candelaria, Resp Res Unit, Santa Cruz De Tenerife, Spain; [Celli, Bartolome R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pulm, Boston, MA 02115 USA	University of Navarra; St. Elizabeth's Medical Center; University of Navarra; Harvard University; Brigham & Women's Hospital; Harvard Medical School	de Torres, JP (corresponding author), Univ Navarra Clin, Dept Pulm, Pamplona, Spain.	jupa65@hotmail.com	Córdoba-Lanús, Elizabeth/B-8573-2014; Varo, Nerea/AAB-3569-2019	Varo, Nerea/0000-0002-2362-9472; de Torres, Juan Pablo/0000-0003-1231-4894; Cordoba-Lanus, Elizabeth/0000-0001-5534-8280				Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bolton CE, 2004, AM J RESP CRIT CARE, V170, P1286, DOI 10.1164/rccm.200406-754OC; Brooks SM, 1982, ATS NEWS, V8, P12; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cohen SBZ, 2007, AM J RESP CRIT CARE, V176, P113, DOI 10.1164/rccm.20011-1655PP; Conti P, 2002, ALLERGY ASTHMA PROC, V23, P103; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; de Torres JP, 2006, EUR RESPIR J, V27, P902, DOI 10.1183/09031936.06.00109605; Di Marco F, 2006, RESP MED, V100, P1767, DOI 10.1016/j.rmed.2006.01.026; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; MANNINO DM, 2002, MMWR-MORBID MORTAL W, V51, pSS6; Marwick JA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-11; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477	27	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16021	10.1371/journal.pone.0016021	http://dx.doi.org/10.1371/journal.pone.0016021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267454	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500035
J	Dye, TD; Apondi, R; Lugada, E				Dye, Timothy De Ver; Apondi, Rose; Lugada, Eric			A Qualitative Assessment of Participation in a Rapid Scale-Up, Diagonally-Integrated MDG-Related Disease Prevention Campaign in Rural Kenya	PLOS ONE			English	Article							HEALTH-CARE; PUBLIC-HEALTH; GLOBAL HEALTH; HIV; DISCLOSURE; SCIENCE; EVENTS; WOMEN	Background: Many countries face severe scale-up barriers toward achievement of MDGs. We ascertained motivational and experiential dimensions of participation in a novel, rapid, "diagonal" Integrated Prevention Campaign (IPC) in rural Kenya that provided prevention goods and services to 47,000 people within one week, aimed at rapidly moving the region toward MDG achievement. Specifically, the IPC provided interventions and commodities targeting disease burden reduction in HIV/AIDS, malaria, and water-borne illness. Methods: Qualitative in-depth interviews (IDI) were conducted with 34 people (18 living with HIV/AIDS and 16 not HIV-infected) randomly selected from IPC attendees consenting to participate. Interviews were examined for themes and patterns to elucidate participant experience and motivation with IPC. Findings: Participants report being primarily motivated to attend IPC to learn of their HIV status (through voluntary counseling and testing), and with receipt of prevention commodities (bednets, water filters, and condoms) providing further incentive. Participants reported that they were satisfied with the IPC experience and offered suggestions to improve future campaigns. Interpretation: Learning their HIV status motivated participants along with the incentive of a wider set of commodities that were rapidly deployed through IPC in this challenging region. The critical role of wanting to know their HIV status combined with commodity incentives may offer a new model for rapid scaled-up of prevention strategies that are wider in scope in rural Africa.	[Dye, Timothy De Ver] SUNY Upstate Med Univ, Syracuse, NY USA; [Apondi, Rose] Uganda Virus Res Inst, Entebbe, Uganda; [Lugada, Eric] CHF Int, Nairobi, Kenya	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Uganda Virus Research Institute	Dye, TD (corresponding author), SUNY Upstate Med Univ, Syracuse, NY USA.	dyet@upstate.edu	Dye, Timothy/HHY-9965-2022		Vestergaard-Frandsen, Lausanne, Switzerland	Vestergaard-Frandsen, Lausanne, Switzerland	This research was supported by Vestergaard-Frandsen, Lausanne, Switzerland. The funders developed the intervention in partnership with other stakeholders, though they had no role in qualitative assessment study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than to provide technical clarification as required.	Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], 2004, COCHRANE DB SYST REV; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Bhattacharya S, 2008, B WORLD HEALTH ORGAN, V86, P163, DOI 10.2471/BLT.08.051979; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Cisse B, 2007, HEALTH POLICY, V80, P51, DOI 10.1016/j.healthpol.2006.02.011; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Gielen AC, 2000, J URBAN HEALTH, V77, P480, DOI 10.1007/BF02386755; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinstead OA, 2001, AIDS, V15, P1045, DOI 10.1097/00002030-200105250-00013; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Magnussen L, 2004, HEALTH AFFAIR, V23, P167, DOI 10.1377/hlthaff.23.3.167; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; McCannon CJ, 2007, JAMA-J AM MED ASSOC, V298, P1937, DOI 10.1001/jama.298.16.1937; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Rothman AJ, 2007, HDB MOTIVATION SCI, P494; Ryan G. W., 2003, COLLECTING INTERPRET; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UN, 2008, MILL DEV GOALS 2008; *UN DEV GROUP, 2009, GOOD PRACT SCAL MDG; UNAIDS, 2004, 4 UNAIDS; *WHO, 2008, VCT EV COUNTR CAS ST; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2009, PUBL HLTH CAMP GETT	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14551	10.1371/journal.pone.0014551	http://dx.doi.org/10.1371/journal.pone.0014551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267452	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500019
J	Clouser, CL; Holtz, CM; Mullett, M; Crankshaw, DL; Briggs, JE; Chauhan, J; VanHoutan, IM; Patterson, SE; Mansky, LM				Clouser, Christine L.; Holtz, Colleen M.; Mullett, Mary; Crankshaw, Duane L.; Briggs, Jacquie E.; Chauhan, Jay; VanHoutan, Ilze Matise; Patterson, Steven E.; Mansky, Louis M.			Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine	PLOS ONE			English	Article							RETROVIRUS-INDUCED IMMUNODEFICIENCY; RIBONUCLEOTIDE REDUCTASE INHIBITORS; DEFECTIVE VIRUS; SYNDROME MAIDS; BONE-MARROW; MURINE AIDS; CELL-LINES; MICE; DISEASE; INDUCTION	Replication of retroviral and host genomes requires ribonucleotide reductase to convert rNTPs to dNTPs, which are then used as substrates for DNA synthesis. Inhibition of ribonucleotide reductase by hydroxyurea (HU) has been previously used to treat cancers as well as HIV. However, the use of HU as an antiretroviral is limited by its associated toxicities such as myelosuppression and hepatotoxicity. In this study, we examined the ribonucleotide reductase inhibitor, gemcitabine, both in cell culture and in C57Bl/6 mice infected with LP-BM5 murine leukemia virus (LP-BM5 MuLV, a murine AIDS model). Gemcitabine decreased infectivity of MuLV in cell culture with an EC50 in the low nanomolar range with no detectable cytotoxicity. Similarly, gemcitabine significantly decreased disease progression in mice infected with LP-BM5. Specifically, gemcitabine treatment decreased spleen size, plasma IgM, and provirus levels compared to LP-BM5 MuLV infected, untreated mice. Gemcitabine efficacy was observed at doses as low as 1 mg/kg/day in the absence of toxicity. Higher doses of gemcitabine (3 mg/kg/day and higher) were associated with toxicity as determined by a loss in body mass. In summary, our findings demonstrate that gemcitabine has antiretroviral activity ex vivo and in vivo in the LP-BM5 MuLV model. These observations together with a recent ex vivo study with HIV-1[1], suggest that gemcitabine has broad antiretroviral activity and could be particularly useful in vivo when used in combination drug therapy.	[Clouser, Christine L.; Holtz, Colleen M.; Patterson, Steven E.; Mansky, Louis M.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Holtz, Colleen M.; Mansky, Louis M.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, MinnCResT Program, Minneapolis, MN 55455 USA; [Chauhan, Jay; Patterson, Steven E.; Mansky, Louis M.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN USA; [Mansky, Louis M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [VanHoutan, Ilze Matise] Univ Minnesota, Masonic Canc Ctr Comparat Pathol Shared Resource, Minneapolis, MN USA; [Mullett, Mary; Crankshaw, Duane L.; Briggs, Jacquie E.] VA Med Ctr, Dept Food Sci & Nutr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Clouser, CL (corresponding author), Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA.	mansky@umn.edu			Academic Health Center; NIH [GM56615, T32 CA009138, T32 DE07288]; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056615, R01GM056615] Funding Source: NIH RePORTER	Academic Health Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported from a Center for Drug Design Funding Agreement, an Academic Health Center Translational Research Grant, and NIH grants GM56615, T32 CA009138 (Cancer Biology Training Grant, to C. L. C.) and T32 DE07288 (MinnCResT Program, to C. M. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Bender DM, 2009, J MED CHEM, V52, P6958, DOI 10.1021/jm901181h; Casabianca A, 2004, J CLIN MICROBIOL, V42, P4361, DOI 10.1128/JCM.42.9.4361-4364.2004; CHATTOPADHYAY SK, 1989, P NATL ACAD SCI USA, V86, P3862, DOI 10.1073/pnas.86.10.3862; CHATTOPADHYAY SK, 1991, J VIROL, V65, P4232, DOI 10.1128/JVI.65.8.4232-4241.1991; Clouser CL, 2010, J VIROL, V84, P9301, DOI 10.1128/JVI.01006-10; Dias ASP, 2006, CURR HIV RES, V4, P431; HARRINGTON RD, 1993, J VIROL, V67; HARTLEY JW, 1989, J VIROL, V63, P1223, DOI 10.1128/JVI.63.3.1223-1231.1989; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lori F, 1999, ANTIVIR THER, V4, P101; Mayhew C, 1997, CELL MOL BIOL, V43, P1019; Mayhew CN, 2002, ANTIVIR RES, V56, P167, DOI 10.1016/S0166-3542(02)00108-0; MORSE HC, 1992, AIDS, V6, P607, DOI 10.1097/00002030-199207000-00001; MORSE HC, 1994, SYMP SOC GEN MICROBI, V51, P265; MOSIER DE, 1987, J EXP MED, V165, P1737, DOI 10.1084/jem.165.6.1737; NOZAKI A, 2010, ARCH VIROL, V45, P66; OHNOTA H, 1990, ANTIMICROB AGENTS CH, V34, P605, DOI 10.1128/AAC.34.4.605; PATTENGALE PK, 1982, AM J PATHOL, V107, P362; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rossi L, 2002, J ANTIMICROB CHEMOTH, V50, P639, DOI 10.1093/jac/dkf205; Sakamoto H, 2006, J GASTROENTEROL, V41, P70, DOI 10.1007/s00535-005-1724-7; SIMARD C, 1995, VIROLOGY, V206, P555, DOI 10.1016/S0042-6822(95)80072-7; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; YETTER RA, 1988, J EXP MED, V168, P623, DOI 10.1084/jem.168.2.623	30	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15840	10.1371/journal.pone.0015840	http://dx.doi.org/10.1371/journal.pone.0015840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264291	Green Submitted, Green Published, gold			2022-12-25	WOS:000286516500013
J	Chertov, O; Zhang, N; Chen, X; Oppenheim, JJ; Lubkowski, J; McGrath, C; Sowder, RC; Crise, BJ; Malyguine, A; Kutzler, MA; Steele, AD; Henderson, EE; Rogers, TJ				Chertov, Oleg; Zhang, Ning; Chen, Xin; Oppenheim, Joost J.; Lubkowski, Jacek; McGrath, Connor; Sowder, Raymond C., II; Crise, Bruce J.; Malyguine, Anatoli; Kutzler, Michele A.; Steele, Amber D.; Henderson, Earl E.; Rogers, Thomas J.			Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; V3 LOOP; RECEPTOR-BINDING; LIGAND-BINDING; CC-CHEMOKINE; R5 HIV-1; CXCR4; CORECEPTOR; IDENTIFICATION	The sequential interaction of the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1) with CD4 and certain chemokine coreceptors initiates host cell entry of the virus. The appropriate chemokines have been shown to inhibit viral replication by blocking interaction of the gp120 envelope protein with the coreceptors. We considered the possibility that this interaction involves a motif of the gp120 that may be structurally homologous to the chemokines. In the amino acid sequences of most chemokines there is a Trp residue located at the beginning of the C-terminal a-helix, which is separated by six residues from the fourth Cys residue. The gp120 of all HIV-1 isolates have a similar motif, which includes the C-terminal part of a variable loop 3 (V3) and N-terminal part of a conserved region 3 (C3). Two synthetic peptides, derived from the relevant gp120 sequence inhibited HIV-1 replication in macrophages and T lymphocytes in sequence-dependent manner. The peptides also prevented binding of anti-CXCR4 antibodies to CXCR4, and inhibited the intracellular Ca(2+) influx in response to CXCL12/SDF-1 alpha. Thus these peptides can be used to dissect gp120 interactions with chemokine receptors and could serve as leads for the design of new inhibitors of HIV-1.	[Chertov, Oleg] NCI, Prot Chem Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Zhang, Ning; Chen, Xin; Oppenheim, Joost J.] NCI, Mol Immunoregulat Lab, Frederick, MD 21701 USA; [Lubkowski, Jacek] NCI, Ctr Macromol Crystallog, Frederick, MD 21701 USA; [McGrath, Connor] Target Struct Based Drug Discovery Grp, Frederick, MD USA; [Sowder, Raymond C., II; Crise, Bruce J.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick, MD USA; [Malyguine, Anatoli] SAIC Frederick Inc, Clin Serv Program, Frederick, MD USA; [Kutzler, Michele A.; Steele, Amber D.; Henderson, Earl E.; Rogers, Thomas J.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Fels Inst Canc Res & Mol Biol,Dept Pharmacol, Philadelphia, PA 19122 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Chertov, O (corresponding author), NCI, Prot Chem Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	rogerst@temple.edu	Chen, Xin n/a/I-6601-2015	Chen, Xin n/a/0000-0002-2628-4027; Chertov, Oleg/0000-0002-0426-2521; Kutzler, Michele/0000-0001-5692-5617	National Cancer Institute, National Institutes of Health (NIH) [N01-CO-12400]; NIH, National Cancer Institute, Center for Cancer Research; United States Public Health Service [DA-14230, DA-25532, P01DA-23860, P30DA-13429, F31 DA-05894]; National Institute on Drug Abuse [DA-06650]; NATIONAL CANCER INSTITUTE [ZIABC009369] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract N01-CO-12400. It was also supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This work was also supported by United States Public Health Service Grants DA-14230, DA-25532, P01DA-23860, P30DA-13429, and F31 DA-05894 (to M. K.), and grant DA-06650 from the National Institute on Drug Abuse. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; CAPON DJ, 1991, ANNU REV IMMUNOL, V9, P649, DOI 10.1146/annurev.iy.09.040191.003245; CHERTOV O, Patent No. 0205063; Choe W, 2001, J VIROL, V75, P10738, DOI 10.1128/JVI.75.22.10738-10745.2001; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLAYTON LK, 1989, NATURE, V339, P548, DOI 10.1038/339548a0; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; Cole SW, 2001, P NATL ACAD SCI USA, V98, P12695, DOI 10.1073/pnas.221134198; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Grainger DJ, 2003, BIOCHEM PHARMACOL, V65, P1027, DOI 10.1016/S0006-2952(02)01626-X; HAGLER AT, 1974, J AM CHEM SOC, V96, P5319, DOI 10.1021/ja00824a004; HAGLER AT, 1985, SCIENCE, V227, P1309, DOI 10.1126/science.3975616; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; HELSETH E, 1990, J VIROL, V64, P6314, DOI 10.1128/JVI.64.12.6314-6318.1990; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; Howard OMZ, 1999, J BIOL CHEM, V274, P16228, DOI 10.1074/jbc.274.23.16228; Hoxie JA, 1998, J REPROD IMMUNOL, V41, P197, DOI 10.1016/S0165-0378(98)00059-X; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Korber B.T., 1998, HUMAN RETROVIRUSES A; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; Moulard M, 1999, J PEPT RES, V53, P647, DOI 10.1034/j.1399-3011.1999.00062.x; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Sakaida H, 1998, J VIROL, V72, P9763, DOI 10.1128/JVI.72.12.9763-9770.1998; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Szabo I, 2003, J LEUKOCYTE BIOL, V74, P1074, DOI 10.1189/jlb.0203067; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wetzel MA, 2002, VIROLOGY, V292, P6, DOI 10.1006/viro.2001.1249; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e14474	10.1371/journal.pone.0014474	http://dx.doi.org/10.1371/journal.pone.0014474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264298	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000001
J	Marcu, O; Lera, MP; Sanchez, ME; Levic, E; Higgins, LA; Shmygelska, A; Fahlen, TF; Nichol, H; Bhattacharya, S				Marcu, Oana; Lera, Matthew P.; Sanchez, Max E.; Levic, Edina; Higgins, Laura A.; Shmygelska, Alena; Fahlen, Thomas F.; Nichol, Helen; Bhattacharya, Sharmila			Innate Immune Responses of Drosophila melanogaster Are Altered by Spaceflight	PLOS ONE			English	Article							HUMORAL STRESS-RESPONSE; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEIN; SYSTEM DYSREGULATION; SCAVENGER RECEPTOR; APOPTOTIC CELLS; LYSOZYME LOCUS; EXPRESSION; RECOGNITION; SPACE	Alterations and impairment of immune responses in humans present a health risk for space exploration missions. The molecular mechanisms underpinning innate immune defense can be confounded by the complexity of the acquired immune system of humans. Drosophila (fruit fly) innate immunity is simpler, and shares many similarities with human innate immunity at the level of molecular and genetic pathways. The goals of this study were to elucidate fundamental immune processes in Drosophila affected by spaceflight and to measure host-pathogen responses post-flight. Five containers, each containing ten female and five male fruit flies, were housed and bred on the space shuttle (average orbit altitude of 330.35 km) for 12 days and 18.5 hours. A new generation of flies was reared in microgravity. In larvae, the immune system was examined by analyzing plasmatocyte number and activity in culture. In adults, the induced immune responses were analyzed by bacterial clearance and quantitative real-time polymerase chain reaction (qPCR) of selected genes following infection with E. coli. The RNA levels of relevant immune pathway genes were determined in both larvae and adults by microarray analysis. The ability of larval plasmatocytes to phagocytose E. coli in culture was attenuated following spaceflight, and in parallel, the expression of genes involved in cell maturation was downregulated. In addition, the level of constitutive expression of pattern recognition receptors and opsonins that specifically recognize bacteria, and of lysozymes, antimicrobial peptide (AMP) pathway and immune stress genes, hallmarks of humoral immunity, were also reduced in larvae. In adults, the efficiency of bacterial clearance measured in vivo following a systemic infection with E. coli post-flight, remained robust. We show that spaceflight altered both cellular and humoral immune responses in Drosophila and that the disruption occurs at multiple interacting pathways.	[Marcu, Oana; Lera, Matthew P.; Levic, Edina; Higgins, Laura A.; Shmygelska, Alena; Bhattacharya, Sharmila] NASA, Space Biosci Div, Ames Res Ctr, Mountain View, CA USA; [Marcu, Oana] SETI Inst, Carl Sagan Ctr, Mountain View, CA USA; [Shmygelska, Alena] Carnegie Mellon Univ, NASA, Ames Res Ctr, Mountain View, CA USA; [Nichol, Helen] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Carnegie Mellon University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Saskatchewan	Marcu, O (corresponding author), NASA, Space Biosci Div, Ames Res Ctr, Mountain View, CA USA.	sharmila.bhattacharya@nasa.gov			NASA [FSB-FIT-2005]	NASA(National Aeronautics & Space Administration (NASA))	This study work was supported by a NASA grant to SB for "Fungal Pathogenesis, Tumorigenesis, and Effects of Host Immunity in the Space Environment" (FSB-FIT-2005). The funder had a role in study design and in supporting data collection.	Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; ARMSTRONG JW, 1995, EXP CELL RES, V216, P160, DOI 10.1006/excr.1995.1020; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2004, J APPL PHYSIOL, V97, P1437, DOI 10.1152/japplphysiol.00259.2004; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; BERRY WD, 1991, J INTERFERON RES, V11, P243, DOI 10.1089/jir.1991.11.243; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Busse MS, 2007, EMBO J, V26, P3826, DOI 10.1038/sj.emboj.7601798; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Fahlen T.F., 2006, GRAVITATIONAL SP BIO, V19, P133; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GOULD CL, 1987, AVIAT SPACE ENVIR MD, V58, P983; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; KNIBIEHLER B, 1987, ROUX ARCH DEV BIOL, V196, P243, DOI 10.1007/BF00376348; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kumei Y, 1996, J BIOTECHNOL, V47, P313, DOI 10.1016/0168-1656(96)01412-5; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; KYLSTEN P, 1992, MOL GEN GENET, V232, P335, DOI 10.1007/BF00266235; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1998, J MOL BIOL, V278, P515, DOI 10.1006/jmbi.1998.1705; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Licato LL, 1999, IMMUNOPHARMACOLOGY, V44, P273, DOI 10.1016/S0162-3109(99)00123-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Marco R, 1996, J BIOTECHNOL, V47, P179, DOI 10.1016/0168-1656(96)01408-3; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Persson C, 2007, INSECT BIOCHEM MOLEC, V37, P1309, DOI 10.1016/j.ibmb.2007.08.003; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Qiu P, 1998, DEVELOPMENT, V125, P1909; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Sackton TB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000797; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shearer WT, 2009, J ALLERGY CLIN IMMUN, V123, P900, DOI 10.1016/j.jaci.2008.12.016; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; STEINER H, 2004, IMMUNOL REV, P83; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; TAYLOR GR, 1986, AVIAT SPACE ENVIR MD, V57, P213; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tokusumi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006429; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; VERNOS I, 1989, International Journal of Developmental Biology, V33, P213; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Yasothornsrikul S, 1997, GENE, V198, P17, DOI 10.1016/S0378-1119(97)00274-6	102	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15361	10.1371/journal.pone.0015361	http://dx.doi.org/10.1371/journal.pone.0015361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264297	Green Published, gold, Green Submitted			2022-12-25	WOS:000286514000005
J	Plummer, P; Zhu, JE; Akiba, M; Pei, DH; Zhang, QJ				Plummer, Paul; Zhu, Jinge; Akiba, Masato; Pei, Dehua; Zhang, Qijing			Identification of a Key Amino Acid of LuxS Involved in AI-2 Production in Campylobacter jejuni	PLOS ONE			English	Article							S-RIBOSYLHOMOCYSTEINASE LUXS; ESCHERICHIA-COLI; GENE-EXPRESSION; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; CLOSTRIDIUM-DIFFICILE; BIOFILM FORMATION; BACTERIAL; AUTOINDUCER-2; VIRULENCE	Autoinducer-2 (AI-2) mediated quorum sensing has been associated with the expression of virulence factors in a number of pathogenic organisms and has been demonstrated to play a role in motility and cytolethal distending toxin (cdt) production in Campylobacter jejuni. We have initiated the work to determine the molecular basis of AI-2 synthesis and the biological functions of quorum sensing in C. jejuni. In this work, two naturally occurring variants of C. jejuni 81116 were identified, one producing high-levels of AI-2 while the other is defective in AI-2 synthesis. Sequence analysis revealed a G92D mutation in the luxS gene of the defective variant. Complementation of the AI-2 2 variant with a plasmid encoded copy of the wild-type luxS gene or reversion of the G92D mutation by site-directed mutagenesis fully restored AI-2(-) production by the variant. These results indicate that the G92D mutation alone is responsible for the loss of AI-2 activity in C. jejuni. Kinetic analyses showed that the G92D LuxS has a similar to 100-fold reduced catalytic activity relative to the wild-type enzyme. Findings from this study identify a previously undescribed amino acid that is essential for AI-2 production by LuxS and provide a unique isogenic pair of naturally occurring variants for us to dissect the functions of AI-2 mediated quorum sensing in Campylobacter.	[Plummer, Paul; Akiba, Masato; Zhang, Qijing] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA; [Plummer, Paul] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Zhu, Jinge; Pei, Dehua] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	Iowa State University; Iowa State University; University System of Ohio; Ohio State University	Plummer, P (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA.	pplummer@iastate.edu	Pei, Dehua/P-4594-2016	Pei, Dehua/0000-0002-2057-6934	National Institute for Allergy and Infectious Disease [K08AI070523-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI070523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by Grant Number K08AI070523-03 from the National Institute for Allergy and Infectious Disease (http://www.niaid.nih.gov). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute for Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JF, 2004, ORG LETT, V6, P3043, DOI 10.1021/ol049182i; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Belval SC, 2006, APPL ENVIRON MICROB, V72, P2644, DOI 10.1128/AEM.72.4.2644-2650.2006; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Carter GP, 2005, J MED MICROBIOL, V54, P119, DOI 10.1099/jmm.0.45817-0; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cloak OM, 2002, APPL ENVIRON MICROB, V68, P4666, DOI 10.1128/AEM.68.9.4666-4671.2002; DAWSON RMC, 1989, DATA BIOCHEMICAL RES; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104; He YP, 2008, FOODBORNE PATHOG DIS, V5, P399, DOI 10.1089/fpd.2008.0106; Heurlier K, 2009, J BACTERIOL, V191, P1293, DOI 10.1128/JB.01170-08; Holmgren K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-73; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jeon B, 2005, MICROBIOL IMMUNOL, V49, P599, DOI 10.1111/j.1348-0421.2005.tb03651.x; Jeon B, 2003, MICROBIOL IMMUNOL, V47, P833, DOI 10.1111/j.1348-0421.2003.tb03449.x; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Lynch SV, 2008, CURR OPIN CRIT CARE, V14, P593, DOI 10.1097/MCC.0b013e32830f1dd5; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; OHTANI K, 2009, J BACTERIOL; Olson CK, 2008, CAMPYLOBACTER, 3RD EDITION, P163; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pei DH, 2004, CURR OPIN CHEM BIOL, V8, P492, DOI 10.1016/j.cbpa.2004.08.003; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Raffa RB, 2005, J PHARMACOL EXP THER, V312, P417, DOI 10.1124/jpet.104.075150; Rajan R, 2005, BIOCHEMISTRY-US, V44, P3745, DOI 10.1021/bi0477384; Ren DC, 2004, APPL ENVIRON MICROB, V70, P2038, DOI 10.1128/AEM.70.4.2038-2043.2004; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Ruzheinikov SN, 2001, J MOL BIOL, V313, P111, DOI 10.1006/jmbi.2001.5027; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Sperondio V, 2007, EXPERT REV ANTI-INFE, V5, P271, DOI 10.1586/14787210.5.2.271; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Zhu J, 2004, BIOCHEMISTRY-US, V43, P10166, DOI 10.1021/bi0491088; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j; Zhu JG, 2008, ACS CHEM BIOL, V3, P110, DOI 10.1021/cb7002048	49	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15876	10.1371/journal.pone.0015876	http://dx.doi.org/10.1371/journal.pone.0015876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264316	gold, Green Published, Green Submitted			2022-12-25	WOS:000286514000009
J	Fox, NJ; White, PCL; McClean, CJ; Marion, G; Evans, A; Hutchings, MR				Fox, Naomi J.; White, Piran C. L.; McClean, Colin J.; Marion, Glenn; Evans, Andy; Hutchings, Michael R.			Predicting Impacts of Climate Change on Fasciola hepatica Risk	PLOS ONE			English	Article							GEOGRAPHIC INFORMATION-SYSTEM; SPATIAL-DISTRIBUTION; ANNUAL PREVALENCE; DISEASE RISK; DAIRY HERDS; CATTLE; MODEL; LOUISIANA; ENGLAND	Fasciola hepatica (liver fluke) is a physically and economically devastating parasitic trematode whose rise in recent years has been attributed to climate change. Climate has an impact on the free-living stages of the parasite and its intermediate host Lymnaea truncatula, with the interactions between rainfall and temperature having the greatest influence on transmission efficacy. There have been a number of short term climate driven forecasts developed to predict the following season's infection risk, with the Ollerenshaw index being the most widely used. Through the synthesis of a modified Ollerenshaw index with the UKCP09 fine scale climate projection data we have developed long term seasonal risk forecasts up to 2070 at a 25 km square resolution. Additionally UKCIP gridded datasets at 5 km square resolution from 1970-2006 were used to highlight the climate-driven increase to date. The maps show unprecedented levels of future fasciolosis risk in parts of the UK, with risk of serious epidemics in Wales by 2050. The seasonal risk maps demonstrate the possible change in the timing of disease outbreaks due to increased risk from overwintering larvae. Despite an overall long term increase in all regions of the UK, spatio-temporal variation in risk levels is expected. Infection risk will reduce in some areas and fluctuate greatly in others with a predicted decrease in summer infection for parts of the UK due to restricted water availability. This forecast is the first approximation of the potential impacts of climate change on fasciolosis risk in the UK. It can be used as a basis for indicating where active disease surveillance should be targeted and where the development of improved mitigation or adaptation measures is likely to bring the greatest benefits.	[Fox, Naomi J.; Evans, Andy; Hutchings, Michael R.] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Fox, Naomi J.; White, Piran C. L.; McClean, Colin J.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Fox, Naomi J.; Marion, Glenn] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	Scottish Agricultural College; University of York - UK; James Hutton Institute	Fox, NJ (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	mike.hutchings@sac.ac.uk	White, Piran C.L./F-5091-2010; Hutchings, Mike/P-6836-2019; White, Piran Crawfurd Limond/AAH-6851-2021; Evans, Andy/AAL-9072-2021; Marion, Glenn/J-4738-2013; guillermo, andres/AAW-4702-2021	White, Piran Crawfurd Limond/0000-0002-7496-5775; Evans, Andy/0000-0002-0272-9941; Hutchings, Mike/0000-0003-3338-471X; Marion, Glenn/0000-0002-0454-9338	Scottish Government	Scottish Government	SAC and BioSS receive funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ASRAT M, 2007, ETHIOPIA VET J, V11, P41; de Waal T., 2007, MAKING SCI WORK FARM, P60; Droogers P., 2002, Irrigation and Drainage Systems, V16, P33, DOI 10.1023/A:1015508322413; Fuentes MV, 2001, ACTA TROP, V79, P87, DOI 10.1016/S0001-706X(01)00106-1; GETTINBY G, 1974, INT J BIOMETEOROL, V18, P319, DOI 10.1007/BF01463722; GOODALL EA, 1991, AGR SYST, V36, P231, DOI 10.1016/0308-521X(91)90026-7; GOODALL EA, 1995, IMA J MATH APPL BUSI, V5, P337; Harle KJ, 2007, AGR SYST, V93, P61, DOI 10.1016/j.agsy.2006.04.003; Kenyon F, 2009, VET PARASITOL, V163, P293, DOI 10.1016/j.vetpar.2009.03.027; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; LUZONPENA M, 1994, VET PARASITOL, V55, P143, DOI 10.1016/0304-4017(94)90065-5; Mader TL, 2004, J ANIM SCI, V82, P3077; Malone JB, 1998, VET PARASITOL, V78, P87, DOI 10.1016/S0304-4017(98)00137-X; MALONE JB, 1992, PARASITOL TODAY, V8, P266, DOI 10.1016/0169-4758(92)90138-R; Malone JB, 1999, FASCIOLOSIS, P151; MALONE JB, 1987, AM J VET RES, V48, P1167; Mas-Coma S, 2009, VET PARASITOL, V163, P264, DOI 10.1016/j.vetpar.2009.03.024; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009; MCILROY SG, 1990, PREV VET MED, V9, P27, DOI 10.1016/0167-5877(90)90039-K; Nardone A, 2006, VET RES COMMUN, V30, P75, DOI 10.1007/s11259-006-0016-x; OLLERENSHAW C. B., 1966, AGR METEOROL, V3, P35, DOI 10.1016/0002-1571(66)90004-5; Ollerenshaw C. B., 1959, Veterinary Record, V71, P591; Pritchard GC, 2005, VET REC, V157, P578, DOI 10.1136/vr.157.19.578; Rapsch C, 2008, VET PARASITOL, V154, P242, DOI 10.1016/j.vetpar.2008.03.030; Rivington M, 2007, ENVIRON MODELL SOFTW, V22, P202, DOI 10.1016/j.envsoft.2005.07.018; van Dijk J, 2008, VET PARASITOL, V158, P73, DOI 10.1016/j.vetpar.2008.08.006; van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991; *VET LAB AG, VET INV SURV REP VID; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Yilma JM, 1998, VET PARASITOL, V78, P103, DOI 10.1016/S0304-4017(98)00136-8; ZUKOWSKI SH, 1993, VET PARASITOL, V47, P51, DOI 10.1016/0304-4017(93)90175-M; Zuur AF, 2007, STAT BIOL HEALTH, pVII	36	146	150	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16126	10.1371/journal.pone.0016126	http://dx.doi.org/10.1371/journal.pone.0016126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249228	Green Submitted, Green Published, gold			2022-12-25	WOS:000286513100027
J	Eisenhauer, N; Milcu, A; Sabais, ACW; Bessler, H; Brenner, J; Engels, C; Klarner, B; Maraun, M; Partsch, S; Roscher, C; Schonert, F; Temperton, VM; Thomisch, K; Weigelt, A; Weisser, WW; Scheu, S				Eisenhauer, Nico; Milcu, Alexandru; Sabais, Alexander C. W.; Bessler, Holger; Brenner, Johanna; Engels, Christof; Klarner, Bernhard; Maraun, Mark; Partsch, Stephan; Roscher, Christiane; Schonert, Felix; Temperton, Vicky M.; Thomisch, Karolin; Weigelt, Alexandra; Weisser, Wolfgang W.; Scheu, Stefan			Plant Diversity Surpasses Plant Functional Groups and Plant Productivity as Driver of Soil Biota in the Long Term	PLOS ONE			English	Article							SPECIES-DIVERSITY; EXPERIMENTAL GRASSLAND; MICROBIAL COMMUNITIES; BIODIVERSITY EXPERIMENT; TERRESTRIAL ECOSYSTEMS; NITROGEN DEPOSITION; CURRENT KNOWLEDGE; ELEVATED CO2; BIOMASS; LEGUMES	Background: One of the most significant consequences of contemporary global change is the rapid decline of biodiversity in many ecosystems. Knowledge of the consequences of biodiversity loss in terrestrial ecosystems is largely restricted to single ecosystem functions. Impacts of key plant functional groups on soil biota are considered to be more important than those of plant diversity; however, current knowledge mainly relies on short-term experiments. Methodology/Principal Findings: We studied changes in the impacts of plant diversity and presence of key functional groups on soil biota by investigating the performance of soil microorganisms and soil fauna two, four and six years after the establishment of model grasslands. The results indicate that temporal changes of plant community effects depend on the trophic affiliation of soil animals: plant diversity effects on decomposers only occurred after six years, changed little in herbivores, but occurred in predators after two years. The results suggest that plant diversity, in terms of species and functional group richness, is the most important plant community property affecting soil biota, exceeding the relevance of plant above-and belowground productivity and the presence of key plant functional groups, i.e. grasses and legumes, with the relevance of the latter decreasing in time. Conclusions/Significance: Plant diversity effects on biota are not only due to the presence of key plant functional groups or plant productivity highlighting the importance of diverse and high-quality plant derived resources, and supporting the validity of the singular hypothesis for soil biota. Our results demonstrate that in the long term plant diversity essentially drives the performance of soil biota questioning the paradigm that belowground communities are not affected by plant diversity and reinforcing the importance of biodiversity for ecosystem functioning.	[Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Milcu, Alexandru] Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England; [Sabais, Alexander C. W.; Partsch, Stephan; Schonert, Felix] Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany; [Bessler, Holger; Engels, Christof] Humboldt Univ, Dept Plant Nutr & Fertilizat, Berlin, Germany; [Brenner, Johanna; Klarner, Bernhard; Maraun, Mark; Thomisch, Karolin; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Temperton, Vicky M.] Forschungszentrum Juelich GmbH, IBG Plant Sci 2, Julich, Germany; [Weigelt, Alexandra] Univ Leipzig, Dept Bot & Funct Biodivers, Inst Biol 1, Leipzig, Germany; [Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany	University of Minnesota System; University of Minnesota Twin Cities; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Technical University of Darmstadt; Humboldt University of Berlin; University of Gottingen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Research Center Julich; Leipzig University; Friedrich Schiller University of Jena	Eisenhauer, N (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	nico.eisenhauer@web.de	Eisenhauer, Nico/I-3191-2019; Scheu, Stefan/H-7049-2015; Eisenhauer, Nico/I-5932-2012; Weisser, Wolfgang W/B-9718-2014; Milcu, Alexandru/X-6267-2018	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Weisser, Wolfgang W/0000-0002-2757-8959; Klarner, Bernhard/0000-0003-1867-4911; Temperton, Vicky/0000-0003-0543-4521; Milcu, Alexandru/0000-0002-2889-1234; Thomisch, Karolin/0000-0002-7144-8369	German Science Foundation [FOR 456, Ei 862/1-1]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	German Science Foundation(German Research Foundation (DFG)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	German Science Foundation (FOR 456), German Science Foundation (Ei 862/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; BAHRMANN R, 1995, BESTIMMUNG WIRBELLOS; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P2430, DOI 10.1016/j.soilbio.2009.09.001; Fjellberg A, 1980, IDENTIFICATION KEYS; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Haase S, 2007, PLANT SOIL, V301, P151, DOI 10.1007/s11104-007-9431-1; Habekost M, 2008, SOIL BIOL BIOCHEM, V40, P2588, DOI 10.1016/j.soilbio.2008.06.019; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hedlund K, 2003, OIKOS, V103, P45, DOI 10.1034/j.1600-0706.2003.12511.x; HEIMER K, 1991, SPINNEN MITTELEUROPA; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Hopkin C., 1969, KEY SPRINGTAILS COLL; Hopkin S. P., 1997, BIOL SPRINGTAILS COL; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kempson D., 1963, Pedobiologia, V3, P1; KLAUSNITZER B, 2005, STRESEMANN EXKURSION, V2; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kulmatiski A, 2008, SOIL BIOL BIOCHEM, V40, P1059, DOI 10.1016/j.soilbio.2007.11.020; Lau JA, 2008, ECOLOGY, V89, P226, DOI 10.1890/07-0423.1; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Milcu A, 2006, OIKOS, V112, P513, DOI 10.1111/j.0030-1299.2006.14292.x; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mulder CPH, 2002, OECOLOGIA, V133, P412, DOI 10.1007/s00442-002-1043-0; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; SABAIS ACW, 2010, REV IN PRESS; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaefer M, 2009, BROHMER FAUNA DEUTSC; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sulkava P, 1998, OECOLOGIA, V116, P390, DOI 10.1007/s004420050602; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Putten Wim H., 2005, P250, DOI 10.1017/CBO9780511541926.015; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Viketoft M, 2009, ECOLOGY, V90, P90, DOI 10.1890/08-0382.1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wardle DA, 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Weigelt A, 2010, ECOLOGY, V91, P929; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zaller JG, 1999, PLANT SOIL, V208, P1, DOI 10.1023/A:1004424720523	80	109	124	16	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16055	10.1371/journal.pone.0016055	http://dx.doi.org/10.1371/journal.pone.0016055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249208	Green Published, gold			2022-12-25	WOS:000286512900020
J	Kulkarni, AA; Thatcher, TH; Olsen, KC; Maggirwar, SB; Phipps, RP; Sime, PJ				Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Maggirwar, Sanjay B.; Phipps, Richard P.; Sime, Patricia J.			PPAR-gamma Ligands Repress TGF beta-Induced Myofibroblast Differentiation by Targeting the PI3K/Akt Pathway: Implications for Therapy of Fibrosis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR-BETA; NF-KAPPA-B; PULMONARY-FIBROSIS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; SIGNALING PATHWAY; LUNG FIBROBLASTS; GENE-TRANSFER	Transforming growth factor beta (TGF beta) induced differentiation of human lung fibroblasts to myofibroblasts is a key event in the pathogenesis of pulmonary fibrosis. Although the typical TGF beta signaling pathway involves the Smad family of transcription factors, we have previously reported that peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands inhibit TGF beta-mediated differentiation of human lung fibroblasts to myofibroblasts via a Smad-independent pathway. TGF beta also activates the phosphatidylinositol 3 kinase/protein kinase B (PI3K/Akt) pathway leading to phosphorylation of Akt(S473). Here, we report that PPAR-gamma ligands, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and 15-deoxy-(12,14)-15d-prostaglandin J(2) (15d-PGJ(2)), inhibit human myofibroblast differentiation of normal and idiopathic pulmonary fibrotic (IPF) fibroblasts, by blocking Akt phosphorylation at Ser473 by a PPAR-gamma-independent mechanism. The PI3K inhibitor LY294002 and a dominant-negative inactive kinase-domain mutant of Akt both inhibited TGF beta-stimulated myofibroblast differentiation, as determined by Western blotting for alpha-smooth muscle actin and calponin. Prostaglandin A(1) (PGA(1)), a structural analogue of 15d-PGJ(2) with an electrophilic center, also reduced TGF beta-driven phosphorylation of Akt, while CAY10410, another analogue that lacks an electrophilic center, did not; implying that the activity of 15d-PGJ(2) and CDDO is dependent on their electrophilic properties. PPAR-gamma ligands inhibited TGF beta-induced Akt phosphorylation via both post-translational and post-transcriptional mechanisms. This inhibition is independent of MAPK-p38 and PTEN but is dependent on TGF beta-induced phosphorylation of FAK, a kinase that acts upstream of Akt. Thus, PPAR-gamma ligands inhibit TGF beta signaling by affecting two pro-survival pathways that culminate in myofibroblast differentiation. Further studies of PPAR-gamma ligands and small electrophilic molecules may lead to a new generation of anti-fibrotic therapeutics.	[Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Olsen, Keith C.; Maggirwar, Sanjay B.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY USA; [Kulkarni, Ajit A.; Thatcher, Thomas H.; Olsen, Keith C.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kulkarni, AA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA.	Patricia_Sime@urmc.rochester.edu		Thatcher, Thomas/0000-0001-7177-3041	National Institutes of Health [HL075432, HL075432-04S1, HL075432-04S2, HL095402-02, T32 HL66988, F30 HL097596, T32 ES07026, P30 ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R03HL095402, R01HL075432, F30HL097596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health Grants: HL075432, HL075432-04S1, HL075432-04S2, HL095402-02, T32 HL66988, F30 HL097596, T32 ES07026 and P30 ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assinder SJ, 2009, BIOCHEM J, V417, P411, DOI 10.1042/BJ20081610; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Berra E, 1998, J BIOL CHEM, V273, P10792, DOI 10.1074/jbc.273.17.10792; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; Deeb Dorrah, 2008, J Exp Ther Oncol, V7, P31; Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC; Ferguson HE, 2009, AM J PHYSIOL-LUNG C, V297, pL912, DOI 10.1152/ajplung.00148.2009; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Han H, 2007, APOPTOSIS, V12, P2101, DOI 10.1007/s10495-007-0124-2; Hart CM, 2008, J INVEST MED, V56, P515, DOI 10.2310/JIM.0b013e318165e89d; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kalantari P, 2009, FASEB J, V23, P2366, DOI 10.1096/fj.08-124982; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kilter H, 2009, DIABETES OBES METAB, V11, P1060, DOI 10.1111/j.1463-1326.2009.01097.x; Kim DH, 2010, ONCOGENE, V29, P2560, DOI 10.1038/onc.2010.8; Lakatos HF, 2007, PPAR RES, V2007, DOI 10.1155/2007/71323; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Mimura Y, 2005, J INVEST DERMATOL, V124, P886, DOI 10.1111/j.0022-202X.2005.23701.x; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Pitha-Rowe I, 2009, INVEST OPHTH VIS SCI, V50, P5339, DOI 10.1167/iovs.09-3648; Roman J, 2008, J INVEST MED, V56, P528, DOI 10.2310/JIM.0b013e3181659932; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; TAN X, RESP RES, V11, P21; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Vinals F, 2001, MOL CELL BIOL, V21, P7218, DOI 10.1128/MCB.21.21.7218-7230.2001; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yamada KM, 2001, J CELL SCI, V114, P2375	59	137	161	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15909	10.1371/journal.pone.0015909	http://dx.doi.org/10.1371/journal.pone.0015909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253589	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900021
J	Tauchi, T; Okabe, S; Ashihara, E; Kimura, S; Maekawa, T; Ohyashiki, K				Tauchi, T.; Okabe, S.; Ashihara, E.; Kimura, S.; Maekawa, T.; Ohyashiki, K.			Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen	ONCOGENE			English	Article						BCR-ABL; tyrosine kinase inhibitor; nilotinib; HSP90; T315I	CHRONIC MYELOID-LEUKEMIA; ABL KINASE INHIBITORS; BCR-ABL; IMATINIB; RESISTANCE; DASATINIB; HEAT-SHOCK-PROTEIN-90; IDENTIFICATION; ACTIVATION; MECHANISMS	To overcome imatinib resistance, more potent ABL tyrosine kinase inhibitors (TKIs), such as nilotinib and dasatinib have been developed, with demonstrable preclinical activity against most imatinib-resistant BCR-ABL kinase domain mutations, with the exception of T315I. However, imatinib-resistant patients already harboring mutations have a higher likelihood of developing further mutations under the selective pressure of potent ABL TKIs. NVP-AUY922 (Novartis) is a novel 4,5-diaryloxazole adenosine triphosphate-binding site heat shock protein 90 (HSP90) inhibitor, which has been shown to inhibit the chaperone function of HSP90 and deplete the levels of HSP90 client protein including BCR-ABL. In this study, we investigated the combined effects of AUY922 and nilotinib on random mutagenesis for BCR-ABL mutation (Blood, 109; 5011, 2007). Compared with single agents, combination with AUY922 and nilotinib was more effective at reducing the outgrowth of resistant cell clones. No outgrowth was observed in the presence of 2 mu M of nilotinib and 20 nM of AUY922. The observed data from the isobologram indicated the synergistic effect of simultaneous exposure to AUY922 and nilotinib even in BaF3 cells expressing BCR-ABL mutants including T315I. In vivo studies also demonstrated that the combination of AUY922 and nilotinib prolonged the survival of mice transplanted with mixture of BaF3 cells expressing wild-type BCR-ABL and mutant forms. Taken together, this study shows that the combination of AUY922 and nilotinib exhibits a desirable therapeutic index that can reduce the in vivo growth of mutant forms of BCR-ABL-expressing cells. Oncogene (2011) 30, 2789-2797; doi: 10.1038/onc.2011.3; published online 31 January 2011	[Tauchi, T.; Okabe, S.; Ohyashiki, K.] Tokyo Med Univ, Dept Internal Med 1, Shinjuku Ku, Tokyo 1600023, Japan; [Ashihara, E.] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Kyoto, Japan; [Kimura, S.] Saga Univ, Dept Internal Med, Fac Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Maekawa, T.] Kyoto Univ, Fac Med, Dept Transfus Med & Cell Therapy, Kyoto, Japan	Tokyo Medical University; Kyoto Prefectural University of Medicine; Saga University; Kyoto University	Tauchi, T (corresponding author), Tokyo Med Univ, Dept Internal Med 1, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	tauchi@tokyo-med.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology)	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a 'High-Tech Research Center' Project for private universities: matching fund subsidy from the MEXT (Ministry of Education, Culture, Sports, Science and Technology), and by the 'University-Industry Joint Research Project' for private universities: matching fund subsidy from the MEXT.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Garg RJ, 2009, BLOOD, V114, P4361, DOI 10.1182/blood-2009-05-221531; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Jabbour E, 2008, BLOOD, V112, P53, DOI 10.1182/blood-2007-11-123950; Kano Y, 2001, BLOOD, V97, P1999, DOI 10.1182/blood.V97.7.1999; Kantarjian H, 2007, BLOOD, V109, P5143, DOI 10.1182/blood-2006-11-056028; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2009, BLOOD, V113, P6322, DOI 10.1182/blood-2008-11-186817; Matsuyama W, 2004, J IMMUNOL, V172, P2332, DOI 10.4049/jimmunol.172.4.2332; Nunoda K, 2007, ONCOGENE, V26, P4179, DOI 10.1038/sj.onc.1210179; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Ottmann O, 2007, BLOOD, V110, P2309, DOI 10.1182/blood-2007-02-073528; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Stuhmer T, 2008, LEUKEMIA, V22, P1604, DOI 10.1038/leu.2008.111; TAUCHI T, 1994, J EXP MED, V179, P167, DOI 10.1084/jem.179.1.167; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007	23	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	24					2789	2797		10.1038/onc.2011.3	http://dx.doi.org/10.1038/onc.2011.3			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21278787				2022-12-25	WOS:000291678500009
J	Kim, HJ; Miron, VE; Dukala, D; Proia, RL; Ludwin, SK; Traka, M; Antel, JP; Soliven, B				Kim, Hye Jung; Miron, Veronique E.; Dukala, Danuta; Proia, Richard L.; Ludwin, Samuel K.; Traka, Maria; Antel, Jack P.; Soliven, Betty			Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model	FASEB JOURNAL			English	Article						FTY720; fingolimod; oligodendrocytes; multiple sclerosis; demyelination; remyelination	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MATURE OLIGODENDROCYTE APOPTOSIS; IMMUNOMODULATORY DRUG FTY720; RELAPSING MULTIPLE-SCLEROSIS; PROTEIN-COUPLED RECEPTORS; PRIMARY DEMYELINATION; SIGNAL-TRANSDUCTION; ORAL FINGOLIMOD; GENE-EXPRESSION	Fingolimod (FTY720) is a sphingosine 1-phosphate (S1P) receptor modulator that regulates lymphocyte trafficking and exerts pleiotropic actions on oligodendrocytes (OLGs) and other neural cells. The purpose of this study was to investigate the role of S1P receptors in a non-T-cell model of demyelination, the cuprizone (cupr) model in C57BL/6 mice. Treatment with FTY720 (1 mg/kg) led to attenuated injury to OLGs, myelin, and axons in the corpus callosum (percentage of myelinated fibers was 44.7% in cupr-water and 63% in cupr-FTY720). Reactive astrogliosis and microgliosis were ameliorated when FTY720 was given from d 1, but astrogliosis was augmented when FTY720 was given from wk 4-9. FTY720 did not promote remyelination in this model. The protective effect of FTY720 was associated with decreased interleukin-1 beta and CCL2 transcripts in the corpus callosum, as well as altered S1P1 expression. Targeted deletion of S1P1 in OLG lineage cells did not lead to obvious clinical phenotype, but resulted in subtle abnormalities in myelin and an increased susceptibility to cupr-induced demyelination. We conclude that S1P receptors expressed by neuroglia are involved in regulating the response to injury, and CNS effects of FTY720 could contribute to its favorable therapeutic response in multiple sclerosis.-Kim, H. J., Miron, V. E., Dukala, D., Proia, R. L., Ludwin, S. K., Traka, M., Antel, J. P., Soliven, B. Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. FASEB J. 25, 1509-1518 (2011). www.fasebj.org	[Kim, Hye Jung; Dukala, Danuta; Traka, Maria; Soliven, Betty] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Miron, Veronique E.; Antel, Jack P.] McGill Univ, Dept Neuroimmunol, Montreal, PQ, Canada; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA; [Ludwin, Samuel K.] Queens Univ, Dept Neuropathol, Kingston, ON, Canada	University of Chicago; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Queens University - Canada	Soliven, B (corresponding author), Univ Chicago, Dept Neurol MC2030, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bsoliven@neurology.bsd.uchicago.edu	Traka, Maria/U-2176-2019; Miron, Veronique E./H-4280-2019; Proia, Richard L/A-7908-2012	Miron, Veronique E./0000-0003-1738-0647; antel, jack/0000-0002-5148-0636; Proia, Richard/0000-0003-0456-1270	U.S. National Institute of Neurological Disorders and Stroke [R21 NS049014]; National MS Society [RG3951A7/1, TR3762-A-1]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; MS Society of Canada; Novartis; Canadian Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056015, ZIADK056018, ZIADK056016, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049014] Funding Source: NIH RePORTER	U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National MS Society(National Multiple Sclerosis Society); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MS Society of Canada; Novartis(Novartis); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. B. Popko, Dr. N. Turgut, Dr. T. Johnson, and B. Durafourt for their assistance or advice in some experiments. This work was supported by the U.S. National Institute of Neurological Disorders and Stroke (R21 NS049014), the National MS Society (RG3951A7/1), and a gift from M. P. Miller (B. S.); the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (R. L. P.); the National MS Society (TR3762-A-1), a grant from the MS Society of Canada, and a grant from Novartis (J.P.A.); and a Canadian Institutes of Health Research studentship (V. E. M.).	Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Bacia A, 2004, GLIA, V48, P156, DOI 10.1002/glia.20067; Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Biancotti JC, 2008, NEUROCHEM RES, V33, P2615, DOI 10.1007/s11064-008-9792-8; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Coelho RP, 2007, J PHARMACOL EXP THER, V323, P626, DOI 10.1124/jpet.107.123927; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Crawford DK, 2009, NEUROSCIENCE, V164, P1407, DOI 10.1016/j.neuroscience.2009.09.069; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Harsan LA, 2008, J NEUROSCI, V28, P14189, DOI 10.1523/JNEUROSCI.4453-08.2008; Hida H, 1999, J NEUROSCI, V19, P7458, DOI 10.1523/JNEUROSCI.19-17-07458.1999; Hiremath MM, 2008, J NEUROIMMUNOL, V203, P23, DOI 10.1016/j.jneuroim.2008.06.034; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Jung CG, 2007, GLIA, V55, P1656, DOI 10.1002/glia.20576; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kim HJ, 2009, J NEUROIMMUNOL, V214, P93, DOI 10.1016/j.jneuroim.2009.07.006; KOMOLY S, 1992, P NATL ACAD SCI USA, V89, P1894, DOI 10.1073/pnas.89.5.1894; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee KD, 2009, J NEUROTRAUM, V26, P2335, DOI 10.1089/neu.2008.0840; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Lindner M, 2009, NEUROSCI LETT, V453, P120, DOI 10.1016/j.neulet.2009.02.004; LUDWIN SK, 1978, LAB INVEST, V39, P597; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; NAYAK D, NEUROSCIENCE, V166, P132; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pebay A, 2001, EUR J NEUROSCI, V13, P2067, DOI 10.1046/j.0953-816x.2001.01585.x; Rao TS, 2003, BRAIN RES, V990, P182, DOI 10.1016/S0006-8993(03)03527-3; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Sidman R.L., 1999, HIGH RESOLUTION MOUS; Soliven B, 2003, AM J PHYSIOL-CELL PH, V284, pC85, DOI 10.1152/ajpcell.00145.2002; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Vana AC, 2007, J NEUROPATH EXP NEUR, V66, P975, DOI 10.1097/NEN.0b013e3181587d46; Veto S, 2010, BRAIN, V133, P822, DOI 10.1093/brain/awp337; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180; Yu NC, 2004, GLIA, V45, P17, DOI 10.1002/glia.10297	61	80	81	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1509	1518		10.1096/fj.10-173203	http://dx.doi.org/10.1096/fj.10-173203			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21248243	Green Published			2022-12-25	WOS:000290023800009
J	Zhou, Z; Hao, Y; Liu, N; Raptis, L; Tsao, MS; Yang, X				Zhou, Z.; Hao, Y.; Liu, N.; Raptis, L.; Tsao, M-S; Yang, X.			TAZ is a novel oncogene in non-small cell lung cancer	ONCOGENE			English	Article						TAZ; lung cancer; Hippo-LATS pathway; transcriptional coactivator; cell proliferation; transformation	EPITHELIAL-MESENCHYMAL TRANSITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; TUMOR-SUPPRESSOR; CONTACT INHIBITION; YAP; PROLIFERATION; PATHOGENESIS; PROGRESSION; EXPRESSION	Transcriptional coactivator with PDZ-binding motif (TAZ) is a transcriptional coactivator involved in the differentiation of stem cell as well as the development of multiple organs. Recently, TAZ has also been identified as a major component of the novel Hippo-LATS tumor suppressor pathway and to function as an oncogene in breast cancer. We show for the first time that TAZ is an oncogene in non-small cell lung cancer (NSCLC). Our results show that TAZ is overexpressed in NSCLC cells and that lentivirus-mediated overexpression of TAZ in HBE135 immortalized human bronchial epithelial cells causes increased cell proliferation and transformation, which can be restored back to its original levels by knockdown of TAZ. In addition, short-hairpin RNA (shRNA)-mediated knockdown of TAZ expression in NSCLC cells suppresses their proliferation and anchorage-independent growth in vitro, and tumor growth in mice in vivo, which can be reversed by re-introduction of shRNA-resistant TAZ into TAZ-knockdown NSCLC cells. These results indicate that TAZ is an oncogene and has an important role in tumorigenicity of NSCLC cells. Therefore, TAZ may present a novel target for the future diagnosis, prognosis and therapy of lung cancer. Oncogene (2011) 30, 2181-2186; doi:10.1038/onc.2010.606; published online 24 January 2011	[Yang, X.] Queens Univ, Dept Pathol & Mol Med, Richardson Labs 201, Kingston, ON K7L 3N6, Canada; [Liu, N.; Tsao, M-S] Princess Margaret Hosp, Dept Pathol, Toronto, ON M4X 1K9, Canada; [Raptis, L.] Queens Univ, Dept Immunol & Microbiol, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Queens University - Canada	Yang, X (corresponding author), Queens Univ, Dept Pathol & Mol Med, Richardson Labs 201, 88 Stuart St, Kingston, ON K7L 3N6, Canada.	yang@cliff.path.queensu.ca	Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405	Canadian Institute of Health Research; Clinical Trust Fund at Queen's University; Ontario Ministry of Research and Innovation, Canada; Canadian Cancer Society [CCSRI-020527]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Clinical Trust Fund at Queen's University; Ontario Ministry of Research and Innovation, Canada(Ministry of Research and Innovation, Ontario); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by a grant from the Canadian Institute of Health Research, a grant from the Clinical Trust Fund at Queen's University, a New Investigator Award from the Canadian Institute of Health Research and an Early Researcher Award from the Ontario Ministry of Research and Innovation, Canada to Xiaolong Yang, and a grant from the Canadian Cancer Society (CCSRI-020527) to Ming-Sound Tsao. We thank Dulcie Lai and Stacy Visser for reading the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brambilla E, 2009, EUR RESPIR J, V33, P1485, DOI 10.1183/09031936.00014009; Cai D, 2010, CANCER RES, V70, P6477, DOI 10.1158/0008-5472.CAN-10-0005; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chow A, 2010, INT J CANCER, V126, P2079, DOI 10.1002/ijc.24878; Dutt A, 2006, CLIN CANCER RES, V12, p4396S, DOI 10.1158/1078-0432.CCR-06-0414; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2009, BIOFACTORS, V35, P338, DOI 10.1002/biof.47; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kim YH, 2010, ONCOGENE, V29, P1421, DOI 10.1038/onc.2009.437; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lo KC, 2008, LUNG CANCER, V59, P315, DOI 10.1016/j.lungcan.2007.08.037; Mitani A, 2009, AM J RESP CRIT CARE, V180, P326, DOI 10.1164/rccm.200812-1827OC; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Strazisar M, 2009, LUNG CANCER, V64, P257, DOI 10.1016/j.lungcan.2008.09.011; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Yokota J, 2004, CANCER SCI, V95, P197, DOI 10.1111/j.1349-7006.2004.tb02203.x; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	32	138	146	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	18					2181	2186		10.1038/onc.2010.606	http://dx.doi.org/10.1038/onc.2010.606			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	759ML	21258416				2022-12-25	WOS:000290249600009
J	Martin, DC; Kim, H; Mackin, NA; Maldonado-Baez, L; Evangelista, CC; Beaudry, VG; Dudgeon, DD; Naiman, DQ; Erdman, SE; Cunningham, KW				Martin, D. Christian; Kim, Hyemin; Mackin, Nancy A.; Maldonado-Baez, Lymarie; Evangelista, Carlos C., Jr.; Beaudry, Veronica G.; Dudgeon, Drew D.; Naiman, Daniel Q.; Erdman, Scott E.; Cunningham, Kyle W.			New Regulators of a High Affinity Ca2+ Influx System Revealed through a Genome-wide Screen in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; BIOACTIVE COMPOUNDS; INTERACTION NETWORK; MEMBRANE-PROTEINS; CALCIUM-CHANNEL; GENE-EXPRESSION; CALCINEURIN; HOMOLOG	The bakers' yeast Saccharomyces cerevisiae utilizes a high affinity Ca2+ influx system (HACS) to survive assaults by mating pheromones, tunicamycin, and azole-class antifungal agents. HACS consists of two known subunits, Cch1 and Mid1, that are homologous and analogous to the catalytic alpha-subunits and regulatory alpha 2 delta-subunits of mammalian voltage-gated calcium channels, respectively. To search for additional subunits and regulators of HACS, a collection of gene knock-out mutants was screened for abnormal uptake of Ca2+ after exposure to mating pheromone or to tunicamycin. The screen revealed that Ecm7 is required for HACS function in most conditions. Cycloheximide chase experiments showed that Ecm7 was stabilized by Mid1, and Mid1 was stabilized by Cch1 in non-signaling conditions, suggesting they all interact. Ecm7 is a member of the PMP-22/EMP/MP20/Claudin superfamily of transmembrane proteins that includes gamma-subunits of voltage-gated calcium channels. Eleven additional members of this superfamily were identified in yeast, but none was required for HACS activity in response to the stimuli. Remarkably, many dozens of genes involved in vesicle-mediated trafficking and protein secretion were required to prevent spontaneous activation of HACS. Taken together, the findings suggest that HACS and calcineurin monitor performance of the membrane trafficking system in yeasts and coordinate compensatory processes. Conservation of this quality control system in Candida glabrata suggests that many pathogenic species of fungi may utilize HACS and calcineurin to resist azoles and other compounds that target membrane biosynthesis.	[Martin, D. Christian; Maldonado-Baez, Lymarie; Evangelista, Carlos C., Jr.; Beaudry, Veronica G.; Dudgeon, Drew D.; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Naiman, Daniel Q.] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD 21218 USA; [Mackin, Nancy A.; Erdman, Scott E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Johns Hopkins University; Johns Hopkins University; Syracuse University	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	kwc@jhu.edu	Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081	National Institutes of Health [GM053082, NS057023]; National Science Foundation [MCB-0131408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM053082 and NS057023 (to K. W. C.). This work was also supported by National Science Foundation Grant MCB-0131408 (to S. E. E.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; DUNN T, 1994, J BIOL CHEM, V269, P7273; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1990, J BIOL CHEM, V265, P13391; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Li WS, 1997, GENETICS, V145, P63; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lussier M, 1997, GENETICS, V147, P435; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Miseta A, 1999, J BIOL CHEM, V274, P5939, DOI 10.1074/jbc.274.9.5939; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; Muller EM, 2001, GENETICS, V159, P1527; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; PENNY II, 1996, APPL STAT, V45, P73; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Sherman F., 1986, METHODS YEAST GENETI; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Treton B, 2000, MOL GEN GENET, V263, P505, DOI 10.1007/s004380051195; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Ward JM, 2001, BIOINFORMATICS, V17, P560, DOI 10.1093/bioinformatics/17.6.560; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002	58	78	85	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10744	10754		10.1074/jbc.M110.177451	http://dx.doi.org/10.1074/jbc.M110.177451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252230	Green Published, hybrid			2022-12-25	WOS:000288547000088
J	Ko, YP; Liang, XW; Smith, CW; Degen, JL; Hook, M				Ko, Ya-Ping; Liang, Xiaowen; Smith, C. Wayne; Degen, Jay L.; Hoeoek, Magnus			Binding of Efb from Staphylococcus aureus to Fibrinogen Blocks Neutrophil Adherence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTAXIS INHIBITORY PROTEIN; TRANSENDOTHELIAL MIGRATION; PLATELET-AGGREGATION; INTEGRIN ALPHA(M)BETA(2); VIRULENCE DETERMINANT; LEUKOCYTE ADHESION; DELAYS APOPTOSIS; IMMUNE EVASION; MICE LACKING; GAMMA-CHAIN	In addition to its pivotal role in hemostasis, fibrinogen (Fg) and provisional fibrin matrices play important roles in inflammation and regulate innate immune responses by interacting with leukocytes. Efb (the extracellular fibrinogen-binding protein) is a secreted Staphylococcus aureus protein that engages host Fg and complement C3. However, the molecular details underlying the Efb-Fg interaction and the biological relevance of this interaction have not been determined. In the present study, we characterize the interaction of Efb with Fg. We demonstrate that the Fg binding activity is located within the intrinsically disordered N-terminal half of Efb (Efb-N) and that the D fragment of Fg is the region that mediates Efb-N binding. More detailed studies of the Efb-N-Fg interactions using ELISA and surface plasmon resonance analyses revealed that Efb-N exhibits a much higher affinity for Fg than typically observed with Fg-binding MSCRAMMs(microbial surface components recognizing adhesive matrix molecules), and data obtained from ELISA analyses using truncated Efb-N constructs demonstrate that Efb-N contains two binding sites located within residues 30-67 and 68-98, respectively. Efb-N inhibits neutrophil adhesion to immobilized Fg by binding to Fg and blocking the interaction of the protein with the leukocyte integrin receptor, alpha(M)beta(2). A motif in the Fg gamma chain previously shown to be central to the alpha(M)beta(2) interaction was shown to be functionally distinguishable from the Efb-N binding site, suggesting that the Fg-Efb interaction indirectly impedes Fg engagement by alpha(M)beta(2). Taken together, these studies provide insights into how Efb interacts with Fg and suggest that Efb may support bacterial virulence at least in part by impeding Fg-driven leukocyte adhesion events.	[Ko, Ya-Ping; Liang, Xiaowen; Hoeoek, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Leukocyte Lab, Houston, TX 77030 USA; [Degen, Jay L.] Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA; [Degen, Jay L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Hook, M (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu		Liang, Xiaowen/0000-0002-6174-2951	National Institutes of Health [AI20624]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI020624, R01AI020624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI20624 (to M. H.).	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; Burns AR, 2000, J CELL SCI, V113, P45; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Cruz-Topete D, 2006, J PATHOL, V210, P325, DOI 10.1002/path.2060; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kuhns DB, 2001, J IMMUNOL, V167, P2869, DOI 10.4049/jimmunol.167.5.2869; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Palma M, 2001, J BIOL CHEM, V276, P31691, DOI 10.1074/jbc.M104554200; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rubel C, 2001, J IMMUNOL, V166, P2002, DOI 10.4049/jimmunol.166.3.2002; Rubel C, 2003, EUR J IMMUNOL, V33, P1429, DOI 10.1002/eji.200323512; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; Shannon O, 2004, THROMB HAEMOSTASIS, V91, P779, DOI 10.1160/TH03-05-0287; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SMITH CW, 1979, J CLIN INVEST, V63, P221, DOI 10.1172/JCI109293; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Tuluc F, 2004, AM J PHYSIOL-CELL PH, V287, pC1264, DOI 10.1152/ajpcell.00177.2004; Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519; Wade D, 1998, BIOCHEM BIOPH RES CO, V248, P690, DOI 10.1006/bbrc.1998.9028; Zhang L, 1999, CELL RES, V9, P171, DOI 10.1038/sj.cr.7290015	52	39	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9865	9874		10.1074/jbc.M110.199687	http://dx.doi.org/10.1074/jbc.M110.199687			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21247890	Green Published, hybrid			2022-12-25	WOS:000288247700110
J	Stergiou, C; Zisimopoulou, P; Tzartos, SJ				Stergiou, Christos; Zisimopoulou, Paraskevi; Tzartos, Socrates J.			Expression of Water-soluble, Ligand-binding Concatameric Extracellular Domains of the Human Neuronal Nicotinic Receptor alpha 4 and beta 2 Subunits in the Yeast Pichia pastoris GLYCOSYLATION IS NOT REQUIRED FOR LIGAND BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; HUMAN BRAIN; SUBTYPES; AGONIST; DESENSITIZATION; PHARMACOLOGY; BUNGAROTOXIN	Nicotinic acetylcholine receptors (nAChRs) are ligand-gated cation channels that are responsible for cell communication via the neurotransmitter acetylcholine. The predominant nAChR subtype in the mammalian brain with a high affinity for nicotine is composed of alpha 4 and beta 2 subunits. This nAChR subtype is responsible for addiction to nicotine and is thought to be implicated in Alzheimer and Parkinson diseases and therefore presents an important target for drug design. In an effort to obtain water-soluble, ligand-binding domains of the human alpha 4 beta 2 nAChR for structural studies, we expressed the extracellular domains (ECDs) of these subunits in the eukaryotic expression system Pichia pastoris. The wild-type ECDs and their mutants containing the more hydrophilic Cys-loop from the snail acetylcholine- binding protein (individually expressed or coexpressed) did not demonstrate any specific interaction with ligands. We then linked the mutated ECDs with the 24-amino acid peptide (AGS)(8) and observed that the beta 2-24-alpha 4 ECD concatamer, but not the alpha 4-24-beta 2 one, exhibited very satisfactory water solubility and ligand binding properties. The I-125-epibatidine and [H-3] nicotine bound to beta 2-24-alpha 4 with dissociation constants (K-d) of 0.38 and 19 nM, respectively, close to the published values for the intact alpha 4 beta 2 AChR. In addition, I-125-epibatidine binding was blocked by nicotine, cytisine, acetylcholine, and carbamylcholine with inhibition constants (K-i) of 20.64, 3.24, 242, and 2,254 nM, respectively. Interestingly, deglycosylation of the concatamer did not affect its ligand binding properties. Furthermore, the deglycosylated beta 2-24-alpha 4 ECD existed mainly in monomeric form, thus forming an appropriate material for structural studies and possibly for pharmacological evaluation of novel alpha 4 beta 2 nAChR-specific agonists.	[Stergiou, Christos; Zisimopoulou, Paraskevi; Tzartos, Socrates J.] Hellenic Pasteur Inst, Dept Biochem, GR-11521 Athens, Greece; [Stergiou, Christos; Tzartos, Socrates J.] Univ Patras, Dept Pharm, GR-26504 Patras, Greece	University of Patras	Tzartos, SJ (corresponding author), Hellenic Pasteur Inst, Dept Biochem, Vas Sofias Ave 127, GR-11521 Athens, Greece.	tzartos@pasteur.gr	Zisimopoulou, P/B-4105-2017		European Community [202088]	European Community(European Commission)	This work was supported by European Community Grant FP7 NeuroCypres under Contract 202088.	Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Avramopoulou V, 2004, J BIOL CHEM, V279, P38287, DOI 10.1074/jbc.M402533200; Bencherif M, 1996, J PHARMACOL EXP THER, V279, P1413; Bisson WH, 2008, J MOL MODEL, V14, P891, DOI 10.1007/s00894-008-0340-x; Bitzopoulou K, 2008, BBA-PROTEINS PROTEOM, V1784, P1226, DOI 10.1016/j.bbapap.2008.04.023; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breese CR, 2000, NEUROPSYCHOPHARMACOL, V23, P351, DOI 10.1016/S0893-133X(00)00121-4; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Chen Y, 2003, NEUROPHARMACOLOGY, V45, P334, DOI 10.1016/S0028-3908(03)00189-8; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Galanti LM, 2008, VASC HEALTH RISK MAN, V4, P837, DOI 10.2147/VHRM.S3250; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Groot-Kormelink PJ, 2006, MOL PHARMACOL, V69, P558, DOI 10.1124/mol.105.019356; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Konstantakaki M, 2008, J MOL GRAPH MODEL, V26, P1333, DOI 10.1016/j.jmgm.2008.01.004; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Marks MJ, 1996, J PHARMACOL EXP THER, V277, P1383; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pedretti A, 2008, BIOCHEM BIOPH RES CO, V369, P648, DOI 10.1016/j.bbrc.2008.02.080; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Person AM, 2005, J BIOL CHEM, V280, P39990, DOI 10.1074/jbc.M505087200; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Schrattenholz A, 1998, J BIOL CHEM, V273, P32393, DOI 10.1074/jbc.273.49.32393; Sharples CGV, 2002, J MED CHEM, V45, P3235, DOI 10.1021/jm020814l; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Wang DX, 1996, J NEUROSCI RES, V44, P350, DOI 10.1002/(SICI)1097-4547(19960515)44:4<350::AID-JNR6>3.0.CO;2-B; Whiteaker P, 2000, BRIT J PHARMACOL, V131, P729, DOI 10.1038/sj.bjp.0703616; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zouridakis M, 2009, BBA-PROTEINS PROTEOM, V1794, P355, DOI 10.1016/j.bbapap.2008.11.002	44	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8884	8892		10.1074/jbc.M110.171645	http://dx.doi.org/10.1074/jbc.M110.171645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252231	hybrid, Green Published			2022-12-25	WOS:000288247700019
J	Pham, T; Mero, P; Booth, JW				Pham, Theodore; Mero, Patricia; Booth, James W.			Dynamics of Macrophage Trogocytosis of Rituximab-Coated B Cells	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; TARGET-CELLS; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; CUTTING EDGE; NK CELLS; T-CELLS; MECHANISM; ENDOCYTOSIS	Macrophages can remove antigen from the surface of antibody-coated cells by a process termed trogocytosis. Using live cell microscopy and flow cytometry, we investigated the dynamics of trogocytosis by RAW264.7 macrophages of Ramos B cells opsonized with the anti-CD20 monoclonal antibody rituximab. Spontaneous and reversible formation of uropods was observed on Ramos cells, and these showed a strong enrichment in rituximab binding. RAW-Ramos conjugate interfaces were highly enriched in rituximab, and transfer of rituximab to the RAW cells in submicron-sized puncta occurred shortly after cell contact. Membrane from the target cells was concomitantly transferred along with rituximab to a variable extent. We established a flow cytometry-based approach to follow the kinetics of transfer and internalization of rituximab. Disruption of actin polymerization nearly eliminated transfer, while blocking phosphatidylinositol 3-kinase activity only resulted in a delay in its acquisition. Inhibition of Src family kinase activity both slowed acquisition and reduced the extent of trogocytosis. The effects of inhibiting these kinases are likely due to their role in efficient formation of cell-cell conjugates. Selective pre-treatment of Ramos cells with phenylarsine oxide blocked uropod formation, reduced enrichment of rituximab at cell-cell interfaces, and reduced the efficiency of trogocytic transfer of rituximab. Our findings highlight that dynamic changes in target cell shape and surface distribution of antigen may significantly influence the progression and extent of trogocytosis. Understanding the mechanistic determinants of macrophage trogocytosis will be important for optimal design of antibody therapies.	[Pham, Theodore; Mero, Patricia; Booth, James W.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Pham, Theodore; Mero, Patricia; Booth, James W.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Pham, T (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	james.booth@utoronto.ca			Canadian Institutes of Health Research [MOP84475]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP84475 from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Beum PV, 2008, J IMMUNOL, V181, P2916, DOI 10.4049/jimmunol.181.4.2916; Beum PV, 2008, J IMMUNOL, V181, P8120, DOI 10.4049/jimmunol.181.11.8120; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Daubeuf S, 2010, J IMMUNOL, V184, P1897, DOI 10.4049/jimmunol.0901570; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; GRIFFIN FM, 1976, J EXP MED, V144, P788, DOI 10.1084/jem.144.3.788; HoWangYin KY, 2010, CELL MOL LIFE SCI, V67, P1133, DOI 10.1007/s00018-009-0239-4; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; McCann FE, 2007, J IMMUNOL, V178, P3418, DOI 10.4049/jimmunol.178.6.3418; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Perosa F, 2007, J IMMUNOL, V179, P7967, DOI 10.4049/jimmunol.179.11.7967; Petrie RJ, 2002, J IMMUNOL, V169, P2886, DOI 10.4049/jimmunol.169.6.2886; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Taylor RP, 2007, NAT CLIN PRACT RHEUM, V3, P86, DOI 10.1038/ncprheum0424; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Williams ME, 2006, J IMMUNOL, V177, P7435, DOI 10.4049/jimmunol.177.10.7435; Zhang QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003097	33	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14498	10.1371/journal.pone.0014498	http://dx.doi.org/10.1371/journal.pone.0014498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264210	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600001
J	Xie, P; Sayers, JR				Xie, Ping; Sayers, Jon R.			A Model for Transition of 5 '-Nuclease Domain of DNA Polymerase I from Inert to Active Modes	PLOS ONE			English	Article							OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; EXONUCLEASE ACTIVITY; CRYSTAL-STRUCTURE; KLENOW FRAGMENT; NUCLEASE DOMAIN; ENDONUCLEASE; REPLICATION; MECHANISM	Bacteria contain DNA polymerase I (PolI), a single polypeptide chain consisting of similar to 930 residues, possessing DNA-dependent DNA polymerase, 3'-5' proofreading and 5'-3' exonuclease (also known as flap endonuclease) activities. PolI is particularly important in the processing of Okazaki fragments generated during lagging strand replication and must ultimately produce a double-stranded substrate with a nick suitable for DNA ligase to seal. PolI's activities must be highly coordinated both temporally and spatially otherwise uncontrolled 5'-nuclease activity could attack a nick and produce extended gaps leading to potentially lethal double-strand breaks. To investigate the mechanism of how PolI efficiently produces these nicks, we present theoretical studies on the dynamics of two possible scenarios or models. In one the flap DNA substrate can transit from the polymerase active site to the 5'-nuclease active site, with the relative position of the two active sites being kept fixed; while the other is that the 5'-nuclease domain can transit from the inactive mode, with the 5'-nuclease active site distant from the cleavage site on the DNA substrate, to the active mode, where the active site and substrate cleavage site are juxtaposed. The theoretical results based on the former scenario are inconsistent with the available experimental data that indicated that the majority of 5'-nucleolytic processing events are carried out by the same PolI molecule that has just extended the upstream primer terminus. By contrast, the theoretical results on the latter model, which is constructed based on available structural studies, are consistent with the experimental data. We thus conclude that the latter model rather than the former one is reasonable to describe the cooperation of the PolI's polymerase and 5'-3' exonuclease activities. Moreover, predicted results for the latter model are presented.	[Xie, Ping] Chinese Acad Sci, Key Lab Soft Matter Phys, Beijing, Peoples R China; [Xie, Ping] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100080, Peoples R China; [Sayers, Jon R.] Univ Sheffield, Sch Med, Krebs Inst, Dept Infect & Immun, Sheffield, S Yorkshire, England	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; University of Sheffield	Xie, P (corresponding author), Chinese Acad Sci, Key Lab Soft Matter Phys, Beijing, Peoples R China.	j.r.sayers@sheffield.ac.uk	Sayers, Jon R/I-8974-2012; Sayers, Jon R/AAP-6179-2020	Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443	National Natural Science Foundation of China [10834014, 10974248]; Biotechnology and Biological Research Council [50/B19466]; Biotechnology and Biological Sciences Research Council [B19466] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm, Grant Nos. 10834014 and 10974248). Work in the Sayers' laboratory is supported by the Biotechnology and Biological Research Council (grant no 50/B19466; http://www.bbsrc.ac.uk) and benefits from infrastructure provided by the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LM, 2009, BIOCHEM J, V418, P285, DOI 10.1042/BJ20081637; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Bu ZM, 2005, P NATL ACAD SCI USA, V102, P17646, DOI 10.1073/pnas.0503388102; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Datta K, 2006, BIOPHYS J, V90, P1739, DOI 10.1529/biophysj.105.071837; DEGENNES PG, 1979, SCALING CONCEPTS POL, pCH3; Delagoutte E, 2003, J BIOL CHEM, V278, P25435, DOI 10.1074/jbc.M303370200; DIAZ A, 1992, MOL MICROBIOL, V6, P3009, DOI 10.1111/j.1365-2958.1992.tb01759.x; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; Gardiner C. W., 1983, HDB STOCHASTIC METHO; Garforth SJ, 1997, NUCLEIC ACIDS RES, V25, P3801, DOI 10.1093/nar/25.19.3801; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Ho DL, 2004, J BIOL CHEM, V279, P39146, DOI 10.1074/jbc.M404565200; Hodskinson MRG, 2007, NUCLEIC ACIDS RES, V35, P4094, DOI 10.1093/nar/gkm396; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; HONEYCUTT RL, 1992, PHYS REV A, V45, P600, DOI 10.1103/PhysRevA.45.600; Imai M, 2007, MOL GENET GENOMICS, V278, P211, DOI 10.1007/s00438-007-0239-8; JOYCE CM, 1987, TRENDS BIOCHEM SCI, V12, P288, DOI 10.1016/0968-0004(87)90143-5; KAMPMEYER PM, 1952, J APPL PHYS, V23, P99, DOI 10.1063/1.1701986; KELLEY WS, 1983, J MOL BIOL, V164, P529, DOI 10.1016/0022-2836(83)90049-9; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KUROSAWA Y, 1975, J MOL BIOL, V96, P653, DOI 10.1016/0022-2836(75)90144-8; Kutyavin IV, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1138; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; LUNDQUIST RC, 1982, CELL, V31, P53, DOI 10.1016/0092-8674(82)90404-4; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Makiela-Dzbenska K, 2009, MOL MICROBIOL, V74, P1114, DOI 10.1111/j.1365-2958.2009.06921.x; Nagata Y, 2002, GENETICS, V160, P13; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; Orlando C, 1998, CLIN CHEM LAB MED, V36, P255, DOI 10.1515/CCLM.1998.045; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Risken H., 1984, FOKKER PLANK EQUATIO; ROBINS P, 1994, J BIOL CHEM, V269, P28535; SAYERS JR, 1994, J THEOR BIOL, V170, P415, DOI 10.1006/jtbi.1994.1202; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SAYERS JR, 1991, NUCLEIC ACIDS RES, V19, P4127, DOI 10.1093/nar/19.15.4127; SETLOW P, 1972, J BIOL CHEM, V247, P232; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c; Urs UK, 1999, ACTA CRYSTALLOGR D, V55, P1971; Xie P, 2008, BBA-BIOENERGETICS, V1777, P1195, DOI 10.1016/j.bbabio.2008.04.040; Xie P, 2007, ARCH BIOCHEM BIOPHYS, V457, P73, DOI 10.1016/j.abb.2006.09.019; Xie P, 2009, J THEOR BIOL, V259, P434, DOI 10.1016/j.jtbi.2009.04.009; Xu Y, 2000, J BIOL CHEM, V275, P20949, DOI 10.1074/jbc.M909135199; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zietlow L, 2008, BIOCHEMISTRY-US, V47, P5460, DOI 10.1021/bi702343y	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16213	10.1371/journal.pone.0016213	http://dx.doi.org/10.1371/journal.pone.0016213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264264	gold, Green Published, Green Accepted			2022-12-25	WOS:000286516500041
J	Baruch-Mordo, S; Breck, SW; Wilson, KR; Broderick, J				Baruch-Mordo, Sharon; Breck, Stewart W.; Wilson, Kenneth R.; Broderick, John			The Carrot or the Stick? Evaluation of Education and Enforcement as Management Tools for Human-Wildlife Conflicts	PLOS ONE			English	Article							AMERICAN BLACK BEAR; CONSERVATION; CARNIVORES; PREDATION; PROGRAMS; LAW	Evidence-based decision-making is critical for implementing conservation actions, especially for human-wildlife conflicts, which have been increasing worldwide. Conservation practitioners recognize that long-term solutions should include altering human behaviors, and public education and enforcement of wildlife-related laws are two management actions frequently implemented, but with little empirical evidence evaluating their success. We used a system where human-black bear conflicts were common, to experimentally test the efficacy of education and enforcement in altering human behavior to better secure attractants (garbage) from bears. We conducted 3 experiments in Aspen CO, USA to evaluate: 1) on-site education in communal dwellings and construction sites, 2) Bear Aware educational campaign in residential neighborhoods, and 3) elevated law enforcement at two levels in the core business area of Aspen. We measured human behaviors as the response including: violation of local wildlife ordinances, garbage availability to bears, and change in use of bear-resistance refuse containers. As implemented, we found little support for education, or enforcement in the form of daily patrolling in changing human behavior, but found more support for proactive enforcement, i.e., dispensing warning notices. More broadly we demonstrated the value of gathering evidence before and after implementing conservation actions, and the dangers of measuring responses in the absence of ecological knowledge. We recommend development of more effective educational methods, application of proactive enforcement, and continued evaluation of tools by directly measuring change in human behavior. We provide empirical evidence adding to the conservation managers' toolbox, informing policy makers, and promoting solutions to human-wildlife conflicts.	[Baruch-Mordo, Sharon; Wilson, Kenneth R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Breck, Stewart W.] USDA WS Natl Wildlife Res Ctr, Ft Collins, CO USA; [Broderick, John] Colorado Div Wildlife, Ft Collins, CO 80526 USA	Colorado State University; United States Department of Agriculture (USDA)	Baruch-Mordo, S (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	Sharon.Baruch-Mordo@colostate.edu	Breck, Stewart/GWC-5825-2022; Wilson, Kenneth R./P-8692-2019		United States Department of Agriculture - National Wildlife Research Center; city of Aspen [5353530]; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	United States Department of Agriculture - National Wildlife Research Center; city of Aspen; Aspen Field Biology Lab; Jack H. Berryman Institute; Rocky Mountain Goats Foundation; Colorado Chapter of The Wildlife Society	This study was funded by the United States Department of Agriculture - National Wildlife Research Center (SWB) (http://www.aphis.usda.gov/wildlife_damage/nwrc/). Additional funds awarded by the city of Aspen to KRW (CSU account no. 5353530). Fellowship and scholarship support given to SBM by Aspen Field Biology Lab, Jack H. Berryman Institute, Rocky Mountain Goats Foundation, and the Colorado Chapter of The Wildlife Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, RESOLVING HUMAN WILD; *ASP CHAMB RES ASS, 2009, ASP DEM PROF REP; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; BARUCHMORDO S, 2000, 1 US CENS BUR AM FAC; BARUCHMORDO S, 2000, PROFILE SELECTED EC; Beckmann JP, 2004, WILDLIFE SOC B, V32, P1141, DOI 10.2193/0091-7648(2004)032[1141:EODTAD]2.0.CO;2; Cameron AC, 1997, J ECONOMETRICS, V77, P329; *CO STAT DEM OFF, 2009, POP TOT COL MUN; Conover MR, 1997, WILDLIFE SOC B, V25, P306; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; Don Carlos Andrew W., 2009, Human Dimensions of Wildlife, V14, P174; Dunn WC, 2008, URSUS, V19, P43, DOI 10.2192/1537-6176(2008)19[43:SEIBCA]2.0.CO;2; Fall MW, 2002, INT BIODETER BIODEGR, V49, P87, DOI 10.1016/S0964-8305(01)00107-X; FEIGHERY E, 1991, JAMA-J AM MED ASSOC, V266, P3168; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; George SL, 2006, SOUTHWEST NAT, V51, P240, DOI 10.1894/0038-4909(2006)51[240:EACOTU]2.0.CO;2; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gore ML, 2006, URSUS, V17, P75, DOI 10.2192/1537-6176(2006)17[75:EPFRAB]2.0.CO;2; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; *INT ASS FISH WILD, 2005, POT COSTS LOS HUNT T; Jachmann H, 1997, J APPL ECOL, V34, P233, DOI 10.2307/2404861; Jachmann H, 2008, BIOL CONSERV, V141, P1906, DOI 10.1016/j.biocon.2008.05.009; Jacobson S.K., 2006, CONSERVATION ED OUTR; JACOBSON SK, 2009, WILDLIFE SOC SCI HUM, P301; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Knarrum V, 2006, URSUS, V17, P67, DOI 10.2192/1537-6176(2006)17[67:BBPODS]2.0.CO;2; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Manfredo M., 2008, WHO CARES WILDLIFE S, Vfirst, DOI [10.1007/978-0-387-77040-6, DOI 10.1007/978-0-387-77040-6]; Manfredo Michael J., 2003, Human Dimensions of Wildlife, V8, P287, DOI 10.1080/716100425; McCleery RA, 2009, SOC NATUR RESOUR, V22, P353, DOI 10.1080/08941920802064414; Messmer Terry A., 2009, Human-Wildlife Conflicts, V3, P10; *NAT AGR IM PROGR, 2005, NAIP IM; Ott RL, 2001, INTRO STAT METHODS D; Peine John D., 2001, Human Dimensions of Wildlife, V6, P223, DOI 10.1080/108712001753461301; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; *SAS I, 2002, SAS SYST WIND V 9 2; Shivik JA, 2006, BIOSCIENCE, V56, P253, DOI 10.1641/0006-3568(2006)056[0253:TFTEWN]2.0.CO;2; Shults RA, 2009, AM J PREV MED, V37, P360, DOI 10.1016/j.amepre.2009.07.005; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Tchamba MN, 1996, BIOL CONSERV, V75, P35, DOI 10.1016/0006-3207(95)00040-2; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vasudevan V, 2009, TRAFFIC INJ PREV, V10, P330, DOI 10.1080/15389580902995190; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Woodroffe R., 2005, PEOPLE WILDLIFE CONF	51	74	75	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e15681	10.1371/journal.pone.0015681	http://dx.doi.org/10.1371/journal.pone.0015681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264267	gold, Green Submitted, Green Published			2022-12-25	WOS:000286514300001
J	Calabrese, A; Schumacher, JW; Schneider, DM; Paninski, L; Woolley, SMN				Calabrese, Ana; Schumacher, Joseph W.; Schneider, David M.; Paninski, Liam; Woolley, Sarah M. N.			A Generalized Linear Model for Estimating Spectrotemporal Receptive Fields from Responses to Natural Sounds	PLOS ONE			English	Article							ZEBRA FINCHES; NEURAL ENSEMBLE; NONLINEARITIES; NEURONS; SONG; DISCRIMINATION; REPRESENTATION; SHRINKAGE; CORTEX	In the auditory system, the stimulus-response properties of single neurons are often described in terms of the spectrotemporal receptive field (STRF), a linear kernel relating the spectrogram of the sound stimulus to the instantaneous firing rate of the neuron. Several algorithms have been used to estimate STRFs from responses to natural stimuli; these algorithms differ in their functional models, cost functions, and regularization methods. Here, we characterize the stimulus-response function of auditory neurons using a generalized linear model (GLM). In this model, each cell's input is described by: 1) a stimulus filter (STRF); and 2) a post-spike filter, which captures dependencies on the neuron's spiking history. The output of the model is given by a series of spike trains rather than instantaneous firing rate, allowing the prediction of spike train responses to novel stimuli. We fit the model by maximum penalized likelihood to the spiking activity of zebra finch auditory midbrain neurons in response to conspecific vocalizations (songs) and modulation limited (ml) noise. We compare this model to normalized reverse correlation (NRC), the traditional method for STRF estimation, in terms of predictive power and the basic tuning properties of the estimated STRFs. We find that a GLM with a sparse prior predicts novel responses to both stimulus classes significantly better than NRC. Importantly, we find that STRFs from the two models derived from the same responses can differ substantially and that GLM STRFs are more consistent between stimulus classes than NRC STRFs. These results suggest that a GLM with a sparse prior provides a more accurate characterization of spectrotemporal tuning than does the NRC method when responses to complex sounds are studied in these neurons.	[Calabrese, Ana; Schumacher, Joseph W.; Schneider, David M.; Paninski, Liam; Woolley, Sarah M. N.] Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA; [Calabrese, Ana; Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY USA; [Woolley, Sarah M. N.] Columbia Univ, Dept Psychol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Calabrese, A (corresponding author), Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA.	sw2277@columbia.edu			Gatsby Initiative in Brain Circuitry, National Institutes of Health [HD007430-11]; National Institutes of Health, National Research Service Award (NRSA) [DC010301-01A110]; National Institutes of Health [R01 DC009810]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009810, F31DC010301] Funding Source: NIH RePORTER	Gatsby Initiative in Brain Circuitry, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Gatsby Initiative in Brain Circuitry, National Institutes of Health training grant HD007430-11, National Institutes of Health, National Research Service Award (NRSA) grant DC010301-01A110, and National Institutes of Health R01 DC009810. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMADIAN Y, 2009, EFFICIENT MARKOV CHA; Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Ahrens MB, 2008, J NEUROSCI, V28, P1929, DOI 10.1523/JNEUROSCI.3377-07.2008; BRILLINGER DR, 1988, BIOL CYBERN, V59, P189, DOI 10.1007/BF00318010; CARVALHO CM, HORSESHOE ESTIMATOR; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Covey E, 1996, J NEUROSCI, V16, P3009; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1368, DOI 10.1073/pnas.89.4.1368; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; Dent ML, 2009, J COMP PSYCHOL, V123, P357, DOI 10.1037/a0016898; DONOHO DL, 1995, J ROY STAT SOC B MET, V57, P301; Eldawlatly S, 2009, NEURAL COMPUT, V21, P450, DOI 10.1162/neco.2008.09-07-606; Escabi MA, 2003, BIOL CYBERN, V89, P350, DOI 10.1007/S00422-003-0440-8; Friedman J., 2008, REGULARIZATION PATHS; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kouh M, 2009, NETWORK-COMP NEURAL, V20, P49, DOI 10.1080/09548980902950891; Lewi J, 2009, NEURAL COMPUT, V21, P619, DOI 10.1162/neco.2008.08-07-594; MACHENS C, 2003, NIPS, V15, P149; Mesgarani N, 2009, J NEUROPHYSIOL, V102, P3329, DOI 10.1152/jn.91128.2008; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; RAMIREZ A, 2010, J NEUROSCI; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; SAHANI M, 2003, NIPS, V15, P317; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Schmidt M., 2007, EUR C MACH LEARN ECM; SCHNEIDER DM, 2010, J NEUROPHYS IN PRESS; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2008, J NEUROPHYSIOL, V99, P2496, DOI 10.1152/jn.01397.2007; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smyth D, 2003, J NEUROSCI, V23, P4746; Snyder Donald Lee, 1991, RANDOM POINT PROCESS, DOI DOI 10.1007/978-1-4612-3166-0; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Woolley SMN, 2004, J NEUROPHYSIOL, V91, P136, DOI 10.1152/jn.00633.2003; Zevin JD, 2004, J NEUROSCI, V24, P5849, DOI 10.1523/JNEUROSCI.1891-04.2004; Zhang T, 2005, ANN STAT, V33, P1538, DOI 10.1214/009053605000000255; ZHAO M, 2010, NEURAL COMPUT, V22, P1; [No title captured]	52	70	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16104	10.1371/journal.pone.0016104	http://dx.doi.org/10.1371/journal.pone.0016104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264310	gold, Green Published, Green Submitted			2022-12-25	WOS:000286514000022
J	Zhang, B; Chen, BB; Wu, T; Tan, YL; Qiu, SA; Xuan, ZY; Zhu, XP; Chen, RS				Zhang, Bo; Chen, Beibei; Wu, Tao; Tan, Yuliang; Qiu, Shuang; Xuan, Zhenyu; Zhu, Xiaopeng; Chen, Runsheng			Estimating the Quality of Reprogrammed Cells Using ES Cell Differentiation Expression Patterns	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; DISEASE; MICE	Somatic cells can be reprogrammed to a pluripotent state by over-expression of defined factors, and pluripotency has been confirmed by the tetraploid complementation assay. However, especially in human cells, estimating the quality of Induced Pluripotent Stem Cell(iPSC) is still difficult. Here, we present a novel supervised method for the assessment of the quality of iPSCs by estimating the gene expression profile using a 2-D "Differentiation-index coordinate", which consists of two "developing lines" that reflects the directions of ES cell differentiation and the changes of cell states during differentiation. By applying a novel liner model to describe the differentiation trajectory, we transformed the ES cell differentiation time-course expression profiles to linear "developing lines"; and use these lines to construct the 2-D "Differentiation-index coordinate" of mouse and human. We compared the published gene expression profiles of iPSCs, ESCs and fibroblasts in mouse and human "Differentiation-index coordinate". Moreover, we defined the Distance index to indicate the qualities of iPS cells, which based on the projection distance of iPSCs-ESCs and iPSCs-fibroblasts. The results indicated that the "Differentiation-index coordinate" can distinguish differentiation states of the different cells types. Furthermore, by applying this method to the analysis of expression profiles in the tetraploid complementation assay, we showed that the Distance index which reflected spatial distributions correlated the pluripotency of iPSCs. We also analyzed the significantly changed gene sets of "developing lines". The results suggest that the method presented here is not only suitable for the estimation of the quality of iPS cells based on expression profiles, but also is a new approach to analyze time-resolved experimental data.	[Zhang, Bo; Chen, Beibei; Wu, Tao; Tan, Yuliang; Qiu, Shuang; Zhu, Xiaopeng; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhang, Bo; Chen, Beibei; Tan, Yuliang; Qiu, Shuang] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China; [Xuan, Zhenyu] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75083 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Texas System; University of Texas Dallas	Zhang, B (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	nimezhu@gmail.com; crs@sun5.ibp.ac.cn	Chen, Runsheng/S-9834-2017; xiaopeng, zhu/A-6755-2011; Wu, Tao/A-1063-2013; zb, aber/A-6874-2011	Chen, Runsheng/0000-0001-6049-8347; xiaopeng, zhu/0000-0003-2007-9820; Wu, Tao/0000-0002-9859-4534; zb, aber/0000-0003-2962-5314; Xuan, Zhenyu/0000-0001-9344-8493	National Program on Key Basic Research Project (973 Program) [2009CB825401]; National Natural Science Foundation of China [60933009]; Chinese Academy of Sciences [KSCX2-YW-R-124]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Program on Key Basic Research Project (973 Program Grant 2009CB825401), the National Natural Science Foundation of China (60933009), and the Innovation Projects (KSCX2-YW-R-124) from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r240; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Nord AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000617; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pewsey E, 2009, MOL CELL PROTEOMICS, V8, P1401, DOI 10.1074/mcp.M800478-MCP200; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Treff NR, 2006, STEM CELLS, V24, P2529, DOI 10.1634/stemcells.2006-0082; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weng J, 2009, J VIROL, V83, P7467, DOI 10.1128/JVI.00163-09; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15336	10.1371/journal.pone.0015336	http://dx.doi.org/10.1371/journal.pone.0015336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21283513	gold, Green Published, Green Submitted			2022-12-25	WOS:000286514000004
J	McLean, MH; Murray, GI; Stewart, KN; Norrie, G; Mayer, C; Hold, GL; Thomson, J; Fyfe, N; Hope, M; Mowat, NAG; Drew, JE; El-Omar, EM				McLean, Mairi H.; Murray, Graeme I.; Stewart, Keith N.; Norrie, Gillian; Mayer, Claus; Hold, Georgina L.; Thomson, John; Fyfe, Nicky; Hope, Mairi; Mowat, N. Ashley G.; Drew, Janice E.; El-Omar, Emad M.			The Inflammatory Microenvironment in Colorectal Neoplasia	PLOS ONE			English	Article							MICE LACKING EXPRESSION; CC-CHEMOKINE CCL23; NEUTROPHIL ELASTASE; GENE-EXPRESSION; PROMOTES ANGIOGENESIS; RANDOMIZED-TRIAL; CARCINOMA-CELLS; NITRIC-OXIDE; BONE-MARROW; CANCER	Colorectal cancer (CRC) is a major cause of mortality and morbidity worldwide. Inflammatory activity within the stroma of invasive colorectal tumours is known to be a key predictor of disease activity with type, density and location of immune cells impacting on patient prognosis. To date, there has been no report of inflammatory phenotype within pre-malignant human colonic adenomas. Assessing the stromal microenvironment and particularly, inflammatory activity within colorectal neoplastic lesions is central to understanding early colorectal carcinogenesis. Inflammatory cell infiltrate was assessed by immunohistochemistry in paired colonic adenoma and adjacent normal colonic mucosa samples, and adenomas exhibiting increasing degrees of epithelial cell dysplasia. Macrophage phenotype was assessed using double stain immunohistochemistry incorporating expression of an intracellular enzyme of function. A targeted array of inflammatory cytokine and receptor genes, validated by RT-PCR, was used to assess inflammatory gene expression. Inflammatory cell infiltrates are a key feature of sporadic adenomatous colonic polyps with increased macrophage, neutrophil and T cell (specifically helper and activated subsets) infiltration in adenomatous colonic polyps, that increases in association with characteristics of high malignant potential, namely, increasing degree of cell dysplasia and adenoma size. Macrophages within adenomas express iNOS, suggestive of a pro-inflammatory phenotype. Several inflammatory cytokine genes (CXCL1, CXCL2, CXCL3, CCL20, IL8, CCL23, CCL19, CCL21, CCL5) are dysregulated in adenomas. This study has provided evidence of increased inflammation within pre-malignant colonic adenomas. This may allow potential mechanistic pathways in the initiation and promotion of early colorectal carcinogenesis to be identified.	[McLean, Mairi H.; Hold, Georgina L.; Thomson, John; Hope, Mairi; Mowat, N. Ashley G.; El-Omar, Emad M.] Univ Aberdeen, Sch Med & Dent, Gastrointestinal Res Grp, Aberdeen, Scotland; [Murray, Graeme I.; Stewart, Keith N.; Fyfe, Nicky] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland; [Norrie, Gillian] Western Gen Hosp, Colorectal Surg Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Mayer, Claus; Drew, Janice E.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Edinburgh; University of Aberdeen	McLean, MH (corresponding author), Univ Aberdeen, Sch Med & Dent, Gastrointestinal Res Grp, Aberdeen, Scotland.	e.el-omar@abdn.ac.uk	El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020; Mayer, Claus-Dieter/L-9353-2013	Hold, Georgina Louise/0000-0001-7573-3397; El-Omar, Emad/0000-0002-0011-3924; McLean, Mairi/0000-0002-7443-2653; Mayer, Claus-Dieter/0000-0001-8788-3149	Friends of Anchor, North of Scotland; (UK) cancer charity [SC025332]; Scottish Government Rural and Environment Research & Analysis Directorate (SGRERAD); Rowett Research Institute, Aberdeen, UK	Friends of Anchor, North of Scotland; (UK) cancer charity; Scottish Government Rural and Environment Research & Analysis Directorate (SGRERAD); Rowett Research Institute, Aberdeen, UK	The funders for this study were (1) a personal clinical fellowship for Dr Mairi McLean from Friends of Anchor, a registered North of Scotland, (UK) cancer charity (registered charity number SC025332), www.friendsofanchor.org, and (2) Scottish Government Rural and Environment Research & Analysis Directorate (SGRERAD) who provided core funding for Dr Janice Drew for work carried out within the Rowett Research Institute, Aberdeen, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier PK, 2005, ANTICANCER RES, V25, P3581; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Cancer Research UK, CANC STAT; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Daemen Anneleen, 2008, Pac Symp Biocomput, P166; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forssmann U, 1997, FEBS LETT, V408, P211, DOI 10.1016/S0014-5793(97)00408-0; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; GRISHAM MB, 1992, GASTROENTEROLOGY, V103, P1260, DOI 10.1016/0016-5085(92)91513-4; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hwang J, 2005, CYTOKINE, V30, P254, DOI 10.1016/j.cyto.2005.01.018; Ichikawa Y, 2002, BIOCHEM BIOPH RES CO, V296, P497, DOI 10.1016/S0006-291X(02)00732-5; Inada M, 1997, RES COMMUN MOL PATH, V97, P229; Ishiko T, 2003, INT CONGR SER, V1255, P327, DOI 10.1016/S0531-5131(03)00825-2; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jeffery N, 2009, HISTOPATHOLOGY, V54, P820, DOI 10.1111/j.1365-2559.2009.03301.x; Kamohara H, 1997, RES COMMUN MOL PATH, V98, P103; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Kitadai Y, 1999, BRIT J CANCER, V81, P647, DOI 10.1038/sj.bjc.6690742; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Macdonald TT, 2003, PARASITE IMMUNOL, V25, P235, DOI 10.1046/j.1365-3024.2003.00632.x; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McLean MH, 2008, HISTOPATHOLOGY, V52, P806, DOI 10.1111/j.1365-2559.2008.03038.x; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Munder M, 1999, J IMMUNOL, V163, P3771; Notterman DA, 2001, CANCER RES, V61, P3124; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Shih CH, 2005, EXP HEMATOL, V33, P1101, DOI 10.1016/j.exphem.2005.06.028; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Son KN, 2006, BIOCHEM BIOPH RES CO, V340, P498, DOI 10.1016/j.bbrc.2005.12.037; Starcher B, 1996, J INVEST DERMATOL, V107, P159, DOI 10.1111/1523-1747.ep12329559; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Sutton A, 2007, MOL CANCER THER, V6, P2948, DOI 10.1158/1535-7163.MCT-07-0114; Tang ZQ, 2007, CANCER RES, V67, P9996, DOI 10.1158/0008-5472.CAN-07-1601; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; VERMEER IT, 2004, NEUTROPHIL MEDIATED; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wen Y, 2006, CLIN CANCER RES, V12, P5951, DOI 10.1158/1078-0432.CCR-06-0736; Wittig BM, 2003, INT J COLORECTAL DIS, V18, P181, DOI 10.1007/s00384-002-0444-1	52	121	125	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15366	10.1371/journal.pone.0015366	http://dx.doi.org/10.1371/journal.pone.0015366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249124	Green Published, gold, Green Submitted			2022-12-25	WOS:000286512900007
J	van Zuylen, WJ; Garceau, V; Idris, A; Schroder, K; Irvine, KM; Lattin, JE; Ovchinnikov, DA; Perkins, AC; Cook, AD; Hamilton, JA; Hertzog, PJ; Stacey, KJ; Kellie, S; Hume, DA; Sweet, MJ				van Zuylen, Wendy J.; Garceau, Valerie; Idris, Adi; Schroder, Kate; Irvine, Katharine M.; Lattin, Jane E.; Ovchinnikov, Dmitry A.; Perkins, Andrew C.; Cook, Andrew D.; Hamilton, John A.; Hertzog, Paul J.; Stacey, Katryn J.; Kellie, Stuart; Hume, David A.; Sweet, Matthew J.			Macrophage Activation and Differentiation Signals Regulate Schlafen-4 Gene Expression: Evidence for Schlafen-4 as a Modulator of Myelopoiesis	PLOS ONE			English	Article							MONONUCLEAR PHAGOCYTE SYSTEM; COLLAGEN-INDUCED ARTHRITIS; VIRAL-INFECTION; TRANSGENIC MICE; IN-VITRO; CELLS; GROWTH; CSF-1; RECEPTOR; PROTEIN	Background: The ten mouse and six human members of the Schlafen (Slfn) gene family all contain an AAA domain. Little is known of their function, but previous studies suggest roles in immune cell development. In this report, we assessed Slfn regulation and function in macrophages, which are key cellular regulators of innate immunity. Methodology/Principal Findings: Multiple members of the Slfn family were up-regulated in mouse bone marrow-derived macrophages (BMM) by the Toll-like Receptor (TLR) 4 agonist lipopolysaccharide (LPS), the TLR3 agonist Poly(I:C), and in disease-affected joints in the collagen-induced model of rheumatoid arthritis. Of these, the most inducible was Slfn4. TLR agonists that signal exclusively through the MyD88 adaptor protein had more modest effects on Slfn4 mRNA levels, thus implicating MyD88-independent signalling and autocrine interferon (IFN)-beta in inducible expression. This was supported by the substantial reduction in basal and LPS-induced Slfn4 mRNA expression in IFNAR-1(-/-) BMM. LPS causes growth arrest in macrophages, and other Slfn family genes have been implicated in growth control. Slfn4 mRNA levels were repressed during macrophage colony-stimulating factor (CSF-1)-mediated differentiation of bone marrow progenitors into BMM. To determine the role of Slfn4 in vivo, we over-expressed the gene specifically in macrophages in mice using a csf1r promoter-driven binary expression system. Transgenic over-expression of Slfn4 in myeloid cells did not alter macrophage colony formation or proliferation in vitro. Monocyte numbers, as well as inflammatory macrophages recruited to the peritoneal cavity, were reduced in transgenic mice that specifically over-expressed Slfn4, while macrophage numbers and hematopoietic activity were increased in the livers and spleens. Conclusions: Slfn4 mRNA levels were up-regulated during macrophage activation but down-regulated during differentiation. Constitutive Slfn4 expression in the myeloid lineage in vivo perturbs myelopoiesis. We hypothesise that the down-regulation of Slfn4 gene expression during macrophage differentiation is a necessary step in development of this lineage.	[van Zuylen, Wendy J.; Idris, Adi; Schroder, Kate; Irvine, Katharine M.; Lattin, Jane E.; Ovchinnikov, Dmitry A.; Perkins, Andrew C.; Stacey, Katryn J.; Kellie, Stuart; Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Garceau, Valerie; Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Garceau, Valerie; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Cook, Andrew D.; Hamilton, John A.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Stacey, Katryn J.; Kellie, Stuart] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Stacey, Katryn J.; Kellie, Stuart; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Royal Melbourne Hospital; University of Melbourne; Monash University; University of Queensland; University of Queensland	van Zuylen, WJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	david.hume@roslin.ed.ac.uk; m.sweet@imb.uq.edu.au	Idris, Adi/N-3500-2016; Perkins, Andrew C/M-3216-2014; Perkins, Andrew/X-4180-2019; Kellie, Stuart/A-6036-2010; Hertzog, Paul J/G-6734-2013; Sweet, Matthew J/F-2229-2011; Hume, David A/C-7695-2013; Hertzog, Paul J/I-7053-2013; Irvine, Katharine M/A-5559-2011; Perkins, Andrew/AAJ-9696-2020; Schroder, Kate/C-6132-2008; Ovchinnikov, Dmitry/J-7963-2014	Idris, Adi/0000-0002-0562-1549; Perkins, Andrew C/0000-0003-3644-7093; Perkins, Andrew/0000-0003-3644-7093; Hertzog, Paul J/0000-0002-1373-8472; Sweet, Matthew J/0000-0002-0406-8139; Hertzog, Paul J/0000-0002-1373-8472; Irvine, Katharine M/0000-0002-6716-1605; Schroder, Kate/0000-0001-9261-3805; Ovchinnikov, Dmitry/0000-0001-9603-8385; Hamilton, John A/0000-0002-9493-9224; Hume, David/0000-0002-2615-1478; Stacey, Katryn/0000-0002-3992-7802; Kellie, Stuart/0000-0002-8163-1474; Cook, Andrew/0000-0002-7314-924X	Cooperative Research Centre for Chronic Inflammatory Diseases	Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by funding from the Cooperative Research Centre for Chronic Inflammatory Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; BARTELMEZ SH, 1985, J CELL PHYSIOL, V122, P362, DOI 10.1002/jcp.1041220305; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; BREEN FN, 1990, BRIT J HAEMATOL, V74, P138, DOI 10.1111/j.1365-2141.1990.tb02556.x; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Campbell IK, 1997, ANN RHEUM DIS, V56, P364, DOI 10.1136/ard.56.6.364; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Caron J, 2006, INFECT IMMUN, V74, P2787, DOI 10.1128/IAI.74.5.2787-2802.2006; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Engler A, 2005, J NEUROIMMUNOL, V162, P103, DOI 10.1016/j.jneuroim.2005.01.017; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Gubser C, 2007, J GEN VIROL, V88, P1667, DOI 10.1099/vir.0.82748-0; Hamilton JA, 1996, J IMMUNOL, V156, P2553; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; HUME DA, 2010, GENOMICS; Irvine KM, 2006, FASEB J, V20, P1921, DOI 10.1096/fj.06-5848fje; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Ovchinnikov DA, 2010, J LEUKOCYTE BIOL, V87, P815, DOI 10.1189/jlb.0809557; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; ROBERTS TL, 2009, SCIENCE; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Schurr JR, 2005, INFECT IMMUN, V73, P532, DOI 10.1128/IAI.73.1.532-545.2005; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sweet MJ, 1998, J INFLAMM, V48, P67; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784	43	51	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15723	10.1371/journal.pone.0015723	http://dx.doi.org/10.1371/journal.pone.0015723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249125	Green Published, gold			2022-12-25	WOS:000286512900009
J	Fousteri, G; Dave, A; Juedes, A; Juntti, T; Morin, B; Togher, L; Farber, DL; von Herrath, M				Fousteri, Georgia; Dave, Amy; Juedes, Amy; Juntti, Therese; Morin, Bret; Togher, Lisa; Farber, Donna L.; von Herrath, Matthias			Increased Memory Conversion of Naive CD8 T Cells Activated during Late Phases of Acute Virus Infection Due to Decreased Cumulative Antigen Exposure	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VIRAL-INFECTION; PROTECTIVE IMMUNITY; DISTINCT ROLES; CUTTING EDGE; EFFECTOR; DIFFERENTIATION; SURVIVAL; PROLIFERATION; EXPRESSION	Background: Memory CD8 T cells form an essential part of protective immunity against viral infections. Antigenic load, costimulation, CD4-help, cytokines and chemokines fluctuate during the course of an antiviral immune response thus affecting CD8 T cell activation and memory conversion. Methodology/Principal Findings: In the present study, naive TCR transgenic LCMV-specific P14 CD8 T cells engaged at a late stage during the acute antiviral LCMV response showed reduced expansion kinetics but greater memory conversion in the spleen. Such late activated cells displayed a memory precursor effector phenotype already at the peak of the systemic antiviral response, suggesting that the environment determined their fate during antigen encounter. In the spleen, the majority of late transferred cells exhibited a central memory phenotype compared to the effector memory displayed by the early transferred cells. Increasing the inflammatory response by exogenous administration of IFN gamma, PolyI:C or CpG did not affect memory conversion in the late transferred group, suggesting that the diverging antigen load early versus later during acute infection had determined their fate. In agreement, reduction in the LCMV antigenic load after ribavirin treatment enhanced the contribution of early transferred cells to the long lasting memory pool. Conclusions/Significance: Our results show that naive CD8 cells, exposed to reduced duration or concentration of antigen during viral infection convert into memory more efficiently, an observation that could have significant implications for vaccine design.	[Fousteri, Georgia; Dave, Amy; Juedes, Amy; Juntti, Therese; Morin, Bret; Togher, Lisa; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY USA	La Jolla Institute for Immunology; Columbia University	Fousteri, G (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA USA.	matthias@liai.org	Fousteri, Georgia/B-1226-2012	Fousteri, Georgia/0000-0001-7745-7517; Farber, Donna/0000-0001-8236-9183; Jhatakia, Amy/0000-0001-6855-5342	Brehm coalition; National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) [AI68818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068818] Funding Source: NIH RePORTER	Brehm coalition; National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the Brehm coalition and National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) grant # AI68818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 2004, J IMMUNOL, V173, P2217, DOI 10.4049/jimmunol.173.4.2217; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; CERNY A, 1988, J VIROL, V62, P1803, DOI 10.1128/JVI.62.5.1803-1807.1988; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Juedes AE, 2004, J EXP MED, V199, P1153, DOI 10.1084/jem.20031873; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lefrancois L, 2006, NAT REV IMMUNOL, V6, P618, DOI 10.1038/nri1866; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Murakami M, 2002, P NATL ACAD SCI USA, V99, P8832, DOI 10.1073/pnas.132254399; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Seiler P, 2000, J VIROL, V74, P5896, DOI 10.1128/JVI.74.13.5896-5901.2000; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Takamura S, 2010, J EXP MED, V207, P1153, DOI 10.1084/jem.20090283; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wakim LM, 2010, CURR OPIN IMMUNOL, V22, P274, DOI 10.1016/j.coi.2010.03.003; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14502	10.1371/journal.pone.0014502	http://dx.doi.org/10.1371/journal.pone.0014502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253594	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900005
J	Kofler, R; Orozco-terWengel, P; De Maio, N; Pandey, RV; Nolte, V; Futschik, A; Kosiol, C; Schlotterer, C				Kofler, Robert; Orozco-terWengel, Pablo; De Maio, Nicola; Pandey, Ram Vinay; Nolte, Viola; Futschik, Andreas; Kosiol, Carolin; Schloetterer, Christian			PoPoolation: A Toolbox for Population Genetic Analysis of Next Generation Sequencing Data from Pooled Individuals	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; RECOMBINATION RATES; DNA POLYMORPHISM; EVOLUTION; ALIGNMENT; MUTATION; SAMPLES; SEQ	Recent statistical analyses suggest that sequencing of pooled samples provides a cost effective approach to determine genome-wide population genetic parameters. Here we introduce PoPoolation, a toolbox specifically designed for the population genetic analysis of sequence data from pooled individuals. PoPoolation calculates estimates of theta(Watterson), theta(p), and Tajima's D that account for the bias introduced by pooling and sequencing errors, as well as divergence between species. Results of genome-wide analyses can be graphically displayed in a sliding window plot. PoPoolation is written in Perl and R and it builds on commonly used data formats. Its source code can be downloaded from http://code.google.com/p/popoolation/. Furthermore, we evaluate the influence of mapping algorithms, sequencing errors, and read coverage on the accuracy of population genetic parameter estimates from pooled data.	[Kofler, Robert; Orozco-terWengel, Pablo; De Maio, Nicola; Pandey, Ram Vinay; Nolte, Viola; Kosiol, Carolin; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria; [Futschik, Andreas] Univ Vienna, Dept Stat, Vienna, Austria	University of Veterinary Medicine Vienna; University of Vienna	Kofler, R (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Schlötterer, Christian/G-6326-2010; Pandey, Ram Vinay/AAA-3544-2022; Schlötterer, Christian/Q-5264-2019; Orozco-terWengel, Pablo Andres/D-1527-2011; Futschik, Andreas/G-3697-2010; Pandey, Ram Vinay/AAL-1701-2021	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526; Orozco-terWengel, Pablo Andres/0000-0002-7951-4148; Futschik, Andreas/0000-0002-7980-0304; Pandey, Ram Vinay/0000-0002-2533-8687; De Maio, Nicola/0000-0002-1776-8564; Kofler, Robert/0000-0001-9960-7248	Austrian Science Funds (FWF) [P19467-B11]; Austrian Science Fund (FWF) [P 19467] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been supported by grants of the Austrian Science Funds (FWF) to Christian Schlotterer (P19467-B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; FUTSCHIK A, 2010, GENETICS IN PRESS; Haubold B, 2010, MOL ECOL, V19, P277, DOI 10.1111/j.1365-294X.2009.04482.x; HU Y, 2010, BIOINFORMATICS; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; TAJIMA F, 1989, GENETICS, V123, P585; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TURNER TL, 2010, NAT GENET; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	350	353	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15925	10.1371/journal.pone.0015925	http://dx.doi.org/10.1371/journal.pone.0015925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253599	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900025
J	Xu, B; Hua, JA; Zhang, YW; Jiang, XH; Zhang, HA; Ma, TL; Zheng, W; Sun, R; Shen, W; Sha, JH; Cooke, HJ; Shi, QH				Xu, Bo; Hua, Juan; Zhang, Yuanwei; Jiang, Xiaohua; Zhang, Huan; Ma, Tieliang; Zheng, Wei; Sun, Rui; Shen, Wei; Sha, Jiahao; Cooke, Howard J.; Shi, Qinghua			Proliferating Cell Nuclear Antigen (PCNA) Regulates Primordial Follicle Assembly by Promoting Apoptosis of Oocytes in Fetal and Neonatal Mouse Ovaries	PLOS ONE			English	Article							GERM-CELL; IN-VITRO; GENE-EXPRESSION; RAT OVARY; GROWTH; MICE; INITIATION; DIFFERENTIATION; SURVIVAL; BCL-2	Primordial follicles, providing all the oocytes available to a female throughout her reproductive life, assemble in perinatal ovaries with individual oocytes surrounded by granulosa cells. In mammals including the mouse, most oocytes die by apoptosis during primordial follicle assembly, but factors that regulate oocyte death remain largely unknown. Proliferating cell nuclear antigen (PCNA), a key regulator in many essential cellular processes, was shown to be differentially expressed during these processes in mouse ovaries using 2D-PAGE and MALDI-TOF/TOF methodology. A V-shaped expression pattern of PCNA in both oocytes and somatic cells was observed during the development of fetal and neonatal mouse ovaries, decreasing from 13.5 to 18.5 dpc and increasing from 18.5 dpc to 5 dpp. This was closely correlated with the meiotic prophase I progression from pre-leptotene to pachytene and from pachytene to diplotene when primordial follicles started to assemble. Inhibition of the increase of PCNA expression by RNA interference in cultured 18.5 dpc mouse ovaries strikingly reduced the apoptosis of oocytes, accompanied by down-regulation of known pro-apoptotic genes, e. g. Bax, caspase-3, and TNF alpha and TNFR2, and up-regulation of Bcl-2, a known anti-apoptotic gene. Moreover, reduced expression of PCNA was observed to significantly increase primordial follicle assembly, but these primordial follicles contained fewer guanulosa cells. Similar results were obtained after down-regulation by RNA interference of Ing1b, a PCNA-binding protein in the UV-induced apoptosis regulation. Thus, our results demonstrate that PCNA regulates primordial follicle assembly by promoting apoptosis of oocytes in fetal and neonatal mouse ovaries.	[Xu, Bo; Hua, Juan; Zhang, Yuanwei; Jiang, Xiaohua; Zhang, Huan; Ma, Tieliang; Zheng, Wei; Sun, Rui; Shi, Qinghua] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shen, Wei] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, Lab Reprod Med, Nanjing, Peoples R China; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Cooke, Howard J.] Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Guelph; Nanjing Medical University; University of Edinburgh; University of Edinburgh	Xu, B (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	qshi@ustc.edu.cn	Zhang, Yuanwei/C-7695-2016; Shi, Qinghua/N-2950-2013	Zhang, Yuanwei/0000-0002-2814-8061; 	National Basic Research Program of China (973) [2006CB504003, 2007CB947401]; Chinese Academy of Sciences [KSCX1-YW-R-51, KSCX2-EW-R-07]	National Basic Research Program of China (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program (2006CB504003, 2007CB947401) of China (973), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-51, KSCX2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla M, 2008, TISSUE CELL, V40, P373, DOI 10.1016/j.tice.2008.03.006; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; BORUM K, 1967, EXP CELL RES, V45, P39, DOI 10.1016/0014-4827(67)90110-3; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; De Felici M, 2004, HUM REPROD UPDATE, V10, P197, DOI 10.1093/humupd/dmh020; De Felici M, 1999, CELL DEATH DIFFER, V6, P908, DOI 10.1038/sj.cdd.4400561; De Felici M, 2008, AUTOPHAGY, V4, P240, DOI 10.4161/auto.5410; De Pol A, 1997, HUM REPROD, V12, P2235, DOI 10.1093/humrep/12.10.2235; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; Dissen GA, 2001, ENDOCRINOLOGY, V142, P2078, DOI 10.1210/en.142.5.2078; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Flaws JA, 2001, BIOL REPROD, V64, P1153, DOI 10.1095/biolreprod64.4.1153; Flaws JA, 2006, TOXICOL APPL PHARM, V215, P51, DOI 10.1016/j.taap.2006.03.003; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; GAPIENKO E F, 1976, Arkhiv Anatomii Gistologii i Embriologii, V70, P30; Garcia-Rudaz C, 2007, DEVELOPMENT, V134, P945, DOI 10.1242/dev.02795; Greenfeld CR, 2007, REPRODUCTION, V133, P865, DOI 10.1530/REP-06-0270; Greenfeld CR, 2007, BIOL REPROD, V76, P224, DOI 10.1095/biolreprod.106.055509; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hutt KJ, 2006, CELL TISSUE RES, V326, P809, DOI 10.1007/s00441-006-0223-3; Kamat A, 1999, P NATL ACAD SCI USA, V96, P4575, DOI 10.1073/pnas.96.8.4575; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Kezele P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1990, DOI 10.2741/kezele; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Korfsmeier KH, 2002, ACTA HISTOCHEM, V104, P73, DOI 10.1078/0065-1281-00632; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Lobascio AM, 2007, REPRODUCTION, V134, P241, DOI 10.1530/REP-07-0141; Marcinkiewicz JL, 2002, FRONT BIOSCI-LANDMRK, V7, pD1997, DOI 10.2741/marcin; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Muskhelishvili L, 2005, TOXICOL PATHOL, V33, P365, DOI 10.1080/01926230590930164; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Picut CA, 2008, TOXICOL PATHOL, V36, P674, DOI 10.1177/0192623308317428; Pinon-Lataillade G, 2004, J CELL SCI, V117, P3691, DOI 10.1242/jcs.01226; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scott M, 2001, J CELL SCI, V114, P3455; Shen W, 2007, REPRODUCTION, V134, P223, DOI 10.1530/REP-06-0378; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tomanek M, 2006, FOLIA HISTOCHEM CYTO, V44, P269; Vairapandi M, 2000, J BIOL CHEM, V275, P16810, DOI 10.1074/jbc.275.22.16810; Wandji SA, 1996, BIOL REPROD, V55, P942, DOI 10.1095/biolreprod55.5.942; Wandji SA, 1997, HUM REPROD, V12, P1993, DOI 10.1093/humrep/12.9.1993; Wang C, 2006, ENDOCRINOLOGY, V147, P1725, DOI 10.1210/en.2005-1208; WANG C, 2010, ENDOCRINOLOGY; Wang NL, 2009, PROTEOMICS, V9, P3425, DOI 10.1002/pmic.200800822; Wen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007372; Zhang ZP, 2010, DNA CELL BIOL, V29, P163, DOI 10.1089/dna.2009.0958	76	87	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16046	10.1371/journal.pone.0016046	http://dx.doi.org/10.1371/journal.pone.0016046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253613	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900038
J	Zhou, LA; Chen, JH; Li, ZZ; Li, XX; Hu, XD; Huang, Y; Zhao, XK; Liang, CZ; Wang, Y; Sun, LA; Shi, M; Xu, XH; Shen, F; Chen, MS; Han, ZJ; Peng, ZY; Zhai, QN; Chen, J; Zhang, ZF; Yang, RL; Ye, JX; Guan, ZC; Yang, HM; Gui, YT; Wang, J; Cai, ZM; Zhang, XQ				Zhou, Liang; Chen, Jiahao; Li, Zhizhong; Li, Xianxin; Hu, Xueda; Huang, Yi; Zhao, Xiaokun; Liang, Chaozhao; Wang, Yong; Sun, Liang; Shi, Min; Xu, Xiaohong; Shen, Feng; Chen, Maoshan; Han, Zujing; Peng, Zhiyu; Zhai, Qingna; Chen, Jing; Zhang, Zhongfu; Yang, Ruilin; Ye, Jiongxian; Guan, Zhichen; Yang, Huanming; Gui, Yaoting; Wang, Jun; Cai, Zhiming; Zhang, Xiuqing			Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; REPRESSORS ZEB1; CANCER; HYPOXIA; PHENOTYPE; SIGNATURE; PROGNOSIS; TUMORS; CLASSIFICATION; CYTOSCAPE	Background: With the advent of second-generation sequencing, the expression of gene transcripts can be digitally measured with high accuracy. The purpose of this study was to systematically profile the expression of both mRNA and miRNA genes in clear cell renal cell carcinoma (ccRCC) using massively parallel sequencing technology. Methodology: The expression of mRNAs and miRNAs were analyzed in tumor tissues and matched normal adjacent tissues obtained from 10 ccRCC patients without distant metastases. In a prevalence screen, some of the most interesting results were validated in a large cohort of ccRCC patients. Principal Findings: A total of 404 miRNAs and 9,799 mRNAs were detected to be differentially expressed in the 10 ccRCC patients. We also identified 56 novel miRNA candidates in at least two samples. In addition to confirming that canonical cancer genes and miRNAs (including VEGFA, DUSP9 and ERBB4; miR-210, miR-184 and miR-206) play pivotal roles in ccRCC development, promising novel candidates (such as PNCK and miR-122) without previous annotation in ccRCC carcinogenesis were also discovered in this study. Pathways controlling cell fates (e. g., cell cycle and apoptosis pathways) and cell communication (e. g., focal adhesion and ECM-receptor interaction) were found to be significantly more likely to be disrupted in ccRCC. Additionally, the results of the prevalence screen revealed that the expression of a miRNA gene cluster located on Xq27.3 was consistently downregulated in at least 76.7% of similar to 50 ccRCC patients. Conclusions: Our study provided a two-dimensional map of the mRNA and miRNA expression profiles of ccRCC using deep sequencing technology. Our results indicate that the phenotypic status of ccRCC is characterized by a loss of normal renal function, downregulation of metabolic genes, and upregulation of many signal transduction genes in key pathways. Furthermore, it can be concluded that downregulation of miRNA genes clustered on Xq27.3 is associated with ccRCC.	[Zhou, Liang; Li, Xianxin; Huang, Yi; Wang, Yong; Sun, Liang; Shi, Min; Zhai, Qingna; Chen, Jing; Zhang, Zhongfu; Yang, Ruilin; Ye, Jiongxian; Guan, Zhichen; Gui, Yaoting; Cai, Zhiming] Peking Univ, Key Lab Stem Cell Biol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen Hosp,Shenzhen PKU HKUST Med Ct, Shenzhen, Peoples R China; [Chen, Jiahao; Li, Zhizhong; Hu, Xueda; Xu, Xiaohong; Shen, Feng; Chen, Maoshan; Han, Zujing; Peng, Zhiyu; Yang, Huanming; Wang, Jun; Zhang, Xiuqing] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Chen, Jiahao; Li, Zhizhong] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Hu, Xueda] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhao, Xiaokun] Cent So Univ, Dept Urosurg, Hosp 2, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Dept Urosurg, Hosp 1, Hefei, Peoples R China; [Yang, Ruilin] Shantou Univ, Coll Med, Shantou, Peoples R China	Hong Kong University of Science & Technology; Peking University; Beijing Genomics Institute (BGI); South China University of Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central South University; Anhui Medical University; Shantou University	Zhou, LA (corresponding author), Peking Univ, Key Lab Stem Cell Biol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen Hosp,Shenzhen PKU HKUST Med Ct, Shenzhen, Peoples R China.	caizhiming2000@yahoo.com.cn; zhangxq@genomics.org.cn	gui, yaoting/GLT-3684-2022; Peng, Zhiyu/GXV-5301-2022; Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Chen, Jiahao/0000-0001-7719-3216; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; CHEN, MAOSHAN/0000-0002-3827-4969	Ministry of Science and Technology of China [2006AA02A302, 2009AA022707]; National Natural Science Foundation of China [30725008, 30811130531, 30900817, 30972992, 30971636]; Shenzhen Municipal Government of China [CXB200903110066A, JC200903190768A, ZD200806180054A]; Renovation Project of Shenzhen and Hong Kong [ZYB200907080110A]; Danish Natural Science Research Council [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government of China; Renovation Project of Shenzhen and Hong Kong; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Shenzhen Key Laboratory, Shenzhen, China	This work was supported by the Ministry of Science and Technology of China, 863 program [2006AA02A302; 2009AA022707]; the National Natural Science Foundation of China [30725008; 30811130531, 30900817, 30972992, 30971636]; the Shenzhen Municipal Government of China [CXB200903110066A; JC200903190768A; ZD200806180054A]; the Renovation Project of Shenzhen and Hong Kong [ZYB200907080110A]; the Danish Natural Science Research Council, the Solexa project [272-07-0196]; the Danish Strategic Research Council [2106-07-0021] and the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A to Z.M.-C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Deb TB, 2008, AM J PHYSIOL-CELL PH, V295, pC365, DOI 10.1152/ajpcell.00449.2007; Gardner HP, 2000, CANCER RES, V60, P5571; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosari F, 2005, CLIN CANCER RES, V11, P5128, DOI 10.1158/1078-0432.CCR-05-0073; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Mizuno N, 2007, DRUG METAB DISPOS, V35, P1429, DOI 10.1124/dmd.106.013912; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; SEIFERT G, 1990, PATHOL RES PRACT, V186, P555, DOI 10.1016/S0344-0338(11)80220-7; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTHERLAND GR, 1979, HUM GENET, V53, P23, DOI 10.1007/BF00289445; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Torres AM, 2008, WORLD J GASTROENTERO, V14, P6616, DOI 10.3748/wjg.14.6616; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Verkman A, 2000, EXPT NEPHROLOGY, V10, P235; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	68	391	415	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2010	5	12							e15224	10.1371/journal.pone.0015224	http://dx.doi.org/10.1371/journal.pone.0015224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701DD	21253009	Green Submitted, Green Published, gold			2022-12-25	WOS:000285793600014
J	Liu, QY; Chen, JW; Liu, L; Zhang, J; Wang, DF; Ma, L; He, YM; Liu, YL; Liu, ZS; Wu, JG				Liu, Quanyan; Chen, Jiwei; Liu, Li; Zhang, Jun; Wang, Dongfeng; Ma, Lu; He, Yueming; Liu, Yingle; Liu, Zhisu; Wu, Jianguo			The X Protein of Hepatitis B Virus Inhibits Apoptosis in Hepatoma Cells through Enhancing the Methionine Adenosyltransferase 2A Gene Expression and Reducing S-Adenosylmethionine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RAT HEPATOCYTES; MOLECULAR FUNCTIONS; GROWTH-FACTOR; MAT2A GENE; INDUCTION; PROLIFERATION; ACTIVATION; HYPOXIA; KINASE	The X protein (HBx) of hepatitis B virus (HBV) is involved in the development of hepatocellular carcinoma (HCC), and methionine adenosyltransferase 2A (MAT2A) promotes the growth of liver cancer cells through altering S-adenosylmethionine homeostasis. Thus, we speculated that a link between HBx and MAT2A may contribute to HCC development. In this study, the effects of HBx on MAT2A expression and cell apoptosis were investigated, and the molecular mechanism by which HBx and MAT2A regulate tumorigenesis was evaluated. Results from immunohistochemistry analyses of 37 pairs of HBV-associated liver cancer tissues/corresponding peritumor tissues showed that HBx and MAT2A are highly expressed in most liver tumor tissues. Our in vitro results revealed that HBx activates MAT2A expression in a dose-dependent manner in hepatoma cells, and such regulation requires the cis-regulatory elements NF-kappa B and CREB on the MAT2A gene promoter. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) further demonstrated that HBx facilitates the binding of NF-kappa B and CREB to MAT2A gene promoter. In addition, overexpression of HBx or MAT2A inhibits cell apoptosis, whereas knockdown of MAT2A expression stimulates apoptosis in hepatoma cells. Furthermore, we demonstrated that HBx reduces MAT1A expression and AdoMet production but enhances MAT2 beta expression. Thus, we proposed that HBx activates MAT2A expression through NF-kappa B and CREB signaling pathways to reduce AdoMet production, inhibit hepatoma cell apoptosis, and perhaps enhance HCC development. These findings should provide new insights into our understanding how the molecular mechanisms underline the effects of HBV infection on the production of MAT2A and the development of HCC.	[Liu, Quanyan; Chen, Jiwei; Liu, Li; Zhang, Jun; Wang, Dongfeng; He, Yueming; Liu, Zhisu] Wuhan Univ, Dept Gen Surg, Digest Dis Res Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Liu, Yingle; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Liu, Yingle; Wu, Jianguo] Wuhan Univ, Chinese French Liver Dis Res Inst, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Ma, Lu] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Hyg Stat, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Liu, ZS (corresponding author), Wuhan Univ, Dept Gen Surg, Digest Dis Res Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China.	spss2005@126.com; jwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895; Liu, Quanyan/0000-0002-5353-0377	National Mega Project on Major Infectious Diseases Prevention and Treatment [2008ZX10002-009, 2009ZX10004-207]; National Mega Project on Major Drug Development [2009ZX09301-014, 2011ZX09401-302]; Major State Basic Research Development Program of China [2005CB522901]; National Science Foundation of China [30730001, 30872491]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0745]; Chinese Ministry of Education [204114208]; Department of Science and Technology of Hubei Province [2005ABC003]; Fundamental Research Funds for the Central Universities [1102001]; Specialized Research Fund for the Doctoral Program of Higher Education [20090141110033]	National Mega Project on Major Infectious Diseases Prevention and Treatment; National Mega Project on Major Drug Development; Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education(Ministry of Education, China); Department of Science and Technology of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Mega Project on Major Infectious Diseases Prevention and Treatment Research Grants 2008ZX10002-009 and 2009ZX10004-207, National Mega Project on Major Drug Development Research Grants 2009ZX09301-014 and 2011ZX09401-302, Major State Basic Research Development Program of China Research Grant 2005CB522901, National Science Foundation of China Research Grants 30730001 and 30872491, Program for Changjiang Scholars and Innovative Research Team in University Research Grant IRT0745, Key Project of Chinese Ministry of Education Research Grant 204114208, Department of Science and Technology of Hubei Province Research Grant 2005ABC003, Fundamental Research Funds for the Central Universities Research Grant 1102001, and Specialized Research Fund for the Doctoral Program of Higher Education Research Grant 20090141110033.	Assrir N, 2010, FRONT BIOSCI-LANDMRK, V15, P12, DOI 10.2741/3602; Avila MA, 1998, GASTROENTEROLOGY, V114, P364, DOI 10.1016/S0016-5085(98)70489-5; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bouchard MJ, 2006, J VIROL, V80, P4406, DOI 10.1128/JVI.80.9.4406-4414.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai JX, 1996, HEPATOLOGY, V24, P1090; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chami M, 2003, J BIOL CHEM, V278, P31745, DOI 10.1074/jbc.M304202200; Chan DW, 2006, J PATHOL, V208, P372, DOI 10.1002/path.1901; Cheng ASL, 2007, CANCER LETT, V253, P43, DOI 10.1016/j.canlet.2007.01.004; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Clippinger AJ, 2009, J VIROL, V83, P4718, DOI 10.1128/JVI.02590-08; Corrales FJ, 2002, J NUTR, V132, p2377S, DOI 10.1093/jn/132.8.2377S; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; Latasa MU, 2001, FASEB J, V15, P1248, DOI 10.1096/fj.00-0556fjev1; Lee ATC, 2007, FRONT BIOSCI-LANDMRK, V12, P234, DOI 10.2741/2061; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Liu QY, 2007, HEPATOL RES, V37, P376, DOI 10.1111/j.1872-034X.2007.00041.x; Liu XH, 2008, BIOCHEM BIOPH RES CO, V373, P643, DOI 10.1016/j.bbrc.2008.06.087; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Martinez-Chantar ML, 2003, J BIOL CHEM, V278, P19885, DOI 10.1074/jbc.M211554200; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Paneda C, 2002, HEPATOLOGY, V35, P1381, DOI 10.1053/jhep.2002.32538; Park Neung Hwa, 2007, Korean J Hepatol, V13, P320; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Wang Q, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-72; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2007, J CELL PHYSIOL, V210, P766, DOI 10.1002/jcp.20891; Yang HP, 2003, J BIOL CHEM, V278, P50887, DOI 10.1074/jbc.M307600200; Yang HP, 2001, FASEB J, V15, P1507, DOI 10.1096/fj.01-0040com; Ye LH, 2008, INTERVIROLOGY, V51, P50, DOI 10.1159/000120289; Ye L, 2007, J HUAZHONG U SCI-MED, V27, P167, DOI 10.1007/s11596-007-0215-x; Zhang JL, 2005, ARCH VIROL, V150, P721, DOI 10.1007/s00705-004-0446-0; Zhang XD, 2006, J LAB CLIN MED, V147, P58, DOI 10.1016/j.lab.2005.10.003	45	48	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17168	17180		10.1074/jbc.M110.167783	http://dx.doi.org/10.1074/jbc.M110.167783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21247894	hybrid, Green Published			2022-12-25	WOS:000290301900066
J	Dhondt, J; Peeraer, E; Verheyen, A; Nuydens, R; Buysschaert, I; Poesen, K; Van Geyte, K; Beerens, M; Shibuya, M; Haigh, JJ; Meert, T; Carmeliet, P; Lambrechts, D				Dhondt, Joke; Peeraer, Eve; Verheyen, An; Nuydens, Rony; Buysschaert, Ian; Poesen, Koen; Van Geyte, Katie; Beerens, Manu; Shibuya, Masabumi; Haigh, Jody J.; Meert, Theo; Carmeliet, Peter; Lambrechts, Diether			Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons	FASEB JOURNAL			English	Article						neurovascular link; distal neuropathy	ENDOTHELIAL GROWTH-FACTOR; INDUCED PERIPHERAL NEUROPATHY; DIABETIC-NEUROPATHY; GENE-TRANSFER; ANGIOGENESIS; INJURY; NERVE; EXPRESSION; CANCER; CELLS	Even though VEGF-B is a homologue of the potent angiogenic factor VEGF, its angiogenic activities have been controversial. Intrigued by findings that VEGF-B may also affect neuronal cells, we assessed the neuroprotective and vasculoprotective effects of VEGF-B in the skin, in which vessels and nerves are functionally intertwined. Although VEGF-B and its FLT1 receptor were prominently expressed in dorsal root ganglion (DRG) neurons innervating the hindlimb skin, they were not essential for nerve function or vascularization of the skin. However, primary DRG cultures lacking VEGF-B or FLT1 exhibited increased neuronal stress and were more susceptible to paclitaxel-induced cell death. Concomitantly, mice lacking VEGF-B or a functional FLT1 developed more retrograde degeneration of sensory neurons in a model of distal neuropathy. On the other hand, the addition of the VEGF-B isoform, VEGF-B(186), to DRG cultures antagonized neuronal stress, maintained the mitochondrial membrane potential and stimulated neuronal survival. Mice overexpressing VEGF-B(186) or FLT1 selectively in neurons were protected against the distal neuropathy, whereas exogenous VEGF-B(186), either delivered by gene transfer or as a recombinant factor, was protective by directly affecting sensory neurons and not the surrounding vasculature. Overall, this indicates that VEGF-B, instead of acting as an angiogenic factor, exerts direct neuroprotective effects through FLT1. These findings also suggest a clinically relevant role for VEGF-B in preventing distal neuropathies.-Dhondt, J., Peeraer, E., Verheyen, A., Nuydens, R., Buysschaert, I., Poesen, K., Van Geyte, K., Beerens, M., Shibuya, M., Haigh, J. J., Meert, T., Carmeliet, P., Lambrechts, D. Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons. FASEB J. 25, 1461-1473 (2011). www.fasebj.org	[Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Flanders Inst Biotechnol, B-3000 Louvain, Belgium; [Dhondt, Joke; Verheyen, An; Buysschaert, Ian; Poesen, Koen; Van Geyte, Katie; Beerens, Manu; Carmeliet, Peter; Lambrechts, Diether] VIB, Vesalius Res Ctr, Louvain, Belgium; [Peeraer, Eve; Verheyen, An; Nuydens, Rony; Meert, Theo] Johnson & Johnson Pharmaceut Res & Dev, Dept Neurosci, Beerse, Belgium; [Peeraer, Eve] Univ Hasselt, Biomed Res Inst, Diepenbeek, Belgium; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Tokyo, Japan; [Haigh, Jody J.] VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, Ghent, Belgium; [Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Johnson & Johnson; Janssen Pharmaceuticals; Hasselt University; Tokyo Medical & Dental University (TMDU); Flanders Institute for Biotechnology (VIB); Ghent University	Lambrechts, D (corresponding author), Katholieke Univ Leuven, Vesalius Res Ctr, Flanders Inst Biotechnol, Campus Gasthuisberg,Herestr 49,Box 912, B-3000 Louvain, Belgium.	diether.lambrechts@vib-kuleuven.be	Verdrengh, Evelien/H-4571-2012; Lambrechts, Diether/AAJ-3167-2020; Carmeliet, Peter/AAQ-5140-2020; Poesen, Koen/B-3759-2013	Lambrechts, Diether/0000-0002-3429-302X; Carmeliet, Peter/0000-0001-7961-1821; haigh, jody/0000-0002-7319-8922; Beerens, Manu/0000-0002-7398-7761	Research Foundation Flanders, Belgium; Institute for the Promotion of Innovation by Science and Technology in Flanders; Geneeskundige stichting Koningin Elisabeth; Muscular Dystrophy Association; governmental Institute for Science and Technology (IWT) for the promotion of research; Katholieke Universiteit Leuven; Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium	Research Foundation Flanders, Belgium(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Geneeskundige stichting Koningin Elisabeth; Muscular Dystrophy Association(Muscular Dystrophy Association); governmental Institute for Science and Technology (IWT) for the promotion of research(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Katholieke Universiteit Leuven(KU Leuven); Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium(Johnson & JohnsonJohnson & Johnson USA)	D. L. is supported by the Research Foundation Flanders, Belgium; J.D. and K. P. are supported by the Institute for the Promotion of Innovation by Science and Technology in Flanders. P. C. is supported by grants from the Geneeskundige stichting Koningin Elisabeth, and by the Muscular Dystrophy Association. This project is partly funded by a research and development grant of the governmental Institute for Science and Technology (IWT) for the promotion of research between universities (D. L., Katholieke Universiteit Leuven) and industry (T. M. and R.N., Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium).	Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Falk T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-49; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; HAGBERG CE, NATURE, V464, P917; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kirchmair R, 2005, CIRCULATION, V111, P2662, DOI 10.1161/CIRCULATIONAHA.104.470849; Kirchmair R, 2007, MOL THER, V15, P69, DOI 10.1038/sj.mt.6300019; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; Lipton SA, 2004, NEW ENGL J MED, V350, P2516, DOI 10.1056/NEJMcibr041121; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; Popovici C, 2002, NEUROSCI LETT, V329, P116, DOI 10.1016/S0304-3940(02)00595-5; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161/01.RES.0000081594.21764.44; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun YJ, 2004, J CEREBR BLOOD F MET, V24, P1146, DOI 10.1097/01.WCB.0000134477.38980.38; Tschachler E, 2004, J INVEST DERMATOL, V122, P177, DOI 10.1046/j.0022-202X.2003.22102.x; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Wilson K, 2006, INT J NEUROPROT NEUR, V3, P31; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; ZENTILIN L, FASEB J, V24, P1467	36	38	40	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1461	1473		10.1096/fj.10-170944	http://dx.doi.org/10.1096/fj.10-170944			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21248239	Bronze, Green Published			2022-12-25	WOS:000290023800005
J	Houliston, RS; Vinogradov, E; Dzieciatkowska, M; Li, JJ; Michael, FS; Karwaski, MF; Brochu, D; Jarrell, HC; Parker, CT; Yuki, N; Mandrell, RE; Gilbert, M				Houliston, R. Scott; Vinogradov, Evgeny; Dzieciatkowska, Monika; Li, Jianjun; Michael, Frank St.; Karwaski, Marie-France; Brochu, Denis; Jarrell, Harold C.; Parker, Craig T.; Yuki, Nobuhiro; Mandrell, Robert E.; Gilbert, Michel			Lipooligosaccharide of Campylobacter jejuni SIMILARITY WITH MULTIPLE TYPES OF MAMMALIAN GLYCANS BEYOND GANGLIOSIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUILLAIN-BARRE-SYNDROME; CORE OLIGOSACCHARIDE REGIONS; GENUS-SPECIFIC EPITOPE; BACTERIAL LIPOPOLYSACCHARIDES; CHLAMYDIA LIPOPOLYSACCHARIDE; CAPILLARY-ELECTROPHORESIS; LIPO-OLIGOSACCHARIDES; HELICOBACTER-PYLORI; STRUCTURAL-ANALYSIS; GANGLIOSIDE MIMICS	Campylobacter jejuni is well known for synthesizing ganglioside mimics within the glycan component of its lipooligosaccharide (LOS), which have been implicated in triggering Guillain-Barre syndrome. We now confirm that this pathogen is capable of synthesizing a much broader spectrum of host glycolipid/glycoprotein mimics within its LOS. P blood group and paragloboside (lacto-N-neotetraose) antigen mimicry is exhibited by RM1221, a strain isolated from a poultry source. RM1503, a gastroenteritis-associated strain, expresses lacto-N-biose and sialyl-Lewis c units, the latter known as the pancreatic tumor-associated antigen, DU-PAN-2 (or LSTa). C. jejuni GC149, a Guillain-Barre ' syndrome-associated strain, expresses an unusual sialic acid-containing hybrid oligosaccharide with similarity to both ganglio and P-k antigens and can, through phase variation of its LOS biosynthesis genes, display GT1a or GD3 ganglioside mimics. We show that the sialyltransferase CstII and the galactosyltransferase CgtD are involved in the synthesis of multiple mimic types, with LOS structural diversity achieved through evolving allelic substrate specificity.	[Houliston, R. Scott; Vinogradov, Evgeny; Dzieciatkowska, Monika; Li, Jianjun; Michael, Frank St.; Karwaski, Marie-France; Brochu, Denis; Jarrell, Harold C.; Gilbert, Michel] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Parker, Craig T.; Mandrell, Robert E.] ARS, USDA, Albany, CA 94710 USA; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Yuki, Nobuhiro] Natl Univ Singapore, Dept Med, Singapore 117597, Singapore	National Research Council Canada; United States Department of Agriculture (USDA); National University of Singapore; National University of Singapore	Gilbert, M (corresponding author), Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada.	michel.gilbert@nrc-cnrc.gc.ca	Mandrell, Robert E/O-9814-2018; Yuki, Nobuhiro/H-3187-2012	Li, Jianjun/0000-0002-6531-3687; Parker, Craig/0000-0002-7719-8882; Gilbert, Michel/0000-0002-0204-4408; Vinogradov, Evgeny/0000-0002-5364-1376				ASPINALL GO, 1993, EUR J BIOCHEM, V213, P1029, DOI 10.1111/j.1432-1033.1993.tb17850.x; ASPINALL GO, 1993, EUR J BIOCHEM, V213, P1017, DOI 10.1111/j.1432-1033.1993.tb17849.x; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2489, DOI 10.1021/bi951852s; ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P241, DOI 10.1021/bi00167a032; Bernatchez S, 2007, GLYCOBIOLOGY, V17, P1333, DOI 10.1093/glycob/cwm090; CHAN NWC, 1995, GLYCOBIOLOGY, V5, P683, DOI 10.1093/glycob/5.7.683; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Dzieciatkowska M, 2007, BIOCHEMISTRY-US, V46, P14704, DOI 10.1021/bi701229k; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Gilbert M, 2008, CAMPYLOBACTER, 3RD EDITION, P483; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Hobley P, 1996, MAGN RESON CHEM, V34, P755; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Houliston RS, 2009, GLYCOBIOLOGY, V19, P153, DOI 10.1093/glycob/cwn117; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; JENNINGS HJ, 1983, CARBOHYD RES, V121, P233, DOI 10.1016/0008-6215(83)84020-8; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Li JJ, 2007, MASS SPECTROM REV, V26, P35, DOI 10.1002/mas.20105; Linton D, 2000, MOL MICROBIOL, V35, P1120, DOI 10.1046/j.1365-2958.2000.01780.x; MANDRELL RE, 1992, INFECT IMMUN, V60, P3017, DOI 10.1128/IAI.60.7.3017-3020.1992; MANDRELL RE, 1993, IMMUNOBIOLOGY, V187, P382, DOI 10.1016/S0171-2985(11)80352-9; MANDRELL RE, 1994, METHOD ENZYMOL, V236, P231; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7; Wakarchuk Warren W, 2003, Methods Mol Biol, V213, P263; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2010, METHODS MOL BIOL, V600, P51, DOI 10.1007/978-1-60761-454-8_4	34	42	43	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.181750	http://dx.doi.org/10.1074/jbc.M110.181750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21257763	Green Published, hybrid			2022-12-25	WOS:000289077500050
J	Grishin, AM; Ajamian, E; Tao, LM; Zhang, LH; Menard, R; Cygler, M				Grishin, Andrey M.; Ajamian, Eunice; Tao, Limei; Zhang, Linhua; Menard, Robert; Cygler, Miroslaw			Structural and Functional Studies of the Escherichia coli Phenylacetyl-CoA Monooxygenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLUENE/O-XYLENE MONOOXYGENASE; METHYLOCOCCUS-CAPSULATUS BATH; SOLUBLE METHANE MONOOXYGENASE; PSEUDOMONAS-STUTZERI OX1; MULTICOMPONENT MONOOXYGENASES; CRYSTAL-STRUCTURE; AROMATIC HYDROXYLATION; PHENOL HYDROXYLASE; PROTEIN COMPLEX; BACTERIAL	The utilization of phenylacetic acid (PA) in Escherichia coli occurs through a hybrid pathway that shows features of both aerobic and anaerobic metabolism. Oxygenation of the aromatic ring is performed by a multisubunit phenylacetyl-coenzyme A oxygenase complex that shares remote homology of two subunits to well studied bacterial multicomponent monooxygenases and was postulated to form a new bacterial multicomponent monooxygenase subfamily. We expressed the subunits PaaA, B, C, D, and E of the PA-CoA oxygenase and showed that PaaABC, PaaAC, and PaaBC form stable subcomplexes that can be purified. In vitro reconstitution of the oxygenase subunits showed that each of the PaaA, B, C, and E subunits are necessary for catalysis, whereas PaaD is not essential. We have determined the crystal structure of the PaaAC complex in a ligand-free form and with several CoA derivatives. We conclude that PaaAC forms a catalytic core with a monooxygenase fold with PaaA being the catalytic alpha subunit and PaaC, the structural beta subunit. PaaAC forms heterotetramers that are organized very differently from other known multisubunit monooxygenases and lacks their conservative network of hydrogen bonds between the di-iron center and protein surface, suggesting different association with the reductase and different mechanisms of electron transport. The PaaA structure shows adaptation of the common access route to the active site for binding a CoA-bound substrate. The enzyme-substrate complex shows the orientation of the aromatic ring, which is poised for oxygenation at the ortho-position, in accordance with the expected chemistry. The PACoA oxygenase complex serves as a paradigm for the new subfamily multicomponent monooxygenases comprising several hundred homologs.	[Tao, Limei; Zhang, Linhua; Menard, Robert; Cygler, Miroslaw] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Grishin, Andrey M.; Ajamian, Eunice; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	National Research Council Canada; McGill University	Cygler, M (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	mirek@bri.nrc.ca			National Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research [GSP-48370]; University of Saskatchewan	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	This work was supported in part by the National Sciences and Engineering Research Council of Canada, the National Research Council, the Canadian Institutes of Health Research, and the University of Saskatchewan. This work was supported by Grant GSP-48370 from Canadian Institutes of Health Research (to M. C.).	Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Batie C. J., 1991, CHEM BIOCH FLAVOENZY, V3, P543; Borodina E, 2007, APPL ENVIRON MICROB, V73, P6460, DOI 10.1128/AEM.00823-07; Cafaro V, 2002, EUR J BIOCHEM, V269, P5689, DOI 10.1046/j.1432-1033.2002.03281.x; Cafaro V, 2004, APPL ENVIRON MICROB, V70, P2211, DOI 10.1128/AEM.70.4.2211-2219.2004; Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez C, 2006, APPL ENVIRON MICROB, V72, P7422, DOI 10.1128/AEM.01550-06; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Grishin AM, 2010, ACTA CRYSTALLOGR F, V66, P1045, DOI 10.1107/S174430911002748X; Ismail W, 2003, EUR J BIOCHEM, V270, P3047, DOI 10.1046/j.1432-1033.2003.03683.x; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Jaganaman S, 2007, PROTEIN EXPRES PURIF, V52, P273, DOI 10.1016/j.pep.2006.09.004; Leungsakul T, 2006, APPL ENVIRON MICROB, V72, P3933, DOI 10.1128/AEM.02966-05; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell KH, 2003, P NATL ACAD SCI USA, V100, P3784, DOI 10.1073/pnas.0636619100; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Notomista E, 2009, APPL ENVIRON MICROB, V75, P823, DOI 10.1128/AEM.01951-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pikus JD, 1997, BIOCHEMISTRY-US, V36, P9283, DOI 10.1021/bi971049t; REINER AM, 1971, BIOCHEMISTRY-US, V10, P2530, DOI 10.1021/bi00789a017; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Sazinsky MH, 2004, BIOCHEMISTRY-US, V43, P16263, DOI 10.1021/bi048140z; TAGAWA K, 1962, NATURE, V195, P537, DOI 10.1038/195537a0; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	36	34	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10735	10743		10.1074/jbc.M110.194423	http://dx.doi.org/10.1074/jbc.M110.194423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247899	Green Published, hybrid			2022-12-25	WOS:000288547000087
J	Soontharapirakkul, K; Promden, W; Yamada, N; Kageyama, H; Incharoensakdi, A; Iwamoto-Kihara, A; Takabe, T				Soontharapirakkul, Kanteera; Promden, Worrawat; Yamada, Nana; Kageyama, Hakuto; Incharoensakdi, Aran; Iwamoto-Kihara, Atsuko; Takabe, Teruhiro			Halotolerant Cyanobacterium Aphanothece halophytica Contains an Na+-dependent F1F0-ATP Synthase with a Potential Role in Salt-stress Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; FUNCTIONAL-CHARACTERIZATION; ESCHERICHIA-COLI; ION SPECIFICITY; PLASMA-MEMBRANE; H+-ATPASE; SUBUNITS; SEQUENCE; GENES; CHLOROPLASTS	Aphanothece halophytica is a halotolerant alkaliphilic cyanobacterium that can grow in media of up to 3.0 M NaCl and pH 11. Here, we show that in addition to a typical H+-ATP synthase, Aphanothece halophytica contains a putative F1F0-type Na+-ATP synthase (ApNa(+)-ATPase) operon (ApNa(+)-atp). The operon consists of nine genes organized in the order of putative subunits beta, epsilon, I, hypothetical protein, a, c, b, alpha, and gamma. Homologous operons could also be found in some cyanobacteria such as Synechococcus sp. PCC 7002 and Acaryochloris marina MBIC11017. The ApNa(+)-atp operon was isolated from the A. halophytica genome and transferred into an Escherichia coli mutant DK8 (Delta atp) deficient in ATP synthase. The inverted membrane vesicles of E. coli DK8 expressing ApNa(+)-ATPase exhibited Na+-dependent ATP hydrolysis activity, which was inhibited by monensin and tributyltin chloride, but not by the protonophore, carbonyl cyanide m-chlorophenyl hydrazone (CCCP). The Na+ ion protected the inhibition of ApNa(+)-ATPase by N,N'-dicyclohexylcarbodiimide. The ATP synthesis activity was also observed using the Na+-loaded inverted membrane vesicles. Expression of the ApNa(+)-atp operon in the heterologous cyanobacterium Synechococcus sp. PCC 7942 showed its localization in the cytoplasmic membrane fractions and increased tolerance to salt stress. These results indicate that A. halophytica has additional Na+-dependent F1F0-ATPase in the cytoplasmic membrane playing a potential role in salt-stress tolerance.	[Soontharapirakkul, Kanteera; Promden, Worrawat; Yamada, Nana; Kageyama, Hakuto; Takabe, Teruhiro] Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi 4688502, Japan; [Soontharapirakkul, Kanteera; Incharoensakdi, Aran] Chulalongkorn Univ, Fac Sci, Bangkok 10330, Thailand; [Iwamoto-Kihara, Atsuko] Nagahama Inst Biosci & Technol, Fac Biosci, Shiga, Nagahama 5260829, Japan; [Takabe, Teruhiro] Meijo Univ, Res Inst, Nagoya, Aichi 4688502, Japan	Meijo University; Chulalongkorn University; Meijo University	Takabe, T (corresponding author), 1-01 Shiogamaguchi,Tenpaku Ku, Aichi 4688502, Japan.	takabe@meijo-u.ac.jp	Kageyama, Hakuto/M-7302-2019; Kageyama, Hakuto/L-6890-2019; PROMDEN, WORRAWAT/GSJ-0691-2022; Kageyama, Hakuto/AAX-1682-2020	Kageyama, Hakuto/0000-0002-7741-7408; PROMDEN, WORRAWAT/0000-0002-3846-8894; 	Ministry of Education, Science, and Culture of Japan; Salt Science Research Foundation; High-Technology Research Center of Meijo University; Royal Golden Jubilee Ph.D. program; 90th Anniversary of Chulalongkorn University Fund	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; High-Technology Research Center of Meijo University; Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); 90th Anniversary of Chulalongkorn University Fund(Chulalongkorn University)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan; the Salt Science Research Foundation; and the High-Technology Research Center of Meijo University. This work was also supported by the Royal Golden Jubilee Ph.D. program and the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphote Endowment Fund) (to K. S.).	BALNOKIN YV, 1994, FEBS LETT, V343, P61, DOI 10.1016/0014-5793(94)80607-1; BERGER S, 1991, FEBS LETT, V286, P129, DOI 10.1016/0014-5793(91)80957-5; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; COZENS AL, 1987, J MOL BIOL, V194, P359, DOI 10.1016/0022-2836(87)90667-X; CURTIS SE, 1987, J BACTERIOL, V169, P80, DOI 10.1128/jb.169.1.80-86.1987; Ferguson SA, 2006, J BACTERIOL, V188, P5045, DOI 10.1128/JB.00128-06; Fukaya F, 2009, APPL ENVIRON MICROB, V75, P6626, DOI 10.1128/AEM.01387-09; KAIM G, 1992, EUR J BIOCHEM, V207, P463, DOI 10.1111/j.1432-1033.1992.tb17072.x; LILL H, 1991, PLANT MOL BIOL, V17, P641, DOI 10.1007/BF00037050; Meier T, 2003, BBA-GENE STRUCT EXPR, V1625, P221, DOI 10.1016/S0167-4781(02)00625-5; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Rahlfs S, 1999, J BIOL CHEM, V274, P33999, DOI 10.1074/jbc.274.48.33999; Shono M, 1996, PLANT CELL PHYSIOL, V37, P385, DOI 10.1093/oxfordjournals.pcp.a028957; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Waditee R, 2004, J BIOL CHEM, V279, P4330, DOI 10.1074/jbc.M310282200; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Waditee R, 2002, P NATL ACAD SCI USA, V99, P4109, DOI 10.1073/pnas.052576899; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Waditee R, 2007, J BIOL CHEM, V282, P34185, DOI 10.1074/jbc.M704939200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wutipraditkul N, 2005, APPL ENVIRON MICROB, V71, P4176, DOI 10.1128/AEM.71.8.4176-4184.2005; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	25	28	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10169	10176		10.1074/jbc.M110.208892	http://dx.doi.org/10.1074/jbc.M110.208892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262962	hybrid, Green Published			2022-12-25	WOS:000288547000032
J	Leonhardt, RM; Vigneron, N; Rahner, C; Cresswell, P				Leonhardt, Ralf M.; Vigneron, Nathalie; Rahner, Christoph; Cresswell, Peter			Proprotein Convertases Process Pmel17 during Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; BASIC-AMINO-ACIDS; SEQUENCE REQUIREMENTS; MELANOSOME BIOGENESIS; ENDOPLASMIC-RETICULUM; PROTEOLYTIC CLEAVAGE; PROPEPTIDE CLEAVAGE; SUBSTRATE CLEAVAGE; GAMMA-SECRETASE; SPLICE VARIANT	Pmel17 is a melanocyte/melanoma-specific protein that traffics to melanosomes where it forms a fibrillar matrix on which melanin gets deposited. Before being cleaved into smaller fibrillogenic fragments the protein undergoes processing by proprotein convertases, a class of serine proteases that typically recognize the canonical motif RX(R/K)R down arrow. The current model of Pmel17 maturation states that this processing step occurs in melanosomes, but in light of recent reports this issue has become controversial. We therefore addressed this question by thoroughly assessing the processing kinetics of either wild-type Pmel17 or a secreted soluble Pmel17 derivative. Our results demonstrate clearly that processing of Pmel17 occurs during secretion and that it does not require entry of the protein into the endocytic system. Strikingly, processing proceeds even in the presence of the secretion inhibitor monensin, suggesting that Pmel17 is an exceptionally good substrate. In line with this, we find that newly synthesized surface Pmel17 is already quantitatively cleaved. Moreover, we demonstrate that Pmel17 function is independent of the sequence identity of its unconventional proprotein convertase-cleavage motif that lacks arginine in P4 position. The data alter the current view of Pmel17 maturation and suggest that the multistep processing of Pmel17 begins with an early cleavage during secretion that primes the protein for later functional processing.	[Leonhardt, Ralf M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Rahner, Christoph; Cresswell, Peter] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Vigneron, Nathalie] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Vigneron, Nathalie] Catholic Univ Louvain, Cellular Genet Unit, de Duve Inst, B-1200 Brussels, Belgium	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Leonhardt, RM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,TAC S669-670, New Haven, CT 06519 USA.	Ralf.Leonhardt@yale.edu		Leonhardt, Ralf Max/0000-0001-6673-8217	National Institutes of Health [R37-AI23081]; Howard Hughes Medical Institute; Yale SPORE in Skin Cancer [5P50 CA121974]; Cancer Research Institute; European Union; Fonds National de la Recherche Scientific (F.N.R.S.), Belgium; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale SPORE in Skin Cancer; Cancer Research Institute; European Union(European Commission); Fonds National de la Recherche Scientific (F.N.R.S.), Belgium(Fonds de la Recherche Scientifique - FNRS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-AI23081, the Howard Hughes Medical Institute, and Yale SPORE in Skin Cancer Grant 5P50 CA121974 (to P.C.).; Supported by a Cancer Research Institute Fellowship. To whom correspondence should be addressed: Dept. of Immunobiology, 300 Cedar St., TAC S669/670, New Haven, CT 06519-1612. Tel.: 203-785-5042; Fax: 203-785-4461; E-mail: Ralf.Leonhardt@yale.edu.; Supported by a Marie Curie Outgoing International Fellowship (OIF) from the European Union and the Fonds National de la Recherche Scientific (F.N.R.S.), Belgium.	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Basque J, 2008, CAN J PHYSIOL PHARM, V86, P606, DOI 10.1139/y08-063; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; CREEMERS JWM, 1993, FEBS LETT, V336, P65, DOI 10.1016/0014-5793(93)81610-C; de Cicco RL, 2007, MOL CARCINOGEN, V46, P654, DOI 10.1002/mc.20331; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Marcinkiewicz M, 1996, ACTA NEUROBIOL EXP, V56, P287; MARK MR, 1992, J BIOL CHEM, V267, P26166; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; ODA K, 1991, BIOCHEM BIOPH RES CO, V179, P1181, DOI 10.1016/0006-291X(91)91696-A; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; REHEMTULLA A, 1992, BLOOD, V79, P2349; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Salvas A, 2005, FEBS LETT, V579, P5621, DOI 10.1016/j.febslet.2005.09.029; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; SONG LX, 1995, J NEUROCHEM, V65, P444; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; VEY M, 1992, VIROLOGY, V188, P408, DOI 10.1016/0042-6822(92)90775-K; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Vigneron N, 2005, TISSUE ANTIGENS, V65, P156, DOI 10.1111/j.1399-0039.2005.00365.x; WATANABE T, 1993, FEBS LETT, V320, P215, DOI 10.1016/0014-5793(93)80589-M; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wouters S, 1998, BIOCHEM J, V336, P311, DOI 10.1042/bj3360311; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200; Zhu YJ, 2010, J BIOL CHEM, V285, P38283, DOI 10.1074/jbc.M110.170530	71	36	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9321	9337		10.1074/jbc.M110.168088	http://dx.doi.org/10.1074/jbc.M110.168088			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21247888	Green Published, hybrid			2022-12-25	WOS:000288247700062
J	Cohen, M; Yossef, R; Erez, T; Kugel, A; Welt, M; Karpasas, MM; Bones, J; Rudd, PM; Taieb, J; Boissin, H; Harats, D; Noy, K; Tekoah, Y; Lichtenstein, RG; Rubin, E; Porgador, A				Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Karpasas, Mark M.; Bones, Jonathan; Rudd, Pauline M.; Taieb, Julien; Boissin, Herve; Harats, Dror; Noy, Karin; Tekoah, Yoram; Lichtenstein, Rachel G.; Rubin, Eitan; Porgador, Angel			Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical Assays	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROSTATE-CANCER; PLASMA PROTEOME; BIOMARKER; TOF; SURFACE; IDENTIFICATION; VALIDATION; DISCOVERY; CARCINOMA	Finding new peptide biomarkers for stomach cancer in human sera that can be implemented into a clinically practicable prediction method for monitoring of stomach cancer. We studied the serum peptidome from two different biorepositories. We first employed a C8-reverse phase liquid chromatography approach for sample purification, followed by mass-spectrometry analysis. These were applied onto serum samples from cancer-free controls and stomach cancer patients at various clinical stages. We then created a bioinformatics analysis pipeline and identified peptide signature discriminating stomach adenocarcinoma patients from cancer-free controls. Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) results from 103 samples revealed 9 signature peptides; with prediction accuracy of 89% in the training set and 88% in the validation set. Three of the discriminating peptides discovered were fragments of Apolipoproteins C-I and C-III (apoC-I and C-III); we further quantified their serum levels, as well as CA19-9 and CRP, employing quantitative commercial-clinical assays in 142 samples. ApoC-I and apoC-III quantitative results correlated with the MS results. We then employed apoB-100-normalized apoC-I and apoC-III, CA19-9 and CRP levels to generate rules set for stomach cancer prediction. For training, we used sera from one repository, and for validation, we used sera from the second repository. Prediction accuracies of 88.4% and 74.4% were obtained in the training and validation sets, respectively. Serum levels of apoC-I and apoC-III combined with other clinical parameters can serve as a basis for the formulation of a diagnostic score for stomach cancer patients.	[Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Rubin, Eitan; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Karpasas, Mark M.] Ben Gurion Univ Negev, Analyt Res Serv, IL-84105 Beer Sheva, Israel; [Karpasas, Mark M.] Ben Gurion Univ Negev, Instrumentat Unit, IL-84105 Beer Sheva, Israel; [Bones, Jonathan; Rudd, Pauline M.] Univ Coll Dublin, Conway Inst, NIBRT, Oxford Glycobiol Lab, Dublin 2, Ireland; [Taieb, Julien; Boissin, Herve] RNTech SAS France, Paris, France; [Tekoah, Yoram; Lichtenstein, Rachel G.] Ben Gurion Univ Negev, Avram & Stella Goren Goldstein Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Harats, Dror] Sheba Med Ctr, Bert Stassburger Lipid Ctr, Ramat Gan, Israel; [Noy, Karin] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Cohen, Meital; Yossef, Rami; Erez, Tamir; Kugel, Aleksandra; Welt, Michael; Rubin, Eitan; Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; University College Dublin; Ben Gurion University; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University	Cohen, M (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	angel@bgu.ac.il	Rubin, Eitan/E-5256-2011; Yoseph, Rami/L-6823-2019; Yossef, Rami/K-5740-2019	Rubin, Eitan/0000-0002-7807-4005; Porgador, Angel/0000-0003-1540-4449; Lichtenstein, Rachel/0000-0002-2225-1068	European Community [GLYFDIS 037661]	European Community(European Commission)	Funding was provided by the European Community (FP6 GLYFDIS 037661). RNTech SAS France is stated as funder due to the fact that JT and HB are/were employees of this company; the contributions of JT and HB are defined as Final approval of the version to be published, and they were not involved in contribution to conception and design, or acquisition of data, or analysis and interpretation of data or drafting the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Bergen HR, 2003, DIS MARKERS, V19, P239; Bidart JM, 1999, CLIN CHEM, V45, P1695; Check E, 2004, NATURE, V429, P496, DOI 10.1038/429496a; Chen JZ, 2007, J CHROMATOGR A, V1162, P117, DOI 10.1016/j.chroma.2007.03.096; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200; Engwegen JYMN, 2006, WORLD J GASTROENTERO, V12, P1536, DOI 10.3748/wjg.v12.i10.1536; Gerber Y, 2002, PREV MED, V35, P42, DOI 10.1006/pmed.2002.1045; Gobel T, 2006, WORLD J GASTROENTERO, V12, P7604; Grizzle WE, 2003, DIS MARKERS, V19, P185, DOI 10.1155/2004/546293; Hortin GL, 2006, CLIN CHEM, V52, P1218, DOI 10.1373/clinchem.2006.067280; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Koomen JM, 2005, J PROTEOME RES, V4, P972, DOI 10.1021/pr050046x; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Lustgarten JL, 2008, BIOINFORMATICS, V24, P1418, DOI 10.1093/bioinformatics/btn125; Marshall J, 2003, J PROTEOME RES, V2, P361, DOI 10.1021/pr030003l; McComb ME, 2007, RAPID COMMUN MASS SP, V21, P44, DOI 10.1002/rcm.2805; McLerran D, 2008, CLIN CHEM, V54, P53, DOI 10.1373/clinchem.2007.091496; McLerran D, 2008, CLIN CHEM, V54, P44, DOI 10.1373/clinchem.2007.091470; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rai AJ, 2004, ANN NY ACAD SCI, V1022, P286, DOI 10.1196/annals.1318.044; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Swartz M, 2009, ANAL METHOD VALIDATI; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2007, NAT PROTOC, V2, P588, DOI 10.1038/nprot.2007.57; Villanueva J, 2006, NAT PROTOC, V1, P880, DOI 10.1038/nprot.2006.128; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Yamamoto-Ishikawa K, 2009, ASIAN J ANDROL, V11, P299, DOI 10.1038/aja.2008.38; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	36	36	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14540	10.1371/journal.pone.0014540	http://dx.doi.org/10.1371/journal.pone.0014540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267442	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500012
J	Jeffers, ES; Bonsall, MB; Willis, KJ				Jeffers, Elizabeth S.; Bonsall, Michael B.; Willis, Kathy J.			Stability in Ecosystem Functioning across a Climatic Threshold and Contrasting Forest Regimes	PLOS ONE			English	Article							NITROGEN; REGENERATION; PERSPECTIVE; FRAMEWORK; DYNAMICS; TREES	Classical ecological theory predicts that changes in the availability of essential resources such as nitrogen should lead to changes in plant community composition due to differences in species-specific nutrient requirements. What remains unknown, however, is the extent to which climate change will alter the relationship between plant communities and the nitrogen cycle. During intervals of climate change, do changes in nitrogen cycling lead to vegetation change or do changes in community composition alter the nitrogen dynamics? We used long-term ecological data to determine the role of nitrogen availability in changes of forest species composition under a rapidly changing climate during the early Holocene (16k to 8k cal. yrs. BP). A statistical computational analysis of ecological data spanning 8,000 years showed that secondary succession from a coniferous to deciduous forest occurred independently of changes in the nitrogen cycle. As oak replaced pine under a warming climate, nitrogen cycling rates increased. Interestingly, the mechanism by which the species interacted with nitrogen remained stable across this threshold change in climate and in the dominant tree species. This suggests that changes in tree population density over successional time scales are not driven by nitrogen availability. Thus, current models of forest succession that incorporate the effects of available nitrogen may be over-estimating tree population responses to changes in this resource, which may result in biased predictions of future forest dynamics under climate warming.	[Jeffers, Elizabeth S.; Willis, Kathy J.] Univ Oxford, Sch Geog, Oxford OX1 3TB, England; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Willis, Kathy J.] Univ Bergen, Dept Biol, Bergen, Norway	University of Oxford; University of Oxford; University of Bergen	Jeffers, ES (corresponding author), Univ Oxford, Sch Geog, Mansfield Rd, Oxford OX1 3TB, England.	michael.bonsall@zoo.ox.ac.uk	Jeffers, Elizabeth S./D-4021-2013	Jeffers, Elizabeth S./0000-0001-9679-5909; Willis, Katherine/0000-0002-6763-2489; Bonsall, Michael/0000-0003-0250-0423	Royal Society; Natural Environment Research Council; NERC [NE/G010730/1] Funding Source: UKRI; Natural Environment Research Council [NE/G010730/1] Funding Source: researchfish	Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by the Royal Society and the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bennett KD, 2001, TRACKING ENV CHANGE, V3, P5, DOI DOI 10.1007/0-306-47668-1_2; BERGLUND BE, 1986, HDB HOLOCENE PALAEOE, V24; Bonsall MB, 2004, J ANIM ECOL, V73, P1043, DOI 10.1111/j.0021-8790.2004.00874.x; BUCK CE, 1999, BCAL ON LINE BAYESIA; Burnham KP, 2002, MODEL SELECTION MULT, VXXVI; Catovsky S, 2002, ECOL APPL, V12, P1611, DOI 10.2307/3099926; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; Clark BR, 2005, AM NAT, V165, P609, DOI 10.1086/430074; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DELCOURT HR, 1991, QUATERNARY ECOLOGY P, V10; Eckstein RL, 1999, NEW PHYTOL, V143, P177, DOI 10.1046/j.1469-8137.1999.00429.x; GREEN DG, 1983, NEW PHYTOL, V94, P459, DOI 10.1111/j.1469-8137.1983.tb03459.x; GREEN DG, 1981, QUATERNARY RES, V15, P265, DOI 10.1016/0033-5894(81)90030-2; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Karolewski P, 2005, WATER AIR SOIL POLL, V160, P95, DOI 10.1007/s11270-005-3941-3; Magill AH, 1997, ECOL APPL, V7, P402, DOI 10.1890/1051-0761(1997)007[0402:BROFET]2.0.CO;2; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; Menge DNL, 2009, AM NAT, V173, P164, DOI 10.1086/595749; MORGAN BJT, 1999, APPL STOCHASTIC MODE, V9; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; PRENTICE IC, 1988, TRENDS ECOL EVOL, V3, P343; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Talbot MR, 2002, DEV PALEOENVIRON RES, V2, P401; Tilman David, 2007, P84; Wallace ZP, 2007, FOREST ECOL MANAG, V243, P210, DOI 10.1016/j.foreco.2007.02.015; Willis KJ, 1997, ECOLOGY, V78, P740, DOI 10.1890/0012-9658(1997)078[0740:DSCCVC]2.0.CO;2; Wolfe BB, 1999, HOLOCENE, V9, P215, DOI 10.1191/095968399669823431; Xu-Ri, 2008, GLOBAL CHANGE BIOL, V14, P1745, DOI 10.1111/j.1365-2486.2008.01625.x	33	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16134	10.1371/journal.pone.0016134	http://dx.doi.org/10.1371/journal.pone.0016134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267469	gold, Green Submitted, Green Published			2022-12-25	WOS:000286519500040
J	Chen, LA; Meng, QH; Kao, W; Xia, Y				Chen, Liang; Meng, Qinghang; Kao, Winston; Xia, Ying			I kappa B Kinase beta Regulates Epithelium Migration during Corneal Wound Healing	PLOS ONE			English	Article							P38 MAP KINASE; INFLAMMATORY SKIN-DISEASE; IKK-BETA; CELL-MIGRATION; GROWTH-FACTORS; ACTIVATION; PROLIFERATION; EXPRESSION; DELETION; APOPTOSIS	The IKK beta is known to regulate transcription factor NF-kappa B activation leading to inflammatory responses. Recent gene knockout studies have shown that IKK beta can orchestrate local inflammatory responses and regulate homeostasis of epithelial tissues. To investigate whether IKK beta has an intrinsic role in epithelial cells, we established an in vivo system in the immune privileged corneal epithelium. We generated triple transgenic Krt12(rtTA/rtTAt)/tet-O-Cre/Ikk beta(F/F) (Ikk beta(Delta CE/Delta CE)) mice by crossing the Krt12-rtTA knock-in mice, which express the reverse tetracycline transcription activator in corneal epithelial cells, with the tet-O-Cre and Ikk beta(F/F) mice. Doxcycline-induced IKK beta ablation occurred in corneal epithelial cells of triple transgenic Ikk beta(Delta CE/Delta CE) mice, but loss of IKK beta did not cause ocular abnormalities in fetal development and postnatal maintenance. Instead, loss of IKK beta significantly delayed healing of corneal epithelial debridement without affecting cell proliferation, apoptosis or macrophage infiltration. In vitro studies with human corneal epithelial cells (HCEpi) also showed that IKK beta was required for cytokine-induced cell migration and wound closure but was dispensable for cell proliferation. In both in vivo and in vitro settings, IKK beta was required for optimal activation of NF-kappa B and p38 signaling in corneal epithelial cells, and p38 activation is likely mediated through formation of an IKK beta-p38 protein complex. Thus, our studies in corneal epithelium reveal a previously un-recognized role for IKK beta in the control of epithelial cell motility and wound healing.	[Chen, Liang; Meng, Qinghang; Xia, Ying] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Kao, Winston] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Chen, LA (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.	ying.xia@uc.edu	Chen, Liang/G-2990-2013	Chen, Liang/0000-0002-6748-9416; Xia, Ying/0000-0001-9532-9527	National Institutes of Health [NIH EY 15227]; Ryan Fellowship; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryan Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work is supported in part by funding from National Institutes of Health (NIH EY 15227) and the Ryan Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anstead G M, 1998, Adv Wound Care, V11, P277; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Bockhart V, 2009, J NEUROSCI, V29, P12919, DOI 10.1523/JNEUROSCI.1496-09.2009; Busti AJ, 2005, PHARMACOTHERAPY, V25, P1566, DOI 10.1592/phco.2005.25.11.1566; Chae S, 2006, J IMMUNOL, V177, P1214, DOI 10.4049/jimmunol.177.2.1214; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen LW, 2007, CRIT CARE MED, V35, P1332, DOI 10.1097/01.CCM.0000261891.30360.F0; Chikama TI, 2005, INVEST OPHTH VIS SCI, V46; Deng MX, 2006, MOL BIOL CELL, V17, P3446, DOI 10.1091/mbc.E06-02-0102; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Hara Y, 2001, EXP EYE RES, V72, P107, DOI 10.1006/exer.2000.0938; Harper EG, 2005, J CELL SCI, V118, P3471, DOI 10.1242/jcs.02475; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hengge UR, 2006, J AM ACAD DERMATOL, V54, P1, DOI 10.1016/j.jaad.2005.01.010; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hori Junko, 2008, J Ocul Biol Dis Infor, V1, P94, DOI 10.1007/s12177-008-9010-6; Hutcheon AEK, 2005, INVEST OPHTH VIS SCI, V46, P2362, DOI 10.1167/iovs.04-0759; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Koch KS, 2009, BIOCHEM BIOPH RES CO, V380, P349, DOI 10.1016/j.bbrc.2009.01.085; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIU CY, 1994, J BIOL CHEM, V269, P24627; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Qiao H, 2009, J INVEST DERMATOL, V129, pS37; Rasoulpour RJ, 2007, BIOL REPROD, V76, P279, DOI 10.1095/biolreprod.106.054924; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2007, CORNEA, V26, pS70, DOI 10.1097/ICO.0b013e31812f6d14; Sastre AP, 2008, J BIOL CHEM, V283, P25871, DOI 10.1074/jbc.M800949200; Schalnus R, 2003, OPHTHALMOLOGICA, V217, P89, DOI 10.1159/000068563; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WANG XG, 1994, INVEST OPHTH VIS SCI, V35, P4001; Wilson SE, 2009, EXP EYE RES, V89, P124, DOI 10.1016/j.exer.2009.02.011; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xie WJ, 2009, BIOCHEM BIOPH RES CO, V379, P1027, DOI 10.1016/j.bbrc.2009.01.009; Yamada N, 2006, INVEST OPHTH VIS SCI, V47, P3286, DOI 10.1167/iovs.05-1205; Yanai R, 2006, EXP EYE RES, V83, P76, DOI 10.1016/j.exer.2005.10.033; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	61	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16132	10.1371/journal.pone.0016132	http://dx.doi.org/10.1371/journal.pone.0016132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264230	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600022
J	Torner, N; Carnicer-Pont, D; Castilla, J; Cayla, J; Godoy, P; Dominguez, A				Torner, Nuria; Carnicer-Pont, Dolors; Castilla, Jesus; Cayla, Joan; Godoy, Pere; Dominguez, Angela		Epidemiol Surveillance Working Grp	Auditing the Management of Vaccine-Preventable Disease Outbreaks: The Need for a Tool	PLOS ONE			English	Article							QUALITY-OF-CARE; PUBLIC-HEALTH; SYSTEM; INTERVENTION; PRESCRIPTION; SURVEILLANCE; PERFORMANCE; RECORD	Public health activities, especially infectious disease control, depend on effective teamwork. We present the results of a pilot audit questionnaire aimed at assessing the quality of public health services in the management of VPD outbreaks. Audit questionnaire with three main areas indicators (structure, process and results) was developed. Guidelines were set and each indicator was assessed by three auditors. Differences in indicator scores according to median size of outbreaks were determined by ANOVA (significance at p <= 0.05). Of 154 outbreaks; eighteen indicators had a satisfactory mean score, indicator "updated guidelines'' and "timely reporting'' had a poor mean score (2.84 +/- 1.06 and 2.44 +/- 1.67, respectively). Statistically significant differences were found according to outbreak size, in the indicators "availability of guidelines/ protocol updated less than 3 years ago'' (p = 0.03) and "days needed for outbreak control'' (p = 0.04). Improving availability of updated guidelines, enhancing timely reporting and adequate recording of control procedures taken is needed to allow for management assessment and improvement.	[Torner, Nuria; Castilla, Jesus; Cayla, Joan; Godoy, Pere; Dominguez, Angela] Gen Catalonia, Dept Hlth, Barcelona, Spain; [Torner, Nuria; Carnicer-Pont, Dolors; Godoy, Pere] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Carnicer-Pont, Dolors; Cayla, Joan] Publ Hlth Agcy Barcelona, Barcelona, Spain; [Castilla, Jesus] Publ Hlth Inst Navarre, Pamplona, Spain; [Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Agency of Barcelona; Public Health Institute of Navarra; University of Barcelona	Torner, N (corresponding author), Gen Catalonia, Dept Hlth, Barcelona, Spain.	nuria.torner@gencat.cat	Castilla, Jesus/B-9048-2008; Etxeberria, Jaione/J-7199-2017; Godoy, Pere/A-7662-2010; , Nuria/AAG-8951-2019; Guevara, Marcela/B-4473-2015	Castilla, Jesus/0000-0002-6396-7265; Godoy, Pere/0000-0002-2896-7286; , Nuria/0000-0003-0143-5295; Guevara, Marcela/0000-0001-9242-6364; Cayla, Joan A./0000-0003-3891-111X; Barrabeig, Irene/0000-0003-4789-7620	CIBER Epidemiologia y Salud Publica (CIBERESP) Institute of Health Carlos III, Madrid, Spain	CIBER Epidemiologia y Salud Publica (CIBERESP) Institute of Health Carlos III, Madrid, Spain(Instituto de Salud Carlos III)	This work was partially funded by CIBER Epidemiologia y Salud Publica (CIBERESP) Institute of Health Carlos III, Madrid, Spain. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auplish S, 1997, J Eval Clin Pract, V3, P77, DOI 10.1111/j.1365-2753.1997.tb00070.x; BAKER EL, 1994, JAMA-J AM MED ASSOC, V272, P1276, DOI 10.1001/jama.272.16.1276; Bjorvell C, 2000, QUAL HEALTH CARE, V9, P6, DOI 10.1136/qhc.9.1.6; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Derose SF, 2003, AM J PREV MED, V25, P347, DOI 10.1016/S0749-3797(03)00208-3; Derose SF, 2003, ANNU REV PUBL HEALTH, V24, P363, DOI 10.1146/annurev.publhealth.24.100901.140847; Derose SF, 2002, ANNU REV PUBL HEALTH, V23, P1, DOI 10.1146/annurev.publhealth.23.092601.095644; Donabedian A., 1980, EXPLORATIONS QUALITY; *FAC PUBL HLTH, 2008, GOOD PUBL HLTH PRACT; GAIR R, 1992, J PUBLIC HEALTH MED, V14, P169; HARTLEY LA, 2002, NURS ECON, V20, P248; Hartley Lou Ann, 2002, Nurs Econ, V20, P235; Jayawardena Suriya, 2007, Am J Ther, V14, P336, DOI 10.1097/01.mjt.0000209681.22077.b9; Johnston N H, 1992, Qual Health Care, V1, P225, DOI 10.1136/qshc.1.4.225; Keyhani S, 2008, MED CARE, V46, P1267, DOI 10.1097/MLR.0b013e31817e18ae; Kipping RR, 2006, J PUBLIC HEALTH, V28, P347, DOI 10.1093/pubmed/fdl065; Krause G, 2008, EURO SURVEILL, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Lester WT, 2006, J GEN INTERN MED, V21, P22, DOI 10.1111/j.1525-1497.2005.00268.x; Lowe G, 2000, J PUBLIC HEALTH MED, V22, P129, DOI 10.1093/pubmed/22.2.129; NAZARETH B, 2007, AUDIT OUTBREAK MANAG; Scutchfield FD, 2009, AM J PREV MED, V36, P266, DOI 10.1016/j.amepre.2008.11.007; SMITH R, 1992, BRIT MED J, V305, P905, DOI 10.1136/bmj.305.6859.905; Straetemans M, 2008, EMERG INFECT DIS, V14, P1610, DOI 10.3201/eid1410.071354; Trepka MJ, 2009, EPIDEMIOL INFECT, V137, P22, DOI 10.1017/S0950268808000721; Vaux S, 2009, EUR J EPIDEMIOL, V24, P149, DOI 10.1007/s10654-009-9315-1; Vogt TM, 2004, HEALTH SERV RES, V39, P511, DOI 10.1111/j.1475-6773.2004.00242.x	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15699	10.1371/journal.pone.0015699	http://dx.doi.org/10.1371/journal.pone.0015699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710ME	21249188	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000006
J	Milling, A; Babujee, L; Allen, C				Milling, Annett; Babujee, Lavanya; Allen, Caitilyn			Ralstonia solanacearum Extracellular Polysaccharide Is a Specific Elicitor of Defense Responses in Wilt-Resistant Tomato Plants	PLOS ONE			English	Article							BACTERIAL WILT; PSEUDOMONAS-SOLANACEARUM; TRANSPOSON MUTAGENESIS; ARABIDOPSIS-THALIANA; PATHOGENIC BACTERIA; GENE-EXPRESSION; RACE-3 BIOVAR-2; SALICYLIC-ACID; IMMUNE-SYSTEM; VIRULENCE	Ralstonia solanacearum, which causes bacterial wilt of diverse plants, produces copious extracellular polysaccharide (EPS), a major virulence factor. The function of EPS in wilt disease is uncertain. Leading hypotheses are that EPS physically obstructs plant water transport, or that EPS cloaks the bacterium from host plant recognition and subsequent defense. Tomato plants infected with R. solanacearum race 3 biovar 2 strain UW551 and tropical strain GMI1000 upregulated genes in both the ethylene (ET) and salicylic acid (SA) defense signal transduction pathways. The horizontally wilt-resistant tomato line Hawaii7996 activated expression of these defense genes faster and to a greater degree in response to R. solanacearum infection than did susceptible cultivar Bonny Best. However, EPS played different roles in resistant and susceptible host responses to R. solanacearum. In susceptible plants the wild-type and eps(-) mutant strains induced generally similar defense responses. But in resistant Hawaii7996 tomato plants, the wild-type pathogens induced significantly greater defense responses than the eps(-) mutants, suggesting that the resistant host recognizes R. solanacearum EPS. Consistent with this idea, purified EPS triggered significant SA pathway defense gene expression in resistant, but not in susceptible, tomato plants. In addition, the eps(-) mutant triggered noticeably less production of defense-associated reactive oxygen species in resistant tomato stems and leaves, despite attaining similar cell densities in planta. Collectively, these data suggest that bacterial wilt-resistant plants can specifically recognize EPS from R. solanacearum.	[Milling, Annett; Babujee, Lavanya; Allen, Caitilyn] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Milling, A (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	cza@plantpath.wisc.edu			Deutsche Forschungsgemeinschaft (DFG); United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Plant Biosecurity [2006-04560]; USDA-Agricultural Research Service Floral and Nursery Crops Research Initiative; University of Wisconsin College of Agricultural and Life Sciences	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Plant Biosecurity(United States Department of Agriculture (USDA)); USDA-Agricultural Research Service Floral and Nursery Crops Research Initiative; University of Wisconsin College of Agricultural and Life Sciences	This research was supported by a Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship to AM and by United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Plant Biosecurity project 2006-04560, the USDA-Agricultural Research Service Floral and Nursery Crops Research Initiative and by the University of Wisconsin College of Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; BOUCHER CA, 1985, J GEN MICROBIOL, V131, P2449; Chen YY, 2009, PHYSIOL PLANTARUM, V136, P324, DOI 10.1111/j.1399-3054.2009.01226.x; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; DANHASH N, 1993, PLANT MOL BIOL, V22, P1017, DOI 10.1007/BF00028974; de Pinto MC, 2003, PLANT CELL PHYSIOL, V44, P803, DOI 10.1093/pcp/pcg105; Denny T., 2006, PLANT ASS BACTERIA; DENNY TP, 1991, MOL PLANT MICROBE IN, V4, P198, DOI 10.1094/MPMI-4-198; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Genin S, 2002, MOL PLANT PATHOL, V3, P111, DOI 10.1046/j.1364-3703.2002.00102.x; Giovanini MP, 2006, MOL PLANT MICROBE IN, V19, P1023, DOI 10.1094/MPMI-19-1023; GRIMAULT V, 1993, PLANT PATHOL, V42, P589, DOI 10.1111/j.1365-3059.1993.tb01539.x; Hanson PM, 1996, HORTSCIENCE, V31, P143, DOI 10.21273/HORTSCI.31.1.143; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hirsch J, 2002, PHYTOPATHOLOGY, V92, P1142, DOI 10.1094/PHYTO.2002.92.10.1142; Ho FI, 2009, BOT STUD, V50, P413; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Katagiri F, 2004, CURR OPIN PLANT BIOL, V7, P506, DOI 10.1016/j.pbi.2004.07.013; LEVVY GA, 1959, BIOCHEM J, V73, P127, DOI 10.1042/bj0730127; Lin YM, 2008, MOL PLANT MICROBE IN, V21, P1261, DOI 10.1094/MPMI-21-9-1261; Makino S, 2006, J DAIRY SCI, V89, P2873, DOI 10.3168/jds.S0022-0302(06)72560-7; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; McGarvey JA, 1999, PHYTOPATHOLOGY, V89, P1233, DOI 10.1094/PHYTO.1999.89.12.1233; Milling A, 2009, PHYTOPATHOLOGY, V99, P1127, DOI 10.1094/PHYTO-99-10-1127; ORGAMBIDE G, 1991, J BIOL CHEM, V266, P8312; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Pfund C, 2004, MOL PLANT MICROBE IN, V17, P696, DOI 10.1094/MPMI.2004.17.6.696; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Romanenko AS, 2003, J PHYTOPATHOL, V151, P1, DOI 10.1046/j.1439-0434.2003.00667.x; Romeiro RS, 1997, J PHYTOPATHOL, V145, P495, DOI 10.1111/j.1439-0434.1997.tb00356.x; Saile E, 1997, PHYTOPATHOLOGY, V87, P1264, DOI 10.1094/PHYTO.1997.87.12.1264; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Smart CD, 2003, MOL PLANT MICROBE IN, V16, P141, DOI 10.1094/MPMI.2003.16.2.141; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; Tans-Kersten J, 1998, APPL ENVIRON MICROB, V64, P4918; Thoquet P, 1996, MOL PLANT MICROBE IN, V9, P826, DOI 10.1094/MPMI-9-0826; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JF, 1998, BACTERIAL WILT DISEASE, P269; Wang JF, 2000, MOL PLANT MICROBE IN, V13, P6, DOI 10.1094/MPMI.2000.13.1.6; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	56	117	127	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15853	10.1371/journal.pone.0015853	http://dx.doi.org/10.1371/journal.pone.0015853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253019	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900015
J	Hallbook, H; Felth, J; Eriksson, A; Fryknas, M; Bohlin, L; Larsson, R; Gullbo, J				Hallbook, Helene; Felth, Jenny; Eriksson, Anna; Fryknas, Marten; Bohlin, Lars; Larsson, Rolf; Gullbo, Joachim			Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia	PLOS ONE			English	Article							MICROCULTURE CYTOTOXICITY ASSAY; ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN TUMOR-CELLS; BREAST-CANCER; NA+/K+-ATPASE; DIGITALIS; APOPTOSIS; EXPRESSION; DIGITOXIN; BUFALIN	Background: Despite years of interest in the anti-cancerous effects of cardiac glycosides (CGs), and numerous studies in vitro and in animals, it has not yet been possible to utilize this potential clinically. Reports have demonstrated promising in vitro effects on different targets as well as a possible therapeutic index/selectivity in vitro and in experimental animals. Recently, however, general inhibition of protein synthesis was suggested as the main mechanism of the anti-cancerous effects of CGs. In addition, evidence of species differences of a magnitude sufficient to explain the results of many studies called for reconsideration of earlier results. Principal Findings: In this report we identified primary B-precursor and T-ALL cells as being particularly susceptible to the cytotoxic effects of CGs. Digitoxin appeared most potent and IC50 values for several patient samples were at concentrations that may be achieved in the clinic. Significant protein synthesis inhibition at concentrations corresponding to IC50 was demonstrated in colorectal tumour cell lines moderately resistant to the cytotoxic effects of digoxin and digitoxin, but not in highly sensitive leukaemia cell lines. Conclusion: It is suggested that further investigation regarding CGs may be focused on diagnoses like T-and B-precursor ALL.	[Hallbook, Helene] Uppsala Univ, Dept Haematol, Univ Hosp, Uppsala, Sweden; [Felth, Jenny; Bohlin, Lars] Uppsala Univ, Dept Med Chem, Div Pharmacognosy, Biomed Ctr, Uppsala, Sweden; [Eriksson, Anna; Fryknas, Marten; Larsson, Rolf; Gullbo, Joachim] Univ Uppsala Hosp, Dept Med Sci, Div Clin Pharmacol, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University; Uppsala University Hospital	Hallbook, H (corresponding author), Uppsala Univ, Dept Haematol, Univ Hosp, Uppsala, Sweden.	helene.hallbook@medsci.uu.se		Eriksson, Anna/0000-0002-8853-1863	Uppsala University Hospital; Lions cancer research found (in Swedish named: "Lions Cancerforskningsfond i Uppsala Orebro regionen")	Uppsala University Hospital; Lions cancer research found (in Swedish named: "Lions Cancerforskningsfond i Uppsala Orebro regionen")	The work was supported by grants from Uppsala University Hospital and from Lions cancer research found (in Swedish named: "Lions Cancerforskningsfond i Uppsala Orebro regionen"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassan R, 2004, CRIT REV ONCOL HEMAT, V50, P223, DOI 10.1016/j.critrevonc.2003.11.003; BECK WT, 1979, CANCER RES, V39, P2070; Bielawski K, 2006, BIOL PHARM BULL, V29, P1493, DOI 10.1248/bpb.29.1493; Bohmer T, 1998, AGE AGEING, V27, P222, DOI 10.1093/ageing/27.2.222; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; GOLDIN AG, 1984, LANCET, V1, P1134; Graves R, 1997, ANAL BIOCHEM, V248, P251, DOI 10.1006/abio.1997.2088; Harris DW, 1996, ANAL BIOCHEM, V243, P249, DOI 10.1006/abio.1996.0513; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Ihenetu K, 2007, CLIN CHEM, V53, P1315, DOI 10.1373/clinchem.2006.082081; JING YK, 1994, JPN J CANCER RES, V85, P645, DOI 10.1111/j.1349-7006.1994.tb02408.x; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Khan MI, 2009, AM J MED SCI, V337, P355, DOI 10.1097/MAJ.0b013e3181942f57; KHAN MI, 2007, ASCO2007 CHIC; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; LARSSON R, 1992, INT J CANCER, V50, P177, DOI 10.1002/ijc.2910500204; Lindhagen E, 2008, NAT PROTOC, V3, P1364, DOI 10.1038/nprot.2008.114; Lopez-Lazaro M, 2006, LEUKEMIA RES, V30, P895, DOI 10.1016/j.leukres.2005.11.005; MASUDA Y, 1995, LEUKEMIA RES, V19, P549, DOI 10.1016/0145-2126(95)00031-I; Mekhail T, 2006, INVEST NEW DRUG, V24, P423, DOI 10.1007/s10637-006-7772-x; NAUMOVSKI L, 1988, CANCER RES, V48, P2876; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Perne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008292; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Stenkvist B, 1999, ONCOL REP, V6, P493; Stenkvist B, 2001, ANTI-CANCER DRUG, V12, P635, DOI 10.1097/00001813-200108000-00012; STENKVIST B, 1979, LANCET, V1, P563; Turan Nevruz, 2006, J Exp Ther Oncol, V6, P31; Weidemann H, 2005, FRONT BIOSCI-LANDMRK, V10, P2165, DOI 10.2741/1688; Winnicka Katarzyna, 2006, Acta Pol Pharm, V63, P109; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x	34	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15718	10.1371/journal.pone.0015718	http://dx.doi.org/10.1371/journal.pone.0015718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246039	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511200012
J	Standiford, TJ; Kuick, R; Bhan, U; Chen, J; Newstead, M; Keshamouni, VG				Standiford, T. J.; Kuick, R.; Bhan, U.; Chen, J.; Newstead, M.; Keshamouni, V. G.			TGF-beta-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth	ONCOGENE			English	Article						IRAK-M; TGF-beta; lung cancer; tumor-associated macrophages; Toll-like receptors	TOLL-LIKE RECEPTORS; TRANSFORMING GROWTH-FACTOR-BETA-1 LEVEL; NEGATIVE REGULATOR; SIGNALING PATHWAY; IMMUNE-RESPONSES; INNATE IMMUNITY; HUMAN MONOCYTES; EARLY-STAGE; CANCER; ADENOCARCINOMA	Tumor-associated macrophages (TAMs) constitute a major component of the immune cell infiltrate observed in the tumor microenvironment (TME). Factors present in the TME, including tumor growth factor-beta (TGF-beta), allow tumors to circumvent host-mediated immune responses to promote tumor progression. However, the molecular mechanism(s) involved are not clear. Toll-like receptors (TLRs) are important mediators of innate immune responses by immune cells, whose activation triggers the production of molecules required for antitumoral responses. Interleukin (IL) receptor-associated kinase (IRAK)-M is an inactive serine/threonine kinase, predominantly expressed in macrophages and is a potent negative regulator of TLR signaling. In this study, we show that TAMs express significantly higher levels of IRAK-M compared with peritoneal macrophages in a syngeneic mouse model of lung cancer. Subcutaneous implantation of Lewis lung carcinoma cells in IRAK-M-/- mice resulted in a five-fold reduction in tumor growth as compared with tumors in wild-type (WT) animals. Furthermore, compared with WT TAMs, TAMs isolated from IRAK-M-/- mice displayed features of a classically activated (M1) rather than alternatively activated (M2) phenotype, as manifest by greater expression of IL-12, interferon-gamma (IFN-gamma) and inducible nitric oxide synthase. Human lung cancer cells induced IRAK-M expression in human peripheral blood mononuclear cells (PBMCs) when co-cultured together. Tumor cell-induced expression of IRAK-M was dependent on the activation of TGF-beta pathway. Similarly, treatment of human PBMCs or mouse macrophage cell line, RAW 264.4, with TGF-beta, induced IRAK-M expression. Interestingly, IRAK-M gene expression in 439 human lung adenocarcinoma tumors correlated with poor survival in patients with lung cancer. Together, our data demonstrates that TGF-beta-dependent induction of IRAK-M expression is an important, clinically relevant mechanism by which tumors may circumvent anti-tumor responses of macrophages. Oncogene (2011) 30, 2475-2484; doi:10.1038/onc.2010.619; published online 31 January 2011	[Standiford, T. J.; Bhan, U.; Chen, J.; Newstead, M.; Keshamouni, V. G.] Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Kuick, R.; Keshamouni, V. G.] Univ Michigan, Med Ctr, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Keshamouni, VG (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, 4062 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	vkeshamo@med.umich.edu		Keshamouni, Venkateshwar/0000-0003-1947-791X	NIH/NCI [R01 CA132571-01]; American Cancer Society [RSG-CSM-116801]; NIH/NHLBI [HL25243, HL097564]; NATIONAL CANCER INSTITUTE [R01CA132571] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097564] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is funded by the NIH/NCI (R01 CA132571-01), and the American Cancer Society (RSG-CSM-116801) grants to VGK, and NIH/NHLBI HL25243 and HL097564 to TJS.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.006; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; JACOBSEN SEW, 1991, BLOOD, V78, P2239, DOI 10.1182/blood.V78.9.2239.bloodjournal7892239; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Johnson SK, 2000, LUNG CANCER-J IASLC, V27, P27, DOI 10.1016/S0169-5002(99)00095-1; Kim WS, 1999, ANTICANCER RES, V19, P301; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kong FM, 1999, CANCER-AM CANCER SOC, V86, P1712, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1712::AID-CNCR12>3.0.CO;2-V; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Moustakas A, 2003, GENE DEV, V17, P2855, DOI 10.1101/gad.1161403; Mytar B, 2003, J LEUKOCYTE BIOL, V74, P1094, DOI 10.1189/jlb.0403140; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Scagliotti G, 2003, LUNG CANCER-J IASLC, V42, pS47, DOI 10.1016/S0169-5002(03)00304-0; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Seya T, 2003, ANTICANCER RES, V23, P4369; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Souquet PJ, 2001, LUNG CANCER-J IASLC, V34, pS155, DOI 10.1016/S0169-5002(01)00361-0; Toonkel RL, 2010, J THORAC ONCOL, V5, P153, DOI 10.1097/JTO.0b013e3181c8cc0c; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004	44	95	101	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	21					2475	2484		10.1038/onc.2010.619	http://dx.doi.org/10.1038/onc.2010.619			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21278795	Green Accepted			2022-12-25	WOS:000291008000009
J	Nagamatsu, G; Kosaka, T; Kawasumi, M; Kinoshita, T; Takubo, K; Akiyama, H; Sudo, T; Kobayashi, T; Oya, M; Suda, T				Nagamatsu, Go; Kosaka, Takeo; Kawasumi, Miyuri; Kinoshita, Taisuke; Takubo, Keiyo; Akiyama, Hideo; Sudo, Tetsuo; Kobayashi, Takashi; Oya, Mototsugu; Suda, Toshio			A Germ Cell-specific Gene, Prmt5, Works in Somatic Cell Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; ARGININE METHYLATION; MOUSE; GENERATION; INDUCTION; HISTONE; EXPRESSION; DYNAMICS; LINEAGE; PRDM14	Germ cells possess the unique ability to acquire totipotency during development in vivo as well as give rise to pluripotent stem cells under the appropriate conditions in vitro. Recent studies in which somatic cells were experimentally converted into pluripotent stem cells revealed that genes expressed in primordial germ cells (PGCs), such as Oct3/4, Sox2, and Lin28, are involved in this reprogramming. These findings suggest that PGCs may be useful for identifying factors that successfully and efficiently reprogram somatic cells into toti- and/or pluripotent stem cells. Here, we show that Blimp-1, Prdm14, and Prmt5, each of which is crucial for PGC development, have the potential to reprogram somatic cells into pluripotent stem cells. Among them, Prmt5 exhibited remarkable reprogramming of mouse embryonic fibroblasts into which Prmt5, Klf4, and Oct3/4 were introduced. The resulting cells exhibited pluripotent gene expression, teratoma formation, and germline transmission in chimeric mice, all of which were indistinguishable from those induced with embryonic stem cells. These data indicate that some of the factors that play essential roles in germ cell development are also active in somatic cell reprogramming.	[Nagamatsu, Go] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab,Shinjuku Ku, Tokyo 1608582, Japan; [Kosaka, Takeo; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo 1608582, Japan; [Kawasumi, Miyuri; Kobayashi, Takashi] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Nagamatsu, Go] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Akiyama, Hideo; Sudo, Tetsuo] Toray New Frontiers Res Labs, Kanagawa 2488555, Japan	Keio University; Keio University; Keio University; Japan Science & Technology Agency (JST)	Nagamatsu, G (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	gonag@sc.itc.keio.ac.jp; sudato@sc.itc.keio.ac.jp	Oya, Mototsugu/K-8592-2013; Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020	Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592	Japan Science and Technology Agency; Project for Realization of Regenerative Medicine; MEXT; Keio University; PREST	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University; PREST	This work was supported by PREST of the Japan Science and Technology Agency and Grant-in-Aid for Young Scientists (B) and a Grant-in-aid for Scientific Research (KAKENHI) on Innovative Areas, "Regulatory Mechanism of Gamate Stem Cells." This work was also supported in part by a grant from the Project for Realization of Regenerative Medicine, and support for the core institutes for iPS cell research was provided by MEXT, a Grant-in-aid for the Global Century COE Program from MEXT to Keio University, and the Keio University Medical Science Fund.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Fujino RS, 2006, MOL ENDOCRINOL, V20, P904, DOI 10.1210/me.2005-0423; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka SS, 2000, GENE DEV, V14, P841; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN X, 2011, STEM CELLS IN PRESS; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	33	50	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10641	10648		10.1074/jbc.M110.216390	http://dx.doi.org/10.1074/jbc.M110.216390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21270127	Green Published, hybrid			2022-12-25	WOS:000288547000078
J	Gee, JE; Glass, MB; Lackner, G; Helsel, LO; Daneshvar, M; Hollis, DG; Jordan, J; Morey, R; Steigerwalt, A; Hertweck, C				Gee, Jay E.; Glass, Mindy B.; Lackner, Gerald; Helsel, Leta O.; Daneshvar, Maryam; Hollis, Dannie G.; Jordan, Jean; Morey, Roger; Steigerwalt, Arnold; Hertweck, Christian			Characterization of Burkholderia rhizoxinica and B. endofungorum Isolated from Clinical Specimens	PLOS ONE			English	Article							FUNGUS RHIZOPUS-MICROSPORUS; BACTERIAL ENDOSYMBIONTS; BAYESIAN-INFERENCE; SP-NOV.; EVOLUTIONARY; RHIZONIN; TOXIN; PSEUDOMALLEI	Eight isolates submitted to CDC from 1989 to 2006 from clinical specimens were initially identified as members of the genus Burkholderia based on preliminary cellular fatty acid analysis and/or 16S rRNA gene sequencing. With the recent descriptions of the new species B. rhizoxinica and B. endofungorum, which are considered endosymbiotic bacteria in Rhizopus microsporus fungi, we now identify seven of these clinical isolates as B. rhizoxinica and one as B. endofungorum based on biochemical testing, 16s rRNA, and DNA-DNA hybridization results. We also further characterize these isolates by assessing toxin production and/or by multiple locus sequence typing.	[Gee, Jay E.; Glass, Mindy B.; Helsel, Leta O.; Daneshvar, Maryam; Hollis, Dannie G.; Jordan, Jean; Morey, Roger; Steigerwalt, Arnold] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Lackner, Gerald; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hertweck, Christian] Univ Jena, Jena, Germany	Centers for Disease Control & Prevention - USA; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Gee, JE (corresponding author), Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	JGee1@cdc.gov	Hertweck, Christian/G-1896-2014; Hertweck, Christian/AAZ-8452-2021	Hertweck, Christian/0000-0002-0367-337X; Hertweck, Christian/0000-0002-0367-337X; Lackner, Gerald/0000-0002-0307-8319; Gee, Jay/0000-0003-4308-1659				BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ibrahim AS, 2008, J INFECT DIS, V198, P1083, DOI 10.1086/591461; IWASAKI S, 1984, J ANTIBIOT, V37, P354, DOI 10.7164/antibiotics.37.354; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lackner G, 2009, TRENDS MICROBIOL, V17, P570, DOI 10.1016/j.tim.2009.09.003; Lackner G, 2009, APPL ENVIRON MICROB, V75, P2982, DOI 10.1128/AEM.01765-08; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Partida-Martinez LP, 2008, MYCOSES, V51, P266, DOI 10.1111/j.1439-0507.2007.01477.x; Partida-Martinez LP, 2007, INT J SYST EVOL MICR, V57, P2583, DOI 10.1099/ijs.0.64660-0; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2007, CURR BIOL, V17, P773, DOI 10.1016/j.cub.2007.03.039; Partida-Martinez LP, 2007, APPL ENVIRON MICROB, V73, P793, DOI 10.1128/AEM.01784-06; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Sato Z., 1983, ANN PHYTOPATHOL SOC, V49, P128; Scherlach K, 2006, J AM CHEM SOC, V128, P11529, DOI 10.1021/ja062953o; STEYN PS, 1983, J CHEM SOC CHEM COMM, P47, DOI 10.1039/c39830000047; Weyant RS, 1995, IDENTIFICATION UNUSU, V2nd; WILSON T, 1984, FOOD CHEM TOXICOL, V22, P275, DOI 10.1016/0278-6915(84)90006-1; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x	27	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15731	10.1371/journal.pone.0015731	http://dx.doi.org/10.1371/journal.pone.0015731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267449	gold, Green Published			2022-12-25	WOS:000286519500026
J	Rajoria, S; Suriano, R; George, A; Shanmugam, A; Schantz, SP; Geliebter, J; Tiwari, RK				Rajoria, Shilpi; Suriano, Robert; George, Andrea; Shanmugam, Arulkumaran; Schantz, Stimson P.; Geliebter, Jan; Tiwari, Raj K.			Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3 '-Diindolylmethane in Thyroid Cancer	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; PROSTATE-CANCER; MOLECULAR TARGETS; CELL INVASION; MUSCLE-CELLS; RECEPTOR; INDOLE-3-CARBINOL; PATHWAY; ACTIVATION	Background: Thyroid cancer is the most common endocrine related cancer with increasing incidences during the past five years. Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significant recurrence rates of thyroid cancer, new preventive modalities are needed. The present study investigates the property of a natural dietary compound found in cruciferous vegetables, 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of thyroid cancer cells through a functional estrogen receptor. Methodology/Principal Findings: Thyroid cancer cell lines were treated with estrogen and/or DIM and subjected to in vitro adhesion, migration and invasion assays to investigate the anti-metastatic and anti-estrogenic effects of DIM. We observed that DIM inhibits estrogen mediated increase in thyroid cell migration, adhesion and invasion, which is also supported by ER-a downregulation (siRNA) studies. Western blot and zymography analyses provided direct evidence for this DIM mediated inhibition of E-2 enhanced metastasis associated events by virtue of targeting essential proteolytic enzymes, namely MMP-2 and MMP-9. Conclusion/Significance: Our data reports for the first time that DIM displays anti-estrogenic like activity by inhibiting estradiol enhanced thyroid cancer cell proliferation and in vitro metastasis associated events, namely adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were determined to be targets of DIM. This anti-estrogen like property of DIM may lead to the development of a novel preventive and/or therapeutic dietary supplement for thyroid cancer patients by targeting progression of the disease.	[Rajoria, Shilpi; Suriano, Robert; George, Andrea; Shanmugam, Arulkumaran; Geliebter, Jan; Tiwari, Raj K.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Schantz, Stimson P.] New York Eye & Ear Infirm, Dept Otolaryngol, New York, NY 10003 USA	New York Medical College; New York Eye & Ear Infirmary of Mount Sinai	Rajoria, S (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	raj_tiwari@nymc.edu			National Cancer Institute [1R01CA131946]; New York Eye and Ear Infirmary, New York, New York; NATIONAL CANCER INSTITUTE [R01CA131946] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York Eye and Ear Infirmary, New York, New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute 1R01CA131946 and clinical funding from the New York Eye and Ear Infirmary, New York, New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Ashok B. T., 2004, Recent Research Developments in Nutrition, Vol. 6, P83; Ashok BT, 2002, EUR J CANCER PREV, V11, pS86; Bode AM, 2009, NAT REV CANCER, V9, P508, DOI 10.1038/nrc2646; Bradlow HL, 2002, ANN NY ACAD SCI, V963, P247; Ciocca DR, 1997, TRENDS ENDOCRIN MET, V8, P313, DOI 10.1016/S1043-2760(97)00122-7; Dalessandri KM, 2004, NUTR CANCER, V50, P161, DOI 10.1207/s15327914nc5002_5; Fitzgibbons SC, 2008, AM SURGEON, V74, P389; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Garikapaty VPS, 2006, PROSTATE, V66, P453, DOI 10.1002/pros.20350; Garikapaty VPS, 2006, BIOCHEM BIOPH RES CO, V340, P718, DOI 10.1016/j.bbrc.2005.12.059; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Hua KQ, 2008, INT J ONCOL, V33, P959, DOI 10.3892/ijo_00000083; Husain S, 2005, INVEST OPHTH VIS SCI, V46, P1706, DOI 10.1167/iovs.04-0993; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamel H, 2010, J OBSTET GYNAECOL CA, V32, P580, DOI 10.1016/S1701-2163(16)34527-3; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Leibelt DA, 2003, TOXICOL SCI, V74, P10, DOI 10.1093/toxsci/kfg103; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Manavathi B, 2006, J CELL PHYSIOL, V207, P594, DOI 10.1002/jcp.20551; Marquez DC, 2006, MOL CELL ENDOCRINOL, V246, P91, DOI 10.1016/j.mce.2005.11.020; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Nikiforov YE, 2008, MODERN PATHOL, V21, pS37, DOI 10.1038/modpathol.2008.10; Nilsson UW, 2007, BREAST CANCER RES TR, V102, P253, DOI 10.1007/s10549-006-9335-4; Noujaim D, 2002, ONCOGENE, V21, P4549, DOI 10.1038/sj.onc.1205552; O-charoenrat P, 2000, CANCER RES, V60, P1121; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Pietras Richard J, 2003, Breast J, V9, P361, DOI 10.1046/j.1524-4741.2003.09510.x; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Rajoria S, 2010, THYROID, V20, P33, DOI 10.1089/thy.2009.0296; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Smith S, 2008, J NUTR, V138, P2379, DOI 10.3945/jn.108.090993; Song RXD, 2006, BIOL REPROD, V75, P9, DOI 10.1095/biolreprod.105.050070; Sun M, 2001, CANCER RES, V61, P5985; Suriano R, 2008, CANCER RES, V68, P6038, DOI 10.1158/0008-5472.CAN-08-1009; TIWARI RK, 1994, J NATL CANCER I, V86, P126, DOI 10.1093/jnci/86.2.126; Tuttle RM, 2008, ENDOCRIN METAB CLIN, V37, P419, DOI 10.1016/j.ecl.2008.02.008; Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Yeh MW, 2006, ENDOCR-RELAT CANCER, V13, P1173, DOI 10.1677/erc.1.01226	50	61	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15879	10.1371/journal.pone.0015879	http://dx.doi.org/10.1371/journal.pone.0015879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267453	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500029
J	Hwang, GM; DiCarlo, AA; Lin, GC				Hwang, Grace M.; DiCarlo, Anthony A.; Lin, Gene C.			An Analysis on the Detection of Biological Contaminants Aboard Aircraft	PLOS ONE			English	Article							LEICESTER-COUGH-MONITOR; AIR-FLOW; SUBJECTIVE ASSESSMENTS; PARTICLE-TRANSPORT; TRANSMISSION; FREQUENCY; VIRUS; INFECTION; SYSTEM; CABIN	The spread of infectious disease via commercial airliner travel is a significant and realistic threat. To shed some light on the feasibility of detecting airborne pathogens, a sensor integration study has been conducted and computational investigations of contaminant transport in an aircraft cabin have been performed. Our study took into consideration sensor sensitivity as well as the time-to-answer, size, weight and the power of best available commercial off-the-shelf (COTS) devices. We conducted computational fluid dynamics simulations to investigate three types of scenarios: (1) nominal breathing (up to 20 breaths per minute) and coughing (20 times per hour); (2) nominal breathing and sneezing (4 times per hour); and (3) nominal breathing only. Each scenario was implemented with one or seven infectious passengers expelling air and sneezes or coughs at the stated frequencies. Scenario 2 was implemented with two additional cases in which one infectious passenger expelled 20 and 50 sneezes per hour, respectively. All computations were based on 90 minutes of sampling using specifications from a COTS aerosol collector and biosensor. Only biosensors that could provide an answer in under 20 minutes without any manual preparation steps were included. The principal finding was that the steady-state bacteria concentrations in aircraft would be high enough to be detected in the case where seven infectious passengers are exhaling under scenarios 1 and 2 and where one infectious passenger is actively exhaling in scenario 2. Breathing alone failed to generate sufficient bacterial particles for detection, and none of the scenarios generated sufficient viral particles for detection to be feasible. These results suggest that more sensitive sensors than the COTS devices currently available and/or sampling of individual passengers would be needed for the detection of bacteria and viruses in aircraft.	[Hwang, Grace M.] Mitre Corp, Dept Off Chief Engineer, Mclean, VA USA; [DiCarlo, Anthony A.] Mitre Corp, Dept Mech & Reliabil Engn, Bedford, MA 01730 USA; [Lin, Gene C.] Mitre Corp, Dept W & Int Redesign, Mclean, VA USA	MITRE Corporation; MITRE Corporation; MITRE Corporation	Hwang, GM (corresponding author), Mitre Corp, Dept Off Chief Engineer, Mclean, VA USA.	gmhwang@mitre.org	Hwang, Grace/L-6096-2019	Hwang, Grace/0000-0002-3335-8688	MITRE Corporation	MITRE Corporation	All three authors work for the funders (i.e., the MITRE Corporation). MITRE is a not-for-profit Corporation that operates four federally funded research and development centers. MITRE has an annual budget allocated to research and development. This work was conducted under the internal R&D program, and the program is run by a set of chief engineers who provide management and financial oversight for the study. Management had no direct role in study design, data collection and analysis. The authors have the discretion to publish their research in the public domain after approval from management is obtained. This work was funded by The MITRE Corporation via the Bio-Threat Aircraft Warning System (BTAWS) research project. The contents of this document reflect the views of the author and The MITRE Corporation and do not necessarily reflect the views of the FAA or the DOT or any other government entities that MITRE supports.	Aboosaidi F., 1991, P SOC AUTOMOTIVE ENG, V246, P249; Armendariz AJ, 2002, J AEROSOL SCI, V33, P133, DOI 10.1016/S0021-8502(01)00152-5; BAKER AJ, 2006, ADA455914 CIV AER I; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Bischoff WE, 2006, J INFECT DIS, V194, P1119, DOI 10.1086/507908; Coyle Michael A, 2005, Cough, V1, P3, DOI 10.1186/1745-9974-1-3; Decalmer SC, 2007, THORAX, V62, P329, DOI 10.1136/thx.2006.067413; DUGUID JP, 1946, J HYG, V4, P471; Emanuel P.A., 2007, BIOL DETECTORS MARKE; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; GARNER RP, 2004, DOTFAAAM047 OFF AER, P1; GERENCHER C, 2010, RES TRANSMISSION DIS, P28; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; Hunt E.H., 1994, AIRPLANE CABIN ENV I; HWANG GM, 2009, TECHNOLOGIES HOMELAN, P477; KESAVAN JS, 2006, ECBCTN028; Key Angela L, 2010, Cough, V6, P4, DOI 10.1186/1745-9974-6-4; Li AM, 2003, THORAX, V58, P974, DOI 10.1136/thorax.58.11.974; Lin CH, 2006, HVAC&R RES, V12, P935, DOI 10.1080/10789669.2006.10391218; Liu X, 2007, INDOOR BUILT ENVIRON, V16, P322, DOI 10.1177/1420326X06079890; LOUDON RG, 1967, AM REV RESPIR DIS, V96, P1137; LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Matos S, 2007, IEEE T BIO-MED ENG, V54, P1472, DOI 10.1109/TBME.2007.900811; Mazumdar S, 2008, J ENVIRON MONITOR, V10, P71, DOI 10.1039/b713187a; MIZUNO T, 1992, ASHRAE TRAN, V98, P329; MO H, 2003, ASHRAE T, V109, P101; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; *NAT RES COUNC, 2006, DEF US AIR TRANSP SY; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; OTTA J, 2009, J CLIN MICROBIOL, V1, P205; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; SAYWELL T, 2003, D JONES FAR E EC REV; Singh A., 2002, ASHRAE T, V108, P13; Smith JA, 2006, THORAX, V61, P425, DOI 10.1136/thx.2005.050963; Smith J, 2006, CHEST, V130, P379, DOI 10.1016/S0012-3692(15)51851-5; Smith Jaclyn A, 2006, Cough, V2, P1, DOI 10.1186/1745-9974-2-1; Staub N.C., 1991, BASIC RESP PHYSL; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Sun YG, 2005, ASHRAE TRAN, V111, P45; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Zhai Z, 2007, HVAC&R RES, V2007, P853, DOI DOI 10.1080/10789669.2007.10391459; Zhang T, 2007, HVAC&R RES, V13, P683, DOI 10.1080/10789669.2007.10390980; Zhang Z, 2007, ATMOS ENVIRON, V41, P5236, DOI 10.1016/j.atmosenv.2006.05.086; Zhang Z, 2006, ATMOS ENVIRON, V40, P3396, DOI 10.1016/j.atmosenv.2006.01.014; Zhang Z, 2009, BUILD ENVIRON, V44, P85, DOI 10.1016/j.buildenv.2008.01.012; Zhang Z, 2007, HVAC&R RES, V13, P871, DOI 10.1080/10789669.2007.10391460; Zihlif N, 2005, PEDIATR PULM, V39, P551, DOI 10.1002/ppul.20202; CLIN INFECT DIS, V51, P1033	55	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14520	10.1371/journal.pone.0014520	http://dx.doi.org/10.1371/journal.pone.0014520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264266	gold, Green Published, Green Submitted			2022-12-25	WOS:000286517600004
J	Shapira, A; Gal-Tanamy, M; Nahary, L; Litvak-Greenfeld, D; Zemel, R; Tur-Kaspa, R; Benhar, I				Shapira, Assaf; Gal-Tanamy, Meital; Nahary, Limor; Litvak-Greenfeld, Dana; Zemel, Romy; Tur-Kaspa, Ran; Benhar, Itai			Engineered Toxins "Zymoxins'' Are Activated by the HCV NS3 Protease by Removal of an Inhibitory Protein Domain	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RICIN-A-CHAIN; RIBOSOME-INACTIVATING PROTEIN; AERUGINOSA EXOTOXIN-A; SHIGA-LIKE TOXIN-1; PSEUDOMONAS EXOTOXIN; SERINE-PROTEASE; MEMBRANE ASSOCIATION; DELETION ANALYSIS; REPLICATION	The synthesis of inactive enzyme precursors, also known as "zymogens,'' serves as a mechanism for regulating the execution of selected catalytic activities in a desirable time and/or site. Zymogens are usually activated by proteolytic cleavage. Many viruses encode proteases that execute key proteolytic steps of the viral life cycle. Here, we describe a proof of concept for a therapeutic approach to fighting viral infections through eradication of virally infected cells exclusively, thus limiting virus production and spread. Using the hepatitis C virus (HCV) as a model, we designed two HCV NS3 protease-activated "zymogenized'' chimeric toxins (which we denote "zymoxins''). In these recombinant constructs, the bacterial and plant toxins diphtheria toxin A (DTA) and Ricin A chain (RTA), respectively, were fused to rationally designed inhibitor peptides/domains via an HCV NS3 protease-cleavable linker. The above toxins were then fused to the binding and translocation domains of Pseudomonas exotoxin A in order to enable translocation into the mammalian cells cytoplasm. We show that these toxins exhibit NS3 cleavage dependent increase in enzymatic activity upon NS3 protease cleavage in vitro. Moreover, a higher level of cytotoxicity was observed when zymoxins were applied to NS3 expressing cells or to HCV infected cells, demonstrating a potential therapeutic window. The increase in toxin activity correlated with NS3 protease activity in the treated cells, thus the therapeutic window was larger in cells expressing recombinant NS3 than in HCV infected cells. This suggests that the "zymoxin'' approach may be most appropriate for application to life-threatening acute infections where much higher levels of the activating protease would be expected.	[Shapira, Assaf; Nahary, Limor; Litvak-Greenfeld, Dana; Benhar, Itai] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran] Tel Aviv Univ, Mol Hepatol Res Lab, Felsenstein Med Res Ctr, Sackler Sch Med, Petah Tiqwa, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Shapira, A (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel.	benhar@post.tau.ac.il		Benhar, Itai/0000-0002-0824-7177	Israel Science Foundation (ISF) [397/08]; Recanati Foundation, Israel [0601242231]; Ministry of Health, Israel [3-4179]	Israel Science Foundation (ISF)(Israel Science Foundation); Recanati Foundation, Israel; Ministry of Health, Israel	This research was supported by grants from the Israel Science Foundation (ISF) (grant No. 397/08), the Recanati Foundation (grant No 0601242231), Israel and by grant No. 3-4179 of the "Ezvonot'' Fund from the Ministry of Health, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; BASS HW, 1992, PLANT CELL, V4, P225, DOI 10.1105/tpc.4.2.225; Berdichevsky Y, 2003, J VIROL METHODS, V107, P245, DOI 10.1016/S0166-0934(02)00255-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Brass Volker, 2006, Int J Med Sci, V3, P29; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; COLLIER RJ, 1971, J BIOL CHEM, V246, P1496; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; DEBINSKI W, 1994, BIOCONJUGATE CHEM, V5, P40, DOI 10.1021/bc00025a006; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dimasi N, 1998, PROTEIN ENG, V11, P1257, DOI 10.1093/protein/11.12.1257; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Falnes PO, 1999, BIOCHEM J, V343, P199, DOI 10.1042/0264-6021:3430199; FitzGerald D, 1991, Semin Cell Biol, V2, P31; Frelin L, 2003, GENE THER, V10, P686, DOI 10.1038/sj.gt.3301933; Gal-Tanamy M, 2005, J MOL BIOL, V347, P991, DOI 10.1016/j.jmb.2005.02.020; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; GUIDIRONTANI C, 1992, MOL MICROBIOL, V6, P1281, DOI 10.1111/j.1365-2958.1992.tb00849.x; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hsu JTA, 2006, CURR PHARM DESIGN, V12, P1301, DOI 10.2174/138161206776361110; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; IGLEWSKI BH, 1977, INFECT IMMUN, V15, P138, DOI 10.1128/IAI.15.1.138-144.1977; Jackson ME, 1999, J CELL SCI, V112, P467; Johnson RJ, 2006, FEBS J, V273, P5457, DOI 10.1111/j.1742-4658.2006.05536.x; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jucovic M, 2008, PROTEIN ENG DES SEL, V21, P631, DOI 10.1093/protein/gzn038; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; KREITMAN RJ, 1995, BIOCHEM J, V307, P29, DOI 10.1042/bj3070029; LAW SK, 2010, NUCL ACIDS RES  0617; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mansfield E, 1996, BIOCONJUGATE CHEM, V7, P557, DOI 10.1021/bc960043y; MAY MJ, 1989, EMBO J, V8, P301, DOI 10.1002/j.1460-2075.1989.tb03377.x; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McGivern DR, 2009, J VIROL, V83, P7422, DOI 10.1128/JVI.00262-09; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Munishkin A, 1995, J BIOL CHEM, V270, P30581, DOI 10.1074/jbc.270.51.30581; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Parikh BA, 2004, MINI-REV MED CHEM, V4, P523, DOI 10.2174/1389557043403800; Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; PITCHER C, 1995, BIOCONJUGATE CHEM, V6, P624, DOI 10.1021/bc00035a018; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Ratts R, 2005, TOP CURR GENET, V11, P1, DOI 10.1007/b102267; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Rychlowska M, 2007, ACTA BIOCHIM POL, V54, P703; Shaki-Loewenstein S, 2005, J IMMUNOL METHODS, V303, P19, DOI 10.1016/j.jim.2005.05.004; Steinkuhler C, 1996, J VIROL, V70, P6694; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; Turcotte RF, 2008, AIDS RES HUM RETROV, V24, P1357, DOI 10.1089/aid.2008.0146; Varshavsky A, 1995, COLD SPRING HARB SYM, V60, P461, DOI 10.1101/SQB.1995.060.01.051; VATER CA, 1995, J BIOL CHEM, V270, P12933, DOI 10.1074/jbc.270.21.12933; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WALSH TA, 1991, J BIOL CHEM, V266, P23422; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Zemel R, 2004, J HEPATOL, V40, P1000, DOI 10.1016/j.jhep.2004.02.026; Zhang RM, 1997, J VIROL, V71, P6208, DOI 10.1128/JVI.71.8.6208-6213.1997; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	76	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15916	10.1371/journal.pone.0015916	http://dx.doi.org/10.1371/journal.pone.0015916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264238	gold, Green Published, Green Submitted			2022-12-25	WOS:000286516500016
J	Freitas, MS; Follmer, C; Costa, LT; Vilani, C; Bianconi, ML; Achete, CA; Silva, JL				Freitas, Monica S.; Follmer, Cristian; Costa, Lilian T.; Vilani, Cecilia; Bianconi, M. Lucia; Achete, Carlos Alberto; Silva, Jerson L.			Measuring the Strength of Interaction between the Ebola Fusion Peptide and Lipid Rafts: Implications for Membrane Fusion and Virus Infection	PLOS ONE			English	Article							FOLATE RECEPTOR-ALPHA; CELLULAR ENTRY; GLYCOPROTEIN; CAVEOLAE; MECHANISM; PROTEINS; CYCLODEXTRINS; TRAFFICKING; ASSOCIATION; INVOLVEMENT	The Ebola fusion peptide (EBO(16)) is a hydrophobic domain that belongs to the GP2 membrane fusion protein of the Ebola virus. It adopts a helical structure in the presence of mimetic membranes that is stabilized by the presence of an aromatic-aromatic interaction established by Trp8 and Phe12. In spite of its infectious cycle becoming better understood recently, several steps still remain unclear, a lacuna that makes it difficult to develop strategies to block infection. In order to gain insight into the mechanism of membrane fusion, we probed the structure, function and energetics of EBO(16) and its mutant W8A, in the absence or presence of different lipid membranes, including isolated domain-resistant membranes (DRM), a good experimental model for lipid rafts. The depletion of cholesterol from living mammalian cells reduced the ability of EBO(16) to induce lipid mixing. On the other hand, EBO(16) was structurally sensitive to interaction with lipid rafts (DRMs), but the same was not observed for W8A mutant. In agreement with these data, W8A showed a poor ability to promote membrane aggregation in comparison to EBO(16). Single molecule AFM experiments showed a high affinity force pattern for the interaction of EBO(16) and DRM, which seems to be a complex energetic event as observed by the calorimetric profile. Our study is the first to show a strong correlation between the initial step of Ebola virus infection and cholesterol, thus providing a rationale for Ebola virus proteins being co-localized with lipid-raft domains. In all, the results show how small fusion peptide sequences have evolved to adopt highly specific and strong interactions with membrane domains. Such features suggest these processes are excellent targets for therapeutic and vaccine approaches to viral diseases.	[Freitas, Monica S.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Ciencias & Tecnol Biol Estrutural & Bio, Rio De Janeiro, Brazil; [Follmer, Cristian] Univ Fed Rio de Janeiro, Inst Quim, Dept Quim Fis, Rio De Janeiro, Brazil; [Costa, Lilian T.; Vilani, Cecilia; Achete, Carlos Alberto] Inmetro, Div Metrol Mat DIMAT, Rio De Janeiro, Brazil; [Bianconi, M. Lucia] Univ Fed Rio de Janeiro, Inst Bioqum Med, Lab Biocalorimetria, Rio De Janeiro, Brazil; [Achete, Carlos Alberto] Univ Fed Rio de Janeiro, COPPE, Programa Engn Met & Mat, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Freitas, MS (corresponding author), FMP, Leibniz Inst Mol Pharmakol, Berlin, Germany.	jerson@bioqmed.ufrj.br	Vilani, Cecilia/AAG-8988-2021; Follmer, Cristian/O-6134-2016; Silva, Jerson/J-8984-2014; de Freitas, Mônica Santos/E-8540-2015; SILVA, JERSON Lima/GRF-1442-2022; Inomat, Inct/H-9989-2013; Achete, carlos/AAS-5843-2021	Follmer, Cristian/0000-0001-6178-0432; Silva, Jerson/0000-0001-9523-9441; de Freitas, Mônica Santos/0000-0003-3105-7918; SILVA, JERSON Lima/0000-0001-9523-9441; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT); Departatmento de Ciencia e Tecnologia/Ministerio da Saude; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT); Departatmento de Ciencia e Tecnologia/Ministerio da Saude; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the following public Brazilian funding agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program), Departatmento de Ciencia e Tecnologia/Ministerio da Saude, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The grants supported the acquisition of consumables and equipments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MA, 2001, J CELL SCI, V114, P3957; Aman MJ, 2003, MICROBES INFECT, V5, P639, DOI 10.1016/S1286-4579(03)00095-9; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; Biswas S, 2008, J GEN PHYSIOL, V131, P503, DOI 10.1085/jgp.200709932; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Gallaher WR, 1996, CELL, V85, P477, DOI 10.1016/S0092-8674(00)81248-9; Gomara MJ, 2004, FEBS LETT, V569, P261, DOI 10.1016/j.febslet.2004.06.006; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Maia LF, 2006, J BIOL CHEM, V281, P29278, DOI 10.1074/jbc.M604689200; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; OSTROWSKY N, 1981, OPT ACTA, V28, P1059, DOI 10.1080/713820704; Ruiz-Arguello MB, 1998, J VIROL, V72, P1775; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Suarez T, 2003, FEBS LETT, V535, P23, DOI 10.1016/S0014-5793(02)03847-4; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Vilani C, 2007, APPL SURF SCI, V254, P131, DOI 10.1016/j.apsusc.2007.07.060; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Volynsky PE, 2005, BIOCHEMISTRY-US, V44, P14626, DOI 10.1021/bi0514562; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	39	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15756	10.1371/journal.pone.0015756	http://dx.doi.org/10.1371/journal.pone.0015756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249196	Green Published, Green Submitted, gold			2022-12-25	WOS:000286515000007
J	Ignatiadis, M; Rothe, F; Chaboteaux, C; Durbecq, V; Rouas, G; Criscitiello, C; Metallo, J; Kheddoumi, N; Singhal, SK; Michiels, S; Veys, I; Rossari, J; Larsimont, D; Carly, B; Pestrin, M; Bessi, S; Buxant, F; Liebens, F; Piccart, M; Sotiriou, C				Ignatiadis, Michail; Rothe, Francoise; Chaboteaux, Carole; Durbecq, Virginie; Rouas, Ghizlane; Criscitiello, Carmen; Metallo, Jessica; Kheddoumi, Naima; Singhal, Sandeep K.; Michiels, Stefan; Veys, Isabelle; Rossari, Jose; Larsimont, Denis; Carly, Birgit; Pestrin, Marta; Bessi, Silvia; Buxant, Frederic; Liebens, Fabienne; Piccart, Martine; Sotiriou, Christos			HER2-Positive Circulating Tumor Cells in Breast Cancer	PLOS ONE			English	Article							HER2 STATUS; STAGE-I; PREDICTS; RECOMMENDATIONS; EXPRESSION; SURVIVAL; BLOOD	Purpose: Circulating Tumor Cells (CTCs) detection and phenotyping are currently evaluated in Breast Cancer (BC). Tumor cell dissemination has been suggested to occur early in BC progression. To interrogate dissemination in BC, we studied CTCs and HER2 expression on CTCs across the spectrum of BC staging. Methods: Spiking experiments with 6 BC cell lines were performed and blood samples from healthy women and women with BC were analyzed for HER2-positive CTCs using the CellSearch (R). Results: Based on BC cell lines experiments, HER2-positive CTCs were defined as CTCs with HER2 immunofluoresence intensity that was at least 2.5 times higher than the background. No HER2-positive CTC was detected in 42 women without BC (95% confidence interval (CI) 0-8.4%) whereas 4.1% (95% CI 1.4-11.4%) of 73 patients with ductal/lobular carcinoma in situ (DCIS/LCIS) had 1 HER2-positive CTC/22.5 mL, 7.9%, (95% CI 4.1-14.9%) of 101 women with non metastatic (M0) BC had >= 1 HER2-positive CTC/22.5 mL (median 1 cell, range 1-3 cells) and 35.9% (95% CI 22.7-51.9%) of 39 patients with metastatic BC had >= 1 HER2-positive CTC/7.5 mL (median 1.5 cells, range 1-42 cells). In CTC-positive women with DCIS/LCIS or M0 BC, HER2-positive CTCs were more commonly detected in HER2-positive (5 of 5 women) than HER2-negative BC (5 of 12 women) (p = 0.03). Conclusion: HER2-positive CTCs were detected in DCIS/LCIS or M0 BC irrespective of the primary tumor HER2 status. Nevertheless, their presence was more common in women with HER2-positive disease. Monitoring of HER2 expression on CTCs might be useful in trials with anti-HER2 therapies.	[Ignatiadis, Michail; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium; [Ignatiadis, Michail; Rothe, Francoise; Chaboteaux, Carole; Durbecq, Virginie; Rouas, Ghizlane; Criscitiello, Carmen; Metallo, Jessica; Kheddoumi, Naima; Singhal, Sandeep K.; Michiels, Stefan; Rossari, Jose; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Breast Canc Translat Res Lab, B-1000 Brussels, Belgium; [Veys, Isabelle] Inst Jules Bordet, Dept Surg Oncol & Gynecol, B-1000 Brussels, Belgium; [Larsimont, Denis] Inst Jules Bordet, Dept Pathol, B-1000 Brussels, Belgium; [Carly, Birgit; Liebens, Fabienne] Hop St Pierre & Erasme, Dept Gynecol, Brussels, Belgium; [Pestrin, Marta; Bessi, Silvia] Hosp Prato, Translat Res Unit, Prato, Italy; [Buxant, Frederic] Hop Erasme, Dept Gynecol, Brussels, Belgium	Institut Jules Bordet; Institut Jules Bordet; Institut Jules Bordet; Institut Jules Bordet; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Prato Hospital; Universite Libre de Bruxelles	Ignatiadis, M (corresponding author), Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium.	Michail.Ignatiadis@bordet.be	Michiels, Stefan/L-1516-2013	Michiels, Stefan/0000-0002-6963-2968	La Fondation Fournier Majoie pour l'innovation; Fonds de la Recherche Scientifique -FNRS; MEDIC Foundation	La Fondation Fournier Majoie pour l'innovation; Fonds de la Recherche Scientifique -FNRS(Fonds de la Recherche Scientifique - FNRS); MEDIC Foundation	Michail Ignatiadis and Christos Sotiriou have received funding for research on Circulating Tumor Cells from "La Fondation Fournier Majoie pour l'innovation", from "Fonds de la Recherche Scientifique -FNRS" and from "MEDIC Foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Braun S, 2001, CANCER RES, V61, P1890; Criscitiello C, 2010, CURR OPIN ONCOL, V22, P552, DOI 10.1097/CCO.0b013e32833de186; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fehm T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1783; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hayes DF, 2002, INT J ONCOL, V21, P1111; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Lang JE, 2009, BREAST CANCER RES TR, V113, P501, DOI 10.1007/s10549-008-9951-2; Leake R, 2000, J CLIN PATHOL, V53, P634, DOI 10.1136/jcp.53.8.634; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Pachmann K, 2005, CLIN CHEM LAB MED, V43, P617, DOI 10.1515/CCLM.2005.107; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030; Riethdorf S, 2010, CLIN CANCER RES, V16, P2634, DOI 10.1158/1078-0432.CCR-09-2042; Sandri MT, 2010, ANN SURG ONCOL, V17, P1539, DOI 10.1245/s10434-010-0918-2; Solomayer EF, 2006, BREAST CANCER RES TR, V98, P179, DOI 10.1007/s10549-005-9147-y; Tibbe AGJ, 2001, CYTOMETRY, V43, P31, DOI 10.1002/1097-0320(20010101)43:1<31::AID-CYTO1016>3.0.CO;2-F; Tibbe AGJ, 2007, CYTOM PART A, V71A, P154, DOI 10.1002/cyto.a.20369; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087	25	148	151	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15624	10.1371/journal.pone.0015624	http://dx.doi.org/10.1371/journal.pone.0015624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264346	Green Submitted, Green Published, gold			2022-12-25	WOS:000286513100008
J	Hugler, M; Petersen, JM; Dubilier, N; Imhoff, JF; Sievert, SM				Huegler, Michael; Petersen, Jillian M.; Dubilier, Nicole; Imhoff, Johannes F.; Sievert, Stefan M.			Pathways of Carbon and Energy Metabolism of the Epibiotic Community Associated with the Deep-Sea Hydrothermal Vent Shrimp Rimicaris exoculata	PLOS ONE			English	Article							INORGANIC SULFUR-COMPOUNDS; TRICARBOXYLIC-ACID CYCLE; MICROBIAL COMMUNITIES; CO2 FIXATION; ULTRAMAFIC ROCKS; TROPHIC ECOLOGY; GILL CHAMBER; BACTERIA; DIVERSITY; FIELD	Background: The shrimp Rimicaris exoculata dominates the faunal biomass at many deep-sea hydrothermal vent sites at the Mid-Atlantic Ridge. In its enlarged gill chamber it harbors a specialized epibiotic bacterial community for which a nutritional role has been proposed. Methodology/Principal Findings: We analyzed specimens from the Snake Pit hydrothermal vent field on the Mid-Atlantic Ridge by complementing a 16S rRNA gene survey with the analysis of genes involved in carbon, sulfur and hydrogen metabolism. In addition to Epsilon-and Gammaproteobacteria, the epibiotic community unexpectedly also consists of Deltaproteobacteria of a single phylotype, closely related to the genus Desulfocapsa. The association of these phylogenetic groups with the shrimp was confirmed by fluorescence in situ hybridization. Based on functional gene analyses, we hypothesize that the Gamma-and Epsilonproteobacteria are capable of autotrophic growth by oxidizing reduced sulfur compounds, and that the Deltaproteobacteria are also involved in sulfur metabolism. In addition, the detection of proteobacterial hydrogenases indicates the potential for hydrogen oxidation in these communities. Interestingly, the frequency of these phylotypes in 16S rRNA gene clone libraries from the mouthparts differ from that of the inner lining of the gill chamber, indicating potential functional compartmentalization. Conclusions: Our data show the specific association of autotrophic bacteria with Rimicaris exoculata from the Snake Pit hydrothermal vent field, and suggest that autotrophic carbon fixation is contributing to the productivity of the epibiotic community with the reductive tricarboxylic acid cycle as one important carbon fixation pathway. This has not been considered in previous studies of carbon fixation and stable carbon isotope composition of the shrimp and its epibionts. Furthermore, the co-occurrence of sulfur-oxidizing and sulfur-reducing epibionts raises the possibility that both may be involved in the syntrophic exchange of sulfur compounds, which could increase the overall efficiency of this epibiotic community.	[Huegler, Michael; Sievert, Stefan M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Huegler, Michael; Imhoff, Johannes F.] IFM GEOMAR, Leibniz Inst Marine Sci, Kiel, Germany; [Petersen, Jillian M.; Dubilier, Nicole] Max Planck Inst Marine Microbiol, Bremen, Germany	Woods Hole Oceanographic Institution; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society	Hugler, M (corresponding author), Technol Ctr TZW, Karlsruhe, Germany.	ssievert@whoi.edu	Dubilier, Nicole/I-8203-2018; Hügler, Michael/A-9155-2018; Imhoff, Johannes F./D-2515-2010; Petersen, Jillian/GVU-6351-2022; Petersen, Jillian/K-6066-2015; Imhoff, Johannes F./AAB-8765-2022	Dubilier, Nicole/0000-0002-9394-825X; Hügler, Michael/0000-0002-2820-0333; Imhoff, Johannes F./0000-0001-8789-0728; Imhoff, Johannes F./0000-0001-8789-0728; Petersen, Jillian/0000-0002-9852-3445; Sievert, Stefan/0000-0002-9541-2707	NSF [OCE-0452333]; Alfried Krupp Wissenschaftskolleg Greifswald, Germany; Max Planck Society; German Research Foundation (DFG) Cluster of Excellence at Marum; MOMARnet; IFM-GEOMAR	NSF(National Science Foundation (NSF)); Alfried Krupp Wissenschaftskolleg Greifswald, Germany; Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation (DFG) Cluster of Excellence at Marum(German Research Foundation (DFG)); MOMARnet; IFM-GEOMAR	Funding was provided through NSF grant OCE-0452333 and the Alfried Krupp Wissenschaftskolleg Greifswald, Germany (SMS), the Max Planck Society, the German Research Foundation (DFG) Cluster of Excellence at Marum, and MOMARnet (ND, JMP), and IFM-GEOMAR (MH, JFI).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; BIEBL H, 1977, ARCH MICROBIOL, V112, P115, DOI 10.1007/BF00446664; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; CAMPBELL AC, 1988, NATURE, V335, P514, DOI 10.1038/335514a0; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; CASANOVA B, 1993, CAH BIOL MAR, V34, P573; Cavanaugh CM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P285; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Corbari L, 2008, AQUAT BIOL, V1, P225, DOI 10.3354/ab00024; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Finster K, 1998, APPL ENVIRON MICROB, V64, P119; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; GALCHENKO VF, 1989, DOKL AKAD NAUK SSSR+, V308, P1478; GEBRUK AV, 1993, MAR ECOL PROG SER, V98, P247, DOI 10.3354/meps098247; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Grabovich MY, 1999, FEMS MICROBIOL LETT, V178, P155, DOI 10.1111/j.1574-6968.1999.tb13772.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hugler M, 2010, FEMS MICROBIOL ECOL, V73, P526, DOI 10.1111/j.1574-6941.2010.00919.x; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; JANNASCH HW, 1991, RIDGE EVENTS, V19; Janssen PH, 1996, ARCH MICROBIOL, V166, P184, DOI 10.1007/s002030050374; KARSON JA, 1989, MAR GEOPHYS RES, V10, P91; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lopez-Garcia P, 2003, ENVIRON MICROBIOL, V5, P961, DOI 10.1046/j.1462-2920.2003.00495.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Peduzzi S, 2003, FEMS MICROBIOL ECOL, V45, P29, DOI 10.1016/S0168-6496(03)00107-7; Perner M, 2007, FEMS MICROBIOL ECOL, V61, P97, DOI 10.1111/j.1574-6941.2007.00325.x; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Petri R, 2001, FEMS MICROBIOL LETT, V197, P171, DOI 10.1111/j.1574-6968.2001.tb10600.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Rieley G, 1999, MAR BIOL, V133, P495, DOI 10.1007/s002270050489; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; Robinson JL, 1995, LIMNOL OCEANOGR, V40, P1496, DOI 10.4319/lo.1995.40.8.1496; Schmidt C, 2009, GEOBIOLOGY, V7, P454, DOI 10.1111/j.1472-4669.2009.00209.x; Schmidt C, 2008, MAR CHEM, V108, P18, DOI 10.1016/j.marchem.2007.09.009; Schmidt C, 2008, J SHELLFISH RES, V27, P79, DOI 10.2983/0730-8000(2008)27[79:IODVIW]2.0.CO;2; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Sievert SM, 2008, MICROBIAL SULFUR METABOLISM, P238, DOI 10.1007/978-3-540-72682-1_19; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; Suzuki Y, 2005, APPL ENVIRON MICROB, V71, P5440, DOI 10.1128/AEM.71.9.5440-5450.2005; Suzuki Y, 2009, J MAR BIOL ASSOC UK, V89, P727, DOI 10.1017/S0025315409000459; Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005; THOMPSON G, 1988, CAN MINERAL, V26, P697; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; WIRSEN CO, 1993, J GEOPHYS RES-SOL EA, V98, P9693, DOI 10.1029/92JB01556; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	67	59	62	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16018	10.1371/journal.pone.0016018	http://dx.doi.org/10.1371/journal.pone.0016018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249205	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000286512900018
J	Shi, ZD; Wang, H; Tarbell, JM				Shi, Zhong-Dong; Wang, Hui; Tarbell, John M.			Heparan Sulfate Proteoglycans Mediate Interstitial Flow Mechanotransduction Regulating MMP-13 Expression and Cell Motility via FAK-ERK in 3D Collagen	PLOS ONE			English	Article							FOCAL ADHESION KINASE; FLUID SHEAR-STRESS; HUMAN AORTIC MEDIA; ENDOTHELIAL-CELLS; CYTOSKELETAL ORGANIZATION; MATRIX; INTEGRINS; GLYCOCALYX; SYNDECAN-4; MIGRATION	Background: Interstitial flow directly affects cells that reside in tissues and regulates tissue physiology and pathology by modulating important cellular processes including proliferation, differentiation, and migration. However, the structures that cells utilize to sense interstitial flow in a 3-dimensional (3D) environment have not yet been elucidated. Previously, we have shown that interstitial flow upregulates matrix metalloproteinase (MMP) expression in rat vascular smooth muscle cells (SMCs) and fibroblasts/myofibroblasts via activation of an ERK1/2-c-Jun pathway, which in turn promotes cell migration in collagen. Herein, we focused on uncovering the flow-induced mechanotransduction mechanism in 3D. Methodology/Principal Findings: Cleavage of rat vascular SMC surface glycocalyx heparan sulfate (HS) chains from proteoglycan (PG) core proteins by heparinase or disruption of HS biosynthesis by silencing N-deacetylase/N-sulfotransferase 1 (NDST1) suppressed interstitial flow-induced ERK1/2 activation, interstitial collagenase (MMP-13) expression, and SMC motility in 3D collagen. Inhibition or knockdown of focal adhesion kinase (FAK) also attenuated or blocked flow-induced ERK1/2 activation, MMP-13 expression, and cell motility. Interstitial flow induced FAK phosphorylation at Tyr925, and this activation was blocked when heparan sulfate proteoglycans (HSPGs) were disrupted. These data suggest that HSPGs mediate interstitial flow-induced mechanotransduction through FAK-ERK. In addition, we show that integrins are crucial for mechanotransduction through HSPGs as they mediate cell spreading and maintain cytoskeletal rigidity. Conclusions/Significance: We propose a conceptual mechanotransduction model wherein cell surface glycocalyx HSPGs, in the presence of integrin-mediated cell-matrix adhesions and cytoskeleton organization, sense interstitial flow and activate the FAK-ERK signaling axis, leading to upregulation of MMP expression and cell motility in 3D. This is the first study to describe a flow-induced mechanotransduction mechanism via HSPG-mediated FAK activation in 3D. This study will be of interest in understanding the flow-related mechanobiology in vascular lesion formation, tissue morphogenesis, cancer cell metastasis, and stem cell differentiation in 3D, and also has implications in tissue engineering.	[Shi, Zhong-Dong; Wang, Hui; Tarbell, John M.] CUNY, Dept Biomed Engn, City Coll New York, New York, NY 10021 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Shi, ZD (corresponding author), CUNY, Dept Biomed Engn, City Coll New York, New York, NY 10021 USA.	tarbell@ccny.cuny.edu	Shi, Zhong-Dong/A-7212-2012		NIH NHLBI [RO1 HL 57093, RO1 HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889, R01HL057093] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH NHLBI grants RO1 HL 57093 (JMT) and RO1 HL 094889 ( JMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie KM, 2005, J APPL PHYSIOL, V98, P242, DOI 10.1152/japplphysiol.01006.2003; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Bellin RM, 2009, P NATL ACAD SCI USA, V106, P22102, DOI 10.1073/pnas.0902639106; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Charni F, 2009, BBA-GEN SUBJECTS, V1790, P1314, DOI 10.1016/j.bbagen.2009.07.015; Chaturvedi LS, 2008, AM J PHYSIOL-CELL PH, V294, pC1350, DOI 10.1152/ajpcell.00027.2008; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Cheung PFY, 2008, INT IMMUNOL, V20, P353, DOI 10.1093/intimm/dxm146; Couchman JR, 2001, INT REV CYTOL, V207, P113; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Das A, 2009, ARTERIOSCL THROM VAS, V29, P562, DOI 10.1161/ATVBAHA.108.182725; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Denhez F, 2002, J BIOL CHEM, V277, P12270, DOI 10.1074/jbc.M110291200; DINGEMANS KP, 1981, VIRCHOWS ARCH A, V392, P199, DOI 10.1007/BF00430821; Dingemans KP, 2000, ANAT REC, V258, P1; Fleury ME, 2006, BIOPHYS J, V91, P113, DOI 10.1529/biophysj.105.080192; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Garanich JS, 2007, AM J PHYSIOL-HEART C, V292, pH3128, DOI 10.1152/ajpheart.00578.2006; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Hoshina N, 2007, GENES CELLS, V12, P1245, DOI 10.1111/j.1365-2443.2007.01130.x; Hosseinkhani H, 2005, TISSUE ENG, V11, P1476, DOI 10.1089/ten.2005.11.1476; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rizzo V, 2009, AM J PHYSIOL-HEART C, V297, pH1196, DOI 10.1152/ajpheart.00499.2009; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; SAKU T, 1989, J BIOL CHEM, V264, P3514; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Shi ZD, 2010, AM J PHYSIOL-HEART C, V298, pH127, DOI 10.1152/ajpheart.00732.2009; Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tarbell JM, 2005, ANN BIOMED ENG, V33, P1719, DOI 10.1007/s10439-005-8775-z; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; Vera RH, 2009, TISSUE ENG PT A, V15, P175, DOI 10.1089/ten.tea.2007.0314; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang S, 2000, ARTERIOSCL THROM VAS, V20, P2220, DOI 10.1161/01.ATV.20.10.2220; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; WILLIAMS JL, 1994, BIORHEOLOGY, V31, P163; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Zamir E, 2001, J CELL SCI, V114, P3583	68	58	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15956	10.1371/journal.pone.0015956	http://dx.doi.org/10.1371/journal.pone.0015956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246051	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511200027
J	Hain, D; Bettencourt, B; Okamura, K; Csorba, T; Meyer, W; Jin, ZG; Biggerstaff, J; Siomi, H; Hutvagner, G; Lai, EC; Welte, M; Muller, HAJ				Hain, Daniel; Bettencourt, Brian; Okamura, Katsutomo; Csorba, Tibor; Meyer, Wibke; Jin, Zhigang; Biggerstaff, Jason; Siomi, Haruhiko; Hutvagner, Gyorgy; Lai, Eric C.; Welte, Michael; Mueller, H. -Arno J.			Natural Variation of the Amino-Terminal Glutamine-Rich Domain in Drosophila Argonaute2 Is Not Associated with Developmental Defects	PLOS ONE			English	Article							RNA INTERFERENCE; ANTIVIRAL IMMUNITY; MESSENGER-RNAS; PROTEIN; GENE; MELANOGASTER; PATHWAY; HETEROCHROMATIN; EVOLUTION; ARMADILLO	The Drosophila argonaute2 (ago2) gene plays a major role in siRNA mediated RNA silencing pathways. Unlike mammalian Argonaute proteins, the Drosophila protein has an unusual amino-terminal domain made up largely of multiple copies of glutamine-rich repeats (GRRs). We report here that the ago2 locus produces an alternative transcript that encodes a putative short isoform without this amino-terminal domain. Several ago2 mutations previously reported to be null alleles only abolish expression of the long, GRR-containing isoform. Analysis of drop out (dop) mutations had previously suggested that variations in GRR copy number result in defects in RNAi and embryonic development. However, we find that dop mutations genetically complement transcript-null alleles of ago2 and that ago2 alleles with variant GRR copy numbers support normal development. In addition, we show that the assembly of the central RNAi machinery, the RISC (RNA induced silencing complex), is unimpaired in embryos when GRR copy number is altered. In fact, we find that GRR copy number is highly variable in natural D. melanogaster populations as well as in laboratory strains. Finally, while many other insects share an extensive, glutamine-rich Ago2 amino-terminal domain, its primary sequence varies drastically between species. Our data indicate that GRR variation does not modulate an essential function of Ago2 and that the amino-terminal domain of Ago2 is subject to rapid evolution.	[Hain, Daniel; Mueller, H. -Arno J.] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland; [Bettencourt, Brian] Alnylam Pharmaceut, Cambridge, MA USA; [Okamura, Katsutomo; Jin, Zhigang; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, New York, NY USA; [Csorba, Tibor; Hutvagner, Gyorgy] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland; [Meyer, Wibke] Univ Dusseldorf, Inst Genet, Dusseldorf, Germany; [Biggerstaff, Jason] Boston Univ, Boston, MA 02215 USA; [Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Welte, Michael] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Dundee; Memorial Sloan Kettering Cancer Center; University of Dundee; Heinrich Heine University Dusseldorf; Boston University; Keio University; University of Rochester	Hain, D (corresponding author), Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland.	h.j.muller@dundee.ac.uk	Welte, Michael/AAH-5589-2019; Müller, Hans-Arno/G-5753-2012; Lai, Eric/AAO-1143-2021; Muller, Hans-Arno/Q-2864-2019; Siomi, Haruhiko/A-7020-2015; Lai, Eric C/A-3412-2008; Csorba, Tibor/A-2359-2014	Welte, Michael/0000-0001-5741-4720; Müller, Hans-Arno/0000-0002-7525-6874; Lai, Eric/0000-0002-8432-5851; Muller, Hans-Arno/0000-0002-7525-6874; Siomi, Haruhiko/0000-0001-8690-3822; Csorba, Tibor/0000-0003-4185-1496; Hutvagner, Gyorgy/0000-0002-7231-9446	European Molecular Biology Organisation (EMBO); Commonwealth of Massachusetts; Wellcome Trust; European Union; Burroughs Wellcome Fund; Alfred Bressler Scholars Fund; National Institutes of Health [R01-GM083300]; National Institute of General Medical Sciences [GM64687]; Deutsche Forschungsgemeinshaft (DFG) [MU1168/5-1, MU1168/5-2, MU1168/5-3]; College of Life Sciences, University of Dundee, Scotland; MRC [G0501679] Funding Source: UKRI; Medical Research Council [G0501679] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064687, R01GM083300] Funding Source: NIH RePORTER	European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Commonwealth of Massachusetts; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alfred Bressler Scholars Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Deutsche Forschungsgemeinshaft (DFG)(German Research Foundation (DFG)); College of Life Sciences, University of Dundee, Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TC was supported by a European Molecular Biology Organisation (EMBO) short term fellowship, BRB received support from the Commonwealth of Massachusetts, and GH was supported by a Wellcome Trust Career Development Fellowship and European Union Framework 6 programme SIROCCO (Silencing RNAs: organisers and coordinators of complexity in eukaryotic organisms). ZJ is a fellow of the National Cancer Institute of Canada Terry Fox Foundation (#700132). KO is a fellow of the Japan Society for the Promotion of Science. ECL was supported by the Burroughs Wellcome Fund, the Alfred Bressler Scholars Fund, and the National Institutes of Health R01-GM083300. MAW was supported by National Institute of General Medical Sciences grant GM64687, DH was a graduate student fellow of the Biotechnological and Biological Sciences Research Council (BBSRC, UK) and HAM was supported by Deutsche Forschungsgemeinshaft (DFG) grant MU1168/5-1, 5-2, 5-3 of the DFG priority programme 'Cell polarity', and funds of the College of Life Sciences, University of Dundee, Scotland. During the time that Dr. Bettencourt performed data analysis and prepared the manuscript he was also serving as an employee of and receiving a regular salary of Alnylam Pharmaceuticals, Inc. Alnylam did not directly or indirectly fund the research that was conducted and Dr. Bettencourt's research and work on the manuscript was not done in his capacity as an employee of Alnylam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bettencourt BR, 2007, J BIOSCIENCES, V32, P537, DOI 10.1007/s12038-007-0053-9; Bettencourt BR, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-5; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; EISEN M, 2007, ASSEMBLY ALIGNEMENT; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; LACHAISE D, 1986, EVOLUTION, V40, P262, DOI 10.1111/j.1558-5646.1986.tb00468.x; Lazzaro BP, 2001, GENETICS, V159, P659; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Murphy D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-92; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998c; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Pepper ASR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007618; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Sainz A, 2003, HEREDITY, V91, P28, DOI 10.1038/sj.hdy.6800275; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Shi HF, 2009, J BIOL CHEM, V284, P36511, DOI 10.1074/jbc.M109.073072; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang RL, 1997, GENETICS, V147, P1091; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	57	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15264	10.1371/journal.pone.0015264	http://dx.doi.org/10.1371/journal.pone.0015264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21253006	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200020
J	Rojas, A; Liu, G; Coleman, I; Nelson, PS; Zhang, M; Dash, R; Fisher, PB; Plymate, SR; Wu, JD				Rojas, A.; Liu, G.; Coleman, I.; Nelson, P. S.; Zhang, M.; Dash, R.; Fisher, P. B.; Plymate, S. R.; Wu, J. D.			IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR	ONCOGENE			English	Article						IL-6; STAT3; tumorigenesis; EMT; IGF-IR; prostate	GROWTH-FACTOR-I; EPITHELIAL-MESENCHYMAL TRANSITIONS; GENE-3 PEG-3 PROMOTER; CANCER-CELLS; PEA3 SITES; EXPRESSION; INTERLEUKIN-6; RECEPTOR; RAS; INFLAMMATION	As an established mediator of inflammation, interleukin-6 (IL-6) is implicated to facilitate prostate cancer progression to androgen independence through transactivation of the androgen receptor. However, whether IL-6 has a causative role in de novo prostate tumorigenesis was never investigated. We now provide the first evidence that IL-6 can induce tumorigenic conversion and further progression to an invasive phenotype of non-tumorigenic benign prostate epithelial cells. Moreover, we find that paracrine IL-6 stimulates the autocrine IL-6 loop and autocrine activation of insulin-like type I growth factor receptor (IGF-IR) to confer the tumorigenic property and also that activation of signal transducer and activator of transcription 3 (STAT3) is critical in these processes. Inhibition of STAT3 activation or IGF-IR signaling suppresses IL-6-mediated malignant conversion and the associated invasive phenotype. Inhibition of STAT3 activation suppresses IL-6-induced upregulation of IGF-IR and its ligands, namely IGF-I and IGF-II. These findings indicate that IL-6 signaling cooperates with IGF-IR signaling in the prostate microenvironment to promote prostate tumorigenesis and progression to aggressiveness. Our findings suggest that STAT3 and IGF-IR may represent potential effective targets for prevention or treatment of prostate cancer. Oncogene (2011) 30, 2345-2355; doi: 10.1038/onc.2010.605; published online 24 January 2011	[Rojas, A.; Liu, G.; Plymate, S. R.; Wu, J. D.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Coleman, I.; Nelson, P. S.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Zhang, M.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98104 USA; [Dash, R.; Fisher, P. B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, VCU Inst Mol Med, Richmond, VA USA; [Dash, R.; Fisher, P. B.] Virginia Commonwealth Univ, VCU Massy Canc Ctr, Richmond, VA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Virginia Commonwealth University; Virginia Commonwealth University	Wu, JD (corresponding author), Univ Washington, Dept Med, 325 9th Ave,Box 359625, Seattle, WA 98104 USA.	wuj@uw.edu	Zhang, Miqin/F-5537-2010	Zhang, Miqin/0000-0001-8974-1494; dash, rupesh/0000-0001-5740-7053	National Institute of Health (NIH) [1K01CA116002, NIH 1R01CA149405, PO1 CA085859, P01 CA104177]; DOD-USARMC IDEA Development Award [W81XWH-06-1-0014]; Pacific Northwest Prostate Cancer [SPORE P50-CA097186]; NATIONAL CANCER INSTITUTE [P01CA085859, R01CA097318, K01CA116002, R01CA149405, P01CA104177, P50CA097186] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD-USARMC IDEA Development Award; Pacific Northwest Prostate Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institute of Health (NIH) Temin Award 1K01CA116002, NIH 1R01CA149405 and DOD-USARMC IDEA Development Award W81XWH-06-1-0014 to JDW and partially supported by the Pacific Northwest Prostate Cancer SPORE P50-CA097186 (JDW) and the NIH Program Project Grant PO1 CA085859 (SRP) and P01 CA104177 (PBF). PBF holds the Thelma Newmeyer Corman Chair in Cancer Research at the VCU Massey Cancer Center.	Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; BAE VL, 1994, INT J CANCER, V58, P721, DOI 10.1002/ijc.2910580517; Bardia A, 2009, CURR OPIN PHARMACOL, V9, P419, DOI 10.1016/j.coph.2009.06.002; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Burtrum D, 2003, CANCER RES, V63, P8912; Coe KJ, 2007, CHEM RES TOXICOL, V20, P1277, DOI 10.1021/tx7001349; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Corcoran NM, 2003, BJU INT, V91, P545, DOI 10.1046/j.1464-410X.2003.04025.x; Damon SE, 2001, ENDOCRINOLOGY, V142, P21, DOI 10.1210/en.142.1.21; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dorff TB, 2010, CLIN CANCER RES, V16, P3028, DOI 10.1158/1078-0432.CCR-09-3122; Finley DS, 2009, J UROLOGY, V182, P1621, DOI 10.1016/j.juro.2009.06.015; Freedland SJ, 2007, EPIDEMIOL REV, V29, P88, DOI 10.1093/epirev/mxm006; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Haverkamp J, 2008, J CELL BIOCHEM, V103, P1344, DOI 10.1002/jcb.21536; Irigaray P, 2007, BIOMED PHARMACOTHER, V61, P665, DOI 10.1016/j.biopha.2007.10.008; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kojima S, 2009, INT J UROL, V16, P161, DOI 10.1111/j.1442-2042.2008.02224.x; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; O'Malley Rebecca L, 2006, Can J Urol, V13 Suppl 2, P11; Paule B, 2007, WORLD J UROL, V25, P477, DOI 10.1007/s00345-007-0175-6; Rosen DG, 2006, METHOD ENZYMOL, V407, P660, DOI 10.1016/S0076-6879(05)07052-7; Rowinsky EK, 2007, CLIN CANCER RES, V13, p5549S, DOI 10.1158/1078-0432.CCR-07-1109; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Soon L, 1999, MOL CELL BIOL, V19, P3816; Su Z, 2001, NUCLEIC ACIDS RES, V29, P1661, DOI 10.1093/nar/29.8.1661; Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125; Su ZZ, 2000, ONCOGENE, V19, P3411, DOI 10.1038/sj.onc.1203666; Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sutcliffe S, 2007, UROL ONCOL-SEMIN ORI, V25, P242, DOI 10.1016/j.urolonc.2006.09.014; Tam L, 2007, BRIT J CANCER, V97, P378, DOI 10.1038/sj.bjc.6603871; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Traynor P, 2008, DIS MARKERS, V24, P157, DOI 10.1155/2008/918087; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544	46	108	115	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	20					2345	2355		10.1038/onc.2010.605	http://dx.doi.org/10.1038/onc.2010.605			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	766NF	21258401	Green Accepted			2022-12-25	WOS:000290789200006
J	Jimenez, M; Martos, A; Vicente, M; Rivas, G				Jimenez, Mercedes; Martos, Ariadna; Vicente, Miguel; Rivas, German			Reconstitution and Organization of Escherichia coli Proto-ring Elements (FtsZ and FtsA) inside Giant Unilamellar Vesicles Obtained from Bacterial Inner Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; PHYSIOLOGICAL CONDITIONS; AMPHITROPIC PROTEINS; NATIVE MEMBRANES; LIPID MIXTURES; ZIPA; DYNAMICS; TUBULIN; ACTIN; MICROSCOPY	We have incorporated, for the first time, FtsZ and FtsA (the soluble proto-ring proteins from Escherichia coli) into bacterial giant unilamellar inner membrane vesicles (GUIMVs). Inside the vesicles, the structural organization and spatial distribution of fluorescently labeled FtsZ and FtsA were determined by confocal microscopy. We found that, in the presence of GDP, FtsZ was homogeneously distributed in the lumen of the vesicle. In the presence of GTP analogs, FtsZ assembled inside the GUIMVs, forming a web of dense spots and fibers. Whereas isolated FtsA was found adsorbed to the inner face of GUIMVs, the addition of FtsZ together with GTP analogs resulted in its dislodgement and its association with the FtsZ fibers in the lumen, suggesting that the FtsA-membrane interaction can be modulated by FtsZ polymers. The use of this novel in vitro system to probe interactions between divisome components will help to determine the biological implications of these findings.	[Jimenez, Mercedes; Martos, Ariadna; Rivas, German] CSIC, Ctr Invest Biol, Chem & Phys Biol Programme, Madrid 28040, Spain; [Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Jimenez, M (corresponding author), CSIC, Ctr Invest Biol, Chem & Phys Biol Programme, Madrid 28040, Spain.	enoe@cib.csic.es; grivas@cib.csic.es	Rivas, German/AFL-7528-2022; Rivas, German/AAG-7458-2022; Jimenez Sarmiento, Mercedes/K-2691-2014	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903	European Commission [HEALTH-F3-2009-223431]; Ministerio de Ciencia e Innovacion Plan Nacional (Spain) [BIO2008-04478-C03-00]; Comunidad de Madrid COMBACT [S-BIO-0260/2006]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion Plan Nacional (Spain); Comunidad de Madrid COMBACT(Comunidad de Madrid)	This work was supported in part by European Commission DIVINOCELL FP7 HEALTH-F3-2009-223431, Ministerio de Ciencia e Innovacion Plan Nacional BIO2008-04478-C03-00 (Spain), and Comunidad de Madrid COMBACT S-BIO-0260/2006 (to G. R. and M. V.).	ALTENDORF KH, 1974, J BACTERIOL, V117, P888, DOI 10.1128/JB.117.2.888-899.1974; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; Dominak LM, 2008, LANGMUIR, V24, P13565, DOI 10.1021/la8028403; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Holtje JV, 2001, BIOCHIMIE, V83, P103, DOI 10.1016/S0300-9084(00)01226-8; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; JONES CA, 1984, EMBO J, V3, P1181, DOI 10.1002/j.1460-2075.1984.tb01948.x; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; PLA J, 1990, J BACTERIOL, V172, P5097, DOI 10.1128/jb.172.9.5097-5102.1990; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	43	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11236	11241		10.1074/jbc.M110.194365	http://dx.doi.org/10.1074/jbc.M110.194365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21257762	Green Published, hybrid			2022-12-25	WOS:000288797100035
J	Dimitrov, NB; Goll, S; Hupert, N; Pourbohloul, B; Meyers, LA				Dimitrov, Nedialko B.; Goll, Sebastian; Hupert, Nathaniel; Pourbohloul, Babak; Meyers, Lauren Ancel			Optimizing Tactics for Use of the US Antiviral Strategic National Stockpile for Pandemic Influenza	PLOS ONE			English	Article							OSELTAMIVIR; VIRUS; TRANSMISSIBILITY	In 2009, public health agencies across the globe worked to mitigate the impact of the swine-origin influenza A (pH1N1) virus. These efforts included intensified surveillance, social distancing, hygiene measures, and the targeted use of antiviral medications to prevent infection (prophylaxis). In addition, aggressive antiviral treatment was recommended for certain patient subgroups to reduce the severity and duration of symptoms. To assist States and other localities meet these needs, the U.S. Government distributed a quarter of the antiviral medications in the Strategic National Stockpile within weeks of the pandemic's start. However, there are no quantitative models guiding the geo-temporal distribution of the remainder of the Stockpile in relation to pandemic spread or severity. We present a tactical optimization model for distributing this stockpile for treatment of infected cases during the early stages of a pandemic like 2009 pH1N1, prior to the wide availability of a strain-specific vaccine. Our optimization method efficiently searches large sets of intervention strategies applied to a stochastic network model of pandemic influenza transmission within and among U.S. cities. The resulting optimized strategies depend on the transmissability of the virus and postulated rates of antiviral uptake and wastage (through misallocation or loss). Our results suggest that an aggressive community-based antiviral treatment strategy involving early, widespread, pro-rata distribution of antivirals to States can contribute to slowing the transmission of mildly transmissible strains, like pH1N1. For more highly transmissible strains, outcomes of antiviral use are more heavily impacted by choice of distribution intervals, quantities per shipment, and timing of shipments in relation to pandemic spread. This study supports previous modeling results suggesting that appropriate antiviral treatment may be an effective mitigation strategy during the early stages of future influenza pandemics, increasing the need for systematic efforts to optimize distribution strategies and provide tactical guidance for public health policy-makers.	[Dimitrov, Nedialko B.] Univ Texas Austin, ORIE Program, Austin, TX 78712 USA; [Hupert, Nathaniel] US Ctr Dis Control & Prevent, Preparedness Modeling Unit, Atlanta, GA USA; [Hupert, Nathaniel] Weill Cornell Med Coll, New York, NY USA; [Pourbohloul, Babak] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Texas System; University of Texas Austin; Centers for Disease Control & Prevention - USA; Cornell University; The Santa Fe Institute	Dimitrov, NB (corresponding author), Univ Texas Austin, ORIE Program, Austin, TX 78712 USA.	ned@alumni.cs.utexas.edu		Meyers, Lauren/0000-0002-5828-8874	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation; NIGMS NIH HHS [U01-GM087719-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Azadivar F., 1999, WSC'99. 1999 Winter Simulation Conference Proceedings. `Simulation - A Bridge to the Future' (Cat. No.99CH37038), P93, DOI 10.1109/WSC.1999.823057; Bajardi P, 2009, Emerg Health Threats J, V2, pe11, DOI 10.3134/ehtj.09.011; Ball F, 1997, ANN APPL PROBAB, V7, P46; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Barnes B, 2007, MATH BIOSCI, V209, P403, DOI 10.1016/j.mbs.2007.02.008; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; *BUR TRANSP STAT, 2008, AIRP MAST COORD DAT; *BUR TRANSP STAT, 2007, OR DEST SURV ALL QUA; COQUELIN P, 2007, ABSCS0703062 COMP RE; Danon L, 2009, EPIDEMICS-NETH, V1, P250, DOI 10.1016/j.epidem.2009.11.002; Doyle A, 2006, J EPIDEMIOL COMMUN H, V60, P399, DOI 10.1136/jech.2005.034082; Even-Dar E., 2002, Computational Learning Theory. 15th Annual Conference on Computational Learning Theory, COLT 2002. Proceedings (Lecture Notes in Artificial Intelligence Vol.2375), P255; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gelly S, 2006, P NIPS NEUR INT PROC; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghani AC, 2009, PLOS CURR INFLUENZA, V1, DOI [10.1371/currents.RRN1130, DOI 10.1371/CURRENTS.RRN1130]; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Hota S, 2007, CLIN INFECT DIS, V45, P1362, DOI 10.1086/522661; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mannor S, 2004, J MACH LEARN RES, V5, P623; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; SCHUCHAT A, 2009, CDC TELEBRIEFING INV; *US BUR CENS, 2000, COUNT COUNT WORK FLO; *US BUR CENS, 2000, METR MICR STAT AR; *US CDC, 2009, CDC EST 2009 H1N1 IN; *US CDC, 2009, CDC HLTH UPD SWIN IN; *US CDC, 2009, QUEST ANSW ANT DRUGS; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; *WHIT HOUS NAT SEC, 2009, NAT FRAM 2009 H1N1 I; Wu JT, 2007, P ROY SOC B-BIOL SCI, V274, P2811, DOI 10.1098/rspb.2007.0893; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779	48	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16094	10.1371/journal.pone.0016094	http://dx.doi.org/10.1371/journal.pone.0016094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21283514	Green Published, gold, Green Submitted			2022-12-25	WOS:000286520600021
J	Rouleau, M; Saxena, V; Rodrigue, A; Paquet, ER; Gagnon, A; Hendzel, MJ; Masson, JY; Ekker, M; Poirier, GG				Rouleau, Michele; Saxena, Vishal; Rodrigue, Amelie; Paquet, Eric R.; Gagnon, Abbie; Hendzel, Michael J.; Masson, Jean-Yves; Ekker, Marc; Poirier, Guy G.			A Key Role for Poly(ADP-Ribose) Polymerase 3 in Ectodermal Specification and Neural Crest Development	PLOS ONE			English	Article							CHROMATIN-STRUCTURE; TARGET GENES; DNA-REPAIR; POLYCOMB; PARP-3; EXPRESSION; BINDING; REST; PLURIPOTENT; ASSOCIATION	Background: The PARP family member poly(ADP-ribose) polymerase 3 (PARP3) is structurally related to the well characterized PARP1 that orchestrates cellular responses to DNA strand breaks and cell death by the synthesis of poly(ADPribose). In contrast to PARP1 and PARP2, the functions of PARP3 are undefined. Here, we reveal critical functions for PARP3 during vertebrate development. Principal Findings: We have used several in vitro and in vivo approaches to examine the possible functions of PARP3 as a transcriptional regulator, a function suggested from its previously reported association with several Polycomb group (PcG) proteins. We demonstrate that PARP3 gene occupancy in the human neuroblastoma cell line SK-N-SH occurs preferentially with developmental genes regulating cell fate specification, tissue patterning, craniofacial development and neurogenesis. Addressing the significance of this association during zebrafish development, we show that morpholino oligonucleotide-directed inhibition of parp3 expression in zebrafish impairs the expression of the neural crest cell specifier sox9a and of dlx3b/dlx4b, the formation of cranial sensory placodes, inner ears and pectoral fins. It delays pigmentation and severely impedes the development of the median fin fold and tail bud. Conclusion: Our findings demonstrate that Parp3 is crucial in the early stages of zebrafish development, possibly by exerting its transcriptional regulatory functions as early as during the specification of the neural plate border.	[Rouleau, Michele; Poirier, Guy G.] CHU Laval, CHUQ Res Ctr, Canc Res Lab, Laval, PQ, Canada; [Rouleau, Michele; Masson, Jean-Yves; Poirier, Guy G.] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada; [Saxena, Vishal; Gagnon, Abbie; Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Rodrigue, Amelie; Paquet, Eric R.; Masson, Jean-Yves] Univ Laval, Hotel Dieu Quebec, Canc Res Ctr, Genome Stabil Lab, Quebec City, PQ G1K 7P4, Canada; [Hendzel, Michael J.] Univ Alberta, Fac Med, Dept Oncol, Edmonton, AB, Canada; [Hendzel, Michael J.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	Laval University; Laval University; University of Ottawa; Laval University; University of Alberta; University of Alberta	Rouleau, M (corresponding author), CHU Laval, CHUQ Res Ctr, Canc Res Lab, Laval, PQ, Canada.	guy.poirier@crchul.ulaval.ca	Hendzel, Michael/C-3391-2009; saxena, vishal/GRJ-5665-2022	Hendzel, Michael/0000-0002-9603-7945; Poirier, Guy/0000-0002-4869-1424; Masson, Jean Yves/0000-0002-4403-7169; Rodrigue, Amelie/0000-0001-9883-7084; Paquet, Eric/0000-0001-9194-1655	Cancer Research Society Inc.; CIHR	Cancer Research Society Inc.; CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by the Cancer Research Society Inc. AR was the recipient of a CIHR doctoral fellowship. JYM is a FRSQ Senior scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Elsalini OA, 2003, DEV BIOL, V263, P67, DOI 10.1016/S0012-1606(03)00436-6; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Esterberg R, 2009, DEV BIOL, V325, P189, DOI 10.1016/j.ydbio.2008.10.017; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hermanson O, 2008, PLOS BIOL, V6, P2094, DOI 10.1371/journal.pbio.0060271; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Johansson M, 1999, GENOMICS, V57, P442, DOI 10.1006/geno.1999.5799; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Loseva O, 2010, J BIOL CHEM, V285, P8054, DOI 10.1074/jbc.M109.077834; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rohr KB, 2001, NEURON, V29, P341, DOI 10.1016/S0896-6273(01)00210-0; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Rouleau M, 2009, J HISTOCHEM CYTOCHEM, V57, P675, DOI 10.1369/jhc.2009.953380; RULTEN SL, 2011, MOL CELL IN PRESS; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Selvaraj V, 2009, J BIOL CHEM, V284, P26070, DOI 10.1074/jbc.M109.013474; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Solomon KS, 2002, DEVELOPMENT, V129, P3127; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003	58	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15834	10.1371/journal.pone.0015834	http://dx.doi.org/10.1371/journal.pone.0015834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264220	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600012
J	Blank, K; Hensel, M; Gerlach, RG				Blank, Kathrin; Hensel, Michael; Gerlach, Roman G.			Rapid and Highly Efficient Method for Scarless Mutagenesis within the Salmonella enterica Chromosome	PLOS ONE			English	Article							ESCHERICHIA-COLI; SECRETION SYSTEM; GENE; TYPHIMURIUM; VIRULENCE; PHOP; IDENTIFICATION; RECOMBINATION; PATHOGENICITY; PURIFICATION	Direct manipulation of bacterial chromosomes by recombination-based techniques has become increasingly important for both cognitive and applied research. Here we demonstrate, for the first time, the combination of the Red recombinase system with I-SceI endonuclease-based selection of successful recombinants after electroporation with short synthetic olignucleotides. We show the generation of scarless gene knockouts as well as site-directed mutagenesis using the Salmonella virulence-associated two component signaling system PhoPQ. The presented approach is very versatile for generating in-frame deletions, point mutations or insertions within bacterial chromosomes.	[Blank, Kathrin; Gerlach, Roman G.] Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany; [Hensel, Michael] Univ Osnabruck, Div Microbiol, Sch Biol Chem, Osnabruck, Germany	Robert Koch Institute; University Osnabruck	Blank, K (corresponding author), Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany.	GerlachR@rki.de		Hensel, Michael/0000-0001-6604-6253; Gerlach, Roman/0000-0002-5718-4758	Robert Koch Institute; Deutsche Forschungsgemeinschaft [MH1964]	Robert Koch Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by an intramural research grant from the Robert Koch Institute (http://www.rki.de) to RGG and grants MH1964 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox MM, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-59; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gerlach RG, 2007, APPL ENVIRON MICROB, V73, P4234, DOI 10.1128/AEM.00509-07; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; Gunn JS, 1996, J BACTERIOL, V178, P6369, DOI 10.1128/jb.178.21.6369-6373.1996; Hansen-Wester I, 2002, INFECT IMMUN, V70, P2351, DOI 10.1128/IAI.70.5.2351-2360.2002; Karlinsey JE, 2007, METHOD ENZYMOL, V421, P199, DOI 10.1016/S0076-6879(06)21016-4; KIER LD, 1979, J BACTERIOL, V138, P155, DOI 10.1128/JB.138.1.155-161.1979; KIER LD, 1977, J BACTERIOL, V130, P399, DOI 10.1128/JB.130.1.399-410.1977; Liang RB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-209; Maloy SR., 1996, GENETIC ANAL PATHOGE; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Ranallo RT, 2006, FEMS IMMUNOL MED MIC, V47, P462, DOI 10.1111/j.1574-695X.2006.00118.x; Rivero-Muller A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm250; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359	26	61	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15763	10.1371/journal.pone.0015763	http://dx.doi.org/10.1371/journal.pone.0015763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264289	Green Published, gold			2022-12-25	WOS:000286516500011
J	Nichols, LA; Adang, LA; Kedes, DH				Nichols, Lisa A.; Adang, Laura A.; Kedes, Dean H.			Rapamycin Blocks Production of KSHV/HHV8: Insights into the Anti-Tumor Activity of an Immunosuppressant Drug	PLOS ONE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; MULTICENTRIC CASTLEMAN-DISEASE; KAPOSIS-SARCOMA; LYTIC REPLICATION; ENDOTHELIAL-CELLS; PERIPHERAL-BLOOD; MAMMALIAN TARGET; GENE-EXPRESSION; PROTEIN; VIRUS	Background: Infection with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) often results in the development of fatal tumors in immunocompromised patients. Studies of renal transplant recipients show that use of the immunosuppressant drug rapamycin, an mTOR inhibitor, both prevents and can induce the regression of Kaposi's sarcoma (KS), an opportunistic tumor that arises within a subset of this infected population. In light of rapamycin's marked anti-KS activity, we tested whether the drug might directly inhibit the KSHV life cycle. We focused on the molecular switch that triggers this predominantly latent virus to enter the lytic (productive) replication phase, since earlier work links this transition to viral persistence and tumorigenesis. Methods and Findings: In latently infected human B cell lines, we found that rapamycin inhibited entry of the virus into the lytic replication cycle, marked by a loss of expression of the lytic switch protein, replication and transcription activator (RTA). To test for viral-specific effects of rapamycin, we focused our studies on a B cell line with resistance to rapamycin-mediated growth inhibition. Using this line, we found that the drug had minimal effect on cell cycle profiles, cellular proliferation, or the expression of other cellular or latent viral proteins, indicating that the RTA suppression was not a result of global cellular dysregulation. Finally, treatment with rapamycin blocked the production of progeny virions. Conclusions: These results indicate that mTOR plays a role in the regulation of RTA expression and, therefore, KSHV production, providing a potential molecular explanation for the marked clinical success of rapamycin in the treatment and prevention of post-transplant Kaposi's sarcoma. The striking inhibition of rapamycin on KSHV lytic replication, thus, helps explain the apparent paradox of an immunosuppressant drug suppressing the pathogenesis of an opportunistic viral infection.	[Nichols, Lisa A.; Adang, Laura A.; Kedes, Dean H.] Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22903 USA; [Nichols, Lisa A.; Adang, Laura A.; Kedes, Dean H.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kedes, Dean H.] Univ Virginia, Dept Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Nichols, LA (corresponding author), Univ Virginia, Myles H Thaler Ctr AIDS & Human Retrovirus Res, Charlottesville, VA 22903 USA.	kedes@virginia.edu			National Institutes of Health [DHK: R-01CA88768, 1 RC2 CA148038, T32 GM07267, T32 AI007046]; University of Virginia Cancer Center [P30 CA44579]; NATIONAL CANCER INSTITUTE [R01CA088768, P30CA044579, RC2CA148038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health (DHK: R-01CA88768 and 1 RC2 CA148038) and through the University of Virginia Cancer Center (P30 CA44579). LAA received support from the NIH Medical Scientist Training Grant (T32 GM07267). LAN received supported from NIH Infectious Disease Training Grant (T32 AI007046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Barozzi P, 2009, TRANSPLANTATION, V88, P597, DOI 10.1097/TP.0b013e3181b15d56; Bottero V, 2009, VIROLOGY, V392, P34, DOI 10.1016/j.virol.2009.07.002; BUBMAN D, 2007, ONCOGENE; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Cai QI, 2006, J VIROL, V80, P7965, DOI 10.1128/JVI.00689-06; Casper C, 2004, BLOOD, V103, P1632, DOI 10.1182/blood-2003-05-1721; Charfi S, 2007, SAUDI J KIDNEY DIS T, V18, P617; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Davis MA, 1997, J NATL CANCER I, V89, P1868, DOI 10.1093/jnci/89.24.1868; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Garcia VD, 2003, TRANSPL INT, V16, P202, DOI 10.1111/j.1432-2277.2003.tb00287.x; Gonzalez-Lopez MA, 2006, DERMATOLOGY, V213, P30, DOI 10.1159/000092834; Grandadam M, 1997, J INFECT DIS, V175, P1198, DOI 10.1086/593567; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Gutierrez-Dalmau A, 2005, TRANSPL P, V37, P3836, DOI 10.1016/j.transproceed.2005.10.076; Hornstein E, 1999, J BIOL CHEM, V274, P1708, DOI 10.1074/jbc.274.3.1708; Jham BC, 2010, J CELL BIOCHEM, V110, P1, DOI 10.1002/jcb.22524; Kolhe N, 2006, INT J CLIN PRACT, V60, P1509, DOI 10.1111/j.1742-1241.2006.00815.x; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LACOMBE F, 1988, CYTOMETRY, V9, P245, DOI 10.1002/cyto.990090310; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Merimsky Ofer, 2008, Sarcoma, V2008, P825093, DOI 10.1155/2008/825093; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Moody CA, 2005, J VIROL, V79, P5499, DOI 10.1128/JVI.79.9.5499-5506.2005; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nepomuceno RR, 2003, CANCER RES, V63, P4472; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Rose NJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-24; Rose NJ, 2001, J GEN VIROL, V82, P435, DOI 10.1099/0022-1317-82-2-435; Roy J, 2002, ANTIMICROB AGENTS CH, V46, P3447, DOI 10.1128/AAC.46.11.3447-3455.2002; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Shaw RN, 2000, AIDS, V14, P899, DOI 10.1097/00002030-200005050-00021; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Sodhi A, 2000, CANCER RES, V60, P4873; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Tomescu C, 2003, J VIROL, V77, P9669, DOI 10.1128/JVI.77.17.9669-9684.2003; Vaysberg M, 2007, TRANSPLANTATION, V83, P1114, DOI 10.1097/01.tp.0000260142.38619.9c; Wang L, 2006, CANCER RES, V66, P3658, DOI 10.1158/0008-5472.CAN-05-3680; Wanner K, 2006, BRIT J HAEMATOL, V134, P475, DOI 10.1111/j.1365-2141.2006.06210.x; Wasywich CA, 2006, J HEART LUNG TRANSPL, V25, P726, DOI 10.1016/j.healun.2006.01.010; Watanabe T, 2003, J VIROL, V77, P6188, DOI 10.1128/JVI.77.11.6188-6196.2003; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; YATSCOFF RW, 1995, THER DRUG MONIT, V17, P666, DOI 10.1097/00007691-199512000-00020; Yilmaz R, 2007, RENAL FAILURE, V29, P103, DOI 10.1080/08860220601039528; Yu YM, 1999, J GEN VIROL, V80, P83, DOI 10.1099/0022-1317-80-1-83; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	68	61	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14535	10.1371/journal.pone.0014535	http://dx.doi.org/10.1371/journal.pone.0014535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264294	gold, Green Submitted, Green Published			2022-12-25	WOS:000286516500008
J	Thie, H; Toleikis, L; Li, JD; von Wasielewski, R; Bastert, G; Schirrmann, T; Esteves, IT; Behrens, CK; Fournes, B; Fournier, N; de Romeuf, C; Hust, M; Dubel, S				Thie, Holger; Toleikis, Lars; Li, Jiandong; von Wasielewski, Reinhard; Bastert, Gunther; Schirrmann, Thomas; Esteves, Isabel Tourais; Behrens, Christian K.; Fournes, Benedict; Fournier, Nathalie; de Romeuf, Christophe; Hust, Michael; Duebel, Stefan			Rise and Fall of an Anti-MUC1 Specific Antibody	PLOS ONE			English	Article							O-LINKED POLYLACTOSAMINOGLYCANS; POLYMORPHIC EPITHELIAL MUCIN; PHAGE DISPLAY LIBRARIES; TUMOR-ASSOCIATED MUCIN; SKIM MILK MUCINS; AFFINITY MATURATION; RECOMBINANT ANTIBODIES; IN-VITRO; ESCHERICHIA-COLI; GENE LIBRARIES	Background: So far, human antibodies with good affinity and specificity for MUC1, a transmembrane protein overexpressed on breast cancers and ovarian carcinomas, and thus a promising target for therapy, were very difficult to generate. Results: A human scFv antibody was isolated from an immune library derived from breast cancer patients immunised with MUC1. The anti-MUC1 scFv reacted with tumour cells in more than 80% of 228 tissue sections of mamma carcinoma samples, while showing very low reactivity with a large panel of non-tumour tissues. By mutagenesis and phage display, affinity of scFvs was increased up to 500fold to 5,7x10(-10) M. Half-life in serum was improved from below 1 day to more than 4 weeks and was correlated with the dimerisation tendency of the individual scFvs. The scFv bound to T47D and MCF-7 mammalian cancer cell lines were recloned into the scFv-Fc and IgG format resulting in decrease of affinity of one binder. The IgG variants with the highest affinity were tested in mouse xenograft models using MCF-7 and OVCAR tumour cells. However, the experiments showed no significant decrease in tumour growth or increase in the survival rates. To study the reasons for the failure of the xenograft experiments, ADCC was analysed in vitro using MCF-7 and OVCAR3 target cells, revealing a low ADCC, possibly due to internalisation, as detected for MCF-7 cells. Conclusions: Antibody phage display starting with immune libraries and followed by affinity maturation is a powerful strategy to generate high affinity human antibodies to difficult targets, in this case shown by the creation of a highly specific antibody with subnanomolar affinity to a very small epitope consisting of four amino acids. Despite these "best in class'' binding parameters, the therapeutic success of this antibody was prevented by the target biology.	[Thie, Holger; Toleikis, Lars; Li, Jiandong; Schirrmann, Thomas; Hust, Michael; Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, D-3300 Braunschweig, Germany; [von Wasielewski, Reinhard] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany; [Bastert, Gunther] Univ Frauenklin Heidelberg, Heidelberg, Germany; [Esteves, Isabel Tourais; Behrens, Christian K.; Fournes, Benedict; Fournier, Nathalie; de Romeuf, Christophe] LFB Biotechnol Res Dept, Lille, France	Braunschweig University of Technology; Hannover Medical School; Ruprecht Karls University Heidelberg	Thie, H (corresponding author), Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.	s.duebel@tu-bs.de		Hust, Michael/0000-0003-3418-6045; Dubel, Stefan/0000-0001-8811-7390	BMBF, SMP; LFB	BMBF, SMP(Federal Ministry of Education & Research (BMBF)); LFB	The initial experiments were financed by the BMBF, SMP "Antibody Factory" in the NGFN2 program. The BMBF (Bundesministerium fur Bildung und Forschung) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was partly financed by LFB. LFB was also involved in the study design, data collection, analysis and decision to publish the data.	Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Albrecht H, 2007, Q J NUCL MED MOL IM, V51, P304; Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Arndt MAE, 2004, FEBS LETT, V578, P257, DOI 10.1016/j.febslet.2004.11.011; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Beatty PL, 2010, CANCER PREV RES, V3, P438, DOI 10.1158/1940-6207.CAPR-09-0194; Blockzjil A, 1998, TUMOR BIOL, V19, P46, DOI 10.1159/000056504; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; BRIGGS S, 1993, EUR J CANCER, V29A, P230, DOI 10.1016/0959-8049(93)90181-E; BURCHELL J, 1989, INT J CANCER, V44, P691, DOI 10.1002/ijc.2910440423; Cardoso DF, 2000, SCAND J IMMUNOL, V51, P337; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; DESHPAPNDE S, 1996, ENZYME IMMUNOASSAYS; DUBEL S, 1992, CELL BIOPHYS, V21, P69; Dubel S, 2007, APPL MICROBIOL BIOT, V74, P723, DOI 10.1007/s00253-006-0810-y; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; FAN X, 2010, PATHOL RES PRACT; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; Gerber HP, 2009, MABS-AUSTIN, V1, P247, DOI 10.4161/mabs.1.3.8515; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; Hanisch FG, 2000, GLYCOBIOLOGY, V10, P439, DOI 10.1093/glycob/10.5.439; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HANISCH FG, 1990, GLYCOCONJUGATE J, V7, P525, DOI 10.1007/BF01189075; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Henderikx P, 2002, AM J PATHOL, V160, P1597, DOI 10.1016/S0002-9440(10)61107-8; Henderikx P, 1998, CANCER RES, V58, P4324; HILKENS J, 1986, CANCER RES, V46, P2582; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang XM, 2004, PROSTATE, V61, P1, DOI 10.1002/pros.20074; Hull S R, 1989, Cancer Commun, V1, P261; HUST M, 2007, HDB THERAPEUTIC ANTI, P45; HUST M, 2010, J BIOTECHNOL; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Hust M, 2009, NEW BIOTECHNOL, V25, P424, DOI 10.1016/j.nbt.2009.03.004; Irving RA, 1996, IMMUNOTECHNOLOGY, V2, P127, DOI 10.1016/1380-2933(96)00044-9; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Karanikas V, 1998, TUMOR BIOL, V19, P71, DOI 10.1159/000056507; Kim SJ, 2008, J IMMUNOL METHODS, V329, P176, DOI 10.1016/j.jim.2007.10.009; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Krebs B, 2001, J IMMUNOL METHODS, V254, P67, DOI 10.1016/S0022-1759(01)00398-2; Kuroda K, 2010, PROSTATE, V70, P1286, DOI 10.1002/pros.21164; Kurtenkov O, 2007, ACTA ONCOL, V46, P316, DOI 10.1080/02841860601055441; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; Lee YC, 2002, J MOL BIOL, V320, P107, DOI 10.1016/S0022-2836(02)00403-5; Lepisto Andrew J, 2008, Cancer Ther, V6, P955; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; Mabry R, 2010, PROTEIN ENG DES SEL, V23, P115, DOI 10.1093/protein/gzp073; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Menzel C, 2008, BLOOD, V111, P3830, DOI 10.1182/blood-2007-04-082768; Meyer T, 2011, VET MICROBIOL, V147, P162, DOI 10.1016/j.vetmic.2010.06.023; Mollova S, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P3, DOI 10.1007/978-3-642-01147-4_1; Mukherjee P, 2001, GLYCOCONJUGATE J, V18, P931, DOI 10.1023/A:1022260711583; Muzard J, 2009, FEBS J, V276, P4207, DOI 10.1111/j.1742-4658.2009.07129.x; Park SG, 2000, BIOCHEM BIOPH RES CO, V275, P553, DOI 10.1006/bbrc.2000.3336; PARRY G, 1990, EXP CELL RES, V188, P302, DOI 10.1016/0014-4827(90)90174-9; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MINI-REV MED CHEM, V9, P1633, DOI 10.2174/138955709791012283; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Pericleous LM, 2005, BRIT J CANCER, V93, P1257, DOI 10.1038/sj.bjc.6602847; Pietersz GA, 1997, CANCER IMMUNOL IMMUN, V44, P323, DOI 10.1007/s002620050389; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; SAFI F, 1991, CANCER-AM CANCER SOC, V68, P574, DOI 10.1002/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B; Sambrook J, 2001, MOL CLONING LAB MANU; Schirrmann T, 2010, METHODS MOL BIOL, V651, P177, DOI 10.1007/978-1-60761-786-0_11; Schirrmann T, 2009, EXPERT OPIN BIOL TH, V9, P79, DOI [10.1517/14712590802631862, 10.1517/14712590802631862 ]; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Schoonooghe S, 2010, PROTEIN ENG DES SEL, V23, P721, DOI 10.1093/protein/gzq044; Schutte M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006625; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Singh R, 2007, CANCER BIOL THER, V6, P481, DOI 10.4161/cbt.6.4.4201; Skrlj N, 2010, APPL BIOCHEM BIOTECH, V160, P1808, DOI 10.1007/s12010-009-8699-4; SPICER AP, 1991, J BIOL CHEM, V266, P15099; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; SWALLOW DM, 1987, NATURE, V328, P82, DOI 10.1038/328082a0; TAYLORPAPADIMITRIOU J, 1981, INT J CANCER, V28, P17, DOI 10.1002/ijc.2910280104; Teicher BA, 2009, CURR CANCER DRUG TAR, V9, P982, DOI 10.2174/156800909790192365; Thie H, 2008, CURR PHARM BIOTECHNO, V9, P439, DOI 10.2174/138920108786786349; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Trahtenherts A, 2009, HYBRIDOMA, V28, P225, DOI 10.1089/hyb.2009.0019; VERHOEYEN ME, 1993, IMMUNOLOGY, V78, P364; Vimal D, 2000, MOL CELL BIOCHEM, V204, P107, DOI 10.1023/A:1007015312036; vonWasielewski R, 1997, J HISTOCHEM CYTOCHEM, V45, P1455, DOI 10.1177/002215549704501102; Wang ZR, 2007, BIOCONJUGATE CHEM, V18, P947, DOI 10.1021/bc0603438; WELSCHOF M, 1995, J IMMUNOL METHODS, V179, P203, DOI 10.1016/0022-1759(94)00286-6; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; Williamson P, 1999, FEMS IMMUNOL MED MIC, V23, P313, DOI 10.1016/S0928-8244(98)00151-5; Yau KYF, 2005, J IMMUNOL METHODS, V297, P213, DOI 10.1016/j.jim.2004.12.005; Zhao XL, 2009, J BIOTECHNOL, V144, P253, DOI 10.1016/j.jbiotec.2009.09.022; Zielinski R, 2009, J IMMUNOTHER, V32, P817, DOI 10.1097/CJI.0b013e3181ad4d5d; ZOTTER S, 1988, INT J CANCER, P38	108	55	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15921	10.1371/journal.pone.0015921	http://dx.doi.org/10.1371/journal.pone.0015921			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264246	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500017
J	Thiel, A; Kesselring, R; Pries, R; Puzik, A; Wittkopf, N; Wollenberg, B				Thiel, Annette; Kesselring, Rebecca; Pries, Ralph; Puzik, Alexander; Wittkopf, Nadine; Wollenberg, Barbara			Expression of the T Cell Receptor alpha beta on a CD123+BDCA2+HLA-DR+ Subpopulation in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; HUMAN PERIPHERAL-BLOOD; SPI-B; CANCER; INTERLEUKIN-6; CYTOKINES; TUMOR; SURVIVAL; CPG; IDENTIFICATION	Human Plasmacytoid Dendritic Cells (PDCs) infiltrating solid tumor tissues and draining lymph nodes of Head and Neck Squamous Cell Carcinoma (HNSCC) show an impaired immune response. In addition to an attenuated secretion of IFN-alpha little is known about other HNSCC-induced functional alterations in PDCs. Particular objectives in this project were to gain new insights regarding tumor-induced phenotypical and functional alterations in the PDC population. We showed by FACS analysis and RT-PCR that HNSCC orchestrates an as yet unknown subpopulation exhibiting functional autonomy in-vitro and in-vivo besides bearing phenotypical resemblance to PDCs and T cells. A subset, positive for the PDC markers CD123, BDCA2, HLA-DR and the T cell receptor alpha beta (TCR-alpha beta) was significantly induced subsequent to stimulation with HNSCC in-vitro (p = 0.009) and also present in metastatic lymph nodes in-vivo. This subgroup could be functionally distinguished due to an enhanced production of IL-2 (p = 0.02), IL-6 (p = 0.0007) and TGF-beta (not significant). Furthermore, after exposure to HNSCC cells, mRNA levels revealed a D-J-beta rearrangement of the TCR-beta chain besides a strong enhancement of the CD3 epsilon chain in the PDC population. Our data indicate an interface between the PDC and T cell lineage. These findings will improve our understanding of phenotypical and functional intricacies concerning the very heterogeneous PDC population in-vivo.	[Thiel, Annette; Kesselring, Rebecca; Pries, Ralph; Wittkopf, Nadine; Wollenberg, Barbara] Univ Schleswig Holstein, Dept Otorhinolaryngol, Lubeck, Germany; [Puzik, Alexander] Univ Freiburg, Dept Pediat, D-7800 Freiburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Freiburg	Thiel, A (corresponding author), Univ Schleswig Holstein, Dept Otorhinolaryngol, Campus Lubeck, Lubeck, Germany.	annettethiel@yahoo.de	Wollenberg, Barbara/AAK-7272-2020; Wollenberg, Barbara/E-7435-2010	Puzik, Alexander/0000-0003-1432-5183	Mildred Scheel-Stiftung (Deutsche Krebshilfe); Werner-and-Klara-Kreitz-Stiftung; Monika-Kutzner-Stiftung; Rudolf-Bartling-Stiftung	Mildred Scheel-Stiftung (Deutsche Krebshilfe)(Deutsche Krebshilfe); Werner-and-Klara-Kreitz-Stiftung; Monika-Kutzner-Stiftung; Rudolf-Bartling-Stiftung	This work was supported by grants from the Mildred Scheel-Stiftung (Deutsche Krebshilfe), the Werner-and-Klara-Kreitz-Stiftung, the Monika-Kutzner-Stiftung and the Rudolf-Bartling-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarstad HJ, 2006, ACTA OTO-LARYNGOL, V126, P1326, DOI 10.1080/00016480600702092; Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Bose Anamika, 2008, Cancer Immun, V8, P10; Bruno L, 1997, J EXP MED, V185, P875, DOI 10.1084/jem.185.5.875; Busch A, 2008, J IMMUNOL, V181, P3965, DOI 10.4049/jimmunol.181.6.3965; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Chin D, 2004, BRIT J PLAST SURG, V57, P595, DOI 10.1016/j.bjps.2004.06.010; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Dasgupta S, 2006, J CELL BIOCHEM, V97, P1036, DOI 10.1002/jcb.20647; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Douglas JG, 2000, HEAD NECK-J SCI SPEC, V22, P826, DOI 10.1002/1097-0347(200012)22:8<826::AID-HED13>3.0.CO;2-P; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; FACCHETTI F, 1989, AM J CLIN PATHOL, V92, P42, DOI 10.1093/ajcp/92.1.42; Garcia-Peydro M, 2006, J IMMUNOL, V177, P3711, DOI 10.4049/jimmunol.177.6.3711; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Hartmann E, 2003, CANCER RES, V63, P6478; Hartmann G, 1996, ANTISENSE NUCLEIC A, V6, P291, DOI 10.1089/oli.1.1996.6.291; Heimdal JH, 2000, LARYNGOSCOPE, V110, P402, DOI 10.1097/00005537-200003000-00013; Heimdal JH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-34; Kanazawa T, 2007, EUR ARCH OTO-RHINO-L, V264, P815, DOI 10.1007/s00405-007-0264-6; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lathers DMR, 2003, HUM IMMUNOL, V64, P1160, DOI 10.1016/j.humimm.2003.08.024; Legrand F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005926; Li YY, 2009, HUM IMMUNOL, V70, P151, DOI 10.1016/j.humimm.2009.01.004; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Pries R, 2006, IN VIVO, V20, P45; Pries R, 2006, CYTOKINE GROWTH F R, V17, P141, DOI 10.1016/j.cytogfr.2006.02.001; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Riedel F, 2005, ANTICANCER RES, V25, P2761; Rothenfusser S, 2002, HUM IMMUNOL, V63, P1111, DOI 10.1016/S0198-8859(02)00749-8; Scales D, 2001, J IMMUNOL, V166, P6437, DOI 10.4049/jimmunol.166.10.6437; Schotte R, 2003, BLOOD, V101, P1015, DOI 10.1182/blood-2002-02-0438; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Sparano A, 2004, OTOLARYNG HEAD NECK, V131, P573, DOI 10.1016/j.otohns.2004.03.016; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Tel J, 2010, J IMMUNOL, V184, P4276, DOI 10.4049/jimmunol.0903286; Thiel A, 2009, ANTICANCER RES, V29, P3019; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Wilkins-Port CE, 2007, CELLS TISSUES ORGANS, V185, P116, DOI 10.1159/000101312; Zitvogel L, 2008, M S-MED SCI, V24, P525, DOI 10.1051/medsci/2008245525	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15997	10.1371/journal.pone.0015997	http://dx.doi.org/10.1371/journal.pone.0015997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264308	Green Published, gold, Green Submitted			2022-12-25	WOS:000286514000014
J	Cawood, R; Wong, SL; Di, Y; Baban, DF; Seymour, LW				Cawood, Ryan; Wong, Suet-Ling; Di, Ying; Baban, Dilair F.; Seymour, Leonard W.			MicroRNA Controlled Adenovirus Mediates Anti-Cancer Efficacy without Affecting Endogenous MicroRNA Activity	PLOS ONE			English	Article							TRANSGENE EXPRESSION; ONCOLYTIC ADENOVIRUS; GENE-THERAPY; IN-VIVO; VIRUS; VECTORS; CANCER; E1A; HEPATOTOXICITY; REPLICATION	MicroRNAs are small non-coding RNA molecules that regulate mRNA translation and stability by binding to complementary sequences usually within the 39 un-translated region (UTR). We have previously shown that the hepatic toxicity caused by wild-type Adenovirus 5 (Ad5WT) in mice can be prevented by incorporating 4 binding sites for the liver-specific microRNA, mir122, into the 3' UTR of E1A mRNA. This virus, termed Ad5mir122, is a promising virotherapy candidate and causes no obvious liver pathology. Herein we show that Ad5mir122 maintains wild-type lytic activity in cancer cells not expressing mir122 and assess any effects of possible mir122 depletion in host cells. Repeat administration of 2 x 10(10) viral particles of Admir122 to HepG2 tumour bearing mice showed significant anti-cancer efficacy. RT-QPCR showed that E1A mRNA was down-regulated 29-fold in liver when compared to Ad5WT. Western blot for E1A confirmed that all protein variants were knocked down. RT-QPCR for mature mir122 in infected livers showed that quantity of mir122 remained unaffected. Genome wide mRNA microarray profiling of infected livers showed that although the transcript level of >3900 different mRNAs changed more than 2-fold following Ad5WT infection, less than 600 were changed by Ad5mir122. These were then filtered to select mRNAs that were only altered by Ad5mir122 and the remaining 21 mRNAs were compared to predicted mir122 targets. No mir122 target mRNAs were affected by Ad5 mir122. These results demonstrate that the exploitation of microRNA regulation to control virus replication does not necessarily affect the level of the microRNA or the endogenous mRNA targets.	[Cawood, Ryan; Wong, Suet-Ling; Di, Ying; Seymour, Leonard W.] Univ Oxford, Dept Clin Pharmacol, Med Virol Res Grp, Oxford, England; [Baban, Dilair F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Genom Grp, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Cawood, R (corresponding author), Univ Oxford, Dept Clin Pharmacol, Med Virol Res Grp, Oxford, England.	len.seymour@clinpharm.ox.ac.uk		Felce, Ling/0000-0001-8534-1629	Cancer Research UK; Medical Research Council; Wellcome Trust; Cancer Research UK [11339] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	RC and YD are supported by Cancer Research UK (http://www.cancer.org.uk/), SLW is funded by a research studentship from the Medical Research Council (www.mrc.ac.uk). The microarray core facility is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bazan-Peregrino M, 2008, HUM GENE THER, V19, P873, DOI 10.1089/hum.2008.047; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edge RE, 2008, MOL THER, V16, P1437, DOI 10.1038/mt.2008.130; Engler H, 2004, VIROLOGY, V328, P52, DOI 10.1016/j.virol.2004.06.043; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fabani MM, 2008, RNA, V14, P336, DOI 10.1261/rna.844108; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; KAMRUD KI, 2010, J VIROLOGY; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KELLY EJ, J VIROLOGY, V84, P1550; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; LEE TC, BIOCH BIOPHYSICAL RE, V396, P596; Lichtenstein DL, 2004, CANCER GENE THER, V11, P819, DOI 10.1038/sj.cgt.7700765; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Majem M, 2006, CANCER GENE THER, V13, P696, DOI 10.1038/sj.cgt.7700940; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Msaouel P, 2009, PROSTATE, V69, P82, DOI 10.1002/pros.20857; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SCHAEFER A, 2001, EUROPEAN UROLOGY, V57, P919; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Suzuki T, 2008, MOL THER, V16, P1719, DOI 10.1038/mt.2008.159; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08	34	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e16152	10.1371/journal.pone.0016152	http://dx.doi.org/10.1371/journal.pone.0016152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264344	gold, Green Published, Green Submitted			2022-12-25	WOS:000286513100029
J	Davies, P; Moualla, D; Brown, DR				Davies, Paul; Moualla, Dima; Brown, David R.			Alpha-Synuclein Is a Cellular Ferrireductase	PLOS ONE			English	Article							METAL-BINDING; COPPER(II) BINDING; IRON; INSIGHTS; PATHOGENESIS; MUTATIONS; DISEASE; CU(II); CU2+	alpha-synuclein (alpha S) is a cellular protein mostly known for the association of its aggregated forms with a variety of diseases that include Parkinson's disease and Dementia with Lewy Bodies. While the role of alpha S in disease is well documented there is currently no agreement on the physiological function of the normal isoform of the protein. Here we provide strong evidence that alpha S is a cellular ferrireductase, responsible for reducing iron (III) to bio available iron (II). The recombinant form of the protein has a V-Max of 2.72 nmols/min/mg and K-m 23 mu M. This activity is also evident in lysates from neuronal cell lines overexpressing alpha S. This activity is dependent on copper bound to alpha S as a cofactor and NADH as an electron donor. Overexpression of alpha-synuclein by cells significantly increases the percentage of iron (II) in cells. The common disease mutations associated with increased susceptibility to PD show differences in activity or iron (II) levels. This discovery may well provide new therapeutic targets for PD and Lewy body dementias.	[Davies, Paul; Moualla, Dima; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Davies, P (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Davies, Paul/0000-0001-8022-2719				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Beyer K, 2009, INT J MOL SCI, V10, P724, DOI 10.3390/ijms10030724; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Bharathi, 2007, BIOCHEM BIOPH RES CO, V359, P115, DOI 10.1016/j.bbrc.2007.05.060; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Brown DR, 2009, BIOCHEM BIOPH RES CO, V380, P377, DOI 10.1016/j.bbrc.2009.01.103; Burke RE, 2004, NEUROLOGIST, V10, P75, DOI 10.1097/01.nrl.0000117822.90759.83; Charkoudian LK, 2006, INORG CHEM, V45, P3657, DOI 10.1021/ic060014r; Davies P, 2009, BIOCHEMISTRY-US, V48, P2610, DOI 10.1021/bi900170n; Drew SC, 2008, J AM CHEM SOC, V130, P7766, DOI 10.1021/ja800708x; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Hong L, 2009, J PHYS CHEM B, V113, P9551, DOI 10.1021/jp809773y; Kienzl E, 1999, LIFE SCI, V65, P1973, DOI 10.1016/S0024-3205(99)00458-0; Lee EN, 2003, J NEUROCHEM, V84, P1128, DOI 10.1046/j.1471-4159.2003.01612.x; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; MASSERANO JM, 1983, MOL CELL BIOCHEM, V53-4, P129; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Simovich MJ, 2002, AM J HEMATOL, V69, P164, DOI 10.1002/ajh.10052; Sung YH, 2006, BBA-PROTEINS PROTEOM, V1764, P5, DOI 10.1016/j.bbapap.2005.11.003; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Wolozin B, 2002, NEUROSCIENTIST, V8, P22, DOI 10.1177/107385840200800107; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Yu S, 2005, MOL NEUROBIOL, V31, P243, DOI 10.1385/MN:31:1-3:243; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118	30	139	144	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15814	10.1371/journal.pone.0015814	http://dx.doi.org/10.1371/journal.pone.0015814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249223	Green Published, gold, Green Submitted			2022-12-25	WOS:000286513100012
J	Pandya, GA; McEllistrem, MC; Venepally, P; Holmes, MH; Jarrahi, B; Sanka, R; Liu, J; Karamycheva, SA; Bai, Y; Fleischmann, RD; Peterson, SN				Pandya, Gagan A.; McEllistrem, M. Catherine; Venepally, Pratap; Holmes, Michael H.; Jarrahi, Behnam; Sanka, Ravi; Liu, Jia; Karamycheva, Svetlana A.; Bai, Yun; Fleischmann, Robert D.; Peterson, Scott N.			Monitoring the Long-Term Molecular Epidemiology of the Pneumococcus and Detection of Potential 'Vaccine Escape' Strains	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; UNITED-STATES; SEQUENCE-ANALYSIS; INVASIVE DISEASE; GENOME SEQUENCE; DIVERSITY; PSPA; RECOMBINATION; VIRULENCE	Background: While the pneumococcal protein conjugate vaccines reduce the incidence in invasive pneumococcal disease (IPD), serotype replacement remains a major concern. Thus, serotype-independent protection with vaccines targeting virulence genes, such as PspA, have been pursued. PspA is comprised of diverse clades that arose through recombination. Therefore, multi-locus sequence typing (MLST)-defined clones could conceivably include strains from multiple PspA clades. As a result, a method is needed which can both monitor the long-term epidemiology of the pneumococcus among a large number of isolates, and analyze vaccine-candidate genes, such as pspA, for mutations and recombination events that could result in 'vaccine escape' strains. Methodology: We developed a resequencing array consisting of five conserved and six variable genes to characterize 72 pneumococcal strains. The phylogenetic analysis of the 11 concatenated genes was performed with the MrBayes program, the single nucleotide polymorphism (SNP) analysis with the DNA Sequence Polymorphism program (DnaSP), and the recombination event analysis with the recombination detection package (RDP). Results: The phylogenetic analysis correlated with MLST, and identified clonal strains with unique PspA clades. The DnaSP analysis correlated with the serotype-specific diversity detected using MLST. Serotypes associated with more than one ST complex had a larger degree of sequence polymorphism than a serotype associated with one ST complex. The RDP analysis confirmed the high frequency of recombination events in the pspA gene. Conclusions: The phylogenetic tree correlated with MLST, and detected multiple PspA clades among clonal strains. The genetic diversity of the strains and the frequency of recombination events in the mosaic gene, pspA were accurately assessed using the DnaSP and RDP programs, respectively. These data provide proof-of-concept that resequencing arrays could play an important role within research and clinical laboratories in both monitoring the molecular epidemiology of the pneumococcus and detecting 'vaccine escape' strains among vaccine-candidate genes.	[Pandya, Gagan A.; Venepally, Pratap; Holmes, Michael H.; Jarrahi, Behnam; Sanka, Ravi; Liu, Jia; Karamycheva, Svetlana A.; Bai, Yun; Fleischmann, Robert D.; Peterson, Scott N.] J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD USA; [McEllistrem, M. Catherine] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	J. Craig Venter Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Pandya, GA (corresponding author), J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD USA.	scottp@jcvi.org			NIAID [N01-AI-15447];  [K23 AI01788-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001788] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID contract No. N01-AI-15447 to Pathogen Functional Genomics Resource Center and K23 AI01788-05 (MCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Beall B, 2000, J CLIN MICROBIOL, V38, P3663, DOI 10.1128/JCM.38.10.3663-3669.2000; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Chen Y, 2007, J CLIN MICROBIOL, V45, P835, DOI 10.1128/JCM.01575-06; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Do T, 2009, MICROBIOL-SGM, V155, P2593, DOI 10.1099/mic.0.027284-0; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feavers IM, 1999, J CLIN MICROBIOL, V37, P3883, DOI 10.1128/JCM.37.12.3883-3887.1999; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; McEllistrem MC, 2009, FUTURE MICROBIOL, V4, P857, DOI 10.2217/FMB.09.58; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mitchell TJ, 2004, PNEUMOCCOCUS, P61; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Nei M., 1987, MOL EVOLUTIONARY GEN; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pandya GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm918; Rehm SJ, 2009, POSTGRAD MED, V121, P101, DOI 10.3810/pgm.2009.11.2069; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Roche H, 2003, INFECT IMMUN, V71, P4498, DOI 10.1128/IAI.71.8.4498-4505.2003; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Snel B, 2005, ANNU REV MICROBIOL, V59, P191, DOI 10.1146/annurev.micro.59.030804.121233; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1983, GENETICS, V105, P437; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Xin W, 2009, INFECT IMMUN, V77, P4518, DOI 10.1128/IAI.00486-09; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994	62	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15950	10.1371/journal.pone.0015950	http://dx.doi.org/10.1371/journal.pone.0015950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264340	Green Published, gold, Green Submitted			2022-12-25	WOS:000286513100021
J	Ma, LG; Xin, HP; Qu, LH; Zhao, J; Yang, LB; Zhao, P; Sun, MX				Ma, Ligang; Xin, Haiping; Qu, Lianghuan; Zhao, Jing; Yang, Libo; Zhao, Peng; Sun, Mengxiang			Transcription Profile Analysis Reveals That Zygotic Division Results in Uneven Distribution of Specific Transcripts in Apical/Basal Cells of Tobacco	PLOS ONE			English	Article							EMBRYONIC PATTERN-FORMATION; ARABIDOPSIS ROOT-MERISTEM; FACTOR FAMILY; EMBRYOGENESIS; EXPRESSION; PROTEIN; PLANTS; GENES; FATE; SUSPENSOR	Background: Asymmetric zygotic division in higher plants results in the formation of an apical cell and a basal cell. These two embryonic cells possess distinct morphologies and cell developmental fates. It has been proposed that unevenly distributed cell fate determinants and/or distinct cell transcript profiles may be the underlying reason for their distinct fates. However, neither of these hypotheses has convincing support due to technical limitations. Methodology/Principal Findings: Using laser-controlled microdissection, we isolated apical and basal cells and constructed cell type-specific cDNA libraries. Transcript profile analysis revealed difference in transcript composition. PCR and qPCR analysis confirmed that transcripts of selected embryogenesis-related genes were cell-type preferentially distributed. Some of the transcripts that existed in zygotes were found distinctly existed in apical or basal cells. The cell type specific de novo transcription was also found after zygotic cell division. Conclusions/Significance: Thus, we found that the transcript diversity occurs between apical and basal cells. Asymmetric zygotic division results in the uneven distribution of some embryogenesis related transcripts in the two-celled proembryos, suggesting that a differential distribution of some specific transcripts in the apical or basal cells may involve in guiding the two cell types to different developmental destinies.	[Ma, Ligang; Xin, Haiping; Qu, Lianghuan; Zhao, Jing; Yang, Libo; Zhao, Peng; Sun, Mengxiang] Wuhan Univ, Coll Life Sci, Minist Educ Plant Dev Biol, Key Lab, Wuhan 430072, Peoples R China	Wuhan University	Ma, LG (corresponding author), Wuhan Univ, Coll Life Sci, Minist Educ Plant Dev Biol, Key Lab, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn	Ma, Ligang/O-9603-2014	Ma, Ligang/0000-0003-3451-5291	'973' Project [2007CB108700]; National Natural Science Fund of China [30521004, 30771131]	'973' Project(National Basic Research Program of China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The project was supported by the '973' Project (2007CB108700), National Natural Science Fund of China (30521004, 30771131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouget FY, 1998, DEVELOPMENT, V125, P1999; Chandler JW, 2009, PLANT MOL BIOL, V69, P57, DOI 10.1007/s11103-008-9405-6; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Fu ChunMei, 1996, Acta Botanica Sinica, V38, P262; Gallagher K, 1997, CURR OPIN CELL BIOL, V9, P842, DOI 10.1016/S0955-0674(97)80086-5; GURDON JB, 1992, CELL, V68, P185, DOI 10.1016/0092-8674(92)90465-O; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; He YC, 2007, PLANT J, V49, P515, DOI 10.1111/j.1365-313X.2006.02970.x; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Irish VF, 2001, CURR OPIN GENET DEV, V11, P424, DOI 10.1016/S0959-437X(00)00213-6; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laux T, 2004, PLANT CELL, V16, pS190, DOI 10.1105/tpc.016014; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; LINDSEY K, 1993, J EXP BOT, V44, P359, DOI 10.1093/jxb/44.2.359; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; Ning J, 2006, FEBS LETT, V580, P1747, DOI 10.1016/j.febslet.2006.02.028; Okamoto T, 2005, PLANT CELL PHYSIOL, V46, P332, DOI 10.1093/pcp/pci032; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERNON DM, 1994, DEV BIOL, V165, P566, DOI 10.1006/dbio.1994.1276; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; Weterings K, 2001, PLANT CELL, V13, P2409, DOI 10.1105/tpc.13.11.2409; Xin HP, 2010, SCI CHINA LIFE SCI, V53, P927, DOI 10.1007/s11427-010-4033-1	32	16	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15971	10.1371/journal.pone.0015971	http://dx.doi.org/10.1371/journal.pone.0015971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249132	Green Published, Green Submitted, gold			2022-12-25	WOS:000286512900015
J	Wen, XY; Abe, T; Kukihara, H; Taguwa, S; Mori, Y; Tani, H; Kato, N; Suzuki, T; Tatsumi, M; Moriishi, K; Matsuura, Y				Wen, Xiaoyu; Abe, Takayuki; Kukihara, Hiroshi; Taguwa, Shuhei; Mori, Yoshio; Tani, Hideki; Kato, Nobuyuki; Suzuki, Tetsuro; Tatsumi, Masashi; Moriishi, Kohji; Matsuura, Yoshiharu			Elimination of Hepatitis C Virus from Hepatocytes by a Selective Activation of Therapeutic Molecules	PLOS ONE			English	Article							RIG-I; ADAPTER PROTEIN; INTERFERON; EXPRESSION; CELLS; IFN; ESTABLISHMENT; PATHOGENESIS; CLEAVAGE; PATHWAY	To eliminate hepatitis C virus (HCV) from infected hepatocytes, we generated two therapeutic molecules specifically activated in cells infected with HCV. A dominant active mutant of interferon (IFN) regulatory factor 7 (IRF7) and a negative regulator of HCV replication, VAP-C (Vesicle-associated membrane protein-associated protein subtype C), were fused with the C-terminal region of IPS-1 (IFN beta promoter stimulator-1), which includes an HCV protease cleavage site that was modified to be localized on the ER membrane, and designated cIRF7 and cVAP-C, respectively. In cells expressing the HCV protease, cIRF7 was cleaved and the processed fragment was migrated into the nucleus, where it activated various IFN promoters, including promoters of IFN alpha 6, IFN beta, and IFN stimulated response element. Activation of the IFN promoters and suppression of viral RNA replication were observed in the HCV replicon cells and in cells infected with the JFH1 strain of HCV (HCVcc) by expression of cIRF7. Suppression of viral RNA replication was observed even in the IFN-resistant replicon cells by the expression of cIRF7. Expression of the cVAP-C also resulted in suppression of HCV replication in both the replicon and HCVcc infected cells. These results suggest that delivery of the therapeutic molecules into the liver of hepatitis C patients, followed by selective activation of the molecules in HCV-infected hepatocytes, is a feasible method for eliminating HCV.	[Wen, Xiaoyu; Abe, Takayuki; Kukihara, Hiroshi; Taguwa, Shuhei; Mori, Yoshio; Tani, Hideki; Moriishi, Kohji; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan; [Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama 7008530, Japan; [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4312102, Japan; [Tatsumi, Masashi] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	Osaka University; Okayama University; Hamamatsu University School of Medicine; National Institute of Infectious Diseases (NIID)	Wen, XY (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan.	matsuura@biken.osaka-u.ac.jp	Moriishi, Kohji/I-4173-2019	Moriishi, Kohji/0000-0002-9542-5188	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology; Osaka University Global Center of Excellence; Foundation for Biomedical Research and Innovation	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Biomedical Research and Innovation(Foundation for Biomedical Research and Innovation, Kobe, Japan)	This work was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare; the Ministry of Education, Culture, Sports, Science, and Technology; the Osaka University Global Center of Excellence Program; and the Foundation for Biomedical Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Blindenbacher A, 2003, GASTROENTEROLOGY, V124, P1465, DOI 10.1016/S0016-5085(03)00290-7; Bukh J, 1999, VIROLOGY, V262, P470, DOI 10.1006/viro.1999.9941; Cerny A, 1999, HEPATOLOGY, V30, P595, DOI 10.1002/hep.510300312; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kukihara H, 2009, J VIROL, V83, P7959, DOI 10.1128/JVI.00889-09; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Naka K, 2005, J GEN VIROL, V86, P2787, DOI 10.1099/vir.0.81124-0; Namba K, 2004, BIOCHEM BIOPH RES CO, V323, P299, DOI 10.1016/j.bbrc.2004.08.091; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Soriano V, 2008, EXPERT OPIN EMERG DR, V13, P1, DOI 10.1517/14728214.13.1.1 ; Tanaka Y, 2010, MICROBIOL IMMUNOL, V54, P206, DOI 10.1111/j.1348-0421.2010.00209.x; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vilasco M, 2006, HEPATOLOGY, V44, P1635, DOI 10.1002/hep.21432; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854; Zhu HZ, 2005, J INTERF CYTOK RES, V25, P528, DOI 10.1089/jir.2005.25.528	41	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15967	10.1371/journal.pone.0015967	http://dx.doi.org/10.1371/journal.pone.0015967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253612	Green Submitted, gold, Green Published			2022-12-25	WOS:000286511900032
J	Tong, YK; Chiu, RWK; Akolekar, R; Leung, TY; Lau, TK; Nicolaides, KH; Lo, YMD				Tong, Yu K.; Chiu, Rossa W. K.; Akolekar, Ranjit; Leung, Tak Y.; Lau, Tze K.; Nicolaides, Kypros H.; Lo, Y. M. Dennis			Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; MATERNAL PLASMA; DIGITAL PCR; PLACENTAL ORIGIN; DNA-METHYLATION; MESSENGER-RNA; ALLELIC RATIO; BLOOD; ANEUPLOIDY; 1ST-TRIMESTER	Background: The putative promoter of the holocarboxylase synthetase (HLCS) gene on chromosome 21 is hypermethylated in placental tissues and could be detected as a fetal-specific DNA marker in maternal plasma. Detection of fetal trisomy 21 (T21) has been demonstrated by an epigenetic-genetic chromosome dosage approach where the amount of hypermethylated HLCS in maternal plasma is normalized using a fetal genetic marker on the Y chromosome as a chromosome dosage reference marker. We explore if this method can be applied on both male and female fetuses with the use of a paternally-inherited fetal single nucleotide polymorphism (SNP) allele on a reference chromosome for chromosome dosage normalization. Methodology: We quantified hypermethylated HLCS molecules using methylation-sensitive restriction endonuclease digestion followed by real-time or digital PCR analyses. For chromosome dosage analysis, we compared the amount of digestion-resistant HLCS to that of a SNP allele (rs6636, a C/G SNP) that the fetus has inherited from the father but absent in the pregnant mother. Principal Findings: Using a fetal-specific SNP allele on a reference chromosome, we analyzed 20 euploid and nine T21 placental tissue samples. All samples with the fetal-specific C allele were correctly classified. One sample from each of the euploid and T21 groups were misclassified when the fetal-specific G allele was used as the reference marker. We then analyzed 33 euploid and 14 T21 maternal plasma samples. All but one sample from each of the euploid and T21 groups were correctly classified using the fetal-specific C allele, while correct classification was achieved for all samples using the fetal-specific G allele as the reference marker. Conclusions: As a proof-of-concept study, we have demonstrated that the epigenetic-genetic chromosome dosage approach can be applied to the prenatal diagnosis of trisomy 21 for both male and female fetuses.	[Tong, Yu K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Ctr Res Circulating Fetal Nucle Acids, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Tong, Yu K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Akolekar, Ranjit; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England; [Leung, Tak Y.; Lau, Tze K.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Chinese University of Hong Kong; Prince of Wales Hospital	Tong, YK (corresponding author), Chinese Univ Hong Kong, Ctr Res Circulating Fetal Nucle Acids, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Lau, Tze Kin/0000-0002-0242-1410; Nicolaides, Kypros/0000-0003-1266-0711	University Grants Committee of the Government of the Hong Kong Special Administration Region, China [AoE/M-04/06]; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administration Region, China; Li Ka Shing Foundation	This study was supported by the University Grants Committee of the Government of the Hong Kong Special Administration Region, China - Areas of Excellence Scheme (AoE/M-04/06). YMDL is supported by the Chair Professorship Scheme of the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2009, TRENDS GENET, V25, P324, DOI 10.1016/j.tig.2009.05.004; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chow KCK, 2007, CLIN CHEM, V53, P141, DOI 10.1373/clinchem.2007.079335; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; Daniels G, 2009, PRENATAL DIAG, V29, P101, DOI 10.1002/pd.2172; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; Kong CW, 2006, PRENATAL DIAG, V26, P925, DOI 10.1002/pd.1528; Lau TK, 2005, CHINESE MED J-PEKING, V118, P1675; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Old RW, 2007, REPROD BIOMED ONLINE, V15, P227, DOI 10.1016/S1472-6483(10)60713-4; Oudejans CBM, 2003, CLIN CHEM, V49, P1445, DOI 10.1373/49.9.1445; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; TABOR A, 1986, LANCET, V1, P1287; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui NBY, 2010, CLIN CHEM, V56, P73, DOI 10.1373/clinchem.2009.132662; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273	34	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15244	10.1371/journal.pone.0015244	http://dx.doi.org/10.1371/journal.pone.0015244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21249119	gold, Green Submitted, Green Published			2022-12-25	WOS:000285575200026
J	Gaborit, N; Larbouret, C; Vallaghe, J; Peyrusson, F; Bascoul-Mollevi, C; Crapez, E; Azria, D; Chardes, T; Poul, MA; Mathis, G; Bazin, H; Pelegrin, A				Gaborit, Nadege; Larbouret, Christel; Vallaghe, Julie; Peyrusson, Frederic; Bascoul-Mollevi, Caroline; Crapez, Evelyne; Azria, David; Chardes, Thierry; Poul, Marie-Alix; Mathis, Gerard; Bazin, Herve; Pelegrin, Andre			Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers A NEW METHOD TO EVALUATE THE EFFICIENCY OF TARGETED THERAPY USING MONOCLONAL ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER CELLS; FACTOR RECEPTOR; QUANTITATIVE-ANALYSIS; EXTRACELLULAR DOMAIN; ERBB RECEPTORS; OVARIAN-CANCER; EGF RECEPTOR; LUNG-CANCER; DIMERIZATION	In oncology, simultaneous inhibition of epidermal growth factor receptor (EGFR) and HER2 by monoclonal antibodies (mAbs) is an efficient therapeutic strategy but the underlying mechanisms are not fully understood. Here, we describe a time-resolved fluorescence resonance energy transfer (TR-FRET) method to quantify EGFR/HER2 heterodimers on cell surface to shed some light on the mechanism of such therapies. First, we tested this antibody-based TR-FRET assay in NIH/3T3 cell lines that express EGFR and/or HER2 and in various tumor cell lines. Then, we used the antibody-based TR-FRET assay to evaluate in vitro the effect of different targeted therapies on EGFR/HER2 heterodimers in the ovarian carcinoma cell line SKOV-3. A simultaneous incubation with Cetuximab (anti-EGFR) and Trastuzumab (anti-HER2) disturbed EGFR/HER2 heterodimers resulting in a 72% reduction. Cetuximab, Trastuzumab or Pertuzumab (antiHER2) alone induced a 48, 44, or 24% reduction, respectively. In contrast, the tyrosine kinase inhibitors Erlotinib and Lapatinib had very little effect on EGFR/HER2 dimers concentration. In vivo, the combination of Cetuximab and Trastuzumab showed a better therapeutic effect (median survival and percentage of tumor-free mice) than the single mAbs. These results suggest a correlation between the extent of the mAb-induced EGFR/HER2 heterodimer reduction and the efficacy of such mAbs in targeted therapies. In conclusion, quantifying EGFR/HER2 heterodimers using our antibody-based TR-FRET assay may represent a useful method to predict the efficacy and explain the mechanisms of action of therapeutic mAbs, in addition to other commonly used techniques that focus on antibody-dependent cellular cytotoxicity, phosphorylation, and cell proliferation.	[Gaborit, Nadege; Larbouret, Christel; Azria, David; Chardes, Thierry; Poul, Marie-Alix; Pelegrin, Andre] Univ Montpellier 1, IRCM, INSERM, CRLC Val dAurelle Paul Lamarque,U896, F-34298 Montpellier, France; [Vallaghe, Julie; Peyrusson, Frederic; Mathis, Gerard; Bazin, Herve] Cisbio, Res Dept, F-30204 Bagnols Sur Ceze, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Pelegrin, A (corresponding author), Univ Montpellier 1, IRCM, INSERM, CRLC Val dAurelle Paul Lamarque,U896, F-34298 Montpellier, France.	andre.pelegrin@inserm.fr	Pèlegrin, André/J-3167-2016; Gaborit, Nadège A/O-7825-2017; Chardès, Thierry/B-5420-2019; Mollevi, Caroline/AAA-6839-2019	Chardès, Thierry/0000-0002-1836-7439; Mollevi, Caroline/0000-0003-4827-3684; Peyrusson, Frederic/0000-0002-5544-8916; Crapez, evelyne/0000-0002-8261-3470; Pelegrin, Andre/0000-0001-9254-2648	Agence Nationale de la Recherche [ANR-07-RIB-003/Dim-HER]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This project was supported by Agence Nationale de la Recherche Grant ANR-07-RIB-003/Dim-HER.	Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Barros FFT, 2010, HISTOPATHOLOGY, V56, P560, DOI 10.1111/j.1365-2559.2010.03494.x; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cai Z, 2008, ONCOGENE, V27, P3870, DOI 10.1038/onc.2008.13; Cappuzzo F, 2003, J CLIN ONCOL, V21, P2658, DOI 10.1200/JCO.2003.01.039; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; De Pas T, 2004, J CLIN ONCOL, V22, P4966, DOI 10.1200/JCO.2004.01.195; Diermeier-Daucher S, 2008, ANN NY ACAD SCI, V1130, P280, DOI 10.1196/annals.1430.003; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Furuuchi K, 2007, J IMMUNOL, V178, P1021, DOI 10.4049/jimmunol.178.2.1021; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Harris M, 2004, LANCET ONCOL, V5, P292, DOI 10.1016/S1470-2045(04)01467-6; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Hendriks BS, 2003, CANCER RES, V63, P1130; Hughes JB, 2009, MOL CANCER THER, V8, P1885, DOI 10.1158/1535-7163.MCT-09-0291; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jain A, 2010, CANCER RES, V70, P1989, DOI 10.1158/0008-5472.CAN-09-3326; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Khan IH, 2010, ASSAY DRUG DEV TECHN, V8, P27, DOI 10.1089/adt.2009.0208; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kristjansdottir K, 2010, EXPERT OPIN BIOL TH, V10, P243, DOI 10.1517/14712590903514090; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Larbouret C, 2010, ANN ONCOL, V21, P98, DOI 10.1093/annonc/mdp496; Larbouret C, 2007, CLIN CANCER RES, V13, P3356, DOI 10.1158/1078-0432.CCR-06-2302; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Mullen P, 2007, MOL CANCER THER, V6, P93, DOI 10.1158/1535-7163.MCT-06-0401; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Patel D, 2009, INT J ONCOL, V34, P25, DOI 10.3892/ijo_00000125; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Shi YN, 2009, DIAGN MOL PATHOL, V18, P11, DOI 10.1097/PDM.0b013e31818cbdb2; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Takai N, 2005, CANCER-AM CANCER SOC, V104, P2701, DOI 10.1002/cncr.21533; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wilkinson JC, 2002, BIOCHEMISTRY-US, V41, P8, DOI 10.1021/bi015839l; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang K, 1996, J BIOL CHEM, V271, P3884	51	42	53	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11337	11345		10.1074/jbc.M111.223503	http://dx.doi.org/10.1074/jbc.M111.223503			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282108	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000288797100046
J	Lalmansingh, AS; Urekar, CJ; Reddi, PP				Lalmansingh, Avin S.; Urekar, Craig J.; Reddi, Prabhakara P.			TDP-43 Is a Transcriptional Repressor THE TESTIS-SPECIFIC MOUSE acrv1 GENE IS A TDP-43 TARGET IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR TDP-43; DNA-BINDING PROTEIN; SPERMATID-SPECIFIC TRANSCRIPTION; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSFECTED DNA; CFTR EXON-9; SP-10 GENE; PROMOTER; CHROMATIN; DISEASE	TDP-43 is an evolutionarily conserved ubiquitously expressed DNA/RNA-binding protein. Although recent studies have shown its association with a variety of neurodegenerative disorders, the function of TDP-43 remains poorly understood. Here we address TDP-43 function using spermatogenesis as a model system. We previously showed that TDP-43 binds to the testis-specific mouse acrv1 gene promoter in vitro via two GTGTGT-motifs and that mutation of these motifs led to premature transcription in spermatocytes of an otherwise round spermatid-specific promoter. The present study tested the hypothesis that TDP-43 represses acrv1 gene transcription in spermatocytes. Plasmid chromatin immunoprecipitation demonstrated that TDP-43 binds to the acrv1 promoter through GTGTGT motifs in vivo. Reporter gene assays showed that TDP-43 represses acrv1 core promoter-driven transcription via the N-terminal RRM1 domain in a histone deacetylase-independent manner. Consistent with repressor role, ChIP on physiologically isolated germ cells confirmed that TDP-43 occupies the endogenous acrv1 promoter in spermatocytes. Surprisingly, however, TDP-43 remains at the promoter in round spermatids, which express acrv1 mRNA. We show that RNA binding-defective TDP-43, but not splice variant isoforms, relieve repressor function. Transitioning from repressive to active histone marks has little effect on TDP-43 occupancy. Finally, we found that RNA polymerase II is recruited but paused at the acrv1 promoter in spermatocytes. Because mutation of TDP-43 sites caused premature transcription in spermatocytes in vivo, TDP-43 may be involved in pausing RNAPII at the acrv1 promoter in spermatocytes. Overall, our study shows that TDP-43 is a transcriptional repressor and that it regulates spatiotemporal expression of the acrv1 gene during spermatogenesis.	[Reddi, Prabhakara P.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Reddi, PP (corresponding author), Univ Virginia, Sch Med, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	ppr5s@virginia.edu	Reddi, Prabhakara/AAY-8092-2020	Reddi, Prabhakara/0000-0003-4891-8964	National Institutes of Health [R01HD36239, 5T32HD007382]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036239, T32HD007382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD36239 (to P. P. R.).; Received support from National Institutes of Health Training Grant 5T32HD007382 awarded to the Center for Research in Reproduction, University of Virginia.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; CEREGHINI S, 1984, EMBO J, V3, P1243, DOI 10.1002/j.1460-2075.1984.tb01959.x; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lalmansingh AS, 2008, ENDOCRINOLOGY, V149, P346, DOI 10.1210/en.2007-0372; Miyake T, 2000, J BIOL CHEM, V275, P40169, DOI 10.1074/jbc.M007138200; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Newberry EP, 1999, BIOCHEMISTRY-US, V38, P10678, DOI 10.1021/bi990967j; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang Yanming, 2004, Novartis Found Symp, V259, P3; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	38	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10970	10982		10.1074/jbc.M110.166587	http://dx.doi.org/10.1074/jbc.M110.166587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21252238	Green Published, hybrid			2022-12-25	WOS:000288797100009
J	Sato, H; Isogai, Y; Masuda, S; Taketomi, Y; Miki, Y; Kamei, D; Hara, S; Kobayashi, T; Ishikawa, Y; Ishii, T; Ikeda, K; Taguchi, R; Ishimoto, Y; Suzuki, N; Yokota, Y; Hanasaki, K; Suzuki-Yamamoto, T; Yamamoto, K; Murakami, M				Sato, Hiroyasu; Isogai, Yuki; Masuda, Seiko; Taketomi, Yoshitaka; Miki, Yoshimi; Kamei, Daisuke; Hara, Shuntaro; Kobayashi, Tetsuyuki; Ishikawa, Yukio; Ishii, Toshiharu; Ikeda, Kazutaka; Taguchi, Ryo; Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji; Suzuki-Yamamoto, Toshiko; Yamamoto, Kei; Murakami, Makoto			Physiological Roles of Group X-secreted Phospholipase A(2) in Reproduction, Gastrointestinal Phospholipid Digestion, and Neuronal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; FOAM CELL-FORMATION; MICE LACKING; GROUP-V; LYSOPHOSPHATIDIC ACID; GROUP-II; INFLAMMATORY HYPERALGESIA; PAIN HYPERSENSITIVITY; STAPHYLOCOCCUS-AUREUS; EMBRYO IMPLANTATION	Although the secreted phospholipase A(2) (sPLA(2)) family has been generally thought to participate in pathologic events such as inflammation and atherosclerosis, relatively high and constitutive expression of group X sPLA(2) (sPLA(2)-X) in restricted sites such as reproductive organs, the gastrointestinal tract, and peripheral neurons raises a question as to the roles played by this enzyme in the physiology of reproduction, digestion, and the nervous system. Herein we used mice with gene disruption or transgenic overexpression of sPLA(2)-X to clarify the homeostatic functions of this enzyme at these locations. Our results suggest that sPLA(2)-X regulates 1) the fertility of spermatozoa, not oocytes, beyond the step of flagellar motility, 2) gastrointestinal phospholipid digestion, perturbation of which is eventually linked to delayed onset of a lean phenotype with reduced adiposity, decreased plasma leptin, and improved muscle insulin tolerance, and 3) neuritogenesis of dorsal root ganglia and the duration of peripheral pain nociception. Thus, besides its inflammatory action proposed previously, sPLA(2)-X participates in physiologic processes including male fertility, gastrointestinal phospholipid digestion linked to adiposity, and neuronal outgrowth and sensing.	[Sato, Hiroyasu; Isogai, Yuki; Masuda, Seiko; Taketomi, Yoshitaka; Miki, Yoshimi; Yamamoto, Kei; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Sato, Hiroyasu; Masuda, Seiko; Taketomi, Yoshitaka; Miki, Yoshimi; Kamei, Daisuke; Hara, Shuntaro] Showa Univ, Sch Pharceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Isogai, Yuki; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Ishikawa, Yukio; Ishii, Toshiharu] Toho Univ, Sch Med, Dept Pathol, Ohta Ku, Tokyo 1438540, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Ishimoto, Yoshikazu; Suzuki, Noriko; Yokota, Yasunori; Hanasaki, Kohji] Shionogi & Co Ltd, Shionogi Res Labs, Osaka 5610825, Japan; [Ikeda, Kazutaka; Suzuki-Yamamoto, Toshiko] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Dept Neutrit Sci, Okayama 7191197, Japan; [Taguchi, Ryo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Murakami, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; Ochanomizu University; University of Tokyo; Shionogi & Company Limited; Okayama Prefectural University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency; Mitsubishi Science Foundation; Uehara Science Foundation; Toray Science Foundation; Grants-in-Aid for Scientific Research [22116005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mitsubishi Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Toray Science Foundation(Toray Industries, Inc.); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid for Scientific Research and for Young Scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, PRESTO and CREST from the Japan Science and Technology Agency, Mitsubishi Science Foundation, the Uehara Science Foundation, and the Toray Science Foundation.	Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Gilham D, 2007, J BIOL CHEM, V282, P24642, DOI 10.1074/jbc.M702530200; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Hamaguchi K, 2003, BBA-MOL CELL BIOL L, V1635, P37, DOI 10.1016/j.bbalip.2003.10.004; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Hobson SA, 2006, J NEUROCHEM, V99, P1000, DOI 10.1111/j.1471-4159.2006.04143.x; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Holstege JC, 2008, P NATL ACAD SCI USA, V105, P6338, DOI 10.1073/pnas.0802176105; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; IKEDA I, 1987, BIOCHIM BIOPHYS ACTA, V921, P245; Ikeno Y, 2005, J BIOL CHEM, V280, P28044, DOI 10.1074/jbc.M503343200; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jacobson L, 1999, ENDOCRINOLOGY, V140, P310, DOI 10.1210/en.140.1.310; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kerr BJ, 2001, PAIN, V93, P267, DOI 10.1016/S0304-3959(01)00326-8; Kim DH, 2008, NEUROSCIENCE, V154, P1077, DOI 10.1016/j.neuroscience.2008.04.033; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Labonte ED, 2010, FASEB J, V24, P2516, DOI 10.1096/fj.09-144436; Laine VJO, 1999, J IMMUNOL, V162, P7402; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Minami T, 1997, BRIT J PHARMACOL, V122, P605, DOI 10.1038/sj.bjp.0701421; Miyado K, 2008, P NATL ACAD SCI USA, V105, P12921, DOI 10.1073/pnas.0710608105; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakano H, 2001, BRIT J PHARMACOL, V133, P438, DOI 10.1038/sj.bjp.0704092; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Reinold H, 2005, J CLIN INVEST, V115, P673; Richmond BL, 2001, GASTROENTEROLOGY, V120, P1193, DOI 10.1053/gast.2001.23254; Riffo MS, 1997, J EXP ZOOL, V279, P81, DOI 10.1002/(SICI)1097-010X(19970901)279:1<81::AID-JEZ8>3.3.CO;2-V; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Shi TJS, 2006, EUR J NEUROSCI, V23, P627, DOI 10.1111/j.1460-9568.2006.04593.x; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Song H, 2002, DEVELOPMENT, V129, P2879; Stock JL, 2001, J CLIN INVEST, V107, P325, DOI 10.1172/JCI6749; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Surrel F, 2009, MOL PHARMACOL, V76, P778, DOI 10.1124/mol.108.053371; Svensson CI, 2005, NEUROSCIENCE, V133, P543, DOI 10.1016/j.neuroscience.2005.01.024; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; Yamamoto K., J BIOL CHEM, V286; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Young SC, 1999, BIOCHEM J, V339, P615, DOI 10.1042/0264-6021:3390615; Zack M, 2011, ATHEROSCLEROSIS, V214, P58, DOI 10.1016/j.atherosclerosis.2010.08.054; Zhou LJ, 2008, EXP NEUROL, V212, P507, DOI 10.1016/j.expneurol.2008.04.034	86	37	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11632	11648		10.1074/jbc.M110.206755	http://dx.doi.org/10.1074/jbc.M110.206755			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21266581	hybrid, Green Published			2022-12-25	WOS:000288797100072
J	Daly, NL; Callaghan, B; Clark, RJ; Nevin, ST; Adams, DJ; Craik, DJ				Daly, Norelle L.; Callaghan, Brid; Clark, Richard J.; Nevin, Simon T.; Adams, David J.; Craik, David J.			Structure and Activity of alpha-Conotoxin PeIA at Nicotinic Acetylcholine Receptor Subtypes and GABA(B) Receptor-coupled N-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SENSORY NEURONS; NEUROPATHIC PAIN; ALPHA-9-ALPHA-10; VC1.1; INHIBITION; RGIA; ANTAGONISTS; MODULATION; DISCOVERY; PEPTIDES	alpha-Conotoxins are peptides from cone snails that target the nicotinic acetylcholine receptor (nAChR). RgIA and Vc1.1 have analgesic activity in animal pain models. Both peptides target the alpha 9 alpha 10 nAChR and inhibit N-type calcium channels via GABA(B) receptor activation, but the mechanism of action of analgesic activity is unknown. PeIA has previously been shown to inhibit the alpha 9 alpha 10 and alpha 3 beta 2 nAChRs. In this study, we have determined the structure of PeIA and shown that it is also a potent inhibitor of N-type calcium channels via GABA(B) receptor activation. The characteristic alpha-conotoxin fold is present in PeIA, but it has a different distribution of surface-exposed hydrophobic and charged residues compared with Vc1.1. Thus, the surface residue distribution, rather than the overall fold, appears to be responsible for the 50-fold increase in selectivity at the alpha 3 beta 2 nAChR by PeIA relative to Vc1.1. In contrast to their difference in potency at the nAChR, the equipotent activity of PeIA and Vc1.1 at the GABA(B) receptor suggests that the GABA(B) receptor is more tolerant to changes in surface residues than is the nAChR. The conserved Asp-Pro-Arg motif of Vc1.1 and RgIA, which is crucial for potency at the alpha 9 alpha 10 nAChR, is not required for activity at GABAB receptor/N-type calcium channels because PeIA has a His-Pro-Ala motif in the equivalent position. This study shows that different structure-activity relationships are associated with the targeting of the GABA(B) receptor versus nAChRs. Furthermore, there is probably a much more diverse range of conotoxins that target the GABA(B) receptor than currently realized.	[Daly, Norelle L.; Clark, Richard J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Nevin, Simon T.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Callaghan, Brid; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia	University of Queensland; University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Daly, NL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	n.daly@imb.uq.edu.au	Adams, David/J-9125-2014; Daly, Norelle L/D-4302-2013; Clark, Richard J/G-8848-2012; Adams, David John/K-3578-2019; Nevin, Simon/B-2663-2014; Craik, David/B-1695-2010; Callaghan, Brid/N-1764-2019	Adams, David/0000-0002-7030-2288; Daly, Norelle L/0000-0002-4697-6602; Clark, Richard J/0000-0002-6807-5426; Adams, David John/0000-0002-7030-2288; Craik, David/0000-0003-0007-6796; Callaghan, Brid/0000-0001-7251-8851	Australian Research Council [DP0986281]; National Health and Medical Research Council [APP456074]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DP0986281 and National Health and Medical Research Council Grant APP456074.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; Dutton JL, 2001, CURR MED CHEM, V8, P327, DOI 10.2174/0929867013373453; Dwoskin LP, 2009, NEUROPSYCHOPHARMACOL, V34, P244, DOI 10.1038/npp.2008.157; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Ellison M, 2008, J MOL BIOL, V377, P1216, DOI 10.1016/j.jmb.2008.01.082; Gotti C, 2006, CURR PHARM DESIGN, V12, P407, DOI 10.2174/138161206775474486; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Livett BG, 2006, TOXICON, V48, P810, DOI 10.1016/j.toxicon.2006.07.023; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; McIntosh JM, 2009, BIOCHEM PHARMACOL, V78, P693, DOI 10.1016/j.bcp.2009.05.020; McIntosh JM, 2000, EUR J PHARMACOL, V393, P205, DOI 10.1016/S0014-2999(99)00887-0; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Millard EL, 2009, J BIOL CHEM, V284, P4944, DOI 10.1074/jbc.M804950200; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; TATEBAYASHI H, 1992, J PHYSIOL-LONDON, V447, P391, DOI 10.1113/jphysiol.1992.sp019008; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Vincler M, 2007, EXPERT OPIN THER TAR, V11, P891, DOI 10.1517/14728222.11.7.891; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	33	38	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10233	10237		10.1074/jbc.M110.196170	http://dx.doi.org/10.1074/jbc.M110.196170			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252227	Green Published, hybrid			2022-12-25	WOS:000288547000040
J	Oruc, I; Guo, XYM; Barton, JJS				Oruc, Ipek; Guo, Xiaoyue M.; Barton, Jason J. S.			Gender in Facial Representations: A Contrast-Based Study of Adaptation within and between the Sexes	PLOS ONE			English	Article							HUMAN VISUAL-SYSTEM; CATEGORICAL PERCEPTION; FACE-SPACE; FEMALE FACES; ORIENTATION; RECOGNITION; MOTION; TILT; DISTINCTIVENESS; THRESHOLDS	Face aftereffects are proving to be an effective means of examining the properties of face-specific processes in the human visual system. We examined the role of gender in the neural representation of faces using a contrast-based adaptation method. If faces of different genders share the same representational face space, then adaptation to a face of one gender should affect both same- and different-gender faces. Further, if these aftereffects differ in magnitude, this may indicate distinct gender-related factors in the organization of this face space. To control for a potential confound between physical similarity and gender, we used a Bayesian ideal observer and human discrimination data to construct a stimulus set in which pairs of different-gender faces were equally dissimilar as same- gender pairs. We found that the recognition of both same-gender and different-gender faces was suppressed following a brief exposure of 100ms. Moreover, recognition was more suppressed for test faces of a different-gender than those of the same-gender as the adaptor, despite the equivalence in physical and psychophysical similarity. Our results suggest that male and female faces likely occupy the same face space, allowing transfer of aftereffects between the genders, but that there are special properties that emerge along gender-defining dimensions of this space.	[Oruc, Ipek; Guo, Xiaoyue M.; Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Oruc, Ipek; Guo, Xiaoyue M.; Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Guo, Xiaoyue M.] Wellesley Coll, Dept Neurosci, Wellesley, MA 02181 USA	University of British Columbia; University of British Columbia; University of British Columbia; Wellesley College	Oruc, I (corresponding author), Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada.	ipor@interchange.ubc.ca	Barton, Jason JS/A-6362-2012; Oruc, Ipek/C-8719-2013	Guo, Xiaoyue Mona/0000-0002-5922-272X	Natural Sciences and Engineering Research Council [RGPIN 355879-08]; University of British Columbia; Canada Research Chair; Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by Discovery Grant RGPIN 355879-08 from the Natural Sciences and Engineering Research Council. MG was supported by a Canadian Institutes of Health Research Summer Studentship from the University of British Columbia graduate program in neuroscience. JB was also supported by a Canada Research Chair and Senior Scholar Award from the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; Bestelmeyer PEG, 2008, COGNITION, V107, P353, DOI 10.1016/j.cognition.2007.07.018; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; BLAKEMORE C, 1971, J PHYSIOL-LONDON, V213, P157, DOI 10.1113/jphysiol.1971.sp009374; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bulthoff I, 2004, VIS COGN, V11, P823, DOI 10.1080/13506280444000012; Campanella S, 2001, VIS COGN, V8, P237, DOI 10.1080/13506280042000072; Clifford CWG, 2002, TRENDS COGN SCI, V6, P136, DOI 10.1016/S1364-6613(00)01856-8; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; Efron B., 1994, INTRO BOOTSTRAP; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Fox CJ, 2008, J VISION, V8, DOI 10.1167/8.3.11; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Green DM, 1988, SIGNAL DETECTION THE; Guo XYM, 2009, VISION RES, V49, P2254, DOI 10.1016/j.visres.2009.06.012; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Huber DE, 2003, COGNITIVE SCI, V27, P403, DOI 10.1016/S0364-0213(03)00012-0; Jaquet E, 2008, J EXP PSYCHOL HUMAN, V34, P101, DOI 10.1037/0096-1523.34.1.101; Johnston RA, 1997, VIS COGN, V4, P59, DOI 10.1080/713756748; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LEVINSON E, 1976, VISION RES, V16, P779, DOI 10.1016/0042-6989(76)90189-9; Little AC, 2005, P ROY SOC B-BIOL SCI, V272, P2283, DOI 10.1098/rspb.2005.3220; LUNDQVIST D, 1998, AVERAGED KAROLINKSA; MAGNUSSEN S, 1986, VISION RES, V26, P661, DOI 10.1016/0042-6989(86)90014-3; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Ng M, 2008, J VISION, V8, DOI 10.1167/8.1.1; Oruc I, 2010, VISION RES, V50, P1845, DOI 10.1016/j.visres.2010.06.005; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rostamirad S, 2009, NEUROREPORT, V20, P1177, DOI 10.1097/WNR.0b013e32832f078d; SEKULER RW, 1968, J OPT SOC AM, V58, P1146, DOI 10.1364/JOSA.58.001146; SERGENT J, 1984, BRIT J PSYCHOL, V75, P221, DOI 10.1111/j.2044-8295.1984.tb01895.x; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; TJAN BS, 1995, VISION RES, V35, P3053, DOI 10.1016/0042-6989(95)00070-G; VALENTINE T, 1992, Q J EXP PSYCHOL-A, V44, P671, DOI 10.1080/14640749208401305; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Valentine T, 2001, SCI PSYCH S, P83; Valentine T., 1995, ACCOUNT OWN RACE BIA; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	48	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16251	10.1371/journal.pone.0016251	http://dx.doi.org/10.1371/journal.pone.0016251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267414	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500049
J	Sinakevitch, I; Mustard, JA; Smith, BH				Sinakevitch, Irina; Mustard, Julie A.; Smith, Brian H.			Distribution of the Octopamine Receptor AmOA1 in the Honey Bee Brain	PLOS ONE			English	Article							UNPAIRED MEDIAN NEURONS; COCKROACH PERIPLANETA-AMERICANA; FLY DROSOPHILA-MELANOGASTER; DIVISION-OF-LABOR; APIS-MELLIFERA L; MUSHROOM BODIES; SUBESOPHAGEAL GANGLION; VISUAL-SYSTEM; CENTRAL COMPLEX; ANTENNAL LOBES	Octopamine plays an important role in many behaviors in invertebrates. It acts via binding to G protein coupled receptors located on the plasma membrane of responsive cells. Several distinct subtypes of octopamine receptors have been found in invertebrates, yet little is known about the expression pattern of these different receptor subtypes and how each subtype may contribute to different behaviors. One honey bee (Apis mellifera) octopamine receptor, AmOA1, was recently cloned and characterized. Here we continue to characterize the AmOA1 receptor by investigating its distribution in the honey bee brain. We used two independent antibodies produced against two distinct peptides in the carboxyl-terminus to study the distribution of the AmOA1 receptor in the honey bee brain. We found that both anti-AmOA1 antibodies revealed labeling of cell body clusters throughout the brain and within the following brain neuropils: the antennal lobes; the calyces, pedunculus, vertical (alpha, gamma) and medial (beta) lobes of the mushroom body; the optic lobes; the subesophageal ganglion; and the central complex. Double immunofluorescence staining using anti-GABA and anti-AmOA1 receptor antibodies revealed that a population of inhibitory GABAergic local interneurons in the antennal lobes express the AmOA1 receptor in the cell bodies, axons and their endings in the glomeruli. In the mushroom bodies, AmOA1 receptors are expressed in a subpopulation of inhibitory GABAergic feedback neurons that ends in the visual (outer half of basal ring and collar regions) and olfactory (lip and inner basal ring region) calyx neuropils, as well as in the collar and lip zones of the vertical and medial lobes. The data suggest that one effect of octopamine via AmOA1 in the antennal lobe and mushroom body is to modulate inhibitory neurons.	[Sinakevitch, Irina; Mustard, Julie A.; Smith, Brian H.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sinakevitch, I (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	brian.h.smith@asu.edu		Mustard, Julie A/0000-0002-1412-1140	National Institutes of Health National Center for Research Resources [RR014166]; National Institute on Deafness and Other Communication Disorders [DC007997]; National Institute on Drug Abuse [DA017694]; Fondation pour Recherche Medicale [UFM20060306548]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA017694] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Fondation pour Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institutes of Health National Center for Research Resources grant RR014166 and National Institute on Deafness and Other Communication Disorders grant DC007997 to BHS; National Institute on Drug Abuse grant DA017694 to JAM; and Fondation pour Recherche Medicale grant UFM20060306548 to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Bacon JP, 1995, J NEUROPHYSIOL, V74, P2739, DOI 10.1152/jn.1995.74.6.2739; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Bornhauser BC, 1997, CELL TISSUE RES, V287, P211, DOI 10.1007/s004410050747; Braunig P, 2004, ACTA BIOL HUNG, V55, P13, DOI 10.1556/ABiol.55.2004.1-4.3; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brown SM, 2006, J COMP NEUROL, V496, P556, DOI 10.1002/cne.20943; Busch S, 2010, J COMP NEUROL, V518, P2355, DOI 10.1002/cne.22337; CANDY DJ, 1978, INSECT BIOCHEM, V8, P177, DOI 10.1016/0020-1790(78)90070-7; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; DAVENPORT AP, 1984, INSECT BIOCHEM, V14, P135, DOI 10.1016/0020-1790(84)90021-0; Dierick HA, 2008, CURR BIOL, V18, pR161, DOI 10.1016/j.cub.2007.12.026; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; ERBER J, 1995, J COMP PHYSIOL A, V176, P111, DOI 10.1007/BF00197757; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Farooqui T, 2003, J NEUROSCI, V23, P5370; Farris SM, 2004, J COMP NEUROL, V474, P325, DOI 10.1002/cne.20146; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; GEFFARD M, 1984, BRAIN RES, V294, P161, DOI 10.1016/0006-8993(84)91323-4; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Grunewald B, 1999, J COMP NEUROL, V404, P114; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Han KA, 1998, J NEUROSCI, V18, P3650; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HOMBERG U, 1985, J INSECT PHYSIOL, V31, P251, DOI 10.1016/0022-1910(85)90127-1; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; KLOPPENBURG P, 1995, J COMP PHYSIOL A, V176, P119, DOI 10.1007/BF00197758; KONINGS PNM, 1988, CELL TISSUE RES, V251, P371, DOI 10.1007/BF00215846; KREISSL S, 1994, J COMP NEUROL, V348, P583, DOI 10.1002/cne.903480408; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Matheson T, 1997, J EXP BIOL, V200, P1317; Mentel T, 2003, J NEUROSCI, V23, P1109, DOI 10.1523/JNEUROSCI.23-04-01109.2003; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; REHDER V, 1988, PROC R SOC SER B-BIO, V235, P179, DOI 10.1098/rspb.1988.0071; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; ROWELL CHF, 1971, J EXP BIOL, V55, P727; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; RYBAK J, 2001, 6 INT C NEUR 29 JUL; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SEGUELA P, 1984, P NATL ACAD SCI-BIOL, V81, P3888, DOI 10.1073/pnas.81.12.3888; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Sinakevitch I, 2001, J COMP NEUROL, V439, P352, DOI 10.1002/cne.1355; Sinakevitch IG, 1996, J COMP NEUROL, V367, P147; SINAKEVITCH IG, 1994, CELL TISSUE RES, V276, P15, DOI 10.1007/BF00354779; Smith BH, 2006, BIOLOGY OF FLORAL SCENT, P263; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Stern M, 1999, MICROSC RES TECHNIQ, V45, P135, DOI 10.1002/(SICI)1097-0029(19990501)45:3<135::AID-JEMT1>3.0.CO;2-G; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; WATSON AHD, 1984, J NEUROCYTOL, V13, P303, DOI 10.1007/BF01148121; Wicher Dieter, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P304, DOI 10.2174/187153007782794290; Widmer A, 2005, J NEUROSCI, V25, P1588, DOI 10.1523/JNEUROSCI.4505-04.2005; Yamagata N, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.016.2009; Zhukovskaya MI, 2006, J INSECT PHYSIOL, V52, P76, DOI 10.1016/j.jinsphys.2005.09.005	81	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14536	10.1371/journal.pone.0014536	http://dx.doi.org/10.1371/journal.pone.0014536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267078	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500010
J	Liu, FY; Hu, XL; Zimmerman, M; Waller, JL; Wu, P; Hayes-Jordan, A; Lev, D; Liu, KB				Liu, Feiyan; Hu, Xiaolin; Zimmerman, Mary; Waller, Jennifer L.; Wu, Ping; Hayes-Jordan, Andrea; Lev, Dina; Liu, Kebin			TNF alpha Cooperates with IFN-gamma to Repress Bcl-xL Expression to Sensitize Metastatic Colon Carcinoma Cells to TRAIL-mediated Apoptosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; LIGAND-INDUCED APOPTOSIS; BREAST-CANCER CELLS; DOWN-REGULATION; COLORECTAL-CANCER; DEATH RECEPTORS; HEPATOCELLULAR-CARCINOMA; INITIATED APOPTOSIS; PROTEIN EXPRESSION	Background: TNF-related apoptosis-inducing ligand (TRAIL) is an immune effector molecule that functions as a selective anti-tumor agent. However, tumor cells, especially metastatic tumor cells often exhibit a TRAIL-resistant phenotype, which is currently a major impediment in TRAIL therapy. The aim of this study is to investigate the synergistic effect of TNF alpha and IFN-gamma in sensitizing metastatic colon carcinoma cells to TRAIL-mediated apoptosis. Methodology/Principal Findings: The efficacy and underlying molecular mechanism of cooperation between TNF alpha and IFN-gamma in sensitizing metastatic colon carcinoma cells to TRAIL-mediated apoptosis were examined. The functional significance of TNF alpha- and IFN-gamma-producing T lymphocyte immunotherapy in combination with TRAIL therapy in suppression of colon carcinoma metastasis was determined in an experimental metastasis mouse model. We observed that TNF alpha or IFN-gamma alone exhibits minimal sensitization effects, but effectively sensitized metastatic colon carcinoma cells to TRAIL-induced apoptosis when used in combination. TNF alpha and IFN-gamma cooperate to repress Bcl-xL expression, whereas TNF alpha represses Survivin expression in the metastatic colon carcinoma cells. Silencing Bcl-xL expression significantly increased the metastatic colon carcinoma cell sensitivity to TRAIL-induced apoptosis. Conversely, overexpression of Bcl-xL significantly decreased the tumor cell sensitivity to TRAIL-induced apoptosis. Furthermore, TNF alpha and IFN-gamma also synergistically enhanced TRAIL-induced caspase-8 activation. TNF alpha and IFN-gamma was up-regulated in activated primary and tumor-specific T cells. TRAIL was expressed in tumor-infiltrating immune cells in vivo, and in tumor-specific cytotoxic T lymphocytes (CTL) ex vivo. Consequently, TRAIL therapy in combination with TNF alpha/IFN-gamma-producing CTL adoptive transfer immunotherapy effectively suppressed colon carcinoma metastasis in vivo. Conclusions/Significance: TNF alpha and IFN-gamma cooperate to overcome TRAIL resistance at least partially through enhancing caspase 8 activation and repressing Bcl-xL expression. Combined CTL immunotherapy and TRAIL therapy hold great promise for further development for the treatment of metastatic colorectal cancer.	[Liu, Feiyan; Wu, Ping] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Feiyan; Hu, Xiaolin; Zimmerman, Mary; Liu, Kebin] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Waller, Jennifer L.] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biostat, Augusta, GA USA; [Hayes-Jordan, Andrea] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Hayes-Jordan, Andrea] Univ Texas MD Anderson Canc Ctr, Dept Pediat Oncol, Houston, TX 77030 USA; [Lev, Dina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Liu, Kebin] Univ Texas MD Anderson Canc Ctr, Sarcoma Res Ctr, Houston, TX 77030 USA	Zhejiang University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, FY (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	Kliu@mcg.edu		Liu, Kebin/0000-0003-1965-7240	National Institutes of Health [CA133085, CA138345]; American Cancer Society [RSG-09-209-01-TBG]; National High Technology Research and Development Program of China [2007AA021504]; NATIONAL CANCER INSTITUTE [R01CA138345, R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support from the National Institutes of Health (CA133085 to KL and CA138345 to DL), the American Cancer Society (RSG-09-209-01-TBG to K.L.), and the National High Technology Research and Development Program of China (2007AA021504 to FL and PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EY, 2002, INT J CANCER, V100, P445, DOI 10.1002/ijc.10516; Ammann JU, 2009, INT J CANCER, V124, P1301, DOI 10.1002/ijc.24068; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bhat UG, 2008, INT J CANCER, V122, P1426, DOI 10.1002/ijc.23239; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Chawla-Sarkar M, 2003, J BIOL CHEM, V278, P39461, DOI 10.1074/jbc.M306111200; Darvas K, 2010, INT J CANCER, V127, P1384, DOI 10.1002/ijc.25170; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Elrod HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012178; Fulda S, 2006, ONCOGENE, V25, P5125, DOI 10.1038/sj.onc.1209518; Gagiannis S, 2009, INT J CANCER, V125, P1551, DOI 10.1002/ijc.24471; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Haynes NM, 2010, J IMMUNOL, V185, P532, DOI 10.4049/jimmunol.0903624; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Jalving M, 2006, CLIN CANCER RES, V12, P4350, DOI 10.1158/1078-0432.CCR-05-2487; Jani TS, 2010, J BIOL CHEM, V285, P19162, DOI 10.1074/jbc.M109.091645; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kabore AF, 2006, APOPTOSIS, V11, P1175, DOI 10.1007/s10495-006-8048-9; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045; Karlsson M, 2010, ANN SURG ONCOL, V17, P1747, DOI 10.1245/s10434-010-0920-8; Kauh J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010376; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lacour S, 2001, CANCER RES, V61, P1645; Li FZ, 2006, AM J PATHOL, V169, P1, DOI 10.2353/ajpath.2006.060121; Li FZ, 2005, ONCOGENE, V24, P1385, DOI 10.1038/sj.onc.1208330; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Lippa MS, 2007, APOPTOSIS, V12, P1465, DOI 10.1007/s10495-007-0076-6; Lissat A, 2007, AM J PATHOL, V170, P1917, DOI 10.2353/ajpath.2007.060993; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Panner A, 2009, CANCER RES, V69, P7911, DOI 10.1158/0008-5472.CAN-09-1287; Psahoulia FH, 2007, MOL CANCER THER, V6, P2591, DOI 10.1158/1535-7163.MCT-07-0001; Ravi R, 2006, CANCER RES, V66, P1730, DOI 10.1158/0008-5472.CAN-05-3377; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Seol DW, 2001, CANCER RES, V61, P1138; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shankar S, 2009, MOL CANCER THER, V8, P1596, DOI 10.1158/1535-7163.MCT-08-1004; Sinicrope FA, 2005, MOL CANCER THER, V4, P1475, DOI 10.1158/1535-7163.MCT-05-0137; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Tekautz TM, 2006, BBA-MOL CELL RES, V1763, P1000, DOI 10.1016/j.bbamcr.2006.06.014; Tillman DM, 2003, CANCER RES, V63, P5118; van der Most RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006982; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Xu J, 2006, CANCER RES, V66, P10092, DOI 10.1158/0008-5472.CAN-06-1633; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang DF, 2008, INT J CANCER, V122, P350, DOI 10.1002/ijc.23090; Yang DF, 2007, J IMMUNOL, V179, P4775, DOI 10.4049/jimmunol.179.7.4775; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhou Y, 2008, J INTERF CYTOK RES, V28, P65, DOI 10.1089/jir.2007.0025; Zimmerman M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014076	73	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16241	10.1371/journal.pone.0016241	http://dx.doi.org/10.1371/journal.pone.0016241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264227	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600023
J	Rivera-Gutierrez, HF; Pinxten, R; Eens, M				Rivera-Gutierrez, Hector F.; Pinxten, Rianne; Eens, Marcel			Difficulties when Assessing Birdsong Learning Programmes under Field Conditions: A Re-Evaluation of Song Repertoire Flexibility in the Great Tit	PLOS ONE			English	Article							PARUS-MAJOR; SEXUAL SELECTION; ACQUISITION; SIMILARITY; SPARROWS; BEHAVIOR; OVERLAP; CHOICE; SIZE; MATE	There is a remarkable diversity of song-learning strategies in songbirds. Establishing whether a species is closed-or open-ended is important to be able to interpret functional and evolutionary consequences of variation in repertoire size. Most of our knowledge regarding the timing of vocal learning is based on laboratory studies, despite the fact that these may not always replicate the complex ecological and social interactions experienced by birds in the wild. Given that field studies cannot provide the experimental control of laboratory studies, it may not be surprising that species such as the great tit that were initially assumed to be closed-ended learners have later been suggested to be open-ended learners. By using an established colour-ringed population, by following a standardized recording protocol, and by taking into account the species' song ecology (using only recordings obtained during peak of singing at dawn), we replicated two previous studies to assess song repertoire learning and flexibility in adult wild great tits elicited by social interactions. First, we performed a playback experiment to test repertoire plasticity elicited by novel versus own songs. Additionally, in a longitudinal study, we followed 30 males in two consecutive years and analysed whether new neighbours influenced any change in the repertoire. Contrary to the previous studies, song repertoire size and composition were found to be highly repeatable both between years and after confrontation with a novel song. Our results suggest that great tits are closed-ended learners and that their song repertoire probably does not change during adulthood. Methodological differences that may have led to an underestimation of the repertoires or population differences may explain the discrepancy in results with previous studies. We argue that a rigorous and standardized assessment of the repertoire is essential when studying age-or playback-induced changes in repertoire size and composition under field conditions.	[Rivera-Gutierrez, Hector F.; Pinxten, Rianne; Eens, Marcel] Univ Antwerp, Ethol Grp, Antwerp, Belgium	University of Antwerp	Rivera-Gutierrez, HF (corresponding author), Univ Antwerp, Ethol Grp, Antwerp, Belgium.	HectorFabio.RiveraGutierrez@ua.ac.be	Eens, Marcel/AAC-8466-2020; Rivera-Gutierrez, Hector/AAE-7879-2020	Rivera-Gutierrez, Hector/0000-0001-6025-3470	University of Antwerp; FWO-Flanders [G.0130.07, G.0280.10N]	University of Antwerp; FWO-Flanders(FWO)	Financial support was provided by the University of Antwerp and FWO-Flanders (Research Projects G.0130.07 and G.0280.10N) to ME and RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2002, ANIM BEHAV, V64, P939, DOI 10.1006/anbe.2002.1974; Beecher MD, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 1: A-G, P164; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Beecher MD, 1996, ECOLOGY EVOLUTION AC; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CHAIKEN M, 1994, BEHAVIOUR, V128, P25, DOI 10.1163/156853994X00037; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; EENS M, 1992, IBIS, V134, P72, DOI 10.1111/j.1474-919X.1992.tb07233.x; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; FALLS JB, 1982, ANIM BEHAV, V30, P997, DOI 10.1016/S0003-3472(82)80188-7; Foote JR, 2009, WILSON J ORNITHOL, V121, P819, DOI 10.1676/08-137.1; Forstmeier W, 2006, BEHAV ECOL SOCIOBIOL, V59, P634, DOI 10.1007/s00265-005-0090-z; Franco P, 2009, ANIM BEHAV, V77, P261, DOI 10.1016/j.anbehav.2008.09.023; Gorissen L, 2005, OECOLOGIA, V145, P504, DOI 10.1007/s00442-005-0091-7; Gorissen L, 2004, AUK, V121, P184, DOI 10.1642/0004-8038(2004)121[0184:ICBMAF]2.0.CO;2; Gosler A, 1993, GREAT TIT; HINDE R, 1952, BEHAVIOUR S2, V1, P1; Holland J, 2001, BEHAVIOUR, V138, P189, DOI 10.1163/15685390151074375; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; KREBS J, 1978, NATURE, V271, P539, DOI 10.1038/271539a0; KREBS JR, 1977, ANIM BEHAV, V25, P475, DOI 10.1016/0003-3472(77)90022-7; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; KREBS JR, 1976, BEHAV ECOL SOCIOBIOL, V1, P215, DOI 10.1007/BF00299198; KROODSMA DE, 1991, AM ZOOL, V31, P318; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; MACE R, 1987, NATURE, V330, P745, DOI 10.1038/330745a0; MACE R, 1987, ARDEA, V75, P123; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; MCGREGOR PK, 1982, BEHAVIOUR, V79, P126, DOI 10.1163/156853982X00210; MCGREGOR PK, 1981, AM NAT, V118, P149, DOI 10.1086/283811; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Nordby JC, 2002, ETHOLOGY, V108, P39, DOI 10.1046/j.1439-0310.2002.00752.x; Nordeen KW, 2004, ANN NY ACAD SCI, V1016, P416, DOI 10.1196/annals.1298.018; NOTTEBOHM F, 1984, CONDOR, V86, P227, DOI 10.2307/1366988; Nowicki S, 1998, AM ZOOL, V38, P179; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; PETERS SS, 1980, ANIM BEHAV, V28, P393, DOI 10.1016/S0003-3472(80)80048-0; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; Rivera-Gutierrez HF, 2010, ETHOLOGY, V116, P951, DOI 10.1111/j.1439-0310.2010.01813.x; Rivera-Gutierrez HF, 2010, ANIM BEHAV, V80, P451, DOI 10.1016/j.anbehav.2010.06.002; SEARCY WA, 1992, AM ZOOL, V32, P71; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Trillo PA, 2005, ANIM BEHAV, V70, P921, DOI 10.1016/j.anbehav.2005.02.004; Van Duyse E, 2005, HORM BEHAV, V48, P243, DOI 10.1016/j.yhbeh.2005.02.013; Van Duyse E, 2003, GEN COMP ENDOCR, V134, P1, DOI 10.1016/S0016-6480(03)00213-2	49	15	15	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16003	10.1371/journal.pone.0016003	http://dx.doi.org/10.1371/journal.pone.0016003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264212	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600016
J	Kanakaraj, I; Jewell, DL; Murphy, JC; Fox, GE; Willson, RC				Kanakaraj, Indhu; Jewell, David L.; Murphy, Jason C.; Fox, George E.; Willson, Richard C.			Removal of PCR Error Products and Unincorporated Primers by Metal-Chelate Affinity Chromatography	PLOS ONE			English	Article							PLASMID DNA; NUCLEIC-ACIDS; POLYMERASE; RNA; PURIFICATION; SEPARATION; IONS	Immobilized Metal Affinity Chromatography (IMAC) has been used for decades to purify proteins on the basis of amino acid content, especially surface-exposed histidines and "histidine tags'' genetically added to recombinant proteins. We and others have extended the use of IMAC to purification of nucleic acids via interactions with the nucleotide bases, especially purines, of single-stranded RNA and DNA. We also have demonstrated the purification of plasmid DNA from contaminating genomic DNA by IMAC capture of selectively-denatured genomic DNA. Here we describe an efficient method of purifying PCR products by specifically removing error products, excess primers, and unincorporated dNTPs from PCR product mixtures using flow-through metal-chelate affinity adsorption. By flowing a PCR product mixture through a Cu(2+)-iminodiacetic acid (IDA) agarose spin column, 94-99% of the dNTPs and nearly all the primers can be removed. Many of the error products commonly formed by Taq polymerase also are removed. Sequencing of the IMAC-processed PCR product gave base-calling accuracy comparable to that obtained with a commercial PCR product purification method. The results show that IMAC matrices (specifically Cu(2+)-IDA agarose) can be used for the purification of PCR products. Due to the generality of the base-specific mechanism of adsorption, IMAC matrices may also be used in the purification of oligonucleotides, cDNA, mRNA and micro RNAs.	[Kanakaraj, Indhu; Fox, George E.; Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Jewell, David L.; Murphy, Jason C.; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Kanakaraj, I (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	willson@uh.edu	Willson, richard/AAD-4832-2019		National Space Biomedical Research Institute (NASA) [NCC 9-58]; Robert A. Welch Foundation [E-1264, E-1451]	National Space Biomedical Research Institute (NASA)(National Aeronautics & Space Administration (NASA)); Robert A. Welch Foundation(The Welch Foundation)	This research was funded by grants to RCW and GEF from the National Space Biomedical Research Institute (NASA Cooperative Agreement NCC 9-58), and from the Robert A. Welch Foundation (Grants E-1264 and E-1451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan S, 2003, BIOTECHNOL LETT, V25, P1111, DOI 10.1023/A:1024148316322; Cano T, 2005, BIOTECHNOL PROGR, V21, P1472, DOI 10.1021/bp050155g; DUSTERHOFT A, 1998, QIAGEN GUIDE TEMPLAT; Eckert K A, 1991, PCR Methods Appl, V1, P17; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FANOUAYI L, 1983, ANN NY ACAD SCI, V413, P300, DOI 10.1111/j.1749-6632.1983.tb47904.x; Fu JY, 2006, J MOL RECOGNIT, V19, P348, DOI 10.1002/jmr.789; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; HUBERT P, 1980, J CHROMATOGR, V198, P247, DOI 10.1016/S0021-9673(00)84764-0; LUO RG, 2002, Patent No. 6365147; Marzilli L.G, 1980, NUCL ACID METAL ION, P179; Murphy JC, 2003, BIOTECHNOL PROGR, V19, P982, DOI 10.1021/bp025563o; Nastasijevic B, 2008, BIOCHEM BIOPH RES CO, V366, P420, DOI 10.1016/j.bbrc.2007.11.169; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Potty ASR, 2006, J CHROMATOGR A, V1115, P88, DOI 10.1016/j.chroma.2006.02.077; Smith J, 1997, P NATL ACAD SCI USA, V94, P6847, DOI 10.1073/pnas.94.13.6847; SULKOWSKI E, 1989, BIOESSAYS, V10, P170, DOI 10.1002/bies.950100508; Tan LH, 2007, CHEM ENG SCI, V62, P5809, DOI 10.1016/j.ces.2007.06.019; Tan LH, 2007, J CHROMATOGR A, V1141, P226, DOI 10.1016/j.chroma.2006.12.023	20	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14512	10.1371/journal.pone.0014512	http://dx.doi.org/10.1371/journal.pone.0014512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264292	gold, Green Published, Green Submitted			2022-12-25	WOS:000286516500003
J	Kostyak, JC; Naik, UP				Kostyak, John C.; Naik, Ulhas P.			Calcium- and Integrin-Binding Protein 1 Regulates Endomitosis and Its Interaction with Polo-Like Kinase 3 Is Enhanced in Endomitotic Dami Cells	PLOS ONE			English	Article							MEGAKARYOCYTIC DIFFERENTIATION; CLEAVAGE FURROW; ACTIN REORGANIZATION; CONTRACTILE RING; TUMOR-SUPPRESSOR; DROSOPHILA-POLO; MITOTIC KINASES; CYCLE ARREST; DNA-DAMAGE; PLK3	Endomitosis is a form of mitosis in which both karyokinesis and cytokinesis are interrupted and is a hallmark of megakaryocyte differentiation. Very little is known about how such a dramatic alteration of the cell cycle in a physiological setting is achieved. Thrombopoietin-induced signaling is essential for induction of endomitosis. Here we show that calcium- and integrin-binding protein 1 (CIB1), a known regulator of platelet integrin alpha(IIb)beta(3) outside-in signaling, regulates endomitosis. We observed that CIB1 expression is increased in primary mouse megakaryocytes compared to mononuclear bone marrow cells as determined by Western blot analysis. Following PMA treatment of Dami cells, a megakaryoblastic cell line, we found that CIB1 protein expression increased concomitant with cell ploidy. Overexpression of CIB1 in Dami cells resulted in multilobated nuclei and led to increased time for a cell to complete cytokinesis as well as increased incidence of furrow regression as observed by time-lapse microscopy. Additionally, we found that surface expression of integrin alpha(IIb)beta(3), an important megakaryocyte marker, was enhanced in CIB1 overexpressing cells as determined by flow cytometry. Furthermore, PMA treatment of CIB1 overexpressing cells led to increased ploidy compared to PMA treated control cells. Interestingly, expression of Polo-like kinase 3 (Plk3), an established CIB1-interacting protein and a key regulator of the mitotic process, decreased upon PMA treatment of Dami cells. Furthermore, PMA treatment augmented the interaction between CIB1 and Plk3, which depended on the duration of treatment. These data suggest that CIB1 is involved in regulating endomitosis, perhaps through its interaction with Plk3.	[Kostyak, John C.; Naik, Ulhas P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Naik, Ulhas P.] Univ Delaware, Dept Chem Engn, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Naik, Ulhas P.] Univ Delaware, Delaware Cardiovasc Res Ctr, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware; University of Delaware; University of Delaware	Kostyak, JC (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	unaik@udel.edu			National Heart Lung and Blood Institute [HL57630]; National Center for Research Resources [P20RR15588]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057630, R01HL057630] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute Grant HL57630 and National Center for Research Resources Grant P20RR15588 (to U.P.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRYSIK Z, NUCL ACIDS RES, V38, P2931; Bahassi ELM, 2004, ONCOGENE, V23, P2658, DOI 10.1038/sj.onc.1207425; Bahassi EM, 2006, MUTAT RES-FUND MOL M, V596, P166, DOI 10.1016/j.mrfmmm.2005.12.002; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Conn CW, 2000, CANCER RES, V60, P6826; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fuhrken PG, 2008, J BIOL CHEM, V283, P15589, DOI 10.1074/jbc.M801923200; Geddis AE, 2004, BLOOD, V104, P1017, DOI 10.1182/blood-2004-02-0419; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Geddis AE, 2006, CELL CYCLE, V5, P538, DOI 10.4161/cc.5.5.2537; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; GREENBERG SM, 1988, BLOOD, V72, P1968; Huang X, 2004, CELL CYCLE, V3, P946; Huebner-Chan D, 2001, MODERN PATHOL, V14, P1000, DOI 10.1038/modpathol.3880425; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jalagadugula G, 2008, THROMB HAEMOSTASIS, V100, P821, DOI 10.1160/TH08-07-0496; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Lepage A, 2000, BLOOD, V96, P4169, DOI 10.1182/blood.V96.13.4169.h8004169_4169_4177; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Mattia G, 2002, BLOOD, V99, P888, DOI 10.1182/blood.V99.3.888; Myer DL, 2005, ONCOGENE, V24, P299, DOI 10.1038/sj.onc.1208278; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Naik MU, 2006, J CELL SCI, V119, P490, DOI 10.1242/jcs.02771; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; NAIK MU, INT J CANC; NAIK MU, 2009, J THROMB HAEMOST; NAIK MU, INT J BIOCH CELL BIO; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nakano K, 2006, MOL BIOL CELL, V17, P1933, DOI 10.1091/mbc.E05-09-0900; Papadantonakis N, 2008, CELL CYCLE, V7, P2352, DOI 10.4161/cc.6325; Rojnuckarin P, 2001, BLOOD, V97, P154, DOI 10.1182/blood.V97.1.154; Sang MX, 2009, GENES CELLS, V14, P775, DOI 10.1111/j.1365-2443.2009.01309.x; Strober W, 2001, CURR PROTOC IMMUNOL, V3; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; van de Weerdt BCM, 2008, BBA-MOL CELL RES, V1783, P1015, DOI 10.1016/j.bbamcr.2008.02.019; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Yang F, 2007, J CELL SCI, V120, P4060, DOI 10.1242/jcs.014795; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06	47	9	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14513	10.1371/journal.pone.0014513	http://dx.doi.org/10.1371/journal.pone.0014513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264284	gold, Green Submitted, Green Published			2022-12-25	WOS:000286516500004
J	Shao, YZ; Hu, WY; Zhong, WR; Li, L				Shao, Yuanzhi; Hu, Wenyong; Zhong, Weirong; Li, Li			Scaling Dynamic Response and Destructive Metabolism in an Immunosurveillant Anti-Tumor System Modulated by Different External Periodic Interventions	PLOS ONE			English	Article							MODEL; PREDATORS; SIZE; LAWS	On the basis of two universal power-law scaling laws, i.e. the scaling dynamic hysteresis in physics and the allometric scaling metabolism in biosystem, we studied the dynamic response and the evolution of an immunosurveillant anti-tumor system subjected to a periodic external intervention, which is equivalent to the scheme of a radiotherapy or chemotherapy, within the framework of the growth dynamics of tumor. Under the modulation of either an abrupt or a gradual change external intervention, the population density of tumors exhibits a dynamic hysteresis to the intervention. The area of dynamic hysteresis loop characterizes a sort of dissipative-therapeutic relationship of the dynamic responding of treated tumors with the dose consumption of accumulated external intervention per cycle of therapy. Scaling the area of dynamic hysteresis loops against the intensity of an external intervention, we deduced a characteristic quantity which was defined as the theoretical therapeutic effectiveness of treated tumor and related with the destructive metabolism of tumor under treatment. The calculated dose-effectiveness profiles, namely the dose cumulant per cycle of intervention versus the therapeutic effectiveness, could be well scaled into a universal quadratic formula regardless of either an abrupt or a gradual change intervention involved. We present a new concept, i.e., the therapy-effect matrix and the dose cumulant matrix, to expound the new finding observed in the growth and regression dynamics of a modulated anti-tumor system.	[Shao, Yuanzhi; Hu, Wenyong] Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhong, Weirong] Jinan Univ, Dept Phys, Guangzhou, Guangdong, Peoples R China; [Li, Li] Sun Yat Sen Univ, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University; Sun Yat Sen University	Shao, YZ (corresponding author), Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China.	stssyz@mail.sysu.edu.cn	zhong, wei-rong/AAO-8565-2020; zhong, wei-rong/F-6365-2012	zhong, wei-rong/0000-0003-3708-2911	National Natural Science Foundation of China [10875178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 10875178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano R, 2006, P NATL ACAD SCI USA, V103, P1639, DOI 10.1073/pnas.0510567103; Chakrabarti BK, 1999, REV MOD PHYS, V71, P847, DOI 10.1103/RevModPhys.71.847; Dreyer O, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.038101; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Garland JM, 1997, J BIOL CHEM, V272, P4680, DOI 10.1074/jbc.272.8.4680; Gillooly JF, 2007, BIOL LETTERS, V3, P99, DOI 10.1098/rsbl.2006.0576; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HE YL, 1993, PHYS REV LETT, V70, P2336, DOI 10.1103/PhysRevLett.70.2336; Head DA, 1997, PHYS REV E, V55, P3312, DOI 10.1103/PhysRevE.55.3312; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; KURZ H, 1998, SCIENCE, V281, pA751; Lefever R., 1978, BIOMATHEMATICS CELL, P333; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; LIU JM, 2001, PHYS REV B, V65; Maimon R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.255502; Mankin R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061106; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; Marquet PA, 2002, SCIENCE, V295, P2229, DOI 10.1126/science.1070587; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; SAVAGE VM, 2008, PLOS COMPUTATIONAL E; Sides SW, 1998, PHYS REV LETT, V81, P834, DOI 10.1103/PhysRevLett.81.834; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; Uchiyama S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061912; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16115	10.1371/journal.pone.0016115	http://dx.doi.org/10.1371/journal.pone.0016115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264252	Green Published, Green Submitted, gold			2022-12-25	WOS:000286516500028
J	Cross, A; Collard, M				Cross, Alan; Collard, Mark			Estimating Surface Area in Early Hominins	PLOS ONE			English	Article							BODY; PROPORTIONS; HEIGHT	Height and weight-based methods of estimating surface area have played an important role in the development of the current consensus regarding the role of thermoregulation in human evolution. However, such methods may not be reliable when applied to early hominins because their limb proportions differ markedly from those of humans. Here, we report a study in which this possibility was evaluated by comparing surface area estimates generated with the best-known height and weight-based method to estimates generated with a method that is sensitive to proportional differences. We found that the two methods yield indistinguishable estimates when applied to taxa whose limb proportions are similar to those of humans, but significantly different results when applied to taxa whose proportions differ from those of humans. We also found that the discrepancy between the estimates generated by the two methods is almost entirely attributable to inter-taxa differences in limb proportions. One corollary of these findings is that we need to reassess hypotheses about the role of thermoregulation in human evolution that have been developed with the aid of height and weight-based methods of estimating body surface area. Another is that we need to use other methods in future work on fossil hominin body surface areas.	[Cross, Alan; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada; [Collard, Mark] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA	Simon Fraser University; University of Missouri System; University of Missouri Columbia	Cross, A (corresponding author), Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada.	agc6@sfu.ca		Collard, Mark/0000-0002-2725-4989	SSHRC-CGS [766-2004-0723, 767-2006-1902]; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University	SSHRC-CGS; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University	This work was supported by SSHRC-CGS 766-2004-0723, SSHRC-CGS 767-2006-1902, the Canada Research Chairs Program, Canada Foundation for Innovation, British Columbia Knowledge Development Fund, Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey BJR, 1996, STAT MED, V15, P1325; Churchill SE, 2007, VERTEBR PALEOBIOL PA, P113; Collard Mark, 2007, P1575, DOI 10.1007/978-3-540-33761-4_51; Crompton RH, 1996, AM J PHYS ANTHROPOL, V99, P547, DOI 10.1002/(SICI)1096-8644(199604)99:4<547::AID-AJPA3>3.0.CO;2-R; Cross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002464; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Haeusler M, 2004, J HUM EVOL, V46, P433, DOI 10.1016/j.jhevol.2004.01.004; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Ruff Christopher B., 1993, Evolutionary Anthropology, V2, P53, DOI 10.1002/evan.1360020207; Trinkaus E., 1981, ASPECTS HUMAN EVOLUT, P187; WHEELER PE, 1993, J HUM EVOL, V24, P13, DOI 10.1006/jhev.1993.1003; WHEELER PE, 1984, J HUM EVOL, V13, P91, DOI 10.1016/S0047-2484(84)80079-2; Yu CY, 2003, APPL ERGON, V34, P273, DOI 10.1016/S0003-6870(03)00007-3	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16107	10.1371/journal.pone.0016107	http://dx.doi.org/10.1371/journal.pone.0016107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710ME	21249191	Green Published, gold			2022-12-25	WOS:000286515000018
J	Minutolo, C; Nadra, AD; Fernandez, C; Taboas, M; Buzzalino, N; Casali, B; Belli, S; Charreau, EH; Alba, L; Dain, L				Minutolo, Carolina; Nadra, Alejandro D.; Fernandez, Cecilia; Taboas, Melisa; Buzzalino, Noemi; Casali, Barbara; Belli, Susana; Charreau, Eduardo H.; Alba, Liliana; Dain, Liliana			Structure-Based Analysis of Five Novel Disease-Causing Mutations in 21-Hydroxylase-Deficient Patients	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; STEROID 21-HYDROXYLASE; MISSENSE MUTATIONS; GENE CONVERSION; MUTATED ALLELES; DEFICIENCY; GENOTYPE; CYP21; PHENOTYPE; ASSOCIATION	Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is the most frequent inborn error of metabolism, and accounts for 90-95% of CAH cases. The affected enzyme, P450C21, is encoded by the CYP21A2 gene, located together with a 98% nucleotide sequence identity CYP21A1P pseudogene, on chromosome 6p21.3. Even though most patients carry CYP21A1P-derived mutations, an increasing number of novel and rare mutations in disease causing alleles were found in the last years. In the present work, we describe five CYP21A2 novel mutations, p.R132C, p.149C, p.M283V, p.E431K and a frameshift g.2511_2512delGG, in four non-classical and one salt wasting patients from Argentina. All novel point mutations are located in CYP21 protein residues that are conserved throughout mammalian species, and none of them were found in control individuals. The putative pathogenic mechanisms of the novel variants were analyzed in silico. A three-dimensional CYP21 structure was generated by homology modeling and the protein design algorithm FoldX was used to calculate changes in stability of CYP21A2 protein. Our analysis revealed changes in protein stability or in the surface charge of the mutant enzymes, which could be related to the clinical manifestation found in patients.	[Minutolo, Carolina; Fernandez, Cecilia; Taboas, Melisa; Buzzalino, Noemi; Casali, Barbara; Alba, Liliana; Dain, Liliana] ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina; [Minutolo, Carolina; Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Fernandez, Cecilia; Charreau, Eduardo H.; Dain, Liliana] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Belli, Susana] Hosp Durand, Div Endocrinol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Minutolo, C (corresponding author), ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina.	ldain@fbmc.fcen.uba.ar	; Nadra, Alejandro/A-5668-2009	DAIN, Liliana/0000-0002-2155-4999; Nadra, Alejandro/0000-0002-7860-3245	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT 2006-00208, 2007-00732]; Universidad de Buenos Aires, Ciencia y Tecnica (UBACYT) [X059]; Roemmers Foundation	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Universidad de Buenos Aires, Ciencia y Tecnica (UBACYT)(University of Buenos Aires); Roemmers Foundation	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT): PICT 2006-00208 (LD), 2007-00732 (ADN) (www.agencia.gov.ar, link Foncyt), Universidad de Buenos Aires, Ciencia y Tecnica (UBACYT) X059 (LD) (http://www.uba.ar/secyt/proyectosencurso/fxuba.php), Roemmers Foundation (LD) (http://www.roemmers.com.ar/acerca/funda/apoyo.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanche H, 1997, HUM GENET, V101, P56, DOI 10.1007/s004390050586; Bleicken C, 2009, HUM MUTAT, V30, pE443, DOI 10.1002/humu.20926; DAIN L, 2006, HUM GENET, V119, P359; Dain LB, 2002, CLIN ENDOCRINOL, V56, P237; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dolzan V, 2005, EUR J ENDOCRINOL, V153, P99, DOI 10.1530/eje.1.01944; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; Ezquieta B, 2002, ACTA PAEDIATR, V91, P892, DOI 10.1080/080352502760148595; Gomes LG, 2008, J CLIN ENDOCR METAB, V93, P2913, DOI 10.1210/jc.2008-0304; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Jaaskelainen J, 1997, J CLIN ENDOCR METAB, V82, P3293, DOI 10.1210/jc.82.10.3293; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Loidi L, 2006, CLIN ENDOCRINOL, V64, P330, DOI 10.1111/j.1365-2265.2006.02465.x; Menassa R, 2008, J CLIN ENDOCR METAB, V93, P1901, DOI 10.1210/jc.2007-2701; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; MILLER WL, 1994, J CLIN ENDOCR METAB, V78, P241, DOI 10.1210/jc.78.2.241; NEW MI, 1989, METABOLIC BASIS INHE, P1881; Nikoshkov A, 1997, J CLIN ENDOCR METAB, V82, P194, DOI 10.1210/jc.82.1.194; Nimkarn S, 1999, J CLIN ENDOCR METAB, V84, P378, DOI 10.1210/jc.84.1.378; OWERBACH D, 1992, J CLIN ENDOCR METAB, V74, P553, DOI 10.1210/jc.74.3.553; Pang Songya, 1997, Current Opinion in Pediatrics, V9, P419, DOI 10.1097/00008480-199708000-00018; Pasqualini T, 2007, MEDICINA-BUENOS AIRE, V67, P253; Pey AL, 2007, AM J HUM GENET, V81, P1006, DOI 10.1086/521879; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; SPEISER PW, 1985, AM J HUM GENET, V37, P650; Tardy V, 2010, J CLIN ENDOCR METAB, V95, P1288, DOI 10.1210/jc.2009-1202; Therrell BL, 2001, ENDOCRIN METAB CLIN, V30, P15, DOI 10.1016/S0889-8529(08)70017-3; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; van der Kamp HJ, 2004, EUR J ENDOCRINOL, V151, pU71, DOI 10.1530/eje.0.151U071; WATANABE N, 1993, EUR J BIOCHEM, V214, P521, DOI 10.1111/j.1432-1033.1993.tb17950.x; WEDELL A, 1993, HUM MOL GENET, V2, P499, DOI 10.1093/hmg/2.5.499; WEDELL A, 1992, P NATL ACAD SCI USA, V89, P7232, DOI 10.1073/pnas.89.15.7232; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; Wijesuriya SD, 1999, J BIOL CHEM, V274, P38097, DOI 10.1074/jbc.274.53.38097; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P2322, DOI 10.1210/jc.80.8.2322; WU DA, 1991, J CLIN INVEST, V88, P519, DOI 10.1172/JCI115334	41	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15899	10.1371/journal.pone.0015899	http://dx.doi.org/10.1371/journal.pone.0015899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264314	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000010
J	Ferreira, KS; Maranhao, AQ; Garcia, MCC; Brigido, MM; Santos, SS; Lopes, JD; Almeida, SR				Ferreira, Karen S.; Maranhao, Andrea Q.; Garcia, Maria C. C.; Brigido, Marcelo M.; Santos, Suelen S.; Lopes, Jose D.; Almeida, Sandro R.			Dendritic Cells Transfected with scFv from Mab 7.B12 Mimicking Original Antigen gp43 Induces Protection against Experimental Paracoccidioidomycosis	PLOS ONE			English	Article							SINGLE-CHAIN FV; CYTOTOXIC T-LYMPHOCYTES; PLASMID DNA; ANTIIDIOTYPIC ANTIBODIES; IDIOTYPIC ANTIBODIES; DISPLAY LIBRARY; INTERNAL IMAGE; GENE GUN; CLASS-I; PROTEIN	Paracoccidioidomycosis (PCM), endemic in Latin America, is a progressive systemic mycosis caused by Paracoccidioides brasiliensis (P. brasiliensis), which primarily attacks lung tissue. Dendritic cells (DCs) are able to initiate a response in naive T cells, and they also participate in Th-cell education. Furthermore, these cells have been used for therapy in several disease models. Here we transfected DCs with a plasmid (pMAC/PS-scFv) encoding a single chain variable fragment (scFv) of an anti-Id antibody that is capable of mimicking gp43, the main antigenic component of P. brasiliensis. First, Balb/c mice were immunized subcutaneously with pMAC/PS-scFv and, after seven days, scFv protein was presented to the regional lymph nodes cells. Moreover, we showed that the DCs transfected with scFv were capable of efficiently activating proliferation of total lymph node cells and inducing a decrease in lung infection. Therefore, our results suggested that the use of scFv-transfected DCs may be a promising therapy in the paracoccidioidomycosis (PCM) model.	[Ferreira, Karen S.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Dept Ciencias Biol, Sao Paulo, Brazil; [Maranhao, Andrea Q.; Brigido, Marcelo M.] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Garcia, Maria C. C.; Santos, Suelen S.; Almeida, Sandro R.] Univ Sao Paulo, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Lopes, Jose D.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Brasilia; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Ferreira, KS (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Dept Ciencias Biol, Sao Paulo, Brazil.	karenspadari@gmail.com	Brigido, Marcelo Macedo/A-1972-2015; Maranhão, Andrea Q/L-4474-2013; Ferreira, Karen/AAA-4363-2022; Maranhão, Andrea Queiroz/S-8696-2019; Brigido, Marcelo/H-2718-2019; almeida, sandro r/F-5816-2012; Santos, Suelen/F-3048-2014; Ferreira/Spadari, Karen SF/D-4437-2013; Maranhão, Andrea/AAC-3560-2019	Brigido, Marcelo Macedo/0000-0002-7136-7059; Maranhão, Andrea Q/0000-0002-1946-7191; Brigido, Marcelo/0000-0002-7136-7059; almeida, sandro r/0000-0002-0562-1610; Maranhão, Andrea/0000-0002-1946-7191; Spadari, Karen/0000-0003-2832-5942	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/57594-9, 07/50568-2]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Process: 07/57594-9)(scholarship to K.S.F. process: 07/50568-2) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, research fellowships to S.R.A. and J.D.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, ANTICANCER RES, V22, P1575; Beninati C, 2006, J EXP MED, V203, P111, DOI 10.1084/jem.20051540; Beninati C, 2000, NAT BIOTECHNOL, V18, P1060, DOI 10.1038/80250; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bona CA, 1996, P SOC EXP BIOL MED, V213, P32; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGIDO MM, 1993, J IMMUNOL, V150, P469; Caldas C, 2000, PROTEIN ENG, V13, P353, DOI 10.1093/protein/13.5.353; Campos-Da-Paz M, 2008, MOL BIOTECHNOL, V39, P155, DOI 10.1007/s12033-008-9055-6; Chang JT, 2000, J IMMUNOL, V164, P100, DOI 10.4049/jimmunol.164.1.100; COLOMA MJ, 1991, BIOTECHNIQUES, V11, P152; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Corr M, 1996, J EXP MED, V184, P1555, DOI 10.1084/jem.184.4.1555; DECAMARGO ZP, 1988, J CLIN MICROBIOL, V26, P2147, DOI 10.1128/JCM.26.10.2147-2151.1988; Depetris M, 2008, J IMMUNOL METHODS, V334, P104, DOI 10.1016/j.jim.2008.02.003; Doe B, 1996, P NATL ACAD SCI USA, V93, P8578, DOI 10.1073/pnas.93.16.8578; Erlandsson A, 2006, MOL IMMUNOL, V43, P599, DOI 10.1016/j.molimm.2005.04.019; Feltquate DM, 1997, J IMMUNOL, V158, P2278; Franco MF., 1989, BAILLIERE CLIN TROP, V4, P185, DOI DOI 10.1590/S0036-46651994000100017; Gesztesi JL, 1996, HYBRIDOMA, V15, P415, DOI 10.1089/hyb.1996.15.415; He FT, 2002, WORLD J GASTROENTERO, V8, P258; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 1997, J IMMUNOL, V159, P11; JERNE NK, 1982, EMBO J, V1, P243, DOI 10.1002/j.1460-2075.1982.tb01154.x; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Juvenale M, 2001, J MED MICROBIOL, V50, P127, DOI 10.1099/0022-1317-50-2-127; Kawano Y, 1996, IMMUNOLOGY, V88, P40, DOI 10.1046/j.1365-2567.1996.d01-634.x; KITANI A, 1993, J IMMUNOL, V151, P3478; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; MENEZES VM, 2006, COCHRANE DB SYST REV, V2; Moll H, 2001, IMMUNOBIOLOGY, V204, P659, DOI 10.1078/0171-2985-00105; NISONOFF A, 1981, CLIN IMMUNOL IMMUNOP, V21, P397, DOI 10.1016/0090-1229(81)90228-2; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5; PAN Y, 1995, FASEB J, V9, P43, DOI 10.1096/fasebj.9.1.7821758; Pignatari GC, 2007, J BIOTECHNOL, V127, P615, DOI 10.1016/j.jbiotec.2006.08.007; Pokorna Dana, 2008, Genet Vaccines Ther, V6, P4, DOI 10.1186/1479-0556-6-4; RESTREPO A, 2005, PRINCIPLES PRACTICE, P3062; Schwegler C, 2005, CANCER RES, V65, P1925, DOI 10.1158/0008-5472.CAN-04-3591; Shibagaki N, 2003, EUR J IMMUNOL, V33, P850, DOI 10.1002/eji.200323709; Shibagaki N, 2002, J IMMUNOL, V168, P2393, DOI 10.4049/jimmunol.168.5.2393; Souza AR, 1998, CLIN EXP IMMUNOL, V114, P40; Souza EB, 2004, CLIN EXP IMMUNOL, V137, P123, DOI 10.1111/j.1365-2249.2004.02507.x; Torres CAT, 1997, J IMMUNOL, V158, P4529; Ulmer JB, 1996, IMMUNOLOGY, V89, P59, DOI 10.1046/j.1365-2567.1996.d01-718.x; WARRENS AN, 1994, INT IMMUNOL, V6, P847, DOI 10.1093/intimm/6.6.847; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; ZAGHOUANI H, 1993, EUR J IMMUNOL, V23, P2746, DOI 10.1002/eji.1830231104; ZHOU H, 1994, NUCLEIC ACIDS RES, V22, P888, DOI 10.1093/nar/22.5.888	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15935	10.1371/journal.pone.0015935	http://dx.doi.org/10.1371/journal.pone.0015935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249212	Green Submitted, Green Published, gold			2022-12-25	WOS:000286512900013
J	Podolska, A; Kaczkowski, B; Busk, PK; Sokilde, R; Litman, T; Fredholm, M; Cirera, S				Podolska, Agnieszka; Kaczkowski, Bogumil; Busk, Peter Kamp; Sokilde, Rolf; Litman, Thomas; Fredholm, Merete; Cirera, Susanna			MicroRNA Expression Profiling of the Porcine Developing Brain	PLOS ONE			English	Article							IDENTIFICATION; DIFFERENTIATION; REVEALS; GROWTH; RNAS	Background: MicroRNAs are small, non-coding RNA molecules that regulate gene expression at the post-transcriptional level and play an important role in the control of developmental and physiological processes. In particular, the developing brain contains an impressive diversity of microRNAs. Most microRNA expression profiling studies have been performed in human or rodents and relatively limited knowledge exists in other mammalian species. The domestic pig is considered to be an excellent, alternate, large mammal model for human-related neurological studies, due to its similarity in both brain development and the growth curve when compared to humans. Considering these similarities, studies examining microRNA expression during porcine brain development could potentially be used to predict the expression profile and role of microRNAs in the human brain. Methodology/Principal Findings: MicroRNA expression profiling by use of microRNA microarrays and qPCR was performed on the porcine developing brain. Our results show that microRNA expression is regulated in a developmentally stage-specific, as well as a tissue-specific manner. Numerous developmental stage or tissue-specific microRNAs including, miR-17, miR-18a, miR-29c, miR-106a, miR-135a and b, miR-221 and miR-222 were found by microarray analysis. Expression profiles of selected candidates were confirmed by qPCR. Conclusions/Significance: The differential expression of specific microRNAs in fetal versus postnatal samples suggests that they likely play an important role in the regulation of developmental and physiological processes during brain development. The data presented here supports the notion that microRNAs act as post-transcriptional switches which may regulate gene expression when required.	[Podolska, Agnieszka; Fredholm, Merete; Cirera, Susanna] Univ Copenhagen, Fac Life Sci, Sect Genet & Bioinformat, Dept Basic Anim & Vet Sci, Copenhagen, Denmark; [Kaczkowski, Bogumil] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Kaczkowski, Bogumil] Univ Copenhagen, Biotech Res & Innovat Ctr, Bioinformat Ctr, Copenhagen, Denmark; [Busk, Peter Kamp] Exiqon AS, Mol Biol, Vedbaek, Denmark; [Sokilde, Rolf; Litman, Thomas] Exiqon AS, Biomarker Discovery, Vedbaek, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Exiqon; Exiqon	Podolska, A (corresponding author), Univ Copenhagen, Fac Life Sci, Sect Genet & Bioinformat, Dept Basic Anim & Vet Sci, Copenhagen, Denmark.	scs@life.ku.dk	Søkilde, Rolf/F-5138-2015; Busk, Peter/Q-8145-2016; Kaczkowski, Bogumil/D-5336-2017; Cirera, Susanna/K-8540-2017	Søkilde, Rolf/0000-0003-3010-3599; Busk, Peter/0000-0003-1920-636X; Kaczkowski, Bogumil/0000-0001-6554-5608; Fredholm, Merete/0000-0002-3563-7648; Cirera, Susanna/0000-0001-8105-1579; Litman, Thomas/0000-0002-6068-901X	Danish National Advanced Technology Foundation; Faculty of Life Sciences, University of Copenhagen	Danish National Advanced Technology Foundation; Faculty of Life Sciences, University of Copenhagen	PKB and TL were employed by Exiqon A/S during the conduct of the study. As such, Exiqon A/S has provided economic support and know how for the project. Study design, data analysis and decision to publish was the responsibility of the academic partners. This study was supported by a grant from the Danish National Advanced Technology Foundation for the project "Pigs and Health", and from a grant from Faculty of Life Sciences, University of Copenhagen for a Ph.D. scholarship to Agnieszka Podolska. These founders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P114, DOI 10.1016/j.mrgentox.2010.05.007; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LARSELL O, 1954, ANAT REC, V118, P73, DOI 10.1002/ar.1091180106; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Xiao B, 2009, J GENET GENOMICS, V36, P695, DOI 10.1016/S1673-8527(08)60162-9; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Zhang CZ, 2009, INT J ONCOL, V34, P1653, DOI 10.3892/ijo_00000296; Zhou B, 2010, ANIM SCI J, V81, P290, DOI 10.1111/j.1740-0929.2010.00742.x	40	49	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e14494	10.1371/journal.pone.0014494	http://dx.doi.org/10.1371/journal.pone.0014494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253018	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511900003
J	Long, QA; Jeffares, DC; Zhang, QR; Ye, K; Nizhynska, V; Ning, ZM; Tyler-Smith, C; Nordborg, M				Long, Quan; Jeffares, Daniel C.; Zhang, Qingrun; Ye, Kai; Nizhynska, Viktoria; Ning, Zemin; Tyler-Smith, Chris; Nordborg, Magnus			PoolHap: Inferring Haplotype Frequencies from Pooled Samples by Next Generation Sequencing	PLOS ONE			English	Article							CELLS; IDENTIFICATION; ISOFORMS	With the advance of next-generation sequencing (NGS) technologies, increasingly ambitious applications are becoming feasible. A particularly powerful one is the sequencing of polymorphic, pooled samples. The pool can be naturally occurring, as in the case of multiple pathogen strains in a blood sample, multiple types of cells in a cancerous tissue sample, or multiple isoforms of mRNA in a cell. In these cases, it's difficult or impossible to partition the subtypes experimentally before sequencing, and those subtype frequencies must hence be inferred. In addition, investigators may occasionally want to artificially pool the sample of a large number of individuals for reasons of cost-efficiency, e. g., when carrying out genetic mapping using bulked segregant analysis. Here we describe PoolHap, a computational tool for inferring haplotype frequencies from pooled samples when haplotypes are known. The key insight into why PoolHap works is that the large number of SNPs that come with genome-wide coverage can compensate for the uneven coverage across the genome. The performance of PoolHap is illustrated and discussed using simulated and real data. We show that PoolHap is able to accurately estimate the proportions of haplotypes with less than 2% error for 34-strain mixtures with 2X total coverage Arabidopsis thaliana whole genome polymorphism data. This method should facilitate greater biological insight into heterogeneous samples that are difficult or impossible to isolate experimentally. Software and users manual are freely available at http://arabidopsis.gmi.oeaw.ac.at/quan/poolhap/.	[Long, Quan; Zhang, Qingrun; Nizhynska, Viktoria; Nordborg, Magnus] Gregor Mendel Inst, Vienna, Austria; [Long, Quan; Jeffares, Daniel C.; Ning, Zemin; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge, England; [Jeffares, Daniel C.] UCL, Res Dept Genet Evolut & Environm, London, England; [Zhang, Qingrun] Chinese Acad Sci, Beijing Inst Gen, Beijing, Peoples R China; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Nordborg, Magnus] Univ So Calif, Los Angeles, CA USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Wellcome Trust Sanger Institute; University of London; University College London; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Southern California	Long, QA (corresponding author), Gregor Mendel Inst, Vienna, Austria.	quan.long@gmi.oeaw.ac.at	Ye, Kai/GSD-9856-2022; Jeffares, Daniel/N-2632-2018; Ning, Zemin/D-2411-2013; Ye, Kai/B-3640-2012	Ye, Kai/0000-0002-2851-6741; Jeffares, Daniel/0000-0001-7320-0706; Nordborg, Magnus/0000-0001-7178-9748; Ning, Zemin/0000-0003-4359-776X	Austrian Academy of Science; Wellcome Trust [085775/Z/08/Z]; National Natural Science Foundation of China [30700442, 30730057]	Austrian Academy of Science; Wellcome Trust(Wellcome TrustEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Austrian Academy of Science (http://www.oeaw.ac.at/english/home.html), the Wellcome Trust (grant 085775/Z/08/Z) (http://www.wellcome.ac.uk/) and National Natural Science Foundation of China (No. 30700442, 30730057) (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Fagotti A, 1998, NUCLEIC ACIDS RES, V26, P2031, DOI 10.1093/nar/26.8.2031; Fuhrman LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002882; Gorlov IP, 2002, ANAL BIOCHEM, V308, P401, DOI 10.1016/S0003-2697(02)00244-0; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIU HP, 2010, DEV COMP IMMUNOL; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; NANAK E, 1995, J MOL RECOGNIT, V8, P77, DOI 10.1002/jmr.300080114; NAVAS P, 1989, CANCER RES, V49, P2147; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Supabandhu J, 2008, MED MYCOL, V46, P41, DOI 10.1080/13693780701513840; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515	15	22	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15292	10.1371/journal.pone.0015292	http://dx.doi.org/10.1371/journal.pone.0015292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21264334	Green Submitted, gold, Green Published			2022-12-25	WOS:000286511200006
J	Garofalo, C; Manara, MC; Nicoletti, G; Marino, MT; Lollini, PL; Astolfi, A; Pandini, G; Lopez-Guerrero, JA; Schaefer, KL; Belfiore, A; Picci, P; Scotlandi, K				Garofalo, C.; Manara, M. C.; Nicoletti, G.; Marino, M. T.; Lollini, P-L; Astolfi, A.; Pandini, G.; Lopez-Guerrero, J. A.; Schaefer, K-L; Belfiore, A.; Picci, P.; Scotlandi, K.			Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling	ONCOGENE			English	Article						sarcomas; IGF-1R; insulin signaling; drug resistance	FACTOR-I RECEPTOR; GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODIES; INHIBITOR BMS-536924; DOWN-REGULATION; CELL-LINES; BREAST; SENSITIVITY; PATHWAY; GENE	Identification of patient selection criteria and understanding of the potential mechanisms involved in the development of resistance are crucial for an appropriate and successful design of clinical trials with anti-insulinlike growth factor (IGF)-1R therapies. Few Ewing's sarcomas are highly sensitive to IGF-1R targeting and understanding the reason why, may hold the secret to improve successful treatments. In this paper, we show that a major mechanism of resistance to highly specific inhibitors of IGF-1R, either antibodies or tyrosine kinase inhibitors may involve enhanced insulin receptor (IR)-A homodimer formation and IGF-2 production. Resistant cells are able to switch from IGF-1/IGF-1R to IGF-2/IRA dependency to maintain sustained activation of AKT and ERK1/2, proliferation, migration and metastasis. These cells also showed higher proliferative response to insulin, in keeping with a switch towards insulin pathways sustaining proliferation and malignancy, rather than metabolism. Our findings demonstrate a role for IR-A in eliciting intrinsic and adaptive resistance to anti-IGF-1R therapies. Thus, we indicate that tumors with low IGF1R: IR ratio are unlikely to greatly benefit from anti-IGF1R therapies and that the efficacy of anti-IGF-1R therapies should be evaluated in relationship to the IRA: IGF-1R ratio in cancer cells. Moreover, we provide evidences supporting IR-A as an important target in sarcoma therapy. Oncogene (2011) 30, 2730-2740; doi: 10.1038/onc.2010.640; published online 31 January 2011	[Scotlandi, K.] Ist Ortoped Rizzoli, CRS Dev Biomol Therapies, I-40136 Bologna, Italy; [Garofalo, C.; Manara, M. C.; Nicoletti, G.; Marino, M. T.; Picci, P.; Scotlandi, K.] Ist Ortoped Rizzoli, Expt Oncol Lab, I-40136 Bologna, Italy; [Lollini, P-L] Univ Bologna, Dept Hematol & Oncol Sci LA Seragnoli, St Orsola Malpighi Hosp, Bologna, Italy; [Astolfi, A.] Univ Bologna, G Prodi Canc Res Ctr, Bologna, Italy; [Pandini, G.] Univ Catania, Dept Internal Med & Med Specialties, Catania, Italy; [Lopez-Guerrero, J. A.] Fdn Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain; [Schaefer, K-L] Univ Med Ctr, Inst Pathol, Dusseldorf, Germany; [Belfiore, A.] Univ Catanzaro, Dept Clin & Expt Med, Catanzaro, Italy	IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Catania; Instituto Valenciano De Oncologia; Magna Graecia University of Catanzaro	Scotlandi, K (corresponding author), Ist Ortoped Rizzoli, CRS Dev Biomol Therapies, Via Barbiano 1-10, I-40136 Bologna, Italy.	katia.scotlandi@ior.it	Belfiore, Antonino/B-4652-2011; Guerrero, Jose Antonio Lopez/Z-2413-2019; Astolfi, Annalisa/K-3034-2016; Pandini, Giuseppe/AAB-9650-2019; Manara, Maria Cristina/K-3366-2018; Garofalo, Cecilia/B-3834-2017; Scotlandi, Katia/J-9009-2016; Lollini, Pier Luigi/A-7644-2008; Picci, Piero/J-5979-2016	Belfiore, Antonino/0000-0002-6181-4193; Guerrero, Jose Antonio Lopez/0000-0002-7369-8388; Astolfi, Annalisa/0000-0002-2732-0747; Pandini, Giuseppe/0000-0003-3747-7649; Manara, Maria Cristina/0000-0001-5686-720X; Garofalo, Cecilia/0000-0001-5334-8930; Scotlandi, Katia/0000-0001-6114-9499; Lollini, Pier Luigi/0000-0003-1702-4108; Picci, Piero/0000-0002-8519-4101	Italian Association for Cancer Research; Italian Ministry of Health [RFPS-2006-3-340280]; Italian Ministry of Research and Instruction; EU [018814]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research and Instruction; EU(European Commission)	We thank Cristina Ghinelli and Alba Balladelli for their help in editing the manuscript. Studies are supported by grants from the Italian Association for Cancer Research (KS and AB), the Italian Ministry of Health (Strategico Oncologia RFPS-2006-3-340280; RF2008 to KS); the Italian Ministry of Research and Instruction (PRIN 2009) and the EU project Eurobonet (#018814).	Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Brierley GV, 2010, ENDOCRINOLOGY, V151, P1418, DOI 10.1210/en.2009-1006; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Dinchuk JE, 2010, ENDOCRINOLOGY, V151, P4123, DOI 10.1210/en.2010-0032; FORSAYETH JR, 1987, J BIOL CHEM, V262, P4134; GANDERTON RH, 1992, BIOCHEM J, V288, P195, DOI 10.1042/bj2880195; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gualberto A, 2010, CLIN CANCER RES, V16, P4654, DOI 10.1158/1078-0432.CCR-10-0089; Hendrickson AEW, 2009, CANCER RES, V69, P7635, DOI 10.1158/0008-5472.CAN-09-0511; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1190, DOI 10.1002/pbc.21450; KULL FC, 1983, J BIOL CHEM, V258, P6561; Machado I, 2009, DIAGN MOL PATHOL, V18, P189, DOI 10.1097/PDM.0b013e3181a06f66; Maloney EK, 2003, CANCER RES, V63, P5073; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Mukohara T, 2009, CANCER LETT, V282, P14, DOI 10.1016/j.canlet.2009.02.056; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Scotlandi K, 1996, CANCER RES, V56, P4570; Scotlandi K, 2008, CURR OPIN ONCOL, V20, P419, DOI 10.1097/CCO.0b013e328302edab; SOOS MA, 1992, J BIOL CHEM, V267, P12955; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Zha JP, 2009, MOL CANCER THER, V8, P2110, DOI 10.1158/1535-7163.MCT-09-0381; Zhang H, 2010, ONCOGENE, V29, P2517, DOI 10.1038/onc.2010.17; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712; Zhou QL, 2004, BIOCHEM SOC T, V32, P817, DOI 10.1042/BST0320817	41	96	102	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	24					2730	2740		10.1038/onc.2010.640	http://dx.doi.org/10.1038/onc.2010.640			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21278796				2022-12-25	WOS:000291678500004
J	Kwan, MD; Sellmyer, MA; Quarto, N; Ho, AM; Wandless, TJ; Longaker, MT				Kwan, Matthew D.; Sellmyer, Mark A.; Quarto, Natalina; Ho, Andrew M.; Wandless, Thomas J.; Longaker, Michael T.			Chemical Control of FGF-2 Release for Promoting Calvarial Healing with Adipose Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PROTEIN STABILITY; BONE-FORMATION; IN-VIVO; HEPARAN-SULFATE; FRACTURE REPAIR; STROMAL CELLS; TISSUE; DIFFERENTIATION; FACTOR-2	Chemical control of protein secretion using a small molecule approach provides a powerful tool to optimize tissue engineering strategies by regulating the spatial and temporal dimensions that are exposed to a specific protein. We placed fibroblast growth factor 2 (FGF-2) under conditional control of a small molecule and demonstrated greater than 50-fold regulation of FGF-2 release as well as tunability, reversibility, and functionality in vitro. We then applied conditional control of FGF-2 secretion to a cell-based, skeletal tissue engineering construct consisting of adipose stem cells (ASCs) on a biomimetic scaffold to promote bone formation in a murine critical-sized calvarial defect model. ASCs are an easily harvested and abundant source of postnatal multipotent cells and have previously been demonstrated to regenerate bone in critical-sized defects. These results suggest that chemically controlled FGF-2 secretion can significantly increase bone formation by ASCs in vivo. This study represents a novel approach toward refining protein delivery for tissue engineering applications.	[Wandless, Thomas J.] Stanford Univ, Sch Med, Clark Ctr, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Kwan, Matthew D.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Longaker, Michael T.] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Quarto, Natalina] Univ Naples Federico II, Dept Struct & Funct Biol, I-80138 Naples, Italy	Stanford University; Stanford University; Stanford University; University of Naples Federico II	Wandless, TJ (corresponding author), Stanford Univ, Sch Med, Clark Ctr, Dept Chem & Syst Biol, W350A,318 Campus Dr, Stanford, CA 94305 USA.	wandless@stanford.edu; longaker@stanford.edu			National Institutes of Health through the NIDCR [R01DE019434, RC2DE020771, R21DE019274]; Oak Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020771, R21DE019274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	National Institutes of Health through the NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oak Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE019434, RC2DE020771, and R21DE019274 through the NIDCR (to M. T. L.). This work was also supported by the Oak Foundation (to M. T. L.).	ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Cartmell S, 2009, J PHARM SCI-US, V98, P430, DOI 10.1002/jps.21431; Chang PC, 2009, HUM GENE THER, V20, P486, DOI 10.1089/hum.2008.114; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053; Chen ST, 2007, J CELL BIOCHEM, V100, P1493, DOI 10.1002/jcb.21136; Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; Naganawa T, 2006, BIOCHEM BIOPH RES CO, V339, P490, DOI 10.1016/j.bbrc.2005.10.215; Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Quarto N, 2008, GENE, V424, P130, DOI 10.1016/j.gene.2008.07.029; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Quarto N, 2006, TISSUE ENG, V12, P1405, DOI 10.1089/ten.2006.12.1405; Radomsky ML, 1998, CLIN ORTHOP RELAT R, pS283; RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898; Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020; Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	39	24	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11307	11313		10.1074/jbc.M110.180042	http://dx.doi.org/10.1074/jbc.M110.180042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262969	hybrid, Green Published			2022-12-25	WOS:000288797100043
J	Pechtl, IC; Kavanagh, D; Mcintosh, N; Harris, CL; Barlow, PN				Pechtl, Isabell C.; Kavanagh, David; Mcintosh, Nicola; Harris, Claire L.; Barlow, Paul N.			Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; DENSE DEPOSIT DISEASE; TRANSLATIONAL MINIREVIEW SERIES; MACULAR DEGENERATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; ALTERNATIVE PATHWAY; REGULATORY DOMAINS; ENDOTHELIAL-CELLS; BINDING-AFFINITY; PROTEIN CD46	Many mutations associated with atypical hemolytic uremic syndrome (aHUS) lie within complement control protein modules 19-20 at the C terminus of the complement regulator factor H (FH). This region mediates preferential action of FH on self, as opposed to foreign, membranes and surfaces. Hence, speculation on disease mechanisms has focused on deficiencies in regulation of complement activation on glomerular capillary beds. Here, we investigate the consequences of aHUS-linked mutations (R53H and R78G) within the FH N-terminal complement control protein module that also carries the I62V variation linked to dense-deposit disease and age-related macular degeneration. This module contributes to a four-module C3b-binding site (FH1-4) needed for complement regulation and sufficient for fluid-phase regulatory activity. Recombinant FH1-4(V62) and FH1-4(I62) bind immobilized C3b with similar affinities (K-D = 10-14 mu M), whereas FH1-4(I62) is slightly more effective than FH1-4(V62) as cofactor for factor I-mediated cleavage of C3b. The mutant (R53H) FH1-4(V62) binds to C3b with comparable affinity (K-D similar to 12 mu M) yet has decreased cofactor activities both in fluid phase and on surface-bound C3b, and exhibits only weak decay-accelerating activity for C3 convertase (C3bBb). The other mutant, (R78G) FH1-4(V62), binds poorly to immobilized C3b (K-D > 35 mu M) and is severely functionally compromised, having decreased cofactor and decay-accelerating activities. Our data support causal links between these mutations and disease; they demonstrate that mutations affecting the N-terminal activities of FH, not just those in the C terminus, can predispose to aHUS. These observations reinforce the notion that deficiency in any one of several FH functional properties can contribute to the pathogenesis of this disease.	[Pechtl, Isabell C.; Mcintosh, Nicola; Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Pechtl, Isabell C.; Mcintosh, Nicola; Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JJ, Midlothian, Scotland; [Kavanagh, David] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Harris, Claire L.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales	University of Edinburgh; University of Edinburgh; Newcastle University - UK; Cardiff University	Barlow, PN (corresponding author), Univ Edinburgh, Sch Chem, Joseph Black Chem Bldg,Kings Bldg,W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	Paul.Barlow@ed.ac.uk	Kavanagh, David/E-8498-2011; Barlow, Paul N/G-2853-2011	Kavanagh, David/0000-0003-4718-0072; 	Medical Research Council United Kingdom [G0701298]; Wellcome Trust [081179]; Kidney Research United Kingdom; Academy of Medical Sciences; MRC [G0701298] Funding Source: UKRI; Medical Research Council [G0701298] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Kidney Research United Kingdom(Kidney Research UK (KRUK)); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council United Kingdom Grant G0701298 (to C. L. H.), Wellcome Trust Grant 081179 (to P. N. B.), and the Kidney Research United Kingdom and the Academy of Medical Sciences (D. K.).	Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blom AM, 2008, J IMMUNOL, V180, P6385, DOI 10.4049/jimmunol.180.9.6385; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Buttner-Mainik A., 2011, PLANT BIOTE IN PRESS; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2004, J AM SOC NEPHROL, V15, P787, DOI 10.1097/01.ASN.0000115702.28859.A7; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; GORDON DL, 1995, J IMMUNOL, V155, P348; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Hegasy GA, 2002, AM J PATHOL, V161, P2027, DOI 10.1016/S0002-9440(10)64481-1; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kavanagh D, 2005, J AM SOC NEPHROL, V16, P2150, DOI 10.1681/ASN.2005010103; Kavanagh D, 2010, PEDIATR NEPHROL, V25, P2431, DOI 10.1007/s00467-010-1555-5; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KUHN S, 1995, J IMMUNOL, V155, P5663; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Neumann HPH, 2003, J MED GENET, V40, P676, DOI 10.1136/jmg.40.9.676; Ormsby RJ, 2006, MOL IMMUNOL, V43, P1624, DOI 10.1016/j.molimm.2005.09.012; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Sahu A, 1998, J IMMUNOL, V160, P5596; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SHARMA AK, 1994, GENE, V143, P301, DOI 10.1016/0378-1119(94)90116-3; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	64	64	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11082	11090		10.1074/jbc.M110.211839	http://dx.doi.org/10.1074/jbc.M110.211839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270465	hybrid, Green Published			2022-12-25	WOS:000288797100019
J	Li, L; Weinreb, V; Francklyn, C; Carter, CW				Li, Li; Weinreb, Violetta; Francklyn, Christopher; Carter, Charles W., Jr.			Histidyl-tRNA Synthetase Urzymes CLASS I AND II AMINOACYL tRNA SYNTHETASE URZYMES HAVE COMPARABLE CATALYTIC ACTIVITIES FOR COGNATE AMINO ACID ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; EVOLUTION; RECEPTOR; ENZYME; DISCRIMINATION; DESIGN; DOMAIN	Four minimal (119 - 145 residue) active site fragments of Escherichia coli Class II histidyl-tRNA synthetase were constructed, expressed as maltose-binding protein fusions, and assayed for histidine activation as fusion proteins and after TEV cleavage, using the (PPi)-P-32 exchange assay. All contain conserved Motifs 1 and 2. Two contain an N-terminal extension of Motif 1 and two contain Motif 3. Five experimental results argue strongly for the authenticity of the observed catalytic activities: (i) active site titration experiments showing high (similar to 0.1-0.55) fractions of active molecules, (ii) release of cryptic activity by TEV cleavage of the fusion proteins, (iii) reduced activity associated with an active site mutation, (iv) quantitative attribution of increased catalytic activity to the intrinsic effects of Motif 3, the N-terminal extension and their synergistic effect, and (v) significantly altered K-m values for both ATP and histidine substrates. It is therefore plausible that neither the insertion domain nor Motif 3 were essential for catalytic activity in the earliest Class II aminoacyl-tRNA synthetases. The mean rate enhancement of all four cleaved constructs is similar to 10(9) times that of the estimated uncatalyzed rate. As observed for the tryptophanyl-tRNA synthetase (TrpRS) Urzyme, these fragments bind ATP tightly but have reduced affinity for cognate amino acids. These fragments thus likely represent Urzymes (Ur = primitive, original, earliest + enzyme) comparable in size and catalytic activity and coded by sequences proposed to be antisense to that coding the previously described Class I TrpRS Urzyme. Their catalytic activities provide metrics for experimental recapitulation of very early evolutionary events.	[Li, Li; Weinreb, Violetta; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Francklyn, Christopher] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Vermont	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			National Institutes of Health [GM078227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899, R01GM078227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078227.	Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; Benner Steven A., 2007, V75, P1; BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Cleland W. W, 1970, ENZYMES, V2, P1; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Gernert D, 2007, J SCI EXP, V21, P135; Guth EC, 2007, MOL CELL, V25, P531, DOI 10.1016/j.molcel.2007.01.015; JOSEPH DR, 1971, J BIOL CHEM, V246, P7610; JOSEPH DR, 1971, J BIOL CHEM, V246, P7602; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Liu HN, 2008, J PHYS CHEM B, V112, P16874, DOI 10.1021/jp807104b; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; PHAM YB, 2009, THESIS U N CAROLINA, P95; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; *SAS I, 2006, JMP VERS 6 0; Schall OF, 1998, J ORG CHEM, V63, P8661, DOI 10.1021/jo971874f; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; Sherlin LD, 2003, STRUCTURE, V11, P591, DOI 10.1016/S0969-2126(03)00074-1; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324	40	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10387	10395		10.1074/jbc.M110.198929	http://dx.doi.org/10.1074/jbc.M110.198929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21270472	Green Published, hybrid			2022-12-25	WOS:000288547000055
J	Yuan, JS; Chen, JJ				Yuan, Jingsong; Chen, Junjie			The Role of the Human SWI5-MEI5 Complex in Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEX; CELL-CYCLE; BRCA2; RAD51; YEAST; DMC1; RECA	The Swi5-Mei5 complex and its homologues are involved in specialized recombination pathways in budding and fission yeasts. Although the fission yeast homologue Swi5-Sfr1 is critical for homologous recombination repair, the budding yeast counterpart Sae3-Mei5 is meiosis-specific, interacts with Dmc1, and promotes assembly of Dmc1 on meiotic chromosomes. Here, we identify and characterize the human SWI5-MEI5 (C9orf119-C10orf78) complex. We showed that SWI5 and MEI5 form a stable complex in vitro and in vivo. The C-terminal Swi5 domain of SWI5 and the middle coiled-coil region of MEI5 dictate this conserved interaction. In addition, SWI5-MEI5 directly interacts with RAD51 in vitro. Depletion of SWI5 or MEI5 in human cells causes defects in homologous recombination repair. Finally, SWI5- or MEI5-depleted cells display enhanced sensitivity to ionizing radiation, consistent with the role of this complex in HR repair. Our results suggest that human SWI5-MEI5 has an evolutionarily conserved function in homologous recombination repair.	[Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org	Yuan, Jingsong/G-4527-2011		National Institutes of Health; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) and a member of M. D. Anderson Cancer Center (CA016672). To whom correspondence should be addressed. Tel.: 713-792-4863; Fax: 713-745-6141; E-mail: jchen8@mdanderson.org.	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Deans B, 2003, CANCER RES, V63, P8181; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Lord CJ, 2007, NAT STRUCT MOL BIOL, V14, P461, DOI 10.1038/nsmb0607-461; McKee AHZ, 1997, GENETICS, V146, P817; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Okada T, 2005, CURR BIOL, V15, pR200, DOI 10.1016/j.cub.2005.03.009; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	32	30	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9888	9893		10.1074/jbc.M110.207290	http://dx.doi.org/10.1074/jbc.M110.207290			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21252223	Green Published, hybrid			2022-12-25	WOS:000288247700112
J	Schott, BH; Seidenbecher, CI; Richter, S; Wustenberg, T; Debska-Vielhaber, G; Schubert, H; Heinze, HJ; Richardson-Klavehn, A; Duzel, E				Schott, Bjoern H.; Seidenbecher, Constanze I.; Richter, Sylvia; Wuestenberg, Torsten; Debska-Vielhaber, Grazyna; Schubert, Heike; Heinze, Hans-Jochen; Richardson-Klavehn, Alan; Duezel, Emrah			Genetic Variation of the Serotonin 2a Receptor Affects Hippocampal Novelty Processing in Humans	PLOS ONE			English	Article							EPISODIC MEMORY; 5-HT2A RECEPTOR; HIS452TYR POLYMORPHISM; INTERNEURONS; RETRIEVAL; AMPLITUDE; BRAIN; AGE	Serotonin (5-hydroxytryptamine, 5-HT) is an important neuromodulator in learning and memory processes. A functional genetic polymorphism of the 5-HT 2a receptor (5-HTR2a His452Tyr), which leads to blunted intracellular signaling, has previously been associated with explicit memory performance in several independent cohorts, but the underlying neural mechanisms are thus far unclear. The human hippocampus plays a critical role in memory, particularly in the detection and encoding of novel information. Here we investigated the relationship of 5-HTR2a His452Tyr and hippocampal novelty processing in 41 young, healthy subjects using functional magnetic resonance imaging (fMRI). Participants performed a novelty/familiarity task with complex scene stimuli, which was followed by a delayed recognition memory test 24 hours later. Compared to His homozygotes, Tyr carriers exhibited a diminished hippocampal response to novel stimuli and a higher tendency to judge novel stimuli as familiar during delayed recognition. Across the cohort, the false alarm rate during delayed recognition correlated negatively with the hippocampal novelty response. Our results suggest that previously reported effects of 5-HTR2a on explicit memory performance may, at least in part, be mediated by alterations of hippocampal novelty processing.	[Schott, Bjoern H.; Seidenbecher, Constanze I.; Richter, Sylvia; Debska-Vielhaber, Grazyna; Schubert, Heike; Heinze, Hans-Jochen] Leibniz Inst Neurobiol, Magdeburg, Germany; [Schott, Bjoern H.; Debska-Vielhaber, Grazyna; Schubert, Heike; Heinze, Hans-Jochen; Richardson-Klavehn, Alan; Duezel, Emrah] Univ Hosp Magdeburg, Dept Neurol, Magdeburg, Germany; [Schott, Bjoern H.; Wuestenberg, Torsten] Charite, Dept Psychiat, Berlin, Germany; [Richter, Sylvia; Heinze, Hans-Jochen; Duezel, Emrah] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Duezel, Emrah] Univ Hosp Magdeburg, Inst Cognit Neurol & Dementia Res, Magdeburg, Germany; [Duezel, Emrah] UCL, Inst Cognit Neurosci, London, England	Leibniz Institut fur Neurobiologie (LIN); University Hospital Magdeburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University Hospital Magdeburg; University of London; University College London	Schott, BH (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	bjoern.schott@med.ovgu.de	Duzel, Emrah/A-1794-2010; Schott, Björn H/U-5626-2017; Schott, Björn H/B-9369-2012	Schott, Björn H/0000-0002-8237-4481; Wustenberg, Torsten/0000-0001-8408-2864; Seidenbecher, Constanze/0000-0002-7433-2716; Duzel, Emrah/0000-0002-0139-5388	Deutsche Forschungsgemeinschaft (DFG) [SFB 779, TP A7, TP A8]; State of Saxony-Anhalt	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); State of Saxony-Anhalt	This work was supported by Deutsche Forschungsgemeinschaft (DFG), SFB 779, TP A7 and A8 (http://www.dfg.de) and State of Saxony-Anhalt, State Research Award to Dr. Bjorn Schott (http://www.sachsen-anhalt.de/LPSA/index.php?id = 3564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner RL, 2000, ACTA PSYCHOL, V105, P127, DOI 10.1016/S0001-6918(00)00057-3; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Filippini N, 2006, EUR J HUM GENET, V14, P443, DOI 10.1038/sj.ejhg.5201573; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Hazelwood LA, 2004, MOL PHARMACOL, V66, P1293, DOI 10.1124/mol.66.5.1293; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MARCUSSON JO, 1984, BRAIN RES, V311, P51, DOI 10.1016/0006-8993(84)91397-0; Ohmura Y, 2010, NEUROPSYCHOPHARMACOL, V35, P1271, DOI 10.1038/npp.2009.229; Ozaki N, 1997, J NEUROCHEM, V68, P2186; Papassotiropoulos A, 2005, NEUROREPORT, V16, P839, DOI 10.1097/00001756-200505310-00012; Papp EC, 1999, NEUROSCIENCE, V90, P369, DOI 10.1016/S0306-4522(98)00455-2; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Serretti A, 2007, CURR MED CHEM, V14, P2053; Sheline YI, 2002, AM J PSYCHIAT, V159, P430, DOI 10.1176/appi.ajp.159.3.430; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner M, 2008, INT J NEUROPSYCHOPH, V11, P1163, DOI 10.1017/S146114570800905X; Wang RY, 1998, BRAIN RES, V779, P309, DOI 10.1016/S0006-8993(97)01174-8	28	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15984	10.1371/journal.pone.0015984	http://dx.doi.org/10.1371/journal.pone.0015984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267461	gold, Green Submitted, Green Published			2022-12-25	WOS:000286519500034
J	Izeddin, I; Specht, CG; Lelek, M; Darzacq, X; Triller, A; Zimmer, C; Dahan, M				Izeddin, Ignacio; Specht, Christian G.; Lelek, Mickael; Darzacq, Xavier; Triller, Antoine; Zimmer, Christophe; Dahan, Maxime			Super-Resolution Dynamic Imaging of Dendritic Spines Using a Low-Affinity Photoconvertible Actin Probe	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LOCALIZATION MICROSCOPY; FLUORESCENCE MICROSCOPY; 3-DIMENSIONAL STRUCTURE; GLUTAMATE RECEPTORS; F-ACTIN; PLASTICITY; PROTEIN; ORGANIZATION; DIFFUSION	The actin cytoskeleton of dendritic spines plays a key role in morphological aspects of synaptic plasticity. The detailed analysis of the spine structure and dynamics in live neurons, however, has been hampered by the diffraction-limited resolution of conventional fluorescence microscopy. The advent of nanoscopic imaging techniques thus holds great promise for the study of these processes. We implemented a strategy for the visualization of morphological changes of dendritic spines over tens of minutes at a lateral resolution of 25 to 65 nm. We have generated a low-affinity photoconvertible probe, capable of reversibly binding to actin and thus allowing long-term photoactivated localization microscopy of the spine cytoskeleton. Using this approach, we resolve structural parameters of spines and record their long-term dynamics at a temporal resolution below one minute. Furthermore, we have determined changes in the spine morphology in response to pharmacologically induced synaptic activity and quantified the actin redistribution underlying these changes. By combining PALM imaging with quantum dot tracking, we could also simultaneously visualize the cytoskeleton and the spine membrane, allowing us to record complementary information on the morphological changes of the spines at super-resolution.	[Izeddin, Ignacio; Dahan, Maxime] Univ Paris 06, CNRS, Ecole Normale Super, Dept Phys,Lab Kastler Brossel,UMR 8552, Paris, France; [Izeddin, Ignacio; Dahan, Maxime] Univ Paris 06, CNRS, Ecole Normale Super, Dept Biol,Lab Kastler Brossel,UMR 8552, Paris, France; [Specht, Christian G.; Triller, Antoine] Ecole Normale Super, INSERM, U1024, F-75231 Paris, France; [Lelek, Mickael; Zimmer, Christophe] Inst Pasteur, CNRS, Grp Imagerie & Modelisat, URA 2582, Paris, France; [Darzacq, Xavier] Ecole Normale Super, CNRS, UMR8541, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Izeddin, I (corresponding author), Univ Paris 06, CNRS, Ecole Normale Super, Dept Phys,Lab Kastler Brossel,UMR 8552, Paris, France.	triller@biologie.ens.fr; maxime.dahan@lkb.ens.fr	Izeddin, Ignacio/H-2628-2013; Dahan, Maxime/F-1740-2010; LELEK, Mickaël/AAW-8152-2021	Izeddin, Ignacio/0000-0002-8476-3915; Darzacq, Xavier/0000-0003-2537-8395; Dahan, Maxime/0000-0002-4943-2491; Specht, Christian G/0000-0001-6038-7735; TRILLER, Antoine/0000-0002-7530-1233	Fondation pour la Recherche Medicale (FRM); Fondation Pierre-Gilles de Gennes; C'Nano Ile de France; Netherlands Organisation for Scientific Research (NWO)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Pierre-Gilles de Gennes; C'Nano Ile de France(Region Ile-de-France); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is supported by the Fondation pour la Recherche Medicale (FRM), the Fondation Pierre-Gilles de Gennes, and C'Nano Ile de France. I.I. acknowledges the Netherlands Organisation for Scientific Research (NWO) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BLOMBERG F, 1977, J CELL BIOL, V74, P204, DOI 10.1083/jcb.74.1.204; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; GAETAN C, 2006, PROCESSUS PONCTUELS; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; MONTAGUE C, 1983, J MUSCLE RES CELL M, V4, P95, DOI 10.1007/BF00711960; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Wang XB, 2007, J NEUROSCI, V27, P12419, DOI 10.1523/JNEUROSCI.2015-07.2007; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; WILSON CJ, 1983, J NEUROSCI, V3, P383; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]	41	109	111	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15611	10.1371/journal.pone.0015611	http://dx.doi.org/10.1371/journal.pone.0015611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264214	gold, Green Published, Green Submitted			2022-12-25	WOS:000286517600010
J	Menke, C; Goncharov, T; Qamar, L; Korch, C; Ford, HL; Behbakht, K; Thorburn, A				Menke, Christina; Goncharov, Tatiana; Qamar, Lubna; Korch, Christopher; Ford, Heide L.; Behbakht, Kian; Thorburn, Andrew			TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; MEDIATED APOPTOSIS; R DEFICIENCY; DEATH DOMAIN; TUMOR; CELLS; METASTASIS; RESISTANCE; PATHWAY; ACTIVATION	Background: Signaling by Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) and Fas ligand (FasL) has been proposed to contribute to the chemosensitivity of tumor cells treated with various other anti-cancer agents. However, the importance of these effects and whether there are differences in vitro and in vivo is unclear. Methodology/Principal Findings: To assess the relative contribution of death receptor pathways to this sensitivity and to determine whether these effects are intrinsic to the tumor cells, we compared the chemosensitivity of isogenic BJAB human lymphoma cells where Fas and TRAIL receptors or just TRAIL receptors were inhibited using mutants of the adaptor protein FADD or by altering the expression of the homeobox transcription factor Six1. Inhibition of TRAIL receptors did not affect in vitro tumor cell killing by various anti-cancer agents indicating that chemosensitivity is not significantly affected by the tumor cell-intrinsic activation of death receptor signaling. However, selective inhibition of TRAIL receptor signaling caused reduced tumor regression and clearance in vivo when tested in a NOD/SCID mouse model. Conclusions: These data show that TRAIL receptor signaling in tumor cells can determine chemosensitivity in vivo but not in vitro and thus imply that TRAIL resistance makes tumors less susceptible to conventional cytotoxic anti-cancer drugs as well as drugs that directly target the TRAIL receptors.	[Menke, Christina; Goncharov, Tatiana; Thorburn, Andrew] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA; [Qamar, Lubna; Ford, Heide L.; Behbakht, Kian] Univ Colorado, Dept Obstet & Gynecol, Sch Med, Aurora, CO USA; [Korch, Christopher] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Menke, C (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA.	Andrew.Thorburn@ucdenver.edu		Behbakht, Kian/0000-0003-4793-9958	National Institutes of Health (NIH) [RO1CA 111421, RO1CA 124545]; Department of Defense [OC060143]; NIH-National Cancer Institute [P30 CA46934]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA124545, R01CA111421] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants RO1CA 111421 (A. T.), RO1CA 124545 (A. T., H. F. & K. B.) and Department of Defense OC060143 (K. B.) and core facilities supported by the NIH-National Cancer Institute Support Grant (P30 CA46934) to University of Colorado Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Fulda S, 1998, CELL DEATH DIFFER, V5, P884, DOI 10.1038/sj.cdd.4400419; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Igney FH, 2005, CANCER IMMUNOL IMMUN, V54, P1127, DOI 10.1007/s00262-005-0680-7; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Schmaltz C, 2002, NAT MED, V8, P1433, DOI 10.1038/nm797; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; Seki N, 2003, CANCER RES, V63, P207; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Tourneur L, 2004, CANCER RES, V64, P8101, DOI 10.1158/0008-5472.CAN-04-2361; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Wajant H, 2006, CANC TREAT, V130, P141; Wang SL, 2004, CANCER RES, V64, P6666, DOI 10.1158/0008-5472.CAN-04-1734; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	30	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14527	10.1371/journal.pone.0014527	http://dx.doi.org/10.1371/journal.pone.0014527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264287	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500007
J	Ohta, S; Imaizumi, Y; Okada, Y; Akamatsu, W; Kuwahara, R; Ohyama, M; Amagai, M; Matsuzaki, Y; Yamanaka, S; Okano, H; Kawakami, Y				Ohta, Shigeki; Imaizumi, Yoichi; Okada, Yohei; Akamatsu, Wado; Kuwahara, Reiko; Ohyama, Manabu; Amagai, Masayuki; Matsuzaki, Yumi; Yamanaka, Shinya; Okano, Hideyuki; Kawakami, Yutaka			Generation of Human Melanocytes from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; MELANOMA; VITILIGO; PATIENT; CANCER; NICHE; SKIN; MAINTENANCE; NEURONS; BIOLOGY	Epidermal melanocytes play an important role in protecting the skin from UV rays, and their functional impairment results in pigment disorders. Additionally, melanomas are considered to arise from mutations that accumulate in melanocyte stem cells. The mechanisms underlying melanocyte differentiation and the defining characteristics of melanocyte stem cells in humans are, however, largely unknown. In the present study, we set out to generate melanocytes from human iPS cells in vitro, leading to a preliminary investigation of the mechanisms of human melanocyte differentiation. We generated iPS cell lines from human dermal fibroblasts using the Yamanaka factors (SOX2, OCT3/4, and KLF4, with or without c-MYC). These iPS cell lines were subsequently used to form embryoid bodies (EBs) and then differentiated into melanocytes via culture supplementation with Wnt3a, SCF, and ET-3. Seven weeks after inducing differentiation, pigmented cells expressing melanocyte markers such as MITF, tyrosinase, SILV, and TYRP1, were detected. Melanosomes were identified in these pigmented cells by electron microscopy, and global gene expression profiling of the pigmented cells showed a high similarity to that of human primary foreskin-derived melanocytes, suggesting the successful generation of melanocytes from iPS cells. This in vitro differentiation system should prove useful for understanding human melanocyte biology and revealing the mechanism of various pigment cell disorders, including melanoma.	[Ohta, Shigeki; Kuwahara, Reiko; Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Imaizumi, Yoichi; Okada, Yohei; Akamatsu, Wado; Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Okada, Yohei] Keio Univ, Sch Med, Kanrinmaru Project, Tokyo, Japan; [Ohyama, Manabu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan	Keio University; Keio University; Keio University; Keio University; Kyoto University; Kyoto University	Ohta, S (corresponding author), Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan.	hidokano@sc.itc.keio.ac.jp; yutakawa@sc.itc.keio.ac.jp	Ohyama, Manabu/J-5524-2014; Ohta, Shigeki/Y-4455-2019; Kawakami, Yutaka/E-7429-2013; Akamatsu, Wado/L-1214-2013; Okada, Yohei/L-1662-2013; Okano, Hideyuki/I-7584-2019; Ohta, shigeki/L-1677-2013; Amagai, Masayuki/K-5325-2013	Ohyama, Manabu/0000-0002-2662-5717; Ohta, Shigeki/0000-0003-2994-4278; Kawakami, Yutaka/0000-0003-4836-2855; Amagai, Masayuki/0000-0003-3314-7052; Imaizumi, Yoichi/0000-0002-8501-9792; Matsuzaki, Yumi/0000-0002-3729-2997	MEXT (Ministry of Education, Culture, Sports, Science and Technology)	MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from MEXT, and a Grant-in-aid for the Global COE program to Keio University from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas O, 2009, BRIT J DERMATOL, V161, P228, DOI 10.1111/j.1365-2133.2009.09250.x; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Boiko AD, NATURE, V466, P133; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Czajkowski R, 2007, DERMATOL SURG, V33, P1027, DOI 10.1111/j.1524-4725.2007.33216.x; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Grichnik JM, 2008, J INVEST DERMATOL, V128, P2365, DOI 10.1038/jid.2008.166; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; KISKINIS E, J CLIN INVEST, V120, P51; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; LI L, J CELL SCI, V123, P853; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; NAKAGAWA M, P NATL ACAD SCI US, V107, P14152; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; NISHIMURA EK, CELL STEM CELL, V6, P130; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; QUINTANA E, CANC CELL, V18, P510; Sabatino M, 2009, CANCER LETT, V279, P119, DOI 10.1016/j.canlet.2008.10.039; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Geel N, 2001, DERMATOLOGY, V202, P162, DOI 10.1159/000051626; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Yamane T, 1999, DEV DYNAM, V216, P450, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0; YU H, J INVEST DERMATOL, V130, P1227; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	42	76	85	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16182	10.1371/journal.pone.0016182	http://dx.doi.org/10.1371/journal.pone.0016182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249204	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000028
J	Shah, N; Lin, BY; Sibenaller, Z; Ryken, T; Lee, H; Yoon, JG; Rostad, S; Foltz, G				Shah, Nameeta; Lin, Biaoyang; Sibenaller, Zita; Ryken, Timothy; Lee, Hwahyung; Yoon, Jae-Geun; Rostad, Steven; Foltz, Greg			Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM	PLOS ONE			English	Article							O6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; GENE-EXPRESSION; GLIOBLASTOMA; HYPERMETHYLATION; SURVIVAL; RADIOTHERAPY; CONCOMITANT; ASSAY	O-6-methylguanine DNA-methyltransferase (MGMT) promoter methylation has been identified as a potential prognostic marker for glioblastoma patients. The relationship between the exact site of promoter methylation and its effect on gene silencing, and the patient's subsequent response to therapy, is still being defined. The aim of this study was to comprehensively characterize cytosine-guanine (CpG) dinucleotide methylation across the entire MGMT promoter and to correlate individual CpG site methylation patterns to mRNA expression, protein expression, and progression-free survival. To best identify the specific MGMT promoter region most predictive of gene silencing and response to therapy, we determined the methylation status of all 97 CpG sites in the MGMT promoter in tumor samples from 70 GBM patients using quantitative bisulfite sequencing. We next identified the CpG site specific and regional methylation patterns most predictive of gene silencing and improved progression-free survival. Using this data, we propose a new classification scheme utilizing methylation data from across the entire promoter and show that an analysis based on this approach, which we call 3R classification, is predictive of progression-free survival (HR = 5.23, 95% C [2.089-13.097], p < 0.0001). To adapt this approach to the clinical setting, we used a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) test based on the 3R classification and show that this test is both feasible in the clinical setting and predictive of progression free survival (HR = 3.076, 95% Cl [1.301-7.27], p = 0.007). We discuss the potential advantages of a test based on this promoter-wide analysis and compare it to the commonly used methylation-specific PCR test. Further prospective validation of these two methods in a large independent patient cohort will be needed to confirm the added value of promoter wide analysis of MGMT methylation in the clinical setting.	[Shah, Nameeta; Lin, Biaoyang; Lee, Hwahyung; Yoon, Jae-Geun; Foltz, Greg] Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA USA; [Sibenaller, Zita] Univ Iowa, Carver Coll Med, Dept Radiat & Oncol, Iowa City, IA USA; [Ryken, Timothy] Iowa Spine & Brain Inst, Waterloo, IA USA; [Rostad, Steven] Cellnetix Pathol & Labs, Seattle, WA USA	Swedish Medical Center; University of Iowa	Shah, N (corresponding author), Swedish Neurosci Inst, Ben & Catherine Ivy Ctr Adv Brain Tumor Treatment, Seattle, WA USA.	greg.foltz@swedish.org	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407	Ben and Catherine Ivy Foundation; Swedish Medical Foundation	Ben and Catherine Ivy Foundation; Swedish Medical Foundation	We gratefully acknowledge the Ben and Catherine Ivy Foundation and the Swedish Medical Foundation for support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanich M, 1996, CANCER RES, V56, P783; Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Brandes JC, 2007, ONCOGENE, V26, P6229, DOI 10.1038/sj.onc.1210433; Cankovic M, 2007, LAB INVEST, V87, P392, DOI 10.1038/labinvest.3700520; Cao VT, 2009, NEUROSURGERY, V65, P866, DOI 10.1227/01.NEU.0000357325.90347.A1; Capper D, 2008, ACTA NEUROPATHOL, V115, P249, DOI 10.1007/s00401-007-0310-x; Criniere E, 2007, J NEURO-ONCOL, V83, P173, DOI 10.1007/s11060-006-9320-0; Eoli M, 2007, CLIN CANCER RES, V13, P2606, DOI 10.1158/1078-0432.CCR-06-2184; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsberg J, 2009, CLIN CANCER RES, V15, P6683, DOI 10.1158/1078-0432.CCR-08-2801; FRITZ G, 1991, MOL CELL BIOL, V11, P4660, DOI 10.1128/MCB.11.9.4660; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grasbon-Frodl EM, 2007, INT J CANCER, V121, P2458, DOI 10.1002/ijc.23020; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitange GJ, 2009, J NEURO-ONCOL, V92, P23, DOI 10.1007/s11060-008-9737-8; Maxwell JA, 2006, MOL CANCER THER, V5, P2531, DOI 10.1158/1535-7163.MCT-06-0106; Mellai Marta, 2009, Cancer Genomics & Proteomics, V6, P219; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; *NAT CANC I, 2010, RTOG 0525 PHAS 3 RAN; *NAT CANC I, 2010, RTOG 0825 PHAS 3 RAN; Parkinson JF, 2008, J NEURO-ONCOL, V87, P71, DOI 10.1007/s11060-007-9486-0; Pieper RO, 1996, J BIOL CHEM, V271, P13916, DOI 10.1074/jbc.271.23.13916; Polley MYC, 2010, NEURO-ONCOLOGY, V12, P274, DOI 10.1093/neuonc/nop034; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanai N, 2009, NEUROTHERAPEUTICS, V6, P478, DOI 10.1016/j.nurt.2009.04.005; Sasai K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-36; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Weiler M, 2010, INT J RADIAT ONCOL, V77, P670, DOI 10.1016/j.ijrobp.2009.05.031; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Yachi K, 2008, INT J ONCOL, V33, P469, DOI 10.3892/ijo_00000029	42	71	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16146	10.1371/journal.pone.0016146	http://dx.doi.org/10.1371/journal.pone.0016146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249131	Green Published, gold, Green Submitted			2022-12-25	WOS:000286512900023
J	Lee, JY; Wei, SJ; Lee, TH				Lee, Ju Yeon; Wei, Sijie; Lee, Tae-Hee			Effects of Histone Acetylation by Piccolo NuA4 on the Structure of a Nucleosome and the Interactions between Two Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKING NUMBER CHANGE; NM CHROMATIN FIBER; ACETYLTRANSFERASE COMPLEX; ASSEMBLY PROTEIN-1; CORE PARTICLE; RNA SYNTHESIS; TAIL DOMAINS; H4; DNA; H3	We characterized the effect of histone acetylation on the structure of a nucleosome and the interactions between two nucleosomes. In this study, nucleosomes reconstituted with the Selex "Widom 601" sequence were acetylated with the Piccolo NuA4 complex, which acetylates mainly H4 N-terminal tail lysine residues and some H2A/H3 N-terminal tail lysine residues. Upon the acetylation, we observed directional unwrapping of nucleosomal DNA that accompanies topology change of the DNA. Interactions between two nucleosomes in solution were also monitored to discover multiple transient dinucleosomal states that can be categorized to short-lived and long-lived (similar to 1 s) states. The formation of dinucleosomes is strongly Mg2+-dependent, and unacetylated nucleosomes favor the formation of long-lived dinucleosomes 4-fold as much as the acetylated ones. These results suggest that the acetylation of histones by Piccolo NuA4 disturbs not only the structure of a nucleosome but also the interactions between two nucleosomes. Lastly, we suggest a structural model for a stable dinucleosomal state where the two nucleosomes are separated by similar to 2 nm face-to-face and rotated by 34 degrees with respect to each other.	[Lee, Ju Yeon; Wei, Sijie; Lee, Tae-Hee] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, TH (corresponding author), Penn State Univ, Dept Chem, 230 Chem Bldg, University Pk, PA 16802 USA.	txl18@psu.edu	Lee, Tae-Hee/A-1266-2010; Wei, Sijie/J-6678-2019	Wei, Sijie/0000-0003-4882-9566	Searle Scholar Award; Henry and Dreyfus New Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097286] Funding Source: NIH RePORTER	Searle Scholar Award; Henry and Dreyfus New Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Searle Scholar Award (to T.-H. L.) and a Henry and Dreyfus New Faculty Award (to T.-H. L.).	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; Baneres JL, 1997, J MOL BIOL, V273, P503, DOI 10.1006/jmbi.1997.1297; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Bertin A, 2007, BIOPHYS J, V92, P2633, DOI 10.1529/biophysj.106.093815; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Selleck W, 2005, MOL CELL BIOL, V25, P5535, DOI 10.1128/MCB.25.13.5535-5542.2005; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Staynov DZ, 2008, BIOESSAYS, V30, P1003, DOI 10.1002/bies.20816; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	54	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11099	11109		10.1074/jbc.M110.192047	http://dx.doi.org/10.1074/jbc.M110.192047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282115	hybrid, Green Published			2022-12-25	WOS:000288797100021
J	Oliveira, CJF; Sa-Nunes, A; Francischetti, IMB; Carregaro, V; Anatriello, E; Silva, JS; Santos, IKFD; Ribeiro, JMC; Ferreira, BR				Oliveira, Carlo Jose F.; Sa-Nunes, Anderson; Francischetti, Ivo M. B.; Carregaro, Vanessa; Anatriello, Elen; Silva, Joao S.; de Miranda Santos, Isabel K. F.; Ribeiro, Jose M. C.; Ferreira, Beatriz R.			Deconstructing Tick Saliva NON-PROTEIN MOLECULES WITH POTENT IMMUNOMODULATORY PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL-FUNCTION; TOLL-LIKE RECEPTOR-2; LONE STAR TICK; RHIPICEPHALUS-SANGUINEUS; PROSTAGLANDIN E-2; IXODES-SCAPULARIS; BOOPHILUS-MICROPLUS; AMBLYOMMA-AMERICANUM; MONOCYTE DIFFERENTIATION; BIOLOGICAL SIGNIFICANCE	Dendritic cells (DCs) are powerful initiators of innate and adaptive immune responses. Ticks are blood-sucking ectoparasite arthropods that suppress host immunity by secreting immunomodulatory molecules in their saliva. Here, compounds present in Rhipicephalus sanguineus tick saliva with immunomodulatory effects on DC differentiation, cytokine production, and costimulatory molecule expression were identified. R. sanguineus tick saliva inhibited IL-12p40 and TNF-alpha while potentiating IL-10 cytokine production by bone marrow-derived DCs stimulated by Toll-like receptor-2, -4, and -9 agonists. To identify the molecules responsible for these effects, we fractionated the saliva through microcon filtration and reversed-phase HPLC and tested each fraction for DC maturation. Fractions with proven effects were analyzed by micro-HPLC tandem mass spectrometry or competition ELISA. Thus, we identified for the first time in tick saliva the purine nucleoside adenosine (concentration of similar to 110pmol/mu l) as a potent anti-inflammatory salivary inhibitor of DC cytokine production. We also found prostaglandin E-2 (PGE(2) similar to 100 nM) with comparable effects in modulating cytokine production by DCs. Both Ado and PGE(2) inhibited cytokine production by inducing cAMP-PKA signaling in DCs. Additionally, both Ado and PGE(2) were able to inhibit expression of CD40 in mature DCs. Finally, flow cytometry analysis revealed that PGE(2), but not Ado, is the differentiation inhibitor of bone marrow-derived DCs. The presence of non-protein molecules adenosine and PGE(2) in tick saliva indicates an important evolutionary mechanism used by ticks to subvert host immune cells and allow them to successfully complete their blood meal and life cycle.	[Ferreira, Beatriz R.] Univ Sao Paulo, Sch Nursing Ribeirao Preto, Dept Maternal Child Nursing & Publ Hlth, BR-14040902 Ribeirao Preto, SP, Brazil; [Oliveira, Carlo Jose F.; Carregaro, Vanessa; Anatriello, Elen; Silva, Joao S.; de Miranda Santos, Isabel K. F.; Ferreira, Beatriz R.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Sa-Nunes, Anderson] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Francischetti, Ivo M. B.; Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ferreira, BR (corresponding author), Univ Sao Paulo, Sch Nursing Ribeirao Preto, Dept Maternal Child Nursing & Publ Hlth, Av Bandeirantes 3900, BR-14040902 Ribeirao Preto, SP, Brazil.	brferrei@usp.br	de Miranda Santos, Isabel K. F./D-5261-2016; Carregaro, Vanessa/D-2913-2012; Ferreira, Beatriz Rossetti/C-2003-2012; Anatriello, Elen/N-1429-2015; Oliveira, Carlo Jose Freire/AAY-8751-2020; Silva, Joao/A-4484-2008; de Miranda Santos, Isabel KF/B-7597-2012; Sa-Nunes, Anderson/D-8667-2012; Sa-Nunes, Anderson/M-5654-2019	Ferreira, Beatriz Rossetti/0000-0002-6781-2236; Silva, Joao/0000-0002-3410-3927; Sa-Nunes, Anderson/0000-0002-1859-4973; Sa-Nunes, Anderson/0000-0002-1859-4973; Ribeiro, Jose/0000-0002-9107-0818; Carregaro, Vanessa/0000-0002-8435-0766; Kinney Ferreira de Miranda Santos, Isabel/0000-0002-0438-4430	National Institutes of Health of the Division of Intramural Research, NIAID; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/54985-4, 07/00035-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Millennium Institute for Vaccine Development and Technology (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [CNPq-420067/2005-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	National Institutes of Health of the Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Millennium Institute for Vaccine Development and Technology (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the Division of Intramural Research, NIAID. This work was supported in part by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 06/54985-4 and 07/00035-8, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Millennium Institute for Vaccine Development and Technology (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) Grant CNPq-420067/2005-1.	Aljamali M, 2002, INSECT BIOCHEM MOLEC, V32, P331, DOI 10.1016/S0965-1748(01)00113-8; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Bergman DK, 1995, EXP PARASITOL, V81, P262, DOI 10.1006/expr.1995.1117; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bowman AS, 1996, PARASITOL TODAY, V12, P388, DOI 10.1016/0169-4758(96)10061-2; BROWN SJ, 1985, EXP PARASITOL, V59, P248, DOI 10.1016/0014-4894(85)90079-7; Cavassani KA, 2005, IMMUNOLOGY, V114, P235, DOI 10.1111/j.1365-2567.2004.02079.x; COLLIS MG, 1989, PHARMACOL THERAPEUT, V41, P143, DOI 10.1016/0163-7258(89)90104-6; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; DICKINSON RG, 1976, AUST J EXP BIOL MED, V54, P475, DOI 10.1038/icb.1976.48; Ferreira BR, 1999, IMMUNOLOGY, V96, P434, DOI 10.1046/j.1365-2567.1999.00683.x; Ferreira BR, 1998, VET IMMUNOL IMMUNOP, V64, P279, DOI 10.1016/S0165-2427(98)00135-4; Fezza F, 2003, BBA-MOL CELL BIOL L, V1633, P61, DOI 10.1016/S1388-1981(03)00087-8; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Giordano D, 2003, J IMMUNOL, V171, P6421, DOI 10.4049/jimmunol.171.12.6421; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; HASLAM RJ, 1975, MOL PHARMACOL, V11, P528; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; HIGGS GA, 1976, B ENTOMOL RES, V66, P665, DOI 10.1017/S0007485300010725; Hollander GA, 1996, P NATL ACAD SCI USA, V93, P4994, DOI 10.1073/pnas.93.10.4994; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inokuma H, 1997, MED VET ENTOMOL, V11, P401, DOI 10.1111/j.1365-2915.1997.tb00429.x; Inokuma H, 1998, J VET MED SCI, V60, P1013, DOI 10.1292/jvms.60.1013; Inokuma H, 1997, MED VET ENTOMOL, V11, P201, DOI 10.1111/j.1365-2915.1997.tb00315.x; INOKUMA H, 1994, J VET MED SCI, V56, P1217, DOI 10.1292/jvms.56.1217; Kashino SS, 2005, EXP PARASITOL, V110, P12, DOI 10.1016/j.exppara.2005.01.006; KATAMURA K, 1995, J IMMUNOL, V155, P4604; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Link AA, 2000, J IMMUNOL, V164, P436, DOI 10.4049/jimmunol.164.1.436; Mandapathil M, 2010, J BIOL CHEM, V285, P27571, DOI 10.1074/jbc.M110.127100; NAJAR HM, 1990, J LEUKOCYTE BIOL, V47, P429, DOI 10.1002/jlb.47.5.429; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Oliveira CJF, 2008, INT J PARASITOL, V38, P705, DOI 10.1016/j.ijpara.2007.10.006; Oliveira CJF, 2010, VET PARASITOL, V167, P288, DOI 10.1016/j.vetpar.2009.09.031; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Ribeiro JMC, 1999, J EXP BIOL, V202, P1551; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; RIBEIRO JMC, 1992, EXP PARASITOL, V74, P112, DOI 10.1016/0014-4894(92)90145-Z; Ribeiro JMC, 2001, J PARASITOL, V87, P915, DOI 10.1645/0022-3395(2001)087[0915:TSAACO]2.0.CO;2; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; Schoeler GB, 1999, EXP PARASITOL, V92, P239, DOI 10.1006/expr.1999.4426; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Stanley D, 2006, ANNU REV ENTOMOL, V51, P25, DOI 10.1146/annurev.ento.51.110104.151021; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Su YY, 2008, CANCER IMMUNOL IMMUN, V57, P1611, DOI 10.1007/s00262-008-0494-5; Subauste CS, 2009, SEMIN IMMUNOL, V21, P273, DOI 10.1016/j.smim.2009.06.003; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; Van Gool SW, 1999, EUR J IMMUNOL, V29, P2367, DOI 10.1002/(SICI)1521-4141(199908)29:08<2367::AID-IMMU2367>3.3.CO;2-V; Vassiliou E, 2003, CELL IMMUNOL, V223, P120, DOI 10.1016/S0008-8749(03)00158-8; Wang H, 1998, NATURE, V391, P753, DOI 10.1038/35773; Wang H, 1999, CELL MOL LIFE SCI, V56, P286, DOI 10.1007/s000180050430; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; Yang L, 2003, J CLIN INVEST, V111, P727, DOI 10.1172/JCI200316492; Zeidner N, 1997, INFECT IMMUN, V65, P3100, DOI 10.1128/IAI.65.8.3100-3106.1997	75	95	97	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10960	10969		10.1074/jbc.M110.205047	http://dx.doi.org/10.1074/jbc.M110.205047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21270122	Green Published, hybrid			2022-12-25	WOS:000288797100008
J	Cifuentes-Diaz, C; Dubourg, O; Irinopoulou, T; Vigny, M; Lachkar, S; Decker, L; Charnay, P; Denisenko, N; Maisonobe, T; Leger, JM; Viala, K; Hauw, JJ; Girault, JA				Cifuentes-Diaz, Carmen; Dubourg, Odile; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Decker, Laurence; Charnay, Patrick; Denisenko, Natalia; Maisonobe, Thierry; Leger, Jean-Marc; Viala, Karine; Hauw, Jean-Jacques; Girault, Jean-Antoine			Nodes of Ranvier and Paranodes in Chronic Acquired Neuropathies	PLOS ONE			English	Article							INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; NERVE BIOPSY; MYELINATED AXONS; DIAGNOSTIC-VALUE; PROTEIN CASPR; POLYNEUROPATHY; LOCALIZATION; CHANNEL; RECOMMENDATIONS; MAINTENANCE	Chronic acquired neuropathies of unknown origin are classified as chronic inflammatory demyelinating polyneuropathies (CIDP) and chronic idiopathic axonal polyneuropathies (CIAP). The diagnosis can be very difficult, although it has important therapeutic implications since CIDP can be improved by immunomodulating treatment. The aim of this study was to examine the possible abnormalities of nodal and paranodal regions in these two types of neuropathies. Longitudinal sections of superficial peroneal nerves were obtained from biopsy material from 12 patients with CIDP and 10 patients with CIAP and studied by immunofluorescence and in some cases electron microscopy. Electron microscopy revealed multiple alterations in the nodal and paranodal regions which predominated in Schwann cells in CIDP and in axons in CIAP. In CIDP paranodin/Caspr immunofluorescence was more widespread than in control nerves, extending along the axon in internodes where it appeared intense. Nodal channels Nav and KCNQ2 were less altered but were also detected in the internodes. In CIAP paranodes, paranodin labeling was irregular and/or decreased. To test the consequences of acquired primary Schwann cells alteration on axonal proteins, we used a mouse model based on induced deletion of the transcription factor Krox-20 gene. In the demyelinated sciatic nerves of these mice we observed alterations similar to those found in CIDP by immunofluorescence, and immunoblotting demonstrated increased levels of paranodin. Finally we examined whether the alterations in paranodin immunoreactivity could have a diagnosis value. In a sample of 16 biopsies, the study of paranodin immunofluorescence by blind evaluators led to correct diagnosis in 70 +/- 4% of the cases. This study characterizes for the first time the abnormalities of nodes of Ranvier in CIAP and CIDP, and the altered expression and distribution of nodal and paranodal proteins. Marked differences were observed between CIDP and CIAP and the alterations in paranodin immunofluorescence may be an interesting tool for their differential diagnosis.	[Cifuentes-Diaz, Carmen; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Denisenko, Natalia; Girault, Jean-Antoine] INSERM, UMR S 839, Paris, France; [Cifuentes-Diaz, Carmen; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Denisenko, Natalia; Hauw, Jean-Jacques; Girault, Jean-Antoine] Univ Paris 06, Paris, France; [Cifuentes-Diaz, Carmen; Irinopoulou, Theano; Vigny, Marc; Lachkar, Sylvie; Denisenko, Natalia; Girault, Jean-Antoine] Inst Fer Moulin, Paris, France; [Dubourg, Odile; Maisonobe, Thierry; Hauw, Jean-Jacques] Hop La Pitie Salpetriere, AP HP, Lab Neuropathol Raymond Escourolle, Paris, France; [Dubourg, Odile; Leger, Jean-Marc] Hop La Pitie Salpetriere, AP HP, Ctr Reference Paris Est, Paris, France; [Decker, Laurence; Charnay, Patrick] Ecole Normale Super, CNRS, UMR 8197, IBENS,INSERM,U1024, F-75231 Paris, France; [Maisonobe, Thierry; Viala, Karine] Hop La Pitie Salpetriere, AP HP, Federat Neurophysiol Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cifuentes-Diaz, C (corresponding author), INSERM, UMR S 839, Paris, France.	jean-antoine.girault@inserm.fr	Girault, Jean-Antoine/F-7518-2013	Girault, Jean-Antoine/0000-0002-7900-1705; Cifuentes Diaz, Carmen/0000-0003-2563-2082; Charnay, Patrick/0000-0002-3847-6042	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique - Hopitaux de Paris (AP-HP)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique - Hopitaux de Paris (AP-HP)	The work was supported by funding from Institut National de la Sante et de la Recherche Medicale (Inserm) and from Assistance Publique - Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLT G, 1975, J NEUROCYTOL, V4, P63, DOI 10.1007/BF01099096; Antoine JC, 2008, POSTGRAD MED J, V84, P378, DOI 10.1136/jnnp.2006.109785; Arroyo EJ, 2002, J NEUROSCI, V22, P1726, DOI 10.1523/JNEUROSCI.22-05-01726.2002; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bosboom WMJ, 2001, BRAIN, V124, P2427, DOI 10.1093/brain/124.12.2427; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Devaux JJ, 2005, J NEUROSCI, V25, P1470, DOI 10.1523/JNEUROSCI.3328-04.2005; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ELLISMAN MH, 1982, P NATL ACAD SCI-BIOL, V79, P6707, DOI 10.1073/pnas.79.21.6707; England JD, 1996, MICROSC RES TECHNIQ, V34, P445, DOI 10.1002/(SICI)1097-0029(19960801)34:5<445::AID-JEMT4>3.0.CO;2-L; FOSTER RE, 1980, SCIENCE, V210, P661, DOI 10.1126/science.6159685; Girault JA, 2002, CURR OPIN NEUROBIOL, V12, P476, DOI 10.1016/S0959-4388(02)00370-7; Henry MA, 2006, PAIN, V124, P222, DOI 10.1016/j.pain.2006.05.028; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KOSKI CL, 2008, J NEUROL SCI; KRENDEL DA, 1989, MUSCLE NERVE, V12, P257, DOI 10.1002/mus.880120402; Kuitwaard K, 2009, DRUGS, V69, P987, DOI 10.2165/00003495-200969080-00004; Li J, 2005, BRAIN, V128, P1168, DOI 10.1093/brain/awh483; Magy L, 2008, REV NEUROL-FRANCE, V164, P1063, DOI 10.1016/j.neurol.2008.09.001; Maisonobe T, 2006, REV NEUROL-FRANCE, V162, P527; Mathis C, 2001, DEVELOPMENT, V128, P4881; MCLEOD JG, 1984, J NEUROL NEUROSUR PS, V47, P530, DOI 10.1136/jnnp.47.5.530; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; NOTERMANS NC, 1994, J NEUROL NEUROSUR PS, V57, P1525, DOI 10.1136/jnnp.57.12.1525; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Vallat JM, 2009, J NEUROPATH EXP NEUR, V68, P833, DOI 10.1097/NEN.0b013e3181af2b9c; Vallat JM, 2003, MUSCLE NERVE, V27, P478, DOI 10.1002/mus.10348; Viala K, 2010, J PERIPHER NERV SYST, V15, P50, DOI 10.1111/j.1529-8027.2010.00251.x; VRANCKEN AF, 2004, COCHRANE DB SYST REV; Wolswijk G, 2003, BRAIN, V126, P1638, DOI 10.1093/brain/awg151	39	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14533	10.1371/journal.pone.0014533	http://dx.doi.org/10.1371/journal.pone.0014533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267074	gold, Green Published, Green Submitted			2022-12-25	WOS:000286519500009
J	Billing, O; Kao, G; Naredi, P				Billing, Ola; Kao, Gautam; Naredi, Peter			Mitochondrial Function Is Required for Secretion of DAF-28/Insulin in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN IMPORT; INSULIN-SECRETION; OXIDATIVE STRESS; GENETIC-ANALYSIS; OUTER-MEMBRANE; LONGEVITY; DAF-16; NEMATODE; COMPLEX	While insulin signaling has been extensively studied in Caenorhabditis elegans in the context of ageing and stress response, less is known about the factors underlying the secretion of insulin ligands upstream of the insulin receptor. Activation of the receptor governs the decision whether to progress through the reproductive lifecycle or to arrest growth and enter hibernation. We find that animals with reduced levels of the mitochondrial outer membrane translocase homologue TOMM-40 arrest growth as larvae and have decreased insulin signaling strength. TOMM-40 acts as a mitochondrial translocase in C. elegans and in its absence animals fail to import a mitochondrial protein reporter across the mitochondrial membrane(s). Inactivation of TOMM-40 evokes the mitochondrial unfolded protein response and causes a collapse of the proton gradient across the inner mitochondrial membrane. Consequently these broadly dysfunctional mitochondria render an inability to couple food abundance to secretion of DAF-28/insulin. The secretion defect is not general in nature since two other neuropeptides, ANF::GFP and INS-22::VENUS, are secreted normally. RNAi against two other putative members of the TOMM complex give similar phenotypes, implying that DAF-28 secretion is sensitive to mitochondrial dysfunction in general. We conclude that mitochondrial function is required for C. elegans to secrete DAF-28/insulin when food is abundant. This modulation of secretion likely represents an additional level of control over DAF-28/insulin function.	[Billing, Ola; Kao, Gautam; Naredi, Peter] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University	Billing, O (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden.	gautam.kao@surgery.umu.se	Naredi, Peter/AAG-1504-2019	Billing, Ola/0000-0001-5824-6263; Naredi, Peter/0000-0002-5652-0422	Swedish Research Council [K2008-68X-20803-01-3]; Swedish Cancer Society [CAN2007/901]; Cancer Research Foundation in Northern Sweden; Vasterbottens County Council; National Institutes of Health National Center for Research Resources (NCRR)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundation in Northern Sweden; Vasterbottens County Council; National Institutes of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Swedish Research Council (K2008-68X-20803-01-3), the Swedish Cancer Society (CAN2007/901), the Cancer Research Foundation in Northern Sweden, and Vasterbottens County Council (ALF-means and Spjutspetsmedel). Some C. elegans strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Arkblad EL, 2002, COMP BIOCHEM PHYS B, V133, P13, DOI 10.1016/S1096-4959(02)00107-0; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collet J, 1998, GENETICS, V148, P187; Curran SP, 2004, J BIOL CHEM, V279, P54655, DOI 10.1074/jbc.M409618200; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Fares H, 2001, GENETICS, V159, P133; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gems D, 1998, GENETICS, V150, P129; Goudeau J, 2010, AGING CELL, V9, P991, DOI 10.1111/j.1474-9726.2010.00625.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HERMAN RK, 1978, GENETICS, V88, P49; Hu Patrick J, 2007, WormBook, P1; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; Kondo M, 2005, MECH AGEING DEV, V126, P637, DOI 10.1016/j.mad.2004.11.011; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Malone EA, 1996, GENETICS, V143, P1193; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Sherman EL, 2006, J BIOL CHEM, V281, P22554, DOI 10.1074/jbc.M601630200; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Tan FJ, 2007, CELL DEATH DIFFER, V14, P1925, DOI 10.1038/sj.cdd.4402215; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	53	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14507	10.1371/journal.pone.0014507	http://dx.doi.org/10.1371/journal.pone.0014507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264209	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600003
J	Nakamura, M; Ohki, S; Suzuki, A; Sakai, K				Nakamura, Masako; Ohki, Shun; Suzuki, Atsushi; Sakai, Kazuhiko			Coral Larvae under Ocean Acidification: Survival, Metabolism, and Metamorphosis	PLOS ONE			English	Article							CO2; SETTLEMENT; SEAWATER; GROWTH; DEPRESSION; STRESS; IMPACT; ENERGY; CARBON; REEFS	Ocean acidification may negatively impact the early life stages of some marine invertebrates including corals. Although reduced growth of juvenile corals in acidified seawater has been reported, coral larvae have been reported to demonstrate some level of tolerance to reduced pH. We hypothesize that the observed tolerance of coral larvae to low pH may be partly explained by reduced metabolic rates in acidified seawater because both calcifying and non-calcifying marine invertebrates could show metabolic depression under reduced pH in order to enhance their survival. In this study, after 3-d and 7-d exposure to three different pH levels (8.0, 7.6, and 7.3), we found that the oxygen consumption of Acropora digitifera larvae tended to be suppressed with reduced pH, although a statistically significant difference was not observed between pH conditions. Larval metamorphosis was also observed, confirming that successful recruitment is impaired when metamorphosis is disrupted, despite larval survival. Results also showed that the metamorphosis rate significantly decreased under acidified seawater conditions after both short (2 h) and long (7 d) term exposure. These results imply that acidified seawater impacts larval physiology, suggesting that suppressed metabolism and metamorphosis may alter the dispersal potential of larvae and subsequently reduce the resilience of coral communities in the near future as the ocean pH decreases.	[Nakamura, Masako; Ohki, Shun; Sakai, Kazuhiko] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Okinawa, Japan; [Suzuki, Atsushi] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki, Japan	University of the Ryukyus; National Institute of Advanced Industrial Science & Technology (AIST)	Nakamura, M (corresponding author), Okinawa Inst Sci & Technol, Okinawa, Japan.	m_coral29@yahoo.co.jp	Suzuki, Atsushi/L-6120-2018	Suzuki, Atsushi/0000-0002-0266-5765; Ohki, Shun/0000-0001-6301-8919; Sakai, Kazuhiko/0000-0003-1905-5952	Ministry of the Environment of Japan [B-084]; Grants-in-Aid for Scientific Research [21247006, 20121002] Funding Source: KAKEN	Ministry of the Environment of Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Acidification Impact on CALcifiers (AICAL) project, lead by Yukihiro Nojiri and funded by Global Environment Research Fund B-084 of the Ministry of the Environment of Japan. The funders has no role in study design, data collection and analysis, decision to publish, or perparation of the manuscript.	Albright R, 2008, CORAL REEFS, V27, P485, DOI 10.1007/s00338-008-0392-5; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; DEGNAN BM, 1995, AM ZOOL, V35, P391; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; Harrison P.L., 1990, CORAL REEFS, V25, P133; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Jackson D, 2002, INT J DEV BIOL, V46, P679; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Langenbuch M, 2004, AQUAT TOXICOL, V70, P55, DOI 10.1016/j.aquatox.2004.07.006; Leitz T, 1997, INVERTEBR REPROD DEV, V31, P109, DOI 10.1080/07924259.1997.9672569; Lewis E., 1998, PROGRAM DEV CO2 SYST; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Morita M, 2006, J EXP BIOL, V209, P4574, DOI 10.1242/jeb.02500; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; Okubo N, 2008, MAR ECOL PROG SER, V366, P305, DOI 10.3354/meps07562; Page LR, 1998, INVERTEBR BIOL, V117, P208, DOI 10.2307/3226987; Reipschlager A, 1996, J EXP BIOL, V199, P1801; RODRIGUEZ JL, 1990, MAR BIOL, V106, P109, DOI 10.1007/BF02114680; Sabine CL, 2007, GREENHOUSE GAS SINKS, P31, DOI 10.1079/9781845931896.0031; Schmich J, 1998, DEV GENES EVOL, V208, P267, DOI 10.1007/s004270050181; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Shilling FM, 1996, BIOL BULL, V191, P402, DOI 10.2307/1543013; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; SUZUKI A, 1995, SEDIMENT GEOL, V99, P259, DOI 10.1016/0037-0738(95)00048-D; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690; WHEATLY MG, 1992, J EXP ZOOL, V263, P127, DOI 10.1002/jez.1402630204	49	108	112	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14521	10.1371/journal.pone.0014521	http://dx.doi.org/10.1371/journal.pone.0014521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264208	gold, Green Published, Green Submitted			2022-12-25	WOS:000286517600005
J	He, HQ; Liu, ZR; Dong, BQ; Zhang, JW; Shu, XQ; Zhou, JJ; Ji, YH				He, Huiqiong; Liu, Zhirui; Dong, Bangqian; Zhang, Jianwei; Shu, Xueqin; Zhou, Jingjing; Ji, Yonghua			Localization of Receptor Site on Insect Sodium Channel for Depressant beta-toxin BmK IT2	PLOS ONE			English	Article							BUTHUS-MARTENSI KARSCH; GATED NA+ CHANNELS; SCORPION TOXIN; MOLECULAR-CLONING; SELECTIVE TOXINS; VOLTAGE SENSOR; NERVOUS-SYSTEM; MESSENGER-RNAS; ALPHA-SUBUNIT; ION CHANNELS	Background: BmK IT2 is regarded as a receptor site-4 modulator of sodium channels with depressant insect toxicity. It also displays anti-nociceptive and anti-convulsant activities in rat models. In this study, the potency and efficacy of BmK IT2 were for the first time assessed and compared among four sodium channel isoforms expressed in Xenopus oocytes. Combined with molecular approach, the receptor site of BmK IT2 was further localized. Principal Findings: 2 mu M BmK IT2 strongly shifted the activation of DmNa(v)1, the sodium channel from Drosophila, to more hyperpolarized potentials; whereas it hardly affected the gating properties of rNa(v)1.2, rNa(v)1.3 and mNa(v)1.6, three mammalian central neuronal sodium channel subtypes. (1) Mutations of Glu(896), Leu(899), Gly(904) in extracellular loop Domain II S3-S4 of DmNa(v)1 abolished the functional action of BmK IT2. (2) BmK IT2-preference for DmNav1 could be conferred by Domain III. Analysis of subsequent DmNa(v)1 mutants highlighted the residues in Domain III pore loop, esp. Ile(1529) was critical for recognition and binding of BmK IT2. Conclusions/Significance: In this study, BmK IT2 displayed total insect-selectivity. Two binding regions, comprising domains II and III of DmNa(v)1, play separated but indispensable roles in the interaction with BmK IT2. The insensitivity of Na(v)1.2, Na(v)1.3 and Na(v)1.6 to BmK IT2 suggests other isoforms or mechanism might be involved in the suppressive activity of BmK IT2 in rat pathological models.	[He, Huiqiong; Liu, Zhirui; Dong, Bangqian; Zhang, Jianwei; Shu, Xueqin; Zhou, Jingjing; Ji, Yonghua] Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China; [He, Huiqiong] Chinese Acad Sci, Shanghai Inst Physiol, Shanghai Inst Biol Sci, Grad Sch, Shanghai 200031, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, HQ (corresponding author), Shanghai Univ, Lab Neuropharmacol & Neurotoxicol, Shanghai, Peoples R China.	yhji@staff.shu.edu.cn	Ji, Yonghua/B-7769-2014		National Basic Research Program of China [2006CB500801, 2010CB529806]; Key discipline 'Molecular Physiology' of the Shanghai Education Committee	National Basic Research Program of China(National Basic Research Program of China); Key discipline 'Molecular Physiology' of the Shanghai Education Committee	This study was supported by National Basic Research Program of China (2006CB500801 and 2010CB529806) and Key discipline 'Molecular Physiology' of the Shanghai Education Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Borchani L, 1996, EUR J BIOCHEM, V241, P525, DOI 10.1111/j.1432-1033.1996.00525.x; Borges A, 2004, TOXICON, V43, P671, DOI 10.1016/j.toxicon.2004.02.022; Bosmans F, 2005, TOXICON, V45, P501, DOI 10.1016/j.toxicon.2004.12.010; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Cestele S, 1997, EUR J BIOCHEM, V243, P93, DOI 10.1111/j.1432-1033.1997.93_1a.x; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chai ZF, 2006, PHARMACOL RES, V54, P85, DOI 10.1016/j.phrs.2006.02.009; Cohen L, 2007, MOL PHARMACOL, V72, P1220, DOI 10.1124/mol.107.039057; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; De Lima ME, 2007, COMP BIOCHEM PHYS C, V146, P264, DOI 10.1016/j.cbpc.2006.10.010; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; GORDON D, 1992, BIOCHEMISTRY-US, V31, P7622, DOI 10.1021/bi00148a025; Gordon D, 2003, EUR J BIOCHEM, V270, P2663, DOI 10.1046/j.1432-1033.2003.03643.x; JI YH, 1994, CHINESE SCI BULL, V39, P945; JI YH, 1994, SCI CHINA SER B, V37, P955; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Li YJ, 2000, NEUROSCI RES, V38, P257, DOI 10.1016/S0168-0102(00)00164-4; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MOSKOWITZ H, 1994, INSECT BIOCHEM MOLEC, V24, P13, DOI 10.1016/0965-1748(94)90118-X; Peng F, 2002, EUR J BIOCHEM, V269, P4468, DOI 10.1046/j.1432-1033.2002.03136.x; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; Tan ZY, 2001, NEUROPHARMACOLOGY, V40, P352, DOI 10.1016/S0028-3908(00)00168-4; Tian CH, 2008, TOXICON, V51, P555, DOI 10.1016/j.toxicon.2007.11.010; Zhao R, 2008, BRIT J PHARMACOL, V154, P1116, DOI 10.1038/bjp.2008.156	33	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14510	10.1371/journal.pone.0014510	http://dx.doi.org/10.1371/journal.pone.0014510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264295	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500002
J	Weigand, MR; Tran, VN; Sundin, GW				Weigand, Michael R.; Tran, Vinh N.; Sundin, George W.			Growth Parameter Components of Adaptive Specificity during Experimental Evolution of the UVR-Inducible Mutator Pseudomonas cichorii 302959	PLOS ONE			English	Article							MUTAGENIC DNA-REPAIR; ESCHERICHIA-COLI; BACTERIAL EVOLUTION; ADAPTATION; FITNESS; POPULATIONS; RADIATION; SELECTION; OPERON; MUTABILITY	Background: Mutagenic DNA repair (MDR) transiently increases mutation rate through the activation of low-fidelity repair polymerases in response to specific, DNA-damaging environmental stress conditions such as ultraviolet radiation (UVR) exposure. These repair polymerases also confer UVR tolerance, intimately linking mutability and survival in bacteria that colone habitats subject to regular UVR exposure. Methodology/Principal Findings: Here, we investigate adaptive specificity in experimental lineages of the highly UVR-mutable epiphytic plant pathogen Pseudomonas cichorii 302959. Relative fitness measurements of isolates and population samples from replicate lineages indicated that adaptive improvements emerged early in all lineages of our evolution experiment and specific increases in relative fitness correlated with distinct improvements in doubling and lag times. Adaptive improvements gained under UVR and non-UVR conditions were acquired preferentially, and differentially contributed to relative fitness under varied growth conditions. Conclusions: These results support our earlier observations that MDR activation may contribute to gains in relative fitness without impeding normal patterns of adaptive specificity in P. cichorii 302959.	[Weigand, Michael R.; Sundin, George W.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Tran, Vinh N.; Sundin, George W.] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Sundin, George W.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Sundin, George W.] Michigan State Univ, Ctr Pathogenesis, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Weigand, MR (corresponding author), Michigan State Univ, Genet Program, E Lansing, MI 48824 USA.	sundin@msu.edu		Weigand, Michael/0000-0002-7278-0160	Michigan Agricultural Experiment Station	Michigan Agricultural Experiment Station	This work was funded by the Michigan Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BROCK BIOL MICROORGA; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Courcelle J, 2001, GENETICS, V158, P41; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; de Visser JAGM, 2002, MICROBIOL-SGM, V148, P1247, DOI 10.1099/00221287-148-5-1247; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Kim JJ, 2000, J BACTERIOL, V182, P6137, DOI 10.1128/JB.182.21.6137-6144.2000; KING EO, 1954, J LAB CLIN MED, V44, P310; Lenski RE, 1998, ANTON LEEUW INT J G, V73, P35, DOI 10.1023/A:1000675521611; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; Loh E, 2010, P NATL ACAD SCI USA, V107, P1154, DOI 10.1073/pnas.0912451107; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Sambrook J., 2002, MOL CLONING LAB MANU; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Sleight SC, 2007, PHYSIOL BIOCHEM ZOOL, V80, P370, DOI 10.1086/518013; Sundin GW, 2007, FEMS MICROBIOL LETT, V277, P11, DOI 10.1111/j.1574-6968.2007.00901.x; Sundin GW, 1999, ENVIRON MICROBIOL, V1, P75, DOI 10.1046/j.1462-2920.1999.00008.x; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Travisano M, 1996, GENETICS, V143, P15; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Weigand MR, 2009, GENETICS, V181, P199, DOI 10.1534/genetics.108.096131; Zhang S, 2004, CAN J MICROBIOL, V50, P29, DOI [10.1139/w03-105, 10.1139/W03-105]	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15975	10.1371/journal.pone.0015975	http://dx.doi.org/10.1371/journal.pone.0015975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264242	Green Submitted, Green Published, gold			2022-12-25	WOS:000286516500020
J	Gardner, KE; Zhou, L; Parra, MA; Chen, XA; Strahl, BD				Gardner, Kathryn E.; Zhou, Li; Parra, Michael A.; Chen, Xian; Strahl, Brian D.			Identification of Lysine 37 of Histone H2B as a Novel Site of Methylation	PLOS ONE			English	Article							DOWN MASS-SPECTROMETRY; PROTEIN-ARGININE METHYLTRANSFERASE; ELECTRON-CAPTURE DISSOCIATION; SET DOMAIN METHYLTRANSFERASE; NUCLEOSOME CORE PARTICLE; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TOP-DOWN; IN-VIVO; POSTTRANSLATIONAL MODIFICATIONS	Recent technological advancements have allowed for highly-sophisticated mass spectrometry-based studies of the histone code, which predicts that combinations of post-translational modifications (PTMs) on histone proteins result in defined biological outcomes mediated by effector proteins that recognize such marks. While significant progress has been made in the identification and characterization of histone PTMs, a full appreciation of the complexity of the histone code will require a complete understanding of all the modifications that putatively contribute to it. Here, using the top-down mass spectrometry approach for identifying PTMs on full-length histones, we report that lysine 37 of histone H2B is dimethylated in the budding yeast Saccharomyces cerevisiae. By generating a modification-specific antibody and yeast strains that harbor mutations in the putative site of methylation, we provide evidence that this mark exist in vivo. Importantly, we show that this lysine residue is highly conserved through evolution, and provide evidence that this methylation event also occurs in higher eukaryotes. By identifying a novel site of histone methylation, this study adds to our overall understanding of the complex number of histone modifications that contribute to chromatin function.	[Gardner, Kathryn E.; Zhou, Li; Parra, Michael A.; Chen, Xian; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gardner, KE (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259	National Institute of Diabetes, Digestive and Kidney Diseases [5 R21 DK082706-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082706] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes, Digestive and Kidney Diseases grant 5 R21 DK082706-02 (B. D. S. and X. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Borchers CH, 2006, P NATL ACAD SCI USA, V103, P3094, DOI 10.1073/pnas.0511289103; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cocklin RR, 2003, J PROTEIN CHEM, V22, P327, DOI 10.1023/A:1025334006014; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; DAI J, 2010, GENETICS; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DELANGE RJ, 1969, J BIOL CHEM, V244, P319; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Freitas MA, 2004, J CELL BIOCHEM, V92, P691, DOI 10.1002/jcb.20106; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; HAN J, 2010, PROTEOMICS; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; HONG L, 1993, J BIOL CHEM, V268, P305; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kalhor HR, 2005, BIOCHEM BIOPH RES CO, V334, P433, DOI 10.1016/j.bbrc.2005.06.111; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kyriss MNM, 2010, MOL CELL BIOL, V30, P3503, DOI 10.1128/MCB.00290-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2004, J AM CHEM SOC, V126, P3386, DOI 10.1021/ja039748i; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Siuti N, 2006, J PROTEOME RES, V5, P233, DOI 10.1021/pr050268v; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ueberheide BM, 2007, INT J MASS SPECTROM, V259, P46, DOI 10.1016/j.ijms.2006.09.001; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	107	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16244	10.1371/journal.pone.0016244	http://dx.doi.org/10.1371/journal.pone.0016244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249157	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000036
J	Hasson, CJ; Miller, RH; Caldwell, GE				Hasson, Christopher J.; Miller, Ross H.; Caldwell, Graham E.			Contractile and Elastic Ankle Joint Muscular Properties in Young and Older Adults	PLOS ONE			English	Article							POWER-VELOCITY CHARACTERISTICS; LENGTH-TENSION RELATIONSHIP; MUSCLE STRENGTH; MECHANICAL-PROPERTIES; TORQUE-VELOCITY; ELDERLY-MEN; GASTROCNEMIUS-MUSCLE; PLANTAR-FLEXION; KNEE EXTENSORS; TENDON	The purpose of this study was to investigate age-related differences in contractile and elastic properties of both dorsi-(DF) and plantarflexor (PF) muscles controlling the ankle joint in young and older adults. Experimental data were collected while twelve young and twelve older male and female participants performed maximal effort isometric and isovelocity contractions on a dynamometer. Equations were fit to the data to give torque-angle (T theta) and torque-angular velocity (T omega) relations. Muscle series-elasticity was measured during ramped dynamometer contractions using ultrasonography to measure aponeurosis extension as a function of torque; second order polynomials were used to characterize the torque-extension (T Delta L) relation. The results showed no age differences in DF maximal torque and none for female PF; however, older males had smaller maximal PF torques compared to young males. In both muscle groups and genders, older adults had decreased concentric force capabilities. Both DF and PF T Delta L relations were more nonlinear in the older adults. Older PF, but not DF muscles, were stiffer compared to young. A simple antagonism model suggested age-related differences in T theta and T omega relations would be magnified if antagonistic torque contributions were included. This assessment of static, dynamic, and elastic joint properties affords a comprehensive view of age-related modifications in muscle function. Although many clinical studies use maximal isometric strength as a marker of functional ability, the results demonstrate that there are also significant age-related modifications in ankle muscle dynamic and elastic properties.	[Hasson, Christopher J.; Miller, Ross H.; Caldwell, Graham E.] Univ Massachusetts Amherst, Dept Kinesiol, Biomech Lab, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Amherst	Hasson, CJ (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	cjhasson@neu.edu	Miller, Ross/K-9344-2015; Miller, Ross/I-7329-2012	Miller, Ross/0000-0002-2924-7993; Hasson, Christopher/0000-0002-9851-0919	National Institutes of Health [R03AG026281]; NATIONAL INSTITUTE ON AGING [R03AG026281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by National Institutes of Health Grant R03AG026281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2000, SCAND J MED SCI SPOR, V10, P58, DOI 10.1034/j.1600-0838.2000.010002058.x; Abbasi AA, 1998, AM J MED SCI, V315, P188, DOI 10.1097/00000441-199803000-00008; Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Bazzucchi I, 2006, MUSCLE NERVE, V33, P191, DOI 10.1002/mus.20462; Behm D G, 1996, Can J Appl Physiol, V21, P403; BELANGER AY, 1983, EUR J APPL PHYSIOL O, V51, P381, DOI 10.1007/BF00429075; Billot M, 2010, MUSCLE NERVE, V41, P511, DOI 10.1002/mus.21530; BLANPIED P, 1993, J GERONTOL, V48, pM58, DOI 10.1093/geronj/48.2.M58; BOBBERT MF, 1990, J BIOMECH, V23, P105, DOI 10.1016/0021-9290(90)90345-4; Bojsen-Moller J, 2004, J APPL PHYSIOL, V97, P1908, DOI 10.1152/japplphysiol.00084.2004; CALDWELL GE, 1993, CAN J APPL PHYSIOL, V18, P274, DOI 10.1139/h93-024; CALDWELL GE, 1995, J APPL BIOMECH, V11, P1; Carmeli E, 2000, GERONTOLOGY, V46, P249, DOI 10.1159/000022168; CHAPMAN AE, 1985, J APPL PHYSIOL, V59, P78, DOI 10.1152/jappl.1985.59.1.78; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Delgado-Lezama R, 1997, J NEUROSCI METH, V78, P125, DOI 10.1016/S0165-0270(97)00143-X; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Epstein M, 2006, J BIOMECH, V39, P2020, DOI 10.1016/j.jbiomech.2005.06.011; ETTEMA GJC, 1989, J BIOMECH, V22, P1209, DOI 10.1016/0021-9290(89)90223-6; Ferri A, 2003, ACTA PHYSIOL SCAND, V177, P69, DOI 10.1046/j.1365-201X.2003.01050.x; FITZHUGH R, 1977, J MATH BIOL, V4, P203, DOI 10.1007/BF00280973; Fukunaga T, 1996, J APPL PHYSIOL, V81, P1430, DOI 10.1152/jappl.1996.81.3.1430; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; HARRIES UJ, 1990, EUR J APPL PHYSIOL, V60, P187, DOI 10.1007/BF00839157; HERZOG W, 1988, J BIOMECH, V21, P5, DOI 10.1016/0021-9290(88)90185-6; Hill A.V, 1970, 1 LAST EXPT MUSCLE M; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HORTOBAGYI T, 1995, J GERONTOL A-BIOL, V50, pB399, DOI 10.1093/gerona/50A.6.B399; Hubley-Kozey C, 2000, EUR J APPL PHYSIOL, V82, P289, DOI 10.1007/s004210000208; HYATT RH, 1990, AGE AGEING, V19, P330, DOI 10.1093/ageing/19.5.330; ITO M, 1998, J APPL PHYSIOL, V80, P1235; JAKOBSSON F, 1988, MUSCLE NERVE, V11, P1211, DOI 10.1002/mus.880111205; JOHNS RJ, 1962, J APPL PHYSIOL, V17, P824, DOI 10.1152/jappl.1962.17.5.824; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; Karamanidis K, 2006, J BIOMECH, V39, P406, DOI 10.1016/j.jbiomech.2004.12.017; Kawakami Y, 2002, EUR J APPL PHYSIOL, V87, P381, DOI 10.1007/s00421-002-0657-6; Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22, DOI 10.1152/jappl.1999.87.1.22; Klass M, 2005, J APPL PHYSIOL, V99, P31, DOI 10.1152/japplphysiol.01426.2004; Lanza IR, 2003, J APPL PHYSIOL, V95, P2361, DOI 10.1152/japplphysiol.00724.2002; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86, DOI 10.1152/ajpcell.1991.261.1.C86; Loram ID, 2004, J PHYSIOL-LONDON, V556, P683, DOI 10.1113/jphysiol.2004.062398; Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x; Maganaris CN, 1998, EXP PHYSIOL, V83, P843, DOI 10.1113/expphysiol.1998.sp004164; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; Magnusson SP, 2003, ACTA PHYSIOL SCAND, V177, P185, DOI 10.1046/j.1365-201X.2003.01048.x; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; MARSH E, 1981, J APPL PHYSIOL, V51, P160, DOI 10.1152/jappl.1981.51.1.160; Muramatsu T, 2001, J APPL PHYSIOL, V90, P1671, DOI 10.1152/jappl.2001.90.5.1671; OBERG B, 1987, MED SCI SPORT EXER, V19, P318; Ochala J, 2005, EUR J APPL PHYSIOL, V94, P126, DOI 10.1007/s00421-004-1299-7; Ochala J, 2004, EXP GERONTOL, V39, P349, DOI 10.1016/j.exger.2003.11.004; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Porter M M, 1995, Can J Appl Physiol, V20, P429; Porter MM, 1997, J GERONTOL A-BIOL, V52, pB125, DOI 10.1093/gerona/52A.2.B125; POULIN MJ, 1992, CAN J SPORT SCI, V17, P3; Roy A, 2009, IEEE T ROBOT, V25, P569, DOI 10.1109/TRO.2009.2019783; SALE D, 1982, J APPL PHYSIOL, V52, P1636, DOI 10.1152/jappl.1982.52.6.1636; SCOTT SH, 1995, J MORPHOL, V224, P73, DOI 10.1002/jmor.1052240109; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; SIEGLER S, 1984, J BIOMECH, V17, P647, DOI 10.1016/0021-9290(84)90118-0; Simoneau E, 2005, J GERONTOL A-BIOL, V60, P439, DOI 10.1093/gerona/60.4.439; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; Simoneau EM, 2009, J ELECTROMYOGR KINES, V19, pE123, DOI 10.1016/j.jelekin.2007.11.006; TAYLOR NAS, 1991, EUR J APPL PHYSIOL O, V62, P116, DOI 10.1007/BF00626766; TAYLOR NAS, 1991, EUR J APPL PHYSIOL O, V62, P180, DOI 10.1007/BF00643739; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; Thom JM, 2007, EUR J APPL PHYSIOL, V100, P613, DOI 10.1007/s00421-007-0481-0; van Donkelaar CC, 1999, J BIOMECH, V32, P755, DOI 10.1016/S0021-9290(99)00073-1; VANDERVOORT AA, 1990, J GERONTOL, V45, pB125, DOI 10.1093/geronj/45.4.B125; VANDERVOORT AA, 1986, J APPL PHYSIOL, V61, P361, DOI 10.1152/jappl.1986.61.1.361; VANSCHAIK CS, 1994, J GERONTOL, V49, pB121, DOI 10.1093/geronj/49.3.B121; Winegard KJ, 1997, J GERONTOL A-BIOL, V52, pB337, DOI 10.1093/gerona/52A.6.B337; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211	81	21	21	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15953	10.1371/journal.pone.0015953	http://dx.doi.org/10.1371/journal.pone.0015953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264315	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000012
J	Stamatakis, EA; Shafto, MA; Williams, G; Tam, P; Tyler, LK				Stamatakis, Emmanuel A.; Shafto, Meredith A.; Williams, Guy; Tam, Phyllis; Tyler, Lorraine K.			White Matter Changes and Word Finding Failures with Increasing Age	PLOS ONE			English	Article							OF-THE-TONGUE; DIFFUSION-TENSOR; OLDER-ADULTS; LANGUAGE PATHWAYS; MICROSTRUCTURE; ASYMMETRY; BRAIN; YOUNG; TIP; RETRIEVAL	Background: Increasing life expectancy necessitates the better understanding of the neurophysiological underpinnings of age-related cognitive changes. The majority of research examining structural-cognitive relationships in aging focuses on the role of age-related changes to grey matter integrity. In the current study, we examined the relationship between age-related changes in white matter and language production. More specifically, we concentrated on word-finding failures, which increase with age. Methodology/Principal Findings: We used Diffusion tensor MRI (a technique used to image, in vivo, the diffusion of water molecules in brain tissue) to relate white matter integrity to measures of successful and unsuccessful picture naming. Diffusion tensor images were used to calculate Fractional Anisotropy (FA) images. FA is considered to be a measure of white matter organization/integrity. FA images were related to measures of successful picture naming and to word finding failures using voxel-based linear regression analyses. Successful naming rates correlated positively with white matter integrity across a broad range of regions implicated in language production. However, word finding failure rates correlated negatively with a more restricted region in the posterior aspect of superior longitudinal fasciculus. Conclusions/Significance: The use of DTI-MRI provides evidence for the relationship between age-related white matter changes in specific language regions and word finding failures in old age.	[Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England; [Stamatakis, Emmanuel A.; Shafto, Meredith A.; Tam, Phyllis; Tyler, Lorraine K.] Univ Cambridge, Dept Expt Psychol, Ctr Speech Language & Brain, Cambridge CB2 3EB, England; [Williams, Guy] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 3EB, England; [Williams, Guy] Univ Cambridge, Dept Neurosurg, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Stamatakis, EA (corresponding author), Univ Cambridge, Sch Clin Med, Div Anaesthesia, Cambridge, England.	eas46@cam.ac.uk		Williams, Guy/0000-0001-5223-6654; Tyler, Lorraine/0000-0002-9943-118X; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Medical Research Council (MRC); Dunhill Medical Trust; Queens' College, Cambridge; Medical Research Council [G19/27, G0500842] Funding Source: researchfish; MRC [G0500842, G19/27] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); Queens' College, Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a Medical Research Council (MRC) programme grant and a Dunhill Medical Trust grant to LKT. EAS is funded by the Stephen Erskine Fellowship, Queens' College, Cambridge. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2004, CURR DIR PSYCHOL SCI, V13, P21, DOI 10.1111/j.0963-7214.2004.01301006.x; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cross ES, 2004, BRAIN LANG, V89, P174, DOI 10.1016/S0093-934X(03)00363-8; DAMASIO AR, 1992, NEW ENGL J MED, V326, P531, DOI 10.1056/NEJM199202203260806; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRIFFITHS JD, 2009, NEUROIMAGE, V47, P289; Hardin R.H., 1994, MINIMAL ENERGY ARRAN; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kaplan E, 1983, BOSTON DIAGNOSTIC AP; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marslen-Wilson WD, 2007, PHILOS T R SOC B, V362, P823, DOI 10.1098/rstb.2007.2091; MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Nelson HE., 1982, NATL ADULT READING T; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; RAZ N, 2005, COGNITIVE NEUROSCIEN; Resnick SM, 2003, J NEUROSCI, V23, P3295; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Shafto MA, 2010, J COGNITIVE NEUROSCI, V22, P1530, DOI 10.1162/jocn.2009.21321; Shipley, 1946, I LIVING SCALE; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Takao H, 2010, MAGN RESON IMAGING, V28, P65, DOI 10.1016/j.mri.2009.05.020; Wechsler D, 1987, MANUAL WESCHLER MEMO; Wernicke C., 1874, APHASISCHE SYMPTOMEN	57	43	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e14496	10.1371/journal.pone.0014496	http://dx.doi.org/10.1371/journal.pone.0014496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249127	Green Published, Green Submitted, gold			2022-12-25	WOS:000286512900002
J	Chen, G; Rogers, AK; League, GP; Nam, SC				Chen, Geng; Rogers, Alicia K.; League, Garrett P.; Nam, Sang-Chul			Genetic Interaction of Centrosomin and Bazooka in Apical Domain Regulation in Drosophila Photoreceptor	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; RETINITIS-PIGMENTOSA; CRUMBS; CELLS; EYE; MORPHOGENESIS; POLARITY; LOCALIZATION; HOMOLOG	Background: Cell polarity genes including Crumbs (Crb) and Par complexes are essential for controlling photoreceptor morphogenesis. Among the Crb and Par complexes, Bazooka (Baz, Par-3 homolog) acts as a nodal component for other cell polarity proteins. Therefore, finding other genes interacting with Baz will help us to understand the cell polarity genes' role in photoreceptor morphogenesis. Methodology/Principal Findings: Here, we have found a genetic interaction between baz and centrosomin (cnn). Cnn is a core protein for centrosome which is a major microtubule-organizing center. We analyzed the effect of the cnn mutation on developing eyes to determine its role in photoreceptor morphogenesis. We found that Cnn is dispensable for retinal differentiation in eye imaginal discs during the larval stage. However, photoreceptors deficient in Cnn display dramatic morphogenesis defects including the mislocalization of Crumbs (Crb) and Bazooka (Baz) during mid-stage pupal eye development, suggesting that Cnn is specifically required for photoreceptor morphogenesis during pupal eye development. This role of Cnn in apical domain modulation was further supported by Cnn's gain-of-function phenotype. Cnn overexpression in photoreceptors caused the expansion of the apical Crb membrane domain, Baz and adherens junctions (AJs). Conclusions/Significance: These results strongly suggest that the interaction of Baz and Cnn is essential for apical domain and AJ modulation during photoreceptor morphogenesis, but not for the initial photoreceptor differentiation in the Drosophila photoreceptor.	[Chen, Geng; Rogers, Alicia K.; League, Garrett P.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X; Rogers, Alicia/0000-0001-5525-6095	Knights Templar Eye Foundation; University Research Committee of Baylor University	Knights Templar Eye Foundation; University Research Committee of Baylor University	This study was supported by grants from the Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef/), and University Research Committee of Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Brodu V, 2010, DEV CELL, V18, P790, DOI [10.1016/j.devcel.2010.03.015, 10.1016/j.devce1.2010.03.015]; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009480; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Eisman RC, 2009, GENETICS, V182, P979, DOI 10.1534/genetics.109.103887; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Guerin CM, 2009, DEVELOPMENT, V136, P1411, DOI 10.1242/dev.031823; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kumar JP, 1995, DEVELOPMENT, V121, P4359; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Malikov V, 2004, MOL BIOL CELL, V15, P2742, DOI 10.1091/mbc.E03-10-0770; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Moutinho-Pereira S, 2009, MOL BIOL CELL, V20, P2796, DOI 10.1091/mbc.E09-01-0011; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Newsome TP, 2000, DEVELOPMENT, V127, P851; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; STUURMAN N, 1995, J CELL SCI, V108, P3137; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; XU T, 1993, DEVELOPMENT, V117, P1223	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16127	10.1371/journal.pone.0016127	http://dx.doi.org/10.1371/journal.pone.0016127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253601	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511900040
J	Dehmer, M; Mowshowitz, A; Emmert-Streib, F				Dehmer, Matthias; Mowshowitz, Abbe; Emmert-Streib, Frank			Connections between Classical and Parametric Network Entropies	PLOS ONE			English	Article							INFORMATION-THEORY; COMPLEX NETWORKS; GRAPHS; INEQUALITIES	This paper explores relationships between classical and parametric measures of graph (or network) complexity. Classical measures are based on vertex decompositions induced by equivalence relations. Parametric measures, on the other hand, are constructed by using information functions to assign probabilities to the vertices. The inequalities established in this paper relating classical and parametric measures lay a foundation for systematic classification of entropy-based measures of graph complexity.	[Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria; [Mowshowitz, Abbe] CUNY, Dept Comp Sci, New York, NY 10021 USA; [Emmert-Streib, Frank] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	City University of New York (CUNY) System; Queens University Belfast	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at	Emmert-Streib, Frank/AAF-2878-2020; Emmert-Streib, Frank/G-8099-2011	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	U.S. Army Research Laboratory [W911NF-06-3-0001]; U.K Ministry of Defense [W911NF-06-3-0001]; Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.K Ministry of Defense; Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Research was sponsored by the U.S. Army Research Laboratory and the U.K Ministry of Defense and was accomplished under Agreement Number W911NF-06-3-0001. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S Army Research Laboratory, the U.S. Government, the U.K. Ministry of Defense or the U.K Government. The U.S. and U.K. Governments are authorized to reproduce and distribute for Government purposes notwithstanding any copyright notation hereon. Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P22029-N13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045102; [Anonymous], T 6 PRAG C INF THEOR; BALABAN AT, 1995, J CHEM INF COMP SCI, V35, P339, DOI 10.1021/ci00025a001; BERTZ SH, 1981, J AM CHEM SOC, V103, P5932, DOI 10.1021/ja00409a063; Bonchev D, 2005; BONCHEV D, 1995, THEOCHEM-J MOL STRUC, V336, P137, DOI 10.1016/0166-1280(94)04081-3; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; BONCHEV D, 1979, COMMUN MATH COMP CHE, V7, P65; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; DEHMER M, 2010, INFORM SCI; Dehmer M, 2010, APPL MATH COMPUT, V215, P4263, DOI 10.1016/j.amc.2009.12.051; Dehmer M, 2008, CYBERNET SYST, V39, P825, DOI 10.1080/01969720802435925; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Emmert-Streib F, 2007, APPL MATH COMPUT, V190, P1783, DOI 10.1016/j.amc.2007.02.095; Emmert-Streib F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-35; EmmertStreib F, 2008, ANALYSIS OF MICROARRAY DATA: A NETWORK-BASED APPROACH, P1; EMMERTSTREIB F, 2010, IET SYSTEMS IN PRESS; Foulds L.R, 1992, GRAPH THEORY APPL; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Krawitz P, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036115; Lyons R, 2010, COMB PROBAB COMPUT, V19, P303, DOI 10.1017/S0963548309990605; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mazurie A, 2008, BIOINFORMATICS, V24, P2579, DOI 10.1093/bioinformatics/btn503; Mehler A, 2010, ENTROPY-SWITZ, V12, P1440, DOI 10.3390/e12061440; Mehler Alexander, 2011, INFORM THEORY COMPLE; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Nikolic S, 2000, J CHEM INF COMP SCI, V40, P920, DOI 10.1021/ci9901183; PATIL A, 2007, IEEE T VEH TECHNOL, V58, P3178; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Sanchirico A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046114; Shannon C., 1964, MATH THEORY COMMUNIC; SIMONYI G, 1995, DIMACS SERIES DISCRE, V20, P399; SKOROBOGATOV VA, 1988, COMMUN MATH COMP CHE, V23, P105; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Temkin O. N, 1996, CHEM REACTION NETWOR; TRINAJSTIC N, 1992, CHEM GRAPH THEORY, pCH10; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; Tutzauer F, 2007, SOC NETWORKS, V29, P249, DOI 10.1016/j.socnet.2006.10.001; Ulanowicz RE, 2001, COMPUT CHEM, V25, P393, DOI 10.1016/S0097-8485(01)00073-0; Wilhelm T, 2007, PHYSICA A, V385, P385, DOI 10.1016/j.physa.2007.06.029; Zhang Z, 1998, IEEE T INFORM THEORY, V44, P1440, DOI 10.1109/18.681320	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15733	10.1371/journal.pone.0015733	http://dx.doi.org/10.1371/journal.pone.0015733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246046	gold, Green Published			2022-12-25	WOS:000286511200013
J	Dallas, ML; Boyle, JP; Milligan, CJ; Sayer, R; Kerrigan, TL; McKinstry, C; Lu, PY; Mankouri, J; Harris, M; Scragg, JL; Pearson, HA; Peers, C				Dallas, Mark L.; Boyle, John P.; Milligan, Carol J.; Sayer, Rachael; Kerrigan, Talitha L.; McKinstry, Connor; Lu, Peiyuan; Mankouri, Jamel; Harris, Mark; Scragg, Jason L.; Pearson, Hugh A.; Peers, Chris			Carbon monoxide protects against oxidant-induced apoptosis via inhibition of K(v)2.1	FASEB JOURNAL			English	Article						potassium channel; hippocampal neuron; heme oxygenase	NEURONAL APOPTOSIS; OXIDATIVE STRESS; HEME OXYGENASE-1; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; POTASSIUM CHANNEL; NITRIC-OXIDE; K+ CHANNEL; KV2.1; BRAIN	Oxidative stress induces neuronal apoptosis and is implicated in cerebral ischemia, head trauma, and age-related neurodegenerative diseases. An early step in this process is the loss of intracellular K+ via K+ channels, and evidence indicates that K(v)2.1 is of particular importance in this regard, being rapidly inserted into the plasma membrane in response to apoptotic stimuli. An additional feature of neuronal oxidative stress is the up-regulation of the inducible enzyme heme oxygenase-1 (HO-1), which catabolizes heme to generate biliverdin, Fe2+, and carbon monoxide (CO). CO provides neuronal protection against stresses such as stroke and excitotoxicity, although the underlying mechanisms are not yet elucidated. Here, we demonstrate that CO reversibly inhibits K(v)2.1. Channel inhibition by CO involves reactive oxygen species and protein kinase G activity. Overexpression of K(v)2.1 in HEK293 cells increases their vulnerability to oxidant-induced apoptosis, and this is reversed by CO. In hippocampal neurons, CO selectively inhibits K(v)2.1, reverses the dramatic oxidant-induced increase in K+ current density, and provides marked protection against oxidant-induced apoptosis. Our results provide a novel mechanism to account for the neuroprotective effects of CO against oxidative apoptosis, which has potential for therapeutic exploitation to provide neuronal protection in situations of oxidative stress.-Dallas, M. L., Boyle, J. P., Milligan, C. J., Sayer, R., Kerrigan, T. L., McKinstry, C., Lu, P., Mankouri, J., Harris, M., Scragg, J. L., Pearson, H. A., Peers, C. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of K(v)2.1. FASEB J. 25, 1519-1530 (2011). www.fasebj.org	[Dallas, Mark L.; Boyle, John P.; McKinstry, Connor; Scragg, Jason L.; Peers, Chris] Univ Leeds, Fac Med & Hlth, Div Cardiovasc & Neuronal Remodelling, Leeds LS2 9JT, W Yorkshire, England; [Milligan, Carol J.; Sayer, Rachael; Kerrigan, Talitha L.; Mankouri, Jamel; Harris, Mark; Pearson, Hugh A.] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Lu, Peiyuan] Hebei Gen Hosp, Dept Neurol, Shijiazhuang, Hebei, Peoples R China	University of Leeds; University of Leeds	Peers, C (corresponding author), Univ Leeds, Fac Med & Hlth, Div Cardiovasc & Neuronal Remodelling, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Boyle, John/N-4868-2016; Dallas, Mark L/A-6654-2013; Kerrigan, Talitha/C-3759-2016; Dallas, Mark/Q-6117-2019	Dallas, Mark/0000-0002-5190-0522; Kerrigan, Talitha/0000-0003-2158-567X; Peers, Chris/0000-0002-8354-346X; Harris, Mark/0000-0002-9821-1003; Mankouri, Jamel/0000-0002-4325-3687	Medical Research Council; Wellcome Trust; British Heart Foundation; Department of International Cooperation, Hebei Province Science and Technology Research Council, China [09396427D]; MRC [G0600936] Funding Source: UKRI; British Heart Foundation [PG/09/013/26885] Funding Source: researchfish; Medical Research Council [G0600936] Funding Source: researchfish; Alzheimer&quot;s Society [121] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Department of International Cooperation, Hebei Province Science and Technology Research Council, China; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Alzheimer&quot;s Society	This work was supported by the Medical Research Council, Wellcome Trust, and British Heart Foundation, and the Department of International Cooperation, Hebei Province Science and Technology Research Council, China (09396427D). The authors are most grateful to Dr. James S. Trimmer (University of California, Davis, CA, USA) for the K<INF>v</INF>2.1-expressing HEK293 cell line and to R. Suman for technical assistance.	Ahmad AS, 2006, NEUROSCIENCE, V141, P1703, DOI 10.1016/j.neuroscience.2006.05.035; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chien WL, 2003, MOL PHARMACOL, V63, P1322, DOI 10.1124/mol.63.6.1322; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; Dallas ML, 2008, NEUROREPORT, V19, P345, DOI 10.1097/WNR.0b013e3282f51045; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Hou ST, 2002, INT REV CYTOL, V221, P93; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Michelakis ED, 2002, CIRC RES, V91, P478, DOI 10.1161/01.RES.0000035057.63303.D1; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Pappolla MA, 1998, AM J PATHOL, V152, P871; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008; Toyoda H, 2010, J NEUROSCI, V30, P5677, DOI 10.1523/JNEUROSCI.5407-09.2010; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	49	72	74	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1519	1530		10.1096/fj.10-173450	http://dx.doi.org/10.1096/fj.10-173450			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21248240				2022-12-25	WOS:000290023800010
J	Soond, SM; Chantry, A				Soond, S. M.; Chantry, A.			Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGF beta signalling and EMT	ONCOGENE			English	Article						TGF beta; Smads; transcription; Ubiquitin ligase	E3; AUTOINHIBITION; APOPTOSIS; PATHWAY; FAMILY; SMURF2; BINDS	Ubiquitin-dependent mechanisms have emerged as essential regulatory elements controlling cellular levels of Smads and TGF beta-dependent biological outputs such as epithelial-mesenchymal transition (EMT). In this study, we identify a HECT E3 ubiquitin ligase known as WWP2 (Full-length WWP2-FL), together with two WWP2 isoforms (N-terminal, WWP2-N; C-terminal WWP2-C), as novel Smad-binding partners. We show that WWP2-FL interacts exclusively with Smad2, Smad3 and Smad7 in the TGF beta pathway. Interestingly, the WWP2-N isoform interacts with Smad2 and Smad3, whereas WWP2-C interacts only with Smad7. In addition, WWP2-FL and WWP2-C have a preference for Smad7 based on protein turnover and ubiquitination studies. Unexpectedly, we also find that WWP2-N, which lacks the HECT ubiquitin ligase domain, can also interact with WWP2-FL in a TGF beta-regulated manner and activate endogenous WWP2 ubiquitin ligase activity causing degradation of unstimulated Smad2 and Smad3. Consistent with our protein interaction data, overexpression and knockdown approaches reveal that WWP2 isoforms differentially modulate TGF beta-dependent transcription and EMT. Finally, we show that selective disruption of WWP2 interactions with inhibitory Smad7 can stabilise Smad7 protein levels and prevent TGF beta-induced EMT. Collectively, our data suggest that WWP2-N can stimulate WWP2-FL leading to increased activity against unstimulated Smad2 and Smad3, and that Smad7 is a preferred substrate for WWP2-FL and WWP2-C following prolonged TGF beta stimulation. Significantly, this is the first report of an interdependent biological role for distinct HECT E3 ubiquitin ligase isoforms, and highlights an entirely novel regulatory paradigm that selectively limits the level of inhibitory and activating Smads. Oncogene (2011) 30, 2451-2462; doi:10.1038/onc.2010.617; published online 24 January 2011	[Soond, S. M.; Chantry, A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Chantry, A (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.chantry@uea.ac.uk			Association for International Research (AICR); BigC Charity; British Skin Foundation; Dunhill Medical Trust; The Dunhill Medical Trust [R162/0510] Funding Source: researchfish	Association for International Research (AICR); BigC Charity; British Skin Foundation; Dunhill Medical Trust(Dunhill Medical Trust); The Dunhill Medical Trust(Dunhill Medical Trust)	We thank Fiona McDonald, Caroline Hill, and Hans Clevers for generously providing cells/plasmids, and Ian Clark and Tracey Swingler for generously providing ATDC5 cDNA samples. This work was supported by the Association for International Research (AICR), with additional funding provided by the BigC Charity, the British Skin Foundation and the Dunhill Medical Trust.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Ellenrieder V, 2001, CANCER RES, V61, P4222; Flasza M, 2002, BIOCHEM BIOPH RES CO, V290, P431, DOI 10.1006/bbrc.2001.6206; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V294, pF1157, DOI 10.1152/ajprenal.00339.2007; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	34	55	58	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	21					2451	2462		10.1038/onc.2010.617	http://dx.doi.org/10.1038/onc.2010.617			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21258410	Green Accepted			2022-12-25	WOS:000291008000007
J	Shiou, SR; Yu, YY; Chen, SZ; Ciancio, MJ; Petrof, EO; Sun, J; Claud, EC				Shiou, Sheng-Ru; Yu, Yueyue; Chen, Sangzi; Ciancio, Mae J.; Petrof, Elaine O.; Sun, Jun; Claud, Erika C.			Erythropoietin Protects Intestinal Epithelial Barrier Function and Lowers the Incidence of Experimental Neonatal Necrotizing Enterocolitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; GROWTH-FACTOR-BETA; INTERFERON-GAMMA; TIGHT JUNCTION; HUMAN-MILK; IN-VITRO; INTRAEPITHELIAL LYMPHOCYTES; FLUID ABSORPTION	The impermeant nature of the intestinal barrier is maintained by tight junctions (TJs) formed between adjacent intestinal epithelial cells. Disruption of TJs and loss of barrier function are associated with a number of gastrointestinal diseases, including neonatal necrotizing enterocolitis (NEC), the leading cause of death from gastrointestinal diseases in preterm infants. Human milk is protective against NEC, and the human milk factor erythropoietin (Epo) has been shown to protect endothelial cell-cell and blood-brain barriers. We hypothesized that Epo may also protect intestinal epithelial barriers, thereby lowering the incidence of NEC. Our data demonstrate that Epo protects enterocyte barrier function by supporting expression of the TJ protein ZO-1. As immaturity is a key factor in NEC, Epo regulation of ZO-1 in the human fetal immature H4 intestinal epithelial cell line was examined and demonstrated Epo-stimulated ZO-1 expression in a dose-dependent manner through the PI3K/Akt pathway. In a rat NEC model, oral administration of Epo lowered the incidence of NEC from 45 to 23% with statistical significance. In addition, Epo treatment protected intestinal barrier function and prevented loss of ZO-1 at the TJs in vivo. These effects were associated with elevated Akt phosphorylation in the intestine. This study reveals a novel role of Epo in the regulation of intestinal epithelial TJs and barrier function and suggests the possible use of enteral Epo as a therapeutic agent for gut diseases.	[Shiou, Sheng-Ru; Yu, Yueyue; Chen, Sangzi; Claud, Erika C.] Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA; [Claud, Erika C.] Univ Chicago, Gastroenterol Sect, Dept Med, Chicago, IL 60637 USA; [Ciancio, Mae J.] Midwestern Univ, Chicago, IL 60515 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Kingston, ON K7L 3M6, Canada; [Sun, Jun] Univ Rochester, Dept Med, Rochester, NY 14627 USA	University of Chicago; University of Chicago; Midwestern University; Queens University - Canada; University of Rochester	Claud, EC (corresponding author), Univ Chicago, Dept Pediat, Sect Neonatol, 5841 S Maryland Ave,MC6060, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institutes of Health from NICHD [R21 AT004044, HD055237, R01 HD059123]; Children Research Foundation [HD062144-01A1]; National Institutes of Health [DK42086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059123, F32HD062144] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health from NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AT004044 (to E. C. C. and E. O. P.) and HD055237 and R01 HD059123 (to E. C. C.) from NICHD. This work was also supported by Children Research Foundation Grant and Kirschstein-NRSA Fellowship Award HD062144-01A1 (to S.-R. S.).; We thank Drs. Jerrold Turner and Le Shen from the Department of Pathology for project suggestions and technical support on intestinal ZO-1 staining, Dr. Amy Noffsinger from the Department of Pathology for scoring of the NEC experiment tissues, and Dr. Christine Labno from the Integrated Microscopy Core Facility for confocal microscopy. The Digestive Disease Research Core Center of the University of Chicago (supported by National Institutes of Health Grant DK42086) provided core facilities and services used for this study.	Akisu M, 2001, EUR J PEDIATR SURG, V11, P167, DOI 10.1055/s-2001-15485; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Anderson JM, 1993, CURR OPIN CELL BIOL, V5, P772, DOI 10.1016/0955-0674(93)90024-K; Bose C, 2008, AM J PHYSIOL-CELL PH, V295, pC394, DOI 10.1152/ajpcell.00423.2007; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Ferrier L, 2003, GASTROENTEROLOGY, V125, P795, DOI 10.1016/S0016-5085(03)01057-6; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; FOULKES EC, 1991, P SOC EXP BIOL MED, V197, P477; Halpern MD, 2006, GASTROENTEROLOGY, V130, P359, DOI 10.1053/j.gastro.2005.10.023; HOLMAN RC, 1989, AM J PUBLIC HEALTH, V79, P987, DOI 10.2105/AJPH.79.8.987; Homma H, 2005, AM J PHYSIOL-GASTR L, V288, pG466, DOI 10.1152/ajpgi.00036.2004; ISRAEL EJ, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13238.x; Juul SE, 1999, PEDIATR RES, V46, P263, DOI 10.1203/00006450-199909000-00003; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kling PJ, 1998, PEDIATR RES, V43, P216, DOI 10.1203/00006450-199802000-00010; KOSLOSKE A, 1994, ACTA PAEDIATR, V83, P2, DOI 10.1111/j.1651-2227.1994.tb13232.x; Kumar SM, 2006, MELANOMA RES, V16, P275, DOI 10.1097/01.cmr.0000222594.60611.c3; Kumral A, 2003, BIOL NEONATE, V84, P325, DOI 10.1159/000073642; KURSCHEID T, 1993, EUR J PEDIATR SURG, V3, P139, DOI 10.1055/s-2008-1063530; Ledbetter DJ, 2000, J PEDIATR SURG, V35, P178, DOI 10.1016/S0022-3468(00)90006-X; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee SM, 2004, BIOCHEM BIOPH RES CO, V320, P1087, DOI 10.1016/j.bbrc.2004.06.060; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liu RQ, 2006, J NEUROCHEM, V96, P1101, DOI 10.1111/j.1471-4159.2005.03597.x; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Madonna R, 2009, EXP CELL RES, V315, P2921, DOI 10.1016/j.yexcr.2009.07.016; Martinez-Estrada OM, 2003, EUR J NEUROSCI, V18, P2538, DOI 10.1046/j.1460-9568.2003.02987.x; Naftalin RJ, 1999, J PHYSIOL-LONDON, V514, P211, DOI 10.1111/j.1469-7793.1999.211af.x; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Piena-Spoel M, 2001, J PEDIATR SURG, V36, P587, DOI 10.1053/jpsu.2001.22288; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Semba Richard D, 2002, J Hum Lact, V18, P252, DOI 10.1177/08934402018003007; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Szakal DN, 2010, VIRCHOWS ARCH, V456, P245, DOI 10.1007/s00428-009-0879-7; Thiagarajah JR, 2000, GUT, V47, P675, DOI 10.1136/gut.47.5.675; Thuijls Geertje, 2010, J Clin Gastroenterol, V44, pe14, DOI 10.1097/MCG.0b013e31819f5652; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Tsukita S, 2000, ANN NY ACAD SCI, V915, P129, DOI 10.1111/j.1749-6632.2000.tb05235.x; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516; Yang H, 2002, ANN SURG, V236, P226, DOI 10.1097/00000658-200208000-00011; Yoo JY, 2009, J NEUROSCI RES, V87, P150, DOI 10.1002/jnr.21832; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zufferey C, 2009, IMMUNOLOGY, V128, P351, DOI 10.1111/j.1365-2567.2009.03110.x	50	79	87	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.154625	http://dx.doi.org/10.1074/jbc.M110.154625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21262973	Green Published, hybrid			2022-12-25	WOS:000289077500027
J	Speckmann, B; Bidmon, HJ; Pinto, A; Anlauf, M; Sies, H; Steinbrenner, H				Speckmann, Bodo; Bidmon, Hans-Juergen; Pinto, Antonio; Anlauf, Martin; Sies, Helmut; Steinbrenner, Holger			Induction of Glutathione Peroxidase 4 Expression during Enterocytic Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER; SELENOPROTEIN-P; MESSENGER-RNA; SELENIUM SUPPLEMENTATION; OXIDATIVE STRESS; CACO-2 CELLS; NF-Y; HYDROPEROXIDE; COLON; MICE	Glutathione peroxidase 4 (GPx4), an abundant selenoenzyme, is ubiquitously expressed in a tissue-, cell-and differentiation-dependent manner, and it is localized in cytoplasmic, mitochondrial, and nuclear cellular compartments. Here, we report cytoplasmic and nuclear localization of GPx4 in Caco-2 intestinal epithelial cells. Enterocytic differentiation of Caco-2 cells triggers an increase in GPx4 mRNA and protein levels, mediated by enhanced promoter activity. We identified a combined cAMP response element (CREB) and CCAAT/enhancer binding protein (C/EBP) site as critical for the differentiation-triggered GPx4 promoter activity. Induction of GPx4 correlated with C/EBP alpha transcript levels during differentiation, suggesting a role of C/EBP alpha as regulator of enterocytic GPx4 expression. Consistent with the in vitro results, GPx4 protein was detected in cytoplasmic and nuclear compartments of enterocytes in human intestinal epithelia. GPx4 is uniformly expressed in colonic crypts and is differentially expressed along the crypt-to-villu saxis in the small intestine with a more pronounced expression of GPx4 in the upper villi, which contain fully differentiated enterocytes. These data suggest that intestinal GPx4 expression is modulated by the enterocytic differentiation program, and the results support a direct role of nuclear GPx4 in the (selenium-dependent) prevention of oxidative damage in the gastrointestinal tract.	[Steinbrenner, Holger] Univ Dusseldorf, Inst Biochem & Mol Biol 1, Fac Med, D-40225 Dusseldorf, Germany; [Bidmon, Hans-Juergen] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany; [Anlauf, Martin] Univ Dusseldorf, Inst Pathol, D-40225 Dusseldorf, Germany; [Sies, Helmut] Univ Dusseldorf, Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; [Sies, Helmut] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; King Saud University	Steinbrenner, H (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 1, Fac Med, Univ Str 1,Geb 22-03, D-40225 Dusseldorf, Germany.	Holger.Steinbrenner@uni-duesseldorf.de	Steinbrenner, Holger/AAD-6323-2019; Sies, Helmut/B-7266-2008; Sies, Helmut/ABE-7355-2020	Sies, Helmut/0000-0002-1000-3198; Steinbrenner, Holger/0000-0003-2754-2435	Deutsche Forschungsgemeinschaft [STE 1782/2-1, SFB 575/B4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants STE 1782/2-1 and SFB 575/B4.	Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Baek IJ, 2007, J MOL HISTOL, V38, P237, DOI 10.1007/s10735-007-9092-7; Bao YP, 1997, FEBS LETT, V410, P210, DOI 10.1016/S0014-5793(97)00591-7; Bartsch H, 2002, BIOL CHEM, V383, P915, DOI 10.1515/BC.2002.098; Bermano G, 2007, GENES NUTR, V2, P225, DOI 10.1007/s12263-007-0052-3; Bestwick CS, 2000, BBA-GEN SUBJECTS, V1474, P47, DOI 10.1016/S0304-4165(99)00212-3; BLAIS S, 1995, DEV DYNAM, V204, P66, DOI 10.1002/aja.1002040109; Boucher MJ, 2005, J CELL PHYSIOL, V202, P178, DOI 10.1002/jcp.20104; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; CHANDRASEKARAN C, 1993, P NATL ACAD SCI USA, V90, P8871, DOI 10.1073/pnas.90.19.8871; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Conrad M, 2007, BIOL CHEM, V388, P1019, DOI 10.1515/BC.2007.130; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; Engle MJ, 1998, J CELL PHYSIOL, V174, P362, DOI 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B; Esworthy RS, 1998, BBA-GEN SUBJECTS, V1381, P213, DOI 10.1016/S0304-4165(98)00032-4; Florian S, 2010, FREE RADICAL BIO MED, V49, P1694, DOI 10.1016/j.freeradbiomed.2010.08.029; Hattori H, 2007, BIOCHEM J, V408, P277, DOI 10.1042/BJ20070245; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Huang HS, 1999, FEBS LETT, V455, P111, DOI 10.1016/S0014-5793(99)00866-2; Huin C, 2002, BIOL CELL, V94, P15, DOI 10.1016/S0248-4900(01)01178-9; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Jacobs ET, 2004, J NATL CANCER I, V96, P1669, DOI 10.1093/jnci/djh310; Kelner MJ, 1998, BIOCHEM BIOPH RES CO, V249, P53, DOI 10.1006/bbrc.1998.9086; Mariadason JM, 2002, CANCER RES, V62, P4791; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Murawaki Y, 2008, CANCER LETT, V259, P218, DOI 10.1016/j.canlet.2007.10.019; Nemoto E, 2009, BONE, V44, P805, DOI 10.1016/j.bone.2008.12.029; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Piana C, 2008, EUR J PHARM BIOPHARM, V69, P1187, DOI 10.1016/j.ejpb.2008.03.008; PINTO M, 1983, BIOL CELL, V47, P323; Ran QT, 2003, FREE RADICAL BIO MED, V35, P1101, DOI 10.1016/S0891-5849(03)00466-0; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Reid ME, 2006, INT J CANCER, V118, P1777, DOI 10.1002/ijc.21529; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Speckmann B, 2010, FREE RADICAL BIO MED, V49, P777, DOI 10.1016/j.freeradbiomed.2010.05.035; Steinbrenner H, 2006, FREE RADICAL RES, V40, P936, DOI 10.1080/10715760600806248; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Suaud L, 1997, BIOCHEM BIOPH RES CO, V235, P820, DOI 10.1006/bbrc.1997.6888; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tham DM, 1998, AM J PHYSIOL-GASTR L, V275, pG1463, DOI 10.1152/ajpgi.1998.275.6.G1463; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Wingler K, 1999, EUR J BIOCHEM, V259, P149, DOI 10.1046/j.1432-1327.1999.00012.x; Yoo MH, 2010, ANTIOXID REDOX SIGN, V12, P819, DOI 10.1089/ars.2009.2891; Zhong ZD, 2000, J BIOL CHEM, V275, P18602, DOI 10.1074/jbc.M001389200	46	41	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10764	10772		10.1074/jbc.M110.216028	http://dx.doi.org/10.1074/jbc.M110.216028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252226	Green Published, hybrid			2022-12-25	WOS:000288547000090
J	Xie, R; Nguyen, S; McKeehan, K; Wang, F; McKeehan, WL; Liu, LY				Xie, Rui; Nguyen, Susan; McKeehan, Kerstin; Wang, Fen; McKeehan, Wallace L.; Liu, Leyuan			Microtubule-associated Protein 1S (MAP1S) Bridges Autophagic Components with Microtubules and Mitochondria to Affect Autophagosomal Biogenesis and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR RASSF1; DEATH INDUCER C19ORF5; CELL-DEATH; BINDING PROTEIN; APOPTOSIS; FUSION; PARKIN; LYSOSOMES; ISOFORM; COMPLEX	The ubiquitously distributed MAP1S is a homologue of the exclusively neuronal distributed microtubule-associated protein 1A and 1B (MAP1A/B). They give rise to multiple isoforms through similar post-translational modification. Isoforms of MAP1S have been implicated in microtubule dynamics and mitotic abnormalities and mitotic cell death. Here we show that ablation of the Map1s gene in mice caused reduction in the B-cell CLL/lymphoma 2 or xL (Bcl-2/xL) and cyclin-dependent kinase inhibitor 1B (P27) protein levels, accumulation of defective mitochondria, and severe defects in response to nutritive stress, suggesting defects in autophagosomal biogenesis and clearance. Furthermore, MAP1S isoforms interacted with the autophagosome-associated light chain 3 of MAP1A/B (LC3), a homologue of yeast autophagy-related gene 8 (ATG8), and recruited it to stable microtubules in a MAP1S and LC3 isoform-dependent mode. In addition, MAP1S interacted with mitochondrion-associated leucine-rich PPR-motif containing protein (LRPPRC) that interacts with the mitophagy initiator and Parkinson disease-related protein Parkin. The three-way interactions of MAP1S isoforms with LC3 and microtubules as well as the interaction of MAP1S with LRPPRC suggest that MAP1S isoforms may play positive roles in integration of autophagic components with microtubules and mitochondria in both autophagosomal biogenesis and degradation. For the first time, our results clarify roles of MAP1S in bridging microtubules and mitochondria with autophagic and mitophagic initiation, maturation, trafficking, and lysosomal clearance. Defects in the MAP1S-regulated autophagy may impact heart disease, cancers, neurodegenerative diseases, and a wide range of other diseases.	[Xie, Rui; Nguyen, Susan; McKeehan, Kerstin; Wang, Fen; McKeehan, Wallace L.; Liu, Leyuan] TX A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA		Liu, LY (corresponding author), TX A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	lliu@ibt.tamhsc.edu	XIE, RUI/N-7325-2014		National Institutes of Health [1R01CA142862, NCI P50 CA140388, CA16672]; Department of Defense [W81XWH]; Susan Komen Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA140388, R01CA142862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA142862 (NCI; to L. L.) and NCI P50 CA140388 (NCI; to W. L. M.). This work was also supported by Department of Defense New Investigator Award W81XWH (to L. L.), the Susan Komen Foundation (to W. L. M.), and aid from the John S. Dunn Research Foundation (to W. L. M.).; We thank Drs. Le Sun and Joe Corvera (A&G Pharmaceuticals, Inc., Columbia, MD) for anti-MAP1S mouse monoclonal antibody 4G1, which is now sold by Precision Antibody (TM) with catalog number AG10006. LC3 cDNA and GFP-LC3 transgenic mice were gifts from Dr. Noboru Mizushima, the Department of Physiology and Cell Biology, Tokyo Medical and Dental University Graduate School and Faculty of Medicine. Transmission electron microscopy was performed by the High Resolution Electron Microscopy Facility in the University of Texas MD Anderson Cancer Center supported by National Institutes of Health Cancer Center Core Grant CA16672.	Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; Ding JQ, 2006, BIOCHEM BIOPH RES CO, V339, P172, DOI 10.1016/j.bbrc.2005.10.199; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; MANN SS, 1994, J BIOL CHEM, V269, P11492; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200	48	80	82	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10367	10377		10.1074/jbc.M110.206532	http://dx.doi.org/10.1074/jbc.M110.206532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262964	Green Published, hybrid			2022-12-25	WOS:000288547000053
J	Barneaud-Rocca, D; Borgese, F; Guizouarn, H				Barneaud-Rocca, Damien; Borgese, Franck; Guizouarn, Helene			Dual Transport Properties of Anion Exchanger 1 THE SAME TRANSMEMBRANE SEGMENT IS INVOLVED IN ANION EXCHANGE AND IN A CATION LEAK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; CELL-VOLUME REGULATION; SCANNING MUTAGENESIS; CHLORIDE CHANNEL; MEMBRANE DOMAIN; POINT MUTATIONS; BAND-3 PROTEIN; IONIC-STRENGTH; HUMAN AE1; ERYTHROCYTE	Previous results suggested that specific point mutations in human anion exchanger 1 (AE1) convert the electroneutral anion exchanger into a monovalent cation conductance. In the present study, the transport site for anion exchange and for the cation leak has been studied by cysteine scanning mutagenesis and sulfhydryl reagent chemistry. Moreover, the role of some highly conserved amino acids within members of the SLC4 family to which AE1 belongs has been assessed in AE1 transport properties. The results suggest that the same transport site within the AE1 spanning domain is involved in anion exchange or in cation transport. A functioning mechanism for this transport site is proposed according to transport properties of the different studied point mutations of AE1.	[Barneaud-Rocca, Damien; Borgese, Franck; Guizouarn, Helene] Univ Nice, IBDC, Ctr Natl Rech Sci, UMR6543, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Guizouarn, H (corresponding author), Univ Nice, IBDC, Ctr Natl Rech Sci, UMR6543, Batiment Sci Nat,28 Av Valrose, F-06108 Nice 2, France.	guizouar@unice.fr		BORGESE, Franck/0000-0001-7718-2111; Guizouarn, Helene/0000-0002-8757-6672				BAMBERG E, 1992, PROGR CELL RES; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Delaunay J, 2004, SEMIN HEMATOL, V41, P165, DOI 10.1053/j.seminhematol.2004.02.005; Ellory JC, 2009, PHILOS T R SOC B, V364, P189, DOI 10.1098/rstb.2008.0154; FIEVET B, 1995, EMBO J, V14, P5158, DOI 10.1002/j.1460-2075.1995.tb00200.x; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Groves JD, 1999, BIOCHEM J, V344, P699, DOI 10.1042/0264-6021:3440699; Guizouarn H, 1999, AM J PHYSIOL-CELL PH, V276, pC210, DOI 10.1152/ajpcell.1999.276.1.C210; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; KNAUF P, 1992, BAND 3 PROTEINS ANIO, P35; Larsson HP, 1996, BIOPHYS J, V70, P733, DOI 10.1016/S0006-3495(96)79613-3; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Martial S, 2006, J CELL PHYSIOL, V207, P829, DOI 10.1002/jcp.20631; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MOTAIS R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P169, DOI 10.1016/0304-4165(91)90248-F; Ryan RM, 2005, CLIN EXP PHARMACOL P, V32, P1, DOI 10.1111/j.1440-1681.2005.04164.x; Stewart GW, 2004, CURR OPIN HEMATOL, V11, P244, DOI 10.1097/01.moh.0000132240.20671.33; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Vandenberg RJ, 2008, CHANNELS, V2, P51, DOI 10.4161/chan.2.1.6047; Walsh S, 2008, AM J PHYSIOL-RENAL, V295, pF343, DOI 10.1152/ajprenal.00587.2007; Walsh S, 2009, BIOCHEM BIOPH RES CO, V382, P668, DOI 10.1016/j.bbrc.2009.03.062; Wrong O, 2002, KIDNEY INT, V62, P10, DOI 10.1046/j.1523-1755.2002.00417.x; Yamaguchi T, 2010, J STRUCT BIOL, V169, P406, DOI 10.1016/j.jsb.2009.12.009; Yenchitsomanus Pa-Thai, 2005, J Mol Genet Med, V1, P49; Yool AJ, 2002, NEWS PHYSIOL SCI, V17, P68, DOI 10.1152/nips.01372.2001; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8909	8916		10.1074/jbc.M110.166819	http://dx.doi.org/10.1074/jbc.M110.166819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21257764	Green Published, hybrid			2022-12-25	WOS:000288247700022
J	Kostallas, G; Lofdahl, PA; Samuelson, P				Kostallas, George; Lofdahl, Per-Ake; Samuelson, Patrik			Substrate Profiling of Tobacco Etch Virus Protease Using a Novel Fluorescence-Assisted Whole-Cell Assay	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRINUCLEOTIDE PHOSPHORAMIDITES; GENETIC-ANALYSIS; DEGRADATION; SPECIFICITY; EXPRESSION; PURIFICATION; PHAGE; IMMOBILIZATION; POLYPEPTIDES	Site-specific proteolysis of proteins plays an important role in many cellular functions and is often key to the virulence of infectious organisms. Efficient methods for characterization of proteases and their substrates will therefore help us understand these fundamental processes and thereby hopefully point towards new therapeutic strategies. Here, a novel whole-cell in vivo method was used to investigate the substrate preference of the sequence specific tobacco etch virus protease (TEVp). The assay, which utilizes protease-mediated intracellular rescue of genetically encoded short-lived fluorescent substrate reporters to enhance the fluorescence of the entire cell, allowed subtle differences in the processing efficiency of closely related substrate peptides to be detected. Quantitative screening of large combinatorial substrate libraries, through flow cytometry analysis and cell sorting, enabled identification of optimal substrates for TEVp. The peptide, ENLYFQG, identical to the protease's natural substrate peptide, emerged as a strong consensus cleavage sequence, and position P3 (tyrosine, Y) and P1 (glutamine, Q) within the substrate peptide were confirmed as being the most important specificity determinants. In position P19, glycine (G), serine (S), cysteine (C), alanine (A) and arginine (R) were among the most prevalent residues observed, all known to generate functional TEVp substrates and largely in line with other published studies stating that there is a strong preference for short aliphatic residues in this position. Interestingly, given the complex hydrogen-bonding network that the P6 glutamate (E) is engaged in within the substrate-enzyme complex, an unexpectedly relaxed residue preference was revealed for this position, which has not been reported earlier. Thus, in the light of our results, we believe that our assay, besides enabling protease substrate profiling, also may serve as a highly competitive platform for directed evolution of proteases and their substrates.	[Kostallas, George; Lofdahl, Per-Ake; Samuelson, Patrik] Royal Inst Technol KTH, Sch Biotechnol, Dept Mol Biotechnol, Stockholm, Sweden	Royal Institute of Technology	Kostallas, G (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Dept Mol Biotechnol, Stockholm, Sweden.	patrik@biotech.kth.se			Swedish Research Council [621-2004-4647]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grant 621-2004-4647 from the Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Bandmann N, 2000, J BIOTECHNOL, V79, P161, DOI 10.1016/S0168-1656(00)00224-8; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Boulware KT, 2010, BIOTECHNOL BIOENG, V106, P339, DOI 10.1002/bit.22693; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dautin N, 2000, J BACTERIOL, V182, P7060, DOI 10.1128/JB.182.24.7060-7066.2000; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Deperthes D, 2002, BIOL CHEM, V383, P1107, DOI 10.1515/BC.2002.119; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Doucet A, 2008, MOL ASPECTS MED, V29, P339, DOI 10.1016/j.mam.2008.04.003; DOUGHERTY WG, 1989, VIROLOGY, V172, P302, DOI 10.1016/0042-6822(89)90132-3; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hersch GL, 2004, P NATL ACAD SCI USA, V101, P12136, DOI 10.1073/pnas.0404733101; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kapust RB, 2002, PROTEIN EXPRES PURIF, V24, P61, DOI 10.1006/prep.2001.1545; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kayushin AL, 1996, NUCLEIC ACIDS RES, V24, P3748, DOI 10.1093/nar/24.19.3748; Larsson M, 2000, J BIOTECHNOL, V80, P143, DOI 10.1016/S0168-1656(00)00258-3; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Marnett AB, 2005, TRENDS BIOTECHNOL, V23, P59, DOI 10.1016/j.tibtech.2004.12.010; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; OHANA RF, 2009, PROTEIN EXPR PURIF; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Puhl AC, 2009, BIOTECHNOL APPL BIOC, V53, P165, DOI 10.1042/BA20080063; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; RUTHER U, 1982, NUCLEIC ACIDS RES, V10, P5765, DOI 10.1093/nar/10.19.5765; Scholle MD, 2006, CHEMBIOCHEM, V7, P834, DOI 10.1002/cbic.200500427; Sellamuthu S, 2008, BIOCHEM BIOPH RES CO, V371, P122, DOI 10.1016/j.bbrc.2008.04.026; Steen J, 2006, PROTEIN EXPRES PURIF, V46, P173, DOI 10.1016/j.pep.2005.12.010; STEERE AN, PROTEIN EXPR PURIF, V72, P32; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967	49	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16136	10.1371/journal.pone.0016136	http://dx.doi.org/10.1371/journal.pone.0016136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267463	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500041
J	Pitter, KL; Galban, CJ; Galban, S; Saeed-Tehrani, O; Li, F; Charles, N; Bradbury, MS; Becher, OJ; Chenevert, TL; Rehemtulla, A; Ross, BD; Holland, EC; Hambardzumyan, D				Pitter, Kenneth L.; Galban, Craig J.; Galban, Stefanie; Saeed-Tehrani, Omid; Li, Fei; Charles, Nikki; Bradbury, Michelle S.; Becher, Oren J.; Chenevert, Thomas L.; Rehemtulla, Alnawaz; Ross, Brian D.; Holland, Eric C.; Hambardzumyan, Dolores			Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; PHASE-II TRIAL; MALIGNANT GLIOMA; BRAIN-TUMORS; ALKYLPHOSPHOLIPID PERIFOSINE; IMAGING BIOMARKER; MAMMALIAN TARGET; LEUKEMIA-CELLS; EARLY RESPONSE; MTOR	Background: Platelet derived growth factor receptor (PDGFR) activity is deregulated in human GBM due to amplification and rearrangement of the PDGFR-alpha gene locus or overexpression of the PDGF ligand, resulting in the activation of downstream kinases such as phosphatidylinositol 3-kinase (PI3K), Akt, and mammalian target of rapamycin (mTOR). Aberrant PDGFR signaling is observed in approximately 25-30% of human GBMs, which are frequently molecularly classified as the proneural subclass. It would be valuable to understand how PDGFR driven GBMs respond to Akt and mTOR inhibition. Methodology/Principal Findings: Using genetically engineered PTEN-intact and PTEN-deficient PDGF-driven mouse models of GBM that closely mimic the histology and genetics of the human PDGF subgroup, we investigated the effect of inhibiting Akt and mTOR alone or in combination in vitro and in vivo. We used perifosine and CCI-779 to inhibit Akt and mTOR, respectively. Here, we show in vitro data demonstrating that the most effective inhibition of Akt and mTOR activity in both PTEN-intact and PTEN-null primary glioma cell cultures is obtained when using both inhibitors in combination. We next investigated if the effects we observed in culture could be duplicated in vivo by treating mice with gliomas for 5 days. The in vivo treatments with the combination of CCI-779 and perifosine resulted in decreased Akt and mTOR signaling, which correlated to decreased proliferation and increased cell death independent of PTEN status, as monitored by immunoblot analysis, histology and MRI. Conclusions/Significance: These findings underline the importance of simultaneously targeting Akt and mTOR to achieve significant down-regulation of the PI3K pathway and support the rationale for testing the perifosine and CCI-779 combination in the human PDGF-subgroup of GBM.	[Pitter, Kenneth L.; Charles, Nikki; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Pitter, Kenneth L.; Charles, Nikki; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Galban, Craig J.; Saeed-Tehrani, Omid; Li, Fei; Chenevert, Thomas L.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI USA; [Bradbury, Michelle S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Becher, Oren J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol & Surg, New York, NY 10021 USA; [Hambardzumyan, Dolores] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Duke University; Duke University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cleveland Clinic Foundation	Pitter, KL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	bdross@umich.edu; hollande@mskcc.org; hambard@ccf.org	Becher, Oren/AAI-7495-2020	Chenevert, Thomas/0000-0003-1476-4274; Becher, Oren/0000-0003-4016-8492; Pitter, Kenneth/0000-0002-9450-313X; Tehrani, Omid/0000-0001-6493-6391	National Institutes of Health (NIH) [U54 CA126518, U01 CA141502-01, P01CA85878, P50CA93990, MSTP GM07739]; Brain Tumor Center; NATIONAL CANCER INSTITUTE [U01CA141502, U54CA126518, P01CA085878, R01CA100688, P50CA093990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Tumor Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants U54 CA126518, U01 CA141502-01, P01CA85878, P50CA93990, MSTP GM07739 (KLP) and by the Brain Tumor Center (http://www.mskcc.org/mskcc/html/289.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Breslin EM, 2005, BRIT J PHARMACOL, V144, P791, DOI 10.1038/sj.bjp.0706061; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Chee KG, 2007, CLIN GENITOURIN CANC, V5, P433, DOI 10.3816/CGC.2007.n.031; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; de la Pena L, 2006, MOL CANCER THER, V5, P1504, DOI 10.1158/1535-7163.MCT-06-0091; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Ernst DS, 2005, INVEST NEW DRUG, V23, P569, DOI 10.1007/s10637-005-1157-4; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fumarola C, 2005, CELL DEATH DIFFER, V12, P1344, DOI 10.1038/sj.cdd.4401660; Galanis E, 2005, J CLIN ONCOL, V23, p115S; Geoerger B, 2001, CANCER RES, V61, P1527; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gonzalez J, 2008, EXPERT REV ANTICANC, V8, P1767, DOI 10.1586/14737140.8.11.1767; HAMBARDZUMYAN D, 2008, STEM CELL REV; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Marsh RD, 2007, AM J CLIN ONCOL-CANC, V30, P26, DOI 10.1097/01.coc.0000251235.46149.43; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; Momota H, 2005, CANCER RES, V65, P7429, DOI 10.1158/0008-5472.CAN-05-1042; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Rasband W., 2006, IMAGEJ; Ross BD, 1998, P NATL ACAD SCI USA, V95, P7012, DOI 10.1073/pnas.95.12.7012; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vink SR, 2006, CLIN CANCER RES, V12, P1615, DOI 10.1158/1078-0432.CCR-05-2033	45	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14545	10.1371/journal.pone.0014545	http://dx.doi.org/10.1371/journal.pone.0014545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267448	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500015
J	Rudramurthy, SM; de Valk, HA; Chakrabarti, A; Meis, JFGM; Klaassen, CHW				Rudramurthy, Shivaprakash M.; de Valk, Hanneke A.; Chakrabarti, Arunaloke; Meis, Jacques F. G. M.; Klaassen, Corne H. W.			High Resolution Genotyping of Clinical Aspergillus flavus Isolates from India Using Microsatellites	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; IN-VITRO; SEXUAL REPRODUCTION; TANDEM REPEATS; FUMIGATUS; SUSCEPTIBILITY; PARASITICUS; OUTBREAK; DNA; ITRACONAZOLE	Background: Worldwide, Aspergillus flavus is the second leading cause of allergic, invasive and colonizing fungal diseases in humans. However, it is the most common species causing fungal rhinosinusitis and eye infections in tropical countries. Despite the growing challenges due to A. flavus, the molecular epidemiology of this fungus has not been well studied. We evaluated the use of microsatellites for high resolution genotyping of A. flavus from India and a possible connection between clinical presentation and genotype of the involved isolate. Methodology/Principal Findings: A panel of nine microsatellite markers were selected from the genome of A. flavus NRRL 3357. These markers were used to type 162 clinical isolates of A. flavus. All nine markers proved to be polymorphic displaying up to 33 alleles per marker. Thirteen isolates proved to be a mixture of different genotypes. Among the 149 pure isolates, 124 different genotypes could be recognized. The discriminatory power (D) for the individual markers ranged from 0.657 to 0.954. The D value of the panel of nine markers combined was 0.997. The multiplex multicolor approach was instrumental in rapid typing of a large number of isolates. There was no correlation between genotype and the clinical presentation of the infection. Conclusions/Significance: There is a large genotypic diversity in clinical A. flavus isolates from India. The presence of more than one genotype in clinical samples illustrates the possibility that persons may be colonized by multiple genotypes and that any isolate from a clinical specimen is not necessarily the one actually causing infection. Microsatellites are excellent typing targets for discriminating between A. flavus isolates from various origins.	[Rudramurthy, Shivaprakash M.; Chakrabarti, Arunaloke] Post Grad Inst Med Educ & Res, Dept Med Microbiol, Mycol Div, Chandigarh, India; [de Valk, Hanneke A.; Meis, Jacques F. G. M.; Klaassen, Corne H. W.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Canisius-Wilhelmina Hospital	Rudramurthy, SM (corresponding author), Post Grad Inst Med Educ & Res, Dept Med Microbiol, Mycol Div, Chandigarh, India.	c.klaassen@cwz.nl	Meis, Jacques F/A-9241-2010; Rudramurthy, Shivaprakash/ABH-6521-2020	Meis, Jacques F/0000-0003-3253-6080; Rudramurthy, Shivaprakash/0000-0002-9097-9253	Labland Clinical Microbiology	Labland Clinical Microbiology	MS received a travel grant from Labland Clinical Microbiology. The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2009, CLIN MICROBIOL INFEC, V15, P260, DOI 10.1111/j.1469-0691.2008.02661.x; Bagyalakshmi R, 2007, J MICROBIOL METH, V68, P1, DOI 10.1016/j.mimet.2006.05.021; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Bart-Delabesse E, 1998, J CLIN MICROBIOL, V36, P2413, DOI 10.1128/JCM.36.9.2413-2418.1998; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chakrabarti A, 2008, RETINA-J RET VIT DIS, V28, P1400, DOI 10.1097/IAE.0b013e318185e943; Chazalet V, 1998, J CLIN MICROBIOL, V36, P1494, DOI 10.1128/JCM.36.6.1494-1500.1998; De Hoog G. S., 2000, ATLAS CLIN FUNGI; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; de Valk HA, 2007, J CLIN MICROBIOL, V45, P1415, DOI 10.1128/JCM.02423-06; de Valk HA, 2007, J MICROBIOL METH, V69, P268, DOI 10.1016/j.mimet.2007.01.009; de Valk HA, 2009, J CYST FIBROS, V8, P110, DOI 10.1016/j.jcf.2008.10.003; Denning DW, 1997, J ANTIMICROB CHEMOTH, V40, P401, DOI 10.1093/jac/40.3.401; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Grubisha LC, 2010, MOL ECOL, V19, P269, DOI 10.1111/j.1365-294X.2009.04467.x; Hadrich I, 2010, J CLIN MICROBIOL, V48, P2396, DOI 10.1128/JCM.01269-09; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Heinemann S, 2004, J HOSP INFECT, V57, P149, DOI 10.1016/j.jhin.2004.02.007; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Horn BW, 2009, FUNGAL GENET BIOL, V46, P169, DOI 10.1016/j.fgb.2008.11.004; Johnson EM, 2000, J ANTIMICROB CHEMOTH, V45, P85, DOI 10.1093/jac/45.1.85; Klaassen CHW, 2007, STUD MYCOL, P47, DOI 10.3114/sim.2007.59.06; Klaassen CHW, 2009, MED MYCOL, V47, pS27, DOI 10.1080/13693780802382244; Midorikawa GEO, 2008, LETT APPL MICROBIOL, V47, P12, DOI 10.1111/j.1472-765X.2008.02377.x; Montiel D, 2003, MYCOL RES, V107, P1427, DOI 10.1017/S0953756203008797; MOODY SF, 1990, APPL ENVIRON MICROB, V56, P2441, DOI 10.1128/AEM.56.8.2441-2452.1990; Morgan J, 2005, MED MYCOL, V43, pS49, DOI 10.1080/13693780400020113; Mosquera J, 2001, ANTIMICROB AGENTS CH, V45, P1456, DOI 10.1128/AAC.45.5.1456-1462.2001; Pasqualotto AC, 2008, MED MYCOL, V46, P275, DOI 10.1080/13693780701624639; Pasqualotto AC, 2009, MED MYCOL, V47, pS261, DOI 10.1080/13693780802247702; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; Varga J, 2006, MED MYCOL, V44, pS149, DOI 10.1080/13693780600823266; Verweij PE, 1996, J CLIN MICROBIOL, V34, P2595, DOI 10.1128/JCM.34.10.2595-2597.1996; Vonberg RP, 2006, J HOSP INFECT, V63, P246, DOI 10.1016/j.jhin.2006.02.014	37	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16086	10.1371/journal.pone.0016086	http://dx.doi.org/10.1371/journal.pone.0016086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264229	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600021
J	Gonsalves, SE; Moses, AM; Razak, Z; Robert, F; Westwood, JT				Gonsalves, Sarah E.; Moses, Alan M.; Razak, Zak; Robert, Francois; Westwood, J. Timothy			Whole-Genome Analysis Reveals That Active Heat Shock Factor Binding Sites Are Mostly Associated with Non-Heat Shock Genes in Drosophila melanogaster	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ECDYSONE RECEPTOR; STRESS RESPONSES; RNA-POLYMERASE; WIDE ANALYSIS; EXPRESSION; MICROARRAY; HSF1; CELLS; PATTERNS	During heat shock (HS) and other stresses, HS gene transcription in eukaryotes is up-regulated by the transcription factor heat shock factor (HSF). While the identities of the major HS genes have been known for more than 30 years, it has been suspected that HSF binds to numerous other genes and potentially regulates their transcription. In this study, we have used a chromatin immunoprecipitation and microarray (ChIP-chip) approach to identify 434 regions in the Drosophila genome that are bound by HSF. We have also performed a transcript analysis of heat shocked Kc167 cells and third instar larvae and compared them to HSF binding sites. The heat-induced transcription profiles were quite different between cells and larvae and surprisingly only about 10% of the genes associated with HSF binding sites show changed transcription. There were also genes that showed changes in transcript levels that did not appear to correlate with HSF binding sites. Analysis of the locations of the HSF binding sites revealed that 57% were contained within genes with approximately 2/3rds of these sites being in introns. We also found that the insulator protein, BEAF, has enriched binding prior to HS to promoters of genes that are bound by HSF upon HS but that are not transcriptionally induced during HS. When the genes associated with HSF binding sites in promoters were analyzed for gene ontology terms, categories such as stress response and transferase activity were enriched whereas analysis of genes having HSF binding sites in introns identified those categories plus ones related to developmental processes and reproduction. These results suggest that Drosophila HSF may be regulating many genes besides the known HS genes and that some of these genes may be regulated during non-stress conditions.	[Gonsalves, Sarah E.; Razak, Zak; Westwood, J. Timothy] Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada; [Moses, Alan M.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Moses, Alan M.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Robert, Francois] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Robert, Francois] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University of Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Gonsalves, SE (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada.	t.westwood@utoronto.ca	Robert, Francois/D-2316-2012		Natural Sciences and Engineering Research Council (NSERC) Canada [138234-06]; NSERC	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Some of the procedures were performed at the Canadian Drosophila Microarray Centre which was supported by an Natural Sciences and Engineering Research Council (NSERC) Canada (http://www.nserc-crsng.gc.ca/) multi-user facility grant. J.T.W. is supported by an NSERC Canada Discovery Grant no. 138234-06. S. E. G. is a recipient of an NSERC Postgraduate Doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2008, P NATL ACAD SCI USA, V105, P11224, DOI 10.1073/pnas.0800620105; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Cahill CM, 1996, J BIOL CHEM, V271, P24874; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Cotto JJ, 1999, BIOCHEM SOC SYMP, P105; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ECHALIER G, 1970, IN VITRO CELL DEV B, V6, P162; Emberly E, 2008, PLOS BIOL, V6, P2896, DOI 10.1371/journal.pbio.0060327; Fernandes M., 1994, BIOL HEAT SHOCK PROT, P375; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; GREENLEAF AL, 1977, CHROMOSOMA, V65, P127; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HO JSL, 2002, CRC SER EXERC PHSIOL, P13; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JAMRICH M, 1977, P NATL ACAD SCI USA, V74, P2079, DOI 10.1073/pnas.74.5.2079; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Leemans R, 2000, P NATL ACAD SCI USA, V97, P12138, DOI 10.1073/pnas.210066997; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Neal SJ, 2006, PHYSIOL GENOMICS, V25, P493, DOI 10.1152/physiolgenomics.00195.2005; Neal SJ, 2003, GENOME, V46, P879, DOI 10.1139/G03-056; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu C., 1994, BIOL HEAT SHOCK PROT, P395; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Xie Y, 2002, BIOCHEM BIOPH RES CO, V291, P1071, DOI 10.1006/bbrc.2002.6562; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	72	56	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15934	10.1371/journal.pone.0015934	http://dx.doi.org/10.1371/journal.pone.0015934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264254	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500018
J	Timmers, S; de Vogel-van den Bosch, J; Hesselink, MKC; van Beurden, D; Schaart, G; Ferraz, MJ; Losen, M; Martinez-Martinez, P; De Baets, MH; Aerts, JMFG; Schrauwen, P				Timmers, Silvie; de Vogel-van den Bosch, Johan; Hesselink, Matthijs K. C.; van Beurden, Denis; Schaart, Gert; Ferraz, Maria Joao; Losen, Mario; Martinez-Martinez, Pilar; De Baets, Marc H.; Aerts, Johannes M. F. G.; Schrauwen, Patrick			Paradoxical Increase in TAG and DAG Content Parallel the Insulin Sensitizing Effect of Unilateral DGAT1 Overexpression in Rat Skeletal Muscle	PLOS ONE			English	Article							FATTY-ACID OXIDATION; DIFFERENTIATION-RELATED PROTEIN; INTRAMYOCELLULAR LIPID-CONTENT; ADIPOSE TRIGLYCERIDE LIPASE; UNCOUPLING PROTEIN-3; CERAMIDE SYNTHESIS; GLUCOSE-TOLERANCE; RESISTANCE; EXERCISE; SENSITIVITY	Background: The involvement of muscle triacylglycerol (TAG) storage in the onset of insulin resistance is questioned and the attention has shifted towards inhibition of insulin signalling by the lipid intermediate diacylglycerol (DAG). The enzyme 1,2-acylCoA:diacylglyceroltransferase-1 (DGAT1) esterifies a fatty acyl-CoA on DAG to form TAG. Therefore, the aim of the present study was to investigate if unilateral overexpression of DGAT1 in adult rat Tibialis anterior (TA) muscle will increase conversion of the lipid intermediate DAG into TAG, thereby improving muscle insulin sensitivity. Methodology/Principal Findings: The DGAT1 gene construct was injected in the left TA muscle of male rats on chow or high-fat (45% kcal) diet for three weeks, followed by application of one 800 V/cm and four 80 V/cm pulses, using the contralateral leg as sham-electroporated control. Seven days after electroporation, muscle specific insulin sensitivity was assessed with a hyperinsulinemic euglycemic clamp using 2-deoxy-[3H] glucose. Here, we provide evidence that unilateral overexpression of DGAT1 in TA muscle of male rats is associated with an increased rather than decreased DAG content. Strikingly, this increase in DAG content was accompanied by improved muscle insulin sensitivity. Interestingly, markers of muscle lipolysis and mitochondrial function were also increased in DGAT1 overexpressing muscle. Conclusions/Significance: We conclude that unilateral DGAT1 overexpression can rescue insulin sensitivity, possibly by increasing DAG and TAG turnover in skeletal muscle. In case of a proper balance between the supply and oxidation of fatty acids in skeletal muscle, the lipid intermediate DAG may not exert harmful effects on insulin signalling.	[Timmers, Silvie; de Vogel-van den Bosch, Johan; Schrauwen, Patrick] TIFN, Wageningen, Netherlands; [Timmers, Silvie; de Vogel-van den Bosch, Johan; van Beurden, Denis; Schrauwen, Patrick] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Hesselink, Matthijs K. C.; Schaart, Gert] Maastricht Univ, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Ferraz, Maria Joao; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Losen, Mario; Martinez-Martinez, Pilar; De Baets, Marc H.] Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Timmers, S (corresponding author), TIFN, Wageningen, Netherlands.	p.schrauwen@hb.unimaas.nl	Timmers, Silvie/A-9422-2016; Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Timmers, Silvie/0000-0003-2852-5274; De Vogel-van den Bosch, Johan/0000-0001-5249-3992; Martinez Martinez, Pilar/0000-0002-5990-3373; Ferraz, Maria Joao/0000-0002-5765-9645; Losen, Mario/0000-0002-9761-0002; schrauwen, patrick/0000-0002-0973-847X	Top Institute Food and Nutrition; Netherlands Organization for Scientific Research (NWO) [918.96.618, 917.66.359]	Top Institute Food and Nutrition; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by Top Institute Food and Nutrition. TI Food and Nutrition was formerly known as WCFS. Partners are major Dutch food companies and research organizations. A VICI (grant 918.96.618) and a VIDI (grant 917.66.359) for innovative research from the Netherlands Organization for Scientific Research (NWO) supports the work of P. Schrauwen and M. Hesselink, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Amati F, 2009, OBESITY, V17, pS71; Bachmann OP, 2001, DIABETES, V50, pA331; Bergman BC, 1999, AM J PHYSIOL-ENDOC M, V276, pE106, DOI 10.1152/ajpendo.1999.276.1.E106; Boden G, 2001, DIABETES, V50, pA319; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; COEN PM, DIABETES, V59, P80; Decombaz J, 2001, AM J PHYSIOL-REG I, V281, pR760, DOI 10.1152/ajpregu.2001.281.3.R760; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox AK, 2004, J APPL PHYSIOL, V97, P11, DOI 10.1152/japplphysiol.01398.2003; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hoeks J, 2003, FEBS LETT, V555, P631, DOI 10.1016/S0014-5793(03)01343-7; Itani S, 2002, DIABETES, V51, pA300; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; MEEX RC, 2009, DIABETES; Meex RCR, 2009, AM J PHYSIOL-REG I, V297, pR913, DOI 10.1152/ajpregu.91053.2008; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; MORRISON WR, 1964, J LIPID RES, V5, P600; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Schenk S, 2005, AM J PHYSIOL-ENDOC M, V288, pE519, DOI 10.1152/ajpendo.00401.2004; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Schrauwen P, 2003, FASEB J, V17, P2272, DOI 10.1096/fj.03-0515fje; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Watt MJ, 2008, MOL ENDOCRINOL, V22, P1200, DOI 10.1210/me.2007-0485; Watt MJ, 2009, CLIN EXP PHARMACOL P, V36, P5, DOI 10.1111/j.1440-1681.2008.05075.x; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	48	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14503	10.1371/journal.pone.0014503	http://dx.doi.org/10.1371/journal.pone.0014503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264296	Green Published, gold, Green Submitted			2022-12-25	WOS:000286516500001
J	Weiss, GE; Clark, EH; Li, SP; Traore, B; Kayentao, K; Ongoiba, A; Hernandez, JN; Doumbo, OK; Pierce, SK; Branch, OH; Crompton, PD				Weiss, Greta E.; Clark, Eva H.; Li, Shanping; Traore, Boubacar; Kayentao, Kassoum; Ongoiba, Aissata; Hernandez, Jean N.; Doumbo, Ogobara K.; Pierce, Susan K.; Branch, OraLee H.; Crompton, Peter D.			A Positive Correlation between Atypical Memory B Cells and Plasmodium falciparum Transmission Intensity in Cross-Sectional Studies in Peru and Mali	PLOS ONE			English	Article							MALARIA; EXPRESSION; IMMUNITY	Background: Antibodies that protect against Plasmodium falciparum (Pf) malaria are only acquired after years of repeated infections. The B cell biology that underlies this observation is poorly understood. We previously reported that "atypical'' memory B cells are increased in children and adults exposed to intense Pf transmission in Mali, similar to what has been observed in individuals infected with HIV. In this study we examined B cell subsets of Pf-infected adults in Peru and Mali to determine if Pf transmission intensity correlates with atypical memory B cell expansion. Methodology/Principal Findings: In this cross-sectional study venous blood was collected from adults in areas of zero (U. S., n = 10), low (Peru, n = 18) and high (Mali, n = 12) Pf transmission. Adults in Peru and Mali were infected with Pf at the time of blood collection. Thawed lymphocytes were analyzed by flow cytometry to quantify B cell subsets, including atypical memory B cells, defined by the cell surface markers CD19(+) CD20(+) CD21(-) CD27(-) CD10(-). In Peru, the mean level of atypical memory B cells, as a percent of total B cells, was higher than U. S. adults (Peru mean: 5.4% [95% CI: 3.61-7.28]; U. S. mean: 1.4% [95% CI: 0.92-1.81]; p<0.0001) but lower than Malian adults (Mali mean 13.1% [95% CI: 10.68-15.57]; p = 0.0001). In Peru, individuals self-reporting >= 1 prior malaria episodes had a higher percentage of atypical memory B cells compared to those reporting no prior episodes (>= 1 prior episodes mean: 6.6% [95% CI: 4.09-9.11]; no prior episodes mean: 3.1% [95% CI: 1.52-4.73]; p = 0.028). Conclusions/Significance: Compared to Pf-naive controls, atypical memory B cells were increased in Peruvian adults exposed to low Pf transmission, and further increased in Malian adults exposed to intense Pf transmission. Understanding the origin, function and antigen specificity of atypical memory B cells in the context of Pf infection could contribute to our understanding of naturally-acquired malaria immunity.	[Weiss, Greta E.; Li, Shanping; Pierce, Susan K.; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Clark, Eva H.; Branch, OraLee H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Clark, Eva H.; Hernandez, Jean N.; Branch, OraLee H.] Univ Nacl Amazonia Peruana, LIPNAA, Iquitos, Loreto, Peru; [Traore, Boubacar; Kayentao, Kassoum; Ongoiba, Aissata; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Branch, OraLee H.] NYU, Dept Med Parasitol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Alabama System; University of Alabama Birmingham; Universidad Nacional de la Amazonia Peruana; University of Bamako; New York University	Weiss, GE (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	pcrompton@niaid.nih.gov	Crompton, Peter/N-1130-2016		NIAID/NIH [R01AI064831]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001155, R01AI064831, ZIAAI001064] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID/NIH grant No. R01AI064831 and the Intramural Research Program of the NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; GOSLING RD, EXPERT REV ANTIINFEC, V8, P589; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	24	65	65	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e15983	10.1371/journal.pone.0015983	http://dx.doi.org/10.1371/journal.pone.0015983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264245	Green Published, Green Submitted, gold			2022-12-25	WOS:000286516500021
J	Cinova, J; De Palma, G; Stepankova, R; Kofronova, O; Kverka, M; Sanz, Y; Tuckova, L				Cinova, Jana; De Palma, Giada; Stepankova, Renata; Kofronova, Olga; Kverka, Miloslav; Sanz, Yolanda; Tuckova, Ludmila			Role of Intestinal Bacteria in Gliadin-Induced Changes in Intestinal Mucosa: Study in Germ-Free Rats	PLOS ONE			English	Article							CELIAC-DISEASE; ALTERED EXPRESSION; MATRIX METALLOPROTEINASES; MICROBIAL-FLORA; COLONIC MUCINS; GOBLET CELLS; INNATE; DEFENSE; GUT; TRANSGLUTAMINASE	Background and Aims: Celiac disease (CD) is a chronic inflammatory disorder of the small intestine that is induced by dietary wheat gluten proteins (gliadins) in genetically predisposed individuals. The overgrowth of potentially pathogenic bacteria and infections has been suggested to contribute to CD pathogenesis. We aimed to study the effects of gliadin and various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production. Methodology/Principal Findings: Changes in gut mucosa were assessed in the intestinal loops of inbred Wistar-AVN rats that were reared under germ-free conditions in the presence of various intestinal bacteria (enterobacteria and bifidobacteria isolated from CD patients and healthy children, respectively) and CD-triggering agents (gliadin and IFN-gamma) by histology, scanning electron microscopy, immunofluorescence, and a rat cytokine antibody array. Adhesion of the bacterial strains to the IEC-6 rat cell line was evaluated in vitro. Gliadin fragments alone or together with the proinflammatory cytokine interferon (IFN)-gamma significantly decreased the number of goblet cells in the small intestine; this effect was more pronounced in the presence of Escherichia coli CBL2 and Shigella CBD8. Shigella CBD8 and IFN-gamma induced the highest mucin secretion and greatest impairment in tight junctions and, consequently, translocation of gliadin fragments into the lamina propria. Shigella CBD8 and E. coli CBL2 strongly adhered to IEC-6 epithelial cells. The number of goblet cells in small intestine increased by the simultaneous incubation of Bifidobacterium bifidum IATA-ES2 with gliadin, IFN-gamma and enterobacteria. B. bifidum IATA-ES2 also enhanced the production of chemotactic factors and inhibitors of metalloproteinases, which can contribute to gut mucosal protection. Conclusions: Our results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal mucosa and, consequently, could be involved in the early stages of CD pathogenesis.	[Cinova, Jana; Stepankova, Renata; Kofronova, Olga; Kverka, Miloslav; Tuckova, Ludmila] Acad Sci Czech Republ, Dept Immunol, Inst Microbiol Vvi, Prague, Czech Republic; [De Palma, Giada; Sanz, Yolanda] Natl Spanish Res Council CSIC, IATA, Microbial Ecophysiol & Nutr Grp, Valencia, Spain	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Cinova, J (corresponding author), Acad Sci Czech Republ, Dept Immunol, Inst Microbiol Vvi, Prague, Czech Republic.	Cinova7@seznam.cz	Kverka, Miloslav/H-2507-2014; De Palma, Giada/AAP-8806-2020; Sanz, Yolanda/H-5498-2012; Gajdosova, Jana/AAP-5872-2020; Kofroňová, Olga/H-7239-2014; stepankova, renata/J-9735-2014	Kverka, Miloslav/0000-0002-1335-5252; De Palma, Giada/0000-0002-2063-7741; Sanz, Yolanda/0000-0002-1615-1976; Kofroňová, Olga/0000-0002-5435-4088; stepankova, renata/0000-0001-7504-6300	Grant Agency of the Czech Republic [310/07/0414, 303/08/0367, P304/10/P406]; Academy of Sciences [IAA500200801, IAA500200710, KJB50020094]; Ministry of Education [AV CR-C.S.I.C. 09/10, 2B06155]; Institutional Research Concept [AVOZ50200510]; Consejo Superior de Investigaciones Cientificas (CSIC, Spain) [2006CZ0030, 2008CZ0023]; Spanish Ministry of Science and Innovation [AGL2008-01440/ALI, CSD2007-00063]; Junta de Ampliacion de Estudios - Consejo Superior de Investigaciones Cientificas (JAE-CSIC; Spain)	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Ministry of Education; Institutional Research Concept; Consejo Superior de Investigaciones Cientificas (CSIC, Spain); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Ampliacion de Estudios - Consejo Superior de Investigaciones Cientificas (JAE-CSIC; Spain)	This work was supported by grants 310/07/0414, 303/08/0367, P304/10/P406 of the Grant Agency of the Czech Republic; IAA500200801, IAA500200710, KJB50020094 of the Academy of Sciences; AV CR-C.S.I.C. 09/10, Project 2B06155 of the Ministry of Education; and Institutional Research Concept AVOZ50200510. This work was also supported by grants 2006CZ0030 and 2008CZ0023 from Consejo Superior de Investigaciones Cientificas (CSIC, Spain) and AGL2008-01440/ALI and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation. The scholarship to G. De Palma from Junta de Ampliacion de Estudios - Consejo Superior de Investigaciones Cientificas (JAE-CSIC; Spain) is fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218; BARRESI G, 1988, HISTOCHEMISTRY, V88, P105, DOI 10.1007/BF00493292; Beauchesne E, 2009, NEUROCHEM INT, V55, P275, DOI 10.1016/j.neuint.2009.03.014; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Collado MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-232; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; Collado Maria Carmen, 2007, Curr Issues Intest Microbiol, V8, P9; CRABTREE JE, 1989, GUT, V30, P1339, DOI 10.1136/gut.30.10.1339; Daum S, 1999, GUT, V44, P17, DOI 10.1136/gut.44.1.17; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Dubois PC, 2008, CLIN EXP IMMUNOL, V153, P162, DOI 10.1111/j.1365-2249.2008.03704.x; Enss ML, 1996, SCAND J GASTROENTERO, V31, P868, DOI 10.3109/00365529609051994; ENSS ML, 1992, J EXP ANIM SCI, V35, P110; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Izquierdo E, 2008, CURR MICROBIOL, V56, P613, DOI 10.1007/s00284-008-9135-7; Kandori H, 1996, EXP ANIM TOKYO, V45, P155, DOI 10.1538/expanim.45.155; Kopecny J, 2008, FOLIA MICROBIOL, V53, P214, DOI 10.1007/s12223-008-0028-8; Kverka M, 2007, CLIN CHEM, V53, P955, DOI 10.1373/clinchem.2006.077107; Lindfors K, 2008, CLIN EXP IMMUNOL, V152, P552, DOI 10.1111/j.1365-2249.2008.03635.x; Maiuri L, 2005, GASTROENTEROLOGY, V129, P1400, DOI 10.1053/j.gastro.2005.07.054; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Meresse B, 2008, GUT, V57, P879, DOI 10.1136/gut.2007.141994; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Palova-Jelinkova L, 2005, J IMMUNOL, V175, P7038, DOI 10.4049/jimmunol.175.10.7038; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Salmela MT, 2002, GUT, V51, P540, DOI 10.1136/gut.51.4.540; Sanchez E, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-50; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; SARTOR RB, 1994, GASTROENTEROLOGY, V106, P533, DOI 10.1016/0016-5085(94)90614-9; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; SHARMA R, 1995, GUT, V36, P209, DOI 10.1136/gut.36.2.209; SHARMA R, 1995, DIGEST DIS SCI, V35, P110; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stepankova R, 1996, SCAND J GASTROENTERO, V31, P551, DOI 10.3109/00365529609009127; STEPANKOVA R, 1979, FOLIA MICROBIOL, V24, P11, DOI 10.1007/BF02927241; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Tlaskalova-Hogenova H, 2002, INT ARCH ALLERGY IMM, V128, P77, DOI 10.1159/000059397; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Tuckova L, 2000, J LEUKOCYTE BIOL, V67, P312, DOI 10.1002/jlb.67.3.312; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Wilson M, 2002, BACTERIAL DIS MECH, DOI [10.1017/CBO9781139164665, DOI 10.1017/CBO9781139164665]; Zebrowska A, 2005, MEDIAT INFLAMM, P373, DOI 10.1155/MI.2005.373	56	96	99	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16169	10.1371/journal.pone.0016169	http://dx.doi.org/10.1371/journal.pone.0016169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249146	Green Published, Green Submitted, gold			2022-12-25	WOS:000286515000024
J	Convertino, M; Elsner, JB; Munoz-Carpena, R; Kiker, GA; Martinez, CJ; Fischer, RA; Linkov, I				Convertino, Matteo; Elsner, James B.; Munoz-Carpena, Rafael; Kiker, Gregory A.; Martinez, Christopher J.; Fischer, Richard A.; Linkov, Igor			Do Tropical Cyclones Shape Shorebird Habitat Patterns? Biogeoclimatology of Snowy Plovers in Florida	PLOS ONE			English	Article							CHARADRIUS-ALEXANDRINUS; BIRD POPULATIONS; NATAL DISPERSAL; HURRICANES; FREQUENCY; AVIFAUNA; FOREST; IMPACT; BEACH	Background: The Gulf coastal ecosystems in Florida are foci of the highest species richness of imperiled shoreline dependent birds in the USA. However environmental processes that affect their macroecological patterns, like occupancy and abundance, are not well unraveled. In Florida the Snowy Plover (Charadrius alexandrinus nivosus) is resident along northern and western white sandy estuarine/ocean beaches and is considered a state-threatened species. Methodology/Principal Findings: Here we show that favorable nesting areas along the Florida Gulf coastline are located in regions impacted relatively more frequently by tropical cyclones. The odds of Snowy Plover nesting in these areas during the spring following a tropical cyclone impact are seven times higher compared to the odds during the spring following a season without a cyclone. The only intensity of a tropical cyclone does not appear to be a significant factor affecting breeding populations. Conclusions/Significance: Nevertheless a future climate scenario featuring fewer, but more extreme cyclones could result in a decrease in the breeding Snowy Plover population and its breeding range. This is because the spatio-temporal frequency of cyclone events was found to significantly affect nest abundance. Due to the similar geographic range and habitat suitability, and no decrease in nest abundance of other shorebirds in Florida after the cyclone season, our results suggest a common bioclimatic feedback between shorebird abundance and tropical cyclones in breeding areas which are affected by cyclones.	[Convertino, Matteo; Munoz-Carpena, Rafael; Kiker, Gregory A.; Martinez, Christopher J.] Univ Florida, IFAS, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Convertino, Matteo; Linkov, Igor] USA, Corps Engineers, Engn Res & Dev Ctr ERDC, Risk & Decis Sci Grp, Concord, MA USA; [Elsner, James B.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Fischer, Richard A.] USA, Corps Engineers, Environm Lab, Engn Res & Dev Ctr ERDC, Vicksburg, MS 39180 USA; [Linkov, Igor] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	State University System of Florida; University of Florida; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; State University System of Florida; Florida State University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Carnegie Mellon University	Convertino, M (corresponding author), Univ Florida, IFAS, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	mconvertino@ufl.edu	Convertino, Matteo/ABD-5828-2021; Linkov, Igor/AAH-5981-2019; Kiker, Gregory A/K-6149-2017; Convertino, Matteo/J-1365-2016; Munoz-Carpena, Rafael/A-7588-2010	Linkov, Igor/0000-0002-0823-8107; Kiker, Gregory A/0000-0001-6215-0686; Convertino, Matteo/0000-0001-7003-7587; Munoz-Carpena, Rafael/0000-0003-2838-1514; Elsner, James/0000-0001-6805-7431	United States Department of Defense [SI-1699, SI-1700]	United States Department of Defense(United States Department of Defense)	This research was supported by the United States Department of Defense, through the Strategic Environmental Research and Development Program (SERDP), Projects SI-1699 and SI-1700. Permission was granted to publish this material by the United States Army Corps of Engineers (USACE) Chief of Engineers. The views and opinions expressed in this paper are those of the individual authors and not those of the United States Army or other sponsor organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; CHUAGOR M, 2010, ENV MODELING SOFTWAR; CLAY R, 2010, LIFE EDGE TECHNICAL; Colwell MA, 2007, WILSON J ORNITHOL, V119, P378, DOI 10.1676/06-038.1; CONVERTINO M, 2010, ECOLOGICAL ENG UNPUB; CONVERTINO M, 2010, ECOLOGICAL MOD UNPUB; CONVERTINO M, 2010, COASTLINE FRAC UNPUB; Conway WC, 2005, J WILDLIFE MANAGE, V69, P174, DOI 10.2193/0022-541X(2005)069<0174:SHUANS>2.0.CO;2; Donoghue JosephF., 2006, 1 FLORIDIANS LAST MA, P31, DOI DOI 10.1007/978-1-4020-4694-0_2; ELSNER J, HURRICANES CLIMATE C; ELSNER J, 2010, HOURLY INTERPOLATED; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Elsner JB, 2001, J CLIMATE, V14, P4341, DOI 10.1175/1520-0442(2001)014<4341:BAOUSH>2.0.CO;2; ELSNER JB, 2001, WEATHER FORECAST, V21, P182; FAC-FWC, 2008, DES THREAT SPEC PROH; *FSA, 2010, TECHN REP; Funk WC, 2007, CONSERV GENET, V8, P1287, DOI 10.1007/s10592-006-9278-7; FWC, 2010, FLOR BEACH NEST BIRD; Godown ME, 2000, BIODIVERS CONSERV, V9, P1313, DOI 10.1023/A:1008924322405; GORNISH E, 2010, GLOBAL CHANGE BIOL, V316; Himes JG, 2006, STATUS DISTRIBUTION; HOUSER C, 2008, J COSTAL RES, V24; Houser C, 2009, EARTH SURF PROC LAND, V34, P613, DOI 10.1002/esp.1730; Keim BD, 2007, J CLIMATE, V20, P3498, DOI 10.1175/JCLI4187.1; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; KUPPER C, 1997, AUK, V126; LAMONTE KM, 2002, STATUS DISTRIBUTION; LEATHERMAN SP, 1979, J ENG GEOLOGY, V12, P281; LOTT CA, 2009, DISTRIBUTION ABUNDAN; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; *NOAA, 2010, HIST HURR TRACKS TEC; Otvos EG, 2004, J COASTAL RES, V20, P326, DOI 10.2112/1551-5036(2004)20[326:BAFHLI]2.0.CO;2; Page GW, 2009, BIRDS N AM ONLINE, DOI [10.2173/bna.154, DOI 10.2173/BNA.154]; Rittenhouse CD, 2010, GLOBAL CHANGE BIOL, V16, P905, DOI 10.1111/j.1365-2486.2009.02101.x; Sheikh P.A, 2005, IMPACT HURRICANE KAT; SHOWSTACK R, 2010, EOS T AGU; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stenzel LE, 2007, AUK, V124, P1023, DOI 10.1642/0004-8038(2007)124[1023:SANDOJ]2.0.CO;2; STONE G, 1996, J COSTAL RES, V12; Stone GW, 2004, MAR GEOL, V210, P63, DOI 10.1016/j.margeo.2004.05.021; Storch D, 2005, SCIENCE, V307, P684, DOI 10.1126/science.1106935; Tossas AG, 2006, CARIBB J SCI, V42, P81; Unitt, 2003, BIRDS SALTON SEA STA; *US FWS, 2007, REC PLAN PAC COAST P; USFWS, 2001, W SNOW PLOV NAT HIST; *USGS, 2009, DAT 2006 INT PIP PLO; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; Walshaw D, 2000, J R STAT SOC C-APPL, V49, P51, DOI 10.1111/1467-9876.00178; WAUER RH, 1992, WILSON BULL, V104, P656; WUNDERLE JM, 1992, AUK, V109, P148, DOI 10.2307/4088275; Xi WM, 2008, J PLANT ECOL-UK, V1, P43, DOI 10.1093/jpe/rtm003; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	53	20	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e15683	10.1371/journal.pone.0015683	http://dx.doi.org/10.1371/journal.pone.0015683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264268	gold, Green Published, Green Submitted			2022-12-25	WOS:000286514300002
J	Bourassa, CV; Riviere, JB; Dion, PA; Bernard, G; Diab, S; Panisset, M; Chouinard, S; Dupre, N; Fournier, H; Raelson, J; Belouchi, M; Rouleau, GA				Bourassa, Cynthia V.; Riviere, Jean-Baptiste; Dion, Patrick A.; Bernard, Genevieve; Diab, Sabrina; Panisset, Michel; Chouinard, Sylvain; Dupre, Nicolas; Fournier, Helene; Raelson, John; Belouchi, Majid; Rouleau, Guy A.			LINGO1 Variants in the French-Canadian Population	PLOS ONE			English	Article							ESSENTIAL TREMOR; GENE; ASSOCIATION; LINKAGE; RISK	Essential tremor (ET) is a complex genetic disorder for which no causative gene has been found. Recently, a genome-wide association study reported that two variants in the LINGO1 locus were associated to this disease. The aim of the present study was to test if this specific association could be replicated using a French-Canadian cohort of 259 ET patients and 479 ethnically matched controls. Our genotyping results lead us to conclude that no association exists between the key variant rs9652490 and ET (P-corr = 1.00).	[Bourassa, Cynthia V.; Riviere, Jean-Baptiste; Dion, Patrick A.; Bernard, Genevieve; Diab, Sabrina; Rouleau, Guy A.] Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Montreal, PQ, Canada; [Bourassa, Cynthia V.; Riviere, Jean-Baptiste; Dion, Patrick A.; Bernard, Genevieve; Diab, Sabrina; Panisset, Michel; Chouinard, Sylvain; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Panisset, Michel; Chouinard, Sylvain] Univ Montreal, CHUM, Montreal, PQ H3C 3J7, Canada; [Dupre, Nicolas] Univ Laval, Fac Med, Dept Neurol Sci, Ctr Hosp Affilie Univ Quebec Enfant Jesus, Quebec City, PQ G1K 7P4, Canada; [Fournier, Helene; Raelson, John; Belouchi, Majid] Genizon BioSci, St Laurent, PQ, Canada; [Rouleau, Guy A.] St Justine Hosp, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Bourassa, CV (corresponding author), Univ Montreal, CHUM Res Ctr, Ctr Excellence Neur, Montreal, PQ, Canada.	guy.rouleau@umontreal.ca	Dupre, Nicolas/Y-1828-2019; Bernard, Geneviève/AAU-7569-2020	Bernard, Geneviève/0000-0002-9634-2966	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	CVB is supported by CIHR-Frederick Banting and Charles Best Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genizon BioSciences Inc. had a role in the collection of some samples used in this study.	Clark LN, 2010, EUR J HUM GENET, V18, P838, DOI 10.1038/ejhg.2010.27; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Louis ED, 2001, NEW ENGL J MED, V345, P887, DOI 10.1056/NEJMcp010928; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Tan EK, 2009, NEUROLOGY, V73, P1161, DOI 10.1212/WNL.0b013e3181bacfc9; Thier S, 2010, MOVEMENT DISORD, V25, P717, DOI 10.1002/mds.22887; Vilarino-Guell C, 2010, NEUROGENETICS, V11, P401, DOI 10.1007/s10048-010-0241-x; Vilarino-Guell C, 2010, PARKINSONISM RELAT D, V16, P109, DOI 10.1016/j.parkreldis.2009.08.006; Zuo X, 2010, NEUROSCI LETT, V481, P69, DOI 10.1016/j.neulet.2010.06.041	13	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16254	10.1371/journal.pone.0016254	http://dx.doi.org/10.1371/journal.pone.0016254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264305	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000025
J	Cahalane, DJ; Clancy, B; Kingsbury, MA; Graf, E; Sporns, O; Finlay, BL				Cahalane, Diarmuid J.; Clancy, Barbara; Kingsbury, Marcy A.; Graf, Ethan; Sporns, Olaf; Finlay, Barbara L.			Network Structure Implied by Initial Axon Outgrowth in Rodent Cortex: Empirical Measurement and Models	PLOS ONE			English	Article							CELLULAR SCALING RULES; BRAIN NETWORKS; ORGANIZATION; PROJECTIONS; CONNECTIVITY; NEOCORTEX	The developmental mechanisms by which the network organization of the adult cortex is established are incompletely understood. Here we report on empirical data on the development of connections in hamster isocortex and use these data to parameterize a network model of early cortical connectivity. Using anterograde tracers at a series of postnatal ages, we investigate the growth of connections in the early cortical sheet and systematically map initial axon extension from sites in anterior (motor), middle (somatosensory) and posterior (visual) cortex. As a general rule, developing axons extend from all sites to cover relatively large portions of the cortical field that include multiple cortical areas. From all sites, outgrowth is anisotropic, covering a greater distance along the medial/lateral axis than along the anterior/posterior axis. These observations are summarized as 2-dimensional probability distributions of axon terminal sites over the cortical sheet. Our network model consists of nodes, representing parcels of cortex, embedded in 2-dimensional space. Network nodes are connected via directed edges, representing axons, drawn according to the empirically derived anisotropic probability distribution. The networks generated are described by a number of graph theoretic measurements including graph efficiency, node betweenness centrality and average shortest path length. To determine if connectional anisotropy helps reduce the total volume occupied by axons, we define and measure a simple metric for the extra volume required by axons crossing. We investigate the impact of different levels of anisotropy on network structure and volume. The empirically observed level of anisotropy suggests a good trade-off between volume reduction and maintenance of both network efficiency and robustness. Future work will test the model's predictions for connectivity in larger cortices to gain insight into how the regulation of axonal outgrowth may have evolved to achieve efficient and economical connectivity in larger brains.	[Cahalane, Diarmuid J.] Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA; [Clancy, Barbara] Univ Cent Arkansas, Conway, AR USA; [Clancy, Barbara] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Kingsbury, Marcy A.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Graf, Ethan] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Program Neurosci, Bloomington, IN USA; [Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Program Cognit Sci, Bloomington, IN USA; [Finlay, Barbara L.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Cornell University; University of Central Arkansas; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University Bloomington; Amherst College; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Cornell University	Cahalane, DJ (corresponding author), Cornell Univ, Ctr Appl Math, Ithaca, NY 14853 USA.	djc338@cornell.edu	Sporns, Olaf/A-1667-2010	Sporns, Olaf/0000-0001-7265-4036; Clancy, Barbara/0000-0002-6882-2225	NIH [R01 19245, P20 RR-16460]; NIMH [T32 MN19389]; NSF [IBN 0138113]; National University of Ireland; JS McDonnell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); National University of Ireland; JS McDonnell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grant R01 19245 to Barbara Finlay, NIMH research fellowships under T32 MN19389 to Barbara Clancy and Marcy Kingsbury, NSF IBN 0138113 to B. Clancy and B. Finlay, and NIH Grant Number P20 RR-16460 to B. Clancy. D. Cahalane was supported by a Traveling Studentship from the National University of Ireland. OS acknowledges support from the JS McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; ANDERSON ML, 2010, BEHAV BRAIN SCI, V33; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bayer S.A., 1991, NEOCORTICAL DEV; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burton H, 2003, J NEUROSCI, V23, P4005; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; DING SL, 1995, J NEUROSCI METH, V57, P67, DOI 10.1016/0165-0270(94)00127-3; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P7, DOI 10.1098/rstb.2000.0546; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Innocenti GM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.011.2010; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Kaiser M, 2009, CEREB CORTEX, V19, P3001, DOI 10.1093/cercor/bhp071; Kingsbury MA, 2000, J COMP NEUROL, V424, P165, DOI 10.1002/1096-9861(20000814)424:1<165::AID-CNE12>3.0.CO;2-U; LATORA V, 2001, EFFICIENT BEHAV SMAL, V87; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; LENT R, 1982, J COMP NEUROL, V206, P227, DOI 10.1002/cne.902060303; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; Molnar Z, 1998, J COMP NEUROL, V398, P491; MORIN LP, 2000, STEREOTAXIC ATLAS GO; MURRE JMJ, 1995, BIOL CYBERN, V73, P529, DOI 10.1007/BF00199545; Newman MEJ., 2006, STRUCTURE DYNAMICS N; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; OLSHAUSEN BA, 2005, NEURAL COMPUT, V17, P1; Pallas SL, 2001, TRENDS NEUROSCI, V24, P417, DOI 10.1016/S0166-2236(00)01853-1; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Reep RL, 2000, BRAIN BEHAV EVOLUT, V56, P212, DOI 10.1159/000047206; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; WINDREM MS, 1991, CEREBRAL CORTEX, V1; Wolfram Research Inc., 2008, MATH VERS 7 0; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhong YM, 2003, CEREB CORTEX, V13, P527, DOI 10.1093/cercor/13.5.527	56	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16113	10.1371/journal.pone.0016113	http://dx.doi.org/10.1371/journal.pone.0016113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264302	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514000023
J	Deleyrolle, LP; Ericksson, G; Morrison, BJ; Lopez, JA; Burrage, K; Burrage, P; Vescovi, A; Rietze, RL; Reynolds, BA				Deleyrolle, Loic P.; Ericksson, Geoffery; Morrison, Brian J.; Lopez, J. Alejandro; Burrage, Kevin; Burrage, Pamela; Vescovi, Angelo; Rietze, Rodney L.; Reynolds, Brent A.			Determination of Somatic and Cancer Stem Cell Self-Renewing Symmetric Division Rate Using Sphere Assays	PLOS ONE			English	Article							IN-VITRO PROPAGATION; NEURAL STEM; PROSPECTIVE IDENTIFICATION; TGF-BETA; DIFFERENTIATION; PROLIFERATION; GENERATION; TUMORS; LINES; EGF	Representing a renewable source for cell replacement, neural stem cells have received substantial attention in recent years. The neurosphere assay represents a method to detect the presence of neural stem cells, however owing to a deficiency of specific and definitive markers to identify them, their quantification and the rate they expand is still indefinite. Here we propose a mathematical interpretation of the neurosphere assay allowing actual measurement of neural stem cell symmetric division frequency. The algorithm of the modeling demonstrates a direct correlation between the overall cell fold expansion over time measured in the sphere assay and the rate stem cells expand via symmetric division. The model offers a methodology to evaluate specifically the effect of diseases and treatments on neural stem cell activity and function. Not only providing new insights in the evaluation of the kinetic features of neural stem cells, our modeling further contemplates cancer biology as cancer stem-like cells have been suggested to maintain tumor growth as somatic stem cells maintain tissue homeostasis. Indeed, tumor stem cell's resistance to therapy makes these cells a necessary target for effective treatment. The neurosphere assay mathematical model presented here allows the assessment of the rate malignant stem-like cells expand via symmetric division and the evaluation of the effects of therapeutics on the self-renewal and proliferative activity of this clinically relevant population that drive tumor growth and recurrence.	[Deleyrolle, Loic P.; Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL 32611 USA; [Deleyrolle, Loic P.; Ericksson, Geoffery; Rietze, Rodney L.; Reynolds, Brent A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Griffith Univ, Brisbane, Qld 4111, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Burrage, Kevin; Burrage, Pamela] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Vescovi, Angelo] Univ Milano Bicocca, Milan, Italy; [Rietze, Rodney L.] Pfizer Regenerat Med, Cambridge, England	State University System of Florida; University of Florida; University of Queensland; Griffith University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; University of Milano-Bicocca; Pfizer	Deleyrolle, LP (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL 32611 USA.	loic.deleyrolle@neurosurgery.ufl.edu; brent.reynolds@neurosurgery.ufl.edu	Burrage, Kevin/J-1289-2012; Lopez, J. Alejandro/P-4129-2019; Vescovi, Angelo Luigi/A-4919-2015; Burrage, Pamela/J-1274-2012; Lopez, J. Alejandro/B-9290-2008	Lopez, J. Alejandro/0000-0001-9370-1516; Vescovi, Angelo Luigi/0000-0002-1742-4112; Lopez, J. Alejandro/0000-0001-9370-1516; Burrage, Kevin/0000-0002-8111-1137	National Institutes of Health (NIH); National Health and Medical Research Council (NHMRC)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Institutes of Health (NIH) and the National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blackmore DG, 2009, STEM CELLS, V27, P2044, DOI 10.1002/stem.120; Boman BM, 2001, CANCER RES, V61, P8408; BOMAN BM, 2007, BIOCH BIOPHYS RES CO; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; GOLMOHAMMADI MG, 2008, STEM CELLS; HALL PA, 1989, DEVELOPMENT, V106, P619; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; McLenachan S, 2009, GROWTH HORM IGF RES, V19, P212, DOI 10.1016/j.ghir.2008.09.003; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; OGAWA M, 1993, BLOOD, V81, P2844; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reynolds BA, 2009, CELL STEM CELL, V5, P466, DOI 10.1016/j.stem.2009.10.017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weiss S, 1996, J NEUROSCI, V16, P7599; WICHA, 2006, CANCER RES, V66, P1895; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	49	48	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15844	10.1371/journal.pone.0015844	http://dx.doi.org/10.1371/journal.pone.0015844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246056	Green Published, gold			2022-12-25	WOS:000286511200019
J	Chandiramani, N; Wang, XH; Margeta, M				Chandiramani, Natasha; Wang, Xianhong; Margeta, Marta			Molecular Basis for Vulnerability to Mitochondrial and Oxidative Stress in a Neuroendocrine CRI-G1 Cell Line	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; GLUTATHIONE DISULFIDE; NRF2 ACTIVATION; MICE; RISK; DJ-1; SULFORAPHANE; METABOLISM; ASTROCYTES	Background: Many age-associated disorders (including diabetes, cancer, and neurodegenerative diseases) are linked to mitochondrial dysfunction, which leads to impaired cellular bioenergetics and increased oxidative stress. However, it is not known what genetic and molecular pathways underlie differential vulnerability to mitochondrial dysfunction observed among different cell types. Methodology/Principal Findings: Starting with an insulinoma cell line as a model for a neuronal/endocrine cell type, we isolated a novel subclonal line (named CRI-G1-RS) that was more susceptible to cell death induced by mitochondrial respiratory chain inhibitors than the parental CRI-G1 line (renamed CRI-G1-RR for clarity). Compared to parental RR cells, RS cells were also more vulnerable to direct oxidative stress, but equally vulnerable to mitochondrial uncoupling and less vulnerable to protein kinase inhibition-induced apoptosis. Thus, differential vulnerability to mitochondrial toxins between these two cell types likely reflects differences in their ability to handle metabolically generated reactive oxygen species rather than differences in ATP production/utilization or in downstream apoptotic machinery. Genome-wide gene expression analysis and follow-up biochemical studies revealed that, in this experimental system, increased vulnerability to mitochondrial and oxidative stress was associated with (1) inhibition of ARE/Nrf2/Keap1 antioxidant pathway; (2) decreased expression of antioxidant and phase I/II conjugation enzymes, most of which are Nrf2 transcriptional targets; (3) increased expression of molecular chaperones, many of which are also considered Nrf2 transcriptional targets; (4) increased expression of beta cell-specific genes and transcription factors that specify/maintain beta cell fate; and (5) reconstitution of glucose-stimulated insulin secretion. Conclusions/Significance: The molecular profile presented here will enable identification of individual genes or gene clusters that shape vulnerability to mitochondrial dysfunction and thus represent potential therapeutic targets for diabetes and neurodegenerative diseases. In addition, the newly identified CRI-G1-RS cell line represents a new experimental model for investigating how endogenous antioxidants affect glucose sensing and insulin release by pancreatic beta cells.	[Chandiramani, Natasha; Wang, Xianhong; Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chandiramani, N (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	Marta.Margeta@ucsf.edu		Margeta, Marta/0000-0001-6889-2488; Emmanuel, Natasha/0000-0003-0130-1094	National Institutes of Health [NS054113]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health grant NS054113 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2004, THESIS U CALIFORNIA; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; CARRINGTON CA, 1986, J ENDOCRINOL, V109, P193, DOI 10.1677/joe.0.1090193; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Fonck C, 2003, BRAIN RES, V975, P214, DOI 10.1016/S0006-8993(03)02675-1; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gier B, 2009, J CLIN INVEST, V119, P3246, DOI 10.1172/JCI38817; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; INBERG A, 2010, J BIOL CHEM; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Leloup C, 2006, DIABETES, V55, pA323; Li XY, 2006, DIABETES, V55, P1592, DOI 10.2337/db05-1357; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Moriscot C, 2007, DIABETES METAB, V33, P44, DOI 10.1016/j.diabet.2006.09.004; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Ohsawa I, 2003, J NEUROCHEM, V84, P1110, DOI 10.1046/j.1471-4159.2003.01619.x; Ohsawa I, 2008, J NEUROSCI, V28, P6239, DOI 10.1523/JNEUROSCI.4956-07.2008; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; R Development Core Team, 2005, R LANG ENV STAT COMP; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Ronnemaa E, 2009, DIABETOLOGIA, V52, P1504, DOI 10.1007/s00125-009-1393-9; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; SIES H, 1984, METHOD ENZYMOL, V105, P445; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang BB, 2008, J NEUROL SCI, V268, P172, DOI 10.1016/j.jns.2007.12.006; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x	63	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2011	6	1							e14485	10.1371/journal.pone.0014485	http://dx.doi.org/10.1371/journal.pone.0014485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KM	21249230	Green Published, gold			2022-12-25	WOS:000286510500004
J	Chen, KC; Wang, YS; Hu, CY; Chang, WC; Liao, YC; Dai, CY; Juo, SHH				Chen, Ku-Chung; Wang, Yung-Song; Hu, Ching-Yu; Chang, Wei-Chiao; Liao, Yi-Chu; Dai, Chia-Yen; Juo, Suh-Hang Hank			OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases	FASEB JOURNAL			English	Article						DNA methylation; DNMT3b; atherosclerosis	LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; MATRIX-METALLOPROTEINASE EXPRESSION; TUMOR-SUPPRESSOR GENES; DNA METHYLTRANSFERASES; OXIDIZED LDL; LUNG-CANCER; IN-VITRO; ATHEROSCLEROSIS; METHYLATION	MicroRNAs (miRNAs), small noncoding RNAs, can control gene expression by binding to their target genes for degradation and/or translational repression. Epigenetic mechanisms are defined as heritable changes in gene expression that do not involve coding sequence modifications. Both mechanisms play an important role in maintaining physiological functions and are also related to disease development. However, few studies report that miRNA-mediated epigenetic regulations are involved in atherosclerosis. In the present study, oxidized low-density lipoprotein (oxLDL) significantly increased primary human aortic smooth muscle cell (HASMC) migration through MMP-2/MMP-9 up-regulation associated with decreased DNA methylation levels. Either mRNA or protein level of DNA methyltransferase 3b (DNMT3b) showed a dose-dependent down-regulation in oxLDL-mediated HASMCs. Knockdown DNMT3b expression enhanced oxLDL-induced DNA demethylation levels of MMP-2/MMP-9. The expression of miRNA-29b (miR-29b), directly targeting DNMT3b, was up-regulated by oxLDL treatment in a dose-dependent manner. OxLDL-mediated MMP-2/MMP-9 up-regulation, DNMT3b down-regulation, and DNA demethylation were all attenuated after knockdown miR-29b expression by antagomiR-29b. We find that oxLDL can up-regulate miR-29b expression, resulting in DNMT3b down-regulation in HASMCs and epigenetically regulated MMP2/MMP-9 genes involved in cell migration. These results show that miRNA-mediated epigenetic regulation may be a novel mechanism in atherosclerosis.-Chen, K.-C., Wang, Y.-S., Hu, C.-Y., Chang, W.-C., Liao, Y C., Dai, C.-Y., Juo, S.-H. H. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 25, 1718-1728 (2011). www.fasebj.org	[Chen, Ku-Chung; Wang, Yung-Song; Chang, Wei-Chiao; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung 807, Taiwan; [Hu, Ching-Yu; Liao, Yi-Chu] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung 807, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ, Dept Internal Med, Hepatobiliary Div, Kaohsiung 807, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan; [Chen, Ku-Chung; Wang, Yung-Song; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Liao, Yi-Chu] Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan; [Liao, Yi-Chu] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 112, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Juo, SHH (corresponding author), Kaohsiung Med Univ, Dept Med Genet, 100 TzYou 1st Rd, Kaohsiung 807, Taiwan.	hjuo@kmu.edu.tw	Huang, Jee-Fu/AAX-4622-2020; Juo, Suh-Hang/C-9545-2009; Chuang, Wan-Long/ABF-7427-2021	Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X; Liao, Yi-Chu/0000-0002-9644-2086; Chang, Wei-Chiao/0000-0002-8573-5924	National Health Research Institutes, Taiwan [NHRI-Ex96-9607PI]; National Science Council, Taiwan [NSC 98-2314-B-037-048]; Kaohsiung Medical University Hospital [KMUH98-8I11]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	The study is supported by grants from the National Health Research Institutes, Taiwan (NHRI-Ex96-9607PI), the National Science Council, Taiwan (NSC 98-2314-B-037-048), and Kaohsiung Medical University Hospital (intramural grant KMUH98-8I11).	Aoyagi M, 1998, HISTOCHEM CELL BIOL, V109, P97, DOI 10.1007/s004180050206; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Chahine MN, 2009, J MOL CELL CARDIOL, V46, P431, DOI 10.1016/j.yjmcc.2008.10.009; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chen JH, 2010, J LIPID RES, V51, P991, DOI 10.1194/jlr.M000398; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chien MW, 2003, J LIPID RES, V44, P1667, DOI 10.1194/jlr.M300006-JLR200; Cui M, 2009, MOL BIOL REP, V36, P2201, DOI 10.1007/s11033-008-9435-9; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hojo Y, 2002, ATHEROSCLEROSIS, V161, P185, DOI 10.1016/S0021-9150(01)00615-3; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Huang YS, 2007, ACTA BIOCH BIOPH SIN, V39, P19, DOI 10.1111/j.1745-7270.2007.00251.x; Janicki JS, 2004, HEART FAIL REV, V9, P33, DOI 10.1023/B:HREV.0000011392.03037.7e; Kalela A, 2002, SCAND J CLIN LAB INV, V62, P337, DOI 10.1080/00365510260296483; Kita T, 2001, ANN NY ACAD SCI, V947, P199; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Kwon YM, 2007, J CANCER RES CLIN, V133, P219, DOI 10.1007/s00432-006-0160-2; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu XQ, 2009, NAT MED, V15, P1357, DOI 10.1038/nm1209-1357; Maziere C, 2010, FREE RADICAL BIO MED, V48, P1382, DOI 10.1016/j.freeradbiomed.2010.02.022; Maziere C, 2009, FREE RADICAL BIO MED, V46, P127, DOI 10.1016/j.freeradbiomed.2008.10.024; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Momi S, 2009, J EXP MED, V206, P2365, DOI 10.1084/jem.20090687; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Pogribny IP, 2009, CELL MOL LIFE SCI, V66, P2249, DOI 10.1007/s00018-009-0015-5; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Sato N, 2003, JNCI-J NATL CANCER I, V95, P327, DOI 10.1093/jnci/95.4.327; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Takada S, 2009, RNA, V15, P1507, DOI 10.1261/rna.1418309; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xiong YN, 2005, GYNECOL ONCOL, V96, P601, DOI 10.1016/j.ygyno.2004.11.047; Yang Shengbo, 2009, Zhongguo Zhong Yao Za Zhi, V34, P611; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zhang CX, 2009, GENOME MED, V1, DOI 10.1186/gm85	47	171	179	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1718	1728		10.1096/fj.10-174904	http://dx.doi.org/10.1096/fj.10-174904			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21266537				2022-12-25	WOS:000290023800027
J	White, RE; Powell, DJ; Berry, C				White, Rhian E.; Powell, David J.; Berry, Colin			HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites	FASEB JOURNAL			English	Article						proteasome; HAART	FALCIPARUM IN-VITRO; CELL-CYCLE CONTROL; PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTIVITY; ASPARTIC PROTEASE; CANDIDA; VIVO; CHLOROQUINE; SAQUINAVIR; UBIQUITIN	HIV proteinase inhibitors reduce the levels of Leishmania parasites in vivo and in vitro, but their biochemical target is unknown. We have identified an ortholog of the yeast Ddi1 protein as the only member of the aspartic proteinase family in Leishmania parasites, and in this study we investigate this protein as a potential target for the drugs. To date, no enzyme assay has been developed for the Ddi1 proteins, but Saccharomyces cerevisiae lacking the DDI1 gene secrete high levels of protein into the medium. We developed an assay in which these knockout yeast were functionally complemented to low secretion by introduction of genes encoding Ddi1 orthologs from Leishmania major or humans. Plasmid alone controls gave no complementation. Treatment of the Ddi1 transformants with HIV proteinase inhibitors showed differential effects dependent on the origin of the Ddi1. Dose responses allowed calculation of IC(50) values; e.g., for nelfinavir, of 3.4 mu M (human Ddi1) and 0.44 mu M (Leishmania Ddi1). IC(50) values with Leishmania constructs mirror the potency of inhibitors against parasites. Our results show that Ddi1 proteins are targets of HIV proteinase inhibitors and indicates the Leishmania Ddi1 as the likely target for these drugs and a potential target for antiparasitic therapy.-White, R.E., Powell, D.J., Berry, C. HIV proteinase inhibitors target the Ddi1-Like protein of Leishmania parasites. FASEB J. 25, 1729-1736 (2011). www.fasebj.org	[White, Rhian E.; Berry, Colin] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AT, S Glam, Wales; [Powell, David J.] GlaxoSmithKline Inc, Med Res Ctr, Stevenage, Herts, England	Cardiff University; GlaxoSmithKline	Berry, C (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	berry@cf.ac.uk	Berry, Colin/A-4338-2010	Berry, Colin/0000-0002-9943-548X; Plummer, Beverley/0000-0002-6559-7237	Biotechnology and Biological Sciences Research Council [BB/D526137/1]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Collaborative Award in Science and Engineering BB/D526137/1 to R.E.W.	Alves CR, 2005, EXP PARASITOL, V109, P38, DOI 10.1016/j.exppara.2004.10.005; Andre P, 1998, P NATL ACAD SCI USA, V95, P13120, DOI 10.1073/pnas.95.22.13120; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Barrett A. J., 2004, HDB PROTEOLYTIC ENZY, V1; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Cassone A, 1999, J INFECT DIS, V180, P448, DOI 10.1086/314871; Cassone A, 2002, TRENDS MICROBIOL, V10, P177, DOI 10.1016/S0966-842X(02)02341-7; Cassone A, 2002, J INFECT DIS, V185, P188, DOI 10.1086/338445; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; Gabriely G, 2008, MOL BIOL CELL, V19, P3625, DOI 10.1091/mbc.E07-05-0462; He ZX, 2008, ANTIMICROB AGENTS CH, V52, P2653, DOI 10.1128/AAC.01329-07; He ZX, 2010, INT J ANTIMICROB AG, V35, P191, DOI 10.1016/j.ijantimicag.2009.09.016; He ZX, 2009, EXP PARASITOL, V123, P122, DOI 10.1016/j.exppara.2009.06.008; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Krylov DM, 2001, CURR BIOL, V11, pR584, DOI 10.1016/S0960-9822(01)00357-8; Lek-Uthai U, 2008, ANTIMICROB AGENTS CH, V52, P2435, DOI 10.1128/AAC.00169-08; Lustgarten V, 1999, MOL CELL BIOL, V19, P4480; Martins TM, 2006, ACTA TROP, V97, P212, DOI 10.1016/j.actatropica.2005.11.001; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Nathoo S, 2003, LANCET, V362, P1039, DOI 10.1016/S0140-6736(03)14414-5; Parikh S, 2006, ANTIMICROB AGENTS CH, V50, P2207, DOI 10.1128/AAC.00022-06; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Peatey CL, 2010, ANTIMICROB AGENTS CH, V54, P1334, DOI 10.1128/AAC.01512-09; Piccinini M, 2002, AIDS, V16, P693, DOI 10.1097/00002030-200203290-00004; Piccinini M, 2005, ANTIVIR THER, V10, P215; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; Redmond AM, 2007, AIDS, V21, P763, DOI 10.1097/QAD.0b013e328031f41a; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Santos LO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004918; Savoia D, 2005, INT J ANTIMICROB AG, V26, P92, DOI 10.1016/j.ijantimicag.2005.04.003; Skinner-Adams TS, 2007, ANTIMICROB AGENTS CH, V51, P759, DOI 10.1128/AAC.00840-06; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Skrbec D, 2002, BIOCHEM BIOPH RES CO, V297, P1350, DOI 10.1016/S0006-291X(02)02372-0; Trudel N, 2008, J INFECT DIS, V198, P1292, DOI 10.1086/592280; Valdivieso E, 2007, EXP PARASITOL, V116, P77, DOI 10.1016/j.exppara.2006.10.006; Valdivieso E, 2010, EXP PARASITOL, V126, P557, DOI 10.1016/j.exppara.2010.06.002; White RE, 2011, FEBS LETT, V585, P139, DOI 10.1016/j.febslet.2010.11.026; Wilson SI, 1997, BBA-PROTEIN STRUCT M, V1339, P113, DOI 10.1016/S0167-4838(96)00224-5	43	38	40	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1729	1736		10.1096/fj.10-178947	http://dx.doi.org/10.1096/fj.10-178947			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21266539	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000290023800028
J	Chou, CY; Ko, TP; Wu, KJ; Huang, KF; Lin, CH; Wong, CH; Wang, AHJ				Chou, Chien-Yu; Ko, Tzu-Ping; Wu, Kuan-Jung; Huang, Kai-Fa; Lin, Chun-Hung; Wong, Chi-Huey; Wang, Andrew H. -J.			Modulation of Substrate Specificities of D-Sialic Acid Aldolase through Single Mutations of Val-251	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLNEURAMINIC ACID; PSEUDAMINIC ACID; LYASE; HELICOBACTER; MECHANISM; SUBFAMILY; PATHWAY; KDO	In a recent directed-evolution study, Escherichia coli D-sialic acid aldolase was converted by introducing eight point mutations into a new enzyme with relaxed specificity, denoted RS-aldolase (also known formerly as L-3-deoxy-manno-2-octulosonic acid (L-KDO) aldolase), which showed a preferred selectivity toward L-KDO. To investigate the underlying molecular basis, we determined the crystal structures of D-sialic acid aldolase and RS-aldolase. All mutations are away from the catalytic center, except for V251I, which is near the opening of the (alpha/beta)(8)-barrel and proximal to the Schiff base-forming Lys-165. The change of specificity from D-sialic acid to RS-aldolase can be attributed mainly to the V251I substitution, which creates a narrower sugar-binding pocket, but without altering the chirality in the reaction center. The crystal structures of D-sialic acid aldolase. L-arabinose and RS-aldolase.hydroxypyruvate complexes and five mutants (V251I, V251L, V251R, V251W, and V251I/V265I) of the D-sialic acid aldolase were also determined, revealing the location of substrate molecules and how the contour of the active site pocket was shaped. Interestingly, by mutating Val251 alone, the enzyme can accept substrates of varying size in the aldolase reactions and still retain stereoselectivity. The engineered D-sialic acid aldolase may find applications in synthesizing unnatural sugars of C-6 to C-10 for the design of antagonists and inhibitors of glycoenzymes.	[Chou, Chien-Yu; Ko, Tzu-Ping; Wu, Kuan-Jung; Huang, Kai-Fa; Lin, Chun-Hung; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chou, Chien-Yu; Ko, Tzu-Ping; Huang, Kai-Fa; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 11529, Taiwan; [Lin, Chun-Hung; Wong, Chi-Huey; Wang, Andrew H. -J.] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Chou, Chien-Yu; Lin, Chun-Hung; Wong, Chi-Huey; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.	ahjwang@gate.sinica.edu.tw	Lin, Chun-Hung/AAM-9711-2021	Lin, Chun-Hung/0000-0002-6795-8825	Institute of Biological Chemistry; National Research Program for Genomic Medicine, Academia Sinica	Institute of Biological Chemistry; National Research Program for Genomic Medicine, Academia Sinica(Ministry of Science and Technology, TaiwanAcademia Sinica - Taiwan)	This work was supported by grants from the Institute of Biological Chemistry and National Research Program for Genomic Medicine, Academia Sinica.	Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campeotto I, 2010, J MOL BIOL, V404, P56, DOI 10.1016/j.jmb.2010.08.008; DEVRIES GH, 1972, ARCH BIOCHEM BIOPHYS, V151, P234, DOI 10.1016/0003-9861(72)90493-6; GANTT R, 1964, BIOCHEMISTRY-US, V3, P1952, DOI 10.1021/bi00900a029; Hsu CC, 2005, P NATL ACAD SCI USA, V102, P9122, DOI 10.1073/pnas.0504033102; IZARD T, 1994, STRUCTURE, V2, P361, DOI 10.1016/S0969-2126(00)00038-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefel MJ, 2000, BIOORGAN MED CHEM, V8, P657, DOI 10.1016/S0968-0896(99)00325-9; Koketsu M, 1997, J MED CHEM, V40, P3332, DOI 10.1021/jm9701280; KOLISIS FN, 1986, BIOCHEM INT, V13, P493; Kozlov IA, 2001, CHEMBIOCHEM, V2, P741, DOI 10.1002/1439-7633(20011001)2:10<741::AID-CBIC741>3.0.CO;2-B; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 1997, J MOL BIOL, V266, P381, DOI 10.1006/jmbi.1996.0769; LIN CH, 1992, J AM CHEM SOC, V114, P10138, DOI 10.1021/ja00052a008; Mahmoudian M, 1997, ENZYME MICROB TECH, V20, P393, DOI 10.1016/S0141-0229(96)00180-9; Maru I, 1998, CARBOHYD RES, V306, P575, DOI 10.1016/S0008-6215(97)10106-9; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAY PH, 1982, METHOD ENZYMOL, V83, P525; Rietschel E T, 1985, Prog Clin Biol Res, V189, P31; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Sears P, 1999, ANGEW CHEM INT EDIT, V38, P2301; SIMPSON RJ, 1976, EUR J BIOCHEM, V70, P501, DOI 10.1111/j.1432-1033.1976.tb11041.x; Smith BJ, 1999, J ORG CHEM, V64, P945, DOI 10.1021/jo981960v; SUTTAJIT M, 1971, J BIOL CHEM, V246, P810; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9	30	6	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14057	14064		10.1074/jbc.M110.179465	http://dx.doi.org/10.1074/jbc.M110.179465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21270125	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000289556200028
J	Boergesen, M; Poulsen, LL; Schmidt, SF; Frigerio, F; Maechler, P; Mandrup, S				Boergesen, Michael; Poulsen, Lars la Cour; Schmidt, Soren Fisker; Frigerio, Francesca; Maechler, Pierre; Mandrup, Susanne			ChREBP Mediates Glucose Repression of Peroxisome Proliferator-activated Receptor alpha Expression in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; CENTER-DOT-MLX; L-PK GENE; PPAR-ALPHA; TRANSCRIPTION FACTOR; INSULIN; METABOLISM; KINASE; IDENTIFICATION; LIPOGENESIS	Chronic exposure to elevated levels of glucose and fatty acids leads to dysfunction of pancreatic beta-cells by mechanisms that are only partly understood. The transcription factor peroxisome proliferator-activated receptor alpha (PPAR alpha) is an important regulator of genes involved in fatty acid metabolism and has been shown to protect against lipid-induced beta-cell dysfunction. We and others have previously shown that expression of the PPAR alpha gene in beta-cells is rapidly repressed by glucose. Here we show that the PPAR alpha gene is transcribed from five alternative transcription start sites, resulting in three alternative first exons that are spliced to exon 2. Expression of all PPAR alpha transcripts is repressed by glucose both in insulinoma cells and in isolated pancreatic islets. The observation that the dynamics of glucose repression of PPAR alpha transcription are very similar to those of glucose activation of target genes by the carbohydrate response element-binding protein (ChREBP) prompted us to investigate the potential role of ChREBP in the regulation of PPAR alpha expression. We show that a constitutively active ChREBP lacking the N-terminal domain efficiently represses PPAR alpha expression in insulinoma cells and in rodent and human islets. In addition, we demonstrate that siRNA-mediated knockdown of ChREBP abrogates glucose repression of PPAR alpha expression as well as induction of well established ChREBP target genes in insulinoma cells. In conclusion, this work shows that ChREBP is a critical and direct mediator of glucose repression of PPAR alpha gene expression in pancreatic beta-cells, suggesting that ChREBP may be important for glucose suppression of the fatty acid oxidation capacity of beta-cells.	[Boergesen, Michael; Poulsen, Lars la Cour; Schmidt, Soren Fisker; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Frigerio, Francesca; Maechler, Pierre] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of Southern Denmark; University of Geneva	Mandrup, S (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	s.mandrup@bmb.sdu.dk		Mandrup, Susanne/0000-0002-0961-5787; Maechler, Pierre/0000-0002-2005-1433; la Cour Poulsen, Lars/0000-0001-5406-3945; Fisker Schmidt, Soren/0000-0003-4449-288X	Juvenile Diabetes Research Foundation; Danish Health Science Research Council; Danish Diabetes Foundation; Nordic Center of Excellence MitoHealth; Swiss National Science Foundation; Novo Nordisk scholarship; Novo Nordisk Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Danish Health Science Research Council; Danish Diabetes Foundation; Nordic Center of Excellence MitoHealth; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo Nordisk scholarship(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank Dr. Giuseppe Merla for providing the pcDNA3-MycEGFP-mChREBP zeta construct. Fresh human islets were provided by the Cell Isolation and Transplantation Center of the Geneva School of Medicine, thanks to the European Consortium for Islet Transplantation "Islet for Research" distribution program sponsored by the Juvenile Diabetes Research Foundation (to Thierry Berne).; This work was supported by grants from the Danish Health Science Research Council, the Danish Diabetes Foundation, and NordForsk given to the Nordic Center of Excellence MitoHealth (to S. M.), as well as grants from the Swiss National Science Foundation (to P. M.).; Supported by a Novo Nordisk scholarship and the Novo Nordisk Foundation.	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Berge K, 2003, J LIPID RES, V44, P118, DOI 10.1194/jlr.M200312-JLR200; Burke SJ, 2009, J MOL BIOL, V392, P578, DOI 10.1016/j.jmb.2009.07.053; Burke SJ, 2009, FASEB J, V23, P2855, DOI 10.1096/fj.08-126631; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chew CH, 2003, BIOCHEM BIOPH RES CO, V305, P235, DOI 10.1016/S0006-291X(03)00731-9; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; Fontes G, 2010, DIABETOLOGIA, V53, P2369, DOI 10.1007/s00125-010-1850-5; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; HEDESKOV CJ, 1975, BIOCHEM J, V152, P571, DOI 10.1042/bj1520571; Hellemans K, 2007, FEBS J, V274, P6094, DOI 10.1111/j.1742-4658.2007.06131.x; Holness MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1087, DOI 10.1152/ajpendo.00375.2006; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2008, BIOCHEM BIOPH RES CO, V374, P95, DOI 10.1016/j.bbrc.2008.06.101; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Joly E, 2009, J DIABETES, V1, P263, DOI 10.1111/j.1753-0407.2009.00043.x; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Lalloyer F, 2006, DIABETES, V55, P1605, DOI 10.2337/db06-0016; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; NISHIMURA M, 1994, J BIOL CHEM, V269, P26100; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; Olofsson CS, 2007, DIABETES, V56, P1888, DOI 10.2337/db06-1150; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Roduit R, 2000, J BIOL CHEM, V275, P35799, DOI 10.1074/jbc.M006001200; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Sun Y, 2008, ENDOCRINOLOGY, V149, P662, DOI 10.1210/en.2007-1275; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zhou YT, 1998, P NATL ACAD SCI USA, V95, P8898, DOI 10.1073/pnas.95.15.8898	58	32	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13214	13225		10.1074/jbc.M110.215467	http://dx.doi.org/10.1074/jbc.M110.215467			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21282101	hybrid, Green Published			2022-12-25	WOS:000289282200042
J	Chen, YH; Yeh, FL; Yeh, SP; Ma, HT; Hung, SC; Hung, MC; Li, LY				Chen, Ya-Huey; Yeh, Fang-Ling; Yeh, Su-Peng; Ma, Haou-Tzong; Hung, Shih-Chieh; Hung, Mien-Chie; Li, Long-Yuan			Myocyte Enhancer Factor-2 Interacting Transcriptional Repressor (MITR) Is a Switch That Promotes Osteogenesis and Inhibits Adipogenesis of Mesenchymal Stem Cells by Inactivating Peroxisome Proliferator-activated Receptor gamma-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; OSTEOBLAST DIFFERENTIATION; METHYLATION; BONE; HYPERTROPHY; METABOLISM; POLYCOMB; MARROW; ENERGY; GENES	EZH2, a catalytic subunit of Polycomb-repressive complex 2 (PRC2), is a histone lysine methyltransferase that methylates lysine 27 of histone H3, resulting in gene silencing. It has been shown that EZH2 plays a pivotal role in fostering self-renewal and inhibiting the differentiation of embryonic stem cells. Mesenchymal stem cells (MSCs) can be induced to differentiate into adipogenic and osteogenic lineages, which are mutually exclusive. However, it is not clear whether the molecular events of EZH2-mediated epigenetic silencing may coordinate differentiation between osteoblasts and adipocytes. Disruption of the balance between adipogenesis and osteogenesis is associated with many diseases; thus, identifying a switch that determines the fate of MSC is critical. In this study, we used EZH2ChIP-on-chip assay to identify differential EZH2 targets in the two differentiation stages on a genome-wide scale. After validating the targets, we found that myocyte enhancer factor-2 interacting transcriptional repressor (MITR)/HDAC9c was expressed in osteoblasts and greatly decreased in adipocytes. We demonstrated that MITR plays a crucial role in the acceleration of MSC osteogenesis and attenuation of MSC adipogenesis through interaction with peroxisome proliferator-activated receptor (PPAR) gamma-2 in the nucleus of osteoblasts, which interrupts PPAR gamma-2 activity and prevents adipogenesis. Together, our results demonstrated that MITR plays a master switch role to balance osteogenic and adipo-genic differentiation of MSCs through regulation of PPAR gamma-2 transcriptional activity.	[Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Ya-Huey; Yeh, Fang-Ling; Hung, Mien-Chie; Li, Long-Yuan] China Med Univ Hosp, Ctr Mol Med, Taichung 40447, Taiwan; [Chen, Ya-Huey; Yeh, Fang-Ling; Hung, Mien-Chie; Li, Long-Yuan] China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan; [Li, Long-Yuan] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Yeh, Su-Peng] China Med Univ Hosp, Div Hematol & Oncol, Dept Med, Taichung 40447, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Surg, Sch Med, Taipei 112, Taiwan; [Ma, Haou-Tzong; Li, Long-Yuan] China Med Univ, Canc Biol & Drug Discovery PhD Program, Taichung 40402, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org; lyl@mail.cmu.edu.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Li, Long-Yuan/0000-0001-7472-8318	Kadoorie Charitable Foundations; MD Anderson Cancer Center-China Medical University Hospital; NSC [99-2632-B-039-001-MY3];  [NSC98-3111-B-039];  [NHRI-EX99-9603BC];  [DOH98-TD-I-111-TM002];  [DOH99-TD-I-111-TM026];  [NSC99-3111-B-039-001];  [DOH100-TD-C-111-005]	Kadoorie Charitable Foundations; MD Anderson Cancer Center-China Medical University Hospital; NSC(Ministry of Science and Technology, Taiwan); ; ; ; ; ; 	This work was supported by Grants NSC98-3111-B-039 (to M.-C.H., L.-Y. L., and S.-P.Y.), NHRI-EX99-9603BC, DOH98-TD-I-111-TM002, DOH99-TD-I-111-TM026, and NSC99-3111-B-039-001 (to L.-Y. L.), DOH100-TD-C-111-005 and NSC 99-2632-B-039-001-MY3 (to M.-C.H. and L.-Y.L.), MD Anderson Cancer Center-China Medical University Hospital Sister Institution Fund, and Kadoorie Charitable Foundations (to M.-C.H.).	Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Catalioto RM, 2009, EXP CELL RES, V315, P3267, DOI 10.1016/j.yexcr.2009.09.012; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Ramsden D, 2003, NAT IMMUNOL, V4, P101, DOI 10.1038/ni0203-101; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Rosen ED, 2000, GENE DEV, V14, P1293; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YJ, 2011, OSTEOPOROSIS INT, V22, P1469, DOI 10.1007/s00198-010-1352-9; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	42	45	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10671	10680		10.1074/jbc.M110.199612	http://dx.doi.org/10.1074/jbc.M110.199612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247904	Green Published, hybrid			2022-12-25	WOS:000288547000081
J	Hansen, IA; Boudko, DY; Shiao, SH; Voronov, DA; Meleshkevitch, EA; Drake, LL; Aguirre, SE; Fox, JM; Attardo, GM; Raikhel, AS				Hansen, Immo A.; Boudko, Dmitri Y.; Shiao, Shin-Hong; Voronov, Dmitri A.; Meleshkevitch, Ella A.; Drake, Lisa L.; Aguirre, Sarah E.; Fox, Jeffrey M.; Attardo, Geoffrey M.; Raikhel, Alexander S.			AaCAT1 of the Yellow Fever Mosquito, Aedes aegypti A NOVEL HISTIDINE-SPECIFIC AMINO ACID TRANSPORTER FROM THE SLC7 FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAT-BODY; MECHANISM; METABOLISM; TARGET; CELLS; BULK; STEP	Insect yolk protein precursor gene expression is regulated by nutritional and endocrine signals. A surge of amino acids in the hemolymph of blood-fed female mosquitoes activates a nutrient signaling system in the fat bodies, which subsequently dere-presses yolk protein precursor genes and makes them responsive to activation by steroid hormones. Orphan transporters of the SLC7 family were identified as essential upstream components of the nutrient signaling system in the fat body of fruit flies and the yellow fever mosquito, Aedes aegypti. However, the transport function of these proteins was unknown. We report expression and functional characterization of AaCAT1, cloned from the fat body of A. aegypti. Expression of AaCAT1 transcript and protein undergoes dynamic changes during postembryonic development of the mosquito. Transcript expression was especially high in the third and fourth larval stages; however, the AaCAT1 protein was detected only in pupa and adult stages. Functional expression and analysis of AaCAT1 in Xenopus oocytes revealed that it acts as a sodium-independent cationic amino acid transporter, with unique selectivity to L-histidine at neutral pH (K-0.5(L-His) = 0.34 +/- 0.07 mM, pH 7.2). Acidification to pH 6.2 dramatically increases AaCAT1-specific His(+)-induced current. RNAi-mediated silencing of AaCAT1 reduces egg yield of subsequent ovipositions. Our data show that AaCAT1 has notable differences in its transport mechanism when compared with related mammalian cationic amino acid transporters. It may execute histidine-specific transport and signaling in mosquito tissues.	[Hansen, Immo A.; Drake, Lisa L.; Aguirre, Sarah E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Hansen, Immo A.; Drake, Lisa L.; Aguirre, Sarah E.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA; [Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Boudko, Dmitri Y.; Voronov, Dmitri A.; Meleshkevitch, Ella A.; Fox, Jeffrey M.] Rosalind Franklin Univ, Chicago Med Sch, Dept Physiol & Biophys, N Chicago, IL 60064 USA; [Shiao, Shin-Hong] Natl Taiwan Univ, Dept Parasitol, Taipei 106, Taiwan; [Attardo, Geoffrey M.] Yale Univ, Yale Sch Publ Hlth, New Haven, CT 06520 USA	New Mexico State University; New Mexico State University; University of California System; University of California Riverside; Chicago Medical School; Rosalind Franklin University Medical & Science; National Taiwan University; Yale University	Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu	Voronov, Dmitry/ABG-1072-2021; Attardo, Geoffrey Michael/I-3320-2019	Attardo, Geoffrey Michael/0000-0001-6265-2969; SHIAO, SHIN-HONG/0000-0002-7749-7807	National Institutes of Health (NIH) NIAID [5R37AI024716, R01 AI-030464]; NIH, NIGMS [1SC2GM092300-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI030464, R37AI024716, R01AI030464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092300] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) NIAID Grant 5R37AI024716 (to A. S. R.), NIH, NIGMS, Grant 1SC2GM092300-01 (to I. A. H.), and NIH, NIAID, Grant R01 AI-030464 (to D. Y. B.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Boudko DY, 2005, P NATL ACAD SCI USA, V102, P1360, DOI 10.1073/pnas.0405183101; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ETOH M, 1994, COMP BIOCHEM PHYS A, V109, P361, DOI 10.1016/0300-9629(94)90139-2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; HAYS AR, 1990, ROUX ARCH DEV BIOL, V199, P114, DOI 10.1007/BF02029559; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; KIM JW, 1991, NATURE, V352, P725, DOI 10.1038/352725a0; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; Meleshkevitch EA, 2006, J EXP BIOL, V209, P3183, DOI 10.1242/jeb.02374; Miller A J, 1994, Symp Soc Exp Biol, V48, P167; Miller MM, 2008, INSECT BIOCHEM MOLEC, V38, P923, DOI 10.1016/j.ibmb.2008.07.005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vekony N, 2001, BIOCHEMISTRY-US, V40, P12387, DOI 10.1021/bi011345c; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	35	26	27	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10803	10813		10.1074/jbc.M110.179739	http://dx.doi.org/10.1074/jbc.M110.179739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21262963	Green Published, hybrid			2022-12-25	WOS:000288547000094
J	Kurihara, S; Suzuki, H; Oshida, M; Benno, Y				Kurihara, Shin; Suzuki, Hideyuki; Oshida, Mayu; Benno, Yoshimi			A Novel Putrescine Importer Required for Type 1 Pili-driven Surface Motility Induced by Extracellular Putrescine in Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYAMINE TRANSPORT; UTILIZATION PATHWAY; VIBRIO-CHOLERAE; GENES; SPERMIDINE; SYSTEM; STIMULATION; CHROMOSOME; EXPRESSION; BIOFILM	Recently, many studies have reported that polyamines play a role in bacterial cell-to-cell signaling processes. The present study describes a novel putrescine importer required for induction of type 1 pili-driven surface motility. The surface motility of the Escherichia coli Delta speAB Delta speC Delta potABCD strain, which cannot produce putrescine and cannot import spermidine from the medium, was induced by extracellular putrescine. Introduction of the gene deletions for known polyamine importers (Delta potE, Delta potFGHI, and Delta puuP) or a putative polyamine importer (Delta ydcSTUV) into the Delta speAB Delta speC Delta potABCD strain did not affect putrescine-induced surface motility. The deletion of yeeF, an annotated putative putrescine importer, in the Delta speAB Delta speC Delta potABCD Delta ydcSTUV strain abolished surface motility in putrescine-supplemented medium. Complementation of yeeF by a plasmid vector restored surface motility. The surface motility observed in the present study was abolished by the deletion of fimA, suggesting that the surface motility is type 1 pili-driven. A transport assay using the yeeF(+) or Delta yeeF strains revealed that YeeF is a novel putrescine importer. The K-m of YeeF (155 mu M) is 40 to 300 times higher than that of other importers reported previously. On the other hand, the V-max of YeeF (9.3 nmol/min/mg) is comparable to that of PotABCD, PotFGHI, and PuuP. The low affinity of YeeF for putrescine may allow E. coli to sense the cell density depending on the concentration of extracellular putrescine.	[Kurihara, Shin; Oshida, Mayu] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kurihara, Shin; Benno, Yoshimi] RIKEN, Benno Lab, Wako, Saitama 3510198, Japan; [Kurihara, Shin; Benno, Yoshimi] Grad Sch Sci & Technol, Div Appl Biol, Kyoto 6068585, Japan; [Kurihara, Shin; Suzuki, Hideyuki; Oshida, Mayu] Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan	Kyoto University; RIKEN; Kyoto Institute of Technology	Kurihara, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	kurisin711@livedoor.com			Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan [21380059]; Japan Society for the Promotion of Science	Bio-oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution. A part of this work was supported by Grant-in-aid for Scientific Research 21380059 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. S.).; Supported by a Japan Society for the Promotion of Science fellowship for young scientists. To whom correspondence should be addressed: Graduate School of Biostudies, Kyoto University, Kitashirakawa, Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan. Fax: 81-75-753-6275; E-mail: kurisin711@livedoor.com.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Brown II, 2001, J BACTERIOL, V183, P3784, DOI 10.1128/JB.183.12.3784-3790.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koyanagi T, 2004, J BACTERIOL, V186, P343, DOI 10.1128/JB.186.2.343-350.2004; KUEHN GD, 1990, PLANT PHYSIOL, V94, P855, DOI 10.1104/pp.94.3.855; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Kurihara S, 2009, FEMS MICROBIOL LETT, V294, P97, DOI 10.1111/j.1574-6968.2009.01552.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P37, DOI 10.1111/j.1348-0421.2007.tb03888.x; Miller J. H., 1992, SHORT COURSE BACTERI, P263; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Schiller D, 2000, J BACTERIOL, V182, P6247, DOI 10.1128/JB.182.21.6247-6249.2000; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; SUZUKI H, 1987, J BACTERIOL, V169, P3926, DOI 10.1128/jb.169.9.3926-3931.1987; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1986, P NATL ACAD SCI USA, V83, P6040, DOI 10.1073/pnas.83.16.6040; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; van Dam L, 2002, NUCLEIC ACIDS RES, V30, P419, DOI 10.1093/nar/30.2.419	38	27	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10185	10192		10.1074/jbc.M110.176032	http://dx.doi.org/10.1074/jbc.M110.176032			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266585	Green Published, hybrid			2022-12-25	WOS:000288547000034
J	Biedenweg, TA; Parsons, MH; Fleming, PA; Blumstein, DT				Biedenweg, Tine A.; Parsons, Michael H.; Fleming, Patricia A.; Blumstein, Daniel T.			Sounds Scary? Lack of Habituation following the Presentation of Novel Sounds	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; WALLABIES MACROPUS-EUGENII; PREDATION; DETERRENTS; VIGILANCE; BEHAVIOR; STARTLE; DEVICE	Background: Animals typically show less habituation to biologically meaningful sounds than to novel signals. We might therefore expect that acoustic deterrents should be based on natural sounds. Methodology: We investigated responses by western grey kangaroos (Macropus fulignosus) towards playback of natural sounds (alarm foot stomps and Australian raven (Corvus coronoides) calls) and artificial sounds (faux snake hiss and bull whip crack). We then increased rate of presentation to examine whether animals would habituate. Finally, we varied frequency of playback to investigate optimal rates of delivery. Principal Findings: Nine behaviors clustered into five Principal Components. PC factors 1 and 2 (animals alert or looking, or hopping and moving out of area) accounted for 36% of variance. PC factor 3 (eating cessation, taking flight, movement out of area) accounted for 13% of variance. Factors 4 and 5 (relaxing, grooming and walking; 12 and 11% of variation, respectively) discontinued upon playback. The whip crack was most evocative; eating was reduced from 75% of time spent prior to playback to 6% following playback (post alarm stomp: 32%, raven call: 49%, hiss: 75%). Additionally, 24% of individuals took flight and moved out of area (50 m radius) in response to the whip crack (foot stomp: 0%, raven call: 8% and 4%, hiss: 6%). Increasing rate of presentation (12x/min x2 min) caused 71% of animals to move out of the area. Conclusions/Significance: The bull whip crack, an artificial sound, was as effective as the alarm stomp at eliciting aversive behaviors. Kangaroos did not fully habituate despite hearing the signal up to 20x/min. Highest rates of playback did not elicit the greatest responses, suggesting that 'more is not always better'. Ultimately, by utilizing both artificial and biological sounds, predictability may be masked or offset, so that habituation is delayed and more effective deterrents may be produced.	[Biedenweg, Tine A.] Curtin Univ Technol, Dept Environm & Aquat Sci, Perth, WA, Australia; [Parsons, Michael H.; Fleming, Patricia A.] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia; [Parsons, Michael H.] SUNY Empire State Coll, Dept Biol, Hartsdale, NY USA; [Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Curtin University; Murdoch University; State University of New York (SUNY) System; SUNY Empire State College; University of California System; University of California Los Angeles	Biedenweg, TA (corresponding author), Curtin Univ Technol, Dept Environm & Aquat Sci, Perth, WA, Australia.	Michael.Parsons@esc.edu	Blumstein, Daniel T./B-6199-2012	Blumstein, Daniel T./0000-0001-5793-9244; Fleming, Patricia/0000-0002-0626-3851	Australian Research Council (ARC) [LPO7766512]; Minerals and Energy Resources Institute of Western Australia (MERIWA) [M394]; Barrick Gold; ChemCentre WA; Iluka Resources	Australian Research Council (ARC)(Australian Research Council); Minerals and Energy Resources Institute of Western Australia (MERIWA); Barrick Gold; ChemCentre WA; Iluka Resources	This research was partly supported by the Australian Research Council LPO7766512 (ARC; http://www.arc.gov.au) and also by the Minerals and Energy Resources Institute of Western Australia M394 (MERIWA; http://www.dmp.wa.gov.au/meriwa/index.asp) sponsored by Barrick Gold, ChemCentre WA, and Iluka Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bender H, 2005, WILDLIFE RES, V32, P649, DOI 10.1071/WR04091; BERGERUD AT, 1984, CAN J ZOOL, V62, P1566, DOI 10.1139/z84-229; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; Blumstein DT, 2002, BEHAV ECOL, V13, P657, DOI 10.1093/beheco/13.5.657; BOMFORD M, 1990, WILDLIFE SOC B, V18, P411; DAVIS M, 1970, J COMP PHYSIOL PSYCH, V72, P177, DOI 10.1037/h0029472; Dawson T.J., 1995, KANGAROOS BIOL LARGE; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; Fischer J, 1998, ANIM BEHAV, V55, P799, DOI 10.1006/anbe.1997.0663; Gelperin A, 2008, J CHEM ECOL, V34, P928, DOI 10.1007/s10886-008-9483-6; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Kastelein RA, 2000, MAR MAMMAL SCI, V16, P46, DOI 10.1111/j.1748-7692.2000.tb00903.x; KOEHLER AE, 1990, P 14 VERT PEST C; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Linhart Samuel B., 1992, Proceedings of the Vertebrate Pest Conference, V15, P386; MCDONALD I, 2007, 6 INT C FERT CONTR W; Mott D. F., 1988, P VERT PEST C, V13, P301; Muirhead S, 2006, WILDLIFE RES, V33, P131, DOI 10.1071/WR04032; NEWSOME AE, 1975, Q REV BIOL, V50, P389, DOI 10.1086/408742; Parsons MH, 2007, J WILDLIFE MANAGE, V71, P1225, DOI 10.2193/2006-096; Parsons MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010403; Parsons Michael H., 2007, BMC Ecology, V7, P13, DOI 10.1186/1472-6785-7-13; PFEIFER WK, 1982, P VERT PEST C, V10, P55; Pusenius J, 2002, ECOGRAPHY, V25, P481, DOI 10.1034/j.1600-0587.2002.250410.x; RAMP D, 2007, EVALUATION ACOUSTIC; Smith ME, 2000, ACTA AGR SCAND A-AN, V50, P304, DOI 10.1080/090647000750069502; SPANIER E, 1980, J APPL ECOL, V17, P287, DOI 10.2307/2402325; Staddon John E.R., 1993, Adaptive Behavior, V1, P421, DOI 10.1177/105971239300100402; STANKOWICH T, 2003, P R SOC B, V272, P2627; Talling JC, 1998, APPL ANIM BEHAV SCI, V58, P255, DOI 10.1016/S0168-1591(97)00142-1; Teilmann J, 2006, MAR MAMMAL SCI, V22, P240, DOI 10.1111/j.1748-7692.2006.00031.x; VerCauteren KC, 2005, WILDLIFE SOC B, V33, P1282, DOI 10.2193/0091-7648(2005)33[1282:EOAAFD]2.0.CO;2; Voipio HM, 1997, SCAND J LAB ANIM SCI, V24, P1; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8	39	26	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14549	10.1371/journal.pone.0014549	http://dx.doi.org/10.1371/journal.pone.0014549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267451	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500017
J	Lima, MA; Rudd, TR; de Farias, EHC; Ebner, LF; Gesteira, TF; de Souza, LM; Mendes, A; Cordula, CR; Martins, JRM; Hoppensteadt, D; Fareed, J; Sassaki, GL; Yates, EA; Tersariol, ILS; Nader, HB				Lima, Marcelo A.; Rudd, Timothy R.; de Farias, Eduardo H. C.; Ebner, Lyvia F.; Gesteira, Tarsis F.; de Souza, Lauro M.; Mendes, Aline; Cordula, Carolina R.; Martins, Joao R. M.; Hoppensteadt, Debra; Fareed, Jawed; Sassaki, Guilherme L.; Yates, Edwin A.; Tersariol, Ivarne L. S.; Nader, Helena B.			A New Approach for Heparin Standardization: Combination of Scanning UV Spectroscopy, Nuclear Magnetic Resonance and Principal Component Analysis	PLOS ONE			English	Article							OVERSULFATED CHONDROITIN SULFATE; ADVERSE CLINICAL EVENTS; BOVINE CRUDE HEPARIN; BENZYL ALCOHOL; CONTAMINANT; GLYCOSAMINOGLYCANS; NMR; SPECTRA	The year 2007 was marked by widespread adverse clinical responses to heparin use, leading to a global recall of potentially affected heparin batches in 2008. Several analytical methods have since been developed to detect impurities in heparin preparations; however, many are costly and dependent on instrumentation with only limited accessibility. A method based on a simple UV-scanning assay, combined with principal component analysis (PCA), was developed to detect impurities, such as glycosaminoglycans, other complex polysaccharides and aromatic compounds, in heparin preparations. Results were confirmed by NMR spectroscopy. This approach provides an additional, sensitive tool to determine heparin purity and safety, even when NMR spectroscopy failed, requiring only standard laboratory equipment and computing facilities.	[Lima, Marcelo A.; de Farias, Eduardo H. C.; Ebner, Lyvia F.; Gesteira, Tarsis F.; Mendes, Aline; Cordula, Carolina R.; Martins, Joao R. M.; Tersariol, Ivarne L. S.; Nader, Helena B.] Univ Fed Sao Paulo, Dept Bioquim, Disciplina Biol Mol, Sao Paulo, Brazil; [Rudd, Timothy R.; Yates, Edwin A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Hoppensteadt, Debra; Fareed, Jawed] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; [de Souza, Lauro M.; Sassaki, Guilherme L.] Univ Fed Parana, Dept Bioquim & Biol Mol, Lab Quim Carboidratos, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal de Sao Paulo (UNIFESP); University of Liverpool; Loyola University Chicago; Universidade Federal do Parana	Lima, MA (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Disciplina Biol Mol, Sao Paulo, Brazil.	hbnader.bioq@epm.br	Rudd, Tim/M-6129-2019; Yates, Edwin A/I-4808-2013; Lima, Marcelo/E-6841-2012; Nader, Helena Bonciani/D-9253-2012; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; Martins, João Roberto M/J-6042-2015; Souza, Lauro/AAE-3273-2019; Martins, João Roberto/AAC-6063-2021; Sassaki, Guilherme/AAM-1112-2020	Rudd, Tim/0000-0003-4434-0333; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; Martins, João Roberto M/0000-0002-0204-3552; Souza, Lauro/0000-0001-9166-2146; Martins, João Roberto/0000-0002-0204-3552; Sassaki, Guilherme/0000-0001-7420-168X; NADER, HELENA/0000-0002-7569-2166; Yates, Edwin/0000-0001-9365-5433	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) www.fapesp.br, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) www.capes.gov.br and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASU B, 1987, LANCET, V1, P1088; CEBULA TA, 1984, INFECT IMMUN, V44, P91, DOI 10.1128/IAI.44.1.91-96.1984; de Micalizzi YC, 1998, TALANTA, V47, P525, DOI 10.1016/S0039-9140(98)00080-0; DIETRICH CP, 1980, MECHANISM SACCHARIDE, P317; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; GERSHANIK J, 1982, NEW ENGL J MED, V307, P1384, DOI 10.1056/NEJM198211253072206; GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7; Guerrini M, 2001, SEMIN THROMB HEMOST, V27, P473, DOI 10.1055/s-2001-17958; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Guerrini M, 2009, THROMB HAEMOSTASIS, V102, P907, DOI 10.1160/TH09-02-0079; Guerrini M, 2009, P NATL ACAD SCI USA, V106, P16956, DOI 10.1073/pnas.0906861106; HERMANN K, 1994, ALLERGY, V49, P569, DOI 10.1111/j.1398-9995.1994.tb01131.x; HOLME KR, 1989, CARBOHYD RES, V186, P301, DOI 10.1016/0008-6215(89)84044-3; HOVINGH P, 1986, BIOCHEM J, V237, P573, DOI 10.1042/bj2370573; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Keire DA, 2010, J PHARMACEUT BIOMED, V51, P921, DOI 10.1016/j.jpba.2009.10.017; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Laux V, 2009, THROMB HAEMOSTASIS, V102, P892, DOI 10.1160/TH09-02-0134; Levieux A, 2001, J IMMUNOASS IMMUNOCH, V22, P323, DOI 10.1081/IAS-100107398; LINDAHL U, 1977, FED PROC, V36, P19; Liverani L, 2009, THROMB HAEMOSTASIS, V102, P846, DOI 10.1160/TH09-01-0064; MCEWEN I, 2008, PHARMEUROPA BIO, V1, P31; McEwen I, 2009, J PHARMACEUT BIOMED, V49, P816, DOI 10.1016/j.jpba.2008.12.012; MCGEOWN MG, 1955, J CLIN PATHOL, V8, P247, DOI 10.1136/jcp.8.3.247; McKee J, 2010, J CLIN PHARMACOL, V50, P1159, DOI 10.1177/0091270009355158; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Nader H. B., 1989, HEPARIN CHEM BIOL PR, P81; NADER HB, 1988, CARBOHYD RES, V184, P292, DOI 10.1016/0008-6215(88)80034-X; Pan J, 2010, J BIOL CHEM, V285, P22964, DOI 10.1074/jbc.M109.063735; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; PERLIN AS, 1971, CARBOHYD RES, V18, P185, DOI 10.1016/S0008-6215(00)80341-9; Rivera V, 2002, J PHARMACEUT BIOMED, V29, P443, DOI 10.1016/S0731-7085(02)00084-5; Rudd TR, 2008, CARBOHYD RES, V343, P2184, DOI 10.1016/j.carres.2007.12.019; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; Rudd TR, 2009, THROMB HAEMOSTASIS, V102, P874, DOI 10.1160/TH08-12-0797; Rudd TR, 2009, GLYCOBIOLOGY, V19, P52, DOI 10.1093/glycob/cwn103; Viskov C, 2009, CLIN APPL THROMB-HEM, V15, P395, DOI 10.1177/1076029609338710; Zhang ZQ, 2009, J PHARM SCI-US, V98, P4017, DOI 10.1002/jps.21729; 2009, PHARMACOPEIAL FORUM, V35	40	25	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15970	10.1371/journal.pone.0015970	http://dx.doi.org/10.1371/journal.pone.0015970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267460	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500033
J	Stieler, JT; Bullmann, T; Kohl, F; Toien, O; Bruckner, MK; Hartig, W; Barnes, BM; Arendt, T				Stieler, Jens T.; Bullmann, Torsten; Kohl, Franziska; Toien, Oivind; Brueckner, Martina K.; Haertig, Wolfgang; Barnes, Brian M.; Arendt, Thomas			The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; CYCLIN-DEPENDENT KINASE-5; ALZHEIMERS-DISEASE; PROTEIN-TAU; MICROTUBULE-BINDING; GROUND-SQUIRRELS; SELF-AGGREGATION; MOUSE-BRAIN; NEURODEGENERATIVE DISEASES; ABNORMAL PHOSPHORYLATION	Abnormal phosphorylation and aggregation of tau protein are hallmarks of a variety of neurological disorders, including Alzheimer's disease (AD). Increased tau phosphorylation is assumed to represent an early event in pathogenesis and a pivotal aspect for aggregation and formation of neurofibrillary tangles. However, the regulation of tau phosphorylation in vivo and the causes for its increased stage of phosphorylation in AD are still not well understood, a fact that is primarily based on the lack of adequate animal models. Recently we described the reversible formation of highly phosphorylated tau protein in hibernating European ground squirrels. Hence, mammalian hibernation represents a model system very well suited to study molecular mechanisms of both tau phosphorylation and dephosphorylation under in vivo physiological conditions. Here, we analysed the extent and kinetics of hibernation-state dependent tau phosphorylation in various brain regions of three species of hibernating mammals: arctic ground squirrels, Syrian hamsters and black bears. Overall, tau protein was highly phosphorylated in torpor states and phosphorylation levels decreased after arousal in all species. Differences between brain regions, hibernation-states and phosphosites were observed with respect to degree and kinetics of tau phosphorylation. Furthermore, we tested the phosphate net turnover of tau protein to analyse potential alterations in kinase and/or phosphatase activities during hibernation. Our results demonstrate that the hibernation-state dependent phosphorylation of tau protein is specifically regulated but involves, in addition, passive, temperature driven regulatory mechanisms. By determining the activity-state profile for key enzymes of tau phosphorylation we could identify kinases potentially involved in the differentially regulated, reversible tau phosphorylation that occurs during hibernation. We show that in black bears hibernation is associated with conformational changes of highly phosphorylated tau protein that are typically related to neuropathological alterations. The particular hibernation characteristics of black bears with a continuous torpor period and an only slightly decreased body temperature, therefore, potentially reflects the limitations of this adaptive reaction pattern and, thus, might indicate a transitional state of a physiological process.	[Stieler, Jens T.; Bullmann, Torsten; Brueckner, Martina K.; Arendt, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, Leipzig, Germany; [Stieler, Jens T.] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Univ Med Ctr, Mainz, Germany; [Kohl, Franziska; Toien, Oivind; Barnes, Brian M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Pathophysiol Neuroglia, Leipzig, Germany	Leipzig University; Johannes Gutenberg University of Mainz; University of Alaska System; University of Alaska Fairbanks; Leipzig University	Stieler, JT (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, Leipzig, Germany.	jens.stieler@gmx.de	Arendt, Thomas/C-8747-2012; Stieler, Jens T/A-5111-2017; Brückner, Martina . K./A-5201-2017	Stieler, Jens T/0000-0002-3770-3258; Toien, Oivind/0000-0001-5967-2483; Arendt, Thomas/0000-0003-4553-1625	Medical Faculty of the University of Leipzig [formel.1-51]; Interdisciplinary Center for Clinical Research at the University of Leipzig [IZKF-C1]; National Science Foundation; U.S. Army Medical Research [W81XWH-06-1-0121]; Material Command	Medical Faculty of the University of Leipzig; Interdisciplinary Center for Clinical Research at the University of Leipzig; National Science Foundation(National Science Foundation (NSF)); U.S. Army Medical Research(United States Department of DefenseUS Army Research Laboratory (ARL)); Material Command	This study was supported by a grant from the Medical Faculty of the University of Leipzig (formel.1-51) to J.T. Stieler, a grant from the Interdisciplinary Center for Clinical Research at the University of Leipzig (IZKF-C1) to T. Arendt, and by grants from the National Science Foundation and Contract W81XWH-06-1-0121, from the U.S. Army Medical Research, and Material Command to B.M. Barnes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Bielska AA, 2006, BIOCHEMISTRY-US, V45, P5527, DOI 10.1021/bi052662c; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Bullmann T, 2007, HIPPOCAMPUS, V17, P98, DOI 10.1002/hipo.20255; Chohan MO, 2005, J NEURAL TRANSM, V112, P1035, DOI 10.1007/s00702-004-0241-9; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P629, DOI 10.1097/00005072-198811000-00006; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Devous MD, 2002, EUR J NUCL MED MOL I, V29, P1685, DOI 10.1007/s00259-002-0967-2; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Du JT, 2007, FEBS J, V274, P5012, DOI 10.1111/j.1742-4658.2007.06018.x; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gartner U, 1998, NEUROBIOL AGING, V19, P535, DOI 10.1016/S0197-4580(98)00094-3; Gasparini L, 2003, TRENDS NEUROSCI, V26, P404, DOI 10.1016/S0166-2236(03)00163-2; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hartig W, 2007, EUR J NEUROSCI, V25, P69, DOI 10.1111/j.1460-9568.2006.05250.x; Haley AP, 2006, MAGN RESON IMAGING, V24, P715, DOI 10.1016/j.mri.2005.12.020; Heininger K, 2000, REV NEUROSCIENCE, V11, P213; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; Ikeda Y, 2007, FEBS LETT, V581, P891, DOI 10.1016/j.febslet.2007.01.064; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Iqbal K, 2005, ACTA NEUROPATHOL, V109, P25, DOI 10.1007/s00401-004-0951-y; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kim YK, 2003, J NUCL MED, V44, P1006; King ME, 2005, BBA-MOL BASIS DIS, V1739, P260, DOI 10.1016/j.bbadis.2004.06.019; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Long RA, 2007, J WILDLIFE MANAGE, V71, P1375, DOI 10.2193/2006-399; LYMAN CP, 1948, J EXP ZOOL, V109, P55, DOI 10.1002/jez.1401090105; MacDonald JA, 2005, INT J BIOCHEM CELL B, V37, P679, DOI 10.1016/j.biocel.2004.05.023; MERCKEN M, 1992, ACTA NEUROPATHOL, V84, P265, DOI 10.1007/BF00227819; Millesi E, 2001, J BIOL RHYTHM, V16, P264, DOI 10.1177/074873001129001971; NELSON RA, 1975, MAYO CLIN PROC, V50, P141; NELSON RA, 1973, MAYO CLIN PROC, V48, P733; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; Oklejewicz M, 2001, J COMP PHYSIOL B, V171, P431; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Stieler J.T., 2008, HYPOMETABOLISM ANIMA, P133; Stieler JT, 2009, J NEURAL TRANSM, V116, P345, DOI 10.1007/s00702-008-0181-x; Strijkstra AM, 2003, NEUROSCI LETT, V344, P29, DOI 10.1016/S0304-3940(03)00399-9; Su B, 2008, J NEUROCHEM, V105, P2098, DOI 10.1111/j.1471-4159.2008.05294.x; Swaab DF, 2003, ALZ DIS ASSOC DIS, V17, pS114, DOI 10.1097/00002093-200307004-00006; Toien O, 1999, FASEB J, V13, pA740; UEDA S, 1995, PHYSIOL BEHAV, V58, P653, DOI 10.1016/0031-9384(95)00095-Z; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x; Zhu XW, 2005, J NEUROSCI RES, V80, P862, DOI 10.1002/jnr.20526	85	76	76	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14530	10.1371/journal.pone.0014530	http://dx.doi.org/10.1371/journal.pone.0014530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267079	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500008
J	Parker, PG; Buckles, EL; Farrington, H; Petren, K; Whiteman, NK; Ricklefs, RE; Bollmer, JL; Jimenez-Uzcategui, G				Parker, Patricia G.; Buckles, Elizabeth L.; Farrington, Heather; Petren, Kenneth; Whiteman, Noah K.; Ricklefs, Robert E.; Bollmer, Jennifer L.; Jimenez-Uzcategui, Gustavo			110 Years of Avipoxvirus in the Galapagos Islands	PLOS ONE			English	Article							DISEASE; POPULATIONS; EXTINCTION; THREATS; EPIZOOTIOLOGY; CONSERVATION; MOCKINGBIRD; DIVERSITY; GENETICS; ORIGIN	The role of disease in regulating populations is controversial, partly owing to the absence of good disease records in historic wildlife populations. We examined birds collected in the Galapagos Islands between 1891 and 1906 that are currently held at the California Academy of Sciences and the Zoologisches Staatssammlung Muenchen, including 3973 specimens representing species from two well-studied families of endemic passerine birds: finches and mockingbirds. Beginning with samples collected in 1899, we observed cutaneous lesions consistent with Avipoxvirus on 226 (6.3%) specimens. Histopathology and viral genotyping of 59 candidate tissue samples from six islands showed that 21 (35.6%) were positive for Avipoxvirus, while alternative diagnoses for some of those testing negative by both methods were feather follicle cysts, non-specific dermatitis, or post mortem fungal colonization. Positive specimens were significantly nonrandomly distributed among islands both for mockingbirds (San Cristobal vs. Espanola, Santa Fe and Santa Cruz) and for finches (San Cristobal and Isabela vs. Santa Cruz and Floreana), and overall highly significantly distributed toward islands that were inhabited by humans (San Cristobal, Isabela, Floreana) vs. uninhabited at the time of collection (Santa Cruz, Santa Fe, Espanola), with only one positive individual on an uninhabited island. Eleven of the positive specimens sequenced successfully were identical at four diagnostic sites to the two canarypox variants previously described in contemporary Galapagos passerines. We conclude that this virus was introduced late in 1890's and was dispersed among islands by a variety of mechanisms, including regular human movements among colonized islands. At present, this disease represents an ongoing threat to the birds on the Galapagos Islands.	[Parker, Patricia G.; Whiteman, Noah K.; Ricklefs, Robert E.; Bollmer, Jennifer L.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Parker, Patricia G.] WildCare Inst, St Louis, MO USA; [Buckles, Elizabeth L.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Farrington, Heather; Petren, Kenneth] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Jimenez-Uzcategui, Gustavo] Charles Darwin Fdn, Dept Vertebrates, Puerto Ayora, Ecuador	University of Missouri System; University of Missouri Saint Louis; Cornell University; University System of Ohio; University of Cincinnati	Parker, PG (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	pparker@umsl.edu	Jimenez-Uzcategui, Gustavo/AAN-7374-2020; Jiménez-Uzcátegui, Gustavo/AAJ-3802-2020	Jimenez-Uzcategui, Gustavo/0000-0001-8520-7534; Whiteman, Noah/0000-0003-1448-4678; Petren, Kenneth/0000-0002-7936-6042	E. Desmond Lee Endowment in Zoological Studies	E. Desmond Lee Endowment in Zoological Studies	This work was supported by the E. Desmond Lee Endowment in Zoological Studies associated with PGP's position. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Bataille A, 2009, P NATL ACAD SCI USA, V106, P10230, DOI 10.1073/pnas.0901308106; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Conway Ainslee, 1947, ENCHANTED ISLANDS; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; DASZAK P, 2003, J PARASITOL, V89, pS37; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; DEEM SL, GALAPAGOS R IN PRESS; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Gifford E. W., 1919, Proceedings of the California Academy of Science (4th Series), V2; Hoeck PEA, 2010, BIOL LETTERS, V6, P212, DOI 10.1098/rsbl.2009.0778; Hoeck PEA, 2010, PHILOS T R SOC B, V365, P1127, DOI 10.1098/rstb.2009.0311; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; JIMENEZUZCATEGU.G, 2007, BRENESIA, V67, P29; JIMENEZUZCATEGU.G, 2008, CENSO CUCUVE FLOREAN; KLEINDORFER S, 2006, J AVIAN BIOL, V22, P247; Levin II, 2009, BIOL CONSERV, V142, P3191, DOI 10.1016/j.biocon.2009.06.017; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Santiago-Alarcon D, 2006, WILSON J ORNITHOL, V118, P194, DOI 10.1676/05-010.1; Sato A, 2001, MOL BIOL EVOL, V18, P299, DOI 10.1093/oxfordjournals.molbev.a003806; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; STEADMAN DW, 1991, QUATERNARY RES, V36, P126, DOI 10.1016/0033-5894(91)90021-V; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; STEADMAN DW, 1986, SMITHSONIAN CONTRIB, V4131, P1; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tripathy D. N., 1993, V4, P5; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Watkins G., 2007, GALAPAGOS RISK SOCIO; Whiteman NK, 2005, IBIS, V147, P844, DOI 10.1111/j.1474-919x.2005.00468.x; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wikelski M, 2004, ECOL SOC, V9	40	59	62	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e15989	10.1371/journal.pone.0015989	http://dx.doi.org/10.1371/journal.pone.0015989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249151	Green Published, gold			2022-12-25	WOS:000286515000009
J	Bergstrom, HC; McDonald, CG; Johnson, LR				Bergstrom, Hadley C.; McDonald, Craig G.; Johnson, Luke R.			Pavlovian Fear Conditioning Activates a Common Pattern of Neurons in the Lateral Amygdala of Individual Brains	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-A; MEMORY; CIRCUITS; RAT	Understanding the physical encoding of a memory (the engram) is a fundamental question in neuroscience. Although it has been established that the lateral amygdala is a key site for encoding associative fear memory, it is currently unclear whether the spatial distribution of neurons encoding a given memory is random or stable. Here we used spatial principal components analysis to quantify the topography of activated neurons, in a select region of the lateral amygdala, from rat brains encoding a Pavlovian conditioned fear memory. Our results demonstrate a stable, spatially patterned organization of amygdala neurons are activated during the formation of a Pavlovian conditioned fear memory. We suggest that this stable neuronal assembly constitutes a spatial dimension of the engram.	[Bergstrom, Hadley C.; Johnson, Luke R.] Uniformed Serv Univ USU, Sch Med, Bethesda, MD USA; [Bergstrom, Hadley C.; Johnson, Luke R.] Ctr Neurosci & Regenerat Med CNRM, Rockville, MD USA; [McDonald, Craig G.] George Mason Univ, Fairfax, VA 22030 USA; [Bergstrom, Hadley C.; Johnson, Luke R.] Ctr Study Traumat Stress CSTS, Bethesda, MD USA	George Mason University	Bergstrom, HC (corresponding author), Uniformed Serv Univ USU, Sch Med, Bethesda, MD USA.	LukeJohnsonPhD@gmail.com	Bergstrom, Hadley/S-1178-2019; McDonald, Craig/H-7390-2013	Bergstrom, Hadley/0000-0003-3677-1619; Johnson PhD, Luke R/0000-0002-5088-1788	Center for the Study of Traumatic Stress (CSTS); Uniformed Services University (USU) [G188KY]	Center for the Study of Traumatic Stress (CSTS); Uniformed Services University (USU)	The authors are grateful to the Center for the Study of Traumatic Stress (CSTS) and the Uniformed Services University (USU) G188KY for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom HC, 2008, SYNAPSE, V62, P31, DOI 10.1002/syn.20467; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DESMITH MJ, 2009, GEOSPATIAL ANAL MATA; Doron NN, 1999, J COMP NEUROL, V412, P383; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Johnson LR, 2004, ANATOMY FEAR MICROCI; Johnson LR, 2009, FRONT NEUROSCI-SWITZ, V3, P198, DOI 10.3389/neuro.01.027.2009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCDONALD CG, 2010, PSYCHOPHYSIOLOGY; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nakamura NH, 2010, NEUROSCIENCE, V166, P994, DOI 10.1016/j.neuroscience.2009.12.069; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Radley JJ, 2007, BRAIN RES, V1134, P87, DOI 10.1016/j.brainres.2006.11.045; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2008, LEARN MEMORY, V15, P55, DOI 10.1101/lm.746808; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Veening JG, 2009, NEUROSCIENCE, V163, P1046, DOI 10.1016/j.neuroscience.2009.06.064	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e15698	10.1371/journal.pone.0015698	http://dx.doi.org/10.1371/journal.pone.0015698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LX	21264324	Green Published, Green Submitted, gold			2022-12-25	WOS:000286514300003
J	Iacob, RE; Zhang, JM; Gray, NS; Engen, JR				Iacob, Roxana E.; Zhang, Jianming; Gray, Nathanael S.; Engen, John R.			Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; TYROSINE KINASE; HYDROGEN-EXCHANGE; IN-VITRO; C-ABL; SELECTIVE INHIBITOR; CRYSTAL-STRUCTURE; T315I MUTANT	Abl kinase inhibitors targeting the ATP binding pocket are currently employed as potent anti-leukemogenic agents but drug resistance has become a significant clinical limitation. Recently, a compound that binds to the myristate pocket of Abl (GNF-5) was shown to act cooperatively with nilotinib, an ATP-competitive inhibitor to target the recalcitrant "T315I" gatekeeper mutant of Bcr-Abl. To uncover an explanation for how drug binding at a distance from the kinase active site could lead to inhibition and how inhibitors could combine their effects, hydrogen exchange mass spectrometry (HX MS) was employed to monitor conformational effects in the presence of both dasatinib, a clinically approved ATP-site inhibitor, and GNF-5. While dasatinib binding to wild type Abl clearly influenced Abl conformation, no binding was detected between dasatinib and T315I. GNF-5, however, elicited the same conformational changes in both wild type and T315I, including changes to dynamics within the ATP site located approximately 25 A from the site of GNF-5 interaction. Simultaneous binding of dasatinib and GNF-5 to T315I caused conformational and/or dynamics changes in Abl such that effects of dasatinib on T315I were the same as when it bound to wild type Abl. These results provide strong biophysical evidence that allosteric interactions play a role in Abl kinase downregulation and that targeting sites outside the ATP binding site can provide an important pharmacological tool to overcome mutations that cause resistance to ATP-competitive inhibitors.	[Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Zhang, Jianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Boston, MA USA; [Zhang, Jianming; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Iacob, RE (corresponding author), Pfizer Inc, Boston, MA USA.	j.engen@neu.edu		Engen, John R./0000-0002-6918-9476	NIH [R01-GM070590]; Novartis Institute of Biomedical Research; Waters Corporation; NATIONAL CANCER INSTITUTE [R01CA130876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institute of Biomedical Research; Waters Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported with funding from the NIH: R01-GM070590 (JRE), the Novartis Institute of Biomedical Research (NSG), and a research collaboration with the Waters Corporation (JRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Dharmasiri K, 1996, ANAL CHEM, V68, P2340, DOI 10.1021/ac9601526; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Giles FJ, 2005, CURR MOL MED, V5, P615, DOI 10.2174/156652405774641115; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Huang WS, 2009, J MED CHEM, V52, P4743, DOI 10.1021/jm900166t; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Jabbour E, 2006, CURR OPIN ONCOL, V18, P578, DOI 10.1097/01.cco.0000245314.97638.d3; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; KORNBERG A, 1951, J BIOL CHEM, V189, P123; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Morgan CR, 2009, CURR PROTOC PROTEIN, P11; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Noronha G, 2008, CURR TOP MED CHEM, V8, P905, DOI 10.2174/156802608784911635; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2010, BLOOD, V115, P4206, DOI 10.1182/blood-2009-11-251751; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x	46	55	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15929	10.1371/journal.pone.0015929	http://dx.doi.org/10.1371/journal.pone.0015929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264348	gold, Green Published, Green Submitted			2022-12-25	WOS:000286513100018
J	Ravi, D; Chen, YD; Karia, B; Brown, A; Gu, TT; Li, J; Carey, MS; Hennessy, BT; Bishop, AJR				Ravi, Dashnamoorthy; Chen, Yidong; Karia, Bijal; Brown, Adam; Gu, Ting Ting; Li, Jie; Carey, Mark S.; Hennessy, Bryan T.; Bishop, Alexander J. R.			14-3-3 sigma Expression Effects G2/M Response to Oxygen and Correlates with Ovarian Cancer Metastasis	PLOS ONE			English	Article							CELL-CYCLE; BREAST-CANCER; DNA-DAMAGE; TUMOR OXYGENATION; MULTIPLE SITES; HUMAN CDC2; SOFT-AGAR; PROTEIN; CARCINOMA; GROWTH	Background: In vitro cell culture experiments with primary cells have reported that cell proliferation is retarded in the presence of ambient compared to physiological O-2 levels. Cancer is primarily a disease of aberrant cell proliferation, therefore, studying cancer cells grown under ambient O-2 may be undesirable. To understand better the impact of O-2 on the propagation of cancer cells in vitro, we compared the growth potential of a panel of ovarian cancer cell lines under ambient (21%) or physiological (3%) O-2. Principal Findings: Our observations demonstrate that similar to primary cells, many cancer cells maintain an inherent sensitivity to O-2, but some display insensitivity to changes in O-2 concentration. Further analysis revealed an association between defective G2/M cell cycle transition regulation and O-2 insensitivity resultant from overexpression of 14-3-3 sigma. Targeting 14-3-3 sigma overexpression with RNAi restored O-2 sensitivity in these cell lines. Additionally, we found that metastatic ovarian tumors frequently overexpress 14-3-3 sigma, which in conjunction with phosphorylated RB, results in poor prognosis. Conclusions: Cancer cells show differential proliferative sensitivity to changes in O-2 concentration. Although a direct link between O-2 insensitivity and metastasis was not determined, this investigation showed that an O-2 insensitive phenotype in cancer cells to correlate with metastatic tumor progression.	[Ravi, Dashnamoorthy; Chen, Yidong; Karia, Bijal; Brown, Adam; Gu, Ting Ting; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Ravi, Dashnamoorthy; Karia, Bijal; Brown, Adam; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Li, Jie; Carey, Mark S.; Hennessy, Bryan T.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA; [Carey, Mark S.] Univ British Columbia, Div Gynecol Oncol, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Hennessy, Bryan T.] Beaumont Hosp, Dept Med Oncol, Dublin 9, Ireland	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; University of British Columbia	Ravi, D (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	bishopa@uthscsa.edu	Dashnamoorthy, Ravi/B-8540-2013	Dashnamoorthy, Ravi/0000-0002-6108-2076; Hennessy, Bryan/0000-0002-7871-6477; Bishop, Alexander/0000-0002-5742-4387	NIEHS [K22-ES12264]; Max and Minnie Tomerlin Voelcker Fund; Robert and Janice McNair Foundation; American Society of Clinical Oncology (ASCO); Cancer FoundationScience Foundation Ireland (SFI)/Health Research Board (HRB (Ireland)); DOD CDRMP [BC093931]; NIA [T32AG021890]; NIH/NCI cancer center [P30 CA054174-17]; NIH/NCRR CTSA [1UL1RR025767]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Max and Minnie Tomerlin Voelcker Fund; Robert and Janice McNair Foundation; American Society of Clinical Oncology (ASCO); Cancer FoundationScience Foundation Ireland (SFI)/Health Research Board (HRB (Ireland))(Science Foundation Ireland); DOD CDRMP; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCRR CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIEHS (K22-ES12264) and a Voelcker Fund Young Investigator Award from the Max and Minnie Tomerlin Voelcker Fund to A.J.R. Bishop. Kleberg Center for Molecular Markers at the M.D. Anderson Cancer Center, The M.D. Anderson Cancer Center Physician Scientist Program, the McNair Scholars Program supported by the Robert and Janice McNair Foundation and an American Society of Clinical Oncology (ASCO) cancer foundation Career Development Award (CDA), Cancer Foundation and by a Science Foundation Ireland (SFI)/Health Research Board (HRB (Ireland)) Translational Research Award (TRA), all to B.T. Hennessy. B. Karia is supported by DOD CDRMP Breast Cancer Research Program Predoctoral Traineeship Award (BC093931). A. Brown is supported by NIA T32 training grant (T32AG021890). Y. Chen is supported by NIH/NCI cancer center grant (P30 CA054174-17) and NIH/NCRR CTSA grant (1UL1RR025767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaiz-Pena GN, 2009, CLIN CANCER RES, V15, P2971, DOI 10.1158/1078-0432.CCR-08-2525; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; BALIN AK, 1978, J CELL BIOL, V78, P390, DOI 10.1083/jcb.78.2.390; Berry L D, 1996, Prog Cell Cycle Res, V2, P99; BRIZEL DM, 1995, INT J RADIAT ONCOL, V32, P1121, DOI 10.1016/0360-3016(95)00106-9; Brown JM, 1998, CANCER RES, V58, P1408; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Carrera S, 2010, J BIOL CHEM, V285, P13658, DOI 10.1074/jbc.M109.062562; Chavez-Munoz C, 2008, J CELL BIOCHEM, V104, P2165, DOI 10.1002/jcb.21774; Cheng L, 2004, CLIN CANCER RES, V10, P3064, DOI 10.1158/1078-0432.CCR-03-0652; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Eguchi T, 2007, ONCOGENE, V26, P509, DOI 10.1038/sj.onc.1209810; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Ghahary A, 2005, J INVEST DERMATOL, V124, P170, DOI 10.1111/j.0022-202X.2004.23521.x; Ghahary A, 2004, J INVEST DERMATOL, V122, P1188, DOI 10.1111/j.0022-202X.2004.22519.x; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; GUPTA V, 1982, CANCER RES, V42, P1005; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HORNSBY PJ, 2003, SCI AGING KNOWLEDGE, pPE21; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ito Y, 2003, CANCER LETT, V200, P161, DOI 10.1016/S0304-3835(03)00282-9; Kaldis P, 2005, CELL CYCLE, V4, P1491, DOI 10.4161/cc.4.11.2124; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KISHIMOTO T, 1994, INT J DEV BIOL, V38, P185; Lam E, 2005, J INVEST DERMATOL, V125, P230, DOI 10.1111/j.0022-202X.2005.23765.x; Laser H, 1937, BIOCHEM J, V31, P1671, DOI 10.1042/bj0311671; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Li ZM, 2009, AM J TRANSL RES, V1, P326; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Magagnin MG, 2006, DRUG RESIST UPDATE, V9, P185, DOI 10.1016/j.drup.2006.07.002; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; Nakayama H, 2005, PATHOL INT, V55, P707, DOI 10.1111/j.1440-1827.2005.01900.x; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Okada T, 2006, ANTICANCER RES, V26, P3105; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Payton M, 2006, CANCER RES, V66, P4299, DOI 10.1158/0008-5472.CAN-05-2507; Perathoner A, 2005, CLIN CANCER RES, V11, P3274, DOI 10.1158/1078-0432.CCR-04-2207; Poot M, 1996, EXP CELL RES, V222, P262, DOI 10.1006/excr.1996.0033; POOT M, 1988, CYTOMETRY, V9, P332, DOI 10.1002/cyto.990090410; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Quayle SN, 2007, CANCER LETT, V254, P137, DOI 10.1016/j.canlet.2007.03.003; Ramirez PT, 2008, GYNECOL ONCOL, V108, P68, DOI 10.1016/j.ygyno.2007.08.071; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Ravi D, 1999, HISTOPATHOLOGY, V34, P241, DOI 10.1046/j.1365-2559.1999.00575.x; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shibuya EK, 2003, CELL CYCLE, V2, P39, DOI 10.4161/cc.2.1.291; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; SRIDHAR KS, 1983, CANCER RES, V43, P4629; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sullivan M, 2006, MOL HUM REPROD, V12, P653, DOI 10.1093/molehr/gal081; Tanaka K, 2004, INT J ONCOL, V25, P1591; TARNOWSKI BI, 1993, PEDIATR PATHOL, V13, P249, DOI 10.3109/15513819309048211; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Treacher DF, 1998, BRIT MED J, V317, P1302, DOI 10.1136/bmj.317.7168.1302; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; van Hemert MJ, 2004, J CELL SCI, V117, P1411, DOI 10.1242/jcs.00990; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yi B, 2009, J CELL BIOCHEM, V106, P858, DOI 10.1002/jcb.22051; Zhang L, 2009, BIOINFORMATICS, V25, P650, DOI 10.1093/bioinformatics/btn663	71	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15864	10.1371/journal.pone.0015864	http://dx.doi.org/10.1371/journal.pone.0015864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249227	Green Published, Green Submitted, gold			2022-12-25	WOS:000286513100015
J	Jufvas, A; Stralfors, P; Vener, AV				Jufvas, Asa; Stralfors, Peter; Vener, Alexander V.			Histone Variants and Their Post-Translational Modifications in Primary Human Fat Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; PHOSPHORYLATION; H2B; PROTEIN; LYSINE; H3; ACETYLATION; METHYLTRANSFERASE; REPLICATION	Epigenetic changes related to human disease cannot be fully addressed by studies of cells from cultures or from other mammals. We isolated human fat cells from subcutaneous abdominal fat tissue of female subjects and extracted histones from either purified nuclei or intact cells. Direct acid extraction of whole adipocytes was more efficient, yielding about 100 mu g of protein with histone content of 60%-70% from 10 mL of fat cells. Differential proteolysis of the protein extracts by trypsin or ArgC-protease followed by nanoLC/MS/MS with alternating CID/ETD peptide sequencing identified 19 histone variants. Four variants were found at the protein level for the first time; particularly HIST2H4B was identified besides the only H4 isoform earlier known to be expressed in humans. Three of the found H2A potentially organize small nucleosomes in transcriptionally active chromatin, while two H2AFY variants inactivate X chromosome in female cells. HIST1H2BA and three of the identified H1 variants had earlier been described only as oocyte or testis specific histones. H2AFX and H2AFY revealed differential and variable N-terminal processing. Out of 78 histone modifications by acetylation/trimethylation, methylation, dimethylation, phosphorylation and ubiquitination, identified from six subjects, 68 were found for the first time. Only 23 of these modifications were detected in two or more subjects, while all the others were individual specific. The direct acid extraction of adipocytes allows for personal epigenetic analyses of human fat tissue, for profiling of histone modifications related to obesity, diabetes and metabolic syndrome, as well as for selection of individual medical treatments.	[Jufvas, Asa; Stralfors, Peter; Vener, Alexander V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Jufvas, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	alexander.vener@liu.se		Stralfors, Peter/0000-0002-1196-1806	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council to P.S. and to A.V.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Akan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004479; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Carlberg I, 2003, P NATL ACAD SCI USA, V100, P757, DOI 10.1073/pnas.0235452100; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; DRABENT B, 1991, GENE, V103, P263, DOI 10.1016/0378-1119(91)90284-I; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Garcia BA, 2008, J PROTEOME RES, V7, P4225, DOI 10.1021/pr800044q; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; HAYASHI T, 1982, J BIOCHEM-TOKYO, V92, P1995, DOI 10.1093/oxfordjournals.jbchem.a134131; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jung HR, 2010, MOL CELL PROTEOMICS, V9, P838, DOI 10.1074/mcp.M900489-MCP200; Kabra Dhiraj G, 2009, Biochim Biophys Acta, V1792, P574, DOI 10.1016/j.bbadis.2009.03.003; KUROKAWA M, 1988, CARCINOGENESIS, V9, P419, DOI 10.1093/carcin/9.3.419; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Lu AP, 2009, J PROTEOME RES, V8, P4207, DOI 10.1021/pr9000652; MARASHI F, 1984, P NATL ACAD SCI-BIOL, V81, P1936, DOI 10.1073/pnas.81.7.1936; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Martin-Gronert MS, 2010, J NUTR, V140, P662, DOI 10.3945/jn.109.111237; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Molina H, 2008, ANAL CHEM, V80, P4825, DOI 10.1021/ac8007785; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oge A, 2007, DIABETOLOGIA, V50, P1099, DOI 10.1007/s00125-007-0617-0; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; OZBAL CC, 1994, CANCER RES, V54, P5599; Raychaudhuri N, 2008, J BIOL CHEM, V283, P13611, DOI 10.1074/jbc.M800128200; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schwanbeck R, 1997, J BIOL CHEM, V272, P27476, DOI 10.1074/jbc.272.43.27476; Shevchenko A, 2002, MOL BIOTECHNOL, V20, P107, DOI 10.1385/MB:20:1:107; Sobott F, 2009, J AM SOC MASS SPECTR, V20, P1652, DOI 10.1016/j.jasms.2009.04.023; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Su XD, 2009, PROTEOMICS, V9, P1197, DOI 10.1002/pmic.200800333; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka M, 2001, DEVELOPMENT, V128, P655; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thakar A, 2009, BIOCHEMISTRY-US, V48, P10852, DOI 10.1021/bi901129e; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Trelle MB, 2007, EXPERT REV PROTEOMIC, V4, P491, DOI 10.1586/14789450.4.4.491; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; YU L, 1994, J BIOL CHEM, V269, P4144; Zalensky AO, 2002, J BIOL CHEM, V277, P43474, DOI 10.1074/jbc.M206065200	71	26	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e15960	10.1371/journal.pone.0015960	http://dx.doi.org/10.1371/journal.pone.0015960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249133	Green Published, gold			2022-12-25	WOS:000286512900014
J	Li, Y; Cang, M; Lee, AS; Zhang, KH; Liu, DJ				Li, Yang; Cang, Ming; Lee, Andrew Stephen; Zhang, Kehua; Liu, Dongjun			Reprogramming of Sheep Fibroblasts into Pluripotency under a Drug-Inducible Expression of Mouse-Derived Defined Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CULTURE-MEDIUM; GENERATION; ESTABLISHMENT; LINES; SYSTEM	Animal embryonic stem cells (ESCs) provide powerful tool for studies of early embryonic development, gene targeting, cloning, and regenerative medicine. However, the majority of attempts to establish ESC lines from large animals, especially ungulate mammals have failed. Recently, another type of pluripotent stem cells, known as induced pluripotent stem cells (iPSCs), have been successfully generated from mouse, human, monkey, rat and pig. In this study we show sheep fibroblasts can be reprogrammed to pluripotency by defined factors using a drug-inducible system. Sheep iPSCs derived in this fashion have a normal karyotype, exhibit morphological features similar to those of human ESCs and express AP, Oct4, Sox2, Nanog and the cell surface marker SSEA-4. Pluripotency of these cells was further confirmed by embryoid body (EB) and teratoma formation assays which generated derivatives of all three germ layers. Our results also show that the substitution of knockout serum replacement (KSR) with fetal bovine serum in culture improves the reprogramming efficiency of sheep iPSCs. Generation of sheep iPSCs places sheep on the front lines of large animal preclinical trials and experiments involving modification of animal genomes.	[Li, Yang] Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Beijing 100871, Peoples R China; [Cang, Ming; Liu, Dongjun] Inner Mongolia Univ, Coll Life Sci, Lab Anim Res Ctr, Hohhot, Peoples R China; [Lee, Andrew Stephen] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Zhang, Kehua] China Japan Friendship Hosp, Inst Clin Med, Dept Immun, Beijing, Peoples R China; [Li, Yang] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100871, Peoples R China	Peking University; Inner Mongolia University; Stanford University; China-Japan Friendship Hospital; Peking University	Li, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Stem Cell Res Ctr, Beijing 100871, Peoples R China.	liyang@bjmu.edu.cn; nmliudongjun@sina.com	Lee, Andrew/GVU-2817-2022		Chinese National 863 Project [2008AA101005]	Chinese National 863 Project	The Chinese National 863 Project (2008AA101005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CAMPBELL KH, 1996, NATURE, P380; Dattena M, 2006, MOL REPROD DEV, V73, P31, DOI 10.1002/mrd.20378; Denning C, 2001, Cloning Stem Cells, V3, P221, DOI 10.1089/15362300152725945; DOETSCHMAN T, 1988, DEV BIOL, V127, P224, DOI 10.1016/0012-1606(88)90204-7; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee ST, 2006, FERTIL STERIL, V86, P1137, DOI 10.1016/j.fertnstert.2006.01.056; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li Y, 2010, CELL REPROGRAM, V12, P237, DOI 10.1089/cell.2009.0103; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Moore K, 1997, IN VITRO CELL DEV-AN, V33, P62; NOTARIANNI E, 1991, J REPROD FERTIL, P255; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TALBOT NC, 1995, MOL REPROD DEV, V42, P35, DOI 10.1002/mrd.1080420106; TALBOT NC, 1993, IN VITRO CELL DEV-AN, V29A, P543; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	37	70	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15947	10.1371/journal.pone.0015947	http://dx.doi.org/10.1371/journal.pone.0015947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253598	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511900029
J	Tessema, GT; Moretro, T; Snipen, L; Axelsson, L; Naterstad, K				Tessema, Girum Tadesse; Moretro, Trond; Snipen, Lars; Axelsson, Lars; Naterstad, Kristine			Global Transcriptional Analysis of Spontaneous Sakacin P-Resistant Mutant Strains of Listeria monocytogenes during Growth on Different Sugars	PLOS ONE			English	Article							CLASS-IIA BACTERIOCINS; PHOSPHOTRANSFERASE SYSTEM; ENTEROCOCCUS-FAECALIS; FITNESS COSTS; PEDIOCIN PA-1; PTS PERMEASE; GENE; PEPTIDE; SENSITIVITY; EXPRESSION	Subclass IIa bacteriocins have strong antilisterial activity and can control the growth of Listeria monocytogenes in food. However, L. monocytogenes may develop resistance towards such bacteriocins. In this follow-up study, the transcriptomes of a high level (L502-1) and a low level (L502-6) spontaneous sakacin P-resistant mutant strain of L. monocytogenes were compared to the wild-type (L502). The growth of the resistant strains was reduced on mannose but not affected on cellobiose and the transcriptomics was performed during growth on these sugars. The mannose phosphotransferase system (PTS) encoded by the mptACD operon (mpt) is known for transporting mannose and also act as a receptor to class IIa bacteriocins. The mpt was repressed in L502-1 and this is in accordance with abolition of the bacteriocin receptor with resistance to class IIa bacteriocins. In contrast, the mpt was induced in L502-6. Despite the induction of the mpt, L502-6 showed 1,000 times more resistance phenotype and reduced growth on mannose suggesting the mannose-PTS may not be functional in L502-6. The microarray data suggests the presence of other transcriptional responses that may be linked to the sakacin P resistance phenotype particularly in L502-6. Most of commonly regulated genes encode proteins involved in transport and energy metabolism. The resistant strains displayed shift in general carbon catabolite control possibly mediated by the mpt. Our data suggest that the resistant strains may have a reduced virulence potential. Growth sugar- and mutant-specific responses were also revealed. The two resistant strains also displayed difference in stability of the sakacin P resistance phenotype, growth in the presence of both the lytic bacteriophage P100 and activated charcoal. Taken together, the present study showed that a single time exposure to the class IIa bacteriocin sakacin P may elicit contrasting phenotypic and transcriptome responses in L. monocytogenes possibly through regulation of the mpt.	[Tessema, Girum Tadesse; Moretro, Trond; Axelsson, Lars; Naterstad, Kristine] Nofima Mat AS, As, Norway; [Tessema, Girum Tadesse; Snipen, Lars] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Nofima; Norwegian University of Life Sciences	Tessema, GT (corresponding author), Nofima Mat AS, As, Norway.	girum.tadesse@nofima.no	Moretro, Trond/AAZ-5689-2021	Moretro, Trond/0000-0001-5176-1158	Foundation for Research Levy on Agricultural Products	Foundation for Research Levy on Agricultural Products	This work was funded by the Foundation for Research Levy on Agricultural Products. TM, LA, and KN are employees at Nofima Mat AS. GTT was a Nofima Mat AS full-time employee at the time when this study was performed. Since GTT, TM, LA, and KN were employees of Nofima Mat AS when the experiments reported in this publication were carried out, Nofima Mat AS is considered by PLoS ONE to have funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Arous S, 2004, FEMS MICROBIOL LETT, V238, P37, DOI 10.1016/j.femsle.2004.07.014; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Carlton RM, 2005, REGUL TOXICOL PHARM, V43, P301, DOI 10.1016/j.yrtph.2005.08.005; Coffey A, 1996, APPL ENVIRON MICROB, V62, P1252, DOI 10.1128/AEM.62.4.1252-1256.1996; D'Angelis CEM, 2009, J FOOD SAFETY, V29, P636, DOI 10.1111/j.1745-4565.2009.00183.x; Dalet K, 2001, MICROBIOL-SGM, V147, P3263, DOI 10.1099/00221287-147-12-3263; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Dieterich G, 2006, NUCLEIC ACIDS RES, V34, pD402, DOI 10.1093/nar/gkj071; Drider D, 2006, MICROBIOL MOL BIOL R, V70, P564, DOI 10.1128/MMBR.00016-05; Dykes GA, 1998, LETT APPL MICROBIOL, V26, P5, DOI 10.1046/j.1472-765X.1998.00255.x; ELLIOTT J, 1978, MOL GEN GENET, V161, P1, DOI 10.1007/BF00266608; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Gravesen A, 2004, APPL ENVIRON MICROB, V70, P1669, DOI 10.1128/AEM.70.3.1669-1679.2004; Gravesen A, 2002, MICROBIOL-SGM, V148, P2361, DOI 10.1099/00221287-148-8-2361; Gravesen A, 2002, APPL ENVIRON MICROB, V68, P756, DOI 10.1128/AEM.68.2.756-764.2002; Guinane CM, 2005, J APPL MICROBIOL, V98, P1316, DOI 10.1111/j.1365-2672.2005.02552.x; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hinds J, 2002, METHOD MICROBIOL, V33, P83; Katla T, 2003, APPL ENVIRON MICROB, V69, P4431, DOI 10.1128/AEM.69.8.4431-4437.2003; Kim HJ, 2006, J BACTERIOL, V188, P179, DOI 10.1128/JB.188.1.179-190.2006; KJOS M, 2010, J BACTERIOL IN PRESS; Kjos M, 2009, MICROBIOL-SGM, V155, P2949, DOI 10.1099/mic.0.030015-0; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Larsen MH, 2006, MOL MICROBIOL, V61, P1622, DOI 10.1111/j.1365-2958.2006.05328.x; Liu D., 2008, HDB LISTERIA MONOCYT; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Martinez RCR, 2005, BRAZ J MICROBIOL, V36, P83, DOI 10.1590/S1517-83822005000100016; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Moretro T, 2005, RES MICROBIOL, V156, P949, DOI 10.1016/j.resmic.2005.05.005; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Naghmouchi K, 2007, FOOD MICROBIOL, V24, P718, DOI 10.1016/j.fm.2007.03.012; Nes IF, 2007, FOOD SCI BIOTECHNOL, V16, P675; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Opsata M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-224; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Ramnath M, 2000, APPL ENVIRON MICROB, V66, P3098, DOI 10.1128/AEM.66.7.3098-3101.2000; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; Rodriguez JM, 2002, CRIT REV FOOD SCI, V42, P91, DOI 10.1080/10408690290825475; RYSER TE, 2007, LISTERIA LISTERIOSIS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soni KA, 2010, FOODBORNE PATHOG DIS, V7, P427, DOI 10.1089/fpd.2009.0432; Stevens MJA, 2010, APPL ENVIRON MICROB, V76, P3748, DOI 10.1128/AEM.00073-10; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; Tessema GT, 2009, APPL ENVIRON MICROB, V75, P6973, DOI 10.1128/AEM.00608-09; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vadyvaloo V, 2004, MICROBIOL-SGM, V150, P3025, DOI 10.1099/mic.0.27059-0; Vadyvaloo V, 2002, APPL ENVIRON MICROB, V68, P5223, DOI 10.1128/AEM.68.11.5223-5230.2002; Vignolo G, 2000, CURR MICROBIOL, V41, P410, DOI 10.1007/s002840010159; Vu-Khac H, 2009, APPL ENVIRON MICROB, V75, P6671, DOI 10.1128/AEM.01104-09	60	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16192	10.1371/journal.pone.0016192	http://dx.doi.org/10.1371/journal.pone.0016192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253597	gold, Green Submitted, Green Published			2022-12-25	WOS:000286511900041
J	Trombetta, B; Cruciani, F; Sellitto, D; Scozzari, R				Trombetta, Beniamino; Cruciani, Fulvio; Sellitto, Daniele; Scozzari, Rosaria			A New Topology of the Human Y Chromosome Haplogroup E1b1 (E-P2) Revealed through the Use of Newly Characterized Binary Polymorphisms	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; MIGRATORY EVENTS; AFRICA; DIVERSITY; EVOLUTION; ORIGIN; TREE	Haplogroup E1b1, defined by the marker P2, is the most represented human Y chromosome haplogroup in Africa. A phylogenetic tree showing the internal structure of this haplogroup was published in 2008. A high degree of internal diversity characterizes this haplogroup, as well as the presence of a set of chromosomes undefined on the basis of a derived character. Here we make an effort to update the phylogeny of this highly diverse haplogroup by including seven mutations which have been newly discovered by direct resequencing. We also try to incorporate five previously-described markers which were not, however, reported in the 2008 tree. Additionally, during the process of mapping, we found that two previously reported SNPs required a new position on the tree. There are three key changes compared to the 2008 phylogeny. Firstly, haplogroup E-M2 (former E1b1a) and haplogroup E-M329 (former E1b1c) are now united by the mutations V38 and V100, reducing the number of E1b1 basal branches to two. The new topology of the tree has important implications concerning the origin of haplogroup E1b1. Secondly, within E1b1b1 (E-M35), two haplogroups (E-V68 and E-V257) show similar phylogenetic and geographic structure, pointing to a genetic bridge between southern European and northern African Y chromosomes. Thirdly, most of the E1b1b1* (E-M35*) paragroup chromosomes are now marked by defining mutations, thus increasing the discriminative power of the haplogroup for use in human evolution and forensics.	[Trombetta, Beniamino; Cruciani, Fulvio; Sellitto, Daniele; Scozzari, Rosaria] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Sellitto, Daniele] CNR, Ist Biol & Patol Mol, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Trombetta, B (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy.	rosaria.scozzari@uniroma1.it	Cruciani, Fulvio/G-6105-2012	Trombetta, Beniamino/0000-0001-8245-9437; Cruciani, Fulvio/0000-0002-6900-024X	Sapienza Universita di Roma; Grandi Progetti di Ateneo	Sapienza Universita di Roma; Grandi Progetti di Ateneo	This work was supported by the Sapienza Universita di Roma, Grandi Progetti di Ateneo (to R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Butler JM, 2005, FORENSIC DNA TYPING; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2008, AM J HUM BIOL, V20, P614, DOI 10.1002/ajhb.20790; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Ellis N, 2002, GENOME RES, V12, P339; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M., 2007, BIOTECHNIQUES, V43, pS16; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	21	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e16073	10.1371/journal.pone.0016073	http://dx.doi.org/10.1371/journal.pone.0016073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253605	Green Submitted, Green Published, gold			2022-12-25	WOS:000286511900039
J	Chowdhury, SR; Savithri, HS				Chowdhury, Soumya Roy; Savithri, Handanahal S.			Interaction of Sesbania Mosaic Virus Movement Protein with VPg and P10: Implication to Specificity of Genome Recognition	PLOS ONE			English	Article							CELL-TO-CELL; DEPENDENT RNA-POLYMERASE; COCKSFOOT-MOTTLE-VIRUS; NATIVELY UNFOLDED VPG; LINKED PROTEIN; SERINE-PROTEASE; CAPSID PROTEIN; POTYVIRUS; BINDING; REPLICATION	Sesbania mosaic virus (SeMV) is a single strand positive-sense RNA plant virus that belongs to the genus Sobemovirus. The mechanism of cell-to-cell movement in sobemoviruses has not been well studied. With a view to identify the viral encoded ancillary proteins of SeMV that may assist in cell-to-cell movement of the virus, all the proteins encoded by SeMV genome were cloned into yeast Matchmaker system 3 and interaction studies were performed. Two proteins namely, viral protein genome linked (VPg) and a 10-kDa protein (P10) c v gft encoded by OFR 2a, were identified as possible interacting partners in addition to the viral coat protein (CP). Further characterization of these interactions revealed that the movement protein (MP) recognizes cognate RNA through interaction with VPg, which is covalently linked to the 59 end of the RNA. Analysis of the deletion mutants delineated the domains of MP involved in the interaction with VPg and P10. This study implicates for the first time that VPg might play an important role in specific recognition of viral genome by MP in SeMV and shed light on the possible role of P10 in the viral movement.	[Chowdhury, Soumya Roy; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Chowdhury, SR (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in			Department of Biotechnology, New Delhi, India; Indian Institute of Science, Bangalore, India [BT/PR9527/INF/22/75/2007/25-9.2009]; University Grant Commission, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Indian Institute of Science, Bangalore, India; University Grant Commission, New Delhi, India(University Grants Commission, India)	The authors thank the Department of Biotechnology, New Delhi, India and Indian Institute of Science, Bangalore, India, grant number BT/PR9527/INF/22/75/2007/25-9.2009, for financial support. Soumya Roy Chowdhury thanks the University Grant Commission, New Delhi, India, for the senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzhanova DV, 2001, EMBO J, V20, P6997, DOI 10.1093/emboj/20.24.6997; BHUVANESHWARI M, 1995, STRUCTURE, V3, P1021, DOI 10.1016/S0969-2126(01)00238-6; Bonneau C, 1998, VIROLOGY, V244, P79, DOI 10.1006/viro.1998.9100; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Carrington JC, 1998, PLANT J, V14, P393, DOI 10.1046/j.1365-313X.1998.00120.x; Carvalho CM, 2003, J GEN VIROL, V84, P2271, DOI 10.1099/vir.0.19101-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOWDHURY SR, 2010, MOL CHARACTERIZATION; Dolja V V, 1995, Virology, V206, P1007, DOI 10.1006/viro.1995.1023; DOLJA VV, 1994, EMBO J, V13, P1482, DOI 10.1002/j.1460-2075.1994.tb06403.x; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; Govind K, 2010, VIROLOGY, V401, P280, DOI 10.1016/j.virol.2010.02.025; Grzela R, 2008, J BIOL CHEM, V283, P213, DOI 10.1074/jbc.M705666200; Gu CJ, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1132, DOI 10.1134/S0006297909100095; HASHIMOTO Y, 1986, ARCH VIROL, V90, P301, DOI 10.1007/BF01317378; Herzog E, 1998, VIROLOGY, V248, P312, DOI 10.1006/viro.1998.9287; Kaiser WJ, 2006, J GEN VIROL, V87, P363, DOI 10.1099/vir.0.81456-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence DM, 2001, J VIROL, V75, P8712, DOI 10.1128/JVI.75.18.8712-8723.2001; Lee JY, 2001, TRENDS MICROBIOL, V9, P5, DOI 10.1016/S0966-842X(00)01901-6; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Lokesh GL, 2001, ARCH VIROL, V146, P209, DOI 10.1007/s007050170170; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Meier M, 2006, VIRUS GENES, V32, P321, DOI 10.1007/s11262-005-6917-x; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; NAIR S, 2009, FEBS LETT; Nair S, 2008, VIROLOGY, V382, P83, DOI 10.1016/j.virol.2008.08.034; Nair S, 2010, VIROLOGY, V396, P106, DOI 10.1016/j.virol.2009.09.025; OSMAN TAM, 1992, J GEN VIROL, V73, P223, DOI 10.1099/0022-1317-73-2-223; Rantalainen KI, 2008, VIROLOGY, V377, P280, DOI 10.1016/j.virol.2008.04.025; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; ROULEAU M, 1994, VIROLOGY, V204, P254, DOI 10.1006/viro.1994.1530; Sarmiento C, 2007, VIRUS RES, V123, P95, DOI 10.1016/j.virusres.2006.07.013; Satheshkumar PS, 2005, J MOL BIOL, V353, P447, DOI 10.1016/j.jmb.2005.08.021; Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200; Satheshkumar PS, 2004, J MOL BIOL, V342, P1001, DOI 10.1016/j.jmb.2004.07.022; Savithri HS, 2010, CURR SCI INDIA, V98, P346; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Sivakumaran K, 1998, VIROLOGY, V252, P376, DOI 10.1006/viro.1998.9489; SKRYABIN KG, 1988, FEBS LETT, V240, P33, DOI 10.1016/0014-5793(88)80335-1; Tamm T, 2000, VIRUS RES, V66, P197, DOI 10.1016/S0168-1702(00)00125-8; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; YOSHIDA N, 1988, J BIOCHEM, V104, P451, DOI 10.1093/oxfordjournals.jbchem.a122488	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15609	10.1371/journal.pone.0015609	http://dx.doi.org/10.1371/journal.pone.0015609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246040	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000286511200010
J	Hammond, SM; Gogliotti, RG; Rao, V; Beauvais, A; Kothary, R; DiDonato, CJ				Hammond, Suzan M.; Gogliotti, Rocky G.; Rao, Vamshi; Beauvais, Ariane; Kothary, Rashmi; DiDonato, Christine J.			Mouse Survival Motor Neuron Alleles That Mimic SMN2 Splicing and Are Inducible Rescue Embryonic Lethality Early in Development but Not Late	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SINGLE NUCLEOTIDE; DETERMINING GENE; CARDIAC DEFECTS; MODEL; EXPRESSION; SMA; MICE; INACTIVATION; PHENOTYPE	Spinal muscular atrophy (SMA) is caused by low survival motor neuron (SMN) levels and patients represent a clinical spectrum due primarily to varying copies of the survival motor neuron-2 (SMN2) gene. Patient and animals studies show that disease severity is abrogated as SMN levels increase. Since therapies currently being pursued target the induction of SMN, it will be important to understand the dosage, timing and cellular requirements of SMN for disease etiology and potential therapeutic intervention. This requires new mouse models that can induce SMN temporally and/or spatially. Here we describe the generation of two hypomorphic Smn alleles, Smn(C-T-Neo) and Smn(2B-Neo). These alleles mimic SMN2 exon 7 splicing, titre Smn levels and are inducible. They were specifically designed so that up to three independent lines of mice could be generated, herein we describe two. In a homozygous state each allele results in embryonic lethality. Analysis of these mutants indicates that greater than 5% of Smn protein is required for normal development. The severe hypomorphic nature of these alleles is caused by inclusion of a loxP-flanked neomycin gene selection cassette in Smn intron 7, which can be removed with Cre recombinase. In vitro and in vivo experiments demonstrate these as inducible Smn alleles. When combined with an inducible Cre mouse, embryonic lethality caused by low Smn levels can be rescued early in gestation but not late. This provides direct genetic evidence that a therapeutic window for SMN inductive therapies may exist. Importantly, these lines fill a void for inducible Smn alleles. They also provide a base from which to generate a large repertoire of SMA models of varying disease severities when combined with other Smn alleles or SMN2-containing mice.	[Hammond, Suzan M.; Gogliotti, Rocky G.; Rao, Vamshi; DiDonato, Christine J.] Childrens Mem Res Ctr, Human Mol Genet Program, Chicago, IL USA; [Hammond, Suzan M.; Gogliotti, Rocky G.; Rao, Vamshi; DiDonato, Christine J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Beauvais, Ariane; Kothary, Rashmi] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Beauvais, Ariane; Kothary, Rashmi] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Northwestern University; Feinberg School of Medicine; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Hammond, SM (corresponding author), Childrens Mem Res Ctr, Human Mol Genet Program, Chicago, IL USA.	c-didonato@northwestern.edu	Rao, Vamshi/AAK-3259-2020	Rao, Vamshi/0000-0002-0130-2292; Kothary, Rashmi/0000-0002-9239-7310; Hammond, Suzan/0000-0002-5640-7569	National Institutes of Health [1RO1NS060926, 1R21HD058311]; Canadian Institutes of Health Research (CIHR); Families of Spinal Muscular Atrophy; NIH [T32 AG000260]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Families of Spinal Muscular Atrophy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by the National Institutes of Health [1RO1NS060926 and 1R21HD058311] to CJD, the Canadian Institutes of Health Research (CIHR) to RK and the Families of Spinal Muscular Atrophy to CJD. RK is a recipient of a University Health Research Chair from the University of Ottawa. RG is supported by a NIH training grant [T32 AG000260] "Drug Discovery Training in Age-related Disorders." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias L, 2009, HUM GENET, V125, P29, DOI 10.1007/s00439-008-0598-1; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Coady TH, 2007, MOL THER, V15, P1471, DOI 10.1038/sj.mt.6300222; Araujo APDC, 2009, J PEDIATR-US, V155, P292, DOI 10.1016/j.jpeds.2009.01.071; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; DiDonato CJ, 2001, HUM MOL GENET, V10, P2727, DOI 10.1093/hmg/10.23.2727; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Garcia P, 2005, GENESIS, V43, P189, DOI 10.1002/gene.20170; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; HEIER CR, 2009, HUM MOL GENET; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Levin SI, 2004, GENESIS, V39, P234, DOI 10.1002/gene.20050; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Papaioannou VE, 2005, MOUSE PHENOTYPES HDB; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Viollet L, 1997, GENOMICS, V40, P185, DOI 10.1006/geno.1996.4551; Vitte JM, 2004, AM J PATHOL, V165, P1731, DOI 10.1016/S0002-9440(10)63428-1; Voronina VA, 2005, GENESIS, V41, P160, DOI 10.1002/gene.20109; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	55	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2010	5	12							e15887	10.1371/journal.pone.0015887	http://dx.doi.org/10.1371/journal.pone.0015887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CZ	21249120	Green Published, gold, Green Submitted			2022-12-25	WOS:000285793200067
J	Li, LH; Zhang, H; Varrin-Doyer, M; Zamvil, SS; Verkman, AS				Li, Lihua; Zhang, Hua; Varrin-Doyer, Michel; Zamvil, Scott S.; Verkman, A. S.			Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation	FASEB JOURNAL			English	Article						water channel; neuromyelitis optics; astrocyte; EAE	NEUROMYELITIS-OPTICA; EXTRACELLULAR-SPACE; WATER; MICE; BRAIN; LACKING; MOUSE; EXPRESSION; DELETION; LESIONS	Aquaporin-4 (AQP4) deficiency in mice reduces neuroinflammation in experimental autoimmune encephalomyelitis (EAE) produced by active immunization with myelin oligodendrocyte glycoprotein peptide (MOG). Potential mechanisms for the protective effect of AQP4 deficiency were investigated, including AQP4-dependent leukocyte and microglia cell function, immune cell entry in the central nervous system (CNS), intrinsic neuroinflammation, and humoral immune response. As we found with active-immunization EAE, neuroinflammation was greatly reduced in AQP4-knockout mice in adoptive-transfer EAE. AQP4 was absent in immune cells, including activated T lymphocytes. The CNS migration of fluorescently labeled, MOG-sensitized T lymphocytes was comparable in wild-type and AQP4-knockout mice. Microglia did not express AQP4. Serum anti-AQP4 antibodies were absent in EAE. Remarkably, intracerebral injection of LPS produced much greater neuroinflammation in wild-type than in AQP4-knockout mice, and cytokine (TNF-alpha and IL-6) secretion was reduced in astrocyte cultures from AQP4-knockout mice. Adenovirus-mediated expression of AQP4, or of an unrelated aquaporin, AQP1, increased cytokine secretion in astrocyte and nonastrocyte cell cultures, supporting the involvement of aquaporin water permeability in cytokine secretion. Our data suggest an intrinsic proinflammatory role of AQP4 involving AQP4-dependent astrocyte swelling and cytokine release. Reduction in AQP4 water transport may be protective in neuroinflammatory CNS diseases.-Li, L., Zhang, H., Varrin-Doyer, M., Zamvil, S. S., Verkman, A. S. Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB J. 25, 1556-1566 (2011). www.fasebj.org	[Li, Lihua; Zhang, Hua; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Li, Lihua; Zhang, Hua; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Varrin-Doyer, Michel; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower,Box 0521, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			Guthy-Jackson Charitable Foundation; U.S. National Institutes of Health (NIH) [DK35124, EY13574, HL73856, DK72517, DK86125, EB00415]; NIH [AI73737, NS63008]; National Multiple Sclerosis Society [RG4124]; Maisin Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, RC1DK086125, R01DK035124, R37DK035124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	Guthy-Jackson Charitable Foundation; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Maisin Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Guthy-Jackson Charitable Foundation (A. S. V. and S.S.Z.); U.S. National Institutes of Health (NIH) grants DK35124, EY13574, HL73856, DK72517, DK86125, and EB00415 (A. S. V.); and NIH grants AI73737 and NS63008, National Multiple Sclerosis Society grant RG4124, and the Maisin Foundation (S.S.Z.).	Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Cho SJ, 2002, P NATL ACAD SCI USA, V99, P4720, DOI 10.1073/pnas.072083499; Martin MD, 2007, FRONT BIOSCI-LANDMRK, V12, P2735, DOI 10.2741/2268; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li LH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-94; Lu DC, 2008, FASEB J, V22, P3216, DOI 10.1096/fj.07-104836; Lyons JA, 2002, EUR J IMMUNOL, V32, P1905, DOI 10.1002/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s88, 10.1002/0471142735.im1501s77]; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Ransohoff RM, 2006, J CLIN INVEST, V116, P2313, DOI 10.1172/JCI29834; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Sugiya H, 2006, J MEMBRANE BIOL, V210, P155, DOI 10.1007/s00232-005-0853-5; Swanson RA, 1997, J NEUROSCI, V17, P932; Tomas-Camardiel M, 2004, J NEUROCHEM, V91, P891, DOI 10.1111/j.1471-4159.2004.02759.x; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Weinshenker BG, 2006, DIS MARKERS, V22, P197, DOI 10.1155/2006/586306; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Zhang H, 2010, BIOPHYS J, V99, P1284, DOI 10.1016/j.bpj.2010.06.023	38	133	149	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1556	1566		10.1096/fj.10-177279	http://dx.doi.org/10.1096/fj.10-177279			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21257712	Green Published			2022-12-25	WOS:000290023800013
J	Trostchansky, A; Bonilla, L; Thomas, CP; O'Donnell, VB; Marnett, LJ; Radi, R; Rubbo, H				Trostchansky, Andres; Bonilla, Lucia; Thomas, Christopher P.; O'Donnell, Valerie B.; Marnett, Lawrence J.; Radi, Rafael; Rubbo, Homero			Nitroarachidonic Acid, a Novel Peroxidase Inhibitor of Prostaglandin Endoperoxide H Synthases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; MANGANO PROTOPORPHYRIN-IX; NITRIC-OXIDE; ARACHIDONIC-ACID; CYCLOOXYGENASE INHIBITION; PLATELET-AGGREGATION; NITROGEN-DIOXIDE; MECHANISM; INACTIVATION; PEROXYNITRITE	Prostaglandin endoperoxide H synthase (PGHS) catalyzes the oxidation of arachidonate to prostaglandin H-2. We have previously synthesized and chemically characterized nitroarachidonic acid (AANO(2)), a novel anti-inflammatory signaling mediator. Herein, the interaction of AANO(2) with PGHS was analyzed. AANO(2) inhibited oxygenase activity of PGHS-1 but not PGHS-2. AANO(2) exhibited time- and concentration-dependent inhibition of peroxidase activity in both PGHS-1 and -2. The plot of k(obs) versus AANO(2) concentrations showed a hyperbolic function with k(inact) = 0.045 s(-1) and K-t(infinity aPP) = 0.019 mu m for PGHS-1 and k(inact) = 0.057 and K-t(infinity app) K-t(infinity aPP) = 0.020 mu m for PGHS-2. Kinetic analysis suggests that inactivation of PGHS by AANO(2) involves two sequential steps: an initial reversible binding event (described by K-t) followed by a practically irreversible event (K-t(infinity aPP)) leading to an inactivated enzyme. Inactivation was associated with irreversible disruption of heme binding to the protein. The inhibitory effects of AANO(2) were selective because other nitro-fatty acids tested, such as nitrooleic acid and nitrolinoleic acid, were unable to inhibit enzyme activity. In activated human platelets, AANO(2) significantly decreased PGHS-1-dependent thromboxane B-2 formation in parallel with a decrease in platelet aggregation, thus confirming the biological relevance of this novel inhibitory pathway.	[Trostchansky, Andres; Bonilla, Lucia; Radi, Rafael; Rubbo, Homero] Fac Med, Dept Bioquim, Montevideo, Uruguay; [Trostchansky, Andres; Bonilla, Lucia; Radi, Rafael; Rubbo, Homero] Fac Med, Ctr Free Radical & Biomed Res, Montevideo, Uruguay; [Thomas, Christopher P.; O'Donnell, Valerie B.] Cardiff Univ, Dept Infect Immun & Biochem, Cardiff CF4 4XN, S Glam, Wales; [Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Cardiff University; Vanderbilt University	Rubbo, H (corresponding author), Fac Med, Dept Bioquim, Avda Gen Flores 2125, Montevideo, Uruguay.	hrubbo@fmed.edu.uy	Thomas, Christopher P/R-5243-2016; O'Donnell, Valerie/C-6948-2012; Trostchansky, Andres/I-5624-2019	Thomas, Christopher P/0000-0001-5840-8613; Trostchansky, Andres/0000-0002-9721-7577; Rubbo, Homero/0000-0002-7897-6551; /0000-0003-4089-8460	National Institutes of Health [GM15431]; Fondo Clemente Estable-ANII [FCE_516]; Programa de Desarrollo Tecnologico-ANII; Wellcome Trust; Howard Hughes Medical Institute; Sistema Nacional de Becas-ANII; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Clemente Estable-ANII; Programa de Desarrollo Tecnologico-ANII; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sistema Nacional de Becas-ANII; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM15431 (to L. J. M.). This work was also supported by Fondo Clemente Estable-ANII Grant FCE_516 (to A. T.), Programa de Desarrollo Tecnologico-ANII (to H. R.), Wellcome Trust (to H. R. and V. O. D.), and Howard Hughes Medical Institute (to R. R.). L. B. was partially supported by a fellowship from Sistema Nacional de Becas-ANII.	AGWU DE, 1983, CAN J COMP MED, V47, P203; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Balazy Michael, 2004, Current Vascular Pharmacology, V2, P81, DOI 10.2174/1570161043476465; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; DiRosa M, 1996, PROSTAG LEUKOTR ESS, V54, P229, DOI 10.1016/S0952-3278(96)90053-8; Goodwin DC, 1999, FASEB J, V13, P1121, DOI 10.1096/fasebj.13.10.1121; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; Kalgutkar AS, 1996, BIOCHEMISTRY-US, V35, P9076, DOI 10.1021/bi9605752; KARTHEIN R, 1987, EUR J BIOCHEM, V166, P173, DOI 10.1111/j.1432-1033.1987.tb13499.x; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; KITZ R, 1962, J BIOL CHEM, V237, P3245; KULMACZ RJ, 1987, PROSTAGLANDINS, V34, P225, DOI 10.1016/0090-6980(87)90246-2; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Marnett LJ, 2002, PROSTAG OTH LIPID M, V68-9, P153, DOI 10.1016/S0090-6980(02)00027-8; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Michibayashi T, 2005, J ATHEROSCLER THROMB, V12, P154, DOI 10.5551/jat.12.154; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; O'Donnell VB, 2000, J BIOL CHEM, V275, P38239, DOI 10.1074/jbc.M001802200; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Trostchansky A, 2007, FREE RADICAL BIO MED, V42, P1029, DOI 10.1016/j.freeradbiomed.2007.01.009; Tsai AL, 1997, J BIOL CHEM, V272, P8885; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Wu G, 2001, J BIOL CHEM, V276, P19879, DOI 10.1074/jbc.M100628200	45	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12891	12900		10.1074/jbc.M110.154518	http://dx.doi.org/10.1074/jbc.M110.154518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21266582	Green Published, hybrid			2022-12-25	WOS:000289282200009
J	Jenkins, CM; Yang, JY; Sims, HF; Gross, RW				Jenkins, Christopher M.; Yang, Jingyue; Sims, Harold F.; Gross, Richard W.			Reversible High Affinity Inhibition of Phosphofructokinase-1 by Acyl-CoA A MECHANISM INTEGRATING GLYCOLYTIC FLUX WITH LIPID METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; AUTOMATED PROTEIN-STRUCTURE; NITRIC-OXIDE SYNTHASE; FATTY-ACID; FRUCTOSE 2,6-BISPHOSPHATE; I-TASSER; GLUCOSE 1,6-BISPHOSPHATE; INSULIN-RESISTANCE; GLYCOGEN-SYNTHESIS; SKELETAL-MUSCLE	The enzyme phosphofructokinase-1 (PFK-1) catalyzes the first committed step of glycolysis and is regulated by a complex array of allosteric effectors that integrate glycolytic flux with cellular bioenergetics. Here, we demonstrate the direct, potent, and reversible inhibition of purified rabbit muscle PFK-1 by low micromolar concentrations of long chain fatty acyl-CoAs (apparent K-i similar to 1 mu M). In sharp contrast, short chain acyl-CoAs, palmitoylcarnitine, and palmitic acid in the presence of CoASH were without effect. Remarkably, MgAMP and MgADP but not MgATP protected PFK-1 against inhibition by palmitoyl-CoA indicating that acyl-CoAs regulate PFK-1 activity in concert with cellular high energy phosphate status. Furthermore, incubation of PFK-1 with [1-C-14] palmitoyl-CoA resulted in robust acylation of the enzyme that was reversible by incubation with acyl-protein thioesterase-1 (APT1). Importantly, APT1 reversed palmitoyl-CoA-mediated inhibition of PFK-1 activity. Mass spectrometric analyses of palmitoylated PFK-1 revealed four sites of acylation, including Cys-114, Cys-170, Cys-351, and Cys-577. PFK-1 in both skeletal muscle extracts and in purified form was inhibited by S-hexadecyl-CoA, a nonhydrolyzable palmitoyl-CoA analog, demonstrating that covalent acylation of PFK-1 was not required for inhibition. Tryptic footprinting suggested that S-hexadecyl-CoA induced a conformational change in PFK-1. Both palmitoyl-CoA and S-hexadecyl-CoA increased the association of PFK-1 with Ca2+/calmodulin, which attenuated the binding of palmitoylated PFK-1 to membrane vesicles. Collectively, these results demonstrate that fatty acyl-CoA modulates phosphofructokinase activity through both covalent and noncovalent interactions to regulate glycolytic flux and enzyme membrane localization via the branch point metabolic node that mediates lipid flux through anabolic and catabolic pathways.	[Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278, RO1HL41250]; LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LipoSpectrum; Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Ashkenazy-Shahar M, 1998, MOL GENET METAB, V65, P213, DOI 10.1006/mgme.1998.2759; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bajaj M, 2005, DIABETES, V54, P3148, DOI 10.2337/diabetes.54.11.3148; BERGER M, 1976, BIOCHEM J, V158, P191, DOI 10.1042/bj1580191; BLOXHAM DP, 1973, ENZYMES, P240; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOCK PE, 1976, J BIOL CHEM, V251, P5637; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; BUSCHMEIER B, 1987, J BIOL CHEM, V262, P9454; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chalkley SM, 1998, METABOLISM, V47, P1121, DOI 10.1016/S0026-0495(98)90287-6; CHENZION M, 1992, INT J BIOCHEM, V24, P1661, DOI 10.1016/0020-711X(92)90185-4; CHOATE GL, 1985, J BIOL CHEM, V260, P4815; COLOMBO G, 1975, J BIOL CHEM, V250, P9404; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Ellis BA, 2000, AM J PHYSIOL-ENDOC M, V279, pE554, DOI 10.1152/ajpendo.2000.279.3.E554; Feuvray D, 2008, DIABETES METAB, V34, pS3, DOI 10.1016/S1262-3636(08)70096-X; Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545; Flaumenhaft R, 2007, BLOOD, V110, P1492, DOI 10.1182/blood-2006-11-055772; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; FROEDE HC, 1968, J BIOL CHEM, V243, P6021; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Golovko MY, 2004, J LIPID RES, V45, P1777, DOI 10.1194/jlr.D400004-JLR200; GROSS RW, 1983, BIOCHEMISTRY-US, V22, P5641, DOI 10.1021/bi00293a028; GROSS RW, 1983, J BIOL CHEM, V258, P5221; HAZEN SL, 1993, J BIOL CHEM, V268, P9892; HAZEN SL, 1994, FEBS LETT, V339, P213, DOI 10.1016/0014-5793(94)80418-4; HILL DE, 1975, BIOCHEMISTRY-US, V14, P203, DOI 10.1021/bi00673a003; Hirabara SM, 2003, FEBS LETT, V541, P109, DOI 10.1016/S0014-5793(03)00316-8; HOOD K, 1976, FEBS LETT, V68, P8, DOI 10.1016/0014-5793(76)80392-4; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; HUSSEY CR, 1977, EUR J BIOCHEM, V80, P497, DOI 10.1111/j.1432-1033.1977.tb11905.x; JENKINS JD, 1984, J BIOL CHEM, V259, P9374; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; KEMP RG, 1969, BIOCHEMISTRY-US, V8, P4490, DOI 10.1021/bi00839a040; KEMP RG, 1968, BIOCHEMISTRY-US, V7, P2596, DOI 10.1021/bi00847a022; LATSHAW SP, 1987, J BIOL CHEM, V262, P10672; LEA MA, 1968, J BIOL CHEM, V243, P1096; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; LUTHER MA, 1986, J BIOL CHEM, V261, P1753; Mansour T E, 1972, Curr Top Cell Regul, V5, P1; Marinho-Carvalho MM, 2006, MOL GENET METAB, V87, P253, DOI 10.1016/j.ymgme.2005.11.002; Marinho-Carvalho MM, 2009, BBA-PROTEINS PROTEOM, V1794, P1175, DOI 10.1016/j.bbapap.2009.02.006; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; MAYR GW, 1984, EUR J BIOCHEM, V143, P521, DOI 10.1111/j.1432-1033.1984.tb08401.x; MAYR GW, 1983, FEBS LETT, V159, P51, DOI 10.1016/0014-5793(83)80415-3; MAYR GW, 1984, EUR J BIOCHEM, V143, P513, DOI 10.1111/j.1432-1033.1984.tb08400.x; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; NEWSHOLME EA, 1962, NATURE, V193, P270, DOI 10.1038/193270a0; PETTIGREW DW, 1979, J BIOL CHEM, V254, P1896; PILKIS SJ, 1981, J BIOL CHEM, V256, P3171; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; POWELL GL, 1981, J BIOL CHEM, V256, P2740; RAMADOSS CS, 1976, J BIOL CHEM, V251, P98; RANDLE PJ, 1963, LANCET, V1, P785; RANDLE PJ, 1994, J CELL BIOCHEM, V55, P1, DOI 10.1002/jcb.240550002; RENNIE MJ, 1976, BIOCHEM J, V156, P647, DOI 10.1042/bj1560647; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scherer PE, 1997, J BIOL CHEM, V272, P20698, DOI 10.1074/jbc.272.33.20698; SHIPP JC, 1961, NATURE, V189, P1018, DOI 10.1038/1891018a0; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4; Sotgia F, 2003, AM J PATHOL, V163, P2619, DOI 10.1016/S0002-9440(10)63616-4; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; UYEDA K, 1981, J BIOL CHEM, V256, P8394; Vallejo J, 2004, BIOCHEMISTRY-US, V43, P16224, DOI 10.1021/bi0490035; Vallejo J, 2004, AM J PHYSIOL-CELL PH, V286, pC43, DOI 10.1152/ajpcell.00483.2002; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; WALTERS DW, 1986, J BIOL CHEM, V261, P5372; WEBER G, 1966, SCIENCE, V154, P1357, DOI 10.1126/science.154.3754.1357; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	83	60	63	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203661	http://dx.doi.org/10.1074/jbc.M110.203661			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21258134	hybrid, Green Published			2022-12-25	WOS:000289077500007
J	Arzy, S; Mohr, C; Molnar-Szakacs, I; Blanke, O				Arzy, Shahar; Mohr, Christine; Molnar-Szakacs, Istvan; Blanke, Olaf			Schizotypal Perceptual Aberrations of Time: Correlation between Score, Behavior and Brain Activity	PLOS ONE			English	Article							TEMPORAL PROCESSING DYSFUNCTION; SCHNEIDERIAN 1ST-RANK SYMPTOMS; COGNITIVE NEUROSCIENCE; EPISODIC MEMORY; FUNCTIONAL MECHANISMS; CONSCIOUS AWARENESS; PERSPECTIVE-TAKING; PREFRONTAL CORTEX; PARIETAL CORTEX; DEFAULT MODE	A fundamental trait of the human self is its continuum experience of space and time. Perceptual aberrations of this spatial and temporal continuity is a major characteristic of schizophrenia spectrum disturbances - including schizophrenia, schizotypal personality disorder and schizotypy. We have previously found the classical Perceptual Aberration Scale (PAS) scores, related to body and space, to be positively correlated with both behavior and temporo-parietal activation in healthy participants performing a task involving self-projection in space. However, not much is known about the relationship between temporal perceptual aberration, behavior and brain activity. To this aim, we composed a temporal Perceptual Aberration Scale (tPAS) similar to the traditional PAS. Testing on 170 participants suggested similar performance for PAS and tPAS. We then correlated tPAS and PAS scores to participants' performance and neural activity in a task of self-projection in time. tPAS scores correlated positively with reaction times across task conditions, as did PAS scores. Evoked potential mapping and electrical neuroimaging showed self-projection in time to recruit a network of brain regions at the left anterior temporal cortex, right temporo-parietal junction, and occipito-temporal cortex, and duration of activation in this network positively correlated with tPAS and PAS scores. These data demonstrate that schizotypal perceptual aberrations of both time and space, as reflected by tPAS and PAS scores, are positively correlated with performance and brain activation during self-projection in time in healthy individuals along the schizophrenia spectrum.	[Arzy, Shahar; Molnar-Szakacs, Istvan; Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland; [Arzy, Shahar] Hadassah Hebrew Univ Hosp, Dept Neurol, Jerusalem, Israel; [Mohr, Christine] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Mohr, Christine] Univ Lausanne, Dept Psychol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Bristol; University of Lausanne	Arzy, S (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Cognit Neurosci, Lausanne, Switzerland.	shahar.arzy@hcuge.ch		Mohr, Christine/0000-0002-3720-7115; Arzy, Shahar/0000-0001-6500-8095	Hadassah's management fund	Hadassah's management fund	SA was partially supported by the Hadassah's management fund for residents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Angyal A, 1936, ARCH NEURO PSYCHIATR, V35, P1029, DOI 10.1001/archneurpsyc.1936.02260050103007; ARZY S, NEUROREPORT, V21, P569; ARZY S, 2009, MENTAL TIME LINE ANA; Arzy S, 2008, J NEUROSCI, V28, P6502, DOI 10.1523/JNEUROSCI.5712-07.2008; Arzy S, 2007, NEUROIMAGE, V35, P326, DOI 10.1016/j.neuroimage.2006.11.027; Arzy S, 2009, EUR J NEUROSCI, V30, P2009, DOI 10.1111/j.1460-9568.2009.06974.x; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Baars B. J., 1997, THEATER CONSCIOUSNES; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bourdet Catherine, 2003, Cogn Neuropsychiatry, V8, P89, DOI 10.1080/13546800244000238; Boyer P, 2007, BRAIN RES REV, V54, P92, DOI 10.1016/j.brainresrev.2006.12.008; BRANDEIS D, 1986, NEUROPSYCHOLOGIA, V24, P151, DOI 10.1016/0028-3932(86)90049-7; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; CARLSON EB, 1993, AM J PSYCHIAT, V150, P1030; Carroll CA, 2008, BRAIN COGNITION, V67, P150, DOI 10.1016/j.bandc.2007.12.005; Cellard C, 2007, BRAIN COGNITION, V64, P201, DOI 10.1016/j.bandc.2007.03.001; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Danion JM, 2007, CAN J PSYCHIAT, V52, P693, DOI 10.1177/070674370705201103; Danion JM, 1999, ARCH GEN PSYCHIAT, V56, P639, DOI 10.1001/archpsyc.56.7.639; Davalos DB, 2005, J NEUROPSYCH CLIN N, V17, P517, DOI 10.1176/appi.neuropsych.17.4.517; Davalos DB, 2003, BRAIN COGNITION, V52, P295, DOI 10.1016/S0278-2626(03)00157-X; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Feinstein A, 1998, SCHIZOPHR RES, V30, P155, DOI 10.1016/S0920-9964(97)00129-1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franck N, 2002, J NEUROPSYCH CLIN N, V14, P277, DOI 10.1176/appi.neuropsych.14.3.277; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1996, BRIT MED BULL, V52, P644; Frith C, 1996, BRIT MED BULL, V52, P618; Frith C, 1996, COGNITIVE BRAIN RES, V5, P175, DOI 10.1016/S0926-6410(96)00054-7; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; GALLUP GG, 2003, SELF SCHIZOPHRENIA N; Ganesan V, 2005, AM J PSYCHIAT, V162, P1545, DOI 10.1176/appi.ajp.162.8.1545; Golland Y, 2008, NEUROPSYCHOLOGIA, V46, P540, DOI 10.1016/j.neuropsychologia.2007.10.003; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Langdon R, 1999, COGNITION, V71, P43, DOI 10.1016/S0010-0277(99)00018-9; LEHMANN D, 1984, PROG NEUROBIOL, V23, P227, DOI 10.1016/0301-0082(84)90003-0; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lenzenweger MF, 2000, SCHIZOPHR RES, V42, P111, DOI 10.1016/S0920-9964(99)00120-6; LENZENWEGER MF, 1994, SCHIZOPHRENIA BULL, V20, P121, DOI 10.1093/schbul/20.1.121; LHAMON WT, 1973, ARCH GEN PSYCHIAT, V28, P44; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mohr C, 2006, BEHAV NEUROSCI, V120, P528, DOI 10.1037/0735-7044.120.3.528; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Platek SA, 2002, SCHIZOPHR RES, V57, P81, DOI 10.1016/S0920-9964(01)00310-3; Ragland JD, 2004, AM J PSYCHIAT, V161, P1004, DOI 10.1176/appi.ajp.161.6.1004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2008, BIOL PSYCHIAT, V64, P18, DOI 10.1016/j.biopsych.2008.04.011; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saito N, 1998, BIOL PSYCHIAT, V43, P794, DOI 10.1016/S0006-3223(97)00547-7; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Tallent KA, 1999, PSYCHIAT RES, V89, P161, DOI 10.1016/S0165-1781(99)00101-8; Tendolkar I, 2002, PSYCHOL MED, V32, P1261, DOI 10.1017/S0033291702006335; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Varela F., 1999, NATURALIZING PHENOME, P265; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vogeley K, 2007, SCHIZOPHRENIA BULL, V33, P157, DOI 10.1093/schbul/sbl056; Walsh V, 2003, CURR BIOL, V13, pR447, DOI 10.1016/S0960-9822(03)00368-3; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	83	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e16154	10.1371/journal.pone.0016154	http://dx.doi.org/10.1371/journal.pone.0016154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267456	Green Published, gold, Green Submitted			2022-12-25	WOS:000286519500043
J	Ondrusch, N; Kreft, J				Ondrusch, Nicolai; Kreft, Juergen			Blue and Red Light Modulates SigB-Dependent Gene Transcription, Swimming Motility and Invasiveness in Listeria monocytogenes	PLOS ONE			English	Article							ENVIRONMENTAL SIGNALING PATHWAY; SIGMA(B)-DEPENDENT STRESS-RESPONSE; PRFA-MEDIATED VIRULENCE; NTP-BINDING-PROPERTIES; BACILLUS-SUBTILIS; RECEPTOR YTVA; FACTOR SIGMA(B); REGULATOR PRFA; LOV DOMAIN; PROTEIN	Background: In a number of gram-positive bacteria, including Listeria, the general stress response is regulated by the alternative sigma factor B (SigB). Common stressors which lead to the activation of SigB and the SigB-dependent regulon are high osmolarity, acid and several more. Recently is has been shown that also blue and red light activates SigB in Bacillus subtilis. Methodology/Principal Findings: By qRT-PCR we analyzed the transcriptional response of the pathogen L. monocytogenes to blue and red light in wild type bacteria and in isogenic deletion mutants for the putative blue-light receptor Lmo0799 and the stress sigma factor SigB. It was found that both blue (455 nm) and red (625 nm) light induced the transcription of sigB and SigB-dependent genes, this induction was completely abolished in the SigB mutant. The blue-light effect was largely dependent on Lmo0799, proving that this protein is a genuine blue-light receptor. The deletion of lmo0799 enhanced the red-light effect, the underlying mechanism as well as that of SigB activation by red light remains unknown. Blue light led to an increased transcription of the internalin A/B genes and of bacterial invasiveness for Caco-2 enterocytes. Exposure to blue light also strongly inhibited swimming motility of the bacteria in a Lmo0799- and SigB-dependent manner, red light had no effect there. Conclusions/Significance: Our data established that visible, in particular blue light is an important environmental signal with an impact on gene expression and physiology of the non-phototrophic bacterium L. monocytogenes. In natural environments these effects will result in sometimes random but potentially also cyclic fluctuations of gene activity, depending on the light conditions prevailing in the respective habitat.	[Ondrusch, Nicolai; Kreft, Juergen] Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany	University of Wurzburg	Ondrusch, N (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Mikrobiol, Wurzburg, Germany.	kreft@biozentrum.uni-wuerzburg.de			German Federal Ministry of Education and Research via Project Management Julich, ERA-NET PathoGenoMics [0313939C]; EU Network of Excellence EuroPathoGenomics	German Federal Ministry of Education and Research via Project Management Julich, ERA-NET PathoGenoMics; EU Network of Excellence EuroPathoGenomics	This work was supported by grants from the German Federal Ministry of Education and Research via Project Management Julich, ERA-NET PathoGenoMics (www.fz-juelich.de/ptj/pathogenomics) (grant no. 0313939C) and by the EU Network of Excellence EuroPathoGenomics (www.noe-epg.uniwuerzburg.de/). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Akbar S, 1997, MOL MICROBIOL, V24, P567, DOI 10.1046/j.1365-2958.1997.3631732.x; Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Becker LA, 1998, J BACTERIOL, V180, P4547, DOI 10.1128/JB.180.17.4547-4554.1998; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Braatsch S, 2004, PHOTOSYNTH RES, V79, P45, DOI 10.1023/B:PRES.0000011924.89742.f9; Buchrieser C, 2007, MICROBES INFECT, V9, P1147, DOI 10.1016/j.micinf.2007.05.002; Buttani V, 2007, EUR BIOPHYS J BIOPHY, V36, P831, DOI 10.1007/s00249-007-0155-1; Buttani V, 2007, PHOTOCH PHOTOBIO SCI, V6, P41, DOI 10.1039/b610375h; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Chaturongakul S, 2004, APPL ENVIRON MICROB, V70, P5349, DOI 10.1128/AEM.70.9.5349-5356.2004; Chaturongakul S, 2008, TRENDS MICROBIOL, V16, P388, DOI 10.1016/j.tim.2008.05.006; Chaturongakul S, 2006, APPL ENVIRON MICROB, V72, P5197, DOI 10.1128/AEM.03058-05; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Ferreira A, 2004, CURR MICROBIOL, V48, P39, DOI 10.1007/s00284-003-4020-x; Ferreira A, 2001, APPL ENVIRON MICROB, V67, P4454, DOI 10.1128/AEM.67.10.4454-4457.2001; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gardan R, 2003, APPL ENVIRON MICROB, V69, P154, DOI 10.1128/AEM.69.1.154-161.2003; GHETTI F, 1992, J PHOTOCH PHOTOBIO B, V15, P185, DOI 10.1016/1011-1344(92)85123-C; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; HALDENWANG WG, 1980, P NATL ACAD SCI-BIOL, V77, P7000, DOI 10.1073/pnas.77.12.7000; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hardwick SW, 2007, J BIOL CHEM, V282, P11562, DOI 10.1074/jbc.M609733200; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hellingwerf KJ, 1996, MOL MICROBIOL, V21, P683, DOI 10.1046/j.1365-2958.1996.411402.x; Hellingwerf KJ, 2002, ANTON LEEUW INT J G, V81, P51, DOI 10.1023/A:1020521424582; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7967, DOI 10.1128/AEM.01085-07; Hu Y, 2007, APPL ENVIRON MICROB, V73, P7981, DOI 10.1128/AEM.01281-07; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Kamp HD, 2009, MOL MICROBIOL, V74, P421, DOI 10.1111/j.1365-2958.2009.06874.x; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kazmierczak MJ, 2006, MICROBIOL-SGM, V152, P1827, DOI 10.1099/mic.0.28758-0; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kim H, 2005, MICROBIOL-SGM, V151, P3215, DOI 10.1099/mic.0.28070-0; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Kreft J, 2002, CURR TOP MICROBIOL, V264, P109; Kreft J, 2001, INT J MED MICROBIOL, V291, P145, DOI 10.1078/1438-4221-00111; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; McGann P, 2007, APPL ENVIRON MICROB, V73, P2919, DOI 10.1128/AEM.02664-06; Mertins S, 2007, J BACTERIOL, V189, P473, DOI 10.1128/JB.00972-06; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Oberpichler I, 2008, ENVIRON MICROBIOL, V10, P2020, DOI 10.1111/j.1462-2920.2008.01618.x; Ogata H, 2009, ACTA CRYSTALLOGR F, V65, P853, DOI 10.1107/S1744309109026670; Olesen I, 2009, FOODBORNE PATHOG DIS, V6, P669, DOI 10.1089/fpd.2008.0243; Oliver HF, 2010, APPL ENVIRON MICROB, V76, P4216, DOI 10.1128/AEM.00031-10; Ollinger J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Personnic N, 2010, INFECT IMMUN, V78, P1979, DOI 10.1128/IAI.01096-09; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Raengpradub S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07; Redmond RW, 1999, PHOTOCHEM PHOTOBIOL, V70, P391, DOI 10.1562/0031-8655(1999)070<0391:ACOSOY>2.3.CO;2; Reeves A, 2010, MICROBIOL-SGM, V156, P990, DOI 10.1099/mic.0.036095-0; Sambrook J, 2001, MOL CLONING LAB MANU; SAUNDERS B, 2007, LISTERIA LISTERIOSIS, P21; Schmid MW, 2005, SYST APPL MICROBIOL, V28, P1, DOI 10.1016/j.syapm.2004.09.005; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Sharrock RA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-230; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Stritzker J, 2005, J BACTERIOL, V187, P2836, DOI 10.1128/JB.187.8.2836-2845.2005; Sue D, 2004, MICROBIOL-SGM, V150, P3843, DOI 10.1099/mic.0.27257-0; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takano H, 2006, J IND MICROBIOL BIOT, V33, P88, DOI 10.1007/s10295-005-0005-z; Tang YF, 2010, PHOTOCH PHOTOBIO SCI, V9, P47, DOI 10.1039/b9pp00075e; THORINGTON L, 1985, ANN NY ACAD SCI, V453, P28, DOI 10.1111/j.1749-6632.1985.tb11796.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van der Horst MA, 2007, TRENDS MICROBIOL, V15, P554, DOI 10.1016/j.tim.2007.09.009; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vierstra RD, 2000, SEMIN CELL DEV BIOL, V11, P511, DOI 10.1006/scdb.2000.0206; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Williams T, 2005, FEMS MICROBIOL LETT, V252, P287, DOI 10.1016/j.femsle.2005.09.011; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465	108	66	69	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16151	10.1371/journal.pone.0016151	http://dx.doi.org/10.1371/journal.pone.0016151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264304	Green Submitted, Green Published, gold			2022-12-25	WOS:000286514000024
J	Pharris, A; Nguyen, TKC; Tishelman, C; Brugha, R; Nguyen, PH; Thorson, A				Pharris, Anastasia; Nguyen Thi Kim Chuc; Tishelman, Carol; Brugha, Ruairi; Nguyen Phuong Hoa; Thorson, Anna			Expanding HIV Testing Efforts in Concentrated Epidemic Settings: A Population-Based Survey from Rural Vietnam	PLOS ONE			English	Article							LOGISTIC-REGRESSION; PREGNANT-WOMEN; CONSEQUENCES; PREVALENCE; COUNTRIES; DETERMINANTS; INFECTION; AIDS; CARE	Background: To improve HIV prevention and care programs, it is important to understand the uptake of HIV testing and to identify population segments in need of increased HIV testing. This is particularly crucial in countries with concentrated HIV epidemics, where HIV prevalence continues to rise in the general population. This study analyzes determinants of HIV testing in a rural Vietnamese population in order to identify potential access barriers and areas for promoting HIV testing services. Methods: A population-based cross-sectional survey of 1874 randomly sampled adults was linked to pregnancy, migration and economic cohort data from a demographic surveillance site (DSS). Multivariate logistic regression analysis was used to determine which factors were associated with having tested for HIV. Results: The age-adjusted prevalence of ever-testing for HIV was 7.6%; however 79% of those who reported feeling at-risk of contracting HIV had never tested. In multivariate analysis, younger age (aOR 1.85, 95% CI 1.14-3.01), higher economic status (aOR 3.4, 95% CI 2.21-5.22), and semi-urban residence (aOR 2.37, 95% CI 1.53-3.66) were associated with having been tested for HIV. HIV testing rates did not differ between women of reproductive age who had recently been pregnant and those who had not. Conclusions: We found low testing uptake (6%) among pregnant women despite an existing prevention of mother-to-child HIV testing policy, and lower-than-expected testing among persons who felt that they were at-risk of HIV. Poverty and residence in a more geographically remote location were associated with less HIV testing. In addition to current HIV testing strategies focusing on high-risk groups, we recommend targeting HIV testing in concentrated HIV epidemic settings to focus on a scaled-up provision of antenatal testing. Additional recommendations include removing financial and geographic access barriers to client-initiated testing, and encouraging provider-initiated testing of those who believe that they are at-risk of HIV.	[Pharris, Anastasia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Nguyen Thi Kim Chuc; Nguyen Phuong Hoa] Hanoi Med Univ, Hlth Syst Res Project, Hanoi, Vietnam; [Tishelman, Carol] Karolinska Inst, Med Management Ctr, Dept Learning Informat Med Management & Eth LIME, Stockholm, Sweden; [Brugha, Ruairi] Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth, Populat Hlth Sci Div, Dublin 2, Ireland	Karolinska Institutet; Hanoi Medical University; Karolinska Institutet; Royal College of Surgeons - Ireland	Pharris, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	anastasia.pharris@ki.se	Tishelman, Carol/AAB-8936-2020; Brugha, Ruairi/C-8420-2012	Tishelman, Carol/0000-0003-4161-0342; Brugha, Ruairi/0000-0003-0729-0197; Thorson, Anna/0000-0002-8703-6561	Sida/SAREC	Sida/SAREC	Sida/SAREC are gratefully acknowledged for financial support to this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, IMP VOL COUNS TEST G; Carrizosa CM, 2010, AIDS PATIENT CARE ST, V24, P333, DOI 10.1089/apc.2009.0138; Castelli Francesco, 2010, Open AIDS J, V4, P28, DOI 10.2174/1874613601004020028; Chamratrithirong A, 2007, NATL SEXUAL BEHAV SU; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dinh TH, 2005, AIDS, V19, P1234, DOI 10.1097/01.aids.0000176228.09474.59; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; Hong K. T., 2004, UNDERSTANDING HIV AI; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Lanoy E, 2007, ANTIVIR THER, V12, P89; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; *MIN HLTH VIETN, 2005, VIETN HIV AIDS EST P; *MIN HLTH VIETN, 2009, VIETN HIV AIDS EST P; Monjok Emmanuel, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P23, DOI 10.1177/1545109709356355; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; *NAT I HYG EP VIET, 2006, VIETN POP AIDS IND S; Nguyen AT, 2008, AIDS RES HUM RETROV, V24, P1017, DOI 10.1089/aid.2007.0267; NGUYEN TA, 2007, B WORLD HEALTH ORGAN, V85, P35; Nguyen Thu Anh, 2008, AIDS Res Ther, V5, P7, DOI 10.1186/1742-6405-5-7; Nguyen TKC, 2003, SCAND J PUBLIC HEALT, V31, P3, DOI 10.1080/14034950310015031; *NIHE, 2006, RES HIV STI INT BIOL; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Oosterhoff P, 2008, AIDS CARE, V20, P654, DOI 10.1080/09540120701687026; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Rutstein S.O., 2004, DHS COMP REPORTS; Schur CL, 2002, J RURAL HEALTH, V18, P337, DOI 10.1111/j.1748-0361.2002.tb00895.x; *SOC REP VIETN, 2004, DEC PRIM MIN APPR NA; TAM VV, 2010, AIDS CARE IN PRESS; *THAIL NAT STAT OF, 2006, THAIL MULT IND CLUST; Thorson A, 2004, J CLIN EPIDEMIOL, V57, P398, DOI 10.1016/j.jclinepi.2002.11.001; Thorson A, 2003, EQUITY EQUALITY CASE; Thu AN, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-39; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; UNAIDS, 2008, REP GLOB AIDS EP; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, WORLD HLTH STAT; World Bank, 2008, WORLD DEV REP	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16017	10.1371/journal.pone.0016017	http://dx.doi.org/10.1371/journal.pone.0016017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710LU	21264303	Green Published, gold			2022-12-25	WOS:000286514000017
J	Rymo, SF; Gerhardt, H; Sand, FW; Lang, R; Uv, A; Betsholtz, C				Rymo, Simin F.; Gerhardt, Holger; Sand, Fredrik Wolfhagen; Lang, Richard; Uv, Anne; Betsholtz, Christer			A Two-Way Communication between Microglial Cells and Angiogenic Sprouts Regulates Angiogenesis in Aortic Ring Cultures	PLOS ONE			English	Article							EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH-FACTOR; NERVOUS-SYSTEM; VEGF; MACROPHAGES; VASCULATURE; INHIBITION; EXPRESSION; ADULT; MODEL	Background: Myeloid cells have been associated with physiological and pathological angiogenesis, but their exact functions in these processes remain poorly defined. Monocyte-derived tissue macrophages of the CNS, or microglial cells, invade the mammalian retina before it becomes vascularized. Recent studies correlate the presence of microglia in the developing CNS with vascular network formation, but it is not clear whether the effect is directly caused by microglia and their contact with the endothelium. Methodology/Principal Findings: We combined in vivo studies of the developing mouse retina with in vitro studies using the aortic ring model to address the role of microglia in developmental angiogenesis. Our in vivo analyses are consistent with previous findings that microglia are present at sites of endothelial tip-cell anastomosis, and genetic ablation of microglia caused a sparser vascular network associated with reduced number of filopodia-bearing sprouts. Addition of microglia in the aortic ring model was sufficient to stimulate vessel sprouting. The effect was independent of physical contact between microglia and endothelial cells, and could be partly mimicked using microglial cell-conditioned medium. Addition of VEGF-A promoted angiogenic sprouts of different morphology in comparison with the microglial cells, and inhibition of VEGF-A did not affect the microglia-induced angiogenic response, arguing that the proangiogenic factor(s) released by microglia is distinct from VEGF-A. Finally, microglia exhibited oriented migration towards the vessels in the aortic ring cultures. Conclusions/Significance: Microglia stimulate vessel sprouting in the aortic ring cultures via a soluble microglial-derived product(s), rather than direct contact with endothelial cells. The observed migration of microglia towards the growing sprouts suggests that their position near endothelial tip-cells could result from attractive cues secreted by the vessels. Our data reveals a two-way communication between microglia and vessels that depends on soluble factors and should extend the understanding of how microglia promote vascular network formation.	[Rymo, Simin F.; Uv, Anne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London, England; [Sand, Fredrik Wolfhagen] Lund Univ, Stem Cell Ctr, Biomed Ctr BMC, Lund, Sweden; [Lang, Richard] Univ Cincinnati, Med Ctr, Visual Syst Grp,Dept Ophthalmol, Div Pediat Ophtalmol,Cincinnati Childrens Hosp, Cincinnati, OH 45267 USA; [Lang, Richard] Univ Cincinnati, Med Ctr, Visual Syst Grp, Div Dev Biol,Cincinnati Childrens Hosp,Dept Ophth, Cincinnati, OH 45267 USA; [Betsholtz, Christer] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Stockholm, Sweden	University of Gothenburg; Cancer Research UK; Lund University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Karolinska Institutet	Rymo, SF (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.	christer.betsholtz@ki.se	Lang, Richard/E-5578-2011; Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Lang, Richard/0000-0002-5212-254X; Gerhardt, Holger/0000-0001-9228-7472	Gothenburg University; Karolinska Institutet; Swedish Cancer Foundation; Swedish Research Council; Leducq Foundation; EU; Swedish Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Ludwig Institute for Cancer Research; Cancer Research UK; Lister Institute of Preventive Medicine; EMBO; National Eye Institute and National Cancer Institute of the NIH	Gothenburg University; Karolinska Institutet(Karolinska Institutet); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Leducq Foundation(Leducq Foundation); EU(European Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Ludwig Institute for Cancer Research; Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; EMBO(European Molecular Biology Organization (EMBO)); National Eye Institute and National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Eye Institute (NEI))	This study was supported by grants from the following sources: to SFR and AU: Gothenburg University; to CB: Karolinska Institutet, the Swedish Cancer Foundation, the Swedish Research Council, the Leducq Foundation, the EU Fp6 Program Lymphangiogenomics, the Swedish Strategic Research Foundation, Knut and Alice Wallenberg Foundation, Inga-Britt and Arne Lundberg Foundation, Torsten and Ragnar Soderberg Foundation and the Ludwig Institute for Cancer Research; to HG, Cancer Research UK, the Lister Institute of Preventive Medicine, the EMBO Young Investigator Programme, the Leducq Foundation; to RL: the National Eye Institute and National Cancer Institute of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; FANTIN A, 2010, BLOOD; Gelati M, 2008, J IMMUNOL, V181, P5711, DOI 10.4049/jimmunol.181.8.5711; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; JORDAN FL, 1988, BRAIN RES REV, V13, P165, DOI 10.1016/0165-0173(88)90019-7; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mitchell P, 2010, BRIT J OPHTHALMOL, V94, P2, DOI 10.1136/bjo.2009.159160; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; NICOSIA RF, 1990, LAB INVEST, V63, P115; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; ZORZI P, 2010, J LEUKOCYTE BIOL	36	153	160	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15846	10.1371/journal.pone.0015846	http://dx.doi.org/10.1371/journal.pone.0015846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21264342	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000286513100013
J	Oeste, CL; Diez-Dacal, B; Bray, F; de Lacoba, MG; de la Torre, BG; Andreu, D; Ruiz-Sanchez, AJ; Perez-Inestrosa, E; Garcia-Dominguez, CA; Rojas, JM; Perez-Sala, D				Oeste, Clara L.; Diez-Dacal, Beatriz; Bray, Francesca; Garcia de Lacoba, Mario; de la Torre, Beatriz G.; Andreu, David; Ruiz-Sanchez, Antonio J.; Perez-Inestrosa, Ezequiel; Garcia-Dominguez, Carlota A.; Rojas, Jose M.; Perez-Sala, Dolores			The C-Terminus of H-Ras as a Target for the Covalent Binding of Reactive Compounds Modulating Ras-Dependent Pathways	PLOS ONE			English	Article							RECYCLING ENDOSOMES; PLASMA-MEMBRANE; PROTEIN; ACTIVATION; PROSTANOIDS; RESOLUTION; INDUCTION; BIOLOGY; FOCUS; J(2)	Ras proteins are crucial players in differentiation and oncogenesis and constitute important drug targets. The localization and activity of Ras proteins are highly dependent on posttranslational modifications at their C-termini. In addition to an isoprenylated cysteine, H-Ras, but not other Ras proteins, possesses two cysteine residues (C181 and C184) in the C-terminal hypervariable domain that act as palmitoylation sites in cells. Cyclopentenone prostaglandins (cyPG) are reactive lipidic mediators that covalently bind to H-Ras and activate H-Ras dependent pathways. Dienone cyPG, such as 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)) and Delta(12)-PGJ(2) selectively bind to the H-Ras hypervariable domain. Here we show that these cyPG bind simultaneously C181 and C184 of H-Ras, thus potentially altering the conformational tendencies of the hypervariable domain. Based on these results, we have explored the capacity of several bifunctional cysteine reactive small molecules to bind to the hypervariable domain of H-Ras proteins. Interestingly, phenylarsine oxide (PAO), a widely used tyrosine phosphatase inhibitor, and dibromobimane, a cross-linking agent used for cysteine mapping, effectively bind H-Ras hypervariable domain. The interaction of PAO with H-Ras takes place in vitro and in cells and blocks modification of H-Ras by 15d-PGJ(2). Moreover, PAO treatment selectively alters H-Ras membrane partition and the pattern of H-Ras activation in cells, from the plasma membrane to endomembranes. These results identify H-Ras as a novel target for PAO. More importantly, these observations reveal that small molecules or reactive intermediates interacting with spatially vicinal cysteines induce intramolecular cross-linking of H-Ras C-terminus potentially contributing to the modulation of Ras-dependent pathways.	[Oeste, Clara L.; Diez-Dacal, Beatriz; Bray, Francesca; Garcia de Lacoba, Mario; Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain; [de la Torre, Beatriz G.; Andreu, David] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Ruiz-Sanchez, Antonio J.; Perez-Inestrosa, Ezequiel] Univ Malaga, Fac Sci, Dept Organ Chem, E-29071 Malaga, Spain; [Garcia-Dominguez, Carlota A.; Rojas, Jose M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Unidad Biol Celular, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Pompeu Fabra University; Universidad de Malaga; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Oeste, CL (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	dperezsala@cib.csic.es	Ruiz-Sánchez, Antonio Jesús/A-9145-2016; de la Torre, Beatriz G./N-6995-2019; Rojas, José M./AAA-3354-2021; Oeste, Clara/O-2873-2014; Rojas, José M/D-3718-2018; Andreu, David/I-4359-2014; de la Torre, Beatriz G/AAF-1419-2020; Ruiz-Sanchez, Antonio J/AAC-3192-2021; Perez-Inestrosa, Ezequiel/H-9801-2015; Perez-Sala, Dolores/L-5969-2014	Ruiz-Sánchez, Antonio Jesús/0000-0001-5272-4287; de la Torre, Beatriz G./0000-0001-8521-9172; Rojas, José M./0000-0002-7547-2825; Oeste, Clara/0000-0002-7035-132X; Rojas, José M/0000-0002-5383-3482; Andreu, David/0000-0002-6317-6666; Perez-Inestrosa, Ezequiel/0000-0001-7546-5273; Perez-Sala, Dolores/0000-0003-0600-665X	European Union [CM1001]; Ministerio de Ciencia e Innovacion and Red Tematica de Investigacion Cooperativa [SAF2009-11642]; Instituto de Salud Carlos III (Spain) [RD07/0064/0007, RD07/0064/0000]; Ministerio de Ciencia e Innovacion (Spain) [BIO2005-07592-CO2-02, BIO2008-04487-CO3-02, BES-2010-033718]; regional government of Catalunya [SGR2005-00494]; Fondo de Investigaciones Sanitarias-Intrasalud [PS09/00562]; Instituto de Salud Carlos III [RD06/0020/0003]; Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias-Beca de Formacion en Investigacion	European Union(European Commission); Ministerio de Ciencia e Innovacion and Red Tematica de Investigacion Cooperativa; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional government of Catalunya; Fondo de Investigaciones Sanitarias-Intrasalud; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Association Against Cancer (AECC); Fondo de Investigaciones Sanitarias-Beca de Formacion en Investigacion	This work was supported by European Union Cooperation in the field of Scientific and Technical research (COST) Action CM1001, grant SAF2009-11642 from Ministerio de Ciencia e Innovacion and Red Tematica de Investigacion Cooperativa from Instituto de Salud Carlos III (Spain) RD07/0064/0007 to DP-S and RD07/0064/0000 to EP-I. Work at Universitat Pompeu Fabra was supported by grants BIO2005-07592-CO2-02 and BIO2008-04487-CO3-02 from Ministerio de Ciencia e Innovacion (Spain) to DA, and by the regional government of Catalunya (SGR2005-00494). JMR's work is supported by Fondo de Investigaciones Sanitarias-Intrasalud (PS09/00562) and Red Tematica de Investigacion Cooperativa RD06/0020/0003 from Instituto de Salud Carlos III, and the Spanish Association Against Cancer (AECC). CLO is the recipient of a predoctoral fellowship from the Formacion de Personal Investigador (FPI) program (Ministerio de Ciencia e Innovacion, Spain, BES-2010-033718). CAG-D is the recipient of a fellowship from Fondo de Investigaciones Sanitarias-Beca de Formacion en Investigacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker TL, 2000, J BIOL CHEM, V275, P22037, DOI 10.1074/jbc.M001813200; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Covian-Nares JF, 2008, DEV BIOL, V316, P135, DOI 10.1016/j.ydbio.2008.01.017; Diez-Dacal B, 2010, THESCIENTIFICWORLDJO, V10, P655, DOI 10.1100/tsw.2010.69; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gerhard R, 2003, MOL PHARMACOL, V63, P1349, DOI 10.1124/mol.63.6.1349; Gharbi S, 2007, J MASS SPECTROM, V42, P1474, DOI 10.1002/jms.1291; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Gomez GA, 2005, J BIOL CHEM, V280, P34997, DOI 10.1074/jbc.M506256200; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; He XQ, 2009, J BIOL CHEM, V284, P12609, DOI 10.1074/jbc.M901204200; Heo J, 2005, J MOL BIOL, V346, P1423, DOI 10.1016/j.jmb.2004.12.050; Ishii T, 2004, CHEM RES TOXICOL, V17, P1313, DOI 10.1021/tx049860+; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MEDEMA RH, 1991, J BIOL CHEM, V266, P21186; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Perez-Sala D, 2003, J BIOL CHEM, V278, P51251, DOI 10.1074/jbc.M309409200; Perez-Sala D, 1999, CELL DEATH DIFFER, V6, P722, DOI 10.1038/sj.cdd.4400557; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sanchez-Gomez FJ, 2010, MOL PHARMACOL, V78, P723, DOI 10.1124/mol.110.065391; Shibata T, 2003, J BIOL CHEM, V278, P26046, DOI 10.1074/jbc.M303690200; Sinz A, 2001, BIOCHEMISTRY-US, V40, P7903, DOI 10.1021/bi010259+; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Valero RA, 2010, TRAFFIC, V11, P1221, DOI 10.1111/j.1600-0854.2010.01091.x; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200	45	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15866	10.1371/journal.pone.0015866	http://dx.doi.org/10.1371/journal.pone.0015866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253588	Green Published, gold			2022-12-25	WOS:000286511900017
J	Merlin, J; Stechly, L; de Beauce, S; Monte, D; Leteurtre, E; van Seuningen, I; Huet, G; Pigny, P				Merlin, J.; Stechly, L.; de Beauce, S.; Monte, D.; Leteurtre, E.; van Seuningen, I.; Huet, G.; Pigny, P.			Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells	ONCOGENE			English	Article						pancreatic cancer; galectin-3; MUC1; EGFR; intracellular localization; endocytosis	GROWTH-FACTOR RECEPTOR; NUCLEAR-LOCALIZATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PRIMARY TUMORS; BETA-CATENIN; C-SRC; ENDOCYTOSIS; CARCINOMA; TRAFFICKING	MUC1 is a transmembrane glycoprotein which is typically expressed at the apical membrane of normal epithelial cells. In cancer cells, the over-expression of MUC1 and its aberrant localization around the cell membrane and in the cytoplasm favours its interaction with different protein partners such as epidermal growth factor receptor (EGFR) and can promote tumour proliferation through the activation of oncogenic signalling pathways. Our aims were to study the mechanisms inducing MUC1 cytoplasmic localization in pancreatic cancer cells, and to decipher their impact on EGFR cellular localization and activation. Our results showed that galectin-3, an endogenous lectin, is co-expressed with MUC1 in human pancreatic ductal adenocarcinoma, and that it favours the endocytosis of MUC1 and EGFR. Depletion of galectin-3 by RNA interference increased the interaction between MUC1 and EGFR, EGFR and ERK-1,2 phosphorylation, and translocation of EGFR to the nucleus. On the contrary, silencing of galectin-3 led to a decrease of cyclin-D1 levels and of cell proliferation. The galectin-3-dependent regulation of MUC1/EGFR functions may represent an interesting mechanism modulating the EGFR-stimulated cell growth of pancreatic cancer cells. Oncogene (2010) 30, 2514-2525; doi: 10.1038/onc.2010.631; published online 24 January 2011	[Merlin, J.; Stechly, L.; de Beauce, S.; Leteurtre, E.; van Seuningen, I.; Huet, G.; Pigny, P.] INSERM, U837, Equipe Mucines Differenciat & Cancerogenese Epith, F-59045 Lille, France; [Merlin, J.; Stechly, L.; de Beauce, S.; Leteurtre, E.; van Seuningen, I.; Huet, G.; Pigny, P.] Univ Lille 2, Ctr Rech Jean Pierre Aubert, Lille, France; [Stechly, L.; Huet, G.; Pigny, P.] CHRU, Ctr Biol & Pathol, Lab Biochimie & Hormonol, Lille, France; [Leteurtre, E.] CHRU, Ctr Biol & Pathol, Serv Anat Pathol, Lille, France; [Monte, D.] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, Inst Rech Interdisciplinaire,USR3078, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Pigny, P (corresponding author), INSERM, U837, Equipe Mucines Differenciat & Cancerogenese Epith, Team 5 Pl Verdun, F-59045 Lille, France.	pascal.pigny@inserm.fr	; VAN SEUNINGEN, Isabelle/N-6176-2016	monte, didier/0000-0002-0613-6203; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694	Comite du Nord de la Ligue Nationale contre le Cancer; french Ligue Nationale contre le Cancer (comite du Nord); Universite de Lille 2; Region Nord-Pas de Calais	Comite du Nord de la Ligue Nationale contre le Cancer; french Ligue Nationale contre le Cancer (comite du Nord); Universite de Lille 2; Region Nord-Pas de Calais(Region Hauts-de-France)	We acknowledge expert support provided by D Trinel, N Jouy and M Figeac. We thank Professor N Porchet and MP Ducourouble for their constant support; G Grard, E Creme, MH Gevaert, R Siminsky, M Samyn and V Dumetz for their technical assistance. J Merlin is a recipient of a PhD fellowship from the Universite de Lille 2 and Region Nord-Pas de Calais. This work was supported by a grant from the Comite du Nord de la Ligue Nationale contre le Cancer (to PP). This work was supported by a grant from the french Ligue Nationale contre le Cancer (comite du Nord).	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Andre S, 2006, BIOORGAN MED CHEM, V14, P6314, DOI 10.1016/j.bmc.2006.05.045; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Davidson PJ, 2006, GLYCOBIOLOGY, V16, P602, DOI 10.1093/glycob/cwj088; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; HUANG L, 2003, CANC BIOL THERAP, V2, P1; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Lahm H, 2000, INT J ONCOL, V17, P519; Langbein S, 2007, HISTOPATHOLOGY, V51, P681, DOI 10.1111/j.1365-2559.2007.02852.x; Leroy X, 2003, UROLOGY, V62, P771, DOI 10.1016/S0090-4295(03)00560-0; Leroy X, 2002, AM J CLIN PATHOL, V118, P47; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; LITVINOV SV, 1993, J BIOL CHEM, V268, P21364; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Monges GM, 1999, AM J CLIN PATHOL, V112, P635; Nakahara S, 2006, J BIOL CHEM, V281, P39649, DOI 10.1074/jbc.M608069200; Nassar H, 2004, MODERN PATHOL, V17, P1045, DOI 10.1038/modpathol.3800166; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Reddish MA, 1998, TUMOR BIOL, V19, P57, DOI 10.1159/000056505; Reis CA, 1998, TUMOR BIOL, V19, P127, DOI 10.1159/000056514; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang Y, 2007, INT J CANCER, V121, P2716, DOI 10.1002/ijc.22997; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154	53	82	83	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	22					2514	2525		10.1038/onc.2010.631	http://dx.doi.org/10.1038/onc.2010.631			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21258405				2022-12-25	WOS:000291198400003
J	Bhattacharyya, S; Balakathiresan, NS; Dalgard, C; Gutti, U; Armistead, D; Jozwik, C; Srivastava, M; Pollard, HB; Biswas, R				Bhattacharyya, Sharmistha; Balakathiresan, Nagaraja S.; Dalgard, Clifton; Gutti, Usha; Armistead, David; Jozwik, Cathy; Srivastava, Meera; Pollard, Harvey B.; Biswas, Roopa			Elevated miR-155 Promotes Inflammation in Cystic Fibrosis by Driving Hyperexpression of Interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; MICRORNA; EXPRESSION; SHIP1; BIOGENESIS; REPRESSION; PATHWAYS; CHILDREN; INFANTS; INHIBIT	Cystic Fibrosis (CF) is characterized by a massive proinflammatory phenotype in the lung arising from profound expression of inflammatory genes, including interleukin-8 (IL-8). We have previously reported that IL-8 mRNA is stabilized in CF lung epithelial cells, resulting in concomitant hyperexpression of IL-8 protein. However, the mechanistic link between mutations in CFTR and acquisition of the proinflammatory phenotype in the CF airway has remained elusive. We hypothesized that specific microRNAs (miRNAs) might mediate this linkage. To identify the potential link, we screened an miRNA library for differential expression in Delta F508-CFTR and wild type CFTR lung epithelial cell lines. Of 22 differentially and significantly expressed miRNAs, we found that expression of miR-155 was more than 5-fold elevated in CF IB3-1 lung epithelial cells in culture, compared with control IB3-1/S9 cells. Clinically, miR-155 was also highly expressed in CF lung epithelial cells and circulating CF neutrophils biopsied from CF patients. We report here that high levels of miR-155 specifically reduced levels of SHIP1, thereby promoting PI3K/Akt activation. However, overexpressing SHIP1 or inhibition of PI3K in CF cells suppressed IL-8 expression. Finally, we found that phospho-Akt levels were elevated in CF lung epithelial cells and were specifically lowered by either antagomir-155 or elevated expression of SHIP1. We therefore suggest that elevated miR-155 contributes to the proinflammatory expression of IL-8 in CF lung epithelial cells by lowering SHIP1 expression and thereby activating the PI3K/Akt signaling pathway. These data suggest that miR-155 may play an important role in the activation of IL-8-dependent inflammation in CF.	[Bhattacharyya, Sharmistha; Balakathiresan, Nagaraja S.; Gutti, Usha; Biswas, Roopa] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Dept Hlth Syst Risk & Contingency Management, Bethesda, MD 20814 USA; [Dalgard, Clifton; Jozwik, Cathy; Srivastava, Meera; Pollard, Harvey B.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Sch Med, Bethesda, MD 20814 USA; [Armistead, David] Appl Biosyst Inc, Foster City, CA 94404 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Thermo Fisher Scientific; Applied Biosystems	Biswas, R (corresponding author), Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Dept Hlth Syst Risk & Contingency Management, Rm B4024, Bethesda, MD 20814 USA.	rbiswas@usuhs.mil	Balakathiresan, Nagaraja Sethuraman/O-3213-2019; Biswas, Roopa/AAC-4928-2020	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; Gutti, Usha/0000-0003-0927-0923; Dalgard, Clifton/0000-0003-2025-8239	USU; National Institutes of Health [RO1-DK053051]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053051] Funding Source: NIH RePORTER	USU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by USU-Intramural Funds (to R. B.), National Institutes of Health (RO1-DK053051, to H. B. P.) and Cystic Fibrosis Foundation (to R. B. and H. B. P.).	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; Bagga Shveta, 2006, Genet Eng (N Y), V27, P1, DOI 10.1007/0-387-25856-6_1; Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; DEAN TP, 1993, PEDIATR RES, V34, P159, DOI 10.1203/00006450-199308000-00010; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Ebner S, 2000, J NEUROSCI RES, V62, P336; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; Felicetti F, 2008, EXPERT REV ANTICANC, V8, P1759, DOI 10.1586/14737140.8.11.1759; Frizzell R A, 1999, Physiol Rev, V79, pS1; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Pollard HB, 2000, ANAT RECORD, V259, pIII; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rane S, 2007, CELL CYCLE, V6, P1850, DOI 10.4161/cc.6.15.4551; Rauh MJ, 2004, BIOCHEM SOC T, V32, P785, DOI 10.1042/BST0320785; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; Stahl HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007158; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wojnarowski C, 1999, EUR RESPIR J, V14, P1136, DOI 10.1183/09031936.99.14511369; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Zhang HL, 2010, CHEMBIOCHEM, V11, P388, DOI 10.1002/cbic.200900545	58	172	181	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11604	11615		10.1074/jbc.M110.198390	http://dx.doi.org/10.1074/jbc.M110.198390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282106	hybrid, Green Published			2022-12-25	WOS:000288797100070
J	Frias, JA; Richman, JE; Erickson, JS; Wackett, LP				Frias, Janice A.; Richman, Jack E.; Erickson, Jasmine S.; Wackett, Lawrence P.			Purification and Characterization of OleA from Xanthomonas campestris and Demonstration of a Non-decarboxylative Claisen Condensation Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN NONISOPRENOID HYDROCARBONS; TO-HEAD HYDROCARBON; LONG-CHAIN; SARCINA-LUTEA; FATTY-ACIDS; BIOSYNTHESIS; BIOCHEMISTRY; SYNTHASE; PROTEIN; INTERMEDIATE	OleA catalyzes the condensation of fatty acyl groups in the first step of bacterial long-chain olefin biosynthesis, but the mechanism of the condensation reaction is controversial. In this study, OleA from Xanthomonas campestris was expressed in Escherichia coli and purified to homogeneity. The purified protein was shown to be active with fatty acyl-CoA substrates that ranged from C-8 to C-16 in length. With limiting myristoyl-CoA (C-14), 1 mol of the free coenzyme A was released/mol of myristoyl-CoA consumed. Using [C-14] myristoyl-CoA, the other products were identified as myristic acid, 2-myristoylmyristic acid, and 14-heptacosanone. 2-Myristoylmyristic acid was indicated to be the physiologically relevant product of OleA in several ways. First, 2-myristoylmyristic acid was the major condensed product in short incubations, but over time, it decreased with the concomitant increase of 14-heptacosanone. Second, synthetic 2-myristoylmyristic acid showed similar decarboxylation kinetics in the absence of OleA. Third, 2-myristoylmyristic acid was shown to be reactive with purified OleC and OleD to generate the olefin 14-heptacosene, a product seen in previous in vivo studies. The decarboxylation product, 14-heptacosanone, did not react with OleC and OleD to produce any demonstrable product. Substantial hydrolysis of fatty acyl-CoA substrates to the corresponding fatty acids was observed, but it is currently unclear if this occurs in vivo. In total, these data are consistent with OleA catalyzing a non-decarboxylative Claisen condensation reaction in the first step of the olefin biosynthetic pathway previously found to be present in at least 70 different bacterial strains.	[Wackett, Lawrence P.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 140 Gortner Lab,1479 Gortner Ave, St Paul, MN 55108 USA.	wacke003@umn.edu			University of Minnesota; Department of Energy [DE-AR0000007]; Initiative for Renewable Energy and the Environment	University of Minnesota(University of Minnesota System); Department of Energy(United States Department of Energy (DOE)); Initiative for Renewable Energy and the Environment(University of Minnesota System)	This work was supported by a University of Minnesota doctoral dissertation fellowship (to J. A. F.) and by Department of Energy ARPA-E Award DE-AR0000007 and the Initiative for Renewable Energy and the Environment (to L. P. W.).	Adams R., 1942, ORGANIC REACTIONS, V1; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P953, DOI 10.1021/bi00831a028; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P3317, DOI 10.1021/bi00836a028; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P1913, DOI 10.1021/bi00833a022; ALBRO PW, 1970, BIOCHEMISTRY-US, V9, P1893, DOI 10.1021/bi00811a005; ALBRO PW, 1969, BIOCHEMISTRY-US, V8, P394, DOI 10.1021/bi00829a055; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Briese RR, 1933, J AM CHEM SOC, V55, P1697, DOI 10.1021/ja01331a066; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3124; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; DAVIS JT, 1987, J BIOL CHEM, V262, P82; Detalle JF, 2004, J ORG CHEM, V69, P6528, DOI 10.1021/jo049464w; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Frias JA, 2010, ACTA CRYSTALLOGR F, V66, P1108, DOI 10.1107/S1744309110031751; Frias JA, 2009, APPL ENVIRON MICROB, V75, P1774, DOI 10.1128/AEM.02547-08; FRIEDMAN L, 2008, Patent No. 2008113041; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Muntendam R, 2009, APPL MICROBIOL BIOT, V84, P1003, DOI 10.1007/s00253-009-2150-1; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Skaff D. A., 2010, ANAL BIOCHEM, V396, P288; Sleeman MC, 2004, J BIOL CHEM, V279, P6730, DOI 10.1074/jbc.M311824200; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; TORNABEN.TG, 1967, J BACTERIOL, V94, P349, DOI 10.1128/JB.94.2.349-358.1967; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Unell M, 2007, FEMS MICROBIOL LETT, V266, P138, DOI 10.1111/j.1574-6968.2006.00502.x; YASHIRO K, 1995, BBA-LIPID LIPID MET, V1258, P288, DOI 10.1016/0005-2760(95)00136-Z	31	43	47	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10930	10938		10.1074/jbc.M110.216127	http://dx.doi.org/10.1074/jbc.M110.216127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21266575	Green Published, hybrid			2022-12-25	WOS:000288797100005
J	Kim, TH; Shivdasani, RA				Kim, Tae-Hee; Shivdasani, Ramesh A.			Genetic Evidence That Intestinal Notch Functions Vary Regionally and Operate through a Common Mechanism of Math1 Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATONAL HOMOLOG 1; STEM-CELLS; SECRETASE INHIBITORS; PROGENITOR CELLS; TRANSGENIC MICE; SELF-RENEWAL; DIFFERENTIATION; FATE; HES-1; RECOMBINATION	Notch signaling is active in many sites, and its diverse activities must require tissue-specific intermediaries, which are largely unknown. In the intestinal epithelium, Notch promotes crypt cell proliferation and inhibits goblet cell differentiation. Pharmacologic studies suggest that the latter effect occurs through the transcription factor Math1/Atoh1, which specifies all intestinal secretory cells. We tested this hypothesis using mouse mutants. Genetic loss of the Notch effector RBP-J kappa alone increases all intestinal secretory lineages, with variation between proximal and distal gut segments. This secretory cell excess observed with RBP-J kappa loss was blocked in the absence of Math1 in RBP-J kappa(Fl/Fl); Math1(Fl/Fl); Villin-Cre((ER-T2)) mice. Loss of both factors also restored progenitor replication, proving that Math1 is epistatic to Notch signaling in both secretory cell differentiation and crypt cell proliferation. Investigating mechanisms downstream of Math1, we found that expression of the known Notch effector protein Hes1 was predictably lost in RBP-J kappa(-/-) mice but surprisingly recovered in RBP-J kappa;Math1 compound conditional mutants. Furthermore, the cell cycle inhibitors p27(Kip1) and p57(Kip2) were selectively overexpressed in duodenal and ileal crypts, respectively, in RBP-J kappa-deficient mice. Regional activation of these products was completely abrogated in the absence of Math1. Thus, all intestinal Notch effects channel through the tissue-restricted factor Math1, which promotes secretory differentiation and cell cycle exit by regionally distinct mechanisms. Our data further suggest that, besides transmitting Notch signals, the transcription factor Hes1 acts downstream of Math1 to regulate expression of cell cycle inhibitors and intestinal crypt cell replication.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shivdasani, RA (corresponding author), 44 Binney St, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu			National Institutes of Health [R01DK081113]; Caring for Carcinoid Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caring for Carcinoid Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081113 (to R. A. S.). This work was also supported by a gift from the Caring for Carcinoid Foundation.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; RUBIN DC, 1992, J BIOL CHEM, V267, P15122; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	30	64	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11427	11433		10.1074/jbc.M110.188797	http://dx.doi.org/10.1074/jbc.M110.188797			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282114	hybrid, Green Published			2022-12-25	WOS:000288797100054
J	Liu, YD; Goetze, AM; Bass, RB; Flynn, GC				Liu, Y. Diana; Goetze, Andrew M.; Bass, Randal B.; Flynn, Gregory C.			N-terminal Glutamate to Pyroglutamate Conversion in Vivo for Human IgG2 Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULINS; ACID; G1	Therapeutic proteins contain a large number of post-translational modifications, some of which could potentially impact their safety or efficacy. In one of these changes, pyroglutamate can form on the N terminus of the polypeptide chain. Both glutamine and glutamate at the N termini of recombinant monoclonal antibodies can cyclize spontaneously to pyroglutamate (pE) in vitro. Glutamate conversion to pyroglutamate occurs more slowly than from glutamine but has been observed under near physiological conditions. Here we investigated to what extent human IgG2 N-terminal glutamate converts to pE in vivo. Pyroglutamate levels increased over time after injection into humans, with the rate of formation differing between polypeptide chains. These changes were replicated for the same antibodies in vitro under physiological pH and temperature conditions, indicating that the changes observed in vivo were due to chemical conversion not differential clearance. Differences in the conversion rates between the light chain and heavy chain on an antibody were eliminated by denaturing the protein, revealing that structural elements affect pE formation rates. By enzymatically releasing pE from endogenous antibodies isolated from human serum, we could estimate the naturally occurring levels of this post-translational modification. Together, these techniques and results can be used to predict the exposure of pE for therapeutic antibodies and to guide criticality assessments for this attribute.	[Liu, Y. Diana; Goetze, Andrew M.; Bass, Randal B.; Flynn, Gregory C.] Amgen Inc, Dept Proc & Prod Dev, Thousand Oaks, CA 91320 USA	Amgen	Flynn, GC (corresponding author), Amgen Inc, Dept Proc & Prod Dev, 1 Amgen Ctr Dr,Mail Stop 30E-1-C, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com	Liu, Y Diana/AAU-4624-2021					Blomback B., 1967, METHOD ENZYMOL, V11, P389; Chelius D, 2006, ANAL CHEM, V78, P2370, DOI 10.1021/ac051827k; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Mozdzanowski J, 1998, ANAL BIOCHEM, V260, P183, DOI 10.1006/abio.1998.2690; Ouellette D, 2010, ANAL BIOCHEM, V397, P37, DOI 10.1016/j.ab.2009.09.027; Qu J, 2002, ANALYST, V127, P66, DOI 10.1039/b108422b; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Yu L, 2006, J PHARMACEUT BIOMED, V42, P455, DOI 10.1016/j.jpba.2006.05.008; Zheng ZQ, 2004, ANAL CHEM, V76, P6374, DOI 10.1021/ac0491206	18	114	123	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11211	11217		10.1074/jbc.M110.185041	http://dx.doi.org/10.1074/jbc.M110.185041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282104	Green Published, hybrid			2022-12-25	WOS:000288797100032
J	Xiao, ZG; Brose, J; Schimo, S; Ackland, SM; La Fontaine, S; Wedd, AG				Xiao, Zhiguang; Brose, Jens; Schimo, Sonja; Ackland, Susan M.; La Fontaine, Sharon; Wedd, Anthony G.			Unification of the Copper(I) Binding Affinities of the Metallo-chaperones Atx1, Atox1, and Related Proteins DETECTION PROBES AND AFFINITY STANDARDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; WEAK MOLECULAR-COMPLEXES; ESCHERICHIA-COLI; CU(I); METALLOCHAPERONE; TRAFFICKING; MECHANISMS; DITHIOTHREITOL; TRANSPORTER; HOMEOSTASIS	Literature estimates of metal-protein affinities are widely scattered for many systems, as highlighted by the class of metallo-chaperone proteins, which includes human Atox1. The discrepancies may be attributed to unreliable detection probes and/or inconsistent affinity standards. In this study, application of the four Cu-I ligand probes bicinchoninate, bathocuproine disulfonate, dithiothreitol (Dtt), and glutathione (GSH) is reviewed, and their Cu-I affinities are re-estimated and unified. Excess bicinchoninate or bathocuproine disulfonate reacts with Cu-I to yield distinct 1:2 chromatophoric complexes [(CuL2)-L-I](3-) with formation constants beta(2) = 10(17.2) and 10(19.8) M-2, respectively. These constants do not depend on proton concentration for pH >= 7.0. Consequently, they are a pair of complementary and stable probes capable of detecting free Cu+ concentrations from 10(-12) to 10(-19) M. Dtt binds Cu-I with K-D similar to 10(-15) M at pH 7, but it is air-sensitive, and its Cu-I affinity varies with pH. The Cu-I binding properties of Atox1 and related proteins (including the fifth and sixth domains at the N terminus of the Wilson protein ATP7B) were assessed with these probes. The results demonstrate the following: (i) their use permits the stoichiometry of high affinity Cu-I binding and the individual quantitative affinities (K-D values) to be determined reliably via noncompetitive and competitive reactions, respectively; (ii) the scattered literature values are unified by using reliable probes on a unified scale; and (iii) Atox1-type proteins bind Cu-I with sub-femtomolar affinities, consistent with tight control of labile Cu+ concentrations in living cells.	Univ Melbourne, Inst Bio21, Melbourne, Vic 3010, Australia; Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Ackland, Susan M.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic 3215, Australia	University of Melbourne; University of Melbourne; Deakin University		z.xiao@unimelb.edu.au	La Fontaine, Sharon/G-7113-2018	La Fontaine, Sharon/0000-0002-9948-074X; Xiao, Zhiguang/0000-0001-6908-8897	Australian Research Council [A29930204]; National Health and Medical Research Council [479502]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant A29930204 and National Health and Medical Research Council Grant 479502.	Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; DERANLEA.DA, 1969, J AM CHEM SOC, V91, P4050, DOI 10.1021/ja01043a005; DERANLEAU DA, 1969, J AM CHEM SOC, V91, P4044, DOI 10.1021/ja01043a004; Djoko KY, 2007, INORG CHEM, V46, P4560, DOI 10.1021/ic070107o; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Freire E., 1990, ANAL CHEM, V62, p950A; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; HAWKINS CJ, 1963, J CHEM SOC, P2996, DOI 10.1039/jr9630002996; Hearnshaw S, 2009, BIOCHEMISTRY-US, V48, P9324, DOI 10.1021/bi9011995; Hong L, 2008, J PHYS CHEM B, V112, P604, DOI 10.1021/jp075747r; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; KUBAS GJ, 1990, INORG SYN, V28, P68, DOI 10.1002/9780470132593.ch15; LAPPIN AG, 1980, INORG CHEM, V19, P407, DOI 10.1021/ic50204a025; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Llanos RM, 2002, DNA CELL BIOL, V21, P259, DOI 10.1089/104454902753759681; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Miras R, 2008, J BIOL INORG CHEM, V13, P195, DOI 10.1007/s00775-007-0310-2; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; PEARD WJ, 1958, J AM CHEM SOC, V80, P1593, DOI 10.1021/ja01540a021; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2008, INORG CHEM, V47, P4338, DOI 10.1021/ic702440e; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	38	181	182	5	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11047	11055		10.1074/jbc.M110.213074	http://dx.doi.org/10.1074/jbc.M110.213074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21258123	Green Published, hybrid			2022-12-25	WOS:000288797100016
J	Lin, CH; Cheng, HW; Ma, HP; Wu, CH; Hong, CY; Chen, BC				Lin, Chien-Huang; Cheng, Hui-Wen; Ma, Hon-Ping; Wu, Chih-Hsiung; Hong, Chuang-Ye; Chen, Bing-Chang			Thrombin Induces NF-kappa B Activation and IL-8/CXCL8 Expression in Lung Epithelial Cells by a Rac1-dependent PI3K/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; CYCLOOXYGENASE-2 EXPRESSION; INTERLEUKIN-8 PRODUCTION; SIGNALING PATHWAYS; IMMUNE-RESPONSE; GENE-EXPRESSION; RAC ACTIVATION	We previously showed that thrombin induces interleukin (IL)-8/CXCL8 expression via the protein kinase C (PKC)alpha/c-Src-dependent I kappa B kinase alpha/beta (IKK alpha/beta)/NF-kappa B signaling pathway in human lung epithelial cells. In this study, we further investigated the roles of Rac1, phosphoinositide 3-kinase (PI3K), and Akt in thrombin-induced NF-kappa B activation and IL-8/CXCL8 expression. Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by a PI3K inhibitor (LY294002), an Akt inhibitor (1-L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), and the dominant negative mutants of Rac1 (RacN17) and Akt (AktDN). Treatment of cells with thrombin caused activation of Rac and Akt. The thrombin-induced increase in Akt activation was inhibited by RacN17 and LY294002. Stimulation of cells with thrombin resulted in increases in IKK alpha/beta activation and kappa B-luciferase activity; these effects were inhibited by RacN17, LY294002, an Akt inhibitor, and AktDN. Treatment of cells with thrombin induced G beta gamma, p85 alpha, and Rac1 complex formation in a time-dependent manner. These results imply that thrombin activates the Rac1/PI3K/Akt pathway through formation of the G beta gamma, Rac1, and p85 alpha complex to induce IKK alpha/beta activation, NF-kappa B transactivation, and IL-8/CXCL8 expression in human lung epithelial cells.	[Lin, Chien-Huang; Cheng, Hui-Wen] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Chen, Bing-Chang] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei 110, Taiwan; [Lin, Chien-Huang; Ma, Hon-Ping; Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Taipei 235, Taiwan; [Lin, Chien-Huang; Hong, Chuang-Ye] Taipei Med Univ, Wang Fang Hosp, Taipei 116, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, BC (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	National Science Council of Taiwan [NSC92-2320-B-038-022, NSC93-2320-B-038-045]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC92-2320-B-038-022 and NSC93-2320-B-038-045 from the National Science Council of Taiwan.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang MS, 2004, MOL PHARMACOL, V66, P561; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chung Kian F., 2005, Current Drug Targets - Inflammation and Allergy, V4, P619, DOI 10.2174/156801005774912806; Chung SW, 2010, BIOCHEM BIOPH RES CO, V396, P748, DOI 10.1016/j.bbrc.2010.05.009; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; John AE, 2009, J IMMUNOL, V183, P4682, DOI 10.4049/jimmunol.0803832; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kim H, 2008, EXP MOL MED, V40, P167, DOI 10.3858/emm.2008.40.2.167; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Moffatt JD, 2004, BRIT J PHARMACOL, V143, P269, DOI 10.1038/sj.bjp.0705926; Mohan S, 2007, AM J PHYSIOL-CELL PH, V292, pC362, DOI 10.1152/ajpcell.00535.2005; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Osada M, 1999, MOL CELL BIOL, V19, P6333; Ostrowska E, 2008, BIOCHEM BIOPH RES CO, V366, P1030, DOI 10.1016/j.bbrc.2007.12.064; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Sakito O, 1996, RESPIRATION, V63, P42; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Soulet C, 2005, J THROMB HAEMOST, V3, P2296, DOI 10.1111/j.1538-7836.2005.01588.x; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Street M, 2006, J CELL SCI, V119, P1528, DOI 10.1242/jcs.02872; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Zheng L, 2007, J LEUKOCYTE BIOL, V82, P619, DOI 10.1189/jlb.0107009	56	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10483	10494		10.1074/jbc.M110.112433	http://dx.doi.org/10.1074/jbc.M110.112433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21266580	Green Published, hybrid			2022-12-25	WOS:000288547000065
J	Rolfe, MD; Ter Beek, A; Graham, AI; Trotter, EW; Asif, HMS; Sanguinetti, G; de Mattos, JT; Poole, RK; Green, J				Rolfe, Matthew D.; Ter Beek, Alex; Graham, Alison I.; Trotter, Eleanor W.; Asif, H. M. Shahzad; Sanguinetti, Guido; de Mattos, Joost Teixeira; Poole, Robert K.; Green, Jeffrey			Transcript Profiling and Inference of Escherichia coli K-12 ArcA Activity across the Range of Physiologically Relevant Oxygen Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; IN-VIVO; PROBABILISTIC INFERENCE; MICROARRAY EXPERIMENTS; 2-COMPONENT SYSTEM; AEROBIC CONDITIONS; 2FE-2S CONVERSION; FNR PROTEIN; REDOX STATE; DNA-BINDING	Oxygen availability is the major determinant of the metabolic modes adopted by Escherichia coli. Although much is known about E. coli gene expression and metabolism under fully aerobic and anaerobic conditions, the intermediate oxygen tensions that are encountered in natural niches are understudied. Here, for the first time, the transcript profiles of E. coli K-12 across the physiologically significant range of oxygen availabilities are described. These suggested a progressive switch to aerobic respiratory metabolism and a remodeling of the cell envelope as oxygen availability increased. The transcriptional responses were consistent with changes in the abundance of cytochrome bd and bo' and the outer membrane protein OmpW. The observed transcript and protein profiles result from changes in the activities of regulators that respond to oxygen itself or to metabolic and environmental signals that are sensitive to oxygen availability (aerobiosis). A probabilistic model (TFInfer) was used to predict the activity of the indirect oxygen-sensing two-component system ArcBA across the aerobiosis range. The model implied that the activity of the regulator ArcA correlated with aerobiosis but not with the redox state of the ubiquinone pool, challenging the idea that ArcA activity is inhibited by oxidized ubiquinone. The amount of phosphorylated ArcA correlated with the predicted ArcA activities and with aerobiosis, suggesting that fermentation product-mediated inhibition of ArcB phosphatase activity is the dominant mechanism for regulating ArcA activity under the conditions used here.	[Rolfe, Matthew D.; Graham, Alison I.; Trotter, Eleanor W.; Poole, Robert K.; Green, Jeffrey] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Ter Beek, Alex; de Mattos, Joost Teixeira] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1090 GE Amsterdam, Netherlands; [Asif, H. M. Shahzad; Sanguinetti, Guido] Univ Edinburgh, Edinburgh ED8 9AB, Midlothian, Scotland	University of Sheffield; University of Amsterdam; University of Edinburgh	Green, J (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	jeff.green@sheffield.ac.uk		Graham, Alison Isobel/0000-0001-7334-9033	Biotechnology and Biological Sciences Research Council UK through SysMO [BB/E019943/1]; Biotechnology and Biological Sciences Research Council [BB/I004122/1, BB/E019943/1] Funding Source: researchfish; BBSRC [BB/I004122/1, BB/E019943/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK through SysMO(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK through SysMO and Project Grant BB/E019943/1.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Allen LAH, 2000, J EXP MED, V191, P1451, DOI 10.1084/jem.191.9.1451; Asif HMS, 2010, BIOINFORMATICS, V26, P2635, DOI 10.1093/bioinformatics/btq469; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chart H., 1994, METHODS PRACTICAL LA, P1; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; DMELLO R, 1995, J BACTERIOL, V177, P867, DOI 10.1128/jb.177.3.867-870.1995; Evans CGT, 1970, METHOD MICROBIOL, V2, P278; Garcia-Ochoa F, 2009, BIOTECHNOL ADV, V27, P153, DOI 10.1016/j.biotechadv.2008.10.006; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guest John R., 1996, P317; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; KITA K, 1986, METHOD ENZYMOL, V126, P94; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P406, DOI 10.1002/bit.10048; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Marshall FA, 2001, MOL MICROBIOL, V39, P747, DOI 10.1046/j.1365-2958.2001.02262.x; Moreau PL, 2007, J BACTERIOL, V189, P2249, DOI 10.1128/JB.01306-06; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Pirt SJ, 1975, PRINCIPLES MICROBE C, P81; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	51	69	70	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10147	10154		10.1074/jbc.M110.211144	http://dx.doi.org/10.1074/jbc.M110.211144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21252224	Green Published, hybrid			2022-12-25	WOS:000288547000029
J	Chao, DY; Cheng, KF; Li, TC; Wu, TN; Chen, CY; Tsai, CA; Chen, JH; Chiu, HT; Lu, JJ; Su, MC; Liao, YH; Chan, WC; Hsieh, YH				Chao, Day-Yu; Cheng, Kuang-Fu; Li, Tsai-Chung; Wu, Trong-Neng; Chen, Chiu-Ying; Tsai, Chen-An; Chen, Jin-Hwa; Chiu, Hsien-Tsai; Lu, Jang-Jih; Su, Mei-Chi; Liao, Yu-Hsin; Chan, Wei-Cheng; Hsieh, Ying-Hen			Serological Evidence of Subclinical Transmission of the 2009 Pandemic H1N1 Influenza Virus Outside of Mexico	PLOS ONE			English	Article							A H1N1; EPIDEMIOLOGY; INFECTION; ANTIBODY	Background: Relying on surveillance of clinical cases limits the ability to understand the full impact and severity of an epidemic, especially when subclinical cases are more likely to be present in the early stages. Little is known of the infection and transmissibility of the 2009 H1N1 pandemic influenza (pH1N1) virus outside of Mexico prior to clinical cases being reported, and of the knowledge pertaining to immunity and incidence of infection during April-June, which is essential for understanding the nature of viral transmissibility as well as for planning surveillance and intervention of future pandemics. Methodology/Principal Findings: Starting in the fall of 2008, 306 persons from households with schoolchildren in central Taiwan were followed sequentially and serum samples were taken in three sampling periods for haemagglutination inhibition (HI) assay. Age-specific incidence rates were calculated based on seroconversion of antibodies to the pH1N1 virus with an HI titre of 1: 40 or more during two periods: April-June and September-October in 2009. The earliest time period with HI titer greater than 40, as well as a four-fold increase of the neutralization titer, was during April 26-May 3. The incidence rates during the pre-epidemic phase (April-June) and the first wave (July-October) of the pandemic were 14.1% and 29.7%, respectively. The transmissibility of the pH1N1 virus during the early phase of the epidemic, as measured by the effective reproductive number R-0, was 1.16 (95% confidence interval (CI): 0.98-1.34). Conclusions: Approximately one in every ten persons was infected with the 2009 pH1N1 virus during the pre-epidemic phase in April-June. The lack of age-pattern in seropositivity is unexpected, perhaps highlighting the importance of children as asymptomatic transmitters of influenza in households. Although without virological confirmation, our data raise the question of whether there was substantial pH1N1 transmission in Taiwan before June, when clinical cases were first detected by the surveillance network.	[Chao, Day-Yu; Liao, Yu-Hsin; Chan, Wei-Cheng] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Cheng, Kuang-Fu; Li, Tsai-Chung; Tsai, Chen-An; Chen, Jin-Hwa; Chiu, Hsien-Tsai] China Med Univ, CMU Biostat Ctr, Taichung, Taiwan; [Li, Tsai-Chung; Wu, Trong-Neng; Tsai, Chen-An; Chen, Jin-Hwa; Hsieh, Ying-Hen] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Wu, Trong-Neng; Chen, Chiu-Ying; Chiu, Hsien-Tsai; Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lu, Jang-Jih] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lu, Jang-Jih; Su, Mei-Chi] China Med Univ Hosp, Dept Lab Med, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chao, DY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010; Chao, Day-Yu/AFH-8360-2022; Li, Tsai-Chung/P-2052-2015	Chao, Day-Yu/0000-0001-7139-026X; Li, Tsai-Chung/0000-0002-3346-7462; Tsai, Chen-An/0000-0002-7490-4331	National Science Council of Taiwan [NSC 97-2118-M-039-004]; China Medical University, Taiwan [CMU 97 323]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This study was supported by National Science Council of Taiwan (NSC 97-2118-M-039-004) and China Medical University, Taiwan (CMU 97 323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter R, 2010, EMERG INFECT DIS, V16, P504, DOI 10.3201/eid1603.091285; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Boelle PY, 2009, EURO SURVEILL, V14; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Principi N, 2004, LANCET INFECT DIS, V4, P75, DOI 10.1016/S1473-3099(04)00926-0; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yang JR, 2010, VIRUS RES, V151, P33, DOI 10.1016/j.virusres.2010.03.011; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14555	10.1371/journal.pone.0014555	http://dx.doi.org/10.1371/journal.pone.0014555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267441	gold, Green Submitted, Green Published			2022-12-25	WOS:000286519500022
J	Inostroza-Ponta, M; Berretta, R; Moscato, P				Inostroza-Ponta, Mario; Berretta, Regina; Moscato, Pablo			QAPgrid: A Two Level QAP-Based Approach for Large-Scale Data Analysis and Visualization	PLOS ONE			English	Article							MEMETIC ALGORITHM; GENETIC ALGORITHM; ASSIGNMENT; SEARCH; LAYOUT	Background: The visualization of large volumes of data is a computationally challenging task that often promises rewarding new insights. There is great potential in the application of new algorithms and models from combinatorial optimisation. Datasets often contain "hidden regularities" and a combined identification and visualization method should reveal these structures and present them in a way that helps analysis. While several methodologies exist, including those that use non-linear optimization algorithms, severe limitations exist even when working with only a few hundred objects. Methodology/Principal Findings: We present a new data visualization approach (QAPgrid) that reveals patterns of similarities and differences in large datasets of objects for which a similarity measure can be computed. Objects are assigned to positions on an underlying square grid in a two-dimensional space. We use the Quadratic Assignment Problem (QAP) as a mathematical model to provide an objective function for assignment of objects to positions on the grid. We employ a Memetic Algorithm (a powerful metaheuristic) to tackle the large instances of this NP-hard combinatorial optimization problem, and we show its performance on the visualization of real data sets. Conclusions/Significance: Overall, the results show that QAPgrid algorithm is able to produce a layout that represents the relationships between objects in the data set. Furthermore, it also represents the relationships between clusters that are feed into the algorithm. We apply the QAPgrid on the 84 Indo-European languages instance, producing a near-optimal layout. Next, we produce a layout of 470 world universities with an observed high degree of correlation with the score used by the Academic Ranking of World Universities compiled in the The Shanghai Jiao Tong University Academic Ranking of World Universities without the need of an ad hoc weighting of attributes. Finally, our Gene Ontology-based study on Saccharomyces cerevisiae fully demonstrates the scalability and precision of our method as a novel alternative tool for functional genomics.	[Inostroza-Ponta, Mario] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Inostroza-Ponta, Mario; Moscato, Pablo] Australian Res Ctr Excellence Bioinformat, Callaghan, NSW, Australia; [Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarkers Discovery & Informat B, Callaghan, NSW 2308, Australia; [Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Informat Based Med Program, Hunter Med Res Inst, New Lambton Hts, Australia	Universidad de Santiago de Chile; University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Inostroza-Ponta, M (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Inostroza-Ponta, Mario/G-7548-2012	Moscato, Pablo/0000-0003-2570-5966; Inostroza-Ponta, Mario/0000-0003-1295-8972; Berretta, Regina/0000-0002-4420-3446	Australian Research Council Centre of Excellence in Bioinformatics; Australian Research Council [DP0559755]; Universidad de Santiago de Chile; Departamento de Investigaciones Cientificas y Tecnologicas [060919IP]; University of Newcastle's Strategic Initiative	Australian Research Council Centre of Excellence in Bioinformatics(Australian Research Council); Australian Research Council(Australian Research Council); Universidad de Santiago de Chile; Departamento de Investigaciones Cientificas y Tecnologicas; University of Newcastle's Strategic Initiative	This project was supported by the the Australian Research Council Centre of Excellence in Bioinformatics (PM) and Australian Research Council Discovery project DP0559755 titled "Evolutionary algorithms for problems in functional genomics data analysis" (PM and RB). The authors also thank for support Universidad de Santiago de Chile (MIP), the Departamento de Investigaciones Cientificas y Tecnologicas project 060919IP and The University of Newcastle's Strategic Initiative Fund (project: Newcastle Bioinformatics Initiative), 2003-2007 (PM, RB, MIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the support of the ARC Centre of Excellence in Bioinformatics and the DICYT-USACH (060919IP).	Abbiw-Jackson R, 2006, COMPUT OPER RES, V33, P3070, DOI 10.1016/j.cor.2005.01.020; Ahuja RK, 2000, COMPUT OPER RES, V27, P917, DOI 10.1016/S0305-0548(99)00067-2; Battiti R., 1994, ORSA Journal on Computing, V6, P126, DOI 10.1287/ijoc.6.2.126; Berretta R, 2004, INT J PROD ECON, V87, P67, DOI 10.1016/S0925-5273(03)00093-8; Berretta R, 1999, NEW IDEAS OPTIMIZATI, P261; Bryant D., 2005, EVOLUTION CULTURAL D, P67; Buriol L, 2004, J HEURISTICS, V10, P483, DOI 10.1023/B:HEUR.0000045321.59202.52; Capp A, 2009, RADIOTHER ONCOL, V90, P400, DOI 10.1016/j.radonc.2008.09.019; CARRIZO J, 1992, P 21 M INF OR BUEN A; Demirel NC, 2006, APPL MATH COMPUT, V183, P427, DOI 10.1016/j.amc.2006.05.073; DICKEY JW, 1972, TRANSPORT RES, V6, P59, DOI 10.1016/0041-1647(72)90111-6; Drezner Z, 2003, INFORMS J COMPUT, V15, P320, DOI 10.1287/ijoc.15.3.320.16076; Drezner Z, 2008, COMPUT OPER RES, V35, P717, DOI 10.1016/j.cor.2006.05.004; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELSHAFEI AN, 1977, OPER RES QUART, V28, P167, DOI 10.2307/3008789; FLEURENT C, 1994, DIMACS SERIES MATH T, V16, P190; Franca PM, 2005, COMPUT IND ENG, V48, P491, DOI 10.1016/j.cie.2003.11.004; Gambardella LM, 1999, J OPER RES SOC, V50, P167, DOI 10.2307/3010565; Glover F., 1997, TABU SEARCH; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156; Inostroza-Ponta M, 2006, INT FED INFO PROC, V217, P179; James T, 2009, EUR J OPER RES, V195, P810, DOI 10.1016/j.ejor.2007.06.061; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; KOOPMANS TC, 1957, ECONOMETRICA, V25, P53, DOI 10.2307/1907742; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; MARGISON S, 2007, 16 ANN NZ INT ED C; Mendes A, 2005, INT CONF PARA PROC, P604, DOI 10.1109/ICPPW.2005.34; Merz P., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P2063, DOI 10.1109/CEC.1999.785529; Merz P, 2000, IEEE T EVOLUT COMPUT, V4, P337, DOI 10.1109/4235.887234; Miranda G, 2005, COMPUT OPER RES, V32, P2937, DOI 10.1016/j.cor.2004.04.014; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Moscato P., 1993, Annals of Operations Research, V41, P85, DOI 10.1007/BF02022564; MOSCATO P, 2003, HDB METAHEURISTICS, P105; Moscato P., 2002, HDB APPL OPTIMIZATIO; MOSCATO P, WILEY ENCY IN PRESS; Rabak CS, 2003, ADV ENG INFORM, V17, P95, DOI 10.1016/j.aei.2003.08.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; *STANF U SGD, 2007, GEN ONT TERM FIND; TAILLARD E, 1991, PARALLEL COMPUT, V17, P443, DOI 10.1016/S0167-8191(05)80147-4; *YWORKS GMBH, 2004, YED JAV GRAPH ED	44	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14468	10.1371/journal.pone.0014468	http://dx.doi.org/10.1371/journal.pone.0014468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21267077	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500001
J	Kitamura, N; Nakamura, Y; Miyamoto, Y; Miyamoto, T; Kabu, K; Yoshida, M; Futamura, M; Ichinose, S; Arakawa, H				Kitamura, Noriaki; Nakamura, Yasuyuki; Miyamoto, Yuji; Miyamoto, Takafumi; Kabu, Koki; Yoshida, Masaki; Futamura, Manabu; Ichinose, Shizuko; Arakawa, Hirofumi			Mieap, a p53-Inducible Protein, Controls Mitochondrial Quality by Repairing or Eliminating Unhealthy Mitochondria	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; AUTOPHAGIC DEGRADATION; TUMOR-SUPPRESSOR; MITOPHAGY; NIX; P53; HOMEOSTASIS; MATURATION; APOPTOSIS; PARKIN	Maintenance of healthy mitochondria prevents aging, cancer, and a variety of degenerative diseases that are due to the result of defective mitochondrial quality control (MQC). Recently, we discovered a novel mechanism for MQC, in which Mieap induces intramitochondrial lysosome-like organella that plays a critical role in the elimination of oxidized mitochondrial proteins (designated MALM for Mieap-induced accumulation of lysosome-like organelles within mitochondria). However, a large part of the mechanisms for MQC remains unknown. Here, we report additional mechanisms for Mieap-regulated MQC. Reactive oxygen species (ROS) scavengers completely inhibited MALM. A mitochondrial outer membrane protein NIX interacted with Mieap in a ROS-dependent manner via the BH3 domain of NIX and the coiled-coil domain of Mieap. Deficiency of NIX also completely impaired MALM. When MALM was inhibited, Mieap induced vacuole-like structures (designated as MIV for Mieap-induced vacuole), which engulfed and degraded the unhealthy mitochondria by accumulating lysosomes. The inactivation of p53 severely impaired both MALM and MIV generation, leading to accumulation of unhealthy mitochondria. These results suggest that (1) mitochondrial ROS and NIX are essential factors for MALM, (2) MIV is a novel mechanism for lysosomal degradation of mitochondria, and (3) the p53-Mieap pathway plays a pivotal role in MQC by repairing or eliminating unhealthy mitochondria via MALM or MIV generation, respectively.	[Kitamura, Noriaki; Nakamura, Yasuyuki; Miyamoto, Yuji; Miyamoto, Takafumi; Kabu, Koki; Yoshida, Masaki; Futamura, Manabu; Arakawa, Hirofumi] Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo, Japan	National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Arakawa, H (corresponding author), Natl Canc Ctr, Res Inst, Canc Med & Biophys Div, Tokyo 104, Japan.	harakawa@ncc.go.jp	Miyamoto, Takafumi/T-6950-2019; Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638; Miyamoto, Takafumi/0000-0001-9363-2864; Miyamoto, Yuji/0000-0003-3948-5044; Kabu, Koki/0000-0003-2753-4259	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [23591966] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant support was provided by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant-in-aid from the Ministry of Health, Labor and Welfare for the 3rd-Term Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Devenish RJ, 2007, AUTOPHAGY, V3, P293, DOI 10.4161/auto.4273; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041; Futamura M, 2007, CANCER RES, V67, P1451, DOI 10.1158/0008-5472.CAN-06-2485; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Kissova I, 2006, FREE RADICAL BIO MED, V41, P1655, DOI 10.1016/j.freeradbiomed.2006.08.012; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Masuda Yoshiko, 2006, J Hum Genet, V51, P652, DOI 10.1007/s10038-006-0004-6; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Mijaljica D, 2007, AUTOPHAGY, V3, P417, DOI 10.4161/auto.4441; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohi N, 1999, CELL DEATH DIFFER, V6, P314, DOI 10.1038/sj.cdd.4400493; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tomiyama A, 2006, JNCI-J NATL CANCER I, V98, P1462, DOI 10.1093/jnci/djj395; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	41	71	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16060	10.1371/journal.pone.0016060	http://dx.doi.org/10.1371/journal.pone.0016060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264228	gold, Green Published, Green Submitted			2022-12-25	WOS:000286517600020
J	Reinhard, H; Vu, TKL; Ohlin, M; Hengel, H; Trilling, M				Reinhard, Henrike; Vu Thuy Khanh Le; Ohlin, Mats; Hengel, Hartmut; Trilling, Mirko			Exploitation of Herpesviral Transactivation Allows Quantitative Reporter Gene-Based Assessment of Virus Entry and Neutralization	PLOS ONE			English	Article							CONGENITAL CYTOMEGALOVIRUS-INFECTION; THYMIDINE KINASE GENE; TRANSFORMED L-CELLS; SIMPLEX-VIRUS; IMMUNOGLOBULIN-G; MICRONEUTRALIZATION ASSAY; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN-D; FC-RECEPTOR; EXPRESSION	Herpesviral entry is a highly elaborated process requiring many proteins to act in precise conjunction. Neutralizing antibodies interfere with this process to abrogate viral infection. Based on promoter transactivation of a reporter gene we established a novel method to quantify herpesvirus entry and neutralization by antibodies. Following infection with mouse and human cytomegalovirus and Herpes simplex virus 1 we observed promoter transactivation resulting in substantial luciferase expression (>1000-fold). No induction was elicited by UV-inactivated viruses. The response was MOI-dependent and immunoblots confirmed a correlation between luciferase induction and pp72-IE1 expression. Monoclonal antibodies, immune sera and purified immunoglobulin preparations decreased virus-dependent luciferase induction dose-dependently, qualifying this approach as surrogate virus neutralization test. Besides the reduced hands-on time, this assay allows analysis of herpesvirus entry in semi-permissive and non-adherent cells, which were previously non-assessable but play significant roles in herpesvirus pathology.	[Reinhard, Henrike; Vu Thuy Khanh Le; Hengel, Hartmut; Trilling, Mirko] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Ohlin, Mats] Lund Univ, Dept Immunotechnol, Lund, Sweden	Heinrich Heine University Dusseldorf; Lund University	Reinhard, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Univ Canc Ctr Hamburg, Dept Internal Med 2, Hamburg, Germany.	hartmut.hengel@uni-duesseldorf.de; mirko.trilling@uni-duesseldorf.de	Ohlin, Mats/A-7307-2010; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020; Trilling, Mirko/AAL-3533-2021	Ohlin, Mats/0000-0002-5105-1938; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; Trilling, Mirko/0000-0003-3659-3541	Deutsche Forschungsgemeinschaft [GK1045, He2526/6-2]; European Commission [FP6-037517]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants of the Deutsche Forschungsgemeinschaft through GK1045 and He2526/6-2 and by the European Commission FP6-037517 'Targetherpes'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abai AM, 2007, J IMMUNOL METHODS, V322, P82, DOI 10.1016/j.jim.2007.02.001; ANDREONI M, 1989, J VIROL METHODS, V23, P157, DOI 10.1016/0166-0934(89)90129-8; Antonsson A, 2001, J GEN VIROL, V82, P1137, DOI 10.1099/0022-1317-82-5-1137; Atalay R, 2002, J VIROL, V76, P8596, DOI 10.1128/JVI.76.17.8596-8608.2002; BAUCKE RB, 1979, J VIROL, V32, P779, DOI 10.1128/JVI.32.3.779-789.1979; BOPPANA SB, 1992, J CLIN MICROBIOL, V30, P721, DOI 10.1128/JCM.30.3.721-723.1992; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Burkhardt C, 2009, J GEN VIROL, V90, P1951, DOI 10.1099/vir.0.010967-0; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Eggers M, 1998, J MED VIROL, V56, P351, DOI 10.1002/(SICI)1096-9071(199812)56:4&lt;351::AID-JMV11&gt;3.0.CO;2-K; Eggers M, 2001, J MED VIROL, V63, P135, DOI 10.1002/1096-9071(20000201)63:2&lt;135::AID-JMV1008&gt;3.0.CO;2-P; Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Le VTK, 2008, J GEN VIROL, V89, P1131, DOI 10.1099/vir.0.83538-0; LEIDEN JM, 1976, J VIROL, V20, P413, DOI 10.1128/JVI.20.2.413-424.1976; Lilley BN, 2001, J VIROL, V75, P11218, DOI 10.1128/JVI.75.22.11218-11221.2001; LIN SS, 1974, J VIROL, V14, P1199, DOI 10.1128/JVI.14.5.1199-1208.1974; Lopez M, 2000, J VIROL, V74, P1267, DOI 10.1128/JVI.74.3.1267-1274.2000; Marshall EE, 2009, J INTERF CYTOK RES, V29, P609, DOI 10.1089/jir.2009.0064; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Nicola AV, 1998, J VIROL, V72, P3595, DOI 10.1128/JVI.72.5.3595-3601.1998; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; OHE Y, 1995, HUM GENE THER, V6, P325, DOI 10.1089/hum.1995.6.3-325; OHLIN M, 1993, J VIROL, V67, P703, DOI 10.1128/JVI.67.2.703-710.1993; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; PEREIRA L, 1980, INFECT IMMUN, V29, P724; Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47; RODRIGUEZ JE, 1987, ARCH VIROL, V94, P177, DOI 10.1007/BF01310712; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Sprague ER, 2008, J VIROL, V82, P3490, DOI 10.1128/JVI.01476-07; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2007, P NATL ACAD SCI USA, V104, P20037, DOI 10.1073/pnas.0709704104; Wang XQ, 2003, J VIROL, V77, P7182, DOI 10.1128/JVI.77.13.7182-7192.2003	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e14532	10.1371/journal.pone.0014532	http://dx.doi.org/10.1371/journal.pone.0014532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264213	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600008
J	Jin, Z; Jin, Y; Kumar-Mendu, S; Degerman, E; Groop, L; Birnir, B				Jin, Zhe; Jin, Yang; Kumar-Mendu, Suresh; Degerman, Eva; Groop, Leif; Birnir, Bryndis			Insulin Reduces Neuronal Excitability by Turning on GABA(A) Channels that Generate Tonic Current	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; A RECEPTORS; INHIBITION; CELLS; ACTIVATION; MEMORY; BRAIN; MICE	Insulin signaling to the brain is important not only for metabolic homeostasis but also for higher brain functions such as cognition. GABA (c-aminobutyric acid) decreases neuronal excitability by activating GABA(A) channels that generate phasic and tonic currents. The level of tonic inhibition in neurons varies. In the hippocampus, interneurons and dentate gyrus granule cells normally have significant tonic currents under basal conditions in contrast to the CA1 pyramidal neurons where it is minimal. Here we show in acute rat hippocamal slices that insulin (1 nM) "turns on" new extrasynaptic GABA(A) channels in CA1 pyramidal neurons resulting in decreased frequency of action potential firing. The channels are activated by more than million times lower GABA concentrations than synaptic channels, generate tonic currents and show outward rectification. The single-channel current amplitude is related to the GABA concentration resulting in a single-channel GABA affinity (EC50) in intact CA1 neurons of 17 pM with the maximal current amplitude reached with 1 nM GABA. They are inhibited by GABA(A) antagonists but have novel pharmacology as the benzodiazepine flumazenil and zolpidem are inverse agonists. The results show that tonic rather than synaptic conductances regulate basal neuronal excitability when significant tonic conductance is expressed and demonstrate an unexpected hormonal control of the inhibitory channel subtypes and excitability of hippocampal neurons. The insulin-induced new channels provide a specific target for rescuing cognition in health and disease.	[Jin, Zhe; Jin, Yang; Kumar-Mendu, Suresh; Birnir, Bryndis] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Degerman, Eva; Groop, Leif] Lund Univ, Lund Univ Diabet Ctr, Lund, Sweden	Uppsala University; Lund University	Jin, Z (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	bryndis.birnir@neuro.uu.se	Jin, Zhe/C-5150-2008	Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266; Mendu, Suresh Kumar/0000-0002-6785-0806	Uppsala University; Swedish Research Council; LUDC; Segerfalks Foundation; Pahlsons Foundation; Fredrik and Ingrid Thurings Foundation; EXODIAB; Svenska Sallskapet	Uppsala University; Swedish Research Council(Swedish Research CouncilEuropean Commission); LUDC; Segerfalks Foundation; Pahlsons Foundation; Fredrik and Ingrid Thurings Foundation; EXODIAB; Svenska Sallskapet	This work is supported by Uppsala University, Swedish Research Council, LUDC, the Segerfalks Foundation, the Pahlsons Foundation and Fredrik and Ingrid Thurings Foundation. ZJ held a Swedish Research Council, EXODIAB and Svenska Sallskapet for Medicinsk Forskning postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Benedict C, 2007, NEUROENDOCRINOLOGY, V86, P136, DOI 10.1159/000106378; BIRNIR B, 1994, J MEMBRANE BIOL, V142, P93; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chisalita SI, 2006, GROWTH HORM IGF RES, V16, P258, DOI 10.1016/j.ghir.2006.06.003; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; de Groote L, 2007, NEUROSCIENCE, V148, P794, DOI 10.1016/j.neuroscience.2007.06.030; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Ju YH, 2009, J NEUROSCI RES, V87, P1737, DOI 10.1002/jnr.21991; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Martin LJ, 2009, BIOCHEM SOC T, V37, P1334, DOI 10.1042/BST0371334; PALOVCIK RA, 1984, BRAIN RES, V309, P187, DOI 10.1016/0006-8993(84)91028-X; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; PRUT L, 2010, GENES BRAIN BEHAV; Ronnemaa E, 2008, NEUROLOGY, V71, P1065, DOI 10.1212/01.wnl.0000310646.32212.3a; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Seaquist ER, 2010, DIABETES, V59, P4, DOI 10.2337/db09-1600; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Tschritter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001196; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792	31	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16188	10.1371/journal.pone.0016188	http://dx.doi.org/10.1371/journal.pone.0016188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264261	Green Published, Green Submitted, gold			2022-12-25	WOS:000286516500036
J	Sueur, C				Sueur, Cedric			A Non-Levy Random Walk in Chacma Baboons: What Does It Mean?	PLOS ONE			English	Article							MOVEMENT PATTERNS; SPATIAL MEMORY; RESOURCES; CONTEXT; RANGE	The Levy walk is found from amoebas to humans and has been described as the optimal strategy for food research. Recent results, however, have generated controversy about this conclusion since animals also display alternatives to the Levy walk such as the Brownian walk or mental maps and because movement patterns found in some species only seem to depend on food patches distribution. Here I show that movement patterns of chacma baboons do not follow a Levy walk but a Brownian process. Moreover this Brownian walk is not the main process responsible for movement patterns of baboons. Findings about their speed and trajectories show that baboons use metal maps and memory to find resources. Thus the Brownian process found in this species appears to be more dependent on the environment or might be an alternative when known food patches are depleted and when animals have to find new resources.	[Sueur, Cedric] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sueur, Cedric] Free Univ Brussels, Unit Social Ecol, Brussels, Belgium	Princeton University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Sueur, C (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	csueur@ulb.ac.be	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	Alsace region; Franco-American Commission; Fyssen Foundation	Alsace region(Region Grand-Est); Franco-American Commission; Fyssen Foundation	This study was funded by the Alsace region (http://www.region-alsace.eu/), the Franco-American Commission and the Fyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RPD, 2002, OIKOS, V98, P134, DOI 10.1034/j.1600-0706.2002.980114.x; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boinski S., 2000, MOVE WHY ANIMALS TRA; Boyer D, 2004, PHYSICA A, V342, P329, DOI 10.1016/j.physa.2004.04.091; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Dai XH, 2007, J MAMMAL, V88, P151, DOI 10.1644/06-MAMM-A-035R1.1; Einstein A, 1956, INVESTIGATIONS THEOR; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Garber PA, 1997, FOLIA PRIMATOL, V68, P236, DOI 10.1159/000157250; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Janson CH, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P309; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Kummer H., 1968, SOCIAL ORG HAMADRYAS; KUMMER H, 1971, ALDINE T; Levandowsky M, 1997, ACTA PROTOZOOL, V36, P237; MACDONALD SE, 1990, J COMP PSYCHOL, V104, P382, DOI 10.1037/0735-7036.104.4.382; MENZEL CR, 1991, ANIM BEHAV, V41, P397, DOI 10.1016/S0003-3472(05)80840-1; MENZEL CR, 1996, AM J OF PRIMATOLOGY, P117; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Pombo AR, 2004, LAND USE NATURE CONS, P313; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Riley EP, 2008, AM J PRIMATOL, V70, P670, DOI 10.1002/ajp.20543; Schreier AL, 2010, ANIM BEHAV, V80, P75, DOI 10.1016/j.anbehav.2010.04.002; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; SIGG H, 1981, FOLIA PRIMATOL, V36, P40, DOI 10.1159/000156008; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; THOMAN DR, 1969, TECHNOMETRICS, V11, P445, DOI 10.2307/1267019; Tomasello M, 1997, PRIMATE COGNITION; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zuberbuhler K., 2010, FORAGING COGNITION N	34	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16131	10.1371/journal.pone.0016131	http://dx.doi.org/10.1371/journal.pone.0016131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249200	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000021
J	VanGuilder, HD; Bixler, GV; Kutzler, L; Brucklacher, RM; Bronson, SK; Kimball, SR; Freeman, WM				VanGuilder, Heather D.; Bixler, Georgina V.; Kutzler, Lydia; Brucklacher, Robert M.; Bronson, Sarah K.; Kimball, Scot R.; Freeman, Willard M.			Multi-Modal Proteomic Analysis of Retinal Protein Expression Alterations in a Rat Model of Diabetic Retinopathy	PLOS ONE			English	Article							DIAZEPAM-BINDING INHIBITOR; DIFFERENCE GEL-ELECTROPHORESIS; GLYCATION END-PRODUCTS; CONTRAST SENSITIVITY; SERUM CERULOPLASMIN; VITREOUS FLUID; MESSENGER-RNA; CELLS; CRYSTALLIN; LOCALIZATION	Background: As a leading cause of adult blindness, diabetic retinopathy is a prevalent and profound complication of diabetes. We have previously reported duration-dependent changes in retinal vascular permeability, apoptosis, and mRNA expression with diabetes in a rat model system. The aim of this study was to identify retinal proteomic alterations associated with functional dysregulation of the diabetic retina to better understand diabetic retinopathy pathogenesis and that could be used as surrogate endpoints in preclinical drug testing studies. Methodology/Principal Findings: A multi-modal proteomic approach of antibody (Luminex)-, electrophoresis (DIGE)-, and LC-MS (iTRAQ)-based quantitation methods was used to maximize coverage of the retinal proteome. Transcriptomic profiling through microarray analysis was included to identify additional targets and assess potential regulation of protein expression changes at the mRNA level. The proteomic approaches proved complementary, with limited overlap in proteomic coverage. Alterations in pro-inflammatory, signaling and crystallin family proteins were confirmed by orthogonal methods in multiple independent animal cohorts. In an independent experiment, insulin replacement therapy normalized the expression of some proteins (Dbi, Anxa5) while other proteins (Cp, Cryba3, Lgals3, Stat3) were only partially normalized and Fgf2 and Crybb2 expression remained elevated. Conclusions/Significance: These results expand the understanding of the changes in retinal protein expression occurring with diabetes and their responsiveness to normalization of blood glucose through insulin therapy. These proteins, especially those not normalized by insulin therapy, may also be useful in preclinical drug development studies.	[VanGuilder, Heather D.; Bixler, Georgina V.; Brucklacher, Robert M.; Freeman, Willard M.] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA; [Kutzler, Lydia; Bronson, Sarah K.; Kimball, Scot R.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	VanGuilder, HD (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA USA.	wfreeman@psu.edu	Freeman, Willard/GYQ-5841-2022	Bronson, Sarah/0000-0002-5456-953X; Freeman, Willard/0000-0001-7027-999X	Juvenile Diabetes Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by funding from the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L M, 1998, J Am Optom Assoc, V69, P690; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, pS851; BARBER EF, 1987, J NUTR, V117, P1615, DOI 10.1093/jn/117.9.1615; Barmack NH, 2004, J NEUROSCI, V24, P1023, DOI 10.1523/JNEUROSCI.3936-03.2004; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bartoli M, 2009, INVEST OPHTH VIS SCI, V50, P4934, DOI 10.1167/iovs.08-2158; BORMANN J, 1991, NEUROPHARMACOLOGY, V30, P1387, DOI 10.1016/S0028-3908(11)80006-7; Brachvogel B, 2001, MECH DEVELOP, V109, P389, DOI 10.1016/S0925-4773(01)00532-9; Brucklacher RM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-26; Campochiaro PA, 1996, J NEUROSCI, V16, P1679; Canning P, 2007, EXP DIABETES RES, DOI 10.1155/2007/51837; Chan PS, 2010, J DIABETES COMPLICAT, V24, P55, DOI 10.1016/j.jdiacomp.2008.10.002; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Chu TJ, 2008, PHYSIOL GENOMICS, V34, P185, DOI 10.1152/physiolgenomics.90201.2008; Compere V, 2010, J MOL ENDOCRINOL, V44, P295, DOI 10.1677/JME-09-0176; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; CUNNINGHAM J, 1995, METABOLISM, V44, P996, DOI 10.1016/0026-0495(95)90095-0; Daimon M, 1998, DIABETES CARE, V21, P1525, DOI 10.2337/diacare.21.9.1525; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; DENKO CW, 1979, AGENTS ACTIONS, V9, P333, DOI 10.1007/BF01970657; DESHMUKH VK, 1985, PHARMACOL RES COMMUN, V17, P633, DOI 10.1016/0031-6989(85)90070-0; DILEO MAS, 1994, DIABETOLOGIA, V37, P911, DOI 10.1007/BF00400947; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Frank RN, 2009, ARCH OPHTHALMOL-CHIC, V127, P330, DOI 10.1001/archophthalmol.2008.607; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Freeman WM, 2009, NEUROSCIENCE, V159, P183, DOI 10.1016/j.neuroscience.2008.12.004; Freeman Willard M, 2009, J Ocul Biol Dis Infor, V2, P202; Frost-Larsen K, 1981, Dev Ophthalmol, V2, P222; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Gao BB, 2009, J PROTEOME RES, V8, P5541, DOI 10.1021/pr9006415; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gotow T, 1996, NEUROSCIENCE, V75, P507, DOI 10.1016/0306-4522(96)00295-3; HANSEN HO, 1991, BIOCHEM J, V277, P341, DOI 10.1042/bj2770341; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; HYVARINEN L, 1983, ACTA OPHTHALMOL, V61, P94; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kim HW, 2009, CURR EYE RES, V34, P976, DOI 10.3109/02713680903249913; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Kirwin SJ, 2009, INVEST OPHTH VIS SCI, V50, P5396, DOI 10.1167/iovs.09-3474; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; KNUDSEN J, 1990, BIOCHEM J, V265, P927, DOI 10.1042/bj2650927; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, pU87; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; Lazzarini R, 2010, IMMUNOPHARM IMMUNOT, V32, P402, DOI 10.3109/08923970903468821; Liu SQ, 2007, CELL MOL IMMUNOL, V4, P65; LOWE WL, 1995, METABOLISM, V44, P1038, DOI 10.1016/0026-0495(95)90102-7; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Masuzawa K, 2006, EXP BIOL MED, V231, P1090; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Oikari S, 2008, ACTA PHYSIOL, V194, P57, DOI 10.1111/j.1748-1716.2008.01860.x; Pugliese G, 2000, DIABETES, V49, P1249, DOI 10.2337/diabetes.49.7.1249; Qian ZY, 2008, J NEUROCHEM, V105, P1287, DOI 10.1111/j.1471-4159.2008.05229.x; Quin GJ, 2007, PROTEOMICS, V7, P2636, DOI 10.1002/pmic.200600486; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; Simo R, 2008, ARCH OPHTHALMOL-CHIC, V126, P1076, DOI 10.1001/archopht.126.8.1076; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Stitt AW, 2005, PHARMACOL REP, V57, P156; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tajima E, 1999, NEUROLOGY, V53, P619; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Umstead TM, 2010, PEDIATR RES, V67, P641, DOI 10.1203/PDR.0b013e3181dceef5; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1; Zaunreiter M, 2005, BRAIN RES, V1032, P1, DOI 10.1016/j.brainres.2004.10.026	86	40	41	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16271	10.1371/journal.pone.0016271	http://dx.doi.org/10.1371/journal.pone.0016271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21249158	Green Submitted, Green Published, gold			2022-12-25	WOS:000286515000037
J	Walia, G; Gajendar, K; Surolia, A				Walia, Guneet; Gajendar, Komatireddy; Surolia, Avadhesha			Identification of Critical Residues of the Mycobacterial Dephosphocoenzyme A Kinase by Site-Directed Mutagenesis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ATP-BINDING; A KINASE; ESCHERICHIA-COLI; ADENYLATE KINASE; P-LOOP; ENZYME; SEQUENCES; PROTEINS; SYNTHASE	Dephosphocoenzyme A kinase performs the transfer of the c-phosphate of ATP to dephosphocoenzyme A, catalyzing the last step of coenzyme A biosynthesis. This enzyme belongs to the P-loop-containing NTP hydrolase superfamily, all members of which posses a three domain topology consisting of a CoA domain that binds the acceptor substrate, the nucleotide binding domain and the lid domain. Differences in the enzymatic organization and regulation between the human and mycobacterial counterparts, have pointed out the tubercular CoaE as a high confidence drug target (HAMAP database). Unfortunately the absence of a three-dimensional crystal structure of the enzyme, either alone or complexed with either of its substrates/regulators, leaves both the reaction mechanism unidentified and the chief players involved in substrate binding, stabilization and catalysis unknown. Based on homology modeling and sequence analysis, we chose residues in the three functional domains of the enzyme to assess their contributions to ligand binding and catalysis using site-directed mutagenesis. Systematically mutating the residues from the P-loop and the nucleotide-binding site identified Lys14 and Arg140 in ATP binding and the stabilization of the phosphoryl intermediate during the phosphotransfer reaction. Mutagenesis of Asp32 and Arg140 showed catalytic efficiencies less than 5-10% of the wild type, indicating the pivotal roles played by these residues in catalysis. Non-conservative substitution of the Leu114 residue identifies this leucine as the critical residue from the hydrophobic cleft involved in leading substrate, DCoA binding. We show that the mycobacterial enzyme requires the Mg(2+) for its catalytic activity. The binding energetics of the interactions of the mutant enzymes with the substrates were characterized in terms of their enthalpic and entropic contributions by ITC, providing a complete picture of the effects of the mutations on activity. The properties of mutants defective in substrate recognition were consistent with the ordered sequential mechanism of substrate addition for CoaE.	[Walia, Guneet; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Gajendar, Komatireddy; Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Walia, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in		KOMATI REDDY, GAJENDAR/0000-0002-1471-4966	Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	This work was supported by a Centre of Excellence grant from the Department of Biotechnology (DBT), Government of India to AS and by another Department of Science and Technology (DST), Government of India grant to AS. AS is also a J. C. Bose Fellow of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Berry MB, 1998, PROTEINS, V32, P276, DOI 10.1002/(SICI)1097-0134(19980815)32:3<276::AID-PROT3>3.0.CO;2-G; Cantwell JS, 2001, BIOCHEMISTRY-US, V40, P3056, DOI 10.1021/bi0020980; DELEPELAIRE P, 1994, J BIOL CHEM, V269, P27952; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Driscoll WJ, 1995, P NATL ACAD SCI USA, V92, P12328, DOI 10.1073/pnas.92.26.12328; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; JEYAKANTHAN J, 2007, CRYSTAL STR IN PRESS; Kraft L, 2002, J MOL BIOL, V318, P1057, DOI 10.1016/S0022-2836(02)00215-2; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; O'Toole N, 2003, PROTEIN SCI, V12, P327, DOI 10.1110/ps.0227803; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1996, BIOCHEMISTRY-US, V35, P9716, DOI 10.1021/bi960642s; Seto A, 2005, PROTEINS, V58, P235, DOI 10.1002/prot.20276; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Walia G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007645; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15228	10.1371/journal.pone.0015228	http://dx.doi.org/10.1371/journal.pone.0015228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264299	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000286514000003
J	Edwards, CJ; Ginja, C; Kantanen, J; Perez-Pardal, L; Tresset, A; Stock, F; Gama, LT; Penedo, MCT; Bradley, DG; Lenstra, JA; Nijman, IJ				Edwards, Ceiridwen J.; Ginja, Catarina; Kantanen, Juha; Perez-Pardal, Lucia; Tresset, Anne; Stock, Frauke; Gama, Luis T.; Penedo, M. Cecilia T.; Bradley, Daniel G.; Lenstra, Johannes A.; Nijman, Isaac J.		European Cattle Genetic Diversity	Dual Origins of Dairy Cattle Farming - Evidence from a Comprehensive Survey of European Y-Chromosomal Variation	PLOS ONE			English	Article							GENETIC DIVERSITY; BOS-TAURUS; DOMESTIC CATTLE; LINKAGE MAP; MITOCHONDRIAL; DNA; AFRICAN; MARKERS; BREEDS; EVOLUTION	Background: Diversity patterns of livestock species are informative to the history of agriculture and indicate uniqueness of breeds as relevant for conservation. So far, most studies on cattle have focused on mitochondrial and autosomal DNA variation. Previous studies of Y-chromosomal variation, with limited breed panels, identified two Bos taurus (taurine) haplogroups (Y1 and Y2; both composed of several haplotypes) and one Bos indicus (indicine/zebu) haplogroup (Y3), as well as a strong phylogeographic structuring of paternal lineages. Methodology and Principal Findings: Haplogroup data were collected for 2087 animals from 138 breeds. For 111 breeds, these were resolved further by genotyping microsatellites INRA189 (10 alleles) and BM861 (2 alleles). European cattle carry exclusively taurine haplotypes, with the zebu Y-chromosomes having appreciable frequencies in Southwest Asian populations. Y1 is predominant in northern and north-western Europe, but is also observed in several Iberian breeds, as well as in Southwest Asia. A single Y1 haplotype is predominant in north-central Europe and a single Y2 haplotype in central Europe. In contrast, we found both Y1 and Y2 haplotypes in Britain, the Nordic region and Russia, with the highest Y-chromosomal diversity seen in the Iberian Peninsula. Conclusions: We propose that the homogeneous Y1 and Y2 regions reflect founder effects associated with the development and expansion of two groups of dairy cattle, the pied or red breeds from the North Sea and Baltic coasts and the spotted, yellow or brown breeds from Switzerland, respectively. The present Y1-Y2 contrast in central Europe coincides with historic, linguistic, religious and cultural boundaries.	[Edwards, Ceiridwen J.; Stock, Frauke; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Edwards, Ceiridwen J.] Univ Oxford, Res Lab Archaeol, Oxford, England; [Ginja, Catarina; Penedo, M. Cecilia T.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Ginja, Catarina; Gama, Luis T.] Inst Nacl Recursos Biol, Dept Genet Melhoramento Anim & Reprod, Fonte Boa, Vale Santarem, Portugal; [Kantanen, Juha] MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland; [Perez-Pardal, Lucia] SERIDA, Area Genet & Reprod Anim, Gijon, Spain; [Tresset, Anne] Museum Natl Hist Nat, CNRS, Paris, France; [Lenstra, Johannes A.; Nijman, Isaac J.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Trinity College Dublin; University of Oxford; University of California System; University of California Davis; Natural Resources Institute Finland (Luke); Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Utrecht University	Edwards, CJ (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	J.A.Lenstra@uu.nl	Bradley, Daniel G/A-3240-2012; gautier, mathieu/F-7429-2010; Cuppen, Edwin/F-5696-2011; Edwards, Ceiridwen/F-8855-2010; Gama, Luis T/N-4172-2018; gautier, mathieu/AAU-8789-2020; Longeri, Maria/L-1557-2017; Goyache, Felix/B-7764-2009; Cuppen, Edwin/H-2389-2016; Simianer, Henner/A-6574-2015; Holm, Lars-Erik/A-4678-2013; Lenstra, Johannes A./H-2988-2019; Kantanen, Juha/AAA-4333-2022	gautier, mathieu/0000-0001-7257-5880; Cuppen, Edwin/0000-0002-0400-9542; Edwards, Ceiridwen/0000-0001-9126-1377; Gama, Luis T/0000-0003-3894-3488; gautier, mathieu/0000-0001-7257-5880; Longeri, Maria/0000-0001-7863-1855; Goyache, Felix/0000-0002-6872-1045; Cuppen, Edwin/0000-0002-0400-9542; Simianer, Henner/0000-0002-7551-3797; Holm, Lars-Erik/0000-0002-5312-3579; Lenstra, Johannes A./0000-0003-1745-7739; Bradley, Daniel G/0000-0001-7335-7092; Perez Pardal, Lucia/0000-0002-9751-6550; Laloe, Denis/0000-0001-8359-0760; Nijman, Isaac/0000-0002-1840-1158; Williams, John/0000-0001-5188-7957; Ginja, Catarina/0000-0003-2278-7089; Medugorac, Ivica/0000-0002-6891-3039	Enterprise Ireland Basic Research Grants Programme [SC/1999/409, SC/2002/510]; Fundacao Portuguesa para a Ciencia e a Tecnologia [SFRH/BD/13502/2003]; Academy of Finland; Finnish Ministry of Agriculture and Forestry; European Union [98-118 (1999-2002)]; Wellcome Trust [047485/Z/96/Z]; CNRS, France;  [BES-2006-13545]	Enterprise Ireland Basic Research Grants Programme; Fundacao Portuguesa para a Ciencia e a Tecnologia; Academy of Finland(Academy of Finland); Finnish Ministry of Agriculture and Forestry; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); CNRS, France(Centre National de la Recherche Scientifique (CNRS)); 	CJE was supported by the Enterprise Ireland Basic Research Grants Programme (project numbers SC/1999/409 and SC/2002/510). CG was supported by a grant from Fundacao Portuguesa para a Ciencia e a Tecnologia (Ref. SFRH/BD/13502/2003). JK was supported by the Academy of Finland and the Finnish Ministry of Agriculture and Forestry (SUNARE-program and 'Russia in Flux' program). LP-P was supported by grant BES-2006-13545. Collection of several samples was supported by the Resgen project 98-118 (1999-2002) funded by the European Union. This work was also part-funded by The Wellcome Trust (grant no. 047485/Z/96/Z), and a Eurocores OMLL Programme Grant via CNRS, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; BAKER CMA, 1980, GENETICS, V11, P127; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; Beja-Pereira A, 2003, J HERED, V94, P243, DOI 10.1093/jhered/esg055; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; BISHOP MD, 1994, GENETICS, V136, P619; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; BRADLEY DG, 1994, ANIM GENET, V25, P7, DOI 10.1111/j.1365-2052.1994.tb00048.x; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Caroli A, 2010, J DAIRY SCI, V93, P1260, DOI 10.3168/jds.2009-2521; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Edwards CJ, 2007, ANIM GENET, V38, P520, DOI 10.1111/j.1365-2052.2007.01638.x; Edwards CJ, 2000, ANIM GENET, V31, P127, DOI 10.1046/j.1365-2052.2000.00602.x; FABER JA, 1962, MEDEDELINGEN LANDBOU, V12, P1; Felius M., 1995, CATTLE BREEDS ENCY; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Ginja C, 2009, J HERED, V100, P148, DOI 10.1093/jhered/esn080; Ginja C, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-18; Ginja C, 2010, J HERED, V101, P201, DOI 10.1093/jhered/esp104; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Healy J. F, 1991, PLINY ELDER NATURAL; Ibeagha-Awemu EM, 2006, TROP ANIM HEALTH PRO, V38, P431, DOI 10.1007/s11250-006-4347-y; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JONES HL, 1924, LOEB CLASSICAL LIB G; Kantanen J, 2009, HEREDITY, V103, P404, DOI 10.1038/hdy.2009.68; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; Laloe D., 2010, Diversity, V2, P932, DOI 10.3390/d2060932; Li MH, 2010, ANIM GENET, V41, P150, DOI 10.1111/j.1365-2052.2009.01980.x; Li MH, 2007, MOL ECOL, V16, P3839, DOI 10.1111/j.1365-294X.2007.03437.x; LOFTUS RT, 1994, ANIM GENET, V25, P265, DOI 10.1111/j.1365-2052.1994.tb00203.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacHugh DE, 1997, GENETICS, V146, P1071; MARCHAND G, 2005, MARGES GRANDS FOYERS, P255; Martin-Burriel I, 2007, J HERED, V98, P687, DOI 10.1093/jhered/esm096; Medugorac I, 2009, MOL ECOL, V18, P3394, DOI 10.1111/j.1365-294X.2009.04286.x; Mohamad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005490; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Negrini R, 2007, ANIM GENET, V38, P60, DOI 10.1111/j.1365-2052.2007.01554.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nijman IJ, 2008, CLADISTICS, V24, P723, DOI 10.1111/j.1096-0031.2008.00201.x; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Perez-Pardal L, 2010, ANIM GENET, V41, P232, DOI 10.1111/j.1365-2052.2009.01988.x; Perez-Pardal L, 2009, ANIM GENET, V40, P560, DOI 10.1111/j.1365-2052.2009.01870.x; Pieragostini E, 2000, COMP BIOCHEM PHYS B, V127, P1, DOI 10.1016/S0305-0491(00)00218-2; Schibler J, 2007, SCHWEIZ ARCH TIERH, V149, P23, DOI 10.1024/0036-7281.149.1.23; Schneider S., 2000, ARLEQUIN VER 2 000 S; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Svensson E, 2008, BIOL LETTERS, V4, P752, DOI 10.1098/rsbl.2008.0342; TEALE AJ, 1995, ANIM GENET, V26, P243, DOI 10.1111/j.1365-2052.1995.tb03251.x; Tresset A., 2007, GOING MESOLITHIC NEO, P189, DOI DOI 10.5871/BACAD/9780197264140.003.0010; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; VAIMAN D, 1994, MAMM GENOME, V5, P288, DOI 10.1007/BF00389543; Verkaar ELC, 2004, MOL BIOL EVOL, V21, P1165, DOI 10.1093/molbev/msh064; WATERBOL.HT, 1968, SCIENCE, V162, P1093, DOI 10.1126/science.162.3858.1093; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898; 2006, ANIM GENET, V37, P475	73	62	66	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15922	10.1371/journal.pone.0015922	http://dx.doi.org/10.1371/journal.pone.0015922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253012	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000286511900024
J	Puccio, S; Chu, J; Pratico, D				Puccio, Simone; Chu, Jin; Pratico, Domenico			Involvement of 5-Lipoxygenase in the Corticosteroid-Dependent Amyloid Beta Formation: In Vitro and In Vivo Evidence	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PSYCHOLOGICAL DISTRESS; TRANSGENIC MICE; UP-REGULATION; MOUSE MODEL; EXPRESSION; CORTISOL; PROTEIN; STRESS; BRAIN	Background: Numerous studies show that high circulating level of glucocorticosteroids is a biochemical characteristic of Alzheimer's disease (AD). These stress hormones can increase the amount of AD-like pathology in animal models of the disease. Since they also up-regulate the 5-Lipoxygenase (5-LO), an enzyme which modulates amyloid beta (A beta) formation, in the present paper we tested the hypothesis that this enzymatic pathway is involved in the glucocorticoid-induced pro-amyloidotic effect. Methodology/Principal Findings: Incubation of neuronal cells with dexamethasone resulted in a significant increase in 5-LO activity and A beta formation. By contrast, pharmacological inhibition of 5-LO prevented the dexamethasone-dependent increase in A beta levels. Mouse embryonic fibroblasts responded with a significant increase in A beta formation after dexamethasone challenge. However, this effect was abolished when dexamethasone was incubated with fibroblasts genetically deficient for 5-LO. No difference in the glucocorticoid receptor levels was observed between the two groups. Finally, treatment of wild type mice with dexamethasone resulted in a significant increase in endogenous brain A beta levels, which was prevented in mice genetically lacking 5-LO. Conclusions: These findings suggest that 5-LO plays a functional role in the glucocorticoid-induced brain AD-like amyloid pathology.	[Puccio, Simone; Chu, Jin; Pratico, Domenico] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Puccio, S (corresponding author), Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA.	praticod@temple.edu	Pratico, Domenico/ABA-9590-2020; Chu, Jin/A-4737-2012; Puccio, Simone/P-9571-2018	Puccio, Simone/0000-0003-4007-4365	National Institutes of Health [AG33568]; Alzheimer's Association [59289]; NATIONAL INSTITUTE ON AGING [R01AG033568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was in funded by grants from the National Institutes of Health (AG33568) and the Alzheimer's Association (59289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinnici CM, 2007, NEUROBIOL AGING, V28, P1457, DOI 10.1016/j.neurobiolaging.2006.06.007; Csernansky JG, 2006, AM J PSYCHIAT, V163, P2164, DOI 10.1176/appi.ajp.163.12.2164; Dong HX, 2009, J ALZHEIMERS DIS, V18, P459, DOI 10.3233/JAD-2009-1152; Firuzi O, 2008, FASEB J, V22, P1169, DOI 10.1096/fj.07-9131.com; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; JEONG YH, FASEB J, V20, P729; MAEDA K, 1991, NEUROBIOL AGING, V12, P161, DOI 10.1016/0197-4580(91)90055-O; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Peskind ER, 2001, NEUROLOGY, V56, P1094, DOI 10.1212/WNL.56.8.1094; Pomara Nunzio, 2003, Psychopharmacol Bull, V37, P120; Qu TY, 2001, J NEUROPSYCH CLIN N, V13, P304, DOI 10.1176/appi.neuropsych.13.2.304; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Riccioni G, 2004, ANN CLIN LAB SCI, V34, P379; Succol F, 2007, J NEUROCHEM, V103, P380, DOI 10.1111/j.1471-4159.2007.04742.x; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Swanwick GRJ, 1998, AM J PSYCHIAT, V155, P286; Uz T, 1998, FASEB J, V12, P439, DOI 10.1096/fasebj.12.6.439; Uz T, 2001, FASEB J, V15, P1792, DOI 10.1096/fj.00-0836fje; Uz T, 1999, J NEUROCHEM, V73, pS209; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V27, P143, DOI 10.1159/000095761; Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15163	10.1371/journal.pone.0015163	http://dx.doi.org/10.1371/journal.pone.0015163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253592	gold, Green Submitted, Green Published			2022-12-25	WOS:000286511900006
J	Sadeh, A; Truskanov, N; Mangel, M; Blaustein, L				Sadeh, Asaf; Truskanov, Noa; Mangel, Marc; Blaustein, Leon			Compensatory Development and Costs of Plasticity: Larval Responses to Desiccated Conspecifics	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; TRADE-OFFS; HISTORY; GROWTH; METAMORPHOSIS; SALAMANDRA; CONTEXT; CONSEQUENCES; EVOLUTIONARY; SELECTION	Understanding constraints on phenotypic plasticity is central to explaining its evolution and the evolution of phenotypes in general, yet there is an ongoing debate on the classification and relationships among types of constraints. Since plasticity is often a developmental process, studies that consider the ontogeny of traits and their developmental mechanisms are beneficial. We manipulated the timing and reliability of cues perceived by fire salamander larvae for the future desiccation of their ephemeral pools to determine whether flexibility in developmental rates is constrained to early ontogeny. We hypothesized that higher rates of development, and particularly compensation for contradictory cues, would incur greater endogenous costs. We found that larvae respond early in ontogeny to dried conspecifics as a cue for future desiccation, but can fully compensate for this response in case more reliable but contradictory cues are later perceived. Patterns of mortality suggested that endogenous costs may depend on instantaneous rates of development, and revealed asymmetrical costs of compensatory development between false positive and false negative early information. Based on the results, we suggest a simple model of costs of development that implies a tradeoff between production costs of plasticity and phenotype-environment mismatch costs, which may potentially underlie the phenomenon of ontogenetic windows constraining plasticity.	[Sadeh, Asaf; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Sadeh, Asaf; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Inst Evolut, IL-31999 Haifa, Israel; [Truskanov, Noa] Univ Haifa, Dept Biol, Fac Nat Sci, IL-31999 Haifa, Israel; [Mangel, Marc] Univ Calif Santa Cruz, Dept Appl Math & Stat, Jack Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Mangel, Marc] Univ Bergen, Dept Biol, Bergen, Norway	University of Haifa; University of Haifa; University of Haifa; University of California System; University of California Santa Cruz; University of Bergen	Sadeh, A (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	asaffield@yahoo.com		Sadeh, Asaf/0000-0002-2704-4033	ISF [961-2008]; NSF [EF-0924195]	ISF(Israel Science Foundation); NSF(National Science Foundation (NSF))	This study was funded by ISF grant 961-2008 awarded to LB and Shirli Bar-David. The work of MM was partially supported by NSF grant EF-0924195. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1988, AM NAT, V131, P91, DOI 10.1086/284775; Altwegg R, 2002, ECOLOGY, V83, P2542, DOI 10.2307/3071813; Arendt J, 2005, FUNCT ECOL, V19, P982, DOI 10.1111/j.1365-2435.2005.01050.x; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Billerbeck JM, 2001, EVOLUTION, V55, P1863; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Callahan HS, 2008, ANN NY ACAD SCI, V1133, P44, DOI 10.1196/annals.1438.008; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; Denver RJ, 1998, ECOLOGY, V79, P1859, DOI 10.1890/0012-9658(1998)079[1859:APIAMR]2.0.CO;2; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Ficetola GF, 2006, EVOL ECOL, V20, P143, DOI 10.1007/s10682-005-5508-6; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; HARRIS RN, 1999, TADPOLES BIOL ANURAN; HENSLEY FR, 1993, ECOLOGY, V74, P2405, DOI 10.2307/1939591; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Inness CLW, 2008, P ROY SOC B-BIOL SCI, V275, P1703, DOI 10.1098/rspb.2008.0357; Kaplan RH, 2006, EVOLUTION, V60, P142; Lane SJ, 2002, J ANIM ECOL, V71, P780, DOI 10.1046/j.1365-2656.2002.00644.x; LEIPS J, 1994, ECOLOGY, V75, P1345, DOI 10.2307/1937459; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Marquez-Garcia M, 2009, EVOL ECOL RES, V11, P803; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; O'Laughlin BE, 2000, OECOLOGIA, V124, P343, DOI 10.1007/s004420000392; Padilla DK, 1996, EVOL ECOL, V10, P105, DOI 10.1007/BF01239351; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; Sadeh A, 2009, ECOL LETT, V12, P1158, DOI 10.1111/j.1461-0248.2009.01371.x; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shemesh H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010824; Sheridan MA, 1998, AM ZOOL, V38, P350; SMITHGILL SJ, 1979, AM NAT, V113, P563, DOI 10.1086/283413; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Spencer M, 1999, ECOL LETT, V2, P157; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Sultan SE, 2007, TRENDS ECOL EVOL, V22, P575, DOI 10.1016/j.tree.2007.06.014; WARBURG MR, 1992, HERPETOL J, V2, P54; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; West-Eberhard Mary Jane, 2003, pi; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	46	18	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15602	10.1371/journal.pone.0015602	http://dx.doi.org/10.1371/journal.pone.0015602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246048	Green Published, Green Submitted, gold			2022-12-25	WOS:000286511200009
J	Stat, M; Bird, CE; Pochon, X; Chasqui, L; Chauka, LJ; Concepcion, GT; Logan, D; Takabayashi, M; Toonen, RJ; Gates, RD				Stat, Michael; Bird, Christopher E.; Pochon, Xavier; Chasqui, Luis; Chauka, Leonard J.; Concepcion, Gregory T.; Logan, Dan; Takabayashi, Misaki; Toonen, Robert J.; Gates, Ruth D.			Variation in Symbiodinium ITS2 Sequence Assemblages among Coral Colonies	PLOS ONE			English	Article							GREAT-BARRIER-REEF; HAPLOTYPE RECONSTRUCTION; SCLERACTINIAN CORALS; ALGAL ENDOSYMBIONTS; CLIMATE-CHANGE; CLADE-D; DIVERSITY; SPECIFICITY; SYMBIONTS; ASSOCIATIONS	Endosymbiotic dinoflagellates in the genus Symbiodinium are fundamentally important to the biology of scleractinian corals, as well as to a variety of other marine organisms. The genus Symbiodinium is genetically and functionally diverse and the taxonomic nature of the union between Symbiodinium and corals is implicated as a key trait determining the environmental tolerance of the symbiosis. Surprisingly, the question of how Symbiodinium diversity partitions within a species across spatial scales of meters to kilometers has received little attention, but is important to understanding the intrinsic biological scope of a given coral population and adaptations to the local environment. Here we address this gap by describing the Symbiodinium ITS2 sequence assemblages recovered from colonies of the reef building coral Montipora capitata sampled across Kane'ohe Bay, Hawai'i. A total of 52 corals were sampled in a nested design of Coral Colony(Site(Region)) reflecting spatial scales of meters to kilometers. A diversity of Symbiodinium ITS2 sequences was recovered with the majority of variance partitioning at the level of the Coral Colony. To confirm this result, the Symbiodinium ITS2 sequence diversity in six M. capitata colonies were analyzed in much greater depth with 35 to 55 clones per colony. The ITS2 sequences and quantitative composition recovered from these colonies varied significantly, indicating that each coral hosted a different assemblage of Symbiodinium. The diversity of Symbiodinium ITS2 sequence assemblages retrieved from individual colonies of M. capitata here highlights the problems inherent in interpreting multi-copy and intra-genomically variable molecular markers, and serves as a context for discussing the utility and biological relevance of assigning species names based on Symbiodinium ITS2 genotyping.	[Stat, Michael; Bird, Christopher E.; Pochon, Xavier; Concepcion, Gregory T.; Toonen, Robert J.; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA; [Chasqui, Luis] Inst Invest Marinas & Costeras Jose Benito Vives, Santa Marta, Colombia; [Chauka, Leonard J.] Univ Dar Es Salaam, Inst Marine Sci, Zanzibar, Tanzania; [Logan, Dan] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Takabayashi, Misaki] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA	University of Hawaii System; University of Dar es Salaam; Victoria University Wellington; University of Hawaii System; University Hawaii Hilo	Stat, M (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA.	stat@hawaii.edu	Stat, Michael/K-5290-2012; Toonen, Rob/K-2891-2012; Pochon, Xavier/K-5844-2019; Toonen, Rob/V-6230-2019	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340; Pochon, Xavier/0000-0001-9510-0407; Stat, Michael/0000-0002-1663-3422	Edwin Pauley Foundation; Global Environment Facility-World Bank Coral [OCE-0752604, OIA-0554657]; Swiss National Science Foundation [PBGEA-115118]; University of Hawaii [R/CR-16 NA050AR4171048]	Edwin Pauley Foundation; Global Environment Facility-World Bank Coral; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Hawaii	This research was funded by the Edwin Pauley Foundation; the Global Environment Facility-World Bank Coral Reef Targeted Research Project (www.gefcoral.org); the National Science Foundation (OCE-0752604 to RDG and OIA-0554657 administered by University of Hawai'i), the Swiss National Science Foundation (PBGEA-115118 to XP), and University of Hawaii Sea Grant College Program (Project #R/CR-16 NA050AR4171048 to MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Apprill AM, 2007, MOL ECOL, V16, P1127, DOI 10.1111/j.1365-294X.2006.03214.x; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2007, MAR ECOL PROG SER, V335, P237, DOI 10.3354/meps335237; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; Concepcion GT, 2006, MOL ECOL NOTES, V6, P1208, DOI 10.1111/j.1471-8286.2006.01493.x; Correa AMS, 2009, CORAL REEFS, V28, P437, DOI 10.1007/s00338-008-0464-6; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Correa AMS, 2011, GLOBAL CHANGE BIOL, V17, P68, DOI 10.1111/j.1365-2486.2010.02242.x; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOLLAND SM, ANAL RAREFACTION 2 0; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hunter RL, 2007, J PHYCOL, V43, P120, DOI 10.1111/j.1529-8817.2006.00309.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kemp DW, 2008, CORAL REEFS, V27, P289, DOI 10.1007/s00338-007-0333-8; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2007, MOL PHYLOGENET EVOL, V45, P417, DOI 10.1016/j.ympev.2007.06.017; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2001, MAR BIOL, V139, P1069; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Rodriguez-Lanetty M, 2001, MAR BIOL, V138, P1175; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Shannon C.E., 1963, MATH THEORY COMMUNIC; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Wright S, 1943, GENETICS, V28, P114	73	77	77	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15854	10.1371/journal.pone.0015854	http://dx.doi.org/10.1371/journal.pone.0015854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246044	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511200022
J	Cash, TP; Gruber, JJ; Hartman, TR; Henske, EP; Simon, MC				Cash, T. P.; Gruber, J. J.; Hartman, T. R.; Henske, E. P.; Simon, M. C.			Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGF beta-mediated transcription	ONCOGENE			English	Article						BHD; apoptosis; Bim; TGF beta; mTOR	RENAL-CELL CARCINOMA; BH3-ONLY PROTEIN BIM; BHD GENE; YOLK-SAC; SIGNALING PATHWAYS; MTOR ACTIVATION; EXPRESSION; GROWTH; MUTATIONS; CANCER	Birt-Hogg-Dube (BHD) syndrome is an inherited cancer susceptibility disease characterized by skin and kidney tumors, as well as cystic lung disease, which results from loss-of-function mutations in the BHD gene. BHD is also inactivated in a significant fraction of patients with sporadic renal cancers and idiopathic cystic lung disease, and little is known about its mode of action. To investigate the molecular and cellular basis of BHD tumor suppressor activity, we generated mutant Bhd mice and embryonic stem cell lines. BHD-deficient cells exhibited defects in cell-intrinsic apoptosis that correlated with reduced expression of the BH3-only protein Bim, which was similarly observed in all human and murine BHD-related tumors examined. We further demonstrate that Bim deficiency in Bhd(-/-) cells is not a consequence of elevated mTOR or ERK activity, but results instead from reduced Bim transcription associated with a general loss of TGF beta-mediated transcription and chromatin modifications. In aggregate, this work identifies a specific tumor suppressive mechanism for BHD in regulating TGF beta-dependent transcription and apoptosis, which has implications for the development of targeted therapies. Oncogene (2011) 30, 2534-2546; doi:10.1038/onc.2010.628; published online 24 January 2011	[Cash, T. P.; Gruber, J. J.; Simon, M. C.] Abramson Family Canc Res Inst, Philadelphia, PA USA; [Cash, T. P.; Simon, M. C.] Univ Penn, Sch Med, Dept Cell & Mol Biol, Philadelphia, PA 19104 USA; [Hartman, T. R.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Henske, E. P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Simon, M. C.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Fox Chase Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Pennsylvania	Simon, MC (corresponding author), 451 BRB 2-2,421 Curie Blvd, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021		Myrovlytis Trust (London, UK); NIH [CA104838]; NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER	Myrovlytis Trust (London, UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Myrovlytis Trust (London, UK) and NIH grant no. CA104838 for funding this work, Marc Yudkoff, Ilana Nissim, Evgueni Daikhin, Hongwei Yu, Anja Runge, and Terri Richardson for technical assistance and Brian Keith, Guoliang Qing, and Xianxin Hua for critically reviewing the manuscript. MCS is an investigator of the Howard Hughes Medical Institute.	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Goumans MJ, 1999, DEVELOPMENT, V126, P3473; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Gunji Y, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049874; Guo Y, 2009, ONCOGENE, V28, P1864, DOI 10.1038/onc.2009.35; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Houde N, 2009, J BIOL CHEM, V284, P23397, DOI 10.1074/jbc.M109.019372; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Khoo SK, 2003, CANCER RES, V63, P4583; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Lademann UA, 2008, THROMB HAEMOSTASIS, V100, P1041, DOI 10.1160/TH08-04-0266; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Savatier P, 1996, ONCOGENE, V12, P309; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Woodward ER, 2008, CLIN CANCER RES, V14, P5925, DOI 10.1158/1078-0432.CCR-08-0608; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325; Zantl N, 2007, ONCOGENE, V26, P7038, DOI 10.1038/sj.onc.1210510; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	48	46	46	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	22					2534	2546		10.1038/onc.2010.628	http://dx.doi.org/10.1038/onc.2010.628			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	771ZE	21258407	Green Published, hybrid			2022-12-25	WOS:000291198400005
J	Sidler, D; Renzulli, P; Schnoz, C; Berger, B; Schneider-Jakob, S; Fluck, C; Inderbitzin, D; Corazza, N; Candinas, D; Brunner, T				Sidler, D.; Renzulli, P.; Schnoz, C.; Berger, B.; Schneider-Jakob, S.; Flueck, C.; Inderbitzin, D.; Corazza, N.; Candinas, D.; Brunner, T.			Colon cancer cells produce immunoregulatory glucocorticoids	ONCOGENE			English	Article						extra-adrenal steroidogenesis; colon cancer; immune escape; nuclear receptors	INTESTINAL EPITHELIAL-CELLS; COLORECTAL-CANCER; TUMOR SURVEILLANCE; IMMUNE PRIVILEGE; LRH-1; LYMPHOCYTES; ACTIVATION; EXPRESSION; APOPTOSIS; SURVIVAL	Glucocorticoids (GC) have important anti-inflammatory and pro-apoptotic activities. Initially thought to be exclusively produced by the adrenal glands, there is now increasing evidence for extra-adrenal sources of GCs. We have previously shown that the intestinal epithelium produces immunoregulatory GCs and that intestinal steroidogenesis is regulated by the nuclear receptor liver receptor homolog-1 (LRH-1). As LRH-1 has been implicated in the development of colon cancer, we here investigated whether LRH-1 regulates GC synthesis in colorectal tumors and whether tumor-produced GCs suppress T-cell activation. Colorectal cancer cell lines and primary tumors were found to express steroidogenic enzymes and regulatory factors required for the de novo synthesis of cortisol. Both cell lines and primary tumors constitutively produced readily detectable levels of cortisol, as measured by radioimmunoassay, thin-layer chromatography and bioassay. Whereas overexpression of LRH-1 significantly increased the expression of steroidogenic enzymes and the synthesis of cortisol, downregulation or inhibition of LRH-1 effectively suppressed these processes, indicating an important role of LRH-1 in colorectal tumor GC synthesis. An immunoregulatory role of tumor-derived GCs could be further confirmed by demonstrating a suppression of T-cell activation. This study describes for the first time cortisol synthesis in a non-endocrine tumor in humans, and suggests that the synthesis of bioactive GCs in colon cancer cells may account as a novel mechanism of tumor immune escape. Oncogene (2011) 30, 2411-2419; doi:10.1038/onc.2010.629; published online 24 January 2011	[Brunner, T.] Univ Konstanz, Dept Biol, Div Biochem Pharmacol, D-78457 Constance, Germany; [Sidler, D.; Schnoz, C.; Berger, B.; Schneider-Jakob, S.; Corazza, N.] Univ Bern, Inst Pathol, Div Expt Pathol, Bern, Switzerland; [Renzulli, P.; Inderbitzin, D.; Candinas, D.] Univ Bern, Insel Univ Hosp, Dept Visceral Surg & Med, Bern, Switzerland; [Flueck, C.] Univ Bern, Univ Childrens Hosp, Div Pediat Endocrinol, Bern, Switzerland	University of Konstanz; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Brunner, T (corresponding author), Univ Konstanz, Dept Biol, Div Biochem Pharmacol, Box 660,Univ Str 10, D-78457 Constance, Germany.	thomas.brunner@uni-konstanz.de	Sidler, Daniel/G-2447-2019; Renzulli, Pietro/GQH-9366-2022	Renzulli, Pietro/0000-0001-5557-5512; Flueck, Christa/0000-0002-4568-5504	Oncosuisse [OCS-02025-02-2007]; Swiss National Science Foundation [310000-121854]	Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Mario Noti, Pamela Bianchi, Andrea Hirsch, Gabi Hofer and Andreas Kappeler for technical help and advice, the members of the Division of Clinical Histopathology for preparation of tissue sections, and Sam Okret and Kristina Schoonjans for reagents. This work was supported by research grants from Oncosuisse (OCS-02025-02-2007) and the Swiss National Science Foundation (310000-121854) to TB. DS was supported by an MD-PhD fellowship from the Swiss National Science Foundation.	Atanasov AG, 2008, FASEB J, V22, P4117, DOI 10.1096/fj.08-114157; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Brunner T, 2001, CELL DEATH DIFFER, V8, P706, DOI 10.1038/sj.cdd.4400854; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cima I, 2006, IMMUNOL LETT, V106, P99, DOI 10.1016/j.imlet.2006.04.005; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Dardis A, 2003, J ENDOCRINOL, V179, P131, DOI 10.1677/joe.0.1790131; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Griffith TS, 1997, IMMUNOL TODAY, V18, P240, DOI 10.1016/S0167-5699(97)81663-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Kempna P, 2007, MOL PHARMACOL, V71, P787, DOI 10.1124/mol.106.028902; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; Mueller M, 2007, ENDOCRINOLOGY, V148, P1445, DOI 10.1210/en.2006-0591; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Noti M, 2009, SEMIN IMMUNOPATHOL, V31, P237, DOI 10.1007/s00281-009-0159-2; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Pazirandeh A, 1999, FASEB J, V13, P893, DOI 10.1096/fasebj.13.8.893; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; TAKEDA Y, 1994, ENDOCRINOLOGY, V135, P2283, DOI 10.1210/en.135.5.2283; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x	35	65	65	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2011	30	21					2411	2419		10.1038/onc.2010.629	http://dx.doi.org/10.1038/onc.2010.629			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	769JF	21258413	Green Submitted			2022-12-25	WOS:000291008000003
J	Sun, Y; Li, WP; Lu, ZD; Chen, R; Ling, J; Ran, QT; Jilka, RL; Chen, XD				Sun, Yun; Li, Weiping; Lu, Zhengding; Chen, Richard; Ling, Jian; Ran, Qitao; Jilka, Robert L.; Chen, Xiao-Dong			Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix	FASEB JOURNAL			English	Article						reactive oxygen species; tissue regeneration; niche	MOUSE BONE-MARROW; SUPEROXIDE DISMUTASE; OXIDATIVE STRESS; DIFFERENTIATION; PROGENITORS; NEIGHBORS; CULTURE; SSEA-4; NICHES; OXYGEN	This study aimed to determine whether aging negatively affects MSC replication and osteogenesis and whether these features could be altered by exposure to an extracellular matrix (ECM) generated by marrow cells from young or old mice. A cell-free ECM was prepared from cultured femoral marrow cells from either 3- or 18-mo-old C57BL/6 mice (young-ECM or old-ECM, respectively). The replication and osteogenesis of young or old MSCs maintained on young-ECM vs. old-ECM as well as plastic were examined in vitro and in vivo. We found that the frequency of MSCs in marrow from old mice, measured by colony-forming cells, was only marginally lower than that of young mice. In contrast, defects in the self-renewal and bone formation capacity of old MSCs were remarkable. These defects were corrected by provision of a young-ECM but not old-ECM. In parallel cultures maintained on a young-ECM, the intracellular levels of reactive oxygen species from both old and young mice were reduced 30-50% compared to those maintained on old-ECM or plastic. We concluded that aging negatively affects the formation of an ECM that normally preserves MSC function, and aged MSCs can be rejuvenated by culture on a young-ECM.-Sun, Y., Li, W., Lu, Z., Chen, Z., Ling, J., Ran, O., Jilka, R. L., Chen, X. D. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J. 25, 1474-1485 (2011). www.fasebj.org	[Sun, Yun; Lu, Zhengding; Chen, Richard; Chen, Xiao-Dong] Univ Texas San Antonio, Dept Comprehens Dent, Div Res, San Antonio, TX 78229 USA; [Ran, Qitao] Univ Texas San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sun, Yun] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Reprod Med, Shanghai 200030, Peoples R China; [Li, Weiping] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Ling, Jian] SW Res Inst, San Antonio, TX USA; [Jilka, Robert L.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Little Rock, AR 72205 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Shanghai Jiao Tong University; Shanghai Jiao Tong University; Southwest Research Institute; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Chen, XD (corresponding author), Univ Texas San Antonio, Dept Comprehens Dent, Div Res, Mail Code 7890,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	liweiping@smhb.gov.ch; chenx4@uthscsa.edu		Chen, Xiao-Dong/0000-0003-1602-806X	University Research Council at UTHSCSA; National Institutes of Health [R21 AG025466]	University Research Council at UTHSCSA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Valerie A. Lee [University of Texas Health Science Center at San Antonio (UTHSCSA)] for her careful review of the manuscript, and Dr. Sergey Leikin [U.S. National Instiute of Child Health and Human Development/National Institutes of Health (NIH)] for his critical discussion about the analysis of Raman spectrum. This work was supported by a grant from the University Research Council Grants Program at UTHSCSA (X. D. C.), and supported by the National Institutes of Health (R21 AG025466; X. D. C.). Analysis of mu CT was performed in the Core Small Animal Imaging Facility, Greehey Children Cancer Research Institute of UTHSCSA.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Blazsek I, 2000, BLOOD, V96, P3763, DOI 10.1182/blood.V96.12.3763.h8003763_3763_3771; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Chen TL, 2004, BONE, V35, P83, DOI 10.1016/j.bone.2004.03.019; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hocking AM, 1998, MATRIX BIOL, V17, P1; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Lareu RR, 2007, TISSUE ENG, V13, P385, DOI 10.1089/ten.2006.0224; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Reems JA, 2008, TRANSFUSION, V48, P620, DOI 10.1111/j.1537-2995.2007.01586.x; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; VLODAVSKY I, 1999, CURRENT PROTOCOLS CE; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	37	141	155	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1474	1485		10.1096/fj.10-161497	http://dx.doi.org/10.1096/fj.10-161497			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21248241	Green Published			2022-12-25	WOS:000290023800006
J	Arora, D; Stopp, S; Bohmer, SA; Schons, J; Godfrey, R; Masson, K; Razumovskaya, E; Ronnstrand, L; Tanzer, S; Bauer, R; Bohmer, FD; Muller, JP				Arora, Deepika; Stopp, Sabine; Boehmer, Sylvia-Annette; Schons, Julia; Godfrey, Rinesh; Masson, Kristina; Razumovskaya, Elena; Ronnstrand, Lars; Taenzer, Simone; Bauer, Reinhard; Boehmer, Frank-D.; Mueller, Joerg P.			Protein-tyrosine Phosphatase DEP-1 Controls Receptor Tyrosine Kinase FLT3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; JUXTAMEMBRANE DOMAIN; ONCOGENIC FLT3; 32D CELLS; MUTATIONS; IDENTIFICATION; TRANSFORMATION; ACTIVATION; GROWTH	Fms-like tyrosine kinase 3 (FLT3) plays an important role in hematopoietic differentiation, and constitutively active FLT3 mutant proteins contribute to the development of acute myeloid leukemia. Little is known about the protein-tyrosine phosphatases (PTP) affecting the signaling activity of FLT3. To identify such PTP, myeloid cells expressing wild type FLT3 were infected with a panel of lentiviral pseudotypes carrying shRNA expression cassettes targeting different PTP. Out of 20 PTP tested, expressed in hematopoietic cells, or presumed to be involved in oncogenesis or tumor suppression, DEP-1 (PTPRJ) was identified as a PTP negatively regulating FLT3 phosphorylation and signaling. Stable 32D myeloid cell lines with strongly reduced DEP-1 levels showed site-selective hyperphosphorylation of FLT3. In particular, the sites pTyr-589, pTyr-591, and pTyr-842 involved in the FLT3 ligand (FL)-mediated activation of FLT3 were hyperphosphorylated the most. Similarly, acute depletion of DEP-1 in the human AML cell line THP-1 caused elevated FLT3 phosphorylation. Direct interaction of DEP-1 and FLT3 was demonstrated by "substrate trapping" experiments showing association of DEP-1 D1205A or C1239S mutant proteins with FLT3 by co-immunoprecipitation. Moreover, activated FLT3 could be dephosphorylated by recombinant DEP-1 in vitro. Enhanced FLT3 phosphorylation in DEP-1-depleted cells was accompanied by enhanced FLT3-dependent activation of ERK and cell proliferation. Stable overexpression of DEP-1 in 32D cells and transient overexpression with FLT3 in HEK293 cells resulted in reduction of FL-mediated FLT3 signaling activity. Furthermore, FL-stimulated colony formation of 32D cells expressing FLT3 in methylcellulose was induced in response to shRNA-mediated DEP-1 knockdown. This transforming effect of DEP-1 knockdown was consistent with a moderately increased activation of STAT5 upon FL stimulation but did not translate into myeloproliferative disease formation in the 32D-C3H/HeJ mouse model. The data indicate that DEP-1 is negatively regulating FLT3 signaling activity and that its loss may contribute to but is not sufficient for leukemogenic cell transformation.	[Arora, Deepika; Stopp, Sabine; Boehmer, Sylvia-Annette; Schons, Julia; Godfrey, Rinesh; Bauer, Reinhard; Boehmer, Frank-D.; Mueller, Joerg P.] Univ Jena, Ctr Mol Biomed, Inst Mol Cell Biol, D-07745 Jena, Germany; [Masson, Kristina; Razumovskaya, Elena; Ronnstrand, Lars] Lund Univ, Malmo Univ Hosp, Dept Lab Med, SE-20502 Malmo, Sweden; [Taenzer, Simone] Leibniz Inst Age Res Fritz Lipmann Inst, Res Grp Immunol, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Lund University; Skane University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Muller, JP (corresponding author), Univ Jena, Ctr Mol Biomed, Inst Mol Cell Biol, D-07745 Jena, Germany.	joerg.mueller2@med.uni-jena.de	Drube, Julia/S-3741-2019	Drube, Julia/0000-0001-6188-2279; Ronnstrand, Lars/0000-0003-1275-5809	European Community [MRTN-CT-2006-035830]; Deutsche Krebshilfe [108401, TP2]	European Community(European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by European Community Grant "PTP-NET" Marie Curie Network MRTN-CT-2006-035830 and Deutsche Krebshilfe Collaborative Grant 108401, TP2 (to F. D. B.).	Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Grundler R, 2003, BLOOD, V102, P646, DOI 10.1182/blood-2002-11-3441; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; HEYWORTH C, 1992, HAEMOPOIESIS PRACTIC, P37; Jandt E, 2003, ONCOGENE, V22, P4175, DOI 10.1038/sj.onc.1206652; Kappert K, 2007, FASEB J, V21, P523, DOI 10.1096/fj.06-6219com; Kelly LM, 2002, CANCER CELL, V1, P421, DOI 10.1016/S1535-6108(02)00070-3; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller JP, 2008, LEUKEMIA, V22, P1945, DOI 10.1038/leu.2008.73; Nakao M, 1996, LEUKEMIA, V10, P1911; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Schmidt-Arras D, 2004, CURR PHARM DESIGN, V10, P1867, DOI 10.2174/1381612043384394; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Small Donald, 2006, Hematology Am Soc Hematol Educ Program, P178; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	44	51	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10918	10929		10.1074/jbc.M110.205021	http://dx.doi.org/10.1074/jbc.M110.205021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21262971	Green Published, hybrid			2022-12-25	WOS:000288797100004
J	Caino, MC; von Burstin, VA; Lopez-Haber, C; Kazanietz, MG				Caino, M. Cecilia; von Burstin, Vivian A.; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.			Differential Regulation of Gene Expression by Protein Kinase C Isozymes as Determined by Genome-wide Expression Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROSTATE-CANCER CELLS; ESTER-INDUCED APOPTOSIS; PHORBOL ESTER; PKC-EPSILON; FACTOR-ALPHA; DELTA; GROWTH; DEATH; PHOSPHORYLATION	Protein kinase C (PKC) isozymes are key signal transducers involved in normal physiology and disease and have been widely implicated in cancer progression. Despite our extensive knowledge of the signaling pathways regulated by PKC isozymes and their effectors, there is essentially no information on how individual members of the PKC family regulate gene transcription. Here, we report the first PKC isozyme-specific analysis of global gene expression by microarray using RNAi depletion of diacylglycerol/phorbol ester-regulated PKCs. A thorough analysis of this microarray data revealed unique patterns of gene expression controlled by PKC alpha, PKC delta, and PKC epsilon, which are remarkably different in cells growing in serum or in response to phorbol ester stimulation. PKC delta is the most relevant isoform in controlling the induction of genes by phorbol ester stimulation, whereas PKC epsilon predominantly regulates gene expression in serum. We also established that two PKC delta-regulated genes, FOSL1 and BCL2A1, mediate the apoptotic effect of phorbol esters or the chemotherapeutic agent etoposide in prostate cancer cells. Our studies offer a unique opportunity for establishing novel transcriptional effectors for PKC isozymes and may have significant functional and therapeutic implications.	[Caino, M. Cecilia; von Burstin, Vivian A.; Lopez-Haber, Cynthia; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazanietz, MG (corresponding author), 421 Curie Blvd,1256 BRB 2-3, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Caino, M. Cecilia/0000-0001-8294-8070; Lopez Haber, Cynthia/0000-0001-9106-543X	National Institutes of Health [CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA89202 (to M.G.K.).	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Adiseshaiah P, 2006, J IMMUNOL, V177, P7193, DOI 10.4049/jimmunol.177.10.7193; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Basu A, 2002, INT J MOL MED, V10, P541; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; BORNER C, 1995, J BIOL CHEM, V270, P78, DOI 10.1074/jbc.270.1.78; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; Cohen S, 2005, LEUKEMIA RES, V29, P923, DOI 10.1016/j.leukres.2005.01.015; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Crosio C, 2006, CELL DEATH DIFFER, V13, P2150, DOI 10.1038/sj.cdd.4401943; DANIEL LW, 1995, CANCER RES, V55, P4844; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kloosterboer FM, 2005, BLOOD, V106, P3955, DOI 10.1182/blood-2004-09-3749; Kucharczak JF, 2005, CELL DEATH DIFFER, V12, P1225, DOI 10.1038/sj.cdd.4401684; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Leo E, 2001, J BIOL CHEM, V276, P8087, DOI 10.1074/jbc.M009450200; Li YK, 1996, J BIOL CHEM, V271, P27025, DOI 10.1074/jbc.271.43.27025; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Maurer F, 1996, J BIOL CHEM, V271, P26074, DOI 10.1074/jbc.271.42.26074; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pickett CA, 2002, MOL ENDOCRINOL, V16, P2840, DOI 10.1210/me.2001-0305; Powell CT, 2006, INT J CANCER, V118, P1572, DOI 10.1002/ijc.21511; Pryhuber GS, 2000, AM J RESP CELL MOL, V22, P150, DOI 10.1165/ajrcmb.22.2.3783; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; SASSONECORSI P, 1990, ONCOGENE, V5, P427; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Slevogt H, 2008, EUR RESPIR J, V31, P725, DOI 10.1183/09031936.00103507; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Townsend KJ, 1998, ONCOGENE, V17, P1223, DOI 10.1038/sj.onc.1202035; Vardarova K, 2009, EUR RESPIR J, V34, P1171, DOI 10.1183/09031936.00171908; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wu DQ, 2002, CANCER RES, V62, P2423; Xu H, 2008, FREE RADICAL BIO MED, V44, P1656, DOI 10.1016/j.freeradbiomed.2008.01.023	49	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11254	11264		10.1074/jbc.M110.194332	http://dx.doi.org/10.1074/jbc.M110.194332			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21252239	hybrid, Green Published			2022-12-25	WOS:000288797100037
J	Huang, GC; Kaufman, AJ; Ramanathan, Y; Singh, B				Huang, Guochang; Kaufman, Andrew J.; Ramanathan, Y.; Singh, Bhuvanesh			SCCRO (DCUN1D1) Promotes Nuclear Translocation and Assembly of the Neddylation E3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEINS; CELL-CYCLE PROGRESSION; CULLIN-RING LIGASES; NEDD8 CONJUGATION; SYSTEM; SCF; PATHWAY; ACTIVATION; SEQUENCE; CUL1	SCCRO/DCUN1D1/DCN1 (squamous cell carcinoma-related oncogene/defective in cullin neddylation 1 domain containing 1/defective in cullin neddylation) serves as an accessory E3 in neddylation by binding to cullin and Ubc12 to allow efficient transfer of Nedd8. In this work we show that SCCRO has broader, pleiotropic effects that are essential for cullin neddylation in vivo. Reduced primary nuclear localization of Cul1 accompanying decreased neddylation and proliferation in SCCRO-/- mouse embryonic fibroblasts led us to investigate whether compartmentalization plays a regulatory role. Decreased nuclear localization, neddylation, and defective proliferation in SCCRO-/- mouse embryonic fibroblasts were rescued by transgenic expression of SCCRO. Expression of reciprocal SCCRO and Cul1-binding mutants confirmed the requirement for SCCRO in nuclear translocation and neddylation of cullins in vivo. Nuclear translocation of Cul1 by tagging with a nuclear localization sequence allowed neddylation independent of SCCRO, but at a lower level. We found that in the nucleus, SCCRO enhances recruitment of Ubc12 to Cul1 to promote neddylation. These findings suggest that SCCRO has an essential role in neddylation in vivo involving nuclear localization of neddylation components and recruitment and proper positioning of Ubc12.	[Huang, Guochang; Kaufman, Andrew J.; Ramanathan, Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Ramanathan, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, 1275 York Ave, New York, NY 10065 USA.	ramanaty@mskcc.org; singhb@mskcc.org			American College of Surgeons; Flight Attendant Medical Research Institute; Falcone Fund; Matheson fellowship; NATIONAL CANCER INSTITUTE [U54CA132378, U54CA137788] Funding Source: NIH RePORTER	American College of Surgeons; Flight Attendant Medical Research Institute; Falcone Fund; Matheson fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a George H. A. Clowes Memorial Research Career Development Award from the American College of Surgeons (to B. S.), a Clinical Innovator Award from Flight Attendant Medical Research Institute (to B. S. and Y. R.), the Falcone Fund (to B. S.), and a Matheson fellowship (to Y. R.).	Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; PTAK C, 1994, J BIOL CHEM, V269, P26539; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	39	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10297	10304		10.1074/jbc.M110.203729	http://dx.doi.org/10.1074/jbc.M110.203729			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21247897	Green Published, hybrid			2022-12-25	WOS:000288547000047
J	Viswanath, K; Ackerson, LK				Viswanath, Kasisomayajula; Ackerson, Leland K.			Race, Ethnicity, Language, Social Class, and Health Communication Inequalities: A Nationally-Representative Cross-Sectional Study	PLOS ONE			English	Article							INFORMATION-SEEKING; DECISION-MAKING; CANCER; INTERNET; TRENDS; DISPARITIES; RESOURCES; PATIENT; SUPPORT; MEDIA	Background: While mass media communications can be an important source of health information, there are substantial social disparities in health knowledge that may be related to media use. The purpose of this study is to investigate how the use of cancer-related health communications is patterned by race, ethnicity, language, and social class. Methodology/Principal Findings: In a nationally-representative cross-sectional telephone survey, 5,187 U.S. adults provided information about demographic characteristics, cancer information seeking, and attention to and trust in health information from television, radio, newspaper, magazines, and the Internet. Cancer information seeking was lowest among Spanish-speaking Hispanics (odds ratio: 0.42; 95% confidence interval: 0.28-0.63) compared to non-Hispanic whites. Spanish-speaking Hispanics were more likely than non-Hispanic whites to pay attention to (odds ratio: 3.10; 95% confidence interval: 2.07-4.66) and trust (odds ratio: 2.61; 95% confidence interval: 1.53-4.47) health messages from the radio. Non-Hispanic blacks were more likely than non-Hispanic whites to pay attention to (odds ratio: 2.39; 95% confidence interval: 1.88-3.04) and trust (odds ratio: 2.16; 95% confidence interval: 1.61-2.90) health messages on television. Those who were college graduates tended to pay more attention to health information from newspapers (odds ratio: 1.98; 95% confidence interval: 1.42-2.75), magazines (odds ratio: 1.86; 95% confidence interval: 1.32-2.60), and the Internet (odds ratio: 4.74; 95% confidence interval: 2.70-8.31) and had less trust in cancer-related health information from television (odds ratio: 0.44; 95% confidence interval: 0.32-0.62) and radio (odds ratio: 0.54; 95% confidence interval: 0.34-0.86) compared to those who were not high school graduates. Conclusions/Significance: Health media use is patterned by race, ethnicity, language and social class. Providing greater access to and enhancing the quality of health media by taking into account factors associated with social determinants may contribute to addressing social disparities in health.	[Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Ackerson, Leland K.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts Lowell, Dept Community Hlth & Sustainabil, Lowell, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell	Viswanath, K (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	leland_ackerson@uml.edu			Dana-Farber/Harvard Cancer Center	Dana-Farber/Harvard Cancer Center	This work was supported by the Dana-Farber/Harvard Cancer Center (http://www.dana-farber.org/res/dana-farber/default.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 2007, ETHNIC DIS, V17, P153; Ackerson LK, 2009, J HEALTH COMMUN, V14, P5, DOI 10.1080/10810730902806836; Arora NK, 2008, J GEN INTERN MED, V23, P223, DOI 10.1007/s11606-007-0406-y; Baty BJ, 2003, AM J MED GENET A, V118A, P146, DOI 10.1002/ajmg.a.10150; Beaudoin CE, 2007, COMMUN RES, V34, P637, DOI 10.1177/0093650207307902; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Brodie M, 2000, HEALTH AFFAIR, V19, P255, DOI 10.1377/hlthaff.19.6.255; Cheong PH, 2007, HEALTH COMMUN, V21, P153, DOI 10.1080/10410230701307188; Cotten SR, 2004, SOC SCI MED, V59, P1795, DOI 10.1016/j.socscimed.2004.02.020; Duerksen SC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-85; Duggan C, 2008, QUAL SAF HEALTH CARE, V17, P85, DOI 10.1136/qshc.2005.017590; Eakin EG, 2001, PSYCHO-ONCOL, V10, P103, DOI 10.1002/pon.500; FINNEGAN JR, 2002, HLTH BEHAV HLTH ED T, P361; Rutten LJF, 2006, J HEALTH COMMUN, V11, P147, DOI 10.1080/10810730600637574; Freimuth VS, 2004, AM J PUBLIC HEALTH, V94, P2053, DOI 10.2105/AJPH.94.12.2053; Friedman DB, 2003, J CANCER EDUC, V18, P43, DOI 10.1207/S15430154JCE1801_14; Gordon NP, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-305; Gronke P, 2007, POLIT COMMUN, V24, P259, DOI 10.1080/10584600701471591; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Hornik R. C., 2002, PUBLIC HLTH COMMUNIC, P1; *I MED, 2003, UN TREATM CONFR RAC; Institute of Medicine (US) Committee on Communication for Behavior Change in the 21st Century: improving the health of diverse populations, 2002, SPEAK HLTH ASS HLTH; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Martin SP, 2007, SOC PROBL, V54, P1, DOI 10.1525/sp.2007.54.1.1; Mayer DK, 2007, PATIENT EDUC COUNS, V65, P342, DOI 10.1016/j.pec.2006.08.015; McNeill LH, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.4.e35; Nelson A. R., 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Niederdeppe J, 2007, HEALTH COMMUN, V22, P153, DOI 10.1080/10410230701454189; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Rimer BK, 2004, CANCER-AM CANCER SOC, V101, P1214, DOI 10.1002/cncr.20512; *USDA, 2008, MEAS RUR RUR URB CON; Viswanath K, 2006, J HEALTH COMMUN, V11, P1, DOI 10.1080/10810730600637426; Viswanath K, 2005, NAT REV CANCER, V5, P828, DOI 10.1038/nrc1718; Viswanath K, 2006, EXAMINING HLTH DISPA, P215; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011	38	122	123	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e14550	10.1371/journal.pone.0014550	http://dx.doi.org/10.1371/journal.pone.0014550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	710NW	21267450	Green Published, Green Submitted, gold			2022-12-25	WOS:000286519500018
J	Bandoh, H; Kida, I; Ueda, H				Bandoh, Hiroshi; Kida, Ikuhiro; Ueda, Hiroshi			Olfactory Responses to Natal Stream Water in Sockeye Salmon by BOLD fMRI	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SEXUAL-BEHAVIOR; PREOPTIC AREAS; FUNCTIONAL MRI; AMINO-ACIDS; TELENCEPHALON; MEMORY; BULB; DISCRIMINATION; STIMULATION	Many studies have shown that juvenile salmon imprint olfactory memory of natal stream odors during downstream migration, and adults recall this stream-specific odor information to discriminate their natal stream during upstream migration for spawning. The odor information processing of the natal stream in the salmon brain, however, has not been clarified. We applied blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging to investigate the odor information processing of the natal stream in the olfactory bulb and telencephalon of lacustrine sockeye salmon (Oncorhynchus nerka). The strong responses to the natal stream water were mainly observed in the lateral area of dorsal telencephalon (Dl), which are homologous to the medial pallium (hippocampus) in terrestrial vertebrates. Although the concentration of L-serine (1 mM) in the control water was 20,000-times higher than that of total amino acid in the natal stream water (47.5 nM), the BOLD signals resulting from the natal stream water were stronger than those by L-serine in the Dl. We concluded that sockeye salmon could process the odor information of the natal stream by integrating information in the Dl area of the telencephalon.	[Bandoh, Hiroshi; Ueda, Hiroshi] Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan; [Kida, Ikuhiro] Tokyo Inst Psychiat, Integrated Neurosci Res Team, Tokyo, Japan; [Ueda, Hiroshi] Hokkaido Univ, Field Sci Ctr No Biosphere, Lab Aquat Ecosyst Conservat, Sapporo, Hokkaido, Japan	Hokkaido University; Tokyo Institute of Psychiatry; Hokkaido University	Bandoh, H (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Div Biosphere Sci, Sapporo, Hokkaido, Japan.	hueda@fsc.hokudai.ac.jp	Kida, Ikuhiro/A-4704-2011; Ueda, Hiroshi/G-4446-2010	Kida, Ikuhiro/0000-0001-6592-3349; Ueda, Hiroshi/0000-0002-4706-8665	Hokkaido University Clark Memorial Foundation; Japanese Society for the Promotion of Science [18208017]; Mitsubishi Foundation [35-4]; Mitsui Co. Ltd [08-A10]	Hokkaido University Clark Memorial Foundation; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; Mitsui Co. Ltd(Mitsui & Co., LTD.)	This study was supported by a research grant to HB from the Hokkaido University Clark Memorial Foundation, as well as partly by Grant-in-Aid for Scientific Research (A) (18208017) from the Japanese Society for the Promotion of Science, a natural science grant (35-4) from the Mitsubishi Foundation, and an environmental research grant (08-A10) from Mitsui & Co. Ltd to HU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni A, 2004, MECH DEVELOP, V121, P977, DOI 10.1016/j.mod.2004.03.023; ANZAI S, 1996, NEUROSCI RES       S, V20, pS223; COOPER JC, 1976, J FISH RES BOARD CAN, V33, P703, DOI 10.1139/f76-087; Dittman AH, 1996, CAN J FISH AQUAT SCI, V53, P434, DOI 10.1139/cjfas-53-2-434; Dittman AH, 1996, J EXP BIOL, V199, P83; EVANS RE, 1985, BRAIN RES, V330, P65, DOI 10.1016/0006-8993(85)90008-3; Folgueira M, 2004, J COMP NEUROL, V480, P180, DOI 10.1002/cne.20340; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; HARA TJ, 1970, J FISH RES BOARD CAN, V27, P565, DOI 10.1139/f70-059; HARA TJ, 1982, CHEMORECEPTION FISHE, P135; Hasler A.D., 1983, OLFACTORY IMPRINTING; Hino H, 2009, J FISH BIOL, V75, P945, DOI 10.1111/j.1095-8649.2009.02341.x; Hyder F, 2001, NMR BIOMED, V14, P413, DOI 10.1002/nbm.733; Kage T, 2004, J COMP NEUROL, V476, P219, DOI 10.1002/cne.20219; KENNETH JL, 2008, P NATL ACAD SCI USA, V105, P19096; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; KOYAMA Y, 1985, ZOOL SCI, V2, P565; LIEM KF, 2001, FUNCTIONAL VERTEBRAT; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nam RH, 2004, NEUROSCI LETT, V370, P248, DOI 10.1016/j.neulet.2004.08.037; Nevitt G., 1998, INTEGR BIOL, V1, P215, DOI [10.1002/(SICI)1520-6602(1998)1:6%3C215:AID-INBI3%3E3.0.CO;2-V, DOI 10.1002/(SICI)1520-6602(1998)1:6<215::AID-INBI3>3.0.C0;2-V]; NEVITT GA, 1994, P NATL ACAD SCI USA, V91, P4288, DOI 10.1073/pnas.91.10.4288; Nikonov AA, 2005, P NATL ACAD SCI USA, V102, P18688, DOI 10.1073/pnas.0505241102; Northcutt RG, 2006, J COMP NEUROL, V494, P903, DOI 10.1002/cne.20853; NORTHCUTT RG, 2006, BRAIN RES B, V75, P191; Quinn TP, 2005, BEHAV ECOLOGY PACIFI, P85; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; Saito K, 2004, NEUROREPORT, V15, P2695; Satou M, 2006, J COMP PHYSIOL A, V192, P135, DOI 10.1007/s00359-005-0056-7; SATOU M, 1984, PHYSIOL BEHAV, V33, P441, DOI 10.1016/0031-9384(84)90167-7; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Shoji T, 2000, CHEM SENSES, V25, P533, DOI 10.1093/chemse/25.5.533; Tabor R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001416; UEDA H, 2010, GEN COMP EN IN PRESS, DOI DOI 10.1016/J.YGEN.2010.02.003; Ueda H, 2007, AM FISH S S, V54, P5; UEDA K, 1971, Journal of the Faculty of Science University of Tokyo Section IV Zoology, V12, P167; UEDA K, 1967, COMP BIOCHEM PHYSIOL, V21, P133, DOI 10.1016/0010-406X(67)90123-5; VADENBURG EH, 2006, J EXP BIOL, V209, P2015; VADENBURG EH, 2005, J NEUROPHYSIOL, V93, P2849; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633; Yamamoto Y, 2009, ZOOL SCI, V26, P778, DOI 10.2108/zsj.26.778	47	26	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e16051	10.1371/journal.pone.0016051	http://dx.doi.org/10.1371/journal.pone.0016051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21264223	Green Published, gold, Green Submitted			2022-12-25	WOS:000286517600018
J	Kalluri, SR; Rothhammer, V; Staszewski, O; Srivastava, R; Petermann, F; Prinz, M; Hemmer, B; Korn, T				Kalluri, Sudhakar Reddy; Rothhammer, Veit; Staszewski, Ori; Srivastava, Rajneesh; Petermann, Franziska; Prinz, Marco; Hemmer, Bernhard; Korn, Thomas			Functional Characterization of Aquaporin-4 Specific T Cells: Towards a Model for Neuromyelitis Optica	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; WATER CHANNEL; BRAIN EDEMA; B-CELLS; LESIONS; MICE; DISEASE; AUTOIMMUNITY; PATHOGENESIS; DISTINCTION	Background: Antibodies to the water channel protein aquaporin-4 (AQP4), which is expressed in astrocytic endfeet at the blood brain barrier, have been identified in the serum of Neuromyelitis optica (NMO) patients and are believed to induce damage to astrocytes. However, AQP4 specific T helper cell responses that are required for the generation of anti-AQP4 antibodies and most likely also for the formation of intraparenchymal CNS lesions have not been characterized. Methodology/Principal Findings: Using overlapping 15-meric peptides of AQP4, we identified the immunogenic T cell epitopes of AQP4 that are restricted to murine major histocompatibility complex (MHC) I-A(b). The N-terminal region of AQP4 was highly immunogenic. More precisely, the intracellular epitope AQP4(22-36) was detected as major immunogenic determinant. AQP4(82-108) (located in the second transmembrane domain), AQP4(139-153) (located in the second extracellular loop), AQP4(211-225) (located in the fifth transmembrane domain), AQP4(235-249) (located in the sixth transmembrane domain), as well as AQP4(289-306) in the intracellular C-terminal region were also immunogenic epitopes. AQP4(22-36) and AQP4(289-303) specific T cells were present in the natural T cell repertoire of wild type C57BL/6 mice and T cell lines were raised. However, active immunization with these AQP4 peptides did not induce signs of spinal cord disease. Rather, sensitization with AQP4 peptides resulted in production of IFN-gamma, but also IL-5 and IL-10 by antigen-specific T cells. Consistent with this cytokine profile, the AQP4 specific antibody response upon immunization with full length AQP4 included IgG1 and IgG2, which are associated with a mixed Th2/Th1 T cell response. Conclusions and Significance: AQP4 is able to induce an autoreactive T cell response. The identification of I-Ab restricted AQP4 specific T cell epitopes will allow us to investigate how AQP4 specific autoimmune reactions are regulated and to establish faithful mouse models of NMO that include both cellular and humoral responses against AQP4.	[Kalluri, Sudhakar Reddy; Rothhammer, Veit; Srivastava, Rajneesh; Petermann, Franziska; Hemmer, Bernhard; Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany; [Staszewski, Ori; Prinz, Marco] Univ Freiburg Klinikum, Dept Neuropathol, Inst Pathol, Freiburg, Germany	Technical University of Munich; University of Freiburg	Kalluri, SR (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany.	korn@lrz.tum.de	Kalluri, Sudhakar Reddy/C-6928-2013; Korn, Thomas/AAE-6960-2019; Srivastava, Rajneesh/A-7943-2012; Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021	Korn, Thomas/0000-0002-3633-0955; Hemmer, Bernhard/0000-0001-5985-6784; Staszewski, Ori/0000-0002-0579-6701	DFG [HE 2386/4-1, KO 2964/2-1, 3-1]; BMBF funded competence network of Multiple Sclerosis (KKNMS); DFG funded research unit [1336]; Gemeinnutzige Hertie-Stiftung; Technical University Munich	DFG(German Research Foundation (DFG)); BMBF funded competence network of Multiple Sclerosis (KKNMS)(Federal Ministry of Education & Research (BMBF)); DFG funded research unit; Gemeinnutzige Hertie-Stiftung; Technical University Munich	SRK and BH were supported by a grant from the DFG (HE 2386/4-1). MP was supported by the BMBF funded competence network of Multiple Sclerosis (KKNMS) and by the DFG funded research unit (FOR) 1336 "From monocytes to brain macrophages - conditions influencing the fate of myeloid cells in the brain". TK was funded by the DFG (KO 2964/2-1 and 3-1) and the Gemeinnutzige Hertie-Stiftung as well as intramural grants from the Technical University Munich (KKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Devic E., 1894, B MED PARIS, V8, P1033; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Jarius S, 2010, CLIN CHEM LAB MED, V48, P659, DOI 10.1515/CCLM.2010.127; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Saini H, 2010, J NEUROIMMUNOL, V221, P68, DOI 10.1016/j.jneuroim.2010.02.007; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Wingerchuk D, 2006, NEUROLOGY, V66, pA380	34	44	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16083	10.1371/journal.pone.0016083	http://dx.doi.org/10.1371/journal.pone.0016083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264240	gold, Green Published, Green Submitted			2022-12-25	WOS:000286516500026
J	Wang, IJ; Tsai, RJF; Yeh, LK; Tsai, RYN; Hu, FR; Kao, WWY				Wang, I-Jong; Tsai, Ray Jui-Fang; Yeh, Lung-Kun; Tsai, Ryan Yao-Nien; Hu, Fung-Rong; Kao, Winston W. Y.			Changes in Corneal Basal Epithelial Phenotypes in an Altered Basement Membrane	PLOS ONE			English	Article							STEM-CELL NICHE; KERATINOCYTE GROWTH-FACTOR; HUMAN OCULAR SURFACE; AMNIOTIC MEMBRANE; AUTOGRAFT TRANSPLANTATION; LIMBAL TRANSPLANTATION; RADIAL KERATOTOMY; CLONAL ANALYSIS; EX-VIVO; EXPRESSION	Background: To examine the corneal epithelial phenotype in an altered basement membrane. Methodology/Principal Findings: Corneas from 9 patients with symptoms of continuous unstable corneal curvature (CUCC) were harvested by penetrating keratoplasty and subjected to histology examination and immunohistochemical staining with transactivating and N-terminally truncated pP63 transcript (Delta Np63), cytokeratin 3 (Krt3), ATP-binding cassette sub-family G member 2 (ABCG2), connexin 43 (CX43), p38 mitogen-activated protein kinases (p38MAPK), activating protein 2 (TFAP2), and extracellular signal-regulated kinase (Erk1/2) monoclonal antibodies. Positive immunostaining with ABCG2, p38MAPK, and TFAP2 monoclonal antibodies was observed in the basal epithelial cells of CUCC patients, and CX43 and Delta Np63 were detected in the full-thickness epithelial cells of CUCC patients. Conclusions/Significance: Our results indicate that alteration of the corneal basement membrane induces a de-differentiation-like phenotype in corneal basal epithelial cells.	[Wang, I-Jong; Hu, Fung-Rong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Tsai, Ray Jui-Fang; Tsai, Ryan Yao-Nien] Taipei Eye Ctr, Taipei, Taiwan; [Tsai, Ray Jui-Fang] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Tsai, Ray Jui-Fang] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Dept Ophthalmol, Coll Med, Chang Gung Mem Hosp Linko, Tao Yuan, Taiwan; [Kao, Winston W. Y.] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	raytsai@ms4.hinet.net		Wang, I-Jong/0000-0002-3045-0614; HU, FUNG-RONG/0000-0002-2102-5317	National Institutes of Health/National Eye Institute (NIH/NEI) [EY 010556]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation;  [NSC-98-3112-B-002-040];  [NSC-98-2627-B-002-004]; NATIONAL EYE INSTITUTE [R01EY010556] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	IJW was supported in part by NSC-98-3112-B-002-040, NSC-98-2627-B-002-004; WWK was supported in part by National Institutes of Health/National Eye Institute (NIH/NEI) grant EY 010556, from the Research to Prevent Blindness and Ohio Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM JL, 1970, AM J OPHTHALMOL, V69, P669, DOI 10.1016/0002-9394(70)91637-5; Bergmanson J, 2001, CORNEA, V20, P866, DOI 10.1097/00003226-200111000-00018; Cheng CC, 2009, J CELL SCI, V122, P4473, DOI 10.1242/jcs.054791; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; GIPSON IK, 1989, EYE, V3, P132, DOI 10.1038/eye.1989.21; Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155; Grueterich M, 2002, ARCH OPHTHALMOL-CHIC, V120, P783; Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003; Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; Hollingsworth JG, 2005, OPHTHAL PHYSL OPT, V25, P254, DOI 10.1111/j.1475-1313.2005.00278.x; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Kamalati T, 1993, EXS, V65, P201; Kedinger M, 1998, PHILOS T R SOC B, V353, P847, DOI 10.1098/rstb.1998.0249; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Lehrer MS, 1998, J CELL SCI, V111, P2867; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; LJUBIMOV AV, 1995, LAB INVEST, V72, P461; Ljubimov AV, 1998, EXP EYE RES, V67, P265, DOI 10.1006/exer.1998.0511; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Peifer M, 1999, NATURE, V400, P213, DOI 10.1038/22214; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Shanmuganathan VA, 2007, BRIT J OPHTHALMOL, V91, P514, DOI 10.1136/bjo.2006.102640; Sherwin T, 2004, CLIN EXP OPHTHALMOL, V32, P211, DOI 10.1111/j.1442-9071.2004.00805.x; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; SOUZA P, 1995, DEVELOPMENT, V121, P2559; STEPP MA, 1995, J HISTOCHEM CYTOCHEM, V43, P353, DOI 10.1177/43.4.7534781; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSAI RJF, 1995, CORNEA, V14, P439; TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003; Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010; Ucakhan Omur O, 2006, Eye Contact Lens, V32, P183; VANTRAPPEN L, 1985, INVEST OPHTH VIS SCI, V26, P220; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e14537	10.1371/journal.pone.0014537	http://dx.doi.org/10.1371/journal.pone.0014537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264285	gold, Green Submitted, Green Published			2022-12-25	WOS:000286516500009
J	de Sousa, AA; Reis, R; Bento-Torres, J; Trevia, N; Lins, NAD; Passos, A; Santos, Z; Diniz, JAP; Vasconcelos, PFD; Cunningham, C; Perry, VH; Diniz, CWP				de Sousa, Aline Andrade; Reis, Renata; Bento-Torres, Joao; Trevia, Nonata; de Almeida Lins, Nara Alves; Passos, Aline; Santos, Zaire; Picanco Diniz, Jose Antonio; da Costa Vasconcelos, Pedro Fernando; Cunningham, Colm; Perry, Victor Hugh; Picano Diniz, Cristovam Wanderley			Influence of Enriched Environment on Viral Encephalitis Outcomes: Behavioral and Neuropathological Changes in Albino Swiss Mice	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; GLYCOSAMINOGLYCAN-BINDING VARIANTS; SPECIES-TYPICAL BEHAVIORS; EXTRACELLULAR-MATRIX; VIRULENCE ATTENUATION; JAPANESE ENCEPHALITIS; HIPPOCAMPAL-LESIONS; CELL LAYER; TENASCIN-R	An enriched environment has previously been described as enhancing natural killer cell activity of recognizing and killing virally infected cells. However, the effects of environmental enrichment on behavioral changes in relation to virus clearance and the neuropathology of encephalitis have not been studied in detail. We tested the hypothesis that environmental enrichment leads to less CNS neuroinvasion and/or more rapid viral clearance in association with T cells without neuronal damage. Stereology-based estimates of activated microglia perineuronal nets and neurons in CA3 were correlated with behavioral changes in the Piry rhabdovirus model of encephalitis in the albino Swiss mouse. Two-month-old female mice maintained in impoverished (IE) or enriched environments (EE) for 3 months were behaviorally tested. After the tests, an equal volume of Piry virus (IEPy, EEPy)-infected or normal brain homogenates were nasally instilled. Eight days post-instillation (dpi), when behavioral changes became apparent, brains were fixed and processed to detect viral antigens, activated microglia, perineuronal nets, and T lymphocytes by immuno-or histochemical reactions. At 20 or 40 dpi, the remaining animals were behaviorally tested and processed for the same markers. In IEPy mice, burrowing activity decreased and recovered earlier (8-10 dpi) than open field (20-40 dpi) but remained unaltered in the EEPy group. EEPy mice presented higher T-cell infiltration, less CNS cell infection by the virus and/or faster virus clearance, less microgliosis, and less damage to the extracellular matrix than IEPy. In both EEPy and IEPy animals, CA3 neuronal number remained unaltered. The results suggest that an enriched environment promotes a more effective immune response to clear CNS virus and not at the cost of CNS damage.	[de Sousa, Aline Andrade; Reis, Renata; Bento-Torres, Joao; Trevia, Nonata; de Almeida Lins, Nara Alves; Passos, Aline; Santos, Zaire; Picano Diniz, Cristovam Wanderley] Fed Univ Para, Inst Ciencias Biol, Hosp Univ Joao de Barros Barreto, Lab Invest Neurodegeneracao & Infeccao, BR-66059 Belem, Para, Brazil; [Picanco Diniz, Jose Antonio; da Costa Vasconcelos, Pedro Fernando] IEC, Dept Arbovirol & Febres Hemorrag, Ananindeua, Brazil; [da Costa Vasconcelos, Pedro Fernando] Univ Estado Para, Dept Patol, Belem, Para, Brazil; [Cunningham, Colm] Trinity Coll Dublin, Inst Neurosci, Sch Biochem & Immunol, Dublin, Ireland; [Perry, Victor Hugh] Univ Southampton, Sch Biol Sci, Southampton, Hants, England	Universidade Federal do Para; Universidade do Estado do Para (UEPA); Trinity College Dublin; University of Southampton	de Sousa, AA (corresponding author), Fed Univ Para, Inst Ciencias Biol, Hosp Univ Joao de Barros Barreto, Lab Invest Neurodegeneracao & Infeccao, BR-66059 Belem, Para, Brazil.	cwpdiniz@gmail.com	Vasconcelos, Pedro/AAH-3142-2019; NETO, JOAO BENTO TORRES/N-5458-2019; FHV, Inct/K-2346-2013; Sousa, Aline/ABE-9376-2020; Bento Torres, João/F-5129-2016; Perry, V. Hugh/Y-2935-2019; Diniz, Cristovam W.P./G-1474-2010; Cunningham, Colm/A-1743-2010	NETO, JOAO BENTO TORRES/0000-0002-9155-9445; Bento Torres, João/0000-0002-9155-9445; Diniz, Cristovam W.P./0000-0001-6611-6880; Cunningham, Colm/0000-0003-1423-5209	CNPq [300460/2005-8, 301955/2007-7, 471444/2006-5]; INCT-FHV/CNPq/CAPES/FAPESPA [573739/2008-0]; FINEP/FADESP [01.04.0043.00]; Instituto Brasileiro de Neurociencias - IBNnet	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-FHV/CNPq/CAPES/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP/FADESP(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Brasileiro de Neurociencias - IBNnet	This study had financial support from CNPq (grant no. 300460/2005-8, 301955/2007-7, and 471444/2006-5), INCT-FHV/CNPq/CAPES/FAPESPA (grant no. 573739/2008-0), and FINEP/FADESP (grant no. 01.04.0043.00). CWPD is supported by Instituto Brasileiro de Neurociencias - IBNnet. REIS, R. R. and SOUSA, A. A. equally contributed to the data generation and analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Altavilla G, 2002, J NEUROVIROL, V8, P180, DOI 10.1080/13550280290049633; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Anastasia A, 2009, J NEUROCHEM, V109, P755, DOI 10.1111/j.1471-4159.2009.06001.x; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P1033, DOI 10.1037/0735-7044.118.5.1033; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; BERGE T., 1975, INT CATALOGUE ARBOVI; BI ZB, 1995, J VIROL, V69, P6466, DOI 10.1128/JVI.69.10.6466-6472.1995; Bonthius DJ, 2004, BRAIN RES PROTOC, V14, P45, DOI 10.1016/j.brainresprot.2004.09.003; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; CHIANG J, IMMUNOL INVEST; Christian AY, 1996, VIRAL IMMUNOL, V9, P195, DOI 10.1089/vim.1996.9.195; Ciavarra RP, 2006, J IMMUNOL, V177, P492, DOI 10.4049/jimmunol.177.1.492; Cunningham C, 2005, NEURODEGENERATION AND PRION DISEASE, P111, DOI 10.1007/0-387-23923-5_5; da Cruz E R, 1981, Rev Inst Med Trop Sao Paulo, V23, P194; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Diniz JAP, 2006, ARCH VIROL, V151, P2519, DOI 10.1007/s00705-006-0812-1; EDWARDS AJ, 1984, CLIN EXP IMMUNOL, V58, P420; Everall IP, 1999, BRAIN PATHOL, V9, P209; FORGER JM, 1991, J VIROL, V65, P4950, DOI 10.1128/JVI.65.9.4950-4958.1991; Franklin SL, 2008, J NEUROPATH EXP NEUR, V67, P189, DOI 10.1097/NEN.0b013e3181654386; Gabriel AF, 2009, BRAIN RES, V1276, P83, DOI 10.1016/j.brainres.2009.04.039; Gaskin S, 2009, BEHAV BRAIN RES, V202, P64, DOI 10.1016/j.bbr.2009.03.016; Gomes-Leal W, 2006, ACTA TROP, V97, P126, DOI 10.1016/j.actatropica.2005.09.006; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; Hascoet M, 2000, PHARMACOL BIOCHEM BE, V67, P45, DOI 10.1016/S0091-3057(00)00293-8; Hilbig H, 2002, J CHEM NEUROANAT, V23, P199, DOI 10.1016/S0891-0618(01)00159-4; Ho Christopher S. K., 2001, Blood, V98, P140; JOHNSTON SC, 2008, ANN NEUROL, V64, pA11; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KETZLER S, 1990, ACTA NEUROPATHOL, V80, P92, DOI 10.1007/BF00294228; KILPATRICK DC, 1986, SCAND J IMMUNOL, V24, P11, DOI 10.1111/j.1365-3083.1986.tb02064.x; Kizaki T, 2008, BIOCHEM BIOPH RES CO, V372, P152, DOI 10.1016/j.bbrc.2008.05.005; Komatsu T, 1997, J IMMUNOL, V159, P3444; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0; Liao HF, 2006, J SPORT MED PHYS FIT, V46, P307; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Magalon K, 2007, EUR J NEUROSCI, V25, P761, DOI 10.1111/j.1460-9568.2007.05335.x; Marcario JK, 2004, J NEUROVIROL, V10, P387, DOI 10.1080/13550280490521131; Marquette C, 1996, J NEUROIMMUNOL, V68, P45, DOI 10.1016/0165-5728(96)00056-2; Marriott AC, 2005, ARCH VIROL, V150, P671, DOI 10.1007/s00705-004-0452-2; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; Nansen A, 2000, EUR J IMMUNOL, V30, P1797, DOI 10.1002/1521-4141(200007)30:7<1797::AID-IMMU1797>3.0.CO;2-B; Olival KJ, 2005, J NEUROVIROL, V11, P441, DOI 10.1080/13550280591002450; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Park CH, 2006, J VET MED SCI, V68, P589, DOI 10.1292/jvms.68.589; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Rasalingam P, 2005, CAN J VET RES, V69, P100; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, pS267; SATO S, 1994, J BIOL CHEM, V269, P4424; Scott CA, 2008, J VIROL, V82, P513, DOI 10.1128/JVI.01677-07; Simonetti T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006780; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; STEEL CD, J NEUROIMMUNOL; Steel CD, 2009, VIROLOGY, V387, P117, DOI 10.1016/j.virol.2009.01.032; Tauber SC, 2009, J NEUROSCI RES, V87, P1877, DOI 10.1002/jnr.22010; Travassos da Rosa Amelia P.A., 2001, American Journal of Tropical Medicine and Hygiene, V64, P93; van den Pol AN, 2009, J COMP NEUROL, V516, P456, DOI 10.1002/cne.22131; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILKS CR, 1984, J HYG-CAMBRIDGE, V93, P147, DOI 10.1017/S0022172400061039; Zhou JH, 2005, J VIROL, V79, P4764, DOI 10.1128/JVI.79.8.4764-4773.2005; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	78	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e15597	10.1371/journal.pone.0015597	http://dx.doi.org/10.1371/journal.pone.0015597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21264301	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000286514000006
J	Lederle, L; Weber, S; Wright, T; Feyder, M; Brigman, JL; Crombag, HS; Saksida, LM; Bussey, TJ; Holmes, A				Lederle, Lauren; Weber, Susanna; Wright, Tara; Feyder, Michael; Brigman, Jonathan L.; Crombag, Hans S.; Saksida, Lisa M.; Bussey, Timothy J.; Holmes, Andrew			Reward-Related Behavioral Paradigms for Addiction Research in the Mouse: Performance of Common Inbred Strains	PLOS ONE			English	Article							REPEATED MATERNAL SEPARATION; CONDITIONED-STIMULUS; AMPA RECEPTOR; MICE; STRESS; EXTINCTION; REINFORCER; PHENOTYPES; DELETION; AMYGDALA	The mouse has emerged as a uniquely valuable species for studying the molecular and genetic basis of complex behaviors and modeling neuropsychiatric disease states. While valid and reliable preclinical assays for reward-related behaviors are critical to understanding addiction-related processes, and various behavioral procedures have been developed and characterized in rats and primates, there have been relatively few studies using operant-based addiction-relevant behavioral paradigms in the mouse. Here we describe the performance of the C57BL/6J inbred mouse strain on three major reward-related paradigms, and replicate the same procedures in two other commonly used inbred strains (DBA/2J, BALB/cJ). We examined Pavlovian-instrumental transfer (PIT) by measuring the ability of an auditory cue associated with food reward to promote an instrumental (lever press) response. In a separate experiment, we assessed the acquisition and extinction of a simple stimulus-reward instrumental behavior on a touchscreen-based task. Reinstatement of this behavior was then examined following either continuous exposure to cues (conditioned reinforcers, CRs) associated with reward, brief reward and CR exposure, or brief reward exposure followed by continuous CR exposure. The third paradigm examined sensitivity of an instrumental (lever press) response to devaluation of food reward (a probe for outcome insensitive, habitual behavior) by repeated pairing with malaise. Results showed that C57BL/6J mice displayed robust PIT, as well as clear extinction and reinstatement, but were insensitive to reinforcer devaluation. DBA/2J mice showed good PIT and (rewarded) reinstatement, but were slow to extinguish and did not show reinforcer devaluation or significant CR-reinstatement. BALB/cJ mice also displayed good PIT, extinction and reinstatement, and retained instrumental responding following devaluation, but, unlike the other strains, demonstrated reduced Pavlovian approach behavior (food magazine head entries). Overall, these assays provide robust paradigms for future studies using the mouse to elucidate the neural, molecular and genetic factors underpinning reward-related behaviors relevant to addiction research.	[Lederle, Lauren; Weber, Susanna; Wright, Tara; Feyder, Michael; Brigman, Jonathan L.; Holmes, Andrew] NIAAA, Sect Behav Sci & Genet, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA; [Crombag, Hans S.] Univ Sussex, Sch Psychol, Behav & Clin Neurosci Res Grp, Brighton, E Sussex, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Med Res Council, Cambridge, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Sussex; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Lederle, L (corresponding author), NIAAA, Sect Behav Sci & Genet, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA.	holmesan@mail.nih.gov	Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016; Brigman, Jonathan/O-4978-2016	Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171; 	National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000411] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research supported by National Institute on Alcohol Abuse and Alcoholism Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2001, BEHAV NEUROSCI, V115, P443, DOI 10.1037/0735-7044.115.2.443; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037/0097-7403.21.3.203; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BAXTER DJ, 1982, ANIM LEARN BEHAV, V10, P201, DOI 10.3758/BF03212271; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boyce-Rustay JM, 2008, BEHAV BRAIN RES, V186, P133, DOI 10.1016/j.bbr.2007.07.031; Brigman JL, 2008, LEARN MEMORY, V15, P50, DOI 10.1101/lm.777308; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chen YC, 2009, NEUROPSYCHOPHARMACOL, V34, P1454, DOI 10.1038/npp.2008.182; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Crabbe J C, 1994, Alcohol Alcohol Suppl, V2, P67; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRAWLEY JN, 2009, WHATS WRONG MY MOUSE; Crombag HS, 2008, EUR J NEUROSCI, V27, P3284, DOI 10.1111/j.1460-9568.2008.06299.x; Crombag HS, 2008, LEARN MEMORY, V15, P299, DOI 10.1101/lm.762508; Crombag HS, 2010, LEARN MEMORY, V17, P807, DOI 10.1101/lm.1610510; CROMBAG HS, 2008, BEHAV BRAIN RES; CRUSIO WE, 2008, STANDARDS PUBLICATIO; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; ESTES WK, 1948, J EXP PSYCHOL, V38, P173, DOI 10.1037/h0057525; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0; Holland PC, 2003, EUR J NEUROSCI, V17, P1680, DOI 10.1046/j.1460-9568.2003.02585.x; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029; Jackson KJ, 2009, NEUROPHARMACOLOGY, V57, P347, DOI 10.1016/j.neuropharm.2009.07.020; Janowsky A, 2001, J PHARMACOL EXP THER, V298, P634; Johnson AW, 2007, J NEUROSCI, V27, P13430, DOI 10.1523/JNEUROSCI.4320-07.2007; Johnson AW, 2007, BEHAV NEUROSCI, V121, P1192, DOI 10.1037/0735-7044.121.6.1192; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; KHEIRBEK MA, LEARN MEM, V17, P148; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; LOVIBOND PF, 1988, BIOL PSYCHOL, V27, P199, DOI 10.1016/0301-0511(88)90052-X; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Mead AN, 2003, J NEUROSCI, V23, P1041; Mead AN, 2003, J NEUROSCI, V23, P9500; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Norcross M, 2008, PSYCHOPHARMACOLOGY, V200, P413, DOI 10.1007/s00213-008-1215-7; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Sanders AC, 2007, NEUROPSYCHOPHARMACOL, V32, P2321, DOI 10.1038/sj.npp.1301368; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Wiltgen BJ, 2007, EUR J NEUROSCI, V25, P2491, DOI 10.1111/j.1460-9568.2007.05487.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Yu CX, 2009, J NEUROSCI, V29, P15100, DOI 10.1523/JNEUROSCI.4215-09.2009	60	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2011	6	1							e15536	10.1371/journal.pone.0015536	http://dx.doi.org/10.1371/journal.pone.0015536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LL	21249214	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000286513100006
J	Brust, JCM; Lygizos, M; Chaiyachati, K; Scott, M; van der Merwe, TL; Moll, AP; Li, XA; Loveday, M; Bamber, SA; Lalloo, UG; Friedland, GH; Shah, NS; Gandhi, NR				Brust, James C. M.; Lygizos, Melissa; Chaiyachati, Krisda; Scott, Michelle; van der Merwe, Theo L.; Moll, Anthony P.; Li, Xuan; Loveday, Marian; Bamber, Sheila A.; Lalloo, Umesh G.; Friedland, Gerald H.; Shah, N. Sarita; Gandhi, Neel R.			Culture Conversion Among HIV Co-Infected Multidrug-Resistant Tuberculosis Patients in Tugela Ferry, South Africa	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; PREDICTORS; OUTCOMES	Background: Little is known about the time to sputum culture conversion in MDR-TB patients co-infected with HIV, although such patients have, historically, had poor outcomes. We describe culture conversion rates among MDR-TB patients with and without HIV-co-infection in a TB-endemic, high-HIV prevalent, resource-limited setting. Methods: Patients with culture-proven MDR-TB were treated with a standardized second-line regimen. Sputum cultures were taken monthly and conversion was defined as two negative cultures taken at least one month apart. Time-to-conversion was measured from the day of initiation of MDR-TB therapy. Subjects with HIV received antiretroviral therapy (ART) regardless of CD4 count. Results: Among 45 MDR-TB patients, 36 (80%) were HIV-co-infected. Overall, 40 (89%) of the 45 patients culture-converted within the first six months and there was no difference in the proportion who converted based on HIV status. Median time-to-conversion was 62 days (IQR 48-111). Among the five patients who did not culture convert, three died, one was transferred to another facility, and one refused further treatment before completing 6 months of therapy. Thus, no patients remained persistently culture-positive at 6 months of therapy. Conclusions: With concurrent second-line TB and ART medications, MDR-TB/HIV co-infected patients can achieve culture conversion rates and times similar to those reported from HIV-negative patients worldwide. Future studies are needed to examine whether similar cure rates are achieved at the end of MDR-TB treatment and to determine the optimal use and timing of ART in the setting of MDR-TB treatment.	[Brust, James C. M.; Li, Xuan; Shah, N. Sarita; Gandhi, Neel R.] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Brust, James C. M.; Li, Xuan; Shah, N. Sarita; Gandhi, Neel R.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Brust, James C. M.; Lygizos, Melissa; Chaiyachati, Krisda; Scott, Michelle; van der Merwe, Theo L.; Moll, Anthony P.; Bamber, Sheila A.; Friedland, Gerald H.; Shah, N. Sarita; Gandhi, Neel R.] Tugela Ferry Care & Res Collaborat TF CARES, Tugela Ferry, South Africa; [Lygizos, Melissa; Chaiyachati, Krisda] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Scott, Michelle] Harvard Univ, Sch Med, Boston, MA USA; [van der Merwe, Theo L.; Moll, Anthony P.; Bamber, Sheila A.] Philanjalo, Tugela Ferry, South Africa; [Loveday, Marian] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Loveday, Marian; Lalloo, Umesh G.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Friedland, Gerald H.] Yale Univ, Sch Med, New Haven, CT USA; [Shah, N. Sarita; Gandhi, Neel R.] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; University of Kwazulu Natal; Yale University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Brust, JCM (corresponding author), Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA.	jcmbrust@gmail.com	Loveday, Marian/M-8016-2013	Loveday, Marian/0000-0001-9205-9314; Chaiyachati, Krisda/0000-0003-3326-6641	National Institute of Allergy and Infectious Diseases [K23AI083088]; Doris Duke Charitable Foundation; U.S. President's Emergency Plan for AIDS Relief (PEPFAR); GlaxoSmithKline; Boehringer Ingelheim; Merck Sharp and Dohme; AstraZeneca; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089349, P30AI051519, K23AI083088, R01AI087465] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp and Dohme(Merck & Company); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases (K23AI083088 to J.C.M.B.); Doris Duke Charitable Foundation (Clinical Scientist Development Awards to N.S.S. and N.R.G; ORACTA grant to G. H. F.); and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Statistical support was provided by the Center for AIDS Research (CFAR) of Albert Einstein College of Medicine/Montefiore Medical Center (P30 AI051519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The project described is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy and Infectious Diseases or the National Institutes of Health.; U.G. L. has no competing interests with respect to this study. He has consulted for GlaxoSmithKline, Boehringer Ingelheim, Merck Sharp and Dohme, and AstraZeneca) and has received financial support from these companies to attend research conferences. The current study, however, was not funded by these or any other pharmaceutical or device companies. None of the companies listed were involved in any part of the study's design, execution, or analysis and Dr. Lalloo's relationship with the listed companies does not affect the authors' adherence to any of PLoS One's policies on sharing data and materials. None of the other authors has any competing or potentially competing interests.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Chirenda J, 2009, 40 UN WORLD C LUNG H; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Lienhardt C, 2010, INT J TUBERC LUNG D, V14, P528; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; MOODLEY P, 2007, 47 INT C ANT AG CHEM; Munsiff SS, 2006, INT J TUBERC LUNG D, V10, P639; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; SALOMON N, 1995, CLIN INFECT DIS, V21, P1245, DOI 10.1093/clinids/21.5.1245; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; *USDA, 2009, DEV DRUGS TREAT MULT; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization (WHO), 2008, 4 WHOIUATLD; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; 2008, 2 M GLOB XDR TB TASK	24	32	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15841	10.1371/journal.pone.0015841	http://dx.doi.org/10.1371/journal.pone.0015841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253585	gold, Green Published, Green Submitted			2022-12-25	WOS:000286511900012
J	Wardle, DJ; Burgon, J; Sabroe, I; Bingle, CD; Whyte, MKB; Renshaw, SA				Wardle, David J.; Burgon, Joseph; Sabroe, Ian; Bingle, Colin D.; Whyte, Moira K. B.; Renshaw, Stephen A.			Effective Caspase Inhibition Blocks Neutrophil Apoptosis and Reveals Mcl-1 as Both a Regulator and a Target of Neutrophil Caspase Activation	PLOS ONE			English	Article							CELL-SURVIVAL; EXPRESSION; RESOLUTION; CLEAVAGE; INFLAMMATION; RECEPTOR; HYPOXIA; DEATH; LIPOPOLYSACCHARIDE; GRANULOCYTES	Human tissue inflammation is terminated, at least in part, by the death of inflammatory neutrophils by apoptosis. The regulation of this process is therefore key to understanding and manipulating inflammation resolution. Previous data have suggested that the short-lived pro-survival Bcl-2 family protein, Mcl-1, is instrumental in determining neutrophil lifespan. However, Mcl-1 can be cleaved following caspase activity, and the possibility therefore remains that the observed fall in Mcl-1 levels is due to caspase activity downstream of caspase activation, rather than being a key event initiating apoptosis in human neutrophils. We demonstrate that apoptosis in highly purified neutrophils can be almost completely abrogated by caspase inhibition with the highly effective di-peptide caspase inhibitor, Q-VD. OPh, confirming the caspase dependence of neutrophil apoptosis. Effective caspase inhibition does not prevent the observed fall in Mcl-1 levels early in ultrapure neutrophil culture, suggesting that this fall in Mcl-1 levels is not a consequence of neutrophil apoptosis. However, at later timepoints, declines in Mcl-1 can be reversed with effective caspase inhibition, suggesting that Mcl-1 is both an upstream regulator and a downstream target of caspase activity in human neutrophils.	[Wardle, David J.; Burgon, Joseph; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Sabroe, Ian; Bingle, Colin D.; Whyte, Moira K. B.; Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Wardle, DJ (corresponding author), Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England.	s.a.renshaw@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013; Renshaw, Steve/E-6192-2010	Sabroe, Ian/0000-0001-9750-8975; Renshaw, Steve/0000-0003-1790-1641; Bingle, Colin/0000-0002-5405-6988	Medical Research Council [G0701932]; MRC Centre [G0700091]; MRC [G0701932, G108/595] Funding Source: UKRI; Medical Research Council [G108/595] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council Senior Clinical Fellowship to SAR (reference number: G0701932), and by an MRC Centre grant (G0700091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Derouet M, 2006, J IMMUNOL, V176, P957, DOI 10.4049/jimmunol.176.2.957; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Edwards SW, 2004, BIOCHEM SOC T, V32, P489, DOI 10.1042/BST0320489; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Harter L, 2001, J TRAUMA, V50, P982; HASLETT C, 1985, AM J PATHOL, V119, P101; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Kato T, 2006, FEBS LETT, V580, P4582, DOI 10.1016/j.febslet.2006.07.034; Knepper-Nicolai B, 1998, J BIOL CHEM, V273, P30530, DOI 10.1074/jbc.273.46.30530; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Leuenroth SJ, 2000, SURGERY, V128, P171, DOI 10.1067/msy.2000.107609; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; LUO HR, 2007, AM J HEMATOL; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Mecklenburgh KI, 2002, BLOOD, V100, P3008, DOI 10.1182/blood-2002-02-0454; Michels J, 2004, ONCOGENE, V23, P4818, DOI 10.1038/sj.onc.1207648; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2; Rasband W., 2006, IMAGEJ; Renshaw SA, 2000, J LEUKOCYTE BIOL, V67, P662, DOI 10.1002/jlb.67.5.662; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Sambrook J, 1989, MOL CLONING LABORATO; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sunil VR, 2002, RESP RES, V3, DOI 10.1186/rr171; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Walmsley SR, 2004, BIOCHEM SOC T, V32, P456, DOI 10.1042/BST0320456; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Zhu D, 2006, P NATL ACAD SCI USA, V103, P14836, DOI 10.1073/pnas.0605722103; ANAL LOCATION DENSIT	39	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15768	10.1371/journal.pone.0015768	http://dx.doi.org/10.1371/journal.pone.0015768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253591	Green Accepted, Green Published, gold			2022-12-25	WOS:000286511900009
J	Bhatia, S; Fei, MJ; Yarlagadda, M; Qi, ZB; Akira, S; Saijo, S; Iwakura, Y; van Rooijen, N; Gibson, GA; St Croix, CM; Ray, A; Ray, P				Bhatia, Shikha; Fei, Mingjian; Yarlagadda, Manohar; Qi, Zengbiao; Akira, Shizuo; Saijo, Shinobu; Iwakura, Yoichiro; van Rooijen, Nico; Gibson, Gregory A.; St Croix, Claudette M.; Ray, Anuradha; Ray, Prabir			Rapid Host Defense against Aspergillus fumigatus Involves Alveolar Macrophages with a Predominance of Alternatively Activated Phenotype	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; CD4(+) T-CELLS; DENDRITIC CELLS; ALLERGIC INFLAMMATION; PNEUMOCYSTIS-CARINII; TYPE-2 INFLAMMATION; CANDIDA-ALBICANS; BINDING PROTEIN; INNATE IMMUNITY; TH2 RESPONSES	The ubiquitous fungus Aspergillus fumigatus is associated with chronic diseases such as invasive pulmonary aspergillosis in immunosuppressed patients and allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis or severe asthma. Because of constant exposure to this fungus, it is critical for the host to exercise an immediate and decisive immune response to clear fungal spores to ward off disease. In this study, we observed that rapidly after infection by A. fumigatus, alveolar macrophages predominantly express Arginase 1 (Arg1), a key marker of alternatively activated macrophages (AAMs). The macrophages were also found to express Ym1 and CD206 that are also expressed by AAMs but not NOS2, which is expressed by classically activated macrophages. The expression of Arg1 was reduced in the absence of the known signaling axis, IL-4R alpha/STAT6, for AAM development. While both Dectin-1 and TLR expressed on the cell surface have been shown to sense A. fumigatus, fungus-induced Arg1 expression in CD11c(+) alveolar macrophages was not dependent on either Dectin-1 or the adaptor MyD88 that mediates intracellular signaling by most TLRs. Alveolar macrophages from WT mice efficiently phagocytosed fungal conidia, but those from mice deficient in Dectin-1 showed impaired fungal uptake. Depletion of macrophages with clodronate-filled liposomes increased fungal burden in infected mice. Collectively, our studies suggest that alveolar macrophages, which predominantly acquire an AAM phenotype following A. fumigatus infection, have a protective role in defense against this fungus.	[Bhatia, Shikha; Fei, Mingjian; Yarlagadda, Manohar; Qi, Zengbiao; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Fei, Mingjian; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Akira, Shizuo] WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan; [Saijo, Shinobu; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Saijo, Shinobu; Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Med Ctr, Amsterdam, Netherlands; [Gibson, Gregory A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [St Croix, Claudette M.] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tokyo; Japan Science & Technology Agency (JST); Vrije Universiteit Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bhatia, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	rayp@pitt.edu	Iwakura, Yoichiro/E-5457-2011; Van Rooijen, Nico/Z-1578-2019; St Croix, Claudette/AAA-3338-2022; Akira, Shizuo/C-3134-2009	Iwakura, Yoichiro/0000-0002-9934-5775; 	U.S. National Institutes of Health [HL 084932, HL060207, AI 048927, HL 077430]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084932, R01HL060207, R01HL077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048927] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the U.S. National Institutes of Health grants HL 084932 (to A.R. and P.R.), HL060207 (to P.R.) and AI 048927 and HL 077430 (to A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Borsuk P, 1999, ACTA BIOCHIM POL, V46, P391, DOI 10.18388/abp.1999_4172; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Bowman JC, 2001, ANTIMICROB AGENTS CH, V45, P3474, DOI 10.1128/AAC.45.12.3474-3481.2001; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gibson PG, 2006, SEM RESP CRIT CARE M, V27, P185, DOI 10.1055/s-2006-939521; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herre J, 2004, CRIT REV IMMUNOL, V24, P193, DOI 10.1615/CritRevImmunol.v24.i3.30; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; MELGERT BN, 2009, AM J RESP CELL MOL B; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olszewska A, 2007, FUNGAL GENET BIOL, V44, P1285, DOI 10.1016/j.fgb.2007.07.001; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Park SJ, 2009, CLIN MICROBIOL REV, V22, P535, DOI 10.1128/CMR.00014-09; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; QIAN QF, 1994, J IMMUNOL, V152, P5000; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Ramaprakash H, 2009, INFECT IMMUN, V77, P108, DOI 10.1128/IAI.00998-08; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Stutz AM, 2003, J IMMUNOL, V170, P1789, DOI 10.4049/jimmunol.170.4.1789; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105; Zhang BC, 2009, J CELL BIOCHEM, V107, P134, DOI 10.1002/jcb.22110; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	71	75	76	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15943	10.1371/journal.pone.0015943	http://dx.doi.org/10.1371/journal.pone.0015943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246055	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000286511200026
J	Jung, J; Kim, HY; Kim, M; Sohn, K; Kim, M; Lee, K				Jung, J.; Kim, H. Y.; Kim, M.; Sohn, K.; Kim, M.; Lee, K.			Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src	ONCOGENE			English	Article						Na; K-ATPase; Src; TCTP; tumorigenesis	HISTAMINE-RELEASING FACTOR; NA,K-ATPASE ALPHA-SUBUNIT; GROWTH-FACTOR RECEPTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NA+/K+-ATPASE; PHOSPHATIDYLINOSITOL 3-KINASE; STIMULATES SYNTHESIS; SIGNAL-TRANSDUCTION; EGF RECEPTOR	Translationally controlled tumor protein (TCTP) is implicated in cell growth and malignant transformation. TCTP has been found to interact directly with the third cytoplasmic domain of the alpha subunit of Na, K-ATPase, but whether this interaction has a role in tumorigenesis is unclear. In this study, we examined TCTP-induced tumor progression signaling networks in human breast epithelial cells, using adenoviral infection. We found that TCTP (a) induces Src release from Na, K-ATPase alpha subunit and Src activation; (b) phosphorylates tyrosine residues 845, 992, 1086, 1148 and 1173 on anti-epidermal growth factor receptor (EGFR); (c) activates PI3K (phosphatidylinositol 3-kinase)-AKT, Ras-Raf-MEK-ERK1/2, Rac-PAK1/2, MKK3/6-p38 and phospholipase C (PLC)-gamma pathways; (d) enhances NADPH oxidase-dependent reactive oxygen species (ROS) generation; (e) stimulates cytoskeletal remodeling and cell motility and (f) upregulates matrix metalloproteinase (MMP) 3 and 13. These findings suggest that TCTP induces tumorigenesis through distinct multicellular signaling pathways involving Src-dependent EGFR transactivation, ROS generation and MMP expression. Oncogene (2011) 30, 2264-2274; doi:10.1038/onc.2010.604; published online 31 January 2011	[Jung, J.; Kim, H. Y.; Kim, M.; Sohn, K.; Kim, M.; Lee, K.] Ewha Womans Univ, Coll Pharm, Ctr Cell Signalling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University	Lee, K (corresponding author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signalling & Drug Discovery Res, Daehyun Dong 11-1, Seoul 120750, South Korea.	klyoon@ewha.ac.kr			Ministry for Health, Welfare Family Affairs [A090030]; Korean Government [2009-0064401]; MEST [R01-2007-000-20263-0]; Seoul RBD Program [ST090801]; MOST/KOSEF [R15-2006-020]	Ministry for Health, Welfare Family Affairs; Korean Government(Korean Government); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul RBD Program(Seoul RBD program); MOST/KOSEF(Korea Science and Engineering Foundation)	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs (A090030), NRF of Korea Grant funded by the Korean Government (2009-0064401), Mid-career Research Program through NRF grant funded by the MEST (R01-2007-000-20263-0), Seoul R&BD Program (ST090801) and the NCRC program of MOST/KOSEF (R15-2006-020).	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen JQ, 2006, BREAST CANCER RES TR, V96, P1, DOI 10.1007/s10549-005-9053-3; Cheon MS, 2008, BIOMED CHROMATOGR, V22, P1091, DOI 10.1002/bmc.1029; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Gnanasekar M, 2007, PARASITOL RES, V101, P1533, DOI 10.1007/s00436-007-0671-z; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haux J, 1999, MED HYPOTHESES, V53, P543, DOI 10.1054/mehy.1999.0985; Impola U, 2005, BRIT J DERMATOL, V152, P720, DOI 10.1111/j.1365-2133.2005.06447.x; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Jung J, 2006, CELL SIGNAL, V18, P2033, DOI 10.1016/j.cellsig.2006.03.014; Kim M, 2009, ARCH BIOCHEM BIOPHYS, V485, P82, DOI 10.1016/j.abb.2009.02.002; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Liu J, 2000, J BIOL CHEM, V275, P27838; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nagano-Ito M, 2009, FEBS LETT, V583, P1363, DOI 10.1016/j.febslet.2009.03.045; Nielsen HV, 1998, ALLERGY, V53, P642, DOI 10.1111/j.1398-9995.1998.tb03950.x; Oikawa K, 2002, BIOCHEM BIOPH RES CO, V290, P984, DOI 10.1006/bbrc.2001.6302; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Teshima S, 1998, J IMMUNOL, V161, P6356; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	45	43	45	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2011	30	19					2264	2274		10.1038/onc.2010.604	http://dx.doi.org/10.1038/onc.2010.604			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	762XD	21278788				2022-12-25	WOS:000290514600009
J	Liu, YS; Baker, JO; Zeng, YN; Himmel, ME; Haas, T; Ding, SY				Liu, Yu-San; Baker, John O.; Zeng, Yining; Himmel, Michael E.; Haas, Thomas; Ding, Shi-You			Cellobiohydrolase Hydrolyzes Crystalline Cellulose on Hydrophobic Faces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; ENZYMATIC-HYDROLYSIS; TRICHODERMA-REESEI; BACTERIAL CELLULOSE; BINDING MODULES; CELL-WALL; PHASE; VISUALIZATION; MICROFIBRILS; CELLULASES	Biodegradation of plant biomass is a slow process in nature, and hydrolysis of cellulose is also widely considered to be a rate-limiting step in the proposed industrial process of converting lignocellulosic materials to biofuels. It is generally known that a team of enzymes including endo-and exocellulases as well as cellobiases are required to act synergistically to hydrolyze cellulose to glucose. The detailed molecular mechanisms of these enzymes have yet to be convincingly elucidated. In this report, atomic force microscopy (AFM) is used to image in real-time the structural changes in Valonia cellulose crystals acted upon by the exocellulase cellobiohydrolase I (CBH I) from Trichoderma reesei. Under AFM, single enzyme molecules could be observed binding only to one face of the cellulose crystal, apparently the hydrophobic face. The surface roughness of cellulose began increasing after adding CBH I, and the overall size of cellulose crystals decreased during an 11-h period. Interestingly, this size reduction apparently occurred only in the width of the crystal, whereas the height remained relatively constant. In addition, the measured cross-section shape of cellulose crystal changed from asymmetric to nearly symmetric. These observed changes brought about by CBH I action may constitute the first direct visualization supporting the idea that the exocellulase selectively hydrolyzes the hydrophobic faces of cellulose. The limited accessibility of the hydrophobic faces in native cellulose may contribute significantly to the rate-limiting slowness of cellulose hydrolysis.	[Liu, Yu-San; Baker, John O.; Zeng, Yining; Himmel, Michael E.; Haas, Thomas; Ding, Shi-You] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Haas, Thomas; Ding, Shi-You] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Ding, SY (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	Shi.you.Ding@nrel.gov	DING, SHIYOU/ABD-8519-2021; Ding, Shi-You/O-1209-2013	DING, SHIYOU/0000-0002-1102-1507; Zeng, Yining/0000-0002-0202-2479	United States Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy; United States DOE Office of Science, Office of Biological and Environmental Research through the BioEnergy Science Center; DOE Bioenergy Research Center	United States Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); United States DOE Office of Science, Office of Biological and Environmental Research through the BioEnergy Science Center(United States Department of Energy (DOE)); DOE Bioenergy Research Center(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy, the Office of the Biomass Program for the work to develop enzymes, and the United States DOE Office of Science, Office of Biological and Environmental Research through the BioEnergy Science Center, a DOE Bioenergy Research Center, for the work on AFM visualization and analysis.	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; Baker AA, 2000, BIOPHYS J, V79, P1139, DOI 10.1016/S0006-3495(00)76367-3; BAKER JO, 1991, ACS SYM SER, V460, P313; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bohn A, 2000, MACROMOL CHEM PHYS, V201, P1913, DOI 10.1002/1521-3935(20001001)201:15<1913::AID-MACP1913>3.0.CO;2-U; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; CHANZY H, 1986, HOLZFORSCHUNG, V40, P25; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; ENARI TM, 1987, CRIT REV BIOTECHNOL, V5, P67, DOI 10.3109/07388558709044153; FAN LT, 1980, BIOTECHNOL BIOENG, V22, P177, DOI 10.1002/bit.260220113; Gardner K. H., 1971, J POLYM SCI C, V36, P327, DOI DOI 10.1002/POLC.5070360124; Helbert W, 2003, BIOMACROMOLECULES, V4, P481, DOI 10.1021/bm020076i; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 2003, POLYMER, V44, P1871, DOI 10.1016/S0032-3861(02)00861-3; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liu H, 2009, ENZYME MICROB TECH, V45, P274, DOI 10.1016/j.enzmictec.2009.06.009; Liu Y. S., 2010, P SPIE, V7571; Liu YS, 2009, CELLULOSE, V16, P587, DOI 10.1007/s10570-009-9306-0; Montanari S, 2005, MACROMOLECULES, V38, P1665, DOI 10.1021/ma048396c; Moran-Mirabal JN, 2008, BIOTECHNOL BIOENG, V101, P1129, DOI 10.1002/bit.21990; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Quirk A, 2010, LANGMUIR, V26, P5007, DOI 10.1021/la9037028; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Revol JF, 1982, CARBOHYD POLYM, V2, P123; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Xu Q, 2009, CELLULOSE, V16, P19, DOI 10.1007/s10570-008-9234-4	32	105	108	0	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11195	11201		10.1074/jbc.M110.216556	http://dx.doi.org/10.1074/jbc.M110.216556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21282110	Green Published, hybrid			2022-12-25	WOS:000288797100030
J	Wu, N; Zhao, XZ; Liu, M; Liu, HZ; Yao, WC; Zhang, YY; Cao, SS; Lin, XK				Wu, Ning; Zhao, Xiangzhong; Liu, Ming; Liu, Haizhou; Yao, Weicheng; Zhang, Yuyan; Cao, Shousong; Lin, Xiukun			Role of MicroRNA-26b in Glioma Development and Its Mediated Regulation on EphA2	PLOS ONE			English	Article							CELL VASCULOGENIC MIMICRY; PROTEIN-TYROSINE KINASES; OVEREXPRESSION; EXPRESSION; RECEPTOR; APOPTOSIS; PROLIFERATION; TUMORIGENESIS; SIGNATURES; TARGET	Background: MicroRNAs (miRNAs) are short, non-coding RNAs that regulate the expression of multiple target genes. Deregulation of miRNAs is common in human tumorigenesis. Low level expression of miR-26b has been found in glioma cells. However, its underlying mechanism of action has not been determined. Methodology/Principal Findings: Real-time PCR was employed to measure the expression level of miR-26b in glioma patients and cells. The level of miR-26b was inversely correlated with the grade of glioma. Ectopic expression of miR-26b inhibited the proliferation, migration and invasion of human glioma cells. A binding site for miR-26b was identified in the 3'UTR of EphA2. Over-expression of miR-26b in glioma cells repressed the endogenous level of EphA2 protein. Vasculogenic mimicry (VM) experiments were performed to further confirm the effects of miR-26b on the regulation of EphA2, and the results showed that miR-26b inhibited the VM processes which regulated by EphA2. Significance: This study demonstrated that miR-26b may act as a tumor suppressor in glioma and it directly regulates EphA2 expression. EphA2 is a direct target of miR-26b, and the down-regulation of EphA2 mediated by miR-26b is dependent on the binding of miR-26b to a specific response element of microRNA in the 3'UTR region of EphA2 mRNA.	[Wu, Ning; Zhao, Xiangzhong; Liu, Ming; Liu, Haizhou; Zhang, Yuyan; Lin, Xiukun] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Yao, Weicheng] Qingdao Med Univ, Inst Brain, Affiliated Hosp, Qingdao, Peoples R China; [Cao, Shousong] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Wu, Ning] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Roswell Park Cancer Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, N (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	shousong.cao@RoswellPark.org; linxiukun@yahoo.com		Lin, Xiukun/0000-0002-0306-4953	National High Technology 863 Program of China [2007AA091403, 200709Z408]; National Innovative Drug Development Programs of China [2009ZX09102-240, 2009ZX09103-661]; National Natural Science Foundation of China [81072065]	National High Technology 863 Program of China(National High Technology Research and Development Program of China); National Innovative Drug Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology 863 Program of China (Nos. 2007AA091403 and 200709Z408), National Innovative Drug Development Programs of China (Nos. 2009ZX09102-240 and 2009ZX09103-661) and National Natural Science Foundation of China (Nos. 81072065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten CIM, 2009, DIS COLON RECTUM, V52, P2028, DOI 10.1007/DCR.0b013e3181beb4ff; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Easty DJ, 2000, MELANOMA RES, V10, P401, DOI 10.1097/00008390-200010000-00001; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hess AR, 2007, DEV DYNAM, V236, P3283, DOI 10.1002/dvdy.21190; Hess AR, 2001, CANCER RES, V61, P3250; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamat AA, 2009, CANCER-AM CANCER SOC, V115, P2684, DOI 10.1002/cncr.24335; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Li X, 2007, TUMOR BIOL, V28, P165, DOI 10.1159/000103010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2008, CANCER BIOL THER, V7, P1098, DOI 10.4161/cbt.7.7.6168; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2002, CANCER RES, V62, P560; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wang JY, 2008, CANCER BIOL THER, V7, P758, DOI 10.4161/cbt.7.5.5765; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xu F, 2005, ANTICANCER RES, V25, P2943; Yue WY, 2005, J HISTOCHEM CYTOCHEM, V53, P997, DOI 10.1369/jhc.4A6521.2005; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang SW, 2007, CANCER LETT, V254, P157, DOI 10.1016/j.canlet.2006.12.036; Zhou ZM, 2008, SURG NEUROL, V70, P562, DOI 10.1016/j.surneu.2008.04.031	42	101	111	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2011	6	1							e16264	10.1371/journal.pone.0016264	http://dx.doi.org/10.1371/journal.pone.0016264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710MS	21264258	Green Submitted, gold, Green Published			2022-12-25	WOS:000286516500042
J	Ridgway, CL; Brage, S; Sharp, SJ; Corder, K; Westgate, KL; van Sluijs, EM; Goodyer, IM; Hallal, PC; Anderssen, SA; Sardinha, LB; Andersen, LB; Ekelund, U				Ridgway, Charlotte L.; Brage, Soren; Sharp, Stephen J.; Corder, Kirsten; Westgate, Kate L.; van Sluijs, Esther M.; Goodyer, Ian M.; Hallal, Pedro C.; Anderssen, Sigmund A.; Sardinha, Luis B.; Andersen, Lars Bo; Ekelund, Ulf			Does Birth Weight Influence Physical Activity in Youth? A Combined Analysis of Four Studies Using Objectively Measured Physical Activity	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; SEDENTARY BEHAVIOR; METABOLIC SYNDROME; RISK-FACTORS; CHILDREN; SIZE; LIFE; ASSOCIATIONS; DETERMINANTS; CHILDHOOD	Animal models suggest growth restriction in utero leads to lower levels of motor activity. Furthermore, individuals with very low birth weight report lower levels of physical activity as adults. The aim of this study was to examine whether birth weight acts as a biological determinant of physical activity and sedentary time. This study uses combined analysis of three European cohorts and one from South America (n = 4,170). Birth weight was measured or parentally reported. Height and weight were measured and used to calculate Body Mass Index (BMI). PA was objectively measured using accelerometry for >= 3 days, >= 10 hours day. Data was standardized to allow comparisons between different monitors. Total physical activity was assessed as counts per minute (cpm), with time spent above moderate activity (MVPA) > 2,000 counts and time spent sedentary (<100 counts). There was no evidence for an association between birth weight and total physical activity (p = 0.9) or MVPA (p = 0.7). Overall there was no evidence for an association between birth weight and sedentary time (p = 0.8). However in the Pelotas study we did find an association between higher birth weight (kg) and lower overall physical activity (cpm) (beta = -31, 95%CI: -58, -46, p = 0.03) and higher birth weight and greater sedentary time (mins/day) (beta = 16.4, 95%CI: 5.3, 27.5, p = 0.004), although this was attenuated and no longer significant with further adjustment for gestational age. Overall this combined analysis suggests that birth weight may not be an important biological determinant of habitual physical activity or sedentary behaviour in children and adolescents.	[Ridgway, Charlotte L.; Brage, Soren; Sharp, Stephen J.; Corder, Kirsten; Westgate, Kate L.; van Sluijs, Esther M.; Ekelund, Ulf] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Goodyer, Ian M.] Univ Cambridge, Cambridge, England; [Hallal, Pedro C.] Univ Fed Pelotas, Pelotas, Brazil; [Anderssen, Sigmund A.; Andersen, Lars Bo] Norwegian Sch Sports Sci, Dept Sports Med, Oslo, Norway; [Sardinha, Luis B.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, P-1499002 Lisbon, Portugal; [Andersen, Lars Bo] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	University of Cambridge; University of Cambridge; Universidade Federal de Pelotas; Norwegian School of Sport Sciences; Universidade de Lisboa; University of Southern Denmark	Ridgway, CL (corresponding author), Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	ulf.ekelund@mrc-epid.cam.ac.uk	Hallal, Pedro C/A-3249-2011; Ekelund, Ulf/AAE-8471-2019; Sardinha, Luís B./ABG-5389-2020; Ridgway, Charlotte/H-4378-2013; Brage, Soren/C-6415-2013; Curtis, Charlotte/AAV-1156-2020; Sardinha, Luís Bettencourt/F-2641-2013	Hallal, Pedro C/0000-0003-1470-6461; Ekelund, Ulf/0000-0003-2115-9267; Sardinha, Luís B./0000-0002-6230-6027; Ridgway, Charlotte/0000-0002-1022-3887; Brage, Soren/0000-0002-1265-7355; Curtis, Charlotte/0000-0002-1022-3887; Sardinha, Luís Bettencourt/0000-0002-6230-6027; van Sluijs, Esther/0000-0001-9141-9082; Westgate, Kate/0000-0002-0283-3562	Danish Heart Foundation; Danish Medical Research Council Health Foundation; Danish Council for Sports Research; Foundation in Memory of Asta Florida Bolding Renee Andersen; Faculty of Health Sciences; University of Southern Denmark; Estonian Science Foundation [3277, 5209]; Norwegian Council of Cardiovascular Diseases; Eckbo Legacy; European Social Fund; Wellcome Trust; NIHR; National Prevention Research Initiative, UK; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474, MC_U106179473] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_U106179474, MC_U106179473] Funding Source: researchfish; National Institute for Health Research [97/29/01, 06/05/01] Funding Source: researchfish	Danish Heart Foundation; Danish Medical Research Council Health Foundation(Danish Medical Research Council); Danish Council for Sports Research; Foundation in Memory of Asta Florida Bolding Renee Andersen; Faculty of Health Sciences(European Commission); University of Southern Denmark; Estonian Science Foundation; Norwegian Council of Cardiovascular Diseases; Eckbo Legacy; European Social Fund(European Social Fund (ESF)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR(National Institute for Health Research (NIHR)); National Prevention Research Initiative, UK; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The EYHS was Supported by grants from the Danish Heart Foundation, the Danish Medical Research Council Health Foundation, the Danish Council for Sports Research, the Foundation in Memory of Asta Florida Bolding Renee Andersen, the Faculty of Health Sciences, the University of Southern Denmark, the Estonian Science Foundation (grant nos. 3277 and 5209), the Norwegian Council of Cardiovascular Diseases, the Eckbo Legacy, and the European Social Fund. The Pelotas study was funded by grants from the Wellcome Trust. The ROOTS study was funded by the The Wellcome Trust and NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC, for Cambridgeshire & Peterborough). The SPEEDY study was funded by grants from the National Prevention Research Initiative, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Barker DJP, 1998, MOTHERS BABIES HLTH; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Boreham CA, 2001, PUBLIC HEALTH, V115, P373; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Corder K, 2005, MED SCI SPORT EXER, V37, P1761, DOI 10.1249/01.mss.0000176466.78408.cc; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Corder K, 2007, J SPORT SCI, V25, P1607, DOI 10.1080/02640410701283841; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Frontini Maria G, 2004, BMC Pediatr, V4, P22, DOI 10.1186/1471-2431-4-22; GOODYER IM, 2009, INT J EPIDEMIOL, V8, P8; Hallal PC, 2006, BMJ-BRIT MED J, V332, P1002, DOI 10.1136/bmj.38776.434560.7C; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; KAJANTIE E, 2010, J PEDIAT, P19; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P411, DOI 10.1007/s10654-008-9259-x; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; Murdey ID, 2004, ANN HUM BIOL, V31, P75, DOI 10.1080/03014460310001636589; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; YLIHARSILA H, 2007, INT J OBES LOND	36	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16125	10.1371/journal.pone.0016125	http://dx.doi.org/10.1371/journal.pone.0016125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264270	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000286514300007
J	Takeuchi, H; Yokota, A; Ohoka, Y; Iwata, M				Takeuchi, Hajime; Yokota, Aya; Ohoka, Yoshiharu; Iwata, Makoto			Cyp26b1 Regulates Retinoic Acid-Dependent Signals in T Cells and Its Expression Is Inhibited by Transforming Growth Factor-beta	PLOS ONE			English	Article							TGF-BETA; DENDRITIC CELLS; METABOLIZING ENZYME; HUMAN CYTOCHROME-P450; RESPONSE ELEMENTS; DIFFERENTIATION; IDENTIFICATION; 4-HYDROXYLASE; ACTIVATION; GENERATION	Background: The vitamin A metabolite, retinoic acid (RA), plays important roles in the regulation of lymphocyte properties. Dendritic cells in gut-related lymphoid organs can produce RA, thereby imprinting gut-homing specificity on T cells and enhancing transforming growth factor (TGF)-beta-dependent induction of Foxp3(+) regulatory T cells upon antigen presentation. In general, RA concentrations in cells and tissues are regulated by its degradation as well. However, it remained unclear if T cells could actively catabolize RA. Methodology/Principal Findings: We assessed the expression of known RA-catabolizing enzymes in T cells from mouse lymphoid tissues. Antigen-experienced CD44(+) T cells in gut-related lymphoid organs selectively expressed Cyp26b1, a member of the cytochrome P450 family 26. However, T cells in the spleen or skin-draining lymph nodes did not significantly express Cyp26b1. Accordingly, physiological levels of RA (1-10 nM) could induce Cyp26b1 expression in naive T cells upon activation in vitro, but could not do so in the presence of TGF-beta. Overexpression of Cyp26b1 significantly suppressed the RA effect to induce expression of the gut-homing receptor CCR9 on T cells. On the other hand, knocking down Cyp26b1 gene expression with small interfering RNA or inhibiting CYP26 enzymatic activity led to enhancement of the RA-induced CCR9 expression. Conclusions/Significance: Our data demonstrate a role for CYP26B1 in regulating RA-dependent signals in activated T cells but not during TGF-beta-dependent differentiation to Foxp3(+) regulatory T cells. Aberrant expression of CYP26B1 may disturb T cell trafficking and differentiation in the gut and its related lymphoid organs.	[Takeuchi, Hajime; Yokota, Aya; Ohoka, Yoshiharu; Iwata, Makoto] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biodef Res, Sanuki, Japan; [Takeuchi, Hajime; Yokota, Aya; Ohoka, Yoshiharu; Iwata, Makoto] CREST, Japan Sci & Technol Agcy, Tokyo, Japan	Tokushima Bunri University; Japan Science & Technology Agency (JST)	Takeuchi, H (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Biodef Res, Kagawa Campus, Sanuki, Japan.	takeuchih@kph.bunri-u.ac.jp; iwatam@kph.bunri-u.ac.jp	Miyakawa, Tsuyoshi/A-7741-2008; Takao, Keizo/B-9527-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Takao, Keizo/0000-0002-4734-3583	Japan Society for the Promotion of Science; Japanese Ministry of Education, Culture, Sports, Science and Technology; Long-Range Research Initiative of Japan Chemical Industry Association; Skylark Food Science Institute, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Long-Range Research Initiative of Japan Chemical Industry Association; Skylark Food Science Institute, Japan	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and from the Japanese Ministry of Education, Culture, Sports, Science and Technology, The Long-Range Research Initiative of Japan Chemical Industry Association, and The Skylark Food Science Institute, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; BRUYNSEELS J, 1990, PROSTATE, V16, P345, DOI 10.1002/pros.2990160409; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MAHMOOD R, 1992, DEVELOPMENT, V115, P67; MAHMOOD R, 1995, ANAT EMBRYOL, V192, P21; Marchetti MN, 1997, DRUG METAB DISPOS, V25, P637; Marikar Y, 1998, J INVEST DERMATOL, V111, P434, DOI 10.1046/j.1523-1747.1998.00297.x; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; NUGENT P, 1995, EXP CELL RES, V220, P495, DOI 10.1006/excr.1995.1341; NUGENT P, 1994, DIFFERENTIATION, V58, P149; OHOKA Y, 2011, J IMMUNOL IN PRESS; Ozpolat B, 2002, AM J HEMATOL, V70, P39, DOI 10.1002/ajh.10099; Papadakis KA, 2001, GASTROENTEROLOGY, V121, P246, DOI 10.1053/gast.2001.27154; Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tahayato A, 2003, GENE EXPR PATTERNS, V3, P449, DOI 10.1016/S1567-133X(03)00066-8; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Takeuchi H, 2010, J IMMUNOL, V185, P5289, DOI 10.4049/jimmunol.1000101; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	46	42	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2011	6	1							e16089	10.1371/journal.pone.0016089	http://dx.doi.org/10.1371/journal.pone.0016089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LJ	21249211	Green Published, Green Submitted, gold			2022-12-25	WOS:000286512900022
J	Bhattacharjee, PS; Huq, TS; Mandal, TK; Graves, RA; Muniruzzaman, S; Clement, C; McFerrin, HE; Hill, JM				Bhattacharjee, Partha S.; Huq, Tashfin S.; Mandal, Tarun K.; Graves, Richard A.; Muniruzzaman, Syed; Clement, Christian; McFerrin, Harris E.; Hill, James M.			A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis	PLOS ONE			English	Article							HEPARIN-BINDING-SITES; E MIMETIC PEPTIDE; NITRIC-OXIDE; CELL-MIGRATION; IN-VITRO; RECEPTOR; KINASE; SRC; LIPOPROTEIN; ACTIVATION	Angiogenesis is a hallmark of tumor development and metastasis and now a validated target for cancer treatment. We previously reported that a novel dimer peptide (apoEdp) derived from the receptor binding region of human apolipoprotein E (apoE) inhibits virus-induced angiogenesis. However, its role in tumor anti-angiogenesis is unknown. This study demonstrates that apoEdp has anti-angiogenic property in vivo through reduction of tumor growth in a mouse model and ocular angiogenesis in a rabbit eye model. Our in vitro studies show that apoEdp inhibits human umbilical vein endothelial cell proliferation, migration, invasion and capillary tube formation. We document that apoEdp inhibits vascular endothelial growth factor-induced Flk-1 activation as well as downstream signaling pathways that involve c-Src, Akt, eNOS, FAK, and ERK1/2. These in vitro data suggest potential sites of the apoE dipeptide inhibition that could occur in vivo. This is the first evidence that a synthetic dimer peptide mimicking human apoE has anti-angiogenesis functions and could be an anti-tumor drug candidate.	[Bhattacharjee, Partha S.; Huq, Tashfin S.; Muniruzzaman, Syed; McFerrin, Harris E.] Xavier Univ, Dept Biol, New Orleans, LA 70125 USA; [Bhattacharjee, Partha S.; Clement, Christian; Hill, James M.] Louisiana State Univ, Dept Ophthalmol, Hlth Sci Ctr, New Orleans, LA USA; [Mandal, Tarun K.; Graves, Richard A.] Xavier Univ, Coll Pharm, New Orleans, LA 70125 USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Dept Microbiol Immunol & Parasitol, Ctr Neurosci, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Dept Pharmacol, Hlth Sci Ctr, New Orleans, LA USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bhattacharjee, PS (corresponding author), Xavier Univ, Dept Biol, New Orleans, LA 70125 USA.	jhill@lsuhsc.edu		Mandal, Tarun/0000-0002-4966-2094	National Institutes of Health (NIH) [EY019144, EY006311, EY02377]; Louisiana Cancer Research Consortium; Xavier University of Louisiana Center for Undergraduate Research; Model Institutions for Excellence (MIE)-Science, Technology, Engineering and Mathematics (STEM); Louisiana Board of Regents, RC/EEP [07-10]; LSU Health Sciences Center; Research to Prevent Blindness; Senior Scientific Investigator Award; Research to Prevent Blindness, New York, New York; Louisiana Lions Eye Foundation, New Orleans, Louisian; Louisiana Board of Regents; Lions International, United States of America; NATIONAL EYE INSTITUTE [R21EY019144, P30EY002377, R01EY006311] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Consortium; Xavier University of Louisiana Center for Undergraduate Research; Model Institutions for Excellence (MIE)-Science, Technology, Engineering and Mathematics (STEM); Louisiana Board of Regents, RC/EEP; LSU Health Sciences Center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Senior Scientific Investigator Award; Research to Prevent Blindness, New York, New York(Research to Prevent Blindness (RPB)); Louisiana Lions Eye Foundation, New Orleans, Louisian; Louisiana Board of Regents; Lions International, United States of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) grants EY019144 (PSB, partial salary; TSH, some supplies, mice purchase and boarding), Louisiana Cancer Research Consortium (PSB, HEM, partial salary; PSB, HEM, TSH, some supplies and mice), Xavier University of Louisiana Center for Undergraduate Research (PSB, partial salary), Model Institutions for Excellence (MIE)-Science, Technology, Engineering and Mathematics (STEM) faculty mini-grants (PSB, supplies), Louisiana Board of Regents, RC/EEP (07-10) (TKM, production of VEGF pellet), NIH grants EY006311 (JMH, partial salaries JMH and CC, some supplies, and rabbit purchase and boarding), and EY02377 (Louisiana State University (LSU) Eye Center Core Grant for Vision Research, partial salary for editorial consultant and statistical analysis), an unrestricted research grant from LSU Health Sciences Center (JMH, some supplies), a Research to Prevent Blindness (RPB) Senior Scientific Investigator Award (JMH, supplies and the apoE dipeptide), an unrestricted grant from Research to Prevent Blindness, New York, New York, to the LSU Eye Center (partial salary for editorial consultant, graphics, and statistical analysis), Louisiana Lions Eye Foundation, New Orleans, Louisiana (part of supplies and rabbit board), Vaccine Center and the South Louisiana Institute for Infectious Disease Research sponsored by the Louisiana Board of Regents (partial salary JMH), and Lions International, United States of America (partial cost of supplies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhattacharjee PS, 2008, INVEST OPHTH VIS SCI, V49, P4263, DOI 10.1167/iovs.08-2077; Bhattacharjee PS, 2009, CURR EYE RES, V34, P99, DOI 10.1080/02713680802647662; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Dredge K, 2010, INVEST NEW DRUG, V28, P276, DOI 10.1007/s10637-009-9245-5; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Fairweather JK, 2008, BIOORGAN MED CHEM, V16, P699, DOI 10.1016/j.bmc.2007.10.044; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Herbst Roy S, 2006, Expert Opin Emerg Drugs, V11, P635, DOI 10.1517/14728214.11.4.635; Hill JM, 2007, EXP EYE RES, V84, P801, DOI 10.1016/j.exer.2006.08.001; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; Huang YD, 2010, CURR OPIN LIPIDOL, V21, P337, DOI 10.1097/MOL.0b013e32833af368; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kelly BA, 2007, FEBS J, V274, P4511, DOI 10.1111/j.1742-4658.2007.05981.x; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim JS, 2003, J BIOL CHEM, V278, P29000, DOI 10.1074/jbc.M301042200; Lee TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009945; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MARZ W, 1993, FEBS LETT, V325, P271, DOI 10.1016/0014-5793(93)81087-G; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Presta M, 2003, CURR PHARM DESIGN, V9, P553, DOI 10.2174/1381612033391379; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schulter V, 2001, ARTERIOSCL THROM VAS, V21, P433, DOI 10.1161/01.ATV.21.3.433; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Su L, 2010, BIOCHEM BIOPH RES CO, V396, P1012, DOI 10.1016/j.bbrc.2010.05.048; Thomas JP, 2003, J CLIN ONCOL, V21, P223, DOI 10.1200/JCO.2003.12.120; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Wegrowski Y, 2004, CRIT REV ONCOL HEMAT, V49, P259, DOI 10.1016/j.critrevonc.2003.10.005; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yi T, 2008, CANCER RES, V68, P1843, DOI 10.1158/0008-5472.CAN-07-5944; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120	53	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15905	10.1371/journal.pone.0015905	http://dx.doi.org/10.1371/journal.pone.0015905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253017	Green Submitted, gold, Green Published			2022-12-25	WOS:000286511900020
J	Budkowska, A; Kakkanas, A; Nerrienet, E; Kalinina, O; Maillard, P; Horm, SV; Dalagiorgou, G; Vassilaki, N; Georgopoulou, U; Martinot, M; Sall, AA; Mavromara, P				Budkowska, Agata; Kakkanas, Athanassios; Nerrienet, Eric; Kalinina, Olga; Maillard, Patrick; Horm, Srey Viseth; Dalagiorgou, Geena; Vassilaki, Niki; Georgopoulou, Urania; Martinot, Michelle; Sall, Amadou Alpha; Mavromara, Penelope			Synonymous Mutations in the Core Gene Are Linked to Unusual Serological Profile in Hepatitis C Virus Infection	PLOS ONE			English	Article							OPEN READING FRAME; F-PROTEIN; MOLECULAR-BIOLOGY; IMMUNOBLOT ASSAY; MAMMALIAN-CELLS; EXPRESSION; TRANSLATION; GENOME; REGION; SEQUENCES	The biological role of the protein encoded by the alternative open reading frame (core+1/ARF) of the Hepatitis C virus (HCV) genome remains elusive, as does the significance of the production of corresponding antibodies in HCV infection. We investigated the prevalence of anti-core and anti-core+1/ARFP antibodies in HCV-positive blood donors from Cambodia, using peptide and recombinant protein-based ELISAs. We detected unusual serological profiles in 3 out of 58 HCV positive plasma of genotype 1a. These patients were negative for anti-core antibodies by commercial and peptide-based assays using C-terminal fragments of core but reacted by Western Blot with full-length core protein. All three patients had high levels of anti-core+1/ARFP antibodies. Cloning of the cDNA that corresponds to the core-coding region from these sera resulted in the expression of both core and core+1/ARFP in mammalian cells. The core protein exhibited high amino-acid homology with a consensus HCV1a sequence. However, 10 identical synonymous mutations were found, and 7 were located in the aa(99-124) region of core. All mutations concerned the third base of a codon, and 5/10 represented a T>C mutation. Prediction analyses of the RNA secondary structure revealed conformational changes within the stem-loop region that contains the core+1/ARFP internal AUG initiator at position 85/87. Using the luciferase tagging approach, we showed that core+1/ARFP expression is more efficient from such a sequence than from the prototype HCV1a RNA. We provide additional evidence of the existence of core+1/ARFP in vivo and new data concerning expression of HCV core protein. We show that HCV patients who do not produce normal anti-core antibodies have unusually high levels of antit-core+1/ARFP and harbour several identical synonymous mutations in the core and core+1/ARFP coding region that result in major changes in predicted RNA structure. Such HCV variants may favour core+1/ARFP production during HCV infection.	[Budkowska, Agata; Maillard, Patrick] Inst Pasteur, CNRS, URA 3015, Paris, France; [Kakkanas, Athanassios; Dalagiorgou, Geena; Vassilaki, Niki; Georgopoulou, Urania; Mavromara, Penelope] Hellenic Pasteur Inst, Mol Virol Lab, Athens, Greece; [Nerrienet, Eric; Horm, Srey Viseth] Pasteur Inst Cambodia, Virol Lab, Phnom Penh, Cambodia; [Kalinina, Olga] Pasteur Inst St Petersburg, Mol Microbiol Virol Lab, St Petersburg, Russia; [Martinot, Michelle] Univ Paris 07, INSERM, Hop Beaujon, U773,Ctr Rech Biomed Bichat Beaujon CRB3, Clichy, France; [Sall, Amadou Alpha] Pasteur Inst Dakar, Dakar, Senegal	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Saint-Petersburg Pasteur Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Budkowska, A (corresponding author), Inst Pasteur, CNRS, URA 3015, Paris, France.	agata.budkowska@pasteur.fr	Georgopoulou, Urania/AAQ-3831-2020; Kalinina, Olga/L-1822-2017; Kakkanas, Athanassios/AAQ-5185-2020; Kalinina, Olga V/M-8482-2016	Kalinina, Olga/0000-0003-1916-5705; Kalinina, Olga V/0000-0002-9445-477X	Institut Pasteur, Paris, France [126]; "Agence Nationale de Recherche sur le SIDA et les Hepatites Virales" (ANRS)	Institut Pasteur, Paris, France; "Agence Nationale de Recherche sur le SIDA et les Hepatites Virales" (ANRS)(ANRSFrench National Research Agency (ANR))	This work was supported by the Transversal Project (PTR#126) from Institut Pasteur, Paris, France. Olga Kalinina was granted a fellowship from the "Agence Nationale de Recherche sur le SIDA et les Hepatites Virales" (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Baril M, 2005, NUCLEIC ACIDS RES, V33, P1474, DOI 10.1093/nar/gki292; Basu A, 2004, J GEN VIROL, V85, P2299, DOI 10.1099/vir.0.80028-0; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; BOUMLIC A, FEBS J, V277, P774; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chuang WCM, 2008, J GEN VIROL, V89, P1890, DOI 10.1099/vir.0.83677-0; Cohen M, 2007, DIGEST DIS SCI, V52, P2427, DOI 10.1007/s10620-006-9630-2; Eng FJ, 2009, J VIROL, V83, P3104, DOI 10.1128/JVI.01679-08; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fiorucci M, 2007, J GEN VIROL, V88, P1149, DOI 10.1099/vir.0.82575-0; Goymer P, 2007, NAT REV GENET, V8, P92, DOI 10.1038/nrg2056; IMBERTI L, 1991, J VIROL METHODS, V34, P233, DOI 10.1016/0166-0934(91)90103-7; Irshad M, 2006, MED PRIN PRACT, V15, P405, DOI 10.1159/000095485; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Lohmann Volker, 2009, V510, P145, DOI 10.1007/978-1-59745-394-3_11; Martin P, 1998, J CLIN MICROBIOL, V36, P387, DOI 10.1128/JCM.36.2.387-390.1998; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Morice Y, 2009, HEPATOLOGY, V49, P1449, DOI 10.1002/hep.22821; Nagasaka A, 1996, J MED VIROL, V49, P91, DOI 10.1002/(SICI)1096-9071(199606)49:2<91::AID-JMV4>3.0.CO;2-E; OKAMOTO H, 1990, JPN J EXP MED, V60, P167; PAWLOTSKY JM, 1995, J CLIN MICROBIOL, V33, P1357, DOI 10.1128/JCM.33.5.1357-1359.1995; Ratinier M, 2008, J GEN VIROL, V89, P1569, DOI 10.1099/vir.0.83614-0; Roussel J, 2003, J GEN VIROL, V84, P1751, DOI 10.1099/vir.0.19065-0; Shao SW, 2009, HEPATOL RES, V39, P282, DOI 10.1111/j.1872-034X.2008.00452.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Troesch M, 2005, AIDS, V19, P775, DOI 10.1097/01.aids.0000168971.57681.6e; Tsao ML, 2006, BIOCHEM BIOPH RES CO, V348, P271, DOI 10.1016/j.bbrc.2006.07.062; Tsitoura P, 2007, FEBS LETT, V581, P4049, DOI 10.1016/j.febslet.2007.07.032; Varaklioti A, 2002, J BIOL CHEM, V277, P17713, DOI 10.1074/jbc.M201722200; Vassilaki N, 2003, J BIOL CHEM, V278, P40503, DOI 10.1074/jbc.M305504200; Vassilaki N, 2008, VIRUS RES, V133, P123, DOI 10.1016/j.virusres.2007.10.019; Vassilaki N, 2007, FEBS J, V274, P4057, DOI 10.1111/j.1742-4658.2007.05929.x; Vassilaki N, 2009, IUBMB LIFE, V61, P739, DOI 10.1002/iub.201; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Wu WB, 2007, INTERVIROLOGY, V50, P341, DOI 10.1159/000107271; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yeh CT, 1997, J GEN VIROL, V78, P2761, DOI 10.1099/0022-1317-78-11-2761; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08	43	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15871	10.1371/journal.pone.0015871	http://dx.doi.org/10.1371/journal.pone.0015871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21283512	Green Published, gold			2022-12-25	WOS:000286511900019
J	Wegmann, F; Krashias, G; Luhn, K; Laamanen, K; Vieira, S; Jeffs, SA; Shattock, RJ; Sattentau, QJ				Wegmann, Frank; Krashias, George; Luehn, Kerstin; Laamanen, Karoliina; Vieira, Sueli; Jeffs, Simon A.; Shattock, Robin J.; Sattentau, Quentin J.			A Novel Strategy for Inducing Enhanced Mucosal HIV-1 Antibody Responses in an Anti-Inflammatory Environment	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GENITAL-TRACT; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; PRO-2000 GEL; IN-VIVO; TYPE-1; TRANSMISSION; CELLS; IMMUNIZATION	Prophylactic vaccination against HIV-1 sexual transmission will probably require antibody elicitation at genital mucosal surfaces. However, HIV-1 envelope glycoprotein (Env)-based antigens are weakly immunogenic, particularly when applied mucosally. The polyanion PRO 2000 is safe for human vaginal application, and thus may represent a potential formulating agent for vaginal delivery of experimental vaccine immunogens. Based upon its biochemical properties, we hypothesized that PRO 2000 might enhance mucosal immunogenicity of HIV-1 envelope glycoprotein (Env)-based antigens, promoting local and systemic immune responses. Vaginal immunization with Env-PRO 2000 resulted in significantly increased titres of Env-specific mucosal IgA and IgG in mice and rabbits, respectively, compared to Env alone, revealing modest but significant mucosal adjuvant activity for PRO 2000. In vitro, PRO 2000 associated with Env, protecting the glycoprotein from proteolytic degradation in human vaginal lavage. Unexpectedly, PRO 2000 antagonized TLR4 activation, suppressing local production of inflammatory cytokines. Since inflammation-mediated recruitment of viral target cells is a major risk factor in HIV-1 transmission, the immune modulatory and anti-inflammatory activities of PRO 2000 combined with its intravaginal safety profile suggests promise as an HIV-1 mucosal vaccine formulating agent.	[Wegmann, Frank; Krashias, George; Laamanen, Karoliina; Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Luehn, Kerstin] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Vieira, Sueli; Jeffs, Simon A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Jefferiss Trust Res Labs, London, England; [Shattock, Robin J.] Univ London, Ctr Infect, London, England	University of Oxford; University of Oxford; Imperial College London; University of London	Wegmann, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	frank.wegmann@path.ox.ac.uk		Wegmann, Frank/0000-0002-9821-1492	Bill and Melinda Gates Foundation [37872]; Wellcome Trust through the Grand Challenges in Global Health initiative [077384]; European Union Network of Excellence; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium; Fondation Dormeur and the Microbicide Development Programme (MDP); Bodossaki Foundation; Medical Research Council [G0000635] Funding Source: researchfish; MRC [G0000635] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust through the Grand Challenges in Global Health initiative(Wellcome Trust); European Union Network of Excellence(European Commission); International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium; Fondation Dormeur and the Microbicide Development Programme (MDP); Bodossaki Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was primarily funded by a grant to St George's, University of London, from the Bill and Melinda Gates Foundation (ref. 37872) and the Wellcome Trust (ref. 077384), through the Grand Challenges in Global Health initiative. The authors also acknowledge support from The European Union Network of Excellence 'EUROPRISE', The International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Consortium, Fondation Dormeur and the Microbicide Development Programme (MDP). QJS is a Jenner Institute Investigator and GK was supported by the Bodossaki Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AW, 2007, IMMUNOL LETT, V110, P1, DOI 10.1016/j.imlet.2007.02.012; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brandtzaeg P, 1997, J REPROD IMMUNOL, V36, P23, DOI 10.1016/S0165-0378(97)00061-2; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Haynes BF, 2008, J ALLERGY CLIN IMMUN, V122, P3, DOI 10.1016/j.jaci.2008.03.036; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Imaoka K, 1998, J IMMUNOL, V161, P5952; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Johansson EL, 1998, INFECT IMMUN, V66, P514, DOI 10.1128/IAI.66.2.514-520.1998; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lacey CJN, 2006, AIDS, V20, P1027, DOI 10.1097/01.aids.0000222075.83490.ca; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mayer KH, 2003, AIDS, V17, P321, DOI 10.1097/00002030-200302140-00005; MCCORMACK S, 2010, LANCET, P17; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; ROEHR B, 2009, BMJ, V18; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Spirig R, 2008, J IMMUNOL, V181, P878, DOI 10.4049/jimmunol.181.2.878; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Takahashi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2358, DOI 10.1271/bbb.70142; Teleshova N, 2008, ANTIMICROB AGENTS CH, V52, P1751, DOI 10.1128/AAC.00707-07; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yip HC, 1999, J IMMUNOL, V162, P3942; Zariffard MR, 2005, J INFECT DIS, V191, P1913, DOI 10.1086/429922; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu Y, 2003, BBA-BIOMEMBRANES, V1611, P234, DOI 10.1016/S0005-2736(03)00060-9	56	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15861	10.1371/journal.pone.0015861	http://dx.doi.org/10.1371/journal.pone.0015861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21253014	Green Published, gold			2022-12-25	WOS:000286511900016
J	Peters, KM; Brooks, BE; Schumacher, MA; Skurray, RA; Brennan, RG; Brown, MH				Peters, Kate M.; Brooks, Benjamin E.; Schumacher, Maria A.; Skurray, Ronald A.; Brennan, Richard G.; Brown, Melissa H.			A Single Acidic Residue Can Guide Binding Site Selection but Does Not Govern QacR Cationic-Drug Affinity	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; TRANSCRIPTIONAL REGULATOR; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURES; CONFORMATIONAL-CHANGE; COMPLEXES REVEAL; STRUCTURAL BASIS; LIGAND-BINDING; TETR FAMILY; DNA-BINDING	Structures of the multidrug-binding repressor protein QacR with monovalent and bivalent cationic drugs revealed that the carboxylate side-chains of E90 and E120 were proximal to the positively charged nitrogens of the ligands ethidium, malachite green and rhodamine 6G, and therefore may contribute to drug neutralization and binding affinity. Here, we report structural, biochemical and in vivo effects of substituting these glutamate residues. Unexpectedly, substitutions had little impact on ligand affinity or in vivo induction capabilities. Structures of QacR(E90Q) and QacR(E120Q) with ethidium or malachite green took similar global conformations that differed significantly from all previously described QacR-drug complexes but still prohibited binding to cognate DNA. Strikingly, the QacR(E90Q)-rhodamine 6G complex revealed two mutually exclusive rhodamine 6G binding sites. Despite multiple structural changes, all drug binding was essentially isoenergetic. Thus, these data strongly suggest that rather than contributing significantly to ligand binding affinity, the role of acidic residues lining the QacR multidrug-binding pocket is primarily to attract and guide cationic drugs to the "best available'' positions within the pocket that elicit QacR induction.	[Peters, Kate M.; Skurray, Ronald A.; Brown, Melissa H.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Brooks, Benjamin E.; Schumacher, Maria A.; Brennan, Richard G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Brown, Melissa H.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	University of Sydney; University of Texas System; UTMD Anderson Cancer Center; Flinders University South Australia	Peters, KM (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	rgbrenna@mdanderson.org; melissa.brown@flinders.edu.au	Giampietro, Vincent P/D-1279-2011; Williams, Steve/D-6979-2011; Brown, Melissa/V-2296-2017; Uher, Rudolf/A-5477-2008	Giampietro, Vincent P/0000-0002-9381-8201; Williams, Steve/0000-0003-4299-1941; Treasure, Janet/0000-0003-0871-4596; Brown, Melissa/0000-0001-6461-7550; Uher, Rudolf/0000-0002-2998-0546; opoku, anita/0000-0001-7243-8157; Brennan, Richard/0000-0001-7647-485X; Brooks, Samantha/0000-0002-9146-6257	National Health and Medical Research Council (Australia) [301941]; National Institutes of Health [AI048593]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Project Grant 301941 from the National Health and Medical Research Council (Australia) (to R.A.S. and M.H.B.) and by grant AI048593 from the National Institutes of Health Grant (to R.G.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Aramaki H, 1995, PROTEIN ENG, V8, P1259, DOI 10.1093/protein/8.12.1259; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brooks BE, 2007, J AM CHEM SOC, V129, P8389, DOI 10.1021/ja072576v; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., 2006, PYMOL MOL GRAPHICS S; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grkovic S, 2003, BIOCHEMISTRY-US, V42, P15226, DOI 10.1021/bi035447+; Grkovic S, 2003, MICROBIOL-SGM, V149, P785, DOI 10.1099/mic.0.25951-0; Grkovic S, 2001, J BACTERIOL, V183, P7102, DOI 10.1128/JB.183.24.7102-7109.2001; Gu RY, 2008, ACTA CRYSTALLOGR F, V64, P584, DOI 10.1107/S1744309108016035; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAATZ GW, 1995, ANTIMICROB AGENTS CH, V39, P2650, DOI 10.1128/AAC.39.12.2650; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, NEWSL PROT CRYSTALL, V26; LYON BR, 1983, ANTIMICROB AGENTS CH, V23, P817, DOI 10.1128/AAC.23.6.817; Madoori PK, 2009, EMBO J, V28, P156, DOI 10.1038/emboj.2008.263; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128, DOI 10.1128/AAC.37.1.128; Paulsen IT, 1996, P NATL ACAD SCI USA, V93, P3630, DOI 10.1073/pnas.93.8.3630; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Peters KM, 2009, BIOCHEMISTRY-US, V48, P9794, DOI 10.1021/bi901102h; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Price CTD, 2002, INT J ANTIMICROB AG, V20, P206, DOI 10.1016/S0924-8579(02)00162-0; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Routh MD, 2009, BBA-PROTEINS PROTEOM, V1794, P844, DOI 10.1016/j.bbapap.2008.12.001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sigal N, 2009, J BIOL CHEM, V284, P6966, DOI 10.1074/jbc.M808877200; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; YOON KP, 1991, J BACTERIOL, V173, P7643, DOI 10.1128/jb.173.23.7643-7649.1991	55	67	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2011	6	1							e15974	10.1371/journal.pone.0015974	http://dx.doi.org/10.1371/journal.pone.0015974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ND	21799807	Green Published, Green Submitted, gold			2022-12-25	WOS:000286517600015
J	Wang, J; Li, CH; Wang, EK; Wang, XD				Wang, Jin; Li, Chunhe; Wang, Erkang; Wang, Xidi			An FPT Approach for Predicting Protein Localization from Yeast Genomic Data	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BAYESIAN NETWORKS; DATA INTEGRATION; GENE-EXPRESSION; CLASSIFICATION; IDENTIFICATION; GENERATION; SEQUENCES; PATTERNS; SYSTEM	Accurately predicting the localization of proteins is of paramount importance in the quest to determine their respective functions within the cellular compartment. Because of the continuous and rapid progress in the fields of genomics and proteomics, more data are available now than ever before. Coincidentally, data mining methods been developed and refined in order to handle this experimental windfall, thus allowing the scientific community to quantitatively address long-standing questions such as that of protein localization. Here, we develop a frequent pattern tree (FPT) approach to generate a minimum set of rules (mFPT) for predicting protein localization. We acquire a series of rules according to the features of yeast genomic data. The mFPT prediction accuracy is benchmarked against other commonly used methods such as Bayesian networks and logistic regression under various statistical measures. Our results show that mFPT gave better performance than other approaches in predicting protein localization. Meanwhile, setting 0.65 as the minimum hit-rate, we obtained 138 proteins that mFPT predicted differently than the simple naive bayesian method (SNB). In our analysis of these 138 proteins, we present novel predictions for the location for 17 proteins, which currently do not have any defined localization. These predictions can serve as putative annotations and should provide preliminary clues for experimentalists. We also compared our predictions against the eukaryotic subcellular localization database and related predictions by others on protein localization. Our method is quite generalized and can thus be applied to discover the underlying rules for protein-protein interactions, genomic interactions, and structure-function relationships, as well as those of other fields of research.	[Wang, Jin; Li, Chunhe; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Astron, Stony Brook, NY 11794 USA; [Li, Chunhe] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Xidi] Citibank NA, Sao Paulo, Brazil	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China.	jin.wang.1@stonybrook.edu; ekwang@ciac.jl.cn	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022; , 汪尔康/P-1748-2019; Li, Chunhe/C-8132-2011	Li, Chunhe/0000-0002-9127-3930	National Science Foundation; National Natural Science Foundation of China [90713022, 20735003]; 973 project [2009CB930100, 2010CB833600]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	JW acknowledges support from the National Science Foundation. CHL and EKW are supported by the National Natural Science Foundation of China (grants 90713022 and 20735003) and the 973 project (grants 2009CB930100 and 2010CB833600). The funder of XW from a commercial company had a role in preparation of the manuscript. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RC, 2001, J PARALLEL DISTR COM, V61, P350, DOI 10.1006/jpdc.2000.1693; Agrawal R., 1994, P 20 INT C VER LARG, P487; ALEXANDROV V, 2001, INT J QUANTUM CHEM, V4, P188; Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Boyd D, 1998, PROTEIN SCI, V7, P201, DOI 10.1002/pro.5560070121; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Frishman D, 1998, BIOINFORMATICS, V14, P551, DOI 10.1093/bioinformatics/14.7.551; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; GERSTEIN M, 2000, PAC S BIOCOMP, V5, P30; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; HAN J, 2000, SIGKDD EXPLORATIONS, V2, P14; Han JW, 2004, DATA MIN KNOWL DISC, V8, P53, DOI 10.1023/B:DAMI.0000005258.31418.83; HAN JW, 2006, DATA MINING CONCEPTS, P475; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Mewes HW, 1998, NUCLEIC ACIDS RES, V26, P33, DOI 10.1093/nar/26.1.33; NACHMAN I, 2004, THESIS HEBREW U; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKAI K, 1996, INTELL SYS MOL BIOL, V4, P109; NAKAI K, 1997, INTELL SYS MOL BIOL, V5, P147; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pierleoni A, 2007, NUCLEIC ACIDS RES, V35, pD208, DOI 10.1093/nar/gkl775; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Riffle M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-263; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stephenson T. A., 2000, INTRO BAYESIAN NETWO; Stryer L, 1996, BIOCHEMISTRY; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; VERHASSELT P, 1995, YEAST, V11, P961, DOI 10.1002/yea.320111007; Wang J, 2009, P NATL ACAD SCI USA, V106, P3752, DOI 10.1073/pnas.0806427106; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38	53	114	143	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14449	10.1371/journal.pone.0014449	http://dx.doi.org/10.1371/journal.pone.0014449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21915343	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600001
J	Zhao, YH; Calon, F; Julien, C; Winkler, JW; Petasis, NA; Lukiw, WJ; Bazan, NG				Zhao, Yuhai; Calon, Frederic; Julien, Carl; Winkler, Jeremy W.; Petasis, Nicos A.; Lukiw, Walter J.; Bazan, Nicolas G.			Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPAR gamma-Mediated Mechanisms in Alzheimer's Disease Models	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; AMYLOID-PRECURSOR-PROTEIN; HUMAN BRAIN-CELLS; POLYUNSATURATED FATTY-ACID; PIGMENT EPITHELIAL-CELLS; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; A-BETA; IN-VITRO; SIGNALING PATHWAY	Neuroprotectin D1 (NPD1) is a stereoselective mediator derived from the omega-3 essential fatty acid docosahexaenoic acid (DHA) with potent inflammatory resolving and neuroprotective bioactivity. NPD1 reduces A beta 42 peptide release from aging human brain cells and is severely depleted in Alzheimer's disease (AD) brain. Here we further characterize the mechanism of NPD1's neurogenic actions using 3xTg-AD mouse models and human neuronal-glial (HNG) cells in primary culture, either challenged with A beta 42 oligomeric peptide, or transfected with beta amyloid precursor protein (beta APP)(sw) (Swedish double mutation APP695(sw), K595N-M596L). We also show that NPD1 downregulates A beta 42-triggered expression of the pro-inflammatory enzyme cyclooxygenase-2 (COX-2) and of B-94 (a TNF-alpha-inducible pro-inflammatory element) and apoptosis in HNG cells. Moreover, NPD1 suppresses A beta 42 peptide shedding by down-regulating beta-secretase-1 (BACE1) while activating the alpha-secretase ADAM10 and up-regulating sAPP alpha, thus shifting the cleavage of beta APP holoenzyme from an amyloidogenic into the non-amyloidogenic pathway. Use of the thiazolidinedione peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist rosiglitazone, the irreversible PPAR gamma antagonist GW9662, and overexpressing PPAR gamma suggests that the NPD1-mediated down-regulation of BACE1 and A beta 42 peptide release is PPAR gamma-dependent. In conclusion, NPD1 bioactivity potently down regulates inflammatory signaling, amyloidogenic APP cleavage and apoptosis, underscoring the potential of this lipid mediator to rescue human brain cells in early stages of neurodegenerations.	[Zhao, Yuhai; Lukiw, Walter J.; Bazan, Nicolas G.] Louisiana State Univ, Neurosci Ctr Excellence, Sch Med, Hlth Sci Ctr, New Orleans, LA USA; [Calon, Frederic; Julien, Carl] Ctr Hosp Univ Laval Res Ctr CHUL, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ, Canada; [Winkler, Jeremy W.; Petasis, Nicos A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Laval University; University of Southern California	Zhao, YH (corresponding author), Univ Texas Hlth Sci Ctr, Houston, TX USA.	wlukiw@lsuhsc.edu; nbazan@lsuhsc.edu	Winkler, Jeremy/C-3198-2008; Petasis, Nicos/B-3162-2009; Bazan, Nicolas/AAN-4121-2020; Calon, Frederic/AAF-4390-2020; Julien, Carl/AAU-5309-2021	Petasis, Nicos/0000-0002-8864-4446; Bazan, Nicolas/0000-0002-9243-5444; Calon, Frederic/0000-0002-4203-0887	National Institutes of Health, National Center for Research Resource [P20 RR016816]; Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038834] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Edward G. Schlieder Educational Foundation; Eye, Ear, Nose & Throat Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, National Center for Research Resource grant (P20 RR016816), the Edward G. Schlieder Educational Foundation, and the Eye, Ear, Nose & Throat Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Avramovich Y, 2002, J BIOL CHEM, V277, P31466, DOI 10.1074/jbc.M201308200; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galasko D, 2010, BIOMARK MED, V4, P27, DOI 10.2217/BMM.09.89; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2010, NAT MED, V16, P1201, DOI 10.1038/nm.2223; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Henke BR, 2004, PROGR MED CHEM, V42, P1, DOI 10.1016/S0079-6468(04)42001-3; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jang JH, 2005, FREE RADICAL BIO MED, V38, P1604, DOI 10.1016/j.freeradbiomed.2005.02.023; JULIEN C, 2008, NEUROBIOL AGING, V159, P296; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marion-Letellier R, 2008, AM J CLIN NUTR, V87, P939, DOI 10.1093/ajcn/87.4.939; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCLACHLAN DRC, 1988, MOL BRAIN RES, V3, P255, DOI 10.1016/0169-328X(88)90048-4; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Roberts LJ, 2005, BRAIN PATHOL, V15, P143; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sahlin C, 2007, EUR J NEUROSCI, V26, P882, DOI 10.1111/j.1460-9568.2007.05719.x; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shie FS, 2009, CURR MED CHEM, V16, P643, DOI 10.2174/092986709787458399; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053; Yang HQ, 2007, EUR J NEUROSCI, V26, P381, DOI 10.1111/j.1460-9568.2007.05648.x; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zhao YH, 2007, NEUROREPORT, V18, P1187, DOI 10.1097/WNR.0b013e32821c56c4	68	195	206	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 5	2011	6	1							e15816	10.1371/journal.pone.0015816	http://dx.doi.org/10.1371/journal.pone.0015816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KT	21246057	Green Submitted, gold, Green Published			2022-12-25	WOS:000286511200016
J	Wang, JB; Zhao, HP; Zhao, YL; Jin, C; Liu, DJ; Kong, WJ; Fang, F; Zhang, L; Wang, HJ; Xiao, XH				Wang, Jia-bo; Zhao, Hai-ping; Zhao, Yan-ling; Jin, Cheng; Liu, Dao-jian; Kong, Wei-jun; Fang, Fang; Zhang, Lin; Wang, Hong-juan; Xiao, Xiao-he			Hepatotoxicity or Hepatoprotection? Pattern Recognition for the Paradoxical Effect of the Chinese Herb Rheum palmatum L. in Treating Rat Liver Injury	PLOS ONE			English	Article							GROWTH-FACTOR; MEDICINE; HEPATITIS; FIBROSIS; RHUBARB; EXPRESSION; EMODIN; ACID	The hepatotoxicity of some Chinese herbs has been a cause for concern in recent years. However, some herbs, such as rhubarb, have been documented as having both therapeutic and toxic effects on the liver, leading to the complex problem of distinguishing the benefits from the risks of using this herb. To comparatively analyze the dose-response relationship between rhubarb and hepatic health, we administrated total rhubarb extract(RE) to normal and carbon tetrachloride(CCl4)-treated rats for 12 weeks at 4 dosage levels(2.00, 5.40, 14.69 and 40.00 g.kg(-1), measured as the quantity of crude material), followed by biochemical and histopathological tests of the rats' livers. A composite pattern was extracted by factor analysis, using all the biochemical indices as variables, into a visual representation of two mathematically obtained factors, which could be interpreted as the fibrosis factor and the cellular injury factor, according to the values of the variable loadings. The curative effect of administering the two lowest dosages of RE to CCl4-treated rats was mainly expressed as a decrease in the extent of cellular injury. The hepatoprotective mechanism of RE might be related to its antioxidant effect, the antagonism of the free radical damage to hepatocytes caused by CCl4. By contrast, the RE-induced liver damage was mainly expressed as a significant increase in the amount of fibrosis in both normal rats at all dosage levels and CCl4-treated rats at the two highest dosage levels. Therefore, the hepatotoxic potential of RE could be attributable to the liver cell fibrosis induced by high doses of the herb. This study illustrates the bidirectional potential of rhubarb and demonstrates the feasibility of using factor analysis to study the dose-response relationships between herbal medicines and hepatotoxicity or the healing effects of these herbs by extracting the underlying interrelationships among a number of functional bio-indices in a holistic manner.	[Wang, Jia-bo; Zhao, Hai-ping; Zhao, Yan-ling; Jin, Cheng; Liu, Dao-jian; Kong, Wei-jun; Fang, Fang; Zhang, Lin; Wang, Hong-juan; Xiao, Xiao-he] 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China; [Zhao, Hai-ping] Jiangxi Univ Tradit Chinese Med, Minist Educ, Key Lab Modern Preparat Tradit Chinese Med, Nanchang, Peoples R China; [Kong, Wei-jun; Fang, Fang; Zhang, Lin] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Jiangxi University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Wang, JB (corresponding author), 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China.	pharmacy302@126.com	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022; , 汪尔康/P-1748-2019; Li, Chunhe/C-8132-2011	Li, Chunhe/0000-0002-9127-3930	National Key Technologies R&D Program of China [2009ZX09502-022]; National Natural Science Foundation of China [30625042, 30973947]	National Key Technologies R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies R&D Program of China (No. 2009ZX09502-022) and by the National Natural Science Foundation of China (No. 30625042 and 30973947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, JAP PHARM; Arosio B, 2000, PHARMACOL TOXICOL, V87, P229, DOI 10.1034/j.1600-0773.2000.d01-79.x; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P199, DOI 10.1080/15321810701454649; Battinelli L, 2004, ANN INTERN MED, V140, pE589, DOI 10.7326/0003-4819-140-7-200404060-00042-w3; Cao Z, 2001, J 4 MILITARY MED U, V22, P530; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chitturi S, 2000, J GASTROEN HEPATOL, V15, P1093, DOI 10.1046/j.1440-1746.2000.02349.x; Ding Y, 2008, EUR J PHARMACOL, V590, P377, DOI 10.1016/j.ejphar.2008.06.044; *EUR DIR QUAL MED, 2001, EUR PHARM; Huang Z H, 1997, Zhongguo Zhong Xi Yi Jie He Za Zhi, V17, P459; Iizuka A, 2004, J ETHNOPHARMACOL, V91, P89, DOI 10.1016/j.jep.2003.11.021; ITOH S, 1995, DIGEST DIS SCI, V40, P1845, DOI 10.1007/BF02212712; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; Jin HY, 2005, LIFE SCI, V76, P2805, DOI 10.1016/j.lfs.2004.09.041; Leung TF, 2005, THORAX, V60, P822, DOI 10.1136/thx.2004.039321; Luo Z. Y., 2007, CHIN ARCH TRADIT CHI, V25, P612; Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029; Medicines and Healthcare products Regulatory Agency, POL MULT LIV REACT; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Napoli J, 1997, HEPATOLOGY, V26, P624, DOI 10.1053/jhep.1997.v26.pm0009303492; *NAT TOX PROGR, 2001, SERIES NAT TOX PROGR, V493; Ni M., 1995, YELLOW EMPERORS CLAS; Qin Y, 2011, J ETHNOPHARMACOL, V133, P1096, DOI 10.1016/j.jep.2010.11.041; Sharma S., 1996, APPL MULTIVARIATE TE, P90; Tafeit E, 2000, COMPUT BIOMED RES, V33, P365, DOI 10.1006/cbmr.2000.1550; Thoefner MB, 2001, PREV VET MED, V48, P201, DOI 10.1016/S0167-5877(00)00193-8; TIAN Y, 2008, CHIN J HISTOCHEM CYT, V17, P303; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Vanderperren B, 2005, ANN PHARMACOTHER, V39, P1353, DOI 10.1345/aph.1E670; WAEL ED, 1997, NMR BIOMED, V10, P99; Wan Shao-hui, 2006, Zhongguo Yaolixue Tongbao, V22, P1405; WANG GS, 1985, CHIN J INTEGR TRAD W, V5, P322; WANG GS, 1985, CHIN J INTEGR TRAD W, V5, P329; Wang JB, 2009, J ETHNOPHARMACOL, V124, P18, DOI 10.1016/j.jep.2009.04.018; World Health Organization, 1999, WHO MONOGRAPHS SELEC, P231; Wu C X, 1984, Zhong Xi Yi Jie He Za Zhi, V4, P88; XU Y, 2005, MOD J INTEGR TRADIT, V14, P600; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x; [张陆勇 Zhang Liuyong], 2004, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V25, P206; Zhao YL, 2009, BASIC CLIN PHARMACOL, V104, P463, DOI 10.1111/j.1742-7843.2009.00389.x; 2005, PHARMACOPOEIA PEOPLE, P17	42	114	143	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24498	10.1371/journal.pone.0024498	http://dx.doi.org/10.1371/journal.pone.0024498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915343	Green Published, gold, Green Submitted			2022-12-25	WOS:000294689200050
J	Yang, Z; Cooper, PR; Damera, G; Mukhopadhyay, I; Cho, H; Kehrl, JH; Panettieri, RA; Druey, KM				Yang, Zhao; Cooper, Philip R.; Damera, Gautam; Mukhopadhyay, Indranil; Cho, Hyeseon; Kehrl, John H.; Panettieri, Reynold A., Jr.; Druey, Kirk M.			beta-Agonist-associated Reduction in RGS5 Expression Promotes Airway Smooth Muscle Hyper-responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY BETA(2)-ADRENOCEPTOR DESENSITIZATION; DOWN-REGULATION; BLOOD-PRESSURE; PROTEIN; RECEPTORS; G(I); REGULATORS; ASTHMA; ENDOTHELIN-1; HYPERTROPHY	Although short-acting and long-acting inhaled beta(2)-adrenergic receptor agonists (SABA and LABA, respectively) relieve asthma symptoms, use of either agent alone without concomitant anti-inflammatory drugs (corticosteroids) may increase the risk of disease exacerbation in some patients. We found previously that pretreatment of human precision-cut lung slices (PCLS) with SABA impaired subsequent beta(2)-agonist-induced bronchodilation, which occurred independently of changes in receptor quantities. Here we provide evidence that prolonged exposure of cultured human airway smooth muscle (HuASM) cells to beta(2)-agonists directly augments procontractile signaling pathways elicited by several compounds including thrombin, bradykinin, and histamine. Such treatment did not increase surface receptor amounts or expression of G proteins and downstream effectors (phospholipase C beta and myosin light chain). In contrast, beta-agonists decreased expression of regulator of G protein signaling 5 (RGS5), which is an inhibitor of G-protein-coupled receptor (GPCR) activity. RGS5 knockdown in HuASM increased agonist-evoked intracellular calcium flux and myosin light chain (MLC) phosphorylation, which are prerequisites for contraction. PCLS from Rgs5(-/-) mice contracted more to carbachol than those from WT mice, indicating that RGS5 negatively regulates bronchial smooth muscle contraction. Repetitive beta(2)-agonist use may not only lead to reduced bronchoprotection but also to sensitization of excitation-contraction signaling pathways as a result of reduced RGS5 expression.	[Yang, Zhao; Mukhopadhyay, Indranil; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Cho, Hyeseon; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Cooper, Philip R.; Damera, Gautam; Panettieri, Reynold A., Jr.] Univ Penn, Pulm Allergy & Crit Care Div, Airways Biol Initiat, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Druey, KM (corresponding author), 10 Ctr Dr,Rm 11N242, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	panettieri, reynold/AAG-9485-2019; Kehrl, John/AAE-6292-2019; Yang, Zhiyong/E-7834-2013	Seefeldt, Lance/0000-0002-6457-9504; Yang, Zhiyong/0000-0001-8186-9450; Kehrl, John/0000-0002-6526-159X	National Institutes of Health, NIAID [AI000939];  [HL5452235];  [HL543102];  [HL544157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000939, Z01AI000939] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIAID (Grant No. AI000939 L. A. D., to K. M. D.) and by Grants HL5452235, HL543102, and HL544157 (to R. A. P.).	Agrawal DK, 2004, J ALLERGY CLIN IMMUN, V113, P503, DOI 10.1016/j.jaci.2003.12.039; Bai Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-34; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Billington CK, 2003, RESP RES, V4; Black JL, 2009, CHEST, V136, P1095, DOI 10.1378/chest.09-0354; Borchers MT, 2003, AM J PHYSIOL-LUNG C, V285, pL114, DOI 10.1152/ajplung.00322.2002; Broadley KJ, 2006, EUR J PHARMACOL, V533, P15, DOI 10.1016/j.ejphar.2005.12.060; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Cooper PR, 2009, PULM PHARMACOL THER, V22, P398, DOI 10.1016/j.pupt.2008.09.008; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Damera G, 2009, BRIT J PHARMACOL, V158, P1429, DOI 10.1111/j.1476-5381.2009.00428.x; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Faisy C, 2006, AM J RESP CELL MOL, V34, P410, DOI 10.1165/rcmb.2005-0091OC; Finney PA, 2000, J CLIN INVEST, V106, P125, DOI 10.1172/JCI8374; Finney PA, 2001, BRIT J PHARMACOL, V132, P1261, DOI 10.1038/sj.bjp.0703946; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Kehrl JH, 2004, CRIT REV IMMUNOL, V24, P409; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Mak JCW, 2000, MOL PHARMACOL, V57, P857; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2006, PHYSIOL GENOMICS, V27, P171, DOI 10.1152/physiolgenomics.00044.2006; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Meurs H, 2008, EUR RESPIR J, V32, P487, DOI 10.1183/09031936.00023608; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Munakata Mitsuru, 2006, Allergol Int, V55, P235, DOI 10.2332/allergolint.55.235; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Penn RB, 2009, P NATL ACAD SCI USA, V106, P2095, DOI 10.1073/pnas.0812935106; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Seki N, 1998, J HUM GENET, V43, P202, DOI 10.1007/s100380050071; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Song KS, 2009, AM J PHYSIOL-LUNG C, V296, pL684, DOI 10.1152/ajplung.90396.2008; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005	54	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11444	11455		10.1074/jbc.M110.212480	http://dx.doi.org/10.1074/jbc.M110.212480			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21454640	Green Published, hybrid			2022-12-25	WOS:000288797100056
J	Xia, HB; Wang, W; Xia, H; Zhao, W; Lu, BR				Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong			Conspecific Crop-Weed Introgression Influences Evolution of Weedy Rice (Oryza sativa f. spontanea) across a Geographical Range	PLOS ONE			English	Article							GENETIC DIVERSITY; RED RICE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; POPULATION-GENETICS; CULTIVATED RICE; HYBRIDIZATION; FLOW; TRAITS; EXTENSIONS	Background: Introgression plays an important role in evolution of plant species via its influences on genetic diversity and differentiation. Outcrossing determines the level of introgression but little is known about the relationships of outcrossing rates, genetic diversity, and differentiation particularly in a weedy taxon that coexists with its conspecific crop. Methodology/Principal Findings: Eleven weedy rice (Oryza sativa f. spontanea) populations from China were analyzed using microsatellite (SSR) fingerprints to study outcrossing rate and its relationship with genetic variability and differentiation. To estimate outcrossing, six highly polymorphic SSR loci were used to analyze >5500 progeny from 216 weedy rice families, applying a mixed mating model; to estimate genetic diversity and differentiation, 22 SSR loci were analyzed based on 301 weedy individuals. Additionally, four weed-crop shared SSR loci were used to estimate the influence of introgression from rice cultivars on weedy rice differentiation. Outcrossing rates varied significantly (0.4 similar to 11.7%) among weedy rice populations showing relatively high overall Nei's genetic diversity (0.635). The observed heterozygosity was significantly correlated with outcrossing rates among populations (r(2) = 0.783; P<0.001) although no obvious correlation between outcrossing rates and genetic diversity parameters was observed. Allelic introgression from rice cultivars to their coexisting weedy rice was detected. Weedy rice populations demonstrated considerable genetic differentiation that was correlated with their spatial distribution (r(2) = 0.734; P<0.001), and possibly also influenced by the introgression from rice cultivars. Conclusions/Significance: Outcrossing rates can significantly affect heterozygosity of populations, which may shape the evolutionary potential of weedy rice. Introgression from the conspecific crop rice can influence the genetic differentiation and possibly evolution of its coexisting weedy rice populations.	[Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong] Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Fudan University	Lu, BR (corresponding author), Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009; Xia, Hui/L-7129-2019	Lu, Bao-Rong/0000-0002-0214-2390; Xia, Hui/0000-0003-2446-5171	Nature Science Foundation of China [30730066, 30871503]; Chinese Ministry of Science and Technology [2006CB100205, 2007CB109202]; National Program of Development of Transgenic New Species of China [2008ZX08011-006]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Program of Development of Transgenic New Species of China	This work was supported by the Nature Science Foundation of China (grant numbers 30730066, 30871503), Chinese Ministry of Science and Technology (grant numbers 2006CB100205, 2007CB109202), and the National Program of Development of Transgenic New Species of China (2008ZX08011-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2005, CROP SCI, V45, P98, DOI 10.2135/cropsci2005.0098; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Burgos NR, 2008, WEED TECHNOL, V22, P200, DOI 10.1614/WT-07-075.1; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hansen LB, 2001, GENET RESOUR CROP EV, V48, P621, DOI 10.1023/A:1013825816443; HARLAN JR, 1965, EUPHYTICA, V14, P173, DOI 10.1007/BF00038984; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hiscock SJ, 2003, PHILOS T R SOC B, V358, P1037, DOI 10.1098/rstb.2003.1297; HOLTSFORD TP, 1989, THEOR APPL GENET, V78, P480, DOI 10.1007/BF00290831; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Ishikawa R, 2005, GENET RESOUR CROP EV, V52, P395, DOI 10.1007/s10722-005-2257-x; Jarne P, 2008, HEREDITY, V100, P431, DOI 10.1038/hdy.2008.2; LANGEVIN SA, 1990, EVOLUTION, V44, P1000, DOI 10.1111/j.1558-5646.1990.tb03820.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; NEI M, 1974, GENETICS, V76, P379; Oka H. I., 1988, Origin of cultivated rice.; OKA H. I. W. T. CHANG, 1959, PHYTON REV INTERNAC BOT EXPTL ARGENTINA, V13, P105; Quilichini A, 2001, HEREDITY, V87, P190, DOI 10.1046/j.1365-2540.2001.00897.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RITLAND K, 1989, EVOLUTION, V43, P848, DOI 10.1111/j.1558-5646.1989.tb05182.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rohlf F. J., 1998, NTSYSPC NUMERICAL TA; Rong J, 2010, PLANT BIOTECHNOL J, V8, P452, DOI 10.1111/j.1467-7652.2009.00488.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Olguin ERS, 2009, TRANSGENIC RES, V18, P633, DOI 10.1007/s11248-009-9255-2; SHAW DV, 1981, P NATL ACAD SCI-BIOL, V78, P1298, DOI 10.1073/pnas.78.2.1298; Shivrain VK, 2008, WEED SCI, V56, P807, DOI 10.1614/WS-08-026.1; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Suh H., 2008, WEEDY RICE; Suh H. S., 1996, International Rice Research Notes, V21, P7; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Vaughan DA, 2002, W CROP SCI, P27; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Wright S, 1921, GENETICS, V6, P111; Wright S, 1978, VARIABILITY NATURAL; Yu GQ, 2005, BIOCHEM GENET, V43, P261, DOI 10.1007/s10528-005-5218-3; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhao R, 2009, AM J BOT, V96, P1138, DOI 10.3732/ajb.0800173	62	95	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16189	10.1371/journal.pone.0016189	http://dx.doi.org/10.1371/journal.pone.0016189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	22174836	Green Published, gold, Green Submitted			2022-12-25	WOS:000286515000030
J	Wang, QY; Chen, GR; Perc, M				Wang, Qingyun; Chen, Guanrong; Perc, Matjaz			Synchronous Bursts on Scale-Free Neuronal Networks with Attractive and Repulsive Coupling	PLOS ONE			English	Article							SYNCHRONIZATION; OSCILLATIONS; REGULARIZATION; CHAOS	This paper investigates the dependence of synchronization transitions of bursting oscillations on the information transmission delay over scale-free neuronal networks with attractive and repulsive coupling. It is shown that for both types of coupling, the delay always plays a subtle role in either promoting or impairing synchronization. In particular, depending on the inherent oscillation period of individual neurons, regions of irregular and regular propagating excitatory fronts appear intermittently as the delay increases. These delay-induced synchronization transitions are manifested as well-expressed minima in the measure for spatiotemporal synchrony. For attractive coupling, the minima appear at every integer multiple of the average oscillation period, while for the repulsive coupling, they appear at every odd multiple of the half of the average oscillation period. The obtained results are robust to the variations of the dynamics of individual neurons, the system size, and the neuronal firing type. Hence, they can be used to characterize attractively or repulsively coupled scale-free neuronal networks with delays.	[Wang, Qingyun] Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China; [Chen, Guanrong] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Dept Phys, SLO-2000 Maribor, Slovenia	Beihang University; City University of Hong Kong; University of Maribor	Wang, QY (corresponding author), Beihang Univ, Dept Dynam & Control, Beijing, Peoples R China.	drwangqy@gmail.com; matjaz.perc@uni-mb.si	wang, qinyu/GYA-0366-2022; Wang, Qingyun/G-2309-2010; Chen, Guanrong/F-6000-2011; Perc, Matjaz/A-5148-2009	Wang, Qingyun/0000-0003-2931-4663; Chen, Guanrong/0000-0003-1381-7418; Perc, Matjaz/0000-0002-3087-541X; Zhang, Min/0000-0001-5812-9518	National Science Foundation of China [10972001, 10702023, 10832006]; Slovenian Research Agency [Z1-2032]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	QW and GC acknowledge support from the National Science Foundation of China (Funds number 10972001, 10702023 and 10832006). MP acknowledges support from the Slovenian Research Agency (Grant Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H. D. I., 1996, Physics-Uspekhi, V39, P337, DOI 10.1070/PU1996v039n04ABEH000141; Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Arenas A, 2006, PHYSICA D, V224, P27, DOI 10.1016/j.physd.2006.09.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista CAS, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016218; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; DAVID G, 2001, PHYS REV LETT, V86, P4179; Drover J, 2004, SIAM J APPL MATH, V65, P69, DOI 10.1137/S0036139903431233; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Gao Z., 2001, PHYS REV E, V65, DOI DOI 10.1103/PHYSREVE.65.016209; Gomez-Gardenes J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012313; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016103; Huang L, 2008, CHAOS, V18, DOI 10.1063/1.2826289; Hunt D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.068701; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kandel E.R., 1991, PRINC NEUROSCI; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Kunichika T., 2003, INT J BIFURCAT CHAOS, V13, P653; Lai YC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108102; Leyva I, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056112; Li XM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083045; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Neiman A, 1999, PHYS REV LETT, V83, P4896, DOI 10.1103/PhysRevLett.83.4896; Nowotny T, 2008, CHAOS, V18, DOI 10.1063/1.2949925; Oh M, 2009, J COMPUT NEUROSCI, V26, P303, DOI 10.1007/s10827-008-0112-8; Osan R, 2002, PHYSICA D, V163, P217, DOI 10.1016/S0167-2789(02)00347-0; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Rossoni E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061904; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Sainz-Trapaga M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031904; Shein M, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036008; Shilnikov AL, 2003, INT J BIFURCAT CHAOS, V13, P3325, DOI 10.1142/S0218127403008521; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Suykens JAK, 2008, CHAOS, V18, DOI 10.1063/1.2985139; Martins TV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041103; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Wang QY, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/383; Wang QY, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/10004; Wang QY, 2006, PHYS LETT A, V356, P17, DOI 10.1016/j.physleta.2006.03.017; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang QY, 2005, CHINESE PHYS LETT, V22, P543, DOI 10.1088/0256-307X/22/3/007; Yanagita T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056218	56	311	316	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2011	6	1							e15851	10.1371/journal.pone.0015851	http://dx.doi.org/10.1371/journal.pone.0015851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710KZ	21701596	Green Published, gold, Green Submitted			2022-12-25	WOS:000286511900014
J	Tanaka, Y; Taneichi, M; Kasai, M; Kakiuchi, T; Uchida, T				Tanaka, Yuriko; Taneichi, Maiko; Kasai, Michiyuki; Kakiuchi, Terutaka; Uchida, Tetsuya			Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8(+) T Cells	PLOS ONE			English	Article							IN-VIVO; VACCINE; RECOGNITION; DIPHTHERIA; TRANSPORT; IMMUNITY; TETANUS; BOOSTER; CYTOSOL; WORLD	We have previously demonstrated that antigens chemically coupled to the surface of liposomes consisting of unsaturated fatty acids were cross-presented by antigen-presenting cells (APCs) to CD8(+) T cells, and that this process resulted in the induction of antigen-specific cytotoxic T lymphocytes. In the present study, the mechanism by which the liposome-coupled antigens were cross-presented to CD8(+) T cells by APCs was investigated. Confocal laser scanning microscopic analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-based liposomes received processing at both MHC class I and class II compartments, while most of the antigens coupled to the surface of saturated-fatty-acid-based liposomes received processing at the class II compartment. In addition, flow cytometric analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-liposomes were taken up by APCs even in a 4 degrees C environment; this was not true of saturated-fatty-acid-liposomes. When two kinds of inhibitors, dimethylamiloride (DMA) and cytochalasin B, which inhibit pinocytosis and phagocytosis by APCs, respectively, were added to the culture of APCs prior to the antigen pulse, DMA but not cytochalasin B significantly reduced uptake of liposome-coupled antigens. Further analysis of intracellular trafficking of liposomal antigens using confocal laser scanning microscopy revealed that a portion of liposome-coupled antigens taken up by APCs were delivered to the lysosome compartment. In agreement with the reduction of antigen uptake by APCs, antigen presentation by APCs was significantly inhibited by DMA, and resulted in the reduction of IFN-gamma production by antigen-specific CD8(+) T cells. These results suggest that antigens coupled to the surface of liposomes consisting of unsaturated fatty acids might be pinocytosed by APCs, loaded onto the class I MHC processing pathway, and presented to CD8(+) T cells. Thus, these liposome-coupled antigens are expected to be applicable for the development of vaccines that induce cellular immunity.	[Tanaka, Yuriko; Kakiuchi, Terutaka] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan; [Taneichi, Maiko; Kasai, Michiyuki; Uchida, Tetsuya] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan	Toho University; National Institute of Infectious Diseases (NIID)	Tanaka, Y (corresponding author), Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan.	taneichi@nih.go.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science [21790963]; Toho University Graduate School of Medicine [08-02]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toho University Graduate School of Medicine(Toho University)	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (to TU), grants-in-aid for young scientists from the Japan Society for the Promotion of Science (21790963 to YT) and the research promotion grant from Toho University Graduate School of Medicine (No. 08-02 to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1996, VACCINE, V14, P1265, DOI 10.1016/S0264-410X(96)00092-8; BANKOWSKI MK, 1995, SCIENCE, V267, P243; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Chen M, 1999, GASTROENTEROLOGY, V116, P135, DOI 10.1016/S0016-5085(99)70237-4; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gurnani K, 2004, J IMMUNOL, V173, P566, DOI 10.4049/jimmunol.173.1.566; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Kasturi SP, 2008, NAT IMMUNOL, V9, P461, DOI 10.1038/ni0508-461; MARK A, 1995, VACCINE, V13, P669, DOI 10.1016/0264-410X(94)00017-H; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Naito S, 1996, INT ARCH ALLERGY IMM, V109, P223, DOI 10.1159/000237241; Nakano Y, 1999, INT ARCH ALLERGY IMM, V120, P199, DOI 10.1159/000024268; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Nothdurft HD, 1996, J INFECTION, V32, P119, DOI 10.1016/S0163-4453(96)91281-5; Ohno S, 2009, VACCINE, V27, P3912, DOI 10.1016/j.vaccine.2009.04.001; Rock KL, 2006, IMMUNITY, V25, P523, DOI 10.1016/j.immuni.2006.09.003; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Taneichi M, 2006, J IMMUNOL, V177, P2324, DOI 10.4049/jimmunol.177.4.2324; UCHIDA T, 1985, J IMMUNOL, V134, P772; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07	31	51	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15225	10.1371/journal.pone.0015225	http://dx.doi.org/10.1371/journal.pone.0015225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179411	Green Submitted, Green Published, gold			2022-12-25	WOS:000285572900015
J	Lin, HY; Kao, CH; Lin, KMC; Kaartinen, V; Yang, LT				Lin, Hsien-Yi; Kao, Cheng-Heng; Lin, Kurt Ming-Chao; Kaartinen, Vesa; Yang, Liang-Tung			Notch Signaling Regulates Late-Stage Epidermal Differentiation and Maintains Postnatal Hair Cycle Homeostasis	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; EPITHELIAL STEM-CELLS; RBP-J; MULTIPLE ROLES; FOLLICLE BULGE; MOUSE MODEL; O-FUCOSE; SKIN; EXPRESSION; ACTIVATION	Background: Notch signaling involves ligand-receptor interactions through direct cell-cell contact. Multiple Notch receptors and ligands are expressed in the epidermis and hair follicles during embryonic development and the adult stage. Although Notch signaling plays an important role in regulating differentiation of the epidermis and hair follicles, it remains unclear how Notch signaling participates in late-stage epidermal differentiation and postnatal hair cycle homeostasis. Methodology and Principal Findings: We applied Cre/loxP system to generate conditional gene targeted mice that allow inactivation of critical components of Notch signaling pathway in the skin. Rbpj, the core component of all four Notch receptors, and Pofut1, an essential factor for ligand-receptor interactions, were inactivated in hair follicle lineages and suprabasal layer of the epidermis using the Tgfb3-Cre mouse line. Rbpj conditional inactivation resulted in granular parakeratosis and reactive epidermal hyperplasia. Pofut1 conditional inactivation led to ultrastructural abnormalities in the granular layer and altered filaggrin processing in the epidermis, suggesting a perturbation of the granular layer differentiation. Disruption of Pofut1 in hair follicle lineages resulted in aberrant telogen morphology, a decrease of bulge stem cell markers, and a concomitant increase of K14-positive keratinocytes in the isthmus of mutant hair follicles. Pofut1-deficent hair follicles displayed a delay in anagen re-entry and dysregulation of proliferation and apoptosis during the hair cycle transition. Moreover, increased DNA double stand breaks were detected in Pofut1-deficent hair follicles, and real time PCR analyses on bulge keratinocytes isolated by FACS revealed an induction of DNA damage response and a paucity of DNA repair machinery in mutant bulge keratinocytes. Significance: our data reveal a role for Notch signaling in regulating late-stage epidermal differentiation. Notch signaling is required for postnatal hair cycle homeostasis by maintaining proper proliferation and differentiation of hair follicle stem cells.	[Lin, Hsien-Yi; Yang, Liang-Tung] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli Cty, Taiwan; [Kao, Cheng-Heng] Chang Gung Univ, Ctr Gen Educ, Tao Yuan, Taiwan; [Lin, Kurt Ming-Chao] Natl Hlth Res Inst, Div Med Engn, Miaoli Cty, Taiwan; [Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	National Health Research Institutes - Taiwan; Chang Gung University; National Health Research Institutes - Taiwan; University of Michigan System; University of Michigan	Lin, HY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli Cty, Taiwan.	ltyang@nhri.org.tw	Kaartinen, Vesa/AAU-5396-2021; Yang, Liang-Tung/B-2661-2010; Lin, Kurt Ming-Chao/E-3975-2010	doddapaneni, harshavardhan/0000-0002-2433-633X; Kaartinen, Vesa/0000-0002-9432-510X; Lin, Kurt/0000-0003-1371-5569	CIRM [T2-00005]; NHRI [97A1-SCPP07-014, 98A1-CSPP13-014, 99A1-CSPP10-014]; NSC [97-2321-B-400-003-MY3]; NIH [DE013085]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013085] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NHRI(National Health Research Institutes - Taiwan); NSC(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the CIRM (T2-00005), NHRI (97A1-SCPP07-014, 98A1-CSPP13-014, 99A1-CSPP10-014), NSC (97-2321-B-400-003-MY3), and NIH (DE013085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Demehri S, 2009, DEVELOPMENT, V136, P891, DOI 10.1242/dev.030700; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guilmeau S, 2008, GASTROENTEROLOGY, V135, P849, DOI 10.1053/j.gastro.2008.05.050; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; HOGAN B, 1994, MANIPULATING MOUSE E, pR17; HU B, GENES DEV, V24, P1519; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KAO CH, 1995, ATHEROSCLEROSIS, V116, P27, DOI 10.1016/0021-9150(95)05519-3; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; OKA C, 1995, DEVELOPMENT, V121, P3291; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SCHMID P, 1993, J PATHOL, V171, P191, DOI 10.1002/path.1711710307; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Turksen K, 2002, DEVELOPMENT, V129, P1775; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weibel E. R., 1973, STEREOLOGICAL TECHNI; Yang LT, 2008, GENESIS, V46, P112, DOI 10.1002/dvg.20372; Zheng JL, 2000, DEVELOPMENT, V127, P4551	63	97	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15842	10.1371/journal.pone.0015842	http://dx.doi.org/10.1371/journal.pone.0015842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21552483	Green Submitted, gold, Green Published			2022-12-25	WOS:000286519500028
J	Wu, CL; Kandarian, SC; Jackman, RW				Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.			Identification of Genes that Elicit Disuse Muscle Atrophy via the Transcription Factors p50 and Bcl-3	PLOS ONE			English	Article							NF-KAPPA-B; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ACTIVATION; EXPRESSION; PROTEIN; TARGET; INFLAMMATION; HOMODIMERS; ATROGIN-1	Skeletal muscle atrophy is a debilitating condition associated with weakness, fatigue, and reduced functional capacity. Nuclear factor-kappaB (NF-kappa B) transcription factors play a critical role in atrophy. Knockout of genes encoding p50 or the NF-kappa B co-transactivator, Bcl-3, abolish disuse atrophy and thus they are NF-kappa B factors required for disuse atrophy. We do not know however, the genes targeted by NF-kappa B that produce the atrophied phenotype. Here we identify the genes required to produce disuse atrophy using gene expression profiling in wild type compared to Nfkb1 (gene encodes p50) and Bcl-3 deficient mice. There were 185 and 240 genes upregulated in wild type mice due to unloading, that were not upregulated in Nfkb1(-/-) and Bcl-3(-/-) mice, respectively, and so these genes were considered direct or indirect targets of p50 and Bcl-3. All of the p50 gene targets were contained in the Bcl-3 gene target list. Most genes were involved with protein degradation, signaling, translation, transcription, and transport. To identify direct targets of p50 and Bcl-3 we performed chromatin immunoprecipitation of selected genes previously shown to have roles in atrophy. Trim63 (MuRF1), Fbxo32 (MAFbx), Ubc, Ctsl, Runx1, Tnfrsf12a (Tweak receptor), and Cxcl10 (IP-10) showed increased Bcl-3 binding to kappa B sites in unloaded muscle and thus were direct targets of Bcl-3. p50 binding to the same sites on these genes either did not change or increased, supporting the idea of p50: Bcl-3 binding complexes. p65 binding to kappa B sites showed decreased or no binding to these genes with unloading. Fbxo9, Psma6, Psmc4, Psmg4, Foxo3, Ankrd1 (CARP), and Eif4ebp1 did not show changes in p65, p50, or Bcl-3 binding to kB sites, and so were considered indirect targets of p50 and Bcl-3. This work represents the first study to use a global approach to identify genes required to produce the atrophied phenotype with disuse.	[Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Wu, CL (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu		TSAO, PO-NIEN/0000-0002-6114-1769; WU, CHEN-CHI/0000-0002-5047-2204; HSIEH, WU-SHIUN/0000-0002-0609-3311; Lee, Chien-Nan/0000-0002-1725-0407; LIN, SHIN-YU/0000-0002-0753-2793; Wu, Chia-Ling/0000-0002-0595-9064	National Institutes of Health [R01 AR041705, R01 AR041705-15S1]; Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health grants R01 AR041705 and R01 AR041705-15S1 to SK and a Boston University Dudley Allen Sargent grant to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Bar-Shai M, 2008, FREE RADICAL BIO MED, V44, P202, DOI 10.1016/j.freeradbiomed.2007.03.019; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Frenette J, 2000, AM J PATHOL, V156, P2103, DOI 10.1016/S0002-9440(10)65081-X; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; RHOADS MG, 2010, EUR J CANC; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Salminen A, 2010, AGEING RES REV, V9, P298, DOI 10.1016/j.arr.2009.11.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; SCHULTE LM, 1993, AM J PHYSIOL, V264, pC1308, DOI 10.1152/ajpcell.1993.264.5.C1308; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yamazaki Y, 2010, BIOCHEM J, V427, P171, DOI 10.1042/BJ20091346	44	57	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16171	10.1371/journal.pone.0016171	http://dx.doi.org/10.1371/journal.pone.0016171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	21811586	gold, Green Published, Green Submitted			2022-12-25	WOS:000286515000025
